PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, SW; Rho, JH; Lee, SY; Yoo, SH; Kim, HY; Chung, WT; Yoo, YH				Lee, Sung Won; Rho, Jee Hyun; Lee, Sang Yeob; Yoo, Seung Hee; Kim, Hye Young; Chung, Won Tae; Yoo, Young Hyun			Alpha B-Crystallin Protects Rat Articular Chondrocytes against Casein Kinase II Inhibition-Induced Apoptosis	PLOS ONE			English	Article							OXIDE-INDUCED APOPTOSIS; PHOSPHORYLATION; EXPRESSION; CK2; INDUCTION; CARTILAGE; CELLS; P53; TRANSLOCATION; PATHOGENESIS	Although alpha alpha B-crystallin is expressed in articular chondrocytes, little is known about its role in these cells. Protein kinase casein kinase 2 (CK2) inhibition induces articular chondrocyte death. The present study examines whether alpha B-crystallin exerts anti-apoptotic activity in articular chondrocytes. Primary rat articular chondrocytes were isolated from knee joint slices. Cells were treated with CK2 inhibitors with or without alpha B-crystallin si RNA. To examine whether the silencing of aB-crystallin sensitizes rat articular chondrocytes to CK2 inhibition induced apoptosis, we assessed apoptosis by performing viability assays, mitochondrial membrane potential measurements, flow cytometry, nuclear morphology observations, and western blot analysis. To investigate the mechanism by which aB-crystallin modulates the extent of CK2 inhibition-mediated chondrocyte death, we utilized confocal microscopy to observe the subcellular location of aB-crystallin and its phosphorylated forms and performed a co-immunoprecipitation assay to observe the interaction between aB-crystallin and CK2. Immunochemistry was employed to examine aB-crystallin expression in cartilage obtained from rats with experimentally induced osteoarthritis (OA). Our results demonstrated that silencing of aB-crystallin sensitized rat articular chondrocytes to CK2 inhibitor -induced apoptosis. Furthermore, CK2 inhibition modulated the expression and subcellular localization of aB-crystallin and its phosphorylated forms and dissociated aB-crystallin from CK2. The population of rat articular chondrocytes expressing aB-crystallin and its phosphorylated forms was reduced in an experimentally induced rat model of OA. In summary, aB-crystallin protects rat articular chondrocytes against CK2 inhibition -induced apoptosis. aB-crystallin may represent a suitable target for pharmacological interventions to prevent OA.	[Lee, Sung Won; Lee, Sang Yeob; Chung, Won Tae] Dong A Univ, Coll Med, Dept Rheumatol, Busan, South Korea; [Rho, Jee Hyun; Yoo, Seung Hee; Kim, Hye Young; Yoo, Young Hyun] Dong A Univ, Coll Med, Dept Anat & Cell Biol, Busan, South Korea; [Rho, Jee Hyun; Yoo, Seung Hee; Kim, Hye Young; Yoo, Young Hyun] Dong A Univ, Coll Med, Mitochondria Hub Regulat Ctr, Busan, South Korea	Dong A University; Dong A University; Dong A University	Yoo, YH (corresponding author), Dong A Univ, Coll Med, Dept Anat & Cell Biol, Busan, South Korea.; Yoo, YH (corresponding author), Dong A Univ, Coll Med, Mitochondria Hub Regulat Ctr, Busan, South Korea.	yhyoo@dau.ac.kr		Lee, Sung Won/0000-0003-1213-1254	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2015R1A2A1A10051603, NRF-2013R1A1A4A01006046, 2016R1A5A2007009]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2015R1A2A1A10051603, NRF-2013R1A1A4A01006046, and 2016R1A5A2007009).	Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/00002281-200209000-00018; Aizawa T, 2001, J ORTHOP RES, V19, P785, DOI 10.1016/S0736-0266(00)00078-4; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Amin Ashok R., 1998, Current Opinion in Rheumatology, V10, P263, DOI 10.1097/00002281-199805000-00018; BENNARDINI F, 1995, BIOCHEM BIOPH RES CO, V208, P742, DOI 10.1006/bbrc.1995.1400; BLANCO FJ, 1995, AM J PATHOL, V146, P75; BLOEMENDAL H, 1977, SCIENCE, V197, P127, DOI 10.1126/science.877544; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; Coustry F, 2012, AM J PATHOL, V180, P738, DOI 10.1016/j.ajpath.2011.10.033; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; den Englesman J, 2005, J BIOL CHEM, V280, P37139, DOI 10.1074/jbc.M504106200; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hashimoto S, 1997, ARTHRITIS RHEUM-US, V40, P1749, DOI 10.1002/art.1780401004; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1266, DOI 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Ishihara K, 2003, BIOCHEM J, V371, P917, DOI 10.1042/BJ20021331; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Jeong WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045754; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim KM, 2012, INT J MOL MED, V29, P1039, DOI 10.3892/ijmm.2012.949; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Lambrecht S, 2009, ARTHRITIS RHEUM-US, V60, P179, DOI 10.1002/art.24152; Lee JS, 2012, NEURO-ONCOLOGY, V14, P1332, DOI 10.1093/neuonc/nos247; Lee SW, 2015, OSTEOARTHR CARTILAGE, V23, P2269, DOI 10.1016/j.joca.2015.06.005; Lee SW, 2008, ARTHRITIS RHEUM-US, V58, P790, DOI 10.1002/art.23220; Lee SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019163; Lee SW, 2004, ARTHRITIS RHEUM-US, V50, P534, DOI 10.1002/art.20052; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li RY, 2011, J NEUROCHEM, V118, P354, DOI 10.1111/j.1471-4159.2011.07317.x; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; Miwa M, 2000, OSTEOARTHR CARTILAGE, V8, P17, DOI 10.1053/joca.1999.0266; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; van den IJssel P, 1999, CURR BIOL, V9, pR103, DOI 10.1016/S0960-9822(99)80061-X; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Yasuhara R, 2005, BIOCHEM J, V389, P315, DOI 10.1042/BJ20041996	48	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166450	10.1371/journal.pone.0166450	http://dx.doi.org/10.1371/journal.pone.0166450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851782	gold, Green Submitted, Green Published			2022-12-27	WOS:000387909300050
J	Li, LL; Illeghems, K; Van Kerrebroeck, S; Borremans, W; Cleenwerck, I; Smagghe, G; Vuyst, LD; Vandamme, P				Li, Leilei; Illeghems, Koen; Van Kerrebroeck, Simon; Borremans, Wim; Cleenwerck, Ilse; Smagghe, Guy; Luc De Vuyst; Vandamme, Peter			Whole-Genome Sequence Analysis of Bombella intestini LMG 28161(T), a Novel Acetic Acid Bacterium Isolated from the Crop of a Red-Tailed Bumble Bee, Bombus lapidarius	PLOS ONE			English	Article							HONEY-BEE; SP-NOV.; ACETOBACTER-PASTEURIANUS; GEN. NOV.; IDENTIFICATION; OXIDASE; TRAITS	The whole-genome sequence of Bombella intestini LMG 28161(T), an endosymbiotic acetic acid bacterium (AAB) occurring in bumble bees, was determined to investigate the molecular mechanisms underlying its metabolic capabilities. The draft genome sequence of B. intestini LMG 28161(T) was 2.02 Mb. Metabolic carbohydrate pathways were in agreement with the metabolite analyses of fermentation experiments and revealed its oxidative capacity towards sucrose, D-glucose, D-fructose and D-mannitol, but not ethanol and glycerol. The results of the fermentation experiments also demonstrated that the lack of effective aeration in small-scale carbohydrate consumption experiments may be responsible for the lack of reproducibility of such results in taxonomic studies of AAB. Finally, compared to the genome sequences of its nearest phylogenetic neighbor and of three other insect associated AAB strains, the B. intestini LMG 28161(T) genome lost 69 orthologs and included 89 unique genes. Although many of the latter were hypothetical they also included several type IV secretion system proteins, amino acid transporter/permeases and membrane proteins which might play a role in the interaction with the bumble bee host.	[Li, Leilei; Vandamme, Peter] Univ Ghent, Fac Sci, Microbiol Lab, KL Ledeganckstr 35, B-9000 Ghent, Belgium; [Illeghems, Koen; Van Kerrebroeck, Simon; Borremans, Wim; Luc De Vuyst] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Res Grp Ind Microbiol & Food Biotechnol, Pl Laan 2, B-1050 Brussels, Belgium; [Cleenwerck, Ilse] Univ Ghent, Fac Sci, BCCM LMG Bacteria Collect, KL Ledeganckstr 35, B-9000 Ghent, Belgium; [Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Coupure Links 653, B-9000 Ghent, Belgium	Ghent University; Vrije Universiteit Brussel; Ghent University; Ghent University	Vandamme, P (corresponding author), Univ Ghent, Fac Sci, Microbiol Lab, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	Peter.Vandamme@ugent.be	Cleenwerck, Ilse/X-1168-2019; Smagghe, Guy/AAE-8914-2019; Li, Leilei/X-5125-2019; Vandamme, Peter/ABG-3431-2021; Van Kerrebroeck, Simon/ABF-3883-2020; Vandamme, Peter AR/B-7967-2009	Smagghe, Guy/0000-0001-8334-3313; Li, Leilei/0000-0003-0185-510X; Vandamme, Peter/0000-0002-5581-7937; Vandamme, Peter AR/0000-0002-5581-7937; Borremans, Wim/0000-0002-7816-8490; De Vuyst, Luc/0000-0002-7534-7186	Federal Public Planning Service Science Policy, Belgium [C4/00/BCCM]; Research Foundation-Flanders (FWO-Vlaanderen) [G.0.910.10.N.10]; Research Council of Ghent University; Vrije Universiteit Brussel [SRP7, IRP2, IOF342]; Hercules Foundation [UABR09004]; Chinese Scholarship Council [2011533075]; Ghent University [01SC1111]	Federal Public Planning Service Science Policy, Belgium; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Research Council of Ghent University(Ghent University); Vrije Universiteit Brussel; Hercules Foundation; Chinese Scholarship Council(China Scholarship Council); Ghent University(Ghent University)	The BCCM/LMG collection is supported by the Federal Public Planning Service Science Policy, Belgium (contract no. C4/00/BCCM). The authors acknowledge the financial support of the Research Foundation-Flanders (FWO-Vlaanderen; http://www.fwo.be; grant no. G.0.910.10.N.10), the Research Council of Ghent University and the Vrije Universiteit Brussel (http://www.vub.ac.beien/ research; SRP7, IRP2 and IOF342 projects) and the Hercules Foundation (grant number UABR09004). L.L. acknowledges the Chinese Scholarship Council (http://www.csc.edu.cn; file no. 2011533075) and Ghent University Co-Funding (http://www.ugent.be/nl/ondeizoek/financiering/: grant no. 01SC1111).	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Backert S, 2015, FUTURE MICROBIOL, V10, P955, DOI [10.2217/FMB.15.32, 10.2217/fmb.15.32]; Bertalan M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-450; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P3018, DOI 10.1021/bi015939r; Cariveau DP, 2014, ISME J, P1; Chouaia B, 2014, GENOME BIOL EVOL, V6, P912, DOI 10.1093/gbe/evu062; Cleenwerck I, 2002, INT J SYST EVOL MICR, V52, P1551, DOI 10.1099/00207713-52-5-1551; Cleenwerck I, 2008, INT J SYST EVOL MICR, V58, P2180, DOI 10.1099/ijs.0.65778-0; Cleenwerck I, 2008, INT J FOOD MICROBIOL, V125, P2, DOI 10.1016/j.ijfoodmicro.2007.04.017; Corby-Harris V, 2014, APPL ENVIRON MICROB, V80, P7460, DOI 10.1128/AEM.02043-14; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Fuentes-Ramirez LE, 2001, INT J SYST EVOL MICR, V51, P1305, DOI 10.1099/00207713-51-4-1305; Gossele A F, 1983, INT J SYST BACTERIOL, V33, P65; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gullo M, 2008, INT J FOOD MICROBIOL, V125, P46, DOI 10.1016/j.ijfoodmicro.2007.11.076; Holscher T, 2006, J BACTERIOL, V188, P7668, DOI 10.1128/JB.01009-06; Illeghems K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-526; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kwong WK, 2014, P NATL ACAD SCI USA, V111, P11509, DOI 10.1073/pnas.1405838111; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li LL, 2015, INT J SYST EVOL MICR, V65, P267, DOI 10.1099/ijs.0.068049-0; Lohaus G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087689; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Matsutani M, 2014, BBA-BIOENERGETICS, V1837, P1810, DOI 10.1016/j.bbabio.2014.05.355; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Moens F, 2014, APPL ENVIRON MICROB, V80, P1848, DOI 10.1128/AEM.03344-13; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Prust C, 2005, NAT BIOTECHNOL, V23, P195, DOI 10.1038/nbt1062; Raspor P, 2008, CRIT REV BIOTECHNOL, V28, P101, DOI 10.1080/07388550802046749 ; Spitaels F, 2014, INT J SYST EVOL MICR, V64, P1134, DOI 10.1099/ijs.0.059311-0; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Wieme AD, 2014, INT J FOOD MICROBIOL, V185, P41, DOI 10.1016/j.ijfoodmicro.2014.05.003	38	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165611	10.1371/journal.pone.0165611	http://dx.doi.org/10.1371/journal.pone.0165611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851750	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300022
J	Siddharthan, T; Rabin, T; Canavan, ME; Nassali, F; Kirchhoff, P; Kalyesubula, R; Coca, S; Rastegar, A; Knauf, F				Siddharthan, Trishul; Rabin, Tracy; Canavan, Maureen E.; Nassali, Faith; Kirchhoff, Phillip; Kalyesubula, Robert; Coca, Steven; Rastegar, Asghar; Knauf, Felix			Implementation of Patient-Centered Education for Chronic-Disease Management in Uganda: An Effectiveness Study	PLOS ONE			English	Article							SATISFACTION; ACTIVATION; CARE; ADHERENCE; SERVICES; PROGRAM	Background The majority of non-communicable disease related deaths occur in low- and middle-income countries. Patient-centered care is an essential component of chronic disease management in high income settings. Objective To examine feasibility of implementation of a validated patient-centered education tool among patients with heart failure in Uganda. Design Mixed-methods, prospective cohort. Settings A private and public cardiology clinic in Mulago National Referral and Teaching Hospital, Kampala, Uganda. Participants Adults with a primary diagnosis of heart failure. Interventions PocketDoktor Educational Booklets with patient-centered health education. Main Measures The primary outcomes were the change in Patient Activation Measure (PAM-13), as well as the acceptability of the PocketDoktor intervention, and feasibility of implementing patient centered education in outpatient clinical settings. Secondary outcomes included the change in satisfaction with overall clinical care and doctor-patient communication. Key Results A total of 105 participants were enrolled at two different clinics: the Mulago Outpatient Department (public) and the Uganda Heart Institute (private). 93 participants completed follow up at 3 months and were included in analysis. The primary analysis showed improved patient activation measure scores regarding disease-specific knowledge, treatment options and prevention of exacerbations among both groups (mean change 0.94 [SD = 1.01], 1.02 [SD = 1.15], and 0.92 [SD = 0.89] among private paying patients and 1.98 [SD = 0.98], 1.93 [SD = 1.02], and 1.45 [SD = 1.02] among public paying patients, p<0.001 for all values) after exposure to the intervention; this effect was significantly larger among indigent patients. Participants reported that materials were easy to read, that they had improved knowledge of disease, and stated improved communication with physicians. Conclusions Patient-centered medical education can improve confidence in self-management as well as satisfaction with doctor-patient communication and overall care in Uganda. Our results show that printed booklets are locally appropriate, highly acceptable and feasible to implement in an LMIC outpatient setting across socioeconomic groups.	[Siddharthan, Trishul] Johns Hopkins Univ, Johns Hopkins Sch Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Siddharthan, Trishul; Rabin, Tracy; Coca, Steven; Rastegar, Asghar; Knauf, Felix] Yale Univ, Dept Med, Yale Sch Med, New Haven, CT 06520 USA; [Canavan, Maureen E.] Yale Univ, Global Hlth Leadership Inst, New Haven, CT USA; [Nassali, Faith; Kalyesubula, Robert] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Kirchhoff, Phillip] Univ Basel Hosp, Dept Surg, Basel, Switzerland; [Coca, Steven] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Nephrol, New York, NY 10029 USA; [Knauf, Felix] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol, Erlangen, Germany	Johns Hopkins University; Johns Hopkins Medicine; Yale University; Yale University; Makerere University; University of Basel; Icahn School of Medicine at Mount Sinai; University of Erlangen Nuremberg	Siddharthan, T (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA.; Siddharthan, T (corresponding author), Yale Univ, Dept Med, Yale Sch Med, New Haven, CT 06520 USA.	Tsiddhal@jhmi.edu	Coca, Steven/L-7801-2019; Knauf, Felix/ABC-2513-2021; Siddharthan, Trishul/ABI-7593-2020	Coca, Steven/0000-0002-0928-9168; Siddharthan, Trishul/0000-0001-9914-1839; Knauf, Felix/0000-0001-5762-1404; Kalyesubula, Robert/0000-0003-3211-163X	Fulbright Scholar Award; Fogarty International Center of the National Institutes of Health [5R25TW009340]; Else Kroner-Fresenius-Stifung [2016_HA44]	Fulbright Scholar Award; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Else Kroner-Fresenius-Stifung	Trishul Siddharthan received funding in part from a Fulbright Scholar Award and from the Fogarty International Center of the National Institutes of Health under Award No. 5R25TW009340. Felix Knauf, Trishul Siddharthan, Tracy Rabin, Robert Kalyesubula and Asghar Rastegar are supported by the Else Kroner-Fresenius-Stifung to establish a center of excellence for patient-centered care and non communicable disease management in Uganda (2016_HA44). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or respective government or non-governmental organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; Bloom D.E., 2012, PGDA WORKING PAPERS, V8712; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; Eikelboom J, 2001, BRIT MED J, V322, P1192, DOI 10.1136/bmj.322.7296.1192; Glaser BG, DISCOVERY GROUNDED T, P7; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Grogan S, 2000, QUAL HEALTH CARE, V9, P210, DOI 10.1136/qhc.9.4.210; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Houle J, 2012, CAN FAM PHYSICIAN, V58, P1366; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Nabbuye-Sekandi J, 2011, INT J QUAL HEALTH C, V23, P516, DOI 10.1093/intqhc/mzr040; Odusola A.O., 2015, WORLD J CARDIOVASCUL, V5, P181, DOI [10.4236/wjcd.2015.57021, DOI 10.4236/WJCD.2015.57021]; Oi K, 2012, UNDERSTANDING ROLE P; Otero C, 2015, Yearb Med Inform, V10, P30, DOI 10.15265/IY-2015-013; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Praveen D, 2013, COMMUNITIES, V5, P6; Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216; Roberts KJ, 2002, AIDS PATIENT CARE ST, V16, P43, DOI 10.1089/108729102753429398; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Saksena P, 2012, TROP MED INT HEALTH, V17, P23, DOI 10.1111/j.1365-3156.2011.02894.x; Siddharthan T, 2015, HEALTH AFFAIR, V34, P1506, DOI 10.1377/hlthaff.2015.0382; Smith SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074373; Stellefson M, 2013, PREV CHRONIC DIS, P10; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; World Bank, 2015, POP DAT 2015; World Health Organization, GLOBAL STATUS REPORT; World Health Organization, 2010, P 3 GEN C PEOPL CTR	31	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166411	10.1371/journal.pone.0166411	http://dx.doi.org/10.1371/journal.pone.0166411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851785	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300046
J	Simione, L; Nolfi, S				Simione, Luca; Nolfi, Stefano			The Emergence of Selective Attention through Probabilistic Associations between Stimuli and Actions	PLOS ONE			English	Article							NEURAL MECHANISMS; VISUAL-ATTENTION; WORKING-MEMORY; MULTIPLE; COMPETITION; COGNITION; MODEL	In this paper we show how a multilayer neural network trained to master a context-dependent task in which the action co-varies with a certain stimulus in a first context and with a second stimulus in an alternative context exhibits selective attention, i.e. filtering out of irrelevant information. This effect is rather robust and it is observed in several variations of the experiment in which the characteristics of the network as well as of the training procedure have been varied. Our result demonstrates how the filtering out of irrelevant information can originate spontaneously as a consequence of the regularities present in context-dependent training set and therefore does not necessarily depend on specific architectural constraints. The post-evaluation of the network in an instructed-delay experimental scenario shows how the behaviour of the network is consistent with the data collected in neuropsychological studies. The analysis of the network at the end of the training process indicates how selective attention originates as a result of the effects caused by relevant and irrelevant stimuli mediated by context-dependent and context-independent bidirectional associations between stimuli and actions that are extracted by the network during the learning.	[Simione, Luca; Nolfi, Stefano] CNR, Inst Cognit Sci & Technol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Simione, L (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	luca_simione@gmail.com	Simione, Luca/AAL-9181-2020	Simione, Luca/0000-0003-1938-8466				Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Binkofski F, 2013, BRAIN LANG, V127, P222, DOI 10.1016/j.bandl.2012.07.007; Bonfiglioli C, 1998, PERCEPT PSYCHOPHYS, V60, P1426, DOI 10.3758/BF03208003; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Castiello U, 1999, TRENDS COGN SCI, V3, P264, DOI 10.1016/S1364-6613(99)01346-7; Chelazzi L, 2011, WIRES COGN SCI, V2, P392, DOI 10.1002/wcs.117; CHIEFFI S, 1993, BRAIN, V116, P1119, DOI 10.1093/brain/116.5.1119; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Deco G, 2004, VISION RES, V44, P621, DOI 10.1016/j.visres.2003.09.037; Deco G, 2001, VIS COGN, V8, P119, DOI 10.1080/13506280042000054; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Heinke D, 2011, COGN COMPUT, V3, P185, DOI 10.1007/s12559-010-9076-x; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Houghton George, 1994, P53; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; Larochelle H, 2009, J MACH LEARN RES, V10, P1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Nothdurft HC, 2000, VISION RES, V40, P1183, DOI 10.1016/S0042-6989(00)00031-6; Pastor-Bernier A, 2011, J NEUROSCI, V31, P7083, DOI 10.1523/JNEUROSCI.5681-10.2011; Payne HE, 2011, J COGNITIVE NEUROSCI, V23, P2046, DOI 10.1162/jocn.2010.21562; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Simione L, 2014, CONNECT SCI, V26, P389, DOI 10.1080/09540091.2014.942597; Simione L, 2012, PSYCHOL REV, V119, P745, DOI 10.1037/a0029345; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Strauss S, 2015, NEURAL NETWORKS, V72, P3, DOI 10.1016/j.neunet.2015.10.005; Tankus A, 2012, J COGNITIVE NEUROSCI, V24, P600, DOI 10.1162/jocn_a_00160; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Elk M., 2013, PHYS LIFE REV; Zorzi M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00515	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166174	10.1371/journal.pone.0166174	http://dx.doi.org/10.1371/journal.pone.0166174			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846301	gold, Green Submitted, Green Published			2022-12-27	WOS:000387794600036
J	Zhao, ZY; Wang, XM; Fan, MX; Yin, DZ; Sun, LM; Jia, J; Tang, CZ; Zheng, XH; Jiang, YW; Wu, J; Gong, JY				Zhao, Zhiyong; Wang, Xiangmin; Fan, Mingxia; Yin, Dazhi; Sun, Limin; Jia, Jie; Tang, Chaozheng; Zheng, Xiaohui; Jiang, Yuwei; Wu, Jie; Gong, Jiayu			Altered Effective Connectivity of the Primary Motor Cortex in Stroke: A Resting-State fMRI Study with Granger Causality Analysis	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; HAND MOVEMENTS; FUNCTIONAL REORGANIZATION; CORTICAL CONNECTIVITY; SUBCORTICAL STROKE; MACAQUE MONKEY; HUMAN BRAIN; AREA F5; RECOVERY; EXECUTION	The primary motor cortex (M1) is often abnormally recruited in stroke patients with motor disabilities. However, little is known about the alterations in the causal connectivity of M1 following stroke. The purpose of the present study was to investigate whether the effective connectivity of the ipsilesional M1 is disturbed in stroke patients who show different outcomes in hand motor function. 23 patients with left-hemisphere subcortical stroke were selected and divided into two subgroups: partially paralyzed hands (PPH) and completely paralyzed hands (CPH). Further, 24 matched healthy controls (HCs) were recruited. A voxel-wise Granger causality analysis (GCA) on the resting-state fMRI data between the ipsilesional M1 and the whole brain was performed to explore differences between the three groups. Our results showed that the influence from the frontoparietal cortices to ipsilesional M1 was diminished in both stroke subgroups and the influence from ipsilesional M1 to the sensorimotor cortices decreased greater in the CPH group than in the PPH group. Moreover, compared with the PPH group, the decreased influence from ipsilesional M1 to the contralesional cerebellum and from the contralesional superior parietal lobe to ipsilesional M1 were observed in the CPH group, and their GCA values were positively correlated with the FMA scores; Conversely, the increased influence from ipsilesional M1 to the ipsilesional middle frontal gyrus and middle temporal gyrus were observed, whose GCA values were negatively correlated with the FMA scores. This study suggests that the abnormalities of casual flow in the ipsilesional M1 are related to the severity of stroke-hand dysfunction, providing valuable information to understand the deficits in resting-state effective connectivity of motor execution and the frontoparietal motor control network during brain plasticity following stroke.	[Zhao, Zhiyong; Wang, Xiangmin; Fan, Mingxia; Zheng, Xiaohui; Jiang, Yuwei; Wu, Jie; Gong, Jiayu] East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Yin, Dazhi] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,State Key Lab Neurosci,Key Lab Prim, Shanghai 200031, Peoples R China; [Sun, Limin; Jia, Jie; Tang, Chaozheng] Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200040, Peoples R China	East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Fan, MX (corresponding author), East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.; Jia, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200040, Peoples R China.	mxfan@phy.ecnu.edu.cn; shannonjj@126.com			China National Natural Science Foundation [81471651]; 12th Five-Year Plan supporting project of Ministry of Science and Technology of the People's Republic of China [2013BA110603]; China National Natural Science Young Foundation [81401859]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2014KIP206]; Open Foundation of Shanghai Key Laboratory of Magnetic Resonance, East China Normal University	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 12th Five-Year Plan supporting project of Ministry of Science and Technology of the People's Republic of China; China National Natural Science Young Foundation; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Open Foundation of Shanghai Key Laboratory of Magnetic Resonance, East China Normal University	This research was supported by the China National Natural Science Foundation grants (grant no. 81471651), the 12th Five-Year Plan supporting project of Ministry of Science and Technology of the People's Republic of China (grant no. 2013BA110603), China National Natural Science Young Foundation (grant no. 81401859), Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (grant no. 2014KIP206), and in part by an Open Foundation of Shanghai Key Laboratory of Magnetic Resonance, East China Normal University.	Bansal AK, 2011, J NEUROPHYSIOL, V105, P1603, DOI 10.1152/jn.00532.2010; Begliomini C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00676; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Buch ER, 2010, J NEUROSCI, V30, P1395, DOI 10.1523/JNEUROSCI.4882-09.2010; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen HF, 2009, NEUROIMAGE, V47, P1844, DOI 10.1016/j.neuroimage.2009.06.026; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Fine EJ, 2002, SEMIN NEUROL, V22, P375, DOI 10.1055/s-2002-36759; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Grefkes C, 2010, NEUROIMAGE, V50, P233, DOI 10.1016/j.neuroimage.2009.12.029; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Isomura Y, 2003, J NEUROSCI, V23, P8002; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Ji GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069351; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Porro CA, 1996, J NEUROSCI, V16, P7688; Prabhu G, 2009, J PHYSIOL-LONDON, V587, P1057, DOI 10.1113/jphysiol.2008.165571; Qi RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053677; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904; Tsai CG, 2012, EUR J NEUROSCI, V35, P634, DOI 10.1111/j.1460-9568.2012.07996.x; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Xie ZJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/603909; Yin DZ, 2013, NEURORADIOLOGY, V55, P761, DOI 10.1007/s00234-013-1146-9; Yin DZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052727; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006	49	26	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166210	10.1371/journal.pone.0166210	http://dx.doi.org/10.1371/journal.pone.0166210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846290	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600038
J	Alhassan, RK; Nketiah-Amponsah, E; Arhinful, DK				Alhassan, Robert Kaba; Nketiah-Amponsah, Edward; Arhinful, Daniel Kojo			A Review of the National Health Insurance Scheme in Ghana: What Are the Sustainability Threats and Prospects?	PLOS ONE			English	Review							CARE; EXPERIENCES	Background The introduction of the national health insurance scheme (NHIS) in Ghana in 2003 significantly contributed to improved health services utilization and health outcomes. However, stagnating active membership, reports of poor quality health care rendered to NHIS-insured clients and cost escalations have raised concerns on the operational and financial sustain ability of the scheme. This paper reviewed peer reviewed articles and grey literature on the sustainability challenges and prospects of the NHIS in Ghana. Methods Electronic search was done for literature published between 2003-2016 on the NHIS and its sustainability in Ghana. A total of 66 publications relevant to health insurance in Ghana and other developing countries were retrieved from Cochrane, PubMed, ScienceDirect and Googlescholar for initial screening. Out of this number, 31 eligible peer reviewed articles were selected for final review based on specific relevance to the Ghanaian context. Results Ability of the NHIS to continue its operations in Ghana is threatened financially and operationally by factors such as: cost escalation, possible political interference, inadequate technical capacity, spatial distribution of health facilities and health workers, inadequate monitoring mechanisms, broad benefits package, large exemption groups, inadequate client education, and limited community engagement. Moreover, poor quality care in NHISaccredited health facilities potentially reduces clients' trust in the scheme and consequently decreases (re)enrolment rates. These sustainability challenges were reviewed and discussed in this paper. Conclusions The NHIS continues to play a critical role towards attaining universal health coverage in Ghana albeit confronted by challenges that could potentially collapse the scheme. Averting this possible predicament will largely depend on concerted efforts of key stakeholders such as health insurance managers, service providers, insurance subscribers, policy makers and political actors.	[Alhassan, Robert Kaba] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Alhassan, Robert Kaba; Arhinful, Daniel Kojo] Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Legon, Accra, Ghana; [Nketiah-Amponsah, Edward] Univ Ghana, Dept Econ, Legon, Accra, Ghana	University of Amsterdam; University of Ghana; University of Ghana	Alhassan, RK (corresponding author), Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.; Alhassan, RK (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Legon, Accra, Ghana.	arkabason@gmail.com	Nketiah-Amponsah, Edward/S-9239-2019	Alhassan, Robert Kaba/0000-0003-4227-4854; Nketiah-Amponsah, Edward/0000-0002-9754-1983	Netherlands government through the Ministry Foreign Affairs; Science for Global Development (WOTRO), Netherlands Organisation for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme [W07.45.104.00]	Netherlands government through the Ministry Foreign Affairs; Science for Global Development (WOTRO), Netherlands Organisation for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme	This review forms part the WOTRO-COHEiSION Ghana Project scientific outputs. The WOTRO-COHEiSION Ghana Project was funded by The Netherlands government through the Ministry Foreign Affairs and the Science for Global Development (WOTRO) which is a division of the Netherlands Organisation for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme (Project no.W07.45.104.00).; This review forms part the WOTRO-COHEiSION Ghana Project scientific outputs. The WOTRO-COHEiSION Ghana Project was funded by The Netherlands government through the Ministry Foreign Affairs and the Science for Global Development (WOTRO) which is a division of the Netherlands Organisation for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme (Project no.W07.45.104.00). The following individuals who were part of the WOTRO-COHEiSION Ghana Project made initial inputs to this review article and they are duly acknowledged for their valuable contributions: Prof. Tobias Rinke de Wit, and Dr. Nicole Spieker.	Abiiro GA, 2013, HEALTH POLICY PLANN, V28, P263, DOI 10.1093/heapol/czs059; Adei D, 2009, CURRENT RES J SOCIAL, V4, P372; Adu KO, 2014, 58411 MPRA; Agyepong IA, 2014, HEALTH RES POLICY SY, V12, P1; Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Agyepong IA, 2011, HEALTH POLICY, V99, P226, DOI 10.1016/j.healthpol.2010.09.018; Akazili J, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-26; Alhassan RK, PLOS ONE, V10, P1; Alhassan RK, 2015, BMC COST EFFECTIVENE, V13, P1; Alhassan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158541; Alhassan RK, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1438-y; Alhassan RK, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-37; Amporfu E, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-4; Ansah EK, 2009, PLOS MED, V6, P48, DOI 10.1371/journal.pmed.1000007; Arhinful D, 2003, 71 AFR STUD CTR; Baltussen R, 2006, TROP MED INT HEALTH, V11, P654, DOI 10.1111/j.1365-3156.2006.01621.x; Blanchet N J, 2012, Ghana Med J, V46, P76; Brugiavini A, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0083-9; Dalinjong PA, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-13; De Allegri M, 2009, TROP MED INT HEALTH, V14, P586, DOI 10.1111/j.1365-3156.2009.02262.x; Djan JO, 1997, INT J GYNECOL OBSTET, V59, pS83, DOI 10.1016/S0020-7292(97)00151-3; Durairaj V, 2010, WHOHSSHSFPB1001 DEP; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Fenny AP, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0063-9; Fusheini D, 2012, 62 POL STUD ASS ANN; Ghana Health Service (GHS), 2011, ANN REPORT; Goudge J, 2010, HLTH POLICY PLANNING, V27, pi55; Greenhalgh T, 2005, SOC SCI MED, V61, P417, DOI 10.1016/j.socscimed.2004.12.001; Karakas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126501; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P291, DOI 10.1016/j.ijgo.2005.10.030; Kyomugisha EL, 2009, AFR HEALTH SCI, V9, P559; Liberati A, 2000, PLOS MED, V6, P1; Macha J, 2012, HEALTH POLICY PLANN, V27, pi46, DOI 10.1093/heapol/czs024; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Mensah J., 2010, EVALUATION GHANA NAT; Ministry of Health (MoH), 2007, IND REV 2006 PROGR W; Ministry of Health (MOH), 2014, WHOL ASS HLTH SECT P; National Health Insurance Authority (NHIA), 2012, ANN REPORT; Nguyen HTH, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-4; Odeyemi IAO, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-9; Owusu-Sekyere E., 2014, PUBLIC HLTH RES, V4, P185; Oyesola R, 1997, INT J GYNECOL OBSTET, V59, pS75, DOI 10.1016/S0020-7292(97)00150-1; Rajkotia Y, 2007, POLITICAL DEV GHANAI; SEND-Ghana, 2010, BAL ACC QUAL CAR ASS; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; Witter S, 2009, GLOB HLTH ACTION, V2, P10; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20; Wood T, 2012, MOBILE TECHNOLOGY CO; World Bank, 2015, IND HLTH EXP TOT GDP; World Health Organization (WHO), 2016, HLTH SYST PUBL AB DE	50	86	86	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165151	10.1371/journal.pone.0165151	http://dx.doi.org/10.1371/journal.pone.0165151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832082	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000010
J	Chen, XH; Seifert, SM; Castillo-Mancilla, JR; Bushman, LR; Zheng, JH; Kiser, JJ; MaWhinney, S; Anderson, PL				Chen, Xinhui; Seifert, Sharon M.; Castillo-Mancilla, Jose R.; Bushman, Lane R.; Zheng, Jia-Hua; Kiser, Jennifer J.; MaWhinney, Samantha; Anderson, Peter L.			Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; VS. SEQUENTIAL-ANALYSIS; HIV-INFECTED ADULTS; POPULATION PHARMACOKINETICS; ANTIRETROVIRAL ACTIVITY; EMTRICITABINE; NUCLEOSIDE; DIPHOSPHATE; PHOSPHORYLATION; PHARMACOLOGY	The coformulation of the nucleos(t) ide analogs (NA) tenofovir (TFV) disoproxil fumarate (TDF) and emtricitabine (FTC) is approved for HIV-infection treatment and prevention. Plasma TFV and FTC undergo complicated hybrid processes to form, accumulate, and retain as their active intracellular anabolites: TFV-diphosphate (TFV-DP) and FTC-triphosphate (FTC-TP). Such complexities manifest in nonlinear intracellular pharmacokinetics (PK). In target cells, TFV-DP/FTC-TP compete with endogenous deoxynucleoside triphosphates (dNTP) at the active site of HIV reverse transcriptase, underscoring the importance of analog: dNTP ratios for antiviral efficacy. However, NA such as TFV and FTC have the potential to disturb the dNTP pool, which could augment or reduce their efficacies. We conducted a pharmacokinetics-pharmacodynamics (PKPD) study among forty subjects receiving daily TDF/FTC (300 mg/200 mg) from the first-dose to pharmacological intracellular steady-state (30 days). TFV/FTC in plasma, TFV-DP/FTC-TP and dNTPs in peripheral blood mononuclear cells (PBMC) were quantified using validated LC/MS/MS methodologies. Concentration-time data were analyzed using nonlinear mixed effects modeling (NONMEM). Formations and the accumulation of intracellular TFV-DP/FTC-TP was driven by plasma TFV/FTC, which was described by a hybrid of first-order formation and saturation. An indirect response link model described the interplay between TFV-DP/FTC-TP and the dNTP pool change. The EC50 (interindividual variability, (% CV)) of TFV-DP and FTC-TP on the inhibition of deoxyadenosine triphosphate (dATP) and deoxycytidine triphosphate (dCTP) production were 1020 fmol/10(6) cells (130%) and 44.4 pmol/10(6) cells (82.5%), resulting in (90% prediction interval) 11% (0.45%, 53%) and 14% (2.6%, 35%) reductions. Model simulations of analog: dNTP molar ratios using IPERGAY dosing suggested that FTC significantly contributes to the protective effect of preexposure prophylaxis (PrEP). Simulation-based intracellular operational multiple dosing half-lives of TFV-DP and FTC-TP were 6.7 days and 33 hours. This model described the formation of intracellular TFV-DP/FTC-TP and the interaction with dNTPs, and can be used to simulate analog: dNTP time course for various dosing strategies.	[Chen, Xinhui; Seifert, Sharon M.; Bushman, Lane R.; Zheng, Jia-Hua; Kiser, Jennifer J.; Anderson, Peter L.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Castillo-Mancilla, Jose R.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA; [MaWhinney, Samantha] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Anderson, PL (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA.	Peter.Anderson@ucdenver.edu	Castillo-Mancilla, Jose/AAN-5116-2020; Castillo-Mancilla, Jose/L-8176-2019	Castillo-Mancilla, Jose/0000-0003-1242-1745	NIH [U01 A184735, U01 A1106499]; Colorado Clinical & Transnational Sciences Institute (CCTSI) [TL1 TR001081]; NIH/NCATS (National Center for Advancing Translational Sciences) Colorado Clinical & Transnational Science Award (CTSA) [UL1 TR001082]; Colorado HIV Research Training Program [T32 AI 7447-23]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI104315] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Clinical & Transnational Sciences Institute (CCTSI); NIH/NCATS (National Center for Advancing Translational Sciences) Colorado Clinical & Transnational Science Award (CTSA); Colorado HIV Research Training Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH U01 A184735 (PLA), NIH U01 A1106499 (PLA), Colorado Clinical & Transnational Sciences Institute (CCTSI) TL1 TR001081 (XC), NIH/NCATS (National Center for Advancing Translational Sciences) Colorado Clinical & Transnational Science Award (CTSA) UL1 TR001082, and Colorado HIV Research Training Program T32 AI 7447-23 (SMS). The study drug was donated by Gilead Sciences, who had no role in the study design, data collection, or decision to publish. This work was conceived and conducted by the investigators. This work does not necessarily represent the views of the NIH or funders.	Ahn JE, 2008, J PHARMACOKINET PHAR, V35, P401, DOI 10.1007/s10928-008-9094-4; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anderson PL, 2011, J ANTIMICROB CHEMOTH, V66, P240, DOI 10.1093/jac/dkq447; Baheti G, 2013, AIDS, V27, P221, DOI 10.1097/QAD.0b013e32835a9a2d; Baheti G, 2011, ANTIMICROB AGENTS CH, V55, P5294, DOI 10.1128/AAC.05317-11; Bantia S, 2003, INT IMMUNOPHARMACOL, V3, P879, DOI 10.1016/S1567-5769(03)00076-6; Barditch-Crovo P, 2001, ANTIMICROB AGENTS CH, V45, P2733, DOI 10.1128/AAC.45.10.2733-2739.2001; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Biswas N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078814; Blum MR, 2007, J CLIN PHARMACOL, V47, P751, DOI 10.1177/0091270007300951; Borroto-Esoda K, 2006, ANTIVIR THER, V11, P377; Bourdais J, 1996, J BIOL CHEM, V271, P7887, DOI 10.1074/jbc.271.14.7887; Burns RN, 2015, J CLIN PHARMACOL, V55, P629, DOI 10.1002/jcph.461; Bushman LR, 2011, J PHARMACEUT BIOMED, V56, P390, DOI 10.1016/j.jpba.2011.05.039; Castillo-Mancilla JR, 2013, AIDS RES HUM RETROV, V29, P384, DOI [10.1089/aid.2012.0089, 10.1089/AID.2012.0089]; Chapman TM, 2003, DRUGS, V63, P1597, DOI 10.2165/00003495-200363150-00006; Chen XH, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3820; Chen XH, 2016, ANTIMICROB AGENTS CH, V60, P5387, DOI 10.1128/AAC.01019-16; Chittick GE, 2006, ANTIMICROB AGENTS CH, V50, P1304, DOI 10.1128/AAC.50.4.1304-1310.2006; Cottrell ML, 2016, J INFECT DIS, V214, P55, DOI 10.1093/infdis/jiw077; Cressey TR, 2015, CLIN INFECT DIS, V61, P633, DOI 10.1093/cid/civ346; Dansirikul C, 2008, J PHARMACOKINET PHAR, V35, P269, DOI 10.1007/s10928-008-9088-2; Deeks ED, 2010, DRUGS, V70, P2315, DOI 10.2165/11203800-000000000-00000; Deeks SG, 1998, ANTIMICROB AGENTS CH, V42, P2380, DOI 10.1128/AAC.42.9.2380; Delahunty T, 2009, J CHROMATOGR B, V877, P1907, DOI 10.1016/j.jchromb.2009.05.029; Dickinson L, 2015, ANTIMICROB AGENTS CH, V59, P6080, DOI 10.1128/AAC.01441-15; Droste JAH, 2005, ANTIMICROB AGENTS CH, V49, P680, DOI 10.1128/AAC.49.2.680-684.2005; Duwal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040382; Goicoechea M, 2010, AIDS, V24, P707, DOI 10.1097/QAD.0b013e32833676eb; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; Hawkins T, 2011, ANTIMICROB AGENTS CH, V55, P1549, DOI 10.1128/AAC.00910-10; Hirt D, 2009, CLIN PHARMACOL THER, V85, P182, DOI 10.1038/clpt.2008.201; Hutmacher MM, 2015, BRIT J CLIN PHARMACO, V79, P132, DOI 10.1111/bcp.12451; Jackson A, 2013, JAIDS-J ACQ IMM DEF, V62, P275, DOI 10.1097/QAI.0b013e3182829bd0; Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4; Jullien V, 2005, ANTIMICROB AGENTS CH, V49, P3361, DOI 10.1128/AAC.49.8.3361-3366.2005; JUSKO WJ, 1995, J PHARMACOKINET BIOP, V23, P5, DOI 10.1007/BF02353781; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Madrasi K, 2014, CPT Pharmacometrics Syst Pharmacol, V3, pe147, DOI 10.1038/psp.2014.46; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina JM, 2004, HIV MED, V5, P99, DOI 10.1111/j.1468-1293.2004.00194.x; Naesens L, 1996, ANTIMICROB AGENTS CH, V40, P22, DOI 10.1128/AAC.40.1.22; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; PORCHET HC, 1988, J PHARMACOL EXP THER, V244, P231; Pruvost A, 2005, ANTIMICROB AGENTS CH, V49, P1907, DOI 10.1128/AAC.49.5.1907-1914.2005; Ramanathan S, 2007, JAIDS-J ACQ IMM DEF, V45, P274; Ray AS, 2004, ANTIMICROB AGENTS CH, V48, P1089, DOI 10.1128/AAC.48.4.1089-1095.2004; Rower JE, 2012, ANTIMICROB AGENTS CH, V56, P3011, DOI 10.1128/AAC.06337-11; Sahin S, 2008, PHARM RES-DORDR, V25, P2869, DOI 10.1007/s11095-008-9787-9; Seifert SM, 2016, AIDS RES HUM RETROVI; Sharma A, 1998, BRIT J CLIN PHARMACO, V45, P229, DOI 10.1046/j.1365-2125.1998.00676.x; Skladanowski AC, 2013, CURR MED CHEM, V20, P4249; Stein DS, 2001, PHARMACOTHERAPY, V21, P11, DOI 10.1592/phco.21.1.11.34439; Sun YN, 1999, J PHARM SCI, V88, P987, DOI 10.1021/js9901155; Uglietti A, 2012, EXPERT OPIN DRUG MET, V8, P1305, DOI 10.1517/17425255.2012.714367; Valade E, 2015, ANTIMICROB AGENTS CH, V59, P6800, DOI 10.1128/AAC.01517-15; Valade E, 2014, ANTIMICROB AGENTS CH, V58, P2256, DOI 10.1128/AAC.02058-13; Varga A, 2013, EUR J PHARM SCI, V48, P307, DOI 10.1016/j.ejps.2012.11.007; Vela JE, 2008, ANTIVIR THER, V13, P789; von Kleist M, 2009, EUR J PHARM SCI, V36, P532, DOI 10.1016/j.ejps.2008.12.010; Wang LH, 2004, AIDS RES HUM RETROV, V20, P1173, DOI 10.1089/aid.2004.20.1173; Zhang LP, 2003, J PHARMACOKINET PHAR, V30, P405, DOI 10.1023/B:JOPA.0000012999.36063.4e; Zhang LP, 2003, J PHARMACOKINET PHAR, V30, P387, DOI 10.1023/B:JOPA.0000012998.04442.1f	63	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165505	10.1371/journal.pone.0165505	http://dx.doi.org/10.1371/journal.pone.0165505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832147	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000016
J	Diaz, IM; Nocon, A; Mehnert, DH; Fredebohm, J; Diehl, F; Holtrup, F				Diaz, Inga Medina; Nocon, Annette; Mehnert, Daniel H.; Fredebohm, Johannes; Diehl, Frank; Holtrup, Frank			Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing	PLOS ONE			English	Article							CELL-FREE DNA; STORAGE-CONDITIONS; SAMPLE STORAGE; PLASMA; MUTATIONS; QUANTIFICATION; RELEASE; SIZE	Objectives Making liquid biopsy testing widely available requires a concept to ship whole blood at ambient temperatures while retaining the integrity of the cell-free DNA (cfDNA) population and stability of blood cells to prevent dilution of circulating tumor DNA (ctDNA) with wild-type genomic DNA. The cell-and DNA-stabilizing properties of Streck Cell-Free DNA BCT blood collection tubes (cfDNA BCTs) were evaluated to determine if they can be utilized in combination with highly sensitive mutation detection technologies. Methods Venous blood from healthy donors or patients with advanced colorectal cancer (CRC) was collected in cfDNA BCTs and standard K2EDTA tubes. Tubes were stored at different temperatures for various times before plasma preparation and DNA extraction. The isolated cfDNA was analyzed for overall DNA yield of short and long DNA fragments using qPCR as well as for mutational changes using BEAMing and Plasma Safe-Sequencing (Safe-SeqS). Results Collection of whole blood from healthy individuals in cfDNA BCTs and storage for up to 5 days at room temperature did not affect the DNA yield and mutation background levels (n = 60). Low-frequency mutant DNA spiked into normal blood samples as well as mutant circulating tumor DNA in blood samples from CRC patients collected in cfDNA BCTs were reliably detected after 3 days of storage at room temperature. However, blood samples stored at <= 10 degrees C and at 40 degrees C for an extended period of time showed elevated normal genomic DNA levels and an abnormally large cellular plasma interface as well as lower plasma volumes. Conclusion Whole blood shipped in cfDNA BCTs over several days can be used for downstream liquid biopsy testing using BEAMing and Safe-SeqS. Since the shipping temperature is a critical factor, special care has to be taken to maintain a defined room temperature range to obtain reliable mutation testing results.	[Diaz, Inga Medina; Nocon, Annette; Mehnert, Daniel H.; Fredebohm, Johannes; Diehl, Frank; Holtrup, Frank] Sysmex Inost GmbH, Res & Dev, Hamburg, Germany		Diehl, F (corresponding author), Sysmex Inost GmbH, Res & Dev, Hamburg, Germany.	diehl.frank@sysmex-inostics.com			Sysmex Inostics GmbH	Sysmex Inostics GmbH	This work was funded by Sysmex Inostics GmbH. The funder provided support in the form of salaries for authors (IMD, AN, DHM, JF, FD, FH) as well as research funds, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Florian Schiffel, Bianca Hohmann, Johanna Weiland and Ann-Kathrin Loeber for their technical help in the laboratory, Matthias Burger for his input during statistical setup of this study, Claudia Stamm and the Service Laboratory team for their contribution during CRC sample analysis as well as the R&D and Production teams of Sysmex Inostics for their support during execution of the study.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bronkhorst AJ, 2015, CLIN CHIM ACTA, V450, P243, DOI 10.1016/j.cca.2015.08.028; Chan KCA, 2005, CLIN CHEM, V51, P781, DOI 10.1373/clinchem.2004.046219; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Das K, 2014, ACTA HISTOCHEM, V116, P55, DOI 10.1016/j.acthis.2013.05.002; Devonshire AS, 2014, ANAL BIOANAL CHEM, V406, P6499, DOI 10.1007/s00216-014-7835-3; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Distler J, 2015, EVALUATION DIFFERENT, p[209, 69]; El Messaoudi S, 2013, CLIN CHIM ACTA, V424, P222, DOI 10.1016/j.cca.2013.05.022; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Fleischhacker M, 2011, CLIN CHIM ACTA, V412, P2085, DOI 10.1016/j.cca.2011.07.011; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Jones FS, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.11538; Kang Q, 2016, CLIN BIOCHEM, V49, P1354, DOI 10.1016/j.clinbiochem.2016.03.012; KARLSEN F, 1994, LAB INVEST, V71, P604; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Malentacchi F, 2015, CLIN CHEM LAB MED, V53, P1935, DOI 10.1515/cclm-2014-1161; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Neil DO, 2014, NEW METHOD DNA EXTRA, P40724; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Norton SE, 2013, J CLIN LAB ANAL, V27, P305, DOI 10.1002/jcla.21603; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Sherwood JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150197; Streck, 2014, CELL FREE DNA BCT IN; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Toro PV, 2015, CLIN BIOCHEM, V48, P993, DOI 10.1016/j.clinbiochem.2015.07.097; Tu M, 2016, ANALYST, V141, P393, DOI 10.1039/c5an01863c; Wong D, 2013, CLIN BIOCHEM, V46, P1099, DOI 10.1016/j.clinbiochem.2013.04.023	33	102	102	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166354	10.1371/journal.pone.0166354	http://dx.doi.org/10.1371/journal.pone.0166354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832189	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000109
J	Galewski, T; Devictor, V				Galewski, Thomas; Devictor, Vincent			When Common Birds Became Rare: Historical Records Shed Light on Long-Term Responses of Bird Communities to Global Change in the Largest Wetland of France	PLOS ONE			English	Article							CAMARGUE SOUTHERN FRANCE; BASE-LINE SYNDROME; ORNITHOLOGICAL REPORT; POPULATION TRENDS; BIODIVERSITY; IMPACTS; RESTORATION; GENERALISTS; INDICATORS; DECLINE	Many species have suffered large population declines due to the anthropogenic influence on ecosystems. Understanding historical population trends is essential for informing best efforts to preserve species. We propose a new method to reconstruct the past structure of a regional species pool, based on historical naturalist literature. Qualitative information collected from annotated checklists and reports can be relevant to identify major long-term community changes. We reviewed ornithological literature on the Camargue, the largest wetland in France. We reconstructed the entire breeding bird community from 1830 to 2009 and translated historical data into semi-quantitative data. This data permitted a calculation of a Community Commonness Index to measure the average level of abundance of species in a community. The Community Specialization and Community Temperature Indices were used to evaluate the potential long-term impact of land-use and climate changes on the composition of the regional bird species pool. We found a decrease in average abundance and specialization between 1950 and 1989, suggesting that changes in land-use negatively impacted the structure and composition of the local bird community by reducing species abundance and removing habitat-specialists (e.g. Southern Grey Shrike, Greater Short-toed Lark). These results are likely to be linked with a major loss of natural habitats in the Camargue between 1942 and 1984 when natural areas and traditional farmland were converted into intensive cultivated lands. We also found fluctuations among species with high versus low temperature preference. However, long-term effects of climate change on the bird community might be blurred by the impact of land-use changes. Overall, our results contrast with those obtained from well-monitored colonial waterbirds showing long-term increases. Our results plead for a more regular use of historical naturalist data when examining long-term changes in species communities as they allow the establishment of an older temporal point of reference and consideration of species not covered by traditional monitoring schemes.	[Galewski, Thomas] Inst Rech Tour Valat, F-13200 Arles, France; [Devictor, Vincent] Univ Montpellier 2, Inst Sci Evolut, UMR 5554, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Galewski, T (corresponding author), Inst Rech Tour Valat, F-13200 Arles, France.	galewski@tourduvalat.org			Prince Albert II of Monaco Foundation; Total Foundation; French Ministry of Environment, Energy and Sea	Prince Albert II of Monaco Foundation; Total Foundation(Total SA); French Ministry of Environment, Energy and Sea	This work was supported by the Prince Albert II of Monaco Foundation, http //www.fpa2.com/ (TG); Total Foundation, http://Mondation.total.com/fr (TG); and French Ministry of Environment, Energy and Sea, http://www.developpement-durable.gouv.fr/(TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We warmly thank Michel Gauthier-Clerc, Yves Kayser, Thomas Blanchon, Damien Cohez, Marc Thibault, Olivier Pineau, Arnaud Bechet, Jocelyn Champagnon, Claire Pernollet, Jacques Blondel and Matthieu Guillemain for long discussions on the past and present status of birds in the Rhone delta as well as Lisa Ernoul and Ilse Geijzendorffer for the improvement to the text. We dedicate this work to all professional and amateur naturalists, of past and present, who gave their time to make the Camargue into one of the most famous birdwatching places in Europe. TG was supported by grants from the Prince Albert II of Monaco Foundation, Total Foundation, and French Ministry of Environment, Energy and Sea.	Askins, 2002, RESTORING N AM BIRDS, P235; Bechet A, 1998, ACTA OECOL, V19, P81, DOI 10.1016/S1146-609X(98)80011-8; Bennett AF, 2010, HABITAT FRAGMENTATIO, P1544; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; BLONDEL J, 1981, GUIDE OISEAUX CAMARG; Bonebrake TC, 2010, CONSERV LETT, V3, P371, DOI 10.1111/j.1755-263X.2010.00139.x; BOUTIN J, 1989, REV ECOL-TERRE VIE, V44, P165; BOUTIN J, 1991, REV ECOL-TERRE VIE, V46, P263; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cramp S., 1974, SEABIRDS BRITAIN IRE; Crespon J, 1840, ORNITHOLOGIE GARD PA; Darluc M, 1782, HIST NATURELLE PROVE; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Ernoul L, 2012, DIAGNOSTIC ECHEC CON, V12; Flitti A, 2009, ATLAS OISEAUX NICHEU; Gal R, 2013, EVOLUTION OCCUPATION; Galewski T, 2011, BIOL CONSERV, V144, P1392, DOI 10.1016/j.biocon.2010.10.030; Gauthier-Clerc M, 2012, OBSERVER OISEAUX CAM; Gibson RN, 2007, OCEANOGRAPHY MARINE; Godet L, 2013, APPL GEOGR, V42, P133, DOI 10.1016/j.apgeog.2013.05.011; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; HAFNER H, 1975, Terre et la Vie, V29, P100; Hafner H., 1970, Terre Vie, V24, P570; HAFNER H, 1985, REV ECOL-TERRE VIE, V40, P87; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Heath M, 2000, BIRDLIFE CONSERV SER; Hilton G, 2006, BIRD CENSUS NEWS, V19, P9; HOFFMANN L., 1960, TERRE ET VIE, V107, P81; Hugues A, 1937, ALAUDA, V9, P151; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Isenmann P, 1993, BIRDS CAMARGUE; Isenmann Paul, 2012, Alauda, V80, P241; Jaubert J. B., 1859, RICHESSES ORNITHOLOG; Johnson AR, 1997, COLON WATERBIRD, V20, P306, DOI 10.2307/1521698; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Kayser Y, 2003, REV ECOL-TERRE VIE, V58, P5; Kayser Y, 2008, REV ECOL-TERRE VIE, V63, P299; Kerbiriou C., 2009, DIVERS DISTRIB, V15, P641, DOI DOI 10.1111/J.1472-4642.2009.00569.X; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kuresoo Andres, 2011, Estonian Journal of Ecology, V60, P88, DOI 10.3176/eco.2011.2.02; Lachat T, 2010, EVOLUTION BIODIVERSI; Laurance WF., 2010, HABITAT DESTRUCTION, P73; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Lovejoy TE, 2006, CLIMATE CHANGE BIODI; Mathevet R, 2002, BIODIVERS CONSERV, V11, P509, DOI 10.1023/A:1014860617353; Mathevet R, 2002, LAND USE POLICY, V19, P277, DOI 10.1016/S0264-8377(02)00025-X; Mathevet R, 2002, CYBERGEO EUR J GEOGR; Mayaud N., 1938, Oiseau Paris, V8, P284; MESLEARD F, 1995, ECOL ENG, V5, P95, DOI 10.1016/0925-8574(95)00015-B; Moisselin J-M, 2002, CLIMATE CHANGE FRANC; Monsarrat S, 2015, CONSERV BIOL; Muller I, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013067; Nager RG, 2010, ARDEA, V98, P309, DOI 10.5253/078.098.0305; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pain D.J, 1997, FARMING BIRDS EUROPE; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Shavit A, 2011, BOST STUD PHILOS HIS, V274, P169, DOI 10.1007/978-90-481-9051-5_12; STAFFORD J, 1971, BIRD STUDY, V18, P218, DOI 10.1080/00063657109476316; Stanley DJ, 1998, J COASTAL RES, V14, P794; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Szep Tibor, 2012, Ornis Hungarica, V20, P13; Tamisier A., 1999, CAMARGUE CANARDS FOU; Teyssedre A, 2014, BIODIVERS CONSERV, P1; Thibault M, 1997, REV ECOL-TERRE VIE, V52, P261; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tucker G.M., 1997, HABITATS BIRDS EUROP; Vackar D, 2012, ECOL INDIC, V17, P58, DOI 10.1016/j.ecolind.2011.04.024; Van Kleunen A, 2003, HABITAT USE EUROPEAN; Vorisek Petr, 2008, Revista Catalana d'Ornitologia, V24, P4; Zuur Alain F., 2009, P1	88	11	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165542	10.1371/journal.pone.0165542	http://dx.doi.org/10.1371/journal.pone.0165542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832127	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000018
J	Jaroenlak, P; Sanguanrut, P; Williams, BAP; Stentiford, GD; Flegel, TW; Sritunyalucksana, K; Itsathitphaisarn, O				Jaroenlak, Pattana; Sanguanrut, Piyachat; Williams, Bryony A. P.; Stentiford, Grant D.; Flegel, Timothy W.; Sritunyalucksana, Kallaya; Itsathitphaisarn, Ornchuma			A Nested PCR Assay to Avoid False Positive Detection of the Microsporidian Enterocytozoon hepatopenaei (EHP) in Environmental Samples in Shrimp Farms	PLOS ONE			English	Article							SPORE WALL PROTEIN; HYBRIDIZATION; PATHOGENS	Hepatopancreatic microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP) is an important disease of cultivated shrimp. Heavy infections may lead to retarded growth and unprofitable harvests. Existing PCR detection methods target the EHP small subunit ribosomal RNA (SSU rRNA) gene (SSU-PCR). However, we discovered that they can give false positive test results due to cross reactivity of the SSU-PCR primers with DNA from closely related microsporidia that infect other aquatic organisms. This is problematic for investigating and monitoring EHP infection pathways. To overcome this problem, a sensitive and specific nested PCR method was developed for detection of the spore wall protein (SWP) gene of EHP (SWP-PCR). The new SWP-PCR method did not produce false positive results from closely related microsporidia. The first PCR step of the SWP-PCR method was 100 times (10(4) plasmid copies per reaction vial) more sensitive than that of the existing SSU-PCR method (10(6) copies) but sensitivity was equal for both in the nested step (10 copies). Since the hepatopancreas of cultivated shrimp is not currently known to be infected with microsporidia other than EHP, the SSU-PCR methods are still valid for analyzing hepatopancreatic samples despite the lower sensitivity than the SWP-PCR method. However, due to its greater specificity and sensitivity, we recommend that the SWP-PCR method be used to screen for EHP in feces, feed and environmental samples for potential EHP carriers.	[Jaroenlak, Pattana; Itsathitphaisarn, Ornchuma] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Jaroenlak, Pattana; Sanguanrut, Piyachat; Flegel, Timothy W.; Itsathitphaisarn, Ornchuma] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok, Thailand; [Sanguanrut, Piyachat; Sritunyalucksana, Kallaya] Natl Ctr Genet Engn & Biotechnol BIOTEC, Shrimp Pathogen Interact Lab SPI, Bangkok, Thailand; [Williams, Bryony A. P.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England; [Stentiford, Grant D.] Ctr Environm Fisheries & Aquaculture Sci, European Community Reference Lab Crustacean Dis, Weymouth, Dorset, England; [Flegel, Timothy W.; Sritunyalucksana, Kallaya] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand	Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Exeter; Centre for Environment Fisheries & Aquaculture Science; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Itsathitphaisarn, O (corresponding author), Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand.; Itsathitphaisarn, O (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok, Thailand.	ornchuma.its@mahidol.ac.th		Williams, Bryony/0000-0003-1123-2176; Jaroenlak, Pattana/0000-0002-2036-232X; Flegel, Timothy W./0000-0002-1913-213X	Agricultural Research Development Agency [CRP5905020530]; Mahidol University; National Research Council Thailand, Division of Plan Administration and Research Budget [2557-79]; Science Achievement Scholarship of Thailand (SAST); DG SANCO of the European Commission; UK Department of Environment, Food and Rural Affairs [FB002]	Agricultural Research Development Agency; Mahidol University; National Research Council Thailand, Division of Plan Administration and Research Budget; Science Achievement Scholarship of Thailand (SAST); DG SANCO of the European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	OI acknowledges support from Agricultural Research Development Agency under project CRP5905020530 and Mahidol University. KS received funding from National Research Council Thailand, Division of Plan Administration and Research Budget/2557-79. PJ is supported by the Science Achievement Scholarship of Thailand (SAST). GDS acknowledges support of DG SANCO of the European Commission, and the UK Department of Environment, Food and Rural Affairs under project FB002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank the owners of shrimp farms who provided the shrimp specimen. OI acknowledges support from Agricultural Research Development Agency under project CRP5905020530 and Mahidol University. KS received funding from National Research Council Thailand, Division of Plan Administration and Research Budget/2557-79. PJ is supported by the Science Achievement Scholarship of Thailand (SAST). GDS acknowledges support of DG SANCO of the European Commission and, the UK Department of Environment, Food and Rural Affairs under project FB002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; Bell TA, 1988, HDB NORMAL PENAEID S, P114; Chayaburakul K, 2004, DIS AQUAT ORGAN, V60, P89, DOI 10.3354/dao060089; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; FLEGEL TW, 1992, DIS ASIAN AQUACULTUR, V1, P181; Freeman MA, 2003, J FISH DIS, V26, P667, DOI 10.1046/j.1365-2761.2003.00498.x; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Hayman JR, 2005, INFECT IMMUN, V73, P841, DOI 10.1128/IAI.73.2.841-848.2005; Hitakarun A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0458-x; Kiryu Y, 2009, DIS AQUAT ORGAN, V84, P237, DOI 10.3354/dao02046; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar Arbind, 2014, Mol Biol Int, V2014, P937308, DOI 10.1155/2014/937308; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Liu Z, 2015, FISH SCI; Lucchi NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031848; Palenzuela O, 2014, INT J PARASITOL, V44, P189, DOI 10.1016/j.ijpara.2013.10.005; Pasharawipas Tirasak, 1994, Asian Fisheries Science, V7, P157; Phromjai J, 2001, DIS AQUAT ORGAN, V46, P153, DOI 10.3354/dao046153; Sambrook J., 2001, MOL CLONING LAB MANU; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Somchai P, 2016, AQUACULT REP, V3, P178, DOI 10.1016/j.aqrep.2016.03.003; Southern TR, 2007, EUKARYOT CELL, V6, P1354, DOI 10.1128/EC.00113-07; Stentiford GD, 2016, TRENDS PARASITOL, V32, P336, DOI 10.1016/j.pt.2015.12.004; Stentiford GD, 2010, INT J PARASITOL, V40, P1433, DOI 10.1016/j.ijpara.2010.04.017; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; Suebsing R, 2013, J APPL MICROBIOL, V114, P1254, DOI 10.1111/jam.12160; Szumowski SC, 2015, CURR OPIN MICROBIOL, V26, P10, DOI 10.1016/j.mib.2015.03.006; Tang KFJ, 2016, J INVERTEBR PATHOL, V140, P1, DOI 10.1016/j.jip.2016.08.004; Tang KFJ, 2015, J INVERTEBR PATHOL, V130, P37, DOI 10.1016/j.jip.2015.06.009; Tangprasittipap A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-139; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; Thitamadee S, 2016, AQUACULTURE, V452, P69, DOI 10.1016/j.aquaculture.2015.10.028; Tourtip S, 2009, J INVERTEBR PATHOL, V102, P21, DOI 10.1016/j.jip.2009.06.004; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	61	78	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166320	10.1371/journal.pone.0166320	http://dx.doi.org/10.1371/journal.pone.0166320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832178	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000096
J	Lee, RTH; Ng, ASM; Ingham, PW				Lee, Raymond Teck Ho; Ng, Ashley Shu Mei; Ingham, Philip W.			Ribozyme Mediated gRNA Generation for In Vitro and In Vivo CRISPR/Cas9 Mutagenesis	PLOS ONE			English	Article							ZEBRAFISH; EXPRESSION; RNA; HEDGEHOG; SYSTEM; TERMINATION; PROMOTER	CRISPR/Cas9 is now regularly used for targeted mutagenesis in a wide variety of systems. Here we report the use of ribozymes for the generation of gRNAs both in vitro and in zebrafish embryos. We show that incorporation of ribozymes increases the types of promoters and number of target sites available for mutagenesis without compromising mutagenesis efficiency. We have tested this by comparing the efficiency of mutagenesis of gRNA constructs with and without ribozymes and also generated a transgenic zebrafish expressing gRNA using a heat shock promoter (RNA polymerase II-dependent promoter) that was able to induce mutagenesis of its target. Our method provides a streamlined approach to test gRNA efficiency as well as increasing the versatility of conditional gene knock out in zebrafish.	[Lee, Raymond Teck Ho; Ng, Ashley Shu Mei; Ingham, Philip W.] ASTAR, Inst Mol & Cell Biol, Dev & Biomed Genet Lab, Singapore, Singapore; [Ingham, Philip W.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Lee, Raymond Teck Ho] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Lee, RTH; Ingham, PW (corresponding author), ASTAR, Inst Mol & Cell Biol, Dev & Biomed Genet Lab, Singapore, Singapore.; Ingham, PW (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Lee, RTH (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	raymondlee@duke_nus.edu.sg; gingham@ntu.edu.sg	Ingham, Philip/U-4253-2019; Ingham, Philip W/G-9903-2011; Ingham, Philip William/AAH-5884-2020	Ingham, Philip W/0000-0001-8224-9958; Ingham, Philip William/0000-0001-8224-9958; Lee, Raymond Teck Ho/0000-0001-6522-3043	Agency for Science Technology and Research (A*STAR); Toh Kian Chui Foundation	Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Toh Kian Chui Foundation	This work was supported by the Agency for Science Technology and Research (A*STAR) and by the Toh Kian Chui Foundation to PWI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Arimbasseri AG, 2013, BBA-GENE REGUL MECH, V1829, P318, DOI 10.1016/j.bbagrm.2012.10.006; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Chen JB, 2012, DNA RES, V19, P423, DOI 10.1093/dnares/dss023; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Di Donato V, 2016, GENOME RES, V26, P681, DOI 10.1101/gr.196170.115; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.12; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Qin W, 2015, CELL RES, V25, P1074, DOI 10.1038/cr.2015.95; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Song J, 2004, BIOCHEM BIOPH RES CO, V323, P573, DOI 10.1016/j.bbrc.2004.08.128; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917	26	18	26	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166020	10.1371/journal.pone.0166020	http://dx.doi.org/10.1371/journal.pone.0166020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832146	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000054
J	Balazy, R; Ciesielski, M; Sterenczak, K; Borowski, Z				Balazy, Radomir; Ciesielski, Mariusz; Sterenczak, Krzysztof; Borowski, Zbigniew			The Role of Topography in the Distribution and Intensity of Damage Caused by Deer in Polish Mountain Forests	PLOS ONE			English	Article							RED DEER; ECOLOGICAL IMPACTS; SELECTION; HERBIVORY	The increase in the deer population observed in recent decades has strongly impacted forest regeneration and the forest itself. The reduction in the quality of raw wood material, as a consequence of deer-mediated damage, constitutes a significant burden on forest owners. The basis for the commencement of preventive actions in this setting is the understanding of the populations and behaviors of deer in their natural environment. Although multiple studies have been carried out regarding this subject, only a few suggested topography as an important factor that may influence the distribution and intensity of deer-mediated damage. The detailed terrain models based on LiDAR data as well as the data on damage caused by deer from the State Forests database enabled thorough analyses of the distribution and intensity of damage in relation to land form in this study. These analyses were performed on three mountain regions in Poland: the Western Sudety Mountains, the Eastern Sudety Mountains, and the Beskidy Mountains. Even though these three regions are located several dozen to several hundred kilometers apart from each other, not all evaluated factors appeared common among them, and therefore, these regions have been analyzed separately. The obtained results indicated that the forest damage caused by deer increased with increasing altitude above 1000 m ASL. However, much larger areas of damage by deer were observed at elevations ranging from 401 to 1000 m ASL than at elevations below 400 m ASL. Moreover, the locations of damage (forest thickets and old stands) indicated that red deer is the species that exerts the strongest pressure on forest ecosystems. Our results show the importance of deer foraging behavior to the structure of the environment.	[Balazy, Radomir; Ciesielski, Mariusz; Sterenczak, Krzysztof; Borowski, Zbigniew] Forest Res Inst, Sekocin Stary, Braci Lesnej 3, PL-05090 Raszyn, Poland	Forest Research Institute	Balazy, R (corresponding author), Forest Res Inst, Sekocin Stary, Braci Lesnej 3, PL-05090 Raszyn, Poland.	r.balazy@ibles.waw.pl	Ciesielski, Mariusz/R-4971-2018; Borowski, Zbigniew/AAI-6571-2020; Balazy, Radomir/Q-6338-2016; Borowski, Zbigniew/AAF-5230-2020; Borowski, Zbigniew/AAL-6483-2021	Ciesielski, Mariusz/0000-0002-1215-140X; Balazy, Radomir/0000-0003-1633-5115; Borowski, Zbigniew/0000-0003-4109-5205; Sterenczak, Krzysztof/0000-0002-9556-0144	State Forests National Forest Holding	State Forests National Forest Holding	The above article was written under the project named "Creation of a Forest Information System Covering the Areas of the Sudety and the Western Beskidy Mountains within the Scope of Forest Condition Monitoring and Assessment" financed by The State Forests National Forest Holding.	Alves J, 2014, MAMM BIOL, V79, P338, DOI 10.1016/j.mambio.2014.05.007; [Anonymous], 2012, INSTR FOR PROT, VII, P46; Beck JL, 2013, WEST N AM NATURALIST, V73, P442, DOI 10.3398/064.073.0414; Borkowski J, 2011, ACTA THERIOL, V56, P239, DOI 10.1007/s13364-010-0023-8; Bugalho MN, 2013, FOREST ECOL MANAG, V308, P90, DOI 10.1016/j.foreco.2013.07.036; Christopher G, 2005, HUM PSYCHOPHARM CLIN, V20, P47, DOI 10.1002/hup.658; Clutton-Brock TH, 2004, NATURE, V429, P261, DOI 10.1038/429261a; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Gerhardt P, 2013, FOREST ECOL MANAG, V310, P173, DOI 10.1016/j.foreco.2013.08.030; Gill R.M.A., 2006, LARGE HERBIVORE ECOL; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Godek M, 2012, PURE APPL GEOPHYS, V169, P1093, DOI 10.1007/s00024-011-0360-9; Heuze P, 2005, FOREST ECOL MANAG, V217, P219, DOI 10.1016/j.foreco.2005.06.003; Homolka M, 2003, FOREST ECOL MANAG, V181, P119, DOI 10.1016/S0378-1127(03)00121-X; Koda R, 2011, FOREST ECOL MANAG, V262, P432, DOI 10.1016/j.foreco.2011.04.009; Kondracki J., 2002, GEOGRAFIA REGIONALNA; Most L, 2015, FOREST ECOL MANAG, V338, P46, DOI 10.1016/j.foreco.2014.11.015; Nopp-Mayr U., 2011, Wildlife Biology in Practice, V7, P66; Pepin D, 2006, FOREST ECOL MANAG, V222, P302, DOI 10.1016/j.foreco.2005.10.034; Reimoser F, 1996, FOREST ECOL MANAG, V88, P107, DOI 10.1016/S0378-1127(96)03816-9; Rooney T., 2011, FORESTRY, V74, P201; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Takeuchi T, 2011, FOREST ECOL MANAG, V261, P2089, DOI 10.1016/j.foreco.2011.03.002; Verheyden H, 2006, MAMMAL REV, V36, P217, DOI 10.1111/j.1365-2907.2006.00085.x	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165967	10.1371/journal.pone.0165967	http://dx.doi.org/10.1371/journal.pone.0165967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851776	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300029
J	Edwards, D; Geng, BY; Li, CS				Edwards, Dianne; Geng, Bao-Yin; Li, Cheng-Sen			New Plants from the Lower Devonian Pingyipu Group, Jiangyou County, Sichuan Province, China	PLOS ONE			English	Article							XUJIACHONG FORMATION; YUNNAN PROVINCE; LAND PLANTS; SP-NOV.; GEN.; ASSEMBLAGES	Descriptions of Lower Devonian plants from Yunnan, South China, have revolutionized concepts of diversity and disparity in tracheophytes soon after they became established on land. Sichuan assemblages have received little attention since their discovery almost 25 years ago and require revision. With this objective, fieldwork involving detailed logging and collection of fossils was undertaken in the Longmenshan Mountain Region, Jiangyou County and yielded the two new taxa described here. They are preserved as coalified compressions and impressions that allowed morphological but not anatomical analyses. Yanmenia (Zosterophyllum) longa comb nov is based on numerous rarely branching shoots with enations resembling lycophyte microphylls, without evidence for vasculature. The presence of sporangia is equivocal making assignation to the Lycopsida conjectural. The plant was recently described as a zosterophyll, but lacks strobili. These are present in the second plant and comprise bivalved sporangia. The strobili terminate aerial stems which arise from a basal axial complex displaying diversity in branching including H-and K-forms. These features characterise the Zosterophyllopsida, although the plant differs from Zosterophyllum in valve shape. Comparisons indicate greatest similarities to the Lower Devonian Guangnania cuneata, from Yunnan, but differences, particularly in the nature of the sporangium border, require the erection of a new species, G. minor. Superficial examination of specimens already published indicate a high degree of endemism at both species and generic level, while this study shows that Yanmenia is confined to Sichuan and Guangnania is one of the very few genera shared with Yunnan, where assemblages also show a high proportion of further endemic genera. Such provincialism noted in the Chinese Lower Devonian is explained by the palaeogeographic isolation of the South China plate, but this cannot account for differences/endemism between the Sichuan and Yunnan floras. Such an enigma demands further integrated geological, palaeobotanical and palynological studies.	[Edwards, Dianne; Geng, Bao-Yin; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Edwards, Dianne] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, S Glam, Wales	Chinese Academy of Sciences; Institute of Botany, CAS; Cardiff University	Edwards, D (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.; Edwards, D (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, S Glam, Wales.	Edwardsd2@cardiff.ac.uk			Royal Society of London	Royal Society of London(Royal Society of London)	We are extremely grateful to the Chinese Academy of Sciences for a Visiting Professorship for Senior Scientists (No. 2013T2S0022 to DE) and the Royal Society of London for funding our long standing collaboration.	Cai C. - Y, 1993, GEOL MAG, V130, P155; Cuerda AJ, 1987, ACTAS, V1, P179; Edwards D, 2001, REV PALAEOBOT PALYNO, V116, P1, DOI 10.1016/S0034-6667(01)00059-8; EDWARDS D, 1976, NEW PHYTOL, V76, P173, DOI 10.1111/j.1469-8137.1976.tb01449.x; Edwards D, 2015, REV PALAEOBOT PALYNO, V221, P220, DOI 10.1016/j.revpalbo.2015.03.007; GENG B-Y, 1983, Acta Botanica Sinica, V25, P574; Geng Bao-Yin, 1992, Acta Botanica Sinica, V34, P450; Geng BY, 1992, ACTA PHYTOTAXON SIN, V30, P197; Hao S., 2001, PLANTS INVADE LAND E, P103; Hao S.-G., 2013, EARLY DEVONIAN POSON; Hao S.-G., 1993, PALEONTOTGR ABT B, V230, P27; HAO SG, 1995, INT J PLANT SCI, V156, P896, DOI 10.1086/297312; Hao SG, 2001, REV PALAEOBOT PALYNO, V116, P55; HAO SG, 1991, CAN J BOT, V69, P873; Hao SG, 2007, INT J PLANT SCI, V168, P477, DOI 10.1086/511011; Hao SG, 2010, NEW PHYTOL, V185, P217, DOI 10.1111/j.1469-8137.2009.03056.x; Hou, 1988, DEVONIAN STRATIGRAPH; Hsu J., 1966, ACTA BOT SIN, V14, P50; HUEBER FM, 1992, ANN MO BOT GARD, V79, P474, DOI 10.2307/2399751; Ishchenko TA, 1975, LATE SILURIAN FLORA; Kenrick P., 1997, ORIGIN EARLY DIVERSI; KIDSTON R, 1923, T ROY SOC EDINBURGH, V53, P405; Lang WH., 1927, T R SOC EDINB, V55, P443, DOI 10.1017/S0080456800016422; Lele K.M., 1961, T R SOC EDIN EARTH, V64, P469; Li C.-S., 1982, ACTA PHYTOTAXON SIN, V20, P331; LI CS, 1992, PALAEONTOLOGY, V35, P257; Li X.X., 1977, ACTA PALAEONTOL, V16, P12; Li XX., 1978, ACTA GEOL SINICA, V52, P1; Liu Yu-Hai, 2002, Vertebrata Palasiatica, V40, P52; Pan J, 1978, DEV S S CHIN, P298; Scotese C.R., 2014, ATLAS DEVONIAN PALEO ATLAS DEVONIAN PALEO, V4; Turner Susan, 1995, Geobios Memoire Special (Villeurbanne), V19, P383; Walton J., 1964, PHYTOMORPHOLOGY, V14, P155; Wang DM, 2004, INT J PLANT SCI, V165, P337, DOI 10.1086/381919; Wang DM, 2002, REV PALAEOBOT PALYNO, V122, P13, DOI 10.1016/S0034-6667(02)00089-1; Wang DM, 2007, ACTA GEOL SINICA, V81, P523; Wang H., 1983, ATLAS PALAEOGEOGRAPH; WANG JQ, 1984, VERTEBRAT PALASIATIC, V22, P219; Wang Y, 2007, GEOL J, V42, P339, DOI 10.1002/gj.1082; Wellman CH, 2012, PALAEONTOLOGY, V55, P583, DOI 10.1111/j.1475-4983.2012.01143.x; Xiong CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075706; Xu HH, 2009, REV PALAEOBOT PALYNO, V153, P331, DOI 10.1016/j.revpalbo.2008.09.007; Yang N, 2009, PALYNOLOGY, V33, P113; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhao Wenjin, 2005, Gudili Xuebao, V7, P305	45	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0163549	10.1371/journal.pone.0163549	http://dx.doi.org/10.1371/journal.pone.0163549			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851760	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000387909300003
J	Fizelova, M; Jauhiainen, R; Stancakova, A; Kuusisto, J; Laakso, M				Fizelova, Maria; Jauhiainen, Raimo; Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku			Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; RESISTANCE; IDENTIFICATION; DYSFUNCTION; MELLITUS; PREDICT	We investigated the association of the Finnish Diabetes Risk Score (FINDRISC) with insulin secretion, insulin sensitivity, and risk of type 2 diabetes, drug-treated hypertension, cardiovascular (CVD) events and total mortality in a follow-up study of the Metabolic Syndrome in Men (METSIM) cohort. The METSIM study includes 10,197 Finnish men, aged 45-73 years, and examined in 2005-2010. Of 8,749 non-diabetic participants of the METSIM study 693 developed incident type 2 diabetes, 225 started antihypertensive medication, 351 had a CVD event, and 392 died during a 8.2-year follow-up. The FINDRISC was significantly associated with decreases in insulin secretion and insulin sensitivity (P<0.0001), and with a 4.14-fold increased risk of incident type 2 diabetes, 2.43-fold increased risk of drug-treated hypertension, 1.61- fold increased risk of CVD, and 1.55-increased risk of total mortality (the FINDRISC >= 12 vs. < 12 points). In conclusion, the FINDRISC predicts impairment in insulin secretion and insulin sensitivity, the conversion to type 2 diabetes, drug-treated hypertension, CVD events and total mortality.	[Fizelova, Maria; Jauhiainen, Raimo; Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Jauhiainen, Raimo; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Laakso, M (corresponding author), Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland.; Laakso, M (corresponding author), Kuopio Univ Hosp, Kuopio, Finland.	markku.laakso@uef.fi	Stancakova, Alena/AAN-6723-2020	Stancakova, Alena/0000-0002-1375-0252	Academy of Finland; Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland; Kuopio University Hospital	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland; Kuopio University Hospital	This work has been supported by the grants from the Academy of Finland, the Finnish Diabetes Research Foundation, the Finnish Cardiovascular Research Foundation, the Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland, and VTR and EVO grants from the Kuopio University Hospital to M.L. The funding bodies named above had no role in the design and conduct of the study; collection management, analysis, and interpretation of the data; and preparation review, or approval of the manuscript. No potential conflicts of interest relevant to this article are reported.r This work has been supported by the grants from the Academy of Finland (to M.L. and A.S.), the Finnish Diabetes Research Foundation, the Finnish Cardiovascular Research Foundation, the Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland, and VTR and EVO grants from the Kuopio University Hospital to M.L. The funding bodies named above had no role in the design and conduct of the study; collection management, analysis, and interpretation of the data; and preparation review, or approval of the manuscript. No potential conflicts of interest relevant to this article are reported.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Bianchi C, 2009, DIABETES, V58, pA257; Brodovicz KG, 2011, DIABETIC MED, V28, P1078, DOI 10.1111/j.1464-5491.2011.03315.x; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ku GMV, 2013, PRIM CARE DIABETES, V7, P249, DOI 10.1016/j.pcd.2013.07.004; LAAKSO M, 1991, ARTERIOSCLER THROMB, V11, P1068, DOI 10.1161/01.ATV.11.4.1068; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lorenzo C, 2010, DIABETES CARE, V33, P67, DOI 10.2337/dc09-1115; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Nakamura M, 2015, KIDNEY INT, V87, P535, DOI 10.1038/ki.2014.351; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Soleimani M, 2015, KIDNEY INT, V87, P497, DOI 10.1038/ki.2014.392; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Wang JJ, 2010, J CLIN ENDOCR METAB, V95, P3858, DOI 10.1210/jc.2010-0012	34	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166584	10.1371/journal.pone.0166584	http://dx.doi.org/10.1371/journal.pone.0166584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851812	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300070
J	McArt, SH; Miles, TD; Rodriguez-Saona, C; Schilder, A; Adler, LS; Grieshop, MJ				McArt, Scott H.; Miles, Timothy D.; Rodriguez-Saona, Cesar; Schilder, Annemiek; Adler, Lynn S.; Grieshop, Matthew J.			Floral Scent Mimicry and Vector-Pathogen Associations in a Pseudoflower-Inducing Plant Pathogen System	PLOS ONE			English	Article							MONILINIA-VACCINII-CORYMBOSI; VIRUS ATTRACT; HOST-PLANT; POLLINATION; BLUEBERRY; FUNGI; INFECTION; DISEASE; TRAITS; TRANSMISSION	Several fungal plant pathogens induce 'pseudoflowers' on their hosts to facilitate insect-mediated transmission of gametes and spores. When spores must be transmitted to host flowers to complete the fungal life cycle, we predict that pseudoflowers should evolve traits that mimic flowers and attract the most effective vectors in the flower-visiting community. We quantified insect visitation to flowers, healthy leaves and leaves infected with Monilinia vaccinii-corymbosi (Mvc), the causative agent of mummy berry disease of blueberry. We developed a nested PCR assay for detecting Mvc spores on bees, flies and other potential insect vectors. We also collected volatiles from blueberry flowers, healthy leaves and leaves infected with Mvc, and experimentally manipulated specific pathogen-induced volatiles to assess attractiveness to potential vectors. Bees and flies accounted for the majority of contacts with flowers, leaves infected with Mvc and healthy leaves. Flowers were contacted most often, while there was no difference between bee or fly contacts with healthy and infected leaves. While bees contacted flowers more often than flies, flies contacted infected leaves more often than bees. Bees were more likely to have Mvc spores on their bodies than flies, suggesting that bees may be more effective vectors than flies for transmitting Mvc spores to flowers. Leaves infected with Mvc had volatile profiles distinct from healthy leaves but similar to flowers. Two volatiles produced by flowers and infected leaves, cinnamyl alcohol and cinnamic aldehyde, were attractive to bees, while no volatiles manipulated were attractive to flies or any other insects. These results suggest that Mvc infection of leaves induces mimicry of floral volatiles, and that transmission occurs primarily via bees, which had the highest likelihood of carrying Mvc spores and visited flowers most frequently.	[McArt, Scott H.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Miles, Timothy D.] Calif State Univ Monterey Bay, Sch Nat Sci, Seaside, CA 93955 USA; [Rodriguez-Saona, Cesar] Rutgers State Univ, Philip E Marucci Ctr, Dept Entomol, Chatsworth, NJ 08019 USA; [Schilder, Annemiek] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Adler, Lynn S.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Grieshop, Matthew J.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Cornell University; California State University System; California State University Monterey Bay; Rutgers State University New Brunswick; Michigan State University; University of Massachusetts System; University of Massachusetts Amherst; Michigan State University	McArt, SH (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	shm33@cornell.edu			USDA NIFA [2012-67012-19854]	USDA NIFA(United States Department of Agriculture (USDA))	This work was supported by the USDA NIFA 2012-67012-19854. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; BATRA LR, 1983, MYCOLOGIA, V75, P131, DOI 10.2307/3792928; BATRA LR, 1985, SCIENCE, V228, P1011, DOI 10.1126/science.228.4702.1011; BEAMAN RS, 1988, AM J BOT, V75, P1148, DOI 10.2307/2444098; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bultman TL, 1998, MYCOL RES, V102, P235, DOI 10.1017/S0953756297004802; Cane JH, 2003, AM J BOT, V90, P1425, DOI 10.3732/ajb.90.10.1425; Cane JH, 2001, ECOL ENTOMOL, V26, P117, DOI 10.1046/j.1365-2311.2001.00309.x; Dean JV, 2008, PHYSIOL PLANTARUM, V132, P417, DOI 10.1111/j.1399-3054.2007.01041.X; DOBSON HEM, 1987, OECOLOGIA, V72, P618, DOI 10.1007/BF00378991; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Eckhardt LG, 2009, FOREST PATHOL, V39, P157, DOI 10.1111/j.1439-0329.2008.00570.x; Ehlenfeldt MK, 2010, HORTSCIENCE, V45, P1205, DOI 10.21273/HORTSCI.45.8.1205; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; ERHARDT A, 1993, BOT J LINN SOC, V111, P229, DOI 10.1111/j.1095-8339.1993.tb01900.x; Feldman TS, 2008, MICROB ECOL, V56, P742, DOI 10.1007/s00248-008-9393-8; Grieshop Matthew J., 2012, American Entomologist, V58, P172; Hamelin RC, 1996, APPL ENVIRON MICROB, V62, P4026, DOI 10.1128/AEM.62.11.4026-4031.1996; Isaacs R, 2010, J APPL ECOL, V47, P841, DOI 10.1111/j.1365-2664.2010.01823.x; JENNERSTEN O, 1988, OIKOS, V51, P163, DOI 10.2307/3565638; JENNERSTEN O, 1991, OECOLOGIA, V86, P88, DOI 10.1007/BF00317394; Jennings W, 1980, QUALITATIVE ANAL; Jurgens A, 2006, NEW PHYTOL, V172, P452, DOI 10.1111/j.1469-8137.2006.01845.x; Kusumoto N, 2014, FOREST PATHOL, V44, P353, DOI 10.1111/efp.12106; Lara C, 2003, AM J BOT, V90, P262, DOI 10.3732/ajb.90.2.262; MacKenzie K, 2009, ACTA HORTIC, V810, P527, DOI 10.17660/ActaHortic.2009.810.70; MacKenzie KE, 1994, POLLINATION 2 ERICAC; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Mauck KE, 2014, PLANT CELL ENVIRON, V37, P1427, DOI 10.1111/pce.12249; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; McArt SH, 2014, ECOL LETT, V17, P624, DOI 10.1111/ele.12257; Mescher MC, 2012, HOST MANIPULATION BY PARASITES, P73; Naef A, 2002, NEW PHYTOL, V154, P717, DOI 10.1046/j.1469-8137.2002.00406.x; Ngugi HK, 2004, PHYSIOL MOL PLANT P, V64, P113, DOI 10.1016/j.pmpp.2004.08.004; Patt JM, 1992, THESIS; Pfunder M, 2000, AM J BOT, V87, P48, DOI 10.2307/2656684; Raguso RA, 1998, MOL ECOL, V7, P1127, DOI 10.1046/j.1365-294x.1998.00426.x; Rao S, 2009, ACTA HORTIC, V810, P539; Rodriguez-Saona C, 2011, ANN BOT-LONDON, V107, P1377, DOI 10.1093/aob/mcr077; Rodriguez-Saona C, 2011, J EXP BOT, V62, P2633, DOI 10.1093/jxb/erq466; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Roy BA, 1998, MYCOLOGIA, V90, P846, DOI 10.2307/3761326; ROY BA, 1993, NATURE, V362, P56, DOI 10.1038/362056a0; ROY BA, 1994, ECOLOGY, V75, P352, DOI 10.2307/1939539; ROY BA, 1994, TRENDS ECOL EVOL, V9, P335, DOI 10.1016/0169-5347(94)90154-6; Roy BA, 1999, TRENDS PLANT SCI, V4, P325, DOI 10.1016/S1360-1385(99)01445-4; Scherm H., 2001, Small Fruits Review, V1, P17, DOI 10.1300/J301v01n04_03; Shapiro L, 2012, ECOL LETT, V15, P1430, DOI 10.1111/ele.12001; Shinners TC, 1996, CAN J PLANT SCI, V76, P493, DOI 10.4141/cjps96-091; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Von Frisch K., 1971, BEES THEIR VISION CH	53	12	12	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165761	10.1371/journal.pone.0165761	http://dx.doi.org/10.1371/journal.pone.0165761			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851747	gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300025
J	Versace, E; Schill, J; Nencini, AM; Vallortigara, G				Versace, Elisabetta; Schill, Jana; Nencini, Andrea Maria; Vallortigara, Giorgio			Naive Chicks Prefer Hollow Objects	PLOS ONE			English	Article							COLOR PREFERENCES; NUMBER	Biological predispositions influence approach and avoid responses from the time of birth or hatching. Neonates of species that require parental care (e.g. human babies and chicks of the domestic fowl) are attracted by stimuli associated with animate social partners, such as face-like configurations, biological motion and self-propulsion. The property of being filled is used as a cue of animacy by 8-month-old human infants but it is not known whether this reflects the effect of previous experience. We used chicks of the domestic fowl (Gallus gallus) to investigate whether the property of being filled vs. hollow elicits spontaneous or learned preferences. To this aim we tested preferences of naive and imprinted chicks for hollow and closed cylinders. Contrary to our expectations, we documented an unlearned attraction for hollow stimuli. The preference for hollow stimuli decreased when chicks were imprinted on filled stimuli but did not increase when chicks were imprinted on hollow stimuli, suggesting that hollowness is not crucial to determine affiliative responses for imprinting objects. When chicks were imprinted on occluded stimuli that could be either filled or hollow, the preference for hollow stimuli emerged again, showing that imprinting does not disrupt the spontaneous preference for hollow objects. Further experiments revealed that hollow objects were mainly attractive by means of depth cues such as darker innards, more than as places to hide or as objects with high contrast. Our findings point to predisposed preferences for hollow objects, and suggest that early predispositions might be driven by factors different from animacy cues.	[Versace, Elisabetta; Schill, Jana; Nencini, Andrea Maria; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Schill, Jana] Univ Osnabruck, Osnabruck, Germany	University of Trento; University Osnabruck	Versace, E (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	elisabetta.versace@unitn.it		Versace, Elisabetta/0000-0003-4578-1851	ERC Advanced Grant [ERC-2011-ADG_20110406, 295517]	ERC Advanced Grant	GV was funded by the ERC Advanced Grant ERC-2011-ADG_20110406, Project No: 295517, PREMESOR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiandetti C, 2011, P ROY SOC B-BIOL SCI, V278, P2621, DOI 10.1098/rspb.2010.2381; Dekker Teun, 2015, Proceedings of the Royal Society Biological Sciences Series B, V282, P20143018, DOI 10.1098/rspb.2014.3018; Di Giorgio E., 2016, BEHAV BRAIN RES; Egorova O V, 2003, Neurosci Behav Physiol, V33, P209, DOI 10.1023/A:1022186911789; Fabricius E, WILDFOWL TRUST ANN R, P84; GELMAN R, 1990, COGNITIVE SCI, V14, P79, DOI 10.1207/s15516709cog1401_5; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Ham AD, 2007, P ROY SOC B-BIOL SCI, V274, P1941, DOI 10.1098/rspb.2007.0538; Horn G, 1985, MEMORY IMPRINTING BR; JOHNSON MH, 1988, ANIM BEHAV, V36, P675, DOI 10.1016/S0003-3472(88)80150-7; Keesey IW, 2015, J CHEM ECOL, V41, P121, DOI 10.1007/s10886-015-0544-3; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Mascalzoni E, 2010, P NATL ACAD SCI USA, V107, P4483, DOI 10.1073/pnas.0908792107; Mayer U, 2016, BEHAV BRAIN RES, V310, P93, DOI 10.1016/j.bbr.2016.05.019; McCabe BJ, 2013, WIRES COGN SCI, V4, P375, DOI 10.1002/wcs.1231; Miura M, 2016, ANIM BEHAV, V116, P171, DOI 10.1016/j.anbehav.2016.03.025; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Rosa-Salva O, 2016, COGNITION; Rosa-Salva O, 2010, DEVELOPMENTAL SCI, V13, P565, DOI 10.1111/j.1467-7687.2009.00914.x; Salva OR, 2015, NEUROSCI BIOBEHAV R, V50, P150, DOI 10.1016/j.neubiorev.2014.12.015; Schaefer HH., 2010, Z TIERPSYCHOL, V16, P161, DOI [10.1111/j.1439-0310.1959.tb02051.x, DOI 10.1111/J.1439-0310.1959.TB02051.X]; SCHULMAN A H, 1970, Animal Behaviour, V18, P461, DOI 10.1016/0003-3472(70)90040-0; Setoh P, 2013, P NATL ACAD SCI USA, V110, P15937, DOI 10.1073/pnas.1314075110; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; VALLORTIGARA G, 1991, ANIM BEHAV, V41, P187, DOI 10.1016/S0003-3472(05)80470-1; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; Vallortigara G., 2012, THEORY EVOLUTION ITS, P189, DOI [10.1007/978-88-470-1974-4_12, DOI 10.1007/978-88-470-1974-4_12]; Vallortigara G, 2012, COGN NEUROPSYCHOL, V29, P213, DOI 10.1080/02643294.2012.654772; Versace E, 2016, BIORXIV, P1; Versace E, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00338; Versace E, 2015, PEERJ, V3, DOI 10.7717/peerj.1214	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166425	10.1371/journal.pone.0166425	http://dx.doi.org/10.1371/journal.pone.0166425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851773	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300047
J	De Lorenzo, G; Drikic, M; Papa, G; Eichwald, C; Burrone, OR; Arnoldi, F				De Lorenzo, Giuditta; Drikic, Marija; Papa, Guido; Eichwald, Catherine; Burrone, Oscar R.; Arnoldi, Francesca			An Inhibitory Motif on the 5 ' UTR of Several Rotavirus Genome Segments Affects Protein Expression and Reverse Genetics Strategies	PLOS ONE			English	Article							SITE-MEDIATED TRANSLATION; T7 RNA-POLYMERASE; MINUS-STRAND SYNTHESIS; MESSENGER-RNA; LA-AUTOANTIGEN; IN-VITRO; BLUETONGUE VIRUS; TRANSCRIPTION; PROMOTER; SEQUENCE	Rotavirus genome consists of eleven segments of dsRNA, each encoding one single protein. Viral mRNAs contain an open reading frame (ORF) flanked by relatively short untranslated regions (UTRs), whose role in the viral cycle remains elusive. Here we investigated the role of 5' UTRs in T7 polymerase-driven cDNAs expression in uninfected cells. The 5' UTRs of eight genome segments (gs3, gs5-6, gs7-11) of the simian SA11 strain showed a strong inhibitory effect on the expression of viral proteins. Decreased protein expression was due to both compromised transcription and translation and was independent of the ORF and the 3' UTR sequences. Analysis of several mutants of the 21-nucleotide long 5' UTR of gs 11 defined an inhibitory motif (IM) represented by its primary sequence rather than its secondary structure. IM was mapped to the 5' terminal 6-nucleotide long pyrimidine-rich tract 5'GGY(U/A) UY-3'. The 5' terminal position within the mRNA was shown to be essentially required, as inhibitory activity was lost when IM was moved to an internal position. We identified two mutations (insertion of a G upstream the 5' UTR and the U to A mutation of the fifth nucleotide of IM) that render IM non-functional and increase the transcription and translation rate to levels that could considerably improve the efficiency of virus helper-free reverse genetics strategies.	[De Lorenzo, Giuditta; Drikic, Marija; Papa, Guido; Burrone, Oscar R.; Arnoldi, Francesca] Int Ctr Genet Engn & Biotechnol, Trieste, Italy; [Arnoldi, Francesca] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Eichwald, Catherine] Univ Zurich, Inst Virol, Zurich, Switzerland; [Drikic, Marija] Univ Calgary, Fac Vet Med UCVM, Dept Prod Anim Hlth, Calgary, AB, Canada	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Zurich; University of Calgary	Burrone, OR; Arnoldi, F (corresponding author), Int Ctr Genet Engn & Biotechnol, Trieste, Italy.; Arnoldi, F (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	burrone@icgeb.org; farnoldi@units.it	Arnoldi, Francesca/AAQ-6859-2021; De Lorenzo, Giuditta/AAZ-9142-2021; Papa, Guido/AAG-5158-2021; ARNOLDI, Francesca/K-5020-2016	De Lorenzo, Giuditta/0000-0002-2736-8740; Papa, Guido/0000-0002-5215-0014; Eichwald, Catherine/0000-0003-0001-4843; ARNOLDI, Francesca/0000-0003-0651-5526	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy [RBFR13209E]	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy	FA was partially supported by a FIRB-Futuro in Ricerca grant (RBFR13209E, http://futuronricerca.miurit) funded by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy. All other authors received no specific funding for this work.	Afrikanova I, 1998, J GEN VIROL, V79, P2679, DOI 10.1099/0022-1317-79-11-2679; Ali N, 2000, J BIOL CHEM, V275, P27531; Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Arnold MM, 2012, J GEN VIROL, V93, P1483, DOI 10.1099/vir.0.041830-0; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Biswas S, 2014, ARCH VIROL, V159, P235, DOI 10.1007/s00705-013-1802-8; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; Contin R, 2011, J VIROL, V85, P2781, DOI 10.1128/JVI.01631-10; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Elroy-Stein O, 2001, CURR PROTOC PROTEIN; Estes M. K., 2014, FIELDS VIROLOGY, P1347; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; GONZALEZ SA, 1991, VIROLOGY, V182, P8, DOI 10.1016/0042-6822(91)90642-O; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Gratia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145998; Harb M, 2008, J VIROL; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; IMAI M, 1983, J VIROL, V47, P125, DOI 10.1128/JVI.47.1.125-136.1983; Johne R, 2016, J VIROL, V90, P1439, DOI 10.1128/JVI.02730-15; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Komoto S, 2008, J VIROL, V82, P6753, DOI 10.1128/JVI.00601-08; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; MCCRAE MA, 1983, VIROLOGY, V126, P204, DOI 10.1016/0042-6822(83)90472-5; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; Montero H, 2006, J VIROL, V80, P9031, DOI 10.1128/JVI.00437-06; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Pudi R, 2003, J BIOL CHEM, V278, P12231, DOI 10.1074/jbc.M210287200; Richards JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074328; Rubio RM, 2013, J VIROL, V87, P6336, DOI 10.1128/JVI.00361-13; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Trask SD, 2013, METHODS, V59, P199, DOI 10.1016/j.ymeth.2012.05.012; Trask SD, 2010, P NATL ACAD SCI USA, V107, P18652, DOI 10.1073/pnas.1011948107; Trask SD, 2010, J VIROL, V84, P1764, DOI 10.1128/JVI.01682-09; Troupin C, 2010, J VIROL, V84, P6711, DOI 10.1128/JVI.00547-10; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Vashist S, 2011, DNA CELL BIOL, V30, P339, DOI 10.1089/dna.2010.1114; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhu JF, 2001, BBA-GENE STRUCT EXPR, V1521, P19, DOI 10.1016/S0167-4781(01)00277-9	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166719	10.1371/journal.pone.0166719	http://dx.doi.org/10.1371/journal.pone.0166719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846320	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000387794600102
J	Tamaki, T; Hirata, M; Nakajima, N; Saito, K; Hashimoto, H; Soeda, S; Uchiyama, Y; Watanabe, M				Tamaki, Tetsuro; Hirata, Maki; Nakajima, Nobuyuki; Saito, Kosuke; Hashimoto, Hiroyuki; Soeda, Shuichi; Uchiyama, Yoshiyasu; Watanabe, Masahiko			A Long-Gap Peripheral Nerve Injury Therapy Using Human Skeletal Muscle-Derived Stem Cells (Sk-SCs): An Achievement of Significant Morphological, Numerical and Functional Recovery	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; BASIC SCIENCE; STROMAL CELLS; SELF-RENEWAL; REGENERATION; ANGIOGENESIS; RECONSTITUTION; REPAIR; TRANSPLANTATION	Losses in vital functions of the somatic motor and sensory nervous system are induced by severe long-gap peripheral nerve transection injury. In such cases, autologous nerve grafts are the gold standard treatment, despite the unavoidable sacrifice of other healthy functions, whereas the prognosis is not always favorable. Here, we use human skeletal musclederived stem cells (Sk-SCs) to reconstitute the function after long nerve-gap injury. Muscles samples were obtained from the amputated legs from 9 patients following unforeseen accidents. The Sk-SCs were isolated using conditioned collagenase solution, and sorted as CD34(+)/45(-)(Sk-34) and CD34(-)/45(-)/29(+) (Sk-DN/29(+)) cells. Cells were separately cultured/expanded under optimal conditions for 2 weeks, then injected into the athymic nude mice sciatic nerve long-gap model (7-mm) bridging an acellular conduit. After 8-12 weeks, active cell engraftment was observed only in the Sk-34 cell transplanted group, showing preferential differentiation into Schwann cells and perineurial/endoneurial cells, as well as formation of the myelin sheath and perineurium/endoneurium surrounding regenerated axons, resulted in 87% of numerical recovery. Differentiation into vascular cell lineage (pericyte and endothelial cells) were also observed. A significant tetanic tension recovery (over 90%) of downstream muscles following electrical stimulation of the sciatic nerve (at upper portion of the gap) was also achieved. In contrast, Sk-DN/29(+) cells were completely eliminated during the first 4 weeks, but relatively higher numerical (83% vs. 41% in axon) and functional (80% vs. 60% in tetanus) recovery than control were observed. Noteworthy, significant increase in the formation of vascular networks in the conduit during the early stage (first 2 weeks) of recovery was observed in both groups with the expression of key factors (mRNA and protein levels), suggesting the paracrine effects to angiogenesis. These results suggested that the human Sk-SCs may be a practical source for autologous stem cell therapy following severe peripheral nerve injury.	[Tamaki, Tetsuro; Hirata, Maki; Nakajima, Nobuyuki; Saito, Kosuke; Hashimoto, Hiroyuki; Soeda, Shuichi; Uchiyama, Yoshiyasu] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Tamaki, Tetsuro] Tokai Univ, Sch Med, Dept Human Struct & Funct, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Hirata, Maki; Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu; Watanabe, Masahiko] Tokai Univ, Sch Med, Dept Orthoped, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Nakajima, Nobuyuki; Soeda, Shuichi] Tokai Univ, Sch Med, Dept Urol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Saito, Kosuke] Tokai Univ, Sch Med, Dept Otolaryngol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.; Tamaki, T (corresponding author), Tokai Univ, Sch Med, Dept Human Struct & Funct, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X; Nakajima, Nobuyuki/0000-0001-6307-032X	Tokai University School of Medicine, Project Research, and Tokai University Research Aid [20122013]; Ministry of Education, Science and Culture Japan	Tokai University School of Medicine, Project Research, and Tokai University Research Aid; Ministry of Education, Science and Culture Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a 20122013 grant from the Tokai University School of Medicine, Project Research, and Tokai University Research Aid, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture Japan. The funders had no no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Aplin AC, 2010, ANGIOGENESIS, V13, P219, DOI 10.1007/s10456-010-9179-8; Castiglioni A, 2014, STEM CELL REP, V2, P92, DOI 10.1016/j.stemcr.2013.12.006; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Crisan M, 2008, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC02B02S4; Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002; Dezawa Mari, 2005, Current Neuropharmacology, V3, P257, DOI 10.2174/157015905774322507; Dubovy Petr, 2004, Anatomical Science International, V79, P198, DOI 10.1111/j.1447-073x.2004.00090.x; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kunigal S, 2007, INT J CANCER, V121, P2307, DOI 10.1002/ijc.22962; Lamszus K, 2000, NEUROSURGERY, V46, P938; Lavasani M, 2014, J CLIN INVEST, V124, P1745, DOI 10.1172/JCI44071; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Matsuse D, 2010, J NEUROPATH EXP NEUR, V69, P973, DOI 10.1097/NEN.0b013e3181eff6dc; Pavlov N, 2001, B CANCER, V88, P725; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Radtke C, 2011, CELL TRANSPLANT, V20, P145, DOI 10.3727/096368910X522081; Rochkind S, 2009, PHOTOMED LASER SURG, V27, P219, DOI 10.1089/pho.2009.9955; Rochkind S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E8; Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580; Shimizu S, 2007, BIOCHEM BIOPH RES CO, V359, P915, DOI 10.1016/j.bbrc.2007.05.212; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2003, EXP CELL RES, V291, P83, DOI 10.1016/S0014-4827(03)00376-8; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Tamaki T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00165; Tamaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091257; Tamaki T, 2013, REGEN MED, V8, P437, DOI 10.2217/rme.13.30; Tamaki T, 2011, CELL TISSUE RES, V344, P147, DOI 10.1007/s00441-010-1127-9; Tansey KE, 2011, ANN BIOMED ENG, V39, P1815, DOI 10.1007/s10439-011-0277-6; Uemura T, 2012, BIOCHEM BIOPH RES CO, V419, P130, DOI 10.1016/j.bbrc.2012.01.154; Walsh SK, 2012, STEM CELL RES, V8, P226, DOI 10.1016/j.scr.2011.11.004; Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013; Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220; Xu XT, 2015, STEM CELL REP, V5, P419, DOI 10.1016/j.stemcr.2015.07.016	42	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166639	10.1371/journal.pone.0166639	http://dx.doi.org/10.1371/journal.pone.0166639			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846318	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600097
J	Apriasz, R; Krueger, T; Marcjasz, G; Sznajd-Weron, K				Apriasz, Rafal; Krueger, Tyll; Marcjasz, Grzegorz; Sznajd-Weron, Katarzyna			The Hunt Opinion Model-An Agent Based Approach to Recurring Fashion Cycles	PLOS ONE			English	Article							DYNAMICS	We study a simple agent-based model of the recurring fashion cycles in the society that consists of two interacting communities: "snobs" and "followers" (or "opinion hunters", hence the name of the model). Followers conform to all other individuals, whereas snobs conform only to their own group and anticonform to the other. The model allows to examine the role of the social structure, i.e. the influence of the number of inter-links between the two communities, as well as the role of the stability of links. The latter is accomplished by considering two versions of the same model - quenched (parameterized by fraction L of fixed inter-links) and annealed (parameterized by probability p that a given inter-link exists). Using Monte Carlo simulations and analytical treatment (the latter only for the annealed model), we show that there is a critical fraction of inter-links, above which recurring cycles occur. For p <= 0.5 we derive a relation between parameters L and p that allows to compare both models and show that the critical value of inter-connections, p*, is the same for both versions of the model (annealed and quenched) but the period of a fashion cycle is shorter for the quenched model. Near the critical point, the cycles are irregular and a change of fashion is difficult to predict. For the annealed model we also provide a deeper theoretical analysis. We conjecture on topological grounds that the so-called saddle node heteroclinic bifurcation appears at p*. For p >= 0.5 we show analytically the existence of the second critical value of p, for which the system undergoes Hopf's bifurcation.	[Apriasz, Rafal; Sznajd-Weron, Katarzyna] Wroclaw Univ Sci & Technol, Dept Theoret Phys, Fac Fundamental Problems Technol, Wroclaw, Poland; [Krueger, Tyll] Wroclaw Univ Sci & Technol, Dept Control Syst & Mechatron, Wroclaw, Poland; [Marcjasz, Grzegorz] Wroclaw Univ Sci & Technol, Fac Pure & Appl Math, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw University of Science & Technology; Wroclaw University of Science & Technology	Sznajd-Weron, K (corresponding author), Wroclaw Univ Sci & Technol, Dept Theoret Phys, Fac Fundamental Problems Technol, Wroclaw, Poland.	katarzyna.weron@pwr.edu.pl		Krueger, Tyll/0000-0001-6983-7413	National Science Centre (NCN, Poland) [2013/11/B/HS4/01061]	National Science Centre (NCN, Poland)(National Science Centre, Poland)	This work was partially supported by funds from the National Science Centre (NCN, Poland; URL: http://ncn.gov.pl/) through grant no. 2013/11/B/HS4/01061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032541; [Anonymous], 1987, CLOTH TEXT RES J, V5, P15, DOI [10.1177/0887302X8700500203, DOI 10.1177/0887302X8700500203]; BAK P, 1982, REP PROG PHYS, V45, P587, DOI 10.1088/0034-4885/45/6/001; Bentley RA, 2007, EVOL HUM BEHAV, V28, P151, DOI 10.1016/j.evolhumbehav.2006.10.002; Benvenuto S., 2000, FASHION G SIMMEL J A, V3; Berger J, 2008, J PERS SOC PSYCHOL, V95, P593, DOI 10.1037/0022-3514.95.3.593; Bond R, 2005, GROUP PROCESS INTERG, V8, P331, DOI 10.1177/1368430205056464; Bouzdine-Chameeva T, 2011, ADV COMPLEX SYST, V14, P871, DOI 10.1142/S0219525911003475; Byrka K, 2016, RENEW SUST ENERG REV, V62, P723, DOI 10.1016/j.rser.2016.04.063; Callahan G, 2015, 2 POPULATION SOCIAL; Cao ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049441; Castellano C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041129; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Curran L., 1999, CLOTH TEXT RES J, V17, P65, DOI [10.1177/0887302X9901700201, DOI 10.1177/0887302X9901700201]; Denrell J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123471; Desportes JP, 1988, ENV SOCIAL PSYCHOL, P57, DOI [10.1007/978-94-009-2802-2_5, DOI 10.1007/978-94-009-2802-2_5]; ELLIOTT RJ, 1961, PHYS REV, V124, P346, DOI 10.1103/PhysRev.124.346; Galak J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153448; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3; Jedrzejewski A, ARXIV160707307PHYSIC; Kowalska-Pyzalska A, 2014, ENERG POLICY, V72, P164, DOI 10.1016/j.enpol.2014.04.021; Krawczyk MJ, 2014, PHYSICA A, V395, P384, DOI 10.1016/j.physa.2013.10.018; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Maciejowska K, 2016, ACTA PHYS POL A, V129, P1045, DOI 10.12693/APhysPolA.129.1045; Marsden JE., 1976, HOPF BIFURCATION ITS, DOI [10.1007/978-1-4612-6374-6, DOI 10.1007/978-1-4612-6374-6, DOI 10.1007/978-1-4612-6374-6_12]; Mellor A, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/48001; Miller CM, 1993, J MARKETING RES, V81, P1133; Mobilia M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012803; Murray J. D., 2002, MATH BIOL; Nail PR, 2016, ACTA PHYS POL A, V129, P1050, DOI 10.12693/APhysPolA.129.1050; Nail PR, 2013, REV GEN PSYCHOL, V17, P1, DOI 10.1037/a0030997; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nyczka P, 2013, J STAT PHYS, V151, P174, DOI 10.1007/s10955-013-0701-4; Nyczka P, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011105; Pareto V., 1916, MIND SOC 3; Rand W, 2011, INT J RES MARK, V28, P181, DOI 10.1016/j.ijresmar.2011.04.002; Richardson J, 1940, ANTHR RECORDS; ROBINSON DE, 1976, AM J SOCIOL, V81, P1133, DOI 10.1086/226188; Ruback RB, 2013, ENVIRON BEHAV, V45, P239, DOI 10.1177/0013916511412589; SELKE W, 1988, PHYS REP, V170, P213, DOI 10.1016/0370-1573(88)90140-8; Shilnikov LP, 2001, METHODS QUALITATIV 2; Siedlecki P, 2016, JASSS-J ARTIF SOC S, V19, DOI 10.18564/jasss.3203; SIMMEL G, 1957, AM J SOCIOL, V62, P541, DOI 10.1086/222102; Smith A., 2012, THEORY MORAL SENTIME; Sood V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041121; Sornette D, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/6/062001; Steele V., 2005, ENCY CLOTHING FASHIO; Suchecki K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011122; Suchecki K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031110; Szwabinski J, 2013, PHYSICA A, V392, P3589, DOI 10.1016/j.physa.2013.03.047; Timpanaro AM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012807; Timpanaro AM, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052808	54	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166323	10.1371/journal.pone.0166323	http://dx.doi.org/10.1371/journal.pone.0166323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835679	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200038
J	Wright, NE; Scerpella, D; Lisdahl, KM				Wright, Natasha E.; Scerpella, Danny; Lisdahl, Krista M.			Marijuana Use Is Associated with Behavioral Approach and Depressive Symptoms in Adolescents and Emerging Adults	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; NATIONAL EPIDEMIOLOGIC SURVEY; CANNABIS USE DISORDERS; AGE-OF-ONSET; ENDOCANNABINOID SYSTEM; SUBSTANCE USE; ALCOHOL-USE; EXECUTIVE DYSFUNCTION; RECEPTOR EXPRESSION; ANXIETY DISORDERS	Background Repeated CB1 binding due to THC results in downregulation of the endocannabinoid system in cortex and limbic regions, perhaps disrupting frontolimbic functioning. This is particularly a concern in young adults who are still undergoing neurodevelopment in frontal and limbic regions. Such disruptions may be linked to increased depressive symptoms, anxiety symptoms, and executive dysfunction, and decreased behavioral approach. Objectives Here we examine the influence of young adult marijuana use on anxiety, depressive symptoms, behavioral approach, and executive dysfunction. The influence of alcohol and gender were also assessed. Methods 84 participants 42 MJ, 42 controls) aged 18- 25 were balanced for gender 39 F). Exclusion criteria included: MRI contraindications, left handed, comorbid Axis-I disorders, major medical or neurologic disorders, prenatal issues, or prenatal alcohol/illicit drug exposure, or excessive other drug use. Participants completed the FrsBE, BIS/BAS, State-Trait Anxiety Inventory State), and BDI-II. Multiple regressions were run to predict anxiety, depressive symptoms, behavioral approach, and executive dysfunction from MJ group status, past year alcohol use, gender, and MJ* gender interactions, controlling for cotinine and ecstasy. Results MJ group predicted increased depressive symptoms p =. 049). Decreased fun-seeking p =. 04), reward response p =. 01), and BAS total p =. 01) were predicted by MJ group. Gender predicted decreased reward responsiveness in females p =. 049) and decreased BIS in females p =. 03). Female marijuana users had increased anxiety symptoms p =. 04) and increased disinhibition p =. 04). Increased cotinine predicted increased drive p =. 046), reward responsiveness p =. 008) and BAS Total p =. 02). Apathy and Executive Dysfunction were not predicted by any measures. All results had small effect sizes. Conclusions/Importance Depressive symptoms were greater in MJ users, while behavioral approach was decreased. Cotinine levels predicted increased behavioral approach. Female MJ users also had greater anxiety and disinhibition. In sum, these findings suggest sub-clinical threshold deficits related to regular marijuana use that are indicative of a need to prevent marijuana use in adolescents and young adults.	[Wright, Natasha E.; Scerpella, Danny; Lisdahl, Krista M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Lisdahl, KM (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	krista.medina@gmail.com	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335; Wade, Natasha/0000-0002-9629-2305	National Institute of Drug Abuse [R03 DA027457, R01 DA030354, RO3 DA027457]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027457, R01DA030354] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institute of Drug Abuse grant R03 DA027457. Dr. Lisdahl was also funded by National Institute of Drug Abuse (R01 DA030354) during manuscript preparation. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the National Institute of Drug Abuse grant RO3 DA027457. Dr. Lisdahl was also funded by National Institute of Drug Abuse (R01 DA030354) during manuscript preparation. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone D, 2008, NEUROIMAGE, V41, P1067, DOI 10.1016/j.neuroimage.2008.02.064; Ashtari M, 2011, J PSYCHIATR RES, V45, P1055, DOI 10.1016/j.jpsychires.2011.01.004; Ashtari M, 2008, J PSYCHIATR RES, V43, P189, DOI 10.1016/j.jpsychires.2008.12.002; Ashton CH, 2011, ACTA PSYCHIAT SCAND, V124, P250, DOI 10.1111/j.1600-0447.2011.01687.x; BAKAN D, 1966, PSYCHOL BULL, V66, P423, DOI 10.1037/h0020412; Bava S, 2013, ALCOHOL CLIN EXP RES, V37, pE181, DOI 10.1111/j.1530-0277.2012.01920.x; Bava S, 2009, PSYCHIAT RES-NEUROIM, V173, P228, DOI 10.1016/j.pscychresns.2009.04.005; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Becker MP, 2014, J CLIN EXP NEUROPSYC, V36, P379, DOI 10.1080/13803395.2014.893996; Bekman NM, 2013, ALCOHOL CLIN EXP RES, V37, P1432, DOI 10.1111/acer.12096; Bloomfield MAP, 2014, PSYCHOPHARMACOLOGY, V231, P2251, DOI 10.1007/s00213-014-3523-4; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budney AJ, 2003, J ABNORM PSYCHOL, V112, P393, DOI 10.1037/0021-843X.112.3.393; Butterworth P, 2014, DRUG ALCOHOL REV, V33, P555, DOI 10.1111/dar.12183; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chen CY, 2002, SOC PSYCH PSYCH EPID, V37, P199, DOI 10.1007/s00127-002-0541-z; Churchwell JC, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00225; DEFONSECA FR, 1993, NEUROREPORT, V4, P135, DOI 10.1097/00001756-199302000-00005; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Demirakca T, 2011, DRUG ALCOHOL DEPEN, V114, P242, DOI 10.1016/j.drugalcdep.2010.09.020; Dorard G, 2008, EUR CHILD ADOLES PSY, V17, P274, DOI 10.1007/s00787-007-0663-7; Dougherty DM, 2013, PSYCHOPHARMACOLOGY, V226, P307, DOI 10.1007/s00213-012-2908-5; Ehrenreich H, 1999, PSYCHOPHARMACOLOGY, V142, P295, DOI 10.1007/s002130050892; Elofson J, 2013, ADDICT BEHAV, V38, P2295, DOI 10.1016/j.addbeh.2013.03.001; Felton JW, 2015, EXP CLIN PSYCHOPHARM, V23, P265, DOI 10.1037/pha0000031; Filbey FM, 2015, BEHAV BRAIN RES, V293, P46, DOI 10.1016/j.bbr.2015.07.029; Fleming RL, 2012, ALCOHOL CLIN EXP RES, V36, P279, DOI 10.1111/j.1530-0277.2011.01615.x; Fontes MA, 2011, BRIT J PSYCHIAT, V198, P442, DOI 10.1192/bjp.bp.110.077479; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grace J, 1999, FRONTAL SYSTEMS BEHA; Grant B F, 1995, J Subst Abuse, V7, P481, DOI 10.1016/0899-3289(95)90017-9; Griffith-Lendering MFH, 2012, J CLIN EXP NEUROPSYC, V34, P688, DOI 10.1080/13803395.2012.668874; Gruber SA, 2014, PSYCHOPHARMACOLOGY, V231, P1455, DOI 10.1007/s00213-013-3326-z; Gruber SA, 2012, PSYCHOL ADDICT BEHAV, V26, P496, DOI 10.1037/a0026269; Gruber SA, 2012, NEUROSCI LETT, V511, P89, DOI 10.1016/j.neulet.2012.01.039; Gruber SA, 2011, EXP CLIN PSYCHOPHARM, V19, P231, DOI 10.1037/a0023034; Hasin DS, 2015, SOC PSYCH PSYCH EPID, V50, P1609, DOI 10.1007/s00127-015-1088-0; Hasin DS, 2015, LANCET PSYCHIAT, V2, P601, DOI 10.1016/S2215-0366(15)00217-5; Heng LJ, 2011, SYNAPSE, V65, P278, DOI 10.1002/syn.20844; Hervas G, 2013, BEHAV THER, V44, P62, DOI 10.1016/j.beth.2012.07.003; Hill MN, 2009, PSYCHONEUROENDOCRINO, V34, P1257, DOI 10.1016/j.psyneuen.2009.03.013; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Howard RJ, 2011, ALCOHOL CLIN EXP RES, V35, P1561, DOI 10.1111/j.1530-0277.2011.01502.x; Hungund BL, 2004, ANN NY ACAD SCI, V1025, P515, DOI 10.1196/annals.1316.064; Jacobsen LK, 2007, BIOL PSYCHIAT, V61, P31, DOI 10.1016/j.biopsych.2006.02.014; Jacobsen LK, 2005, BIOL PSYCHIAT, V57, P56, DOI 10.1016/j.biopsych.2004.10.022; Johnston L., 2012, MONITORING FUTURE NA; Johnston L., 2015, MONITORING FUTURE NA; Kedzior KK, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-136; Keeney BK, 2012, PHARMACOL BIOCHEM BE, V101, P528, DOI 10.1016/j.pbb.2012.02.017; Keeney BK, 2008, BEHAV PHARMACOL, V19, P812, DOI 10.1097/FBP.0b013e32831c3b6b; Khan SS, 2013, DRUG ALCOHOL DEPEN, V130, P101, DOI 10.1016/j.drugalcdep.2012.10.015; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Liang WB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/596179; Lisdahl Krista M, 2013, Front Psychiatry, V4, P53, DOI 10.3389/fpsyt.2013.00053; Lisdahl Krista M, 2014, Curr Addict Rep, V1, P144; Lisdahl KM, 2012, J INT NEUROPSYCH SOC, V18, P678, DOI 10.1017/S1355617712000276; LoBue C, 2014, AM J DRUG ALCOHOL AB, V40, P455, DOI 10.3109/00952990.2014.939752; Long LE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-87; Lopez-Larson MP, 2011, BEHAV BRAIN RES, V220, P164, DOI 10.1016/j.bbr.2011.02.001; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Martinez-Loredo V, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0019-0; McFarland BR, 2006, J AFFECT DISORDERS, V91, P229, DOI 10.1016/j.jad.2006.01.012; McHale S, 2008, HUM PSYCHOPHARM CLIN, V23, P409, DOI 10.1002/hup.941; McQueeny T, 2011, BEHAV BRAIN RES, V224, P128, DOI 10.1016/j.bbr.2011.05.031; Medina KL, 2007, DRUG ALCOHOL DEPEN, V87, P303, DOI 10.1016/j.drugalcdep.2006.09.003; Medina KL, 2007, J CHILD PSYCHOL PSYC, V48, P592, DOI 10.1111/j.1469-7610.2007.01728.x; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Medina KL, 2007, J INT NEUROPSYCH SOC, V13, P807, DOI 10.1017/S1355617707071032; Medina KL, 2009, ADDICT BIOL, V14, P457, DOI 10.1111/j.1369-1600.2009.00166.x; Midanik LT, 2007, DRUG ALCOHOL DEPEN, V90, P72, DOI 10.1016/j.drugalcdep.2007.02.024; Miech R. A., 2015, MONITORING FUTURE NA, V1; Moreno M, 2012, DRUG ALCOHOL DEPEN, V124, P355, DOI 10.1016/j.drugalcdep.2012.02.011; Pujol J, 2014, J PSYCHIATR RES, V51, P68, DOI 10.1016/j.jpsychires.2013.12.008; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Rubino T, 2012, J PSYCHOPHARMACOL, V26, P177, DOI 10.1177/0269881111405362; Schacht JP, 2012, NEUROPSYCHOPHARMACOL, V37, P2368, DOI 10.1038/npp.2012.92; Scholes-Balog KE, 2013, J ADOLESCENCE, V36, P519, DOI 10.1016/j.adolescence.2013.03.001; Shollenbarger SG, INTRINSIC FRON UNPUB; Shollenbarger SG, 2015, NEUROIMAGE-CLIN, V8, P117, DOI 10.1016/j.nicl.2015.03.024; Silva L, 2015, NEUROSCI LETT, V602, P89, DOI 10.1016/j.neulet.2015.06.033; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Simons JS, 2014, J ABNORM PSYCHOL, V123, P676, DOI 10.1037/a0036926; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Solowij N, 2012, PSYCHOPHARMACOLOGY, V219, P575, DOI 10.1007/s00213-011-2486-y; Spear LP, 2014, NEUROTOXICOL TERATOL, V41, P51, DOI 10.1016/j.ntt.2013.11.006; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Takagi M, 2011, DRUG ALCOHOL REV, V30, P629, DOI 10.1111/j.1465-3362.2010.00256.x; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Taubitz LE, 2015, PERS INDIV DIFFER, V80, P107, DOI 10.1016/j.paid.2015.02.029; van Laar M, 2007, ADDICTION, V102, P1251, DOI 10.1111/j.1360-0443.2007.01875.x; van Leeuwen AP, 2011, J STUD ALCOHOL DRUGS, V72, P70, DOI 10.15288/jsad.2011.72.70; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Winward JL, 2014, J INT NEUROPSYCH SOC, V20, P218, DOI 10.1017/S1355617713001410; Wittchen HU, 2007, DRUG ALCOHOL DEPEN, V88, pS60, DOI 10.1016/j.drugalcdep.2006.12.013; World Health Organization, 2011, GLOB STAT REP ALC HL; Wrege J, 2014, CURR PHARM DESIGN, V20, P2126, DOI 10.2174/13816128113199990428; Xu JS, 2012, HUM BRAIN MAPP, V33, P994, DOI 10.1002/hbm.21275; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057	100	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166005	10.1371/journal.pone.0166005	http://dx.doi.org/10.1371/journal.pone.0166005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835662	Green Submitted, Green Published, gold			2022-12-27	WOS:000387779200018
J	Buzza, G; Lovell, GP; Askew, CD; Kerherve, H; Solomon, C				Buzza, Gavin; Lovell, Geoff P.; Askew, Christopher D.; Kerherve, Hugo; Solomon, Colin			The Effect of Short and Long Term Endurance Training on Systemic, and Muscle and Prefrontal Cortex Tissue Oxygen Utilisation in 40-60 Year Old Women	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CITRATE SYNTHASE ACTIVITY; ALVEOLAR GAS-EXCHANGE; PULMONARY O-2 UPTAKE; CEREBRAL OXYGENATION; EXERCISE PERFORMANCE; BLOOD-FLOW; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-RESPONSES; VENTILATORY THRESHOLD	Purpose Aerobic endurance training (ET) increases systemic and peripheral oxygen utilisation over time, the adaptation pattern not being linear. However, the timing and mechanisms of changes in oxygen utilisation, associated with training beyond one year are not known. This study tested the hypothesis that in women aged 40-60 years performing the same current training load; systemic O-2 utilisation (VO2) and tissue deoxyhaemoglobin (HHb) in the Vastus Lateralis (VL) and Gastrocnemius (GAST) would be higher in long term trained (LTT; > 5 yr) compared to a short term trained (STT; 6-24 months) participants during ramp incremental (RI) cycling, but similar during square-wave constant load (SWCL) cycling performed at the same relative intensity (below ventilatory turn point [VTP]); and that pre-frontal cortex (PFC) HHb would be similar between participant groups in both exercise conditions. Methods Thirteen STT and 13 LTT participants performed RI and SWCL conditions on separate days. VO2, and VL, GAST, and PFC HHb were measured simultaneously. Results VO2peak was higher in LTT compared to STT, and VO2 was higher in LTT at each relative intensities of 25%, 80% and 90% of VTP in SWCL. HHb in the VL was significantly higher in LTT compared to STT at peak exercise (4.54 +/- 3.82 vs 1.55 +/- 2.33 mu M), and at 25% (0.99 +/- 1.43 vs 0.04 +/- 0.96 mu M), 80% (3.19 +/- 2.93 vs 1.14 +/- 1.82 mu M) and 90% (4.62 +/- 3.12 vs 2.07 +/- 2.49 mu M) of VTP in SWCL. Conclusions The additional (12.9 +/- 9.3) years of ET in LTT, resulted in higher VO2, and HHb in the VL at peak exercise, and sub D VTP exercise. These results indicate that in women 40-60 years old, systemic and muscle O-2 utilisation continues to improve with ET beyond two years.	[Buzza, Gavin; Askew, Christopher D.; Kerherve, Hugo; Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia; [Lovell, Geoff P.] Univ Sunshine Coast, Sch Social Sci, Sippy Downs, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast	Buzza, G (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia.	gbuzza@usc.edu.au		Askew, Christopher/0000-0001-8076-8789				Amann M, 2008, J APPL PHYSIOL, V104, P861, DOI 10.1152/japplphysiol.01008.2007; Anaya SA, 2009, MED SCI SPORT EXER, V41, P971, DOI 10.1249/MSS.0b013e3181930009; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bhambhani Y, 2007, RESP PHYSIOL NEUROBI, V156, P196, DOI 10.1016/j.resp.2006.08.009; Bhambhani YN, 1997, MED SCI SPORT EXER, V29, P402, DOI 10.1097/00005768-199703000-00017; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Bredin SSD, 2013, CAN FAM PHYSICIAN, V59, P273; CHANCE B, 1992, AM J PHYSIOL, V262, pC766, DOI 10.1152/ajpcell.1992.262.3.C766; Chuang ML, 2002, MED SCI SPORT EXER, V34, P1614, DOI 10.1097/00005768-200210000-00013; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dean TM, 2003, J APPL PHYSIOL, V95, P2537, DOI 10.1152/japplphysiol.00672.2003; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; DESOUZA MJ, 1990, MED SCI SPORT EXER, V22, P575, DOI 10.1249/00005768-199010000-00006; Dogra S, 2013, APPL PHYSIOL NUTR ME, V38, P154, DOI 10.1139/apnm-2012-0173; Dogra S, 2012, J SPORT SCI MED, V11, P745; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Eston R G, 1988, Br J Sports Med, V22, P153; EVANS SL, 1995, J APPL PHYSIOL, V78, P1931, DOI 10.1152/jappl.1995.78.5.1931; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Ferreira LF, 2006, RESP PHYSIOL NEUROBI, V153, P237, DOI 10.1016/j.resp.2005.11.004; Ferreira LF, 2005, J APPL PHYSIOL, V98, P1820, DOI 10.1152/japplphysiol.00907.2004; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Gaskill SE, 2001, INT J SPORTS MED, V22, P586, DOI 10.1055/s-2001-18522; Grey TM, 2015, MED SCI SPORT EXER, V47, P289, DOI 10.1249/MSS.0000000000000398; HAGBERG JM, 1988, J APPL PHYSIOL, V65, P101, DOI 10.1152/jappl.1988.65.1.101; Hamaoka T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2805437; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V269, pE150, DOI 10.1152/ajpendo.1995.269.1.E150; Hiroyuki H, 2002, EUR J APPL PHYSIOL, V87, P343, DOI 10.1007/s00421-002-0644-y; Hoppeler H, 2000, ACTA PHYSIOL SCAND, V168, P445, DOI 10.1046/j.1365-201x.2000.00696.x; Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337; Huang GY, 2016, EUR J PREV CARDIOL, V23, P518, DOI 10.1177/2047487315582322; Iversen N, 2011, EXP GERONTOL, V46, P670, DOI 10.1016/j.exger.2011.03.004; Jakovljevic DG, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002086; Jones B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120338; JURKOWSKI JEH, 1981, J APPL PHYSIOL, V51, P1493, DOI 10.1152/jappl.1981.51.6.1493; KOHRT WM, 1991, J APPL PHYSIOL, V71, P2004, DOI 10.1152/jappl.1991.71.5.2004; MAFFULLI N, 1994, J SPORT MED PHYS FIT, V34, P242; Marcell TJ, 2003, MED SCI SPORT EXER, V35, P810, DOI 10.1249/01.MSS.0000065002.69572.6F; McCole SD, 1999, J APPL PHYSIOL, V87, P2334, DOI 10.1152/jappl.1999.87.6.2334; MCPARLAND C, 1992, RESP PHYSIOL, V90, P311, DOI 10.1016/0034-5687(92)90111-9; MORGAN DW, 1992, MED SCI SPORT EXER, V24, P456; MORGAN DW, 1989, MED SCI SPORT EXER, V21, P78, DOI 10.1249/00005768-198902000-00014; Murias JM, 2011, J GERONTOL A-BIOL, V66, P957, DOI 10.1093/gerona/glr096; Murias JM, 2011, EUR J APPL PHYSIOL, V111, P235, DOI 10.1007/s00421-010-1649-6; Murias JM, 2010, MED SCI SPORT EXER, V42, P1891, DOI 10.1249/MSS.0b013e3181dd0bba; Neary JP, 2008, CLIN PHYSIOL FUNCT I, V28, P364, DOI 10.1111/j.1475-097X.2008.00822.x; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Oussaidene K, 2015, RESP PHYSIOL NEUROBI, V205, P53, DOI 10.1016/j.resp.2014.10.009; Oussaidene K, 2013, EUR J APPL PHYSIOL, V113, P2047, DOI 10.1007/s00421-013-2637-4; Parker BA, 2008, EUR J APPL PHYSIOL, V103, P343, DOI 10.1007/s00421-008-0711-0; Peltonen JE, 2013, RESP PHYSIOL NEUROBI, V188, P102, DOI 10.1016/j.resp.2013.05.014; Peltonen JE, 2012, RESP PHYSIOL NEUROBI, V181, P267, DOI 10.1016/j.resp.2012.04.002; Peltonen JE, 2009, RESP PHYSIOL NEUROBI, V169, P24, DOI 10.1016/j.resp.2009.08.013; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; POSNER JD, 1992, J AM GERIATR SOC, V40, P1; Proctor DN, 2004, MED SCI SPORT EXER, V36, P623, DOI 10.1249/01.MSS.0000121951.10417.B5; Rupp T, 2008, EUR J APPL PHYSIOL, V102, P153, DOI 10.1007/s00421-007-0568-7; SEALS DR, 1984, J APPL PHYSIOL, V57, P1024, DOI 10.1152/jappl.1984.57.4.1024; Sheel AW, 2012, COMPR PHYSIOL, V2, P1093, DOI 10.1002/cphy.c100046; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; SPINA RJ, 1993, J APPL PHYSIOL, V75, P849, DOI 10.1152/jappl.1993.75.2.849; STEPHENSON LA, 1982, MED SCI SPORT EXER, V14, P270, DOI 10.1249/00005768-198204000-00003; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Tanaka H, 1997, J APPL PHYSIOL, V83, P1947, DOI 10.1152/jappl.1997.83.6.1947; Tanaka H, 2003, J APPL PHYSIOL, V95, P2152, DOI 10.1152/japplphysiol.00320.2003; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; Vanhees L, 2012, EUR J PREV CARDIOL, V19, P670, DOI 10.1177/2047487312437059; Wang BD, 2012, EUR J APPL PHYSIOL, V112, P567, DOI 10.1007/s00421-011-2007-z	71	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165433	10.1371/journal.pone.0165433	http://dx.doi.org/10.1371/journal.pone.0165433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832088	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000013
J	Schmidt, LB; Goertz, S; Wohlfahrt, J; Melbye, M; Munch, TN				Schmidt, Linnea Boegeskov; Goertz, Sanne; Wohlfahrt, Jan; Melbye, Mads; Munch, Tina Noergaard			Recurrent Intracerebral Hemorrhage: Associations with Comorbidities and Medicine with Antithrombotic Effects	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; LONG-TERM PROGNOSIS; BLOOD-PRESSURE; RISK; STROKE; ANTICOAGULATION; RESUMPTION; MORTALITY; WARFARIN; VALIDITY	Background Intracerebral hemorrhage (ICH) is a disease with high mortality and a substantial risk of recurrence. However, the recurrence risk is poorly documented and the knowledge of potential predictors for recurrence among co-morbidities and medicine with antithrombotic effect is limited. Objectives 1) To estimate the short- and long-term cumulative risks of recurrent intracerebral hemorrhage (ICH). 2) To investigate associations between typical comorbid diseases, surgical treatment, use of medicine with antithrombotic effects, including antithrombotic treatment (ATT), selective serotonin reuptake inhibitors (SSRI's), and nonsteroidal anti-inflammatory drugs (NSAID's) with recurrent ICH. Methods The cohort consisted of all individuals diagnosed with a primary ICH in Denmark 1996-2011. Information on comorbidities, surgical treatment for the primary ICH, and the use of ATT, SSRI's and NSAID's was retrieved from the Danish national health registers. The cumulative recurrence risk of ICH was estimated using the Aalen-Johansen estimator, thus taking into account the competing risk of death. Associations with potential predictors of recurrent ICH were estimated as rate ratios (RR's) using Poisson regression. Propensity score matching was used for the analyses of medicine with antithrombotic effects. Results Among 15,270 individuals diagnosed with a primary ICH, 2,053 recurrences were recorded, resulting in cumulative recurrence risk of 8.9% after one year and 13.7% after five years. Surgical treatment and renal insufficiency were associated with increased recurrence risks (RR 1.64, 95% CI 1.39-1.93 and RR 1.72, 95% CI 1.34-2.17, respectively), whereas antihypertensive treatment was associated with a reduced risk (RR 0.82, 95% CI 0.74-0.91). We observed non-significant associations between the use of any of the investigated medicines with antithrombotic effect (ATT, SSRI's, NSAID's) and recurrent ICH. Conclusions The substantial short- and long-term recurrence risks warrant aggressive management of hypertension following a primary ICH, particularly in patients treated surgically for the primary ICH, and patients with renal insufficiency.	[Schmidt, Linnea Boegeskov; Goertz, Sanne; Wohlfahrt, Jan; Melbye, Mads; Munch, Tina Noergaard] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Munch, Tina Noergaard] Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen	Munch, TN (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.; Munch, TN (corresponding author), Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark.	TNM@ssi.dk		melbye, mads/0000-0001-8264-6785; Munch, Tina Norgaard/0000-0001-5938-000X; Schmidt, Linnea Boegeskov/0000-0001-6162-3090	Novo Nordisk Foundation; A.P. Moller Foundation for the Advancement of Medical Science	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A.P. Moller Foundation for the Advancement of Medical Science	The study was supported by a scholarship from the Novo Nordisk Foundation and The A.P. Moller Foundation for the Advancement of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Arakawa S, 1998, STROKE, V29, P1806, DOI 10.1161/01.STR.29.9.1806; Biffi A, 2010, NEUROLOGY, V04, P693; Bjerkreim AT, 2016, J STROKE CEREBROVASC, V25, P157, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.009; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Christensen MC, 2009, CEREBROVASC DIS, V27, P353, DOI 10.1159/000202012; FitzMaurice E, 2008, STROKE, V39, P2151, DOI 10.1161/STROKEAHA.107.508861; Flynn RWV, 2010, STROKE, V41, P2606, DOI 10.1161/STROKEAHA.110.589143; Flynn RWV, 2010, CARDIOVASC THER, V28, P177, DOI 10.1111/j.1755-5922.2009.00118.x; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Huhtakangas J, 2013, STROKE, V44, P585, DOI 10.1161/STROKEAHA.112.671230; Izumihara A, 2005, SURG NEUROL, V64, P160, DOI 10.1016/j.surneu.2004.09.010; Johnsen SP, 2003, STROKE, V34, P387, DOI 10.1161/01.STR.0000054057.11892.5B; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kremer PHC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142338; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Majeed A, 2010, STROKE, V41, P2860, DOI 10.1161/STROKEAHA.110.593087; Mendelow AD, 2005, LANCET, V365, P387; Nakamura K, 2008, STROKE, V39, P1694, DOI 10.1161/STROKEAHA.107.496752; Neau JP, 1997, NEUROLOGY, V49, P106, DOI 10.1212/WNL.49.1.106; PASSERO S, 1995, STROKE, V26, P1189, DOI 10.1161/01.STR.26.7.1189; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pezzini A, 2013, STROKE, V44, P1584, DOI 10.1161/STROKEAHA.111.000069; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Rix TA, 2012, SCAND CARDIOVASC J, V46, P149, DOI 10.3109/14017431.2012.673728; Shin D, 2014, J NEUROL, V261, P686, DOI 10.1007/s00415-014-7251-9; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Viswanathan A, 2006, NEUROLOGY, V66, P206, DOI 10.1212/01.wnl.0000194267.09060.77; Weimar C, 2011, CEREBROVASC DIS, V32, P283, DOI 10.1159/000330643; Yung D, 2012, CAN J CARDIOL, V28, P33, DOI 10.1016/j.cjca.2011.10.002	34	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166223	10.1371/journal.pone.0166223	http://dx.doi.org/10.1371/journal.pone.0166223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832176	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000077
J	Gouwy, M; Ruytinx, P; Radice, E; Claudi, F; Van Raemdonck, K; Bonecchi, R; Locati, M; Struyf, S				Gouwy, Mieke; Ruytinx, Pieter; Radice, Egle; Claudi, Federico; Van Raemdonck, Katrien; Bonecchi, Raffaella; Locati, Massimo; Struyf, Sofie			CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; CHEMOKINE PLATELET-FACTOR-4; RECEPTOR; EXPRESSION; VARIANT; POLARIZATION; LYMPHOCYTES; ACTIVATION; INHIBITOR; MOLECULES	Upon inflammation, circulating monocytes leave the bloodstream and migrate into the tissues, where they differentiate after exposure to various growth factors, cytokines or infectious agents. The best defined macrophage polarization types are M1 and M2. However, the platelet-derived CXC chemokine CXCL4 induces the polarization of macrophages into a unique phenotype. In this study, we compared the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells (iMDDC). Differently to M-CSF and CXCL4, CXCL4L1 is not a survival factor for monocytes. Moreover, the expression of the chemokine receptors CCR2, CCR5 and CXCR3 was significantly higher on CXCL4L1-treated monocytes compared to M-CSF- and CXCL4-stimulated monocytes. IL-1 receptor antagonist (IL-1RN) expression was upregulated by CXCL4 and downregulated by CXCL4L1, respectively, whereas both chemokines reduced the expression of the mannose receptor (MRC). Furthermore, through activation of CXCR3, CXCL4L1-stimulated monocytes released significantly higher amounts of CCL2 and CXCL8 compared to CXCL4-treated monocytes, indicating more pronounced inflammatory traits for CXCL4L1. In contrast, in CXCL4L1-treated monocytes, the production of CCL22 was lower. Compared to iMDDC generated in the presence of CXCL4L1, CXCL4treated iMDDC showed an enhanced phagocytic capacity and downregulation of expression of certain surface markers (e.g. CD1a) and specific enzymes (e.g. MMP-9 and MMP-12). CXCL4 and CXCL4L1 did not affect the chemokine receptor expression on iMDDC and cytokine production (CCL2, CCL18, CCL22, CXCL8, IL-10) by CXCL4- or CXCL4L1-differentiated iMDDC was similar. We can conclude that both CXCL4 and CXCL4L1 exert a direct effect on monocytes and iMDDC. However, the resulting phenotypes are different, which suggests a unique role for the two CXCL4 variants in physiology and/or pathology.	[Gouwy, Mieke; Ruytinx, Pieter; Radice, Egle; Claudi, Federico; Van Raemdonck, Katrien; Struyf, Sofie] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res,Lab Mol Immunol, Leuven, Belgium; [Bonecchi, Raffaella; Locati, Massimo] Humanitas Clin & Res Ctr, Rozzano, Italy	KU Leuven; IRCCS Humanitas Research Hospital	Struyf, S (corresponding author), Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Rega Inst Med Res,Lab Mol Immunol, Leuven, Belgium.	sofie.struf@kuleuven.be	Bonecchi, Raffaella/ABI-2390-2020; Locati, Massimo/ABF-6807-2021; Van Raemdonck, Katrien/AAG-4286-2020; Gouwy, Mieke/I-4642-2018; Struyf, Sofie/U-2455-2017	Gouwy, Mieke/0000-0002-4035-4810; Struyf, Sofie/0000-0003-4558-0769; Bonecchi, Raffaella/0000-0003-3346-5333	Concerted Research Actions (G.O.A.) of the Regional Government of Flanders; Fund for Scientific Research of Flanders (F.W.O - Vlaanderen); Interuniversity Attraction Poles Program-Belgian Science Policy [P7/40]	Concerted Research Actions (G.O.A.) of the Regional Government of Flanders; Fund for Scientific Research of Flanders (F.W.O - Vlaanderen)(FWO); Interuniversity Attraction Poles Program-Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by the Concerted Research Actions (G.O.A.) of the Regional Government of Flanders (SS), the Fund for Scientific Research of Flanders (F.W.O. - Vlaanderen) (SS) and the Interuniversity Attraction Poles Program (P7/40)-Belgian Science Policy (SS).	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bellora F, 2012, EUR J IMMUNOL, V42, P1618, DOI 10.1002/eji.201142173; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Erbel C, 2015, INNATE IMMUN-LONDON, V21, P255, DOI 10.1177/1753425914526461; Fricke I, 2004, FASEB J, V18, P1588, DOI 10.1096/fj.03-1435fje; Furuya M, 2012, CANCER BIOL THER, V13, P671, DOI 10.4161/cbt.20084; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gleissner CA, 2012, CURR VASC PHARMACOL, V10, P563; Gleissner CA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00001; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gordon S, 2012, CIRC RES, V110, P1546, DOI 10.1161/RES.0b013e31825ec26d; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Jian J, 2016, ONCOTARGET IN PRESS; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Kasper B, 2011, EUR J CELL BIOL, V90, P521, DOI 10.1016/j.ejcb.2010.12.002; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSTER AD, 1995, J EXP MED, V182, P219, DOI 10.1084/jem.182.1.219; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Mueller A, 2008, J LEUKOCYTE BIOL, V83, P875, DOI 10.1189/jlb.1006645; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nesmelova IV, 2008, J BIOL CHEM, V283, P24155, DOI 10.1074/jbc.M803308200; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Schutyser E, 2002, J BIOL CHEM, V277, P24584, DOI 10.1074/jbc.M112275200; Schwartzkopff F, 2012, INNATE IMMUN-LONDON, V18, P124, DOI 10.1177/1753425910388833; Sozzani S, 1998, J IMMUNOL, V161, P1083; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; Tanaka T, 1997, NAT MED, V3, P437, DOI 10.1038/nm0497-437; Van Raemdonck K, 2014, ANGIOGENESIS, V17, P631, DOI 10.1007/s10456-014-9417-6; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Vandooren J, 2015, BIOCHEM J, V465, P259, DOI 10.1042/BJ20140418; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Verbeke H, 2010, HUM PATHOL, V41, P990, DOI 10.1016/j.humpath.2009.09.021; Xia CQ, 2003, INT IMMUNOL, V15, P1007, DOI 10.1093/intimm/dxg100	46	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166006	10.1371/journal.pone.0166006	http://dx.doi.org/10.1371/journal.pone.0166006			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828999	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300073
J	Kieffer, A; Cardoso, GP; Thill, C; Verspyck, E; Marret, S				Kieffer, Amelie; Cardoso, Gaelle Pinto; Thill, Caroline; Verspyck, Eric; Marret, Stephane		Perinatal Network Haute-Normandie	Outcome at Two Years of Very Preterm Infants Born after Rupture of Membranes before Viability	PLOS ONE			English	Article							MIDTRIMESTER PREMATURE RUPTURE; EXPECTANT MANAGEMENT; PULMONARY HYPOPLASIA; 2ND-TRIMESTER RUPTURE; CEREBRAL-PALSY; SURVIVAL; CHORIOAMNIONITIS; MORTALITY; DELIVERY	Purpose To compare the respiratory and neurological outcomes at two years of age of preterm children born before 33 weeks of gestation (WG) after early preterm premature rupture of membranes (EPPROM) between 14 and 24 WG with preterm children without EPPROM. Design and Patients This single-center case-control retrospective study was conducted at Rouen University Hospital between 1 st January 2000 and 31 st December 2010. All the cases with EPPROM born from 26WG to 32WG were included. Each newborn was matched by sex, gestational age (GA) and year of birth to two very preterm children, born without EPPROM. At two years of corrected age, motor and cognitive abilities were assessed by routine score based on the Amiel-Tison and Denver developmental scales. Results Ninety-four cases with EPPROM before 24WG have been included. The 31 children born from 26WG to 32WG were matched with 62 controls. The EPPROM group had poorer clinical evaluation at one year for motor (p = 0.003) and cognitive developmental scores (p = 0.016). Neuromotor rehabilitation was performed more often (p = 0.013). However, there was no difference at 2 years of age. Children born after EPPROM were hospitalized more often for bronchiolitis (p<0.001) during their first 2 years, which correlates with increased incidence of pneumothorax (p = 0.017), pulmonary hypoplasia (p = 0.004) and bronchopulmonary dysplasia (p = 0.005) during neonatal period. Conclusion At two years, despite an increase in severe bronchiolitis and the need for more neuromotor rehabilitation during the first month of the life after discharge, there was no difference in neurological outcomes in the very preterm children of the EPPROM group compared to those born at a similar GA without EPPROM.	[Kieffer, Amelie; Cardoso, Gaelle Pinto; Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Med, Funct Educ Ctr, Child & Reference Ctr Learning Disabil, Rouen, France; [Kieffer, Amelie; Cardoso, Gaelle Pinto; Verspyck, Eric; Marret, Stephane] Univ Rouen, Inst Biomed Res & Innovat, Sch Med, Reg Inserm Team ERI Neovasc Microvasc Endothelium, Rouen, France; [Thill, Caroline] Rouen Univ Hosp, Dept Biostat, Rouen, France; [Verspyck, Eric] Rouen Univ Hosp, Dept Obstet, Rouen, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen	Kieffer, A (corresponding author), Rouen Univ Hosp, Dept Neonatal Med, Funct Educ Ctr, Child & Reference Ctr Learning Disabil, Rouen, France.; Kieffer, A (corresponding author), Univ Rouen, Inst Biomed Res & Innovat, Sch Med, Reg Inserm Team ERI Neovasc Microvasc Endothelium, Rouen, France.	a.kieffer@ch-calais.fr		Marret, Stephane/0000-0002-2858-148X	FEDER (the European Regional Development Fund of Haute-Normandie)	FEDER (the European Regional Development Fund of Haute-Normandie)	This study was supported by the FEDER (the European Regional Development Fund of Haute-Normandie). The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We are grateful to Nikki-Sabourin-Gibbs, Rouen University Hospital, for reviewing the manuscript in English, and Nathalie Mestre, for providing assistance. This study was supported by the FEDER (the European Regional Development Fund of Haute-Normandie). We are indebted to the women and children who participated in the study. The composition of the Perinatal network of Haute-Normandie was as follows: Belvedere Hospital (Mont St-Aignan): Dr. S. Pauthier, Dr C. Levavasseur; Bernay Hospital: Dr. F. Faggianelli, Dr. F. Mokdad; Dieppe Hospital: Dr. M. Cingotti, Dr. E. Jeannot; ElbeufHospital: Dr. M. Paquet, Dr. N. Demarque; Evreux Hospital: Dr. E. Machevin, Dr. M. Levy; Fecamp Hospital: Dr. J-Y. Baril, Dr H. Lahrach; Gisors Hospital: Dr. B. Louis-Juste; Le Havre Hospital: Dr. A. Talbot, Dr. H. Bruel; Clinic Aubepines (Dieppe): Dr. J. Le Long, Dr. C. Lambert; Lillebonne Hospital: Dr. S. Ba; Clinic Mathilde (Rouen): Dr. M. Durand-Reville, Dr. F. Levavasseur; L'Estuaire private Hospital (Le Havre): Dr J-F Le Digabel, Dr J. Stoller; Vernon Hospital: Dr F. Truong-Canh, Dr. M. Rouha; Rouen University Hospital: Prof. L. Marpeau, Prof. S. Marret, and Mrs C. Leveque.	Amiel-Tison C, 2011, NEUROLOGICAL DEV BIR; Arnaud C, 2007, ARCH PEDIAT ADOL MED, V161, P1053, DOI 10.1001/archpedi.161.11.1053; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Dinsmoor MJ, 2004, AM J OBSTET GYNECOL, V190, P183, DOI 10.1016/S0002-9378(03)00926-8; Farooqi A, 1998, OBSTET GYNECOL, V92, P895, DOI 10.1016/S0029-7844(98)00287-7; Foix-L'Helias L, 2008, BJOG-INT J OBSTET GY, V115, P275, DOI 10.1111/j.1471-0528.2007.01566.x; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Henderson-Smart DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF40, DOI 10.1136/adc.2005.072264; Johanzon M, 2008, OBSTET GYNECOL, V111, P42, DOI 10.1097/01.AOG.0000295866.97499.35; Kilbride HW, 1996, AM J OBSTET GYNECOL, V175, P675; Laudy JAM, 2002, PEDIATRICS, V109, P250, DOI 10.1542/peds.109.2.250; Lee T, 2001, CLIN PERINATOL, V28, P721, DOI 10.1016/S0095-5108(03)00073-3; Lindner W, 2002, J PEDIATR-US, V140, P177, DOI 10.1067/mpd.2002.121697; Manuck TA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.045; Manuck TA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.030; Medina TM, 2006, AM FAM PHYSICIAN, V73, P659; Melamed N, 2011, AM J OBSTET GYNECOL, V204, DOI [10.1016/j.ajog.2010.08.02, DOI 10.1016/J.AJOG.2010.08.02]; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pasquier JC, 2009, EUR J OBSTET GYN R B, V143, P18, DOI 10.1016/j.ejogrb.2008.10.017; Pristauz G, 2008, INT J GYNECOL OBSTET, V101, P264, DOI 10.1016/j.ijgo.2007.12.007; RIB DM, 1993, AM J PERINAT, V10, P369, DOI 10.1055/s-2007-994764; Schucker JL, 1996, SEMIN PERINATOL, V20, P389, DOI 10.1016/S0146-0005(96)80006-1; Storme L, 2007, ARCH PEDIATRIE, V14, pS42, DOI 10.1016/S0929-693X(07)80010-8; Svigos JM, 2001, AUST NZ J OBSTET GYN, V41, P170, DOI 10.1111/j.1479-828X.2001.tb01203.x; Tanir HM, 2003, INT J GYNECOL OBSTET, V82, P167, DOI 10.1016/S0020-7292(03)00125-5; Verspyck E, 2014, ACTA PAEDIATR, V103, P256, DOI 10.1111/apa.12489; Watterberg KL, 1996, PEDIATRICS, V97, P210; Winn HN, 2000, AM J OBSTET GYNECOL, V182, P1638, DOI 10.1067/mob.2000.107435; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Xiao ZH, 2000, EUR J OBSTET GYN R B, V90, P67, DOI 10.1016/S0301-2115(99)00232-8	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166130	10.1371/journal.pone.0166130	http://dx.doi.org/10.1371/journal.pone.0166130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829004	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300087
J	Pansini, R; Shi, L; Wang, RW				Pansini, Riccardo; Shi, Lei; Wang, Rui-Wu			Women Tend to Defect in a Social Dilemma Game in Southwest China	PLOS ONE			English	Article							GENDER-DIFFERENCES; MATRILINEAL MOSUO; COOPERATION; PUNISHMENT; EVOLUTION; SEX; PROMOTES; GREED; FEAR	Cooperation theories assume that interacting individuals can change their strategies under different expected payoffs, depending on their social status or social situations. When looking at sex differences in cooperation, the existing studies have found that the genders cooperate at similar frequencies. However, the majority of the data originate within Western human societies. In this paper, we explore whether there are gender differences in cooperation in China. An Iterated Prisoner's Dilemma game with a punishment option was used to gather data about Southwest Chinese subjects in a culture in which men have a hierarchical advantage over women. Results indicate that men invested into partners significantly more than women did (34% male vs. 24% female) while women, in turn, were more likely to defect (65% female vs. 50% male). In this region, women have customarily held less economic power and they are used to obtain a payoff typically lower than men. We suggest that the women's willingness to invest in cooperation has decreased throughout evolutionary time, providing us with an illustration of a culturally-driven shift towards a disparity in gender cooperation interests.	[Pansini, Riccardo] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Pansini, Riccardo; Shi, Lei] Yunnan Univ Finance & Econ, Stat & Math Coll, Kunming 650221, Peoples R China; [Wang, Rui-Wu] Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University of Finance & Economics; Northwestern Polytechnical University	Pansini, R (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.; Pansini, R (corresponding author), Yunnan Univ Finance & Econ, Stat & Math Coll, Kunming 650221, Peoples R China.; Wang, RW (corresponding author), Northwestern Polytech Univ, Ctr Ecol & Environm Sci, Xian 710072, Peoples R China.	r.pansini@gmail.com; ruiwukiz@hotmail.com	Pansini, Riccardo/AAP-2686-2020	Pansini, Riccardo/0000-0001-5046-0601	National Science Fund for Distinguished Young Scholars [31325005]; National Natural Science Foundation of China-Yunnan United fund [U1302267]; Chinese Academy of Science (CAS) Special Fund for the Excellent Youth [KSCX2-EW-Q-9]; CAS [2015PB058]; NSFC [31300318, 31170408, 31270433, 31450110421, 11671348]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China-Yunnan United fund(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science (CAS) Special Fund for the Excellent Youth; CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	Funding was obtained from the National Science Fund for Distinguished Young Scholars (31325005), and National Natural Science Foundation of China-Yunnan United fund (U1302267), the Chinese Academy of Science (CAS) Special Fund for the Excellent Youth (KSCX2-EW-Q-9), the CAS President's International Fellowship Initiative (2015PB058), and other NSFC grants (31300318, 31170408, 31270433, 31450110421, 11671348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our experimental subjects, who managed to entertain themselves for little money in exchange. Thanks to Haiqiang Lan, Master's student of the Behavioral and Experimental Economics Research Center, who contributed to data collection. Derek Dunn, Marko Jusup, Zhen Wang, Michele Mignini, Rebekka Kesberg, Anna Dreber kindly commented on earlier versions of the manuscript. Funding was obtained from the National Science Fund for Distinguished Young Scholars (31325005), and National Natural Science Foundation of China-Yunnan United fund (U1302267), the Chinese Academy of Science (CAS) Special Fund for the Excellent Youth (KSCX2-EW-Q-9), the CAS President's International Fellowship Initiative (2015PB058), and other NSFC grants (31300318, 31170408, 31270433, 31450110421, 11671348).	Molina JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083700; Attane I, 2012, CHINA PERSPECT, V4, P5; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balafoutas L, 2014, P NATL ACAD SCI USA, V111, P15924, DOI 10.1073/pnas.1413170111; Balliet D, 2011, PSYCHOL BULL, V137, P881, DOI 10.1037/a0025354; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Barker JL, 2016, J EVOLUTION BIOL, V29, P560, DOI 10.1111/jeb.12805; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Birnbaum GE, 2014, PERSONALITY SOCIAL P; Boehm C., 1999, HIERARCHY FOREST EVO; Charness G, 2009, ECONOMETRICA, V77, P909, DOI 10.3982/ECTA7416; Cox JC, 2013, SOUTH ECON J, V79, P496, DOI 10.4284/0038-4038-2012.186; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Dal Bo P, 2005, AM ECON REV, V95, P1591; David-Barrett T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118329; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Dyble M, 2015, SCIENCE, V348, P796, DOI 10.1126/science.aaa5139; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Falk A, 2015, CESIFO AR C BEH EC M; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Fehr E, 2007, ANNU REV SOCIOL, V33, P43, DOI 10.1146/annurev.soc.33.040406.131812; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Friebel G, 2013, WORKING PAPER; FUDENBERG D, 1994, ECONOMETRICA, V62, P997, DOI 10.2307/2951505; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Gong BL, 2015, EXP ECON, V18, P302, DOI 10.1007/s10683-014-9403-2; Gong BL, 2012, J ECON BEHAV ORGAN, V83, P59, DOI 10.1016/j.jebo.2011.06.010; Kuwabara K, 2005, SOC FORCES, V84, P1257, DOI 10.1353/sof.2006.0020; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Mattison SM, 2014, AM ANTHROPOL, V116, P591, DOI 10.1111/aman.12125; Nee V, 1996, AM J SOCIOL, V101, P908, DOI 10.1086/230784; Niederle M, 2015, HDB EXPT EC, V2; Page SE, 2007, DIFFERENCE: HOW THE POWER OF DIVERSITY CREATES BETTER GROUPS, FIRMS, SCHOOLS, AND SOCIETIES, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Reuters, 2015, REUTERS; Seabright P, 2012, WAR OF THE SEXES: HOW CONFLICT AND COOPERATION HAVE SHAPED MEN AND WOMEN FROM PREHISTORY TO THE PRESENT, P1; Sigmund K., 2010, CALCULUS SELFISHNESS; Simpson B, 2003, SOC FORCES, V82, P35, DOI 10.1353/sof.2003.0081; SIMPSON JA, 1992, J PERS, V60, P31, DOI 10.1111/j.1467-6494.1992.tb00264.x; Stewart AJ, 2014, P NATL ACAD SCI USA, V111, P17558, DOI 10.1073/pnas.1408618111; Szathmary E, 1995, MAJOR TRANSITIONS EV; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wang RW, 2010, SCI CHINA LIFE SCI, V53, P1041, DOI 10.1007/s11427-010-4016-2; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Xiu L, 2013, CONTEMP ECON POLICY, V31, P235, DOI 10.1111/j.1465-7287.2011.00307.x	55	3	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166101	10.1371/journal.pone.0166101	http://dx.doi.org/10.1371/journal.pone.0166101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829046	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300080
J	Villanueva, R; Vidal, EAG; Fernandez-Alvarez, FA; Nabhitabhata, J				Villanueva, Roger; Vidal, Erica A. G.; Fernandez-Alvarez, Fernando A.; Nabhitabhata, Jaruwat			Early Mode of Life and Hatchling Size in Cephalopod Molluscs: Influence on the Species Distributional Ranges	PLOS ONE			English	Article							SQUID DOSIDICUS-GIGAS; OCTOPUS ENTEROCTOPUS-MEGALOCYATHUS; CALAMARY SEPIOTEUTHIS-AUSTRALIS; PELAGIC LARVAL DURATION; GULF-OF-CALIFORNIA; EMBRYONIC-DEVELOPMENT; DEEP-SEA; 1ST DESCRIPTION; LABORATORY CULTURE; LOLIGINID SQUIDS	Cephalopods (nautiluses, cuttlefishes, squids and octopuses) exhibit direct development and display two major developmental modes: planktonic and benthic. Planktonic hatchlings are small and go through some degree of morphological changes during the planktonic phase, which can last from days to months, with ocean currents enhancing their dispersal capacity. Benthic hatchlings are usually large, miniature-like adults and have comparatively reduced dispersal potential. We examined the relationship between early developmental mode, hatchling size and species latitudinal distribution range of 110 species hatched in the laboratory, which represent 13% of the total number of live cephalopod species described to date. Results showed that species with planktonic hatchlings reach broader distributional ranges in comparison with species with benthic hatchlings. In addition, squids and octopods follow an inverse relationship between hatchling size and species latitudinal distribution. In both groups, species with smaller hatchlings have broader latitudinal distribution ranges. Thus, squid and octopod species with larger hatchlings have latitudinal distributions of comparatively minor extension. This pattern also emerges when all species are grouped by genus (n = 41), but was not detected for cuttlefishes, a group composed mainly of species with large and benthic hatchlings. However, when hatchling size was compared to adult size, it was observed that the smaller the hatchlings, the broader the latitudinal distributional range of the species for cuttlefishes, squids and octopuses. This was also valid for all cephalopod species with benthic hatchlings pooled together. Hatchling size and associated developmental mode and dispersal potential seem to be main influential factors in determining the distributional range of cephalopods.	[Villanueva, Roger; Vidal, Erica A. G.; Fernandez-Alvarez, Fernando A.] Passeig Maritim Barceloneta, CSIC, Inst Ciencies Mar, Barcelona, Spain; [Vidal, Erica A. G.] Univ Fed Parana UFPR, Ctr Estudos Mar, Pontal Do Parana, Brazil; [Nabhitabhata, Jaruwat] Prince Songkla Univ, Fac Sci, Excellence Ctr Biodivers Peninsular Thailand CBIP, Hat Yai, Songkhla, Thailand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidade Federal do Parana; Prince of Songkla University	Villanueva, R (corresponding author), Passeig Maritim Barceloneta, CSIC, Inst Ciencies Mar, Barcelona, Spain.	roger@icm.csic.es	Vidal, Erica A G/C-9032-2013; Fernández-Álvarez, Fernando Ángel/B-6196-2014; Nabhitabhata, Jaruwat/AAF-2144-2019; Villanueva, Roger/D-6911-2011	Vidal, Erica A G/0000-0003-4781-8670; Fernández-Álvarez, Fernando Ángel/0000-0002-8679-7377; Villanueva, Roger/0000-0001-8122-3449	Spanish Ministry of Economy and Competiveness [BES-2013-063551]; Brazilian National Research Council Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [250017/2013-0, 207680/2014-0]; Spanish Ministry of Education and Culture [PRX15/00100, AGL2012-39077, CALOCEAN-2]	Spanish Ministry of Economy and Competiveness(Spanish Government); Brazilian National Research Council Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Spanish Ministry of Education and Culture(Spanish Government)	FAFA was supported by a predoctoral fellowship (BES-2013-063551) of the Spanish Ministry of Economy and Competiveness; URL: http://www.mineco.gob.es/portal/siteimineco?lang_choosenzen. EAGV was funded by the Brazilian National Research Council Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Grants no. 250017/2013-0; 207680/2014-0); URL: http://www.ctmq.br/. RV was funded by the Spanish Ministry of Education and Culture (Grant no. PRX15/00100); URL: http://mm.mecd.gob.es/portada-mecdi and by the Spanish Ministry of Economy and Competiveness (Grant no. AGL2012-39077, CALOCEAN-2); URL: http://www.mineco.gob.es/portal/siteimireco?chnosen=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam W., 1962, CEPHALOPODES ARCHIPE, P7; Allcock AL, 1997, MAR BIOL, V129, P97, DOI 10.1007/s002270050150; AMBROSE RF, 1981, VELIGER, V24, P139; Anderson FE, 2011, J MOLLUS STUD, V77, P65, DOI 10.1093/mollus/eyq034; Arkhipkin AI, 2000, J MOLLUS STUD, V66, P551, DOI 10.1093/mollus/66.4.551; Arkhipkin AI, 1999, J PLANKTON RES, V21, P401, DOI 10.1093/plankt/21.2.401; Arnold John M., 1990, Journal of Cephalopod Biology, V1, P117; Aungtonya Charatsee, 2011, Phuket Marine Biological Center Research Bulletin, V70, P15; BAEG GH, 1992, VELIGER, V35, P234; Barratt IM, 2007, MAR BIOL, V150, P387, DOI 10.1007/s00227-006-0365-6; Bartol IK, 2009, J EXP BIOL, V212, P1506, DOI 10.1242/jeb.026948; Bartol IK, 2008, INTEGR COMP BIOL, V48, P720, DOI 10.1093/icb/icn043; BATHAM E. J., 1957, TRANS ROY SOC NEW ZEALAND, V84, P629; Bergstrom B., 1983, P75; Blackburn S, 1998, VELIGER, V41, P249; BOERO F, 1993, BIOL J LINN SOC, V48, P239, DOI 10.1111/j.1095-8312.1993.tb00890.x; Boletzky S.v., 1983, P53; Boletzky S. v., 1983, P31; Boletzky S.v., 1987, P5; BOLETZKY S V, 1983, Memoirs of the National Museum of Victoria, V44, P147; BOLETZKY SV, 1975, B SOC ZOOL FR, V100, P361; BOLETZKY SV, 1971, MAR BIOL, V8, P82, DOI 10.1007/BF00349349; Boletzky SV, 1988, RAPPORT COMMISSION I, V31, P256; BOUCHAUD O, 1991, B MAR SCI, V49, P333; Bower JR, 2012, BIOL BULL-US, V223, P259, DOI 10.1086/BBLv223n3p259; Bower JR, 1999, MAR ECOL PROG SER, V185, P203, DOI 10.3354/meps185203; Boyle P.R., 1983, P365; Boyle P. R., 2005, CEPHALOPODS ECOLOGY; Bozzano A, 2009, MAR BIOL, V156, P1359, DOI 10.1007/s00227-009-1177-2; BRIDGES TS, 1993, BIOL BULL, V184, P144, DOI 10.2307/1542224; BROUGH EJ, 1965, T ROY SOC NZ ZOOL, V6, P7; Byern J V, 2012, AQUAT BIOL, V17, P19, DOI DOI 10.3354/AB00445; Caamal-Monsreal C, 2015, AQUACULTURE, V441, P84, DOI 10.1016/j.aquaculture.2015.01.020; Caldwell RL, COMMUNICATION; Cardoso Franz, 2013, Rev. peru biol., V20, P129; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; Carrasco SA, 2014, NEW ZEAL J ZOOL, V41, P32, DOI 10.1080/03014223.2013.827126; Ceriola L, 2010, J MAR BIOL ASSOC UK, V90, P755, DOI 10.1017/S0025315409991445; Chen DS, 1996, BIOL BULL, V190, P69, DOI 10.2307/1542676; Cheng RB, 2012, MOL BIOL REP, V39, P3461, DOI 10.1007/s11033-011-1118-2; Cheng SH, 2014, HYDROBIOLOGIA, V725, P165, DOI 10.1007/s10750-013-1778-0; CHOE S, 1966, B MAR SCI, V16, P330; Collins MA, 2001, J MAR BIOL ASSOC UK, V81, P105, DOI 10.1017/S0025315401003459; Collins MA, 2006, OCEANOGR MAR BIOL, V44, P277; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cronin ER, 2000, MAR BIOL, V136, P863, DOI 10.1007/s002270000274; Dan S, 2012, AQUAT BIOL, V17, P181, DOI 10.3354/ab00474; Alejo-Plata MD, 2014, AM MALACOL BULL, V32, P132, DOI 10.4003/006.032.0101; DERUSHA R H, 1987, Pacific Science, V41, P104; Dominguez-Contreras JF, 2013, AM MALACOL BULL, V31, P95, DOI 10.4003/006.031.0122; Doubleday ZA, 2016, CURR BIOL, V26, pR406, DOI 10.1016/j.cub.2016.04.002; Downey-Breedt NJ, 2016, FISH OCEANOGR, V25, P28, DOI 10.1111/fog.12132; Durward R.D., 1980, ICNAF SEL PAPERS, V6, P7; Farias A, 2011, CIENC MAR, V37, P11, DOI 10.7773/cm.v37i1.1736; Fernandez-Alvarez FA, 2016, ZOOLOGICAL IN PRESS, DOI [10.1371/journal.pone.0165334, DOI 10.1371/JOURNAL.PONE.0165334]; Finn J., 2013, CEPHALOPODS WORLD AN, V3, P228; FORSYTHE J W, 1985, Vie et Milieu, V35, P273; FORSYTHE JW, 1991, B MAR SCI, V49, P88; FORSYTHE JW, 1994, J ZOOL, V233, P175, DOI 10.1111/j.1469-7998.1994.tb08582.x; Gleadall Ian G., 2016, Species Diversity, V21, P31, DOI 10.12782/sd.21.1.031; Gowland FC, 2002, J ZOOL, V258, P505, DOI 10.1017/S0952836902001668; Grasse B, 2014, DRUM CROAKER, V45, P58; Guerra A, 2001, VELIGER, V44, P109; Guzik MT, 2004, THESIS; HAIMOVICI M, 1991, B MAR SCI, V49, P221; Hanlon R.T., 1983, P293; Hanlon R.T., 1983, P251; HANLON R T, 1989, Aquaculture and Fisheries Management, V20, P15, DOI 10.1111/j.1365-2109.1989.tb00438.x; HANLON RT, 1985, LAB ANIM SCI, V35, P33; HANLON RT, 1987, FISH B-NOAA, V85, P163; Hanlon RT, 1997, BIOL BULL-US, V192, P364, DOI 10.2307/1542746; Hanlon RT, 1845, SMITHSONIAN CONTRIBU, V513, P37; Hanlon RT, 1980, B AM MALACOLOGICAL U, V1979, P53; HARTWICK B, 1983, CEPHALOPOD LIFE CYCL, V1, P277; Hayashi S., 1995, B TOYAMA PREFECTURAL, V7, P1; Higgins FA, 2012, J THERM BIOL, V37, P83, DOI 10.1016/j.jtherbio.2011.11.004; Higgins KL, 2013, MAR ECOL PROG SER, V486, P203, DOI 10.3354/meps10330; Hochberg FG, 2006, MOLLUSCAN RES, V26, P128; Hochberg FG., 1992, SMITHSON CONTRIB ZOO, P213; Hoving HJT, 2014, ADV MAR BIOL, V67, P235, DOI 10.1016/B978-0-12-800287-2.00003-2; Ibanez CM, 2014, HYDROBIOLOGIA, V725, P205, DOI 10.1007/s10750-013-1518-5; Iglesias J, 2004, AQUACULT INT, V12, P481, DOI 10.1023/B:AQUI.0000042142.88449.bc; Iglesias J, 2014, CEPHALOPOD CULTURE; Ignatius B, 2006, CURR SCI INDIA, V91, P1089; Ikeda Y, 2005, AQUAC RES, V36, P409, DOI 10.1111/j.1365-2109.2005.01217.x; Ikeda Y, 1999, J MAR BIOL ASSOC UK, V79, P757, DOI 10.1017/S0025315498000939; IRIBARNE OO, 1991, J ZOOL, V223, P549, DOI 10.1111/j.1469-7998.1991.tb04387.x; Itami K., 1963, Bulletin of the Japanese Society of Scientific Fisheries, V29, P514; ITO H, 1985, Bulletin of the Hokkaido National Fisheries Research Institute, P99; Ivarez F, 2015, GENUS OMMASTREPHES O; Jereb P, 2013, CEPHALOPODS WORLD AN, V3; Jereb P., 2010, MYOPSID OEGOPSID SQU, V2, P605; Jivaluk Jutamas, 2005, Phuket Marine Biological Center Research Bulletin, V66, P117; Johnsen S, 1999, BIOL BULL, V197, P26, DOI 10.2307/1542994; JOLL LM, 1976, MAR BIOL, V36, P327, DOI 10.1007/BF00389194; Jones NJE, 2010, J SHELLFISH RES, V29, P241, DOI 10.2983/035.029.0121; Kaneko N, 2006, MOLLUSCAN RES, V26, P113; Kaneko N, 2011, MALACOLOGIA, V54, P97, DOI 10.4002/040.054.0102; Kim Byung Gyun, 2001, Korean Journal of Malacology, V17, P85; KUBODERA T, 1991, B MAR SCI, V49, P235; Lang MA, 1997, P WORKSH FISH MARK P; Laptikhovsky V, 2013, AQUAT BIOL, V18, P21, DOI 10.3354/ab00486; LAROE ET, 1971, MAR BIOL, V9, P9, DOI 10.1007/BF00348813; Leite TS, COMMUNICATION; Lenz TM, 2015, AM MALACOL BULL, V33, P101, DOI 10.4003/006.033.0115; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Levin Lisa A., 1995, P1; Gonzalez ML, 2008, AQUAC RES, V39, P1569, DOI 10.1111/j.1365-2109.2008.02019.x; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; Mangold K., 1983, P387; MANGOLD K, 1971, MAR BIOL, V8, P109, DOI 10.1007/BF00350926; Mangold Katharina, 1998, Smithsonian Contributions to Zoology, V586, P521; Mangold-Wirz K, 1976, RAPPORT COMMISSION I, V23, P83; Markaida U, 2005, FISH B-NOAA, V103, P219; Marquez L, 2013, HELGOLAND MAR RES, V67, P461, DOI 10.1007/s10152-012-0335-y; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; Martins RS, 2014, FISH OCEANOGR, V23, P116, DOI 10.1111/fog.12046; Martins RS, 2010, J EXP MAR BIOL ECOL, V386, P19, DOI 10.1016/j.jembe.2010.02.014; MAURIS E, 1989, MAR BEHAV PHYSIOL, V14, P189, DOI 10.1080/10236248909378705; MCCONATHY DA, 1980, MALACOLOGIA, V19, P279; Miske V, 2006, MOLLUSCAN RES, V26, P169; Miyahara K, 2006, J MOLLUS STUD, V72, P199, DOI 10.1093/mollus/eyi068; Mladineo Ivona, 2003, Acta Adriatica, V44, P77; Moreira AA, 2011, J EXP MAR BIOL ECOL, V407, P34, DOI 10.1016/j.jembe.2011.06.029; Muus B, 2002, MALACOLOGIA, V44, P175; Nabhitabhata J., 1998, SPECIAL PUBLICATION, V18, P25; Nabhitabhata J., 2005, PHUKET MAR BIOL CTR, V66, P337; Nabhitabhata J., COMMUNICATION; Nabhitabhata J, 2003, DEP FISHERIES CONTRI, P17; Nabhitabhata J, 2004, RAYONG COASTAL FISHE; Nabhitabhata J, 2015, ALLOPATRIC VARIATION, P97; Nabhitabhata Jaruwat, 1996, Phuket Marine Biological Center Special Publication, V16, P83; Nabhitabhata Jaruwat, 2005, Phuket Marine Biological Center Research Bulletin, V66, P351; Nabhitabhata Jaruwat, 1997, Phuket Marine Biological Center Special Publication, V17, P289; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; NATSUKARI Y, 1991, MAR BEHAV PHYSIOL, V18, P149, DOI 10.1080/10236249109378785; Natsukari Y, 1970, B FACULTY FISHERIES, V30, P15; Nesis K. N., 1987, CEPHALOPODS WORLD; Norman M. D., 2013, CEPHALOPODS WORLD AN, V3, P36; Norman Mark, 2000, P1; NORMAN MD, 1993, P BIOL SOC WASH, V106, P645; Norman MD, 2000, CEPHALOPODS WORLD GU; ODOR RK, 1986, AM MALACOL BULL, V4, P55; OKUBO S, 1995, VELIGER, V38, P192; Okubo S., 1979, ANIMALS NATURE, V9, P2; Okubo S, 1980, SHIMA MARINELAND Q, V25, P4; Okutani T., 1987, P1; OKUTANI T, 1978, Venus the Japanese Journal of Malacology, V37, P245; Okutani T, 1988, B OCEAN RES I U TOKY, V26; Okutani T, 2007, J MOLLUS STUD, V73, P287, DOI 10.1093/mollus/eym026; Ortiz N, 2006, J PLANKTON RES, V28, P881, DOI 10.1093/plankt/fbl023; Ortiz N, 2011, FISH RES, V110, P217, DOI 10.1016/j.fishres.2011.03.016; Ortiz N, 2011, J MAR BIOL ASSOC UK, V91, P705, DOI 10.1017/S0025315410001232; OShea S., 1999, NIWA BIODIVERSITY ME, V112, P1; Otero J, 2009, MAR ECOL PROG SER, V386, P123, DOI 10.3354/meps08041; OVERATH H, 1974, MAR BIOL, V27, P333, DOI 10.1007/BF00394369; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; PACKARD A, 1969, NATURE, V221, P875, DOI 10.1038/221875a0; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Palumbi Stephen R., 1995, P369; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; Promboon P, 2011, SCI MAR, V75, P811, DOI 10.3989/scimar.2011.75n4811; Puneeta P, 2015, J EXP BIOL, V218, P3825, DOI 10.1242/jeb.127670; Quintana D, 2015, AQUACULTURE, V446, P206, DOI 10.1016/j.aquaculture.2015.04.023; Reid A., 2005, CHAMBERED NAUTILUSES, V1, P57; Reid A., 2005, FAO SPECIES CATALOGU, V1, P153; Reid A, 2005, CEPHALOPODS WORLD AN, V1, P204; Roberts MJ, 2005, AFR J MAR SCI, V27, P375, DOI 10.2989/18142320509504096; Robison B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103437; RODANICHE AF, 1984, B MAR SCI, V35, P99; Rodrigues M, 2011, HELGOLAND MAR RES, V65, P43, DOI 10.1007/s10152-010-0199-y; Roper, 2010, CEPHALOPODS WORLD AN, P384; Roper C.F., 2006, CHAMBERED NAUTILUSES, V1; Roper C. F. E., 2010, FAO SPECIES CATALOGU, V2, P269; Roper CFE, 2010, CEPHALOPODS WORLD AN, V2, P200; Roper CFE, 2010, CEPHALOPODS WORLD AN, P183; Rosa R, 2012, MAR ECOL PROG SER, V464, P153, DOI 10.3354/meps09822; Rowell T.W., 1985, Northwest Atlantic Fisheries Organization Scientific Council Studies, P77; Saito Hiroaki, 1993, P457; Sakaguchi Hideo, 2002, Bulletin of the Japanese Society of Fisheries Oceanography, V66, P11; Sakai M, 1998, S AFR J MARINE SCI, V20, P255; SAKURAI Y, 1995, VELIGER, V38, P185; Sales Joao Braullio L, 2014, PLoS One, V9, pe88693, DOI 10.1371/journal.pone.0088693; SANCHEZ P, 1988, S AFR J MARINE SCI, V7, P69, DOI 10.2989/025776188784379107; Sato N, 2009, ICES J MAR SCI, V66, P811, DOI 10.1093/icesjms/fsp145; SCHELTEMA RS, 1989, OLSEN INT S, P183; SEGAWA S, 1988, VELIGER, V30, P230; Segawa S, 2002, B MAR SCI, V71, P801; Singley C.T., 1983, P69; Snyder S., 1986, AM MALACOL B, V4, P241; Snyder S, 1986, AM ASS ZOOL PARKS AQ, P781; Sreeja V, 2012, MOLLUSCAN RES, V32, P43; Staaf D, 2010, MARINE ECOLOGY PROGR, V418, P168; Staaf DJ, 2008, J MAR BIOL ASSOC UK, V88, P759, DOI 10.1017/S0025315408001422; Steer MA, 2003, MAR ECOL PROG SER, V261, P175, DOI 10.3354/meps261175; Steer MA, 2003, MAR FRESHWATER RES, V54, P217, DOI 10.1071/MF02107; Stranks TN, 1996, AM MALACOL BULL, V12, P145; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; Strugnell JM, 2011, DEEP-SEA RES PT II, V58, P196, DOI 10.1016/j.dsr2.2010.05.015; Sugimoto C, 2012, FISHERIES SCI, V78, P287, DOI 10.1007/s12562-011-0464-2; Sukhsangchan Charuay, 2007, Kasetsart Journal Natural Sciences, V41, P531; Summers William C., 1989, Journal of Cephalopod Biology, V1, P21; Teixeira PB., 2011, BIOL REPROD POLVO OC; THOMAS RF, 1977, B MAR SCI, V27, P353; Thore S., 1949, Dana Reports, VNo. 33, P1; TRANTER DJ, 1973, MAR BIOL, V18, P115, DOI 10.1007/BF00348686; Triantafillos L, 2005, ICES J MAR SCI, V62, P1665, DOI 10.1016/j.icesjms.2005.06.004; TURK P E, 1986, Vie et Milieu, V36, P9; Umezu Y, 2012, GROWTH MATURATION ME, P28; Uriarte I., 2014, CEPHALOPOD CULTURE, P365, DOI DOI 10.1007/978-94-017-8648-5; Uriarte I, 2010, BIOL BULL-US, V218, P200, DOI 10.1086/BBLv218n2p200; van der Vyver JSF, 2016, J MAR BIOL ASSOC UK, V96, P1507, DOI 10.1017/S0025315415001794; van Heukelem W.F., 1983, P267; VECCHIONE M, 1995, S AFR J MARINE SCI, V15, P1; Vecchione M, 1997, VIE MILIEU, V47; Veness C., MOVABLE TYPE SCRIPTS; Vidal E. A. G., 2014, CEPHALOPOD CULTURE, P271, DOI [10.1007/978-94-017-8648-5_16, DOI 10.1007/978-94-017-8648-5_16]; Vidal EAG, 2005, AQUAT LIVING RESOUR, V18, P385, DOI 10.1051/alr:2005040; Vidal EAG, 2002, MAR BIOL, V140, P117, DOI 10.1007/s002270100683; Vidal EAG, 2002, B MAR SCI, V71, P915; Vidal EAG, COMMUNICATION; Vidal EAG, 2010, FISH RES, V106, P199, DOI 10.1016/j.fishres.2010.08.009; VILLANUEVA R, 1993, J NAT HIST, V27, P15, DOI 10.1080/00222939300770021; Villanueva R, 2000, MAR BIOL, V136, P449, DOI 10.1007/s002270050704; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; Villanueva R, 1997, MAR BIOL, V129, P113, DOI 10.1007/s002270050152; Villanueva R, 1997, J EXP MAR BIOL ECOL, V208, P169, DOI 10.1016/S0022-0981(96)02670-6; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Villanueva R, 2012, AQUACULTURE, V342, P125, DOI 10.1016/j.aquaculture.2012.02.025; Villanueva R, 2011, J EXP MAR BIOL ECOL, V407, P54, DOI 10.1016/j.jembe.2011.07.012; Voight JR, 2004, J MOLLUS STUD, V70, P400, DOI 10.1093/mollus/70.4.400; von Boletsky S., 1973, Helgolander Wissenschaftliche Meeresuntersuchungen, V25, P135; von Boletzky S., 1984, Vie et Milieu, V34, P87; von Boletzky S, 2001, J MAR BIOL ASSOC UK, V81, P703, DOI 10.1017/S002531540100443X; VONBOLETZKY S, 1982, MALACOLOGIA, V22, P197; VOSS G L, 1990, Proceedings of the California Academy of Sciences, V47, P47; Voss G.L., 1988, P253; VOSS GIBERT L., 1963, U S NATL MUS BULL, V234, P1; Voss Gilbert L., 1998, Smithsonian Contributions to Zoology, V586, P457; Warnke K, 1999, VELIGER, V42, P211; Warnke KM, 2012, NEUES JAHRB GEOL P-A, V266, P51, DOI 10.1127/0077-7749/2012/0259; Watanabe K, 1996, AM MALACOL BULL, V13, P73; Wood JB, 2000, MAR BIOL, V136, P91, DOI 10.1007/s002270050012; Wood JB, 1998, MALACOLOGIA, V39, P11; Yamazaki A, 2002, ZOOL SCI, V19, P763, DOI 10.2108/zsj.19.763; YANG WT, 1986, FISH B-NOAA, V84, P771; Yatsu A, 1999, FISHERIES SCI, V65, P904, DOI 10.2331/fishsci.65.904; Ylitalo HA, 2014, MOLLUSCAN RES, V34, P79, DOI 10.1080/13235818.2013.860871; Yoo HK, 2014, FISHERIES SCI, V80, P925, DOI 10.1007/s12562-014-0767-1; YOUNG RE, 1988, MALACOLOGIA, V29, P201; YOUNG RE, 1972, PAC SCI, V26, P400; YOUNG RE, 1989, VELIGER, V32, P152; Zheng XD., 2014, CEPHALOPOD CULTURE C, P415, DOI [10.1007/978-94-017-8648-5_22, DOI 10.1007/978-94-017-8648-5, DOI 10.1007/978-94-017-8648-5_22]; Zheng Xiaodong, 2010, Transactions of Oceanology and Limnology, V3, P24	255	50	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165334	10.1371/journal.pone.0165334	http://dx.doi.org/10.1371/journal.pone.0165334			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829039	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300039
J	Coetzer, W; Moodley, D; Gerber, A				Coetzer, Willem; Moodley, Deshendran; Gerber, Aurona			Eliciting and Representing High-Level Knowledge Requirements to Discover Ecological Knowledge in Flower-Visiting Data	PLOS ONE			English	Article							BIODIVERSITY; POLLINATORS; ONTOLOGY; NETWORKS	Observations of individual organisms (data) can be combined with expert ecological knowledge of species, especially causal knowledge, to model and extract from flower-visiting data useful information about behavioral interactions between insect and plant organisms, such as nectar foraging and pollen transfer. We describe and evaluate a method to elicit and represent such expert causal knowledge of behavioral ecology, and discuss the potential for wider application of this method to the design of knowledge-based systems for knowledge discovery in biodiversity and ecosystem informatics.	[Coetzer, Willem] SAIAB South African Inst Aquat Biodivers, Private Bag 1015, ZA-6140 Grahamstown, South Africa; [Coetzer, Willem; Moodley, Deshendran; Gerber, Aurona] CSIR Meraka, CAIR Ctr Artificial Intelligence Res, ZA-0001 Pretoria, South Africa; [Gerber, Aurona] Univ Pretoria, Dept Informat, Private Bag X20, ZA-0028 Hatfield, South Africa; [Moodley, Deshendran] Univ Cape Town, Dept Comp Sci, Private Bag X3, ZA-7701 Rondebosch, South Africa; [Coetzer, Willem] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X54001, ZA-4000 Durban, South Africa	National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; University of Pretoria; University of Cape Town; University of Kwazulu Natal	Coetzer, W (corresponding author), SAIAB South African Inst Aquat Biodivers, Private Bag 1015, ZA-6140 Grahamstown, South Africa.; Coetzer, W (corresponding author), CSIR Meraka, CAIR Ctr Artificial Intelligence Res, ZA-0001 Pretoria, South Africa.; Coetzer, W (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X54001, ZA-4000 Durban, South Africa.	w.coetzer@saiab.ac.za	Moodley, Deshendran/N-6228-2013; Gerber, Aurona/AAF-6255-2019	Moodley, Deshendran/0000-0002-4340-9178; Gerber, Aurona/0000-0003-1743-8167; Coetzer, Willem/0000-0003-2214-3910				[Anonymous], 2005, FUNDAMENTALS ECOLOGY; Bartomeus I, 2014, PEERJ, V2, DOI 10.7717/peerj.328; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Brilhante V, 2004, LECT NOTES ARTIF INT, V3171, P144; CHARNIAK E, 1991, AI MAG, V12, P50; Coetzer W, 2014, ECOL INFORM, V24, P47, DOI 10.1016/j.ecoinf.2014.06.008; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Gerber A, 2014, FRONT ART INT APPL 2, P277; Gess S.K., 1996, THE POLLEN WASPS; Gess SK, 2004, J KANSAS ENTOMOL SOC, V77, P602, DOI 10.2317/E7.1; Gess SK, 2010, SANBI BIODIVERS SER, P1; Hardisty A, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-16; Hunter A, 2010, KNOWL ENG REV, V25, P199, DOI 10.1017/S0269888910000019; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; Jax K, 2006, Q REV BIOL, V81, P237, DOI 10.1086/506237; Keet CM, 2005, LECT NOTES COMPUT SC, V3615, P46; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Kokar MM, 2009, INFORM FUSION, V10, P83, DOI 10.1016/j.inffus.2007.01.004; Madin J, 2007, ECOL INFORM, V2, P279, DOI 10.1016/j.ecoinf.2007.05.004; Michener WK, 2007, J INTELL INF SYST, V29, P111, DOI 10.1007/s10844-006-0034-8; Michener WK, 2012, TRENDS ECOL EVOL, V27, P85, DOI 10.1016/j.tree.2011.11.016; Neapolitan RE, 2003, MOL BIOL, V6, P674, DOI DOI 10.1145/1327942.1327961; Pauw A, 2006, AM J BOT, V93, P917, DOI 10.3732/ajb.93.6.917; Pauw A, 2011, OIKOS, V120, P344, DOI 10.1111/j.1600-0706.2010.19039.x; Pennington DD, 2008, INT J METADATA SEMAN, P210; Peterson AT, 2010, SYST BIODIVERS, V8, P159, DOI 10.1080/14772001003739369; Walls RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089606; Whitehead V. B., 2001, Annals of the South African Museum, V108, P143; Williams RJ, 2006, J WEB SEMANT, V4, P237, DOI 10.1016/j.websem.2006.06.002	31	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166559	10.1371/journal.pone.0166559	http://dx.doi.org/10.1371/journal.pone.0166559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851814	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300067
J	Dai, L; Hu, WW; Xia, L; Xia, M; Yang, Q				Dai, Lei; Hu, Wei Wei; Xia, Lu; Xia, Mi; Yang, Qian			Transmissible Gastroenteritis Virus Infection Enhances SGLT1 and GLUT2 Expression to Increase Glucose Uptake	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; EPIDEMIC DIARRHEA VIRUS; COTRANSPORTER SGLT1; CANCER-CELLS; KINASE; ABSORPTION; TRANSPORTERS; INHIBITION; RECEPTOR; REPLICATION	Transmissible gastroenteritis virus (TGEV) is a coronavirus that causes villus atrophy, followed by crypt hyperplasia, reduces the activities of intestinal digestive enzymes, and disrupts the absorption of intestinal nutrients. In vivo, TGEV primarily targets and infects intestinal epithelial cells, which play an important role in glucose absorption via the apical and basolateral transporters Na+-dependent glucose transporter 1 (SGLT1) and facilitative glucose transporter 2 (GLUT2), respectively. In this study, we therefore sought to evaluate the effects of TGEV infection on glucose uptake and SGLT1 and GLUT2 expression. Our data demonstrate that infection with TGEV resulted in increased glucose uptake and augmented expression of EGFR, SGLT1 and GLUT2. Moreover, inhibition studies showed that EGFR modulated glucose uptake in control and TGEV infected cells. Finally, high glucose absorption was subsequently found to promote TGEV replication.	[Dai, Lei; Hu, Wei Wei; Xia, Lu; Xia, Mi; Yang, Qian] Nanjing Agr Univ, Vet Coll, Weigang 1, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Vet Coll, Weigang 1, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn			National Natural Science Foundation of China [31372465]; National Basic Research Program of China (973 program) [2013CB127302]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (31372465), National Basic Research Program of China (973 program 2013CB127302) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDELL D, 1984, MICROBIOS, V39, P95; Boccia MM, 1999, NEUROBIOL LEARN MEM, V71, P104, DOI 10.1006/nlme.1998.3856; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Chambers JW, 2010, J VIROL, V84, P1867, DOI 10.1128/JVI.02123-09; Chen XX, 2015, VET RES, V46, DOI 10.1186/s13567-015-0168-1; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Elfeber K, 2004, HISTOCHEM CELL BIOL, V121, P201, DOI 10.1007/s00418-004-0633-9; ENJUANES L, 2000, VIRUS TAXONOMY CLASS; Fleming SE, 1997, AM J PHYSIOL-GASTR L, V273, pG968, DOI 10.1152/ajpgi.1997.273.4.G968; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Halaihel N, 2000, AM J PHYSIOL-GASTR L, V279, pG587, DOI 10.1152/ajpgi.2000.279.3.G587; Hammer HF, 2012, GASTROENTEROL CLIN N, V41, P611, DOI 10.1016/j.gtc.2012.06.003; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Helliwell PA, 2000, BIOCHEM J, V350, P149, DOI 10.1042/0264-6021:3500149; Hu W., 2016, ONCOTARGET; Hu WW, 2014, ARCH VIROL, V159, P2295, DOI 10.1007/s00705-014-2080-9; INMAN WH, 1985, P NATL ACAD SCI USA, V82, P1346, DOI 10.1073/pnas.82.5.1346; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2001, J PHYSIOL-LONDON, V531, P585, DOI 10.1111/j.1469-7793.2001.0585h.x; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; LANDINI MP, 1984, J GEN VIROL, V65, P1229, DOI 10.1099/0022-1317-65-7-1229; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee MY, 2006, AM J PHYSIOL-GASTR L, V291, pG744, DOI 10.1152/ajpgi.00551.2005; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Penzes Z, 2001, VIRUS GENES, V23, P105, DOI 10.1023/A:1011147832586; Ren JG, 2013, PROSTATE, V73, P1453, DOI 10.1002/pros.22692; Roder PV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089977; SAITO Y, 1984, NEUROLOGY, V34, P276, DOI 10.1212/WNL.34.3.276; Shin HJ, 2011, J BIOL CHEM, V286, P29872, DOI 10.1074/jbc.M111.259978; SHIRAZIBEECHEY SP, 1994, BIOCHEM SOC T, V22, P655, DOI 10.1042/bst0220655; Siddell S.G., 1995, CORONAVIRIDAE, P141, DOI [DOI 10.1007/978-1-4899-1531-3_7, 10.1007/978-1-4899-1531-3_7]; Takai N, 2010, MOL MED REP, V3, P479, DOI 10.3892/mmr_00000284; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wesley RD, 2003, VET MICROBIOL, V95, P175, DOI 10.1016/S0378-1135(03)00150-0; Zhao SS, 2014, VIRUS RES, V192, P34, DOI 10.1016/j.virusres.2014.08.014	46	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165585	10.1371/journal.pone.0165585	http://dx.doi.org/10.1371/journal.pone.0165585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851758	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300021
J	Henkels, KM; Muppani, NR; Gomez-Cambronero, J				Henkels, Karen M.; Muppani, Naveen Reddy; Gomez-Cambronero, Julian			PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases	PLOS ONE			English	Article							PHOSPHOLIPASE-D; INTERLEUKIN-8 SECRETION; CANCER; D2; ACTIVATION; EXPRESSION; MICROENVIRONMENT; INVASION; GROWTH; ANGIOGENESIS	Phospholipase D-2 (PLD2) has a key role in breast cancer formation and metastasis formation with PLD small inhibitors reducing primary tumor growth. This study aimed to evaluate the importance of targeting PLD on the tumor microenvironment. We provide evidence about the beneficial effect of PLD inhibitors [FIPI (dual PLD1/PLD2) or VU0155072-2 (PLD2 inhibitor)] on avoiding infiltration of tumor-helping macrophages and neutrophils. Tumor growth and metastasis within the primary tumors had low (<20% over controls) PLD enzyme activity. Unexpectedly, we found that the inhibitors also affected PLD2 gene expression and protein albeit at a lesser extent. The later could indicate that targeting both the actual PLD enzyme and its activity could be beneficial for potential cancer treatments in vivo. F4/80 and Ly6G staining of macrophages and neutrophils, respectively, and Arg1 staining data were consistent with M2 and N2 polarization. NOS2 staining increased in xenotransplants upon treatment with PLD2 inhibitors suggesting the novel observation that an increased recruitment of M1 macrophages occurred in primary tumors. PLD inhibitor-treated primary tumors had large, fragile, necrotic areas that were Arg1(+) for M2 macrophages. The xenotransplants also caused the formation of large F4/80(+) and Ly6G(+) (>100 mu m) clusters in lungs. However, PLD inhibitors, particularly FIPI, were able to diminish leukocyte presence. Ex vivo chemotaxis and PLD activity of peripheral blood neutrophils (PMN) and peritoneal macrophages was also determined. Whereas PMN had impaired functionality, macrophages did not. This significantly increased ("emboldened") macrophage function was due to PLD inhibition. Since tumor-associated leukocytes in primary tumors and metastases were targeted via PLD inhibition, we posit that these inhibitors have a key role in cancer regression, while still affording an appropriate inflammatory response at least from off-site innate immunity macrophages.	[Gomez-Cambronero, Julian] Brigham & Women Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Gomez-Cambronero, Julian] Harvard Med Sch, Boston, MA 02115 USA; [Henkels, Karen M.; Muppani, Naveen Reddy; Gomez-Cambronero, Julian] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Brigham & Women Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA.; Gomez-Cambronero, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Gomez-Cambronero, J (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health (NIH) [HL05665314]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH, HL05665314).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arun SN, 2013, J LIPID RES, V54, P581, DOI 10.1194/jlr.M027060; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901; BUCANA CD, 1992, AM J PATHOL, V141, P1225; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; De Larco JE, 2003, P NATL ACAD SCI USA, V100, P13988, DOI 10.1073/pnas.2335921100; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; Foster DA, 2003, MOL CANCER RES, V1, P789; Fridlender ZG, 2013, BRIT J CANCER, V108, P1288, DOI 10.1038/bjc.2013.93; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fritz JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00587; Fu X, 2015, INT IMMUNOPHARMACOL, V28, P666, DOI 10.1016/j.intimp.2015.07.033; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Ganesan R, 2015, BBA-MOL CELL BIOL L, V1851, P261, DOI 10.1016/j.bbalip.2014.12.007; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hayes TS, 1999, CELL SIGNAL, V11, P195, DOI 10.1016/S0898-6568(98)00066-7; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hu XL, 2012, CELL MOL IMMUNOL, V9, P464, DOI 10.1038/cmi.2012.47; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Kaczmarek M, 2012, WSPOLCZESNA ONKOL, V16, P279, DOI 10.5114/wo.2012.30054; Kim YR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-144; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Leek RD, 1996, CANCER RES, V56, P4625; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Mantovani A, 2011, NAT MED, V17, P285, DOI 10.1038/nm0311-285; MEATS JE, 1993, AGENTS ACTIONS, V39, pC14, DOI 10.1007/BF01972706; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Oshimoto H, 2003, ONCOL RES, V14, P31, DOI 10.3727/000000003108748586; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Peng HJ, 2011, MOL CELL BIOL, V31, P2227, DOI 10.1128/MCB.01348-10; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Uchida H, 1999, ANTICANCER RES, V19, P671; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Zenger E, 2002, CANCER RES, V62, P5536; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	56	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166553	10.1371/journal.pone.0166553	http://dx.doi.org/10.1371/journal.pone.0166553			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851813	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300066
J	Hertach, T; Puissant, S; Gogala, M; Trilar, T; Hagmann, R; Baur, H; Kunz, G; Wade, EJ; Loader, SP; Simon, C; Nagel, P				Hertach, Thomas; Puissant, Stephane; Gogala, Matija; Trilar, Tomi; Hagmann, Reto; Baur, Hannes; Kunz, Gernot; Wade, Elizabeth J.; Loader, Simon P.; Simon, Chris; Nagel, Peter			Complex within a Complex: Integrative Taxonomy Reveals Hidden Diversity in Cicadetta brevipennis (Hemiptera: Cicadidae) and Unexpected Relationships with a Song Divergent Relative	PLOS ONE			English	Article							NEW-ZEALAND CICADAS; SPECIES DELIMITATION; MITOCHONDRIAL-DNA; GENE FLOW; PHYLOGENETIC UTILITY; CALLING SONGS; SENSU-LATO; PHYLOGEOGRAPHY; HYBRIDIZATION; SPECIATION	Multiple sources of data in combination are essential for species delimitation and classification of difficult taxonomic groups. Here we investigate a cicada taxon with unusual cryptic diversity and we attempt to resolve seemingly contradictory data sets. Cicada songs act as species-specific premating barriers and have been used extensively to reveal hidden taxonomic diversity in morphologically similar species. The Palaearctic Cicadetta montana species complex is an excellent example where distinct song patterns have disclosed multiple recently described species. Indeed, two taxa turned out to be especially diverse in that they form a "complex within the complex" : the Cicadetta cerdaniensis song group (four species studied previously) and Cicadetta brevipennis (examined in details here). Based on acoustic, morphological, molecular, ecological and spatial data sampled throughout their broad European distribution, we find that Cicadetta brevipennis s.l. comprises five lineages. The most distinct lineage is identified as Cicadetta petryi Schumacher, 1924, which we reassign to the species level. Cicadetta brevipennis litoralis Puissant & Hertach ssp. n. and Cicadetta brevipennis hippolaidica Hertach ssp. n. are new to science. The latter hybridizes with Cicadetta brevipennis brevipennis Fieber, 1876 at a zone inferred from intermediate song patterns. The fifth lineage requires additional investigation. The C. cerdaniensis and the C. brevipennis song groups exhibit characteristic, clearly distinct basic song patterns that act as reproductive barriers. However, they remain completely intermixed in the Bayesian and maximum likelihood COI and COII mitochondrial DNA phylogenies. The closest relative of each of the four cerdaniensis group species is a brevipennis group taxon. In our favoured scenario the phylogenetic pairs originated in common Pleistocene glacial refuges where the taxa speciated and experienced sporadic inter-group hybridization leading to extensive introgression and mitochondrial capture.	[Hertach, Thomas; Hagmann, Reto; Loader, Simon P.; Nagel, Peter] Univ Basel, Dept Environm Sci, Biogeog, Basel, Switzerland; [Hertach, Thomas; Hagmann, Reto; Baur, Hannes] Burgergemeinde Bern, Nat Hist Museum, Dept Invertebrates, Bern, Switzerland; [Puissant, Stephane] Museum Jardin Sci, Dijon, France; [Puissant, Stephane] Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, Evolut,Biodiversite, Paris, France; [Gogala, Matija] Slovenian Acad Sci & Arts, Ljubljana, Slovenia; [Trilar, Tomi] Slovenian Museum Nat Hist, Ljubljana, Slovenia; [Baur, Hannes] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Kunz, Gernot] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Wade, Elizabeth J.; Simon, Chris] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Wade, Elizabeth J.] USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Loader, Simon P.] Univ Roehampton, Dept Life Sci, London, England	University of Basel; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Slovenian Academy of Sciences & Arts (SASA); University of Bern; University of Graz; University of Connecticut; United States Department of Agriculture (USDA); Roehampton University	Hertach, T (corresponding author), Univ Basel, Dept Environm Sci, Biogeog, Basel, Switzerland.; Hertach, T (corresponding author), Burgergemeinde Bern, Nat Hist Museum, Dept Invertebrates, Bern, Switzerland.	thomas.hertach@unibas.ch	Trilar, Tomi/ABA-6909-2020		Wolfermann-Nageli Foundation; Zigerli-Hegi Foundation; Walter Haefner Foundation; Paul Schiller Foundation; Biedermann-Mantel Foundation; Temperatio Foundation; Otto Gamma Foundation and Pro Natura; Ministry of Higher Education, Science and Technology of the Republic of Slovenia [P1-0255]; US National Science Foundation [DEB-0955849]	Wolfermann-Nageli Foundation; Zigerli-Hegi Foundation; Walter Haefner Foundation; Paul Schiller Foundation; Biedermann-Mantel Foundation; Temperatio Foundation; Otto Gamma Foundation and Pro Natura; Ministry of Higher Education, Science and Technology of the Republic of Slovenia; US National Science Foundation(National Science Foundation (NSF))	The Swiss cicada project (TH) was financed by the following funders: Wolfermann-Nageli Foundation; Zigerli-Hegi Foundation; Walter Haefner Foundation; Paul Schiller Foundation (http://www.paul-schiller-stiftung.ch); Biedermann-Mantel Foundation; Temperatio Foundation (http://www.temperatio.ch); Otto Gamma Foundation and Pro Natura (http://www.pronatura.ch). The travel expenses in Italy (TH) are covered by the Freiwillige Akademische Gesellschaft Basel (http://www.fag-basel.ch). The research of TT was part of the programme "Communities, relations and communications in the ecosystems" (no. P1-0255), financed by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia. The work of EW and CS was supported by the US National Science Foundation (http:/www.nsf.gov) under grant number DEB-0955849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Alexander R. D., 1962, Miscellaneous Publications Museum of Zoology University of Michigan, Vno. 121, P1; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barbanera F, 2009, MOL PHYLOGENET EVOL, V52, P103, DOI 10.1016/j.ympev.2009.02.006; Baroni Urbani C, 1977, MEM SOC ENTOMOL ITAL, V56, P35; Bennik RM, 2016, SYST ENTOMOL, V41, P309, DOI 10.1111/syen.12155; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Boitier E, 2006, ARVERNSIS, V37-38, P7; Boulard M, 1995, POSTURES CYMBALISATI; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Buckley TR, 2009, P ROY SOC B-BIOL SCI, V276, P1055, DOI 10.1098/rspb.2008.1552; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chan KMA, 2005, EVOLUTION, V59, P720; Correggiari AM, 1996, J QUATERNARY SCI, V9, P697; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delorme Q, 1790, TETTIGETALNA ARGENTA, V71, P31; Den Hollander Jerone, 1995, P440; Drosopoulos S, 2006, CONT T ENT, P219; DUGDALE JS, 1978, NEW ZEAL J ZOOL, V5, P295, DOI 10.1080/03014223.1978.10428319; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feder JL, 2013, J EVOLUTION BIOL, V26, P261, DOI 10.1111/jeb.12009; Fieber FX, 1876, REV MAG ZOOL, V4, P11; Fonseca PJ, 2002, J COMP PHYSIOL A, V187, P971, DOI 10.1007/s00359-001-0267-5; Fritz U, 2005, ZOOL SCR, V34, P351, DOI 10.1111/j.1463-6409.2005.00188.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gogala A., 2008, P121; Gogala M, 2004, AN ACAD BRAS CIENC, V76, P316, DOI 10.1590/S0001-37652004000200020; Gogala Matija, 2014, Acta Entomologica Slovenica, V22, P101; Gogala Matija, 1999, Reichenbachia, V33, P91; Gottsberger B, 2007, J COMP PHYSIOL A, V193, P703, DOI 10.1007/s00359-007-0225-y; GRANT PR, 1995, EVOLUTION, V49, P229, DOI 10.1111/j.1558-5646.1995.tb02235.x; Gurcel Kevin, 2015, Entomologiste (Paris), V71, P245; Gvozdik V, 2015, MOL PHYLOGENET EVOL, V83, P143, DOI 10.1016/j.ympev.2014.11.012; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellrigl K., 1996, TIERWELT SUDTIROLS; Hertach Thomas, 2007, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V80, P37; Hertach T, 2015, ZOOL J LINN SOC-LOND, V173, P320, DOI 10.1111/zoj.12212; Hertach T, 2011, ZOOTAXA, P25, DOI 10.11646/zootaxa.2771.1.3; Hertach T, 2013, REV SUISSE ZOOL, V120, P229; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hey J, 2012, EVOLUTION, V66, P1413, DOI 10.1111/j.1558-5646.2011.01542.x; Hugel Sylvain, 2008, Bulletin de la Societe Entomologique de Mulhouse, V64, P5; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL; Klasa Anna, 2015, Chronmy Przyrode Ojczysta, V71, P108; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lecocq T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-263; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Marshall DC, 2011, SYST BIOL, V60, P482, DOI 10.1093/sysbio/syr017; Marshall DC, 2009, MOL ECOL, V18, P1995, DOI 10.1111/j.1365-294X.2009.04155.x; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Meineke T., 2012, Entomologische Nachrichten und Berichte, V56, P133; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Minelli A, 2006, ITALIAN FAUNAL PROVI, P37; Moore W, 2014, CURR BIOL, V24, P2435, DOI 10.1016/j.cub.2014.09.022; Moulds MS, 2005, REC AUST MUS, V57, P375, DOI 10.3853/j.0067-1975.57.2005.1447; Nicholls JA, 2012, MOL ECOL, V21, P4051, DOI 10.1111/j.1365-294X.2012.05683.x; Nunes VL, 2014, MOL ECOL RESOUR, V14, P27, DOI 10.1111/1755-0998.12158; Owen CL, 2015, MOL PHYLOGENET EVOL, V83, P258, DOI 10.1016/j.ympev.2014.07.008; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paterson H.E.H., 1985, Transvaal Museum Monograph, P21; Pfeifer MA, 2015, FAUNA FLORA RHEINL P, V13, P121; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Podnar M, 2005, MOL ECOL, V14, P575, DOI 10.1111/j.1365-294X.2005.02427.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Popov AV, 1997, ACTA ENTOMOL SLOV, V5, P89; Popple LW, 2013, ZOOTAXA, V3730, P1; Puissant S., 2001, ECOLE PRAT HAUTES ET, V14, P141; Puissant S., 2006, BE A DEILHAC ET AYNA; Puissant S, 2010, SYST BIODIVERS, V8, P555, DOI 10.1080/14772000.2010.532832; Puissant Stephane, 2000, EPHE Biologie et Evolution des Insectes, V13, P111; Quartau JA, 2006, CONT T ENT, P227; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2007, TRACER V1 5 2007; Schilthuizen M., 2002, FROGS FLIES DANDELIO; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schumacher F., 1924, Deutsche Entomologische Zeitschrift, V1924, P329; SHACKLETON JC, 1984, J FIELD ARCHAEOL, V11, P307, DOI 10.1179/009346984791535476; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smadja CM, 2011, MOL ECOL, V20, P5123, DOI 10.1111/j.1365-294X.2011.05350.x; Solis-Lemus C, 2015, EVOLUTION, V69, P492, DOI 10.1111/evo.12582; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Sueur J, 2003, SYST ENTOMOL, V28, P481, DOI 10.1046/j.1365-3113.2003.00222.x; Sueur Jerome, 2007, Zootaxa, V1442, P55; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Sullivan J, 2014, HEREDITY, V113, P185, DOI 10.1038/hdy.2014.27; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Trilar T., 2004, Linzer Biologische Beitraege, V36, P1383; Trilar T., 2012, Folia Entomologica Hungarica, V73, P9; Trilar T, 2008, B INSECTOL, V61, P185; Trilar Tomi, 2006, Acta Entomologica Slovenica, V14, P175; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Villet Martin, 1995, P422; Wade EJ, 2015, J EVOLUTION BIOL, V28, P2318, DOI 10.1111/jeb.12756; Warren BH, 2012, EVOLUTION, V66, P1490, DOI 10.1111/j.1558-5646.2011.01550.x; Wickham H., 2009, GGPLOF2 ELEGANT GRAP; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zunino M, 2004, BIOGEOGRAFIA DIMENSI	109	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165562	10.1371/journal.pone.0165562	http://dx.doi.org/10.1371/journal.pone.0165562			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851754	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300020
J	Hertzog, LR; Ebeling, A; Meyer, ST; Eisenhauerm, N; Fischer, C; Hildebrandt, A; Wagg, C; Weisser, WW				Hertzog, Lionel R.; Ebeling, Anne; Meyer, Sebastian T.; Eisenhauerm, Nico; Fischer, Christine; Hildebrandt, Anke; Wagg, Cameron; Weisser, Wolfgang W.			High Survival of Lasius niger during Summer Flooding in a European Grassland	PLOS ONE			English	Article							TERRESTRIAL INVERTEBRATES; HYMENOPTERA; INUNDATION; MANGROVE; ANTS; FORMICIDAE; STABILITY	Climate change is projected to increase the frequency of extreme events, such as flooding and droughts, which are anticipated to have negative effects on the biodiversity of primary producers and consequently the associated consumer communities. Here we assessed the effects of an extreme early summer flooding event in 2013 on ant colonies along an experimental gradient of plant species richness in a temperate grassland. We tested the effects of flood duration, plant species richness, plant cover, soil temperature, and soil porosity on ant occurrence and abundance. We found that the ant community was dominated by Lasius niger, whose presence and abundance after the flood was not significantly affected by any of the tested variables, including plant species richness. We found the same level of occupation by L. niger at the field site after the flood (surveyed in 2013) as before the flood (surveyed in 2006). Thus, there were no negative effects of the flood on the presence of L. niger in the plots. We can exclude recolonisation as a possible explanation of ant presence in the field site due to the short time period between the end of the flood and survey as well as to the absence of a spatial pattern in the occupancy data. Thus, the omnipresence of this dominant ant species 1 month after the flood indicates that the colonies were able to survive a 3-week summer flood. The observed ant species proved to be flood resistant despite experiencing such extreme climatic events very rarely.	[Hertzog, Lionel R.; Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, D-85354 Freising Weihenstephan, Germany; [Ebeling, Anne] Friedrich Schiller Univ Jena, Inst Ecol, Dornburger Str 159, D-07745 Jena, Germany; [Eisenhauerm, Nico; Hildebrandt, Anke] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Eisenhauerm, Nico] Univ Leipzig, Inst Biol, Johannisallee 21, D-04103 Leipzig, Germany; [Fischer, Christine; Hildebrandt, Anke] Friedrich Schiller Univ Jena, Inst Geosci, Burgweg 11, D-07749 Jena, Germany; [Fischer, Christine; Hildebrandt, Anke] Max Planck Inst Biogeochem, FOB 100164, D-07701 Jena, Germany; [Wagg, Cameron] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurestr 190, CH-8057 Zurich, Switzerland	Technical University of Munich; Friedrich Schiller University of Jena; Leipzig University; Friedrich Schiller University of Jena; Max Planck Society; University of Zurich	Hertzog, LR (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, D-85354 Freising Weihenstephan, Germany.	I.hertzog@tum.de	Wagg, Cameron/O-4318-2019; Eisenhauer, Nico/I-5932-2012; Weisser, Wolfgang W/B-9718-2014; Eisenhauer, Nico/I-3191-2019; Meyer, Sebastian Tobias/AAH-3856-2021; Hildebrandt, Anke/J-7062-2012	Wagg, Cameron/0000-0002-9738-6901; Eisenhauer, Nico/0000-0002-0371-6720; Weisser, Wolfgang W/0000-0002-2757-8959; Eisenhauer, Nico/0000-0002-0371-6720; Meyer, Sebastian Tobias/0000-0003-0833-1472; Hildebrandt, Anke/0000-0001-8643-1634; Hertzog, Lionel/0000-0003-0869-9672	German Research Foundation [FOR 456, FOR 1451, FZT 118]; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation [FZT 118]; Technische Universitat Munchen	German Research Foundation(German Research Foundation (DFG)); German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation; Technische Universitat Munchen	All authors received funding from the German Research Foundation (http://www.dfg.de/en/) grant number FOR 456 and FOR 1451. NE received support from the German Research Foundation grant FZT 118. The German Research Foundation and the Technische Universitat Munchen provided support for Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are deeply grateful for the help provided by the gardener team of the Jena Experiment as well as by the student helpers in weeding the field site and helping with the data collection. We are deeply grateful to Viktor Malakhov for providing us with the rights to use his photos of the flood. We thank Lars Clement for providing the data from the 2006 ant survey and Winfried Voigt for the ant dataset of 2005. We also thank Christiane Roscher and Alexandra Weigelt for granting us access to the plant cover data. The Jena Experiment is funded by the German Research Foundation (FOR 456, FOR 1451). Further support came from the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, funded by the German Research Foundation (FZT 118). This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing.	Adis J, 2002, FRESHWATER BIOL, V47, P711, DOI 10.1046/j.1365-2427.2002.00892.x; Anderson C, 2002, INSECT SOC, V49, P99, DOI 10.1007/s00040-002-8286-y; Arndt E, 2011, ENTOMOL GEN, V33, P39; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bloschl G, 2013, HYDROL EARTH SYST SC, V17, P5197, DOI 10.5194/hess-17-5197-2013; BOOMSMA JJ, 1982, ECOL ENTOMOL, V7, P121, DOI 10.1111/j.1365-2311.1982.tb00650.x; Devigne C, 2006, INSECT SOC, V53, P46, DOI 10.1007/s00040-005-0834-9; Dietrich Christian O., 1998, Myrmecologische Nachrichten, V2, P35; Ellenberg H., 1996, VEGETATION MITTELEUR, V1095; ELMES GW, 1971, J ANIM ECOL, V40, P495, DOI 10.2307/3258; Fischer C, 2015, PLANT SOIL, V397, P1, DOI 10.1007/s11104-014-2373-5; Folgarait PJ, 2003, BIOL FERT SOILS, V38, P349, DOI 10.1007/s00374-003-0655-9; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; KLUGE G, 2000, KLIMA AUSGEWAHLTER O; Lipowsky A, 2015, PERSPECT PLANT ECOL, V17, P66, DOI 10.1016/j.ppees.2014.11.003; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Maschwitz U, 2000, NATURWISSENSCHAFTEN, V87, P563, DOI 10.1007/s001140050780; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Nielsen MG, 1997, INSECT SOC, V44, P15, DOI 10.1007/s000400050026; Nielsen MG, 2006, PHYSIOL ENTOMOL, V31, P120, DOI 10.1111/j.1365-3032.2005.00492.x; Nielsen MG, 2011, MYRMECOL NEWS, V14, P113; Passera L., 1994, CHARACTERISTICS TRAM, P23; Philpott SM, 2010, ANT ECOLOGY, P137; Plum N, 2005, WETLANDS, V25, P721, DOI 10.1672/0277-5212(2005)025[0721:TIIFGA]2.0.CO;2; Proulx R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013382; Purcell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089211; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rust MK, 2000, J AGR URBAN ENTOMOL, V17, P201; Schowalter TD, 2012, ANNU REV ENTOMOL, V57, P1, DOI 10.1146/annurev-ento-120710-100610; Schroter K, 2015, HYDROL EARTH SYST SC, V19, P309, DOI 10.5194/hess-19-309-2015; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Stein C, 2013, HOCHWASSER ELBE DONA; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; WILSON EDWARD O., 1955, BULL MUS COMP ZOOL HARVARD UNIV, V113, P1; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092	37	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0152777	10.1371/journal.pone.0152777	http://dx.doi.org/10.1371/journal.pone.0152777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851761	Green Published, gold			2022-12-27	WOS:000387909300001
J	Kranzhofer, DK; Gilsbach, R; Gruning, BA; Backofen, R; Nuhrenberg, TG; Hein, L				Kranzhoefer, David K.; Gilsbach, Ralf; Gruening, Bjoern A.; Backofen, Rolf; Nuehrenberg, Thomas G.; Hein, Lutz			5'-Hydroxymethylcytosine Precedes Loss of CpG Methylation in Enhancers and Genes Undergoing Activation in Cardiomyocyte Maturation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MAMMALIAN DNA; TET PROTEINS; THYMINE DNA; GENOME; DIFFERENTIATION; CHROMATIN; DYNAMICS; REVEALS; 5-CARBOXYLCYTOSINE	Background Cardiomyocytes undergo major changes in DNA methylation during maturation and transition to a non-proliferative state after birth. 5'-hydroxylation of methylated cytosines (5hmC) is not only involved in DNA loss of CpG methylation but is also thought to be an epigenetic mark with unique distribution and functions. Here, we sought to get insight into the dynamics of 5'-hydroxymethylcytosine in newborn and adult cardiomyocytes. Methods Cardiomyocyte nuclei from newborn and adult C57BL/6 mice were purified by flow cytometric sorting. 5hmC-containing DNA was captured by selective chemical labeling, followed by deep sequencing. Sequencing reads of library replicates were mapped independently (n = 3 for newborn, n = 2 for adult mice) and merged for further analysis steps. 5hmC coverage was normalized to read length and the total number of mapped reads (RPKM). MethylC-Seq, ChIP-Seq and RNA-Seq data sets of newborn and adult cardiomyocytes served to elucidate specific features of 5hmC at gene bodies and around low methylated regions (LMRs) representing regulatory genomic regions with enhancer function. Results 163,544 and 315,220 5hmC peaks were identified in P1 and adult cardiomyocytes, respectively. Of these peaks, 66,641 were common between P1 and adult cardiomyocytes with more than 50% reciprocal overlap. P1 and adult 5hmC peaks were overrepresented in genic features such as exons, introns, 3'- and 5'-untranslated regions (UTRs), promotors and transcription end sites (TES). During cardiomyocyte maturation, 5hmC was found to be enriched at sites of subsequent DNA loss of CpG methylation such as gene bodies of upregulated genes (i.e. Atp2a2, Tnni3, Mb, Pdk4). Additionally, centers of postnatally established enhancers were premarked by 5hmC before DNA loss of CpG methylation. Conclusions Simultaneous analysis of 5hmC-Seq, MethylC-Seq, RNA-Seq and ChIP-Seq data at two defined time points of cardiomyocyte maturation demonstrates that 5hmC is positively associated with gene expression and decorates sites of subsequent DNA loss of CpG methylation.	[Kranzhoefer, David K.; Gilsbach, Ralf; Nuehrenberg, Thomas G.; Hein, Lutz] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Fac Med, Freiburg, Germany; [Gruening, Bjoern A.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, Freiburg, Germany; [Nuehrenberg, Thomas G.] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany; [Hein, Lutz] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; Universitats Herzzentrum Freiburg; University of Freiburg	Nuhrenberg, TG; Hein, L (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Fac Med, Freiburg, Germany.; Nuhrenberg, TG (corresponding author), Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany.; Hein, L (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany.	thomas.nuehrenberg@universitaets-herzzentrum.de; lutz.hein@pharmakol.uni-freiburg.de	Hein, Lutz/GRJ-8644-2022; Backofen, Rolf/AAC-1569-2021	Gilsbach, Ralf/0000-0002-0895-1535; Gruning, Bjorn/0000-0002-3079-6586	Deutsche Forschungsgemeinschaft [SFB992]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, SFB992, www.dfg.de.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bogdanovic O, 2016, NAT GENET, V48, P417, DOI 10.1038/ng.3522; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; He AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5907; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirai M, 2016, CIRC RES, V118, P20, DOI 10.1161/CIRCRESAHA.115.307697; Hon GC, 2014, MOL CELL, V56, P286, DOI 10.1016/j.molcel.2014.08.026; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Ivanov M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r83; Jonker SS, 2016, J ENDOCRINOL, V228, pR1, DOI 10.1530/JOE-15-0309; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lu FL, 2014, GENE DEV, V28, P2103, DOI 10.1101/gad.248005.114; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mann IK, 2013, GENOME RES, V23, P988, DOI 10.1101/gr.146654.112; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor CEM R.R, 2014, FUNCTIONAL ANAL DNA, Vxv; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Nuhrenberg T, 2014, CELL TISSUE RES, V356, P585, DOI 10.1007/s00441-014-1887-8; Orlanski S, 2016, P NATL ACAD SCI USA, V113, P5018, DOI 10.1073/pnas.1604365113; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002; Preissl S, 2015, CIRC RES, V117, P413, DOI 10.1161/CIRCRESAHA.115.306337; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Soonpaa MH, 2015, CELL, V163, P781, DOI 10.1016/j.cell.2015.10.037; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	64	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166575	10.1371/journal.pone.0166575	http://dx.doi.org/10.1371/journal.pone.0166575			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851806	Green Submitted, gold, Green Published			2022-12-27	WOS:000387909300069
J	Rebala, K; Rabtsava, AA; Kotova, SA; Kipen, VN; Zhurina, NV; Gandzha, AI; Tsybovsky, IS				Rebala, Krzysztof; Rabtsava, Aline A.; Kotova, Svetlana A.; Kipen, Viachaslau N.; Zhurina, Natalja V.; Gandzha, Alla I.; Tsybovsky, Iosif S.			STR Profiling for Discrimination between Wild and Domestic Swine Specimens and between Main Breeds of Domestic Pigs Reared in Belarus	PLOS ONE			English	Article							GENETIC TRACEABILITY; PARENTAGE CONTROL; IDENTIFICATION; BOARS; PRODUCTS; DIFFERENTIATION; BIODIVERSITY; MARKERS; SCROFA; SYSTEM	A panel comprising 16 short tandem repeats (STRs) and a gender-specific amelogenin marker was worked out and tested for robustness in discrimination between wild and domestic swine subspecies encountered in Europe, between regional populations of wild boars and between main breeds of domestic pigs reared in Belarus. The STR dataset comprised 310 wild boars, inhabiting all administrative regions of Belarus, and 313 domestic pigs, representing three local and three cosmopolitan lines. Additionally, a total of 835 wild boars were genotyped for the presence of melanocortin 1 receptor (MC1R) alleles specific for domestic pigs. Correctness of assignment of STR profiles to appropriate populations was measured by log-likelihood ratios (log-LRs). All samples were correctly identified as wild boars or domestic pigs with average log-LR of 42.4 (LR = 2.6x10(18)). On the other hand, as many as 50 out of 835 (6.0%) genotyped wild boars from Belarus possessed MC1R alleles specific to domestic pigs, demonstrating supremacy of our STR profiling system over traditional differentiation between wild boars and domestic pigs, based on single binary markers. Mean log-LRs for allocation of wild boars to their regions of origin and of domestic pigs to appropriate breeds were 2.3 (LR = 9.7) and 13.4 (LR = 6.6x10(5)), respectively. Our results demonstrate the developed STR profiling system to be a highly efficient tool for differentiation between wild and domestic swine subspecies and between diverse breeds of domestic pigs as well as for verification of genetic identity of porcine specimens for the purpose of forensic investigations of wildlife crimes, assurance of veterinary public health, parentage control in animal husbandry, food safety management and traceability of livestock products.	[Rebala, Krzysztof] Med Univ Gdansk, Dept Forens Med, Gdansk, Poland; [Rabtsava, Aline A.; Kotova, Svetlana A.; Kipen, Viachaslau N.; Tsybovsky, Iosif S.] State Comm Forens Expertises, Sci & Pract Ctr, Minsk, BELARUS; [Zhurina, Natalja V.; Gandzha, Alla I.] Natl Acad Sci Anim Husb, Sci & Pract Ctr, Zhodino, BELARUS	Fahrenheit Universities; Medical University Gdansk; National Academy of Sciences of Belarus (NASB); Scientific & Practical Centre for Animal Husbandry of the National Academy of Sciences of Belarus	Rebala, K (corresponding author), Med Univ Gdansk, Dept Forens Med, Gdansk, Poland.	k.rebala@gumed.edu.pl	Rębała, Krzysztof/U-9856-2018; Kipen, Slava/Y-8813-2019	Rębała, Krzysztof/0000-0003-2236-7455; Kipen, Slava/0000-0002-7822-0746; Svetlana, Kotova/0000-0002-6521-7732				Alves E, 2009, ANIMAL, V3, P1216, DOI 10.1017/S1751731109004819; Aravena P., 2007, Agro-Ciencia, V23, P133; Babicz M, 2013, ANIM GENET, V44, P357, DOI 10.1111/age.12023; Ballin NZ, 2010, MEAT SCI, V86, P577, DOI 10.1016/j.meatsci.2010.06.001; Brodmann PD, 2001, EUR FOOD RES TECHNOL, V212, P491, DOI 10.1007/s002170000284; Buckleton J, 2005, FORENSIC DNA EVIDENCE INTERPRETATION, P27; Buckleton J, 2005, FORENSIC DNA EVIDENCE INTERPRETATION, P65; Caratti S, 2010, FORENSIC SCI INT-GEN, V4, P339, DOI 10.1016/j.fsigen.2010.07.001; Chen KF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-54; Cherel P, 2011, ANIM GENET, V42, P659, DOI 10.1111/j.1365-2052.2011.02187.x; Conyers CM, 2012, J AGR FOOD CHEM, V60, P3341, DOI 10.1021/jf205109b; Dalvit C, 2007, MEAT SCI, V77, P437, DOI 10.1016/j.meatsci.2007.05.027; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fajardo V, 2010, TRENDS FOOD SCI TECH, V21, P408, DOI 10.1016/j.tifs.2010.06.002; Fontanesi L, 2016, LIVEST SCI, V184, P71, DOI 10.1016/j.livsci.2015.12.007; Fontanesi L, 2014, MEAT SCI, V98, P781, DOI 10.1016/j.meatsci.2014.07.026; Fontanesi L, 2008, MOL REPROD DEV, V75, P1662, DOI 10.1002/mrd.20903; Frantz AC, 2013, BIOL J LINN SOC, V110, P104, DOI 10.1111/bij.12111; Goedbloed DJ, 2013, MOL ECOL, V22, P856, DOI 10.1111/j.1365-294X.2012.05670.x; Groenen MAM, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0204-2; Iyengar A, 2014, J NAT CONSERV, V22, P195, DOI 10.1016/j.jnc.2013.12.001; Khomenko S., 2013, EMPRES WATCH, V28, P1, DOI DOI 10.1016/J.MEATSCI.2007.06.018; Koutsogiannouli EA, 2010, MAMM BIOL, V75, P69, DOI 10.1016/j.mambio.2008.08.001; Lin YC, 2014, FORENSIC SCI INT-GEN, V9, P12, DOI 10.1016/j.fsigen.2013.10.006; Linacre Adrian, 2011, Investig Genet, V2, P2, DOI 10.1186/2041-2223-2-2; Lorenzini R, 2005, FORENSIC SCI INT, V153, P218, DOI 10.1016/j.forsciint.2005.04.032; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Menendez J, 2015, ARCH TIERZUCHT, V58, P217, DOI 10.5194/aab-58-217-2015; Montiel-Sosa JF, 2000, J AGR FOOD CHEM, V48, P2829, DOI 10.1021/jf9907438; Nechtelberger D, 2001, ANIM BIOTECHNOL, V12, P141, DOI 10.1081/ABIO-100108340; Ogden R, 2015, FORENSIC SCI INT-GEN, V18, P152, DOI 10.1016/j.fsigen.2015.02.008; Oh JD, 2014, ASIAN AUSTRAL J ANIM, V27, P926, DOI 10.5713/ajas.2013.13829; Pigs Porter V., 2016, MASONS WORLD ENCY LI, P517; Putnova L, 2003, CZECH J ANIM SCI, V48, P307; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rebala Krzysztof, 2015, Forensic Sci Int Genet, V16, P105, DOI 10.1016/j.fsigen.2014.12.011; Robino C, 2008, FORENS SCI INT-GEN S, V1, P614, DOI 10.1016/j.fsigss.2007.10.202; ROHRER GA, 1994, GENETICS, V136, P231; Tereba A., 1999, PROFILES DNA, V3, P14; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; Wilkinson S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-580; Yaemmeeklin W, 2009, THAI J VET MED, V39, P259	42	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166563	10.1371/journal.pone.0166563	http://dx.doi.org/10.1371/journal.pone.0166563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851802	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300068
J	Bubak, AN; Yaeger, JDW; Renner, KJ; Swallow, JG; Greene, MJ				Bubak, Andrew N.; Yaeger, Jazmine D. W.; Renner, Kenneth J.; Swallow, John G.; Greene, Michael J.			Neuromodulation of Nestmate Recognition Decisions by Pavement Ants	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; SUPERORGANISM; AGGRESSION; BEHAVIOR	Ant colonies are distributed systems that are regulated in a non-hierarchical manner. Without a central authority, individuals inform their decisions by comparing information in local cues to a set of inherent behavioral rules. Individual behavioral decisions collectively change colony behavior and lead to self-organization capable of solving complex problems such as the decision to engage in aggressive societal conflicts with neighbors. Despite the relevance to colony fitness, the mechanisms that drive individual decisions leading to cooperative behavior are not well understood. Here we show how sensory information, both tactile and chemical, and social context-isolation, nestmate interaction, or fighting non-nestmates-affects brain monoamine levels in pavement ants (Tetramorium caespitum). Our results provide evidence that changes in octopamine and serotonin in the brains of individuals are sufficient to alter the decision by pavement ants to be aggressive towards non-nestmate ants whereas increased brain levels of dopamine correlate to physical fighting. We propose a model in which the changes in brain states of many workers collectively lead to the self-organization of societal aggression between neighboring colonies of pavement ants.	[Bubak, Andrew N.; Swallow, John G.; Greene, Michael J.] Univ Colorado Denver, Dept Integrat Biol, Denver, CO 80204 USA; [Bubak, Andrew N.] Univ Colorado Anschutz Med Campus, Neurosci Program, Denver, CO USA; [Yaeger, Jazmine D. W.; Renner, Kenneth J.] Univ South Dakota, Dept Biol, Vermillion, SD 57069 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of South Dakota	Greene, MJ (corresponding author), Univ Colorado Denver, Dept Integrat Biol, Denver, CO 80204 USA.	michael.greene@ucdenver.edu	Bubak, Andrew/GLR-6501-2022		Center for Brain and Behavioral Research (CBBRe) Pilot grant; University of South Dakota; NSF [IOS 1256898]	Center for Brain and Behavioral Research (CBBRe) Pilot grant; University of South Dakota; NSF(National Science Foundation (NSF))	The research was supported, in part, by a Center for Brain and Behavioral Research (CBBRe) Pilot grant to KJR, University of South Dakota, and NSF grant # IOS 1256898 to JGS.r The research was supported, in part, by a Center for Brain and Behavioral Research (CBBRe) Pilot grant to KJR, University of South Dakota, and NSF grant # IOS 1256898 to JGS. The authors thank Kevin Hoover, William Schuman, Harper Jocque, and Erin Sanders for their comments on the manuscript.	Adams ES, 2016, MYRMECOL NEWS, V23, P101; ADAMS ES, 1990, ANIM BEHAV, V39, P321, DOI 10.1016/S0003-3472(05)80877-2; [Anonymous], 2010, ANT ENCOUNTERS INTER; Arganda S, 2012, P NATL ACAD SCI USA, V109, P20508, DOI 10.1073/pnas.1210664109; Boulay R, 2000, J EXP BIOL, V203, P513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bubak AN, 2014, BEHAV BRAIN RES, V219, P124; Bubak AN, 2015, BEHAV BRAIN RES, V292, P521, DOI 10.1016/j.bbr.2015.07.028; Bubak AN, 2014, CURR ZOOL, V60, P778, DOI 10.1093/czoolo/60.6.778; Bubak AN, 2013, J NEUROSCI METH, V219, P124, DOI 10.1016/j.jneumeth.2013.07.006; BUGG RL, 1994, AGR ECOSYST ENVIRON, V50, P11, DOI 10.1016/0167-8809(94)90121-X; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Cassidy KA, 2015, BEHAV ECOL, V26, P1352, DOI 10.1093/beheco/arv081; Collignon B, 2010, P ROY SOC B-BIOL SCI, V277, P1267, DOI 10.1098/rspb.2009.1976; Countryman SM, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00025; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Esponda F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2838; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; HOLLDOBLER B, 1976, SCIENCE, V192, P912, DOI 10.1126/science.192.4242.912; Hoover KM, 2016, CURR ZOOL, V62, P277, DOI 10.1093/cz/zow041; Kamhi JF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0704; Kamhi JF, 2013, BRAIN BEHAV EVOLUT, V82, P220, DOI 10.1159/000356091; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; McGlynn TP, 1999, TRENDS ECOL EVOL, V14, P489, DOI 10.1016/S0169-5347(99)01730-9; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Muscedere ML, 2012, J COMP PHYSIOL A, V198, P219, DOI 10.1007/s00359-011-0701-2; Nelson D.R., 1995, WAXES CHEM MOL BIOL, P1; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Plowes NJR, 2008, SELF ORG CONFLICTS T; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Robinson EJH, 2014, P BIOL SCI ROYAL SOC, P281; Robinson GE, 1999, NATURE, V399, P534, DOI 10.1038/21095; Scharf ME, 2004, J ECON ENTOMOL, V97, P601, DOI 10.1603/0022-0493-97.2.601; Stevenson PA, 2013, CURR OPIN NEUROBIOL, V23, P318, DOI 10.1016/j.conb.2013.03.002; Sturgis SJ, 2012, MYRMECOL NEWS, V16, P101; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706	38	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166417	10.1371/journal.pone.0166417	http://dx.doi.org/10.1371/journal.pone.0166417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846261	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600059
J	Port, M; Herodin, F; Valente, M; Drouet, M; Ullmann, R; Douche-Senf, S; Lamkowski, A; Majewski, M; Abend, M				Port, Matthias; Herodin, Francis; Valente, Marco; Drouet, Michel; Ullmann, Reinhard; Douche-Senf, Sven; Lamkowski, Andreas; Majewski, Matthaeus; Abend, Michael			MicroRNA Expression for Early Prediction of Late Occurring Hematologic Acute Radiation Syndrome in Baboons	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; CHROMOSOME-ABERRATIONS; CHERNOBYL ACCIDENT; THYROID-CANCER; SIGNATURES; RESIDENTS; EXPOSURE; UNCERTAINTIES; IRRADIATION; PREFECTURE	For effective medical management of radiation-exposed persons after a radiological/nuclear event, blood-based screening measures in the first few days that could predict hematologic acute radiation syndrome (HARS) are needed. For HARS severity prediction, we used microRNA (miRNA) expression changes measured on days one and two after irradiation in a baboon model. Eighteen baboons underwent different patterns of partial or total body irradiation, corresponding to an equivalent dose of 2.5 or 5 Gy. According to changes in blood cell counts (BCC) the surviving baboons (n = 17) exhibited mild (H1-2, n = 4) or more severe (H2-3, n = 13) HARS. In a two Stage study design we screened 667 miRNAs using a quantitative real-time polymerase chain reaction (qRT-PCR) platform. In Stage II we validated candidates where miRNAs had to show a similar regulation (up- or down-regulated) and a significant 2-fold miRNA expression difference over H0. Seventy-two candidate miRNAs (42 for H1-2 and 30 for H2-3) were forwarded for validation. Forty-two of the H1-2 miRNA candidates from the screening phase entered the validation step and 20 of them showed a statistically significant 2-4 fold up-regulation relative to the unexposed reference (H0). Fifteen of the 30 H2-3 miRNAs were validated in Stage II. All miRNAs appeared 2-3 fold down-regulated over H0 and allowed an almost complete separation of HARS categories; the strongest candidate, miR-342-3p, showed a sustained and 10-fold down-regulation on both days 1 and 2. In summary, our data support the medical decision making of the HARS even within the first two days after exposure where diagnostic tools for early medical decision are required but so far missing. The miRNA species identified and in particular miR-342-3p add to the previously identified mRNAs and complete the portfolio of identified mRNA and miRNA transcripts for HARS prediction and medical management.	[Port, Matthias; Ullmann, Reinhard; Douche-Senf, Sven; Lamkowski, Andreas; Majewski, Matthaeus; Abend, Michael] Bundeswehr Inst Radiobiol, Munich, Germany; [Herodin, Francis; Valente, Marco; Drouet, Michel] Inst Rech Biomed Armees, Bretigny Sur Orge, France		Abend, M (corresponding author), Bundeswehr Inst Radiobiol, Munich, Germany.	michaelabend@bundeswehr.org	Valente, Marco/A-8833-2018	Port, Matthias/0000-0002-8496-5883	French Ministry of Defense; German Ministry of Defense	French Ministry of Defense; German Ministry of Defense	This work was supported by both the French and the German Ministry of Defense.	Aavik E, 2004, FASEB J, V18, P130, DOI 10.1096/fj.04-2225fje; Abend M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039103; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akiba S, 2012, J RADIOL PROT, V32, P1, DOI 10.1088/0952-4746/32/1/1; Beinke C, 2013, RADIAT RES, V180, P129, DOI 10.1667/RR3235.1; Boldt S, 2012, INT J RADIAT BIOL, V88, P267, DOI 10.3109/09553002.2012.638358; Bouville A, 2006, RADIAT RES, V166, P158, DOI 10.1667/RR3370.1; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; Drozdovitch V, 2007, RADIAT PROT DOSIM, V127, P540, DOI 10.1093/rpd/ncm360; Friesecke I, 2001, BRIT J RADIOL, V74, P121, DOI 10.1259/bjr.74.878.740121; Iaea, 2001, TECH REP SER, V138; Kamada N, 2012, J ENVIRON RADIOACTIV, V110, P84, DOI 10.1016/j.jenvrad.2012.02.007; Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9; Kopecky KJ, 2006, RADIAT RES, V166, P367, DOI 10.1667/RR3596.1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Natarajan AT, 1998, MUTAT RES-FUND MOL M, V400, P299, DOI 10.1016/S0027-5107(98)00021-9; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Paul S, 2011, INT J RADIAT BIOL, V87, P791, DOI 10.3109/09553002.2011.568574; Port M, 2016, 1 GENERATION GENE EX, P39, DOI [10.1667/RR14318.1, DOI 10.1667/RR14318.1]; Ramalho AT, 1998, MUTAT RES-FUND MOL M, V404, P97, DOI 10.1016/S0027-5107(98)00099-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherwin JRA, 2010, ENDOCRINOLOGY, V151, P4982, DOI 10.1210/en.2010-0275; Shi Q, 2010, CLIN EXP PHARMACOL P, V37, P178, DOI 10.1111/j.1440-1681.2009.05260.x; Singh VK, 2012, RADIAT RES, V177, P781, DOI 10.1667/RR2894.1; Singh VK, 2012, CYTOKINE, V58, P406, DOI 10.1016/j.cyto.2012.03.011; Valente M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132194	29	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165307	10.1371/journal.pone.0165307	http://dx.doi.org/10.1371/journal.pone.0165307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846229	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600011
J	Shamsi, TN; Parveen, R; Amir, M; Baig, MA; Qureshi, MI; Ali, S; Fatima, S				Shamsi, Tooba Naz; Parveen, Romana; Amir, Mohd.; Baig, Mohd. Affan; Qureshi, M. Irfan; Ali, Sher; Fatima, Sadaf			Allium sativum Protease Inhibitor: A Novel Kunitz Trypsin Inhibitor from Garlic Is a New Comrade of the Serpin Family	PLOS ONE			English	Article							ALPHA-AMYLASE INHIBITOR; PROTEINASE-INHIBITORS; PURIFICATION; CANCER; CHEMOPREVENTION; RESISTANCE; STABILITY; DISEASE	Purpose This study was aimed to purify and characterize the Protease inhibitor (PI) from a plant Allium sativum (garlic) with strong medicinal properties and to explore its phytodrug potentials. Methods Allium sativum Protease Inhibitor (ASPI) was purified using ammonium sulphate fraction-ation and Fast Protein Liquid Chromatography on anion exchanger Hi-Trap DEAE column. The purified protein was analyzed for its purity and molecular weight by SDS PAGE. The confirmation of presence of trypsin inhibiting PI was performed by MALDI TOF-TOF and analyzed by MASCOT database. The ASPI was further investigated for its kinetic properties and stability under extreme conditions of pH, temperature and chemical denaturants. Secondary structure was determined by Circular Dichorism (CD) spectroscopy. Results ASPI of similar to 15 kDa inhibited trypsin and matched "truncated kunitz Trypsin Inhibitor (Glycine max)" in MASCOT database. The purified ASPI showed 30376.1371 U/mg specific activity with a fold purity of 159.92 and yield similar to 93%. ASPI was quite stable in the range of pH 2-12 showing a decline in the activity around pH 4-5 suggesting that the pI value of the protein as ASPI aggregates in this range. ASPI showed stability to a broad range of temperature (10-80 degrees C) but declined beyond 80 degrees C. Further, detergents, oxidizing agents and reducing agents demonstrated change in ASPI activity under varying concentrations. The kinetic analysis revealed sigmoidal relationship of velocity with substrate concentration with Vmax 240.8 (mu M/min) and Km value of 0.12 mu M. ASPI showed uncompetitive inhibition with a Ki of 0.08 +/- 0.01 nM). The Far UV CD depicted 2.0% alpha-helices and 51% beta-sheets at native pH. Conclusions To conclude, purified similar to 15 kDa ASPI exhibited fair stability in wide range of pH and temperature Overall, there was an increase in purification fold with remarkable yield. Chemical modification studies suggested the presence of lysine and tryptophan residues as lead amino acids present in the reactive sites. Therefore, ASPI with trypsin inhibitory property has the potential to be used as a non-cytotoxic clinical agents.	[Shamsi, Tooba Naz; Parveen, Romana; Baig, Mohd. Affan; Qureshi, M. Irfan; Fatima, Sadaf] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India; [Amir, Mohd.; Ali, Sher] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia; Jamia Millia Islamia	Fatima, S (corresponding author), Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India.	amu.jmi@rediffmail.com	Qureshi, M Irfan/CAF-0824-2022; Shamsi, Tooba/ADE-5752-2022; Amir, Mohammad/GOK-1613-2022	Qureshi, M Irfan/0000-0001-9625-0036; Shamsi, Tooba/0000-0001-7164-0791; AMIR, MOHD/0000-0001-9524-0899; Baig, Affan/0000-0002-6203-2097	DST-SERB	DST-SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	TNS, RP, MA and MAB are thankful to Central Instrumentation Facility, Department of Biotechnology, JMI and Cyanobacterial Biotechnology Lab and Microbiology Research Lab, Department of Biosciences, JMI, New Delhi to allow the access to instruments for the research work. SF is thankful to Dr Md Imtaiyaz Hassan, Center for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India for their guidance throughout the research work. SA is grateful to DST-SERB for the award of JC Bose Fellowship.	Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; BHAT AV, 1989, J BIOSCIENCE, V14, P351, DOI 10.1007/BF02703421; Cherqui A, 2001, INSECT BIOCHEM MOLEC, V31, P761, DOI 10.1016/S0965-1748(00)00172-7; Chung JG, 1999, J APPL TOXICOL, V19, P75; Clawson GA, 1996, CANCER INVEST, V14, P597, DOI 10.3109/07357909609076904; Devrim E, 2007, MOL NUTR FOOD RES, V51, P1319, DOI 10.1002/mnfr.200600302; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Gorinstein S, 2007, MOL NUTR FOOD RES, V51, P1365, DOI 10.1002/mnfr.200700064; Haq SK, 2005, BIOCHIMIE, V87, P1127, DOI 10.1016/j.biochi.2005.05.007; Haq SK, 2003, J PROTEIN CHEM, V22, P543, DOI 10.1023/B:JOPC.0000005504.57372.5b; Heidtmann HH, 1997, CLIN EXP METASTAS, V15, P368, DOI 10.1023/A:1018494020001; HOCMAN G, 1992, INT J BIOCHEM, V24, P1365, DOI 10.1016/0020-711X(92)90061-5; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; Ishimoto M, 1996, ENTOMOL EXP APPL, V79, P309, DOI 10.1007/BF00186289; Kidric M, 2002, BIOCHEM BIOPH RES CO, V297, P962, DOI 10.1016/S0006-291X(02)02328-8; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; Krishnan V.M., 2015, FOOD SCI HUM WELL, V4, P97, DOI [10.1016/j.fshw.2015.06.003, DOI 10.1016/J.FSHW.2015.06.003]; Kritchevsky D., 1991, Trends in Food Science & Technology, V2, P141, DOI 10.1016/0924-2244(91)90658-6; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanzotti V, 2006, J CHROMATOGR A, V1112, P3, DOI 10.1016/j.chroma.2005.12.016; Lau BHS, 2001, J NUTR, V131, p985S, DOI 10.1093/jn/131.3.985S; Lawton JM, 1998, BIOCHEM J, V334, P219, DOI 10.1042/bj3340219; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macedo MLR, 2003, BBA-GEN SUBJECTS, V1621, P170, DOI 10.1016/S0304-4165(03)00055-2; MOORE GS, 1977, MYCOLOGIA, V69, P341, DOI 10.2307/3758659; NEURATH H, 1989, TRENDS BIOCHEM SCI, V14, P268, DOI 10.1016/0968-0004(89)90061-3; Ogawa Masahiro, 2003, Journal of Medicinal Food, V6, P317; Oliva MLV, 2010, BIOCHIMIE, V92, P1667, DOI 10.1016/j.biochi.2010.03.021; Pandhare J, 2002, BIORESOURCE TECHNOL, V84, P165, DOI 10.1016/S0960-8524(02)00025-1; Patil DN, 2009, ACTA CRYSTALLOGR F, V65, P736, DOI 10.1107/S1744309109023495; Prathibha S, 1995, PLANT FOOD HUM NUTR, V48, P247, DOI 10.1007/BF01088446; Rahman K, 2006, J NUTR, V136, p736S, DOI 10.1093/jn/136.3.736S; Richardson MJ., 1991, METHODS PLANT BIOCH, P259; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; SCHROEDER HE, 1995, PLANT PHYSIOL, V107, P1233, DOI 10.1104/pp.107.4.1233; Sever N, 2002, BIOL CHEM, V383, P839, DOI 10.1515/BC.2002.088; SHADE RE, 1994, BIO-TECHNOL, V12, P793, DOI 10.1038/nbt0894-793; Shrivastava B, 2003, INSECT BIOCHEM MOLEC, V33, P1025, DOI 10.1016/S0965-1748(03)00117-6; SUMIYOSHI H, 1990, CANCER RES, V50, P5084; Vogel R., 1968, NATURAL PROTEINASE I	42	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165572	10.1371/journal.pone.0165572	http://dx.doi.org/10.1371/journal.pone.0165572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846232	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600015
J	So, R; Song, S; Lee, JE; Yoon, HJ				So, Rina; Song, Sihan; Lee, Jung Eun; Yoon, Hyung-Jin			The Association between Renal Hyperfiltration and the Sources of Habitual Protein Intake and Dietary Acid Load in a General Population with Preserved Renal Function: The KoGES Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR HYPERFILTRATION; HEALTHY; ADULTS; RISK; HYPERTENSION; ALBUMINURIA	Although the differential response of the kidney to the acute load of various sources of dietary protein in subjects with normal renal function is well known, the influence of habitual dietary protein intake and dietary acid load on renal function has not been tested well. The association between renal hyperfiltration (RHF), the earlier and possibly reversible stage of chronic kidney disease, and the sources of habitual dietary protein and dietary acid load was analyzed with the baseline data of 123,169 middle-aged healthy Koreans of a large prospective cohort study, who had a baseline estimated glomerular filtration rate (eGFR) > 60 mL/min/m 2 and no known history of diabetes and/or hypertension. eGFR was calculated with the Chronic Kidney Disease Epidemiology Collaboration equation using serum creatinine and RHF was defined as eGFR > 95 th percentile after adjustment for age, sex, height, and body weight. Dietary acid load was calculated with estimated net endogenous acid production (eNEAP). Although the level of habitual intake of animal protein was positively and vegetable protein was negatively associated with RHF, this association was significant only in women and younger participants (younger than sex-specific median age). The odds for RHF increased as the percentile rank of eNEAP increased until about the 50 th percentile and then leveled off. The positive association between eNEAP and RHF was significant in both sexes and age groups. Dietary acid load was associated with RHF regardless of sex and age and rather than the amount of the total or the individual sources of habitual dietary protein, may be a better target for the dietary intervention of chronic kidney disease.	[So, Rina; Yoon, Hyung-Jin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Song, Sihan] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Lee, Jung Eun] Seoul Natl Univ, Coll Human Ecol, Dept Food & Nutr, Seoul, South Korea	Seoul National University (SNU); Sookmyung Women's University; Seoul National University (SNU)	Yoon, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea.	hjyoon@snu.ac.kr	Lee, Jung Eun/AAC-5634-2020; So, Rina/GXM-7545-2022	Lee, Jung Eun/0000-0003-1141-878X; 	Korea Health Industry Development Institute [HI16C0367]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	HJY is supported by the Korea Health Industry Development Institute grant HI16C0367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Akter S, 2015, NUTRITION, V31, P298, DOI 10.1016/j.nut.2014.07.007; Banerjee T, 2015, J AM SOC NEPHROL, V26, P1693, DOI 10.1681/ASN.2014040332; Banerjee T, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-137; Beasley JM, 2011, J NUTR, V141, P1502, DOI 10.3945/jn.110.135814; BERGSTROM J, 1985, ACTA MED SCAND, V217, P189; Bernstein AM, 2007, J AM DIET ASSOC, V107, P644, DOI 10.1016/j.jada.2007.01.002; Brandle E, 1996, EUR J CLIN NUTR, V50, P734; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Cachat F, 2013, NEPHROL DIAL TRANSPL, V28, P386, DOI 10.1093/ndt/gfs494; CHAN AYM, 1988, J CLIN INVEST, V81, P245, DOI 10.1172/JCI113302; Engberink MF, 2012, AM J CLIN NUTR, V95, P1438, DOI 10.3945/ajcn.111.022343; Halbesma N, 2009, J AM SOC NEPHROL, V20, P1797, DOI 10.1681/ASN.2008060649; Hariharan D, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0529-6; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kim Y, 2016, INT J EPIDEMIOL; KING AJ, 1993, J AM SOC NEPHROL, V3, P1723; KONTESSIS P, 1990, KIDNEY INT, V38, P136, DOI 10.1038/ki.1990.178; Lin CK, 2010, J HEALTH POPUL NUTR, V28, P470; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Maeda I, 2011, CLIN J AM SOC NEPHRO, V6, P2462, DOI 10.2215/CJN.00700111; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Melsom T, 2012, CLIN J AM SOC NEPHRO, V7, P1801, DOI 10.2215/CJN.02980312; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Park M, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-015-0218-y; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Park M, 2013, MED SCI SPORT EXER, V45, P217, DOI 10.1249/MSS.0b013e318271b39f; Pugliese G, 2014, ACTA DIABETOL, V51, P905, DOI 10.1007/s00592-014-0650-7; Rebholz CM, 2015, AM J NEPHROL, V42, P427, DOI 10.1159/000443746; Riccio E, 2015, CLIN EXP NEPHROL, V19, P161, DOI 10.1007/s10157-014-1041-7; Rosolowsky ET, 2008, DIABETES RES CLIN PR, V82, pS46, DOI 10.1016/j.diabres.2008.09.018; Stephenson TJ, 2005, CLIN NEPHROL, V64, P1; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WISEMAN MJ, 1987, NEPHRON, V46, P37, DOI 10.1159/000184293	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166495	10.1371/journal.pone.0166495	http://dx.doi.org/10.1371/journal.pone.0166495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846266	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600071
J	Tian, CO; Li, ZF; Yang, ZG; Huang, QH; Liu, JM; Hong, B				Tian, Chunou; Li, Zifu; Yang, Zhigang; Huang, Qinghai; Liu, Jianmin; Hong, Bo			Plasma MicroRNA-16 Is a Biomarker for Diagnosis, Stratification, and Prognosis of Hyperacute Cerebral Infarction	PLOS ONE			English	Article							CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; ISCHEMIC-STROKE; CELL-DEATH; IDENTIFICATION; BRAIN	Indices for the diagnosis of hyperacute cerebral infarction (HACI) and the prediction of prognosis are essential for timely and appropriate management. MicroRNAs (miRNAs) that regulate gene expression following stroke have potential use as prognostic markers of HACI. Here, we explored whether concentrations of circulating miRNAs correlate with clinical outcomes and thus form a system of stroke stratification. Plasma samples from patients with HACI (n = 7) and age-matched healthy volunteers (HVT, n = 4) were screened by microarray to find differentially expressed miRNAs, some of which were further verified by quantitative reverse transcription polymerase chain reaction (qRT-PCR) (HACI: HVT = 33: 23). The target genes of the miRNAs with verified differential expression were investigated by GO and KEEG analyses. Using the TOAST (OCSP) criteria and the 3-month modified Rankin Score (mRS), relationships among the expression patterns of specific miRNAs, stroke stratification, and clinical prognosis were determined. The microarray analysis revealed 12 differentially expressed miRNAs. Among seven selected miRNAs verified with qRT-PCR, miR-16 expression in the HACI group was the most significantly different from the HVT group (P < 0.01). Bioinformatics analysis showed that the potential target genes of miR-16 were mainly involved in programmed cell death and the p53 signaling pathways. Receiver operating characteristic (ROC) analysis showed that the area under the curve (AUC) of miR-16 was 0.775 (sensitivity 69.7% and specificity 87%) and 0.952 (sensitivity 100% and specificity 91.3%) in overall patients and patients with large artery atherosclerosis (LAAS), respectively. Elevated miR-16 expression was associated with the stroke subtype of LAAS, total anterior circulation infarction, partial anterior circulation infarction, and poor prognosis (P < 0.05). A diagnostic method based on rapid measurement of plasma miR-16 has the potential to identify hyperacute cerebral infarction with LAAS with high sensitivity and specificity, which would inform and improve early treatment decisions and disease management.	[Tian, Chunou; Li, Zifu; Yang, Zhigang; Huang, Qinghai; Liu, Jianmin; Hong, Bo] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Tian, Chunou] 422 Hosp PLA, Dept Neurosurg, Zhanjiang, Guangdong, Peoples R China	Naval Medical University	Hong, B (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	hongbosmmu@vip.126.com		Li, Zifu/0000-0002-9332-3786	National Natural Science Foundation of China [31370810]; Shanghai Municipal Commission of Health and Family Planning [201640094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This study was funded by grants from the National Natural Science Foundation of China (31370810) (BH) (http://www.mnsfc.gov.cn/). It was also funded by grants from the Shanghai Municipal Commission of Health and Family Planning (201640094) (ZL) (http://www.wsjsw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2010, MOL NEUROBIOL, V41, P206, DOI 10.1007/s12035-010-8100-1; Barakat W, 2014, EUR J PHARMACOL, V724, P43, DOI 10.1016/j.ejphar.2013.12.032; Bennion DM, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316661060; Cheyuo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122833; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Felling RJ, 2015, EXP NEUROL, V268, P37, DOI 10.1016/j.expneurol.2014.09.017; Hong LZ, 2010, NEUROSCI BULL, V26, P232, DOI 10.1007/s12264-010-1111-0; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Jahr S, 2001, CANCER RES, V61, P1659; Jiang Z, 2014, NEUROSCI LETT, V566, P298, DOI 10.1016/j.neulet.2014.02.066; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Li PF, 2015, CELL MOL NEUROBIOL, V35, P433, DOI 10.1007/s10571-014-0139-5; Lian TT, 2015, INT J MOL SCI, V16, P13427, DOI 10.3390/ijms160613427; Llombart V, 2016, J NEUROCHEM, V136, P416, DOI 10.1111/jnc.13419; Long GW, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-178; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Peng GP, 2015, TRANSL STROKE RES, V6, P437, DOI 10.1007/s12975-015-0422-x; Picascia A, 2015, J NEUROIMMUNOL, V289, P111, DOI 10.1016/j.jneuroim.2015.10.013; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Tsai PC, 2013, J VASC RES, V50, P346, DOI 10.1159/000351767; Wang WH, 2014, J STROKE CEREBROVASC, V23, P2607, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.002; Wang Y, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-77; Wang Y, 2014, INT J CLIN EXP PATHO, V7, P4067; Xu ZF, 2005, NEUROSCI LETT, V375, P181, DOI 10.1016/j.neulet.2004.11.039; Yang YL, 2016, THER CLIN RISK MANAG, V12, P1049, DOI 10.2147/TCRM.S107053; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Zeng Lili, 2011, Front Biosci (Elite Ed), V3, P1265	29	38	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166688	10.1371/journal.pone.0166688	http://dx.doi.org/10.1371/journal.pone.0166688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846323	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600101
J	Neis, EPJG; Bloemen, JG; Rensen, SS; van der Vorst, JR; van den Broek, MA; Venema, K; Buurman, WA; Dejong, CHC				Neis, Evelien P. J. G.; Bloemen, Johanne G.; Rensen, Sander S.; van der Vorst, Joost R.; van den Broek, Maartje A.; Venema, Koen; Buurman, Wim A.; Dejong, Cornelis H. C.			Effects of Liver Resection on Hepatic Short-Chain Fatty Acid Metabolism in Humans	PLOS ONE			English	Article							GUT MICROBIOTA; ENERGY-METABOLISM; COLONIC FUNCTION; RECEPTOR GPR43; BUTYRATE; PROPIONATE; DIET; ABSORPTION; CITRULLINE; RELEVANCE	Aim To determine whether acute loss of liver tissue affects hepatic short-chain fatty acid (SCFA) clearance. Methods Blood was sampled from the radial artery, portal vein, and hepatic vein before and after hepatic resection in 30 patients undergoing partial liver resection. Plasma SCFA levels were measured by liquid chromatography-mass spectrometry. SCFA exchange across gut and liver was calculated from arteriovenous differences and plasma flow. Liver volume was estimated by CT liver volumetry. Results The gut produced significant amounts of acetate, propionate, and butyrate (39.4 +/- 13.5, 6.2 +/- 1.3, and 9.5 +/- 2.6 mu mol.kgbw(-1).h(-1)), which did not change after partial hepatectomy (p = 0.67, p = 0.59 and p = 0.24). Hepatic propionate uptake did not differ significantly before and after resection (-6.4 +/- 1.4 vs. -8.4 +/- 1.5 mu mol.kgbw(-1).h(-1), p = 0.49). Hepatic acetate and butyrate uptake increased significantly upon partial liver resection (acetate: -35.1 +/- 13.0 vs. -39.6 +/- 9.4 mu mol.kgbw(-1).h(-1), p = 0.0011; butyrate: -9.9 +/- 2.7 vs. -11.5 +/- 2.4 mu mol.kgbw(-1).h(-1), p = 0.0006). Arterial SCFA concentrations were not different before and after partial liver resection (acetate: 176.9 +/- 17.3 vs. 142.3 +/- 12.5 mu mol/L, p = 0.18; propionate: 7.2 +/- 1.4 vs. 5.6 +/- 0.6 mu mol/L, p = 0.38; butyrate: 4.3 +/- 0.7 vs. 3.6 +/- 0.6 mu mol/L, p = 0.73). Conclusion The liver maintains its capacity to clear acetate, propionate, and butyrate from the portal blood upon acute loss of liver tissue.	[Neis, Evelien P. J. G.; Bloemen, Johanne G.; Venema, Koen; Dejong, Cornelis H. C.] TI Food & Nutr, NL-6709 PA Wageningen, Netherlands; [Neis, Evelien P. J. G.; Bloemen, Johanne G.; Rensen, Sander S.; van den Broek, Maartje A.; Buurman, Wim A.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Surg, Med Ctr, NL-6229 HX Maastricht, Netherlands; [van der Vorst, Joost R.; van den Broek, Maartje A.] Leiden Univ, Med Ctr, Dept Surg, NL-2333 ZA Leiden, Netherlands; [Venema, Koen] Wageningen Univ, Beneficial Microbes Consultancy, NL-6708 PB Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	Neis, EPJG (corresponding author), TI Food & Nutr, NL-6709 PA Wageningen, Netherlands.; Neis, EPJG (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Surg, Med Ctr, NL-6229 HX Maastricht, Netherlands.	e.neis@maastrichtuniversity.nl	Rensen, Sander/J-3224-2019; van der Vorst, Joost/ABI-3142-2020	Rensen, Sander/0000-0001-5054-8400; van der Vorst, Joost/0000-0002-0669-4272	TI Food and Nutrition	TI Food and Nutrition	The research was funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x; BERGMAN EN, 1971, AM J PHYSIOL, V221, P586, DOI 10.1152/ajplegacy.1971.221.2.586; Bloemen JG, 2010, DIS COLON RECTUM, V53, P1069, DOI 10.1007/DCR.0b013e3181d881b7; Bloemen JG, 2009, CLIN NUTR, V28, P657, DOI 10.1016/j.clnu.2009.05.011; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Canani RB, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-4; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Faerch K, 2015, DIABETES, V64, P2513, DOI 10.2337/db14-1751; Feliz Brady, 2003, Arch Pathol Lab Med, V127, pe325; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Kimura I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00085; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kristensen NB, 2004, J ANIM SCI, V82, P3549; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; MANNS JG, 1967, AM J PHYSIOL, V212, P747, DOI 10.1152/ajplegacy.1967.212.4.747; Matsumoto N, 2006, KIDNEY INT, V69, P257, DOI 10.1038/sj.ki.5000028; Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; van de Poll MCG, 2007, AM J PHYSIOL-GASTR L, V293, pG956, DOI 10.1152/ajpgi.00366.2006; van de Poll MCG, 2007, J PHYSIOL-LONDON, V581, P819, DOI 10.1113/jphysiol.2006.126029; van de Poll MCG, 2007, AM J CLIN NUTR, V85, P167, DOI 10.1093/ajcn/85.1.167; van der Vorst JR, 2010, WORLD J SURG, V34, P2426, DOI 10.1007/s00268-010-0663-5; van Eijk HMH, 2009, J CHROMATOGR B, V877, P719, DOI 10.1016/j.jchromb.2009.01.039; VERNAY MY, 1987, GUT, V28, P1077, DOI 10.1136/gut.28.9.1077; Wachtershauser A, 2000, EUR J NUTR, V39, P164, DOI 10.1007/s003940070020; Watzl B, 2005, BRIT J NUTR, V93, pS49, DOI 10.1079/BJN20041357; Welters CFM, 2002, DIS COLON RECTUM, V45, P621, DOI 10.1007/s10350-004-6257-2; Wilson AJ, 1997, GASTROENTEROLOGY, V113, P487, DOI 10.1053/gast.1997.v113.pm9247468	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166161	10.1371/journal.pone.0166161	http://dx.doi.org/10.1371/journal.pone.0166161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835668	gold, Green Submitted, Green Published			2022-12-27	WOS:000387779200029
J	Rob, D; Marek, J; Dostalova, G; Golan, L; Linhart, A				Rob, Daniel; Marek, Josef; Dostalova, Gabriela; Golan, Lubor; Linhart, Ales			Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; XANTHINE-OXIDASE INHIBITION; CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR MASS; CARDIAC ENERGY-METABOLISM; ALL-CAUSE MORTALITY; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HEART-FAILURE; OXIDATIVE STRESS	Background Serum uric acid (UA) elevation is common in patients with cardiovascular, renal and metabolic diseases. However, no study to date has analysed the role of UA in Fabry disease (FD). Objectives To evaluate the association between serum UA levels and mortality and morbidity in FD. Materials and Methods We conducted a post-hoc analysis of a prospectively followed-up cohort of 124 patients with genetically proven FD. Serum UA levels were acquired at baseline; clinical events and mortality were assessed during regular visits every 6 to 12 months. The primary endpoint was a composite of multiple secondary outcomes: all-cause mortality, adverse cardiovascular events, progression of renal dysfunction and stroke or transient ischaemic attack (TIA). Predictive value was assessed using the Cox proportional hazards model and the Kaplan Meyer estimator. Results During follow-up of 7.4 +/- 3.7 years, 64 (52%) patients reached the primary combined endpoint. Overall, UA levels were significantly associated with combined outcome (p < 0.001) and remained independently associated after correcting for age, sex and estimated glomerular filtration rate (hazard ratio [HR] per 20 mu mol/l increase 1.09, 95% confidence interval [95% CI] (1.00-1.19), p = 0.04). UA was associated with overall mortality in univariate analysis (p = 0.021); however, the association did not reach statistical significance after multivariate correction (HR per 20 mu mol/l increase 1.07 95% CI 0.93-1.25, p = 0.32). Higher UA levels were also associated with cardiac adverse outcomes, progression of left ventricular hypertrophy and progression of renal dysfunction (ps < 0.001). No association was observed between UA levels and stroke or TIA (p = 0.323). Conclusion and Implications Increased serum UA levels may represent an independent risk factor for adverse clinical outcomes in Fabry patients and are associated with all-cause mortality. UA is a widely available and cheap biomarker that may improve risk stratification of Fabry patients in clinical practice.	[Linhart, Ales] Charles Univ Prague, Dept Med 2, Dept Cardiovasc Med, Fac Med 1, Prague, Czech Republic; Gen Univ Hosp, Prague, Czech Republic	Charles University Prague; General University Hospital Prague	Linhart, A (corresponding author), Charles Univ Prague, Dept Med 2, Dept Cardiovasc Med, Fac Med 1, Prague, Czech Republic.	alinh@lf1.cuni.cz	Rob, Daniel/K-8374-2017; Linhart, Ales/O-2375-2017; Golan, Lubor/O-2359-2017	Rob, Daniel/0000-0002-3927-2674; Linhart, Ales/0000-0002-3372-7850; Golan, Lubor/0000-0003-1705-1157	Charles University in Prague, PRVOUK [P35, LINHART 205035-3]	Charles University in Prague, PRVOUK	This work was supported by the grant of Charles University in Prague, PRVOUK, P35, LINHART 205035-3.	BAKHTIYAROV ZA, 1989, TERAPEVT ARKH, V61, P68; Biancini GB, 2012, BBA-MOL BASIS DIS, V1822, P226, DOI 10.1016/j.bbadis.2011.11.001; Bickel C, 2002, AM J CARDIOL, V89, P12, DOI 10.1016/S0002-9149(01)02155-5; Biegstraaten M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0253-6; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Choi YJ, 2014, FASEB J, V28, P3197, DOI 10.1096/fj.13-247148; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Doehner W, 2011, SEMIN NEPHROL, V31, P433, DOI 10.1016/j.semnephrol.2011.08.007; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; George J, 2009, VASC HEALTH RISK MAN, V5, P265, DOI 10.2147/VHRM.S4265; Germain DP, 2015, J MED GENET, V52, P353, DOI 10.1136/jmedgenet-2014-102797; Giordano C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/382918; Givertz MM, 2015, CIRCULATION, V131, P1763, DOI 10.1161/CIRCULATIONAHA.114.014536; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Harrison D, 2003, AM J CARDIOL, V91, p7A; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Higgins P, 2014, HEART, V100, P1085, DOI 10.1136/heartjnl-2014-305683; Higgins P, 2012, CARDIOVASC THER, V30, P217, DOI 10.1111/j.1755-5922.2011.00277.x; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; Iwashima Y, 2006, HYPERTENSION, V47, P195, DOI 10.1161/01.HYP.0000200033.14574.14; JARASCH ED, 1981, CELL, V25, P67, DOI 10.1016/0092-8674(81)90232-4; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Joly DA, 2014, KIDNEY INT, V86, P5, DOI 10.1038/ki.2014.126; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kao MP, 2011, J AM SOC NEPHROL, V22, P1382, DOI 10.1681/ASN.2010111185; Karetova D, 2010, VASA, V39, P123, DOI 10.1024/0301-1526/a000017; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kim Hyungseop, 2010, Congest Heart Fail, V16, P153, DOI 10.1111/j.1751-7133.2010.00144.x; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Machann W, 2011, EUR J HEART FAIL, V13, P278, DOI 10.1093/eurjhf/hfq211; Moore DF, 2004, J MAGN RESON IMAGING, V20, P674, DOI 10.1002/jmri.20162; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Palecek T, 2010, INT J CARDIOL, V144, P337, DOI 10.1016/j.ijcard.2009.03.045; Riegersperger M, 2011, INT UROL NEPHROL, V43, P441, DOI 10.1007/s11255-011-9929-6; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schiffmann R, 2006, VIRCHOWS ARCH, V448, P337, DOI 10.1007/s00428-005-0089-x; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Thanassoulis G, 2010, ARCH INTERN MED, V170, P1358, DOI 10.1001/archinternmed.2010.198; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Yiginer O, 2008, CLIN RES CARDIOL, V97, P334, DOI 10.1007/s00392-007-0636-3; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023; Zhu L, 2015, CAN J CARDIOL, V31, P1252, DOI 10.1016/j.cjca.2015.02.018; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	63	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166290	10.1371/journal.pone.0166290	http://dx.doi.org/10.1371/journal.pone.0166290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835692	Green Published, gold			2022-12-27	WOS:000387779200035
J	Lenoir-Wijnkoop, I; Gerlier, L; Roy, D; Reid, G				Lenoir-Wijnkoop, Irene; Gerlier, Laetitia; Roy, Denis; Reid, Gregor			The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada	PLOS ONE			English	Article							UNIVERSAL INFLUENZA IMMUNIZATION; ANTIBIOTIC PRESCRIPTIONS; METAANALYSIS; NUTRITION; CHILDREN; ILLNESS; RISK; LACTOBACILLUS; PREVENTION; MORTALITY	Introduction There is accumulating evidence supporting the use of probiotics, which are defined as "live micro-organisms which, when administered in adequate amounts, confer a health benefit on the host", as a preventive measure against respiratory tract infections (RTI). Two recent metaanalyses showed probiotic consumption (daily intake of 10 7 to 10 10 CFU in any form for up to 3 months) significantly reduced RTI duration, frequency, antibiotic use and work absenteeism. Objectives The aim of this study was to assess the impact of probiotic use in terms of number of RTI episodes and days averted, and the number of antibiotic prescriptions and missed workdays averted, in the general population of Canada. In addition, the corresponding economic impact from both a healthcare payer and a productivity perspective was estimated. Methods A microsimulation model was developed to reproduce the Canadian population (sample rate of 1/1000 = 35 540 individuals) employing age and gender. RTI incidence was taken from FluWatch consultation rates for influenza-like illness (2013-14) and StatCan all-cause consultations statistics. The model was calibrated on a 2.1% RTI annual incidence in the general population (5.2 million RTI days) and included known risk factors (smoking status, shared living conditions and vaccination status). RTI-related antibiotic prescriptions and work absenteeism were obtained from the literature. Results The results indicate that probiotic use saved 573 000-2.3 million RTI-days, according to the YHEC-Cochrane scenarios respectively. These reductions were associated with an avoidance of 52 000-84 000 antibiotic courses and 330 000-500 000 sick-leave days. A projection of corresponding costs reductions amounted to Can$ 1.3-8.9 million from the healthcare payer perspective and Can$ 61.2-99.7 million when adding productivity losses. Conclusion The analysis shows that the potential of probiotics to reduce RTI-related events may have a substantial clinical and economic impact in Canada.	[Lenoir-Wijnkoop, Irene] Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands; [Lenoir-Wijnkoop, Irene] Danone Co, Director Publ Hlth & Sci Relat, Paris, France; [Gerlier, Laetitia] QuintilesIMS Real World Evidence, Zaventem, Belgium; [Roy, Denis] Univ Laval, Dept Food Sci, Quebec City, PQ G1K 7P4, Canada; [Reid, Gregor] Univ Western Ontario, Canadian Res & Dev Ctr Probiot, London, ON, Canada	Utrecht University; Danone Nutricia; IQVIA; Laval University; Western University (University of Western Ontario)	Lenoir-Wijnkoop, I (corresponding author), Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands.; Lenoir-Wijnkoop, I (corresponding author), Danone Co, Director Publ Hlth & Sci Relat, Paris, France.	P.I.Lenoir-Wijnkoop@uu.nl	Reid, Gregor/ABE-8327-2020; Roy, Denis/H-4998-2011	Reid, Gregor/0000-0001-9658-5696; Roy, Denis/0000-0002-4229-9245; Lenoir-Wijnkoop, Irene/0000-0001-9853-8076	Alliance for Education on Probiotics (AEP); Danone; IMS RWES HEOR	Alliance for Education on Probiotics (AEP); Danone(Danone Nutricia); IMS RWES HEOR(Health Economics & Outcomes Research Ltd)	This study was funded by an unrestricted educational grant from the Alliance for Education on Probiotics (AEP, URL: http://wwwaeprobio.com/). AEP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ILW is employed by Danone and LG is employed by IMS RWES HEOR. Danone and IMS RWES HEOR provided support in the form of salaries for authors ILW and LG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, Consum Rep, V76, P12; Bensenor IM, 2001, ANN EPIDEMIOL, V11, P225, DOI 10.1016/S1047-2797(00)00214-3; Caffarelli C, 2015, EXPERT REV ANTI-INFE, V13, P1517, DOI 10.1586/14787210.2015.1096775; Center for Disease Control and Prevention, STOPP SPREAD GERMS H; Centers for Disease Control and Prevention (CDC), FASTSTATS PHYS OFF V; Freijer K, 2015, Eur J Clin Nutr, V69, P539, DOI 10.1038/ejcn.2014.280; Gionet L, FLU VACCINATION RATE; Government of Canada, WEEKL INFL REP; Government of Canada, INFL DEF; Grin PM, 2013, CAN J UROL, V20, P6607; Hao Q, 2015, COCHRANE DATABASE SY, V3; Heneghan CJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20420; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Ioannidis JPA, 2016, AM J CLIN NUTR, V103, P1385, DOI 10.3945/ajcn.116.136085; JAAKKOLA JJK, 1995, EUR J EPIDEMIOL, V11, P213, DOI 10.1007/BF01719490; Jefferson T, 2014, COCHRANE DATABASE SY, V13; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004879.pub5, 10.1002/14651858.CD004879.pub4]; Kang EJ, 2013, KOREAN J FAM MED, V34, P2, DOI 10.4082/kjfm.2013.34.1.2; King S, 2014, BRIT J NUTR, V112, P41, DOI 10.1017/S0007114514000075; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Kwong JC, 2009, CLIN INFECT DIS, V49, P750, DOI 10.1086/605087; Lenoir-Wijnkoop I, 2012, BRIT J NUTR, V108, P1714, DOI 10.1017/S0007114512003704; Lenoir-Wijnkoop I, 2011, Br J Nutr, V105, P157, DOI 10.1017/S0007114510003041; Lenoir-Wijnkoop I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122765; Liu S, 2013, INDIAN PEDIATR, V50, P377, DOI 10.1007/s13312-013-0123-z; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Maki KC, 2014, ADV NUTR, V5, P7, DOI 10.3945/an.113.004929; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Morgan Steve, 2013, CANADIAN RX ATLAS; Olsen R, 2016, NEONATOLOGY, V109, P105, DOI 10.1159/000441274; Ozen M, 2015, EXPERT OPIN BIOL TH, V15, P9, DOI 10.1517/14712598.2015.980233; Palmer LA, 2010, VACCINE, V28, P5049, DOI 10.1016/j.vaccine.2010.05.011; Public Health Agency of Canada, AB FLUWATCH; Public Health Agency of Canada, EC BURD ILLN CAN 200; Public Health Agency of Canada, 2012, VACC COV AD CAN RES; Ritchie ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034938; Saterdal Ingvil, 2012, Glob Adv Health Med, V1, P124, DOI 10.7453/gahmj.2012.1.2.014; Schanzer D, 1992, PLOS ONE; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Statistics Canada, 2014, HLTH IND PROF ANN ES; Statistics Canada, CONT MED DOCT AG GRO; Statistics Canada, POP SEX AG GROUP; Statistics Canada, SMOK SEX PROV TERR; Sun J, 2015, ANN MED, V47, P430, DOI 10.3109/07853890.2015.1071872; van Dijk L, 2011, FAM PRACT, V28, P624, DOI 10.1093/fampra/cmr043; Vervloet M, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2015.83; Virk RK, 2016, EXPERT REV ANTI-INFE, V14, P365, DOI 10.1586/14787210.2016.1155450; Vouloumanou EK, 2009, INT J ANTIMICROB AG, V34, DOI 10.1016/j.ijantimicag.2008.11.005; Wang YZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004509; World Health Organization FaAOotUN, 2002, REP JOINT FAO WHO WO	52	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166232	10.1371/journal.pone.0166232	http://dx.doi.org/10.1371/journal.pone.0166232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832195	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000080
J	Lo, YL; Liou, GG; Lyu, JH; Hsiao, M; Hsu, TL; Wong, CH				Lo, Yen-Lung; Liou, Gunn-Guang; Lyu, Jia-Huei; Hsiao, Michael; Hsu, Tsui-Ling; Wong, Chi-Huey			Dengue Virus Infection Is through a Cooperative Interaction between a Mannose Receptor and CLEC5A on Macrophage as a Multivalent Hetero-Complex	PLOS ONE			English	Article							DC-SIGN; ENTRY; CELLS; COLOCALIZATION; ACTIVATION; BIOSENSOR; IMMUNITY; BINDING; PCR	Dengue fever is a mosquito-borne viral pandemic disease that is widespread in the tropical and subtropical areas. Dengue virus uses human mannose-binding receptor (MR) and DC-SIGN on macrophages as primary receptors, and CLEC5A as signaling receptor to sense the dengue virus invasion and then to signal and stimulate macrophages to secrete cytokines. But the interplay between MR/DC-SIGN and CLEC5A is unknown. Here we demonstrate a plausible mechanism for the interaction, i.e. MR/DC-SIGN first attracts the virus with high avidity, and the virus concurrently interacts with CLEC5A in close proximity to form a multivalent hetero-complex and facilitate CLEC5A-mediated signal transduction. Our study suggests that the cooperation between a high-avidity lectin-virus interaction and a nearby low-avidity signaling receptor provides a necessary connection between binding and signaling. Understanding this mechanism may lead to the development of a new antiviral strategy.	[Lo, Yen-Lung; Lyu, Jia-Huei; Hsiao, Michael; Hsu, Tsui-Ling; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Liou, Gunn-Guang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lo, Yen-Lung; Wong, Chi-Huey] Acad Sinica, Chem Biol & Mol Biophys, Taiwan Int Grad Program, Taipei, Taiwan; [Lo, Yen-Lung; Wong, Chi-Huey] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wong, CH (corresponding author), Acad Sinica, Genom Res Ctr, Taipei, Taiwan.; Wong, CH (corresponding author), Acad Sinica, Chem Biol & Mol Biophys, Taiwan Int Grad Program, Taipei, Taiwan.; Wong, CH (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	chwong@gate.sinica.edu.tw	Hsu, Tsui-Ling/H-6704-2015; Liou, Gunn‐Guang/AAI-9787-2020; Hsu, Tsui-Ling/AAE-8821-2019; Hsiao, Michael/U-6238-2019	Hsu, Tsui-Ling/0000-0002-2912-3261; Hsiao, Michael/0000-0001-8529-9213; Liou, Gan-Guang/0000-0002-2619-8516	Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Academia Sinica, Taiwan. We would like to thank Dr. Yi-Ling Lin, Academia Sinica, for her technical and material support in virus handling. We would also like to thank the confocal image core facility, the EM core facility, the electrophysiology core facility, and the mass spectroscopy core facility of Academia Sinica for making this work possible.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655; Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; Dubayle J, 2015, VACCINE, V33, P1360, DOI 10.1016/j.vaccine.2015.01.047; Frenzel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106882; Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Knipe D, 2013, FIELDS VIROLOGY; Lagache T, 2015, CYTOM PART A, V87A, P568, DOI 10.1002/cyto.a.22629; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Panyi G, 2003, P NATL ACAD SCI USA, V100, P2592, DOI 10.1073/pnas.0438057100; Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tung YT, 2014, NANOMED-NANOTECHNOL, V10, P1335, DOI 10.1016/j.nano.2014.03.009; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; World Health Organization, 2012, GLOB STRAT DENG PREV, V35; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090	33	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166474	10.1371/journal.pone.0166474	http://dx.doi.org/10.1371/journal.pone.0166474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832191	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000128
J	Cheng, BB; Bandi, V; Wei, MY; Pei, YB; D'Souza, F; Nguyen, KT; Hong, Y; Yuan, BH				Cheng, Bingbing; Bandi, Venugopal; Wei, Ming-Yuan; Pei, Yanbo; D'Souza, Francis; Nguyen, Kytai T.; Hong, Yi; Yuan, Baohong			High-Resolution Ultrasound-Switchable Fluorescence Imaging in Centimeter-Deep Tissue Phantoms with High Signal-To-Noise Ratio and High Sensitivity via Novel Contrast Agents	PLOS ONE			English	Article							ENCODED LIGHT; MICROSCOPY; TOMOGRAPHY; REGIME	For many years, investigators have sought after high-resolution fluorescence imaging in centimeter-deep tissue because many interesting in vivo phenomena-such as the presence of immune system cells, tumor angiogenesis, and metastasis-may be located deep in tissue. Previously, we developed a new imaging technique to achieve high spatial resolution in sub-centimeter deep tissue phantoms named continuous-wave ultrasound-switchable fluorescence (CW-USF). The principle is to use a focused ultrasound wave to externally and locally switch on and off the fluorophore emission from a small volume (close to ultrasound focal volume). By making improvements in three aspects of this technique: excellent near-infrared USF contrast agents, a sensitive frequency-domain USF imaging system, and an effective signal processing algorithm, for the first time this study has achieved high spatial resolution (similar to 900 mu m) in 3-centimeter-deep tissue phantoms with high signal-to-noise ratio (SNR) and high sensitivity (3.4 picomoles of fluorophore in a volume of 68 nanoliters can be detected). We have achieved these results in both tissue-mimic phantoms and porcine muscle tissues. We have also demonstrated multi-color USF to image and distinguish two fluorophores with different wavelengths, which might be very useful for simultaneously imaging of multiple targets and observing their interactions in the future. This work has opened the door for future studies of high-resolution centimeter-deep tissue fluorescence imaging.	[Cheng, Bingbing; Wei, Ming-Yuan; Pei, Yanbo; Yuan, Baohong] Univ Texas Arlington, Dept Bioengn, Ultrasound & Opt Imaging Lab, Arlington, TX 76010 USA; [Cheng, Bingbing; Wei, Ming-Yuan; Pei, Yanbo; Nguyen, Kytai T.; Hong, Yi; Yuan, Baohong] Univ Texas Arlington, Joint Biomed Engn Program, Dallas, TX 75235 USA; [Cheng, Bingbing; Wei, Ming-Yuan; Pei, Yanbo; Nguyen, Kytai T.; Hong, Yi; Yuan, Baohong] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75235 USA; [Bandi, Venugopal; D'Souza, Francis] Univ North Texas, Dept Chem, 1155 Union Circle,305070, Denton, TX 76203 USA; [Nguyen, Kytai T.; Hong, Yi] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76010 USA	University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Denton; University of Texas System; University of Texas Arlington	Yuan, BH (corresponding author), Univ Texas Arlington, Dept Bioengn, Ultrasound & Opt Imaging Lab, Arlington, TX 76010 USA.; Yuan, BH (corresponding author), Univ Texas Arlington, Joint Biomed Engn Program, Dallas, TX 75235 USA.; Yuan, BH (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75235 USA.	baohong@uta.edu	Hong, Yi/AAA-8971-2022; Wei, Michael Ming-Yuan/B-1529-2014; Bandi, Venu/I-8391-2018	Wei, Michael Ming-Yuan/0000-0002-4626-0014; Bandi, Venu/0000-0003-3602-9641; Hong, Yi/0000-0002-5846-2596; Cheng, Bingbing/0000-0002-1336-4781	NSF [CBET-1253199, 1401188]; NHARP [13310]; NIH/NIBIB [7R15EB012312-02]; CPRIT [RP120052]; NIH/NHLBI [R01HL118498]	NSF(National Science Foundation (NSF)); NHARP; NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CPRIT; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by funding from the NSF CBET-1253199 (BY), the NHARP 13310 (BY), the NIH/NIBIB 7R15EB012312-02 (BY), the CPRIT RP120052 (BY), the NIH/NHLBI R01HL118498 (KN), and the NSF 1401188 (FD).	Andresen V, 2009, CURR OPIN BIOTECH, V20, P54, DOI 10.1016/j.copbio.2009.02.008; AYERS F, 2008, P SOC PHOTO-OPT INS, V6870; Cai WB, 2008, J NUCL MED, V49, p113S, DOI 10.2967/jnumed.107.045922; Cheng BB, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2280997; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; Grabtchak S, 2014, PHYS MED BIOL, V59, P2431, DOI 10.1088/0031-9155/59/10/2431; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hong GS, 2014, NAT PHOTONICS, V8, P723, DOI [10.1038/NPHOTON.2014.166, 10.1038/nphoton.2014.166]; Horstmeyer R, 2015, NAT PHOTONICS, V9, P563, DOI [10.1038/nphoton.2015.140, 10.1038/NPHOTON.2015.140]; Huynh NT, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.020505; Judkewitz B, 2013, NAT PHOTONICS, V7, P300, DOI [10.1038/nphoton.2013.31, 10.1038/NPHOTON.2013.31]; Lai PX, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075604; Lin YT, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056007; Lin YT, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681378; Marriott G, 2008, P NATL ACAD SCI USA, V105, P17789, DOI 10.1073/pnas.0808882105; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Pei YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04690; REICHARDT C, 1994, CHEM REV, V94, P2319, DOI 10.1021/cr00032a005; Si K, 2012, NAT PHOTONICS, V6, P657, DOI [10.1038/nphoton.2012.205, 10.1038/NPHOTON.2012.205]; Si K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00748; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Wang YM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1925; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838; Xu XA, 2011, NAT PHOTONICS, V5, P154, DOI 10.1038/NPHOTON.2010.306; Yuan BH, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737211	25	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165963	10.1371/journal.pone.0165963	http://dx.doi.org/10.1371/journal.pone.0165963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829050	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300070
J	Moro, CF; Fernandez-Woodbridge, A; D'souza, MA; Zhang, QN; Bozoky, B; Kandaswamy, SV; Catalano, P; Heuchel, R; Shtembari, S; Del Chiaro, M; Danielsson, O; Bjornstedt, M; Lohr, JM; Isaksson, B; Verbeke, C; Bozoky, B				Moro, Carlos Fernandez; Fernandez-Woodbridge, Alejandro; D'souza, Melroy Alistair; Zhang, Qianni; Bozoky, Benedek; Kandaswamy, Senthil Vasan; Catalano, Piera; Heuchel, Rainer; Shtembari, Sonia; Del Chiaro, Marco; Danielsson, Olof; Bjornstedt, Mikael; Lohr, J. Matthias; Isaksson, Bengt; Verbeke, Caroline; Bozoky, Bela			Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; INTESTINAL-TYPE; CANCER; EXPRESSION; CHOLANGIOCARCINOMA; METASTASIS; AMPULLARY; CARCINOMA; SURVIVAL; TISSUE	Background & Aims Adenocarcinomas of the pancreatobiliary system are currently classified by their primary anatomical location. In particular, the pathological diagnosis of intrahepatic cholangiocarcinoma is still considered as a diagnosis of exclusion of metastatic adenocarcinoma. Periampullary cancers have been previously classified according to the histological type of differentiation (pancreatobiliary, intestinal), but overlapping morphological features hinder their differential diagnosis. We performed an integrative immunohistochemical analysis of pancreato-biliary tumors to improve their diagnosis and prediction of outcome. Methods This was a retrospective observational cohort study on patients with adenocarcinoma of the pancreatobiliary system who underwent diagnostic core needle biopsy or surgical resection at a tertiary referral center. 409 tumor samples were analyzed with up to 27 conventional antibodies used in diagnostic pathology. Immunohistochemical scoring system was the percentage of stained tumor cells. Bioinformatic analysis, internal validation, and survival analysis were performed. Results Hierarchical clustering and differential expression analysis identified three immunohistochemical tumor types (extrahepatic pancreatobiliary, intestinal, and intrahepatic cholangiocarcinoma) and the discriminant markers between them. Among patients who underwent surgical resection of their primary tumor with curative intent, the intestinal type showed an adjusted hazard ratio of 0.19 for overall survival (95% confidence interval 0.05-0.72; p value = 0.014) compared to the extrahepatic pancreatobiliary type. Conclusions Integrative immunohistochemical classification of adenocarcinomas of the pancreatobiliary system results in a characteristic immunohistochemical profile for intrahepatic cholangiocarcinoma and intestinal type adenocarcinoma, which helps in distinguishing them from metastatic and pancreatobiliary type adenocarcinoma, respectively. A diagnostic immunohistochemical panel and additional extended panels of discriminant markers are proposed as guidance for their pathological diagnosis.	[Moro, Carlos Fernandez; Danielsson, Olof; Bjornstedt, Mikael] Karolinska Inst, Div Pathol, Dept Lab Med LABMED, Stockholm, Sweden; [Moro, Carlos Fernandez; Shtembari, Sonia; Danielsson, Olof; Bjornstedt, Mikael; Verbeke, Caroline; Bozoky, Bela] Karolinska Univ Hosp, Dept Clin Pathol Cytol, Stockholm, Sweden; [Fernandez-Woodbridge, Alejandro; Bozoky, Benedek] Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Stockholm, Sweden; [D'souza, Melroy Alistair; Heuchel, Rainer; Del Chiaro, Marco; Lohr, J. Matthias; Isaksson, Bengt] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [D'souza, Melroy Alistair; Del Chiaro, Marco; Lohr, J. Matthias; Isaksson, Bengt] Karolinska Univ Hosp, Ctr Digest Dis, Stockholm, Sweden; [Zhang, Qianni] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England; [Kandaswamy, Senthil Vasan] Karolinska Inst, Dept Med Epidemiol & Biostat MEB, Stockholm, Sweden; [Catalano, Piera] Osped Fatebenefratelli S Giovanni Calibita, Serv Pathol, Rome, Italy	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of London; Queen Mary University London; Karolinska Institutet	Moro, CF (corresponding author), Karolinska Inst, Div Pathol, Dept Lab Med LABMED, Stockholm, Sweden.; Moro, CF (corresponding author), Karolinska Univ Hosp, Dept Clin Pathol Cytol, Stockholm, Sweden.	carlos.fernandez.moro@ki.se	Löhr, Matthias/A-3692-2012; Heuchel, Rainer/P-7875-2019	Löhr, Matthias/0000-0002-7647-198X; Heuchel, Rainer/0000-0002-2782-585X; Verbeke, Caroline/0000-0002-1111-9715; Fernandez, Alejandro/0000-0001-8179-9341; Zhang, Qianni/0000-0001-7685-2187	Stockholm County Council (ALF); Swedish Cancer and Allergy Foundation; Research Funds of the Radiumhemmet, Stockholm	Stockholm County Council (ALF)(Stockholm County Council); Swedish Cancer and Allergy Foundation; Research Funds of the Radiumhemmet, Stockholm	This study was supported by grants from the Stockholm County Council (ALF), the Swedish Cancer and Allergy Foundation, and the Research Funds of the Radiumhemmet, Stockholm.	Albores-Saavedra J, 2007, ANN DIAGN PATHOL, V11, P3, DOI 10.1016/j.anndiagpath.2006.06.008; Azodo IA, 2014, MED RADIOL RADIAT ON, P1, DOI 10.1007/978-3-642-40558-7_1; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Bosman F. T., 2010, WHO classification of tumours of the digestive system; Bronsert P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-428; Cao DF, 2007, MODERN PATHOL, V20, P570, DOI 10.1038/modpathol.3800772; Carter JT, 2008, J AM COLL SURGEONS, V207, P210, DOI 10.1016/j.jamcollsurg.2008.01.028; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Edge SB, 2010, AJCC CANC STAGING MA; Einama T, 2011, PANCREAS, V40, P1276, DOI 10.1097/MPA.0b013e318221bed8; Embuscado EE, 2005, CANCER BIOL THER, V4, P548, DOI 10.4161/cbt.4.5.1663; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; Gandou C, 2013, HUM PATHOL, V44, P811, DOI 10.1016/j.humpath.2012.08.004; Grira N, 2004, REP MUSCLE EUR NETW; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Harrell F, RMS REGRESSION MODEL; Hastie T., IMPUTE IMPUTATION MI; Hong F, RANKPROD RANK PRODUC; Hornick JL, 2005, AM J SURG PATHOL, V29, P381, DOI 10.1097/01.pas.0000149710.01559.fe; Igarashi S, 2012, HISTOPATHOLOGY, V61, P266, DOI 10.1111/j.1365-2559.2012.04218.x; Karabork A, 2010, PATHOL RES PRACT, V206, P572, DOI 10.1016/j.prp.2010.03.004; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Lohr JM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5261; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; Moriya T, 2011, INT J SURG PATHOL, V19, P441, DOI 10.1177/1066896911405654; Nakatsuka S, 2006, MODERN PATHOL, V19, P804, DOI 10.1038/modpathol.3800588; Oshima M, 2013, ANN SURG, V258, P336, DOI 10.1097/SLA.0b013e3182827a65; Pollard KS, MULTTEST HESAMPLING; RCore Team, 2020, R LANG ENV STAT COMP; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Rubbia-Brandt L, 2014, MED RADIOL RADIAT ON, P57, DOI 10.1007/978-3-642-40558-7_4; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sobin L, 2009, TNM CLASSIFICATION M; Therneau TM, SURVIVAL PACKAGE SUR; Tibshirani R, 2011, SAMR SAM SIGNIFICANC; Tremosini S, 2012, GUT, V61, P1481, DOI 10.1136/gutjnl-2011-301862; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Westgaard A, 2013, ANN SURG ONCOL, V20, P430, DOI 10.1245/s10434-012-2603-0; Westgaard A, 2009, HISTOPATHOLOGY, V54, P337, DOI 10.1111/j.1365-2559.2009.03227.x; Wyatt J., 2012, STANDARDS DATASETS R; Yonezawa S, 2010, J HEPATO-BIL-PAN SCI, V17, P108, DOI 10.1007/s00534-009-0174-7	45	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166067	10.1371/journal.pone.0166067	http://dx.doi.org/10.1371/journal.pone.0166067			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829047	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300077
J	Syberg-Olsen, MJ; Irwin, NAT; Vannini, C; Erra, F; Di Giuseppe, G; Boscaro, V; Keeling, PJ				Syberg-Olsen, Mitchell J.; Irwin, Nicholas A. T.; Vannini, Claudia; Erra, Fabrizio; Di Giuseppe, Graziano; Boscaro, Vittorio; Keeling, Patrick J.			Biogeography and Character Evolution of the Ciliate Genus Euplotes (Spirotrichea, Euplotia), with Description of Euplotes curdsi sp nov.	PLOS ONE			English	Article							N. SP; SPECIES IDENTIFICATION; PROTOZOAN CILIATE; MARINE CILIATE; CILIOPHORA; RNA; PHYLOGENY; SEQUENCE; HYPOTRICHIDA; WOODRUFFI	Ciliates comprise a diverse and ecologically important phylum of unicellular protists. One of the most specious and best-defined genera is Euplotes, which constitutes more than 70 morphospecies, many of which have never been molecularly tested. The increasing number of described Euplotes taxa emphasizes the importance for detailed characterizations of new ones, requiring standardized morphological observations, sequencing of molecular markers and careful comparison with previous literature. Here we describe Euplotes curdsi sp. nov., distinguishable by the combination of the following features: 45-65 mu m length, oval or elongated shape with both ends rounded, narrow peristome with 25-34 adoral membranelles, conspicuous paroral membrane, double-eurystomus dorsal argyrome type, 6-7 dorsolateral kineties and 10 frontoventral cirri. Three populations of the novel species have been found in brackish and marine samples in the Mediterranean and the White Sea. We provide the SSU rRNA gene sequences of these populations, and an updated phylogeny of the genus Euplotes. Using the molecular phylogenetic tree, we inferred aspects of the biogeographical history of the genus and the evolution of its most important taxonomic characters in order to provide a frame for future descriptions. Ultimately, these data reveal recurrent trends of freshwater invasion and highlight the dynamic, yet convergent, morphological evolution of Euplotes.	[Syberg-Olsen, Mitchell J.; Irwin, Nicholas A. T.; Boscaro, Vittorio; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada; [Vannini, Claudia; Erra, Fabrizio; Di Giuseppe, Graziano] Univ Pisa, Dipartimento Biol, Pisa, Italy	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of Pisa	Boscaro, V (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada.	vittorio.boscaro@botany.ubc.ca	Boscaro, Vittorio/J-5857-2012	Boscaro, Vittorio/0000-0003-4374-1231; Keeling, Patrick/0000-0002-7644-0745; Syberg-Olsen, Mitchell/0000-0003-1627-8472; Di Giuseppe, Graziano/0000-0002-9999-7650	Natural Sciences and Engineering Research Council [227301]; Tula Foundation to the Centre for Microbial Diversity and Evolution	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation to the Centre for Microbial Diversity and Evolution	This work was supported by a grant from the Natural Sciences and Engineering Research Council (227301). VB was supported by a fellowship from the Tula Foundation to the Centre for Microbial Diversity and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMALIEV F. G., 1966, ACTA PROTOZOOL, V4, P169; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BEALE G, 1990, TRENDS GENET, V6, P137, DOI 10.1016/0168-9525(90)90132-P; BEAVER JR, 1989, MICROBIAL ECOL, V17, P111, DOI 10.1007/BF02011847; BORROR AC, 1995, J EUKARYOT MICROBIOL, V42, P457, DOI 10.1111/j.1550-7408.1995.tb05891.x; BORROR AC, 1968, J PROTOZOOL, V15, P802, DOI 10.1111/j.1550-7408.1968.tb02218.x; Boscaro V, 2014, PROTIST, V165, P527, DOI 10.1016/j.protis.2014.05.004; Boscaro V, 2013, P NATL ACAD SCI USA, V110, P18590, DOI 10.1073/pnas.1316687110; CARTER HP, 1972, T AM MICROSC SOC, V91, P466, DOI 10.2307/3225477; Chen XR, 2014, CHIN J OCEANOL LIMN, V32, P426, DOI 10.1007/s00343-014-3147-x; Chen XR, 2013, ACTA PROTOZOOL, V52, P73, DOI 10.4467/16890027AP.13.008.1087; CURDS C R, 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P3; Dai RH, 2013, J EUKARYOT MICROBIOL, V60, P70, DOI 10.1111/jeu.12007; Di Giuseppe G, 2014, EUR J PROTISTOL, V50, P402, DOI 10.1016/j.ejop.2014.05.001; Di Giuseppe G, 2011, P NATL ACAD SCI USA, V108, P3181, DOI 10.1073/pnas.1019432108; DILLER WF, 1966, BIOL BULL, V131, P437, DOI 10.2307/1539983; Dolan JR, 2012, J EUKARYOT MICROBIOL, V59, P511, DOI 10.1111/j.1550-7408.2012.00646.x; Dragesco J., 1966, Archiv fuer Protistenkunde, V109, P155; FENCHEL T, 1972, Archiv fuer Protistenkunde, V114, P231; Foissner Wilhelm, 2002, Denisia, V5, P1; Fokin SI, 2008, J EUKARYOT MICROBIOL, V55, P214, DOI 10.1111/j.1550-7408.2008.00322.x; Fokin SI, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-203; Fotedar R, 2016, J EUKARYOT MICROBIOL, V63, P578, DOI 10.1111/jeu.12305; Gallagher AE, 1971, ESSENTIALS PRACTICAL; Gates M.A., 1979, Bulletin of the British Museum (Natural History) Zoology, V35, P127; Gentekaki E, 2010, J EUKARYOT MICROBIOL, V57, P508, DOI 10.1111/j.1550-7408.2010.00505.x; Gortz H-D, PROKARYOTES; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; HECKMANN K, 1983, J PROTOZOOL, V30, P284, DOI 10.1111/j.1550-7408.1983.tb02917.x; Jiang JM, 2010, EUR J PROTISTOL, V46, P121, DOI 10.1016/j.ejop.2009.11.003; Jiang JM, 2010, INT J SYST EVOL MICR, V60, P1241, DOI 10.1099/ijs.0.012120-0; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; La Terza A, 2001, MOL ECOL, V10, P1061, DOI 10.1046/j.1365-294X.2001.01242.x; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessard EJ, 1996, J EXP MAR BIOL ECOL, V204, P43, DOI 10.1016/0022-0981(96)02580-4; Liu MJ, 2015, ACTA PROTOZOOL, V54, P171, DOI 10.4467/16890027AP.15.014.3211; Lobban CS, 2005, MAR BIOL, V147, P1055, DOI 10.1007/s00227-005-0024-3; Lynn D.H, 2008, CIL PROT CHAR CLASS, V3rd ed.; Marziale F, 2008, FEBS J, V275, P5367, DOI 10.1111/j.1742-4658.2008.06666.x; Petroni G, 2002, MOL PHYLOGENET EVOL, V22, P118, DOI 10.1006/mpev.2001.1030; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosati G, 2004, J EUKARYOT MICROBIOL, V51, P49, DOI 10.1111/j.1550-7408.2004.tb00160.x; Rossi A, 2016, EUR J PROTISTOL, V53, P11, DOI 10.1016/j.ejop.2015.12.005; Schmidt SL, 2007, J EUKARYOT MICROBIOL, V54, P201, DOI 10.1111/j.1550-7408.2007.00250.x; Schwarz MVJ, 2007, J EUKARYOT MICROBIOL, V54, P125, DOI 10.1111/j.1550-7408.2007.00243x; Senra MVX, 2016, MICROB ECOL, V71, P505, DOI 10.1007/s00248-015-0668-6; Shao C, 2010, CHIN J OCEANOL LIMN, V28, P593, DOI 10.1007/s00343-010-9128-9; SONNEBORN TM, 1975, T AM MICROSC SOC, V94, P155, DOI 10.2307/3224977; Stoeck T, 2014, MOL ECOL RESOUR, V14, P458, DOI 10.1111/1755-0998.12195; Tuffrau M, 2000, EUR J PROTISTOL, V36, P355, DOI 10.1016/S0932-4739(00)80041-3; TUFFRAU MICHEL, 1960, HYDROBIOLOGIA, V15, P1, DOI 10.1007/BF00048080; VALBONESI A, 1990, POLAR BIOL, V11, P47; VALBONESI A, 1995, EUR J PROTISTOL, V31, P32, DOI 10.1016/S0932-4739(11)80353-6; VALLESI A, 1995, NATURE, V376, P522, DOI 10.1038/376522a0; Vallesi A, 2008, MOL PHYLOGENET EVOL, V47, P439, DOI 10.1016/j.ympev.2007.11.025; Vallesi A, 2014, J EUKARYOT MICROBIOL, V61, P620, DOI 10.1111/jeu.12140; Vannini C, 2005, J EUKARYOT MICROBIOL, V52, P116, DOI 10.1111/j.1550-7408.2005.04-3319.x; Vannini C, 2004, INT J SYST EVOL MICR, V54, P1151, DOI 10.1099/ijs.0.02759-0; Vannini C, 2007, ENVIRON MICROBIOL, V9, P347, DOI 10.1111/j.1462-2920.2006.01144.x; Vannini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087718; Vannini C, 2012, ENVIRON MICROBIOL, V14, P2553, DOI 10.1111/j.1462-2920.2012.02760.x; Vogt A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004032; Wallengren H, 1900, BIH K SVENSK VET, V26, P1; WASHBURN ES, 1972, J PROTOZOOL, V19, P604, DOI 10.1111/j.1550-7408.1972.tb03541.x; Wichterman E., 1964, T AM MICROSC SOC, V83, P362; Wichterman R., 1986, BIOL PARAMECIUM, V2nd ed., DOI DOI 10.1007/978-1-4757-0372-6; Wilbert N, 2008, J NAT HIST, V42, P979, DOI 10.1080/00222930701877540; Zhao Y, 2016, MOL PHYLOGENET EVOL, V94, P718, DOI 10.1016/j.ympev.2015.10.017	70	28	29	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165442	10.1371/journal.pone.0165442	http://dx.doi.org/10.1371/journal.pone.0165442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828996	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300046
J	Wang, YH; Xiao, L; Guo, SM; An, FY; Du, DZ				Wang, Yanhua; Xiao, Lu; Guo, Shaomin; An, Fengyun; Du, Dezhi			Fine Mapping and Whole-Genome Resequencing Identify the Seed Coat Color Gene in Brassica rapa	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DISEASE-RESISTANCE; MOLECULAR MARKERS; CAMPESTRIS L; NAPUS L; YELLOW; QTL; IDENTIFICATION; POPULATIONS; BLACK	A yellow seed coat is a desirable agronomic trait in the seeds of oilseed-type Brassica crops. In this study, we identified a candidate gene for seed coat color in Dahuang, a land race of Brassica rapa. A previous study of Dahuang mapped the seed coat color gene Brsc1 to a 2.8-Mb interval on chromosome A9 of B. rapa. In the present study, the density of the linkage map for Brsc1 was increased by adding simple sequence repeat (SSR) markers, and the candidate region for Brsc1 was narrowed to 1.04 Mb. In addition, whole-genome resequencing with bulked segregant analysis (BSA) was conducted to identify candidate intervals for Brsc1. A genome-wide comparison of SNP profiles was performed between yellow-seeded and brown-seeded bulk samples. SNP index analyses identified a major candidate interval on chromosome A9 (A09:18,255,838-18,934,000, 678 kb) containing a long overlap with the target region recovered from the fine mapping results. According to gene annotation, Bra028067(BrTT1) is an important candidate gene for Brsc1 in the overlapping region. Quantitative reverse transcription (qRT)-PCR revealed that BrTT1 mainly functions in the seed. Point mutations and small deletions in BrTT1 were found between yellow- and brown-seeded Dahuang plants. Collectively, the expression and sequence analysis results provide preliminary evidence that BrTT1 is a candidate gene for the seed coat color trait in Dahuang.	[Wang, Yanhua; Xiao, Lu; Guo, Shaomin; An, Fengyun; Du, Dezhi] Qinghai Univ, Acad Agr & Forestry Sci, Qinghai Res Branch, Natl Rapeseed Genet Improvement Ctr,Key Lab Sprin, Xining, Qinghai, Peoples R China	Qinghai University	Du, DZ (corresponding author), Qinghai Univ, Acad Agr & Forestry Sci, Qinghai Res Branch, Natl Rapeseed Genet Improvement Ctr,Key Lab Sprin, Xining, Qinghai, Peoples R China.	qhurape@126.com	wang, yanhua/GPT-1596-2022		National Key Research and Development Plan of China [2016YFD0101300]; Industry Technology System of Rapeseed in China [CARS-13]; National Natural Science Foundation of China [31560398]; National High-level personnel of special support program	National Key Research and Development Plan of China; Industry Technology System of Rapeseed in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-level personnel of special support program	The work was funded by National Key Research and Development Plan of China (2016YFD0101300), Industry Technology System of Rapeseed in China (CARS-13), National Natural Science Foundation of China (31560398) and National High-level personnel of special support program.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; AHMED SU, 1971, CROP SCI, V11, P309, DOI 10.2135/cropsci1971.0011183X001100020047x; Appelhagen I, 2014, PLANTA, V240, P955, DOI 10.1007/s00425-014-2088-0; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Bagheri H, 2013, SPAN J AGRIC RES, V11, P1085, DOI 10.5424/sjar/2013114-4160; CHEN BY, 1992, EUPHYTICA, V59, P157, DOI 10.1007/BF00041268; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Grover A, 2016, CRIT REV BIOTECHNOL, V36, P290, DOI 10.3109/07388551.2014.959891; Guo N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-426; He JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00484; Jiang JJ, 2013, J INTEGR PLANT BIOL, V55, P537, DOI 10.1111/jipb.12039; Kebede B, 2012, GENOME, V55, P813, DOI 10.1139/g2012-066; Kosambi DD, 1944, AM MATH MON, P382, DOI [10.1080/00029890.1944.11999118, DOI 10.1007/978-81-322-3676-4_17, 10.1007/978-81-322-3676-4_17]; Lee J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0424-6; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044145; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071110; Lou P, 2007, J EXP BOT, V58, P4005, DOI 10.1093/jxb/erm255; Lu HF, 2014, THEOR APPL GENET, V127, P1491, DOI 10.1007/s00122-014-2313-z; Marles MAS, 2004, J SCI FOOD AGR, V84, P251, DOI 10.1002/jsfa.1621; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miah G, 2013, INT J MOL SCI, V14, P22499, DOI 10.3390/ijms141122499; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Padmaja LK, 2014, THEOR APPL GENET, V127, P339, DOI 10.1007/s00122-013-2222-6; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Rahman MH, 2001, PLANT BREEDING, V120, P463, DOI 10.1046/j.1439-0523.2001.00640.x; Rahman M, 2007, THEOR APPL GENET, V115, P1101, DOI 10.1007/s00122-007-0636-8; Rahman M, 2014, PLANT BREEDING, V133, P381, DOI 10.1111/pbr.12165; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; SHIRZADEGAN M, 1985, FETT WISS TECHNOL, V87, P235, DOI 10.1002/lipi.19850870605; Stein A, 2013, PLANT BREEDING, V132, P382, DOI 10.1111/pbr.12073; Stringam G, 1974, P 4 INT RAP C GERM G; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Xiao L, 2012, THEOR APPL GENET, V124, P903, DOI 10.1007/s00122-011-1754-x; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yu CY, 2013, J APPL GENET, V54, P135, DOI 10.1007/s13353-012-0132-y; Zaman M. W., 1989, Sveriges Utsadesforenings Tidskrift, V99, P205; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y; Zhao HuiYan, 2014, Acta Agronomica Sinica, V40, P965; Zhao JJ, 2005, THEOR APPL GENET, V110, P1301, DOI 10.1007/s00122-005-1967-y	44	24	28	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166464	10.1371/journal.pone.0166464	http://dx.doi.org/10.1371/journal.pone.0166464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829069	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300108
J	Jensen, MBV; Horsfall, LE; Wardrope, C; Togneri, PD; Marles-Wright, J; Rosser, SJ				Jensen, Mai-Britt V.; Horsfall, Louise E.; Wardrope, Caroline; Togneri, Peter D.; Marles-Wright, Jon; Rosser, Susan J.			Characterisation of a New Family of Carboxyl Esterases with an OsmC Domain	PLOS ONE			English	Article							ENZYMES; SEQUENCE; CLASSIFICATION; ASSIGNMENT; PROTEINS; FEATURES; LIPASE	Proteins in the serine esterase family are widely distributed in bacterial phyla and display activity against a range of biologically produced and chemically synthesized esters. A serine esterase from the psychrophilic bacterium Pseudoalteromonas arctica with a C-terminal OsmC-like domain was recently characterized; here we report on the identification and characterization of further putative esterases with OsmC-like domains constituting a new esterase family that is found in a variety of bacterial species from different environmental niches. All of these proteins contained the Ser-Asp-His motif common to serine esterases and a highly conserved pentapeptide nucleophilic elbow motif. We produced these proteins heterologously in Escherichia coli and demonstrated their activity against a range of esterase substrates. Two of the esterases characterized have activity of over two orders of magnitude higher than other members of the family, and are active over a wide temperature range. We determined the crystal structure of the esterase domain of the protein from Rhodothermus marinus and show that it conforms to the classical alpha/beta hydrolase fold with an extended 'lid' region, which occludes the active site of the protein in the crystal. The expansion of characterized members of the esterase family and demonstration of activity over a wide-range of temperatures could be of use in biotechnological applications such as the pharmaceutical, detergent, bioremediation and dairy industries.	[Jensen, Mai-Britt V.; Horsfall, Louise E.; Wardrope, Caroline; Marles-Wright, Jon; Rosser, Susan J.] Univ Edinburgh, Sch Biol Sci, Inst Quantitat Biol Biochem & Biotechnol, Edinburgh, Midlothian, Scotland; [Jensen, Mai-Britt V.; Horsfall, Louise E.; Togneri, Peter D.; Rosser, Susan J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cellular & Syst Biol, Glasgow, Lanark, Scotland; [Marles-Wright, Jon] Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England	University of Edinburgh; University of Glasgow; Newcastle University - UK	Jensen, MBV; Rosser, SJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Quantitat Biol Biochem & Biotechnol, Edinburgh, Midlothian, Scotland.; Jensen, MBV; Rosser, SJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cellular & Syst Biol, Glasgow, Lanark, Scotland.	Mai-Britt.Jensen@ed.ac.uk; Susan.Rosser@ed.ac.uk	Horsfall, Louise/C-7809-2014	Horsfall, Louise/0000-0003-1594-2992; Rosser, Susan/0000-0002-2560-6485; Marles-Wright, Jon/0000-0002-9156-3284	Wellcome Trust; EPSRC UK [EP/H035206/1, EP/H035222/1, EP/H035192/1]; EPSRC [EP/H035206/1, EP/H035192/1, EP/H035222/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H035222/1, EP/H035206/1, EP/H035192/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Wellcome Trust ISSF funds for the crystallisation facilities at the University of Edinburgh. MVJ, LEH, PDT were supported by EPSRC UK grants EP/H035206/1, EP/H035222/1, and EP/H035192/1 (https://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Al Khudary R, 2010, EXTREMOPHILES, V14, P273, DOI 10.1007/s00792-010-0306-7; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Burg Van Den B, 2002, SELECTION MUTATIONS, P333; Cavicchioli R, 2011, MICROB BIOTECHNOL, V4, P449, DOI 10.1111/j.1751-7915.2011.00258.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CYGLER M, 1993, PROTEIN SCI, V2, P366; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Giuliani SE, 2008, BIOCHEMISTRY-US, V47, P13974, DOI 10.1021/bi801648r; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hahn JS, 2000, J BIOL CHEM, V275, P38254, DOI 10.1074/jbc.M006079200; Hess M, 2008, EXTREMOPHILES, V12, P351, DOI 10.1007/s00792-008-0139-9; JARVINEN KT, 1994, ENVIRON SCI TECHNOL, V28, P2387, DOI 10.1021/es00062a025; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023269; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Margesin R, 1999, J CHEM TECHNOL BIOT, V74, P381; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Panda T, 2005, APPL MICROBIOL BIOT, V67, P160, DOI 10.1007/s00253-004-1840-y; Park SC, 2008, BBA-PROTEINS PROTEOM, V1784, P783, DOI 10.1016/j.bbapap.2008.02.002; PORTER GR, 1958, NATURE, V182, P927, DOI 10.1038/182927a0; Reyes-Duarte D, 2005, ANGEW CHEM INT EDIT, V44, P7553, DOI 10.1002/anie.200502461; Saikolappan S, 2011, TUBERCULOSIS, V91, pS119, DOI 10.1016/j.tube.2011.10.021; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wikmark Y, 2016, CHEMBIOCHEM, V17, P141, DOI 10.1002/cbic.201500471; Wilkins MR, 1999, METH MOL B, V112, P531; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; WOLFF SP, METHODS ENZYMOL, V233, P182; Yang CY, 2006, ACTA CRYSTALLOGR F, V62, P498, DOI 10.1107/S1744309106016265	46	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166128	10.1371/journal.pone.0166128	http://dx.doi.org/10.1371/journal.pone.0166128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851780	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000387909300037
J	Bhattacharjee, B; Shafi, M; Acharjee, A				Bhattacharjee, Biplab; Shafi, Muhammad; Acharjee, Animesh			Investigating the Influence Relationship Models for Stocks in Indian Equity Market: A Weighted Network Modelling Study	PLOS ONE			English	Article							SCALE-FREE NETWORK; DYNAMICS	The socio-economic systems today possess high levels of both interconnectedness and interdependencies, and such system-level relationships behave very dynamically. In such situations, it is all around perceived that influence is a perplexing power that has an overseeing part in affecting the dynamics and behaviours of involved ones. As a result of the force & direction of influence, the transformative change of one entity has a cogent aftereffect on the other entities in the system. The current study employs directed weighted networks for investigating the influential relationship patterns existent in a typical equity market as an outcome of inter-stock interactions happening at the market level, the sectorial level and the industrial level. The study dataset is derived from 335 constituent stocks of 'Standard & Poor Bombay Stock Exchange 500 index' and study period is 1st June 2005 to 30th June 2015. The study identifies the set of most dynamically influential stocks & their respective temporal pattern at three hierarchical levels: the complete equity market, different sectors, and constituting industry segments of those sectors. A detailed influence relationship analysis is performed for the sectorial level network of the construction sector, and it was found that stocks belonging to the cement industry possessed high influence within this sector. Also, the detailed network analysis of construction sector revealed that it follows scale-free characteristics and power law distribution. In the industry specific influence relationship analysis for cement industry, methods based on threshold filtering and minimum spanning tree were employed to derive a set of sub-graphs having temporally stable high-correlation structure over this ten years period.	[Bhattacharjee, Biplab; Shafi, Muhammad; Acharjee, Animesh] Natl Inst Technol, Sch Management Studies, Calicut, Kerala, India; [Acharjee, Animesh] Univ Cambridge, Dept Biochem, Sanger Bldg, Cambridge, England	National Institute of Technology (NIT System); National Institute of Technology Calicut; University of Cambridge	Acharjee, A (corresponding author), Natl Inst Technol, Sch Management Studies, Calicut, Kerala, India.; Acharjee, A (corresponding author), Univ Cambridge, Dept Biochem, Sanger Bldg, Cambridge, England.	animesh.acharjee@gmail.com	Muhammad, Shafi/S-8496-2016; Acharjee, Animesh/AAC-7637-2019	Muhammad, Shafi/0000-0002-6667-576X; Acharjee, Animesh/0000-0003-2735-7010				Acharjee A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1043-4; Arora N, 2006, LECT NOTES COMPUT SC, V3991, P16; Arthur WB, 2006, HANDB ECON, V13, P1551; Asthana S, 2016, BUSINESS STANDARD MU; Barabasi A-L, 2003, LINKED EVERYTHING IS; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bolgorian M, 2010, PHYSICA A, V389, P3822, DOI 10.1016/j.physa.2010.05.017; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chinazzi M, SSRN ELECT J; CNN. Atlantia, 2013, GLOB 500; Colander D., 2004, REV POLITICAL EC, V16, P485, DOI DOI 10.1080/0953825042000256702; Fortune. com. New York City, 2015, FORT 500; Foster J, 2005, CAMB J ECON, V29, P873, DOI 10.1093/cje/bei083; Galazka M, 2011, INT REV FINANC ANAL, V20, P1, DOI 10.1016/j.irfa.2010.11.002; Garas A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113043; Goyal S, 2013, STRONG TIES SMALL WO; Hu P, 2013, ADV INTEL SYS RES, V64, P411; Huang S, SSRN ELECT J; Huang WQ, 2016, PHYSICA A, V456, P183, DOI 10.1016/j.physa.2016.03.034; IANS, 2016, TIM IND REL IND LTD; icicibank. com. Mumbai, 2014, US; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang Z.-Q., 2013, QUANT FINANC LETT, V1, P1, DOI DOI 10.1080/21649502.2013.802877; Jiang ZQ, 2010, PHYSICA A, V389, P4929, DOI 10.1016/j.physa.2010.07.024; Jung WS, 2006, PHYSICA A, V361, P263, DOI 10.1016/j.physa.2005.06.081; Kim HJ, 2002, J KOREAN PHYS SOC, V40, P1105; Kim HJ, 2002, J PHYS SOC JPN, V71, P2133, DOI 10.1143/JPSJ.71.2133; Kim HJ, 2008, MOD PHYS LETT B, V22, P3053, DOI 10.1142/S0217984908017564; Kirman A, 1997, J EVOL ECON, V7, P339, DOI 10.1007/s001910050047; Koschutzki D, 2010, J THEOR BIOL, V265, P261, DOI 10.1016/j.jtbi.2010.05.009; Lautier D, 2012, ENERG J, V33, P215, DOI 10.5547/01956574.33.3.8; Li MX, 2015, PHYSICA A, V419, P575, DOI 10.1016/j.physa.2014.10.039; Liao C, 2014, 2014 INTERNATIONAL CONFERENCE ON DATA SCIENCE AND ADVANCED ANALYTICS (DSAA), P244, DOI 10.1109/DSAA.2014.7058080; Liu XF, 2010, 2010 INT S NONL THEO, P402; Majapa M, 2016, PHYSICA A, V445, P35, DOI 10.1016/j.physa.2015.10.108; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Martin R, 2007, J ECON GEOGR, V7, P573, DOI 10.1093/jeg/lbm019; Monechi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125546; National Stock Exchange, 2013, TOP 50 CO MARK CAP M; Onnela J. P., 2006, PRACTICAL FRUITS ECO, P302; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; Onnela JP, 2002, EUR PHYS J B, V30, P285, DOI 10.1140/epjb/e2002-00380-9; OSC's Investor Office, 2016, GETSMARTERABOUTMONEY; Ray A, 2006, EVOLUTION STATE BANK, V4; RIL. com. Mumbai, 2013, ANN REP 2012 13; Rosser JB, 1999, J ECON PERSPECT, V13, P169, DOI 10.1257/jep.13.4.169; ROY R. B., 2011, PROC COMP SCI 2 INT, V5, P442, DOI DOI 10.1016/j.procs.2011.07.057; Samal A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-118; Sandoval L, 2015, J RISK FINANC MANAG, V8, P227, DOI 10.3390/jrfm8020227; Schiavo S, 2010, QUANT FINANC, V10, P389, DOI 10.1080/14697680902882420; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sieczka P, 2009, PHYSICA A, V388, P1621, DOI 10.1016/j.physa.2009.01.004; Soh H, 2010, PHYSICA A, V389, P5852, DOI 10.1016/j.physa.2010.08.015; Song DM, 2009, PHYSICA A, V388, P2450, DOI 10.1016/j.physa.2009.03.004; Sun XQ, 2011, PHYSICA A, V390, P3427, DOI 10.1016/j.physa.2011.04.006; Tabak BM, 2010, PHYSICA A, V389, P3240, DOI 10.1016/j.physa.2010.04.002; Tesfatsion L, 2003, INFORM SCIENCES, V149, P263, DOI 10.1016/S0020-0255(02)00280-3; Wang GJ, 2015, PHYSICA A, V424, P176, DOI 10.1016/j.physa.2015.01.025; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang CX, 2014, PHYSICA A, V400, P168, DOI 10.1016/j.physa.2014.01.011; Zhu L, 2016, PROCEDIA ENGINEER, V138, P186, DOI 10.1016/j.proeng.2016.01.249	63	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166087	10.1371/journal.pone.0166087	http://dx.doi.org/10.1371/journal.pone.0166087			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846251	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600031
J	Fukano, K; Okamatsu-Ogura, Y; Tsubota, A; Nio-Kobayashi, J; Kimura, K				Fukano, Keigo; Okamatsu-Ogura, Yuko; Tsubota, Ayumi; Nio-Kobayashi, Junko; Kimura, Kazuhiro			Cold Exposure Induces Proliferation of Mature Brown Adipocyte in a beta 3-Adrenergic Receptor-Mediated Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; ADIPOSE-TISSUE; UNCOUPLING PROTEIN; PRIMARY CULTURE; MICE; FAT; DIFFERENTIATION; THERMOGENESIS; ANGIOGENESIS	Hyperplasia of brown adipose tissue (BAT) is a fundamental mechanism for adaptation to survive in the cold environment in rodents. To determine which cell types comprising BAT contribute to tissue hyperplasia, immunohistochemical analysis using a proliferative marker Ki67 was performed on the BAT from 6-week-old C57BLJ6J mice housed at 23 degrees C (control) or 10 degrees C (cold) for 5 days. Interestingly, in the control group, the cell proliferative marker Ki67 was detected in the nuclei of uncoupling protein 1-positive mature brown adipocytes (7.2% +/- 0.4% of brown adipocyte), as well as in the non-adipocyte stromal-vascular (SV) cells (19.6% +/- 2.3% of SV cells), which include preadiopocytes. The percentage of Ki67-positive brown adipocytes increased to 25.6% +/- 1.8% at Day 1 after cold exposure and was significantly higher than the non-cold acclimated control until Day 5 (21.8%+/- 1.7%). On the other hand, the percentage of Ki67-positive SV cells gradually increased by a cold exposure and peaked to 42.1%+/- 8.3% at Day 5. Injection of a beta 3-adrenergic receptor (beta 3-AR) agonist for continuous 5 days increased the number of Ki67-positive brown adipocytes even at Day 1 but not that of SV cells. In addition, the beta 3-AR antagonist, but not beta 1-AR antagonist, attenuated the cold exposure-induced increase in the number of Ki67-positive brown adipocytes. These results suggest that mature brown adipocytes proliferate immediately after cold exposure in a beta 3-AR-mediated pathway. Thus, proliferation of mature brown adipocytes as well as preadipocytes in SV cells may contribute to cold exposure-induced BAT hyperplasia.	[Fukano, Keigo; Okamatsu-Ogura, Yuko; Tsubota, Ayumi; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan; [Nio-Kobayashi, Junko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido 0650013, Japan	Hokkaido University; Hokkaido University	Okamatsu-Ogura, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan.	y-okamatsu@vetmed.hokudai.ac.jp	Kimura, Kazuhiro/A-5029-2012; Okamatsu-Ogura, Yuko/AAI-5602-2020	NIO-KOBAYASHI, Junko/0000-0003-3019-2923	JSPS KAKENHI [15J02438, 26860684, 15H04545]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported in part by JSPS KAKENHI Grant Number 15J02438 for KF, 26860684 and 15H04545 for YOO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Masayuki Saito (Hokkaido University) for the helpful discussion and Dr. Teruo Kawada (Kyoto University) for the kind gift of the anti-UCP1 antibody. This study is supported in part by JSPS KAKENHI Grant Number 26860684, 15J02438, and 15H04545.	Asano A, 1999, J VET MED SCI, V61, P403, DOI 10.1292/jvms.61.403; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; BUKOWIECKI LJ, 1986, AM J PHYSIOL, V250, pC880, DOI 10.1152/ajpcell.1986.250.6.C880; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Duchamp C, 1997, AM J PHYSIOL-ENDOC M, V272, pE453, DOI 10.1152/ajpendo.1997.272.3.E453; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Garcia B, 1997, ENDOCRINOLOGY, V138, P4227, DOI 10.1210/en.138.10.4227; GELOEN A, 1992, AM J PHYSIOL, V263, pR1176, DOI 10.1152/ajpregu.1992.263.6.R1176; GELOEN A, 1988, AM J PHYSIOL, V254, pC175, DOI 10.1152/ajpcell.1988.254.1.C175; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iwanaga T, 2009, BIOMED RES-TOKYO, V30, P217, DOI 10.2220/biomedres.30.217; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; NAGASE I, 1994, JPN J VET RES, V42, P137; NECHAD M, 1994, COMP BIOCHEM PHYS A, V107, P381, DOI 10.1016/0300-9629(94)90396-4; Nisoli E, 1996, ENDOCRINOLOGY, V137, P495, DOI 10.1210/en.137.2.495; Okamatsu-Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084229; Okamatsu-Ogura Y, 2007, OBES RES CLIN PRACT, V1, P233, DOI 10.1016/j.orcp.2007.08.001; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sun K, 2014, MOL METAB, V3, P474, DOI 10.1016/j.molmet.2014.03.010; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; YAMASHITA H, 1994, LIFE SCI, V55, P141, DOI 10.1016/0024-3205(94)90105-8; YAMASHITA H, 1995, CELL GROWTH DIFFER, V6, P1457	29	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166579	10.1371/journal.pone.0166579	http://dx.doi.org/10.1371/journal.pone.0166579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846311	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600086
J	Mishra, PJ; Mishra, PJ; Merlino, G				Mishra, Prasun J.; Mishra, Pravin J.; Merlino, Glenn			Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; MALIGNANT-MELANOMA; SITE POLYMORPHISM; TUMOR-SUPPRESSOR; RESISTANCE; CELLS; CANCER; MICE; APOPTOSIS; MCL-1	Aims Cutaneous malignant melanoma is among the deadliest human cancers, broadly resistant to most clinical therapies. A majority of patients with BRAF(V600E) melanomas respond well to inhibitors such as vemurafenib, but all ultimately relapse. Moreover, there are no viable treatment options available for other non-BRAF melanoma subtypes in the clinic. A key to improving treatment options lies in a better understanding of mechanisms underlying melanoma progression, which are complex and heterogeneous. Methods In this study we integrated gene and microRNA (miRNA) expression data from genetically engineered mouse models of highly and poorly malignant melanocytic tumors, as well as available human melanoma databases, and discovered an important role for a pathway centered on a tumor suppressor miRNA, miR-32. Results Malignant tumors frequently exhibited poor expression of miR-32, whose targets include NRAS, PI3K and notably, MCL-1. Accordingly, MCL-1 was often highly expressed in melanomas, and when knocked down diminished oncogenic potential. Forced MCL-1 overexpression transformed immortalized primary mouse melanocytes, but only when also expressing activating mutations in BRAF, CRAF or PI3K. Importantly, both miR-32 replacement therapy and the MCL-1-specific antagonist sabutoclax demonstrated single-agent efficacy, and acted synergistically in combination with vemurafenib in preclinical melanoma models. Conclusions We here identify miR-32/ MCL-1 pathway members as key early genetic events driving melanoma progression, and suggest that their inhibition may be an effective anti-melanoma strategy irrespective of NRAS, BRAF, and PTEN status.	[Mishra, Prasun J.] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Mishra, Prasun J.; Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Mishra, Pravin J.] Dixie Reg Med Ctr, Precis Genom, Intermt Healthcare, St George, UT USA	Roche Holding; Genentech; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Intermountain Healthcare; Intermountain Medical Center	Mishra, PJ (corresponding author), Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA.; Mishra, PJ; Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	mishra.prasun@gene.com; gmerlino@helix.nih.gov			Intramural Research Program of the Center of Cancer Research, NCI, NIH; NCI Cancer Research Training Award [C5IL039280]; NCI; Genentech; NATIONAL CANCER INSTITUTE [ZIABC008756] Funding Source: NIH RePORTER	Intramural Research Program of the Center of Cancer Research, NCI, NIH; NCI Cancer Research Training Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the Intramural Research Program of the Center of Cancer Research, NCI, NIH, and in part by NCI Cancer Research Training Award C5IL039280, and NCI Director's Innovation Awards in 2009 and 2011 (to PJM). PJM is employed by Genentech Inc. at present. The funder provided support in the form of salaries to PJM (Genentech), GM (NCI), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The work was supported by the Intramural Research Program of the Center of Cancer Research, NCI, NIH, and in part by NCI Cancer Research Training Award C5IL039280, and NCI Director's Innovation Awards in 2009 and 2011 (to PJM). PJM is employed by Genentech Inc. at present. The funder provided support in the form of salaries to PJM (Genentech), GM (NCI), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Sabutoclax was a generous gift from Dr. Paul B. Fisher, Virginia Commonwealth University, Richmond, VA and was also purchased from APEXBIO. Some of the human melanocytes and melanoma cell lines were obtained from Dr. Meenhard Herlyn, The Wistar Institute Melanoma Research Center, PA and from Cell Culture Core Facility, Yale Skin Diseases Research Center Core, Department of Dermatology, Yale University School of Medicine.	Becker TM, 2014, ONCOGENE, V33, P1158, DOI 10.1038/onc.2013.45; Beillard E, 2012, RNA, V18, P1091, DOI 10.1261/rna.031831.111; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dash R, 2011, P NATL ACAD SCI USA, V108, P8785, DOI 10.1073/pnas.1100769108; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Freedberg DE, 2008, JNCI-J NATL CANCER I, V100, P784, DOI 10.1093/jnci/djn157; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Ma YB, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027935; Magro PG, 2004, CANCER RES, V64, P4338, DOI 10.1158/0008-5472.CAN-03-1045; McKee CS, 2013, EXP DERMATOL, V22, P767, DOI 10.1111/exd.12254; Mishra PJ, 2010, ONCOGENE, V29, P2449, DOI 10.1038/onc.2009.521; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008445; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Placzek WJ, 2011, J BIOL CHEM, V286, P39829, DOI 10.1074/jbc.M111.305326; Recio JA, 2002, CANCER RES, V62, P6724; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S20; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; SVIDERSKAYA EV, 1995, DEVELOPMENT, V121, P1547; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Tang LR, 1998, CLIN CANCER RES, V4, P1865; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Wilgenhof S, 2013, J IMMUNOTHER, V36, P215, DOI 10.1097/CJI.0b013e31828eed39; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	37	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165102	10.1371/journal.pone.0165102	http://dx.doi.org/10.1371/journal.pone.0165102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846237	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600008
J	Protudjer, JLP; Vetander, M; Kull, I; Hedlin, G; van Hage, M; Wickman, M; Bergstrom, A				Protudjer, Jennifer L. P.; Vetander, Mirja; Kull, Inger; Hedlin, Gunilla; van Hage, Marianne; Wickman, Magnus; Bergstrom, Anna			Food-Related Symptoms and Food Allergy in Swedish Children from Early Life to Adolescence	PLOS ONE			English	Article							COW MILK ALLERGY; QUALITY-OF-LIFE; NATURAL-HISTORY; HYPERSENSITIVITY; PREVALENCE; SENSITIZATION; ANAPHYLAXIS; PARENTS; EPIDEMIOLOGY; ASSOCIATION	Background Risk factors for persistence of food-related symptoms (FRS) and food allergy (FA) from early life to adolescence are incompletely understood. The aim of this study was to identify risk factors for FRS and FA in adolescence amongst children with FRS or FA in the first four years of life (early life). Methods In children enrolled in a Swedish birth cohort and followed to 16 years (n = 2572), we defined children with early life FRS in the absence of FA, and FA. Corresponding phenotypes were defined at 16 years. Associations between potential risk factors at 4 years and FRS and FA at 16 years were investigated using logistic regression. Results Early life FRS and FA prevalences were 12.2% and 6.8%, respectively. Amongst children with early life FRS, 35.7% had FRS or FA at 16 years, whereas 74.3% of the children with early life FA had FA at 16 years. For each of the early life phenotypes, parental allergy, early life allergic multimorbidity, early life reactions to peanuts/tree nuts and IgE reactivity at 4 years were statistically significantly associated with FRS or FA at 16 years. In contrast, male sex was associated with an increased risk of FA at 16 years among children with early life FA only. Conclusions In early life, food-related symptoms are twice as common as food allergy. Unlike food allergy, food-related symptoms often remit by adolescence. Yet, these phenotypes have many common risk factors for persistence to adolescence.	[Protudjer, Jennifer L. P.; Vetander, Mirja; Kull, Inger; Wickman, Magnus; Bergstrom, Anna] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Protudjer, Jennifer L. P.; Vetander, Mirja; Kull, Inger; Hedlin, Gunilla; van Hage, Marianne; Wickman, Magnus; Bergstrom, Anna] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Vetander, Mirja; Kull, Inger; Wickman, Magnus] Sachs Children & Youth Hosp, Sodersjukhuset, Stockholm, Sweden; [Kull, Inger] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Hedlin, Gunilla] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [van Hage, Marianne] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden; [van Hage, Marianne] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Protudjer, JLP (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.; Protudjer, JLP (corresponding author), Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden.	jennifer.protudjer@ki.se	van Hage, Marianne/A-9678-2017	van Hage, Marianne/0000-0003-3091-1596; Kull, Inger/0000-0001-6096-3771	Swedish Asthma and Allergy Association's Research Foundation, Centre for Allergy Research (CfA), Karolinska Institutet; Stockholm County Council; Swedish Research Council; Swedish Research Council for Health Working Life and Welfare, Sweden; European Commission's Seventh Framework 29 Program MeDALL [261357]; Karin and Sten Mortstedt Initiative on Anaphylaxis	Swedish Asthma and Allergy Association's Research Foundation, Centre for Allergy Research (CfA), Karolinska Institutet; Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health Working Life and Welfare, Sweden; European Commission's Seventh Framework 29 Program MeDALL; Karin and Sten Mortstedt Initiative on Anaphylaxis	The BAMSE study, the cohort on which this study is based has received supported by the Swedish Asthma and Allergy Association's Research Foundation, Centre for Allergy Research (CfA), Karolinska Institutet; Stockholm County Council, the Swedish Research Council and the Swedish Research Council for Health Working Life and Welfare, Sweden. We also acknowledge the European Commission's Seventh Framework 29 Program MeDALL (grant agreement 261357). At the time of data analysis and writing, two of the authors (JP and MV) were postdoctoral researchers funded by the Karin and Sten Mortstedt Initiative on Anaphylaxis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alduraywish SA, 2015, PEDIAT ALLERGY IMMUN; Arshad SH, 2014, J ALLERGY CLIN IMMUN, V134, P1462, DOI 10.1016/j.jaci.2014.09.026; BISHOP JM, 1990, J PEDIATR-US, V116, P862, DOI 10.1016/S0022-3476(05)80641-9; Fox M, 2013, EUR J PUBLIC HEALTH, V23, P757, DOI 10.1093/eurpub/ckt010; Grabenhenrich LB, 2015, J ALLERGY CLIN IMMUN, V136, P932, DOI 10.1016/j.jaci.2015.03.040; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Gupta RS, 2013, ANN ALLERG ASTHMA IM, V111, P194, DOI 10.1016/j.anai.2013.06.026; HOST A, 1990, ALLERGY, V45, P587, DOI 10.1111/j.1398-9995.1990.tb00944.x; Keet CA, 2014, ANN ALLERG ASTHMA IM, V112, P222, DOI 10.1016/j.anai.2013.12.007; Kivisto E JE, 2016, J ALLERGY CLIN IMMUN; Kivisto JE, 2016, ALLERGY, V71, P677, DOI 10.1111/all.12837; Koplin JJ, 2014, ALLERGY, V69, P1639, DOI 10.1111/all.12487; Kusunoki T, 2010, PEDIATR ALLERGY IMMU, V21, P60, DOI 10.1111/j.1399-3038.2009.00982.x; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Luccioli S, 2014, PEDIATRICS, V134, pS21, DOI 10.1542/peds.2014-0646E; Mai XM, 2008, ALLERGY, V63, P1499, DOI 10.1111/j.1398-9995.2008.01792.x; Marklund B, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-48; Munoz-Cano R, 2016, J INVEST ALLERG CLIN, V26, P73, DOI 10.18176/jiaci.0046; Neuman-Sunshine DL, 2012, ANN ALLERG ASTHMA IM, V108, P326, DOI 10.1016/j.anai.2011.11.010; Nwaru BI, 2013, J ALLERGY CLIN IMMUN, V131, P78, DOI 10.1016/j.jaci.2012.10.028; Ostblom E, 2008, CLIN EXP ALLERGY, V38, P1325, DOI 10.1111/j.1365-2222.2008.03010.x; Ostblom E, 2008, ALLERGY, V63, P211, DOI 10.1111/j.1398-9995.2007.01559.x; Panesar SS, 2013, ALLERGY, V68, P1353, DOI 10.1111/all.12272; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Protudjer JLP, 2015, J ALLER CL IMM-PRACT, V3, P68, DOI 10.1016/j.jaip.2014.09.021; Protudjer JL, 2016, CLIN TRANSL IN PRESS; Pyrhonen K, 2013, ACTA PAEDIATR, V102, P982, DOI 10.1111/apa.12342; Roehr CC, 2004, CLIN EXP ALLERGY, V34, P1534, DOI 10.1111/j.1365-2222.2004.02080.x; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Santos A, 2010, PEDIAT ALLERG IMM-UK, V21, P1127, DOI 10.1111/j.1399-3038.2010.01040.x; Savage JH, 2007, J ALLERGY CLIN IMMUN, V120, P1413, DOI 10.1016/j.jaci.2007.09.040; Schnabel E, 2010, CLIN EXP ALLERGY, V40, P450, DOI 10.1111/j.1365-2222.2009.03400.x; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P492, DOI 10.1016/j.jaci.2013.12.1041; Soller L, 2012, J ALLERGY CLIN IMMUN, V130, P986, DOI 10.1016/j.jaci.2012.06.029; Strinnholm A, 2014, ACTA PAEDIATR, V103, P1290, DOI 10.1111/apa.12772; Turnbull JL, 2015, ALIMENT PHARM THER, V41, P3, DOI 10.1111/apt.12984; Vanderhoof J A, 1998, Curr Opin Clin Nutr Metab Care, V1, P419, DOI 10.1097/00075197-199809000-00009; Venter C, 2008, ALLERGY, V63, P354, DOI 10.1111/j.1398-9995.2007.01570.x; Venter C, 2006, PEDIAT ALLERG IMM-UK, V17, P356, DOI 10.1111/j.1399-3038.2006.00428.x; Venter C, 2015, PEDIAT ALLERG IMM-UK, V26, P126, DOI 10.1111/pai.12337; Vetander M, 2014, CLIN EXP ALLERGY, V44, P113, DOI 10.1111/cea.12203; Vetander M, 2012, CLIN EXP ALLERGY, V42, P568, DOI 10.1111/j.1365-2222.2011.03954.x; Westman M, 2015, J ALLERGY CLIN IMMUN, V135, P1199, DOI 10.1016/j.jaci.2014.10.042; Winberg A, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-32; Yavuz ST, 2013, ANN ALLERG ASTHMA IM, V110, P284, DOI 10.1016/j.anai.2013.01.018	47	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166347	10.1371/journal.pone.0166347	http://dx.doi.org/10.1371/journal.pone.0166347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846286	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600048
J	Zheng, YC; Ai, DN; Zhang, P; Gao, YF; Xia, LK; Du, SD; Sang, XT; Yang, J				Zheng, Yongchang; Ai, Danni; Zhang, Pan; Gao, Yefei; Xia, Likun; Du, Shunda; Sang, Xinting; Yang, Jian			Feature Learning Based Random Walk for Liver Segmentation	PLOS ONE			English	Article							SHAPE MODEL	Liver segmentation is a significant processing technique for computer-assisted diagnosis. This method has attracted considerable attention and achieved effective result. However, liver segmentation using computed tomography (CT) images remains a challenging task because of the low contrast between the liver and adjacent organs. This paper proposes a feature-learning-based random walk method for liver segmentation using CT images. Four texture features were extracted and then classified to determine the classification probability corresponding to the test images. Seed points on the original test image were automatically selected and further used in the random walk (RW) algorithm to achieve comparable results to previous segmentation methods.	[Zheng, Yongchang; Du, Shunda; Sang, Xinting] Chinese Acad Med Sci, Dept Liver Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Zheng, Yongchang; Du, Shunda; Sang, Xinting] Peking Union Med Coll, Beijing 100730, Peoples R China; [Ai, Danni; Zhang, Pan; Gao, Yefei; Xia, Likun; Yang, Jian] Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Institute of Technology	Ai, DN (corresponding author), Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China.	danni@bit.edu.cn			National Hi-Tech Research and Development Program [2015AA043203]; National Science Foundation Program of China [61501030, 61572076]; China Postdoctoral Science Foundation [2015M570940]	National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China); National Science Foundation Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Hi-Tech Research and Development Program (2015AA043203), the National Science Foundation Program of China (61501030, 61572076), the China Postdoctoral Science Foundation funded project (2015M570940).	Al-Shaikhli SDS, 2015, COMPUTER VISION PATT; Campadelli P, 2009, ARTIF INTELL MED, V45, P185, DOI 10.1016/j.artmed.2008.07.020; Chi Y, 2007, P MICCAI WORKSH 3D S, P167; Dag I, 2006, J COMPUT APPL MATH, V190, P532, DOI 10.1016/j.cam.2005.04.026; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Furukawa D., 2007, P MICCAI WORKSH 3 D, P117; Gao LM, 1996, RADIOLOGY, V201, P359, DOI 10.1148/radiology.201.2.8888223; Gauriau R, 2013, P 5 WORKSH COMP CLIN, P241; George Linguraru Marius, 2012, COMPUTATIONAL CLIN A, V7029, P198; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Haugen AS, 2015, ANN SURG, V261, P821, DOI 10.1097/SLA.0000000000000716; Haustermans K., 2007, P MICCAI WORKSH 3D S, P197; Heimann T, 2007, LECT NOTES COMPUT SC, V4584, P1; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Huang C, INT C EL COMM CONTR, P126; Hufnagel H, 2007, LECT NOTES COMPUT SC, V4791, P959; Kainmuller D., 2007, P MICCAI WORKSHOP 3D, V109, P116; Li XC, 2008, ENG APPL ARTIF INTEL, V21, P785, DOI 10.1016/j.engappai.2007.07.001; Lienhart R, 2002, IEEE IMAGE PROC, P900; Mahjoub Mohamed Ali, 2011, CANADIAN J IMAGE PRO, V2, P92; Meng B, 2015, IEEE T BIOMEDICAL EN; Meng B., 2014, SPIE DEV XRAY TOMOGR; Mharib AM, 2012, ARTIF INTELL REV, V37, P83, DOI 10.1007/s10462-011-9220-3; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Rikxoort E., 2007, P MICCAI WORKSH 3 D, P101; Saddi M., 2007, P MICCAI WORKSH 3D S, P207; Seghers D., 2007, P MICCAI WORKSH 3 D, P135; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Soh L., 1999, IEEE T GEOSCIENCE RE, V37; Vapnik V., 1998, STAT LEARNING THEORY; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wei YT, 2014, APPL MECH MATER, V513-517, P3115, DOI 10.4028/www.scientific.net/AMM.513-517.3115; Wimmer A, 2009, LECT NOTES COMPUT SC, V5762, P26, DOI 10.1007/978-3-642-04271-3_4	37	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0164098	10.1371/journal.pone.0164098	http://dx.doi.org/10.1371/journal.pone.0164098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846217	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600004
J	Ji, XT; Niu, YF; Shen, LC				Ji, Xiaoting; Niu, Yifeng; Shen, Lincheng			Robust Satisficing Decision Making for Unmanned Aerial Vehicle Complex Missions under Severe Uncertainty	PLOS ONE			English	Article							UAV	This paper presents a robust satisficing decision-making method for Unmanned Aerial Vehicles (UAVs) executing complex missions in an uncertain environment. Motivated by the info-gap decision theory, we formulate this problem as a novel robust satisficing optimization problem, of which the objective is to maximize the robustness while satisfying some desired mission requirements. Specifically, a new info-gap based Markov Decision Process (IMDP) is constructed to abstract the uncertain UAV system and specify the complex mission requirements with the Linear Temporal Logic (LTL). A robust satisficing policy is obtained to maximize the robustness to the uncertain IMDP while ensuring a desired probability of satisfying the LTL specifications. To this end, we propose a two-stage robust satisficing solution strategy which consists of the construction of a product IMDP and the generation of a robust satisficing policy. In the first stage, a product IMDP is constructed by combining the IMDP with an automaton representing the LTL specifications. In the second, an algorithm based on robust dynamic programming is proposed to generate a robust satisficing policy, while an associated robustness evaluation algorithm is presented to evaluate the robustness. Finally, through Monte Carlo simulation, the effectiveness of our algorithms is demonstrated on an UAV search mission under severe uncertainty so that the resulting policy can maximize the robustness while reaching the desired performance level. Furthermore, by comparing the proposed method with other robust decision-making methods, it can be concluded that our policy can tolerate higher uncertainty so that the desired performance level can be guaranteed, which indicates that the proposed method is much more effective in real applications.	[Ji, Xiaoting; Niu, Yifeng; Shen, Lincheng] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Niu, YF (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	niuyifeng@nudt.edu.cn			National Natural Science Foundation of China [61403410]; National Natural Science Foundation (NNSF) of China [61403410]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, 61403410, http://www.nsfc.gov.cn/, YN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation (NNSF) of China under Grant 61403410.	[Anonymous], 2003, MR1626RPC RAND CORP; Berman ESF, 2012, SENSOR ACTUAT B-CHEM, V169, P128, DOI 10.1016/j.snb.2012.04.036; Bertuccelli LF, 2012, IEEE CONTR SYST MAG, V32, P96, DOI 10.1109/MCS.2012.2205478; Bhatia A, 2011, IEEE ROBOT AUTOM MAG, V18, P55, DOI 10.1109/MRA.2011.942115; Brown CB, 2006, STRUCT SAF, V33, P122; Bulatov D, 2012, INT ARCH PHOTOGRAMME, V3822, P75, DOI [10.5194/isprsarchives-XXXVIII-1-C22-75-2011, DOI 10.5194/ISPRSARCHIVES-XXXVIII-1-C22-75-]; Chang HS, 2005, IEEE T AUTOMAT CONTR, V50, P1804, DOI 10.1109/TAC.2005.858644; Christel Baier, 2008, PRINCIPLES MODEL CHE; Ding X. C., 2011, IFAC, V18, P3515; Ding XC, 2014, IEEE T AUTOMAT CONTR, V59, P1244, DOI 10.1109/TAC.2014.2298143; Farrar C, 2012, SOC PHOT INSTR ENG C, V26; Givan R, 1997, BOUNDED PARAMETER MA, DOI [10.1007/3-540-63912-889, DOI 10.1007/3-540-63912-889]; Goldfarb D, 2003, MATH OPER RES, V28, P1, DOI 10.1287/moor.28.1.1.14260; Goode A, 2001, SOLVING UNCERTAIN MA; Goodrich MA, 2008, J FIELD ROBOT, V25, P89, DOI 10.1002/rob.20226; Hu XX, 2015, J CENT SOUTH UNIV, V22, P4263, DOI 10.1007/s11771-015-2975-y; Iscold P, 2010, IEEE T AERO ELEC SYS, V46, P335, DOI 10.1109/TAES.2010.5417166; Itay S, 2011, IEEE T ROBOTICS, V26, P1032; Iyengar GN, 2005, MATH OPER RES, V30, P257, DOI 10.1287/moor.1040.0129; Ji X, 2015, MATH PROBLEMS ENG, V5; Kalyanasundaram S, 2002, IEEE DECIS CONTR P, P3799; Klein J, 2006, THEOR COMPUT SCI, V363, P182, DOI 10.1016/j.tcs.2006.07.022; Kupferman O, 1998, FORM METHOD SYST DES, V19, P685; Kwiatkowska Marta, 2011, Computer Aided Verification. Proceedings 23rd International Conference, CAV 2011, P585, DOI 10.1007/978-3-642-22110-1_47; Lacerda B, 2014, IEEE INT C INT ROBOT, P1511, DOI 10.1109/IROS.2014.6942756; Lempert RJ, 2006, MANAGE SCI, V52, P514, DOI 10.1287/mnsc.1050.0472; Lempert RJ, 2007, RISK ANAL, V27, P1009, DOI 10.1111/j.1539-6924.2007.00940.x; Loizou S. G., 2005, IEEE C DEC CONTR, P153; Luna R., 2014, WORKSH ALG FDN ROB, P335; MANKTELOW K. I., 1999, REASONING THINKING; McInerney D, 2012, CLIMATIC CHANGE, V112, P547, DOI 10.1007/s10584-011-0377-1; Nilim A, 2005, OPER RES, V53, P780, DOI 10.1287/opre.1050.0216; Pierce SG, 2006, IEEE T NEURAL NETWOR, V17, P1349, DOI 10.1109/TNN.2006.880363; Puterman ML., 1994, WILEY SERIES PROBABI, V37, P353, DOI [10.1002/9780470316887, DOI 10.1002/9780470316887]; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; SATIA JK, 1973, OPER RES, V21, P728, DOI 10.1287/opre.21.3.728; Semsch E, 2009, 2009 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 2, P82; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; WHITE CC, 1994, OPER RES, V42, P739, DOI 10.1287/opre.42.4.739; Wolff EM, 2012, IEEE DECIS CONTR P, P3372, DOI 10.1109/CDC.2012.6426174; Wongpiromsarn T, 2010, HSSC 10: PROCEEDINGS OF THE 13TH ACM INTERNATIONAL CONFERENCE ON HYBRID SYSTEMS: COMPUTATION AND CONTROL, P101	42	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166448	10.1371/journal.pone.0166448	http://dx.doi.org/10.1371/journal.pone.0166448			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835670	Green Submitted, Green Published, gold			2022-12-27	WOS:000387779200051
J	Liu, ZH; Gao, YL; Yang, H; Bao, HY; Qin, LH; Zhu, CT; Chen, YW; Hu, ZY				Liu, Zhonghua; Gao, Yulu; Yang, Hua; Bao, Haiyang; Qin, Lianhua; Zhu, Changtai; Chen, Yawen; Hu, Zhongyi			Impact of Hypoxia on Drug Resistance and Growth Characteristics of Mycobacterium tuberculosis Clinical Isolates	PLOS ONE			English	Article							IN-VITRO; ADAPTATION; BINDING; GENE; EXPRESSION; CULTURE; DOMAIN; SENSOR; VIVO; DEVS	Mycobacterium tuberculosis (MTB) is a specific aerobic bacterium, but can survive under hypoxic conditions, such as those in lung cheese necrosis, granulomas, or macrophages. It is not clear whether the drug sensitivity and growth characteristics of MTB under hypoxic conditions are different from those under aerobic conditions. In this study, we examined the drug resistance and growth characteristics of MTB clinical isolates by a large sample of in vitro drug susceptibility tests, using an automatic growth instrument. Under hypoxic conditions, variance in drug resistance was observed in nearly one-third of the MTB strains and was defined as MTB strains with changed drug sensitivity (MTB-CDS). Among these strains, resistance in a considerable proportion of clinical strains was significantly increased, and some strains emerged as multi-drug resistant. Growth test results revealed a high growth rate and large survival number in macrophages under hypoxia in MTB-CDS. According to the results of fluorescence quantitative PCR, the expression of some genes, including RegX3 (involving RIF resistance), Rv0194 (efflux pump gene), four genes related to transcription regulation (KstR, DosR, Rv0081 and WhiB3) and gene related to translation regulation (DATIN), were upregulated significantly under hypoxic conditions compared to that under aerobic conditions (p < 0.05). Thus, we concluded that some MTB clinical isolates can survive under hypoxic conditions and their resistance could change. As for poor clinical outcomes in patients, based on routine drug susceptibility testing, drug susceptibility tests for tuberculosis under hypoxic conditions should also be recommended. However, the detailed mechanisms of the effect of hypoxia on drug sensitivity and growth characteristics of MTB clinical isolates still requires further study.	[Liu, Zhonghua; Yang, Hua; Bao, Haiyang; Qin, Lianhua; Hu, Zhongyi] Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Sch Med, Shanghai, Peoples R China; [Gao, Yulu] Nanjing Univ Tradit Chinese Med, Dept Lab Med, Kunshan Hosp, Kunshan, Peoples R China; [Chen, Yawen] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nursing, Shanghai, Peoples R China; [Zhu, Changtai] Shanghai Jiao Tong Univ, Dept Transfus, Affiliated Peoples Hosp 6, Shanghai, Peoples R China	Tongji University; Nanjing University of Chinese Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, ZY (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Sch Med, Shanghai, Peoples R China.; Chen, YW (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nursing, Shanghai, Peoples R China.; Zhu, CT (corresponding author), Shanghai Jiao Tong Univ, Dept Transfus, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.	zct101@163.com; yawenchen2211@163.com; shhuzy@163.com	zhu, changtai/W-6581-2019; Zhu, Changtai/V-1583-2017	zhu, changtai/0000-0002-5250-1937; Zhu, Changtai/0000-0002-5250-1937	National Basic Research Program of China (973 Program) [2012CB518706]; National Natural Science Foundation of China [81201253]; Research Grant from Shanghai Hospital Development Center [SHDC12015910]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grant from Shanghai Hospital Development Center	This project was funded by the National Basic Research Program of China (973 Program, no. 2012CB518706), the National Natural Science Foundation of China (no. 81201253), and Research Grant from Shanghai Hospital Development Center (no. SHDC12015910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Aziz AA, 2013, TROP DOCT, V43, P66, DOI 10.1177/0049475513490421; Abomoelak B, 2009, J BACTERIOL, V191, P5941, DOI 10.1128/JB.00778-09; Andrade BH, 2013, REV SOC BRAS MED TRO, V46, P441, DOI 10.1590/0037-8682-0047-2013; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bagchi G, 2003, MICROBIOL-SGM, V149, P2303, DOI 10.1099/mic.0.C0120-0; Chen Jian, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P135; Coronel J, 2014, CLIN MICROBIOL INFEC, V20, P536, DOI 10.1111/1469-0691.12401; Devasundaram S, 2016, INFECT GENET EVOL, V40, P21, DOI 10.1016/j.meegid.2016.01.007; Dhingra S, 2012, FEMS MICROBIOL LETT, V330, P66, DOI 10.1111/j.1574-6968.2012.02534.x; Dione N, 2016, CLIN MICROBIOL INFEC, V22, P53, DOI 10.1016/j.cmi.2015.10.032; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; FESENKO LD, 1987, VRACHEBNOE DELO, P57; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Gupta AK, 2010, INDIAN J MED RES, V132, P176; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hofman S, 2016, EXPERT OPIN EMERG DR, V21, P103, DOI 10.1517/14728214.2016.1151000; Kaur K, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-195; Kharatmal S, 2009, J MICROBIOL METH, V78, P161, DOI 10.1016/j.mimet.2009.05.008; Klinkenberg LG, 2013, J INFECT DIS, V207, P1525, DOI 10.1093/infdis/jit049; Kumar A, 2013, CYTOKINE, V64, P258, DOI 10.1016/j.cyto.2013.06.310; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038709; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Kumar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004139; Li Jing, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P796; Li Liang, 2004, Zhonghua Yi Xue Za Zhi, V84, P1678; Liu CH, 2011, EPIDEMIOL INFECT, V139, P1909, DOI 10.1017/S0950268810003158; Campos GNL, 2014, INT J IMMUNOGENET, V41, P54, DOI 10.1111/iji.12080; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; McGillivray A, 2015, J BIOL CHEM, V290, P2351, DOI 10.1074/jbc.M114.615534; Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235; Nickel D, 2012, J IMMUNOL, V188, P4001, DOI 10.4049/jimmunol.1100976; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Qualls JE, 2016, SEMIN IMMUNOPATHOL, V38, P139, DOI 10.1007/s00281-015-0534-0; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sakuma T, 1995, Kekkaku, V70, P1; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Saxena AK, 2013, INT J ANTIMICROB AG, V42, P27, DOI 10.1016/j.ijantimicag.2013.03.007; Schreuder LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107283; Sharadamma N, 2011, FEBS J, V278, P3447, DOI 10.1111/j.1742-4658.2011.08267.x; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Stenina MA, 2003, B EXP BIOL MED+, V135, P178, DOI 10.1023/A:1023884201722; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Xiao He-ping, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P481; Yamamoto T, 1996, Kekkaku, V71, P331; Zenk SF, 2015, MED MICROBIOL IMMUN	50	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166052	10.1371/journal.pone.0166052	http://dx.doi.org/10.1371/journal.pone.0166052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835653	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200022
J	Cissen, M; van Wely, M; Scholten, I; Mansell, S; de Bruin, JP; Mol, B; Braat, D; Repping, S; Hamer, G				Cissen, Maartje; van Wely, Madelon; Scholten, Irma; Mansell, Steven; de Bruin, Jan Peter; Mol, Ben Willem; Braat, Didi; Repping, Sjoerd; Hamer, Geert			Measuring Sperm DNA Fragmentation and Clinical Outcomes of Medically Assisted Reproduction: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CHROMATIN-STRUCTURE ASSAY; IN-VITRO FERTILIZATION; DEOXYRIBONUCLEIC-ACID FRAGMENTATION; DENSITY GRADIENT CENTRIFUGATION; PREGNANCY FOLLOWING ICSI; DIFF-QUIK STAIN; EMBRYO QUALITY; INTRAUTERINE INSEMINATION; HUMAN SPERMATOZOA; DISPERSION-TEST	Sperm DNA fragmentation has been associated with reduced fertilization rates, embryo quality, pregnancy rates and increased miscarriage rates. Various methods exist to test sperm DNA fragmentation such as the sperm chromatin structure assay (SCSA), the sperm chromatin dispersion (SCD) test, the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labelling (TUNEL) assay and the single cell gel electrophoresis (Comet) assay. We performed a systematic review and meta-analysis to assess the value of measuring sperm DNA fragmentation in predicting chance of ongoing pregnancy with IVF or ICSI. Out of 658 unique studies, 30 had extractable data and were thus included in the meta-analysis. Overall, the sperm DNA fragmentation tests had a reasonable to good sensitivity. A wide variety of other factors may also affect the IVF/ICSI outcome, reflected by limited to very low specificity. The constructed hierarchical summary receiver operating characteristic (HSROC) curve indicated a fair discriminatory capacity of the TUNEL assay (area under the curve (AUC) of 0.71; 95% CI 0.66 to 0.74) and Comet assay (AUC of 0.73; 95% CI 0.19 to 0.97). The SCSA and the SCD test had poor predictive capacity. Importantly, for the TUNEL assay, SCD test and Comet assay, meta-regression showed no differences in predictive value between IVF and ICSI. For the SCSA meta-regression indicated the predictive values for IVF and ICSI were different. The present review suggests that current sperm DNA fragmentation tests have limited capacity to predict the chance of pregnancy in the context of MAR. Furthermore, sperm DNA fragmentation tests have little or no difference in predictive value between IVF and ICSI. At this moment, there is insufficient evidence to recommend the routine use of sperm DNA fragmentation tests in couples undergoing MAR both for the prediction of pregnancy and for the choice of treatment. Given the significant limitations of the evidence and the methodological weakness and design of the included studies, we do urge for further research on the predictive value of sperm DNA fragmentation for the chance of pregnancy after MAR, also in comparison with other predictors of pregnancy after MAR.	[Cissen, Maartje; de Bruin, Jan Peter] Jeroen Bosch Hosp, Dept Obstet & Gynaecol, sHertogenbosch, Netherlands; [van Wely, Madelon; Scholten, Irma; Repping, Sjoerd; Hamer, Geert] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Amsterdam, Netherlands; [Mansell, Steven] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Mol, Ben Willem] Univ Adelaide, Robinson Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Braat, Didi] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, Nijmegen, Netherlands	Jeroen Bosch Ziekenhuis; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California Berkeley; Robinson Research Institute; University of Adelaide; Radboud University Nijmegen	van Wely, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Amsterdam, Netherlands.	m.vanwely@amc.uva.nl	Braat, D.D.M./H-8017-2014; van Wely, Madelon/GXV-1757-2022	van Wely, Madelon/0000-0001-8263-213X; Hamer, Geert/0000-0002-9583-6796	Jeroen Bosch hospital, 's-Hertogenbosch, the Netherlands	Jeroen Bosch hospital, 's-Hertogenbosch, the Netherlands	This research was financially supported by the Jeroen Bosch hospital, 's-Hertogenbosch, the Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hassan D, 2006, REPROD BIOMED ONLINE, V12, P447, DOI 10.1016/S1472-6483(10)61997-9; Aitken R John, 2010, Handb Exp Pharmacol, P99, DOI 10.1007/978-3-642-02062-9_7; Alkhayal A, 2013, J ASSIST REPROD GEN, V30, P1519, DOI 10.1007/s10815-013-0101-3; Angelopoulos T, 1998, FERTIL STERIL, V69, P740, DOI 10.1016/S0015-0282(98)00016-8; Anifandis G, 2015, ANDROLOGIA, V47, P295, DOI 10.1111/and.12259; [Anonymous], [No title captured]; Ashwood-Smith MJ, 1996, MOL HUM REPROD, V2, P46, DOI 10.1093/molehr/2.1.46; Avendano C, 2010, FERTIL STERIL, V94, P549, DOI 10.1016/j.fertnstert.2009.02.050; Bakos HW, 2008, INT J ANDROL, V31, P518, DOI 10.1111/j.1365-2605.2007.00803.x; Benchaib M, 2003, HUM REPROD, V18, P1023, DOI 10.1093/humrep/deg228; Benchaib M, 2007, FERTIL STERIL, V87, P93, DOI 10.1016/j.fertnstert.2006.05.057; Boe-Hansen GB, 2006, HUM REPROD, V21, P1576, DOI 10.1093/humrep/del019; Boissonneault G, 2002, FEBS LETT, V514, P111, DOI 10.1016/S0014-5793(02)02380-3; Borini A, 2006, HUM REPROD, V21, P2876, DOI 10.1093/humrep/del251; BRANDRIFF B, 1981, SCIENCE, V211, P1431, DOI 10.1126/science.7466400; Breznik BP, 2013, FERTIL STERIL, V99, P1233, DOI 10.1016/j.fertnstert.2012.11.048; Bungum M, 2007, HUM REPROD, V22, P174, DOI 10.1093/humrep/del326; Bungum M, 2004, HUM REPROD, V19, P1401, DOI 10.1093/humrep/deh280; Bungum M, 2008, HUM REPROD, V23, P4, DOI 10.1093/humrep/dem353; Caglar GS, 2007, IN VIVO, V21, P1075; Carrell DT, 2001, J ANDROL, V22, P604; Cebesoy FB, 2006, ARCH ANDROLOGY, V52, P397, DOI 10.1080/01485010600666953; Check JH, 2005, ARCH ANDROLOGY, V51, P121, DOI 10.1080/014850190518125; Chi Hee-Jun, 2011, Clin Exp Reprod Med, V38, P10, DOI 10.5653/cerm.2011.38.1.10; CLAASSENS OE, 1992, HUM REPROD, V7, P242, DOI 10.1093/oxfordjournals.humrep.a137625; Colagar A Hosseinzadeh, 2007, Pak J Biol Sci, V10, P3870, DOI 10.3923/pjbs.2007.3870.3874; Collins JA, 2008, FERTIL STERIL, V89, P823, DOI 10.1016/j.fertnstert.2007.04.055; Dar S, 2013, FERTIL STERIL, V100, P75, DOI 10.1016/j.fertnstert.2013.03.011; Daris B, 2010, ARCH GYNECOL OBSTET, V281, P363, DOI 10.1007/s00404-009-1140-y; de la Calle JFV, 2008, FERTIL STERIL, V90, P1792, DOI 10.1016/j.fertnstert.2007.09.021; DEZIEGLER D, 1990, FERTIL STERIL, V54, P682; Duran EH, 1998, HUM REPROD, V13, P1235, DOI 10.1093/humrep/13.5.1235; Duran EH, 2002, HUM REPROD, V17, P3122, DOI 10.1093/humrep/17.12.3122; Edwards KW, 2015, J REPROD MED, V60, P6; Enciso M, 2006, J ANDROL, V27, P106, DOI 10.2164/jandrol.05115; Erenpreiss J, 2006, HUM REPROD, V21, P2061, DOI 10.1093/humrep/del134; Esbert M, 2011, REPROD BIOMED ONLINE, V23, P704, DOI 10.1016/j.rbmo.2011.07.010; Evenson D, 2006, REPROD BIOMED ONLINE, V12, P466, DOI 10.1016/S1472-6483(10)62000-7; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Fang Li, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P432, DOI 10.3760/cma.j.issn.1003-9406.2011.04.017; Fernandez JL, 2005, FERTIL STERIL, V84, P833, DOI 10.1016/j.fertnstert.2004.11.089; Frydman N, 2008, FERTIL STERIL, V89, P92, DOI 10.1016/j.fertnstert.2007.02.022; Gandini L, 2004, HUM REPROD, V19, P1409, DOI 10.1093/humrep/deh233; Garolla A, 2015, REPROD BIOMED ONLINE, V31, P100, DOI 10.1016/j.rbmo.2015.03.009; Gosalvez J, 2013, ASIAN J ANDROL, V15, P812, DOI 10.1038/aja.2013.74; Greco E, 2005, HUM REPROD, V20, P226, DOI 10.1093/humrep/deh590; Gu Long-jie, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P156, DOI 10.3760/cma.j.issn.1003-9406.2011.02.008; Gu LJ, 2009, FERTIL STERIL, V92, P1344, DOI 10.1016/j.fertnstert.2009.03.031; Guerin P, 2005, Gynecol Obstet Fertil, V33, P665, DOI 10.1016/j.gyobfe.2005.07.015; Hammadeh ME, 2008, ARCH GYNECOL OBSTET, V277, P515, DOI 10.1007/s00404-007-0507-1; Hammadeh ME, 2006, REPROD BIOMED ONLINE, V13, P696, DOI 10.1016/S1472-6483(10)60661-X; Hammadeh ME, 2001, INT J ANDROL, V24, P311, DOI 10.1046/j.1365-2605.2001.00308.x; Hammadeh ME, 2001, ARCH ANDROLOGY, V47, P83, DOI 10.1080/014850101316901262; Hammadeh ME, 1996, HUM REPROD, V11, P2468; Hammadeh ME, 1998, ANDROLOGIA, V30, P29; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henkel R, 2004, FERTIL STERIL, V81, P965, DOI 10.1016/j.fertnstert.2003.09.044; Henkel Ralf, 2003, Reprod Biomed Online, V7, P477; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoshi K, 1996, FERTIL STERIL, V66, P634, DOI 10.1016/S0015-0282(16)58581-1; Host E, 1999, ACTA OBSTET GYN SCAN, V78, P622, DOI 10.1034/j.1600-0412.1999.780710.x; Host E, 2000, ACTA OBSTET GYN SCAN, V79, P189, DOI 10.1034/j.1600-0412.2000.079003189.x; Huang CC, 2005, FERTIL STERIL, V84, P130, DOI 10.1016/j.fertnstert.2004.08.042; Hughes CM, 1997, MUTAT RES-FUND MOL M, V374, P261, DOI 10.1016/S0027-5107(96)00241-2; Irez T, 2015, ANDROLOGIA, V47, P438, DOI 10.1111/and.12286; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Jiang H, 2011, J OBSTET GYNAECOL, V31, P636, DOI 10.3109/01443615.2011.590910; Jiang Huan-Huan, 2011, Zhonghua Nan Ke Xue, V17, P1083; Jin JY, 2015, FERTIL STERIL, V103, P910, DOI 10.1016/j.fertnstert.2015.01.014; Karydis S, 2005, IN VIVO, V19, P921; Katayose H, 2003, FERTIL STERIL, V79, P670, DOI 10.1016/S0015-0282(02)04815-X; Kennedy C, 2011, REPROD BIOMED ONLINE, V22, P272, DOI 10.1016/j.rbmo.2010.11.020; Khalili Mohammad Ali, 2014, J Reprod Infertil, V15, P35; Larson KL, 2000, HUM REPROD, V15, P1717, DOI 10.1093/humrep/15.8.1717; Larson-Cook KL, 2003, FERTIL STERIL, V80, P895, DOI 10.1016/S0015-0282(03)01116-6; Lazaros LA, 2011, J ASSIST REPROD GEN, V28, P885, DOI 10.1007/s10815-011-9611-z; Lewis SEM, 2004, HUM REPROD, V19, P1385, DOI 10.1093/humrep/deh227; Lewis SEM, 2008, SYST BIOL REPROD MED, V54, P111, DOI 10.1080/19396360801957739; Li N, 2011, GUANGXI MED J, V03; Li ZX, 2006, J ASSIST REPROD GEN, V23, P367, DOI 10.1007/s10815-006-9066-9; Lin MH, 2008, FERTIL STERIL, V90, P352, DOI 10.1016/j.fertnstert.2007.06.018; Liu J, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/162587; Lopes S, 1998, FERTIL STERIL, V69, P528, DOI 10.1016/S0015-0282(97)00536-0; Lopez G, 2013, ASIAN J ANDROL, V15, P790, DOI 10.1038/aja.2013.81; Macaskill P, 2010, COCHRANE HDB SYSTEMA, V1st; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; McEvoy A, 2014, FERTIL STERIL, V102, P981, DOI 10.1016/j.fertnstert.2014.07.737; McLay DW, 2003, REPRODUCTION, V125, P625, DOI 10.1530/rep.0.1250625; Meseguer M, 2011, FERTIL STERIL, V95, P124, DOI 10.1016/j.fertnstert.2010.05.055; Micinski P, 2009, REPROD BIOL, V9, P65, DOI 10.1016/S1642-431X(12)60095-3; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Moustafa MH, 2004, HUM REPROD, V19, P129, DOI 10.1093/humrep/deh024; Muriel L, 2006, HUM REPROD, V21, P738, DOI 10.1093/humrep/dei403; Muriel L, 2006, FERTIL STERIL, V85, P371, DOI 10.1016/j.fertnstert.2005.07.1327; Nasr-Esfahani MH, 2008, J ASSIST REPROD GEN, V25, P197, DOI 10.1007/s10815-008-9223-4; Ni WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094956; Nicopoullos JDM, 2008, BJU INT, V101, P1553, DOI 10.1111/j.1464-410X.2008.07518.x; Nijs M, 2011, ANDROLOGIA, V43, P174, DOI 10.1111/j.1439-0272.2010.01040.x; Nijs M, 2009, REPROD BIOMED ONLINE, V19, P671, DOI 10.1016/j.rbmo.2009.07.002; Niu ZH, 2011, ASIAN J ANDROL, V13, P862, DOI 10.1038/aja.2011.77; Nunez-Calonge R, 2012, REPROD SCI, V19, P1163, DOI 10.1177/1933719112459238; Oleszczuk K, 2016, ANDROLOGY-US, V4, P290, DOI 10.1111/andr.12153; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; Osman A, 2015, REPROD BIOMED ONLINE, V30, P120, DOI 10.1016/j.rbmo.2014.10.018; Ozmen B, 2007, REPROD BIOMED ONLINE, V15, P208, DOI 10.1016/S1472-6483(10)60710-9; Palermo GD, 2014, FERTIL STERIL, V102, P1508, DOI 10.1016/j.fertnstert.2014.10.008; Payne JF, 2005, FERTIL STERIL, V84, P356, DOI 10.1016/j.fertnstert.2005.02.032; Raju GAR, 2012, ANDROLOGIA, V44, P490, DOI 10.1111/j.1439-0272.2011.01213.x; Ramos L, 2004, REPROD BIOMED ONLINE, V8, P392, DOI 10.1016/S1472-6483(10)60922-4; Ramos L, 2002, FERTIL STERIL, V77, P233, DOI 10.1016/S0015-0282(01)02962-4; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rubes J, 2005, HUM REPROD, V20, P2776, DOI 10.1093/humrep/dei122; Saalu L C, 2010, Pak J Biol Sci, V13, P413; Sadeghi Mohamad Reza, 2009, Avicenna Journal of Medical Biotechnology, V1, P173; Sakkas D, 2002, BIOL REPROD, V66, P1061, DOI 10.1095/biolreprod66.4.1061; Sakkas D, 1996, HUM REPROD, V11, P837; Saleh RA, 2003, FERTIL STERIL, V79, P1597, DOI 10.1016/S0015-0282(03)00337-6; Saleh RA, 2002, FERTIL STERIL, V78, P313, DOI 10.1016/S0015-0282(02)03219-3; Sanchez-Martin P, 2013, SYST BIOL REPROD MED, V59, P256, DOI 10.3109/19396368.2013.790919; Scares SR, 2008, CURR OPIN OBSTET GYN, V20, P281, DOI 10.1097/GCO.0b013e3282fc9c1e; Seli E, 2004, FERTIL STERIL, V82, P378, DOI 10.1016/j.fertnstert.2003.12.039; Shamsi MB, 2008, INDIAN J MED RES, V127, P115; Shamsi MB, 2010, INDIAN J BIOCHEM BIO, V47, P38; Shamsi MB, 2009, MUTAT RES-FUND MOL M, V665, P29, DOI 10.1016/j.mrfmmm.2009.02.017; Shamsi MB, 2011, J ASSIST REPROD GEN, V28, P1073, DOI 10.1007/s10815-011-9631-8; Sharbatoghli M, 2012, ARCH GYNECOL OBSTET, V286, P1315, DOI 10.1007/s00404-012-2440-1; Sharif K, 2013, MIDDLE EAST FERTIL S, V18, P78, DOI 10.1016/j.mefs.2013.02.001; Sharma RK, 2010, UROLOGY, V76, P1380, DOI 10.1016/j.urology.2010.04.036; Simon L, 2014, HUM REPROD, V29, P904, DOI 10.1093/humrep/deu040; Simon L, 2013, REPROD BIOMED ONLINE, V26, P68, DOI 10.1016/j.rbmo.2012.09.019; Simon L, 2011, REPROD BIOMED ONLINE, V23, P724, DOI 10.1016/j.rbmo.2011.08.010; Simon L, 2011, FERTIL STERIL, V95, P652, DOI 10.1016/j.fertnstert.2010.08.019; Simon L, 2010, HUM REPROD, V25, P1594, DOI 10.1093/humrep/deq103; Smit M, 2010, J UROLOGY, V183, P662, DOI 10.1016/j.juro.2009.10.010; Smit M, 2010, J UROLOGY, V183, P270, DOI 10.1016/j.juro.2009.08.161; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Speyer BE, 2010, HUM REPROD, V25, P1609, DOI 10.1093/humrep/deq116; Steele EK, 1999, MOL HUM REPROD, V5, P831, DOI 10.1093/molehr/5.9.831; Sun JG, 1997, BIOL REPROD, V56, P602, DOI 10.1095/biolreprod56.3.602; Tarozzi N, 2009, REPROD BIOMED ONLINE, V18, P486, DOI 10.1016/S1472-6483(10)60124-1; Tavalaee M, 2009, FERTIL STERIL, V91, P1119, DOI 10.1016/j.fertnstert.2008.01.063; Tavares RS, 2013, ANDROLOGY-US, V1, P830, DOI 10.1111/j.2047-2927.2013.00127.x; Tijani HA, 2010, HUM FERTIL, V13, P226, DOI 10.3109/14647273.2010.533811; Tomlinson MJ, 2001, HUM REPROD, V16, P2160, DOI 10.1093/humrep/16.10.2160; Tomsu M, 2002, HUM REPROD, V17, P1856, DOI 10.1093/humrep/17.7.1856; van der Steeg JW, 2011, FERTIL STERIL, V95, P1013, DOI 10.1016/j.fertnstert.2010.02.024; van Weert JM, 2008, J REPROD MED, V53, P250; van Weert JM, 2004, FERTIL STERIL, V82, P612, DOI 10.1016/j.fertnstert.2004.01.042; Venkatesh S, 2011, ARCH GYNECOL OBSTET, V283, P121, DOI 10.1007/s00404-010-1645-4; Venkatesh S, 2009, ANDROLOGIA, V41, P251, DOI 10.1111/j.1439-0272.2009.00943.x; Vermeij WP, 2014, CURR OPIN GENET DEV, V26, P124, DOI 10.1016/j.gde.2014.06.006; Virant-Klun I, 2002, J ASSIST REPROD GEN, V19, P319, DOI 10.1023/A:1016006509036; Virro MR, 2004, FERTIL STERIL, V81, P1289, DOI 10.1016/j.fertnstert.2003.09.063; Wang M, 2014, J ASSIST REPROD GEN, V31, P1655, DOI 10.1007/s10815-014-0339-4; Weber RFA, 2005, ADV CLIN CHEM, V40, P317, DOI 10.1016/S0065-2423(05)40008-6; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xi Di, 2016, Zhonghua Nan Ke Xue, V22, P77; [徐步芳 Xu Bufang], 2011, [中国男科学杂志, Chinese Journal of Andrology], V25, P23; Yang Xiao-Yu, 2013, Zhonghua Nan Ke Xue, V19, P1082; Yang Xiao-yu, 2011, Zhonghua Nan Ke Xue, V17, P977; Yilmaz S, 2010, INT J FERTIL STERIL, V4, P73; Zhang LH, 2010, FERTIL STERIL, V94, P1027, DOI 10.1016/j.fertnstert.2009.04.034; Zhang Z, 2015, J ASSIST REPROD GEN, V32, P17, DOI 10.1007/s10815-014-0374-1; Zhao J, 2014, FERTIL STERIL, V102, P998, DOI 10.1016/j.fertnstert.2014.06.033; Zini A, 2005, HUM REPROD, V20, P3476, DOI 10.1093/humrep/dei266	168	169	177	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165125	10.1371/journal.pone.0165125	http://dx.doi.org/10.1371/journal.pone.0165125			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832085	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000009
J	Fang, L; Yao, ZJ; An, JP; Chen, XJ; Xie, YW; Zhao, H; Mao, JF; Liang, WS; Ma, XX				Fang, Lei; Yao, Zhijun; An, Jianping; Chen, Xuejiao; Xie, Yuanwei; Zhao, Hui; Mao, Junfeng; Liang, Wangsheng; Ma, Xiangxing			Topological Organization of Metabolic Brain Networks in Pre-Chemotherapy Cancer with Depression: A Resting-State PET Study	PLOS ONE			English	Article							BREAST-CANCER; FUNCTIONAL CONNECTIVITY; GLUCOSE-METABOLISM; COGNITIVE FUNCTION; CORTICAL NETWORKS; WORKING-MEMORY; BASAL GANGLIA; SMALL-WORLD; MRI; DYSFUNCTION	This study aimed to investigate the metabolic brain network and its relationship with depression symptoms using F-18-fluorodeoxyglucose positron emission tomography data in 78 pre-chemotherapy cancer patients with depression and 80 matched healthy subjects. Functional and structural imbalance or disruption of brain networks frequently occur following chemotherapy in cancer patients. However, few studies have focused on the topological organization of the metabolic brain network in cancer with depression, especially those without chemotherapy. The nodal and global parameters of the metabolic brain network were computed for cancer patients and healthy subjects. Significant decreases in metabolism were found in the frontal and temporal gyri in cancer patients compared with healthy subjects. Negative correlations between depression and metabolism were found predominantly in the inferior frontal and cuneus regions, whereas positive correlations were observed in several regions, primarily including the insula, hippocampus, amygdala, and middle temporal gyri. Furthermore, a higher clustering efficiency, longer path length, and fewer hubs were found in cancer patients compared with healthy subjects. The topological organization of the whole-brain metabolic networks may be disrupted in cancer. Finally, the present findings may provide a new avenue for exploring the neurobiological mechanism, which plays a key role in lessening the depression effects in pre-chemotherapy cancer patients.	[Fang, Lei; Ma, Xiangxing] Shandong Univ, Affiliated Hosp 1, Dept Radiol, Qilu Hosp, 107 Cultural West Rd, Jinan 250012, Shandong, Peoples R China; [Fang, Lei; Mao, Junfeng; Liang, Wangsheng] Lanzhou Mil Area Command, PET CT Ctr, Affiliated Lanzhou Gen Hosp, 333 South Binhe Rd, Lanzhou 730050, Gansu, Peoples R China; [Yao, Zhijun; Chen, Xuejiao; Xie, Yuanwei] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Gansu, Peoples R China; [An, Jianping; Zhao, Hui] Lanzhou Mil Area Command, Dept Nucl Med, Affiliated Lanzhou Gen Hosp, 333 South Binhe Rd, Lanzhou 730050, Gansu, Peoples R China	Shandong University; Lanzhou University	Ma, XX (corresponding author), Shandong Univ, Affiliated Hosp 1, Dept Radiol, Qilu Hosp, 107 Cultural West Rd, Jinan 250012, Shandong, Peoples R China.	maxiangxing@126.com	ma, xiang/GSE-2438-2022					Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Ausems MGEM, 2000, AM J HUM GENET, V67, P91; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bruno J, 2012, NEUROBIOL DIS, V48, P329, DOI 10.1016/j.nbd.2012.07.009; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Collins B, 2009, PSYCHO-ONCOLOGY, V18, P134, DOI 10.1002/pon.1379; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Debess J, 2010, BREAST CANCER RES TR, V121, P91, DOI 10.1007/s10549-010-0756-8; Deprez S, 2011, HUM BRAIN MAPP, V32, P480, DOI 10.1002/hbm.21033; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Eberling JL, 2004, NEUROIMAGE, V21, P364, DOI 10.1016/j.neuroimage.2003.08.037; Fan HGM, 2005, J CLIN ONCOL, V23, P8025, DOI 10.1200/JCO.2005.01.6550; Fujiwara T, 1997, Ann Nucl Med, V11, P307; GILMORE HE, 1988, J AM ACAD CHILD PSY, V27, P145, DOI 10.1097/00004583-198801000-00033; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Gosselin N, 2006, BRAIN, V129, P2585, DOI 10.1093/brain/awl240; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P796; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hirono N, 1998, NEUROLOGY, V50, P380, DOI 10.1212/WNL.50.2.380; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Janelsins MC, 2011, SEMIN ONCOL, V38, P431, DOI 10.1053/j.seminoncol.2011.03.014; Joo EY, 2005, BRAIN, V128, P1802, DOI 10.1093/brain/awh534; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Jung MS, 2017, BRAIN IMAGING BEHAV, V11, P86, DOI 10.1007/s11682-016-9507-8; Kesler SR, 2015, NEUROBIOL AGING, V36, P2429, DOI 10.1016/j.neurobiolaging.2015.04.015; Kim LS, 2008, NEUROSCI LETT, V447, P1, DOI 10.1016/j.neulet.2008.09.077; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Li C, 2013, PLOS ONE, V8; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; Liu Z, 2014, PLOS ONE, V9; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; McDonald BC, 2013, BRAIN IMAGING BEHAV, V7, P374, DOI 10.1007/s11682-013-9256-x; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Mitchell Alex J, 2013, Lancet Oncol, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Mosher CE, 2013, BREAST J, V19, P285, DOI 10.1111/tbj.12107; Muller VI, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00268; Murray EA, 2011, BIOL PSYCHIAT, V69, pE43, DOI 10.1016/j.biopsych.2010.09.041; Perani D, 2014, NEUROIMAGE-CLIN, V6, P445, DOI 10.1016/j.nicl.2014.10.009; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Qiu XZ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00235; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Russo S, 2004, PSYCHOSOM MED, V66, P422, DOI 10.1097/01.psy.0000126204.97565.91; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Scherling C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00122; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Servaes P, 1999, BEHAV MED, V25, P23, DOI 10.1080/08964289909596735; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Stafford L, 2016, BREAST, V26, P100, DOI 10.1016/j.breast.2016.01.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Suwa T, 2012, J AFFECT DISORDERS, V136, P1039, DOI 10.1016/j.jad.2011.11.040; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tarapore PE, 2013, J NEUROSURG, V119, pA563; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Votaw JR, 2001, J NUCL MED, V42, P701; Wang JH, 2015, FRONT HUM NEUROSCI, V9; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125922; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	78	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							0166049	10.1371/journal.pone.0166049	http://dx.doi.org/10.1371/journal.pone.0166049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832148	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000059
J	Hu, YZ; Zhao, HY; Ai, XB				Hu, Yanzhu; Zhao, Huiyang; Ai, Xinbo			Inferring Weighted Directed Association Network from Multivariate Time Series with a Synthetic Method of Partial Symbolic Transfer Entropy Spectrum and Granger Causality	PLOS ONE			English	Article							LOCAL SIMILARITY ANALYSIS; DYNAMICS	Complex network methodology is very useful for complex system explorer. However, the relationships among variables in complex system are usually not clear. Therefore, inferring association networks among variables from their observed data has been a popular research topic. We propose a synthetic method, named small-shuffle partial symbolic transfer entropy spectrum (SSPSTES), for inferring association network from multivariate time series. The method synthesizes surrogate data, partial symbolic transfer entropy (PSTE) and Granger causality. A proper threshold selection is crucial for common correlation identification methods and it is not easy for users. The proposed method can not only identify the strong correlation without selecting a threshold but also has the ability of correlation quantification, direction identification and temporal relation identification. The method can be divided into three layers, i.e. data layer, model layer and network layer. In the model layer, the method identifies all the possible pair-wise correlation. In the network layer, we introduce a filter algorithm to remove the indirect weak correlation and retain strong correlation. Finally, we build a weighted adjacency matrix, the value of each entry representing the correlation level between pair-wise variables, and then get the weighted directed association network. Two numerical simulated data from linear system and nonlinear system are illustrated to show the steps and performance of the proposed approach. The ability of the proposed method is approved by an application finally.	[Hu, Yanzhu; Zhao, Huiyang; Ai, Xinbo] Beijing Univ Posts & Telecommun, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing 100876, Peoples R China; [Zhao, Huiyang] Xuchang Univ, Sch Informat Engn, Xuchang 461000, Peoples R China	Beijing University of Posts & Telecommunications; Xuchang University	Zhao, HY (corresponding author), Beijing Univ Posts & Telecommun, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing 100876, Peoples R China.; Zhao, HY (corresponding author), Xuchang Univ, Sch Informat Engn, Xuchang 461000, Peoples R China.	zhyjky@l63.com			National Natural Science Foundation of China [61503034, 61627816]; Beijing Science and Technology Program [D151100004715001]; Key Scientific Research Project of Henan Province Universities [156520031]; Xuchang Science and Technology Program [1502098]; National Key Research and Development Program of China [2016YFC0701309-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Program; Key Scientific Research Project of Henan Province Universities; Xuchang Science and Technology Program; National Key Research and Development Program of China	This work is funded by the National Natural Science Foundation of China (61503034)), by the Beijing Science and Technology Program (D151100004715001), by the Key Scientific Research Project of Henan Province Universities (156520031), by the Xuchang Science and Technology Program (1502098), by the National Key Research and Development Program of China (2016YFC0701309-01) and the National Natural Science Foundation of China (61627816).; We thank all challenge participants for their invaluable contribution. We thank the anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper. This paper is supported by the National Natural Science Foundation of China (61503034), by the Beijing Science and Technology Program (D151100004715001), by the Key Scientific Research Project of Henan Province Universities (15B520031), by the Xuchang Science and Technology Program (1502098), by the National Key Research and Development Program of China (2016YFC0701309-01) and the National Natural Science Foundation of China (61627816). We thank all the fund organizations for offering us the studying conditions.	Ai XB, 2014, ENTROPY-SWITZ, V16, P5753, DOI 10.3390/e16115753; Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; Cecchi GA, 2008, I S BIOMED IMAGING, P604, DOI 10.1109/ISBI.2008.4541068; Chai LE, 2014, CURR BIOINFORM, V9, P531, DOI 10.2174/1574893609666140421210333; Deng LF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26976; Dynamic S., 2012, EUPHYTICA, V183, P361, DOI [10.1007/s10681-011-0538-3, DOI 10.1007/S10681-011-0538-3]; Evans TS, 2012, SCIENTOMETRICS, V93, P473, DOI 10.1007/s11192-012-0694-9; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fernandez-Rosales IY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126234; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Goldberg SR, 2015, SCIENTOMETRICS, V105, P1577, DOI 10.1007/s11192-015-1737-9; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guo XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087446; Han L, 2008, BIOSYSTEMS, V91, P158, DOI 10.1016/j.biosystems.2007.08.008; Hill SM, 2016, NAT METHODS, V13, P310, DOI [10.1038/NMETH.3773, 10.1038/nmeth.3773]; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Ma HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07464; Mahdevar G, 2013, GENES GENET SYST, V88, P301, DOI 10.1266/ggs.88.301; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; Michael S, 2005, APPL NONLINEAR TIME; Nakamura T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.041114; Nakamura T, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032323; Papana A, 2013, PARTIAL SYMBOLIC TRA, P13; PRICE DJD, 1965, SCIENCE, V149, P510; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schiatti L, 2015, PHYSIOL MEAS, V36, P827, DOI 10.1088/0967-3334/36/4/827; SIMS CA, 1972, AM ECON REV, V62, P540; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thomas MC, 2006, ELEMENTS INFORM THEO; Thorniley J., 2011, IMPROVED TRANSFER EN, P797; Tilghman P, 2013, MILCOM 2013 2013 IEE; Villaverde Alejandro F, 2013, Cells, V2, P306, DOI 10.3390/cells2020306; Walker DM, 2010, ANIM BEHAV, V79, P351, DOI 10.1016/j.anbehav.2009.11.011; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wiener N., 1956, THEORY PREDICTION; Xia LC, 2013, BIOINFORMATICS, V29, P230, DOI 10.1093/bioinformatics/bts668; Yuan YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016835; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	46	6	6	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166084	10.1371/journal.pone.0166084	http://dx.doi.org/10.1371/journal.pone.0166084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832153	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000063
J	Seybold, AC; Wharton, DA; Thorne, MAS; Marshall, CJ				Seybold, Anna C.; Wharton, David A.; Thorne, Michael A. S.; Marshall, Craig J.			Establishing RNAi in a Non-Model Organism: The Antarctic Nematode Panagrolaimus sp DAW1	PLOS ONE			English	Article							ELEGANS CHROMOSOME-I; CAENORHABDITIS-ELEGANS; CRYOPROTECTIVE DEHYDRATION; INTERFERENCE; DAVIDI; PROTEINS; EMBRYOGENESIS; DIVERSITY; SURVIVAL; EFFICACY	The Antarctic nematode Panagrolaimus sp. DAW1 is one of the only organisms known to survive extensive intracellular freezing throughout its tissues. Although the physiological mechanisms of this extreme adaptation are partly understood, the molecular mechanisms remain largely unknown. RNAi is a method that allows the examination of gene function in a direct, targeted manner, by knocking out specific mRNAs and revealing the effects on the phenotype. In this study we have explored the viability of RNAi in Panagrolaimus sp. DAW1. In the first trial, nematodes were fed E. coli expressing Panagrolaimus sp. DAW1 dsRNA of the embryonic lethal genes rps-2 and dhc, and the blister gene duox. Pd-rps-2(RNAi)-treated nematodes showed a significant decrease in larval hatching. However, qPCR showed no significant decrease in the amount of rps-2 mRNA in Pd-rps-2(RNAi)-treated animals. Several soaking protocols for dsRNA uptake were investigated using the fluorescent dye FITC. Desiccation-enhanced soaking showed the strongest uptake of FITC and resulted in a significant and consistent decrease of mRNA levels of two of the four tested genes (rps-2 and tps-2a), suggesting effective uptake of dsRNA-containing solution by the nematode. These findings suggest that RNAi by desiccation-enhanced soaking is viable in Panagrolaimus sp. DAW1 and provide the first functional genomic approach to investigate freezing tolerance in this non-model organism. RNAi, in conjunction with qPCR, can be used to screen for candidate genes involved in intracellular freezing tolerance in Panagrolaimus sp. DAW1.	[Seybold, Anna C.; Marshall, Craig J.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Wharton, David A.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Thorne, Michael A. S.] NERC, British Antarctic Survey, Cambridge, England; [Marshall, Craig J.] Univ Otago, Genet Otago, Dunedin, New Zealand	University of Otago; University of Otago; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Otago	Marshall, CJ (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.; Marshall, CJ (corresponding author), Univ Otago, Genet Otago, Dunedin, New Zealand.	craig.marshall@otago.ac.nz	Marshall, Craig J./C-6668-2009	Marshall, Craig J./0000-0003-4186-0368; Thorne, Michael/0000-0001-7759-612X	NERC [bas0100036] Funding Source: UKRI; Natural Environment Research Council [bas0100036] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; [Anonymous], 2021, LANG ENV STAT COMP; Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; Bretz F., 2016, MULTIPLE COMP USING; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Davies PL, 2014, TRENDS BIOCHEM SCI, V39, P548, DOI 10.1016/j.tibs.2014.09.005; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flegg JIM, 1970, USDA TECHNICAL B, P5; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Geldhof P, 2006, INT J PARASITOL, V36, P801, DOI 10.1016/j.ijpara.2005.12.004; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kushwaha S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001770; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lendner M, 2008, MOL BIOCHEM PARASIT, V161, P21, DOI 10.1016/j.molbiopara.2008.06.003; Lewis SC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-15; Lopez-Martinez G, 2012, J MED ENTOMOL, V49, P215, DOI 10.1603/ME11122; Moens M, 2011, MOL PHYSL BASIS NEMA, DOI [10.1079/9781845936877.0000, DOI 10.1079/9781845936877.0000]; Park JE, 2008, MOL CELLS, V26, P81; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Raymond MR, 2014, ANTARCT SCI, V26, P15, DOI 10.1017/S0954102013000230; Raymond MR, 2013, ANTARCT SCI, V25, P347, DOI 10.1017/S0954102012001162; Shannon AJ, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-58; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Thorne MAS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104526; Visser A, 2006, PARASITOLOGY, V133, P777, DOI 10.1017/S0031182006001004; WHARTON DA, 1995, J EXP BIOL, V198, P1381; WHARTON DA, 1989, NEW ZEAL J ZOOL, V16, P467, DOI 10.1080/03014223.1989.10422914; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 2005, CRYOBIOLOGY, V50, P21, DOI 10.1016/j.cryobiol.2004.09.004; Wharton DA, 2003, J EXP BIOL, V206, P215, DOI 10.1242/jeb.00083; WHARTON DA, 1993, FUND APPL NEMATOL, V16, P17; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8; Xie B-Y, 2010, NEMATOLOGY, V12, P225, DOI [10.1163/138855409X12469541205044, DOI 10.1163/138855409X12469541205044]; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	39	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166228	10.1371/journal.pone.0166228	http://dx.doi.org/10.1371/journal.pone.0166228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832164	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000079
J	Tang, CY; Wang, B				Tang, Chaoying; Wang, Biao			A No-Reference Adaptive Blockiness Measure for JPEG Compressed Images	PLOS ONE			English	Article							QUALITY ASSESSMENT	Digital images have been extensively used in education, research, and entertainment. Many of these images, taken by consumer cameras, are compressed by the JPEG algorithm for effective storage and transmission. Blocking artifact is a well-known problem caused by this algorithm. Effective measurement of blocking artifacts plays an important role in the design, optimization, and evaluation of image compression algorithms. In this paper, we propose a no-reference objective blockiness measure, which is adaptive to high frequency component in an image. Difference of entropies across blocks and variation of block boundary pixel values in edge images are adopted to calculate the blockiness level in areas with low and high frequency component, respectively. Extensive experimental results prove that the proposed measure is effective and stable across a wide variety of images. It is robust to image noise and can be used for real-world image quality monitoring and control. Index Terms-JPEG, no-reference, blockiness measure	[Tang, Chaoying; Wang, Biao] Nanjing Univ Aeronaut & Astronaut, Coll Automat Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics	Tang, CY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Automat Engn, Nanjing, Jiangsu, Peoples R China.	cytang@nuaa.edu.cn			National Natural Science Foundation of China [61403196]; Natural Science Foundation of Jiangsu Province [BK20140837]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20133218120018]; Fundamental Research Funds for the Central Universities [NS2014030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (61403196), the Natural Science Foundation of Jiangsu Province (BK20140837), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20133218120018), and the Fundamental Research Funds for the Central Universities (NS2014030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (61403196), the Natural Science Foundation of Jiangsu Province (BK20140837), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20133218120018), and the Fundamental Research Funds for the Central Universities (NS2014030).	Bovik AC, 2001, INT CONF ACOUST SPEE, P1725, DOI 10.1109/ICASSP.2001.941272; Chandler DM, 2007, IEEE T IMAGE PROCESS, V16, P2284, DOI 10.1109/TIP.2007.901820; Chen CH, 2010, LECT NOTES COMPUT SC, V6297, P112, DOI 10.1007/978-3-642-15702-8_11; Freitas PG, 2016, 2016 EIGHTH INTERNATIONAL CONFERENCE ON QUALITY OF MULTIMEDIA EXPERIENCE (QOMEX); Golestaneh S. Alireza, 2014, IEEE Signal Processing Letters, V21, P155, DOI 10.1109/LSP.2013.2296038; Horita Y., MICT IMAGE QUALITY E; Larson E., CATEGORICAL IMAGE QU; Lee S, 2012, SIGNAL PROCESS-IMAGE, V27, P31, DOI 10.1016/j.image.2011.08.002; Li LD, 2014, IEEE SIGNAL PROC LET, V21, P918, DOI 10.1109/LSP.2014.2320743; Li LD, 2014, IEEE SIGNAL PROC LET, V21, P122, DOI 10.1109/LSP.2013.2294333; Li YM, 2015, NEUROCOMPUTING, V154, P94, DOI 10.1016/j.neucom.2014.12.015; Liu H, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/263540; Liu LX, 2014, SIGNAL PROCESS-IMAGE, V29, P856, DOI 10.1016/j.image.2014.06.006; Liu LX, 2014, SIGNAL PROCESS-IMAGE, V29, P494, DOI 10.1016/j.image.2014.02.004; Mittal A, 2012, IEEE T IMAGE PROCESS, V21, P4695, DOI 10.1109/TIP.2012.2214050; Moorthy AK, 2009, IEEE J-STSP, V3, P193, DOI 10.1109/JSTSP.2009.2015374; Ninassi A., SUBJECTIVEJ QUALITY; Pan F, 2007, MULTIDIM SYST SIGN P, V18, P297, DOI 10.1007/s11045-006-0008-6; Perra C., 2005, P IEEE INT C IM PROC, P389, DOI [DOI 10.1109/ICIP.2005.1529769, 10.1109/ICIP.2005.1529769]; Ponomarenko N., 2009, ADV MOD RADIOELECTRO, V10, P30; Ponomarenko N, 2015, SIGNAL PROCESS-IMAGE, V30, P57, DOI 10.1016/j.image.2014.10.009; Ren YL, 2015, LECT NOTES COMPUT SC, V9242, P472, DOI 10.1007/978-3-319-23989-7_48; Sheikh H.R., LIVE IMAGE QUALITY A; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, IEEE IMAGE PROC, P477; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Wang Z, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P981, DOI 10.1109/ICIP.2000.899622; Wang Z, 2009, IEEE SIGNAL PROC MAG, V26, P98, DOI 10.1109/MSP.2008.930649; Ye P, 2012, PROC CVPR IEEE, P1098, DOI 10.1109/CVPR.2012.6247789	29	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165664	10.1371/journal.pone.0165664	http://dx.doi.org/10.1371/journal.pone.0165664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832092	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000023
J	de Souza, ACC; Moreira, TMM; de Oliveira, ES; de Menezes, AVB; Loureiro, AMO; Silva, CBD; Linard, JG; de Almeida, ILS; Mattos, SM; Borges, JWP				Caetano de Souza, Ana Celia; Magalhaes Moreira, Thereza Maria; de Oliveira, Edmar Souza; Bezerra de Menezes, Anaize Viana; Oliveira Loureiro, Aline Maria; de Araujo Silva, Camila Brasileiro; Linard, Jair Gomes; Sales de Almeida, Italo Lennon; Mattos, Samuel Miranda; Pereira Borges, Jose Wicto			Effectiveness of Educational Technology in Promoting Quality of Life and Treatment Adherence in Hypertensive People	PLOS ONE			English	Article							BLOOD-PRESSURE; OLMESARTAN; VALIDATION	The objective of this study was to test the effectiveness of an educational intervention with use of educational technology (flipchart) to promote quality of life (QOL) and treatment adherence in people with hypertension. It was an intervention study of before-and-after type conducted with 116 hypertensive people registered in Primary Health Care Units. The educational interventions were conducted using the flipchart educational technology. Quality of life was assessed through the MINICHAL (lowest score = better QOL) and the QATSH (higher score = better adherence) was used to assess the adherence to hypertension treatment. Both were measured before and after applying the intervention. In the analysis, we used the Student's t-test for paired data. The average baseline quality of life was 11.66 +/- 7.55, and 7.71 +/- 5.72 two months after the intervention, showing a statistically significant reduction (p < 0.001) and mean of differences of 3.95. The average baseline adherence to treatment was 98.03 +/- 7.08 and 100.71 +/- 6.88 two months after the intervention, which is statistically significant (p < 0.001), and mean of differences of 2.68. The conclusion was that the educational intervention using the flipchart improved the total score of quality of life in the scores of physical and mental domains, and increased adherence to hypertension treatment in people with the disease.	[Caetano de Souza, Ana Celia] Univ Fed Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Univ Estadual Ceara UECE, Unit Clin Pharmacol,Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil; [Magalhaes Moreira, Thereza Maria] Univ Estadual Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Postgrad Program Publ Hlth PPSAC, Fortaleza, Ceara, Brazil; [de Oliveira, Edmar Souza] Hosp Carlos Alberto Studart Gomes, Fortaleza, Ceara, Brazil; [Bezerra de Menezes, Anaize Viana] Univ Estadual Ceara UECE, Fortaleza, Ceara, Brazil; [Oliveira Loureiro, Aline Maria] Hosp Geral Fortaleza, Liver Transplant Unit, Fortaleza, Ceara, Brazil; [Magalhaes Moreira, Thereza Maria; de Araujo Silva, Camila Brasileiro; Linard, Jair Gomes] Univ Estadual Ceara, Postgrad Program Publ Hlth PPSAC, Fortaleza, Ceara, Brazil; [Sales de Almeida, Italo Lennon; Mattos, Samuel Miranda] Univ Estadual Ceara, Scholarship Sci Initiat, Fortaleza, Ceara, Brazil; [Pereira Borges, Jose Wicto] Univ Estadual Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Fortaleza, Ceara, Brazil; [Pereira Borges, Jose Wicto] Univ Fed Piaui, Postgrad Program Hlth & Community PPGSC, Teresina, Brazil; [Caetano de Souza, Ana Celia] Univ Fed Ceara, Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil	Universidade Estadual do Ceara; Universidade Federal do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Federal do Piaui; Universidade Federal do Ceara	de Souza, ACC (corresponding author), Univ Fed Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Univ Estadual Ceara UECE, Unit Clin Pharmacol,Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil.; de Souza, ACC (corresponding author), Univ Fed Ceara, Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil.	anaceliacs.doc@gmail.com	Mattos, Samuel Miranda/AAB-4099-2019; Borges, José Wicto Pereira/R-2705-2016; MOREIRA, THEREZA MARIA MAGALHÃES/D-1240-2014; de Almeida, Ítalo Lennon Sales/AAF-9559-2021	Mattos, Samuel Miranda/0000-0002-1837-9480; Borges, José Wicto Pereira/0000-0002-3292-1942; MOREIRA, THEREZA MARIA MAGALHÃES/0000-0003-1424-0649; de Almeida, Ítalo Lennon Sales/0000-0002-8013-8565				Bramlage P, 2010, EXPERT OPIN PHARMACO, V11, P2779, DOI 10.1517/14656566.2010.521499; Brasil. Ministerio da Sau A de. Secretaria de Atenc Saude, 2014, MIN SAUD CAD AT BAS, V38; Chin YR, 2014, ASIAN NURS RES, V8, P267, DOI 10.1016/j.anr.2014.10.002; da Silva PM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0216-6; Doak CC, 1996, TEACHING PATIENTS LO; Houston TK, 2011, ANN INTERN MED, V154, P77, DOI 10.7326/0003-4819-154-2-201101180-00004; Lauziere Therese A, 2013, Can J Cardiovasc Nurs, V23, P12; Mahmoud MIH, 2012, J TAIBAH UNIV MED SC, V7, P92, DOI 10.1016/j.jtumed.2012.11.004; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; MARSHALL IJ, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E3953; Mohammadi Eesa, 2006, Int J Nurs Pract, V12, P153, DOI 10.1111/j.1440-172X.2006.00563.x; Montori VM, 2007, PLOS MED, V4, P1303, DOI 10.1371/journal.pmed.0040233; Rodrigues MTP, 2014, REV SAUDE PUBL, V48, P232, DOI 10.1590/S0034-8910.2014048005044; Parana A, SECRETARIA ESTADO ED; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Schmidt AC, 2008, EXPERT OPIN PHARMACO, V9, P1641, DOI 10.1517/14656566.9.10.1641 ; Schmieder RE, 2013, J HYPERTENS, V31, P610, DOI 10.1097/HJH.0b013e32835d6e53; Schulz Renata Berberi, 2008, Arq. Bras. Cardiol., V90, P139, DOI 10.1590/S0066-782X2008000200010; Schulz Ute, 2008, Psychol Health Med, V13, P423, DOI 10.1080/13548500701660442; Shibuya A, 2011, BLOOD PRESS MONIT, V16, P224, DOI 10.1097/MBP.0b013e32834af7ba; Souza ACC, 2015, THESIS; Souza Ana Célia Caetano de, 2014, Rev. esc. enferm. USP, V48, P944, DOI 10.1590/S0080-6234201400005000023; Talaei M, 2014, J HYPERTENS, V32, P30, DOI 10.1097/HJH.0b013e32836591d4; Radovanovic CAT, 2014, REV LAT-AM ENFERM, V22, P547, DOI 10.1590/0104-1169.3345.2450; Zyoud SH, 2013, INT J CARDIOL, V168, P2981, DOI 10.1016/j.ijcard.2013.04.105	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165311	10.1371/journal.pone.0165311	http://dx.doi.org/10.1371/journal.pone.0165311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851752	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300013
J	Stahl, T; Zaal, MP; Skitka, LJ				Stahl, Tomas; Zaal, Maarten P.; Skitka, Linda J.			Moralized Rationality: Relying on Logic and Evidence in the Formation and Evaluation of Belief Can Be Seen as a Moral Issue	PLOS ONE			English	Article							CONVICTION; COMPETENCE; JUDGMENTS; DECISION; RELIGION; MYTH	In the present article we demonstrate stable individual differences in the extent to which a reliance on logic and evidence in the formation and evaluation of beliefs is perceived as a moral virtue, and a reliance on less rational processes is perceived as a vice. We refer to this individual difference variable as moralized rationality. Eight studies are reported in which an instrument to measure individual differences in moralized rationality is validated. Results show that the Moralized Rationality Scale (MRS) is internally consistent, and captures something distinct from the personal importance people attach to being rational (Studies 1-3). Furthermore, the MRS has high test-retest reliability (Study 4), is conceptually distinct from frequently used measures of individual differences in moral values, and it is negatively related to common beliefs that are not supported by scientific evidence (Study 5). We further demonstrate that the MRS predicts morally laden reactions, such as a desire for punishment, of people who rely on irrational (vs. rational) ways of forming and evaluating beliefs (Studies 6 and 7). Finally, we show that the MRS uniquely predicts motivation to contribute to a charity that works to prevent the spread of irrational beliefs (Study 8). We conclude that (1) there are stable individual differences in the extent to which people moralize a reliance on rationality in the formation and evaluation of beliefs, (2) that these individual differences do not reduce to the personal importance attached to rationality, and (3) that individual differences in moralized rationality have important motivational and interpersonal consequences.	[Stahl, Tomas; Skitka, Linda J.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA; [Zaal, Maarten P.] Univ Exeter, Dept Psychol, Exeter, Devon, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Exeter	Stahl, T (corresponding author), Univ Illinois, Dept Psychol, Chicago, IL 60680 USA.	tstahl@uic.edu	Skitka, Linda/P-4085-2019; Carroll, Joseph/D-1158-2011	Skitka, Linda/0000-0002-7078-0650; Carroll, Joseph/0000-0003-2656-1378; Zaal, Maarten/0000-0002-4084-0798	Marie Curie Intra-European Fellowship [328485]	Marie Curie Intra-European Fellowship(European Commission)	The contribution of MPZ was funded by a Marie Curie Intra-European Fellowship (328485) (URL: http://ec.europa.eu/research/index.cfm).	Aiken L. S., 1991, MULTIPLE REGRESSION; Aquino K, 2002, J PERS SOC PSYCHOL, V83, P1423, DOI 10.1037//0022-3514.83.6.1423; Aramovich NP, 2012, SOC INFLUENCE, V7, P21, DOI 10.1080/15534510.2011.640199; Bastian B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061842; Boudry M, 2010, Q REV BIOL, V85, P473, DOI 10.1086/656904; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Carlsmith KM, 2002, J PERS SOC PSYCHOL, V83, P284, DOI [10.1037/0022-3514.83.2.284, 10.1037//0022-3514.83.2.284]; CHAIKEN S, 1994, J PERS SOC PSYCHOL, V66, P460, DOI 10.1037/0022-3514.66.3.460; Chaiken S., 1996, PSYCHOL ACTION LINKI, P553; Cialdini R.B, 2001, INFLUENCE SCI PRACTI; Cohen J., 2003, APPL MULTIPLE REGRES; Conway P, 2013, J PERS SOC PSYCHOL, V104, P216, DOI 10.1037/a0031021; Costello A. B., 2005, PRACTICAL ASSESSMENT, V10, P173, DOI DOI 10.1234/12345678; Dawkins R., 2006, GOD DELUSION; Dennett D. C., 2006, BREAKING SPELL RELIG; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; Ellemers N, 2008, J PERS SOC PSYCHOL, V95, P1397, DOI 10.1037/a0012628; Epstein S, 1996, J PERS SOC PSYCHOL, V71, P390, DOI 10.1037/0022-3514.71.2.390; Farias M, 2013, J EXP SOC PSYCHOL, V49, P1210, DOI 10.1016/j.jesp.2013.05.008; Gibbs JC, 2007, DEV REV, V27, P443, DOI 10.1016/j.dr.2007.04.001; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2013, ADV EXP SOC PSYCHOL, V47, P55, DOI 10.1016/B978-0-12-407236-7.00002-4; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gray K, 2014, J EXP PSYCHOL GEN, V143, P1600, DOI 10.1037/a0036149; Gray K, 2012, PSYCHOL INQ, V23, P101, DOI 10.1080/1047840X.2012.651387; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2003, J APPL SOC PSYCHOL, V33, P1, DOI 10.1111/j.1559-1816.2003.tb02071.x; Harris JR, 1998, THE NURTURE ASSUMPTI; Harris S, 2010, MORAL LANDSCAPE SCI; Harris Sam, 2004, END FAITH RELIG TERR; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Heilbron JL, 2005, ST SCI HUM, P279; Hitchens Christopher., 2007, GOD IS NOT GREAT REL; Hollingworth RM, 2003, TOXICOL SCI, V71, P2, DOI 10.1093/toxsci/71.1.2; Hornsey MJ, 2003, BRIT J SOC PSYCHOL, V42, P319, DOI 10.1348/014466603322438189; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jost JT, 2012, MOTIV EMOTION, V36, P55, DOI 10.1007/s11031-011-9260-7; Kahan D. M., 2013, 307 YAL LAW SCH; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kant I., 1959, FDN METAPHYSICS MORA; Kerlinger FN, 1973, FDN BEHAV RES, V2nd; Kesebir P, 2011, SOC PERSONAL PSYCHOL, V5, P878, DOI 10.1111/j.1751-9004.2011.00397.x; Kohlberg L., 1969, HDB SOCIALIZATION TH, P347, DOI DOI 10.12691/EDUCATION-3-9-16; Koleva SP, 2012, J RES PERS, V46, P184, DOI 10.1016/j.jrp.2012.01.006; Krochik M., 2014, ADV MOTIVATION SCI, V1, P181, DOI [10.1016/bs.adms.2014.08.005, DOI 10.1016/BS.ADMS.2014.08.005]; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Leach CW, 2007, J PERS SOC PSYCHOL, V93, P234, DOI 10.1037/0022-3514.93.2.234; Lurie A., 2010, HUFFINGTON POST; Meier BP, 2015, J PSYCHOL, V149, P219, DOI 10.1080/00223980.2013.866929; Mill JohnStuart., 1957, UTILITARIANISM; Mooney C., 2012, THE REPUBLICAN BRAIN; Morgan G., 2011, THESIS; Morgan GS, 2010, ANAL SOC ISS PUB POL, V10, P307, DOI 10.1111/j.1530-2415.2010.01204.x; Morris H. M., 1974, SCI CREATIONISM; Motyl M, 2014, ANAL SOC ISS PUB POL, V14, P123, DOI 10.1111/asap.12044; Motyl M, 2014, J EXP SOC PSYCHOL, V51, P1, DOI 10.1016/j.jesp.2013.10.010; Nichols S, 2003, COGNITION, V90, pB23, DOI 10.1016/S0010-0277(03)00160-4; Norenzayan A, 2013, TRENDS COGN SCI, V17, P20, DOI 10.1016/j.tics.2012.11.006; NUCCI LP, 1978, CHILD DEV, V49, P400, DOI 10.2307/1128704; Orenstein A, 2002, J SCI STUD RELIG, V41, P301, DOI 10.1111/1468-5906.00118; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; Peirce Ch, 1877, POPULAR SCI MONTHLY, V12, P1, DOI DOI 10.7135/UPO9780857286512.036; Petty R.E., 1986, ADV EXPT SOCIAL PSYC, V19, P123, DOI [10.1016/S0065-2601(08)60214-2, DOI 10.1016/S0065-2601(08)60214-2, https://doi.org/10.1016/S0065-2601(08)60214-2]; Pinker S, 2002, BLANK SLATE MODERN D; Pizarro DA, 2012, SOCIAL PSYCHOL MORAL; Plante T. G., 1997, PASTOR PSYCHOL, V45, P375, DOI [10.1007/BF02230993, DOI 10.1007/BF02230993, 10.1007/]; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Proctor J, 2006, ANN ASSOC AM GEOGR, V96, P188, DOI 10.1111/j.1467-8306.2006.00508.x; ROKEACH M, 1955, J Abnorm Psychol, V51, P87, DOI 10.1037/h0040666; Rokeach M., 1960, OPEN CLOSED MIND INV; Ronald P, 2011, GENETICS, V188, P11, DOI 10.1534/genetics.111.128553; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schweder RA, 1997, MORALITY HLTH; Shaha A., 2010, GUARDIAN; Skitka L. J., 2014, ADV MORAL PSYCHOL; Skitka LJ, 2008, POLIT PSYCHOL, V29, P29, DOI 10.1111/j.1467-9221.2007.00611.x; Skitka LJ, 2011, EMOT REV, V3, P328, DOI 10.1177/1754073911402374; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; Stahl T, 2016, SOC COGNITION, V34, P133; Tetlock PE, 2000, J PERS SOC PSYCHOL, V78, P853, DOI 10.1037/0022-3514.78.5.853; Tomas JM, 1999, STRUCT EQU MODELING, V6, P84, DOI 10.1080/10705519909540120; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Turiel E., 1978, NEW DIR CHILD ADOLES, P45, DOI DOI 10.1002/CD.23219780105; Turiel E., 2002, CULTURE MORALITY SOC; van Zomeren M, 2012, BRIT J SOC PSYCHOL, V51, P52, DOI 10.1111/j.2044-8309.2010.02000.x; Wright JC, 2008, PERS SOC PSYCHOL B, V34, P1461, DOI 10.1177/0146167208322557; Yzerbyt VY, 2004, J EXP SOC PSYCHOL, V40, P424, DOI 10.1016/j.jesp.2003.10.001; Zaal MP, 2011, BRIT J SOC PSYCHOL, V50, P670, DOI 10.1111/j.2044-8309.2011.02069.x; Zaal MP, GROUP PROCE IN PRESS; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	96	33	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166332	10.1371/journal.pone.0166332	http://dx.doi.org/10.1371/journal.pone.0166332			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851777	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300043
J	Ishige-Wada, M; Kwon, SM; Eguchi, M; Hozumi, K; Iwaguro, H; Matsumoto, T; Fukuda, N; Mugishima, H; Masuda, H; Asahara, T				Ishige-Wada, Mika; Kwon, Sang-Mo; Eguchi, Masamichi; Hozumi, Katsuto; Iwaguro, Hideki; Matsumoto, Taro; Fukuda, Noboru; Mugishima, Hideo; Masuda, Haruchika; Asahara, Takayuki			Jagged-1 Signaling in the Bone Marrow Microenvironment Promotes Endothelial Progenitor Cell Expansion and Commitment of CD133(+) Human Cord Blood Cells for Postnatal Vasculogenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; VASCULAR DEVELOPMENT; EMBRYONIC LETHALITY; IN-VIVO; NOTCH1; LIGAND; EXPRESSION; NEOVASCULARIZATION; DIFFERENTIATION; ANGIOGENESIS	Notch signaling is involved in cell fate decisions during murine vascular development and hematopoiesis in the microenvironment of bone marrow. To investigate the close relationship between hematopoietic stem cells and human endothelial progenitor cells (EPCs) in the bone marrow niche, we examined the effects of Notch signals [Jagged-1 and Delta-like ligand (Dll)-1] on the proliferation and differentiation of human CD133(+) cell-derived EPCs. We established stromal systems using HESS-5 murine bone marrow cells transfected with human Jagged-1 (hJagged-1) or human Dll-1 (hDll-1). CD133(+) cord blood cells were co-cultured with the stromal cells for 7 days, and then their proliferation, differentiation, and EPC colony formation was evaluated. We found that hJagged-1 induced the proliferation and differentiation of CD133(+) cord blood EPCs. In contrast, hDll-1 had little effect. CD133(+) cells stimulated by hJagged-1 differentiated into CD31(+)/KDR+ cells, expressed vascular endothelial growth factor-A, and showed enhanced EPC colony formation compared with CD133(+) cells stimulated by hDll-1. To evaluate the angiogenic properties of hJagged-1-and hDll-1stimulated EPCs in vivo, we transplanted these cells into the ischemic hindlimbs of nude mice. Transplantation of EPCs stimulated by hJagged-1, but not hDll-1, increased regional blood flow and capillary density in ischemic hindlimb muscles. This is the first study to show that human Notch signaling influences EPC proliferation and differentiation in the bone marrow microenvironment. Human Jagged-1 induced the proliferation and differentiation of CD133(+) cord blood progenitors compared with hDll-1. Thus, hJagged-1 signaling in the bone marrow niche may be used to expand EPCs for therapeutic angiogenesis.	[Ishige-Wada, Mika; Kwon, Sang-Mo; Eguchi, Masamichi; Iwaguro, Hideki; Masuda, Haruchika; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan; [Ishige-Wada, Mika; Mugishima, Hideo] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Hozumi, Katsuto] Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa, Japan; [Matsumoto, Taro] Nihon Univ, Sch Med, Div Cell Regenerat & Transplantat, Tokyo, Japan; [Fukuda, Noboru] Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan	Tokai University; Nihon University; Tokai University; Nihon University; Nihon University	Asahara, T (corresponding author), Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan.	asa777@is.icc.u-tokai.ac.jp		Fukuda, Noboru/0000-0003-0098-054X	Ministry of Education, Science, Sports, and Culture of Japan [19790542, 15K09603, 25461091]; Japan Agency for Medical Research and Development [15bk0104012h0003]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by a a grant from the Ministry of Education, Science, Sports, and Culture of Japan 19790542 to Dr Mika Ishige-Wada; a grant from the Ministry of Education, Science, Sports, and Culture of Japan 15K09603 to Dr Mika Ishige-Wada; a grant from the Ministry of Education, Science, Sports, and Culture of Japan 25461091 to Dr Haruchika Masada; a grant from Japan Agency for Medical Research and Development 15bk0104012h0003 to Dr Takayuki Asahara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2000, EXP HEMATOL, V28, P690, DOI 10.1016/S0301-472X(00)00154-5; Aoki M, 2004, STEM CELLS, V22, P994, DOI 10.1634/stemcells.22-6-994; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Choi JH, 2004, J BIOL CHEM, V279, P49430, DOI 10.1074/jbc.M402088200; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hrabe DAM, 1997, NATURE, V386, P717, DOI DOI 10.1038/386717A0; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kamei N, 2012, J NEUROTRAUM, V29, P1758, DOI 10.1089/neu.2011.2139; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Lassaletta AD, 2014, CIRC J, V78, P743, DOI 10.1253/circj.CJ-13-0685; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Qian CF, 2009, INT J MOL MED, V24, P445, DOI 10.3892/ijmm_00000251; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Suzuki T, 2005, INT J HEMATOL, V82, P285, DOI 10.1532/IJH97.05115; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Vercauteren SM, 2004, BLOOD, V104, P2315, DOI 10.1182/blood-2004-01-0204; Wada M, 2003, INT J HEMATOL, V77, P245, DOI 10.1007/BF02983781; Walker L, 2001, STEM CELLS, V19, P543, DOI 10.1634/stemcells.19-6-543	43	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166660	10.1371/journal.pone.0166660	http://dx.doi.org/10.1371/journal.pone.0166660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846321	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600100
J	Okano, J; Kojima, H; Katagi, M; Nakagawa, T; Nakae, Y; Terashima, T; Kurakane, T; Kubota, M; Maegawa, H; Udagawa, J				Okano, Junko; Kojima, Hideto; Katagi, Miwako; Nakagawa, Takahiko; Nakae, Yuki; Terashima, Tomoya; Kurakane, Takeshi; Kubota, Mamoru; Maegawa, Hiroshi; Udagawa, Jun			Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice	PLOS ONE			English	Article							STRATUM-CORNEUM; IN-VIVO; MELLITUS; CELLS; KERATINOCYTES; MODEL; FOOT; DIFFERENTIATION; SENSITIVITY; HOMEOSTASIS	Diabetes causes skin complications, including xerosis and foot ulcers. Ulcers complicated by infections exacerbate skin conditions, and in severe cases, limb/toe amputations are required to prevent the development of sepsis. Here, we hypothesize that hyperglycemia induces skin barrier dysfunction with alterations of epidermal integrity. The effects of hyperglycemia on the epidermis were examined in streptozotocin-induced diabetic mice with/without insulin therapy. The results showed that dye leakages were prominent, and transepidermal water loss after tape stripping was exacerbated in diabetic mice. These data indicate that hyperglycemia impaired skin barrier functions. Additionally, the distribution of the protein associated with the tight junction structure, tight junction protein-1 (ZO-1), was characterized by diffuse and significantly wider expression in the diabetic mice compared to that in the control mice. In turn, epidermal cell number was significantly reduced and basal cells were irregularly aligned with ultrastructural alterations in diabetic mice. In contrast, the number of corneocytes, namely, denucleated and terminally differentiated keratinocytes significantly increased, while their sensitivity to mechanical stress was enhanced in the diabetic mice. We found that cell proliferation was significantly decreased, while apoptotic cells were comparable in the skin of diabetic mice, compared to those in the control mice. In the epidermis, Keratin 5 and keratin 14 expressions were reduced, while keratin 10 and loricrin were ectopically induced in diabetic mice. These data suggest that hyperglycemia altered keratinocyte proliferation/differentiation. Finally, these phenotypes observed in diabetic mice were mitigated by insulin treatment. Reduction in basal cell number and perturbation of the proliferation/differentiation process could be the underlying mechanisms for impaired skin barrier functions in diabetic mice.	[Okano, Junko; Kurakane, Takeshi; Kubota, Mamoru; Udagawa, Jun] Shiga Univ Med Sci, Dept Anat & Cell Biol, Shiga, Japan; [Kojima, Hideto; Katagi, Miwako; Nakae, Yuki; Terashima, Tomoya] Shiga Univ Med Sci, Dept Stem Cell Biol, Shiga, Japan; [Kojima, Hideto; Katagi, Miwako; Nakae, Yuki; Terashima, Tomoya] Shiga Univ Med Sci, Dept Regenerat Med, Shiga, Japan; [Nakagawa, Takahiko] Nara Med Univ, Ind Acad Govt Collaborat Ctr, Nara, Japan; [Maegawa, Hiroshi] Shiga Univ Med Sci, Internal Med, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Nara Medical University; Shiga University of Medical Science	Okano, J (corresponding author), Shiga Univ Med Sci, Dept Anat & Cell Biol, Shiga, Japan.	jokano@belle.shiga-med.ac.jp		Maegawa, Hiroshi/0000-0002-4611-8149	Japanese Ministry of Education, Culture, Sports, Science and Technology [26462730]; Cosmetology Research Foundation; Astrazeneca	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cosmetology Research Foundation; Astrazeneca(AstraZeneca)	Support was provided by Grant-in-aid from the Japanese Ministry of Education, Culture, Sports Science and Technology (26462730); Grant-in-aid from the Cosmetology Research Foundation; and Grant-in-aid from Astrazeneca.; We thank T. Yamamoto and Y. Mori for their technical assistance. This work was supported by a grant-in aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (no. 26462730 to JO), and grants in-aid from the Cosmetology Research Foundation and Astrazeneca to JO.	Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Bertheim U, 2002, ACTA DERM-VENEREOL, V82, P329, DOI 10.1080/000155502320624041; Bognar P, 2014, J INVEST DERMATOL, V134, P105, DOI 10.1038/jid.2013.307; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chen XF, 2010, EXP DERMATOL, V19, P1088, DOI 10.1111/j.1600-0625.2010.01137.x; Eaglstein WH, 2009, ARCH DERMATOL, V145, P467, DOI 10.1001/archdermatol.2009.31; Farage M.A., 2017, TXB AGING SKIN, V2nd ed.; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P309; Geng SM, 2006, J CELL SCI, V119, P4901, DOI 10.1242/jcs.03282; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Hamilton MA, 2013, J AOAC INT, V96, P1138, DOI 10.5740/jaoacint.12-217; Harel A, 2002, BIOCHEM PHARMACOL, V63, P171, DOI 10.1016/S0006-2952(01)00847-4; Holzmann S, 2004, J INVEST DERMATOL, V122, P1165, DOI 10.1111/j.0022-202X.2004.22520.x; Indra AK, 2011, METHODS MOL BIOL, V763, P73, DOI 10.1007/978-1-61779-191-8_4; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kemeny L, 2002, BRIT J DERMATOL, V146, P764, DOI 10.1046/j.1365-2133.2002.04663.x; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Kojima H, 1998, P ASSOC AM PHYSICIAN, V110, P197; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-1; LOPEZFRANCO R, 1994, P NATL ACAD SCI USA, V91, P12228, DOI 10.1073/pnas.91.25.12228; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Ngo BT, 2005, AM J CLIN DERMATOL, V6, P225, DOI 10.2165/00128071-200506040-00003; Okano J, 2015, BIOCHEM BIOPH RES CO, V461, P695, DOI 10.1016/j.bbrc.2015.04.094; Okano J, 2012, J CELL SCI, V125, P1827, DOI 10.1242/jcs.101550; Papini M, 2013, GIORN ITAL DERMAT V, V148, P603; Park HY, 2011, EXP DERMATOL, V20, P969, DOI 10.1111/j.1600-0625.2011.01364.x; Pavicic Tatjana, 2006, J Dtsch Dermatol Ges, V4, P935, DOI 10.1111/j.1610-0387.2006.06123.x; Pinkus H, 1966, G Ital Dermatol Minerva Dermatol, V107, P1115; Poradzka A, 2013, ACTA POL PHARM, V70, P587; Quondamatteo F, 2014, CELL TISSUE RES, V355, P1, DOI 10.1007/s00441-013-1751-2; Rawlings A.V., 2008, DRUG DISCOV TODAY DI, V5, DOI [10.1016/j.ddmec.2008.03.001, DOI 10.1016/J.DDMEC.2008.03.001]; Rodgers KE, 2006, WOUND REPAIR REGEN, V14, P298, DOI 10.1111/j.1743-6109.2006.00124.x; Sakai S, 2005, BRIT J DERMATOL, V153, P319, DOI 10.1111/j.1365-2133.2005.06756.x; Sakai S, 2003, J INVEST DERMATOL, V120, P79, DOI 10.1046/j.1523-1747.2003.12006.x; Sakurai K, 2002, J DERMATOL SCI, V30, P37, DOI 10.1016/S0923-1811(02)00047-6; Schwindt DA, 1998, J INVEST DERMATOL, V111, P385, DOI 10.1046/j.1523-1747.1998.00321.x; Seirafi H, 2009, J EUR ACAD DERMATOL, V23, P146, DOI 10.1111/j.1468-3083.2008.02950.x; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Sotiropoulou PA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008383; Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627; Suaya JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060057; Taylor KR, 2011, J INVEST DERMATOL, V131, P2409, DOI 10.1038/jid.2011.241; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Yu HM, 2016, EXP CELL RES, V342, P11, DOI 10.1016/j.yexcr.2016.02.012; Zakharov P, 2010, PHYSIOL MEAS, V31, P193, DOI 10.1088/0967-3334/31/2/006; Zheng JM, 2008, BRIT J PHARMACOL, V153, P1456, DOI 10.1038/bjp.2008.26; Zipes DP, 2014, CARDIAC ELECTROPHYSI	54	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166215	10.1371/journal.pone.0166215	http://dx.doi.org/10.1371/journal.pone.0166215			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846299	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600041
J	de Assis, DCS; da Silva, GR; Lanza, IP; Ribeiro, ACDR; Lana, AMQ; Lara, LJC; de Figueiredo, TC; Cancado, SD				Sampaio de Assis, Debora Cristina; da Silva, Guilherme Resende; Lanza, Isabela Pereira; dos Santos Rossi Ribeiro, Ana Claudia; Quintao Lana, Angela Maria; Camargos Lara, Leonardo Jose; de Figueiredo, Tadeu Chaves; Cancado, Silvana de Vasconcelos			Evaluation of the Presence and Levels of Enrofloxacin, Ciprofloxacin, Sulfaquinoxaline and Oxytetracycline in Broiler Chickens after Drug Administration	PLOS ONE			English	Article							TISSUE CONCENTRATIONS; ESCHERICHIA-COLI; MUSCLE-TISSUES; LC-MS/MS; RESIDUES; PHARMACOKINETICS; VALIDATION; DEPLETION; METABOLITES; KINETICS	The depletion times of enrofloxacin and its metabolite ciprofloxacin as well as sulfaquinoxaline and oxytetracycline were evaluated in broiler chickens that had been subjected to pharmacological treatment. The presence and residue levels of these drugs in muscle tissue were evaluated using an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method that was validated in this work. The results showed the presence of all antimicrobial residues; however, the presence of residues at concentrations higher than the drugs' maximum residue limit (MRL) of 100 mu g kg(-1) was found only during the treatment period for oxytetracycline and until two days after discontinuation of the medication for enrofloxacin, ciprofloxacin and sulfaquinoxaline. It was concluded that the residues of all antimicrobials were rapidly metabolized from the broiler muscles; after four days of withdrawal, the levels were lower than the limit of quantification (LOO) of the method for the studied analytes.	[Sampaio de Assis, Debora Cristina; da Silva, Guilherme Resende; Lanza, Isabela Pereira; Quintao Lana, Angela Maria; Camargos Lara, Leonardo Jose; de Figueiredo, Tadeu Chaves; Cancado, Silvana de Vasconcelos] Univ Fed Minas Gerais, Escola Vet, Dept Tecnol & Inspecao Prod Origem Anim, Belo Horizonte, MG, Brazil; [dos Santos Rossi Ribeiro, Ana Claudia] Minist Agr Pecuaria & Abastecimento, Lab Nacl Agr LANAGRO MG, Pedro Leopoldo, MG, Brazil	Universidade Federal de Minas Gerais	de Assis, DCS (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Tecnol & Inspecao Prod Origem Anim, Belo Horizonte, MG, Brazil.	debora@vet.ufmg.br	Assis, Débora/I-2571-2018; Lara, Leonardo/Y-4339-2019; Lana, Angela Maria/ABH-6903-2020; Lara, Leonardo/HGC-9970-2022; Cançado, S. V./E-5307-2017	Assis, Débora/0000-0002-3388-6501; Cançado, S. V./0000-0003-0268-7603; LARA, LEONARDO/0000-0003-1025-4605	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Colegiado de Pos-Graduacao em Ciencia Animal; Pro-Reitoria de Pesquisa at the Universidade Federal de Minas Gerais (UFMG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Colegiado de Pos-Graduacao em Ciencia Animal; Pro-Reitoria de Pesquisa at the Universidade Federal de Minas Gerais (UFMG)	Funding was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Colegiado de Pos-Graduacao em Ciencia Animal and the Pro-Reitoria de Pesquisa at the Universidade Federal de Minas Gerais (UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElAziz MI, 1997, BRIT POULTRY SCI, V38, P164, DOI 10.1080/00071669708417963; Anadon A, 2008, FOOD CHEM TOXICOL, V46, P662, DOI 10.1016/j.fct.2007.09.086; Anadon A, 2002, AM J VET RES, V63, P927, DOI 10.2460/ajvr.2002.63.927; Anadon A, 2001, RES VET SCI, V71, P101, DOI 10.1053/rvsc.2001.0494; [Anonymous], 2005, INT C HARM VAL AN PR; Attaie R, 2015, J DAIRY SCI, V98, P4370, DOI 10.3168/jds.2014-8616; Bogialli S, 2009, ANAL BIOANAL CHEM, V395, P947, DOI 10.1007/s00216-009-2930-6; Boison JO, 2015, ANAL BIOANAL CHEM, V407, P4065, DOI 10.1007/s00216-015-8644-z; Bousquet E, 2003, BRIT POULTRY SCI, V44, P822, DOI 10.1080/00071660410001667032; Bugyei K, 1999, CAN J VET RES, V63, P193; Codex Alimentarius Commission, 2009, 18 SESS COD COMM RES; Companyo R, 2009, ANAL BIOANAL CHEM, V395, P877, DOI 10.1007/s00216-009-2969-4; Moreno-Bondi MC, 2009, ANAL BIOANAL CHEM, V395, P921, DOI 10.1007/s00216-009-2920-8; Da Silva RG, 2006, J VET PHARMACOL THER, V29, P365, DOI 10.1111/j.1365-2885.2006.00755.x; de Almeida MP, 2015, TALANTA, V144, P922, DOI 10.1016/j.talanta.2015.07.048; Doyle M. E., 2006, FRI BRIEFINGS; DYER DC, 1989, AM J VET RES, V50, P522; European Medicine Agency (EMA), 2012, BAYTR 10 OR SOL ASS; Fedeniuk RW, 2015, J CHROMATOGR B, V983, P1, DOI 10.1016/j.jchromb.2014.12.035; Fletouris DJ, 2009, J VET PHARMACOL THER, V32, P56, DOI 10.1111/j.1365-2885.2008.01003.x; Gberindyer F. A., 2010, International Journal of Poultry Science, V9, P273; Goetting V, 2011, J VET PHARMACOL THER, V34, P521, DOI 10.1111/j.1365-2885.2011.01287.x; Gustafson RH, 1997, J APPL MICROBIOL, V83, P531, DOI 10.1046/j.1365-2672.1997.00280.x; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; Hoff RB, 2015, TALANTA, V134, P768, DOI 10.1016/j.talanta.2014.10.045; de Mendoza JH, 2012, FOOD CHEM, V134, P1149, DOI 10.1016/j.foodchem.2012.02.108; INMETRO-Instituto Nacional de Metrologia Normalizacao e Qualidade Industrial, 2011, DOQCGCRE008 INMETRO, V04, P1; Ito NMK, 2005, FARMACOLOGIA APLICAD, P115; 임종환, 2010, [Journal of Veterinary Clinics, 한국임상수의학회지], V27, P565; Knoll U, 1999, J VET PHARMACOL THER, V22, P239, DOI 10.1046/j.1365-2885.1999.00217.x; Kools SAE, 2008, REGUL TOXICOL PHARM, V50, P59, DOI 10.1016/j.yrtph.2007.06.003; Korolkovas A, FRANC FFAC; Kuhne M, 2000, FOOD CONTROL, V11, P175, DOI 10.1016/S0956-7135(99)00092-4; Landoni MF, 2015, VET J, V205, P21, DOI 10.1016/j.tvjl.2015.04.016; Li RQ, 2015, FISH PHYSIOL BIOCHEM, V41, P803, DOI 10.1007/s10695-015-0047-8; Martinez M, 2006, VET J, V172, P10, DOI 10.1016/j.tvjl.2005.07.010; Miranda JM, 2008, POULTRY SCI, V87, P1643, DOI 10.3382/ps.2007-00485; Odore R, 2015, POULTRY SCI, V94, P1979, DOI 10.3382/ps/pev141; Ovando HG, 1999, J VET PHARMACOL THER, V22, P209, DOI 10.1046/j.1365-2885.1999.00211.x; Palermo-Neto J, 2011, FARMACOLOGIA APLICAD; Paschoal JAR, 2012, J VET PHARMACOL THER, V35, P90, DOI 10.1111/j.1365-2885.2011.01294.x; Perez-Trallero E, 2003, ENFERM INFEC MICR CL, V21, P520, DOI 10.1157/13052338; Petrovic J, 2006, ACTA VET-BEOGRAD, V56, P497, DOI 10.2298/AVB0606497P; Reyes-Herrera I, 2011, POULTRY SCI, V90, P481, DOI 10.3382/ps.2010-01057; Ribani M, 2007, J CHROMATOGR A, V1156, P201, DOI 10.1016/j.chroma.2006.12.080; Serrano JM, 1999, J VET PHARMACOL THER, V22, P148, DOI 10.1046/j.1365-2885.1999.00197.x; Slana M, 2014, J VET PHARMACOL THER, V37, P611, DOI 10.1111/jvp.12130; Soliman GA, 2000, DEUT TIERARZTL WOCH, V107, P23; Spinosa HS, FARMACOLOGIA APLICAD	49	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166402	10.1371/journal.pone.0166402	http://dx.doi.org/10.1371/journal.pone.0166402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846314	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600058
J	van Tuijl, LA; Glashouwer, KA; Bockting, CLH; Tendeiro, JN; Penninx, BWJH; de Jong, PJ				van Tuijl, Lonneke A.; Glashouwer, Klaske A.; Bockting, Claudi L. H.; Tendeiro, Jorge N.; Penninx, Brenda W. J. H.; de Jong, Peter J.			Implicit and Explicit Self-Esteem in Current, Remitted, Recovered, and Comorbid Depression and Anxiety Disorders: The NESDA Study	PLOS ONE			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; INDIVIDUAL-DIFFERENCES; ASSOCIATION TEST; SOCIAL ANXIETY; DISCREPANCIES; RELIABILITY; SYMPTOMS; VULNERABILITY; CONSEQUENCES; METAANALYSIS	Background Dual processing models of psychopathology emphasize the relevance of differentiating between deliberative self-evaluative processes (explicit self-esteem; ESE) and automati-cally-elicited affective self-associations (implicit self-esteem; ISE). It has been proposed that both low ESE and ISE would be involved in major depressive disorder (MDD) and anxiety disorders (AD). Further, it has been hypothesized that MDD and AD may result in a low ISE "scar" that may contribute to recurrence after remission. However, the available evidence provides no straightforward support for the relevance of low ISE in MDD/AD, and studies testing the relevance of discrepant SE even showed that especially high ISE combined with low ESE is predictive of the development of internalizing symptoms. However, these earlier findings have been limited by small sample sizes, poorly defined groups in terms of comorbidity and phase of the disorders, and by using inadequate indices of discrepant SE. Therefore, this study tested further the proposed role of ISE and discrepant SE in a large-scale study allowing for stricter differentiation between groups and phase of disorder. Method In the context of the Netherlands Study of Depression and Anxiety (NESDA), we selected participants with current MDD (n = 60), AD (n = 111), and comorbid MDD/AD (n = 71), remitted MDD (n = 41), AD (n = 29), and comorbid MDD/AD (n = 14), recovered MDD (n = 136) and AD (n = 98), and never MDD or AD controls (n = 382). The Implicit Association Test was used to index ISE and the Rosenberg Self-Esteem Scale indexed ESE. Results Controls reported higher ESE than all other groups, and current comorbid MDD/AD had lower ESE than all other clinical groups. ISE was only lower than controls in current comorbid AD/MDD. Discrepant self-esteem (difference between ISE and ESE) was not associated with disorder status once controlling for ESE. Limitations Cross-sectional design limits causal inferences. Conclusion Findings suggest a prominent role for ESE in MDD and AD, while in comorbid MDD/AD negative self-evaluations are also present at the implicit level. There was no evidence to support the view that AD and MDD would result in a low ISE "scar".	[van Tuijl, Lonneke A.; Glashouwer, Klaske A.; Bockting, Claudi L. H.; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Bockting, Claudi L. H.] Univ Utrecht, Dept Clin Psychol & Expt Psychopathol, Utrecht, Netherlands; [Tendeiro, Jorge N.] Univ Groningen, Dept Psychometr & Stat, Groningen, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands	University of Groningen; Utrecht University; University of Groningen; Vrije Universiteit Amsterdam	van Tuijl, LA (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	L.A.van.tuijl@rug.nl	Penninx, Brenda WJH/S-7627-2017; Bockting, Claudi L/K-3768-2019; Tendeiro, Jorge/AAE-2167-2021; de Jong, Peter/E-9095-2014; de Jong, Peter/ABB-1750-2020	Penninx, Brenda WJH/0000-0001-7779-9672; Bockting, Claudi L/0000-0002-9220-9244; de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Tendeiro, Jorge/0000-0003-1660-3642; van Tuijl, Lonneke/0000-0001-9031-0886	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; Leiden University Medical Center; University Medical Center Groningen	Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; Leiden University Medical Center; University Medical Center Groningen	The infrastructure for the NESDA study (www.nesda.nl) has been funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002; http://www.zonmw.nl/en/) and participating universities (VU University Medical Center, Leiden University Medical Center, University Medical Center Groningen).	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Asendorpf JB, 2002, J PERS SOC PSYCHOL, V83, P380, DOI 10.1037//0022-3514.83.2.380; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beevers CG, 2005, CLIN PSYCHOL REV, V25, P975, DOI 10.1016/j.cpr.2005.03.003; Bockting C, 2015, CLIN PSYCHOL REV; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Brinol P, 2006, J PERS SOC PSYCHOL, V91, P154, DOI 10.1037/0022-3514.91.1.154; Brown GW, 1996, BRIT J PSYCHIAT, V168, P50, DOI 10.1192/S0007125000298413; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Creemers DHM, 2012, J BEHAV THER EXP PSY, V43, P638, DOI 10.1016/j.jbtep.2011.09.006; de Jong PJ, 2012, PSYCHOL MED, V42, P475, DOI 10.1017/S0033291711001358; de Jong PJ, 2002, BEHAV RES THER, V40, P501, DOI 10.1016/S0005-7967(01)00022-5; De Raedt R, 2006, BEHAV RES THER, V44, P1017, DOI 10.1016/j.brat.2005.08.003; de Ruiter NMP, 2015, THESIS; DeHart T, 2013, CURR ISS SOC PSYCHOL, P99; Falk CF, 2015, J PERS, V83, P56, DOI 10.1111/jopy.12082; Farmer AS, 2014, CLIN PSYCHOL SCI, V2, P187, DOI 10.1177/2167702613495200; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Fiedler K, 2006, EUR REV SOC PSYCHOL, V17, P74, DOI [10.1080/10463280600681248, DOI 10.1080/10463280600681248]; Franck E, 2008, COGNITION EMOTION, V22, P1588, DOI 10.1080/02699930801921271; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Franck E, 2007, BEHAV RES THER, V45, P1531, DOI 10.1016/j.brat.2007.01.003; Franck E, 2007, J BEHAV THER EXP PSY, V38, P75, DOI 10.1016/j.jbtep.2006.05.003; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Glashouwer KA, 2013, J BEHAV THER EXP PSY, V44, P262, DOI 10.1016/j.jbtep.2012.11.005; Glashouwer KA, 2013, J BEHAV THER EXP PSY, V44, P105, DOI 10.1016/j.jbtep.2012.07.015; Glashouwer KA, 2010, J PSYCHOPATHOL BEHAV, V32, P428, DOI 10.1007/s10862-009-9156-y; Greenier KD, 1999, J PERS, V67, P185; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Jordan CH, 2007, J PERS SOC PSYCHOL, V93, P1067, DOI 10.1037/0022-3514.93.6.1067; Korrelboom K, 2012, DEPRESS ANXIETY, V29, P102, DOI 10.1002/da.20921; Leeuwis FH, 2015, J ABNORM CHILD PSYCH, V43, P909, DOI 10.1007/s10802-014-9959-5; Lemmens LHJM, 2014, J BEHAV THER EXP PSY, V45, P196, DOI 10.1016/j.jbtep.2013.10.006; LEWINSOHN PM, 1981, J ABNORM PSYCHOL, V90, P213, DOI 10.1037//0021-843X.110.2.203; Neiss MB, 2009, J PERS, V77, P327, DOI 10.1111/j.1467-6494.2008.00549.x; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Ohayon MM, 2010, J PSYCHOSOM RES, V68, P235, DOI 10.1016/j.jpsychores.2009.07.018; Orvaschel H, 1997, J CLIN CHILD PSYCHOL, V26, P285, DOI 10.1207/s15374424jccp2603_7; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Phillips WJ, 2010, CLIN PSYCHOL REV, V30, P691, DOI 10.1016/j.cpr.2010.05.002; Remue J, 2013, COGNITION EMOTION, V27, P1441, DOI 10.1080/02699931.2013.786681; Risch AK, 2010, J BEHAV THER EXP PSY, V41, P199, DOI 10.1016/j.jbtep.2010.01.003; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rosenberg M, 1989, SOC ADOLESCENT SELF; Rudolph A, 2010, Z PSYCHOL, V218, P12, DOI 10.1027/0044-3409/a000003; RUSH AJ, 1986, PSYCHIAT RES, V18, P65; Schroder-Abe M, 2007, EUR J PERSONALITY, V21, P319, DOI 10.1002/per.626; SILVERSTONE PH, 1991, BRIT J CLIN PSYCHOL, V30, P185, DOI 10.1111/j.2044-8260.1991.tb00936.x; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Spalding LR, 1999, PSYCHOL SCI, V10, P535, DOI 10.1111/1467-9280.00202; Tanner RJ, 2006, BEHAV RES THER, V44, P1397, DOI 10.1016/j.brat.2005.10.007; Vasey MW, 2012, BEHAV RES THER, V50, P767, DOI 10.1016/j.brat.2012.08.007; WACKER HR, 1990, INT CONGR SER, V900, P138; WITTCHEN HU, 1989, ARCH GEN PSYCHIAT, V46, P437; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Zeigler-Hill V, 2006, J PERS, V74, P119, DOI 10.1111/j.1467-6494.2005.00371.x; Zeigler-Hill V, 2010, 2 FACES SELF ESTEEM, P392; Zeigler-Hill V, 2011, J CONTEMP PSYCHOTHER, V41, P157, DOI 10.1007/s10879-010-9167-8	67	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166116	10.1371/journal.pone.0166116	http://dx.doi.org/10.1371/journal.pone.0166116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846292	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600033
J	Duez, M; Giraud, M; Herbert, R; Rocher, T; Salson, M; Thonier, F				Duez, Marc; Giraud, Mathieu; Herbert, Ryan; Rocher, Tatiana; Salson, Mikael; Thonier, Florian			Vidjil: A Web Platform for Analysis of High-Throughput Repertoire Sequencing	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SOFTWARE; CHILDHOOD; QUEST; TCR	Background The B and T lymphocytes are white blood cells playing a key role in the adaptive immunity. A part of their DNA, called the V(D) J recombinations, is specific to each lymphocyte, and enables recognition of specific antigenes. Today, with new sequencing techniques, one can get billions of DNA sequences from these regions. With dedicated Repertoire Sequencing (RepSeq) methods, it is now possible to picture population of lymphocytes, and to monitor more accurately the immune response as well as pathologies such as leukemia. Methods and Results Vidjil is an open-source platform for the interactive analysis of high-throughput sequencing data from lymphocyte recombinations. It contains an algorithm gathering reads into clonotypes according to their V(D) J junctions, a web application made of a sample, experiment and patient database and a visualization for the analysis of clonotypes along the time. Vidjil is implemented in C++, Python and Javascript and licensed under the GPLv3 open-source license. Source code, binaries and a public web server are available at http://www.vidjil.org and at http://bioinfo.lille.inria.fr/vidjil. Using the Vidjil web application consists of four steps: 1. uploading a raw sequence file (typically a FASTQ); 2. running RepSeq analysis software; 3. visualizing the results; 4. annotating the results and saving them for future use. For the end-user, the Vidjil web application needs no specific installation and just requires a connection and a modern web browser. Vidjil is used by labs in hematology or immunology for research and clinical applications.	[Giraud, Mathieu; Herbert, Ryan; Rocher, Tatiana; Salson, Mikael] Univ Lille, CRIStAL Ctr Rech Informat Signal & Automat Lille, CNRS, UMR 9189, F-59000 Lille, France; [Giraud, Mathieu; Herbert, Ryan; Rocher, Tatiana; Salson, Mikael] Inria Lille, F-59650 Villeneuve Dascq, France; [Duez, Marc] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Duez, Marc] SIRIC ONCOLille, F-59000 Lille, France; [Thonier, Florian] Hop Necker Enfants Malad, INSERM, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Centrale Lille; Universite de Lille; University of Bristol; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Giraud, M (corresponding author), Univ Lille, CRIStAL Ctr Rech Informat Signal & Automat Lille, CNRS, UMR 9189, F-59000 Lille, France.; Giraud, M (corresponding author), Inria Lille, F-59650 Villeneuve Dascq, France.	contact@vidjil.org		Rocher, Tatiana/0000-0002-1220-6335; Giraud, Mathieu/0000-0003-2741-8047	SIRIC ONCOLiIIe [INCa-DGOS-Inserm 6041]	SIRIC ONCOLiIIe	This work was supported by SIRIC ONCOLiIIe, Grant INCa-DGOS-Inserm 6041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bystry V, 2017, BIOINFORMATICS, V33, P435, DOI 10.1093/bioinformatics/btw634; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Ferret Y, 2016, BRIT J HAEMATOL, V173, P413, DOI 10.1111/bjh.13981; Finkel R. A., 1974, Acta Informatica, V4, P1, DOI 10.1007/BF00288933; Fischer HJ, 2016, J NEUROIMMUNOL, V290, P26, DOI 10.1016/j.jneuroim.2015.10.020; Giraud M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-409; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Grardel N, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.1083.1083; Howie B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5624; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kotrova M, 2015, BLOOD, V126, P1045, DOI 10.1182/blood-2015-07-655159; Kuchenbecker L., 2015, BIOINFORMATICS, V31, DOI DOI 10.1093/BIOINFORMATIONBH309; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P595, DOI 10.1101/pdb.top115; Linker RA, 2015, EUR J IMMUNOL, V45, P1326, DOI 10.1002/eji.201444985; Moorhouse MJ, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0059-7; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; Salson M, HIGH THROUGHPU UNPUB; Salson M, DATASET SEQUEN UNPUB; Schaller S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0687-9; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Yang XW, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/697170; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	32	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166126	10.1371/journal.pone.0166126	http://dx.doi.org/10.1371/journal.pone.0166126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835690	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200027
J	Harris, R; van Kranenburg, P; de Jong, BM				Harris, Robert; van Kranenburg, Peter; de Jong, Bauke M.			Behavioral Quantification of Audiomotor Transformations in Improvising and Score-Dependent Musicians	PLOS ONE			English	Article							AUDITORY-FEEDBACK; PROFESSIONAL PIANISTS; KEYBOARD PERFORMANCE; PERCEPTION; PITCH; PATTERNS; MELODIES; IMPLICIT; SYSTEMS; CORTEX	The historically developed practice of learning to play a music instrument from notes instead of by imitation or improvisation makes it possible to contrast two types of skilled musicians characterized not only by dissimilar performance practices, but also disparate methods of audiomotor learning. In a recent fMRI study comparing these two groups of musicians while they either imagined playing along with a recording or covertly assessed the quality of the performance, we observed activation of a right-hemisphere network of posterior superior parietal and dorsal premotor cortices in improvising musicians, indicating more efficient audiomotor transformation. In the present study, we investigated the detailed performance characteristics underlying the ability of both groups of musicians to replicate music on the basis of aural perception alone. Twenty-two classically-trained improvising and score-dependent musicians listened to short, unfamiliar two-part excerpts presented with headphones. They played along or replicated the excerpts by ear on a digital piano, either with or without aural feedback. In addition, they were asked to harmonize or transpose some of the excerpts either to a different key or to the relative minor. MIDI recordings of their performances were compared with recordings of the aural model. Concordance was expressed in an audiomotor alignment score computed with the help of music information retrieval algorithms. Significantly higher alignment scores were found when contrasting groups, voices, and tasks. The present study demonstrates the superior ability of improvising musicians to replicate both the pitch and rhythm of aurally perceived music at the keyboard, not only in the original key, but also in other tonalities. Taken together with the enhanced activation of the right dorsal frontoparietal network found in our previous fMRI study, these results underscore the conclusion that the practice of improvising music can be associated with enhanced audiomotor transformation in response to aurally perceived music.	[Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Harris, Robert] Hanze Univ Appl Sci, Prince Claus Conservatoire, Groningen, Netherlands; [van Kranenburg, Peter] Meertens Inst, Amsterdam, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Meertens Institute (KNAW)	Harris, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.; Harris, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.; Harris, R (corresponding author), Hanze Univ Appl Sci, Prince Claus Conservatoire, Groningen, Netherlands.	r.i.harris@pl.hanze.nl		de Jong, Bauke M./0000-0002-6568-5739				[Anonymous], 1998, ADV INFANCY RES; [Anonymous], 1989, MANUAL ADV MEASURES; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Baumann S, 2007, BRAIN RES, V1161, P65, DOI 10.1016/j.brainres.2007.05.045; Brown RM, 2013, J COGNITIVE NEUROSCI, V25, P313, DOI 10.1162/jocn_a_00322; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Cleeremans A., 1993, MECH IMPLICIT LEARNI; Drost UC, 2005, Q J EXP PSYCHOL-A, V58, P1376, DOI 10.1080/02724980443000610; Finney SA, 2003, MEM COGNITION, V31, P51, DOI 10.3758/BF03196082; Finney SA, 1997, MUSIC PERCEPT, V15, P153; Foster NEV, 2010, CEREB CORTEX, V20, P1350, DOI 10.1093/cercor/bhp199; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2008, NEUROREPORT, V19, P361, DOI 10.1097/WNR.0b013e3282f51d91; Grachten M, P 6 INT C MUS INF RE; Harris R, 2015, BRAIN RES, V1624, P253, DOI 10.1016/j.brainres.2015.06.050; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hove MJ, 2014, P NATL ACAD SCI USA, V111, P10383, DOI 10.1073/pnas.1402039111; Kranenburg VP, P INT C MUS INF RETR; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; Lemstrom Kjell, 2000, THESIS; Marie C., 2012, PSYCHOMUSICOLOGY, V22, P97, DOI [10.1037/a0030858, DOI 10.1037/A0030858]; Marie C, 2014, NEUROPSYCHOLOGIA, V57, P50, DOI 10.1016/j.neuropsychologia.2014.02.023; Marie C, 2013, CEREB CORTEX, V23, P660, DOI 10.1093/cercor/bhs050; Milner A. D., 1995, VISUAL BRAIN ACTION; MONGEAU M, 1990, COMPUT HUMANITIES, V24, P161, DOI 10.1007/BF00117340; MOORE R, 1992, INT REV AESTHET SOC, V23, P61, DOI 10.2307/836956; Morgan-Short K, 2012, J COGNITIVE NEUROSCI, V24, P933, DOI 10.1162/jocn_a_00119; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nettl B., 1998, COURSE PERFORMANCE S; Newport EL, 2004, COGNITIVE PSYCHOL, V48, P127, DOI 10.1016/S0010-0285(03)00128-2; Novembre G, 2011, CONSCIOUS COGN, V20, P1232, DOI 10.1016/j.concog.2011.03.009; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; PALMER C, 1994, PERCEPT PSYCHOPHYS, V56, P301, DOI 10.3758/BF03209764; Pfordresher PQ, 2012, ACTA PSYCHOL, V139, P166, DOI 10.1016/j.actpsy.2011.10.009; REBER PJ, 1994, LEARN MEMORY, V1, P217; Repp BH, 1999, MUSIC PERCEPT, V16, P409; Ruiz M. H., 2009, P INT S PERF SCI, P187; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Seppanen M, 2007, NEUROBIOL LEARN MEM, V87, P236, DOI 10.1016/j.nlm.2006.08.011; SERGENT J, 1992, SCIENCE, V257, P106, DOI 10.1126/science.1621084; SHAFFER LH, 1981, COGNITIVE PSYCHOL, V13, P326, DOI 10.1016/0010-0285(81)90013-X; Stewart L, 2003, NEUROIMAGE, V20, P71, DOI 10.1016/S1053-8119(03)00248-9; Stewart L, 2013, Q J EXP PSYCHOL, V66, P37, DOI 10.1080/17470218.2012.687385; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; Trimarchi PD, 2011, PSYCHOL RES-PSYCH FO, V75, P122, DOI 10.1007/s00426-010-0292-5; Ullman M, 2005, MIND CONTEXT ADULT 2, P141; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Vuust P, 2012, NEUROPSYCHOLOGIA, V50, P1432, DOI 10.1016/j.neuropsychologia.2012.02.028; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Willingham DB, 1999, PSYCHOL SCI, V10, P531, DOI 10.1111/1467-9280.00201; Wiora W., 1941, JB VOLKSLIEDFORSCHUN, V7, P128, DOI DOI 10.2307/846331; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Woody RH, 2010, J RES MUSIC EDUC, V58, P101, DOI 10.1177/0022429410370785; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239	59	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166033	10.1371/journal.pone.0166033	http://dx.doi.org/10.1371/journal.pone.0166033			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835631	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200021
J	Kozlov, MV; Skoracka, A; Zverev, V; Lewandowski, M; Zvereva, EL				Kozlov, Mikhail V.; Skoracka, Anna; Zverev, Vitali; Lewandowski, Mariusz; Zvereva, Elena L.			Two Birch Species Demonstrate Opposite Latitudinal Patterns in Infestation by Gall-Making Mites in Northern Europe	PLOS ONE			English	Article							INSECT HERBIVORY; ERIOPHYOID MITE; SPATIAL-DISTRIBUTION; BETULA-PENDULA; B-PUBESCENS; TREES; GRADIENTS; RESPONSES; FOLIAGE; LOSSES	Latitudinal patterns in herbivory, i.e. variations in plant losses to animals with latitude, are generally explained by temperature gradients. However, earlier studies suggest that geographical variation in abundance and diversity of gall-makers may be driven by precipitation rather than by temperature. To test the above hypothesis, we examined communities of eriophyoid mites (Acari: Eriophyoidea) on leaves of Betula pendula and B. pubescens in boreal forests in Northern Europe. We sampled ten sites for each of five latitudinal gradients from 2008-2011, counted galls of six morphological types and identified mites extracted from these galls. DNA analysis revealed cryptic species within two of six morphologically defined mite species, and these cryptic species induced different types of galls. When data from all types of galls and from two birch species were pooled, the percentage of galled leaves did not change with latitude. However, we discovered pronounced variation in latitudinal changes between birch species. Infestation by eriophyoid mites increased towards the north in B. pendula and decreased in B. pubescens, while diversity of galls decreased towards the north in B. pendula and did not change in B. pubescens. The percentage of galled leaves did not differ among geographical gradients and study years, but was 20% lower in late summer relative to early summer, indicating premature abscission of infested leaves. Our data suggest that precipitation has little effect on abundance and diversity of eriophyoid mites, and that climate warming may impose opposite effects on infestation of two birch species by galling mites, favouring B. pendula near the northern tree limit.	[Kozlov, Mikhail V.; Zverev, Vitali; Zvereva, Elena L.] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [Skoracka, Anna] Adam Mickiewicz Univ, Populat Ecol Lab, Fac Biol, Poznan, Poland; [Lewandowski, Mariusz] Warsaw Univ Life Sci SGGW, Fac Agr Biotechnol & Landscape Architecture, Dept Appl Entomol, Warsaw, Poland	University of Turku; Adam Mickiewicz University; Warsaw University of Life Sciences	Kozlov, MV (corresponding author), Univ Turku, Sect Ecol, Dept Biol, Turku, Finland.	mikoz@utu.fi	Kozlov, Mikhail V./I-5037-2013; Lewandowski, Mariusz/H-2184-2011; Lewandowski, Mariusz/N-1142-2019; Zvereva, Elena L./M-8490-2016; Skoracka, Anna/E-6002-2011	Kozlov, Mikhail V./0000-0002-9500-4244; Lewandowski, Mariusz/0000-0001-5360-0382; Lewandowski, Mariusz/0000-0001-5360-0382; Zvereva, Elena L./0000-0003-2934-3421; Skoracka, Anna/0000-0002-9485-532X	Academy of Finland [122133, 276671]; University of Turku, Finland; Faculty of Biology, Adam Mickiewicz University, Poland	Academy of Finland(Academy of Finland); University of Turku, Finland; Faculty of Biology, Adam Mickiewicz University, Poland	The study was supported by the Academy of Finland (www.aka.fi; projects 122133, 276671 and researcher exchange grants to M. Kozlov), by a strategic research grant from the University of Turku, Finland (www.utu.fi), and by Faculty of Biology, Adam Mickiewicz University, Poland (https://international.amu.edU.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrine Jr JW, 2003, REVISED KEYS WORLD G; Amrine JW, 1996, WORLD CROP PESTS ERI, V6, P383, DOI DOI 10.1016/S1572; Amrine JW, 2015, CATALOG ERIOPHYOIDEA; Amrine JW Jr, 1994, CATALOG ERIOPHYOIDEA; ATKINSON MD, 1992, J ECOL, V80, P837, DOI 10.2307/2260870; Bouneb M, 2014, EXP APPL ACAROL, V62, P161, DOI 10.1007/s10493-013-9733-3; Buchta I., 2004, Journal of Forest Science (Prague), V50, P566; Canestrini G, 1891, ATTI SOC VENETO TREN, V12, P40; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; Castagnoli M, 1996, ERIOPHYOID MITES THE, P543, DOI DOI 10.3791/51738; de Lillo E, 2010, EXP APPL ACAROL, V51, P283, DOI 10.1007/s10493-009-9311-x; Ellis WN, 2015, LEAFMINERS PLANT GAL; Ermakov VI, 1986, MECH BIRCH ADAPTION; FAO, 2006, NEW LOCCLIM LOC CLIM; Fernandes GW, 1994, GALL FORMING INSECTS, P42; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; Ishihara MI, 2007, J APPL ENTOMOL, V131, P585, DOI 10.1111/j.1439-0418.2007.01207.x; Isidorov V, 2014, BIOCHEM SYST ECOL, V52, P41, DOI 10.1016/j.bse.2013.12.008; Junttila O, 2003, SCAND J FOREST RES, V18, P208, DOI 10.1080/02827580308624; Koricheva J, 1996, ENVIRON POLLUT, V93, P345, DOI 10.1016/S0269-7491(96)00039-5; Kotlarski S, 2014, GEOSCI MODEL DEV, V7, P1297, DOI 10.5194/gmd-7-1297-2014; Kozlov MV, 2008, CLIMATIC CHANGE, V87, P107, DOI 10.1007/s10584-007-9348-y; Kozlov MV, 2015, ECOGRAPHY, V38, P1026, DOI 10.1111/ecog.01401; Kozlov MV, 2015, GLOBAL ECOL BIOGEOGR, V24, P1126, DOI 10.1111/geb.12347; Kozlov MV, 2015, POLAR BIOL, V38, P967, DOI 10.1007/s00300-015-1655-6; Kozlov MV, 2015, GLOBAL CHANGE BIOL, V21, P106, DOI 10.1111/gcb.12682; Kozlov MV, 2013, ECOGRAPHY, V36, P1138, DOI 10.1111/j.1600-0587.2013.00272.x; Kuczynski L, 2005, EXP APPL ACAROL, V36, P277, DOI 10.1007/s10493-005-7551-y; Kula E., 2010, Folia Oecologica, V37, P61; Kula E, 2008, INT J ACAROL, V34, P155, DOI 10.1080/01647950808683719; Leckey EH, 2014, ACTA OECOL, V61, P1, DOI 10.1016/j.actao.2014.08.001; Lewandowski M, 2014, EXP APPL ACAROL, V63, P497, DOI 10.1007/s10493-014-9805-z; Lim JY, 2015, GLOBAL ECOL BIOGEOGR, V24, P1106, DOI 10.1111/geb.12336; Lindroth JI, 1899, ACTA SOC PRO FAUNA F, V18, P1; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Moreira X, 2015, OIKOS, V124, P1444, DOI 10.1111/oik.02040; Mosbacher JB, 2013, POLAR BIOL, V36, P1735, DOI 10.1007/s00300-013-1393-6; Nalepa A., 1919, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V69, P25; Nalepa A., 1891, NOVA ACTA LEOP AKAD, V55, P362; Nalepa A, 1892, FEUILLE JEUNES NATUR, V22, P118; Navajas M, 2010, EXP APPL ACAROL, V51, P257, DOI 10.1007/s10493-009-9301-z; NUCKOLS MS, 1995, ECOL ENTOMOL, V20, P253, DOI 10.1111/j.1365-2311.1995.tb00455.x; Palme AE, 2004, MOL ECOL, V13, P167, DOI 10.1046/j.1365-294X.2003.02034.x; Patankar R, 2013, ARCT ANTARCT ALP RES, V45, P99, DOI 10.1657/1938-4246-45.1.99; Petanovic R, 2010, EXP APPL ACAROL, V51, P61, DOI 10.1007/s10493-010-9351-2; Petanovic R, 2010, EXP APPL ACAROL, V51, P81, DOI 10.1007/s10493-009-9328-1; ROIVAENEN H., 1950, ACTA ENT FENNICA, V7., P1; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Schenk MF, 2008, TREE GENET GENOMES, V4, P911, DOI 10.1007/s11295-008-0162-0; Skoracka A, 2014, BIOL J LINN SOC, V111, P421, DOI 10.1111/bij.12213; Soika Grazyna, 2006, Biological Letters, V43, P367; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turcotte MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0555; Valkama E, 2005, OECOLOGIA, V146, P385, DOI 10.1007/s00442-005-0216-z; Vehvilainen H, 2006, BASIC APPL ECOL, V7, P1, DOI 10.1016/j.baae.2005.05.003; VUORISALO T, 1989, OIKOS, V55, P370, DOI 10.2307/3565597; Wang N, 2014, MOL ECOL, V23, P2771, DOI 10.1111/mec.12768; Welter S.C., 1989, P135; Westphal E, 1996, ERIOPHYOID MITES THE, P231, DOI DOI 10.1016/S1572-4379(96)80014-5; WILLSON MF, 1990, AM MIDL NAT, V123, P408, DOI 10.2307/2426571; Zvereva EL, 2012, OECOLOGIA, V169, P441, DOI 10.1007/s00442-011-2210-y	61	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166641	10.1371/journal.pone.0166641	http://dx.doi.org/10.1371/journal.pone.0166641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835702	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200063
J	Musalek, M; Scharoun, SM; Bryden, PJ				Musalek, Martin; Scharoun, Sara Marie; Bryden, Pamela J.			Using Bishop's Card Reaching Task to Assess Hand Preference in 8-to 10-Year-Old Czech Children	PLOS ONE			English	Article							EDINBURGH HANDEDNESS INVENTORY; CEREBRAL LATERALIZATION; MOTOR CORTEX; PERFORMANCE; LANGUAGE; MODEL; RELIABILITY; MIDLINE; SPEECH; SKILL	Hand preference is one of the most apparent functional asymmetry in humans. Under contralateral control, performance is more proficient with the preferred hand; however, the difference between the two hands is greater in right handers, considering left handers generally display less cerebral lateralization. One method of evaluating hand preference is Bishop's card reaching task; however, information regarding validity and sensitivity with children in limited. This study assessed the relationship between Bishop's card reaching task and five hand preference tasks in 8- to 10-year-old typically-developing children from the Czech Republic (N = 376). Structural equation modelling identified a one factor model as the most suitable, including Bishop's card reaching task and three hand preference tasks (ringing, throwing, and rolling with dice). The factor validity (. 89) and sensitivity of Bishop's card reaching task (90% to 97%) provided a very good identification of hand preference. These results support the suitability of Bishop's card reaching task as a separate test for determining hand preference in children. Accordingly, we suggest that the assessment of handedness, particularly in neurodevelopmental disorders where the proportion of right-handers and left-handers is disrupted (e.g., children with DCD or ADHD), should make use of Bishop's card reaching task alongside other unimanual tasks.	[Musalek, Martin] Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic; [Scharoun, Sara Marie] Nipissing Univ, Sch Phys & Hlth Educ, North Bay, ON, Canada; [Bryden, Pamela J.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada	Charles University Prague; Nipissing University; Wilfrid Laurier University	Scharoun, SM (corresponding author), Nipissing Univ, Sch Phys & Hlth Educ, North Bay, ON, Canada.	saras@nipissingu.ca	Bryden, Pam/AAF-6706-2020; Benson, Sara Scharoun/AAG-5946-2020; Musalek, Martin/M-9802-2017	Benson, Sara Scharoun/0000-0002-3329-6392; Musalek, Martin/0000-0003-1070-8304; Bryden, Pamela/0000-0001-8862-3402	Social-Sciences Aspects of Human Movement Studies [PRVOUK P39]; Czech Science Foundation [14-29358P]	Social-Sciences Aspects of Human Movement Studies; Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by project PRVOUK P39, Social-Sciences Aspects of Human Movement Studies and by the Czech Science Foundation, project No. 14-29358P.	Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; ANNETT M, 1981, TRENDS NEUROSCI, V4, P256, DOI 10.1016/0166-2236(81)90080-1; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Annett M., 1981, ANN DYSLEXIA, V31, P103, DOI [10.1007/BF02658604, DOI 10.1007/BF02658604]; Ayres A.J., 1972, SENSORY INTEGRATION; Ayres AJ, 1980, SO CALIFORNIA INTEGR; Baker F.B., 2004, ITEM RESPONSE THEORY; Banerjee M, 1999, CAN J STAT, V27, P3, DOI 10.2307/3315487; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; Brown SG, 2006, LATERALITY, V11, P1, DOI 10.1080/1357650054200000440; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Bryden P, 2003, BRAIN COGNITION, V53, P111; Bryden PJ, 2007, DEV NEUROPSYCHOL, V32, P825, DOI 10.1080/87565640701539667; Bryden PJ, 2006, DEV PSYCHOBIOL, V48, P121, DOI 10.1002/dev.20120; Calvert G A, 1998, Laterality, V3, P255, DOI 10.1080/135765098397287; Carlier M, 2006, BRAIN COGNITION, V61, P255, DOI 10.1016/j.bandc.2006.01.007; Cohen J.E., 1988, STAT POWER ANAL BEHA; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; Cornish KM, 1996, J AUTISM DEV DISORD, V26, P597, DOI 10.1007/BF02172349; DODDS AG, 1978, NEUROPSYCHOLOGIA, V16, P247, DOI 10.1016/0028-3932(78)90115-X; Doyen AL, 2002, LATERALITY, V7, P115, DOI 10.1080/13576500143000140; Doyen AL, 2008, LATERALITY, V13, P179, DOI 10.1080/13576500701764124; Dragovic M, 2004, LATERALITY, V9, P411, DOI 10.1080/13576500342000248; FINLAYSON MAJ, 1976, PERCEPT MOTOR SKILL, V43, P475, DOI 10.2466/pms.1976.43.2.475; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Gut M, 2007, ACTA NEUROBIOL EXP, V67, P43; Hammond G, 2002, NEUROSCI BIOBEHAV R, V26, P285, DOI 10.1016/S0149-7634(02)00003-9; HARRIS LJ, 1993, BRAIN LANG, V45, P108, DOI 10.1006/brln.1993.1037; Hendl J, 2009, PREHLED STAT METOD A; Herron J., 2012, NEUROPSYCHOLOGY LEFT; Hill E L, 1998, Laterality, V3, P295; Hill EL, 2009, BRAIN COGNITION, V71, P99, DOI 10.1016/j.bandc.2009.04.006; Hugdahl K., 2010, 2 HALVES BRAIN INFOR; Ida Y, 1996, CAN J EXP PSYCHOL, V50, P234, DOI 10.1037/1196-1961.50.2.234; Jancke J, 1998, COGNITIVE BRAIN RES, V6, P279; Kerlinger FN, 2000, FDN BEHAV RES, P665; Khedr EM, 2002, EUR J APPL PHYSIOL, V87, P469, DOI 10.1007/s00421-002-0652-y; Kline R., 2011, HDB INNOVATION SOCIA, P562, DOI [10.4135/9781446268261, DOI 10.4135/9781446268261, 10.4135/9781446268261.n31]; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Komarc M, 2012, CZECH KINANTHROPOL, V16, P77; Krippendorff K., 1980, CONTENT ANAL INTRO I; Liederman J., 1983, MANUAL SPECIALIZATIO, P82; McDonald, 1999, TEST THEORY UNIFIED, DOI DOI 10.4324/9781410601087; MCFARLAND K, 1980, BRIT J PSYCHOL, V71, P135, DOI 10.1111/j.2044-8295.1980.tb02739.x; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P115, DOI DOI 10.1037/0894-4105.6.2.115; Michell D., 1999, PHYSIOTHERAPY, V85, P607, DOI [10.1016/S0031-9406(05)66041-5, DOI 10.1016/S0031-9406(05)66041-5]; Milenkovic S, 2013, LATERALITY, V18, P340, DOI 10.1080/1357650X.2012.683196; Musalek M, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01513; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Muthen L.K., 2010, MPLUS USERS GUIDE ST; Ocklenburg S, 2014, FRONT PSYCHOL, V5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLEARY DS, 1980, CHILD DEV, V51, P743, DOI 10.2307/1129460; Pool EM, 2015, NEUROIMAGE, V109, P298, DOI 10.1016/j.neuroimage.2015.01.034; PROVINE RR, 1979, CHILD DEV, V50, P437, DOI 10.1111/j.1467-8624.1979.tb04126.x; Provins KA, 1997, PSYCHOL REV, V104, P554, DOI 10.1037/0033-295X.104.3.554; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Scharoun SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00082; SINGH M, 1994, INT J NEUROSCI, V74, P33, DOI 10.3109/00207459408987227; Springer S. P, 1998, LEFT BRAIN RIGHT BRA; STEENHUIS RE, 1990, J CLIN EXP NEUROPSYC, V12, P921, DOI 10.1080/01688639008401031; STEENHUIS RE, 1989, CORTEX, V25, P289, DOI 10.1016/S0010-9452(89)80044-9; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; TAPLEY SM, 1985, NEUROPSYCHOLOGIA, V23, P215, DOI 10.1016/0028-3932(85)90105-8; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Viviani P, 1998, EXP BRAIN RES, V120, P531, DOI 10.1007/s002210050428; West S. G., 1995, STRUCTURAL EQUATION, P56; Yahagi S, 1999, NEUROSCI LETT, V276, P185, DOI 10.1016/S0304-3940(99)00823-X	71	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166337	10.1371/journal.pone.0166337	http://dx.doi.org/10.1371/journal.pone.0166337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835677	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200041
J	Zwicker, D				Zwicker, David			Normalized Neural Representations of Complex Odors	PLOS ONE			English	Article							OLFACTORY-BULB; LATERAL INHIBITION; MIXTURES; NEURONS; SENSITIVITY; SPARSE; MODEL; TRANSFORMATIONS; ENHANCEMENT; VERTEBRATES	The olfactory system removes correlations in natural odors using a network of inhibitory neurons in the olfactory bulb. It has been proposed that this network integrates the response from all olfactory receptors and inhibits them equally. However, how such global inhibition influences the neural representations of odors is unclear. Here, we study a simple statistical model of the processing in the olfactory bulb, which leads to concentration-invariant, sparse representations of the odor composition. We show that the inhibition strength can be tuned to obtain sparse representations that are still useful to discriminate odors that vary in relative concentration, size, and composition. The model reveals two generic consequences of global inhibition: (i) odors with many molecular species are more difficult to discriminate and (ii) receptor arrays with heterogeneous sensitivities perform badly. Comparing these predictions to experiments will help us to understand the role of global inhibition in shaping normalized odor representations in the olfactory bulb.	[Zwicker, David] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Zwicker, David] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Zwicker, D (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Zwicker, D (corresponding author), Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA.	dzwicker@seas.harvard.edu	Zwicker, David/AAL-8751-2020	Zwicker, David/0000-0002-3909-3334	Simons Foundation; German Science Foundation [ZW 222/1-1]	Simons Foundation; German Science Foundation(German Research Foundation (DFG))	This research was funded by the Simons Foundation (https://www.simonsfoundation.org/) and the German Science Foundation (www.dfg.de/en;) through ZW 222/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I thank Michael P. Brenner, Alexander T. Mathis, Venkatesh N. Murthy, Mikhail Tikhonov, and Christoph A. Weber for helpful discussions and comments on the manuscript. This research was funded by the Simons Foundation and the German Science Foundation through ZW 222/1-1.	Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Banerjee A, 2015, NEURON, V87, P193, DOI 10.1016/j.neuron.2015.06.019; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Berck ME, 2016, ELIFE, V5, DOI 10.7554/eLife.14859; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Blauvelt DG, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00046; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; CAIN WS, 1977, SCIENCE, V195, P796, DOI 10.1126/science.836592; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Cleland Thomas A, 2011, Front Neuroeng, V4, P21, DOI 10.3389/fneng.2011.00021; Cleland TA, 2010, TRENDS NEUROSCI, V33, P130, DOI 10.1016/j.tins.2009.12.004; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Demb JB, 2015, ANNU REV VIS SCI, V1, P263, DOI 10.1146/annurev-vision-082114-035334; Ganguli S, 2012, ANNU REV NEUROSCI, V35, P485, DOI 10.1146/annurev-neuro-062111-150410; Geramita MA, 2016, ELIFE, V5, DOI 10.7554/eLife.16039; Getz WM, 1999, CHEM SENSES, V24, P351, DOI 10.1093/chemse/24.4.351; Goyert HF, 2007, BRAIN RES BULL, V72, P1, DOI 10.1016/j.brainresbull.2006.12.010; Gupta P, 2015, NAT NEUROSCI, V18, P272, DOI 10.1038/nn.3913; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; HAINER R M, 1954, Ann N Y Acad Sci, V58, P158, DOI 10.1111/j.1749-6632.1954.tb54851.x; Hong EJ, 2015, NEURON, V85, P573, DOI 10.1016/j.neuron.2014.12.040; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jinks A, 2001, PHYSIOL BEHAV, V72, P51, DOI 10.1016/S0031-9384(00)00407-8; Jinks A, 1999, PERCEPTION, V28, P395, DOI 10.1068/p2898; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; LI Z, 1990, BIOL CYBERN, V62, P349, DOI 10.1007/BF00201449; Li Z., 1994, MODELS NEURAL NETWOR, P221, DOI [10.1007/978-1-4612-4320-5_6, DOI 10.1007/978-1-4612-4320-5_6]; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Linster C, 1997, BEHAV BRAIN RES, V84, P117, DOI 10.1016/S0166-4328(97)83331-1; LOWE G, 1995, P NATL ACAD SCI USA, V92, P7864, DOI 10.1073/pnas.92.17.7864; Mainland JD, 2014, TRENDS NEUROSCI, V37, P443, DOI 10.1016/j.tins.2014.05.005; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mathis A, 2016, BIORXIV; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Nikolova N, 2004, QSAR COMB SCI, V22, P1006, DOI 10.1002/qsar.200330831; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Roland B, 2016, ELIFE, V5, DOI 10.7554/eLife.16335; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Teixeira CSS, 2016, CHEM SENSES, V41, P105, DOI 10.1093/chemse/bjv075; Sirotin YB, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0083-15.2015; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stevens CF, 2016, P NATL ACAD SCI USA, V113, P6737, DOI 10.1073/pnas.1606339113; Stitzel SE, 2011, ANNU REV BIOMED ENG, V13, P1, DOI [10.1146/annurev-bioeng-071910-124633, 10.1146/annurev-bioeng-071910-12463.3]; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Tikhonov M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150486; Tkacik G, 2016, ANNU REV CONDEN MA P, V7, P89, DOI 10.1146/annurev-conmatphys-031214-014803; Uchida N, 2014, ANNU REV NEUROSCI, V37, P363, DOI 10.1146/annurev-neuro-071013-013941; Uchida N, 2008, FRONT SYST NEUROSCI, V1, DOI 10.3389/neuro.06.003.2007; Ukhanov K, 2010, J NEUROPHYSIOL, V103, P1114, DOI 10.1152/jn.00980.2009; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Weiss T, 2012, P NATL ACAD SCI USA, V109, P19959, DOI 10.1073/pnas.1208110109; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Wilson RI, 2011, CURR OPIN NEUROBIOL, V21, P254, DOI 10.1016/j.conb.2011.03.002; Wright GA, 2005, RECENT ADV PHYTOCHEM, V39, P191; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yu CR, 2017, EXP NEUROL, V287, P395, DOI 10.1016/j.expneurol.2016.06.001; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang DK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/507143; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zwicker D, 2016, P NATL ACAD SCI USA, V113, P5570, DOI 10.1073/pnas.1600357113	84	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166456	10.1371/journal.pone.0166456	http://dx.doi.org/10.1371/journal.pone.0166456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835696	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200052
J	Horii, N; Sato, K; Mesaki, N; Iemitsu, M				Horii, Naoki; Sato, Koji; Mesaki, Noboru; Iemitsu, Motoyuki			Increased Muscular 5 alpha-Dihydrotestosterone in Response to Resistance Training Relates to Skeletal Muscle Mass and Glucose Metabolism in Type 2 Diabetic Rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; EXERCISE; DHEA; TESTOSTERONE; STRENGTH; DEHYDROEPIANDROSTERONE; TRANSLOCATION; ENZYMES	Regular resistance exercise induces skeletal muscle hypertrophy and improvement of glycemic control in type 2 diabetes patients. Administration of dehydroepiandrosterone (DHEA), a sex steroid hormone precursor, increases 5 alpha-dihydrotestosterone (DHT) synthesis and is associated with improvements in fasting blood glucose level and skeletal muscle hypertrophy. Therefore, the aim of this study was to investigate whether increase in muscle DHT levels, induced by chronic resistance exercise, can contribute to skeletal muscle hypertrophy and concomitant improvement of muscular glucose metabolism in type 2 diabetic rats. Male 20-week-old type 2 diabetic rats (OLETF) were randomly divided into 3 groups: sedentary control, resistance training (3 times a week on alternate days for 8 weeks), or resistance training with continuous infusion of a 5 alpha-reductase inhibitor (n = 8 each group). Age-matched, healthy nondiabetic Long-Evans Tokushima Otsuka (LETO) rats (n = 8) were used as controls. The results indicated that OLETF rats showed significant decrease in muscular DHEA, free testosterone, DHT levels, and protein expression of steroidogenic enzymes, with loss of skeletal muscle mass and hyperglycemia, compared to that of LETO rats. However, 8-week resistance training in OLETF rats significantly increased the levels of muscle sex steroid hormones and protein expression of steroidogenic enzymes with a concomitant increase in skeletal muscle mass, improved fasting glucose level, and insulin sensitivity index. Moreover, resistance training accelerated glucose transporter-4 (GLUT-4) translocation and protein kinase B and C-zeta/lambda(IA phosphorylation. Administering the 5a-reductase inhibitor in resistance-trained OLETF rats resulted in suppression of the exercise induced effects on skeletal muscle mass, fasting glucose level, insulin sensitivity index, and GLUT-4 signaling, with a decline in muscular DHT levels. These findings suggest that resistance training-induced elevation of muscular DHT levels may contribute to improvement of hyperglycemia and skeletal muscle hypertrophy in type 2 diabetic rats.	[Horii, Naoki; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport Hlth Sci, Kusatsu, Shiga, Japan; [Sato, Koji] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Mesaki, Noboru] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Ritsumeikan University; Kobe University; University of Tsukuba	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport Hlth Sci, Kusatsu, Shiga, Japan.	iemitsu@fc.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26282199, 15H03091]; Grants-in-Aid for Scientific Research [15H03091] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#26282199, M. lemitsu and #15H03091, N. Mesaki). Please show the URL in this grant as follows: https://www.jsps.go.jp/english/ndex.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therefore, all authors have no conflict of interest.	Aizawa K, 2007, AM J PHYSIOL-ENDOC M, V292, pE577, DOI 10.1152/ajpendo.00367.2006; Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995; [Anonymous], 2012, GLOBAL STATUS REPORT; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Horii N, 2016, HORM METAB RES, V48, P207, DOI 10.1055/s-0035-1564132; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Kim JY, 2015, DIABETES METAB J, V39, P424, DOI 10.4093/dmj.2015.39.5.424; Kristiansen S, 2001, AM J PHYSIOL-ENDOC M, V281, pE608, DOI 10.1152/ajpendo.2001.281.3.E608; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Motamed N, 2016, J DIABETES COMPLICAT, V30, P269, DOI 10.1016/j.jdiacomp.2015.11.019; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000239; Sato K, 2014, FASEB J, V28, P1891, DOI 10.1096/fj.13-245480; Sato K, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-47; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Usui T, 2014, FEBS LETT, V588, P1935, DOI 10.1016/j.febslet.2014.03.051; White JR, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-6; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20; Yamaguchi Y, 1998, CLIN ENDOCRINOL, V49, P377, DOI 10.1046/j.1365-2265.1998.00533.x; Yang ZY, 2014, SPORTS MED, V44, P487, DOI 10.1007/s40279-013-0128-8	32	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165689	10.1371/journal.pone.0165689	http://dx.doi.org/10.1371/journal.pone.0165689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832095	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000025
J	Joseph, MB; Stutz, WE; Johnson, PTJ				Joseph, Maxwell B.; Stutz, William E.; Johnson, Pieter T. J.			Multilevel Models for the Distribution of Hosts and Symbionts	PLOS ONE			English	Article							INFECTIOUS-DISEASES; BIOTIC INTERACTIONS; WILDLIFE DISEASE; OCCUPANCY; POPULATION; IMPERFECT; ABUNDANCE; EPIDEMIOLOGY; COOCCURRENCE; PREVALENCE	Symbiont occurrence is influenced by host occurrence and vice versa, which leads to correlations in host-symbiont distributions at multiple levels. Interactions between co-infecting symbionts within host individuals can cause correlations in the abundance of two symbiont species across individual hosts. Similarly, interactions between symbiont transmission and host population dynamics can drive correlations between symbiont and host abundance across habitat patches. If ignored, these interactions can confound estimated responses of hosts and symbionts to other factors. Here, we present a general hierarchical modeling framework for distributions of hosts and symbionts, estimating correlations in host-symbiont distributions at the among-site, within-site, among-species, and among individual levels. We present an empirical example from a multi-host multi-parasite system involving amphibians and their micro- and macroparasites. Amphibian hosts and their parasites were correlated at multiple levels of organization. Macroparasites often co-infected individual hosts, but rarely co-infected with the amphibian chytrid fungus. Such correlations may result from interactions among parasites and hosts, joint responses to environmental factors, or sampling bias. Joint host-symbiont models account for environmental constraints and species interactions while partitioning variance and dependence in abundance at multiple levels. This framework can be adapted to a wide variety of study systems and sampling designs.	[Joseph, Maxwell B.] Univ Colorado, Earth Lab, Boulder, CO 80309 USA; [Stutz, William E.; Johnson, Pieter T. J.] Univ Colorado, Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Joseph, MB (corresponding author), Univ Colorado, Earth Lab, Boulder, CO 80309 USA.	maxwell.b.joseph@colorado.edu	Joseph, Maxwell/Z-5422-2019	Joseph, Maxwell/0000-0002-7745-9990; JOHNSON, PIETER/0000-0002-7997-5390	National Institutes of Health, Ecology and Evolution of Infectious Diseases Program [R01GM109499]; National Science Foundation [DEB-1149308]; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109499] Funding Source: NIH RePORTER	National Institutes of Health, Ecology and Evolution of Infectious Diseases Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health, Ecology and Evolution of Infectious Diseases Program (R01GM109499), the National Science Foundation (DEB-1149308), and the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Melina Allahverdian, Dana Calhoun, Kelly DeRolf, Jackie Gregory, Emily Hannon, Jeremy Henderson, Megan Housman, Aaron Klingborg, Bryan LaFonte, Keegan McCaffrey, Travis McDevitt-Galles, Mary Toothman, and Vanessa Wuerthner for assistance with data collection. We also thank Tad Dallas, Helen McCreery, Joseph Mihaljevic, Lauren Shoemaker, Timothy Szewczyk, and Topher Weiss-Lehman for feedback on the manuscript. Finally, we gratefully acknowledge contributions of data and intellectual suggestions from Cheryl Briggs, Jason Hoverman, Jason Rohr, and Andrew Blaustein. This research was supported by funding from the National Institutes of Health, Ecology and Evolution of Infectious Diseases Program (R01GM109499), the National Science Foundation (DEB-1149308), and the David and Lucile Packard Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; AITCHISON J, 1989, BIOMETRIKA, V76, P643; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; [Anonymous], 2000, CAUSALITY; ASHFORD JR, 1970, BIOMETRICS, V26, P535, DOI 10.2307/2529107; Ashford RW, 2003, EMERG INFECT DIS, V9, P1495; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; Broms KM, 2015, ECOLOGY IN PRESS, DOI [10.1890/15-0416.1, DOI 10.1890/15-0416.1]; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Clark JS, 2014, ECOL APPL, V24, P990, DOI 10.1890/13-1015.1; Dorazio RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094323; Ebert D, 2000, AM NAT, V156, P459, DOI 10.1086/303404; Gelman A., 2007, DATA ANAL USING REGR; He FL, 2003, AM NAT, V162, P366, DOI 10.1086/377190; He FL, 2002, ECOSCIENCE, V9, P119, DOI 10.1080/11956860.2002.11682698; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Holt RD, 2000, ECOL LETT, V3, P41, DOI 10.1046/j.1461-0248.2000.00116.x; Hoverman JT, 2013, OECOLOGIA, V173, P1471, DOI 10.1007/s00442-013-2692-x; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, P NATL ACAD SCI USA, V109, P9006, DOI 10.1073/pnas.1201790109; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 2011, ECOLOGY, V92, P535, DOI 10.1890/10-0570.1; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Joseph MB, 2016, ECOLOGY, V97, P765, DOI 10.1890/15-0833.1; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mihaljevic JR, 2012, TRENDS ECOL EVOL, V27, P323, DOI 10.1016/j.tree.2012.01.011; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Pena D, 2003, J MULTIVARIATE ANAL, V85, P361, DOI 10.1016/S0047-259X(02)00061-1; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; Puoti Massimo, 2002, AIDS Reviews, V4, P27; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Stan Development Team, 2015, STAN C LIB PROB SAMP; Stan Development Team, 2015, RSTAN R INT STAN; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	52	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165768	10.1371/journal.pone.0165768	http://dx.doi.org/10.1371/journal.pone.0165768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832124	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000033
J	Gulumian, M; Verbeek, J; Andraos, C; Sanabria, N; de Jager, P				Gulumian, Mary; Verbeek, Jos; Andraos, Charlene; Sanabria, Natasha; de Jager, Pieter			Systematic Review of Screening and Surveillance Programs to Protect Workers from Nanomaterials	PLOS ONE			English	Review							HANDLING ENGINEERED NANOMATERIALS; MEDICAL-SURVEILLANCE; RISK-MANAGEMENT; EPIDEMIOLOGIC-RESEARCH; HEALTH SURVEILLANCE; EXPOSURE-REGISTRIES; NANO-OBJECTS; NANOPARTICLES; NANOTECHNOLOGY; MARKERS	Background Screening and surveillance approaches for workers exposed to nanomaterials could aid in early detection of health effects, provide data for epidemiological studies and inform action to decrease exposure. The aim of this review is to identify such screening and surveillance approaches, in order to extract available data regarding (i) the studies that have successfully been implemented in present day, (ii) identification of the most common and/or toxic nano-related health hazards for workers and (iii) possible exposure surveillance markers. This review contributes to the current understanding of the risk associated with nanomaterials by determining the knowledge gap and making recommendations based on current findings. Methods A systematic review was conducted. PubMed and Embase were searched to identify articles reporting on any surveillance-related study that described both exposure to nanomaterials and the health indicators that were measured. Four reviewers worked in pairs to independently assess the eligibility of studies and risk of bias before extraction of data. Studies were categorised according to the type of study and the medical surveillance performed, which included the type of nanomaterial, any exposure details provided, as well as health indicators and biomarkers tested. Results Initially 92 studies were identified, from which 84 full texts were assessed for eligibility. Seven studies met all the inclusion criteria, i.e. those performed in Taiwan, Korea, Czech Republic and the US. Of these, six compared health indicators between exposed and unexposed workers and one study described a surveillance program. All studies were at a high risk of bias. Workers were exposed to a mix of nanomaterials in three studies, carbon based nanomaterials in two studies, nano-silver in one study and nano-titanium oxide in the other study. Two studies did not find a difference in biomarkers between exposed and unexposed workers. In addition, differences in early effects on pulmonary function or neurobehavioral tests were not observed. One study found an increased prevalence of allergic dermatitis and "sneezing" in the exposed group. Conclusions This review of recently published data on surveillance studies proves that there is a gap in the current knowledge, where most of the surveillance-related studies reported do not follow a set format that provides the required information on ENM characterisation, the type of exposure and the measured indicators/biomarkers. Hence, there is very low quality evidence that screening and surveillance might detect adverse health effects associated with workplace exposure. This systematic review is relevant because it proves that, although surveillance programs have been initiated and preliminary results are being published, the current studies are actually not answering the important questions or solving the overall problem regarding what the potential health hazards are among workers either handling or potentially exposed to ENMs. The recommendations, thus proposed, are based on an obvious need for (i) exposure registries, where longitudinal follow-up studies should inform surveillance, (ii) known exposure measurements or summary indices for ENMs as a reference (iii) validation of candidate biomarkers and (iv) studies that compare the effects of these surveillance approaches to usual care, e.g. those commonly followed for bulk-size hazardous materials.	[Gulumian, Mary; Andraos, Charlene; Sanabria, Natasha] Natl Inst Occupat Hlth, Dept Toxicol & Biochem, Natl Hlth Lab Serv, Johannesburg, South Africa; [Verbeek, Jos] Finnish Inst Occupat Hlth, Helsinki, Finland; [de Jager, Pieter] Natl Inst Occupat Hlth, Dept Epidemiol & Surveillance, Natl Hlth Lab Serv, Johannesburg, South Africa; [de Jager, Pieter] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa	National Health Laboratory Service; Finnish Institute of Occupational Health; National Health Laboratory Service; University of Witwatersrand	Gulumian, M (corresponding author), Natl Inst Occupat Hlth, Dept Toxicol & Biochem, Natl Hlth Lab Serv, Johannesburg, South Africa.	Mary.Gulumian@nioh.nhis.ac.za	Sanabria, Natasha/AAY-4665-2020	Sanabria, Natasha/0000-0002-1613-6178; Andraos, Charlene/0000-0002-3049-0392				Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Anita RE, 2014, INT J NANOMED, V9, P3999, DOI [10.2147/IJN.S63064, DOI 10.2147/IJN.S63064]; Bergamaschi E, 2012, J NANOMATER, V2012, DOI 10.1155/2012/564121; Boutou-Kempf O, 2011, J OCCUP ENVIRON MED, V53, pS103, DOI 10.1097/JOM.0b013e31821b1d68; Brouwer D, 2012, ANN OCCUP HYG, V56, P1, DOI 10.1093/annhyg/mer099; Donaldson K, 2004, OCCUP ENVIRON MED, V61, P727, DOI 10.1136/oem.2004.013243; Elsaesser A, 2012, ADV DRUG DELIVER REV, V64, P129, DOI 10.1016/j.addr.2011.09.001; Gause CB, 2011, J OCCUP ENVIRON MED, V53, pS28, DOI 10.1097/JOM.0b013e31821ad5f1; Gullapalli S, 2011, CHEM ENG PROG, V107, P28; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Hyytinen E.R., 2014, GUIDANCE HLTH SURVEI; Kuempel ED, 2012, ANN OCCUP HYG, V56, P491, DOI 10.1093/annhyg/mes040; Kuhlbusch TAJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-22; Lee JH, 2010, TOX RESEARCH, V26, P95, DOI 10.5487/TR.2010.26.2.095; Lee JH, 2012, NANOTOXICOLOGY, V6, P667, DOI 10.3109/17435390.2011.600840; Lee JS, 2015, NANOTOXICOLOGY, V9, P802, DOI 10.3109/17435390.2014.978404; Liao HY, 2014, NANOTOXICOLOGY, V8, P100, DOI 10.3109/17435390.2013.858793; Liao HY, 2014, IND HEALTH, V52, P199, DOI 10.2486/indhealth.2013-0100; Liou SH, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3219-7; Liou SH, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0878-5; Maynard AD, 2006, NANO TODAY, V1, P22, DOI 10.1016/S1748-0132(06)70045-7; Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39; Nasterlack M, 2008, INT ARCH OCC ENV HEA, V81, P721, DOI 10.1007/s00420-007-0245-5; Nasterlack M, 2011, J OCCUP ENVIRON MED, V53, pS18, DOI 10.1097/JOM.0b013e31821b1d54; National Institute for Occupational Safety and Health NIOSH, 2013, NIOSH CURR INT B, V65; Osmond MJ, 2010, NANOTOXICOLOGY, V4, P15, DOI 10.3109/17435390903502028; Paik SY, 2008, ANN OCCUP HYG, V52, P419, DOI 10.1093/annhyg/men041; Park B, 2008, INHAL TOXICOL, V20, P547, DOI [10.1080/08958370801915309, 10.1080/08958370801915309 ]; Pelclova D, 2016, OCCUP ENVIRON MED, V73, P110, DOI 10.1136/oemed-2015-103161; Pelclova D, 2015, CLIN TOXICOL, V53, P645; Schulte P, 2008, J OCCUP ENVIRON HYG, V5, P239, DOI 10.1080/15459620801907840; Schulte PA, 2008, J OCCUP ENVIRON MED, V50, P517, DOI 10.1097/JOM.0b013e31816515f7; Schulte PA, 2011, J OCCUP ENVIRON MED, V53, pS3, DOI 10.1097/JOM.0b013e31821b1b28; Stebounova LV, 2012, WIRES NANOMED NANOBI, V4, P310, DOI 10.1002/wnan.174; Trout DB, 2011, J OCCUP ENVIRON MED, V53, pS22, DOI 10.1097/JOM.0b013e31821b1e45; Trout DB, 2010, TOXICOLOGY, V269, P128, DOI 10.1016/j.tox.2009.12.006; Vlachogianni T, 2013, LUNG CANCER-TARGETS, V4, P71, DOI 10.2147/LCTT.S23216; Wu WT, 2014, INT J MOL SCI, V15, P878, DOI 10.3390/ijms15010878	38	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166071	10.1371/journal.pone.0166071	http://dx.doi.org/10.1371/journal.pone.0166071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829014	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300078
J	Ye, XJ; McCluskey, MD				Ye, Xianjun; McCluskey, Matthew D.			Modular Scanning Confocal Microscope with Digital Image Processing	PLOS ONE			English	Article								In conventional confocal microscopy, a physical pinhole is placed at the image plane prior to the detector to limit the observation volume. In this work, we present a modular design of a scanning confocal microscope which uses a CCD camera to replace the physical pinhole for materials science applications. Experimental scans were performed on a microscope resolution target, a semiconductor chip carrier, and a piece of etched silicon wafer. The data collected by the CCD were processed to yield images of the specimen. By selecting effective pixels in the recorded CCD images, a virtual pinhole is created. By analyzing the image moments of the imaging data, a lateral resolution enhancement is achieved by using a 20 x / NA = 0.4 microscope objective at 532 nm laser wavelength.	[Ye, Xianjun; McCluskey, Matthew D.] Washington State Univ, Dept Phys & Astron, Pullman, WA 99164 USA	Washington State University	Ye, XJ; McCluskey, MD (corresponding author), Washington State Univ, Dept Phys & Astron, Pullman, WA 99164 USA.	xianjun.ye@wsu.edu; mattmcc@wsu.edu	Ye, Xianjun/H-2910-2015; McCluskey, Matthew/I-2454-2014	Ye, Xianjun/0000-0002-1136-4040; McCluskey, Matthew/0000-0002-0786-4106	National Science Foundation [DMR-1561419]; Division Of Materials Research [1561419] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the National Science Foundation (http://www.nsf.gov), Grant No. DMR-1561419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betran-Parrazal L, 2014, J NEUROSCI METH, V225, P57, DOI 10.1016/j.jneumeth.2014.01.003; Botvinick EL, 2000, PROC SPIE, V3921, P12, DOI 10.1117/12.384208; Fetter AL, 2003, THEORETICAL MECH PAR; GU M, 1991, J OPT SOC AM A, V8, P1755, DOI 10.1364/JOSAA.8.001755; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; JUSKAITIS R, 1994, APPL OPTICS, V33, P578, DOI 10.1364/AO.33.000578; KIMURA S, 1991, APPL OPTICS, V30, P2143, DOI 10.1364/AO.30.002143; Liang MH, 1997, OPT LETT, V22, P751, DOI 10.1364/OL.22.000751; Martial FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043942; McCluskey MD, 2013, Patent Application, Patent No. [14/018,604, 14018604]; MINSKY M, 1988, SCANNING, V10, P128, DOI 10.1002/sca.4950100403; Muller CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198101; Sanchez-Ortiga E, 2012, OPT LETT, V37, P1280, DOI 10.1364/OL.37.001280; SHEPPARD CJR, 1988, OPTIK, V80, P53; Weisshart K., 2014, BASIC PRINCIPLE AIRY	15	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166212	10.1371/journal.pone.0166212	http://dx.doi.org/10.1371/journal.pone.0166212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829052	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300095
J	Williams, KA; Miles, DB				Williams, Kelly A.; Miles, Donald B.			Demographic Costs Associated with Differences in Habitat Space Occupancy	PLOS ONE			English	Article							NEST-SITE SELECTION; HARDWOOD FORESTS; GRINNELLIAN NICHE; BIRD COMMUNITIES; HOODED WARBLERS; SOUTHERN OHIO; SIBERIAN JAY; PATTERNS; CONSERVATION; LANDSCAPE	Delimiting the habitat characteristics describing the environmental conditions required by a species has become a critical tool for predicting organismal responses to environmental change. Grinnell emphasized the effects of environmental factors on the ability of a population to maintain a positive growth rate, yet few studies have included demographic or reproductive data in analyses of the Grinnellian niche. Identifying differences in habitat exploitation patterns in response to structural variation in the environment presents an incomplete description of the ability of species to adapt to changing habitats if demographic traits are not included. We estimated the vegetation characteristics used by individuals within a population of hooded warblers (Setophaga citrina) across a spatial transect that includes three structurally different forest habitats. We predicted individuals should select similar structural characteristics within each habitat and have similar reproductive success across sample sites. In the two years post burn, adults were present but no young fledged indicating the habitat requirements necessary for reproduction were absent in this habitat. We found significant differences in habitat space occupied by individuals in unaltered and harvested habitats. Nesting habitats used by female warblers differed from available habitat. Fledging success was lower in the harvested habitat 10 to 12 years post-harvest. In the harvested habitat, fledging success was greater on mesic slopes but decreased along a habitat gradient to xeric ridgetops, suggesting compensation in habitat use does not ameliorate fitness costs. In contrast, there was no difference in the number of fledged young along this gradient in the unaltered habitat. Based solely on occupancy data, traditional ecological niche models would incorrectly conclude the environmental characteristics found across the three forested habitats are included in the Grinnellian niche of the hooded warbler. However, examination of demographic and environmental data simultaneously allows differentiation between occupied habitat space and niche space.	[Williams, Kelly A.; Miles, Donald B.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	Ohio University	Williams, KA (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	williak5@ohio.edu	Miles, Donald B./AFW-0480-2022	Miles, Donald/0000-0001-5768-179X	Ohio Center for Ecology and Evolutionary Studies Research Fellowship; Ohio Avian Project Initiative; Midwest Birding Symposium Conservation Fund; Ohio University Graduate Student Senate Original Work Grants; National Fire and Fire Surrogate Project; Scioto Valley Bird and Nature Club	Ohio Center for Ecology and Evolutionary Studies Research Fellowship; Ohio Avian Project Initiative; Midwest Birding Symposium Conservation Fund; Ohio University Graduate Student Senate Original Work Grants; National Fire and Fire Surrogate Project; Scioto Valley Bird and Nature Club	This work was funded by an Ohio Center for Ecology and Evolutionary Studies Research Fellowship, the Ohio Avian Project Initiative, the Midwest Birding Symposium Conservation Fund, Ohio University Graduate Student Senate Original Work Grants, the National Fire and Fire Surrogate Project and the Scioto Valley Bird and Nature Club.	Albrecht MA, 2006, FOREST ECOL MANAG, V226, P88, DOI 10.1016/j.foreco.2005.12.061; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Artman VL, 2001, CONSERV BIOL, V15, P1423, DOI 10.1046/j.1523-1739.2001.00181.x; Basille M, 2008, ECOL MODEL, V211, P233, DOI 10.1016/j.ecolmodel.2007.09.006; Bayne EM, 2001, AUK, V118, P380, DOI 10.1642/0004-8038(2001)118[0380:EOHFOP]2.0.CO;2; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; Benson TJ, 2010, J WILDLIFE MANAGE, V74, P81, DOI 10.2193/2008-442; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bisson IA, 2000, CAN J ZOOL, V78, P858, DOI 10.1139/cjz-78-5-858; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Burnham B. A., 2002, MODEL SELECTION MULT; Calcagno V, 2013, GLMULTI MODEL SELECT; Clavero M, 2010, GLOBAL ECOL BIOGEOGR, V19, P684, DOI 10.1111/j.1466-8238.2010.00544.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Culbert PD, 2013, AUK, V130, P656, DOI 10.1525/auk.2013.13007; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; Evans Ogden LJ, 1994, BIRDS N AM, DOI [10.2173/bna.110, DOI 10.2173/BNA.110]; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Grinnell J., 1917, Auk Cambridge Mass, V34; Hansen BB, 2009, OIKOS, V118, P859, DOI 10.1111/j.1600-0706.2009.17098.x; Heltzel JM, 2006, J WILDLIFE MANAGE, V70, P1416, DOI 10.2193/0022-541X(2006)70[1416:EOSLOB]2.0.CO;2; Hillen J, 2011, ANN ZOOL FENN, V48, P180, DOI 10.5735/086.048.0306; HOLMES RT, 1986, WILSON BULL, V98, P196; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Hopkins KP, 2011, BIOL J LINN SOC, V102, P878, DOI 10.1111/j.1095-8312.2011.01618.x; Howlett JS, 1996, AUK, V113, P1; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; JAMES FC, 1984, AM NAT, V124, P17, DOI 10.1086/284250; Kaliontzopoulou A, 2010, J EVOLUTION BIOL, V23, P1234, DOI 10.1111/j.1420-9101.2010.01984.x; Legendre P., 2012, NUMERICAL ECOLOGY; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; LYNCH JF, 1985, AUK, V102, P714; Lyons JE, 2005, CONDOR, V107, P41, DOI 10.1650/7462; Martin T. E., 1997, BBIRD FIELD PROTOCOL; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; McDermott ME, 2011, FOREST ECOL MANAG, V261, P373, DOI 10.1016/j.foreco.2010.10.020; MORTON ES, 1990, AM NAT, V135, P319, DOI 10.1086/285048; Nagy LR, 2004, J AVIAN BIOL, V35, P487, DOI 10.1111/j.0908-8857.2004.03429.x; Neudorf DL, 1997, BEHAV ECOL, V8, P595, DOI 10.1093/beheco/8.6.595; Oksanen J., **DATA OBJECT**; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; ORNAT AL, 1990, AUK, V107, P539; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Waldrop TA, 2008, FOREST ECOL MANAG, V255, P3117, DOI 10.1016/j.foreco.2007.11.010; Wallendorf MJ, 2007, J WILDLIFE MANAGE, V71, P1899, DOI 10.2193/2006-386; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; Whittam RM, 2002, CAN J ZOOL, V80, P644, DOI 10.1139/Z02-039; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Williams Kate, 2013, THESIS; Yaussy DA, 2003, NE299 USDA FOR SERV, P99; Yaussy DA, 2001, NE4153	61	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165472	10.1371/journal.pone.0165472	http://dx.doi.org/10.1371/journal.pone.0165472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851742	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300018
J	Bledsoe, JW; Peterson, BC; Swanson, KS; Small, BC				Bledsoe, Jacob W.; Peterson, Brian C.; Swanson, Kelly S.; Small, Brian C.			Ontogenetic Characterization of the Intestinal Microbiota of Channel Catfish through 16S rRNA Gene Sequencing Reveals Insights on Temporal Shifts and the Influence of Environmental Microbes	PLOS ONE			English	Article							FRESH-WATER FISH; GUT MICROBIOTA; GASTROINTESTINAL MICROBIOTA; BACTERIAL COMMUNITY; ATLANTIC SALMON; IMMUNE-SYSTEM; DIVERSITY; ZEBRAFISH; BRADYRHIZOBIUM; TILAPIA	Aquaculture recently overtook capture fisheries as the largest producer of food fish, but to continue increasing fish production the industry is in search of better methods of improving fish health and growth. Pre- and probiotic supplementation has gained attention as a means of solving these issues, however, for such approaches to be successful, we must first gain a more holistic understanding of the factors influencing the microbial communities present in the intestines of fish. In this study, we characterize the bacterial communities associated with the digestive tract of a highly valuable U.S. aquaculture species, channel catfish Ictalurus punctatus, over the first 193 days of life to evaluate temporal changes that may occur throughout ontogenetic development of the host. Intestinal microbiota were surveyed with high-throughput DNA sequencing of 16S rRNA V4 gene amplicons derived from fish at 3, 65, 125, and 193 days post hatch (dph), while also characterizing the environmental microbes derived from the water supply and the administered diets. Microbial communities inhabiting the intestines of catfish early in life were dynamic, with significant shifts occurring up to 125 dph when the microbiota somewhat stabilized, as shifts were less apparent between 125 to 193 dph. Bacterial phyla present in the gut of catfish throughout ontogeny include Bacteroidetes, Firmicutes, Fusobacteria, and Proteobacteria; with the species Cetobacterium somerae and Plesiomonas shigelloides showing the highest abundance in the catfish microbiota after 3 dph. Comparisons of the gut microbiota to the environmental microbes reveals that the fish gut is maintained as a niche habitat, separate from the overall microbial communities present in diets and water-supply. Although, there is also evidence that the environmental microbiota serves as an inoculum to the fish gut. Our results have implications for future research related to channel catfish biology and culture, and increase our understanding of ontogenetic effects on the microbiota of teleost fish.	[Bledsoe, Jacob W.] Southern Illinois Univ, Dept Anim Sci, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA; [Peterson, Brian C.] USDA ARS, Warmwater Aquaculture Res Unit, Stoneville, MS 38776 USA; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Bledsoe, Jacob W.; Small, Brian C.] Univ Idaho, Dept Fish & Wildlife Sci, Inst Aquaculture Res, Hagerman, ID 83332 USA	Southern Illinois University System; Southern Illinois University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Idaho; University of Idaho	Small, BC (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Inst Aquaculture Res, Hagerman, ID 83332 USA.	bcsmail@uidaho.edu	Small, Brian/V-7653-2019	Swanson, Kelly/0000-0001-5518-3076; Bledsoe, Jacob/0000-0003-4819-3326	United States Department of Agriculture, Agricultural Research Service, Warmwater Aquaculture Research Unit [6066-31000-013-00]; ARS [ARS-0428104] Funding Source: Federal RePORTER	United States Department of Agriculture, Agricultural Research Service, Warmwater Aquaculture Research Unit; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The project was funded by the United States Department of Agriculture, Agricultural Research Service, Warmwater Aquaculture Research Unit (6066-31000-013-00; http://www.ars.usda/gov/research/protects/projects.htm?acc_no 428191).	American Veterinary Medical Association, 2007, AVMA GUID EUTH; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2015, 2014 US CATFISH DATA; AOAC International, 2000, OFF METH AN 2000; Bakke I, 2015, ENVIRON MICROBIOL, V17, P3914, DOI 10.1111/1462-2920.12888; Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Bolnick DI, 2014, ECOL LETT, V17, P979, DOI 10.1111/ele.12301; Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772; Burr JJ, 2012, DIRECT-FED MICROBIALS AND PREBIOTICS FOR ANIMALS: SCIENCE AND MECHANISMS OF ACTION, P163, DOI 10.1007/978-1-4614-1311-0_11; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chapman MG, 1999, MAR ECOL PROG SER, V180, P257, DOI 10.3354/meps180257; De Schryver P, 2014, ISME J, V8, P2360, DOI 10.1038/ismej.2014.84; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; FAO, 2014, STATE WORLD FISHERIE; Giatsis C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103641; Givens CE, 2012, FISH TALE COMPARISON; Gomez D, 2013, FISH SHELLFISH IMMUN, V35, P1729, DOI 10.1016/j.fsi.2013.09.032; Gorley C.K., 2006, GETTING STARTED PRIM; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Karp NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111239; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Larsen AM, 2014, J APPL MICROBIOL, V116, P1396, DOI 10.1111/jam.12475; Lategan MJ, 2006, AQUACULTURE, V254, P115, DOI 10.1016/j.aquaculture.2005.11.019; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Lees H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100916; Li J, 2014, J APPL MICROBIOL, V117, P1750, DOI 10.1111/jam.12663; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Liu YC, 2012, DIS AQUAT ORGAN, V99, P207, DOI 10.3354/dao02477; Llewellyn MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00207; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Merrifield DL, 2014, AQUACULTURE NUTRITION: GUT HEALTH, PROBIOTICS AND PREBIOTICS, P185; Mohammed HH, 2015, VET RES, V46, DOI 10.1186/s13567-015-0215-y; Navarrete P, 2008, J AQUAT ANIM HEALTH, V20, P177, DOI 10.1577/H07-043.1; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Petrie-Hanson L, 2001, VET IMMUNOL IMMUNOP, V81, P113, DOI 10.1016/S0165-2427(01)00331-2; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reveco FE, 2014, AQUACULTURE, V420, P262, DOI 10.1016/j.aquaculture.2013.11.007; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Rivas R, 2009, SYST APPL MICROBIOL, V32, P101, DOI 10.1016/j.syapm.2008.12.005; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Shoemaker CA, 2001, AM J VET RES, V62, P174, DOI 10.2460/ajvr.2001.62.174; Small BC, 2006, MANAGING HATCH RATE; Smith CCR, 2015, ISME J, V9, P2515, DOI 10.1038/ismej.2015.64; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stephens WZ, 2016, ISME J, V10, P644, DOI 10.1038/ismej.2015.140; Sugita H, 1996, AQUACULTURE, V145, P195, DOI 10.1016/S0044-8486(96)01319-1; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; Wang WS, 1997, COMP IMMUNOL MICROB, V20, P261, DOI 10.1016/S0147-9571(96)00035-5; Wong S, 2015, MBIO, V6, DOI 10.1128/mBio.00687-15; Wong SD, 2012, MOL ECOL, V21, P3100, DOI 10.1111/j.1365-294X.2012.05646.x; Xia JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-266; Xing MX, 2013, FEMS MICROBIOL ECOL, V86, P432, DOI 10.1111/1574-6941.12174; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	75	64	67	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166379	10.1371/journal.pone.0166379	http://dx.doi.org/10.1371/journal.pone.0166379			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846300	gold, Green Published			2022-12-27	WOS:000387794600054
J	Hu, JL; Li, ZF; Wang, XC; Hong, L; He, H; Chen, WG; Li, LX; Shen, AH; Liu, XJ; Yuan, SG; Zhou, JG; Tan, WW; Zhou, WZ; Tang, FY; Zhu, FC; Bao, CJ				Hu, Jian-li; Li, Zhi-feng; Wang, Xiao-chen; Hong, Lei; He, Hao; Chen, Wei-guo; Li, Lu-xun; Shen, Ai-hua; Liu, Xue-jian; Yuan, Shou-guo; Zhou, Jian-gang; Tan, Wen-wen; Zhou, Wei-zhong; Tang, Fen-yang; Zhu, Feng-cai; Bao, Chang-jun			Risk Factors for Bunyavirus-Associated Severe Fever with Thrombocytopenia Syndrome: A Community-Based Case-Control Study	PLOS ONE			English	Article							SYNDROME VIRUS; TICKS; IDENTIFICATION; PHLEBOVIRUS	Background Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a novel bunyavirus. Previous studies about risk factors for SFTSV infection have yielded inconsistent results, and behavior factors have not been fully clarified. Methods A community-based, 1: 4 matched case-control study was carried out to investigate the risk factors for SFTS in China. Cases of SFTS were defined as laboratory-confirmed cases that tested positive for real-time PCR (RT-PCR) for severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) or positive for IgM antibodies against SFTSV. Controls of four neighborhood subjects were selected by matching for sex, age, and occupation. Standardized questionnaires were used to collect detailed information about their demographics and risk factors for SFTSV infection. Results A total of 334 subjects participated in the study including 69 cases and 265 controls. The median age of the cases was 59.5 years, 55.1% were male, and 87.0% were farmers. No differences in demographics were observed between cases and controls. In the final multivariate analysis, tick bites two weeks prior to disease onset (OR = 8.04, 95% CI 3.34-19.37) and the presence of weeds and shrubs around the house (OR = 3.46, 95% CI 0.96 +/- 12.46) were found to be risk factors for SFTSV infection; taking preventative measures during outdoor activities (OR = 0.12, 95% CI 0.01-1.01) provided greater protection from SFTSV infection. Conclusions Our results further confirm that SFTSV is transmitted by tick bites and prove that preventative measures that reduce exposure to ticks can prevent SFTSV infection. More efforts should be directed toward health education and behavior change for high-risk populations, especially outdoor workers, in SFTS endemic areas.	[Hu, Jian-li; Li, Zhi-feng; Wang, Xiao-chen; Zhou, Wei-zhong; Tang, Fen-yang; Zhu, Feng-cai; Bao, Chang-jun] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Li, Zhi-feng] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Hong, Lei] Nanjing Municipal Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [He, Hao] Gulou Dist Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Chen, Wei-guo] Chuzhou Municipal Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Chuzhou, Anhui, Peoples R China; [Li, Lu-xun; Shen, Ai-hua] Lishui Dist Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Liu, Xue-jian; Yuan, Shou-guo] Xuyi Cty Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Huaian, Jiangsu, Peoples R China; [Zhou, Jian-gang; Tan, Wen-wen] Yixing Cty Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing University	Bao, CJ (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	bao2000_cn@163.com			Science & Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention [BE2015714]; Natural Science Foundation of China [81373055]; 10th Summit of Six Top Talents of Jiangsu Province [WS-2013-061]	Science & Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 10th Summit of Six Top Talents of Jiangsu Province	This study was financially supported by the Science & Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention (No. BE2015714), and partly supported by Natural Science Foundation of China (No.81373055), and the 10th Summit of Six Top Talents of Jiangsu Province (WS-2013-061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam S, 2016, BIOMED REP, V4, P15, DOI 10.3892/br.2015.545; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Bao CJ, 2011, NEW ENGL J MED, V365, P862, DOI 10.1056/NEJMc1106000; Denic S, 2011, CASE REP INFECT DIS, V2011, DOI 10.1155/2011/204056; Ding F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003267; Huang Xue-Yong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P165; Jiang Xiao-lin, 2012, Chinese Journal of Virology, V28, P252; Jiao YJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004092; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Kang Kai, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P106; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Li Yi-fan, 2011, Journal of Traffic and Transportation Engineering, V11, P36; Li ZF, 2013, J MED VIROL, V85, P370, DOI 10.1002/jmv.23415; Liang SY, 2014, AM J TROP MED HYG, V90, P256, DOI 10.4269/ajtmh.13-0423; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679; Liu Li, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P168; Liu Y., 2012, CHIN J PREMED, V46, P500; Marzi A, 2015, EMERG INFECT DIS, V21, P305, DOI 10.3201/eid2102.141649; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Wang SW, 2015, AM J TROP MED HYG, V92, P684, DOI 10.4269/ajtmh.14-0008; Xing XS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002533; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	27	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166611	10.1371/journal.pone.0166611	http://dx.doi.org/10.1371/journal.pone.0166611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846273	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600091
J	Labadzhyan, A; Cui, JR; Peterfy, M; Guo, XQ; Chen, YDI; Hsueh, WA; Rotter, JI; Goodarzi, MO				Labadzhyan, Artak; Cui, Jinrui; Peterfy, Miklos; Guo, Xiuqing; Chen, Yii-Der I.; Hsueh, Willa A.; Rotter, Jerome I.; Goodarzi, Mark O.			Insulin Clearance Is Associated with Hepatic Lipase Activity and Lipid and Adiposity Traits in Mexican Americans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FATTY LIVER-DISEASE; METABOLIC SYNDROME; RESISTANCE ATHEROSCLEROSIS; LIPOPROTEIN-LIPASE; SECRETION; GENE; VARIANTS; PROTEIN; HYPERINSULINEMIA	Reduction in insulin clearance plays an important role in the compensatory response to insulin resistance. Given the importance of this trait to the pathogenesis of diabetes, a deeper understanding of its regulation is warranted. Our goal was to identify metabolic and cardiovascular traits that are independently associated with metabolic clearance rate of insulin (MCRI). We conducted a cross-sectional analysis of metabolic and cardiovascular traits in 765 participants from the Mexican-American Coronary Artery Disease (MACAD) project who had undergone blood sampling, oral glucose tolerance test, euglycemic-hyperinsulinemic clamp, dual-energy X-ray absorptiometry, and carotid ultrasound. We assessed correlations of MCRI with traits from seven domains, including anthropometry, biomarkers, cardiovascular, glucose homeostasis, lipase activity, lipid profile, and liver function tests. We found inverse independent correlations between MCRI and hepatic lipase (P = 0.0004), insulin secretion (P = 0.0002), alanine aminotransferase (P = 0.0045), total fat mass (P = 0.014), and diabetes (P = 0.03). MCRI and apolipoprotein A-I exhibited a positive independent correlation (P = 0.035). These results generate a hypothesis that lipid and adiposity associated traits related to liver function may play a role in insulin clearance.	[Labadzhyan, Artak; Cui, Jinrui; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Los Angeles, CA 90048 USA; [Peterfy, Miklos] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Guo, Xiuqing; Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Hsueh, Willa A.] Ohio State Univ, Dept Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University System of Ohio; Ohio State University	Goodarzi, MO (corresponding author), Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Los Angeles, CA 90048 USA.	mark.goodarzi@cshs.org	Rotter, Jerome/AAY-6598-2021; Goodarzi, Mark/AAH-7106-2021; Labadzhyan, Artak/AAH-6003-2021	Goodarzi, Mark/0000-0001-6364-5103; Labadzhyan, Artak/0000-0002-8288-6698	National Institutes of Health [R01-HL088457, R01-DK079888, P30-DK063491]; National Center for Research Resources [M01-RR00425]; University of California Los Angeles Clinical and Translational Science Institute [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of California Los Angeles Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health grants R01-HL088457, R01-DK079888, P30-DK063491, M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources), and UL1TR000124 (University of California Los Angeles Clinical and Translational Science Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema W, 2011, CURR ATHEROSCLER REP, V13, P257, DOI 10.1007/s11883-011-0175-2; ANTONIELLO S, 1989, CLIN CHIM ACTA, V183, P343, DOI 10.1016/0009-8981(89)90369-0; Auletta M, 1995, ENZYME PROTEIN, V48, P197, DOI 10.1159/000474989; Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Bril F, 2014, HEPATOLOGY, V59, P2178, DOI 10.1002/hep.26988; Carr MC, 2001, J CLIN ENDOCR METAB, V86, P2831, DOI 10.1210/jc.86.6.2831; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Gambino R, 2007, HEPATOLOGY, V45, P1097, DOI 10.1002/hep.21631; Goodarzi MO, 2013, DIABETOLOGIA, V56, P1282, DOI 10.1007/s00125-013-2880-6; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P4816, DOI 10.1210/jc.2005-0389; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Goodarzi MO, 2005, DIABETES, V54, P1228, DOI 10.2337/diabetes.54.4.1228; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karavia EA, 2012, MOL MED, V18, P901, DOI 10.2119/molmed.2012.00113; Kim MK, 2015, OBESITY, V23, P2430, DOI 10.1002/oby.21256; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Lee CC, 2013, DIABETES OBES METAB, V15, P441, DOI 10.1111/dom.12049; Lee CC, 2013, DIABETES CARE, V36, P901, DOI 10.2337/dc12-1316; Lewis GF, 2004, DIABETES, V53, P2893, DOI 10.2337/diabetes.53.11.2893; Lichtash CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065954; Lorenzo C, 2013, DIABETES CARE, V36, P101, DOI 10.2337/dc12-0101; Marini MA, 2014, ACTA DIABETOL, V51, P257, DOI 10.1007/s00592-013-0511-9; Miksztowicz V, 2012, DIABETES-METAB RES, V28, P535, DOI 10.1002/dmrr.2312; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Palmer ND, 2015, DIABETES, V64, P1853, DOI 10.2337/db14-0732; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Perret B, 2002, J LIPID RES, V43, P1163, DOI 10.1194/jlr.R100020-JLR200; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Straznicky NE, 2015, J CLIN ENDOCR METAB, V100, P1544, DOI 10.1210/jc.2014-3796; Wang D, 2006, OBESITY SILVER SPRIN, V14, P1192, DOI [10.1038/oby.2006.136, DOI 10.1038/OBY.2006.136]; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166263	10.1371/journal.pone.0166263	http://dx.doi.org/10.1371/journal.pone.0166263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846285	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600043
J	van der Fels-Klerx, HJ; Camenzuli, L; van der Lee, MK; Oonincx, DGAB				van der Fels-Klerx, H. J.; Camenzuli, L.; van der Lee, M. K.; Oonincx, D. G. A. B.			Uptake of Cadmium, Lead and Arsenic by Tenebrio molitor and Hermetia illucens from Contaminated Substrates	PLOS ONE			English	Article							FEED PRODUCTION; EDIBLE INSECTS; ACCUMULATION; LARVAE; FOOD; ZINC; COLEOPTERA; DIPTERA; BINDING; SAFETY	Insects have potential as a novel source of protein in feed and food production in Europe, provided they can be used safely. To date, limited information is available on the safety of insects, and toxic elements are one of the potential hazards of concern. Therefore, we aimed to investigate the potential accumulation of cadmium, lead and arsenic in larvae of two insect species, Tenebrio molitor (yellow mealworm) and Hermetia illucens (black soldier fly), which seem to hold potential as a source of food or feed. An experiment was designed with 14 treatments, each in triplicate, per insect species. Twelve treatments used feed that was spiked with cadmium, lead or arsenic at 0.5, 1 and 2 times the respective maximum allowable levels (ML) in complete feed, as established by the European Commission (EC). Two of the 14 treatments consisted of controls, using non-spiked feed. All insects per container (replicate) were harvested when the first larva in that container had completed its larval stage. Development time, survival rates and fresh weights were similar over all treatments, except for development time and total live weight of the half of the maximum limit treatment for cadmium of the black soldier fly. Bioaccumulation (bioaccumulation factor > 1) was seen in all treatments (including two controls) for lead and cadmium in black soldier fly larvae, and for the three arsenic treatments in the yellow mealworm larvae. In the three cadmium treatments, concentrations of cadmium in black soldier fly larvae are higher than the current EC maximum limit for feed materials. The same was seen for the 1.0 and 2.0 ML treatments of arsenic in the yellow mealworm larvae. From this study, it can be concluded that if insects are used as feed materials, the maximum limits of these elements in complete feed should be revised per insect species.	[van der Fels-Klerx, H. J.; Camenzuli, L.; van der Lee, M. K.] RIKILT Wageningen Univ & Res, Akkermaalsbos 2, NL-6708 WB Wageningen, Netherlands; [Oonincx, D. G. A. B.] Wageningen Univ, Dept Entomol, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van der Fels-Klerx, HJ (corresponding author), RIKILT Wageningen Univ & Res, Akkermaalsbos 2, NL-6708 WB Wageningen, Netherlands.	ine.vanderfels@wur.nl		Camenzuli, Louise/0000-0002-4444-0978	Ministry of Economic Affairs, The Netherlands, through the STW programma Novel Proteins, Project In@food [12638]; Ministry of Economic Affairs, through the STW project In2Food	Ministry of Economic Affairs, The Netherlands, through the STW programma Novel Proteins, Project In@food; Ministry of Economic Affairs, through the STW project In2Food	This work was supported by the Ministry of Economic Affairs, The Netherlands, through the STW programma Novel Proteins, Project In@food (grant No 12638 to HJvdF DO LC MvdL) (http://www.stw.nl/nl/content/onderzoeksprogrammavan-ez-en-stw-voor-eiwitinnovates-van-start). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the financial contribution of the Ministry of Economic Affairs, through the STW project In2Food. Also, the contribution of Ab van Polanen to the chemical analyses at RIKILT is acknowledged, as well as the contribution of Van der Veen in the procedure for the homogeneity testing at RIKILT. Myriem Bouziane is thanked for her contributions to the experiments with BSF, and Pascal van Keulen for his contribution to the experiment with the mealworms.	Belluco S, 2013, COMPR REV FOOD SCI F, V12, P296, DOI 10.1111/1541-4337.12014; Bosch G, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.23; Braeckman B, 1999, ENVIRON RES, V80, P231, DOI 10.1006/enrs.1998.3897; Charlton AJ, 2015, J INSECTS FOOD FEED, V1, P7, DOI 10.3920/JIFF2014.0020; Craig A, 1999, AQUAT TOXICOL, V44, P255, DOI 10.1016/S0166-445X(98)00086-1; Crawford LA, 1996, ENVIRON POLLUT, V92, P241, DOI 10.1016/0269-7491(96)00004-8; CRAWFORD LA, 1995, J APPL ECOL, V32, P528, DOI 10.2307/2404650; DALLINGER R, 1993, SETAC SP P, P245; Devkota B, 1992, P 6 INT C BIOIND DET; Diener S, 2015, J INSECTS FOOD FEED, V1, P261, DOI 10.3920/JIFF2015.0030; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Finke M.D., 2013, MASS PRODUCTION BENE; Gongalsky BK, 2004, B ENV CONTAMINATION, V72, P1115, DOI [10.1007/s00128-004-0359-3, DOI 10.1007/S00128-004-0359-3]; HARE L, 1991, CAN J FISH AQUAT SCI, V48, P39, DOI 10.1139/f91-006; HUNTER BA, 1987, J APPL ECOL, V24, P587, DOI 10.2307/2403895; Kazimirova M, 2000, ENVIRON TOXICOL CHEM, V19, P1822, DOI [10.1897/1551-5028(2000)019&lt;1822:MABCCD&gt;2.3.CO;2, 10.1002/etc.5620190716]; Lauverjat S., 1989, Biology of Metals, V2, P97, DOI 10.1007/BF01129208; LINDQVIST L, 1995, COMP BIOCHEM PHYS C, V111, P325, DOI 10.1016/0742-8413(95)00057-U; LINDQVIST L, 1992, ENVIRON ENTOMOL, V21, P160, DOI 10.1093/ee/21.1.160; LOUDON C, 1988, J INSECT PHYSIOL, V34, P97, DOI 10.1016/0022-1910(88)90160-6; MARONI G, 1985, INSECT BIOCHEM, V15, P55, DOI 10.1016/0020-1790(85)90044-7; Maryanski M, 2002, ECOTOXICOLOGY, V11, P127, DOI 10.1023/A:1014425113481; Miglietta PP, 2015, WATER-SUI, V7, P6190, DOI 10.3390/w7116190; Mireji PO, 2010, ECOTOX ENVIRON SAFE, V73, P46, DOI 10.1016/j.ecoenv.2009.08.004; Moriarty MM, 2009, ENVIRON SCI TECHNOL, V43, P4818, DOI 10.1021/es900086r; Morrissey CA, 2007, ENVIRON SCI TECHNOL, V41, P1494, DOI 10.1021/es061967r; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pedersen SA, 2008, COMP BIOCHEM PHYS C, V148, P217, DOI 10.1016/j.cbpc.2008.05.013; Postma JF, 1996, ENVIRON TOXICOL CHEM, V15, P332, DOI [10.1897/1551-5028(1996)015&lt;0332:ICEIMA&gt;2.3.CO;2, 10.1002/etc.5620150317]; Rahman MM, 2009, ENVIRON GEOCHEM HLTH, V31, P201, DOI 10.1007/s10653-008-9236-z; Rumpold B. A., 2014, Food Chain, V4, P129, DOI 10.3362/2046-1887.2014.013; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; SCHMIDT GH, 1994, ECOTOX ENVIRON SAFE, V29, P148, DOI 10.1016/0147-6513(94)90016-7; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; van Broekhoven S, 2015, J INSECT PHYSIOL, V73, P1, DOI 10.1016/j.jinsphys.2014.12.005; van der Spiegel M, 2013, COMPR REV FOOD SCI F, V12, P662, DOI 10.1111/1541-4337.12032; Van Huis A., 2013, EDIBLE INSECTS FUTUR; van Zanten HHE, 2015, J CLEAN PROD, V102, P362, DOI 10.1016/j.jclepro.2015.04.106; Veldkamp T., 2012, 638 WAG UR LIV RES; Vijver M, 2003, ECOTOX ENVIRON SAFE, V54, P277, DOI 10.1016/S0147-6513(02)00027-1; WEAVER DK, 1990, J INSECT PHYSIOL, V36, P531, DOI 10.1016/0022-1910(90)90105-O; Wu Guo-Xing, 2006, Insect Science, V13, P31, DOI 10.1111/j.1744-7917.2006.00065.x; Yasunobu A, 1984, COMP BIOCH PHYSL C, V78, P315	46	78	80	10	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166186	10.1371/journal.pone.0166186	http://dx.doi.org/10.1371/journal.pone.0166186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846238	Green Submitted, gold, Green Published			2022-12-27	WOS:000387794600037
J	Kim, J; Kim, J; Lee, SH; Kepreotis, SV; Yoo, J; Chun, JS; Hajjar, RJ; Jeong, D; Park, WJ				Kim, Jooyeon; Kim, Jihwa; Lee, Seung Hee; Kepreotis, Sacha V.; Yoo, Jimeen; Chun, Jang-Soo; Hajjar, Roger J.; Jeong, Dongtak; Park, Woo Jin			Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-beta Signaling	PLOS ONE			English	Article							FIBROBLAST PRECURSORS; MOLECULAR-CLONING; MYOFIBROBLAST; EXPRESSION; GROWTH	Cytokine-like 1 (Cytl1) is a secreted protein that is involved in diverse biological processes. A comparative modeling study indicated that Cytl1 is structurally and functionally similar to monocyte chemoattractant protein 1 (MCP-1). As MCP-1 plays an important role in cardiac fibrosis (CF) and heart failure (HF), we investigated the role of Cytl1 in a mouse model of CF and HF. Cytl1 was upregulated in the failing mouse heart. Pressure overload-induced CF was significantly attenuated in cytl1 knock-out (KO) mice compared to that from wild-type (WT) mice. By contrast, adeno-associated virus (AAV)-mediated overexpression of cytl1 alone led to the development of CF in vivo. The endothelial-mesenchymal transition (EndMT) and the transdifferentiation of fibroblasts (FBs) to myofibroblasts (MFBs) have been suggested to contribute considerably to CF. Adenovirus-mediated overexpression of cytl1 was sufficient to induce these two critical CF-related processes in vitro, which were completely abrogated by co-treatment with SB-431542, an antagonist of TGF-beta receptor 1. Cytl1 induced the expression of TGF-beta 2 both in vivo and in vitro. Antagonizing the receptor for MCP-1, C-C chemokine receptor type 2 (CCR2), with CAS 445479-97-0 did not block the pro-fibrotic activity of Cytl1 in vitro. Collectively, our data suggest that Cytl1 plays an essential role in CF likely through activating the TGF-beta-SMAD signaling pathway. Although the receptor for Cyt1l remains to be identified, Cytl1 provides a novel platform for the development of anti-CF therapies.	[Kim, Jooyeon; Kim, Jihwa; Lee, Seung Hee; Chun, Jang-Soo; Park, Woo Jin] GIST, Coll Life Sci, Gwangju 61005, South Korea; [Kepreotis, Sacha V.; Yoo, Jimeen; Hajjar, Roger J.; Jeong, Dongtak] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA	Gwangju Institute of Science & Technology (GIST); Icahn School of Medicine at Mount Sinai	Park, WJ (corresponding author), GIST, Coll Life Sci, Gwangju 61005, South Korea.; Jeong, D (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA.	dongtak.jeong@mssm.edu; woojinpark@icloud.com	Dongtak, Jeong/AGZ-5435-2022; Jeong, Dongtak/AAK-4194-2020; Jeong, Dongtak/ABA-7745-2020	Jeong, Dongtak/0000-0003-4153-3498; Yoo, Jimeen/0000-0001-9283-3963	Bio & Medical Technology Development Program [2015M3A9E6028951]; Basic Research Laboratory Program of NRF - Korean government [2016R1A4A1009895]; GIST	Bio & Medical Technology Development Program; Basic Research Laboratory Program of NRF - Korean government; GIST	This work was supported by the Bio & Medical Technology Development Program (2015M3A9E6028951) and the Basic Research Laboratory Program (2016R1A4A1009895) of NRF funded by the Korean government and a grant from the Systems Biology Infrastructure Establishment Grant provided by GIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; 이성호, 2011, Carbon Letters, V12, P26; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; deBakker JMT, 1996, J AM COLL CARDIOL, V27, P1071, DOI 10.1016/0735-1097(95)00612-5; Ficker M, 2004, DEV BIOL, V268, P7, DOI 10.1016/j.ydbio.2003.11.023; Frangogiannis NG, 2005, TRENDS CARDIOVAS MED, V15, P163, DOI 10.1016/j.tcm.2005.06.005; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jeon JH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/271419; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kim J, 2014, BIOCHEM BIOPH RES CO, V447, P649, DOI 10.1016/j.bbrc.2014.04.061; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; Lu YJ, 2016, INFLAMMATION, V39, P10, DOI 10.1007/s10753-015-0217-y; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Oh JG, 2013, J MOL CELL CARDIOL, V56, P63, DOI 10.1016/j.yjmcc.2012.12.005; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Weber KT, 2000, CURR OPIN CARDIOL, V15, P264, DOI 10.1097/00001573-200007000-00010; Wen MJ, 2012, INT J ONCOL, V41, P1419, DOI 10.3892/ijo.2012.1552; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu J, 2011, AM J PHYSIOL-HEART C, V301, pH538, DOI 10.1152/ajpheart.01114.2010	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166480	10.1371/journal.pone.0166480	http://dx.doi.org/10.1371/journal.pone.0166480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835665	Green Submitted, gold, Green Published			2022-12-27	WOS:000387779200053
J	Lee, WD; Wang, KC; Tsai, YF; Chou, PC; Tsai, LK; Chien, CL				Lee, Wen-Di; Wang, Kuo-Chuan; Tsai, Yi-Fen; Chou, Pin-Chun; Tsai, Li-Kai; Chien, Chung-Liang			Subarachnoid Hemorrhage Promotes Proliferation, Differentiation, and Migration of Neural Stem Cells via BDNF Upregulation	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; NITRIC-OXIDE; BRAIN; MICROGLIA; NEURONS; SVZ; INFLAMMATION; REPLACEMENT	Patients who suffer from subarachnoid hemorrhage (SAH) usually have long-term neurological impairments. Endogenous neurogenesis might play a potential role in functional recovery after SAH; however, the underlying neurogenesis mechanism is still unclear. We assessed the extent of neurogenesis in the subventricular zone (SVZ) to better understand the neurogenesis mechanism after SAH. We performed a rat model of SAH to examine the extent of neurogenesis in the SVZ and assessed functional effects of the neurotrophic factors in the cerebrospinal fluid (CSF) on neural stem cells (NSCs) after SAH. In this study, the proliferation, differentiation, and migratory capacities of NSCs in the SVZ were significantly increased on days 5 and 7 post SAH. Furthermore, treatment of cultured rat fetal NSCs with the CSF collected from rats on days 5 and 7 post SAH enhanced their proliferation, differentiation, and migration. Enzyme-linked immunosorbent assay (ELISA) of the CSF detected a marked increase in the concentration of brain-derived neurotrophic factor (BDNF). Treating the cultured NSCs with recombinant BDNF (at the same concentration as that in the CSF) or with CSF from SAH rats, directly, stimulated proliferation, differentiation, and migration to a similar extent. BDNF expression was upregulated in the SVZ of rats on days 5 and 7 post SAH, and BDNF release occurred from NSCs, astrocytes, and microglia in the SVZ. These results indicate that SAH triggers the expression of BDNF, which promotes the proliferation, differentiation, and migration of NSCs in the SVZ after SAH.	[Lee, Wen-Di; Chou, Pin-Chun; Chien, Chung-Liang] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Wang, Kuo-Chuan; Tsai, Yi-Fen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Wang, Kuo-Chuan; Tsai, Yi-Fen; Tsai, Li-Kai] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Tsai, Li-Kai] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Tsai, Li-Kai] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chien, CL (corresponding author), Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	milikai@ntuh.gov.tw; chien@ntu.edu.tw			Ministry of Science and Technology, Taiwan [NSC-100-2320-B-002-085]; National Taiwan University Hospital [104-002608]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the grants to CLC (NSC-100-2320-B-002-085) from the Ministry of Science and Technology, Taiwan, and to LKT (104-002608) from the National Taiwan University Hospital.	Akaneya Y, 1997, J NEUROSCI, V17, P6707; Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bath KG, 2010, DEV NEUROBIOL, V70, P339, DOI 10.1002/dneu.20781; Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Chen GQ, 1999, J NEUROSCI, V19, P7983; Chen K, 2007, MOL CELL NEUROSCI, V36, P108, DOI 10.1016/j.mcn.2007.06.004; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Deierborg T, 2010, NEUROSCIENCE, V171, P1386, DOI 10.1016/j.neuroscience.2010.09.045; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Gratacos E, 2001, J NEUROCHEM, V79, P747, DOI 10.1046/j.1471-4159.2001.00570.x; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HAYMAN LA, 1989, AM J ROENTGENOL, V153, P135, DOI 10.2214/ajr.153.1.135; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ishikawa Y, 2000, J NEUROCHEM, V75, P494, DOI 10.1046/j.1471-4159.2000.0750494.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Lahteinen S, 2002, EUR J NEUROSCI, V15, P721; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Morrison ME, 1998, J NEUROSCI, V18, P3563; Numakawa T, 2000, NEUROSCI RES, V37, P59, DOI 10.1016/S0168-0102(00)00103-6; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Sgubin D, 2007, J NEUROSCI RES, V85, P1647, DOI 10.1002/jnr.21303; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Sun F, 2012, PLOS ONE, V7, P1; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	54	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165460	10.1371/journal.pone.0165460	http://dx.doi.org/10.1371/journal.pone.0165460			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832087	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000014
J	Wang, ZH; Fan, C; Myint, SW; Wang, CH				Wang, Zhi-Hua; Fan, Chao; Myint, Soe W.; Wang, Chenghao			Size Matters: What Are the Characteristic Source Areas for Urban Planning Strategies?	PLOS ONE			English	Article							HEAT-ISLAND; ANTHROPOGENIC HEAT; ENERGY; VEGETATION; CLIMATE; IMPACT; PHOENIX; EXCHANGE; SURFACE; ALBEDO	Urban environmental measurements and observational statistics should reflect the properties generated over an adjacent area of adequate length where homogeneity is usually assumed. The determination of this characteristic source area that gives sufficient representation of the horizontal coverage of a sensing instrument or the fetch of transported quantities is of critical importance to guide the design and implementation of urban landscape planning strategies. In this study, we aim to unify two different methods for estimating source areas, viz. the statistical correlation method commonly used by geographers for landscape fragmentation and the mechanistic footprint model by meteorologists for atmospheric measurements. Good agreement was found in the intercomparison of the estimate of source areas by the two methods, based on 2-m air temperature measurement collected using a network of weather stations. The results can be extended to shed new lights on urban planning strategies, such as the use of urban vegetation for heat mitigation. In general, a sizable patch of landscape is required in order to play an effective role in regulating the local environment, proportional to the height at which stakeholders' interest is mainly concerned.	[Wang, Zhi-Hua; Wang, Chenghao] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA; [Fan, Chao; Myint, Soe W.] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wang, ZH (corresponding author), Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA.	zhwang@asu.edu	Wang, Chenghao/O-7961-2017; Wang, Zhi-Hua/A-3391-2008	Wang, Chenghao/0000-0001-8846-4130; Wang, Zhi-Hua/0000-0001-9155-8605	U.S. National Science Foundation [CBET-1435881, CBET-1444758, SES-1462086]; Directorate For Engineering [1435881] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1444758] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	ZHW and CW received funding from the U.S. National Science Foundation (http://www.nsf.gov) under grant numbers CBET-1435881, CBET-1444758, and SES-1462086. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the U.S. National Science Foundation under grant numbers: CBET-1435881, CBET-1444758, and SES-1462086 (DCDC III). The authors thank the Academic Editor, Dr. Juergen P. Kropp and the two anonymous reviewers for their constructive feedback.	Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Brazel A, 2000, CLIMATE RES, V15, P123, DOI 10.3354/cr015123; Buyantuyev A, 2010, LANDSCAPE ECOL, V25, P17, DOI 10.1007/s10980-009-9402-4; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Chow WTL, 2014, INT J CLIMATOL, V34, P3863, DOI 10.1002/joc.3947; Dennison P.E., 2000, P 9 JPL AIRB EARTH S, P119; Dvorak B, 2010, LANDSCAPE URBAN PLAN, V96, P197, DOI 10.1016/j.landurbplan.2010.04.009; Dyer A. J., 1974, Boundary-Layer Meteorology, V7, P363, DOI 10.1007/BF00240838; Fan C, 2015, PROG PHYS GEOG, V39, P199, DOI 10.1177/0309133314567583; FISCHER EM, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2006GL029068; Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4; Kolokotroni M, 2007, SOL ENERGY, V81, P102, DOI 10.1016/j.solener.2006.06.005; Kormann R, 2001, BOUND-LAY METEOROL, V99, P207, DOI 10.1023/A:1018991015119; Lee TW, 2012, URBAN CLIM, V2, P16, DOI 10.1016/j.uclim.2012.10.005; Myint SW, 2009, INT J REMOTE SENS, V30, P2237, DOI 10.1080/01431160802549328; Myint SW, 2010, GISCI REMOTE SENS, V47, P301, DOI 10.2747/1548-1603.47.3.301; Myint SW, 2004, PHOTOGRAMM ENG REM S, V70, P803, DOI 10.14358/PERS.70.7.803; Narumi D, 2009, ENVIRON RES, V109, P421, DOI 10.1016/j.envres.2009.02.013; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; PASQUILL F, 1972, Q J ROY METEOR SOC, V98, P469, DOI 10.1002/qj.49709841702; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Sailor DJ, 2011, INT J CLIMATOL, V31, P189, DOI 10.1002/joc.2106; Santamouris M, 2001, SOL ENERGY, V70, P201, DOI 10.1016/S0038-092X(00)00095-5; Schmid HP, 2002, AGR FOREST METEOROL, V113, P159, DOI 10.1016/S0168-1923(02)00107-7; Song JY, 2015, BUILD ENVIRON, V94, P558, DOI 10.1016/j.buildenv.2015.10.016; Stull R.B., 1988, ATMOSPHERIC OCEANOGR; Taha H, 1997, ENERG BUILDINGS, V25, P99, DOI 10.1016/S0378-7788(96)00999-1; United Nations (UN), 2014, STESASERA352 UN DOEA; Wang ZH, 2016, APPL ENERG, V161, P437, DOI 10.1016/j.apenergy.2015.10.047; Wang ZH, 2014, URBAN CLIM, V10, P19, DOI 10.1016/j.uclim.2014.08.004; Wang ZH, 2014, SOL ENERGY, V110, P704, DOI 10.1016/j.solener.2014.10.012; Wang ZH, 2013, Q J ROY METEOR SOC, V139, P1643, DOI 10.1002/qj.2032; Yang JC, 2016, J HYDROMETEOROL, V17, P1031, DOI 10.1175/JHM-D-15-0112.1; Yang JC, 2015, RENEW SUST ENERG REV, V47, P830, DOI 10.1016/j.rser.2015.03.092; Yang JC, 2014, BUILD ENVIRON, V75, P250, DOI 10.1016/j.buildenv.2014.02.006	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165726	10.1371/journal.pone.0165726	http://dx.doi.org/10.1371/journal.pone.0165726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832111	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000031
J	Amatngalim, GD; Broekman, W; Daniel, NM; van der Vlugt, LEPM; van Schadewijk, A; Taube, C; Hiemstra, PS				Amatngalim, Gimano D.; Broekman, Winifred; Daniel, Nadia M.; van der Vlugt, Lucien E. P. M.; van Schadewijk, Annemarie; Taube, Christian; Hiemstra, Pieter S.			Cigarette Smoke Modulates Repair and Innate Immunity following Injury to Airway Epithelial Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BASAL-CELLS; DIFFERENTIATION; PROLIFERATION; ROLES	Cigarette smoking is the main risk factor associated with chronic obstructive pulmonary disease (COPD), and contributes to COPD development and progression by causing epithelial injury and inflammation. Whereas it is known that cigarette smoke (CS) may affect the innate immune function of airway epithelial cells and epithelial repair, this has so far not been explored in an integrated design using mucociliary differentiated airway epithelial cells. In this study, we examined the effect of whole CS exposure on wound repair and the innate immune activity of mucociliary differentiated primary bronchial epithelial cells, upon injury induced by disruption of epithelial barrier integrity or by mechanical wounding. Upon mechanical injury CS caused a delayed recovery in the epithelial barrier integrity and wound closure. Furthermore CS enhanced innate immune responses, as demonstrated by increased expression of the antimicrobial protein RNase 7. These differential effects on epithelial repair and innate immunity were both mediated by CS-induced oxidative stress. Overall, our findings demonstrate modulation of wound repair and innate immune responses of injured airway epithelial cells that may contribute to COPD development and progression.	[Amatngalim, Gimano D.; Broekman, Winifred; Daniel, Nadia M.; van der Vlugt, Lucien E. P. M.; van Schadewijk, Annemarie; Taube, Christian; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Amatngalim, GD (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands.	G.D.Amatngalim@lumc.nl	Amatngalim, Gimano/AGQ-6886-2022; M.Daniel, Nadia/AAF-5778-2019	Amatngalim, Gimano/0000-0003-3442-1754; M.Daniel, Nadia/0000-0001-7907-4675	Galapagos N.V., the Netherlands	Galapagos N.V., the Netherlands(Netherlands Government)	This work was supported by an unrestricted research grant from Galapagos N.V., the Netherlands. The funder had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LEC, 2015, CHEST, V148, P1307, DOI 10.1378/chest.15-0409; Allen-Gipson DS, 2013, AM J RESP CELL MOL, V48, P665, DOI 10.1165/rcmb.2011-0273OC; Amatngalim GD, 2015, J IMMUNOL, V194, P3340, DOI 10.4049/jimmunol.1402169; Beisswenger C, 2004, RESPIRATION, V71, P402, DOI 10.1159/000079647; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Erjefalt JS, 1997, THORAX, V52, P213, DOI 10.1136/thx.52.3.213; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Heijink IH, 2012, EUR RESPIR J, V39, P419, DOI 10.1183/09031936.00193810; Heijink IH, 2014, AM J RESP CRIT CARE, V189, P1439, DOI 10.1164/rccm.201311-1982LE; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Luppi F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-140; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Perotin JM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0151-9; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Shaykhiev R, 2015, EUR RESPIR J, V46, P894, DOI 10.1183/13993003.00521-2015; Shaykhiev Renat, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS252, DOI 10.1513/AnnalsATS.201402-049AW; Teixeira VH, 2013, ELIFE, P2; Thai P, 2013, AM J RESP CELL MOL, V49, P204, DOI 10.1165/rcmb.2013-0159RC; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; van Wetering S, 2007, MOL IMMUNOL, V44, P803, DOI 10.1016/j.molimm.2006.04.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang HJ, 2001, AM J RESP CELL MOL, V25, P772, DOI 10.1165/ajrcmb.25.6.4458; White SR, 2008, AM J PHYSIOL-LUNG C, V295, pL1018, DOI 10.1152/ajplung.00065.2008	33	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166255	10.1371/journal.pone.0166255	http://dx.doi.org/10.1371/journal.pone.0166255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829065	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300101
J	Cheng, YC; Hannaoui, S; John, TR; Dudas, S; Czub, S; Gilch, S				Cheng, Yo Ching; Hannaoui, Samia; John, Theodore R.; Dudas, Sandor; Czub, Stefanie; Gilch, Sabine			Early and Non-Invasive Detection of Chronic Wasting Disease Prions in Elk Feces by Real Time Quaking Induced Conversion	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CERVUS-ELAPHUS-NELSONI; TRANSGENIC MICE; ORAL-TRANSMISSION; INFECTIOUS PRIONS; SPECIES BARRIERS; DEER; PROTEIN; SCRAPIE; ANIMALS	Chronic wasting disease (CWD) is a fatal prion disease of wild and captive cervids in North America. Prions are infectious agents composed of a misfolded version of a host-encoded protein, termed PrPsc. Infected cervids excrete and secrete prions, contributing to lateral transmission. Geographical distribution is expanding and case numbers in wild cervids are increasing. Recently, the first European cases of CWD have been reported in a wild reindeer and two moose from Norway. Therefore, methods to detect the infection early in the incubation time using easily available samples are desirable to facilitate effective disease management. We have adapted the real-time quaking induced conversion (RT-QuIC) assay, a sensitive in vitro prion amplification method, for pre-clinical detection of prion seeding activity in elk feces. Testing fecal samples from orally inoculated elk taken at various time points post infection revealed early shedding and detectable prion seeding activity throughout the disease course. Early shedding was also found in two elk encoding a PrP genotype associated with reduced susceptibility for CWD. In summary, we suggest that detection of CWD prions in feces by RT-QuIC may become a useful tool to support CWD surveillance in wild and captive cervids. The finding of early shedding independent of the elk's prion protein genotype raises the question whether prolonged survival is beneficial, considering accumulation of environmental prions and its contribution to CWD transmission upon extended duration of shedding.	[Cheng, Yo Ching; Hannaoui, Samia; Gilch, Sabine] Univ Calgary, Dept Ecosyst & Publ Hlth, Fac Vet Med, Calgary, AB, Canada; [John, Theodore R.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Dudas, Sandor; Czub, Stefanie] Lethbridge Labs, Canadian Food Inspect Agcy, Lethbridge, AB, Canada	University of Calgary; University of Wyoming; Canadian Food Inspection Agency	Gilch, S (corresponding author), Univ Calgary, Dept Ecosyst & Publ Hlth, Fac Vet Med, Calgary, AB, Canada.	sgilch@ucalgary.ca			Canada Research Chair program; Alberta Prion Research Institute [201300027]; Margaret Gunn Endowment for Animal Research	Canada Research Chair program(Canada Research Chairs); Alberta Prion Research Institute; Margaret Gunn Endowment for Animal Research	SG is supported by the Canada Research Chair program (http://www.chairs-chaires.gc.ca/home-accuell-eng.aspx). This work was supported by grant 201300027 from the Alberta Prion Research Institute (http://www.prioninstitute.ca/) and a grant from the Margaret Gunn Endowment for Animal Research to SG.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Asano Sanae, 2005, Animal Science Journal, V76, P447, DOI 10.1111/j.1740-0929.2005.00289.x; Balachandran A, 2010, CAN VET J, V51, P169; Barria MA, 2011, J BIOL CHEM, V286, P7490, DOI 10.1074/jbc.M110.198465; Basu U, 2012, PRION, V6, P282, DOI 10.4161/pri.19915; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cortez L, 2014, PRION, V8; Davenport KA, 2015, J VIROL, V89, P9524, DOI 10.1128/JVI.01439-15; Denkers ND, 2016, J GEN VIROL; Elder AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080203; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Gordon PMK, 2009, NUCLEIC ACIDS RES, V37, P550, DOI 10.1093/nar/gkn963; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hamir AN, 2006, J VET DIAGN INVEST, V18, P110, DOI 10.1177/104063870601800118; Henderson D.M., 2014, J GEN VIROL; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Hughson AG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005914; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kruger D, 2009, VET RES, V40, DOI 10.1051/vetres:2008042; Kujala P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002449; Kyle LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066715; LANSBURY PT, 1994, SCIENCE, V265, P1510, DOI 10.1126/science.8079159; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Orru CD, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1004983, 10.1371/journal.ppat.1005117]; Orru CD, 2015, J CLIN MICROBIOL, V53, P1115, DOI 10.1128/JCM.02906-14; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Pritzkow S, 2015, CELL REP, V11, P1168, DOI 10.1016/j.celrep.2015.04.036; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Robinson SJ, 2012, PRION, V6, P153, DOI 10.4161/pri.19640; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Schatzl HM, 1997, LANCET, V349, P1603, DOI 10.1016/S0140-6736(05)61632-7; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Sigurdson CJ, 2011, J NEUROSCI, V31, P13840, DOI 10.1523/JNEUROSCI.3504-11.2011; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Terry LA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-65; Vascellari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048969; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340	55	44	44	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166187	10.1371/journal.pone.0166187	http://dx.doi.org/10.1371/journal.pone.0166187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829062	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300094
J	von Beeren, C; Maruyama, M; Kronauer, DJC				von Beeren, Christoph; Maruyama, Munetoshi; Kronauer, Daniel J. C.			Community Sampling and Integrative Taxonomy Reveal New Species and Host Specificity in the Army Ant-Associated Beetle Genus Tetradonia (Coleoptera, Staphylinidae, Aleocharinae)	PLOS ONE			English	Article							EXPERIMENTAL EVOLUTION; MOLECULAR PHYLOGENY; FLIES DIPTERA; SPECIALIZATION; ECITOCHARINI; HYMENOPTERA; DIVERSITY	Army ant colonies host a diverse community of arthropod symbionts. Among the best-studied symbiont communities are those of Neotropical army ants of the genus Eciton. It is clear, however, that even in these comparatively well studied systems, a large proportion of symbiont biodiversity remains unknown. Even more striking is our lack of knowledge regarding the nature and specificity of these host-symbiont interactions. Here we surveyed the diversity and host specificity of rove beetles of the genus Tetradonia Wasmann, 1894 (Staphylinidae: Aleocharinae). Systematic community sampling of 58 colonies of the six local Eciton species at La Selva Biological Station, Costa Rica, combined with an integrative taxonomic approach, allowed us to uncover species diversity, host specificity, and co-occurrence patterns of symbionts in unprecedented detail. We used an integrative taxonomic approach combining morphological and genetic analyses, to delineate species boundaries. Mitochondrial DNA barcodes were analyzed for 362 Tetradonia specimens, and additional nuclear markers for a subset of 88 specimens. All analyses supported the presence of five Tetradonia species, including two species new to science. Host specificity is highly variable across species, ranging from generalists such as T. laticeps, which parasitizes all six local Eciton species, to specialists such as T. lizonae, which primarily parasitizes a single species, E. hamatum. Here we provide a dichotomous key along with diagnostic molecular characters for identification of Tetradonia species at La Selva Biological Station. By reliably assessing biodiversity and providing tools for species identification, we hope to set the baseline for future studies of the ecological and evolutionary dynamics in these species-rich host-symbiont networks.	[von Beeren, Christoph; Kronauer, Daniel J. C.] Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA; [von Beeren, Christoph] Tech Univ Darmstadt, Dept Biol, Ecol Networks, D-64287 Darmstadt, Germany; [Maruyama, Munetoshi] Kyushu Univ Museum, Hakozaki 6-10-1, Fukuoka 8128581, Japan	Rockefeller University; Technical University of Darmstadt	von Beeren, C (corresponding author), Rockefeller Univ, Lab Social Evolut & Behav, New York, NY 10065 USA.; von Beeren, C (corresponding author), Tech Univ Darmstadt, Dept Biol, Ecol Networks, D-64287 Darmstadt, Germany.	cvonbeeren@gmail.com			German Science Foundation [BE 5177/1-1, BE 5177/3-1]; National Geographic Society's Committee for Research and Exploration [9393-13]; Bristol-Myers Squibb Postdoctoral Fellowship from The Rockefeller University	German Science Foundation(German Research Foundation (DFG)); National Geographic Society's Committee for Research and Exploration(National Geographic Society); Bristol-Myers Squibb Postdoctoral Fellowship from The Rockefeller University	CvB was supported by the German Science Foundation (BE 5177/1-1 and BE 5177/3-1), the National Geographic Society's Committee for Research and Exploration (9393-13) and a Bristol-Myers Squibb Postdoctoral Fellowship from The Rockefeller University.	AKRE ROGER D., 1966, J KANS ENTOMOL SOC, V39, P745; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bili M, 2016, OECOLOGIA, P1; Borgmeier T., 1955, Studia Entomologica Rio de Janeiro, Vno. 3, P1; Borgmeier T., 1953, VORARBEITEN REVISION; Combes Claude, 2005, ART BEING PARASITE; Disney RHL, 2007, SOCIOBIOLOGY, V49, P1; Donisthorpe H. St. G. K., 1927; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Ellwood MD, 2016, ACTA OECOLOGICA; Elven H, 2012, ZOOL SCR, V41, P617, DOI 10.1111/j.1463-6409.2012.00553.x; Fabricius JC, 1781, HAMBURGI CAROL ERNES, DOI DOI 10.5962/BHL.TITLE.36509; Funk WC, 2011, P ROYAL SOC B, P1; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Gotwald WH, 1995, ARMY ANTS BIOL SOCIA; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hlavac P, 2011, ZOOTAXA, P1; HOLLDOBL.B, 1969, SCIENCE, V166, P757, DOI 10.1126/science.166.3906.757; Holldobler B., 1990, pi; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Ivens ABF, 2016, ANNU REV ENTOMOL, V61, P353, DOI 10.1146/annurev-ento-010715-023719; Jacobson HR, 1998, SOCIOBIOLOGY, V31, P151; JOSHI A, 1995, EVOL ECOL, V9, P82, DOI 10.1007/BF01237699; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KATAKURA H, 1989, EVOLUTION, V43, P1045, DOI 10.1111/j.1558-5646.1989.tb02549.x; Kistner D. H., 1982, Social insects. Vol. III, P1; KISTNER DH, 1990, SOCIOBIOLOGY, V17, P333; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Legros M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-159; Longino J, 2007, ANTS COSTA RICA; Malenke JR, 2009, EVOLUTION, V63, P1427, DOI 10.1111/j.1558-5646.2009.00642.x; Maruyama Munetoshi, 2004, Elytra, V32, P276; Maruyama Munetoshi, 2006, National Science Museum Monographs, P1; Mayr E., 1942, P1; Mayr G., 1886, WIENER ENTOMOLOGISCH, V5, P115; Mittelbach GG, 2012, COMMUNITY ECOLOGY, P1; Morand S, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P1, DOI 10.1017/CBO9781139794749; Osswald J, 2013, SYST ENTOMOL, V38, P507, DOI 10.1111/syen.12011; Pace R., 2008, BIODIVERSITY S AM, V1, P225; Pace Roberto, 2015, Beitraege zur Entomologie, V65, P85; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Parker J, 2014, CURR BIOL, V24, P2428, DOI 10.1016/j.cub.2014.08.068; Parker Meaghan, 2012, Methods Mol Biol, V858, P269, DOI 10.1007/978-1-61779-591-6_13; Parmentier T, 2016, INSECTES SOCIAUX; Poulin R, 2003, PARASITOLOGY, V126, P473, DOI 10.1017/S0031182003002993; REICHENSPERGER AUGUST, 1935, ARB MORPHOL U TAX ENT BERLIN DAHLEM, V2, P188; Rettenmeyer CW, 2011, INSECT SOC, V58, P281, DOI 10.1007/s00040-010-0128-8; RETTENMEYER CARL W., 1963, ANN ENTOMOL SOC AMER, V56, P170; Rettenmeyer CW., 1961, ARTHROPODS ASS NEOTR; Rettenmeyer CW., 1962, P N CENTRAL BRANCH E, V17, P14; Roger J, 1863, BERLINER ENTOMOLOGIS, V7, P131, DOI DOI 10.1002/MMND.18630070116; Sawada K, 1972, CONTRIBUTIONS BIOL L, V24, P31; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; SEEVERS CHARLES H., 1965, FIELDI ANA ZOOL, V47, P139; Smith F., 1859, CATALOGUE HYMENOPTER; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JA, 2005, SPECIALIZATIONS HOST; von Beeren C, 2016, MOL ECOL, V25, P990, DOI 10.1111/mec.13500; von Beeren C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08297; Wasmann E, 1894, ANGABE LEBENSWEISE B; WATKINS JF, 1982, J KANSAS ENTOMOL SOC, V55, P197; Watkins JF., 1976, IDENTIFICATION DISTR; WEBER NEAL A., 1949, AMER MUS NOVITATES, V1441, P1; Weitschek E, 2013, MOL ECOL RESOUR, V13, P1043, DOI 10.1111/1755-0998.12073	66	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165056	10.1371/journal.pone.0165056	http://dx.doi.org/10.1371/journal.pone.0165056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829037	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300028
J	Walsh, DM; Merson, TD; Landman, KA; Hughes, BD				Walsh, Darragh M.; Merson, Tobias D.; Landman, Kerry A.; Hughes, Barry D.			Evidence for Cooperative Selection of Axons for Myelination by Adjacent Oligodendrocytes in the Optic Nerve	PLOS ONE			English	Article							IN-VIVO; INDIVIDUAL OLIGODENDROCYTES; MICE; SYSTEM; NUMBER	The cellular mechanisms that regulate the topographic arrangement of myelin internodes along axons remain largely uncharacterized. Recent clonal analysis of oligodendrocyte morphologies in the mouse optic nerve revealed that adjacent oligodendrocytes frequently formed adjacent internodes on one or more axons in common, whereas oligodendrocytes in the optic nerve were never observed to myelinate the same axon more than once. By modelling the process of axonal selection at the single cell level, we demonstrate that internode length and primary process length constrain the capacity of oligodendrocytes to myelinate the same axon more than once. On the other hand, probabilistic analysis reveals that the observed juxtaposition of myelin internodes among common sets of axons by adjacent oligodendrocytes is highly unlikely to occur by chance. Our analysis may reveal a hitherto unknown level of communication between adjacent oligodendrocytes in the selection of axons for myelination. Together, our analyses provide novel insights into the mechanisms that define the spatial organization of myelin internodes within white matter at the single cell level.	[Walsh, Darragh M.; Landman, Kerry A.; Hughes, Barry D.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic 3010, Australia; [Merson, Tobias D.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health	Walsh, DM (corresponding author), Univ Melbourne, Sch Math & Stat, Melbourne, Vic 3010, Australia.	darragh.walsh@unimelb.edu.au	Merson, Tobias D/D-5375-2015; Hughes, Barry Douglas/AAB-9382-2020; Walsh, Darragh/C-8084-2019	Merson, Tobias D/0000-0002-7246-3608; Hughes, Barry Douglas/0000-0003-3594-4303; Walsh, Darragh/0000-0003-4903-1046	Australian Research Council Discovery Project [DP140100339]; Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme; Australian Research Council [FT150100207]	Australian Research Council Discovery Project(Australian Research Council); Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme; Australian Research Council(Australian Research Council)	This research was supported by an Australian Research Council Discovery Project (DP140100339) and the Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme. Dr. Tobias Merson was supported by an Australian Research Council Future Fellowship (FT150100207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by an Australian Research Council Discovery Project (DP140100339) and the Melbourne Neuroscience Institute Interdisciplinary Seed Funding Scheme. Dr. Tobias Merson was supported by an Australian Research Council Future Fellowship (FT150100207). We thank Dr. Laura Dumas for helpful discussions on her data, Dr. William R. Holmes for valuable discussions and Dr. James McCaw and Dr. James Osborne for useful comments on the manuscript.	Bartsch S, 1997, BRAIN RES, V762, P231, DOI 10.1016/S0006-8993(97)00484-8; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Czopka T, 2013, DEV CELL, V25, P599, DOI 10.1016/j.devcel.2013.05.013; Dangata YY, 1996, J ANAT, V189, P117; Dangata YY, 1997, EUR J MORPHOL, V35, P3, DOI 10.1076/ejom.35.1.3.13057; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dumas L, 2015, GLIA, V63, P699, DOI 10.1002/glia.22779; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Feller W., 1971, INTRO PROBABILITY TH, VI; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; HONJIN R, 1977, ARCH HISTOL JAPON, V40, P321, DOI 10.1679/aohc1950.40.321; Mensch S, 2015, NAT NEUROSCI, V18, P628, DOI 10.1038/nn.3991; Simons M, 2013, CURR OPIN CELL BIOL, V25, P512, DOI 10.1016/j.ceb.2013.04.007; Tijms H., 2007, UNDERSTANDING PROBAB, V2nd, P17; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165673	10.1371/journal.pone.0165673	http://dx.doi.org/10.1371/journal.pone.0165673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829049	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300054
J	Kerkhoven, AH; Russo, P; Land-Zandstra, AM; Saxena, A; Rodenburg, FJ				Kerkhoven, Anne H.; Russo, Pedro; Land-Zandstra, Anne M.; Saxena, Aayush; Rodenburg, Frans J.			Gender Stereotypes in Science Education Resources: A Visual Content Analysis	PLOS ONE			English	Article							GIRLS; SCIENTIST; STUDENTS; PERFORMANCE; INTERESTS; TEXTBOOKS; LANGUAGE; PHYSICS; ISSUES; WOMEN	More men are studying and working in science fields than women. This could be an effect of the prevalence of gender stereotypes (e.g., science is for men, not for women). Aside from the media and people's social lives, such stereotypes can also occur in education. Ways in which stereotypes are visible in education include the use of gender-biased visuals, language, teaching methods, and teachers' attitudes. The goal of this study was to determine whether science education resources for primary school contained gender-biased visuals. Specifically, the total number of men and women depicted, and the profession and activity of each person in the visuals were noted. The analysis showed that there were more men than women depicted with a science profession and that more women than men were depicted as teachers. This study shows that there is a stereotypical representation of men and women in online science education resources, highlighting the changes needed to create a balanced representation of men and women. Even if the stereotypical representation of men and women in science is a true reflection of the gender distribution in science, we should aim for a more balanced representation. Such a balance is an essential first step towards showing children that both men and women can do science, which will contribute to more gender-balanced science and technology fields.	[Kerkhoven, Anne H.; Russo, Pedro; Saxena, Aayush] Leiden Univ, Leiden Observ, Leiden, Netherlands; [Kerkhoven, Anne H.; Russo, Pedro; Land-Zandstra, Anne M.] Leiden Univ, Dept Sci Commun & Soc, Leiden, Netherlands; [Rodenburg, Frans J.] Leiden Univ, Dept Math, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Russo, P (corresponding author), Leiden Univ, Leiden Observ, Leiden, Netherlands.; Russo, P (corresponding author), Leiden Univ, Dept Sci Commun & Soc, Leiden, Netherlands.	russo@strw.leidenuniv.nl	Saxena, Aayush/AAF-8559-2021	Saxena, Aayush/0000-0001-5333-9970; Rodenburg, Frans/0000-0002-5285-7562; Russo, Pedro/0000-0002-8589-7800; Land-Zandstra, Anne/0000-0002-7604-9092				AAUW, 2013, WHY SO FEW; Adamo SA, 2013, BIOSCIENCE, V63, P43, DOI 10.1525/bio.2013.63.1.9; Ambady N, 2001, PSYCHOL SCI, V12, P385, DOI 10.1111/1467-9280.00371; Archer L, 2013, PEDAGOG CULT SOC, V21, P171, DOI 10.1080/14681366.2012.748676; Archer L, 2012, SCI EDUC, V96, P967, DOI 10.1002/sce.21031; Avraamidou L, 2013, RES SCI TECHNOL EDUC, V31, P90, DOI 10.1080/02635143.2012.761605; Blumberg R.L., 2007, PROSPECTS, V38, P345, DOI [10.1007/s11125-009-9086-1, https://doi.org/10.1007/s11125-009-9086-1, DOI 10.1007/S11125-009-9086-1]; Booy C, 2011, TRENDANALYSE GENDER; Brotman JS, 2008, J RES SCI TEACH, V45, P971, DOI 10.1002/tea.20241; Brugeilles C, 2009, PROMOTING GENDER EQU; Buck GA, 2008, SCI EDUC, V92, P688, DOI 10.1002/sce.20257; Carlone HB, 2004, J RES SCI TEACH, V41, P392, DOI 10.1002/tea.20006; Chilisa B., 2000, ASSESSMENT ED, V7, P61; Dawson C, 2000, INT J SCI EDUC, V22, P557, DOI 10.1080/095006900289660; Desprez-Bouanchaud A, 1999, UNESCOS WORKSH; Desy E.A., 2011, SCI ED, V20, P23; Elgar AG, 2004, INT J SCI EDUC, V26, P875, DOI 10.1080/0950069032000138888; Elgar AG, 1999, 4 ANN C DEP SCI MATH; European Commission, 2015, SCI ITS GIRL THING; European Commission, 2014, REACH GEND EQ SCI TE; European Medicines Agency. Kadcyla, 2013, SCI ENV POLICY, P1; Farenga SJ, 1999, SCI EDUC, V83, P55, DOI 10.1002/(SICI)1098-237X(199901)83:1<55::AID-SCE3>3.0.CO;2-O; Good JJ, 2010, J SOC PSYCHOL, V150, P132, DOI 10.1080/00224540903366552; Hannover B, 2004, LEARN INSTR, V14, P51, DOI 10.1016/j.learninstruc.2003.10.002; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Hofer SI, 2015, INT J SCI EDUC, V37, P2879, DOI 10.1080/09500693.2015.1114190; Hughes G, 2001, GENDER EDUC, V13, P275, DOI 10.1080/09540250120063562; Hutchinson J, 2009, STEM CAREER AWARENES; Institute of Physics and Royal Astronomical Society, 2015, GAZ FUT EXP MAL FEM; Jidesjo A., 2012, NORDINA, V4, DOI [10.5617/nordina.288, DOI 10.5617/NORDINA.288]; Jones MG, 2000, SCI EDUC, V84, P180, DOI 10.1002/(SICI)1098-237X(200003)84:2<180::AID-SCE3>3.0.CO;2-X; Kerger S, 2011, BRIT J EDUC PSYCHOL, V81, P606, DOI 10.1111/j.2044-8279.2011.02019.x; Kitchen S., 2006, EVALUATION CURRICULU; Lee JFK, 2009, GENDER EDUC, V21, P353, DOI 10.1080/09540250802392257; Lombard M, 2002, HUM COMMUN RES, V28, P587, DOI 10.1111/j.1468-2958.2002.tb00826.x; Maher D, 2012, AUSTRALAS J EDUC TEC, V28, P138; McKown C, 2003, CHILD DEV, V74, P498, DOI 10.1111/1467-8624.7402012; Moore Julie A., 2007, Technology, Pedagogy and Education, V16, P215, DOI 10.1080/14759390701406844; Moser F, 2014, EUR J PSYCHOL EDUC, V29, P387, DOI 10.1007/s10212-013-0204-3; Newton LD, 1998, INT J SCI EDUC, V20, P1137, DOI 10.1080/0950069980200909; Peplau L.A., 1999, GENDER CULTURE ETHNI, P23; Recker M, 2013, TEACHER DESIGN USING; Reuben E, 2014, P NATL ACAD SCI USA, V111, P4403, DOI 10.1073/pnas.1314788111; Rice C, 2014, SCI IN BALANCE; Scientix. eu, 2015, RESOURCE REPOSITORY; Sjoberg S., 2010, ROSE PROJECT OVERVIE; Snyder T. D., 2015, DIGEST ED STAT 2013; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Tan AL, 2017, PUBLIC UNDERST SCI, V26, P520, DOI 10.1177/0963662515615086; Trumper R., 2006, SCI ED INT, V17, P31, DOI 10.1007/s10956-006-0355-6; UNESCO, 2019, WOM SCI; United States census bureau, 2010, AM FACT FIND SEX AG; Warrington M, 2000, GENDER EDUC, V12, P493, DOI 10.1080/09540250020004126; Whiteley P. P. E., 1996, PHYS ED, V31; Zittleman K, 2002, J TEACH EDUC, V53, P168, DOI 10.1177/0022487102053002008	55	40	40	13	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165037	10.1371/journal.pone.0165037	http://dx.doi.org/10.1371/journal.pone.0165037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851759	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300007
J	Elwood, PC; Morgan, G; Galante, J; Chia, JWK; Dolwani, S; Graziano, JM; Kelson, M; Lanas, A; Longley, M; Phillips, CJ; Pickering, J; Roberts, SE; Soon, SS; Steward, W; Morris, D; Weightmanm, AL				Elwood, Peter C.; Morgan, Gareth; Galante, Julieta; Chia, John W. K.; Dolwani, Sunil; Graziano, J. Michael; Kelson, Mark; Lanas, Angel; Longley, Marcus; Phillips, Ceri J.; Pickering, Janet; Roberts, Stephen E.; Soon, Swee S.; Steward, Will; Morris, Delyth; Weightmanm, Alison L.			Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk	PLOS ONE			English	Review							COLORECTAL-CANCER; PEPTIC-ULCER; HEMORRHAGIC STROKE; AMERICAN-COLLEGE; MORTALITY; ASSOCIATION; OUTCOMES; ANTICOAGULANTS; IMPROVEMENT; BENEFITS	Background Aspirin has been shown to lower the incidence and the mortality of vascular disease and cancer but its wider adoption appears to be seriously impeded by concerns about gastrointestinal (GI) bleeding. Unlike heart attacks, stroke and cancer, GI bleeding is an acute event, usually followed by complete recovery. We propose therefore that a more appropriate evaluation of the risk-benefit balance would be based on fatal adverse events, rather than on the incidence of bleeding. We therefore present a literature search and meta-analysis to ascertain fatal events attributable to low-dose aspirin. Methods In a systematic literature review we identified reports of randomised controlled trials of aspirin in which both total GI bleeding events and bleeds that led to death had been reported. Principal investigators of studies in which fatal events had not been adequately described were contacted via email and asked for further details. A meta-analyses was then performed to estimate the risk of fatal gastrointestinal bleeding attributable to low-dose aspirin. Results Eleven randomised trials were identified in the literature search. In these the relative risk (RR) of 'major' incident GI bleeding in subjects who had been randomised to low-dose aspirin was 1.55 (95% CI 1.33, 1.83), and the risk of a bleed attributable to aspirin being fatal was 0.45 (95% CI 0.25, 0.80). In all the subjects randomised to aspirin, compared with those randomised not to receive aspirin, there was no significant increase in the risk of a fatal bleed (RR 0.77; 95% CI 0.41, 1.43). Conclusions The majority of the adverse events caused by aspirin are GI bleeds, and there appears to be no valid evidence that the overall frequency of fatal GI bleeds is increased by aspirin. The substantive risk for prophylactic aspirin is therefore cerebral haemorrhage which can be fatal or severely disabling, with an estimated risk of one death and one disabling stroke for every 1,000 people taking aspirin for ten years. These adverse effects of aspirin should be weighed against the reductions in vascular disease and cancer.	[Elwood, Peter C.; Morgan, Gareth; Galante, Julieta; Kelson, Mark; Pickering, Janet; Weightmanm, Alison L.] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff, S Glam, Wales; [Morgan, Gareth] Hywel Dda Univ Hlth Board, Llanelli, Wales; [Galante, Julieta] Univ Cambridge, Dept Psychiat, Cambridge, England; [Chia, John W. K.] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Dolwani, Sunil] Cardiff Univ, Inst Canc & Genet, Cardiff, S Glam, Wales; [Graziano, J. Michael] Harvard Med Sch, Boston, MA USA; [Lanas, Angel] Univ Zaragoza, IIS Aragon, CIBEReshd, Univ Clin Hosp, Zaragoza, Spain; [Longley, Marcus] Univ South Wales, Welsh Inst Hlth & Social Care, Cardiff, S Glam, Wales; [Phillips, Ceri J.] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Roberts, Stephen E.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Soon, Swee S.] Natl Univ Singapore, Dept Pharm, Singapore, Singapore; [Steward, Will] Univ Leicester, Dept Canc Studies, Leicester, Leics, England; [Morris, Delyth] Cardiff Univ, Univ Lib Serv, Cardiff, S Glam, Wales; [Weightmanm, Alison L.] Cardiff Univ, SURE, Cardiff, S Glam, Wales	Cardiff University; University of Cambridge; National Cancer Centre Singapore (NCCS); Cardiff University; Harvard University; Harvard Medical School; University of Zaragoza; University of South Wales; Swansea University; Swansea University; National University of Singapore; University of Leicester; Cardiff University; Cardiff University	Morgan, G (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff, S Glam, Wales.; Morgan, G (corresponding author), Hywel Dda Univ Hlth Board, Llanelli, Wales.	gareth.morgan5@wales.nhs.uk	Weightman, Alison/A-4680-2010; Kelson, Mark/E-6753-2016	Weightman, Alison/0000-0001-5210-3798; Kelson, Mark/0000-0001-7744-3780; Morris, Delyth/0000-0001-8529-1270; Phillips, Ceri/0000-0003-1076-9289; Elwood, Peter/0000-0003-4352-1570; Galante, Julieta/0000-0002-4108-5341	Universities and Health Services	Universities and Health Services	The funders who were in effect the Universities and Health Services who paid the salaries of the authors - had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Daya H, 2014, J DIGEST DIS, V15, P283, DOI 10.1111/1751-2980.12140; Agra AM, 2012, LANCET ONCOLOGY, V13, P518, DOI [10.1016/S1470-2045(12)70112-2, DOI 10.1016/S1470-2045(12)70112-2]; Ahsberg K, 2010, ALIMENT PHARM THER, V32, P801, DOI 10.1111/j.1365-2036.2010.04399.x; Ahsberg K, 2010, SCAND J GASTROENTERO, V45, P1404, DOI 10.3109/00365521.2010.510567; [Anonymous], 2012, EUR HEART J, V33, P1635, DOI [10.1093/eurheartj/ehs092, DOI 10.1093/EURHEARTJ/EHS092]; [Anonymous], 1998, LANCET, V351, P233; Baigent Colin, 2005, BMJ, V330, P1442, DOI 10.1136/bmj.330.7505.1442; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Battistoni A, 2015, CLIN CARDIOL, DOI [10.1002/cic.22394, DOI 10.1002/CIC.22394]; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Button LA, 2011, ALIMENT PHARM THER, V33, P64, DOI 10.1111/j.1365-2036.2010.04495.x; Calonge N, 2009, ANN INTERN MED, V150, P396; Chubak J, 2015, 1505228EF1 KAIS PERM, V133; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EGGER M, 1995, SYSTEMATIC REV HLTH; Elwood P, 2010, J EPIDEMIOL COMMUN H, V64, P761, DOI 10.1136/jech.2009.087767; Elwood PC, ASPIRIN TREAT MENT C; Feigin FL, 2014, LANCET, V383, P245; Rodriguez LAG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160046; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Gonzalez-Perez A, 2013, NEUROLOGY, V81, P559, DOI 10.1212/WNL.0b013e31829e6eff; Gorelick PB, 2005, STROKE, V36, P1801, DOI 10.1161/01.STR.0000174189.81153.85; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hassan C, 2012, GUT, V61, P1172, DOI 10.1136/gutjnl-2011-300206; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HIGGINS JPT, COCHRANE HANDBOOK FO; Hochholzer W, 2011, CIRCULATION, V123, P2681, DOI 10.1161/CIRCULATIONAHA.110.002683; Hreinsson JP, 2013, EUR J GASTROEN HEPAT, V25, P37, DOI 10.1097/MEG.0b013e32835948e3; Hreinsson JP, 2015, J CLIN GAWSTROENTERO; Ivanusa M, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-26; Janu-Llopis E., GLOBAL EC BURDEN NON; Kang JY, 2006, ALIMENT PHARM THERAP, V24, P65, DOI 10.1111/j.1365-2036.2006.02960.x; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; Kaviani Mohammad J, 2010, Saudi J Gastroenterol, V16, P253, DOI 10.4103/1319-3767.70608; Lanas A, 2005, AM J GASTROENTEROL, V100, P1685, DOI 10.1111/j.1572-0241.2005.41833.x; Lanas A, 2011, CLIN GASTROENTEROL H, V9, P762, DOI 10.1016/j.cgh.2011.05.020; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Lieberman D, 2010, GASTROENTEROLOGY, V138, P2115, DOI 10.1053/j.gastro.2010.02.006; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mariotto AB, 2011, J CANC I, DOI [10.1093/jnci/djg495, DOI 10.1093/JNCI/DJG495]; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Mills EJ, 2012, AM J MED, V125, P560, DOI 10.1016/j.amjmed.2012.01.017; Mose Hanne, 2006, Am J Geriatr Pharmacother, V4, P244, DOI 10.1016/j.amjopharm.2006.09.006; Narum S, 2013, EUR J CLIN PHARMACOL, V69, P1445, DOI 10.1007/s00228-013-1479-7; NORRVING B, 1991, LANCET, V338, P1345; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Peura DA, 1997, AM J GASTROENTEROL, V92, P924; Pignone M, 2013, J GEN INTERN MED MAY; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Roussomoustakaki M, 2000, ANN GASTROENTEROL, V13, P225; Sandercock P, 1997, LANCET, V349, P1569; Soon SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107866; Stegeman I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127194; Sung JJY, 2010, AM J GASTROENTEROL, V105, P84, DOI 10.1038/ajg.2009.507; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Wehbeh A, 2015, DIGEST DIS SCI, V60, P2077, DOI 10.1007/s10620-015-3604-1; Wu C, 2015, THROMB RES, V135, P243, DOI 10.1016/j.thromres.2014.10.033; Zhao Y, 2006, HOSPITALIZATIONS FOR	68	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166166	10.1371/journal.pone.0166166	http://dx.doi.org/10.1371/journal.pone.0166166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846246	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000387794600035
J	Gygi, JT; Fux, E; Grob, A; Hagmann-von Arx, P				Gygi, Jasmin T.; Fux, Elodie; Grob, Alexander; Hagmann-von Arx, Priska			Measurement Invariance and Latent Mean Differences in the Reynolds Intellectual Assessment Scales (RIAS): Does the German Version of the RIAS Allow a Valid Assessment of Individuals with a Migration Background?	PLOS ONE			English	Article							TESTING MEASUREMENT INVARIANCE; FIT INDEXES; WISC-IV; CHILDREN; INVOLVEMENT; IMMIGRANTS; MODELS; POWER	This study examined measurement invariance and latent mean differences in the German version of the Reynolds Intellectual Assessment Scales (RIAS) for 316 individuals with a migration background (defined as speaking German as a second language) and 316 sexand age-matched natives. The RIAS measures general intelligence (single-factor structure) and its two components, verbal and nonverbal intelligence (two-factor structure). Results of a multi-group confirmatory factor analysis showed scalar invariance for the two-factor and partial scalar invariance for the single-factor structure. We conclude that the two-factor structure of the RIAS is comparable across groups. Hence, verbal and nonverbal intelligence but not general intelligence should be considered when comparing RIAS test results of individuals with and without a migration background. Further, latent mean differences especially on the verbal, but also on the nonverbal intelligence index indicate language barriers for individuals with a migration background, as subtests corresponding to verbal intelligence require higher skills in German language. Moreover, cultural, environmental, and social factors that have to be taken into account when assessing individuals with a migration background are discussed.	[Gygi, Jasmin T.; Fux, Elodie; Grob, Alexander; Hagmann-von Arx, Priska] Univ Basel, Dept Psychol, Basel, Switzerland	University of Basel	Gygi, JT (corresponding author), Univ Basel, Dept Psychol, Basel, Switzerland.	jasmin.gygi@unibas.ch	Grob, Alexander/AAU-5842-2021					Andrews J. J. W., 2007, J PSYCHOEDUCATIONAL, V25, P402, DOI DOI 10.1177/0734282907300381; [Anonymous], 2004, PSYCHOL SCI; Appel M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00900; Arbuckle J.L., 2013, AMOS 22 COMPUTER SOF; Baltes BB, 2010, J MANAGE PSYCHOL, V25, P148, DOI 10.1108/02683941011019357; Beaujean AA, 2014, PSYCHOL ASSESSMENT, V26, P1394, DOI 10.1037/pas0000029; Beaujean AA, 2009, PSYCHOL SCHOOLS, V46, P932, DOI 10.1002/pits.20435; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Bundesamt fur Statistik, 2015, MIGR INT; Bundesamt fur Statistik, 2014, VERT VERF QUIV QUINT; Canivez G. L., 2016, INTELLIGENT TESTING, P683; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, V1st ed., DOI [10.1017/CBO9780511571312, DOI 10.1017/CBO9780511571312]; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daseking M, 2008, KINDH ENTWICKL, V17, P76, DOI 10.1026/0942-5403.17.2.76; Calero MD, 2013, PSYCHOL SCHOOLS, V50, P705, DOI 10.1002/pits.21701; Calero MD, 2013, EUR J PSYCHOL EDUC, V28, P133, DOI 10.1007/s10212-012-0107-8; Dombrowski SC, 2008, CAN J SCH PSYCHOL, V23, P223, DOI 10.1177/0829573508324458; Dombrowski SC, 2009, J PSYCHOEDUC ASSESS, V27, P494, DOI 10.1177/0734282909333179; Elliott Robert W, 2004, Arch Clin Neuropsychol, V19, P325, DOI 10.1016/j.acn.2003.10.001; Eurostat, 2014, EU WORLD PROP; Goldstein S, 2015, HDB INTELLIGENCE EVO, DOI [10.1007/978-1-4939-1562-0, DOI 10.1007/978-1-4939-1562-0]; Gygi JT, 2016, REYNOLDS INTELLECTUA; Hagmann-von Arx P, 2014, REYNOLDS INTELLECTUA; Hagmann-von Arx P, 2013, DIAGNOSTICA, V59, P170, DOI 10.1026/0012-1924/a000091; Harris JG, 2008, WISC 4 CLIN ASSESSME, P409; Hartmann P, 2011, DOKUMENTATION DANSKE; Hessels MG, 1997, ED CHILD PSYCHOL, V14, P121; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd, DOI DOI 10.1016/S0005-7967(02)00184-5; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Irwin JK, 2014, CLIN NEUROPSYCHOL, V28, P1258, DOI 10.1080/13854046.2014.975843; Klingner JK, 2007, HDB DEV DISABILITIES, P55; Lahaie C, 2008, SOC SCI QUART, V89, P684, DOI 10.1111/j.1540-6237.2008.00554.x; LEE S, 1990, MULTIVAR BEHAV RES, V25, P313, DOI 10.1207/s15327906mbr2503_4; MacCallum RC, 2006, PSYCHOL METHODS, V11, P19, DOI 10.1037/1082-989X.11.1.19; Mackintosh Nicholas J., 2011, IQ HUMAN INTELLIGENC; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Meredith W, 2006, MED CARE, V44, pS69, DOI 10.1097/01.mlr.0000245438.73837.89; Milfont TL, 2010, INT J PSYCHOL RES, V3, P111; Nelson JM, 2007, J SCHOOL PSYCHOL, V45, P439, DOI 10.1016/j.jsp.2007.03.003; Nelson JM, 2012, PSYCHOL ASSESSMENT, V24, P129, DOI 10.1037/a0024878; Proctor BD, 2015, CURRENT POPULATION R; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Resing WCM, 2009, LEARN INDIVID DIFFER, V19, P445, DOI 10.1016/j.lindif.2009.03.006; Reynolds C.R., 2003, REYNOLDS INTELLECTUA; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; Santamaria P, 2009, RIAS ESCALAS INTELIG; Statistisches Bundesamt, 2015, BEV; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Sternberg R. J., 2002, DYNAMIC TESTING NATU; te Nijenhuis J, 2016, INTELLIGENCE, V54, P117, DOI 10.1016/j.intell.2015.12.003; Turney K, 2009, J EDUC RES, V102, P257, DOI 10.3200/JOER.102.4.257-271; Vygotsky L.S., 1978, MIND SOC DEV HIGHER, P79, DOI DOI 10.2307/J.CTVJF9VZ4.11; Weiss L. G., 2006, WISC 4 ADV CLIN INTE, P1; Widaman K.F., 1997, SCI PREVENTION METHO, P281, DOI [10.1037/10222-009, DOI 10.1037/10222-009]	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166533	10.1371/journal.pone.0166533	http://dx.doi.org/10.1371/journal.pone.0166533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846270	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600078
J	Koh, D; bin Abdullah, AMK; Wang, P; Lin, N; Luo, N				Koh, David; bin Abdullah, Awg Muhammad Khairulamin; Wang, Pei; Lin, Naing; Luo, Nan			Validation of Brunei's Malay EQ-5D Questionnaire in Patients with Type 2 Diabetes	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; MELLITUS; SINGAPORE; EUROQOL; INDEX	Background The Malay spoken in Brunei a South East Asian country where Malay is the national language is distinctive and different from Malay spoken in Malaysia, Singapore and Indonesia. This study aimed to develop a Brunei Malay version of the 5-level EQ-5D questionnaire (EQ-5D-5L) and to assess its psychometric properties among patients with type 2 diabetes mellitus (T2DM). Methods The Brunei Malay EQ-5D-5L was developed by culturally adapting two existing Malay versions. A total of 154 Bruneians with T2DM completed the questionnaire in two different points of time with one week apart. Known-groups validity of the utility-based EQ-5D-5L index and visual analogue scale (EQ-VAS) was evaluated by comparing subgroups of patients known to differ in health status. Test-retest reliability was assessed using the intra-class correlation coefficient (ICC) or Cohen's kappa. Results As hypothesized, patients known to have 'better' health had higher EQ-5D-5L index scores than those having 'worse' health in all 7 known-groups comparisons. The hypothesized difference in the EQ-VAS scores was observed in only 4 of the 7 known-groups comparisons. Kappa values ranged from 0.206 to 0.446 for the EQ-5D-5L items; the ICC value for the EQ-5D- 5L index and EQ-VAS was 0.626 and 0.521, respectively. Conclusions The utility-based EQ-5D-5L index appears to be valid and reliable for measuring the health of Brunei patients with T2DM. The validity of the EQ-VAS in Brunei requires further investigation.	[Koh, David; bin Abdullah, Awg Muhammad Khairulamin; Lin, Naing] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Bandar Seri Begawan, Brunei; [Koh, David; Wang, Pei; Luo, Nan] Natl Univ Singapore, SSH Sch Publ Hlth, Singapore, Singapore	University Brunei Darussalam; National University of Singapore	Luo, N (corresponding author), Natl Univ Singapore, SSH Sch Publ Hlth, Singapore, Singapore.	ephln@nus.edu.sg		Koh, David/0000-0001-6803-7879	Brunei Darussalam	Brunei Darussalam	This work was supported by the BRC4 research grant from Brunei Darussalam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2013, OPTOMETRY VISION SCI, V90, P861, DOI 10.1097/OPX.0000000000000004; [Anonymous], 2011, BRUNEI TIMES; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brunei Ministry of Health Statistics, 2011, HLTH INF BOOKL; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Fayers P., 2007, QUALITY LIFE ASSESSM; Gulliford MC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-4; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Janssen MF, 2011, DIABETIC MED, V28, P395, DOI 10.1111/j.1464-5491.2010.03136.x; Jerant A, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.2; Jia YX, 2014, QUAL LIFE RES, V23, P2355, DOI 10.1007/s11136-014-0670-3; Kanyongo GY, 2007, JMASM, V1, P81; Kim TH, 2013, QUAL LIFE RES, V22, P2245, DOI 10.1007/s11136-012-0331-3; Landis JR, 1977, MEASUREMENT OBSERVER, V33, P159; Lewis M. P., 2015, ETHNOLOGUE LANGUAGES, V18th; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; Luo N, 2014, PHARMACOECONOMICS, V32, P495, DOI 10.1007/s40273-014-0142-1; Luo N, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-32; Megan Davidson, 2014, ENCY QUALITY LIFE WE, P3481; Mizawa M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/138027; Pan CW, 2016, MED DECIS MAKING, V36, P234, DOI 10.1177/0272989X15606903; Pan CW, 2015, QUAL LIFE RES, V24, P1767, DOI 10.1007/s11136-014-0902-6; Shim YT, 2012, DIABETIC MED, V29, pE241, DOI 10.1111/j.1464-5491.2012.03689.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; Wang Y, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0297-2	26	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165555	10.1371/journal.pone.0165555	http://dx.doi.org/10.1371/journal.pone.0165555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835652	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200008
J	Rai, R; Chauhan, SK; Singh, VV; Rai, M; Rai, G				Rai, Richa; Chauhan, Sudhir Kumar; Singh, Vikas Vikram; Rai, Madhukar; Rai, Geeta			RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EXTRACELLULAR TRAP DEGRADATION; EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD; DISEASE-ACTIVITY; T-CELLS; GENE-EXPRESSION; NEUROTROPHIC FACTOR; DNA METHYLATION; MESSENGER-RNA	Systemic lupus erythematosus (SLE) patients exhibit immense heterogeneity which is challenging from the diagnostic perspective. Emerging high throughput sequencing technologies have been proved to be a useful platform to understand the complex and dynamic disease processes. SLE patients categorised based on autoantibody specificities are reported to have differential immuno-regulatory mechanisms. Therefore, we performed RNA-seq analysis to identify transcriptomics of SLE patients with distinguished autoantibody specificities. The SLE patients were segregated into three subsets based on the type of autoantibodies present in their sera (anti-dsDNA(+) group with anti-dsDNA autoantibody alone; anti-ENA(+) group having autoantibodies against extractable nuclear antigens (ENA) only, and anti-dsDNA(+)ENA(+) group having autoantibodies to both dsDNA and ENA). Global transcriptome profiling for each SLE patients subsets was performed using Illumina (R) Hiseq-2000 platform. The biological relevance of dysregulated transcripts in each SLE subsets was assessed by ingenuity pathway analysis (IPA) software. We observed that dysregulation in the transcriptome expression pattern was clearly distinct in each SLE patients subsets. IPA analysis of transcripts uniquely expressed in different SLE groups revealed specific biological pathways to be affected in each SLE subsets. Multiple cytokine signaling pathways were specifically dysregulated in anti-dsDNA(+) patients whereas Interferon signaling was predominantly dysregulated in anti-ENA(+) patients. In anti-dsDNA(+) ENA(+) patients regulation of actin based motility by Rho pathway was significantly affected. The granulocyte gene signature was a common feature to all SLE subsets; however, anti-dsDNA(+) group showed relatively predominant expression of these genes. Dysregulation of Plasma cell related transcripts were higher in anti-dsDNA(+) and anti-ENA(+) patients as compared to antidsDNA (+) ENA(+). Association of specific canonical pathways with the uniquely expressed transcripts in each SLE subgroup indicates that specific immunological disease mechanisms are operative in distinct SLE patients' subsets. This 'sub-grouping' approach could further be useful for clinical evaluation of SLE patients and devising targeted therapeutics.	[Rai, Richa; Chauhan, Sudhir Kumar; Singh, Vikas Vikram; Rai, Geeta] Banaras Hindu Univ, Dept Mol & Human Genet, Inst Sci, Varanasi, Uttar Pradesh, India; [Rai, Madhukar] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Rai, G (corresponding author), Banaras Hindu Univ, Dept Mol & Human Genet, Inst Sci, Varanasi, Uttar Pradesh, India.	geetarair74@gmail.com	Singh, Vikas Vikram/I-7596-2019; Rai, Richa/GMW-8723-2022	Singh, Vikas Vikram/0000-0001-6304-9942; Rai, Geeta/0000-0001-8162-8964	Department of Biotechnology, Government of India [BT/PR4619/MED/30/834/2012]; Council of Scientific & Industrial Research, New Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific & Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by a grant (BT/PR4619/MED/30/834/2012) from the Department of Biotechnology, Government of India (http://dbtindia.nic.in/index.asp) to GR. RR was supported by junior and senior research fellowship from Council of Scientific & Industrial Research (http://www.csirhrdg.resin/), New Delhi, India. The funding agency had no role in study design, data collection, analysis and decision to publish the paper.	Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Alegretti AP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/725684; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Besliu Alina Nicoleta, 2009, Roum Arch Microbiol Immunol, V68, P69; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Cai Z, 2015, LUPUS, V24, P1257, DOI 10.1177/0961203315585815; Cedeno S, 2003, CLIN IMMUNOL, V106, P41, DOI 10.1016/S1521-6616(02)00052-9; Chauhan SK, 2015, IMMUNOL LETT, V168, P254, DOI 10.1016/j.imlet.2015.09.016; Chauhan SK, 2014, J CLIN IMMUNOL, V34, P491, DOI 10.1007/s10875-014-0008-5; Chauhan SK, 2013, J CLIN IMMUNOL, V33, P954, DOI 10.1007/s10875-013-9887-0; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Darrah E, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00428; Davas EM, 1999, CLIN RHEUMATOL, V18, P17, DOI 10.1007/s100670050045; De La Torre M, 2009, LUPUS, V18, P216, DOI 10.1177/0961203308096068; Ellyard JI, 2014, ARTHRITIS RHEUMATOL, V66, P3382, DOI 10.1002/art.38824; FROST P. G., 1968, CLIN EXP IMMUNOL, V3, P447; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; HADJIYANNAKI K, 1972, CLIN EXP IMMUNOL, V11, P291; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; HARA M, 1987, RHEUMATOL INT, V7, P83, DOI 10.1007/BF00270312; Harley JB, 2006, BULL HOSP JT DIS, V64, P45; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hrycek A, 2007, AUTOIMMUNITY, V40, P23, DOI 10.1080/08916930601168093; Huang WQ, 2002, ARTHRITIS RHEUM-US, V46, P1554, DOI 10.1002/art.10273; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Ikenouchi-Sugita Atsuko, 2008, Neuropsychiatr Dis Treat, V4, P1277; Ivanov VN, 1997, J BIOL CHEM, V272, P8558; Jacob N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3349; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Jury EC, 2010, EUR J IMMUNOL, V40, P569, DOI 10.1002/eji.200939781; Kakumanu P, 2009, J RHEUMATOL, V36, P2682, DOI 10.3899/jrheum.090338; Karapetyan Armen R, 2013, Cancers (Basel), V5, P462, DOI 10.3390/cancers5020462; Kawano M, 1999, CLIN EXP IMMUNOL, V116, P542; Kawasaki M, 2011, LUPUS, V20, P1231, DOI 10.1177/0961203311409963; Kidani Y, 2014, J CLIN INVEST, V124, P482, DOI 10.1172/JCI74141; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kyttaris VC, 2011, ARTHRITIS RHEUM-US, V63, P2058, DOI 10.1002/art.30353; Leffler J, 2012, J IMMUNOL, V188, P3522, DOI 10.4049/jimmunol.1102404; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugar PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044362; Maroder M, 1996, J IMMUNOL, V157, P2864; Mohamed AAA, 2015, ARTHRITIS RHEUMATOL, V67; Mosca M, 2011, CLIN EXP RHEUMATOL, V29, pS126; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Nakou M, 2008, ARTHRITIS RHEUM, V58, P3541, DOI 10.1002/art.23961; Niewold TB, 2005, CLIN RHEUMATOL, V24, P178, DOI 10.1007/s10067-004-1024-2; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Park YW, 2009, ARTHRITIS RHEUM-US, V60, P1753, DOI 10.1002/art.24556; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Perl A, 2004, INT REV IMMUNOL, V23, P293, DOI 10.1080/08830180490452576; Perl Andras, 2012, Methods Mol Biol, V900, P61, DOI 10.1007/978-1-60761-720-4_4; Poole BD, 2006, AUTOIMMUNITY, V39, P63, DOI 10.1080/08916930500484849; Rai G, 2016, IMMUNOL RES, V64, P14, DOI 10.1007/s12026-015-8672-y; Rai R, 2015, IMMUNOL LETT, V164, P25, DOI 10.1016/j.imlet.2015.01.007; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Rupper A, 2001, J CELL SCI, V114, P2449; Rus V, 2004, CLIN IMMUNOL, V112, P231, DOI 10.1016/j.clim.2004.06.005; Rus V, 2002, CLIN IMMUNOL, V102, P283, DOI 10.1006/clim.2001.5182; Seitz HM, 2010, INT REV IMMUNOL, V29, P184, DOI 10.3109/08830181003602507; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Shi LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093846; Sipka S, 2001, ANN RHEUM DIS, V60, P380, DOI 10.1136/ard.60.4.380; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Sullivan RP, 2012, J IMMUNOL, V188, P3019, DOI 10.4049/jimmunol.1102294; Tamashiro LF, 2014, RHEUMATOLOGY, V53, P2182, DOI 10.1093/rheumatology/keu251; Tang Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/826182; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Tsumiyama K, 2011, J IMMUNOL, V186, P4424; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398; Wu TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037210; Xiong W, 2011, THER ADV MUSCULOSKEL, V3, P255, DOI 10.1177/1759720X11415456; Ye S, 2003, RHEUMATOLOGY, V42, P1155, DOI 10.1093/rheumatology/keg315; Yin XY, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-21; Yu C, 2014, J AUTOIMMUN, V48-49, P10, DOI 10.1016/j.jaut.2014.01.004; Zhang Z, 2015, ARTHRITIS RHEUMATOL, V67, P785, DOI 10.1002/art.38964; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103207; Zhao M, 2014, J AUTOIMMUN, V54, P127, DOI 10.1016/j.jaut.2014.07.002	88	27	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166312	10.1371/journal.pone.0166312	http://dx.doi.org/10.1371/journal.pone.0166312			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835693	Green Submitted, Green Published, gold			2022-12-27	WOS:000387779200036
J	Sirotkina, M; Douroudis, K; Papadogiannakis, N; Westgren, M				Sirotkina, Meeli; Douroudis, Konstantinos; Papadogiannakis, Nikos; Westgren, Magnus			Clinical Outcome in Singleton and Multiple Pregnancies with Placental Chorangioma	PLOS ONE			English	Article							TWIN; DISEASE; LESIONS	Introduction Chorangiomas (CAs) are the most common non-trophoblastic tumor-like-lesions of the placenta. Although the clinical significance of small CAs is unknown, the large lesions are often associated with maternal and fetal complications. The aim of our study was to assess the maternal clinical characteristics and neonatal outcome in singleton and multiple pregnancies with placental CA. Materials and Methods Among 15742 selected placentas 170 CAs were diagnosed. Pregnancy and neonatal outcomes were analyzed in singleton (n = 121) and multiple (n = 49) pregnancy groups including 121 and 100 neonates, respectively. Results The frequency of APGAR score < 7 at 5 minutes (p = 0,012), abnormal pulsatility index (p = 0,034), and abnormal blood flow class (p = 0,011) were significantly higher in neonates from singleton compared to multiple pregnancies. Significantly smaller CAs in singleton pregnancies were related to small for gestational age neonates (p = 0,00040) and neonates admitted to the neonatal care unit (p = 0,028). In singleton pregnancies, significantly smaller CAs were associated to maternal preeclampsia (p = 0,039) and larger CAs to multiparity (p = 0,005) and smoking (p = 0,001) groups. The frequency of preeclampsia was high in both singleton and multiple pregnancy groups (41,32% vs 26,53%, respectively), however, the difference did not reach the level of statistical significance. Discussion A high incidence of preeclampsia in cohort of placental CA might lead to a possible recognition of CAs as potential morphologic indicator of placental hypoxia. Conclusion A more favorable pregnancy outcome in multiple gestations compared to the singleton gestations with CAs might reflect an adaptive mechanism for increased demand of oxygen and associated placental tissue hypoxia in this group.	[Sirotkina, Meeli; Papadogiannakis, Nikos] Karolinska Univ, Sect Perinatal Pathol, Dept Pathol, Huddinge Hosp, Stockholm, Sweden; [Sirotkina, Meeli; Papadogiannakis, Nikos] Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden; [Douroudis, Konstantinos] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Douroudis, Konstantinos] Univ Bergen, Dept Clin Med, Bergen, Norway; [Westgren, Magnus] Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Westgren, Magnus] Karolinska Univ Hosp, Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Bergen; Haukeland University Hospital; University of Bergen; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Sirotkina, M (corresponding author), Karolinska Univ, Sect Perinatal Pathol, Dept Pathol, Huddinge Hosp, Stockholm, Sweden.; Sirotkina, M (corresponding author), Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden.	meeli.saotkina@ki.se		Douroudis, Konstantinos/0000-0002-6383-7145				Amer HZM, 2010, FETAL PEDIATR PATHOL, V29, P199, DOI 10.3109/15513815.2010.487009; Faupel-Badger JM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.035; GOSLING RG, 1971, ANGIOLOGY, V22, P52, DOI 10.1177/000331977102200109; Krotz S, 2002, TWIN RES, V5, P8; LAURIN J, 1987, BRIT J OBSTET GYNAEC, V94, P940, DOI 10.1111/j.1471-0528.1987.tb02267.x; Ley D, 2000, ACTA PAEDIATR, V89, P1330, DOI 10.1080/080352500300002525; Luo ZC, 2006, OBSTET GYNECOL, V108, P1138, DOI 10.1097/01.AOG.0000238335.61452.89; Maynard SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.042; Ni YY, 2016, INT J GYNECOL OBSTET, V132, P325, DOI 10.1016/j.ijgo.2015.07.029; Ogino S, 2000, HUM PATHOL, V31, P945, DOI 10.1053/hupa.2000.9036; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sirotkina M, 2016, PLACENTA, V39, P154, DOI 10.1016/j.placenta.2016.01.020; van Gemert MJC, 2016, BIRTH DEFECTS RES A, V106, P733, DOI 10.1002/bdra.23531	13	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166562	10.1371/journal.pone.0166562	http://dx.doi.org/10.1371/journal.pone.0166562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835686	gold, Green Submitted, Green Published			2022-12-27	WOS:000387779200058
J	Bhide, P; Gund, P; Kar, A				Bhide, Prajkta; Gund, Pooja; Kar, Anita			Prevalence of Congenital Anomalies in an Indian Maternal Cohort: Healthcare, Prevention, and Surveillance Implications	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; BIRTH PREVALENCE	Background India lacks a national birth defects surveillance. Data on the prevalence of congenital anomalies are available mostly from hospital-based, cross-sectional studies. This is the first cohort study from India, where 2107 women were followed till pregnancy outcome, in order to measure the prevalence and types of congenital anomalies, their contribution to neonatal mortality, implications for surveillance, and the health service needs for prevention and management. Methods The study followed a cohort of 2107 pregnant women till outcome which was miscarriage, termination of pregnancy, live or stillbirth, neonatal and post-neonatal mortality. Case ascertainment of congenital anomalies was done through visual examination, followed by various investigations. Rates of congenital anomaly affected births were reported per 10 000 births. Health service needs were described through retrospective analysis of events surrounding the diagnosis of a congenital anomaly. Results Among 1822 births, the total prevalence of major congenital anomalies was 230.51 (170.99-310.11) per 10 000 births. Congenital heart defects were the most commonly reported anomalies in the cohort with a prevalence of 65.86 (37.72-114.77) per 10 000 births. Although neural tube defects were two and a half times less as compared to congenital heart defects, they were nevertheless significant at a prevalence of 27.44 (11.73-64.08) per 10 000 births. In this cohort, congenital anomalies were the second largest cause of neonatal deaths. The congenital anomaly prenatal diagnosis prevalence was 10.98 per 1000 births and the congenital anomaly termination of pregnancy rate was 4.39 per 1000 births. Conclusions This first cohort study from India establishes that the congenital anomaly rates were high, affecting one in forty four births in the cohort. The prevalence of congenital anomalies was identical to the stillbirth prevalence in the cohort, highlighting their public health importance. The results of this study identify the need for a well defined national programme with components of prevention, care and surveillance.	[Bhide, Prajkta; Gund, Pooja; Kar, Anita] Savitribai Phule Pune Univ, Sch Hlth Sci, Pune 411007, Maharashtra, India	Savitribai Phule Pune University	Kar, A (corresponding author), Savitribai Phule Pune Univ, Sch Hlth Sci, Pune 411007, Maharashtra, India.	akar@unipune.ac.in			University Grant Commission-University with Potential for Excellence (UGC-UPE) Holistic area "Translation research in the health of women and children" [UGC-UPE 262 B(2)]; Departmental Research Development Programme Fund of Savitribai Phule Pune University	University Grant Commission-University with Potential for Excellence (UGC-UPE) Holistic area "Translation research in the health of women and children"; Departmental Research Development Programme Fund of Savitribai Phule Pune University	The study was supported by the University Grant Commission-University with Potential for Excellence (UGC-UPE) Holistic area "Translation research in the health of women and children" grant number UGC-UPE 262 B(2) and the Departmental Research Development Programme Fund of Savitribai Phule Pune University.	AGARWAL SS, 1991, INDIAN J MED RES-B, V94, P413; [Anonymous], 2014, SAMPL REG SYST STAT; [Anonymous], 2006, ETH GUID BIOM RES HU; Baruah J, 2015, INDIAN J PEDIATR, V82, P917, DOI 10.1007/s12098-014-1685-z; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bharucha BA., 1998, IND J HUM GENET, V4, P84; Bhide P, 2013, BIRTH DEFECTS RES A, V97, P437, DOI 10.1002/bdra.23153; Christianson A, 2004, ANNU REV GENOM HUM G, V5, P219, DOI 10.1146/annurev.genom.5.061903.175935; Christianson A., 2006, GLOBAL REPORT BIRTH; Doke PP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-543; Gund P., 2016, J WOMENS HEAL CARE, V05, P1, DOI [10.4172/2167-0420.1000296, DOI 10.4172/2167-0420.1000296]; INPI, 2018, NORMATIVE INSTRUCTIO; IOM, 2003, RED BIRTH DEF M CHAL; Kar A., 2015, PUBLIC HLTH DEV INDI, P222; Khoshnood B, 2011, BIRTH DEFECTS RES A, V91, pS16, DOI 10.1002/bdra.20776; Kulshrestha R, 1983, Indian Pediatr, V20, P45; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Penchaszadeh Victor B, 2002, Community Genet, V5, P61, DOI 10.1159/000064632; Sachdeva Sandeep, 2014, Indian J Public Health, V58, P54, DOI 10.4103/0019-557X.128170; Taksande Amar, 2010, Indian J Hum Genet, V16, P159, DOI 10.4103/0971-6866.73412; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; United Nations Children's Fund, 2014, STAT WORLDS CHILDR 2; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; VERMA M, 1991, Indian Journal of Pediatrics, V58, P245, DOI 10.1007/BF02751129; WHO, 1999, SERV PREV MAN GEN DI; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 2014, BIRTH DEF SURV MAN P	30	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166408	10.1371/journal.pone.0166408	http://dx.doi.org/10.1371/journal.pone.0166408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832123	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000121
J	Fabiani, M; Riccardo, F; Di Napoli, A; Gargiulo, L; Declich, S; Petrelli, A				Fabiani, Massimo; Riccardo, Flavia; Di Napoli, Anteo; Gargiulo, Lidia; Declich, Silvia; Petrelli, Alessio			Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study	PLOS ONE			English	Article							SELF-REPORT; HEALTH; IMMUNIZATION; CHILDREN; MEASLES; DISEASE; AGE	Background Due to their increased vulnerability, immigrants are considered a priority group for communicable disease prevention and control in Europe. This study aims to compare influenza vaccination coverage (IVC) between regular immigrants and Italian citizens at risk for its complications and evaluate factors affecting differences. Methods Based on data collected by the National Institute of Statistics during a population-based cross-sectional survey conducted in Italy in 2012-2013, we analysed information on 42,048 adult residents (>= 18 years) at risk for influenza-related complications and with free access to vaccination (elderly residents >= 65 years and residents with specific chronic diseases). We compared IVC between 885 regular immigrants and 41,163 Italian citizens using log-binomial models and stratifying immigrants by area of origin and length of stay in Italy (recent: < 10 years; long-term: >= 10 years). Results IVC among all immigrants was 16.9% compared to 40.2% among Italian citizens (vaccination coverage ratio (VCR) = 0.42, 95% confidence interval (CI): 0.36-0.49). Adjusting for sex, age and area of residence, this difference was greatly reduced but remained statistically significant (VCR = 0.71, 95 CI: 0.61-0.81). Further adjustment for socio-economic factors (education, occupation, family composition and economic status) and a composite indicator of health-services utilization did not affect the difference (VCR = 0.78, 95% CI: 0.68-0.90). However, after adjustments, only long-term immigrants from Africa (VCR = 0.49, 95% CI: 0.28-0.85) and recent immigrants (VCR = 0.58, 95% CI: 0.43-0.78) showed a significantly different IVC compared to Italian citizens. Conclusions Differences in demographic characteristics, socio-economic conditions and health-services utilization explained the reduced IVC in most long-term immigrants compared to Italian citizens. By contrast, these differences did not explain the reduced IVC in long-term immigrants from Africa and recent immigrants. This suggests that IVC in these sub-groups is affected by other informal barriers (e.g., cultural and linguistic) that need to be investigated to promote effective immunization access strategies.	[Fabiani, Massimo; Riccardo, Flavia; Declich, Silvia] Italian Natl Inst Hlth ISS, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, Rome, Italy; [Riccardo, Flavia] European Ctr Dis Prevent & Control ECDC, European Programme Intervent Epidemiol Training E, Stockholm, Sweden; [Di Napoli, Anteo; Petrelli, Alessio] Natl Inst Hlth Migrat & Poverty INMP, Rome, Italy; [Gargiulo, Lidia] Natl Inst Stat ISTAT, Rome, Italy	Istituto Superiore di Sanita (ISS); European Centre for Disease Prevention & Control	Fabiani, M (corresponding author), Italian Natl Inst Hlth ISS, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, Rome, Italy.	massimo.fabiani@iss.it	Di Napoli, Anteo/AAN-1659-2020; Riccardo, Flavia/GRJ-5156-2022; Di Napoli, Anteo/S-6477-2018	Di Napoli, Anteo/0000-0003-3207-8761; Riccardo, Flavia/0000-0002-1582-6329; Di Napoli, Anteo/0000-0003-3207-8761; Fabiani, Massimo/0000-0002-5893-7117; Petrelli, Alessio/0000-0002-7533-7260; Declich, Silvia/0000-0002-5916-3889				[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, GLOB VACC ACT PLAN 2; Barsanti S, 2013, 042013 I MAN SCUOL S; Bonanni P, 2015, EPIDEMIOL PREV, V39, P146; Borras E, 2007, VACCINE, V25, P3240, DOI 10.1016/j.vaccine.2007.01.026; Centro Studi e Ricerche IDOS, 2015, DOSSIER STAT IMMIGRA; Chiaradia G, 2011, ITAL J PUBLIC HLTH, V8, P268; European Centre for Disease Prevention and Control (ECDC), 2015, TECHN REP SEAS INFL; Eurostat, 2016, MIGR MIGR POP STAT; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Grimaldi-Bensouda L, 2013, PHARMACOEPIDEM DR S, V22, P278, DOI 10.1002/pds.3401; ISTAT, 2013, MULT SURV HOUS HLTH; Italian Ministry of Health, 2015, PREV CONTR INFL RACC; Italian National Institute of Statistics (ISTAT), 2015, IMM NUOV CITT CONFR; Italian National Institute of Statistics (ISTAT), 2015, DEM FIG; Italian National Statistical System (SISTAN), 2013, PROGR STAT NAZ 2011; Jimenez-Garcia R, 2014, VACCINE, V32, P4386, DOI 10.1016/j.vaccine.2014.06.074; Jimenez-Garcia R, 2014, HUM VACC IMMUNOTHER, V10, P449, DOI 10.4161/hv.27152; Kentikelenis A, 2015, EUR J PUBLIC HEALTH, V25, P937, DOI 10.1093/eurpub/ckv151; Mladovsky P, 2012, CLIN MED, V12, P248, DOI 10.7861/clinmedicine.12-3-248; Norredam M, 2014, TROP MED INT HEALTH, V19, P958, DOI 10.1111/tmi.12340; Pallasch G, 2005, GESUNDHEITSWESEN, V67, P33, DOI 10.1055/s-2004-813912; PAPAVERO G., 2015, SBARCHI RICHIEDENTI; Poethko-Muller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042867; Poethko-Muller C, 2009, VACCINE, V27, P2563, DOI 10.1016/j.vaccine.2009.02.009; Razum O, 2006, INT J EPIDEMIOL, V35, P919, DOI 10.1093/ije/dyl143; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Riccardo F, 2015, INT J ENV RES PUB HE, V12, P11640, DOI 10.3390/ijerph120911640; Riccardo F, 2012, HEALTH POLICY, V105, P17, DOI 10.1016/j.healthpol.2012.02.004; Rizzo C, 2010, EURO SURVEILL; The Council of the European Union, 2009, COUNC REC SEAS INFL; United Nations, 2016, INT MIGR REP 2015 HI; Vandermeulen C, 2008, EUR J PEDIATR, V167, P1161, DOI 10.1007/s00431-007-0652-3; Venturelli F, 2014, 7 EUR PUBL HLTH C GL; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organization, 2010, HLTH MIGR WAY FORW R; World Health Organization (WHO), 2015, SUMM WHO SAGE CONCL; Wormann T., 2011, Migration and health in the European Union, P121	38	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166517	10.1371/journal.pone.0166517	http://dx.doi.org/10.1371/journal.pone.0166517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832186	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000133
J	Henin, S; Fein, D; Smouha, E; Parra, LC				Henin, Simon; Fein, Dovid; Smouha, Eric; Parra, Lucas C.			The Effects of Compensatory Auditory Stimulation and High-Definition Transcranial Direct Current Stimulation (HD-tDCS) on Tinnitus Perception - A Randomized Pilot Study	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; RESIDUAL INHIBITION; HEARING; ANXIETY; SCALE; TONES	Background Tinnitus correlates with elevated hearing thresholds and reduced cochlear compression. We hypothesized that reduced peripheral input leads to elevated neuronal gain resulting in the perception of a phantom sound. Objective The purpose of this pilot study was to test whether compensating for this peripheral deficit could reduce the tinnitus percept acutely using customized auditory stimulation. To further enhance the effects of auditory stimulation, this intervention was paired with high-definition transcranial direct current stimulation (HD-tDCS). Methods A randomized sham-controlled, single blind study was conducted in a clinical setting on adult participants with chronic tinnitus (n = 14). Compensatory auditory stimulation (CAS) and HD-tDCS were administered either individually or in combination in order to access the effects of both interventions on tinnitus perception. CAS consisted of sound exposure typical to daily living (20-minute sound-track of a TV show), which was adapted with compressive gain to compensate for deficits in each subject's individual audiograms. Minimum masking levels and the visual analog scale were used to assess the strength of the tinnitus percept immediately before and after the treatment intervention. Results CAS reduced minimum masking levels, and visual analog scale trended towards improvement. Effects of HD-tDCS could not be resolved with the current sample size. Conclusions The results of this pilot study suggest that providing tailored auditory stimulation with frequency-specific gain and compression may alleviate tinnitus in a clinical population. Further experimentation with longer interventions is warranted in order to optimize effect sizes.	[Henin, Simon; Fein, Dovid; Parra, Lucas C.] CUNY City Coll, Dept Biomed Engn, 160 Convent Ave, New York, NY 10027 USA; [Smouha, Eric] Mt Sinai Med Ctr, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA	City University of New York (CUNY) System; City College of New York (CUNY); Icahn School of Medicine at Mount Sinai	Henin, S (corresponding author), CUNY City Coll, Dept Biomed Engn, 160 Convent Ave, New York, NY 10027 USA.	shenin@gc.cuny.edu						Adamchic I, 2012, AM J AUDIOL, V21, P215, DOI 10.1044/1059-0889(2012/12-0010); Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; De Ridder D, 2011, J NEUROSURG, V114, P903, DOI 10.3171/2010.11.JNS10197; De Ridder Dirk, 2007, Int J Med Sci, V4, P237; Dorn PA, 2001, J ACOUST SOC AM, V110, P3119, DOI 10.1121/1.1417524; FELDMANN H, 1971, AUDIOLOGY, V10, P138; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Garin P, 2011, J NEUROL, V258, P1940, DOI 10.1007/s00415-011-6037-6; Joos K, 2014, NEURAL PLAST, V2014, P8, DOI DOI 10.3389/FNHUM.2014.00783; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Meikle Mary B, 2008, Trends Amplif, V12, P223, DOI 10.1177/1084713808319943; Parra LC, 2007, J ACOUST SOC AM, V121, P1632, DOI 10.1121/1.2431346; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2007, PROG BRAIN RES, V166, P487, DOI 10.1016/S0079-6123(07)66047-6; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Searchfield GD, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00046; Shekhawat GS, 2015, NEUROREHAB NEURAL RE, V29, P837, DOI 10.1177/1545968314567152; Shekhawat GS, 2014, NEUROREHAB NEURAL RE, V28, P410, DOI 10.1177/1545968313508655; Teismann H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089904; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; WILSON PH, 1991, J SPEECH HEAR RES, V34, P197, DOI 10.1044/jshr.3401.197; Zhou X, 2011, HEARING RES, V277, P107, DOI 10.1016/j.heares.2011.02.006; Zhou X, 2010, J ACOUST SOC AM, V127, P970, DOI 10.1121/1.3277156; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	28	7	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166208	10.1371/journal.pone.0166208	http://dx.doi.org/10.1371/journal.pone.0166208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832140	Green Published, gold			2022-12-27	WOS:000387725000076
J	Kazmi, M; Aziz, A; Akhtar, P; Ikram, N				Kazmi, Majida; Aziz, Arshad; Akhtar, Pervez; Ikram, Nassar			A Low Cost Structurally Optimized Design for Diverse Filter Types	PLOS ONE			English	Article							2-D CONVOLUTION; ARCHITECTURE; EDGE	A wide range of image processing applications deploys two dimensional (2D)-filters for performing diversified tasks such as image enhancement, edge detection, noise suppression, multi scale decomposition and compression etc. All of these tasks require multiple type of 2D-filters simultaneously to acquire the desired results. The resource hungry conventional approach is not a viable option for implementing these computationally intensive 2D-filters especially in a resource constraint environment. Thus it calls for optimized solutions. Mostly the optimization of these filters are based on exploiting structural properties. A common shortcoming of all previously reported optimized approaches is their restricted applicability only for a specific filter type. These narrow scoped solutions completely disregard the versatility attribute of advanced image processing applications and in turn offset their effectiveness while implementing a complete application. This paper presents an efficient framework which exploits the structural properties of 2D-filters for effectually reducing its computational cost along with an added advantage of versatility for supporting diverse filter types. A composite symmetric filter structure is introduced which exploits the identities of quadrant and circular T-symmetries in two distinct filter regions simultaneously. These T-symmetries effectually reduce the number of filter coefficients and consequently its multipliers count. The proposed framework at the same time empowers this composite filter structure with additional capabilities of realizing all of its psi-symmetry based subtypes and also its special asymmetric filters case. The two-fold optimized framework thus reduces filter computational cost up to 75% as compared to the conventional approach as well as its versatility attribute not only supports diverse filter types but also offers further cost reduction via resource sharing for sequential implementation of diversified image processing applications especially in a constraint environment.	[Kazmi, Majida; Aziz, Arshad; Akhtar, Pervez; Ikram, Nassar] Natl Univ Sci & Technol, Dept Elect Engn PNEC, H-12, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Kazmi, M (corresponding author), Natl Univ Sci & Technol, Dept Elect Engn PNEC, H-12, Islamabad, Pakistan.	majida.kazmi@pnec.nust.edu.pk						Aguilar-Gonzalez A, 2019, J REAL-TIME IMAGE PR, V16, P305, DOI 10.1007/s11554-015-0535-1; AlNajjar M, 2014, LECT NOTES ELECTR EN, V114, P1, DOI 10.1007/978-1-4614-1857-3; Amin A, 2015, APPL GEOPHYS, V12, P334, DOI 10.1007/s11770-015-0512-2; Andria G, 2012, MEASUREMENT, V45, P1792, DOI 10.1016/j.measurement.2012.04.005; [Anonymous], 1973, PATTERN CLASSIFICATI; Fiz JA, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-22; Bailey DG., 2011, DESIGN EMBEDDED IMAG, DOI 10.1002/9780470828519; Bashar F, 2014, ADV ELECTR COMPUT EN, V14, P69, DOI 10.4316/AECE.2014.01011; Bosi B, 1999, IEEE T VLSI SYST, V7, P299, DOI 10.1109/92.784091; Chang CH, 2004, IEEE T CIRCUITS-I, V51, P1985, DOI 10.1109/tcsi.2004.835683; Chen Wai-Kai., 2009, FUNDAMENTALS CIRCUIT, VThird; Chen Y. L., 2006, THESIS; Chondronasios A, 2016, INT J ADV MANUF TECH, V83, P33, DOI 10.1007/s00170-015-7514-3; Chu J, 2013, OPT LASER TECHNOL, V45, P756, DOI 10.1016/j.optlastec.2012.04.040; D'Alberto P, 2007, ANN IEEE SYM FIELD P, P173, DOI [10.1109/FCCM.2007.58, 10.1109/FCCM.2007.34]; Di Carlo S, 2015, IEEE T VLSI SYST, V23, P2198, DOI 10.1109/TVLSI.2014.2357181; Fiack L, 2015, J REAL-TIME IMAGE PR, V10, P699, DOI 10.1007/s11554-013-0391-9; Fialka O, 10 INT C INF VIS IV, P609; FREI W, 1977, IEEE T COMPUT, V26, P988, DOI 10.1109/TC.1977.1674733; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Gu P, 2016, ULTRASONICS, V65, P51, DOI 10.1016/j.ultras.2015.10.023; Haidekker M. A., 2011, ADV BIOMEDICAL IMAGE; Inc X, 2014, ART 7 FPGAS DAT SHEE; Toledo-Moreo FJ, 2012, J SYST ARCHITECT, V58, P277, DOI 10.1016/j.sysarc.2012.06.002; Karabiber F, 2011, J SIGNAL PROCESS SYS, V64, P447, DOI 10.1007/s11265-010-0504-7; Katuri R, 1991, COMPUTER VISION PRIN; Kockanat S, 2015, ARTIF INTELL REV, V44, P265, DOI 10.1007/s10462-014-9427-1; Majurski M, P IEEE C COMP VIS PA, P95; Marr D., 1980, P ROYAL SOC LONDON B; Mccoy SJ., 1999, US Patent, Patent No. [5,926,580, 5926580]; Perri S, 2007, IET CIRC DEVICE SYST, V1, P263, DOI 10.1049/iet-cds:20070056; Rao L, 2016, J SIGNAL PROCESS SYS, V82, P1, DOI 10.1007/s11265-015-0969-5; Reddy H, 2009, CIRCUITS FILTERS HDB; Reddy H. C., 2003, IEEE Circuits and Systems Magazine, V3, P4, DOI 10.1109/MCAS.2003.1263396; Shanbhag S S, 2014, J Med Eng, V2014, P619081, DOI 10.1155/2014/619081; Shirazi N., 1995, Field-Programmable Logic and Applications. 5th International Workshop, FPL '95. Proceedings, P282; Smith SW, 1997, SCI ENG GUIDE DIGITA; Sonka M., 2014, CENGAGE LEARNING, DOI [10.1007/978-1-4899-3216-7, DOI 10.1007/978-1-4899-3216-7]; van Werkhovena B, 2014, FUTURE GENER COMP SY, V30, P14, DOI 10.1016/j.future.2013.09.003; Woods R., 2008, FPGA BASED IMPLEMENT, DOI [10.1002/9780470713785, DOI 10.1002/9780470713785]; Yang WP, 2012, COMPUT ELECTR ENG, V38, P1213, DOI 10.1016/j.compeleceng.2012.05.014; Yasmin J, 2015, INT ARAB J INF TECHN, V12, DOI [10.5120/7779-0865, DOI 10.5120/7779-0865]; Yu CL, 2011, J SIGNAL PROCESS SYS, V64, P109, DOI 10.1007/s11265-010-0500-y; Zhang B, 2013, J IND MICROBIOL BIOT, P1; Zhang MZ, 2007, INTEGRATION, V40, P490, DOI 10.1016/j.vlsi.2006.07.001	45	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166056	10.1371/journal.pone.0166056	http://dx.doi.org/10.1371/journal.pone.0166056			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832133	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000061
J	Ma, B; Marcotte, D; Paramasivam, M; Michelsen, K; Wang, T; Bertolotti-Ciarlet, A; Jones, JH; Moree, B; Butko, M; Salafsky, J; Sun, X; Mckee, T; Silvian, LF				Ma, Bin; Marcotte, Doug; Paramasivam, Murugan; Michelsen, Klaus; Wang, Ti; Bertolotti-Ciarlet, Andrea; Jones, John Howard; Moree, Ben; Butko, Margaret; Salafsky, Joshua; Sun, Xin; McKee, Timothy; Silvian, Laura F.			ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis	PLOS ONE			English	Article							MOTOR-NEURON DEATH; 2ND-HARMONIC GENERATION; NECROSIS; KINASE; INHIBITOR; MOLECULES; BINDING; PROTEIN; ACTIVATION; DOMAIN	MLKL is a pore forming pseudokinase involved in the final stage of necroptosis, a form of programmed cell death. Its phosphorylation by RIPK3 is necessary for triggering necroptosis but not for triggering apoptosis, which makes it a unique target for pharmacological inhibition to block necroptotic cell death. This mechanism has been described as playing a role in disease progression in neurodegenerative and inflammatory diseases. A type II kinase inhibitor (cpd 1) has been described that reportedly binds to the MLKL pseudokinase domain and prevents necroptosis. Here we describe five compounds that bind to the MLKL ATP-binding site, however the four MLKL-selective compounds have no activity in rescuing cells from necroptosis. We use kinase selectivity panels, crystallography and a new conformationally sensitive method of measuring protein conformational changes (SHG) to confirm that the one previously reported compound that can rescue cells (cpd 1) is a non-selective type II inhibitor that also inhibits the upstream kinase RIPK1. Although this compound can shift the GFE motif of the activation loop to an "out" position, the accessibility of the key residue Ser358 in the MLKL activation loop is not affected by compound binding to the MLKL active site. Our studies indicate that an ATP-pocket inhibitor of the MLKL pseudokinase domain does not have any impact on the necroptosis pathway, which is contrary to a previously reported study.	[Ma, Bin; Marcotte, Doug; Paramasivam, Murugan; Michelsen, Klaus; Wang, Ti; Bertolotti-Ciarlet, Andrea; Jones, John Howard; Sun, Xin; McKee, Timothy; Silvian, Laura F.] Biogen Inc, Drug Discovery, Cambridge, MA 02142 USA; [Moree, Ben; Butko, Margaret; Salafsky, Joshua] Biodesy Inc, San Francisco, CA 94080 USA; [McKee, Timothy] Rodin Therapeut, 400 Technol Sq, Cambridge, MA 02139 USA	Biogen	Silvian, LF (corresponding author), Biogen Inc, Drug Discovery, Cambridge, MA 02142 USA.	laurasilvian@biogen.com	Ma, Bin/AAD-2694-2019	Moree, Ben/0000-0002-8811-7400	Biogen; Biodesy	Biogen(Biogen); Biodesy	Biogen and Biodesy are commercial entities, who have provided financial support in the form of authors' salaries and research materials. Neither funding organization played a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The specific roles of these authors are articulated in the 'author contributions' section.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Dar AC, 2011, EVOLUTION PROTEIN KI, DOI [10.1146/annurev-biochem-090308-173656., DOI 10.1146/ANNUREV-BIOCHEM-090308-173656]; de Almagro MC, 2015, SEMIN CELL DEV BIOL, V39, P56, DOI 10.1016/j.semcdb.2015.02.002; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Harris PA, 2013, ACS MED CHEM LETT, V4, P1238, DOI 10.1021/ml400382p; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Jacobsen AV, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.386; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lawrence CP, 2005, FEBS LETT, V579, P6465, DOI 10.1016/j.febslet.2005.10.041; Liu S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/290182; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moree B, 2015, J BIOL CHEM, V290, P27582, DOI 10.1074/jbc.M114.636027; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murphy JM, 2014, BIOCHEM J, V457, P369, DOI 10.1042/BJ20131270; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Qu Y, 2016, EXP NEUROL, V279, P223, DOI 10.1016/j.expneurol.2016.03.011; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Salafsky JS, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218846; Salafsky JS, 2007, PHYS CHEM CHEM PHYS, V9, P5704, DOI 10.1039/b710505c; Salafsky JS, 2001, CHEM PHYS LETT, V342, P485, DOI 10.1016/S0009-2614(01)00623-6; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Suda J, 2016, J IMMUNOL, V197, P3120, DOI 10.4049/jimmunol.1600690; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vanden Berghe T, 2016, CELL MOL LIFE SCI, V73, P2137, DOI 10.1007/s00018-016-2189-y; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033	31	20	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165983	10.1371/journal.pone.0165983	http://dx.doi.org/10.1371/journal.pone.0165983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832137	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000052
J	Moraes, AP; Simoes, AO; Alayon, DIO; de Barros, F; Forni-Martins, ER				Moraes, Ana Paula; Simoes, Andre Olmos; Alayon, Dario Isidro Ojeda; de Barros, Fabio; Forni-Martins, Eliana Regina			Detecting Mechanisms of Karyotype Evolution in Heterotaxis (Orchidaceae)	PLOS ONE			English	Article							CHROMOSOME-NUMBER EVOLUTION; 45S RDNA SITES; CENTRIC FISSION; GENOME SIZE; HETEROCHROMATIN; REARRANGEMENTS; INFERENCE; DNA; CYTOTAXONOMY; MAXILLARIA	The karyotype is shaped by different chromosome rearrangements during species evolution. However, determining which rearrangements are responsible for karyotype changes is a challenging task and the combination of a robust phylogeny with refined karyotype characterization, GS measurements and bioinformatic modelling is necessary. Here, this approach was applied in Heterotaxis to determine what chromosome rearrangements were responsible for the dysploidy variation. We used two datasets (nrDNA and cpDNA, both under MP and BI) to infer the phylogenetic relationships among Heterotaxis species and the closely related genera Nitidobulbon and Ornithidium. Such phylogenies were used as framework to infer how karyotype evolution occurred using statistical methods. The nrDNA recovered Ornithidium, Nitidobulbon and Heterotaxis as monophyletic under both MP and BI; while cpDNA could not completely separate the three genera under both methods. Based on the GS, we recovered two groups within Heterotaxis: (1) "small GS", corresponding to the Sessilis grade, composed of plants with smaller genomes and smaller morphological structure, and (2) "large GS", corresponding to the Discolor Glade, composed of plants with large genomes and robust morphological structures. The robust karyotype modeling, using both nrDNA phylogenies, allowed us to infer that the ancestral Heterotaxis karyotype presented 2n = 40, probably with a proximal 45S rDNA on a metacentric chromosome pair. The chromosome number variation was caused by ascending dysploidy (chromosome fission involving the proximal 45S rDNA site resulting in two acrocentric chromosome pairs holding a terminal 45S rDNA), with subsequent descending dysploidy (fusion) in two species, H. maleolens and H. sessilis. However, besides dysploidy, our analysis detected another important chromosome rearrangement in the Orchidaceae: chromosome inversion, that promoted 5S rDNA site duplication and relocation.	[Moraes, Ana Paula; Simoes, Andre Olmos; Forni-Martins, Eliana Regina] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil; [Moraes, Ana Paula] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil; [Moraes, Ana Paula] Univ Fed Sao Paulo UNIFESP, Inst Ciencia & Tecnol, Sao Jose Dos Campos, SP, Brazil; [Alayon, Dario Isidro Ojeda] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada; [Alayon, Dario Isidro Ojeda] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [de Barros, Fabio] Inst Bot, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); University of British Columbia; University of British Columbia; Instituto de Botanica - Sao Paulo	Moraes, AP (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil.; Moraes, AP (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil.; Moraes, AP (corresponding author), Univ Fed Sao Paulo UNIFESP, Inst Ciencia & Tecnol, Sao Jose Dos Campos, SP, Brazil.	apaulademoraes@gmail.com	Simoes, Andre O/E-6244-2013; Alayon, Dario Isidro Ojeda/I-2520-2013; Forni-Martins, Eliana/N-1201-2019; Moraes, Ana Paula/C-5105-2016; de Barros, Fábio/D-6412-2015	Simoes, Andre O/0000-0001-6555-8759; Alayon, Dario Isidro Ojeda/0000-0001-8181-4804; Forni-Martins, Eliana/0000-0002-8889-4955; Moraes, Ana Paula/0000-0002-9878-3925; de Barros, Fábio/0000-0002-9943-3417	Sao Paulo Research Foundation [2008/03673-8, 2011/22215-3]; CONACyT; National Council of Scientific and Technological Research [304506/2013-3, 06142/2011-2]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Scientific and Technological Research(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Sao Paulo Research Foundation (http://www.fapesp.br/en/; 2008/03673-8 and 2011/22215-3 to APM), CONACyT (http://www.conacyt.mx/; to DIOA), and the National Council of Scientific and Technological Research (http://cnpq.br/CNPq; Research Productivity Grant 304506/2013-3 to FB and 06142/2011-2 to EFM).	Apples R, 1998, CHROMOSOME BIOL; Atwood J. T., 1999, FIELDIANA BOT, V40, P1; Ayres M., 2007, BIOESTAT APLICACOES; Barros F., 2002, HOEHNEA, V29, P109; Beaulieu JM, 2005, NEW PHYTOL, V179, P975; BENNETT MD, 1987, NEW PHYTOL, V106, P177, DOI 10.1111/j.1469-8137.1987.tb04689.x; Biondo Elaine, 2005, Braz. J. Bot., V28, P797, DOI 10.1590/S0100-84042005000400014; BLUMENSCHEIN A, 1963, CIENCIA CULTURA, V15, P255; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Cabral JS, 2006, GENET MOL BIOL, V29, P659, DOI 10.1590/S1415-47572006000400015; Carnevali G, 1991, THESIS; Christenson EA, 1999, P 16 WORLD ORCH C, P279; Cox AV, 1998, AM J BOT, V85, P681, DOI 10.2307/2446538; Dahmer N, 2011, PLANT SYST EVOL, V291, P211, DOI 10.1007/s00606-010-0382-2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Escudero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085266; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Felix LP, 2010, BOT J LINN SOC, V163, P234, DOI 10.1111/j.1095-8339.2010.01059.x; Felix LP, 2000, GENET MOL BIOL, V23, P957, DOI 10.1590/S1415-47572000000400041; Giuseppina B, 2010, CARYOLOGIA, V63, P184, DOI 10.1080/00087114.2010.10589725; Glick L, 2014, MOL BIOL EVOL, V31, P1914, DOI 10.1093/molbev/msu122; Guerra M, 2008, CYTOGENET GENOME RES, V120, P339, DOI 10.1159/000121083; Guerra M, 2012, PLANT BIOSYST, V146, P703, DOI 10.1080/11263504.2012.717973; Hoehne FC, 1947, ARQ BOT EST SAO PAUL; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1986, AM NAT, V128, P900, DOI 10.1086/284612; Imai HT, 2001, J THEOR BIOL, V210, P475, DOI 10.1006/jtbi.2001.2327; Jones K, 1998, BOT REV, V64, P273, DOI 10.1007/BF02856567; KARASAWA K, 1980, CYTOLOGIA, V45, P97, DOI 10.1508/cytologia.45.97; King M., 1993, SPECIES EVOLUTION; Knight CA, 2008, ANN BOT-LONDON, V101, P759, DOI 10.1093/aob/mcm321; Koehler S, 2008, ANN BOT-LONDON, V102, P491, DOI 10.1093/aob/mcn128; Lan TY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-126; Levin D. A, 2002, OX ECOL EV; Lysak MA, 1998, CARYOLOGIA, V51, P123, DOI 10.1080/00087114.1998.10589127; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Moraes AP, 2015, BOT J LINN SOC, V177, P27, DOI 10.1111/boj.12232; Moraes AP, 2012, BOT J LINN SOC, V170, P29, DOI 10.1111/j.1095-8339.2012.01266.x; Moscone EA, 2007, CHROMOSOME RES, V15, P931, DOI 10.1007/s10577-007-1174-6; Nakata M, 1983, ANN TSUKUBA BOT GARD, V2, P11; Ojeda I, 2005, NOVON, V15, P572; Ojeda I, 2009, GENERA ORCHIDACEAR 2, V5, P147; OJEDA I, 2003, LANKESTERIANA, V7, P45; Pedrosa A, 2002, GENETICS, V161, P1661; Pellicer J, 2013, GENOME, V56, P437, DOI 10.1139/gen-2013-0039; Pellicer J, 2014, NEW PHYTOL, V201, P1484, DOI 10.1111/nph.12617; Pellicer J, 2012, ANN BOT-LONDON, V110, P1185, DOI 10.1093/aob/mcs185; Perry J, 2004, CHROMOSOME RES, V12, P627, DOI 10.1023/B:CHRO.0000036594.38997.59; Peruzzi L, 2013, PLANT BIOSYST, V147, P1238, DOI 10.1080/11263504.2013.861533; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A., 2007, TRACER V1 5; Rambaut A, 2007, TREEANNOTATOR V1 5 4; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schubert I, 2016, TRENDS PLANT SCI, V21, P749, DOI 10.1016/j.tplants.2016.06.003; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; SCHWARZACHER T, 1982, PLANT SYST EVOL, V141, P91, DOI 10.1007/BF00986411; Severns PM, 2008, CONSERV BIOL, V22, P1641, DOI 10.1111/j.1523-1739.2008.01058.x; Sousa A, 2014, ANN BOT-LONDON, V113, P669, DOI 10.1093/aob/mct302; Souza BCQ, 2011, THESIS; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wang XY, 2015, NEW PHYTOL, V205, P378, DOI 10.1111/nph.12985; Wanzenbock EM, 1997, PLANT J, V11, P1007, DOI 10.1046/j.1365-313X.1997.11051007.x; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Whitten WM, 2007, AM J BOT, V94, P1860, DOI 10.3732/ajb.94.11.1860; [No title captured]	70	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165960	10.1371/journal.pone.0165960	http://dx.doi.org/10.1371/journal.pone.0165960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832130	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000047
J	Park, SK; Hur, M; Kim, E; Kim, WH; Park, JB; Kim, Y; Yang, JH; Jun, TG; Kim, CS				Park, Sun-Kyung; Hur, Min; Kim, Eunhee; Kim, Won Ho; Park, Jung Bo; Kim, Youngwon; Yang, Ji-Hyuk; Jun, Tae-Gook; Kim, Chung Su			Risk Factors for Acute Kidney Injury after Congenital Cardiac Surgery in Infants and Children: A Retrospective Observational Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; HEART-DISEASE; CARDIOPULMONARY BYPASS; FLUID OVERLOAD; OUTCOMES; INFLAMMATION; PREMATURITY; ANEMIA	Acute kidney injury (AKI) after pediatric cardiac surgery is associated with high morbidity and mortality. Modifiable risk factors for postoperative AKI including perioperative anesthesia -related parameters were assessed. The authors conducted a single-center, retrospective cohort study of 220 patients (aged 10 days to 19 years) who underwent congenital cardiac surgery between January and December 2012. The incidence of AKI within 7 days postoperatively was determined using the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Ninety-two patients (41.8%) developed AKI and 18 (8.2%) required renal replacement therapy within the first postoperative week. Among patients who developed AKI, 57 patients (25.9%) were KDIGO stage 1, 27 patients (12.3%) were KDIGO stage 2, and eight patients (3.6%) were KDIGO stage 3. RACHS-1 (Risk-Adjusted classification for Congenital Heart Surgery) category, perioperative transfusion and fluid administration as well as fluid overload were compared between patients with and without AKI. Multivariable logistic regression analyses determined the risk factors for AKI. AKI was associated with longer hospital stay or ICU stay, and frequent sternal wound infections. Younger age (<12 months) [odds ratio (OR), 4.01; 95% confidence interval (CI), 1.77-9.06], longer cardiopulmonary bypass (CPB) time (OR, 2.45; 95% CI, 1.24-4.84), and low preoperative hemoglobin (OR, 2.40; 95% CI, 1.07-5.40) were independent risk factors for AKI. Fluid overload was not a significant predictor for AKI. When a variable of hemoglobin concentration increase (>3 g/dI) from preoperative level on POD1 was entered into the multivariable analysis, it was independently associated with postoperative AKI (OR, 6.51; 95% CI, 2.23-19.03 compared with no increase). This association was significant after adjustment with patient demographics, medication history and RACHS-1 category (hemoglobin increase >3g/dl vs. no increase: adjusted OR, 6.94; 95% CI, 2.33-20.69), regardless of different age groups and cyanotic or non-cyanotic heart disease. Prospective trials are required to evaluate whether correction of preoperative anemia and prevention of hemoconcentration may ameliorate postoperative AKI in patients who underwent congenital cardiac surgery.	[Park, Sun-Kyung; Hur, Min; Kim, Eunhee; Kim, Won Ho; Kim, Youngwon] Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Park, Jung Bo; Kim, Chung Su] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Yang, Ji-Hyuk; Jun, Tae-Gook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, WH (corresponding author), Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	wonhokim.ane@gmail.com	Park, Sun/GSD-9620-2022; Kim, Won Ho/S-8671-2019	Kim, Won Ho/0000-0003-1748-1296				Abu-Omar Y, 2006, PERFUSION-UK, V21, P209, DOI 10.1191/0267659106pf870oa; AlAbbas A, 2013, PEDIATR NEPHROL, V28, P1127, DOI 10.1007/s00467-013-2454-3; Amar D, 2007, EUR J CARDIO-THORAC, V32, P431, DOI 10.1016/j.ejcts.2007.06.017; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Aydin SI, 2012, ANN THORAC SURG, V94, P1589, DOI 10.1016/j.athoracsur.2012.06.050; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; Baskurt OK, 1998, FREE RADICAL BIO MED, V24, P102, DOI 10.1016/S0891-5849(97)00169-X; Bellomo R, 2008, INT J ARTIF ORGANS, V31, P166, DOI 10.1177/039139880803100210; Bishara N, 2009, SEMIN PERINATOL, V33, P29, DOI 10.1053/j.semperi.2008.10.006; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Haase M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001426; Haddad F, 2011, J CARD FAIL, V17, P533, DOI 10.1016/j.cardfail.2011.03.003; Hammel JM, 2013, ANN THORAC SURG, V96, P1721, DOI 10.1016/j.athoracsur.2013.06.033; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Huo YL, 2009, J APPL PHYSIOL, V107, P500, DOI 10.1152/japplphysiol.91013.2008; Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028; Karkouti K, 2011, ANESTHESIOLOGY, V115, P523, DOI 10.1097/ALN.0b013e318229a7e8; Kim E, 2016, J CARDIOTHORAC VASC; Kim WH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000273; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Lex DJ, 2014, ANN THORAC SURG, V97, P202, DOI 10.1016/j.athoracsur.2013.09.014; Li S, 2011, CRIT CARE MED, V39, P1493, DOI 10.1097/CCM.0b013e31821201d3; Mariscalco G, 2011, ANN THORAC SURG, V92, P1539, DOI 10.1016/j.athoracsur.2011.04.123; Matsumoto T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126229; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110865; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Morgan CJ, 2013, J PEDIATR-US, V162, P120, DOI 10.1016/j.jpeds.2012.06.054; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Onder AM, 2016, PEDIATR CRIT CARE ME, V17, P753, DOI 10.1097/PCC.0000000000000834; Pedersen KR, 2007, ACTA ANAESTH SCAND, V51, P1344, DOI 10.1111/j.1399-6576.2007.01379.x; Piggott KD, 2015, WORLD J PEDIATR CONG, V6, P401, DOI 10.1177/2150135115586814; Ricci Z, 2011, CRIT CARE, V15, DOI 10.1186/cc10295; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Schwartz GJ, 2007, PEDIATR NEPHROL, V22, P1839, DOI 10.1007/s00467-006-0358-1; Seguin J, 2014, CRIT CARE MED, V42, P2591, DOI 10.1097/CCM.0000000000000517; Selewski DT, 2014, INTENS CARE MED, V40, P1481, DOI 10.1007/s00134-014-3391-8; Shacham Y, 2015, CLIN EXP NEPHROL, V19, P838, DOI 10.1007/s10157-014-1071-1; Shin SR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2985148; Skippen P W, 2005, Crit Care Resusc, V7, P286; Strauss RG, 2001, TRANSFUS MED REV, V15, P213, DOI 10.1053/tmrv.2001.24592; Taylor ML, 2013, J THORAC CARDIOV SUR, V146, P146, DOI 10.1016/j.jtcvs.2012.09.008; Toth R, 2012, ANN THORAC SURG, V93, P1984, DOI 10.1016/j.athoracsur.2011.10.046; Westhoff JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143628; Xu JR, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001360; Zappitelli M, 2009, KIDNEY INT, V76, P885, DOI 10.1038/ki.2009.270	47	66	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166328	10.1371/journal.pone.0166328	http://dx.doi.org/10.1371/journal.pone.0166328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832187	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000100
J	Qi, LF; Liu, Y; Tao, HZ; Xiao, N; Li, JN; Kong, LY; Hou, LT				Qi, Lifang; Liu, Yan; Tao, Huizhu; Xiao, Ning; Li, Jinnian; Kong, Lingyan; Hou, Liting			Screening a Phage Display Library for Two Novel OmpU-Binding Peptides with Adhesion Antagonistic Activity against Vibrio mimicus	PLOS ONE			English	Article							POLYSTYRENE; ANTIBODIES; INFECTION; AFFINITY; CATFISH	Vibrio mimicus is a pathogen that causes ascites disease in fish. We have previously demonstrated that the outer membrane protein U (OmpU) is an important adhesin in V. mimicus. Here eight specific OmpU-binding phage clones, which presented three different OmpU-binding peptides (designated P1, P2, P3), were screened from a commercially available phage displayed 12-mer peptide library using rOmpU protein as target. Then, synthetic OmpU-binding peptides were measured for their adhesion antagonistic activity and binding affinity via adhesion inhibition test and non-competitive ELISA, respectively. The results showed that after co-incubated with the mixture of rOmpU and P3, visible green fluorescence could be observed on the epithelioma papulosum cyprinidi (EPC) cells surface; while the EPC cells co-incubated with the mixture of rOmpU and P1/P2 exhibited little green fluorescence. The average adhesion number of V. mimicus 04-14 isolate before and after treatment with peptide was 21.4 +/- 1.5, 20.8 +/- 0.8 (irrelevant peptide), 20.2 +/- 0.5 (P3), 5.1 +/- 0.7 (P1) and 3.4 +/- 0.8 (P2), respectively. There was a significant decrease in the adhesive level of 04-14 isolate treated with P1/ P2 compared to the untreated isolate (p<0.01). The affinity constants of P1 and P2 were (6.17 +/- 0.19) x 10(8) L/mol and (1.24 +/- 0.56) x 10(9) L/mol, respectively. Furthermore, protective effects of P1 and P2 on grass carps challenged with V. mimicus were preliminary detected. It was found there was delayed death of fish in the groups treated with P1/P2, and the survival rate of challenged fish improved with the increase of the dose of adhesion antagonistic peptide. Taken together, two novel OmpUbinding peptides, which possessed adhesion antagonistic activity, high affinity and a certain degree of antibacterial activity against V. mimicus, were screened and identified.	[Qi, Lifang; Liu, Yan; Tao, Huizhu; Xiao, Ning; Li, Jinnian; Kong, Lingyan; Hou, Liting] Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei 230036, Peoples R China	Anhui Agricultural University	Li, JN (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei 230036, Peoples R China.	lijinnian2000@163.com	li, lijinnian/HDO-3498-2022		China Natural Science Foundation [31272696, 31672698]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the China Natural Science Foundation (No. 31272696 and No.31672698). http://www.nsfc.gov.cn/publish/portal1/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albericio F, 2012, FUTURE MED CHEM, V4, P1527, DOI [10.4155/fmc.12.94, 10.4155/FMC.12.94]; Azimzadeh A, 1990, J Mol Recognit, V3, P108, DOI 10.1002/jmr.300030304; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; [毕仙民 BI Xianmin], 2007, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V32, P232; BOUDET F, 1991, J IMMUNOL METHODS, V142, P73, DOI 10.1016/0022-1759(91)90294-P; Cen JY, 2013, FISH SHELLFISH IMMUN, V34, P291, DOI 10.1016/j.fsi.2012.11.015; Gao HuiHui, 2015, Journal of Fisheries of China, V39, P557; Geng Y, 2014, AQUACULTURE, V433, P82, DOI 10.1016/j.aquaculture.2014.05.053; Hamzeh-Mivehroud M, 2012, CHEM BIOL DRUG DES, V79, P246, DOI 10.1111/j.1747-0285.2011.01282.x; Hoogenboom Hennie R, 2002, Methods Mol Biol, V178, P1; Kim SY, 2010, J DAIRY SCI, V93, P3610, DOI 10.3168/jds.2010-3129; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Loomans EEMG, 1997, ANAL BIOCHEM, V248, P117, DOI 10.1006/abio.1997.2119; LOOMANS EEMG, 1995, J IMMUNOL METHODS, V184, P207, DOI 10.1016/0022-1759(95)00089-S; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; Sidhu SS, 2000, CURR OPIN BIOTECH, V11, P610, DOI 10.1016/S0958-1669(00)00152-X; Sneha S, 2014, PLOS ONE, V10; STENBERG M, 1988, J IMMUNOL METHODS, V113, P3, DOI 10.1016/0022-1759(88)90376-6; [许元生 Xu Yuansheng], 2014, [免疫学杂志, Immunological Journal], V30, P560; Xueqin L, 2015, PLOS ONE, V10; Yang Q, 2005, VACCINE, V23, P4088, DOI 10.1016/j.vaccine.2004.07.005; Young KN, 2014, PLOS ONE, V10; Zhang X, 2014, AQUACULTURE, V432, P119, DOI 10.1016/j.aquaculture.2014.04.039	24	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165092	10.1371/journal.pone.0165092	http://dx.doi.org/10.1371/journal.pone.0165092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832083	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000008
J	Ahmed, BS; Sahib, MA; Gambardella, LM; Afzal, W; Zamli, KZ				Ahmed, Bestoun S.; Sahib, Mouayad A.; Gambardella, Luca M.; Afzal, Wasif; Zamli, Kamal Z.			Optimum Design of (PID mu)-D-lambda Controller for an Automatic Voltage Regulator System Using Combinatorial Test Design	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; PID CONTROLLER; PERFORMANCE ANALYSIS; COVERING ARRAYS; ALGORITHM; GENERATION; STRATEGY	Combinatorial test design is a plan of test that aims to reduce the amount of test cases systematically by choosing a subset of the test cases based on the combination of input variables. The subset covers all possible combinations of a given strength and hence tries to match the effectiveness of the exhaustive set. This mechanism of reduction has been used successfully in software testing research with t-way testing (where t indicates the interaction strength of combinations). Potentially, other systems may exhibit many similarities with this approach. Hence, it could form an emerging application in different areas of research due to its usefulness. To this end, more recently it has been applied in a few research areas successfully. In this paper, we explore the applicability of combinatorial test design technique for Fractional Order (FO), Proportional-Integral-Derivative (PID) parameter design controller, named as FOPID, for an automatic voltage regulator (AVR) system. Throughout the paper, we justify this new application theoretically and practically through simulations. In addition, we report on first experiments indicating its practical use in this field. We design different algorithms and adapted other strategies to cover all the combinations with an optimum and effective test set. Our findings indicate that combinatorial test design can find the combinations that lead to optimum design. Besides this, we also found that by increasing the strength of combination, we can approach to the optimum design in a way that with only 4-way combinatorial set, we can get the effectiveness of an exhaustive test set. This significantly reduced the number of tests needed and thus leads to an approach that optimizes design of parameters quickly.	[Ahmed, Bestoun S.; Gambardella, Luca M.] Ist Dalle Molle Studi SullIntelligenza Artificial, CH-6928 Manno Lugano, Switzerland; [Ahmed, Bestoun S.; Sahib, Mouayad A.] Salahaddin Univ, Engn Coll, Software & Informat Engn Dept, Erbil, Kurdistan Regio, Iraq; [Afzal, Wasif] Malardalen Univ, Sch Innovat Design & Engn, Vasteras, Sweden; [Zamli, Kamal Z.] Univ Malaysia Pahang Lebuhraya Tun Rezak, Fac Comp Syst & Software Engn, IBM Ctr Excellence, Kuantan 26300, Pahang Darul Ma, Malaysia	Universita della Svizzera Italiana; Salahaddin University; Malardalen University	Ahmed, BS (corresponding author), Ist Dalle Molle Studi SullIntelligenza Artificial, CH-6928 Manno Lugano, Switzerland.; Ahmed, BS (corresponding author), Salahaddin Univ, Engn Coll, Software & Informat Engn Dept, Erbil, Kurdistan Regio, Iraq.	bestoun@idsia.ch	Sahib, Mouayad A./R-9376-2017; Zamli, Kamal Z./F-6437-2010; Ahmed, Bestoun S./B-4429-2010	Sahib, Mouayad A./0000-0001-5670-0979; Zamli, Kamal Z./0000-0003-4626-0513; Ahmed, Bestoun S./0000-0001-9051-7609	Ministry of Higher Education, Malaysia [RDU130617]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	The work reported in this paper is funded by the generous Exploratory Research Grant "A Computational Strategy for Sequenced based t-way Testing" from the Ministry of Higher Education, Malaysia, grant number RDU130617.r The work reported in this paper is funded by the generous Exploratory Research Grant-"A Computational Strategy for Sequenced based t-way Testing" from the Ministry of Higher Education, Malaysia, Grant number: RDU130617.	Ahmed BS, 2015, INFORM SOFTWARE TECH, V66, P13, DOI 10.1016/j.infsof.2015.05.005; Ahmed BS, 2012, APPL SOFT COMPUT, V12, P1330, DOI 10.1016/j.asoc.2011.11.029; AlRashidi MR, 2009, IEEE T EVOLUT COMPUT, V13, P913, DOI 10.1109/TEVC.2006.880326; Arya Y, 2016, SWARM EVOLU IN PRESS; Babu AGS, 2016, IFAC PAPERSONLINE, V49, P456, DOI 10.1016/j.ifacol.2016.03.096; BORODAI SY, 1992, CYBERN SYST ANAL+, V28, P504, DOI 10.1007/BF01124983; Bouafoura MK, 2010, COMMUN NONLINEAR SCI, V15, P1267, DOI 10.1016/j.cnsns.2009.05.047; Bryce RC, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1082; Cohen M. B., 2006, SIGSOFT SOFTW ENG NO, V31, P1, DOI DOI 10.1145/1218776.1218785; Cohen MB, 2008, DISCRETE MATH, V308, P2709, DOI 10.1016/j.disc.2006.06.036; Cohen MB, 2008, IEEE T SOFTWARE ENG, V34, P633, DOI 10.1109/TSE.2008.50; Dorcak L, 2002, P ICCC 2001 KRVN POL, P15; Gaing ZL, 2004, IEEE T ENERGY CONVER, V19, P384, DOI 10.1109/TEC.2003.821821; Gozde H, 2011, J FRANKLIN I, V348, P1927, DOI 10.1016/j.jfranklin.2011.05.012; Grindal M, 2005, SOFTW TEST VERIF REL, V15, P167, DOI 10.1002/stvr.319; Harman M, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379787; Hartman A, 2005, GRAPH THEORY, COMBINATORICS AND ALGORITHMS: INTERDISCIPLINARY APPLICATIONS, P237; Hoskins DS, 2005, P 5 INT WORKSH SOFTW, P131; Krohling RA, 2001, IEEE T EVOLUT COMPUT, V5, P78, DOI 10.1109/4235.910467; Kuliamin VV, 2011, PROGRAM COMPUT SOFT+, V37, P121, DOI 10.1134/S0361768811030029; Lee CH, 2010, EXPERT SYST APPL, V37, P8871, DOI 10.1016/j.eswa.2010.06.009; Lei Y, 2008, SOFTW TEST VERIF REL, V18, P125, DOI 10.1002/stvr.381; Lei Y, 2007, SOFTW TEST VERIF REL, V17, P207, DOI 10.1002/stvr.369; Ma CB, 2004, IEEE INT POWER ELEC, P1477; Mahmoud T, 2015, EXPERT SYST APPL, V42, P8753, DOI 10.1016/j.eswa.2015.07.029; Meng L, 2009, P 21 ANN INT C CHIN, P3885, DOI [10.1109/CCDC.2009.5191796, DOI 10.1109/CCDC.2009.5191796]; Nie CH, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1883612.1883618; Nurmela KJ, 2004, DISCRETE APPL MATH, V138, P143, DOI 10.1016/S0166-218X(03)00291-9; Oustaloup A, 1999, SERIE AUTOMATIQUE HE; Panda S, 2012, J FRANKLIN I, V349, P2609, DOI 10.1016/j.jfranklin.2012.06.008; Pelillo M, 2001, EVOLUTIONARY GAME DY, P182, DOI [10.1007/3-540-45365-2_19, DOI 10.1007/3-540-45365-2_19]; Petras I., 1999, Journal of Electrical Engineering, V50, P284; Podlubny I, 1999, IEEE T AUTOMAT CONTR, V44, P208, DOI 10.1109/9.739144; Ramezanian H, 2013, J CONTROL AUTOM ELEC, V24, P601, DOI 10.1007/s40313-013-0057-7; Sahib MA, 2014, J CONTROL SCI ENG, V2014, DOI 10.1155/2014/576868; Sahib MA, 2016, J ADV RES, V7, P125, DOI 10.1016/j.jare.2015.03.004; Sahib MA, 2015, ENG SCI TECHNOL, V18, P194, DOI 10.1016/j.jestch.2014.11.006; Shasha DE, 2001, PLANT PHYSIOL, V127, P1590, DOI 10.1104/pp.010683; Shiba T., 2004, Proceedings of the 28th Annual International Computer Software and Applications Conference. COMPSAC 2004, P72, DOI 10.1109/CMPSAC.2004.1342808; Sloane N., 1993, J COMB DES, V1, P51, DOI [DOI 10.1002/JCD.3180010106, 10.1002/jcd.3180010106]; Tang YG, 2012, EXPERT SYST APPL, V39, P6887, DOI 10.1016/j.eswa.2012.01.007; Vinagre BM, 2000, IFAC WORK S, P51; Visioli A, 2001, IEE P-CONTR THEOR AP, V148, P1, DOI 10.1049/ip-cta:20010232; Wang WH, 2016, SOFTW TEST VERIF REL, V26, P318, DOI 10.1002/stvr.1599; Wang WH, 2011, I C DEPEND SYS NETWO, P269, DOI [10.1109/ICMTMA.2011.638, 10.1109/DSN.2011.5958225]; WU QH, 1992, IEEE T NEURAL NETWOR, V3, P95, DOI 10.1109/72.105421; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002; Zamani A, 2016, ISA T, V64, P56, DOI 10.1016/j.isatra.2016.04.021; Zamani M, 2009, CONTROL ENG PRACT, V17, P1380, DOI 10.1016/j.conengprac.2009.07.005; Zeng GQ, 2015, NEUROCOMPUTING, V160, P173, DOI 10.1016/j.neucom.2015.02.051	51	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166150	10.1371/journal.pone.0166150	http://dx.doi.org/10.1371/journal.pone.0166150			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829025	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300090
J	Liu, S; Li, SJ; Wang, BJ; Lin, X; Wu, Y; Liu, H; Qu, XM; Dai, JH; Zhou, XT; Zhou, H				Liu, Shuai; Li, Shengjie; Wang, Bingjie; Lin, Xiao; Wu, Yi; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao			Scleral Cross-Linking Using Riboflavin UVA Irradiation for the Prevention of Myopia Progression in a Guinea Pig Model: Blocked Axial Extension and Altered Scleral Microstructure	PLOS ONE			English	Article							COLLAGEN; REINFORCEMENT; ULTRAVIOLET; ELONGATION; MONKEYS	Purpose To develop methods of collagen cross-linking (CXL) in the sclera for the treatment of progressive myopia and to investigate the biomechanical and histological changes that occur in as a result. Methods Twenty 14-day-old guinea pigs were divided into 3 groups: the cross-linking group (CL, n = 8), non cross-linking group (NCL, n = 8), and control group (n = 4). The scleras of the right eyes of the guinea pigs in the CL group were surgically exposed and riboflavin was dropped onto the irradiation zone for 20 seconds prior to ultraviolet-A (UVA) irradiation. The same procedure was conducted on the NCL group but without UVA irradiation. No procedure was conducted on the control group. The right eyes of the guinea pigs in the CL and NCL groups were then fitted with -10.00DS optics for six weeks. Retinoscopy and the axial lengths (AXL) were measured at baseline, and at the second, fourth and sixth weeks post-treatment in all three groups. All animal subjects were euthanized after the sixth week and then biomechanical and histopathological examinations of the scleras were conducted. Results The mean AXL of the NCL group was longer than both the control and CL groups at six weeks (P = 0.001). The mean refractive error in the NCL group was statistically significantly more negative than both the control and the CL groups at six weeks (P = 0.001). The scleral collagen fiber arrangements of the CL and control groups were denser and more regularly distributed than the NCL group. Ultimate stress of the sclera was lowest in the NCL group, followed by the CL then the control group (P<0.05). Ultimate strain (%) of the sclera was lowest in the CL group followed by the NCL and then the control group (P<0.05). Conclusion Our study demonstrates that scleral CXL using riboflavin UVA irradiation effectively prevents the progression of myopia by increasing scleral biomechanical strength in a guinea pig model.	[Liu, Shuai; Li, Shengjie; Wang, Bingjie; Lin, Xiao; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China; [Liu, Shuai] First Peoples Hosp Hefei, Dept Prehosp Emergency, Hefei, Anhui, Peoples R China; [Wang, Bingjie; Lin, Xiao; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao] Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China; [Wang, Bingjie; Lin, Xiao; Liu, Hong; Qu, Xiaomei; Dai, Jinhui; Zhou, Xingtao; Zhou, Hao] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China; [Li, Shengjie] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Clin Lab, Shanghai, Peoples R China; [Wu, Yi] Anhui Med Univ, Peoples Hosp Fuyang, Infect Dept, Hefei, Anhui, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Anhui Medical University	Zhou, H (corresponding author), Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Visual Sci, Shanghai, Peoples R China.; Zhou, H (corresponding author), Fudan Univ, Minist Hlth, Key Lab Myopia, Shanghai, Peoples R China.; Zhou, H (corresponding author), Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai, Peoples R China.	zheent@163.com	zhou, xt/GWZ-9212-2022; Li, Shengjie/AAU-7902-2021	Wang, Bingjie/0000-0002-1199-6240; Lin, Xiao/0000-0002-5867-6455	Shanghai Science and Technology Committee [134119a5100]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research project was supported by Shanghai Science and Technology Committee (134119a5100).; This research project was supported by the Shanghai Science and Technology Committee (134119a5100). The authors would like to acknowledge Dr Rajeev Naidu, BOptom (Hons), B. Sc. (UNSW), Sydney, Australia, for his help in editing and proofreading the final paper.	Avetisov ES, 1997, ACTA OPHTHALMOL SCAN, V75, P618; BALDWIN WR, 1981, AM J OPTOM PHYS OPT, V58, P516; Choi S, 2013, LASER MED SCI, V28, P1289, DOI 10.1007/s10103-012-1237-6; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Dotan A, 2014, EXP EYE RES, V127, P190, DOI 10.1016/j.exer.2014.07.019; FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314; Gilmartin B, 2004, CLIN EXP OPHTHALMOL, V32, P305, DOI 10.1111/j.1442-9071.2004.00831.x; Hovakimyan M, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/406850; Hung LF, 2000, INVEST OPHTH VIS SCI, V41, P1259; IUVONE PM, 1991, INVEST OPHTH VIS SCI, V32, P1674; Jacob JT, 1997, J BIOMED MATER RES, V37, P525, DOI 10.1002/(SICI)1097-4636(19971215)37:4<525::AID-JBM11>3.0.CO;2-7; LIU K-R, 1986, Taiwan yixuehui zazhi, V85, P1032; Lu F, 2009, EXP EYE RES, V89, P101, DOI 10.1016/j.exer.2009.02.019; MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; NORTON TT, 1995, INVEST OPHTH VIS SCI, V36, pS760; Pitts JD, 2002, PHOTOCHEM PHOTOBIOL, V76, P135, DOI 10.1562/0031-8655(2002)076<0135:NPFMET>2.0.CO;2; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Saw SM, 2002, BRIT J OPHTHALMOL, V86, P1306, DOI 10.1136/bjo.86.11.1306; SMITH EL, 1980, INVEST OPHTH VIS SCI, V19, P1250; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Weiss AH, 2003, BRIT J OPHTHALMOL, V87, P1025, DOI 10.1136/bjo.87.8.1025; Wollensak G, 2005, ACTA OPHTHALMOL SCAN, V83, P477, DOI 10.1111/j.1600-0420.2005.00447.x; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1	26	17	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165792	10.1371/journal.pone.0165792	http://dx.doi.org/10.1371/journal.pone.0165792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829051	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300061
J	Lutz, AF; Immerzeel, WW; Kraaijenbrink, PDA; Shrestha, AB; Bierkens, MFP				Lutz, A. F.; Immerzeel, W. W.; Kraaijenbrink, P. D. A.; Shrestha, A. B.; Bierkens, M. F. P.			Climate Change Impacts on the Upper Indus Hydrology: Sources, Shifts and Extremes	PLOS ONE			English	Article							GLACIER MASS BALANCES; RISING RIVER FLOWS; BIAS CORRECTION; SNOW COVER; KARAKORAM-HIMALAYA; STATISTICAL CORRECTION; WATER-RESOURCES; PRECIPITATION; BASIN; MODEL	The Indus basin heavily depends on its upstream mountainous part for the downstream supply of water while downstream demands are high. Since downstream demands will likely continue to increase, accurate hydrological projections for the future supply are important. We use an ensemble of statistically downscaled CMIP5 General Circulation Model outputs for RCP4.5 and RCP8.5 to force a cryospheric-hydrological model and generate transient hydrological projections for the entire 21 st century for the upper Indus basin. Three methodological advances are introduced: (i) A new precipitation dataset that corrects for the underestimation of high-altitude precipitation is used. (ii) The model is calibrated using data on river runoff, snow cover and geodetic glacier mass balance. (iii) An advanced statistical downscaling technique is used that accounts for changes in precipitation extremes. The analysis of the results focuses on changes in sources of runoff, seasonality and hydrological extremes. We conclude that the future of the upper Indus basin's water availability is highly uncertain in the long run, mainly due to the large spread in the future precipitation projections. Despite large uncertainties in the future climate and long-term water availability, basin-wide patterns and trends of seasonal shifts in water availability are consistent across climate change scenarios. Most prominent is the attenuation of the annual hydrograph and shift from summer peak flow towards the other seasons for most ensemble members. In addition there are distinct spatial patterns in the response that relate to monsoon influence and the importance of meltwater. Analysis of future hydrological extremes reveals that increases in intensity and frequency of extreme discharges are very likely for most of the upper Indus basin and most ensemble members.	[Lutz, A. F.; Immerzeel, W. W.] FutureWater, Costerweg 1V, NL-6702 AA Wageningen, Netherlands; [Lutz, A. F.; Immerzeel, W. W.; Kraaijenbrink, P. D. A.; Bierkens, M. F. P.] Univ Utrecht, Dept Phys Geog, POB 80115, NL-3508 TC Utrecht, Netherlands; [Shrestha, A. B.] Int Ctr Integrated Mt Dev, GPO Box 3226, Khumaltar, Kathmandu, Nepal	Utrecht University	Lutz, AF (corresponding author), FutureWater, Costerweg 1V, NL-6702 AA Wageningen, Netherlands.; Lutz, AF (corresponding author), Univ Utrecht, Dept Phys Geog, POB 80115, NL-3508 TC Utrecht, Netherlands.	a.lutz@futurewater.nl	Bierkens, Marc F.P./AAE-8176-2019	Lutz, Arthur/0000-0002-6327-1487; Immerzeel, Walter/0000-0002-2010-9543; Kraaijenbrink, Philip/0000-0002-0126-8602; Bierkens, Marc F.P./0000-0002-7411-6562	United Kingdom's Department for International Development (DFID); e International Development Research Centre (IDRC), Ottawa, Canada; European Research Council (ERC) [676819]; ICIMOD; AFL; WWI; ABS; WWI [676819]	United Kingdom's Department for International Development (DFID); e International Development Research Centre (IDRC), Ottawa, Canada; European Research Council (ERC)(European Research Council (ERC)); ICIMOD; AFL; WWI; ABS; WWI	This study was undertaken under the Indus Basin Programme of ICI MOD, funded in part by the United Kingdom's Department for International Development (DFID), through their financial support of core research at ICIMOD. This work is partly carried out by the Himalayan Adaptation, Water and Resilience (HI-AWARE) consortium under the Collaborative Adaptation Research Initiative in Africa and Asia (CARIAA) with financial support from the United Kingdom's Department for International Development (DFID) and the International Development Research Centre (IDRC), Ottawa, Canada. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 676819). In addition, this work was partially supported by core funds of ICIMOD contributed by the governments of Afghanistan, Australia, Austria, Bangladesh, Bhutan, China, India, Myanmar, Nepal, Norway, Pakistan, Switzerland, and the United Kingdom. DFID partly funds ICIMOD's Indus Basin Programme, under which this study was undertaken. These funds partly supported the contributions of AFL, WWI and ABS. DFID and IDRC funds the HI-AWARE consortium, of which ICIMOD and FutureWater are consortium members. These funds partly supported the contributions of AFL, WWI and ABS. ERC partly funded the contribution of WWI through grant agreement 676819. ICIMOD core funds partly funded the contribution of ABS. AFL and WWI are employed by FutureWater. Future Water provided support in the form of salaries for authors AFL and WWI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali S, 2015, ENVIRON RES LETT, P10, DOI [10.1086/1748-9326/10/014007, DOI 10.1086/1748-9326/10/014007]; Archer DR, 2004, HYDROL EARTH SYST SC, V8, P47, DOI 10.5194/hess-8-47-2004; Arnell NW, 1999, GLOBAL ENVIRON CHANG, V9, pS31, DOI 10.1016/S0959-3780(99)00017-5; Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Bahr DB, 1997, J GEOPHYS RES-SOL EA, V102, P20355, DOI 10.1029/97JB01696; Bajracharya S.R., 2011, STATUS GLACIERS HIND; Barros AP, 2004, NAT HAZARD EARTH SYS, V4, P29, DOI 10.5194/nhess-4-29-2004; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bernhardt M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043086; Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; Biemans H, 2013, SCI TOTAL ENVIRON, V468, pS117, DOI 10.1016/j.scitotenv.2013.05.092; Biemans H, 2009, J HYDROMETEOROL, V10, P1011, DOI 10.1175/2008JHM1067.1; Bliss A, 2014, J GEOPHYS RES-EARTH, V119, P717, DOI 10.1002/2013JF002931; Bocchiola D, 2011, HYDROL EARTH SYST SC, V15, P2059, DOI 10.5194/hess-15-2059-2011; Bocchiola D, 2013, THEOR APPL CLIMATOL, V113, P611, DOI 10.1007/s00704-012-0803-y; Bookhagen B, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001426; Bordoy R, 2013, J APPL METEOROL CLIM, V52, P82, DOI 10.1175/JAMC-D-11-0149.1; Cannon AJ, 2015, J CLIMATE, V28, P1260, DOI 10.1175/JCLI-D-14-00636.1; Cannon F, 2016, THEOR APPL CLIMATOL, V125, P27, DOI 10.1007/s00704-015-1489-8; Cannon F, 2015, CLIM DYNAM, V44, P441, DOI 10.1007/s00382-014-2248-8; Cheema MJM, 2014, GROUNDWATER, V52, P25, DOI 10.1111/gwat.12027; Cheema MJM, 2012, INT J REMOTE SENS, V33, P2603, DOI 10.1080/01431161.2011.617397; Dahri ZH, 2016, SCI TOTAL ENVIRON, V548, P289, DOI 10.1016/j.scitotenv.2016.01.001; De Souza K, 2015, REG ENVIRON CHANGE, V15, P747, DOI 10.1007/s10113-015-0755-8; Defourny P., 2007, P ISPRS COMM 7 MIDT, P8; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Doherty J., 2005, PEST MODEL INDEPENDE, V5th; Ehret U, 2012, HYDROL EARTH SYST SC, V16, P3391, DOI 10.5194/hess-16-3391-2012; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2012, HARM WORLD SOIL DAT; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Forsythe N, 2014, J HYDROL, V517, P1019, DOI 10.1016/j.jhydrol.2014.06.031; Fowler HJ, 2006, J CLIMATE, V19, P4276, DOI 10.1175/JCLI3860.1; Frey H, 2014, CRYOSPHERE, V8, P2313, DOI 10.5194/tc-8-2313-2014; Gardelle J, 2013, CRYOSPHERE, V7, P1263, DOI 10.5194/tc-7-1263-2013; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Gleeson T, 2012, NATURE, V488, P197, DOI 10.1038/nature11295; Gobiet A, 2015, HYDROL EARTH SYST SC, V19, P4055, DOI 10.5194/hess-19-4055-2015; Gumbel EJ, 1941, ANN MATH STAT, V12, P163, DOI 10.1214/aoms/1177731747; Hall DK, 2002, REMOTE SENS ENVIRON, V83, P181, DOI 10.1016/S0034-4257(02)00095-0; Hasson S, 2014, HYDROL EARTH SYST SC, V18, P4077, DOI 10.5194/hess-18-4077-2014; Hempel S, 2013, EARTH SYST DYNAM, V4, P219, DOI 10.5194/esd-4-219-2013; Hewitt K, 2007, J GLACIOL, V53, P181, DOI 10.3189/172756507782202829; Hewitt K, 2011, MT RES DEV, V31, P188, DOI 10.1659/MRD-JOURNAL-D-11-00020.1; Hock R, 2003, J HYDROL, V282, P104, DOI 10.1016/S0022-1694(03)00257-9; Houze RA, 2011, B AM METEOROL SOC, V92, P291, DOI 10.1175/2010BAMS3173.1; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Immerzeel WW, 2015, HYDROL EARTH SYST SC, V19, P4673, DOI 10.5194/hess-19-4673-2015; Immerzeel WW, 2013, NAT GEOSCI, V6, P742, DOI [10.1038/NGEO1896, 10.1038/ngeo1896]; Immerzeel WW, 2012, NAT GEOSCI, V5, P841, DOI 10.1038/ngeo1643; Immerzeel WW, 2009, REMOTE SENS ENVIRON, V113, P40, DOI 10.1016/j.rse.2008.08.010; Immerzeel WW, 2012, MT RES DEV, V32, P30, DOI 10.1659/MRD-JOURNAL-D-11-00097.1; Jain SK, 2007, INDUS BASIN HYDROLOG; Joseph, 2016, CRYOSPH DISCUSS, P1, DOI [10.5194/tc-2016-197, DOI 10.5194/TC-2016-197]; Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kapnick SB, 2014, NAT GEOSCI, V7, P834, DOI 10.1038/NGEO2269; Kay AL, 2009, CLIMATIC CHANGE, V92, P41, DOI 10.1007/s10584-008-9471-4; Keshavarzi A., 2010, ProEnvironment / ProMediu, V3, P322; Khan F, 2015, INT J GLOBAL WARM, V8, P46, DOI 10.1504/IJGW.2015.071583; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Koppes M, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00059; Kraaijenbrink P., 2013, ADV DELTA CHANGE MET; Leander R, 2007, J HYDROL, V332, P487, DOI 10.1016/j.jhydrol.2006.08.006; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lenaerts JTM, 2010, CRYOSPHERE, V4, P179, DOI 10.5194/tc-4-179-2010; Lutz AF, 2014, NAT CLIM CHANGE, V4, P587, DOI [10.1038/NCLIMATE2237, 10.1038/nclimate2237]; Lutz AF, 2013, HYDROL EARTH SYST SC, V17, P3661, DOI 10.5194/hess-17-3661-2013; Lutz AF, 2016, INT J CLIMA IN PRESS; MacDonald MK, 2010, HYDROL EARTH SYST SC, V14, P1401, DOI 10.5194/hess-14-1401-2010; Mathison C, 2015, HYDROL EARTH SYST SC, V19, P4783, DOI 10.5194/hess-19-4783-2015; Maurer EP, 2014, HYDROL EARTH SYST SC, V18, P915, DOI 10.5194/hess-18-915-2014; Maussion F, 2014, J CLIMATE, V27, P1910, DOI 10.1175/JCLI-D-13-00282.1; Mir RA, 2015, INT J REMOTE SENS, V36, P3837, DOI 10.1080/01431161.2015.1070320; Mirza UK, 2008, RENEW SUST ENERG REV, V12, P1641, DOI 10.1016/j.rser.2007.01.028; Mishra V, 2015, J GEOPHYS RES-ATMOS, V120, P2689, DOI 10.1002/2014JD022650; Molg T, 2014, NAT CLIM CHANGE, V4, P68, DOI [10.1038/nclimate2055, 10.1038/NCLIMATE2055]; Mukhopadhyay B, 2015, INT J RIVER BASIN MA, V13, P87, DOI 10.1080/15715124.2014.965718; Mukhopadhyay B, 2015, J HYDROL, V527, P119, DOI 10.1016/j.jhydrol.2015.04.045; Mukhopadhyay B, 2014, J HYDROL, V513, P192, DOI 10.1016/j.jhydrol.2014.03.042; Mukhopadhyay B, 2014, J HYDROL, V509, P549, DOI 10.1016/j.jhydrol.2013.11.059; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nepal S, 2015, INT J WATER RESOUR D, V31, P201, DOI 10.1080/07900627.2015.1030494; Nuimura T, 2015, CRYOSPHERE, V9, P849, DOI 10.5194/tc-9-849-2015; Palazzi E, 2013, J GEOPHYS RES-ATMOS, V118, P85, DOI 10.1029/2012JD018697; Palazzi E, 2015, CLIM DYNAM, V45, P21, DOI 10.1007/s00382-014-2341-z; Parajka J, 2013, HYDROL EARTH SYST SC, V17, P1783, DOI 10.5194/hess-17-1783-2013; Paul F, 2004, REMOTE SENS ENVIRON, V89, P510, DOI 10.1016/j.rse.2003.11.007; Pellicciotti F, 2012, MT RES DEV, V32, P39, DOI 10.1659/MRD-JOURNAL-D-11-00092.1; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Quincey DJ, 2009, J GLACIOL, V55, P1061, DOI 10.3189/002214309790794913; Quincey DJ, 2015, J GEOPHYS RES-EARTH, V120, P1288, DOI 10.1002/2015JF003515; Qureshi AS, 2011, MT RES DEV, V31, P252, DOI 10.1659/MRD-JOURNAL-D-11-00019.1; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Ragettli S, 2013, WATER RESOUR RES, V49, P6048, DOI 10.1002/wrcr.20450; Rajbhandari R, 2015, CLIM DYNAM, V44, P339, DOI 10.1007/s00382-014-2183-8; Ramesh KV, 2014, SCI REP-UK, V4, DOI 10.1038/srep04071; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Reggiani P, 2015, HYDROL RES, V46, P446, DOI 10.2166/nh.2014.060; Richey AS, 2015, WATER RESOUR RES, V51, P5217, DOI 10.1002/2015WR017349; Rozenberg J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/095006; Scherler D, 2011, NAT GEOSCI, V4, P156, DOI [10.1038/ngeo1068, 10.1038/NGEO1068]; Sharif M, 2013, HYDROL EARTH SYST SC, V17, P1503, DOI 10.5194/hess-17-1503-2013; Siddiqi A, 2012, ENERG POLICY, V50, P228, DOI 10.1016/j.enpol.2012.06.063; Soncini A, 2015, J HYDROMETEOROL, V16, P306, DOI 10.1175/JHM-D-14-0043.1; Sorg A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104018; Sperber K, 2013, CLIM DYNAM, V41, P2711, DOI 10.1007/s00382-012-1607-6; Sperber KR, 2014, CLIM DYNAM, V43, P3219, DOI 10.1007/s00382-014-2099-3; Strasser U, 2008, CRYOSPHERE, V2, P53, DOI 10.5194/tc-2-53-2008; Tachikawa T, 2011, INT GEOSCI REMOTE SE, P3657, DOI 10.1109/IGARSS.2011.6050017; Tahir AA, 2011, HYDROL EARTH SYST SC, V15, P2275, DOI 10.5194/hess-15-2275-2011; Tahir AA, 2015, SCI TOTAL ENVIRON, V505, P748, DOI 10.1016/j.scitotenv.2014.10.065; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Terink W, 2015, GEOSCI MODEL DEV, V8, P2009, DOI 10.5194/gmd-8-2009-2015; Themessl MJ, 2011, INT J CLIMATOL, V31, P1530, DOI 10.1002/joc.2168; Turner AG, 2012, NAT CLIM CHANGE, V2, P587, DOI 10.1038/NCLIMATE1495; United Nations, 2015, ESAPWP241 UN; van Pelt SC, 2012, HYDROL EARTH SYST SC, V16, P4517, DOI 10.5194/hess-16-4517-2012; Viste E, 2015, CRYOSPHERE, V9, P1147, DOI 10.5194/tc-9-1147-2015; Wagnon P, 2013, CRYOSPHERE, V7, P1769, DOI 10.5194/tc-7-1769-2013; Wanders N, 2015, J HYDROL, V526, P208, DOI 10.1016/j.jhydrol.2014.10.047; Wilcke RAI, 2016, ENVIRON MODELL SOFTW, V78, P191, DOI 10.1016/j.envsoft.2016.01.002; Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1; Zhang Y, 2006, ANN GLACIOL-SER, V43, P301, DOI 10.3189/172756406781811952; Zhao LY, 2014, GLOBAL PLANET CHANGE, V122, P197, DOI 10.1016/j.gloplacha.2014.08.006	126	170	172	11	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165630	10.1371/journal.pone.0165630	http://dx.doi.org/10.1371/journal.pone.0165630			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828994	Green Published, gold			2022-12-27	WOS:000387724300052
J	Mansfeldt, CB; Heavner, GW; Rowe, AR; Hayete, B; Church, BW; Richardson, RE				Mansfeldt, Cresten B.; Heavner, Gretchen W.; Rowe, Annette R.; Hayete, Boris; Church, Bruce W.; Richardson, Ruth E.			Inferring Gene Networks for Strains of Dehalococcoides Highlights Conserved Relationships between Genes Encoding Core Catabolic and Cell-Wall Structural Proteins	PLOS ONE			English	Article							TRANSCRIPTOMIC MICROARRAY ANALYSIS; ORGANOHALIDE-RESPIRING BACTERIA; REDUCTIVE-DEHALOGENASE; VINYL-CHLORIDE; ENRICHMENT CULTURES; FIELD DEMONSTRATION; RESPIRATION RATES; MCCARTYI STRAIN; MESSENGER-RNA; ETHENOGENES	The interpretation of high-throughput gene expression data for non-model microorganisms remains obscured because of the high fraction of hypothetical genes and the limited number of methods for the robust inference of gene networks. Therefore, to elucidate gene gene and gene-condition linkages in the bioremediation-important genus Dehalococcoides, we applied a Bayesian inference strategy called Reverse Engineering/Forward Simulation (REFS (TM)) on transcriptomic data collected from two organohalide-respiring communities containing different Dehalococcoides mccartyi strains: the Cornell University mixed community D2 and the commercially available KB-1 (R) bioaugmentation culture. In total, 49 and 24 microarray datasets were included in the REFS (TM) analysis to generate an ensemble of 1,000 networks for the Dehalococcoides population in the Cornell D2 and KB-1 (R) culture, respectively. Considering only linkages that appeared in the consensus network for each culture (exceeding the determined frequency cutoff of >= 60%), the resulting Cornell D2 and KB-1 (R) consensus networks maintained 1,105 nodes (genes or conditions) with 974 edges and 1,714 nodes with 1,455 edges, respectively. These consensus networks captured multiple strong and biologically informative relationships. One of the main highlighted relationships shared between these two cultures was a direct edge between the transcript encoding for the major reductive dehalogenase (tceA (D2) or vcrA (KB-1 (R))) and the transcript for the putative S-layer cell wall protein (DET1407 (D2) or KB1_1396 (KB-1 (R))). Additionally, transcripts for two key oxidoreductases (a [Ni Fe] hydrogenase, Hup, and a protein with similarity to a formate dehydrogenase, "Fdh") were strongly linked, generalizing a strong relationship noted previously for Dehalococcoides mccartyi strain 195 to multiple strains of Dehalococcoides. Notably, the pangenome array utilized when monitoring the KB-1 (R) culture was capable of resolving signals from multiple strains, and the network inference engine was able to reconstruct gene networks in the distinct strain populations.	[Mansfeldt, Cresten B.; Heavner, Gretchen W.; Richardson, Ruth E.] Cornell Univ, Dept Civil & Environm Engn, Ithaca, NY 14853 USA; [Rowe, Annette R.] Cornell Univ, Field Microbiol, Ithaca, NY USA; [Hayete, Boris; Church, Bruce W.] GNS Healthcare, Cambridge, MA USA	Cornell University; Cornell University	Mansfeldt, CB (corresponding author), Cornell Univ, Dept Civil & Environm Engn, Ithaca, NY 14853 USA.	cbm59@cornell.edu	Richardson, Ruth E/B-8265-2017; Hayete, Boris/ABD-4515-2020	Hayete, Boris/0000-0002-2521-1889; Mansfeldt, Cresten/0000-0002-5656-6463; Rowe, Annette/0000-0002-8761-6857	Department of Defense Army Research Office [W911NF-07-1-0249]; National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Program [CBET-0731169]; GNS Healthcare	Department of Defense Army Research Office(United States Department of Defense); National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Program; GNS Healthcare	Funding was provided to RER for this study by the Department of Defense Army Research Office (http://www.aro.army.mil/; W911NF-07-1-0249) and the National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) Program (http://www.nsf.gov/div/index.jsp?div=CBET; CBET-0731169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GNS Healthcare provided support in the form of salaries for authors [BH, BWC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	DISTEFANO TD, 1991, APPL ENVIRON MICROB, V57, P2287, DOI 10.1128/AEM.57.8.2287-2292.1991; Duhamel M, 2002, WATER RES, V36, P4193, DOI 10.1016/S0043-1354(02)00151-3; Duhamel M, 2004, APPL ENVIRON MICROB, V70, P5538, DOI 10.1128/AEM.70.9.5538-5545.2004; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Heavner G., 2013, BIOKINETIC MODELING; Heavner GLW, 2013, ENVIRON SCI TECHNOL, V47, P3724, DOI 10.1021/es303517s; Hug LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-327; Hug LA, 2011, APPL ENVIRON MICROB, V77, P5361, DOI 10.1128/AEM.00063-11; Islam MA, 2016, MICROB BIOTECHNOL, V9, P47, DOI 10.1111/1751-7915.12315; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Johnson DR, 2008, APPL ENVIRON MICROB, V74, P2864, DOI 10.1128/AEM.02208-07; Johnson DR, 2009, FEMS MICROBIOL LETT, V294, P198, DOI 10.1111/j.1574-6968.2009.01569.x; Kublik A, 2016, ENVIRON MICROBIOL, V18, P3044, DOI 10.1111/1462-2920.13200; Lee PKH, 2012, APPL ENVIRON MICROB, V78, P1424, DOI 10.1128/AEM.06792-11; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Loffler FE, 2013, INT J SYST EVOL MICR, V63, P625, DOI 10.1099/ijs.0.034926-0; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; Mansfeldt CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118404; Mansfeldt CB, 2014, APPL ENVIRON MICROB, V80, P6062, DOI 10.1128/AEM.02130-14; Maphosa F, 2010, TRENDS BIOTECHNOL, V28, P308, DOI 10.1016/j.tibtech.2010.03.005; Marco-Urrea E, 2011, J BACTERIOL, V193, P5171, DOI 10.1128/JB.05120-11; Marshall IPG, 2014, FEMS MICROBIOL ECOL, V87, P428, DOI 10.1111/1574-6941.12235; McMurdie PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000714; Morris RM, 2007, APPL ENVIRON MICROB, V73, P320, DOI 10.1128/AEM.02129-06; Neumann A, 1998, J BACTERIOL, V180, P4140, DOI 10.1128/JB.180.16.4140-4145.1998; Parthasarathy A, 2015, J AM CHEM SOC, V137, P3525, DOI 10.1021/ja511653d; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P5099, DOI 10.1021/es702912t; Rahm BG, 2008, ENVIRON SCI TECHNOL, V42, P416, DOI 10.1021/es071455s; Rahm BG, 2006, APPL ENVIRON MICROB, V72, P5486, DOI 10.1128/AEM.00855-06; Rowe AR, 2015, APPL MICROBIOL BIOT, V99, P2313, DOI 10.1007/s00253-014-6220-7; Rowe AR, 2012, ENVIRON SCI TECHNOL, V46, P9388, DOI 10.1021/es300996c; Scheutz C, 2008, ENVIRON SCI TECHNOL, V42, P9302, DOI 10.1021/es800764t; Seshadri R, 2005, SCIENCE, V307, P105, DOI 10.1126/science.1102226; Tang SQ, 2013, APPL ENVIRON MICROB, V79, P974, DOI 10.1128/AEM.01873-12; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Wagner A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0317; Waller AS, 2012, APPL ENVIRON MICROB, V78, P1178, DOI 10.1128/AEM.06416-11; Waller AS, 2005, APPL ENVIRON MICROB, V71, P8257, DOI 10.1128/AEM.71.12.8257-8264.2005; Werner JJ, 2009, ENVIRON MICROBIOL, V11, P2687, DOI 10.1111/j.1462-2920.2009.01996.x; Xiang Y, 2014, GENE REGUL SYST BIO, V8, P45, DOI 10.4137/GRSB.S13140; Xing H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001105	42	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166234	10.1371/journal.pone.0166234	http://dx.doi.org/10.1371/journal.pone.0166234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829029	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300098
J	Durrheim, K; Quayle, M; Tredoux, CG; Titlestad, K; Tooke, L				Durrheim, Kevin; Quayle, Michael; Tredoux, Colin G.; Titlestad, Kim; Tooke, Larry			Investigating the Evolution of Ingroup Favoritism Using a Minimal Group Interaction Paradigm: The Effects of Inter- and Intragroup Interdependence	PLOS ONE			English	Article							IN-GROUP FAVORITISM; SOCIAL IDENTITY; GROUP MEMBERSHIP; SELF-CATEGORIZATION; DISCRIMINATION; COOPERATION; IMPACT; RECIPROCITY; ALTRUISM; CRITIQUE	We investigated the effect of structural interdependencies between groups (especially inequality), and interdependencies between individuals on ingroup favoritism in minimal group situations. Previous research has attempted to determine whether ingroup favoritism is produced by categorization or intragroup interdependencies (reciprocation expectations), but recent literature suggests that it is not possible to tease these influences apart. We report two studies that investigate how ingroup favoritism evolves over time in social interaction. The levels of ingroup favoritism were affected by categorization and inequality, and the level of ingroup favoritism changed over time, increasing or decreasing depending on the nature of the initial intergroup structure. We conclude by providing two explanations for this change: emergent norms, and changes to the intergroup situation produced by interaction. Our experiments confirm the value of studying the evolution of minimal group behavior, especially for explaining why low status groups act to preserve intergroup inequalities.	[Durrheim, Kevin; Quayle, Michael; Titlestad, Kim; Tooke, Larry] Univ KwaZulu Natal, Dept Psychol, Pietermaritzburg, Kwazulu Natal, South Africa; [Quayle, Michael] Univ Limerick, Dept Psychol, Limerick, Ireland; [Tredoux, Colin G.] Univ Cape Town, Dept Psychol, Cape Town, Western Cape, South Africa	University of Kwazulu Natal; University of Limerick; University of Cape Town	Durrheim, K (corresponding author), Univ KwaZulu Natal, Dept Psychol, Pietermaritzburg, Kwazulu Natal, South Africa.	durrheim@ukzn.ac.za	Quayle, Michael/N-6414-2017; Tredoux, Colin G/E-7235-2010	Quayle, Michael/0000-0002-7497-0566; Tredoux, Colin G/0000-0002-9653-786X	National Research Foundation of South Africa Grant [BS1203160707]	National Research Foundation of South Africa Grant	Support was provided by National Research Foundation of South Africa Grant (BS1203160707) awarded to Kevin Durrheim [https://nrfsubmission.nrf.ac.za/NrfMklI/Default.aspx].; This research was supported by a National Research Foundation of South Africa Grant (BS1203160707) awarded to Kevin Durrheim.	Balliet D, 2014, PSYCHOL BULL, V140, P1556, DOI 10.1037/a0037737; Bettencourt BA, 2001, PSYCHOL BULL, V127, P520, DOI 10.1037//0033-2909.127.4.520; Billig M, 1976, SOCIAL PSYCHOLOGY AN; Billig M, 2012, BEYOND PREJUDICE; Brewer M.B., 2008, RATIONALITY SOCIAL R, P215, DOI DOI 10.4324/9780203889695; Cacault MP, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00729; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Condor S., 2003, THEORIES CONTROVERSI, P153; De S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17963; Diehl M, 1989, BRIT J SOC PSYCHOL, V28, P227, DOI [10.1111/j.2044-8309.1989.tb00865.x, DOI 10.1111/J.2044-8309.1989.TB00865.X]; Dorrough AR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00476; Everett JAC, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00015; Fu F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00460; Gaertner L, 2000, J PERS SOC PSYCHOL, V79, P77, DOI 10.1037//0022-3514.79.1.77; Gaertner L, 2001, EUR J SOC PSYCHOL, V31, P143, DOI 10.1002/ejsp.28; Gagnon A, 1996, PERS SOC PSYCHOL B, V22, P1289, DOI 10.1177/01461672962212009; Gao SP, 2015, PHYS LETT A, V379, P333, DOI 10.1016/j.physleta.2014.11.035; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Goette L, 2012, MANAGE SCI, V58, P948, DOI 10.1287/mnsc.1110.1466; Hammond RA, 2006, J CONFLICT RESOLUT, V50, P926, DOI 10.1177/0022002706293470; Hertel G, 2001, J EXP SOC PSYCHOL, V37, P316, DOI 10.1006/jesp.2000.1447; Hertel G, 1994, EUROPEAN J SOCIAL PS, V24, P131; Jetten J, 1996, J PERS SOC PSYCHOL, V71, P1222, DOI 10.1037/0022-3514.71.6.1222; Jost J., 2003, EUROPEAN REV SOCIAL, V13, P111, DOI [DOI 10.1080/10463280240000046, 10.1080/10463280240000046]; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Karp D., 1993, JAPANESE J EXPT SOCI, V32, P231, DOI [10.2130/jjesp.32.231, DOI 10.2130/JJESP.32.231, https://doi.org/10.2130/jjesp.32.231]; Lei V, 2010, SOUTH ECON J, V76, P1049, DOI 10.4284/sej.2010.76.4.1049; LOCKSLEY A, 1980, J PERS SOC PSYCHOL, V39, P773, DOI 10.1037/0022-3514.39.5.773; Masuda N, 2015, F1000PRIME REPORTS, V7, P1; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakamura M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-213; Platow MJ, 2012, SOC PSYCHOL PERS SCI, V3, P5, DOI 10.1177/1948550611407081; Postmes T, 2005, J PERS SOC PSYCHOL, V89, P747, DOI 10.1037/0022-3514.89.5.747; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; RABBIE JM, 1989, EUR J SOC PSYCHOL, V19, P171, DOI 10.1002/ejsp.2420190302; Rubin M, 2014, GROUP PROCESS INTERG, V17, P563, DOI 10.1177/1368430213514122; Saguy T, 2009, PSYCHOL SCI, V20, P114, DOI 10.1111/j.1467-9280.2008.02261.x; SHERIF M, 1958, AM J SOCIOL, V63, P349, DOI 10.1086/222258; Sherif M., 1966, GROUP CONFLICT COOPE; Simpson B, 2006, RATION SOC, V18, P443, DOI 10.1177/1043463106066381; Stroebe K, 2005, PERS SOC PSYCHOL B, V31, P831, DOI 10.1177/0146167204271659; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H, 1970, SCI AM, V223, P96, DOI 10.1038/scientificamerican1170-96; Tajfel H., 1981, HUMAN GROUPS SOCIAL, DOI DOI 10.1002/EJSP.2420120209; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 1972, CONTEXT SOCIAL PSYCH, P69; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tajfel Henri, 1978, SOCIAL PSYCHOL MINOR; Thomas EF, 2016, GROUP PROCESS INTERG, V19, P137, DOI 10.1177/1368430215612217; Turner J.C., 2012, THEORIES SOCIAL PSYC, P399, DOI [10.4135/9781446249222.n46, DOI 10.4135/9781446249222.N46]; Turner J.C., 1996, SOCIAL GROUPS IDENTI, P25; Turner J.C., 1987, REDISCOVERING SOCIAL; Yamagishi T, 1999, ADV GROUP, V16, P161; Yamagishi T, 2000, SOC PSYCHOL QUART, V63, P116, DOI 10.2307/2695887; Yamagishi T, 2008, RATION SOC, V20, P5, DOI 10.1177/1043463107085442	56	5	8	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165974	10.1371/journal.pone.0165974	http://dx.doi.org/10.1371/journal.pone.0165974			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851791	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300030
J	Han, TS; Tian, S; Wang, L; Liang, X; Cui, HL; Du, SS; Na, GQ; Na, LX; Sun, CH				Han, Tianshu; Tian, Shuang; Wang, Li; Liang, Xi; Cui, Hongli; Du, Shanshan; Na, Guanqiong; Na, Lixin; Sun, Changhao			Dietary Information Improves Model Performance and Predictive Ability of a Noninvasive Type 2 Diabetes Risk Model	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; SCORE; MELLITUS; CONSUMPTION; REDUCTION	There is no diabetes risk model that includes dietary predictors in Asia. We sought to develop a diet-containing noninvasive diabetes risk model in Northern China and to evaluate whether dietary predictors can improve model performance and predictive ability. Cross-sectional data for 9,734 adults aged 20-74 years old were used as the derivation data, and results obtained for a cohort of 4,515 adults with 4.2 years of follow-up were used as the validation data. We used a logistic regression model to develop a diet-containing noninvasive risk model. Akaike's information criterion (AIC), area under curve (AUC), integrated discrimination improvements (IDI), net classification improvement (NRI) and calibration statistics were calculated to explicitly assess the effect of dietary predictors on a diabetes risk model. A diet-containing type 2 diabetes risk model was developed. The significant dietary predictors including the consumption of staple foods, livestock, eggs, potato, dairy products, fresh fruit and vegetables were included in the risk model. Dietary predictors improved the noninvasive diabetes risk model with a significant increase in the AUC (delta AUC = 0.03, P<0.001), an increase in relative IDI (24.6%, P-value for IDI <0.001), an increase in NRI (category-free NRI = 0.155, P<0.001), an increase in sensitivity of the model with 7.3% and a decrease in AIC (delta AIC = 199.5). The results of the validation data were similar to the derivation data. The calibration of the diet-containing diabetes risk model was better than that of the risk model without dietary predictors in the validation data. Dietary information improves model performance and predictive ability of noninvasive type 2 diabetes risk model based on classic risk factors. Dietary information may be useful for developing a noninvasive diabetes risk model.	[Han, Tianshu; Tian, Shuang; Wang, Li; Liang, Xi; Cui, Hongli; Du, Shanshan; Na, Guanqiong; Na, Lixin; Sun, Changhao] Harbin Med Univ, Natl Key Discipline, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China	Harbin Medical University	Na, LX; Sun, CH (corresponding author), Harbin Med Univ, Natl Key Discipline, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China.	nalixin2003@163.com; changhaosun2002@163.com	SUN, CHANG/GXM-3680-2022		National High Technology Research; National 12th five-year Scientific and Technical Support Program of China [2012BAI02B00]; Harbin Medical University [WLD-QN1406]	National High Technology Research(National High Technology Research and Development Program of China); National 12th five-year Scientific and Technical Support Program of China; Harbin Medical University	This work was supported by the National High Technology Research and the National 12th five-year Scientific and Technical Support Program of China (2012BAI02B00) [Sun]; Wu Liande Grant of Harbin Medical University (WLD-QN1406) [Na].	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; American Diabetes Association, 1998, DIABETES CARE S1, V12, pS20, DOI DOI 10.2337/DIACARE.21.1.S20; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Baik I, 2013, EUR J CLIN NUTR, V67, P25, DOI 10.1038/ejcn.2012.175; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c4229; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Huang LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027703; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; McGeechan K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-86; Na LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122598; Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Simmons RK, 2007, DIABETIC MED, V24, P830, DOI 10.1111/j.1464-5491.2007.02173.x; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Sun F, 2009, DIABETES RES CLIN PR, V85, P228, DOI 10.1016/j.diabres.2009.05.005; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou XH, 2013, DIABETES CARE, V36, P3944, DOI 10.2337/dc13-0593	31	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166206	10.1371/journal.pone.0166206	http://dx.doi.org/10.1371/journal.pone.0166206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851788	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300041
J	Baldo, V; Cocchio, S; Gallo, T; Furlan, P; Romor, P; Bertoncello, C; Buja, A; Baldovin, T				Baldo, Vincenzo; Cocchio, Silvia; Gallo, Tolinda; Furlan, Patrizia; Romor, Pierantonio; Bertoncello, Chiara; Buja, Alessandra; Baldovin, Tatjana			Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience	PLOS ONE			English	Article							LONG-TERM MORTALITY; RISK-FACTORS; HOSPITALIZATION; ETIOLOGY	Background Community-acquired pneumonia (CAP) is an important cause of illness and death worldwide, particularly among the elderly. Previous studies on the factors associated with mortality in patients hospitalized for CAP revealed a direct association between the type of microorganism involved, the characteristics of the patient and mortality. Vaccination status against pneumococcal disease was not considered. We conducted a retrospective analysis on the mortality rates after a first hospitalization for CAP in north-east Italy with a view to examining especially the role of anti-pneumococcal vaccination as a factor associated with pneumonia-related mortality at one year. Method Between 2012-2013, patients aged 65+ hospitalized with a primary diagnosis of CAP, identified based on International Classification of Diseases, Ninth Revision, Clinical Modification codes 481-486, were enrolled in the study only once. Patients were divided into three groups by pneumococcal vaccination status: 1) 13-valent pneumococcal conjugate vaccine (PCV13) prior to their hospitalization; 2) 23-valent pneumococcal polysaccharide vaccine (PPV23) within 5 years before hospitalization and 3) unvaccinated or PPV23 more than 5 years prior to admission. Gender, age, length of hospital stay and influenza vaccination were considered. Comorbidities were ascertained by means of a properly coded diagnosis. Every patient was followed up for 1 year and the outcome investigated was mortality for any cause and for pneumonia. Results A total of 4,030 patient were included in the study; mean age at the time of admission to hospital was 84.3 +/- 7.7; 50.9% were female. 74.2% of subjects had at least one comorbidity; 73.7% has been vaccinated against influenza. Regard to pneumococcal vaccine, 80.4% of patients were not vaccinated, 14.5% vaccinated with PPV23 and 5.1% with PCV13. The 1year survival rates after hospitalization for pneumonia were 83.6%, 85.9% and 89.3% in the unvaccinated, PPV23 and PCV13 groups, respectively. Regression analysis indicated that the risk of death due to pneumonia increased significantly with age (adjusted OR: 1.073; 1.061-1.085), shorter hospital stay (adjusted OR: 0.981; 0.971-0.990), and male gender (adjusted OR: 1.372; 1.165-1.616). The model also confirmed the pneumococcal 13-valent conjugated vaccine as an independent protective factor for mortality-related pneumonia (adjusted OR: 0.599; 0.390-0.921). Conclusion The main finding of our observational cohort study is a high mortality rate among elderly patients admitted to hospital for pneumonia. The present study suggests a protective role for PCV13 vaccination.	[Baldo, Vincenzo; Cocchio, Silvia; Furlan, Patrizia; Bertoncello, Chiara; Buja, Alessandra; Baldovin, Tatjana] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Hyg & Publ Hlth Unit, Padua, Italy; [Gallo, Tolinda; Romor, Pierantonio] EuroHlth Net, Friuli Venezia Giulia Reg Hlth Directorate, Udine, Italy	University of Padua	Baldo, V (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Hyg & Publ Hlth Unit, Padua, Italy.	vincenzo.baldo@unipd.it	Buja, Alessandra/AAN-8141-2020; Vincenzo, Baldo/D-7822-2018; Cocchio, Silvia/Z-2327-2019; Baldo, Vincenzo/V-4005-2019	Buja, Alessandra/0000-0003-2216-3807; Vincenzo, Baldo/0000-0001-6012-9453; Baldo, Vincenzo/0000-0001-6012-9453; Bertoncello, Chiara/0000-0003-4040-8601; FURLAN, PATRIZIA/0000-0001-5345-7037; BALDOVIN, TATJANA/0000-0002-7375-9187; Cocchio, Silvia/0000-0003-3801-0901				Adamuz J, 2014, J INFECTION, V68, P534, DOI 10.1016/j.jinf.2014.02.006; [Anonymous], 2012, GAZZETTA UFFICIALE R, V72, P47; Baldo V, 2016, JPMH IN PRESS; Baldo V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-485; Brito V, 2010, THORAX, V65, P944, DOI 10.1136/thx.2010.138131; Bruns AHW, 2011, CLIN MICROBIOL INFEC, V17, P763, DOI 10.1111/j.1469-0691.2010.03296.x; Cangemi R, 2015, AM J CARDIOL, V116, P647, DOI 10.1016/j.amjcard.2015.05.028; Cavallazzi R, 2015, RESP MED, V109, P743, DOI 10.1016/j.rmed.2015.04.007; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Eurich DT, 2015, AM J RESP CRIT CARE, V192, P597, DOI 10.1164/rccm.201501-0140OC; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Hebert PL, 2005, MED CARE RES REV, V62, P560, DOI 10.1177/1077558705279310; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Holter JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148741; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Khawaja A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-94; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; Millett ERC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008737; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Oosterheert J J, 2004, Ned Tijdschr Geneeskd, V148, P1765; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Stupka John E, 2009, Aging health, V5, P763, DOI 10.2217/ahe.09.74; Tan YK, 1998, EUR RESPIR J, V12, P113, DOI 10.1183/09031936.98.12010113; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Vila-Corcoles A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-73; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; WHO Pneumococcal vaccines, 2012, WKLY EPIDEMIOL REC, V87, P129; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2013, CHEST, V144, P1008, DOI 10.1378/chest.12-2818; Yu H, 2012, J AM GERIATR SOC, V60, P2137, DOI 10.1111/j.1532-5415.2012.04208.x	32	17	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166637	10.1371/journal.pone.0166637	http://dx.doi.org/10.1371/journal.pone.0166637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846277	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600096
J	Chermak, E; Donato, R; Lensink, MF; Petta, A; Serra, L; Scarano, V; Cavallo, L; Oliva, R				Chermak, Edrisse; De Donato, Renato; Lensink, Marc F.; Petta, Andrea; Serra, Luigi; Scarano, Vittorio; Cavallo, Luigi; Oliva, Romina			Introducing a Clustering Step in a Consensus Approach for the Scoring of Protein-Protein Docking Models	PLOS ONE			English	Article							BLIND PREDICTIONS; RESIDUE CONTACTS; CAPRI; COMPLEXES; RANKING; PRINCIPLES; INTERFACE; ANALYZE	Correctly scoring protein-protein docking models to single out native-like ones is an open challenge. It is also an object of assessment in CAPRI (Critical Assessment of PRedicted Interactions), the community-wide blind docking experiment. We introduced in the field the first pure consensus method, CONSRANK, which ranks models based on their ability to match the most conserved contacts in the ensemble they belong to. In CAPRI, scorers are asked to evaluate a set of available models and select the top ten ones, based on their own scoring approach. Scorers' performance is ranked based on the number of targets/interfaces for which they could provide at least one correct solution. In such terms, blind testing in CAPRI Round 30 (a joint prediction round with CASP11) has shown that critical cases for CONSRANK are represented by targets showing multiple interfaces or for which only a very small number of correct solutions are available. To address these challenging cases, CONSRANK has now been modified to include a contact-based clustering of the models as a preliminary step of the scoring process. We used an agglomerative hierarchical clustering based on the number of common inter-residue contacts within the models. Two criteria, with different thresholds, were explored in the cluster generation, setting either the number of common contacts or of total clusters. For each clustering approach, after selecting the top (most populated) ten clusters, CONSRANK was run on these clusters and the top-ranked model for each cluster was selected, in the limit of 10 models per target. We have applied our modified scoring approach, Clust-CONSRANK, to SCORE_SET, a set of CAPRI scoring models made recently available by CAPRI assessors, and to the subset of homodimeric targets in CAPRI Round 30 for which CONSRANK failed to include a correct solution within the ten selected models. Results show that, for the challenging cases, the clustering step typically enriches the ten top ranked models in native-like solutions. The best performing clustering approaches we tested indeed lead to more than double the number of cases for which at least one correct solution can be included within the top ten ranked models.	[Chermak, Edrisse; De Donato, Renato; Cavallo, Luigi] King Abdullah Univ Sci & Technol, Kaust Catalysis Ctr, Thuwal 239556900, Saudi Arabia; [De Donato, Renato; Petta, Andrea; Serra, Luigi; Scarano, Vittorio] Univ Salerno, Dipartimento Informat& Applicaz, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy; [Lensink, Marc F.] Univ Lille, CNRS, UGSF, UMR8576, F-59000 Lille, France; [Oliva, Romina] Univ Parthenope Naples, Ctr Direz Isola C4, Dept Sci & Technol, I-80143 Naples, Italy	King Abdullah University of Science & Technology; University of Salerno; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Parthenope University Naples	Oliva, R (corresponding author), Univ Parthenope Naples, Ctr Direz Isola C4, Dept Sci & Technol, I-80143 Naples, Italy.	romina.oliva@uniparthenope.it	Oliva, Romina/ABA-6313-2021; Cavallo, Luigi/D-5215-2019; Lensink, Marc F/A-1678-2008; Scarano, Vittorio/B-1353-2010	Oliva, Romina/0000-0002-6156-6249; Cavallo, Luigi/0000-0002-1398-338X; Lensink, Marc F/0000-0003-3957-9470; Scarano, Vittorio/0000-0001-8437-5253	Regione Campania [LR5-AF2008]; Finanziamento peril sostegno della ricerca individuale di Ateneo University Parthenope; King Abdullah University of Science and Technology	Regione Campania(Regione Campania); Finanziamento peril sostegno della ricerca individuale di Ateneo University Parthenope; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	RO has been supported by Regione Campania (LR5-AF2008) and by "Finanziamento peril sostegno della ricerca individuale di Ateneo" 2015-Universita Parthenope. LC thanks the King Abdullah University of Science and Technology for supporting this research.; RO has been supported by Regione Campania (LR5-AF2008) and by "Finanziamento per it sostegno della ricerca individuale di Ateneo" 2015-University Parthenope. LC thanks the King Abdullah University of Science and Technology for supporting this research.	Abdel-Azeim S, 2014, BIOCHEMISTRY-US, V53, P6992, DOI 10.1021/bi500770p; Abdel-Azeim S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S5-S1; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Calvanese L, 2016, J STRUCT BIOL; Chermak E, 2015, BIOINFORMATICS, V31, P1481, DOI 10.1093/bioinformatics/btu837; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Huang SY, 2015, DRUG DISCOV TODAY, V20, P969, DOI 10.1016/j.drudis.2015.03.007; Huang SY, 2014, DRUG DISCOV TODAY, V19, P1081, DOI 10.1016/j.drudis.2014.02.005; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones E., 2001, SCIPY OPEN SOURCE SC; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lancellotti S, 2016, THROMB HAEMOSTASIS, V115, P51, DOI 10.1160/TH15-02-0119; Lensink MF, 2016, PROTEINS, V84, P323, DOI 10.1002/prot.25007; Lensink MF, 2014, PROTEINS, V82, P3163, DOI 10.1002/prot.24678; Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Moal IH, 2013, CURR OPIN STRUC BIOL, V23, P862, DOI 10.1016/j.sbi.2013.06.017; Moal IH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-286; Mullner D, 2013, J STAT SOFTW, V53, P1; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Oliva R, 2015, MOLECULES, V20, P12045, DOI 10.3390/molecules200712045; Oliva R, 2013, PROTEINS, V81, P1571, DOI 10.1002/prot.24314; Rodrigues JPGLM, 2012, PROTEINS, V80, P1810, DOI 10.1002/prot.24078; Vakser IA, 2014, BIOPHYS J, V107, P1785, DOI 10.1016/j.bpj.2014.08.033; Vangone A, 2013, PROTEINS, P2095, DOI [10.1002/prot.24428, DOI 10.1002/PROT.24428]; Vangone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102839; Vangone A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S19; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; WL D, 2002, PYMOL MOL GRAPHICS S	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166460	10.1371/journal.pone.0166460	http://dx.doi.org/10.1371/journal.pone.0166460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846259	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600066
J	Kaale, E; Manyanga, V; Chambuso, M; Liana, J; Rutta, E; Embrey, M; Layloff, T; Johnson, K				Kaale, Eliangiringa; Manyanga, Vicky; Chambuso, Mhina; Liana, Jafary; Rutta, Edmund; Embrey, Martha; Layloff, Thomas; Johnson, Keith			The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania	PLOS ONE			English	Article							TROPICAL CONDITIONS; CHEMICAL-STABILITY; ERGOMETRINE; INSTABILITY; COUNTRIES; INJECTION; TABLETS	Introduction The purpose of this study was to investigate the quality of a select group of medicines sold in accredited drug dispensing outlets (ADDOs) and pharmacies in different regions of Tanzania as part of an in-depth cross-sectional assessment of community access to medicines and community use of medicines. Methods We collected 242 samples of amoxicillin trihydrate, artemether-lumefantrine (ALu), co-trimoxazole, ergometrine maleate, paracetamol, and quinine from selected ADDOs and pharmacies in Mbeya, Morogoro, Singida, and Tanga regions. The analysis included physical examination and testing with validated analytical techniques. Assays for eight of nine products were conducted using high-performance thin-layer chromatography (HPTLC). For ALu tablets, we used a two-tiered approach, where tier 1 was a semi-quantitative Global Pharma Health Fund-Minilab (R) method and tier 2 was high-performance liquid chromatography (HPLC) as described in The International Pharmacopoeia's monograph for artemether-lumefantrine. Results and Discussion The physical examination of samples revealed no defects in the solid and oral liquid dosage forms, but unusual discoloration in an injectable solution, ergometrine maleate. For ALu, the results showed that of 38 samples, 31 (81.6%) passed tier 1 testing and 7 (18.4%) gave inconclusive drug content results. The inconclusive ALu samples were submitted for tier 2 testing and all met the quality standards. The pass rate using the HPTLC and TLC/HPLC assays was 93.8%; the failures were the ergometrine maleate samples purchased from both ADDOs and pharmacies. The disintegration testing of the solid dosage forms was conducted in accordance with US Pharmacopeia monographs. Only two samples of paracetamol, 1.2% of the solid dosage forms, failed to comply to standards. The study revealed a high overall rate of 92.6% of samples that met the quality standards. Although the overall failure rate was 7.4%, it is important to note that this was largely limited to one product and likely due to poor distribution and storage rather than poor manufacturing practices. Conclusions Over 90% of the medicines sold in ADDOs and pharmacies met quality standards. Policy makers need to reconsider ergometrine maleate's place on the list of medicines that ADDOs are allowed to dispense, by either substituting a more temperature-stable therapeutically equivalent product or requiring those sites to have refrigerators, which is not a feasible option for rural Tanzania.	[Kaale, Eliangiringa; Manyanga, Vicky; Chambuso, Mhina] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dar Es Salaam, Tanzania; [Liana, Jafary] Pharmaceut & Hlth Technol Grp, Management Sci Hlth, Dar Es Salaam, Tanzania; [Rutta, Edmund; Embrey, Martha; Layloff, Thomas; Johnson, Keith] Pharmaceut & Hlth Technol Grp, Management Sci Hlth, Arlington, VA USA	Muhimbili University of Health & Allied Sciences	Kaale, E (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dar Es Salaam, Tanzania.	Elia.kaale@muha.ac.tz	Kaale, Eliangiringa/AAC-8561-2019	Kaale, Eliangiringa/0000-0001-6008-3539	Bill & Melinda Gates Foundation [0PP1017439]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study on which this manuscript is based was funded by the Bill & Melinda Gates Foundation through a grant to Management Sciences for Health (MSH) (URL: http://www.msh.org/), #0PP1017439, that, in turn, subcontracted with MUHAS (#SDSI-2012- 17). MSH employees, Dr. Edmund Rutta, Mr. Keith Johnson, Dr. Suleiman Kimatta, and Mr. Jafary Liana were involved as technical advisors in the design of the study and provided logistics support during data collection and advice during data analysis. The Gates Foundation had no input into the study design, data collection, analysis or the preparation of the manuscript. MSH provided MUHAS unrestricted access to the data.	Al-Abdulla I, 2013, TOXICON, V64, P38, DOI 10.1016/j.toxicon.2012.12.022; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; [Anonymous], 2012, INT PHARM; ASKER AF, 1990, DRUG DEV IND PHARM, V16, P165, DOI 10.3109/03639049009115993; Bate R, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-33; Batty KT, 1996, J PHARM PHARMACOL, V48, P22, DOI 10.1111/j.2042-7158.1996.tb05870.x; DEGROOT ANJA, 1995, J CLIN PHARM THER, V20, P115; Eu/ACP/WHO Renewed Paetnership, 2016, WHOEMPPAU201607 EUAC; HOGERZEIL HV, 1994, BRIT MED J, V308, P59; Hogerzeil HV, 1996, EUR J OBSTET GYN R B, V69, P25, DOI 10.1016/0301-2115(95)02530-8; HOGERZEIL HV, 1991, LANCET, V338, P754, DOI 10.1016/0140-6736(91)91470-F; HOGERZEIL HV, 1994, TROP DOCT, V24, P112, DOI 10.1177/004947559402400305; Jahnke RWO, 2001, DRUG INF J, V35, P941; Jansen FH, 2007, CURR MED CHEM, V14, P3243, DOI 10.2174/092986707782793844; Herrera ASM, 2009, TOXICON, V53, P609, DOI 10.1016/j.toxicon.2009.01.012; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Risha PG, 2003, EUR J CLIN PHARMACOL, V59, P135, DOI 10.1007/s00228-003-0587-1; Rutta E, 2014, INT J TUBERC LUNG D, V18, P1108, DOI 10.5588/ijtld.14.0020; Rutta Edmund, 2015, J Pharm Policy Pract, V8, P23, DOI 10.1186/s40545-015-0044-4; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; WALKER GJA, 1988, LANCET, V2, P393; Zahn M, 2006, J PHARM SCI-US, V95, P946, DOI 10.1002/jps.20584	22	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165785	10.1371/journal.pone.0165785	http://dx.doi.org/10.1371/journal.pone.0165785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846216	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600019
J	Shaharir, SS; Hussein, H; Rajalingham, S; Said, MSM; Gafor, AHA; Mohd, R; Mustafar, R				Shaharir, Syahrul Sazliyana; Hussein, Heselynn; Rajalingham, Sakthiswary; Said, Mohd Shahrir Mohamed; Gafor, Abdul Halim Abdul; Mohd, Rozita; Mustafar, Ruslinda			Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide	PLOS ONE			English	Article							COLLABORATING-CLINICS/AMERICAN-COLLEGE; ORGAN DAMAGE; INCEPTION COHORT; DISEASE EXPRESSION; ETHNIC-GROUPS; ASSOCIATION; PREDICTORS; SURVIVAL; INDEX; HYDROXYCHLOROQUINE	Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease and despite the improvement in the survival in the past few decades, the morbidity due to disease damage remains significant. The objectives of this study were to investigate the disease damagepattern and determine the associated factors of damage in the multi-ethnic Malaysian SLE patients. We consecutively 424SLE patients who attended a consistent follow-up at the National University of Malaysia Medical Centre and Putrajaya Hospital were recruited. Disease damage was assessed using the SLICC/ACR (Systemic Lupus International Collaborating Clinics/American College of Rheumatology) Damage Index (SDI) scores. Information on their demographics and disease characteristicswere obtained from the clinical record. Univariate analysis was performed and the best model of independent predictors of disease damage was determined by multivariate logistic regression analysis. A total of 182 patients (42.9%) had disease damage (SDI >= 1). A significantly higher number of Indian patients had disease/organ damage and they predominantly developed steroid-induced diabetes mellitus (SDM). Patients with corticosteroid-induced osteoporosis (CIOP) were more likely to be Malayswhile majority of patients who developed malignancy were Chinese (p< 0.05). In the univariate and multivariate analyses, disease damage was significantly associated with age, Indian ethnicity, lower mean cumulative C3 level, neuropsychiatry lupus (NPSLE), and antiphospholipid syndrome (APLS). Patients who had ever and early treatment with hydroxychloroquine( HCQ) were less likely to develop disease damage while more patients who had received oral prednisolone >= 1mg/kg daily over 2 weeks had disease damage (p< 0.05). In conclusion, there were inter-ethnic differences in the damage pattern and risks among SLE patients.	[Shaharir, Syahrul Sazliyana; Hussein, Heselynn; Rajalingham, Sakthiswary; Said, Mohd Shahrir Mohamed; Gafor, Abdul Halim Abdul; Mohd, Rozita; Mustafar, Ruslinda] Pusat Perubatan Univ Kebangsaan Malaysia UKMMC, Dept Internal Med, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia; [Hussein, Heselynn] Putrajaya Hosp, Dept Med, Jalan P9,Presint 7, Putrajaya 62250, Malaysia		Shaharir, SS (corresponding author), Pusat Perubatan Univ Kebangsaan Malaysia UKMMC, Dept Internal Med, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia.	ssazliona@gmail.com	Said, Mohd Shahrir Mohamed/AAR-2680-2020; Gafor, Abdul Halim Abdul/L-4405-2017; Sakthiswary, Rajalingham/E-8565-2017	Gafor, Abdul Halim Abdul/0000-0003-3950-2844; 				Akhavan PS, 2013, J RHEUMATOL, V40, P831, DOI 10.3899/jrheum.120572; Alarcon GS, 2011, REUMATOL CLIN, V7, P3, DOI 10.1016/j.reuma.2010.11.001; Alarcon GS, 2001, ARTHRITIS RHEUM, V44, P2797, DOI 10.1002/1529-0131(200112)44:12<2797::AID-ART467>3.0.CO;2-9; [Anonymous], 2016, CURRENTPOPULATION ES; Bernatsky S, 2005, J RHEUMATOL, V32, P820; Bruce IN, 2015, ANN RHEUM DIS, V74, P1706, DOI 10.1136/annrheumdis-2013-205171; Chambers SA, 2009, RHEUMATOLOGY, V48, P673, DOI 10.1093/rheumatology/kep062; Conti F, 2016, LUPUS, V25, P719, DOI 10.1177/0961203315627199; Cooper GS, 2007, ARTHRIT RHEUM-ARTHR, V57, P993, DOI 10.1002/art.22894; del Toro ME, 2010, REUMATOL CLIN, V6, P11, DOI 10.1016/j.reuma.2009.04.007; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2000, J RHEUMATOL, V27, P373; Gladman DD, 2003, J RHEUMATOL, V30, P1955; Golder V, 2013, LUPUS, V22, P1425, DOI 10.1177/0961203313500547; Goncalves MJ, 2015, LUPUS, V24, P256, DOI 10.1177/0961203314555172; Hiramatsu N, 2008, RHEUMATOLOGY, V47, P702, DOI 10.1093/rheumatology/ken019; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jasmin R, 2013, LUPUS, V22, P967, DOI 10.1177/0961203313496299; Jonsen A, 2002, RHEUMATOLOGY, V41, P1308, DOI 10.1093/rheumatology/41.11.1308; Kasitanon N, 2006, MEDICINE, V85, P147, DOI 10.1097/01.md.0000224709.70133.f7; Letchuman G R, 2010, Med J Malaysia, V65, P180; Mok CC, 2013, ANN RHEUM DIS, V71, P545, DOI 10.1136/annrheumdis-2012-eular.3163; Mok CC, 2009, SCAND J RHEUMATOL, V38, P121, DOI 10.1080/03009740802415527; Mok CC, 2003, J RHEUMATOL, V30, P1513; Molad Y, 2002, LUPUS, V11, P356, DOI 10.1191/0961203302lu203ra; Nazaimoon WMW, 2013, DIABETIC MED, V30, P825, DOI 10.1111/dme.12161; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P4021, DOI 10.1002/art.34672; Pons-Estel BA, 2004, MEDICINE, V83, P1, DOI 10.1097/01.md.0000104742.42401.e2; Rabbani MA, 2009, LUPUS, V18, P848, DOI 10.1177/0961203309103410; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rivest C, 2000, J RHEUMATOL, V27, P680; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Shaharir SS, 2014, LUPUS, V23, P436, DOI 10.1177/0961203313518624; Shaharir SS, 2015, INT J RHEUM DIS, V18, P541, DOI 10.1111/1756-185X.12474; Shahrir M, 2008, INT J RHEUM DIS, V11, P287, DOI 10.1111/j.1756-185X.2008.00379.x; Sung YK, 2007, J RHEUMATOL, V34, P987; Tan VMH, 2015, BRIT J NUTR, V113, P1228, DOI 10.1017/S0007114515000586; Thumboo J, 2000, LUPUS, V9, P702, DOI 10.1191/096120300666529212; Thumboo J., 2006, APLAR J RHEUMATOL, V9, P320, DOI DOI 10.1111/J.1479-8077.2006.00235.X; Toloza SMA, 2004, ARTHRITIS RHEUM-US, V50, P3177, DOI 10.1002/art.20578; Wang F, 1997, LUPUS, V6, P248, DOI 10.1177/096120339700600306; Yee CS, 2015, RHEUMATOLOGY, V54, P836, DOI 10.1093/rheumatology/keu412; Zonana-Nacach A, 1998, LUPUS, V7, P119, DOI 10.1191/096120398678919831; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	44	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166270	10.1371/journal.pone.0166270	http://dx.doi.org/10.1371/journal.pone.0166270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846298	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600045
J	Simmons, KM; Alkanani, AK; McDaniel, KA; Goyne, C; Miao, DM; Zhao, ZY; Yu, LP; Michels, AW				Simmons, Kimber M.; Alkanani, Aimon K.; McDaniel, Kristen A.; Goyne, Christopher; Miao, Dongmei; Zhao, Zhiyuan; Yu, Liping; Michels, Aaron W.			Islet Autoantibody Measurements from Dried Blood Spots on Filter Paper Strongly Correlate to Serum Levels	PLOS ONE			English	Article							RISK; INSULIN; PROGRESSION; APPEARANCE; CHILDREN; PREDICTION; ANTIBODIES; ASSAYS; AGE	Type 1 diabetes (T1D) is increasing in incidence and predictable with measurement of serum islet autoantibodies (iAb) years prior to clinical disease onset. Identifying iAb positive individuals reduces diabetic ketoacidosis and identifies individuals for T1D prevention trials. However, large scale screening for iAb remains challenging as assays have varying sensitivities and specificities, insulin autoantibodies remain difficult to measure and venipuncture is generally required to obtain serum. We developed an approach to reliably measure all four major iAb, including insulin autoantibodies, from dried blood spots (DBS) on filter-paper. By spiking iAb positive serum into iAb negative whole blood in a dose titration, we optimized the conditions for autoantibody elution from filter paper as measured by fluid phase radioimmunoassays. After assessing stability of measuring iAb from DBS over time, we then screened iAb from DBS and the corresponding serum in new-onset T1D (n = 52), and controls (n = 72) which included first-degree relatives of T1D patients. iAb measured from eluted DBS in new-onset T1D strongly correlated with serum measurements (R-2 = 0.96 for mIAA, GADA = 0.94, IA-2A = 0.85, ZnT8A = 0.82, p<0.01 for each autoantibody). There were no false positives in control subjects, and 5/6 with previously unknown iAb positivity in sera were detected using DBS. With further validation, measuring iAb from DBS can be a reliable method to screen for T1D risk.	[Simmons, Kimber M.; Alkanani, Aimon K.; McDaniel, Kristen A.; Miao, Dongmei; Zhao, Zhiyuan; Yu, Liping; Michels, Aaron W.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Goyne, Christopher] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University Bloomington	Simmons, KM (corresponding author), Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.	kimber.simmons@childrenscolorado.org			National Institute of Diabetes and Digestive Kidney Diseases [K08 DK095995]; Juvenile Diabetes Research Foundation [2-SRA-2016-202-S-B]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK095995] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive Kidney Diseases (K08 DK095995) and Juvenile Diabetes Research Foundation (2-SRA-2016-202-S-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; Bazzigaluppi E, 1999, DIABETES CARE, V22, P275, DOI 10.2337/diacare.22.2.275; Bingley PJ, 2015, DIABETES TECHNOL THE, V17, P867, DOI 10.1089/dia.2015.0133; Bonifacio E, 2015, JAMA-J AM MED ASSOC, V313, P1541, DOI 10.1001/jama.2015.2928; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Cameron FJ, 2014, DIABETES CARE, V37, P1554, DOI 10.2337/dc13-1904; DEAN BM, 1986, DIABETOLOGIA, V29, P339, DOI 10.1007/BF00452073; Demirev PA, 2013, ANAL CHEM, V85, P779, DOI 10.1021/ac303205m; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Krischer JP, 2015, DIABETOLOGIA, V58, P980, DOI 10.1007/s00125-015-3514-y; Kupila A, 2001, DIABETOLOGIA, V44, P290, DOI 10.1007/s001250051616; Larsson HE, 2011, DIABETES CARE, V34, P2347, DOI 10.2337/dc11-1026; Lin A, 2015, DIABETES CARE, V38, P236, DOI 10.2337/dc14-1385; Rewers A, 2015, JAMA-J AM MED ASSOC, V313, P1570, DOI 10.1001/jama.2015.1414; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Semenkovich K, 2016, PEDIATR DIABETES, V17, P492, DOI 10.1111/pedi.12314; Simell S, 2010, DIABETES CARE, V33, P774, DOI 10.2337/dc09-1217; Siraj ES, 2012, HORM METAB RES, V44, P855, DOI 10.1055/s-0032-1316349; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Steck AK, 2015, DIABETES CARE, V38, P808, DOI 10.2337/dc14-2426; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Triolo TM, 2009, DIABETES CARE, V32, P769, DOI 10.2337/dc08-1872; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Winkler C, 2012, PEDIATR DIABETES, V13, P301, DOI 10.1111/j.1399-5448.2011.00829.x; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; 2002, THE NEW ENGLAND JOUR, V346, P1685, DOI DOI 10.1056/NEJMOA012350	31	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166213	10.1371/journal.pone.0166213	http://dx.doi.org/10.1371/journal.pone.0166213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846247	Green Published, gold			2022-12-27	WOS:000387794600039
J	Xu, MP; Yu, HY; Chen, YY; Xu, JL; Zheng, JW; Yu, XP				Xu, Meiping; Yu, Huanyun; Chen, Yuanyuan; Xu, Jinling; Zheng, Jingwei; Yu, Xinping			Long-Term Quality of Life in Adult Patients with Strabismus after Corrective Surgery Compared to the General Population	PLOS ONE			English	Article							PSYCHOSOCIAL-ASPECTS; INTERMITTENT EXOTROPIA; AS-20 SCORE; EMPLOYMENT; CHILDREN; VISION; IMPACT	Purpose To evaluate the status of and factors associated with long-term health-related quality of life (HROOL) in adult patients with strabismus following corrective surgery. Methods Prospective cross-sectional study. A total of 122 adults who underwent corrective surgery and were followed up for at least 1 year were recruited. Pre- and post-operative HRQOL were evaluated using the Chinese version of the Adult Strabismus 20 (AS-20). Demographics and clinical characteristics were recorded. Eighty-nine age-matched, normal individuals without a history of strabismus were recruited as a control group. Results AS-20 scores improved significantly in the psychosocial subscale and total scale after surgery for a11122 patients, but not in the function subscale. HRQOL was better in the successful cases than in the non-successful cases (p<0.005). Subjects who recovered stereo function had better HRQOL than those who did not (p<0.01). Compared to the control population, the patients had poorer HRQOL post-operatively, with only approximately 30% of the subjects having scores within the normal threshold scores. The self-sense of a lack of ocular deviation and a successful surgical outcome were significant factors associated with postoperative HRQOL status. Conclusions HROOL, as evaluated by AS-20 scores, improved in the patients after surgery but was worse than that in the general population. Successful surgical outcomes and a sense of good alignment were the main factors that correlated with increased post-operative HROOL. Positive assessments of surgical results by patients may benefit post-operative HROOL.	[Xu, Meiping; Yu, Huanyun; Chen, Yuanyuan; Xu, Jinling; Zheng, Jingwei; Yu, Xinping] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Yu, XP (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	yu-xinping@163.com	Chen, Yuanyuan/GXG-2130-2022					Alpak G, 2014, BRIT J OPHTHALMOL, V98, P876, DOI 10.1136/bjophthalmol-2014-304888; Beauchamp CL, 2006, J AAPOS, V10, P394, DOI 10.1016/j.jaapos.2006.06.004; Beauchamp GR, 2005, J AAPOS, V9, P141, DOI 10.1016/j.jaapos.2004.11.015; Burke JP, 1997, J PEDIAT OPHTH STRAB, V34, P159; Coats DK, 2000, OPHTHALMOLOGY, V107, P402, DOI 10.1016/S0161-6420(99)00035-4; Dickmann A, 2013, J AAPOS, V17, P25, DOI 10.1016/j.jaapos.2012.09.017; Durnian JM, 2010, J AAPOS, V14, P469, DOI 10.1016/j.jaapos.2010.08.013; Durnian JM, 2009, J AAPOS, V13, P477, DOI 10.1016/j.jaapos.2009.06.006; Eustis S, 1987, J Pediatr Ophthalmol Strabismus, V24, P232; Fujiike K, 2011, JPN J OPHTHALMOL, V55, P268, DOI 10.1007/s10384-011-0022-6; Glasman P, 2013, EYE, V27, P1249, DOI 10.1038/eye.2013.174; Granet DB, 2011, BRIT J OPHTHALMOL, V95, P443, DOI 10.1136/bjo.2010.188326; Hatt SR, 2008, ARCH OPHTHALMOL-CHIC, V126, P1525, DOI 10.1001/archopht.126.11.1525; Hatt SR, 2007, AM J OPHTHALMOL, V144, P643, DOI 10.1016/j.ajo.2007.06.032; Hatt SR, 2014, OPHTHALMOLOGY, V121, P2070, DOI 10.1016/j.ophtha.2014.04.031; Hatt SR, 2012, OPHTHALMOLOGY, V119, P1930, DOI 10.1016/j.ophtha.2012.02.035; Hatt SR, 2012, AM J OPHTHALMOL, V153, P614, DOI 10.1016/j.ajo.2011.10.001; Hatt SR, 2010, OPHTHALMOLOGY, V117, P2322, DOI 10.1016/j.ophtha.2010.03.042; Hatt SR, 2010, OPHTHALMOLOGY, V117, P163, DOI 10.1016/j.ophtha.2009.06.038; Hatt SR, 2009, AM J OPHTHALMOL, V148, P558, DOI 10.1016/j.ajo.2009.05.009; Hatt SR, 2009, OPHTHALMOLOGY, V116, P139, DOI 10.1016/j.ophtha.2008.08.043; Jackson S, 2006, BRIT J OPHTHALMOL, V90, P883, DOI 10.1136/bjo.2005.089516; Jackson S, 2013, BRIT J OPHTHALMOL, V97, P419, DOI 10.1136/bjophthalmol-2012-302983; Keech R V, 1987, J Pediatr Ophthalmol Strabismus, V24, P97; Koc F, 2013, BRIT J OPHTHALMOL, V97, P1425, DOI 10.1136/bjophthalmol-2013-303704; Leske DA, 2010, AM J OPHTHALMOL, V149, P672, DOI 10.1016/j.ajo.2009.11.004; McBain HB, 2014, BRIT J OPHTHALMOL, V98, P550, DOI 10.1136/bjophthalmol-2013-304220; McBain HB, 2014, SURV OPHTHALMOL, V59, P185, DOI 10.1016/j.survophthal.2013.04.001; McKenzie JA, 2009, ARCH OPHTHALMOL-CHIC, V127, P743, DOI 10.1001/archophthalmol.2009.68; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Mojon-Azzi SM, 2009, ACTA OPHTHALMOL, V87, P784, DOI 10.1111/j.1755-3768.2008.01352.x; Mojon-Azzi SM, 2011, BRIT J OPHTHALMOL, V95, P473, DOI 10.1136/bjo.2010.185793; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Tandon AK, 2014, J AAPOS, V18, P423, DOI 10.1016/j.jaapos.2014.05.009; van de Graaf E S, 2004, Strabismus, V12, P181; Xu JL, 2012, J PEDIAT OPHTH STRAB, V49, P170, DOI 10.3928/01913913-20110920-02; Yu HY, 2013, OPHTHAL EPIDEMIOL, V20, P239, DOI 10.3109/09286586.2013.809771	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166418	10.1371/journal.pone.0166418	http://dx.doi.org/10.1371/journal.pone.0166418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846304	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600060
J	Yeh, WC; Jiang, YZ; Chen, YF; Chen, Z				Yeh, Wei-Chang; Jiang, Yunzhi; Chen, Yee-Fen; Chen, Zhe			A New Soft Computing Method for K-Harmonic Means Clustering	PLOS ONE			English	Article							SIMPLIFIED SWARM OPTIMIZATION; SEARCH; ALGORITHM	The K-harmonic means clustering algorithm (KHM) is a new clustering method used to group data such that the sum of the harmonic averages of the distances between each entity and all cluster centroids is minimized. Because it is less sensitive to initialization than K-means (KM), many researchers have recently been attracted to studying KHM. In this study, the proposed iSSO-KHM is based on an improved simplified swarm optimization (iSSO) and integrates a variable neighborhood search (VNS) for KHM clustering. As evidence of the utility of the proposed iSSO-KHM, we present extensive computational results on eight benchmark problems. From the computational results, the comparison appears to support the superiority of the proposed iSSO-KHM over previously developed algorithms for all experiments in the literature.	[Yeh, Wei-Chang] Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Integrat & Collaborat Lab, Hsinchu, Taiwan; [Jiang, Yunzhi] Guangdong Polytech Normal Univ, Sch Automat, Guangzhou, Guangdong, Peoples R China; [Chen, Yee-Fen] Hsiuping Univ Sci & Technol, Dept Ind Engn & Management, Taichung, Taiwan; [Chen, Zhe] Changan Univ, Sch Informat Engn, Xian, Peoples R China	National Tsing Hua University; Guangdong Polytechnic Normal University; Chang'an University	Yeh, WC (corresponding author), Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Integrat & Collaborat Lab, Hsinchu, Taiwan.	yeh@ieee.org	YEH, WEI-CHANG/AAH-4172-2019	YEH, WEI-CHANG/0000-0001-7393-0768	National Science Council of Taiwan, R.O.C. [NSC101-2221- E-007-079- MY3, NSC 102-2221-E-007-086-MY3]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was also supported in part by the National Science Council of Taiwan, R.O.C. under grant NSC101-2221- E-007-079- MY3 and NSC 102-2221-E-007-086-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I wish to thank the anonymous editor and the reviewers for their constructive comments and recommendations, which have significantly improved the presentation of this paper. This research was supported in part by the National Science Council of Taiwan, R.O.C. under grant NSC101-2221- E-007-079- MY3 and NSC 102-2221-E-007-086-MY3.	Abshouri Azam Amin, 2012, J COMMUNICATION COMP, V9, P387; Aghdasi T., 2014, INT J MECHATRONICS E, V4, P485; Alguwaizani A, 2011, APPL MATH MODEL, V35, P2688, DOI 10.1016/j.apm.2010.11.032; Anderberg M. R., 1973, CLUSTER ANAL APPL; Ayech MW, 2012, INT C PATT RECOG, P222; Azizipanah-Abarghooee R, 2013, INT J ELEC POWER, V49, P414, DOI 10.1016/j.ijepes.2013.01.013; Chung YY, 2012, APPL SOFT COMPUT, V12, P3014, DOI 10.1016/j.asoc.2012.04.020; Dalli A., EACL 2003; FORGY EW, 1965, BIOMETRICS, V21, P768; Gungor Z, 2008, APPL MATH MODEL, V32, P1115, DOI 10.1016/j.apm.2007.03.011; Gungor Z, 2007, APPL MATH COMPUT, V184, P199, DOI 10.1016/j.amc.2006.05.166; Handl J, 2003, FR ART INT, V104, P204; Huang CL, 2015, RELIAB ENG SYST SAFE, V142, P221, DOI 10.1016/j.ress.2015.06.002; Hung CH, 2013, APPL MATH MODEL, V37, P10123, DOI 10.1016/j.apm.2013.05.052; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jiang H, 2010, EXPERT SYST APPL, V37, P8679, DOI 10.1016/j.eswa.2010.06.061; Lee JH, 2015, APPL MATH COMPUT, V270, P13, DOI 10.1016/j.amc.2015.07.120; Mirkin B., 2005, CLUSTERING DATA MINI; Serapiao ABS, 2016, APPL SOFT COMPUT, V41, P290, DOI 10.1016/j.asoc.2015.12.032; Steinhaus H., 1957, B ACAD POL SCI, V4, P801; Thakare A. D., 2014, INT J COMPUTER APPL, V99, P5; Yang FQ, 2009, EXPERT SYST APPL, V36, P9847, DOI 10.1016/j.eswa.2009.02.003; Yeh W. C., 2008, 972221E007099MY3 NSC; Yeh WC, 2016, NEUROCOMPUTING, V173, P1720, DOI 10.1016/j.neucom.2015.09.045; Yeh WC, 2015, KNOWL-BASED SYST, V82, P60, DOI 10.1016/j.knosys.2015.02.022; Yeh WC, 2014, KNOWL-BASED SYST, V64, P1, DOI 10.1016/j.knosys.2014.03.011; Yeh WC, 2013, IEEE T NEUR NET LEAR, V24, P661, DOI 10.1109/TNNLS.2012.2232678; Yeh WC, 2012, INFORM SCIENCES, V197, P65, DOI 10.1016/j.ins.2012.02.009; Yeh WC, 2012, COMPUT OPER RES, V39, P2168, DOI 10.1016/j.cor.2011.10.027; Yeh WC, 2009, EXPERT SYST APPL, V36, P9192, DOI 10.1016/j.eswa.2008.12.024; Yeh WC, 2009, EXPERT SYST APPL, V36, P8204, DOI 10.1016/j.eswa.2008.10.004; Yin MH, 2011, EXPERT SYST APPL, V38, P9319, DOI 10.1016/j.eswa.2011.01.018; Zhang B., 2000, HPL2000137; Zhang B., 1999, INT WORKSH TEMP SPAT; Zhou ZP, 2015, LECT NOTES COMPUT SC, V9243, P140, DOI 10.1007/978-3-319-23862-3_14	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0164754	10.1371/journal.pone.0164754	http://dx.doi.org/10.1371/journal.pone.0164754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846228	Green Published, gold			2022-12-27	WOS:000387794600006
J	Bittencourt, CR; Izar, MCD; Schwerz, VL; Povoa, RMD; Fonseca, HAR; Fonseca, MIH; Bianco, HT; Franca, CN; Ferreira, CED; Fonseca, FAH				de Oliveira Bittencourt, Celia Regina; de Oliveira Izar, Maria Cristina; Schwerz, Valdir Lauro; dos Santos Povoa, Rui Manuel; Rodrigues Fonseca, Henrique Andrade; Helfenstein Fonseca, Marilia Izar; Bianco, Henrique Tria; Franca, Carolina Nunes; dos Santos Ferreira, Carlos Eduardo; Helfenstein Fonseca, Francisco Antonio			Effects of High-Intensity Training of Professional Runners on Myocardial Hypertrophy and Subclinical Atherosclerosis	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; FLOW-MEDIATED DILATION; MALE-ATHLETES HEART; CARDIOVASCULAR-DISEASE; AMERICAN-SOCIETY; BLOOD-PRESSURE; RISK; ECHOCARDIOGRAPHY; CARDIOMYOPATHY; THICKNESS	To evaluate the effects of long-term exposure to high-intensity training among professional runners on cardiac hypertrophy and subclinical atherosclerosis. Prospective study included runners of both sexes (n = 52) and age and gender matched controls (n = 57), without classical cardiovascular risk factors. Ventricular hypertrophy was quantified by echocardiography by linear method and carotid intima-media thickness (cIMT) by 2-D images obtained by ultrasonography. Endothelial function was evaluated by flowmediated dilation (FMD). Steroid hormones were quantified by HPLC followed by LC-MS/MS. Higher left ventricular (LV) mass index was found in male athletes (p< 0.0001 vs. other groups). When adjusted for gender, the degree of left ventricular mass index classified as mildly, moderately or severely abnormal was obtained in 26%, 35%, and 30%, respectively, of female athletes, and in 39%, 14%, and 21%, respectively, of male athletes. Higher ratio of the early (E) to late (A) ventricular filling velocities was found in athletes of both genders. Male athletes presented lower cIMT in the right (p = 0.012 vs. male controls) and left (p< 0.0001 vs. male controls) common carotid arteries, without differences in cIMT between female athletes and controls. FMD results were similar among groups. Higher serum testosterone levels were found in male athletes (p< 0.0001 vs. other groups) and they were correlated with LV mass (r = 0.50, p< 0.0001). The chronic exposure of high-intensity training among professional runners of both genders was associated with increased ventricular mass and adaptive remodeling. Less subclinical atherosclerosis was found in male athletes. Differences in steroid hormones may account in part for these findings.	[de Oliveira Bittencourt, Celia Regina; de Oliveira Izar, Maria Cristina; Schwerz, Valdir Lauro; dos Santos Povoa, Rui Manuel; Rodrigues Fonseca, Henrique Andrade; Helfenstein Fonseca, Marilia Izar; Bianco, Henrique Tria; Franca, Carolina Nunes; dos Santos Ferreira, Carlos Eduardo; Helfenstein Fonseca, Francisco Antonio] Univ Fed Sao Paulo, Div Cardiol, Sao Paulo, Brazil; [Franca, Carolina Nunes] Univ Santo Amaro, Sao Paulo, Brazil; [dos Santos Ferreira, Carlos Eduardo] Albert Einstein Israeli Hosp, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Santo Amaro (UNISA); Hospital Israelita Albert Einstein	Fonseca, FAH (corresponding author), Univ Fed Sao Paulo, Div Cardiol, Sao Paulo, Brazil.	fahfonseca@terra.com.br	Izar, Maria/AAG-7499-2020; Fonseca, Henrique A/P-8412-2015; Bianco, Henrique Tria/L-3895-2014; de Oliveira Izar, Maria Cristina/H-6107-2012; França, Carolina Nunes/J-2429-2015	Izar, Maria/0000-0002-5738-2623; Fonseca, Henrique A/0000-0001-8360-8465; Bianco, Henrique Tria/0000-0001-6746-8327; França, Carolina Nunes/0000-0002-4167-4293	Sao Paulo Research Foundation (FAPESP) [2010/50242-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the The Sao Paulo Research Foundation (FAPESP), grant # 2010/50242-2.; This study was supported by the The Sao Paulo Research Foundation (FAPESP), grant # 2010/50242-2. We thank the Albert Einstein Israeli Hospital for the hormonal analyses.	Achar S, 2010, AM J CARDIOL, V106, P893, DOI 10.1016/j.amjcard.2010.05.013; Augustine JA, 2016, ATHEROSCLEROSIS, V244, P157, DOI 10.1016/j.atherosclerosis.2015.11.011; Berry JD, 2009, CIRCULATION, V119, P382, DOI 10.1161/CIRCULATIONAHA.108.800235; Brandao SA, 2010, AM J HYPERTENS, V23, P208, DOI 10.1038/ajh.2009.214; Caselli S, 2014, AM J CARDIOL, V114, P1383, DOI 10.1016/j.amjcard.2014.07.070; D'Andrea A, 2007, BRIT J SPORT MED, V41, P149, DOI 10.1136/bjsm.2006.030171; da Silva EFR, 2011, AIDS, V25, P1595, DOI 10.1097/QAD.0b013e32834980f4; Green DJ, 2013, MED SCI SPORT EXER, V45, P75, DOI 10.1249/MSS.0b013e318269affe; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hespanhol LC, 2015, SPORTS MED, V45, P1455, DOI 10.1007/s40279-015-0359-y; Howard G, 1993, ARIC INVESTIGATORS S, V24, P1297; Jouffroy R, 2015, AM J CARDIOL, V116, P1284, DOI 10.1016/j.amjcard.2015.07.045; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lauschke J, 2009, CLIN RES CARDIOL, V98, P80, DOI 10.1007/s00392-008-0721-2; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Naylor LH, 2008, SPORTS MED, V38, P69, DOI 10.2165/00007256-200838010-00006; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Rawlins J, 2009, EUR J ECHOCARDIOGR, V10, P350, DOI 10.1093/ejechocard/jep017; Sato K, 2015, J STEROID BIOCHEM, V145, P200, DOI 10.1016/j.jsbmb.2014.03.009; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Shechter M, 2014, AM J CARDIOL, V113, P162, DOI 10.1016/j.amjcard.2013.08.051; Simsek Z, 2013, ECHOCARDIOGR-J CARD, V30, P1202, DOI 10.1111/echo.12263; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Taylor BA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004498; Tzou Wendy S, 2007, Prev Cardiol, V10, P181, DOI 10.1111/j.1520-037X.2007.06450.x; Urhausen A, 1999, SPORTS MED, V28, P237, DOI 10.2165/00007256-199928040-00002; Utomi V, 2014, HEART, V100, P1264, DOI 10.1136/heartjnl-2014-305904; Utomi V, 2013, HEART, V99, P1727, DOI 10.1136/heartjnl-2012-303465; Warren MP, 2001, J ENDOCRINOL, V170, P3, DOI 10.1677/joe.0.1700003; Yang QH, 2015, AM J PREV MED, V48, P58, DOI 10.1016/j.amepre.2014.09.014	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166009	10.1371/journal.pone.0166009	http://dx.doi.org/10.1371/journal.pone.0166009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835659	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200019
J	Yang, MS; Lee, JY; Kim, J; Kim, GW; Kim, BK; Kim, JY; Park, HW; Cho, SH; Min, KU; Kang, HR				Yang, Min-Suk; Lee, Jin Yong; Kim, Jayeun; Kim, Gun-Woo; Kim, Byung-Keun; Kim, Ju-Young; Park, Heung-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun			Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea	PLOS ONE			English	Article							ERYTHEMA MULTIFORME; EPIDEMIOLOGY; PREVALENCE; FEATURES; DRUGS	Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening diseases; however, it is hard to estimate their incidence due to the rarity of these diseases. We evaluated the incidence of SJS and TEN using a nationwide administrative database. Methods We used a national medical insurance review system (Health Insurance Review and Assessment) database which contained the claim data of the entire nation from 2009 to 2013 to estimate the accurate incidence of SJS and TEN in Korea. The diagnostic codes of L511 (SJS) or L512 (TEN) from the International Classification of Diseases-10th revision were used to define the target study population. We also retrospectively followed up a 2011 SJS and TEN cohort for 24 months in order to assess the in-hospital mortality, related complications and total claims cost due to SJS and TEN. Results A total of 1,167 (938 SJS and 229 TEN) cases were newly diagnosed from 2010 to 2013. The age-and sex-standardized annual incidences estimated in this study were 3.96 to 5.03 in SJS and 0.94 to 1.45 in TEN per million. There was no significant change in annual incidence throughout the study periods. When analyzed by 10-year age groups, the annual incidence was the lowest in group 20-29 years and the highest in group 70 for both SJS and TEN. Based on the 2011 cohort analysis, the in-hospital mortality were 5.7 and 15.1% for SJS and TEN, respectively. The mortality increased with age, particularly, after 40 years of age. Among the complications related with SJS or TEN, ocular sequelae was the most common (43.1 and 43.4% of SJS and TEN patients, respectively) followed by urethral sequelae (5.7 and 9.4% of SJS and TEN patients, respectively). Conclusion Overall, our data suggest that SJS, and TEN are infrequent but constantly arise throughout the years.	[Yang, Min-Suk; Kim, Gun-Woo; Kim, Byung-Keun; Kim, Ju-Young; Park, Heung-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Yang, Min-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Yang, Min-Suk; Kim, Gun-Woo; Kim, Byung-Keun; Kim, Ju-Young; Park, Heung-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Jin Yong] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Publ Hlth Med Serv, Seoul, South Korea; [Kim, Jayeun] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Kim, Ju-Young; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ Hosp, Drug Safety Monitoring Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kang, HR (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea.; Kang, HR (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kang, HR (corresponding author), Seoul Natl Univ Hosp, Drug Safety Monitoring Ctr, Seoul, South Korea.	helenmed@snu.ac.kr	Park, Heung-Woo/AAW-7690-2020	Park, Heung-Woo/0000-0002-6970-3228; Kim, Ju-Young/0000-0003-3841-8122	Seoul National University Hospital [30-2015-0020]	Seoul National University Hospital	This work was supported by a grant from Seoul National University Hospital (#30-2015-0020) URL: http://www.snuh.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Choon SE, 2012, INDIAN J DERMATOL VE, V78, P734, DOI 10.4103/0378-6323.102367; De Rojas MV, 2007, BRIT J OPHTHALMOL, V91, P1048, DOI 10.1136/bjo.2006.109124; Finkelstein Y, 2014, JAMA-J AM MED ASSOC, V311, P2231, DOI 10.1001/jama.2014.839; HUFF JC, 1992, SEMIN DERMATOL, V11, P207; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Mockenhaupt M, 2012, CHEM IMMUNOL ALLERGY, V97, P1, DOI 10.1159/000335612; Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]; Oplatek A, 2006, J BURN CARE RES, V27, P26, DOI 10.1097/01.bcr.0000194268.01514.f8; Park SY, 2016, J CLIN NEUROL, V12, P340, DOI 10.3988/jcn.2016.12.3.340; Park SB, 2016, SPINE, V41, P328, DOI 10.1097/BRS.0000000000001291; ROUJEAU JC, 1990, ARCH DERMATOL, V126, P37, DOI 10.1001/archderm.126.1.37; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Rzany B, 1996, J CLIN EPIDEMIOL, V49, P769, DOI 10.1016/0895-4356(96)00035-2; SCHOPF E, 1991, ARCH DERMATOL, V127, P839, DOI 10.1001/archderm.127.6.839; Schwartz RA, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2013.05.002; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Sekula P, 2011, J BURN CARE RES, V32, P237, DOI 10.1097/BCR.0b013e31820aafbc; Wetter DA, 2010, MAYO CLIN PROC, V85, P131, DOI 10.4065/mcp.2009.0379; Yang MS, 2013, INT ARCH ALLERGY IMM, V162, P346, DOI 10.1159/000354918; Yip LW, 2007, ALLERGY, V62, P527, DOI 10.1111/j.1398-9995.2006.01295.x	25	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165933	10.1371/journal.pone.0165933	http://dx.doi.org/10.1371/journal.pone.0165933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835661	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200017
J	Blom, RM; van Wingen, GA; van der Wal, SJ; Luigjes, J; van Dijk, MT; Scholte, HS; Denys, D				Blom, Rianne M.; van Wingen, Guido A.; van der Wal, Sija J.; Luigjes, Judy; van Dijk, Milenna T.; Scholte, H. Steven; Denys, Damiaan			The Desire for Amputation or Paralyzation: Evidence for Structural Brain Anomalies in Body Integrity Identity Disorder (BIID)	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; ANOREXIA-NERVOSA; INSULAR CORTEX; LIMB OWNERSHIP; RUBBER HAND; XENOMELIA; METAANALYSIS; MOTOR; SOMATOPARAPHRENIA; APOTEMNOPHILIA	Background Body Integrity Identity Disorder (BIID) is a condition in which individuals perceive a mismatch between their internal body scheme and physical body shape, resulting in an absolute desire to be either amputated or paralyzed. The condition is hypothesized to be of congenital nature, but evidence for a neuro-anatomical basis is sparse. Methods We collected T1-weighted structural magnetic resonance imaging scans on a 3T scanner in eight individuals with BIID and 24 matched healthy controls, and analyzed the data using voxel-based morphometry. Results The results showed reduced grey matter volume in the left dorsal and ventral premotor cortices and larger grey matter volume in the cerebellum (lobule Vila) in individuals with BIID compared to controls. Conclusion The premotor cortex and cerebellum are thought to be crucial for the experience of body ownership and the integration of multisensory information. Our results suggest that BIID is associated with structural brain anomalies and might result from a dysfunction in the integration of multisensory information, leading to the feeling of disunity between the mental and physical body shape.	[Blom, Rianne M.; van Wingen, Guido A.; van der Wal, Sija J.; Luigjes, Judy; van Dijk, Milenna T.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [van Wingen, Guido A.; Luigjes, Judy; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, Amsterdam, Netherlands; [Scholte, H. Steven] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Denys, Damiaan] Netherlands Inst Neurosci, Amsterdam, Netherlands; [van Dijk, Milenna T.] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); New York University	Blom, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands.	riannemb@gmail.com	van Wingen, Guido/AAK-8462-2021; luigjes, judy/P-5161-2014; Scholte, H.Steven/ABD-1737-2020	van Wingen, Guido/0000-0003-3076-5891; Scholte, H.Steven/0000-0002-9839-1788; van der Wal, Sija/0000-0002-3064-3934	Department of Psychiatry of the Academical Medical Center	Department of Psychiatry of the Academical Medical Center	The study was funded by the Department of Psychiatry of the Academical Medical Center. JL, GAvW, RMB and DD received salary from this department.	Amianto F, 2013, PSYCHIAT RES-NEUROIM, V213, P210, DOI 10.1016/j.pscychresns.2013.03.010; Arzy S, 2006, ARCH NEUROL-CHICAGO, V63, P1022, DOI 10.1001/archneur.63.7.1022; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Bekrater-Bodmann R, 2012, BRAIN RES, V1452, P130, DOI 10.1016/j.brainres.2012.03.001; Blom R M, 2014, Tijdschr Psychiatr, V56, P54; Blom RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034702; Blom RM, 2014, NED TIJDSCHR GENEES, V158, pA7146; Boghi A, 2011, PSYCHIAT RES-NEUROIM, V192, P154, DOI 10.1016/j.pscychresns.2010.12.008; Bottini G, 2015, NEUROCASE, V21, P394, DOI 10.1080/13554794.2014.902969; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brang D, 2008, NEUROREPORT, V19, P1305, DOI 10.1097/WNR.0b013e32830abc4d; Brugger P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00204; Bruno RL, 1997, SEX DISABIL, V15, P243, DOI 10.1023/A:1024769330761; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Everaerd W., AM J PSYCHOTHER, P285; Feinberg TE, 2010, J NEUROL NEUROSUR PS, V81, P276, DOI 10.1136/jnnp.2009.188946; Fiorio M, 2014, J COGNITIVE NEUROSCI, V26, P712, DOI 10.1162/jocn_a_00522; First MB, 2005, PSYCHOL MED, V35, P919, DOI 10.1017/S0033291704003320; First MB, 2012, PSYCHOPATHOLOGY, V45, P3, DOI 10.1159/000330503; Gentile G, 2015, NEUROIMAGE, V109, P328, DOI 10.1016/j.neuroimage.2015.01.008; GESCHWIND DH, 1995, NEUROLOGY, V45, P802, DOI 10.1212/WNL.45.4.802; Giummarra MJ, 2011, NEUROPSYCHOL REV, V21, P320, DOI 10.1007/s11065-011-9184-8; Giummarra MJ, 2012, PARALYZED DESIRE NEW, P1; Graff-Radford J, 2013, J NEUROL, V260, P1880, DOI 10.1007/s00415-013-6898-y; Hilti LM, 2013, BRAIN, V136, P318, DOI 10.1093/brain/aws316; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Kasten E, 2014, PSYCHOL BEHAV SCI, V3, P222, DOI DOI 10.11648/j.pbs.20140306.17; Lenggenhager B, 2015, NEUROPSYCHOLOGY, V29, P205, DOI 10.1037/neu0000143; Lenggenhager B, 2014, CORTEX, V54, P210, DOI 10.1016/j.cortex.2014.02.004; Limanowski J, 2016, SOC COGN AFFECT NEUR, V11, P1130, DOI 10.1093/scan/nsv079; Loetscher T, 2006, J NEUROL NEUROSUR PS, V77, P1099, DOI 10.1136/jnnp.2005.087163; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McGeoch PD, 2011, J NEUROL NEUROSUR PS, V82, P1314, DOI 10.1136/jnnp-2011-300224; MONEY J, 1977, J SEX RES, V13, P115, DOI 10.1080/00224497709550967; Money J., 1984, SEX DISABIL, V7, P43, DOI [10.1007/bf01101829, DOI 10.1007/BF01101829]; Pearce JMS, 2007, EUR NEUROL, V57, P62, DOI 10.1159/000097122; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Romano D, 2015, CONSCIOUS COGN, V34, P140, DOI 10.1016/j.concog.2015.04.008; Scepkowski Lisa A, 2003, Behav Cogn Neurosci Rev, V2, P261, DOI 10.1177/1534582303260119; Sedda A, 2014, NEUROPSYCH DIS TREAT, V10, P1255, DOI 10.2147/NDT.S53385; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Titova OE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-110; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; van Dijk MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072212; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011	53	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165789	10.1371/journal.pone.0165789	http://dx.doi.org/10.1371/journal.pone.0165789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832097	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000034
J	Choudhury, SM; Arora, T; Alebbi, S; Ahmed, L; Aden, A; Omar, O; Taheri, S				Choudhury, Sopna M.; Arora, Teresa; Alebbi, Seham; Ahmed, Lina; Aden, Abdi; Omar, Omar; Taheri, Shahrad			How Do Qataris Source Health Information?	PLOS ONE			English	Article							SEEKING BEHAVIOR; INTERNET; ASSOCIATION; SEEKERS; CARE	Background Qatar is experiencing rapid population expansion with increasing demands on healthcare services for both acute and chronic conditions. Sourcing accurate information about health conditions is crucial, yet the methods used for sourcing health information in Qatar are currently unknown. Gaining a better understanding of the sources the Qatari population use to recognize and manage health and/or disease will help to develop strategies to educate individuals about existing and emerging health problems. Objective To investigate the methods used by the Qatari population to source health information. We hypothesized that the Internet would be a key service used to access health information by the Qatari population. Methods A researcher-led questionnaire was used to collect information from Qatari adults, aged 18-85 years. Participants were approached in shopping centers and public places in Doha, the capital city of Qatar. The questionnaire was used to ascertain information concerning demo-graphics, health status, and utilization of health care services during the past year as well as sources of health information used. Results Data from a total of 394 eligible participants were included. The Internet was widely used for seeking health information among the Qatari population (71.1%). A greater proportion of Qatari females (78.7%) reported searching for health-related information using the Internet compared to Qatari males (60.8%). Other commonly used sources were family and friends (37.8%) and Primary Health Care Centers (31.2%). Google was the most commonly used search engine (94.8%). Gender, age and education levels were all significant predictors of Internet use for heath information (P<0.001 for all predictors). Females were 2.9 times more likely than males (P<0.001) and people educated to university or college level were 3.03 times more likely (P<0.001) to use the Internet for heath information. Conclusions The Internet is a widely used source to obtain health-related information by the Qatari population. Internet search engines can be utilized to guide users to websites, developed and monitored by healthcare providers, to help convey reliable and accurate health information to Qatar's growing population.	[Choudhury, Sopna M.; Arora, Teresa; Alebbi, Seham; Ahmed, Lina; Aden, Abdi; Omar, Omar; Taheri, Shahrad] Qatar Fdn Educ City, Dept Med & Clin Res Core, Weill Cornell Med Qatar, Doha, Qatar; [Taheri, Shahrad] Hamad Med Corp, Dept Med, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation	Taheri, S (corresponding author), Qatar Fdn Educ City, Dept Med & Clin Res Core, Weill Cornell Med Qatar, Doha, Qatar.; Taheri, S (corresponding author), Hamad Med Corp, Dept Med, Doha, Qatar.	staheri@me.com	Taheri, Shahrad/O-9721-2016	Taheri, Shahrad/0000-0001-8314-1500; Choudhury, Sopna Mannan/0000-0001-5017-6977; Arora, Teresa/0000-0001-8360-7358; Hasabelgawi, Lina/0000-0001-9512-8231	Qatar Foundation through the Biomedical Research Program at Weill Cornell Medicine in Qatar; Clinical Research Core at Weill Cornell Medicine in Qatar	Qatar Foundation through the Biomedical Research Program at Weill Cornell Medicine in Qatar(Qatar National Research Fund (QNRF)Qatar Foundation (QF)); Clinical Research Core at Weill Cornell Medicine in Qatar(Qatar National Research Fund (QNRF))	The study was supported by the Qatar Foundation through the Biomedical Research Program at Weill Cornell Medicine in Qatar. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Clinical Research Core at Weill Cornell Medicine in Qatar for supporting the study: Odette Chagoury, Sahar Agouba, Abeer El Shewehy, Youssra Dakroury, Salma Ahmed, Afnan Albahri, Raji Katibe, Mohammad Samer Younes.	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; AlGhamdi KM, 2012, INT J MED INFORM, V81, P363, DOI 10.1016/j.ijmedinf.2011.12.004; Andres L, 2010, TELECOMMUN POLICY, V34, P323, DOI 10.1016/j.telpol.2010.01.003; Atkinson NL, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1035; Bellin L E, 1986, J Community Health, V11, P155, DOI 10.1007/BF01338796; Bianco A, 2013, J MED INTERNET RES, V15, P268, DOI 10.2196/jmir.2752; Brown JB, 2002, PATIENT EDUC COUNS, V48, P225, DOI 10.1016/S0738-3991(02)00175-1; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Dutta-Bergman MJ, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.2.e15; Galdas P., 2009, MENS HLTH BODY IDENT, P63; Gallagher S, 2009, J Evid Based Med, V2, P99, DOI 10.1111/j.1756-5391.2009.01021.x; Gidwani R, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3801; Gray NJ, 2005, SOC SCI MED, V60, P1467, DOI 10.1016/j.socscimed.2004.08.010; Hargittai E, 2010, SOCIOL INQ, V80, P92, DOI 10.1111/j.1475-682X.2009.00317.x; International Diabetes Federation, 2013, IDF DIAB ATL; Jamal A, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4312; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; Lambert SD, 2007, QUAL HEALTH RES, V17, P1006, DOI 10.1177/1049732307305199; Li J, 2015, HLTH INFORM J; Li N, 2014, FAM PRACT, V31, P550, DOI 10.1093/fampra/cmu034; Manierre MJ, 2015, SOC SCI MED, V128, P151, DOI 10.1016/j.socscimed.2015.01.028; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pew Research Centre, SOURC HLTH INF; Powell J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1600; Stoeckle J, 1987, ENCOUNTERS PATIENTS; Supreme Council of Health Qatar., NAT HLTH STRAT 2011; Supreme Council of Information and Communication (ictQATAR), 2015, QAT NAT ICT PLAN 201; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Weaver JB, 2010, AM J PUBLIC HEALTH, V100, P1520, DOI 10.2105/AJPH.2009.180521; World Health Organization W, 2013, RES UN HLTH COV WORL	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166250	10.1371/journal.pone.0166250	http://dx.doi.org/10.1371/journal.pone.0166250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832112	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000085
J	Lee, J; Cho, NW				Lee, Jihwan; Cho, Nam-Wook			Fast Outlier Detection Using a Grid-Based Algorithm	PLOS ONE			English	Article								As one of data mining techniques, outlier detection aims to discover outlying observations that deviate substantially from the reminder of the data. Recently, the Local Outlier Factor (LOF) algorithm has been successfully applied to outlier detection. However, due to the computational complexity of the LOF algorithm, its application to large data with high dimension has been limited. The aim of this paper is to propose grid-based algorithm that reduces the computation time required by the LOF algorithm to determine the k-nearest neighbors. The algorithm divides the data spaces in to a smaller number of regions, called as a "grid", and calculates the LOF value of each grid. To examine the effectiveness of the proposed method, several experiments incorporating different parameters were conducted. The proposed method demonstrated a significant computation time reduction with predictable and acceptable trade-off errors. Then, the proposed methodology was successfully applied to real database transaction logs of Korea Atomic Energy Research Institute. As a result, we show that for a very large dataset, the grid-LOF can be considered as an acceptable approximation for the original LOF. Moreover, it can also be effectively used for real-time outlier detection.	[Lee, Jihwan] Hankuk Univ Foreign Studies, Dept Ind & Management Engn, Gyunggi Do, South Korea; [Cho, Nam-Wook] Seoul Natl Univ Sci & Technol, Dept Ind & Informat Syst Engn, Seoul, South Korea	Hankuk University Foreign Studies; Seoul National University of Science & Technology	Cho, NW (corresponding author), Seoul Natl Univ Sci & Technol, Dept Ind & Informat Syst Engn, Seoul, South Korea.	nwcho@seoultech.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology (MEST) [NRF-2013R1A1A22011169]; Hankuk University of Foreign Studies Research Fund	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology (MEST); Hankuk University of Foreign Studies Research Fund	This work was supported by the research program funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (MEST) (NRF-2013R1A1A22011169). This work was also supported by Hankuk University of Foreign Studies Research Fund of 2016.	Aggarwal C. C., 2001, SIGMOD Record, V30, P37, DOI 10.1145/376284.375668; Blake C, UCI REPOSITORY MACHI; Breunig MM, 2000, SIGMOD REC, V29, P93, DOI 10.1145/335191.335388; Faloutsos C., 1995, SIGMOD Record, V24, P163, DOI 10.1145/568271.223812; Fukunaga K., 2013, INTRO STAT PATTERN R; Hawkins D. M, 1980, IDENTIFICATION OUTLI; Kang B, 2012, EXPERT SYST APPL, V39, P6061, DOI 10.1016/j.eswa.2011.12.007; Kim S, 2013, SCI WORLD J, DOI 10.1155/2013/175702; Kim S, 2011, EXPERT SYST APPL, V38, P9587, DOI 10.1016/j.eswa.2011.01.162; Lazarevic A, 2003, SIAM PROC S, P25; Maloof MA, 2006, MACHINE LEARNING DAT; Pokrajac D, P IEEE S COMP INT DA, P504; Strang G., 2006, LINEAR ALGEBRA ITS A; Vetterling W.T., 1988, NUMERICAL RECIPES C	14	4	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165972	10.1371/journal.pone.0165972	http://dx.doi.org/10.1371/journal.pone.0165972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832163	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000050
J	Pennington, M; Gentry-Maharaj, A; Karpinskyj, C; Miners, A; Taylor, J; Manchanda, R; Iyer, R; Griffin, M; Ryan, A; Jacobs, I; Menon, U; Legood, R				Pennington, Mark; Gentry-Maharaj, Aleksandra; Karpinskyj, Chloe; Miners, Alec; Taylor, Julie; Manchanda, Ranjit; Iyer, Rema; Griffin, Michelle; Ryan, Andy; Jacobs, Ian; Menon, Usha; Legood, Rosa			Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)	PLOS ONE			English	Article							MEDICAL COSTS; SOCIOECONOMIC INEQUALITIES; MULTIPLE IMPUTATION; COLORECTAL-CANCER; CENSORED-DATA; HYSTERECTOMY; SURVIVAL; STAGE; ADENOCARCINOMA; MULTICENTER	Background There is limited evidence on the costs of Endometrial Cancer (EC) by stage of disease. We estimated the long-term secondary care costs of EC according to stage at diagnosis in an English population-based cohort. Methods Women participating in UKCTOCS and diagnosed with EC following enrolment (2001- 2005) and prior to 31 st Dec 2009 were identified to have EC through multiple sources. Survival was calculated through data linkage to death registry. Costs estimates were derived from hospital records accessed from Hospital Episode Statistics (HES) with additional patient level covariates derived from case notes and patient questionnaires. Missing and censored data was imputed using Multiple Imputation. Regression analysis of cost and survival was undertaken. Results 491 of 641 women with EC were included. Five year total costs were strongly dependent on stage, ranging from 9,475 pound (diagnosis at stage IA/IB) to 26,080 pound (diagnosis at stage III). Stage, grade and BMI were the strongest predictors of costs. The majority of costs for stage I/II EC were incurred in the first six months after diagnosis while for stage III/IV considerable costs accrued after the first six months. Conclusions In addition to survival advantages, there are significant cost savings if patients with EC are detected earlier.	[Pennington, Mark] Kings Coll London, Inst Psychiat Psychol & Neurosci, David Goldberg Ctr, Kings Hlth Econ, London, England; [Gentry-Maharaj, Aleksandra; Karpinskyj, Chloe; Taylor, Julie; Iyer, Rema; Griffin, Michelle; Ryan, Andy; Jacobs, Ian; Menon, Usha] UCL, Inst Womens Hlth, Dept Womens Canc, London, England; [Miners, Alec; Legood, Rosa] London Sch Hyg & Trop Med, Dept Hlth Serv Res, London, England; [Manchanda, Ranjit] Queen Mary Univ London, Barts Canc Inst, London, England; [Jacobs, Ian] Univ New South Wales, Sydney, NSW, Australia	University of London; King's College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London; University of New South Wales Sydney	Menon, U (corresponding author), UCL, Inst Womens Hlth, Dept Womens Canc, London, England.	u.menon@ucl.a.c.uk	Legood, Rosa/GQZ-9121-2022; Menon, Usha/C-4716-2008; Pennington, Mark/AAS-9946-2020; Manchanda, Ranjit/AEP-0906-2022	Legood, Rosa/0000-0003-2761-5227; Menon, Usha/0000-0003-3708-1732; Pennington, Mark/0000-0002-1392-8700; Manchanda, Ranjit/0000-0003-3381-5057; Jacobs, Ian/0000-0002-5005-2672; Karpinskyj, Chloe/0000-0003-0870-9287	Cancer Research UK (CRUK Grant) [A16008]; Medical Research Council; Department of Health; Eve Appeal; MRC [G9901012, G0801228] Funding Source: UKRI; Cancer Research UK [16008] Funding Source: researchfish; Medical Research Council [G9901012, G0801228] Funding Source: researchfish; National Institute for Health Research [CL-2009-18-006] Funding Source: researchfish	Cancer Research UK (CRUK Grant); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Eve Appeal; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The analysis underpinning this study was supported with a grant from Cancer Research UK (CRUK Grant No: A16008) awarded to RL (http://www.cancerresearchuk. org/funding for researchers). The trial (UKCTOCS) for which the patients in this study form a subgroup was funded by the Medical Research Council, Cancer Research UK, the Department of Health and the Eve Appeal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CANC INC MORT UK; [Anonymous], OPCS 4 CLASS; [Anonymous], UT CANC MORT STAT; [Anonymous], SIMPL GUID PAYM RES; Bailey K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1609-5; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Brooks SE, 2002, GYNECOL ONCOL, V85, P242, DOI 10.1006/gyno.2002.6591; Brooks SE, 2001, CANCER, V92, P950, DOI 10.1002/1097-0142(20010815)92:4<950::AID-CNCR1405>3.0.CO;2-O; Brown ML, 1999, MED CARE, V37, P1249, DOI 10.1097/00005650-199912000-00008; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Burton A, 2007, CLIN TRIALS, V4, P154, DOI 10.1177/1740774507076914; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clements AE, 2013, GYNECOL ONCOL, V128, P166, DOI 10.1016/j.ygyno.2012.10.007; Cohn DE, 2007, OBSTET GYNECOL, V109, P1388, DOI 10.1097/01.AOG.0000262897.21628.06; Cohn DE, 2013, GYNECOL ONCOL, V130, P403, DOI 10.1016/j.ygyno.2013.05.026; Coleman MP, 2001, CANCER, V91, P208, DOI 10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-E; Creasman WT, 1989, GYNECOL ONCOL, V35; Dowdy SC, 2012, OBSTET GYNECOL, V120, P1419, DOI [10.1097/AOG.0b013e3182737538, http://10.1097/AOG.0b013e3182737538]; Evans T, 2011, BRIT J CANCER, V104, P1505, DOI 10.1038/bjc.2011.68; Fanning J, 2004, GYNECOL ONCOL, V93, P632, DOI 10.1016/j.ygyno.2004.03.002; Gemignani ML, 1999, GYNECOL ONCOL, V73, P5, DOI 10.1006/gyno.1998.5311; Geue C, 2012, HEALTH ECON, V21, P1201, DOI 10.1002/hec.1785; Ghosh K, 2001, GYNECOL ONCOL, V83, P378, DOI 10.1006/gyno.2001.6428; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Holt PJE, 2012, BRIT J SURG, V99, P58, DOI 10.1002/bjs.7680; Jacobs I, 2011, LANCET ONCOL, V12, P38, DOI 10.1016/S1470-2045(10)70268-0; Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Lachance JA, 2008, GYNECOL ONCOL, V108, P77, DOI 10.1016/j.ygyno.2007.08.072; Lang K, 2009, CLIN GASTROENTEROL H, V7, P198, DOI 10.1016/j.cgh.2008.08.034; Lau S, 2012, OBSTET GYNECOL, V119, P717, DOI 10.1097/AOG.0b013e31824c0956; Lin DY, 1997, BIOMETRICS, V53, P419, DOI 10.2307/2533947; Madison T, 2004, AM J PUBLIC HEALTH, V94, P2104, DOI 10.2105/AJPH.94.12.2104; Menon U, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2079; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; National Institute for Health and Clinical Excellence, 2013, GUID METH TECHN APPR; Noble M, 2008, ENGLISH INDICES DEPR; O'Hagan A, 2004, J HEALTH ECON, V23, P615, DOI 10.1016/j.jhealeco.2003.06.006; Oostenbrink JB, 2005, HEALTH ECON, V14, P763, DOI 10.1002/hed.966; Randall TC, 2003, J CLIN ONCOL, V21, P4200, DOI 10.1200/JCO.2003.01.218; Rankins NC, 2007, GYNECOL ONCOL, V106, P388, DOI 10.1016/j.ygyno.2007.04.015; Rappange DR, 2008, PHARMACOECONOMICS, V26, P815, DOI 10.2165/00019053-200826100-00003; Rubin D. B., 2004, MULTIPLE IMPUTATION; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Solomon T, 2014, STAT B; StataCorp, 2013, STATA STAT SOFTW REL; Wolstenholme JL, 1998, INT J TECHNOL ASSESS, V14, P277, DOI 10.1017/S0266462300012253; Wolstenholme JL, 1998, EUR J CANCER, V34, P1889, DOI 10.1016/S0959-8049(98)00232-9; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; World Health Organization, INT CLASS DIS; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; Yu X, 2011, GYNECOL ONCOL, V121, pS21, DOI 10.1016/j.ygyno.2010.12.055	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165539	10.1371/journal.pone.0165539	http://dx.doi.org/10.1371/journal.pone.0165539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829038	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000387724300049
J	Konno, T; Nakano, R; Mamiya, R; Tsuchiya, H; Kitanaka, T; Namba, S; Kitanaka, N; Okabayashi, K; Narita, T; Sugiya, H				Konno, Tadayoshi; Nakano, Rei; Mamiya, Ryo; Tsuchiya, Hisashi; Kitanaka, Taku; Namba, Shinichi; Kitanaka, Nanako; Okabayashi, Ken; Narita, Takanori; Sugiya, Hiroshi			Expression and Function of Interleukin-1 beta-Induced Neutrophil Gelatinase-Associated Lipocalin in Renal Tubular Cells	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; EPITHELIAL-MESENCHYMAL TRANSITION; EARLY URINARY BIOMARKER; PATHOPHYSIOLOGY; INFLAMMASOMES; REPERFUSION; PATHWAYS; MARKER; NGAL; DISRUPTION	Acute kidney injury (AKI) is characterized by a sudden loss of renal function. Early recognition of AKI, especially in critically ill patients, is essential for adequate therapy. Currently, neutrophil gelatinase-associated lipocalin (NGAL) is considered to be an effective biomarker of AKI; however, the regulation of its expression and function in renal tubular cells remains unclear. In this study, we investigated the regulation of the expression and function of NGAL in IL-1 beta-treated Madin-Darby canine kidney (MDCK) cells as a model of renal tubular cells. IL-1 beta induced a disturbance in the localization of E-cadherin and zonaoccludin-1 (ZO-1). The transepithelial electrical resistance (TER) also decreased 5 days after IL-1 beta treatment. IL-1 beta induced NGAL mRNA expression and protein secretion in a time-and dose- dependent manner, which occurred faster than the decrease in TER. In the presence of ERK1/2 and p38 inhibitors, IL- 1 beta-induced NGAL mRNA expression and protein secretion were significantly attenuated. In the presence of recombinant NGAL, IL-1 beta-induced disturbance in the localization of E-cadherin and ZO-1 was attenuated, and the decrease in TER was partially maintained. These results suggest that NGAL can be used as a biomarker for AKI and that it functions as a protector from AKI.	[Konno, Tadayoshi; Nakano, Rei; Mamiya, Ryo; Tsuchiya, Hisashi; Kitanaka, Taku; Namba, Shinichi; Kitanaka, Nanako; Okabayashi, Ken; Narita, Takanori; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Narita, Takanori/F-1092-2011	Okabayashi, Ken/0000-0003-2525-9265; Nakano, Rei/0000-0003-0255-6347; Narita, Takanori/0000-0003-0295-5014; Namba, Shinichi/0000-0002-9182-3656	Ministry of Education, Science, Sports, and Culture of Japan [15K07728]; Grants-in-Aid for Scientific Research [15K07728] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (#15K07728) from the Ministry of Education, Science, Sports, and Culture of Japan (https://www.jsps.go.jp) (HS). There was no additional external funding received for this study.; This work was supported in part by a Grant-in-Aid for Scientific Research (#15K07728) from the Ministry of Education, Science, Sports, and Culture of Japan. We would like to thank Editage (www.editage.jp) for English language editing.	Anders HJ, 2013, KIDNEY INT, V84, P225, DOI 10.1038/ki.2013.122; Bahmani P, 2010, CELL STRESS CHAPERON, V15, P395, DOI 10.1007/s12192-009-0154-5; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gul CB, 2008, CLIN BIOCHEM, V41, P544, DOI 10.1016/j.clinbiochem.2008.01.002; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; Hutton HL, 2016, NEPHROLOGY, V21, P736, DOI 10.1111/nep.12785; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Kimura K, 2009, INVEST OPHTH VIS SCI, V50, P597, DOI 10.1167/iovs.08-2606; Korrapati MC, 2012, J PHARMACOL EXP THER, V341, P126, DOI 10.1124/jpet.111.190249; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee CH, 2015, J CELL PHYSIOL, V230, P875, DOI 10.1002/jcp.24816; Mao SS, 2011, INT J MOL MED, V27, P555, DOI 10.3892/ijmm.2011.613; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Masood H, 2015, KIDNEY DIS-BASEL, V1, P187, DOI 10.1159/000438843; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; Peerapen P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01041; Sancho-Martinez SM, 2015, CLIN KIDNEY J, V8, P548, DOI 10.1093/ckj/sfv069; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Sugiura T, 1999, KIDNEY INT, V56, pS167, DOI 10.1046/j.1523-1755.1999.07143.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Trachtman H, 2006, PEDIATR NEPHROL, V21, P989, DOI 10.1007/s00467-006-0146-y; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vinuesa E, 2008, AM J PHYSIOL-RENAL, V295, pF1554, DOI 10.1152/ajprenal.90250.2008; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; Yang JR, 2014, AM J PHYSIOL-RENAL, V306, pF75, DOI 10.1152/ajprenal.00117.2013; Zang XJ, 2014, INT UROL NEPHROL, V46, P1673, DOI 10.1007/s11255-014-0749-3; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	51	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166707	10.1371/journal.pone.0166707	http://dx.doi.org/10.1371/journal.pone.0166707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851800	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300080
J	Ramaiya, MK; Sullivan, KA; O'Donnell, K; Cunningham, CK; Shayo, AM; Mmbaga, BT; Dow, DE				Ramaiya, Megan K.; Sullivan, Kristen A.; O'Donnell, Karen; Cunningham, Coleen K.; Shayo, Aisa M.; Mmbaga, Blandina T.; Dow, Dorothy E.			A Qualitative Exploration of the Mental Health and Psychosocial Contexts of HIV-Positive Adolescents in Tanzania	PLOS ONE			English	Article							AIDS-ORPHANED CHILDREN; SUB-SAHARAN AFRICA; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; POSTTRAUMATIC STRESS; INFECTED CHILDREN; YOUNG-ADULTS; CAPE-TOWN; DEPRESSION; HIV/AIDS	Although 85% of HIV-positive adolescents reside in sub-Saharan Africa, little is known about the psychosocial and mental health factors affecting their daily well-being. Identifying these contextual variables is key to development of culturally appropriate and effective interventions for this understudied and high-risk population. The purpose of this study was to identify salient psychosocial and mental health challenges confronted by HIV-positive youth in a resource-poor Tanzanian setting. A total of 24 qualitative interviews were conducted with a convenience sample of adolescents aged 12-24 receiving outpatient HIV care at a medical center in Moshi, Tanzania. All interviews were audio-recorded, transcribed, and coded using thematic analysis. Psychosocial challenges identified included loss of one or more parents, chronic domestic abuse, financial stressors restricting access to medical care and education, and high levels of internalized and community stigma among peers and other social contacts. Over half of youth (56%) reported difficulties coming to terms with their HIV diagnosis and espoused related feelings of self-blame. These findings highlight the urgent need to develop culturally proficient programs aimed at helping adolescents cope with these manifold challenges. Results from this study guided the development of Sauti ya Vijana (The Voice of Youth), a 10-session group mental health intervention designed to address the psychosocial and mental health needs of HIV-positive Tanzanian youth.	[Ramaiya, Megan K.; O'Donnell, Karen] Duke Univ, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC USA; [Ramaiya, Megan K.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Sullivan, Kristen A.] Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC 27514 USA; [O'Donnell, Karen] Duke Univ, Ctr Child & Family Hlth, Durham, NC USA; [Cunningham, Coleen K.; Dow, Dorothy E.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Durham, NC USA; [Shayo, Aisa M.; Mmbaga, Blandina T.; Dow, Dorothy E.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	Duke University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Kilimanjaro Christian Medical Centre	Sullivan, KA (corresponding author), Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC 27514 USA.	ksullivan@med.unc.edu	Dow, Dorothy/H-8164-2019; Mmbaga, Blandina Theophil/AAR-8707-2021	Mmbaga, Blandina Theophil/0000-0002-5550-1916	Duke University Center for AIDS Research (CFAR); NIH [P30 A1064518, R25 TW009337]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant; Department of Pediatrics, Duke University Medical Center [T32 HD060558]; International Scientist Research Development Award - Fogarty International Center [K01 TW-009985]; National Institute of Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060558] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW009985, R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant; Department of Pediatrics, Duke University Medical Center; International Scientist Research Development Award - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Duke University Center for AIDS Research (CFAR), an NIH funded program (P30 A1064518), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant to the Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center (T32 HD060558) and by NIH Research Training Grant R25 TW009337 and International Scientist Research Development Award (K01 TW-009985) funded by the Fogarty International Center and the National Institute of Mental Health (to DED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Duke University Center for AIDS Research (CFAR), an NIH funded program (P30 AI064518), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant to the Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center (T32 HD060558) and by NIH Research Training Grant R25 TW009337 and International Scientist Research Development Award (K01 TW-009985) funded by the Fogarty International Center and the National Institute of Mental Health (to DED). Authors had control of all primary data.	Akena D, 2013, AIDS CARE, V25, P1245, DOI 10.1080/09540121.2013.764385; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; Betancourt T, 2014, PEDIATRICS, V134, pE464, DOI 10.1542/peds.2013-2734; Betancourt TS, 2013, J CHILD PSYCHOL PSYC, V54, P423, DOI 10.1111/j.1469-7610.2012.02613.x; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Cluver L, 2007, AIDS CARE, V19, P318, DOI 10.1080/09540120600986578; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2013, SOC SCI MED, V87, P185, DOI 10.1016/j.socscimed.2013.03.028; Cluver L, 2011, JAIDS-J ACQ IMM DEF, V58, P336, DOI 10.1097/QAI.0b013e31822f0d82; Cluver L, 2011, NATURE, V474, P27, DOI 10.1038/474027a; Cluver L, 2009, VULNERABLE CHILD YOU, V4, P185, DOI 10.1080/17450120902730196; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Cluver L, 2009, AIDS CARE, V21, P732, DOI 10.1080/09540120802511885; Cluver LD, 2012, J CHILD PSYCHOL PSYC, V53, P363, DOI 10.1111/j.1469-7610.2011.02459.x; Cluver L, 2009, J TRAUMA STRESS, V22, P106, DOI 10.1002/jts.20396; Cohen JA, 2010, CHILD ABUSE NEGLECT, V34, P215, DOI 10.1016/j.chiabu.2009.12.003; DeLaMora Patricia, 2006, Curr HIV/AIDS Rep, V3, P74, DOI 10.1007/s11904-006-0021-2; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Dow DE, 2016, AIDS CARE, P1; Dow DE, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0567-3; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Govender K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-615; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Harder VS, 2012, J TRAUMA STRESS, V25, P64, DOI 10.1002/jts.21660; Joint United Nations Programme on HIV/AIDS, 2013, GLOBAL REPORT UNAIDS; Kahana SY, 2013, AIDS BEHAV, V17, P41, DOI 10.1007/s10461-012-0159-4; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Mavhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070254; Mellins CA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18593; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Merzel C, 2008, AIDS PATIENT CARE ST, V22, P977, DOI 10.1089/apc.2008.0048; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Morantz G, 2013, VULNERABLE CHILD YOU, V8, P338, DOI 10.1080/17450128.2013.764476; Murray LK, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-24; Musisi S, 2009, East Afr Med J, V86, P16; Mutumba M, 2015, AIDS PATIENT CARE ST, V29, P86, DOI 10.1089/apc.2014.0222; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; O'Donnell K, 2014, J TRAUMA STRESS, V27, P664, DOI 10.1002/jts.21970; Pao M, 2000, ARCH PEDIAT ADOL MED, V154, P240, DOI 10.1001/archpedi.154.3.240; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Radcliffe J, 2007, AIDS PATIENT CARE ST, V21, P501, DOI 10.1089/apc.2006.0144; Robson E, 2006, POPUL SPACE PLACE, V12, P93, DOI 10.1002/psp.392; Steinberg A, 2008, ENCY PSYCHOL TRAUMA, P673; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Strydom H, 2005, INT SOC WORK, V48, P569, DOI 10.1177/0020872805055321; Stuart S, 2012, INTERPERSONAL PSYCHO; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Whetten K, 2011, J TRAUMA STRESS, V24, P174, DOI 10.1002/jts.20625; WHO, 2013, HIV AD GUID HIV TEST; World Health Organization, 2011, MENT HLTH ATL UN REP; World Health Organization, 2011, MHGAP INT GUID MENT	54	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165936	10.1371/journal.pone.0165936	http://dx.doi.org/10.1371/journal.pone.0165936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851797	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300028
J	Bergquist, H; Rocha, CSJ; Alvarez-Asencio, R; Nguyen, CH; Rutland, MW; Smith, CIE; Good, L; Nielsen, PE; Zain, R				Bergquist, Helen; Rocha, Cristina S. J.; Alvarez-Asencio, Ruben; Chi-Hung Nguyen; Rutland, Mark. W.; Smith, C. I. Edvard; Good, Liam; Nielsen, Peter E.; Zain, Rula			Disruption of Higher Order DNA Structures in Friedreich's Ataxia (GAA)(n) Repeats by PNA or LNA Targeting	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; INTERSTRAND CROSS-LINKS; DOUBLE-STRANDED DNA; DOT-TTC REPEATS; STICKY DNA; NUCLEIC-ACIDS; DUPLEX DNA; IN-VIVO; (GAA)(N)CENTER-DOT(TTC)(N) REPEATS; BENZOQUINOQUINOXALINE DERIVATIVES	Expansion of (GAA)(n) repeats in the first intron of the Frataxin gene is associated with reduced mRNA and protein levels and the development of Friedreich's ataxia. (GAA)(n) expansions form non-canonical structures, including intramolecular triplex (H-DNA), and Rloops and are associated with epigenetic modifications. With the aim of interfering with higher order H-DNA (like) DNA structures within pathological (GAA)(n) expansions, we examined sequence-specific interaction of peptide nucleic acid (PNA) with (GAA)(n) repeats of different lengths (short: n= 9, medium: n= 75 or long: n= 115) by chemical probing of triple helical and single stranded regions. We found that a triplex structure (H-DNA) forms at GAA repeats of different lengths; however, single stranded regions were not detected within the medium size pathological repeat, suggesting the presence of a more complex structure. Furthermore, (GAA) 4-PNA binding of the repeat abolished all detectable triplex DNA structures, whereas (CTT) 5-PNA did not. We present evidence that (GAA) 4-PNA can invade the DNA at the repeat region by binding the DNA CTT strand, thereby preventing non-canonical-DNA formation, and that triplex invasion complexes by (CTT) 5-PNA form at the GAA repeats. Locked nucleic acid (LNA) oligonucleotides also inhibited triplex formation at GAA repeat expansions, and atomic force microscopy analysis showed significant relaxation of plasmid morphology in the presence of GAA-LNA. Thus, by inhibiting disease related higher order DNA structures in the Frataxin gene, such PNA and LNA oligomers may have potential for discovery of drugs aiming at recovering Frataxin expression.	[Bergquist, Helen] Uppsala Univ, Dept Med Biochem & Microbiol, Microbiol Immunol, Uppsala, Sweden; [Bergquist, Helen; Rocha, Cristina S. J.; Smith, C. I. Edvard; Zain, Rula] Karolinska Inst, Dept Lab Med, Clin Res Ctr, SE-14186 Huddinge, Sweden; [Alvarez-Asencio, Ruben; Rutland, Mark. W.] KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Chem, Stockholm, Sweden; [Chi-Hung Nguyen] PSL Res Univ, Ctr Univ, Lab Pharmacochim, Inst Curie,INSERM,UMR 9187,U1196,CNRS, Orsay, France; [Good, Liam] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, London WC1E 7HU, England; [Nielsen, Peter E.] Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Zain, Rula] Karolinska Univ Hosp, Dept Clin Genet, Ctr Rare Dis, SE-17176 Stockholm, Sweden; [Alvarez-Asencio, Ruben] Fdn IMDEA Nanociencia, 9 Campus Univ Cantoblanco, Madrid, Spain	Uppsala University; Karolinska Institutet; Royal Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; University of London; University of London Royal Veterinary College; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; IMDEA Nanociencia	Zain, R (corresponding author), Karolinska Inst, Dept Lab Med, Clin Res Ctr, SE-14186 Huddinge, Sweden.; Zain, R (corresponding author), Karolinska Univ Hosp, Dept Clin Genet, Ctr Rare Dis, SE-17176 Stockholm, Sweden.	rula.zain@ki.se	Nguyen, Chi/GZG-5146-2022; Rutland, Mark W/F-8890-2012; Nguyen, Chi/GWR-1592-2022; Álvarez-Asencio, Rubén/I-3583-2015	Rutland, Mark W/0000-0002-8935-8070; Álvarez-Asencio, Rubén/0000-0002-0790-194X; Rocha, Cristina/0000-0002-6008-9532; Good, Liam/0000-0002-2798-8640; SMITH, C. I. Edvard/0000-0003-1907-3392; /0000-0001-8771-330X	Knut och Alice Wallenbergs Stiftelse; Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council; Landells stiftelse for neurologisk forskning	Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council(Swedish Research CouncilEuropean Commission); Landells stiftelse for neurologisk forskning	This work was financially supported by The Knut och Alice Wallenbergs Stiftelse, Magnus Bergvalls Stiftelse, Carl Tryggers Stiftelse for Vetenskaplig Forskning, The Swedish Research Council and Landells stiftelse for neurologisk forskning.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Amiri H, 2005, J MOL BIOL, V351, P776, DOI 10.1016/j.jmb.2005.03.044; Bentin T, 2006, NUCLEIC ACIDS RES, V34, P5790, DOI 10.1093/nar/gkl736; Bergquist H, 2009, CHEMBIOCHEM, V10, P2629, DOI 10.1002/cbic.200900263; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Billingsley DJ, 2010, PHYS CHEM CHEM PHYS, V12, P14727, DOI 10.1039/c0cp01347a; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Datta HJ, 2001, J BIOL CHEM, V276, P18018, DOI 10.1074/jbc.M011646200; DEMIDOV VV, 1995, P NATL ACAD SCI USA, V92, P2637, DOI 10.1073/pnas.92.7.2637; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; EGHOLM M, 1995, NUCLEIC ACIDS RES, V23, P217, DOI 10.1093/nar/23.2.217; Escude C, 1998, P NATL ACAD SCI USA, V95, P3591, DOI 10.1073/pnas.95.7.3591; Follonier C, 2013, NAT STRUCT MOL BIOL, V20, P486, DOI 10.1038/nsmb.2520; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grant L, 2006, FEBS LETT, V580, P5399, DOI 10.1016/j.febslet.2006.09.006; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Hansen ME, 2009, NUCLEIC ACIDS RES, V37, P4498, DOI 10.1093/nar/gkp437; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hu JX, 2014, NUCLEIC ACID THER, V24, P199, DOI 10.1089/nat.2013.0476; Jain A, 2002, J BIOMOL STRUCT DYN, V19, P691, DOI 10.1080/07391102.2002.10506775; Jain A, 2010, BIOCHIMIE, V92, P317, DOI 10.1016/j.biochi.2009.12.012; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kosaganov YN, 2000, BIOCHEMISTRY-US, V39, P11742, DOI 10.1021/bi0006417; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Li LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10606; Liu Y, 2008, NUCLEIC ACIDS RES, V36, P4680, DOI 10.1093/nar/gkn438; Lundin KE, 2013, ADV GENET, V82, P47, DOI 10.1016/B978-0-12-407676-1.00002-0; lvarez-Asencio R, 2016, J MECH BEHAV BIOMED, V54, P185, DOI [10.1016/j.jmbbm.2015.09.014, DOI 10.1016/J.JMBBM.2015.09.014]; Lyubchenko YL, 2011, METHODS, V54, P274, DOI 10.1016/j.ymeth.2011.02.001; Mariappan SVS, 1999, J MOL BIOL, V285, P2035, DOI 10.1006/jmbi.1998.2435; Moreno PMD, 2013, NUCLEIC ACIDS RES, V41, P3257, DOI 10.1093/nar/gkt007; Napierala M, 2004, J BIOL CHEM, V279, P6444, DOI 10.1074/jbc.M309596200; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Nielsen PE, 1996, J AM CHEM SOC, V118, P2287, DOI 10.1021/ja953125q; Nielsen Peter E., 1994, Journal of Molecular Recognition, V7, P165, DOI 10.1002/jmr.300070303; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pandolfo M, 2002, MITOCHONDRION, V2, P87, DOI 10.1016/S1567-7249(02)00039-9; Pietrement O, 2003, LANGMUIR, V19, P2536, DOI 10.1021/la026942u; Pittenger BB, 2009, BURKER APPL NOTE, V128, P1, DOI 10.13140/RG.2.1.4463.8246; Potaman V N, 1999, Nucleic Acids Res, V27, pe5, DOI 10.1093/nar/27.15.e5; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Pyne A, 2014, SMALL, V10, P3257, DOI 10.1002/smll.201400265; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j; Roberts RW, 1996, J MOL BIOL, V260, P135, DOI 10.1006/jmbi.1996.0388; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Son LS, 2006, J MOL BIOL, V360, P267, DOI 10.1016/j.jmb.2006.05.025; Suzuki Y, 2011, WIRES NANOMED NANOBI, V3, P574, DOI 10.1002/wnan.150; Vasquez KM, 2002, P NATL ACAD SCI USA, V99, P5848, DOI 10.1073/pnas.082193799; Vetcher AA, 2002, J BIOL CHEM, V277, P39217, DOI 10.1074/jbc.M205209200; Vetcher AA, 2002, J BIOL CHEM, V277, P39228, DOI 10.1074/jbc.M205210200; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200; Wu Q, 2007, MOL CARCINOGEN, V46, P15, DOI 10.1002/mc.20261; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Zaid A, 2004, CHEMBIOCHEM, V5, P1550, DOI 10.1002/cbic.200400074; Zain R, 2003, CHEMBIOCHEM, V4, P856, DOI 10.1002/cbic.200300621; Zain R, 1999, CHEM BIOL, V6, P771, DOI 10.1016/S1074-5521(99)80124-0; Zhang X, 2000, NUCLEIC ACIDS RES, V28, P3332, DOI 10.1093/nar/28.17.3332; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399	69	13	13	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165788	10.1371/journal.pone.0165788	http://dx.doi.org/10.1371/journal.pone.0165788			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846236	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600020
J	Qian, J; Mummalaneni, SK; Alkahtani, RM; Mahavadi, S; Murthy, KS; Grider, JR; Lyall, V				Qian, Jie; Mummalaneni, Shobha K.; Alkahtani, Reem M.; Mahavadi, Sunila; Murthy, Karnam S.; Grider, John R.; Lyall, Vijay			Nicotine-Induced Effects on Nicotinic Acetylcholine Receptors (nAChRs), Ca2+ and Brain-Derived Neurotrophic Factor (BDNF) in STC-1 Cells	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BITTER TASTE RECEPTORS; GASTROINTESTINAL-TRACT; UP-REGULATION; EXPRESSION; RELEASE; GUT; SECRETION; MOUSE; TRANSDUCTION	In addition to the T2R bitter taste receptors, neuronal nicotinic acetylcholine receptors (nAChRs) have recently been shown to be involved in the bitter taste transduction of nicotine, acetylcholine and ethanol. However, at present it is not clear if nAChRs are expressed in enteroendocrine cells other than beta cells of the pancreas and enterochromaffin cells, and if they play a role in the synthesis and release of neurohumoral peptides. Accordingly, we investigated the expression and functional role of nAChRs in enteroendocrine STC-1 cells. Our studies using RT-PCR, qRT-PCR, immunohistochemical and Western blotting techniques demonstrate that STC-1 cells express several alpha and beta nAChR subunits. Exposing STC-1 cells to nicotine acutely (24h) or chronically (4 days) induced a differential increase in the expression of nAChR subunit mRNA and protein in a dose- and time-dependent fashion. Mecamylamine, a non-selective antagonist of nAChRs, inhibited the nicotine induced increase in mRNA expression of nAChRs. Exposing STC-1 cells to nicotine increased intracellular Ca2+ in a dose-dependent manner that was inhibited in the presence of mecamylamine or dihydro-beta-erythroidine, a alpha 4 beta 2 nAChR antagonist. Brain-derived neurotrophic factor (BDNF) mRNA and protein were detected in STC-1 cells using RT-PCR, specific BDNF antibody, and enzyme-linked immunosorbent assay. Acute nicotine exposure (30 min) decreased the cellular content of BDNF in STC-1 cells. The nicotine-induced decrease in BDNF was inhibited in the presence of mecamylamine. We also detected alpha 3 and beta 4 mRNA in intestinal mucosal cells and alpha 3 protein expression in intestinal enteroendocrine cells. We conclude that STC-1 cells and intestinal enteroendocrine cells express nAChRs. In STC-1 cells nAChR expression is modulated by exposure to nicotine in a dose- and time-dependent manner. Nicotine interacts with nAChRs and inhibits BDNF expression in STC-1 cells.	[Qian, Jie; Mummalaneni, Shobha K.; Alkahtani, Reem M.; Mahavadi, Sunila; Murthy, Karnam S.; Grider, John R.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23219 USA	Virginia Commonwealth University	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23219 USA.	vijay.lyall@vcuhelth.org			National Institute on Deafness and Other Communication Disorders [DC11569]; National Institute of Diabetes and Digestive and Kidney Diseases [DK34153, DK28300]; National Cancer Institute [PA30 CM6059]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028300, R01DK034153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders, grant DC11569 to VL; National Institute of Diabetes and Digestive and Kidney Diseases, grant DK34153 to JRG; National Institute of Diabetes and Digestive and Kidney Diseases, grant DK28300 to KSM and National Cancer Institute, grant PA30 CM6059-Core Imaging Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qudah M, 2015, NEUROGASTROENT MOTIL, V27, P1162, DOI 10.1111/nmo.12604; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Bala V, 2011, GASTROENTEROLOGY, V140, pS324; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; Brondel L, 1999, INT J OBESITY, V23, P34, DOI 10.1038/sj.ijo.0800754; Brown KC, 2013, J BIOL CHEM, V288, P33049, DOI 10.1074/jbc.M113.501601; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; CHEN MC, 2006, J PHYSICS, V291, pC726, DOI DOI 10.1152/AIPCELL.00003.2006; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Dehkordi O, 2010, LIFE SCI, V86, P281, DOI 10.1016/j.lfs.2009.12.016; Depoortere I, 2015, PEPTIDES, V66, P9, DOI 10.1016/j.peptides.2015.01.013; DeSimone J. A., 2015, THESIS, P667; DeSimone JA, 2006, AM J PHYSIOL-GASTR L, V291, pG1005, DOI 10.1152/ajpgi.00235.2006; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Fox AM, 2015, J BIOL CHEM, V290, P24403, DOI 10.1074/jbc.M115.661827; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; Gallego X, 2012, ALCOHOL, V46, P205, DOI 10.1016/j.alcohol.2011.11.005; Geraedts MCP, 2011, OBES REV, V12, P470, DOI 10.1111/j.1467-789X.2010.00788.x; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grider JR, 2006, GASTROENTEROLOGY, V130, P771, DOI 10.1053/j.gastro.2005.12.026; GRITZ E R, 1988, Alimentary Pharmacology and Therapeutics, V2, P173; Hendrickson Linzy M, 2013, Front Psychiatry, V4, P29, DOI 10.3389/fpsyt.2013.00029; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang T, 2015, DEV BIOL, V405, P225, DOI 10.1016/j.ydbio.2015.07.006; Ishida Y, 2002, MOL BRAIN RES, V107, P17, DOI 10.1016/S0169-328X(02)00441-2; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Kido MA, 2003, J DENT RES, V82, P393, DOI 10.1177/154405910308200513; Kim KS, 2014, DIABETOLOGIA, V57, P2117, DOI 10.1007/s00125-014-3326-5; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; LEE K, 1992, N-S ARCH PHARMACOL, V345, P363; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; McConnell WM, 1995, DIGEST DIS SCI, V40, P2608, DOI 10.1007/BF02220449; Meng LB, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0097-15.2015; Miyata M, 2014, BIOMED RES-TOKYO, V35, P171, DOI 10.2220/biomedres.35.171; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Mummalaneni S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098049; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Parker SL, 2004, MOL PHARMACOL, V65, P611, DOI 10.1124/mol.65.3.611; Ren ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127936; Richardson CE, 2003, QJM-INT J MED, V96, P57, DOI 10.1093/qjmed/hcg007; Saitoh O, 2007, NEUROREPORT, V18, P1991, DOI 10.1097/WNR.0b013e3282f242d3; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schneider DA, 2000, J PHARMACOL EXP THER, V294, P363; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Sturz GR, 2011, CHEM SENSES, V36, P375, DOI 10.1093/chemse/bjq146; Sun CS, 2015, J NEUROSCI, V35, P409, DOI 10.1523/JNEUROSCI.2381-14.2015; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Wang XY, 2015, NEUROL SCI, V36, P289, DOI 10.1007/s10072-014-1934-y; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yee C, 2005, J COMP NEUROL, V490, P371, DOI 10.1002/cne.20670; Yee CL, 2003, J COMP NEUROL, V459, P15, DOI 10.1002/cne.10589; Yeomans MR, 1998, P NUTR SOC, V57, P609, DOI 10.1079/PNS19980089; Zhou XP, 2002, J PHARMACOL EXP THER, V302, P889, DOI 10.1124/jpet.102.033548; Zoli M, 2012, NICOTINE TOB RES, V14, P1270, DOI 10.1093/ntr/nts159	65	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166565	10.1371/journal.pone.0166565	http://dx.doi.org/10.1371/journal.pone.0166565			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846263	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600082
J	Wang, DC; Meng, G; Zheng, MH; Zhang, YH; Chen, AP; Wu, JH; Wei, JW				Wang, Diancheng; Meng, Gang; Zheng, Meihong; Zhang, Yonghui; Chen, Aiping; Wu, Junhua; Wei, Jiwu			The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							KIDNEY-TYPE GLUTAMINASE; CANCER-CELLS; IN-VITRO; APOPTOSIS; GROWTH; ARTEMISININ; SUPPRESSION; METABOLISM; EXPRESSION; MECHANISM	Reprogrammed metabolism and redox homeostasis are potential targets of cancer therapy. Our previous study demonstrated that the kidney form of glutaminase (GLS1) is highly expressed in hepatocellular carcinoma (HCC) cells and can be used as a target for effective anticancer therapy. Dihydroartemisinin (DHA) increases intracellular reactive oxygen species (ROS) levels leading to cytotoxicity in cancer cells. However, the heterogeneity of cancer cells often leads to differing responses to oxidative lesions. For instance, cancer cells with high ratio of GSH/GSSG, a critical ROS scavenger, are resistant to ROS-induced cytotoxicity. We postulate that a combinatorial strategy firstly disrupting redox homeostasis followed by DHA might yield a profound antitumor efficacy. In this study, when HCC cells were treated with a GLS1 inhibitor 968, the ROS elimination capacity was significantly reduced in HCC cells, which rendered HCC cells but not normal endothelial cells more sensitive to DHA-mediated cytotoxicity. We further confirmed that this synergistic antitumor efficacy was mediated by excessive ROS generation in HCC cells. NAC, a ROS inhibitor, partly rescued the combinatorial cytotoxic effect of 968 and DHA. Given that GLS1 is a potential antitumor target and DHA has been safely used in clinic, our findings provide new insight into liver cancer therapy targeting glutamine metabolism combined with the ROS generator DHA, which can be readily translated into cancer clinical trials.	[Wang, Diancheng; Meng, Gang; Zheng, Meihong; Zhang, Yonghui; Chen, Aiping; Wu, Junhua; Wei, Jiwu] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China; [Wei, Jiwu] Nanjing Univ Hightech Inst, Suzhou 215123, Peoples R China	Nanjing University	Wu, JH; Wei, JW (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China.; Wei, JW (corresponding author), Nanjing Univ Hightech Inst, Suzhou 215123, Peoples R China.	wujunhua@nju.edu.cn; wjw@nju.edu.cn		zhang, yonghui/0000-0001-7542-5183	National Natural Science Foundation of China [81172143, 81472820]; Jiangsu Special Program for Clinical Medical Science and Technology [BL2014054]; Natural Science Foundation of Jiangsu Province [BK20141324]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Special Program for Clinical Medical Science and Technology; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (81172143 and 81472820, http://www.nsfc.gov.cn/), Jiangsu Special Program for Clinical Medical Science and Technology (BL2014054, http://www.jskjjh.gov.cn/13kjskj2/), and the Natural Science Foundation of Jiangsu Province (no. BK20141324, http://www.jskjjh.gov.cn/13kjskj2/).; This work was supported by the National Natural Science Foundation of China (81172143 and 81472820), Jiangsu Special Program for Clinical Medical Science and Technology (BL2014054) and the Natural Science Foundation of Jiangsu Province (no. BK20141324). We thank Translational Medicine Core facilities of Medical School of Nanjing University for instruments supporting.	Chen H, 2010, J CANCER RES CLIN, V136, P897, DOI 10.1007/s00432-009-0731-0; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Huang XJ, 2007, J PHARM PHARMACOL, V59, P849, DOI 10.1211/jpp.59.6.0011; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1045, DOI 10.1111/j.1745-7254.2007.00612.x; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li Jun, 2005, Yao Xue Xue Bao, V40, P1041; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Lu JJ, 2011, INVEST NEW DRUG, V29, P1276, DOI 10.1007/s10637-010-9481-8; Lu WQ, 2010, CANCER CELL, V18, P199, DOI 10.1016/j.ccr.2010.08.017; Lu YY, 2010, FEBS LETT, V584, P4019, DOI 10.1016/j.febslet.2010.08.014; Lu YY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-16; Ma Zhen-qiu, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P267; Meng G, 2014, INT J CANCER, V134, P1958, DOI 10.1002/ijc.28416; Nam W, 2007, HEAD NECK-J SCI SPEC, V29, P335, DOI 10.1002/hed.20524; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sun HJ, 2013, TUMOR BIOL, V34, P3791, DOI 10.1007/s13277-013-0963-0; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tan WF, 2011, PHYTOMEDICINE, V18, P158, DOI 10.1016/j.phymed.2010.07.003; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wang SJ, 2011, CANCER CHEMOTH PHARM, V68, P1421, DOI 10.1007/s00280-011-1643-7; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wu XH, 2006, ANTI-CANCER DRUG, V17, P839, DOI 10.1097/01.cad.0000224443.85834.32; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Yu DC, 2015, ONCOTARGET, V6, P7619, DOI 10.18632/oncotarget.3196; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002	42	23	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166423	10.1371/journal.pone.0166423	http://dx.doi.org/10.1371/journal.pone.0166423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835669	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200050
J	Cheung, C; Bietz, MJ; Patrick, K; Bloss, CS				Cheung, Cynthia; Bietz, Matthew J.; Patrick, Kevin; Bloss, Cinnamon S.			Privacy Attitudes among Early Adopters of Emerging Health Technologies	PLOS ONE			English	Article							PERSONAL GENOME PROJECT	Introduction Advances in health technology such as genome sequencing and wearable sensors now allow for the collection of highly granular personal health data from individuals. It is unclear how people think about privacy in the context of these emerging health technologies. An open question is whether early adopters of these advances conceptualize privacy in different ways than non-early adopters. Purpose This study sought to understand privacy attitudes of early adopters of emerging health technologies. Methods Transcripts from in-depth, semi-structured interviews with early adopters of genome sequencing and health devices and apps were analyzed with a focus on participant attitudes and perceptions of privacy. Themes were extracted using inductive content analysis. Results Although interviewees were willing to share personal data to support scientific advancements, they still expressed concerns, as well as uncertainty about who has access to their data, and for what purpose. In short, they were not dismissive of privacy risks. Key privacy related findings are organized into four themes as follows: first, personal data privacy; second, control over personal information; third, concerns about discrimination; and fourth, contributing personal data to science. Conclusion Early adopters of emerging health technologies appear to have more complex and nuanced conceptions of privacy than might be expected based on their adoption of personal health technologies and participation in open science. Early adopters also voiced uncertainty about the privacy implications of their decisions to use new technologies and share their data for research. Though not representative of the general public, studies of early adopters can provide important insights into evolving attitudes toward privacy in the context of emerging health technologies and personal health data research.	[Cheung, Cynthia; Bietz, Matthew J.; Patrick, Kevin; Bloss, Cinnamon S.] Univ Calif San Diego, Ctr Wireless & Populat Hlth Syst, Calit2, La Jolla, CA 92093 USA; [Bietz, Matthew J.] Univ Calif Irvine, Dept Informat, Donald Bren Sch Informat & Comp Sci, Irvine, CA USA; [Patrick, Kevin; Bloss, Cinnamon S.] Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Bloss, Cinnamon S.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California San Diego; University of California System; University of California San Diego	Bloss, CS (corresponding author), Univ Calif San Diego, Ctr Wireless & Populat Hlth Syst, Calit2, La Jolla, CA 92093 USA.; Bloss, CS (corresponding author), Univ Calif San Diego, Sch Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.; Bloss, CS (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA.	cbloss@uosd.edu		Bloss, Cinnamon/0000-0003-1315-8387	Robert Wood Johnson Foundation [71693]; National Human Genome Research Institute [R01 HG008753]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008753] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Robert Wood Johnson Foundation (http://www.rwjf.org/) ("The Health Data Exploration (HDE) project", PI: KP, #71693, 2013-2017); and the National Human Genome Research Institute (https://www.genome.gov/) ("Impact of Privacy Environments for Personal Health Data on Patients", PI: CB, #R01 HG008753, 2015-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti A, 2015, SCIENCE, V347, P509, DOI 10.1126/science.aaa1465; Anderson C., 2008, WIRED MAGAZINE, V16; Angrist M, 2009, PERS MED, V6, P691, DOI 10.2217/PME.09.48; Ball MP, 2014, GENOME MED, V6, DOI 10.1186/gm527; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Bietz MJ, 2016, J AM MED INFORM ASSN, V23, pE42, DOI 10.1093/jamia/ocv118; Burt RS, 2005, BROKERAGE CLOSURE IN; Corbin J, 2014, BASICS QUALITATIVE R; Gollust SE, 2012, PUBLIC HEALTH GENOM, V15, P22, DOI 10.1159/000327296; Green RC, 2015, NEW ENGL J MED, V372, P397, DOI 10.1056/NEJMp1404776; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; Malin B, 2001, P AMIA S; Mayer-Schonberger V, 2015, SCIENCE, V347, P481, DOI 10.1126/science.aaa5358; McDonald Aleecia M., 2008, ISJLP, V4, P543; Meyer G, 2004, J HEALTH COMMUN, V9, P59, DOI 10.1080/10810730490271539; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rubinstein IS, 2013, INT DATA PRIV LAW, V3, P74, DOI 10.1093/idpl/ips036; Sheehan KB, 2005, J PUBLIC POLICY MARK, V24, P273, DOI 10.1509/jppm.2005.24.2.273; Slovic P, 2010, SAUDE SOC, V19, P731, DOI 10.1590/S0104-12902010000400002; Solove DJ, 2006, U PENN LAW REV, V154, P477, DOI 10.2307/40041279; Tene O., 2012, NW J TECH INTELL PRO, V11, pxxvii; Turow J., 2005, DEP PAPERS ASC; Turow Joseph, 2015, TRADEOFF FALLACY; Viseu A., 2004, Information Communication & Society, V7, P92, DOI 10.1080/1369118042000208924; Westin A. F., 2007, RESULTS NATL SURVEY, P2011; Westin AF, 1995, EQUIFAX HARRIS MIDDE, V73; Wolf SM, 2013, ANNU REV GENOM HUM G, V14, P557, DOI 10.1146/annurev-genom-091212-153506	28	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166389	10.1371/journal.pone.0166389	http://dx.doi.org/10.1371/journal.pone.0166389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832194	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000120
J	Hew, J; Solon-Biet, SM; McMahon, AC; Ruohonen, K; Raubenheimer, D; Ballard, JWO; Le Couteur, DG; Nicholls, C; Li, Z; Maitz, PKM; Wang, YW; Simpson, SJ				Hew, Jonathan; Solon-Biet, Samantha M.; McMahon, Aisling C.; Ruohonen, Kari; Raubenheimer, David; Ballard, J. William O.; Le Couteur, David G.; Nicholls, Caroline; Li, Zhe; Maitz, Peter K. M.; Wang, Yiwei; Simpson, Stephen J.			The Effects of Dietary Macronutrient Balance on Skin Structure in Aging Male and Female Mice	PLOS ONE			English	Article							PROTEIN-ENERGY MALNUTRITION; GENDER-DIFFERENCES; ADIPOSE-TISSUE; RAT SKIN; NUTRITION; PHYSIOLOGY; HISTOLOGY; AGE; FIBROBLASTS; THICKNESS	Nutrition influences skin structure; however, a systematic investigation into how energy and macronutrients (protein, carbohydrate and fat) affects the skin has yet to be conducted. We evaluated the associations between macronutrients, energy intake and skin structure in mice fed 25 experimental diets and a control diet for 15 months using the Geometric Framework, a novel method of nutritional analysis. Skin structure was associated with the ratio of dietary macronutrients eaten, not energy intake, and the nature of the effect differed between the sexes. In males, skin structure was primarily associated with protein intake, whereas in females carbohydrate intake was the primary correlate. In both sexes, the dermis and subcutaneous fat thicknesses were inversely proportional. Subcutaneous fat thickness varied positively with fat intake, due to enlarged adipocytes rather than increased adipocyte number. We therefore demonstrated clear interactions between skin structure and macronutrient intakes, with the associations being sex-specific and dependent on dietary macronutrient balance.	[Hew, Jonathan; Nicholls, Caroline; Li, Zhe; Maitz, Peter K. M.; Wang, Yiwei] Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res & Reconstruct Surg, Sydney, NSW 2139, Australia; [Solon-Biet, Samantha M.; McMahon, Aisling C.; Le Couteur, David G.] Univ Sydney, Concord Hosp, Ageing & Alzheimers Inst, Sydney, NSW 2139, Australia; [Solon-Biet, Samantha M.; McMahon, Aisling C.; Le Couteur, David G.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2139, Australia; [Solon-Biet, Samantha M.; Raubenheimer, David; Le Couteur, David G.; Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Solon-Biet, Samantha M.; Raubenheimer, David; Le Couteur, David G.; Simpson, Stephen J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Ruohonen, Kari] EWOS Innovat, N-4335 Dirdal, Norway; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Ballard, J. William O.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Nicholls, Caroline; Li, Zhe; Maitz, Peter K. M.] Concord Repatriat Gen Hosp, Burns Unit, Concord, Australia	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney; Concord Repatriation General Hospital	Wang, YW (corresponding author), Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res & Reconstruct Surg, Sydney, NSW 2139, Australia.; Simpson, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.; Simpson, SJ (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	yiweiwang@anzac.edu.au; stephen.simpon@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Maitz, Peter/GQI-2475-2022; Ekanayake, Kanchana/P-8817-2016; Ballard, John William O./ABB-2743-2020; Solon-Biet, Samantha/R-6551-2017	Ballard, John William O./0000-0002-2358-6003; Solon-Biet, Samantha/0000-0003-0608-958X; Simpson, Stephen J./0000-0003-0256-7687; Maitz, Peter/0000-0002-8257-7414; Raubenheimer, David/0000-0001-9050-1447	Australian National Health and Medical Research Council (NHMRC) [571328]; Ageing and Alzheimer's Institute (AAAI) of Concord RG Hospital for research materials; Australian Research Council; NHMRC [GNT 1110098]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ageing and Alzheimer's Institute (AAAI) of Concord RG Hospital for research materials; Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding was obtained from the Australian National Health and Medical Research Council (NHMRC project grant 571328), the Ageing and Alzheimer's Institute (AAAI) of Concord RG Hospital for research materials. SJS was supported by an Australian Research Council Laureate Fellowship. DR is an Adjunct Professor in the New Zealand Institute for Advanced Study, Massey University, Auckland. SMS-B is supported by a NHMRC Early Career Fellowship (GNT 1110098). KR is employed by EWOS Innovation. EWOS Innovation provided support in the form of salary for author KR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arnold M, 2006, PLAST RECONSTR SURG, V117, p42S, DOI 10.1097/01.prs.0000225432.17501.6c; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; BARBUL A, 1994, CLIN DERMATOL, V12, P133, DOI 10.1016/0738-081X(94)90264-X; Barker LA, 2011, INT J ENV RES PUB HE, V8, P514, DOI 10.3390/ijerph8020514; Booth A, 2014, HORM MOL BIOL CLIN I, V17, P13, DOI 10.1515/hmbci-2014-0009; Brown KL, 2010, CLIN DERMATOL, V28, P432, DOI 10.1016/j.clindermatol.2010.03.028; Dao H, 2007, GENDER MED, V4, P308; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; Ezure T, 2011, J INVEST DERMATOL, V131, P2004, DOI 10.1038/jid.2011.145; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Gantwerker EA, 2011, FACIAL PLAST SURG CL, V19, P441, DOI 10.1016/j.fsc.2011.06.009; Hwa C, 2011, DERMATOL THER, V24, P464, DOI 10.1111/j.1529-8019.2012.01460.x; Khavkin J, 2011, FACIAL PLAST SURG CL, V19, P229, DOI 10.1016/j.fsc.2011.04.003; Klein J, 2007, EXP DERMATOL, V16, P45, DOI 10.1111/j.1600-0625.2006.00519.x; Lakdawala N, 2013, CLIN DERMATOL, V31, P677, DOI [10.1016/j.clindermatol.2013.05.004, 10.1016/j.clindermato1.2013.05.004]; Le Couteur DG, 2015, J GERONTOL A-BIOL, V70, P1499, DOI 10.1093/gerona/glu196; Leite SN, 2011, AN BRAS DERMATOL, V86, P681, DOI 10.1590/S0365-05962011000400009; LOEWENTHAL LA, 1955, J INVEST DERMATOL, V24, P429, DOI 10.1038/jid.1955.58; Makrantonaki E, 2008, EXP GERONTOL, V43, P939, DOI 10.1016/j.exger.2008.07.005; Makrantonaki E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050393; MCLAREN DS, 1987, ARCH DERMATOL, V123, P1674, DOI 10.1001/archderm.123.12.1674b; Moverare S, 2002, J INVEST DERMATOL, V119, P1053, DOI 10.1046/j.1523-1747.2002.00637.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Rivera-Gonzalez G, 2014, COLD SPRING HARB PER, V4, P1; Robert L, 2009, PATHOL BIOL, V57, P336, DOI 10.1016/j.patbio.2008.09.007; Scheinfeld NS, 2004, CLIN DERMATOL, V22, P303, DOI 10.1016/j.clindermatol.2004.01.001; Shu YY, 2011, AM J CLIN DERMATOL, V12, P297, DOI 10.2165/11589180-000000000-00000; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Simanainen U, 2015, HORM CANCER-US, V6, P45, DOI 10.1007/s12672-014-0210-1; Simpson SJ, 2012, NATURE NUTR UNIFYING, P248; Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033; SJOSTROM L, 1972, METABOLISM, V21, P1143, DOI 10.1016/0026-0495(72)90109-6; Solon-Biet SM, 2015, P NATL ACAD SCI USA, V112, P3481, DOI 10.1073/pnas.1422041112; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Stevenson S, 2007, CLIN INTERV AGING, V2, P283; Sugiyama A, 2011, J VET MED SCI, V73, P831, DOI 10.1292/jvms.10-0399; THAVARAJ V, 1989, J TROP PEDIATRICS, V35, P105, DOI 10.1093/tropej/35.3.105; Thomas JR, 2005, LARYNGOSCOPE, V115, P405, DOI 10.1097/01.mlg.0000157845.86154.48; Wild T, 2010, NUTRITION, V26, P862, DOI 10.1016/j.nut.2010.05.008; Williams JZ, 2003, SURG CLIN N AM, V83, P571, DOI 10.1016/S0039-6109(02)00193-7; Yamane T, 2010, MOL NUTR FOOD RES, V54, pS53, DOI 10.1002/mnfr.201000022; Yosipovitch G, 2007, J AM ACAD DERMATOL, V56, P901, DOI 10.1016/j.jaad.2006.12.004	45	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166175	10.1371/journal.pone.0166175	http://dx.doi.org/10.1371/journal.pone.0166175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832138	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000073
J	Li, WH; Guo, J; Li, FW; Niu, CN				Li, Wenhui; Guo, Jian; Li, Fanwen; Niu, Chune			Evaluation of Crossbreeding of Australian Superfine Merinos with Gansu Alpine Finewool Sheep to Improve Wool Characteristics	PLOS ONE			English	Article							TRAITS; REPRODUCTION; GROWTH	Crossbreeding of Australian Superfine Merinos (ASMs) with Gansu Alpine Finewool (GAF) sheep and an evaluation of the potential benefits of this genetic cross has not been previously conducted. 13 ASMs were crossbred with GAF sheep over a five year period with backcrossing designed to assess heterosis. Data from 11,178 lambs sired by 189 rams were used in the study. Genotype, birth year, birth type, dam age, sex and/or management group, and record age were fitted as fixed effects and within-genotype sire fitted as a random effect. Crossbreeds of 1/2 ASM expressed the most desirable effects for improving average fiber diameter (AFD), clean fleece weight (CFW), yield, coefficient of variation of AFD (CVAFD), yearling staple length (YSL) to AFD ratio (YSUAFD), and CFW to metabolic yearling bodyweight (YWT0.75) ratio (CFWNWT0.75) but showed the least post-weaning average daily gain (powADG) and YWT. Genotype of backcrossing with 1/4 ASM obtained moderate improvements in AFD, CFW, CVAFD, and YSUAFD but the highest YSL, WWT, and prwADG. Except for yield (-1.42%) and CFWNWT0.75 (-1%), heterosis estimates were generally low and positive, and ranged from 0.1% for CVAFD to 4% for powADG, which indicates the potential to improve relevant traits through exploiting heterosis to a varying extent. The ASMs sampled in this study were found to be superior to GAFs for AFD, CFW, yield, and CVAFD by 19.82%, 11.68%, 14.47%, and 6.99%, respectively, but inferior for YSL, PowADG, and YWT by 4.36%, 50.97%, and 16.93%, respectively. ASMs also appeared to be more efficient than GAFs in clean wool production (25.34%) and staple length growth (16.17%). The results of our study strongly suggest that an infusion of ASM genes via crossbreeding is an effective and appropriate approach to improve wool microns and wool production from GAF sheep, and we make recommendations to tackle the undesirable traits of YWT and YSL from ASM introduction.	[Li, Wenhui; Li, Fanwen] Gansu Prov Sheep Breeding Technol Extens Stn, Sunan, Gansu, Peoples R China; [Guo, Jian; Niu, Chune] CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Li, WH (corresponding author), Gansu Prov Sheep Breeding Technol Extens Stn, Sunan, Gansu, Peoples R China.	whleee2004@163.com			Fund for Modern China Wool & Cashmere Technology Research System [CARS-40-33]; Fund for Gansu Provincial Science and Technology Supporting Program [1604NKCG046]; fund for Gansu Provincial 10th Five Year Key Science and Technology Project [GS022-A41-052]	Fund for Modern China Wool & Cashmere Technology Research System; Fund for Gansu Provincial Science and Technology Supporting Program; fund for Gansu Provincial 10th Five Year Key Science and Technology Project	This work was supported by the Fund for Modern China Wool & Cashmere Technology Research System (Grant no.CARS-40-33); the Fund for Gansu Provincial Science and Technology Supporting Program (Grant no. 1604NKCG046); the fund for Gansu Provincial 10th Five Year Key Science and Technology Project (Grant no. GS022-A41-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NR, 2003, AUST J AGR RES, V54, P1, DOI 10.1071/AR02059; Australian Wool Testing Authority Limited, 2015, MICR PROF DAT AUSTR; BUTLER LG, 1993, AUST J EXP AGR, V33, P397, DOI 10.1071/EA9930397; Chen WD, 1988, WOOL TECH SHEEP BREE, V36, P24; Dickerson GE., 1969, ANIM BREED ABSTR, V37, P191; Elena Ghita, 2007, ARCH ZOOTECH, V10, P102; Fogarty N. M., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P32; GANAI TAS, 1993, INDIAN J ANIM SCI, V63, P783; Gilmour AR, 2009, ASREML USER GUIDE RE; Greeff J, 1995, J ANIM BREED GEN, V11, P595; Hygate L, 1999, P ASS ADV BREED GENE, V13, P50; Kinghorn B. P., 1987, Proceedings of the the Sixth Conference, Australian Association of Animal Breeding and Genetics, University of Western Australia, Perth, WA, Australia, 9-11 February 1987., P112; Kinghorn BP, 1987, MERINO IMPROVEMENT P, P398; Li WH, 2012, ANIM PROD SCI, V52, P321, DOI 10.1071/AN11157; MCGUIRK B, 1988, WOOL TECH SHEEP BREE, V36, P28; MORTIMER SI, 1988, WOOL TECH SHEEP BREE, V35, P208; Purvis I., 1990, P 4 WORLD C GEN APPL, VXV, P220; Rong WH, 1998, WOOL TECH SHEEP BREE, V46, P133; Safari E, 2005, LIVEST PROD SCI, V92, P271, DOI 10.1016/j.livprodsci.2004.09.003; Snowder GD, 1998, SHEEP GOAT RES J, V12, P108; Sun SZ, 1997, CHIN J ANIM SCI, V27, P37; Swan AA, 2005, P 16 C ASS ADV AN BR, P165	22	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166374	10.1371/journal.pone.0166374	http://dx.doi.org/10.1371/journal.pone.0166374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832155	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000115
J	Melachroinou, K; Leandrou, E; Valkimadi, PE; Memou, A; Hadjigeorgiou, G; Stefanis, L; Rideout, HJ				Melachroinou, Katerina; Leandrou, Emmanouela; Valkimadi, Polytimi-Eleni; Memou, Anna; Hadjigeorgiou, Georgios; Stefanis, Leonidas; Rideout, Hardy J.			Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; 14-3-3 BINDING; PROTEIN; G2019S; DEPHOSPHORYLATION; PHOSPHORYLATION; COMMON; RISK	Background Despite the plethora of sequence variants in LRRK2, only a few clearly segregate with PD. Even within this group of pathogenic mutations, the phenotypic profile can differ widely. Objective We examined multiple properties of LRRK2 behavior in cellular models over-expressing three sequence variants described in Greek PD patients in comparison to several known pathogenic and non-pathogenic LRRK2 mutations, to determine if specific phenotypes associated with pathogenic LRRK2 can be observed in other less-common sequence variants for which pathogenicity is unclear based on clinical and/or genetic data alone. Methods The oligomerization, activity, phosphorylation, and interaction with FADD was assessed in HEK293T cells over-expressing LRRK2; while the induction of neuronal death was determined by quantifying apoptotic nuclei in primary neurons transiently expressing LRRK2. Results One LRRK2 variant, A211V, exhibited a modest increase in kinase activity, whereas only the pathogenic mutants G2019S and I2020T displayed significantly altered auto-phosphorylation. We observed an induction of detergent-insoluble high molecular weight structures upon expression of pathogenic LRRK2 mutants, but not the other LRRK2 variants. In contrast, each of the variants tested induced apoptotic death of cultured neurons similar to pathogenic LRRK2 in a FADD-dependent manner. Conclusions Overall, despite differences in some properties of LRRK2 function such as kinase activity and its oligomerization, each of the LRRK2 variants examined induced neuronal death to a similar extent. Furthermore, our findings further strengthen the notion of a convergence on the extrinsic cell death pathway common to mutations in LRRK2 that are capable of inducing neuronal death.	[Melachroinou, Katerina; Leandrou, Emmanouela; Valkimadi, Polytimi-Eleni; Memou, Anna; Stefanis, Leonidas; Rideout, Hardy J.] Acad Athens, Div Basic Neurosci, Biomed Res Fdn, Athens, Greece; [Hadjigeorgiou, Georgios] Inst Biomed Res & Technol CERETETH, Dept Neurogenet, Larisa, Greece; [Hadjigeorgiou, Georgios] Univ Thessaly, Dept Neurol, Sch Med, Larisa, Greece; [Stefanis, Leonidas] Univ Athens, Sch Med, Dept Neurol 2, Athens, Greece	Academy of Athens; University of Thessaly; Athens Medical School; National & Kapodistrian University of Athens	Rideout, HJ (corresponding author), Acad Athens, Div Basic Neurosci, Biomed Res Fdn, Athens, Greece.	hrideout@bioacademy.gr	Stefanis, Leonidas/AAD-7192-2019	Melachroinou, Katerina/0000-0001-6906-6946; Leandrou, Emmanouela/0000-0001-7364-0445	International Research Grants Program award from the Parkinson's Disease Foundation; Innovation Grant from Parkinson's UK [K-1208]; Michael J Fox Foundation for Parkinson's Research [8418]; Hellenic General Secretariat of Research and Technology ("SINERGASIA") [09SigmaYN-12-876]; Parkinson&quot;s UK [K-1208] Funding Source: researchfish	International Research Grants Program award from the Parkinson's Disease Foundation; Innovation Grant from Parkinson's UK; Michael J Fox Foundation for Parkinson's Research; Hellenic General Secretariat of Research and Technology ("SINERGASIA"); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by an International Research Grants Program award from the Parkinson's Disease Foundation (HJR), an Innovation Grant from Parkinson's UK (K-1208; HJR), The Michael J Fox Foundation for Parkinson's Research (ID# 8418; HJR); and by the Hellenic General Secretariat of Research and Technology ("SINERGASIA", 09 Sigma YN-12-876; LS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Biosa A, 2013, HUM MOL GENET, V22, P1140, DOI 10.1093/hmg/dds522; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Bozi M, 2014, EUR J NEUROL, V21, P963, DOI 10.1111/ene.12315; Chia R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6827; Di Fonzo A, 2006, NEUROGENETICS, V7, P133, DOI 10.1007/s10048-006-0041-5; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Haugarvoll K, 2008, NEUROLOGY, V70, P1456, DOI 10.1212/01.wnl.0000304044.22253.03; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kalinderi K, 2007, EUR J NEUROL, V14, P1088, DOI 10.1111/j.1468-1331.2007.01867.x; Kamikawaji S, 2013, BIOCHEMISTRY-US, V52, P6052, DOI 10.1021/bi400596m; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Lobbestael E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33897; Lobbestael E, 2013, BIOCHEM J, V456, P119, DOI 10.1042/BJ20121772; Marder K, 2015, NEUROLOGY, V85, P89, DOI 10.1212/WNL.0000000000001708; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Paisan-Ruiz C, 2013, J PARKINSON DIS, V3, P85, DOI 10.3233/JPD-130192; Papapetropoulos S, 2008, J CLIN NEUROSCI, V15, P1027, DOI 10.1016/j.jocn.2007.08.013; Pungaliya PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013672; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Reyniers L, 2014, J NEUROCHEM, V131, P239, DOI 10.1111/jnc.12798; Reynolds A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00054; Rideout HJ, 2014, NEUROCHEM RES, V39, P576, DOI 10.1007/s11064-013-1073-5; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skibinski G, 2014, J NEUROSCI, V34, P418, DOI 10.1523/JNEUROSCI.2712-13.2014; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Spanaki C, 2006, NEUROLOGY, V67, P1518, DOI 10.1212/01.wnl.0000239829.33936.73; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Vancraenenbroeck R, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00051; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Xiromerisiou G, 2007, EUR J NEUROL, V14, P7, DOI 10.1111/j.1468-1331.2006.01551.x; Zhao J, 2015, BIOCHEM J, V469, P107, DOI 10.1042/BJ20141305	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166053	10.1371/journal.pone.0166053	http://dx.doi.org/10.1371/journal.pone.0166053			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832104	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000060
J	Recek, N; Andjelic, S; Hojnik, N; Filipic, G; Lazovic, S; Vesel, A; Primc, G; Mozetic, M; Hawlina, M; Petrovski, G; Cvelbar, U				Recek, Nina; Andjelic, Sofija; Hojnik, Nataga; Filipic, Gregor; Lazovic, Sasa; Vesel, Alenka; Primc, Gregor; Mozetic, Miran; Hawlina, Marko; Petrovski, Goran; Cvelbar, Uros			Microplasma Induced Cell Morphological Changes and Apoptosis of Ex Vivo Cultured Human Anterior Lens Epithelial Cells - Relevance to Capsular Opacification	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; LIPID-PEROXIDATION; GAS-FLOW; PLASMA; DAMAGE; DNA; STERILIZATION; STRESS	Inducing selective or targeted cell apoptosis without affecting large number of neighbouring cells remains a challenge. A plausible method for treatment of posterior capsular opacification (PCO) due to remaining lens epithelial cells (LECs) by reactive chemistry induced by localized single electrode microplasma discharge at top of a needle-like glass electrode with spot size-3 pm is hereby presented. The focused and highly-localized atmospheric pressure microplasma jet with electrode discharge could induce a dose-dependent apoptosis in selected and targeted individual LECs, which could be confirmed by real-time monitoring of the morphological and structural changes at cellular level. Direct cell treatment with micro plasma inside the medium appeared more effective in inducing apoptosis (caspase 8 positivity and DNA fragmentation) at a highly targeted cell level compared to treatment on top of the medium (indirect treatment). Our results show that single cell specific micropipette plasma can be used to selectively induce demise in LECs which remain in the capsular bag after cataract surgery and thus prevent their migration (CXCR4 positivity) to the posterior lens capsule and PCO formation.	[Recek, Nina; Hojnik, Nataga; Filipic, Gregor; Vesel, Alenka; Primc, Gregor; Mozetic, Miran; Cvelbar, Uros] Jozef Stefan Inst, Dept Surface Engn & Optoelect F4, Ljubljana, Slovenia; [Andjelic, Sofija; Hawlina, Marko] Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia; [Lazovic, Sasa] Univ Belgrade, Inst Phys Belgrade, Belgrade, Serbia; [Petrovski, Goran] Univ Szeged, Dept Ophthalmol, Stem Cells & Eye Res Lab, Fac Med, Szeged, Hungary; [Petrovski, Goran] Univ Oslo, Oslo Univ Hosp, Dept Ophthalmol, Ctr Eye Res, Oslo, Norway	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University Medical Centre Ljubljana; University of Belgrade; Szeged University; University of Oslo	Andjelic, S (corresponding author), Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia.	sofija.andjelic@kcij.si	Filipič, Gregor/T-4900-2018; Hawlina, Marko/AAZ-8084-2020; Lazovic, Sasa/Q-5056-2016; Cvelbar, Uros/AAE-7916-2019; Vesel, Alenka/I-3934-2014; Primc, Gregor/AAF-6450-2019	Filipič, Gregor/0000-0003-0153-5181; Lazovic, Sasa/0000-0003-1696-9134; Vesel, Alenka/0000-0003-3782-6001; Petrovski, Goran/0000-0003-2905-9252; Cvelbar, Uros/0000-0002-1957-0789; Primc, Gregor/0000-0002-3959-776X	Slovenian Research Agency (ARRS) [P3-0333, P2-0082]; EU COST [MP1101, TP1208]; NATO [SPS 984555]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); EU COST(European Cooperation in Science and Technology (COST)); NATO(NATO (North Atlantic Treaty Organisation))	The work has been supported by the Slovenian Research Agency (ARRS) programs P3-0333 & P2-0082, EU COST programs MP1101 & TP1208, and NATO grant SPS 984555.	Andjelic S, 2014, ACTA OPHTHALMOL, V92, DOI 10.1111/j.1755-3768.2014.S078.x; Andjelic S, 2015, ACTA OPHTHALMOL, V93, pE499, DOI 10.1111/aos.12655; Andjelic S, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/232659; Andjelic S, 2011, ACTA OPHTHALMOL, V89, pe645, DOI 10.1111/j.1755-3768.2011.02199.x; [Anonymous], SPECTROCHIMICA ACT B, V103-104, P124; Arjunan KP, 2015, INT J MOL SCI, V16, P2971, DOI 10.3390/ijms16022971; Dobrynin D, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/7/075201; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Duncan G, 2007, INVEST OPHTH VIS SCI, V48, P2701, DOI 10.1167/iovs.06-1345; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P1949, DOI 10.1109/TPS.2010.2041075; Hao PF, 2005, J MICROMECH MICROENG, V15, P2069, DOI 10.1088/0960-1317/15/11/011; Hensel K, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4919559; Isbary G, 2013, CLIN PLASMA MED, V1, P25, DOI 10.1016/j.cpme.2013.06.001; Joshi RP, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041920; Joshi RP, 2006, BIOCHEM BIOPH RES CO, V348, P643, DOI 10.1016/j.bbrc.2006.07.144; Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim GC, 2009, J KOREAN PHYS SOC, V54, P628, DOI 10.3938/jkps.54.628; Kim JY, 2010, APPL PHYS LETT, V96; Laurita R, 2015, CLIN PLASMA MED, V3, P53, DOI 10.1016/j.cpme.2015.10.001; Lazovic S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896626; Lazovic S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083037; Li QT, 2000, BIOCHEM BIOPH RES CO, V273, P72, DOI 10.1006/bbrc.2000.2908; Liu FX, 2010, PLASMA PROCESS POLYM, V7, P231, DOI 10.1002/ppap.200900070; Malovic G, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/3/034014; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; Miletic M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/34/345401; Morfill G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113041; Mukai M, 2009, SUPRAMOL CHEM, V21, P284, DOI 10.1080/10610270802468439; O'Connell D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3521502; Ohkawa H, 2006, SURF COAT TECH, V200, P5829, DOI 10.1016/j.surfcoat.2005.08.124; Park BJ, 2003, PHYS PLASMAS, V10, P4539, DOI 10.1063/1.1613655; Qu B, 1999, FREE RADICAL BIO MED, V27, P1095, DOI 10.1016/S0891-5849(99)00143-4; RAMANATHAN L, 1994, BIOL TRACE ELEM RES, V40, P59, DOI 10.1007/BF02916821; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rossi C, 2000, SENSOR ACTUAT A-PHYS, V87, P96, DOI 10.1016/S0924-4247(00)00464-7; Rumbach P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8248; Scholtz V, 2010, PLASMA PROCESS POLYM, V7, P237, DOI 10.1002/ppap.200900072; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Stoffels E, 2008, IEEE T PLASMA SCI, V36, P1441, DOI 10.1109/TPS.2008.2001084; Takayama M, 2006, THIN SOLID FILMS, V506, P396, DOI 10.1016/j.tsf.2005.08.332; Tan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101299; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017	48	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165883	10.1371/journal.pone.0165883	http://dx.doi.org/10.1371/journal.pone.0165883			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832099	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000387725000038
J	van Roest, MHG; van der Aa, MA; van der Geest, LGM; de Jong, KP				van Roest, Margijske H. G.; van der Aa, Maaike A.; van der Geest, Lydia G. M.; de Jong, Koert P.			The Impact of Socioeconomic Status, Surgical Resection and Type of Hospital on Survival in Patients with Pancreatic Cancer. A Population-Based Study in The Netherlands	PLOS ONE			English	Article							UNITED-STATES; ADENOCARCINOMA; DISPARITIES; MORTALITY; RISK; CARE; PANCREATICODUODENECTOMY; SURGERY; TRENDS; SOUTH	The influence of socioeconomic inequalities in pancreatic cancer patients and especially its effect in patients who had a resection is not known. Hospital type in which resection is performed might also influence outcome. Patients diagnosed with pancreatic cancer from 1989 to 2011 (n = 34,757) were selected from the population-based Netherlands Cancer Registry. Postal code was used to determine SES. Multivariable survival analyses using Cox regression were conducted to discriminate independent risk factors for death. Patients living in a high SES neighborhood more often underwent resection and more often were operated in a university hospital. After adjustment for clinicopathological factors, risk of dying was increased independently for patients with intermediate and low SES compared to patients with high SES. After resection, no survival difference was found among patients in the three SES groups. However, survival was better for patients treated in university hospitals compared to patients treated in non-university hospitals. Low SES was an independent risk factor for poor survival in patients with pancreatic cancer. SES was not an adverse risk factor after resection. Resection in non-university hospitals was associated with a worse prognosis.	[van Roest, Margijske H. G.; de Jong, Koert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreatobiliary Surg Liver Transplant, Groningen, Netherlands; [van der Aa, Maaike A.; van der Geest, Lydia G. M.] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands	University of Groningen	de Jong, KP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreatobiliary Surg Liver Transplant, Groningen, Netherlands.	k.p.de.jong@umcg.nl						Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; Aziz Z, 2010, BREAST, V19, P38, DOI 10.1016/j.breast.2009.10.005; Bernards N, 2015, ACTA ONCOL, V54, P403, DOI 10.3109/0284186X.2014.953257; BLOT WJ, 1978, CANCER, V42, P373, DOI 10.1002/1097-0142(197807)42:1<373::AID-CNCR2820420156>3.0.CO;2-L; Bowman KC, 2010, AM SURGEON, V76, P164; Cheung MC, 2010, CANCER-AM CANCER SOC, V116, P723, DOI 10.1002/cncr.24758; Cheung R, 2013, ASIAN PAC J CANCER P, V14, P159, DOI 10.7314/APJCP.2013.14.1.159; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Conway DI, 2010, EUR J CANCER, V46, P588, DOI 10.1016/j.ejca.2009.09.028; Cress RD, 2006, CANCER CAUSE CONTROL, V17, P403, DOI 10.1007/s10552-005-0539-4; de Wilde RF, 2012, BRIT J SURG, V99, P404, DOI 10.1002/bjs.8664; Effenberger KE, 2012, INT J CANCER, V131, pE475, DOI 10.1002/ijc.26439; Enewold Lindsey, 2015, J Gastrointest Cancer, V46, P9, DOI 10.1007/s12029-014-9668-x; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Janes RH, 1996, ANN SURG, V223, P261, DOI 10.1097/00000658-199603000-00006; Knol F, 1998, HIGH LOW LOW HIGH DE; Krzyzanowska MK, 2003, J CLIN ONCOL, V21, P3409, DOI 10.1200/JCO.2003.03.007; Kuhn Y, 2010, EJSO-EUR J SURG ONC, V36, P496, DOI 10.1016/j.ejso.2009.08.006; Le H, 2008, CANCER EPIDEM BIOMAR, V17, P2737, DOI 10.1158/1055-9965.EPI-08-0417; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949; Markossian TW, 2015, AUST J RURAL HLTH; McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763; Murphy MM, 2010, SURGERY, V147, P733, DOI 10.1016/j.surg.2009.10.050; Nilsen TIL, 2000, CANCER CAUSE CONTROL, V11, P645, DOI 10.1023/A:1008916123357; Niu XL, 2010, J HEALTH CARE POOR U, V21, P144, DOI 10.1353/hpu.0.0263; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; SCHOUTEN LJ, 1993, INT J EPIDEMIOL, V22, P369, DOI 10.1093/ije/22.3.369; Seyedin S, 2012, AM SURGEON, V78, P1128; Shahian DM, 2012, ACAD MED, V87, P701, DOI 10.1097/ACM.0b013e318253676a; Shapiro M, 2015, JAMA SURG; Siemerink EJM, 2011, CANCER EPIDEMIOL, V35, P413, DOI 10.1016/j.canep.2011.02.015; SOBIN L, 2002, TNM ATLAS; van Oost FJ, 2006, EJSO, V32, P548, DOI 10.1016/j.ejso.2006.01.019; van Roest MHG, 2008, ANN SURG, V248, P97, DOI 10.1097/SLA.0b013e31817b6609; Vandewalle Laurence, 2015, ASEAN INTERPARLIAMEN, P1; Wittekind C, 2005, INT CLASSIFICATION D; Wolfson JA, 2015, CANCER-AM CANCER SOC, V121, P3885, DOI 10.1002/cncr.29576; Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986; Zell JA, 2007, CANCER EPIDEM BIOMAR, V16, P546, DOI 10.1158/1055-9965.EPI-06-0893	41	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166449	10.1371/journal.pone.0166449	http://dx.doi.org/10.1371/journal.pone.0166449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832174	Green Published, gold			2022-12-27	WOS:000387725000127
J	Mazzei, M; Fronte, B; Sagona, S; Carrozza, ML; Forzan, M; Pizzurro, F; Bibbiani, C; Miragliotta, V; Abramo, F; Millanta, F; Bagliacca, M; Poli, A; Felicioli, A				Mazzei, Maurizio; Fronte, Baldassare; Sagona, Simona; Carrozza, Maria Luisa; Forzan, Mario; Pizzurro, Federica; Bibbiani, Carlo; Miragliotta, Vincenzo; Abramo, Francesca; Millanta, Francesca; Bagliacca, Marco; Poli, Alessandro; Felicioli, Antonio			Effect of 1,3-1,6 beta-Glucan on Natural and Experimental Deformed Wing Virus Infection in Newly Emerged Honeybees (Apis mellifera ligustica)	PLOS ONE			English	Article							PROPHENOLOXIDASE; IMMUNITY; REPLICATION; EXPRESSION; DROSOPHILA; PATHWAYS; SYSTEM; BEES	The Western Honeybee is a key pollinator for natural as well as agricultural ecosystems. In the last decade massive honeybee colony losses have been observed worldwide, the result of a complex syndrome triggered by multiple stress factors, with the RNA virus Deformed Wing Virus (DWV) and the mite Varroa destructor playing crucial roles. The mite supports replication of DWV to high titers, which exert an immunosuppressive action and correlate with the onset of the disease. The aim of this study was to investigate the effect of 1,3-1,6 beta-glucan, a natural innate immune system modulator, on honeybee response to low-titer natural and high-titer experimental DWV infection. As the effects exerted by beta-glucans can be remarkably different, depending on the target organism and the dose administered, two parallel experiments were performed, where 1,3-1,6 beta-glucan at a concentration of 0.5% and 2% respectively, was added to the diet of three cohorts of newly emerged honeybees, which were sampled from a Varroa-free apiary and harboured a low endogenous DWV viral titer. Each cohort was subjected to one of the following experimental treatments: no injection, injection of a high-copy number DWV suspension into the haemocel (experimental DWV infection) or injection of PBS into the haemocoel (physical injury). Control bees fed a beta-glucan-free diet were subjected to the same treatments. Viral load, survival rate, haemocyte populations and phenoloxidase activity of each experimental group were measured and compared. The results indicated that oral administration of 0.5% beta-glucan to naturally infected honeybees was associated with a significantly decrease of the number of infected bees and viral load they carried, and with a significant increase of the survival rate, suggesting that this natural immune modulator molecule might contribute to increase honeybee resistance to viral infection.	[Mazzei, Maurizio; Fronte, Baldassare; Sagona, Simona; Forzan, Mario; Pizzurro, Federica; Bibbiani, Carlo; Miragliotta, Vincenzo; Abramo, Francesca; Millanta, Francesca; Bagliacca, Marco; Poli, Alessandro; Felicioli, Antonio] Univ Pisa, Dept Vet Sci, Pisa, Italy; [Carrozza, Maria Luisa] Scuola Normale Super Pisa, Pisa, Italy	University of Pisa; Scuola Normale Superiore di Pisa	Mazzei, M (corresponding author), Univ Pisa, Dept Vet Sci, Pisa, Italy.	maurizio.mazzei@unipi.it	sagona, simona/GXH-0254-2022; Felicioli, Antonio/AAT-2167-2021; Miragliotta, Vincenzo/K-7361-2015; Pizzurro, Federica/D-8325-2017; Bibbiani, Carlo/D-6477-2017; Sagona, Simona/AAT-8969-2021; Mazzei, Maurizio/H-5788-2016	Miragliotta, Vincenzo/0000-0001-7896-5695; Pizzurro, Federica/0000-0003-3875-6148; Bibbiani, Carlo/0000-0002-9730-9498; Mazzei, Maurizio/0000-0003-3797-8320; FRONTE, BALDASSARE/0000-0002-8480-318X; Poli, Alessandro/0000-0003-1254-5772; Forzan, Mario/0000-0003-2474-8219	University of Pisa (PROGETTI DI RICERCA DI ATENEO PRA) [0053]	University of Pisa (PROGETTI DI RICERCA DI ATENEO PRA)	This research was supported by a grant from the University of Pisa (PROGETTI DI RICERCA DI ATENEO PRA 2015 n. 0053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Boman HG, 1986, ANTIBACTERIAL IMMUNE, P63, DOI [10.1007/978-3-642-70768-1_6, DOI 10.1007/978-3-642-70768-1_6]; Brutscher LM, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/941897; Bull JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003083; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; El Mohandes S. S., 2010, J BIOL SCI, V3, P213; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Giusti M, 2016, APIDOLOGIE, V47, P688, DOI 10.1007/s13592-015-0417-3; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Guselle NJ, 2007, J FISH DIS, V30, P111, DOI 10.1111/j.1365-2761.2007.00781.x; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hudson LN, 2014, ECOL EVOL, V4, P4701, DOI 10.1002/ece3.1303; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Lourenco AP, 2005, INSECT BIOCHEM MOLEC, V35, P541, DOI 10.1016/j.ibmb.2005.01.013; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Nazzi F, 2014, TRENDS PARASITOL, V30, P556, DOI 10.1016/j.pt.2014.09.006; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Pathak K, 2014, CURRENT PHARM CLIN, V4, P71; Patil U.S., 2012, INT J PHARM PHARM SC, V4, P30, DOI DOI 10.5455/NJPPP.2017.7.0203808032017; Potts SG, 2011, J APICULT RES, V50, P152, DOI 10.3896/IBRA.1.50.2.07; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Sabcaliu A, 2010, B UASVM, V67, P313; SAS INSTITUTE, 2008, JMP STAT GRAPH GUID; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; Soltanian S, 2009, CRIT REV MICROBIOL, V35, P109, DOI 10.1080/10408410902753746; Szymas B, 2003, APIDOLOGIE, V34, P97, DOI 10.1051/apido:2003012; THEODORSSONNORHEIM E, 1986, COMPUT METH PROG BIO, V23, P57, DOI 10.1016/0169-2607(86)90081-7; Underwood R., 2007, BEE CULTURE, V35, P13; Van Wettere Arnaud, 2007, Veterinary Clinics of North America Exotic Animal Practice, V10, P235, DOI 10.1016/j.cvex.2006.11.003; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	47	20	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166297	10.1371/journal.pone.0166297	http://dx.doi.org/10.1371/journal.pone.0166297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829027	Green Published, gold			2022-12-27	WOS:000387724300104
J	Canto, CB; Witter, L; De Zeeuw, CI				Canto, Cathrin B.; Witter, Laurens; De Zeeuw, Chris I.			Whole-Cell Properties of Cerebellar Nuclei Neurons In Vivo	PLOS ONE			English	Article							NON-GABAERGIC CELLS; ELECTROPHYSIOLOGICAL PROPERTIES; INFERIOR OLIVE; BRAIN-STEM; FASTIGIAL NUCLEUS; PREFRONTAL CORTEX; ENTORHINAL CORTEX; PYRAMIDAL CELLS; FIRING PATTERNS; FIBER TERMINALS	Cerebellar nuclei neurons integrate sensorimotor information and form the final output of the cerebellum, projecting to premotor brainstem targets. This implies that, in contrast to specialized neurons and interneurons in cortical regions, neurons within the nuclei encode and integrate complex information that is most likely reflected in a large variation of intrinsic membrane properties and integrative capacities of individual neurons. Yet, whether this large variation in properties is reflected in a heterogeneous physiological cell population of cerebellar nuclei neurons with well or poorly defined cell types remains to be determined. Indeed, the cell electrophysiological properties of cerebellar nuclei neurons have been identified in vitro in young rodents, but whether these properties are similar to the in vivo adult situation has not been shown. In this comprehensive study we present and compare the in vivo properties of 144 cerebellar nuclei neurons in adult ketamine-xylazine anesthetized mice. We found regularly firing (N = 88) and spontaneously bursting (N = 56) neurons. Membrane-resistance, capacitance, spike half-width and firing frequency all widely varied as a continuum, ranging from 9.63 to 3352.1 M Omega, from 6.7 to 772.57 pF, from 0.178 to 1.98 ms, and from 0 to 176.6 Hz, respectively. At the same time, several of these parameters were correlated with each other. Capacitance decreased with membrane resistance (R-2 = 0.12, P<0.001), intensity of rebound spiking increased with membrane resistance (for 100 ms duration R-2 = 0.1503, P = 0.0011), membrane resistance decreased with membrane time constant (R-2 = 0.045, P = 0.031) and increased with spike half-width (R-2 = 0.023, P<0.001), while capacitance increased with firing frequency (R-2 = 0.29, P<0.001). However, classes of neuron subtypes could not be identified using merely k-clustering of their intrinsic firing properties and/or integrative properties following activation of their Purkinje cell input. Instead, using whole-cell parameters in combination with morphological criteria revealed by intracellular labelling with Neurobiotin (N = 18) allowed for electrophysiological identification of larger (29.3-50 mu m soma diameter) and smaller (<21.2 mu m) cerebellar nuclei neurons with significant differences in membrane properties. Larger cells had a lower membrane resistance and a shorter spike, with a tendency for higher capacitance. Thus, in general cerebellar nuclei neurons appear to offer a rich and wide continuum of physiological properties that stand in contrast to neurons in most cortical regions such as those of the cerebral and cerebellar cortex, in which different classes of neurons operate in a narrower territory of electrophysiological parameter space. The current dataset will help computational modelers of the cerebellar nuclei to update and improve their cerebellar motor learning and performance models by incorporating the large variation of the in vivo properties of cerebellar nuclei neurons. The cellular complexity of cerebellar nuclei neurons may endow the nuclei to perform the intricate computations required for sensorimotor coordination.	[Canto, Cathrin B.; Witter, Laurens; De Zeeuw, Chris I.] Royal Dutch Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Witter, Laurens] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	De Zeeuw, CI (corresponding author), Royal Dutch Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.; De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	Witter, Laurens/AAB-1461-2019	Witter, Laurens/0000-0003-2357-0578	Dutch Organization for Medical Science [ZonMW]; NWO-VENI Fellowship; Life Sciences (NWO-ALW); Senter (Neuro-Bsik); ERC-Advanced Grant; ERC-POC programs of the European Community	Dutch Organization for Medical Science [ZonMW](Netherlands Organization for Health Research and Development); NWO-VENI Fellowship(Netherlands Organization for Scientific Research (NWO)); Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Senter (Neuro-Bsik); ERC-Advanced Grant(European Research Council (ERC)); ERC-POC programs of the European Community	This work was supported by the Dutch Organization for Medical Science [ZonMW; CIDZ], NWO-VENI Fellowship [CC], Life Sciences (NWO-ALW; CDIZ), Senter (Neuro-Bsik; CIDZ), ERC-Advanced Grant [CIDZ] and ERC-POC [CIDZ] programs of the European Community.	Afshari FS, 2004, J NEUROPHYSIOL, V92, P2831, DOI 10.1152/jn.00261.2004; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Ankri L, 2015, ELIFE, V4, DOI 10.7554/eLife.06262; Arancillo M, 2015, J NEUROPHYSIOL, V113, P578, DOI 10.1152/jn.00586.2014; Aumann TD, 1996, J COMP NEUROL, V376, P420; Aumann TD, 1996, J COMP NEUROL, V368, P608, DOI 10.1002/(SICI)1096-9861(19960513)368:4<608::AID-CNE11>3.0.CO;2-D; Bagnall MW, 2009, J NEUROSCI, V29, P10104, DOI 10.1523/JNEUROSCI.2087-09.2009; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Boudewijns ZSRM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00099; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Czubayko U, 2001, J NEUROPHYSIOL, V85, P2017, DOI 10.1152/jn.2001.85.5.2017; D'Angelo E, 2016, CEREBELLUM, V15, P139, DOI 10.1007/s12311-015-0711-7; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Degenetais E, 2002, CEREB CORTEX, V12, P1, DOI 10.1093/cercor/12.1.1; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DEZEEUW CI, 1988, BRAIN RES, V447, P369, DOI 10.1016/0006-8993(88)91142-0; DeZeeuw CI, 1996, ANN NY ACAD SCI, V781, P607; DEZEEUW CI, 1990, NEUROSCIENCE, V34, P645, DOI 10.1016/0306-4522(90)90171-Y; Dezeeuw CI, 2015, COLD SPRING HARB PER; Engbers JDT, 2011, J PHYSIOL-LONDON, V589, P5391, DOI 10.1113/jphysiol.2011.215632; Funahashi M, 2000, BRAIN RES, V884, P104, DOI 10.1016/S0006-8993(00)02854-7; Gao ZY, 2016, NEURON, V89, P645, DOI 10.1016/j.neuron.2016.01.008; Gauck V, 2000, J NEUROSCI, V20, P3006; Gauck V, 2003, J NEUROSCI, V23, P8109; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Houck BD, 2015, J COMP NEUROL, V523, P2254, DOI 10.1002/cne.23787; Husson Z, 2014, J NEUROSCI, V34, P9418, DOI 10.1523/JNEUROSCI.0401-14.2014; Jaeger D, 2011, CEREBELLUM, V10, P659, DOI 10.1007/s12311-011-0248-3; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Koch Christof, 1999, P1; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Kononenko NL, 2007, CELL TISSUE RES, V330, P179, DOI 10.1007/s00441-007-0425-3; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leto K, 2015, CONSENSUS PAPER CERE, P1; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Luque NR, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00097; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mapelli L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00169; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Molineux ML, 2008, J NEUROPHYSIOL, V100, P2684, DOI 10.1152/jn.90427.2008; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Najac M, 2015, J NEUROSCI, V35, P544, DOI 10.1523/JNEUROSCI.3583-14.2015; OBERDICK J, 1993, NEURON, V10, P1007, DOI 10.1016/0896-6273(93)90050-2; Pugh JR, 2009, TRENDS NEUROSCI, V32, P170, DOI 10.1016/j.tins.2008.12.001; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Raman IM, 2000, J NEUROSCI, V20, P9004; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Sangrey T, 2010, EUR J NEUROSCI, V32, P1646, DOI 10.1111/j.1460-9568.2010.07408.x; Schlosser B, 1998, NEUROSCI LETT, V249, P13, DOI 10.1016/S0304-3940(98)00366-8; Sekirnjak C, 2002, J NEUROSCI, V22, P2083, DOI 10.1523/JNEUROSCI.22-06-02083.2002; Shin M, 2011, J NEUROSCI, V31, P10776, DOI 10.1523/JNEUROSCI.0768-11.2011; SIMPSON JI, 1989, PROG BRAIN RES, V80, P213; Sokoloff G, 2015, J NEUROPHYSIOL AM PH; Steuber V, 2013, NEURAL NETWORKS, V47, P112, DOI 10.1016/j.neunet.2012.11.006; Steuber V, 2011, J COMPUT NEUROSCI, V30, P633, DOI 10.1007/s10827-010-0282-z; Sultan F, 2003, J COMP NEUROL, V455, P139, DOI 10.1002/cne.10443; Szilagyi T, 2011, ROM J MORPHOL EMBRYO, V52, P15; Tadayonnejad R, 2010, CEREBELLUM, P13; Teune TM, 1998, J COMP NEUROL, V392, P164, DOI 10.1002/(SICI)1096-9861(19980309)392:2<164::AID-CNE2>3.0.CO;2-0; Teune TM, 2000, PROG BRAIN RES, V124, P141; Uusisaari M, 2008, NEUROSCIENCE, V156, P537, DOI 10.1016/j.neuroscience.2008.07.060; Uusisaari M, 2007, J NEUROPHYSIOL, V97, P901, DOI 10.1152/jn.00974.2006; Uusisaari M, 2011, J PHYSIOL-LONDON, V589, P3441, DOI 10.1113/jphysiol.2010.201582; Uusisaari M, 2011, CEREBELLUM, V10, P637, DOI 10.1007/s12311-010-0240-3; Uusisaari M, 2010, CEREBELLUM, V9, P42, DOI 10.1007/s12311-009-0137-1; Uusisaari MY, 2012, CEREBELLUM, V11, P420, DOI 10.1007/s12311-011-0350-6; VANDERWANT JJL, 1987, J COMP NEUROL, V258, P70, DOI 10.1002/cne.902580105; VANDERWANT JJL, 1989, J COMP NEUROL, V288, P1, DOI 10.1002/cne.902880102; VANDERWANT JJL, 1987, J COMP NEUROL, V258, P81, DOI 10.1002/cne.902580106; Witter L, 2016, NEURON ELSEVIER, P670; Witter L, 2015, CEREBELLUM, V14, P506, DOI 10.1007/s12311-015-0654-z; Witter L, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00133	78	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165887	10.1371/journal.pone.0165887	http://dx.doi.org/10.1371/journal.pone.0165887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851801	gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300026
J	Lampe, N; Biron, DG; Brown, JMC; Incerti, S; Marin, P; Maigne, L; Sarramia, D; Seznec, H; Breton, V				Lampe, Nathanael; Biron, David G.; Brown, Jeremy M. C.; Incerti, Sebastien; Marin, Pierre; Maigne, Lydia; Sarramia, David; Seznec, Herve; Breton, Vincent			Simulating the Impact of the Natural Radiation Background on Bacterial Systems: Implications for Very Low Radiation Biological Experiments	PLOS ONE			English	Article							INDUCED GENOMIC INSTABILITY; ESCHERICHIA-COLI; IONIZING-RADIATION; DEINOCOCCUS-RADIODURANS; MUTATION-RATES; PROTEIN DAMAGE; DNA-DAMAGE; V79 CELLS; MECHANISMS; EVOLUTION	At very low radiation dose rates, the effects of energy depositions in cells by ionizing radiation is best understood stochastically, as ionizing particles deposit energy along tracks separated by distances often much larger than the size of cells. We present a thorough analysis of the stochastic impact of the natural radiative background on cells, focusing our attention on E. coli grown as part of a long term evolution experiment in both underground and surface laboratories. The chance per day that a particle track interacts with a cell in the surface laboratory was found to be 6 x 10(-5) day(-1), 100 times less than the expected daily mutation rate for E. coli under our experimental conditions. In order for the chance cells are hit to approach the mutation rate, a gamma background dose rate of 20 mu Gy hr(-1) is predicted to be required.	[Lampe, Nathanael; Marin, Pierre; Maigne, Lydia; Sarramia, David; Breton, Vincent] Univ Blaise Pascal, Clermont Univ, CNRS IN2P3, Lab Phys Corpusculaire, BP 10448, F-63000 Clermont Ferrand, France; [Biron, David G.] Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, Lab Microorganismes Genome & Environm, BP 10448, F-63000 Clermont Ferrand, France; [Brown, Jeremy M. C.] Queens Univ Belfast, Sch Math & Phys, Belfast, Antrim, North Ireland; [Incerti, Sebastien; Seznec, Herve] Univ Bordeaux, CENBG, UMR 5797, F-33170 Gradignan, France; [Incerti, Sebastien; Seznec, Herve] CNRS, CENBG, IN2P3, UMR 5797, F-33170 Gradignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Queens University Belfast; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux	Lampe, N (corresponding author), Univ Blaise Pascal, Clermont Univ, CNRS IN2P3, Lab Phys Corpusculaire, BP 10448, F-63000 Clermont Ferrand, France.	lampe@clermont.in2p3.fr	SEZNEC, Hervé/ABB-1602-2021; Incerti, Sebastien L/T-3006-2017; Maigne, Lydia/H-3137-2018	SEZNEC, Hervé/0000-0001-6180-8925; Maigne, Lydia/0000-0002-0414-8462; Brown, Jeremy/0000-0001-9508-6190; Breton, Vincent/0000-0001-8197-7080; Incerti, Sebastien/0000-0002-0619-2053; MARIN, Pierre/0000-0002-8304-138X; David, SARRAMIA/0000-0002-7062-9707	Conseil General de l'Allier; Long Term Ecological Research program "Zone Atelier Territoires Uraniferes dans l'Arc Hercynien"; Electricite de France	Conseil General de l'Allier(Region Auvergne-Rhone-Alpes); Long Term Ecological Research program "Zone Atelier Territoires Uraniferes dans l'Arc Hercynien"; Electricite de France	The Conseil General de l'Allier funds the PhD scholarship of NL. Funding has been received from the Long Term Ecological Research program "Zone Atelier Territoires Uraniferes dans l'Arc Hercynien" and Electricite de France in support of this project.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; Allison J, 2016, NUCL INSTRUM METH A, V835, P186, DOI 10.1016/j.nima.2016.06.125; BALDWIN WW, 1995, J BACTERIOL, V177, P235, DOI 10.1128/jb.177.1.235-237.1995; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Berger M. J., 1998, STOPPING POWER RANGE; Bernal MA, 2015, PHYS MEDICA, P1; Boubriak II, 2008, ANN BOT-LONDON, V101, P267, DOI 10.1093/aob/mcm276; BOUVILLE A, 1988, RADIAT PROT DOSIM, V24, P293; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; Cameron JA, 2004, NUCL DATA SHEETS, V102, P293, DOI 10.1016/j.nds.2004.06.001; Carbone MC, 2009, RADIAT ENVIRON BIOPH, V48, P189, DOI 10.1007/s00411-008-0208-6; Carlton BC, 1981, MANUAL METHODS GENER, P222; Castillo H, 2015, INT J RADIAT BIOL, V91, P749, DOI 10.3109/09553002.2015.1062571; Chirkin D, 2004, FLUXES ATMOSPHERIC L, DOI [10.48550/ARXIV.HEP-PH/0407078, DOI 10.48550/ARXIV.HEP-PH/0407078]; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Douglass M, 2012, MED PHYS, V39, P3509, DOI 10.1118/1.4719963; El Naqa I, 2012, PHYS MED BIOL, V57, pR75, DOI 10.1088/0031-9155/57/11/R75; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Fratini E, 2015, RADIAT ENVIRON BIOPH, V54, P183, DOI 10.1007/s00411-015-0587-4; Friedland W, 2011, MUTAT RES-FUND MOL M, V711, P28, DOI 10.1016/j.mrfmmm.2011.01.003; Godin M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789694; Gordon MS, 2004, IEEE T NUCL SCI, V51, P3427, DOI 10.1109/TNS.2004.839134; Groom DE, 2001, ATOM DATA NUCL DATA, V78, P183, DOI 10.1006/adnd.2001.0861; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; IRSN, 2015, PELGUIS VERS 1 19 0; Katz JI, 2015, INT J RADIAT BIOL, V2016, P3002; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Kudryasheva NS, 2015, J ENVIRON RADIOACTIV, V142, P68, DOI 10.1016/j.jenvrad.2015.01.012; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lampe N, MULTISCALE GEANT4 SI; Lampe N, 2016, EPJ WEB CONF, V124, DOI 10.1051/epjconf/201612400006; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Liang Y, 2016, PHYS MED BIOL, V61, P445, DOI 10.1088/0031-9155/61/1/445; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Malczewski D, 2012, J RADIOANAL NUCL CH, V292, P751, DOI 10.1007/s10967-011-1497-9; McNamara AL, 2012, INT J RADIAT BIOL, V88, P164, DOI 10.3109/09553002.2011.627975; Merrifield Matt, 2013, Frontiers in Genetics, V4, P40, DOI 10.3389/fgene.2013.00040; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; MOZUMDER A, 1966, RADIAT RES, V28, P203, DOI 10.2307/3572190; Nikjoo H, 2006, RADIAT MEAS, V41, P1052, DOI 10.1016/j.radmeas.2006.02.001; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Piquemal F, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12110-3; Planel G., 1976, Proceedings of a symposium on Biological Effects of Low-Level Radiation Pertinent to Man and His Environment, P127; PLANEL H, 1987, HEALTH PHYS, V52, P571, DOI 10.1097/00004032-198705000-00007; RADICELLA JP, 1988, P NATL ACAD SCI USA, V85, P9674, DOI 10.1073/pnas.85.24.9674; Reshes G, 2008, BIOPHYS J, V94, P251, DOI 10.1529/biophysj.107.104398; ROSENBERGER RF, 1983, MOL GEN GENET, V191, P207, DOI 10.1007/BF00334815; Ruiz-Gonzalez MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22969; Satta L, 2002, RADIAT ENVIRON BIOPH, V41, P217, DOI 10.1007/s00411-002-0159-2; SATTA L, 1995, MUTAT RES LETT, V347, P129, DOI 10.1016/0165-7992(95)00031-3; Sears V.F., 1992, NEUTRON NEWS, V3, P29, DOI DOI 10.1080/10448639208218770; Smith Geoffrey Battle, 2011, Health Phys, V100, P263, DOI 10.1097/HP.0b013e318208cd44; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR, 2000, ANN B EXP NAT RAD SO; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Zavilgelsky GB, 1998, J PHOTOCH PHOTOBIO B, V43, P152, DOI 10.1016/S1011-1344(98)00099-2	64	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166364	10.1371/journal.pone.0166364	http://dx.doi.org/10.1371/journal.pone.0166364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851794	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300044
J	Pizarro-Delgado, J; Deeney, JT; Corkey, BE; Tamarit-Rodriguez, J				Pizarro-Delgado, Javier; Deeney, Jude T.; Corkey, Barbara E.; Tamarit-Rodriguez, Jorge			Direct Stimulation of Islet Insulin Secretion by Glycolytic and Mitochondrial Metabolites in KCl-Depolarized Islets	PLOS ONE			English	Article							PANCREATIC-ISLETS; REGULATORY ROLE; GLUCOSE; DEHYDROGENASE; CONTRIBUTES; INHIBITION; ACID	We have previously demonstrated that islet depolarization with 70 mM KCl opens Cx36 hemichannels and allows diffusion of small metabolites and cofactors through the beta-cell plasma membrane. We have investigated in this islet "permeabilized" model whether glycolytic and citric acid cycle intermediates stimulate insulin secretion and how it correlates with ATP production (islet content plus extracellular nucleotide accumulation). Glycolytic intermediates (10 mM) stimulated insulin secretion and ATP production similarly. However, they showed differential sensitivities to respiratory chain or enzyme inhibitors. Pyruvate showed a lower secretory capacity and less ATP production than phosphoenolpyruvate, implicating an important role for glycolytic generation of ATP. ATP production by glucose-6-phosphate was not sensitive to a pyruvate kinase inhibitor that effectively suppressed the phosphoenol-pyruvate-induced secretory response and islet ATP rise. Strong suppression of both insulin secretion and ATP production induced by glucose-6-phosphate was caused by 10 mu M antimycin A, implicating an important role for the glycerophosphate shuttle in transferring reducing equivalents to the mitochondria. Five citric acid cycle intermediates were investigated for their secretory and ATP production capacity (succinate, fumarate, malate, isocitrate and alpha-ketoglutarate at 5 mM, together with ADP and/or NADP(+) to feed the NADPH re-oxidation cycles). The magnitude of the secretory response was very similar among the different mitochondrial metabolites but alpha-ketoglutarate showed a more sustained second phase of secretion. Gabaculine (1 mM, a GABA-transaminase inhibitor) suppressed the second phase of secretion and the ATP-production stimulated by alpha-ketoglutarate, supporting a role for the GABA shuttle in the control of glucose-induced insulin secretion. None of the other citric acid intermediates essayed showed any suppression of both insulin secretion or ATP-production by the presence of gabaculine. We propose that endogenous GABA metabolism in the "GABA-shunt" facilitates ATP production in the citric acid cycle for an optimal insulin secretion.	[Pizarro-Delgado, Javier; Deeney, Jude T.; Corkey, Barbara E.; Tamarit-Rodriguez, Jorge] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Pizarro-Delgado, Javier; Tamarit-Rodriguez, Jorge] Univ Complutense, Sch Med, Dept Biochem, Madrid, Spain	Boston University; Complutense University of Madrid	Tamarit-Rodriguez, J (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	tamarit@med.ucm.es	PIZARRO-DELGADO, JAVIER/E-7268-2012	Deeney, Jude/0000-0003-0988-9419; PIZARRO-DELGADO, JAVIER/0000-0002-3735-844X	National Institutes of Health of the United States of America; Ministerio de Economia y Competitividad	National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad(Spanish Government)	National Institutes of Health of the United States of America (www.nih.gov) and Ministerio de Economia y Competitividad (www.mineco.gob.es).	Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Feksa LR, 2003, BRAIN RES, V968, P199, DOI 10.1016/S0006-8993(03)02239-X; Fernandez-Pascual S, 2004, BIOCHEM J, V379, P721, DOI 10.1042/BJ20031826; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HELLMAN B, 1975, DIABETOLOGIA, V11, P495, DOI 10.1007/BF01222098; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MALAISSE WJ, 1988, DIABETES RES CLIN EX, V7, P53; Mukala-Nsengu A, 2004, BIOCHEM PHARMACOL, V67, P981, DOI 10.1016/j.bcp.2003.10.024; Pizarro-Delgado J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140096; Pizarro-Delgado J, 2014, AM J PHYSIOL-ENDOC M, V306, pE1354, DOI 10.1152/ajpendo.00358.2013; Pizarro-Delgado J, 2010, BIOCHEM J, V431, P381, DOI 10.1042/BJ20100714; Pizarro-Delgado J, 2009, BIOCHEM J, V419, P359, DOI 10.1042/BJ20081731; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Winnock F, 2002, AM J PHYSIOL-ENDOC M, V282, pE937, DOI 10.1152/ajpendo.00071.2001	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166111	10.1371/journal.pone.0166111	http://dx.doi.org/10.1371/journal.pone.0166111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851770	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300036
J	Sun, O; Liu, ZX				Sun, Ou; Liu, Zhixin			Comparison of Monetary Policy Actions and Central Bank Communication on Tackling Asset Price Bubbles-Evidence from China's Stock Market	PLOS ONE			English	Article							VECTOR AUTOREGRESSIONS; IMPACT	We examine the different effects of monetary policy actions and central bank communication on China's stock market bubbles with a Time-varying Parameter SVAR model. We find that with negative responses of fundamental component and positive responses of bubble component of asset prices, contractionary monetary policy induces the observed stock prices to rise during periods of large bubbles. By contrast, central bank communication acts on the market through expectation guidance and has more significant effects on stock prices in the long run, which implies that central bank communication be used as an effective long-term instrument for the central bank's policymaking.	[Sun, Ou; Liu, Zhixin] Beihang Univ, Sch Econ & Management, Beijing, Peoples R China	Beihang University	Sun, O (corresponding author), Beihang Univ, Sch Econ & Management, Beijing, Peoples R China.	sunou@buaa.edu.cn			National Natural Science Foundation of China [70821061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China [grant number 70821061]; http://www.nsfc.gov.cn/. The author who received the funding is Zhixin Liu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian Z, 2012, EC RES J, V12, P15; Blinder AS, 2008, J ECON LIT, V46, P910, DOI 10.1257/jel.46.4.910; Born B, 2013, ECON J, V124, P701; Born B, 2012, INT FINANC, V15, P179, DOI 10.1111/j.1468-2362.2012.01301.x; Brand C, 2010, J EUR ECON ASSOC, V8, P1266, DOI 10.1111/j.1542-4774.2010.tb00555.x; Chen G, 2009, EC RES J, V5, P106; Chen GD, 2013, SENSOR REV, V33, P25, DOI 10.1108/02602281311294324; Cochrane JH, 2002, AM ECON REV, V92, P90, DOI 10.1257/000282802320189069; Connolly E, 2004, RBA RES DISCUSSION P; Del Negro Marco, 2012, 574 FED RES BANK NEW; Ehrmann M, 2007, J MONEY CREDIT BANK, V39, P509, DOI 10.1111/j.0022-2879.2007.00034.x; Faust J, 2004, J MONETARY ECON, V51, P1107, DOI 10.1016/j.jmoneco.2003.11.001; Feltham G., 1995, CONTEMP ACCOUNT RES, V11, P689, DOI [10.1111/j.1911-3846.1995.tb00462.x, DOI 10.1111/J.1911-3846.1995.TB00462]; Feng K, 2011, EC RES J S, V2, P51; Fratzscher M, 2008, J MACROECON, V30, P1651, DOI 10.1016/j.jmacro.2008.07.002; Friedman BM, 2015, MANCH SCH, V83, P5, DOI 10.1111/manc.12095; Friedman M., 1963, MONETARY HIST US 186; Friedrich H., 2007, SWISS J EC STAT, V143, P155, DOI DOI 10.1007/BF03399237; Furlanetto F, 2008, INT J CENT BANK, V7, P91; Gali J, 2015, AM ECON J-MACROECON, V7, P233, DOI 10.1257/mac.20140003; Gali J, 2014, AM ECON REV, V104, P721, DOI 10.1257/AER.104.3.721; Gertler M, 2015, AM ECON J-MACROECON, V7, P44, DOI 10.1257/mac.20130329; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Gurkaynak RS Sack B Swanson ET, 2005, INT J OFCENTRAL BANK, V1, P55; Jansen D.-J., 2007, EUR J POLIT ECON, V23, P245; Kliesen KL, 2004, FED RESERVE BANK ST, V86, P9; Kohn D.L., 2003, CENTRAL BANK TALK DO, DOI [10.2139/ssrn.483524, DOI 10.2139/SSRN.483524]; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082771; Lu Zhengfei, 2012, EC RES J; Neuenkirch M, 2013, J BANK FINANC, V37, P4278, DOI 10.1016/j.jbankfin.2013.07.044; Ouyang Z, 2014, EC RES J; Primiceri GE, 2005, REV ECON STUD, V72, P821, DOI 10.1111/j.1467-937X.2005.00353.x; Ranaldo A, 2010, J INT MONEY FINANC, V29, P486, DOI 10.1016/j.jimonfin.2009.07.004; Rigobon R, 2004, J MONETARY ECON, V51, P1553, DOI 10.1016/j.jmoneco.2004.02.004; Rigobon R, 2003, Q J ECON, V118, P639, DOI 10.1162/003355303321675473; Romer Christina D., 1989, NBER MACROECON ANNU, P121; Sarno L, 2001, J ECON LIT, V39, P839, DOI 10.1257/jel.39.3.839; Scherbina A, 2014, QUANT FINANC, V14, P589, DOI 10.1080/14697688.2012.755266; [孙彬 Sun Bin], 2012, [系统工程理论与实践, Systems Engineering-Theory & Practice], V32, P1027; Tan Z, 2014, EC RES J; Wachtel, 1982, CRISIS EC FINANCIAL, P295, DOI [10.3386/w0945, DOI 10.3386/W0945]; Woodford Michael, 2005, P EC POL S	42	1	1	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166526	10.1371/journal.pone.0166526	http://dx.doi.org/10.1371/journal.pone.0166526			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851796	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300061
J	Carvalho, TF; Haddad, JPA; Paixao, TA; Santos, RL				Carvalho, Tatiane F.; Haddad, Joao Paulo A.; Paixao, Tatiane A.; Santos, Renato L.			Meta-Analysis and Advancement of Brucellosis Vaccinology	PLOS ONE			English	Article							ZN SUPEROXIDE-DISMUTASE; PROTEIN CONFERS PROTECTION; ABORTUS 544 INFECTION; O-POLYSACCHARIDE SYNTHESIS; OUTER-MEMBRANE PROTEIN-31; ROUGH-PHENOTYPE VACCINE; BALB/C MICE; DNA VACCINE; IMMUNE-RESPONSE; MELITENSIS INFECTION	Background/Objectives In spite of all the research effort for developing new vaccines against brucellosis, it remains unclear whether these new vaccine technologies will in fact become widely used. The goal of this study was to perform a meta-analysis to identify parameters that influence vaccine efficacy as well as a descriptive analysis on how the field of Brucella vaccinology is advancing concerning type of vaccine, improvement of protection on animal models over time, and factors that may affect protection in the mouse model. Methods A total of 117 publications that met the criteria were selected for inclusion in this study, with a total of 782 individual experiments analyzed. Results Attenuated (n = 221), inactivated (n = 66) and mutant (n = 102) vaccines provided median protection index above 2, whereas subunit (n = 287), DNA (n = 68), and vectored (n = 38) vaccines provided protection indexes lower than 2. When all categories of experimental vaccines are analyzed together, the trend line clearly demonstrates that there was no improvement of the protection indexes over the past 30 years, with a low negative and non significant linear coefficient. A meta-regression model was developed including all vaccine categories (attenuated, DNA, inactivated, mutant, subunit, and vectored) considering the protection index as a dependent variable and the other parameters (mouse strain, route of vaccination, number of vaccinations, use of adjuvant, challenge Brucella species) as independent variables. Some of these variables influenced the expected protection index of experimental vaccines against Brucella spp. in the mouse model. Conclusion In spite of the large number of publication over the past 30 years, our results indicate that there is not clear trend to improve the protective potential of these experimental vaccines.	[Carvalho, Tatiane F.; Santos, Renato L.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [Haddad, Joao Paulo A.] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil; [Paixao, Tatiane A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Santos, RL (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil.	rsantos@vet.ufmg.br	de Lima Santos, Renato/A-1134-2008; Paixao, Tatiane/A-2871-2013	de Lima Santos, Renato/0000-0002-4830-0470; HADDAD, JOAO PAULO/0000-0003-2823-6288; Paixao, Tatiane/0000-0001-8284-9902	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil); CNPq	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Work in RLS lab is supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil), and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil). RLS and JPAH have fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RLS, TAP and JPAH have fellowships from CNPq.	Abkar M, 2015, VET RES COMMUN, V39, P217, DOI 10.1007/s11259-015-9645-2; Abkar M, 2015, APMIS, V123, P667, DOI 10.1111/apm.12400; Adone R, 2008, VACCINE, V26, P4913, DOI 10.1016/j.vaccine.2008.07.030; Adone R, 2005, INFECT IMMUN, V73, P4198, DOI 10.1128/IAI.73.7.4198-4204.2005; Adone R, 2011, VACCINE, V29, P2523, DOI 10.1016/j.vaccine.2011.01.072; Al-Mariri A, 2014, ARCH MED VET, V46, P53, DOI 10.4067/s0301-732x2014000100008; Al-Mariri A, 2002, INFECT IMMUN, V70, P1915, DOI 10.1128/IAI.70.4.1915-1923.2002; Al-Mariri A, 2001, INFECT IMMUN, V69, P6264, DOI 10.1128/IAI.69.10.6264-6270.2001; Al-Mariri A, 2001, INFECT IMMUN, V69, P4816, DOI 10.1128/IAI.69.8.4816-4822.2001; Al-Mariri A, 2013, J INFECT DEV COUNTR, V7, P329, DOI 10.3855/jidc.2296; Al-Mariri A, 2012, BIOLOGICALS, V40, P140, DOI 10.1016/j.biologicals.2012.01.002; Al-Mariri A, 2010, VACCINE, V28, P1766, DOI 10.1016/j.vaccine.2009.12.012; Allen CA, 1998, INFECT IMMUN, V66, P1008, DOI 10.1128/IAI.66.3.1008-1016.1998; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Barrio MB, 2009, VACCINE, V27, P1741, DOI 10.1016/j.vaccine.2009.01.025; Bhattacharjee AK, 2006, INFECT IMMUN, V74, P5820, DOI 10.1128/IAI.00331-06; Blasco JM, 1997, PREV VET MED, V31, P275, DOI 10.1016/S0167-5877(96)01110-5; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; BOSSERAY N, 1990, VACCINE, V8, P462, DOI 10.1016/0264-410X(90)90247-J; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; Cabrera A, 2009, IMMUNOBIOLOGY, V214, P467, DOI 10.1016/j.imbio.2008.11.016; Cascio A, 2011, CLIN MICROBIOL INFEC, V17, P336, DOI 10.1111/j.1469-0691.2010.03451.x; Cassataro J, 2005, INFECT IMMUN, V73, P8079, DOI 10.1128/IAI.73.12.8079-8088.2005; Cassataro J, 2005, INFECT IMMUN, V73, P6537, DOI 10.1128/IAI.73.10.6537-6546.2005; Cassataro J, 2002, VACCINE, V20, P1660, DOI 10.1016/S0264-410X(01)00498-4; Cassataro J, 2007, VACCINE, V25, P5958, DOI 10.1016/j.vaccine.2007.05.049; Cassataro J, 2007, CLIN VACCINE IMMUNOL, V14, P869, DOI 10.1128/CVI.00472-06; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Cespedes S, 2000, J MED MICROBIOL, V49, P165, DOI 10.1099/0022-1317-49-2-165; CHEERS C, 1984, DEV BIOL STAND, V56, P237; Clapp B, 2011, INFECT IMMUN, V79, P4165, DOI 10.1128/IAI.05080-11; Clausse M, 2014, CLIN VACCINE IMMUNOL, V21, P1689, DOI 10.1128/CVI.00527-14; Clausse M, 2013, VACCINE, V31, P6129, DOI 10.1016/j.vaccine.2013.07.041; Cloeckaert A, 2004, VACCINE, V22, P2827, DOI 10.1016/j.vaccine.2004.01.001; Commander NJ, 2007, VACCINE, V25, P43, DOI 10.1016/j.vaccine.2006.07.046; Commander Nicola J, 2010, Genet Vaccines Ther, V8, P5, DOI 10.1186/1479-0556-8-5; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Martins RD, 2012, J CONTROL RELEASE, V162, P553, DOI 10.1016/j.jconrel.2012.07.030; Dabral N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107180; Avila-Calderon ED, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/743509; DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P4990; DEBAGUES MPJ, 1994, INFECT IMMUN, V62, P632; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Edmonds M, 2000, VET MICROBIOL, V76, P81, DOI 10.1016/S0378-1135(00)00225-X; Estein SM, 2003, MICROBES INFECT, V5, P85, DOI 10.1016/S1286-4579(02)00075-8; Estevan M, 2006, VACCINE, V24, P4179, DOI 10.1016/j.vaccine.2006.01.038; Ficht TA, 2002, VET MICROBIOL, V90, P311, DOI 10.1016/S0378-1135(02)00216-X; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Florentino MA, 2008, VET MICROBIOL, V132, P302, DOI 10.1016/j.vetmic.2008.05.003; Ghasemi A, 2015, VACCINE, V33, P5532, DOI 10.1016/j.vaccine.2015.09.013; Ghasemi A, 2014, VACCINE, V32, P6659, DOI 10.1016/j.vaccine.2014.09.013; Ghasemi A, 2014, MOL IMMUNOL, V62, P142, DOI 10.1016/j.molimm.2014.06.017; Goel D, 2013, VACCINE, V31, P1231, DOI 10.1016/j.vaccine.2012.12.043; Goel D, 2012, MOL IMMUNOL, V51, P159, DOI 10.1016/j.molimm.2012.02.126; Golshani M, 2015, MOL IMMUNOL, V66, P384, DOI 10.1016/j.molimm.2015.04.015; Golshani M, 2015, MOL IMMUNOL, V65, P287, DOI 10.1016/j.molimm.2015.01.009; Gomez G, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00017; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Gonzalez-Smith A, 2006, IMMUNOBIOLOGY, V211, P65, DOI 10.1016/j.imbio.2005.09.004; Grillo MJ, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-29; Grillo MJ, 2006, VACCINE, V24, P2910, DOI 10.1016/j.vaccine.2005.12.038; Guilloteau LA, 1999, VACCINE, V17, P353, DOI 10.1016/S0264-410X(98)00205-9; Gupta VK, 2007, RES VET SCI, V82, P305, DOI 10.1016/j.rvsc.2006.07.014; Hamdy MER, 2002, VET MICROBIOL, V88, P85, DOI 10.1016/S0378-1135(02)00088-3; Harms Jerome S, 2009, J Immune Based Ther Vaccines, V7, P1, DOI 10.1186/1476-8518-7-1; He YQ, 2002, INFECT IMMUN, V70, P2535, DOI 10.1128/IAI.70.5.2535-2543.2002; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Hu XD, 2010, VACCINE, V28, P2408, DOI 10.1016/j.vaccine.2009.12.076; Iannino F, 2015, VACCINE, V33, P2248, DOI 10.1016/j.vaccine.2015.03.033; Izadjoo MJ, 2004, INFECT IMMUN, V72, P4031, DOI 10.1128/IAI.72.7.4031-4039.2004; Jain L, 2015, BIOLOGICALS, V43, P369, DOI 10.1016/j.biologicals.2015.06.006; Jain S, 2014, VACCINE, V32, P4537, DOI 10.1016/j.vaccine.2014.06.012; Jain S, 2013, WORLD J MICROB BIOT, V29, P907, DOI 10.1007/s11274-012-1247-3; Jain-Gupta N, 2012, FEMS IMMUNOL MED MIC, V66, P436, DOI 10.1111/1574-695X.12010; Kahl-McDonagh MM, 2006, INFECT IMMUN, V74, P4048, DOI 10.1128/IAI.01787-05; Kaushik P, 2010, VET RES COMMUN, V34, P119, DOI 10.1007/s11259-009-9337-x; Lalsiamthara J, 2015, VACCINE, V33, P2577, DOI 10.1016/j.vaccine.2015.04.004; Lean IJ, 2009, J DAIRY SCI, V92, P3545, DOI 10.3168/jds.2009-2140; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Li XB, 2012, VET MICROBIOL, V161, P137, DOI 10.1016/j.vetmic.2012.07.016; Li ZQ, 2015, J VET SCI, V16, P467, DOI 10.4142/jvs.2015.16.4.467; Li ZQ, 2015, MOL IMMUNOL, V66, P276, DOI 10.1016/j.molimm.2015.04.004; Liljeqvist S, 1999, J BIOTECHNOL, V73, P1, DOI 10.1016/S0168-1656(99)00107-8; Lim JJ, 2012, J VET SCI, V13, P287, DOI 10.4142/jvs.2012.13.3.287; Liu J, 2015, VET IMMUNOL IMMUNOP, V166, P138, DOI 10.1016/j.vetimm.2015.04.008; Luo D, 2006, INFECT IMMUN, V74, P2734, DOI 10.1128/IAI.74.5.2734-2741.2006; Macedo AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138131; Mallick AI, 2007, VACCINE, V25, P7873, DOI 10.1016/j.vaccine.2007.09.008; Mancilla M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-105; Miranda KL, 2015, VACCINE, V33, P507, DOI 10.1016/j.vaccine.2014.11.056; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Moustafa D, 2011, VACCINE, V29, P784, DOI 10.1016/j.vaccine.2010.11.018; Munoz-Montesino C, 2004, INFECT IMMUN, V72, P2081, DOI 10.1128/IAI.72.4.2081-2087.2004; Murillo M, 2001, VACCINE, V19, P4099, DOI 10.1016/S0264-410X(01)00177-3; Neta AVC, 2010, VET J, V184, P146, DOI 10.1016/j.tvjl.2009.04.010; NICOLETTI P, 1984, Vaccine, V2, P133, DOI 10.1016/0264-410X(84)90004-5; Nicoletti P, 1990, Adv Biotechnol Processes, V13, P147; OIE Biological Standards Commission, 2008, MANUAL OF DIAGNOSTIC; Oliveira SC, 1996, VACCINE, V14, P959, DOI 10.1016/0264-410X(96)00018-7; Olsen SC, 2013, REV SCI TECH OIE, V32, P207; Onate AA, 2005, INFECT IMMUN, V73, P3294, DOI 10.1128/IAI.73.6.3294-3300.2005; Onate AA, 2003, INFECT IMMUN, V71, P4857, DOI 10.1128/IAI.71.9.4857-4861.2003; Onate AA, 1999, INFECT IMMUN, V67, P986; Palomares-Resendiz E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00035; Pappas G, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/j.ijantimicag.2010.06.013; Pasquali P, 2003, INFECT IMMUN, V71, P2326, DOI 10.1128/IAI.71.5.2326-2330.2003; Pasquevich KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016203; Pasquevich KA, 2010, J IMMUNOL, V184, P5200, DOI 10.4049/jimmunol.0902209; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poester FP, 2013, REV SCI TECH OIE, V32, P105; Poester FP, 2006, VACCINE, V24, P5327, DOI 10.1016/j.vaccine.2006.04.020; Pollak CN, 2015, CLIN VACCINE IMMUNOL, V22, P274, DOI 10.1128/CVI.00653-14; PUGH GW, 1991, VET MICROBIOL, V26, P167, DOI 10.1016/0378-1135(91)90053-I; Truong QL, 2014, CLIN VACCINE IMMUNOL, V21, P1573, DOI 10.1128/CVI.00164-14; Retamal-Diaz A, 2014, CLIN VACCINE IMMUNOL, V21, P1474, DOI 10.1128/CVI.00554-14; Riquelme-Neira R, 2013, VACCINE, V31, P3663, DOI 10.1016/j.vaccine.2013.06.013; Rosinha GMS, 2002, INFECT IMMUN, V70, P5036, DOI 10.1128/IAI.70.9.5036-5044.2002; Rosinha GMS, 2002, J MED MICROBIOL, V51, P661, DOI 10.1099/0022-1317-51-8-661; Saez D, 2012, VACCINE, V30, P1283, DOI 10.1016/j.vaccine.2011.12.088; Sanakkayala N, 2005, CLIN DIAGN LAB IMMUN, V12, P1429, DOI 10.1128/CDLI.12.12.1429-1436.2005; Lacerda TLS, 2010, VACCINE, V28, P5627, DOI 10.1016/j.vaccine.2010.06.023; Santos RL, 2013, PESQUI VET BRASIL, V33, P759, DOI 10.1590/S0100-736X2013000600012; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Silva APC, 2015, CLIN VACCINE IMMUNOL, V22, P789, DOI 10.1128/CVI.00191-15; Silva APC, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0136865, DOI 10.1371/JOURNAL.PONE.0136865]; Silva TMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114532; Silva TMA, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/518323; Singh D, 2015, MOL IMMUNOL, V68, P272, DOI 10.1016/j.molimm.2015.09.011; Singh D, 2015, VACCINE, V33, P2786, DOI 10.1016/j.vaccine.2015.04.030; Singha H, 2008, MICROBES INFECT, V10, P1089, DOI 10.1016/j.micinf.2008.05.007; Singha H, 2011, VACCINE, V29, P4720, DOI 10.1016/j.vaccine.2011.04.088; Sislema-Egas F, 2012, VACCINE, V30, P7286, DOI 10.1016/j.vaccine.2012.09.039; Soler-Llorens P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0072-0; Souza Filho JA, 2015, INFECT IMMUN, V83, P1458; TABATABAI LB, 1994, VACCINE, V12, P919, DOI 10.1016/0264-410X(94)90035-3; Tabynov K, 2014, VACCINE, V32, P2034, DOI 10.1016/j.vaccine.2014.02.058; Tamura S, 2010, JPN J INFECT DIS, V63, P8; Titball RW, 2008, DRUG DISCOV TODAY, V13, P596, DOI 10.1016/j.drudis.2008.04.010; Todd TE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S3; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; Ugalde JE, 2003, INFECT IMMUN, V71, P6264, DOI 10.1128/IAI.71.11.6264-6269.2003; Velikovsky CA, 2003, INFECT IMMUN, V71, P5750, DOI 10.1128/IAI.71.10.5750-5755.2003; Velikovsky CA, 2002, INFECT IMMUN, V70, P2507, DOI 10.1128/IAI.70.5.2507-2511.2002; Vemulapalli R, 2000, INFECT IMMUN, V68, P3286, DOI 10.1128/IAI.68.6.3286-3289.2000; Verma SK, 2012, WORLD J MICROB BIOT, V28, P2487, DOI 10.1007/s11274-012-1056-8; Wang XH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01193; Wang Z, 2013, CLIN VACCINE IMMUNOL, V20, P174, DOI 10.1128/CVI.00573-12; WINTER AJ, 1988, INFECT IMMUN, V56, P2808, DOI 10.1128/IAI.56.11.2808-2817.1988; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yang YL, 2011, MOL IMMUNOL, V49, P175, DOI 10.1016/j.molimm.2011.08.009; Yang YL, 2011, FEMS IMMUNOL MED MIC, V61, P159, DOI 10.1111/j.1574-695X.2010.00758.x; YOUNG EJ, 1979, INFECT IMMUN, V26, P680, DOI 10.1128/IAI.26.2.680-685.1979; Yu DH, 2007, DNA CELL BIOL, V26, P435, DOI 10.1089/dna.2006.0552; Zhang JB, 2014, J MICROBIOL, V52, P681, DOI 10.1007/s12275-014-3689-9; Zhang JB, 2013, MICROBIOL IMMUNOL, V57, P502, DOI 10.1111/1348-0421.12065; Zhao ZP, 2009, VACCINE, V27, P5214, DOI 10.1016/j.vaccine.2009.06.075	162	28	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166582	10.1371/journal.pone.0166582	http://dx.doi.org/10.1371/journal.pone.0166582			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846274	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600088
J	Galesloot, TE; Verweij, N; Traglia, M; Barbieri, C; van Dijk, F; Geurts-Moespot, AJ; Girelli, D; Kiemeney, LALM; Sweep, FCGJ; Swertz, MA; van der Meer, P; Camaschella, C; Toniolo, D; Vermeulen, SH; van der Harst, P; Swinkels, DW				Galesloot, Tessel E.; Verweij, Niek; Traglia, Michela; Barbieri, Caterina; van Dijk, Freerk; Geurts-Moespot, Anneke J.; Girelli, Domenico; Kiemeney, Lambertus A. L. M.; Sweep, Fred C. G. J.; Swertz, Morris A.; van der Meer, Peter; Camaschella, Clara; Toniolo, Daniela; Vermeulen, Sita H.; van der Harst, Pim; Swinkels, Dorine W.			Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY IRON STORES; COMMON VARIANTS; HFE; POPULATION; TMPRSS6; RISK; HEMOCHROMATOSIS; DEFICIENCY; PARAMETERS	Serum hepcidin concentration is regulated by iron status, inflammation, erythropoiesis and numerous other factors, but underlying processes are incompletely understood. We studied the association of common and rare single nucleotide variants (SNVs) with serum hepcidin in one Italian study and two large Dutch population-based studies. We genotyped common SNVs with genome-wide association study (GWAS) arrays and subsequently performed imputation using the 1000 Genomes reference panel. Cohort-specificGWAS were performed for log-transformed serum hepcidin, adjusted for age and gender, and results were combined in a fixed-effects meta-analysis (total N 6,096). Six top SNVs (p< 5x10(-6)) were genotyped in 3,821 additional samples, but associations were not replicated. Furthermore, we meta-analyzed cohort-specific exome array association results of rare SNVs with serum hepcidin that were available for two of the three cohorts (total N 3,226), but no exome-wide significant signal (p< 1.4x10(-6)) was identified. Gene-based meta-analyses revealed 19 genes that showed significant association with hepcidin. Our results suggest the absence of common SNVs and rare exonic SNVs explaining a large proportion of phenotypic variation in serum hepcidin. We recommend extension of our study once additional substantial cohorts with hepcidin measurements, GWAS and/or exome array data become available in order to increase power to identify variants that explain a smaller proportion of hepcidin variation. In addition, we encourage follow-up of the potentially interesting genes that resulted from the gene-based analysis of low-frequency and rare variants.	[Galesloot, Tessel E.; Kiemeney, Lambertus A. L. M.; Sweep, Fred C. G. J.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Verweij, Niek; van der Meer, Peter; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Traglia, Michela; Barbieri, Caterina; Camaschella, Clara; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, Milan, Italy; [Barbieri, Caterina] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [van Dijk, Freerk; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, Groningen, Netherlands; [van Dijk, Freerk; Swertz, Morris A.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Geurts-Moespot, Anneke J.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Geurts-Moespot, Anneke J.; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen, Netherlands; [Girelli, Domenico] Univ Verona, Sect Internal Med, Dept Med, Verona, Italy; [Camaschella, Clara] Univ Vita Salute San Raffaele, Milan, Italy	Radboud University Nijmegen; University of Groningen; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Trieste; University of Groningen; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; University of Verona; Vita-Salute San Raffaele University	Swinkels, DW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands.; Swinkels, DW (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen, Netherlands.	Dorine.Swinkels@radboudumc.nl	Sweep, C.G.J./H-8096-2014; Toniolo, Daniela/AAE-2969-2019; Swinkels, Dorine W./H-8098-2014; Verweij, Niek/A-4499-2017; Girelli, Domenico/B-1183-2008; Galesloot, Tessel/P-6667-2015; Vermeulen, Sita H./L-4716-2015; Verweij, Niek/ABC-6249-2021; Traglia, Michela/AAX-5816-2020; Kiemeney, Lambertus A./D-3357-2009	Sweep, C.G.J./0000-0003-1103-3070; Toniolo, Daniela/0000-0001-9545-6032; Swinkels, Dorine W./0000-0002-1040-9446; Girelli, Domenico/0000-0001-9684-1899; Galesloot, Tessel/0000-0002-2717-3679; Vermeulen, Sita H./0000-0003-4913-8601; Verweij, Niek/0000-0002-4303-7685; Kiemeney, Lambertus A./0000-0002-2368-1326; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation, NCF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO); Dutch Kidney Foundation [E033]; National Institutes of Health [LM010098]; Netherlands Organization for Scientific Research (NWO-Groot) [175.010.2007.006]; Netherlands Organization for Scientific Research (NWO VENI) [916.761.70]; Netherlands Organization for Scientific Research (ZonMW) [90.700.441]; Dutch Inter University Cardiology Institute Netherlands; Netherlands Heart Foundation [NHS201013280]; Compagnia di San Paolo, Torino, Italy; Fondazione Cariplo, Italy; Ministry of Health, Ricerca Finalizzata; Ministry of Health, CCM; Ministry of Health, PRIN; Telethon, Italy	Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation, NCF); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO-Groot)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO VENI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Dutch Inter University Cardiology Institute Netherlands; Netherlands Heart Foundation(Netherlands Heart Foundation); Compagnia di San Paolo, Torino, Italy(Compagnia di San Paolo); Fondazione Cariplo, Italy(Fondazione Cariplo); Ministry of Health, Ricerca Finalizzata; Ministry of Health, CCM; Ministry of Health, PRIN(Ministry of Education, Universities and Research (MIUR)); Telethon, Italy(Fondazione Telethon)	This work was supported by the Stichting Nationale Computerfaciliteiten (National Computing Facilities Foundation, NCF) for the use of supercomputer facilities, with financial support from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organization for Scientific Research, NWO); PREVEND genetics is supported by the Dutch Kidney Foundation (grant E033), the National Institutes of Health (grant LM010098), The Netherlands Organization for Scientific Research (NWO-Groot 175.010.2007.006, NWO VENI grant 916.761.70, ZonMW 90.700.441), and the Dutch Inter University Cardiology Institute Netherlands; N. Verweij is supported by the Netherlands Heart Foundation (grant NHS201013280); funds from Compagnia di San Paolo, Torino, Italy; Fondazione Cariplo, Italy and Ministry of Health, Ricerca Finalizzata 2008 and CCM 2010, PRIN 2009 and Telethon, Italy to DT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DWS is an employee of Radboudumc and not of the hepcidinanalysis.com initiative. The hepcidinanalysis.com initiative is thus not a funder and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Benyamin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5926; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Cherayil BJ, 2010, ARCH IMMUNOL THER EX, V58, P407, DOI 10.1007/s00005-010-0095-9; Colonna V, 2013, EUR J HUM GENET, V21, P89, DOI 10.1038/ejhg.2012.113; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Falchi M, 2004, AM J HUM GENET, V75, P1015, DOI 10.1086/426155; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Galesloot TE, 2013, J MED GENET, V50, P593, DOI 10.1136/jmedgenet-2013-101673; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lee JH, 2014, FRONT GENET, V4, DOI 10.3389/fgene.2013.00310; Liu DJJ, 2014, NAT GENET, V46, P200, DOI 10.1038/ng.2852; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mainous AG, 2013, AM J HEMATOL, V88, P492, DOI 10.1002/ajh.23438; Middelberg RPS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-123; Mishra A, 2015, TWIN RES HUM GENET, V18, P86, DOI 10.1017/thg.2014.79; Montonen J, 2012, DIABETOLOGIA, V55, P2613, DOI 10.1007/s00125-012-2633-y; Murphy AT, 2007, BLOOD, V110, P1048, DOI 10.1182/blood-2006-11-057471; Nai A, 2011, BLOOD, V118; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pichler I, 2011, HUM MOL GENET, V20, P1232, DOI 10.1093/hmg/ddq552; Schaap CCM, 2013, CLIN CHEM, V59, P527, DOI 10.1373/clinchem.2012.194977; Swinkels DW, 2006, CLIN CHEM, V52, P950, DOI 10.1373/clinchem.2006.068684; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; Traglia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007554; van Dijk BAC, 2008, BRIT J HAEMATOL, V142, P979, DOI 10.1111/j.1365-2141.2008.07273.x; van Meurs JBJ, 2013, AM J CLIN NUTR, V98, P668, DOI 10.3945/ajcn.112.044545; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	50	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166628	10.1371/journal.pone.0166628	http://dx.doi.org/10.1371/journal.pone.0166628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846281	gold, Green Published			2022-12-27	WOS:000387794600093
J	Mehlhorn, J; Rehkaemper, G				Mehlhorn, Julia; Rehkaemper, Gerd			The Influence of Social Parameters on the Homing Behavior of Pigeons	PLOS ONE			English	Article							LEADERSHIP; ORIENTATION; NAVIGATION; BIRDS	Homing pigeons develop preferred routes when released alone several times from the same site, but they sometimes diverge from their preferred route when subsequently released with another pigeon. Additionally, group flights show a better homing performance than solo flights. But this knowledge is based on studies involving both sexes and lacks analyses of social parameters such as mating or breeding status, even though it is known that such parameters have an influence on behavior and on motivation for specific behavioral patterns. GPS trackers were used to track 24 homing pigeons (9 breeding pairs and 6 unmated females) as they performed a familiar 10km route in various pair and group combinations. Comparisons of efficiency indices (quotient between straight-line distance and pigeon's track) reveal that unmated females show the best efficiency in single flights. Generally, group flights show the best efficiency followed by pair flights with a social partner of the opposite sex. Pair flights with the mated partner exhibit the poorest performance. Additionally, just before squabs hatching, females show a higher efficiency index when released at 8 am, compared to releases at 2 pm. Our results indicate that homing flight efficiency can provide insight into individual motivation and that social parameters have an influence on homing performance on a familiar route.	[Mehlhorn, Julia; Rehkaemper, Gerd] Univ Duesseldorf, Inst Anat 1, Res Grp Comparat Neurobiol & Evolutionary Res, Dusseldorf, Germany		Mehlhorn, J (corresponding author), Univ Duesseldorf, Inst Anat 1, Res Grp Comparat Neurobiol & Evolutionary Res, Dusseldorf, Germany.	julia.mehlhom@uni-duesseldorf.de						Bell A, 2013, BEHAV ECOL, V24, P16, DOI 10.1093/beheco/ars148; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; CLAUSEN DM, 1958, EXPERIENTIA, V14, P386, DOI 10.1007/BF02159172; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; DelSeppia C, 1996, ANIM BEHAV, V52, P33, DOI 10.1006/anbe.1996.0150; Flack A, 2013, J EXP BIOL, V216, P1434, DOI 10.1242/jeb.082800; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; Gould JL, 2006, CURR BIOL, V16, pR920, DOI 10.1016/j.cub.2006.09.051; Guilford T, 2014, J EXP BIOL, V217, P169, DOI 10.1242/jeb.092908; Johnston RF, 1995, FERAL PIGEONS; Jorge PE, 2012, J EXP BIOL, V215, P2414, DOI 10.1242/jeb.070375; Lipp H.-P., 1996, ACTA BIOL BENRODIS S, V3, P85; LIPP HP, 1983, COMP BIOCHEM PHYS A, V76, P743, DOI 10.1016/0300-9629(83)90136-6; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Mehlhorn J, 2009, NATURWISSENSCHAFTEN, V96, P1011, DOI 10.1007/s00114-009-0560-7; MICHENER MC, 1967, J EXP BIOL, V47, P99; PAPI F, 1974, J COMP PHYSIOL, V94, P187, DOI 10.1007/BF00611866; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Pettit B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2160; Rosler G, 1998, DIE BRIEFTAUBE; Santos CD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147497; Schiffner I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112439; Schiffner I, 2009, NATURWISSENSCHAFTEN, V96, P251, DOI 10.1007/s00114-008-0476-7; SCHMIDTKOENIG K, 1990, EXPERIENTIA, V46, P336, DOI 10.1007/BF01952166; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Steiner I, 2000, PHYSIOL BEHAV, V71, P589, DOI 10.1016/S0031-9384(00)00409-1; VISALBERGHI E, 1979, BIOL BULL, V125, P246; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; WALLRAFF HG, 1978, OIKOS, V30, P401, DOI 10.2307/3543490; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wiltschko R, 2007, ANIM BEHAV, V74, P1229, DOI 10.1016/j.anbehav.2007.01.028	32	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166572	10.1371/journal.pone.0166572	http://dx.doi.org/10.1371/journal.pone.0166572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846262	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600084
J	Yu, P; Pan, YS; Wang, YJ; Wang, XW; Liu, LP; Ji, RJ; Meng, X; Jing, J; Tong, X; Guo, L; Wang, YL				Yu, Ping; Pan, Yuesong; Wang, Yongjun; Wang, Xianwei; Liu, Liping; Ji, Ruijun; Meng, Xia; Jing, Jing; Tong, Xu; Guo, Li; Wang, Yilong			External Validation of a Case-Mix Adjustment Model for the Standardized Reporting of 30-Day Stroke Mortality Rates in China	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; PROGNOSTIC MODELS; SCORE; PREDICTORS; DISABILITY; SURVIVAL; SCALE; RISK; AGE	Background and Purpose A case-mix adjustment model has been developed and externally validated, demonstrating promise. However, the model has not been thoroughly tested among populations in China. In our study, we evaluated the performance of the model in Chinese patients with acute stroke. Methods The case-mix adjustment model A includes items on age, presence of atrial fibrillation on admission, National Institutes of Health Stroke Severity Scale (NIHSS) score on admission, and stroke type. Model B is similar to Model A but includes only the consciousness component of the NIHSS score. Both model A and B were evaluated to predict 30-day mortality rates in 13,948 patients with acute stroke from the China National Stroke Registry. The discrimination of the models was quantified by c-statistic. Calibration was assessed using Pearson's correlation coefficient. Results The c-statistic of model A in our external validation cohort was 0.80 (95% confidence interval, 0.79-0.82), and the c-statistic of model B was 0.82 (95% confidence interval, 0.81-0.84). Excellent calibration was reported in the two models with Pearson's correlation coefficient (0.892 for model A, p<0.001; 0.927 for model B, p=0.008). Conclusions The case-mix adjustment model could be used to effectively predict 30-day mortality rates in Chinese patients with acute stroke.	[Yu, Ping; Guo, Li] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Peoples R China; [Pan, Yuesong; Wang, Yongjun; Wang, Xianwei; Meng, Xia; Jing, Jing; Wang, Yilong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Tiantan Clin Trial & Res Ctr Stroke, Beijing, Peoples R China; [Pan, Yuesong] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Wang, Yongjun; Liu, Liping; Ji, Ruijun; Wang, Yilong] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Yongjun; Ji, Ruijun; Wang, Yilong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Vasc Neurol, Beijing, Peoples R China; [Liu, Liping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Neurointens Care Unit, Beijing, Peoples R China; [Tong, Xu] Hebei Med Univ, Tangshan Gongren Hosp, Dept Neurol, Tangshan, Hebei, Peoples R China; [Yu, Ping] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei Province, Peoples R China; [Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Hebei Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Hebei Medical University; Hebei Medical University; Capital Medical University	Guo, L (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Peoples R China.; Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Tiantan Clin Trial & Res Ctr Stroke, Beijing, Peoples R China.; Wang, YL (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Vasc Neurol, Beijing, Peoples R China.	guoli6hb@163.com; yilong528@gmail.com	Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789	Ministry of Science and Technology; Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China [2008ZX09312_008]; State Key Development Program of (for) Basic Research of China [2009CB521905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China; State Key Development Program of (for) Basic Research of China(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China (2008ZX09312_008) and State Key Development Program of (for) Basic Research of China (2009CB521905).	Abdul-Rahim AH, 2016, STROKE, V47, P74, DOI 10.1161/STROKEAHA.115.009898; ALLEN CMC, 1984, J NEUROL NEUROSUR PS, V47, P475, DOI 10.1136/jnnp.47.5.475; Bray BD, 2014, STROKE, V45, P3374, DOI 10.1161/STROKEAHA.114.006451; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; FRITHZ G, 1976, ACTA MED SCAND, V199, P133; FULLERTON KJ, 1988, Q J MED, V66, P147; GOMPERTZ P, 1994, J NEUROL NEUROSUR PS, V57, P932, DOI 10.1136/jnnp.57.8.932; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Myint PK, 2014, INT J STROKE, V9, P278, DOI 10.1111/ijs.12088; Papavasileiou V, 2013, STROKE, V44, P1616, DOI 10.1161/STROKEAHA.113.001047; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; SHEIKH K, 1983, J EPIDEMIOL COMMUN H, V37, P70, DOI 10.1136/jech.37.1.70; Smith EE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005207; Teale EA, 2012, CLIN REHABIL, V26, P771, DOI 10.1177/0269215511433068; TUHRIM S, 1991, ANN NEUROL, V29, P658, DOI 10.1002/ana.410290614; Wang XG, 2015, CNS NEUROSCI THER, V21, P657, DOI 10.1111/cns.12421; Wang Y, 2003, ARCH PHYS MED REHAB, V84, P1006, DOI 10.1016/S0003-9993(03)00032-7; Wang Y, 2001, J CLIN EPIDEMIOL, V54, P766, DOI 10.1016/S0895-4356(01)00338-9; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8; Zhang N, 2013, STROKE, V44, P1924, DOI 10.1161/STROKEAHA.111.000172; Zhang N, 2012, STROKE, V43, P3108, DOI 10.1161/STROKEAHA.112.669085	28	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166069	10.1371/journal.pone.0166069	http://dx.doi.org/10.1371/journal.pone.0166069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846282	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600030
J	Cherepnalkoski, D; Karpf, A; Mozetic, I; Grcar, M				Cherepnalkoski, Darko; Karpf, Andreas; Mozetic, Igor; Grcar, Miha			Cohesion and Coalition Formation in the European Parliament: Roll-Call Votes and Twitter Activities	PLOS ONE			English	Article							NETWORK; BEHAVIOR; PATTERNS; MODELS	We study the cohesion within and the coalitions between political groups in the Eighth European Parliament (2014-2019) by analyzing two entirely different aspects of the behavior of the Members of the European Parliament (MEPs) in the policy-making processes. On one hand, we analyze their co-voting patterns and, on the other, their retweeting behavior. We make use of two diverse datasets in the analysis. The first one is the roll-call vote dataset, where cohesion is regarded as the tendency to co-vote within a group, and a coalition is formed when the members of several groups exhibit a high degree of co-voting agreement on a subject. The second dataset comes from Twitter; it captures the retweeting (i.e., endorsing) behavior of the MEPs and implies cohesion (retweets within the same group) and coalitions (retweets between groups) from a completely different perspective. We employ two different methodologies to analyze the cohesion and coalitions. The first one is based on Krippendorff's Alpha reliability, used to measure the agreement between raters in data-analysis scenarios, and the second one is based on Exponential Random Graph Models, often used in social-network analysis. We give general insights into the cohesion of political groups in the European Parliament, explore whether coalitions are formed in the same way for different policy areas, and examine to what degree the retweeting behavior of MEPs corresponds to their co-voting patterns. A novel and interesting aspect of our work is the relationship between the co-voting and retweeting patterns.	[Cherepnalkoski, Darko; Mozetic, Igor; Grcar, Miha] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia; [Karpf, Andreas] Univ Pantheon Sorbonne, Paris Sch Econ, Paris, France	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Paris School of Economics	Cherepnalkoski, D; Grcar, M (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia.	darko.cerepnalkoski@gmail.com; miha.grcar@ijs.si		Mozetic, Igor/0000-0002-5466-0608	EC project SIMPOL [610704]; EC project DOLFINS [640772]; Slovenian ARRS programme Knowledge Technologies [P2-103]	EC project SIMPOL; EC project DOLFINS; Slovenian ARRS programme Knowledge Technologies	This work was supported in part by the EC projects SIMPOL (no. 610704) and DOLFINS (no. 640772), and by the Slovenian ARRS programme Knowledge Technologies (no. P2-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2011, P 5 INT AAAI C WEB S; ATTINA F, 1990, EUR J POLIT RES, V18, P557, DOI 10.1111/j.1475-6765.1990.tb00248.x; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Borondo J, 2014, PHYSICA A, V414, P403, DOI 10.1016/j.physa.2014.06.089; Borondo J, 2012, CHAOS, V22, DOI 10.1063/1.4729139; Brzinski JB, 1995, STATE EUROPEAN UNION, V3, P135; Cherepnalkoski Darko, 2016, Appl Netw Sci, V1, P2, DOI 10.1007/s41109-016-0001-4; Conover M. D., 2011, P 3 IEEE C SOC COMP; Conover M. D., 2011, P 5 AAAI C WEBL SOC; Cranmer SJ, 2011, POLIT ANAL, V19, P66, DOI 10.1093/pan/mpq037; Dal Maso C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116046; Ecom YH, 2015, PLOS ONE, V10; European Parliament, 2016, ROLL CALL VOT DAT; Grcar M, 2016, STUDIES COMPUTATIONA; Hix S, 2002, AM J POLIT SCI, V46, P688, DOI 10.2307/3088408; Hix S, 2007, THEME EUR GOVERN, P1, DOI 10.1017/CBO9780511491955; Hix S, 2005, BRIT J POLIT SCI, V35, P209, DOI 10.1017/S0007123405000128; Hix S, 2009, LEGIS STUD QUART, V34, P159, DOI 10.3162/036298009788314282; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Kreppel A, 1999, COMP POLIT STUD, V32, P933, DOI 10.1177/0010414099032008002; Krippendorff K., 2012, CONTENT ANAL INTRO I; Krivitsky PN, 2012, ELECTRON J STAT, V6, P1100, DOI 10.1214/12-EJS696; Lazer D, 2011, PS-POLIT SCI POLIT, V44, P61, DOI 10.1017/S1049096510001873; Lubbers MJ, 2003, SOC NETWORKS, V25, P309, DOI 10.1016/S0378-8733(03)00013-3; Porter MA, 2005, P NATL ACAD SCI USA, V102, P7057, DOI 10.1073/pnas.0500191102; Quanjel M, 1993, GROWING COHESION EUR; Ranco G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138441; Rice SA, 1928, PLOS ONE; Ripley RM, 2011, MANUAL RSIENA, V1; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Scheid J, 2016, EMP AFTER, P1, DOI 10.9783/9780812291988; Smailovic J., 2015, IEEE DSAA 2015, P1; Snijders TAB, 2003, J MATH SOCIOL, V27, P123, DOI 10.1080/00222500305892; VoteWatch, 2011, VOT 2009 2014 EUR PA; Waugh AS., 2009, PARTY POLARIZATION C; Zhang Y, 2008, PHYSICA A, V387, P1705, DOI 10.1016/j.physa.2007.11.004	37	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166586	10.1371/journal.pone.0166586	http://dx.doi.org/10.1371/journal.pone.0166586			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835683	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200060
J	Okamoto, K; Yamasaki, M; Takao, K; Soya, S; Iwasaki, M; Sasaki, K; Magoori, K; Sakakibara, I; Miyakawa, T; Mieda, M; Watanabe, M; Sakai, J; Yanagisawa, M; Sakurai, T				Okamoto, Kitaro; Yamasaki, Miwako; Takao, Keizo; Soya, Shingo; Iwasaki, Monica; Sasaki, Koh; Magoori, Kenta; Sakakibara, Iori; Miyakawa, Tsuyoshi; Mieda, Michihiro; Watanabe, Masahiko; Sakai, Juro; Yanagisawa, Masashi; Sakurai, Takeshi			QRFP-Deficient Mice Are Hypophagic, Lean, Hypoactive and Exhibit Increased Anxiety-Like Behavior	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; FAT FOOD-INTAKE; OREXIN NEURONS; ENERGY-BALANCE; FEMALE RATS; RECEPTOR; OBESITY; LIGAND; GPR103; SLEEP	How the hypothalamus transmits hunger information to other brain regions to govern whole brain function to orchestrate feeding behavior has remained largely unknown. Our present study suggests the importance of a recently found lateral hypothalamic neuropeptide, QRFP, in this signaling. Qrfp(-/-) mice were hypophagic and lean, and exhibited increased anxiety-like behavior, and were hypoactive in novel circumstances as compared with wild type littermates. They also showed decreased wakefulness time in the early hours of the dark period. Histological studies suggested that QRFP neurons receive rich innervations from neurons in the arcuate nucleus which is a primary region for sensing the body's metabolic state by detecting levels of leptin, ghrelin and glucose. These observations suggest that QRFP is an important mediator that acts as a downstream mediator of the arcuate nucleus and regulates feeding behavior, mood, wakefulness and activity.	[Okamoto, Kitaro; Soya, Shingo; Iwasaki, Monica; Sasaki, Koh; Mieda, Michihiro; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa 9208640, Japan; [Yamasaki, Miwako; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, 38 Nishigonaka Myodaiji, Okazaki, Aichi 4448585, Japan; [Takao, Keizo] Toyama Univ, Div Anim Resources & Dev, Life Sci Res Ctr, Toyama 9308555, Japan; [Magoori, Kenta; Sakakibara, Iori; Sakai, Juro] Univ Tokyo, Div Metab Med, RCAST, Tokyo 1538904, Japan; [Sakakibara, Iori; Sakai, Juro; Yanagisawa, Masashi; Sakurai, Takeshi] Japan Sci & Technol Agcy, ERATO Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; [Yanagisawa, Masashi; Sakurai, Takeshi] Univ Tsukuba, Fac Med, Int Inst Integrat Sleep Med IIIS, Tsukuba, Ibaraki 3058575, Japan	Kanazawa University; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Toyama; University of Tokyo; Japan Science & Technology Agency (JST); Fujita Health University; University of Tsukuba	Sakurai, T (corresponding author), Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa 9208640, Japan.; Sakurai, T (corresponding author), Japan Sci & Technol Agcy, ERATO Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan.; Sakurai, T (corresponding author), Univ Tsukuba, Fac Med, Int Inst Integrat Sleep Med IIIS, Tsukuba, Ibaraki 3058575, Japan.	sakurai.takeshi.gf@u.tsukuba.ac.jp	Takao, Keizo/B-9527-2008; Yamasaki, Miwako/I-8053-2014; Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Yamasaki, Miwako/0000-0003-4974-9349; Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Mieda, Michihiro/0000-0002-2451-7034; Soya, Shingo/0000-0001-7222-5012; Sakai, Juro/0000-0003-4043-1035; Miyakawa, Tsuyoshi/0000-0003-0137-8200	Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [16H06401]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [16K01946, 16H06462, 16H05120] Funding Source: KAKEN	Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers." This work was also supported by a Grant-in-Aid for Scientific Research on Priority Areas Integrative Brain Research (IBR-shien) and a Grant-in-Aid for Scientific Research on Innovative Areas (16H06401) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; The authors thank Ms. Satsuki Sawada and Yuki C. Saito for their excellent technical assistance. This research was funded by the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers." This work was also supported by a Grant-in-Aid for Scientific Research on Priority Areas-Integrative Brain Research (IBR-shien)-and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Allerton TD, 2015, PEPTIDES, V69, P77, DOI 10.1016/j.peptides.2015.04.006; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Atasoy D, 2012, NATURE; Beck B, 2009, BIOCHEM BIOPH RES CO, V383, P78, DOI 10.1016/j.bbrc.2009.03.132; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Friedman JM, 1997, NATURE, V385, P119, DOI 10.1038/385119a0; Fukusumi S, 2003, J BIOL CHEM, V278, P46387, DOI 10.1074/jbc.M305270200; Georgsson J, 2014, J MED CHEM, V57, P5935, DOI 10.1021/jm401951t; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Jiang Y, 2003, J BIOL CHEM, V278, P27652, DOI 10.1074/jbc.M302945200; Lectez B, 2009, ENDOCRINOLOGY, V150, P2342, DOI 10.1210/en.2008-1432; Moriya R, 2006, ENDOCRINOLOGY, V147, P2916, DOI 10.1210/en.2005-1580; Mulumba M, 2010, MOL ENDOCRINOL, V24, P1615, DOI 10.1210/me.2010-0010; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Primeaux SD, 2013, HORM METAB RES, V45, P967, DOI 10.1055/s-0033-1353181; Primeaux SD, 2008, PEPTIDES, V29, P1994, DOI 10.1016/j.peptides.2008.07.024; Primeaux SD, 2011, PEPTIDES, V32, P1270, DOI 10.1016/j.peptides.2011.03.022; Ramanjaneya M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1049, DOI 10.1152/ajpendo.00191.2013; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sakurai T, 2014, NAT REV NEUROSCI, V15, P719, DOI 10.1038/nrn3837; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schreiber AL, 2016, NEUROPEPTIDES, V58, P103, DOI 10.1016/j.npep.2016.01.004; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Takasaki C, 2010, EUR J NEUROSCI, V32, P1326, DOI 10.1111/j.1460-9568.2010.07377.x; Takayasu S, 2006, P NATL ACAD SCI USA, V103, P7438, DOI 10.1073/pnas.0602371103; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Tsunematsu T, 2014, J NEUROSCI, V34, P6896, DOI 10.1523/JNEUROSCI.5344-13.2014; Ukena K, 2010, ENDOCRINOLOGY, V151, P2255, DOI 10.1210/en.2009-1478; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zagoracz O, 2015, BRAIN RES BULL, V118, P58, DOI 10.1016/j.brainresbull.2015.09.004	38	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0164716	10.1371/journal.pone.0164716	http://dx.doi.org/10.1371/journal.pone.0164716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835635	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200002
J	Pace, E; Luo, H; Bobian, M; Panekkad, A; Zhang, XG; Zhang, HM; Zhang, JS				Pace, Edward; Luo, Hao; Bobian, Michael; Panekkad, Ajay; Zhang, Xueguo; Zhang, Huiming; Zhang, Jinsheng			A Conditioned Behavioral Paradigm for Assessing Onset and Lasting Tinnitus in Rats	PLOS ONE			English	Article							SALICYLATE-INDUCED TINNITUS; INDUCED HEARING-LOSS; TRAUMA-INDUCED TINNITUS; GAP DETECTION DEFICITS; ANIMAL-MODEL; ACOUSTIC TRAUMA; RECEPTOR AGONISTS; NEURAL ACTIVITY; NOISE; HYPERACUSIS	Numerous behavioral paradigms have been developed to assess tinnitus-like behavior in animals. Nevertheless, they are often limited by prolonged training requirements, as well as an inability to simultaneously assess onset and lasting tinnitus behavior, tinnitus pitch or duration, or tinnitus presence without grouping data from multiple animals or testing sessions. To enhance behavioral testing of tinnitus, we developed a conditioned licking suppression paradigm to determine the pitch(s) of both onset and lasting tinnitus-like behavior within individual animals. Rats learned to lick water during broadband or narrowband noises, and to suppress licking to avoid footshocks during silence. After noise exposure, rats significantly increased licking during silent trials, suggesting onset tinnitus-like behavior. Lasting tinnitus-behavior, however, was exhibited in about half of noise-exposed rats through 7 weeks post-exposure tested. Licking activity during narrowband sound trials remained unchanged following noise exposure, while ABR hearing thresholds fully recovered and were comparable between tinnitus((+)) and tinnitus((-)) rats. To assess another tinnitus inducer, rats were injected with sodium salicylate. They demonstrated high pitch tinnitus-like behavior, but later recovered by 5 days post-injection. Further control studies showed that 1): sham noise-exposed rats tested with footshock did not exhibit tinnitus-like behavior, and 2): noise-exposed or sham rats tested without footshocks showed no fundamental changes in behavior compared to those tested with shocks. Together, these results demonstrate that this paradigm can efficiently test the development of noise-and salicylate-induced tinnitus behavior. The ability to assess tinnitus individually, over time, and without averaging data enables us to realistically address tinnitus in a clinically relevant way. Thus, we believe that this optimized behavioral paradigm will facilitate investigations into the mechanisms of tinnitus and development of effective treatments.	[Pace, Edward; Luo, Hao; Bobian, Michael; Zhang, Xueguo; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4201 St Antoine, Detroit, MI 48201 USA; [Panekkad, Ajay] Wayne State Coll Engn, Dept Elect Engn, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA; [Zhang, Huiming] Univ Windsor, Dept Biol Sci, 401 Sunset Ave, Windsor, ON, Canada; [Zhang, Jinsheng] Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, 60 Farnsworth St, Detroit, MI 48202 USA	Wayne State University; University of Windsor; Wayne State University	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4201 St Antoine, Detroit, MI 48201 USA.; Zhang, JS (corresponding author), Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, 60 Farnsworth St, Detroit, MI 48202 USA.	jinzhang@med.wayne.edu	张, 锦胜/GXF-8167-2022; Zhang, Hui/HHN-8494-2022		Wayne State University Research funds;  [NIH5R21DC014335-02];  [NIH1R21DC014335-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC014335] Funding Source: NIH RePORTER	Wayne State University Research funds; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was partially supported by Wayne State University Research funds and NIH5R21DC014335-02.; The authors would like to thank Evan Hill for his valuable feedback during the early stages of developing this behavioral paradigm, and Nafi Yassar for helping us to develop the software used for behavioral testing. We would also like to thank Yiwen Zheng for her helpful comments on a previous version of this manuscript. This work was partially supported by Wayne State University Research funds and NIH1R21DC014335-01.	Adams P F, 1995, Vital Health Stat 10, P1; ATHERLEY GR, 1968, J ACOUST SOC AM, V44, P1503, DOI 10.1121/1.1911288; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064726; Berger JI, 2013, J NEUROSCI METH, V213, P188, DOI 10.1016/j.jneumeth.2012.12.023; Boyen K, 2015, EAR HEARING, V36, pe138, DOI 10.1097/AUD.0000000000000156; Brennan JF, 1991, ACTA NEUROBIOL EXP W, P12; Brozoski TJ, 2007, JARO-J ASSOC RES OTO, V8, P105, DOI 10.1007/s10162-006-0067-2; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; Chung JW, 2007, ANESTH ANALG, V104, P1404, DOI 10.1213/01.ane.0000261508.24083.6c; Dauman Nicolas, 2012, Int J Qual Stud Health Well-being, V7, P1, DOI 10.3402/qhw.v7i0.19540; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Granjeiro RC, 2013, OTOLARYNG HEAD NECK, V148, P658, DOI 10.1177/0194599812473554; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; Guitton MJ, 2003, J NEUROSCI, V23, P3944; HALLBERG LRM, 1993, BRIT J AUDIOL, V27, P19, DOI 10.3109/03005369309077885; Hayes SH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00179; Heffner HE, 2005, BEHAV NEUROSCI, V119, P734, DOI 10.1037/0735-7044.119.3.734; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-X; Heffner HE, 2012, BEHAV TESTS TINNITUS; Heffner HE, 2011, BEHAV RES METHODS, V43, P577, DOI 10.3758/s13428-011-0061-4; Heffner LE, 2012, BEHAV TESTS TINNITUS; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Hu SS, 2014, INFLAMMATION, V37, P365, DOI 10.1007/s10753-013-9748-2; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Kim JU, 2005, LARYNGOSCOPE, V115, P1996, DOI 10.1097/01.mlg.0000180173.81034.4d; Kim YH, 2016, LARYNGOSCOPE, V126, P447, DOI 10.1002/lary.25446; Kizawa K, 2010, NEUROSCIENCE, V165, P1323, DOI 10.1016/j.neuroscience.2009.11.048; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Lewis J E, 2002, J Am Acad Audiol, V13, P339; Liu XP, 2015, HEARING RES, V323, P51, DOI 10.1016/j.heares.2015.01.013; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lobarinas E, 2015, JARO-J ASSOC RES OTO, V16, P263, DOI 10.1007/s10162-014-0500-x; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; LOEB M, 1967, J ACOUST SOC AM, V42, P453, DOI 10.1121/1.1910600; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Mahmoudian S, 2012, J RES MED SCI, V17, P242; McFadden D., 1982, TINNITUS FACTS THEOR; Norman M, 2012, HEARING RES, V290, P64, DOI 10.1016/j.heares.2012.03.015; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Radziwon KE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00031; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Stolzberg D, 2013, J NEUROSCI METH, V219, P224, DOI 10.1016/j.jneumeth.2013.07.021; Stolzberg D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00028; Tan J, 2007, NEUROSCIENCE, V145, P715, DOI 10.1016/j.neuroscience.2006.11.067; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; USDoV Affairs, ANN BEN REP VET BEN; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zheng YW, 2015, EUR J PHARMACOL, V761, P206, DOI 10.1016/j.ejphar.2015.05.007; Zheng YW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00060; Zheng YW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/724195; Zheng Yiwen, 2012, Front Neurol, V3, P127; Zheng YW, 2010, HEARING RES, V268, P145, DOI 10.1016/j.heares.2010.05.015; Zheng Y, 2011, ACM T WEB, V5, DOI 10.1145/1921591.1921596	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166346	10.1371/journal.pone.0166346	http://dx.doi.org/10.1371/journal.pone.0166346			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835697	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200042
J	Storgaard, H; Gluud, LL; Bennett, C; Grondahl, MF; Christensen, MB; Knop, FK; Vilsboll, T				Storgaard, Heidi; Gluud, Lise L.; Bennett, Cathy; Grondahl, Magnus F.; Christensen, Mikkel B.; Knop, Filip K.; Vilsboll, Tina			Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INADEQUATE GLYCEMIC CONTROL; ADD-ON THERAPY; METFORMIN PLUS SULFONYLUREA; LONG-TERM EFFICACY; DIPEPTIDYL PEPTIDASE-4 INHIBITORS; LIVER-FUNCTION TESTS; DOUBLE-BLIND; JAPANESE PATIENTS; SGLT2 INHIBITOR; CARDIOVASCULAR-DISEASE	Objective Sodium-glucose co-transporter 2 inhibitors (SGLT2-i) are a novel drug class for the treatment of diabetes. We aimed at describing the maximal benefits and risks associated with SGLT2-i for patients with type 2 diabetes. Design Systematic review and meta-analysis. Data Sources and Study Selection We included double-blinded, randomised controlled trials (RCTs) evaluating SGLT2-i administered in the highest approved therapeutic doses (canagliflozin 300 mg/day, dapagliflozin 10 mg/day, and empagliflozin 25 mg/day) for >= 12 weeks. Comparison groups could receive placebo or oral antidiabetic drugs (OAD) including metformin, sulphonylureas (SU), or dipeptidyl peptidase 4 inhibitors (DPP-4-i). Trials were identified through electronic databases and extensive manual searches. Primary outcomes were glycated haemoglobin A1c (HbA1c) levels, serious adverse events, death, severe hypoglycaemia, ketoacidosis and CVD. Secondary outcomes were fasting plasma glucose, body weight, blood pressure, heart rate, lipids, liver function tests, creatinine and adverse events including infections. The quality of the evidence was assessed using GRADE. Results Meta-analysis of 34 RCTs with 9,154 patients showed that SGLT2-i reduced HbA1c compared with placebo (mean difference -0.69%, 95% confidence interval -0.75 to -0.62%). We downgraded the evidence to 'low quality' due to variability and evidence of publication bias (P = 0.015). Canagliflozin was associated with the largest reduction in HbA1c (-0.85%, -0.99% to -0.71%). There were no differences between SGLT2-i and placebo for serious adverse events. SGLT2-i increased the risk of urinary and genital tract infections and increased serum creatinine, and exerted beneficial effects on bodyweight, blood pressure, lipids and alanine aminotransferase (moderate to low quality evidence). Analysis of 12 RCTs found a beneficial effect of SGLT2-i on HbA1c compared with OAD (-0.20%, -0.28 to -0.13%; moderate quality evidence). Conclusion This review includes a large number of patients with type 2 diabetes and found that SGLT2-i reduces HbA1c with a notable increased risk in non-serious adverse events. The analyses may overestimate the intervention benefit due bias.	[Storgaard, Heidi; Grondahl, Magnus F.; Christensen, Mikkel B.; Knop, Filip K.; Vilsboll, Tina] Univ Copenhagen, Gentofte Hosp, Ctr Diabet Res, Hellerup, Denmark; [Gluud, Lise L.] Univ Copenhagen, Hvidovre Hosp, Gastrounit, Hvidovre, Denmark; [Bennett, Cathy] Coventry Univ, Ctr Technol Enabled Hlth Res, Coventry, W Midlands, England; [Christensen, Mikkel B.] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Knop, Filip K.; Vilsboll, Tina] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Knop, Filip K.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Coventry University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Storgaard, H (corresponding author), Univ Copenhagen, Gentofte Hosp, Ctr Diabet Res, Hellerup, Denmark.	Hstorgaard@dadlnet.dk	Christensen, Mikkel/H-5861-2013; Grøndahl, Magnus F.G./ABD-2052-2021; Bennett, Cathy/A-2386-2016; Knop, Filip K/GQI-2604-2022; Gluud, Lise L/AAY-2120-2020	Christensen, Mikkel/0000-0002-8774-1797; Grøndahl, Magnus F.G./0000-0001-6475-765X; Bennett, Cathy/0000-0002-9112-5698; Knop, Filip K/0000-0002-2495-5034; Gluud, Lise L/0000-0002-9462-4468; Storgaard, Heidi/0000-0003-1177-2658	YODA Project [2014-0340]; NNF Center for Basic Metabolic Research [Holst Group] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016230, NNF12OC1015904, NNF16OC0020224] Funding Source: researchfish	YODA Project; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study, carried out under YODA Project Protocol #:2014-0340, used data obtained from the Yale University Open Data Access Project, which has an agreement with Janssen Research and Development LLC. The interpretation and reporting of research using these data are solely the responsibility of the authors and does not necessarily represent the official views of the Yale University Open Data Access Project or Janssen Research and Development LLC. We sincerely thank Boehringer Ingelheim for provision of the additional data used in this systematic review. We sincerely thank Jennifer Sugg, formerly from AstraZeneca Delaware, USA and Katja Rohwedder, AstraZeneca Germany for providing additional data used in this review.	Ahmed Mohamed H, 2015, J Family Med Prim Care, V4, P45, DOI 10.4103/2249-4863.152252; [Anonymous], 2014, REV MAN REVMAN COMP; Bailey CJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-193; Bailey CJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-43; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Baker WL, 2014, J AM SOC HYPERTENS, V8, P262, DOI 10.1016/j.jash.2014.01.007; Berhan A, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-58; Bode B, 2015, DIABETES OBES METAB, V17, P294, DOI 10.1111/dom.12428; Bode Bruce, 2013, Hosp Pract (1995), V41, P72, DOI 10.3810/hp.2013.04.1020; Bolinder J, 2014, DIABETES OBES METAB, V16, P159, DOI 10.1111/dom.12189; Bolinder J, 2012, J CLIN ENDOCR METAB, V97, P1020, DOI 10.1210/jc.2011-2260; Cefalu WT, 2015, DIABETES CARE, V38, P1218, DOI 10.2337/dc14-0315; Cefalu WT, 2013, LANCET, V382, P941, DOI 10.1016/S0140-6736(13)60683-2; Childers K, 2014, ADDITIONAL DATA HDL; Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008; DeFronzo RA, 2015, DIABETES CARE, V38, P384, DOI 10.2337/dc14-2364; Del Prato S, 2015, DIABETES OBES METAB, V17, P581, DOI 10.1111/dom.12459; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; EMA, 2015, EUR MED AG ASS REP D; EMA, 2013, EMA7185312013; EMA, 2014, EMEAHC0026770000; Ferrannini E, 2013, DIABETES OBES METAB, V15, P721, DOI 10.1111/dom.12081; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Ferrannini E, 2013, DIABETES CARE, V36, P4015, DOI 10.2337/dc13-0663; Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243; Ferrannini E, 2010, DIABETES CARE, V33, P2217, DOI 10.2337/dc10-0612; Forst T, 2014, DIABETES OBES METAB, V16, P467, DOI 10.1111/dom.12273; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Goring S, 2014, DIABETES OBES METAB, V16, P433, DOI 10.1111/dom.12239; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Haering HU, 2015, DIABETES RES CLIN PR, V110, P82, DOI 10.1016/j.diabres.2015.05.044; Haring HU, 2014, DIABETES CARE, V37, P1650, DOI 10.2337/dc13-2105; Haring HU, 2013, DIABETES CARE, V36, P3396, DOI 10.2337/dc12-2673; Heerspink HJL, 2013, DIABETES OBES METAB, V15, P853, DOI 10.1111/dom.12127; Henry RR, 2012, INT J CLIN PRACT, V66, P446, DOI 10.1111/j.1742-1241.2012.02911.x; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inagaki N, 2013, DIABETES OBES METAB, V15, P1136, DOI 10.1111/dom.12149; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jabbour SA, 2014, DIABETES CARE, V37, P740, DOI 10.2337/dc13-0467; Ji LN, 2014, CLIN THER, V36, P84, DOI 10.1016/j.clinthera.2013.11.002; Jose P, 2006, J AM SOC NEPHROL, V17, P2886, DOI 10.1681/ASN.2006010063; Kadowaki T, 2014, ADV THER, V31, P621, DOI 10.1007/s12325-014-0126-8; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kaku K, 2014, DIABETES OBES METAB, V16, P1102, DOI 10.1111/dom.12325; Kaku K, 2013, DIABETES OBES METAB, V15, P432, DOI 10.1111/dom.12047; Kalra S, 2014, DIABETES THER, V5, P355, DOI 10.1007/s13300-014-0089-4; Kovacs CS, 2014, DIABETES OBES METAB, V16, P147, DOI 10.1111/dom.12188; Kovacs CS, 2015, CLIN THER, V37, P1773, DOI 10.1016/j.clinthera.2015.05.511; Laakso M, 2010, DIABETES CARE, V33, P442, DOI 10.2337/dc09-0749; Lavalle-Gonzalez FJ, 2013, DIABETOLOGIA, V56, P2582, DOI 10.1007/s00125-013-3039-1; Leiter LA, 2016, DIABETES METAB, V42, P25, DOI 10.1016/j.diabet.2015.10.003; Leiter LA, 2015, DIABETES CARE, V38, P355, DOI 10.2337/dc13-2762; Leiter LA, 2014, J AM GERIATR SOC, V62, P1252, DOI 10.1111/jgs.12881; Lewin A, 2015, DIABETES CARE, V38, P394, DOI 10.2337/dc14-2365; Liakos A, 2014, DIABETES OBES METAB, V16, P984, DOI 10.1111/dom.12307; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Liu H, 2014, WORLD J GASTROENTERO, V20, P8407, DOI 10.3748/wjg.v20.i26.8407; Ljunggren O, 2012, DIABETES OBES METAB, V14, P990, DOI 10.1111/j.1463-1326.2012.01630.x; Lund S, 2014, ADDITIONAL DATA LDL; Mathieu C, 2015, DIABETES CARE, V38, P2009, DOI 10.2337/dc15-0779; Matthaei S, 2015, DIABETES OBES METAB, V17, P1075, DOI 10.1111/dom.12543; Matthaei S, 2015, DIABETES CARE, V38, P365, DOI 10.2337/dc14-0666; Merker L, 2015, DIABETIC MED, V32, P1555, DOI 10.1111/dme.12814; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Nahrebne K, 2014, ASTRAZENECA PHARM; Nauck MA, 2014, DIABETES OBES METAB, V16, P1111, DOI 10.1111/dom.12327; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; Neal B, 2013, AM HEART J, V166, P217, DOI 10.1016/j.ahj.2013.05.007; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Raz I, 2016, MULTICENTER TRIAL EV; Ridderstrale M, 2014, LANCET DIABETES ENDO, V2, P691, DOI 10.1016/S2213-8587(14)70120-2; Ridderstrale M, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-129; Roden M, 2013, LANCET DIABETES ENDO, V1, P208, DOI 10.1016/S2213-8587(13)70084-6; Rosenstock J, 2015, DIABETES OBES METAB, V17, DOI 10.1111/dom.12503; Rosenstock J, 2013, DIABETES OBES METAB, V15, P1154, DOI 10.1111/dom.12185; Rosenstock J, 2015, DIABETES CARE, V38, P376, DOI 10.2337/dc14-1142; Rosenstock J, 2014, DIABETES CARE, V37, P1815, DOI 10.2337/dc13-3055; Rosenstock J, 2012, DIABETES CARE, V35, P1473, DOI 10.2337/dc11-1693; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Ross S, 2015, DIABETES OBES METAB, V17, P699, DOI 10.1111/dom.12469; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schernthaner G, 2013, DIABETES CARE, V36, P2508, DOI 10.2337/dc12-2491; Schunemann H., 2013, GRADE HDB GRADING QU; Shyangdan Deepson S, 2016, BMJ Open, V6, pe009417, DOI 10.1136/bmjopen-2015-009417; Singh AK, 2016, EXPERT REV CLIN PHAR, V9, P229, DOI 10.1586/17512433.2016.1123616; Sonesson C, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0356-y; Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054; Stenlof K, 2014, CURR MED RES OPIN, V30, P163, DOI 10.1185/03007995.2013.850066; Storgaard H, 2016, BASIC CLIN PHARMACOL, V118, P168, DOI 10.1111/bcpt.12457; Storgaard H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005378; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Strojek K, 2011, DIABETES OBES METAB, V13, P928, DOI 10.1111/j.1463-1326.2011.01434.x; Strojek K, 2014, DIABETES THER, V5, P267, DOI 10.1007/s13300-014-0072-0; Triplitt C, 2015, EXPERT OPIN PHARMACO, V16, P2819, DOI 10.1517/14656566.2015.1114098; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Wilding JPH, 2014, DIABETES OBES METAB, V16, P124, DOI 10.1111/dom.12187; Wilding JPH, 2013, INT J CLIN PRACT, V67, P1267, DOI 10.1111/ijcp.12322; Wilding JPH, 2012, ANN INTERN MED, V156, P405, DOI 10.7326/0003-4819-156-6-201203200-00003; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Wu JHY, 2016, LANCET DIABETES ENDO, V4, P411, DOI 10.1016/S2213-8587(16)00052-8; Yilmaz Y, 2010, WORLD J HEPATOL, V2, P143, DOI 10.4254/wjh.v2.i4.143; Yoon J, 2015, VALUE HEALTH, V18, pA599, DOI 10.1016/j.jval.2015.09.2050; Zaccardi F, 2016, DIABETES OBES METAB, V18, P783, DOI 10.1111/dom.12670; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	106	142	157	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166125	10.1371/journal.pone.0166125	http://dx.doi.org/10.1371/journal.pone.0166125			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835680	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200026
J	Anton-Sanchez, L; Bielza, C; Larranaga, P; DeFelipe, J				Anton-Sanchez, Laura; Bielza, Concha; Larranaga, Pedro; DeFelipe, Javier			Wiring Economy of Pyramidal Cells in the Juvenile Rat Somatosensory Cortex	PLOS ONE			English	Article							DENDRITIC STRUCTURE; NEURONS	Ever since Cajal hypothesized that the structure of neurons is designed in such a way as to save space, time and matter, numerous researchers have analyzed wiring properties at different scales of brain organization. Here we test the hypothesis that individual pyramidal cells, the most abundant type of neuron in the cerebral cortex, optimize brain connectivity in terms of wiring length. In this study, we analyze the neuronal wiring of complete basal arborizations of pyramidal neurons in layer II, Ill, IV, Va, Vb and VI of the hindlimb somatosensory cortical region of postnatal day 14 rats. For each cell, we search for the optimal basal arborization and compare its length with the length of the real dendritic structure. Here the optimal arborization is defined as the arborization that has the shortest total wiring length provided that all neuron bifurcations are respected and the extent of the dendritic arborizations remain unchanged. We use graph theory and evolutionary computation techniques to search for the minimal wiring arborizations. Despite morphological differences between pyramidal neurons located in different cortical layers, we found that the neuronal wiring is near-optimal in all cases (the biggest difference between the shortest synthetic wiring found for a dendritic arborization and the length of its real wiring was less than 5%). We found, however, that the real neuronal wiring was significantly closer to the best solution found in layers II, Ill and IV. Our studies show that the wiring economy of cortical neurons is related not to the type of neurons or their morphological complexities but to general wiring economy principles.	[Anton-Sanchez, Laura; Bielza, Concha; Larranaga, Pedro] Univ Politecn Madrid, Dept Inteligencia Artificial, Escuela Tecn Super Ingenieros Informat, Madrid, Spain; [DeFelipe, Javier] Univ Politecn Madrid, Lab Cajal Circuitos Corticales, Ctr Tecnol Biomed, Madrid, Spain; [DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Anton-Sanchez, L (corresponding author), Univ Politecn Madrid, Dept Inteligencia Artificial, Escuela Tecn Super Ingenieros Informat, Madrid, Spain.	l.anton-sanchez@upm.es	DEFELIPE, JAVIER/D-1195-2014; Bielza, Concha/F-9277-2013; Larranaga, Pedro/F-9293-2013	DEFELIPE, JAVIER/0000-0001-5484-0660; Bielza, Concha/0000-0001-7109-2668; Larranaga, Pedro/0000-0003-0652-9872; Anton-Sanchez, Laura/0000-0002-5556-1759	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain [C080020-09, TIN2013-41592-P]; Regional Government of Madrid [S2013/ICE-2845-CASI-CAM-CM]; European Union's Horizon 2020 research and innovation programme [720270]; Spanish MINECO scholarship at the Residencia de Estudiantes	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain(Spanish Government); Regional Government of Madrid; European Union's Horizon 2020 research and innovation programme; Spanish MINECO scholarship at the Residencia de Estudiantes	This work has been partially supported by the Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain (C080020-09; the Spanish partner of the EPFL's Blue Brain initiative) and TIN2013-41592-P projects, by the Regional Government of Madrid through the S2013/ICE-2845-CASI-CAM-CM project, and by the European Union's Horizon 2020 research and innovation programme under grant agreement No. 720270. LA-S acknowledges support from the Spanish MINECO scholarship at the Residencia de Estudiantes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thankfully acknowledge the computer resources, technical expertise and assistance provided by the Supercomputing and Visualization Center of Madrid (CeSViMa). The authors would like to thank Isabel Fernaud-Espinosa for her technical assistance. LA-S acknowledges support from the Spanish MINECO scholarship at the Residencia de Estudiantes.	Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anton-Sanchez L, 2016, NEUROINFORMATICS, V14, P453, DOI 10.1007/s12021-016-9309-6; Cajal SR, 1904, TEXTURA SISTEMA NERV, V2, P903; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Cuntz H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-21; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; Cuntz H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000251; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Elston G.N., 2007, P191; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Holland J.H., 1975, ADAPTATION NATURAL A; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Rojo C, 2015, EVOLUTIONARY COMPUTA; Rojo C, 2016, CEREB CORTEX, V26, P2811, DOI 10.1093/cercor/bhv316; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Syswerda G., 1991, FDN GENETIC ALGORITH, V1, P94, DOI DOI 10.1016/B978-0-08-050684-5.50009-4; Wen Q, 2008, J NEUROPHYSIOL, V99, P2320, DOI 10.1152/jn.00280.2007; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165915	10.1371/journal.pone.0165915	http://dx.doi.org/10.1371/journal.pone.0165915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832100	Green Published, gold, Green Accepted			2022-12-27	WOS:000387725000040
J	Heidmann, I; Schade-Kampmann, G; Lambalk, J; Ottiger, M; Di Berardino, M				Heidmann, Iris; Schade-Kampmann, Grit; Lambalk, Joep; Ottiger, Marcel; Di Berardino, Marco			Impedance Flow Cytometry: A Novel Technique in Pollen Analysis	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; HEAT-STRESS; CARBOHYDRATE CONCENTRATION; TOMATO POLLEN; VIABILITY; GERMINATION; EXPRESSION; FERTILITY; RESERVES; CALCIUM	Introduction An efficient and reliable method to estimate plant cell viability, especially of pollen, is important for plant breeding research and plant production processes. Pollen quality is determined by classical methods, like staining techniques or in vitro pollen germination, each having disadvantages with respect to reliability, analysis speed, and species dependency. Analysing single cells based on their dielectric properties by impedance flow cytometry (IFC) has developed into a common method for cellular characterisation in microbiology and medicine during the last decade. The aim of this study is to demonstrate the potential of IFC in plant cell analysis with the focus on pollen. Method Developing and mature pollen grains were analysed during their passage through a microfluidic chip to which radio frequencies of 0.5 to 12 MHz were applied. The acquired data provided information about the developmental stage, viability, and germination capacity. The biological relevance of the acquired IFC data was confirmed by classical staining methods, inactivation controls, as well as pollen germination assays. Results Different stages of developing pollen, dead, viable and germinating pollen populations could be detected and quantified by IFC. Pollen viability analysis by classical FDA staining showed a high correlation with IFC data. In parallel, pollen with active germination potential could be discriminated from the dead and the viable but non-germinating population. Conclusion The presented data demonstrate that IFC is an efficient, label-free, reliable and non-destructive technique to analyse pollen quality in a species-independent manner.	[Heidmann, Iris; Lambalk, Joep] Enza Zaden, Res & Dev BV, POB 7, NL-1600 AA Enkhuizen, Netherlands; [Schade-Kampmann, Grit; Ottiger, Marcel; Di Berardino, Marco] Amphasys AG, Technopk Lucerne, CH-6039 Root D4, Switzerland		Heidmann, I (corresponding author), Enza Zaden, Res & Dev BV, POB 7, NL-1600 AA Enkhuizen, Netherlands.	i.heidmann@enzazaden.nl	Heidmann, Iris/AAL-1293-2021	Heidmann, Iris/0000-0002-4389-2120	Enza Zaden; Amphasys	Enza Zaden; Amphasys	This study was jointly financed and conducted by Enza Zaden and Amphasys to develop a method to analyse pollen quality in a reliable and efficient way. Enza Zaden R&D B.V funded the project by providing the salaries for IH and JL and Amphasys funded its part by providing the salaries for GSK, MO, MDB. The companies approve the wish of the authors to publish but did not have any additional role in the study design,	Azzarello E., 2012, PLANT ELECTROPHYSIOL, P205, DOI [10.1007/978-3-642-29119-7_9, DOI 10.1007/978-3-642-29119-7_9]; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Cheung KC, 2010, CYTOM PART A, V77A, P648, DOI 10.1002/cyto.a.20910; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Dafni A, 2000, PLANT SYST EVOL, V222, P113, DOI 10.1007/BF00984098; David F, 2012, BIOTECHNOL BIOENG, V109, P483, DOI 10.1002/bit.23345; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; De Storme N, 2013, PLANT REPROD, V26, P65, DOI 10.1007/s00497-012-0209-0; DEBLOIS RW, 1970, REV SCI INSTRUM, V41, P909, DOI 10.1063/1.1684724; Demidov D, 2014, PLANT J, V80, P449, DOI 10.1111/tpj.12647; Fila J, 2016, MOL CELL PROTEOMICS, V15, P1338, DOI 10.1074/mcp.M115.051672; Firon N, 2006, SCI HORTIC-AMSTERDAM, V109, P212, DOI 10.1016/j.scienta.2006.03.007; Firon N, 2012, ANN BOT-LONDON, V109, P1201, DOI 10.1093/aob/mcs070; Franchi GG, 1996, FLORA, V191, P143; Garcia CC, 2007, GRANA, V46, P13, DOI 10.1080/00173130601179217; Garcia-Pardo C., 2016, PROC IEEE 27 ANN INT, P1, DOI DOI 10.1109/PIMRC.2016.7794780; Gawad S, 2001, LAB CHIP, V1, P76, DOI 10.1039/b103933b; Geng XM, 2013, GRANA, V52, P202, DOI 10.1080/00173134.2013.819033; Hansson J, 2011, INERTIAL PARTICLE FO, P1777; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; HECKER RJ, 1986, EUPHYTICA, V35, P777, DOI 10.1007/BF00028585; HERRERO MP, 1980, CROP SCI, V20, P796, DOI 10.2135/cropsci1980.0011183X002000060030x; Heslop-Harrison J. S., 1992, Sexual plant reproduction. Lectures presented on a course, University of Siena, Italy, 15 November to 2 December 1991., P41; HESLOPHARRISON J, 1979, AM J BOT, V66, P737, DOI 10.2307/2442418; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; Ischebeck T, 2014, MOL CELL PROTEOMICS, V13, P295, DOI 10.1074/mcp.M113.028100; ISSARAKRAISILA M, 1994, ANN BOT-LONDON, V73, P231, DOI 10.1006/anbo.1994.1028; Johnson SA, 2001, PLANT PHYSIOL, V126, P685, DOI 10.1104/pp.126.2.685; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Kelly JK, 2002, AM J BOT, V89, P1021, DOI 10.3732/ajb.89.6.1021; Khan MMR, 2013, SCI HORTIC-AMSTERDAM, V157, P39, DOI 10.1016/j.scienta.2013.04.010; Lang V, 2014, PROTOPLASMA, V251, P477, DOI 10.1007/s00709-013-0555-2; Maluszynski M., 2003, DOUBLED HAPLOID PROD; Maraschin SF, 2005, J EXP BOT, V56, P1711, DOI 10.1093/jxb/eri190; MATTON DP, 1994, P NATL ACAD SCI USA, V91, P1992, DOI 10.1073/pnas.91.6.1992; Muller F, 2016, PLANT REPROD, V29, P107, DOI 10.1007/s00497-016-0282-x; Orczyk W, 2003, PLANT CELL TISS ORG, V74, P1, DOI 10.1023/A:1023396405655; Otto F, 1990, Methods Cell Biol, V33, P105; Pacini E, 2006, PROTOPLASMA, V228, P73, DOI 10.1007/s00709-006-0169-z; Parrotta L, 2016, PLANTA, V243, P43, DOI 10.1007/s00425-015-2394-1; Pierzchalski A, 2012, LAB CHIP, V12, P4533, DOI 10.1039/c2lc40408g; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Rutley N, 2015, PLANT REPROD, V28, P73, DOI 10.1007/s00497-015-0261-7; Sabuncu AC, 2011, MICROFLUIDIC DEVICE; Schwacke R, 1999, PLANT CELL, V11, P377, DOI 10.1105/tpc.11.3.377; Sharma KD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00402; Shen YH, 2014, PHYSIOL PLANTARUM, V150, P425, DOI 10.1111/ppl.12085; Shivanna K. R., 1989, Sexual Plant Reproduction, V2, P137, DOI 10.1007/BF00192759; Song J, 2007, J EXP BOT, V58, P4235, DOI 10.1093/jxb/erm280; Song JJ, 2002, PLANT CELL PHYSIOL, V43, P619, DOI 10.1093/pcp/pcf078; Spencer D, 2016, LAB CHIP, V16, P2467, DOI 10.1039/c6lc00339g; Steinhorst L, 2013, BBA-MOL CELL RES, V1833, P1573, DOI 10.1016/j.bbamcr.2012.10.009; Towil L. E., 2010, PLANT BREED REV, V13, P179; Twell D, 2011, SEX PLANT REPROD, V24, P149, DOI 10.1007/s00497-010-0157-5; Vizintin L, 2004, ACTA BIOL CRACOV BOT, V46, P177; Volkov AG, 2012, PLANT ELECTROPHYSIOL; Wei DM, 2015, J AM SOC HORTIC SCI, V140, P356, DOI 10.21273/JASHS.140.4.356; Yafouz B, 2013, SENSORS-BASEL, V13, P9029, DOI 10.3390/s130709029; Zechmann B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-54; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	63	40	41	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165531	10.1371/journal.pone.0165531	http://dx.doi.org/10.1371/journal.pone.0165531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832091	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000017
J	Cherubin, P; Garcia, MC; Curtis, D; Britt, CBT; Craft, JW; Burress, H; Berndt, C; Reddy, S; Guyette, J; Zheng, TY; Huo, Q; Quinones, B; Briggs, JM; Teter, K				Cherubin, Patrick; Garcia, Maria Camila; Curtis, David; Britt, Christopher B. T.; Craft, John W., Jr.; Burress, Helen; Berndt, Chris; Reddy, Srikar; Guyette, Jessica; Zheng, Tianyu; Huo, Qun; Quinones, Beatriz; Briggs, James M.; Teter, Ken			Inhibition of Cholera Toxin and Other AB Toxins by Polyphenolic Compounds	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; INDUCED FLUID ACCUMULATION; ENDOPLASMIC-RETICULUM; SHIGA TOXIN; ADP-RIBOSYLTRANSFERASE; DEGRADATION PATHWAY; PLANT POLYPHENOLS; A1 POLYPEPTIDE; TARGET-CELLS; VERO CELLS	Cholera toxin (CT) is an AB-type protein toxin that contains a catalytic A1 subunit, an A2 linker, and a cell-binding B homopentamer. The CT holotoxin is released into the extracellular environment, but CTA1 attacks a target within the cytosol of a host cell. We recently reported that grape extract confers substantial resistance to CT. Here, we used a cell culture system to identify twelve individual phenolic compounds from grape extract that inhibit CT. Additional studies determined the mechanism of inhibition for a subset of the compounds: two inhibited CT binding to the cell surface and even stripped CT from the plasma membrane of a target cell; two inhibited the enzymatic activity of CTA1; and four blocked cytosolic toxin activity without directly affecting the enzymatic function of CTA1. Individual polyphenolic compounds from grape extract could also generate cellular resistance to diphtheria toxin, exotoxin A, and ricin. We have thus identified individual toxin inhibitors from grape extract and some of their mechanisms of inhibition against CT.	[Cherubin, Patrick; Garcia, Maria Camila; Curtis, David; Britt, Christopher B. T.; Burress, Helen; Berndt, Chris; Reddy, Srikar; Guyette, Jessica; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Craft, John W., Jr.; Briggs, James M.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Zheng, Tianyu; Huo, Qun] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Zheng, Tianyu; Huo, Qun] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Quinones, Beatriz] USDA ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, Albany, CA USA; [Curtis, David] Valencia Coll, Orlando, FL USA	State University System of Florida; University of Central Florida; University of Houston System; University of Houston; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; United States Department of Agriculture (USDA)	Teter, K (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	kteter@mail.ucf.edu		Briggs, James/0000-0001-5863-8945; Cherubin, Patrick/0000-0002-3567-836X; Craft, John/0000-0002-5679-5629; Quinones, Beatriz/0000-0001-5010-9889; Teter, Ken/0000-0003-4176-9361	U.S. Department of Agriculture, Agricultural Research Service [2030-42000-051-00D, 58-5325-4-024]; ARS [ARS-0430420] Funding Source: Federal RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This material is based upon work supported by the U.S. Department of Agriculture, Agricultural Research Service (www.ars.usda.gov/)-CRIS project no. 2030-42000-051-00D under the Non-Assistance Cooperative Agreement (NACA) no. 58-5325-4-024 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee T, 2014, MOL MICROBIOL, V94, P898, DOI 10.1111/mmi.12807; Barth H, 2011, N-S ARCH PHARMACOL, V383, P237, DOI 10.1007/s00210-010-0581-y; Brijesh S, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-47; Burress H, 2014, J BIOL CHEM, V289, P33644, DOI 10.1074/jbc.M114.609800; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Cho JA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00051; Choi O, 2007, MICROB PATHOGENESIS, V42, P215, DOI 10.1016/j.micpath.2007.01.007; Friedman M, 2014, J AGR FOOD CHEM, V62, P6025, DOI 10.1021/jf501266s; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; Jobling MG, 2015, TOXINS, V7, P919, DOI 10.3390/toxins7030919; Kimura R, 2000, APPL ENVIRON MICROB, V66, P2513, DOI 10.1128/AEM.66.6.2513-2519.2000; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2011, METHODS MOL BIOL, V739, P49, DOI 10.1007/978-1-61779-102-4_5; Miyamoto T, 2014, FOOD CONTROL, V42, P263, DOI 10.1016/j.foodcont.2014.02.017; Morinaga N, 2005, J BIOL CHEM, V280, P23303, DOI 10.1074/JBC.M502093200; Morinaga N, 2010, TOXICON, V56, P29, DOI 10.1016/j.toxicon.2010.03.009; Muanprasat C, 2013, FUTURE MED CHEM, V5, P781, DOI [10.4155/FMC.13.42, 10.4155/fmc.13.42]; Murphy JR, 2011, TOXINS, V3, P294, DOI 10.3390/toxins3030294; Oi H, 2002, P NATL ACAD SCI USA, V99, P3042, DOI 10.1073/pnas.052709499; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Quinones B, 2009, APPL ENVIRON MICROB, V75, P1410, DOI 10.1128/AEM.02230-08; Ray S, 2012, J BIOL CHEM, V287, P30395, DOI 10.1074/jbc.M112.385575; Reddy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073390; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Saha P, 2013, ANTIMICROB AGENTS CH, V57, P4373, DOI 10.1128/AAC.00122-13; Saito T, 2002, MICROBIOL IMMUNOL, V46, P249, DOI 10.1111/j.1348-0421.2002.tb02693.x; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; Seal BS, 2013, ANIM HEALTH RES REV, V14, P78, DOI 10.1017/S1466252313000030; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shi John, 2003, Journal of Medicinal Food, V6, P291, DOI 10.1089/109662003772519831; SOMAN G, 1986, BIOCHEMISTRY-US, V25, P4113, DOI 10.1021/bi00362a019; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Taylor M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003925; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K., 2013, MOONLIGHTING CELL ST, P323; Teter K, 2013, BIOMOLECULES, V3, P997, DOI 10.3390/biom3040997; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Verhelst R, 2013, VET MICROBIOL, V163, P319, DOI 10.1016/j.vetmic.2012.12.039; Wallace RJ, 2010, BRIT POULTRY SCI, V51, P461, DOI 10.1080/00071668.2010.506908; WELSH CF, 1994, MOL CELL BIOCHEM, V138, P157, DOI 10.1007/BF00928458; Windisch W, 2008, J Anim Sci, V86, pE140; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yoshino N, 2009, VACCINE, V27, P4808, DOI 10.1016/j.vaccine.2009.05.081	45	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166477	10.1371/journal.pone.0166477	http://dx.doi.org/10.1371/journal.pone.0166477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829022	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300110
J	Imran, M; Tang, K; Liu, JY				Imran, Muhammad; Tang, Kai; Liu, Jin-Yuan			Comparative Genome-Wide Analysis of the Malate Dehydrogenase Gene Families in Cotton	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FIBER; ARABIDOPSIS; GROWTH; PLANT; EXPRESSION; NAD; MECHANISMS; ISOENZYMES; OXIDATION	Malate dehydrogenases (MDHs) play crucial roles in the physiological processes of plant growth and development. In this study, 13 and 25 MDH genes were identified from Gossypium raimondii and Gossypium hirsutum, respectively. Using these and 13 previously reported Gossypium arboretum MDH genes, a comparative molecular analysis between identified MDH genes from G. raimondii, G. hirsutum, and G. arboretum was performed. Based on multiple sequence alignments, cotton MDHs were divided into five subgroups: mitochondrial MDH, peroxisomal MDH, plastidial MDH, chloroplastic MDH and cytoplasmic MDH. Almost all of the MDHs within the same subgroup shared similar gene structure, amino acid sequence, and conserved motifs in their functional domains. An analysis of chromosomal localization suggested that segmental duplication played a major role in the expansion of cotton MDH gene families. Additionally, a selective pressure analysis indicated that purifying selection acted as a vital force in the evolution of MDH gene families in cotton. Meanwhile, an expression analysis showed the distinct expression profiles of GhMDHs in different vegetative tissues and at different fiber developmental stages, suggesting the functional diversification of these genes in cotton growth and fiber development. Finally, a promoter analysis indicated redundant but typical cis-regulatory elements for the potential functions and stress activity of many MDH genes. This study provides fundamental information for a better understanding of cotton MDH gene families and aids in functional analyses of the MDH genes in cotton fiber development.	[Imran, Muhammad; Tang, Kai; Liu, Jin-Yuan] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing 100084, Peoples R China	Tsinghua University	Liu, JY (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing 100084, Peoples R China.	liujy@mail.tsinghua..edu.cn	Imran, Muhammad/AEK-4305-2022	Imran, Muhammad/0000-0001-7552-8326	National Transgenic Animals and Plants Research Project [2011ZX08005-003, 2011ZX08009-003]	National Transgenic Animals and Plants Research Project	This work was supported by grants from the National Transgenic Animals and Plants Research Project (2011ZX08005-003 and 2011ZX08009-003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya T, 2006, PLANTA, V223, P1272, DOI 10.1007/s00425-005-0176-x; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Basra AS, 1999, GROWTH REGULATION CO, P47; Beeler S, 2014, PLANT PHYSIOL, V164, P1175, DOI 10.1104/pp.113.233866; BIRKTOFT JJ, 1983, J BIOL CHEM, V258, P472; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Cao XF, 2015, SCI CHINA LIFE SCI, V58, P515, DOI 10.1007/s11427-015-4862-z; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Chi YH, 2011, DNA RES, V18, P1, DOI 10.1093/dnares/dsq031; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Cosgrove DJ, 1997, PLANTA, V203, pS130, DOI 10.1007/PL00008101; Cronn RC, 1999, P NATL ACAD SCI USA, V96, P14406, DOI 10.1073/pnas.96.25.14406; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DHINDSA RS, 1975, PLANT PHYSIOL, V56, P394, DOI 10.1104/pp.56.3.394; Ding Y, 2004, BIOCHIMIE, V86, P509, DOI 10.1016/j.biochi.2004.07.011; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferguson DL, 1996, J AGR FOOD CHEM, V44, P4022, DOI 10.1021/jf9602028; Fricke W, 2006, PLANT CELL MONOGR, P7; GIETL C, 1982, PLANT PHYSIOL, V70, P483, DOI 10.1104/pp.70.2.483; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Hebbelmann I, 2012, J EXP BOT, V63, P1445, DOI 10.1093/jxb/err386; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imran M, 2016, PAK J BOT, V48, P1081; JOURNET EP, 1981, PLANT PHYSIOL, V67, P467, DOI 10.1104/pp.67.3.467; Kim Yu Jin, 2008, [KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 한국약용작물학회지], V16, P261; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li QF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01180; Li W, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00732; Li XR, 2010, J EXP BOT, V61, P287, DOI 10.1093/jxb/erp299; Liu FL, 2005, PLANT PHYSIOL, V137, P1115, DOI 10.1104/pp.104.055475; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGO GP, 1969, P NATL ACAD SCI USA, V62, P104, DOI 10.1073/pnas.62.1.104; Martin C, 2010, PLANT PHYSIOL, V154, P506, DOI 10.1104/pp.110.161331; Menckhoff L, 2013, J PROTEOMICS, V80, P66, DOI 10.1016/j.jprot.2012.12.015; Musrati RA, 1998, GEN PHYSIOL BIOPHYS, V17, P193; NICHOLLS DJ, 1992, BIOCHEM BIOPH RES CO, V189, P1057, DOI 10.1016/0006-291X(92)92311-K; Nunes-Nesi A, 2005, PLANT PHYSIOL, V137, P611, DOI 10.1104/pp.104.055566; Pracharoenwattana I, 2007, PLANT J, V50, P381, DOI 10.1111/j.1365-313X.2007.03055.x; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Seagull R. W., 2004, Journal of Cotton Science, V8, P105; Selinski J, 2014, MOL PLANT, V7, P170, DOI 10.1093/mp/sst151; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tesfaye M, 2001, PLANT PHYSIOL, V127, P1836, DOI 10.1104/pp.010376; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todeschini AL, 2014, TRENDS GENET, V30, P211, DOI 10.1016/j.tig.2014.04.002; Tomaz T, 2010, PLANT PHYSIOL, V154, P1143, DOI 10.1104/pp.110.161612; Tripathi AK, 2004, EUR J BIOCHEM, V271, P3488, DOI 10.1111/j.1432-1033.2004.04281.x; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang ZA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10343; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Weiner J, 2006, FEBS J, V273, P2037, DOI 10.1111/j.1742-4658.2006.05220.x; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; Xiao YH, 2010, J PLANT PHYSIOL, V167, P829, DOI 10.1016/j.jplph.2010.01.003; Yao YX, 2011, PLANT PHYSIOL BIOCH, V49, P257, DOI 10.1016/j.plaphy.2010.12.009; YUEH AY, 1989, BIOCHEM J, V258, P221, DOI 10.1042/bj2580221; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	79	12	13	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166341	10.1371/journal.pone.0166341	http://dx.doi.org/10.1371/journal.pone.0166341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829020	gold, Green Submitted, Green Published			2022-12-27	WOS:000387724300106
J	Pal, K; Ngin, C; Tuot, S; Chhoun, P; Ly, C; Chhim, S; Luong, MA; Tatomir, B; Yi, SY				Pal, Khuondyla; Ngin, Chanrith; Tuot, Sovannary; Chhoun, Pheak; Ly, Cheaty; Chhim, Srean; Minh-Anh Luong; Tatomir, Brent; Yi, Siyan			Acceptability Study on HIV Self-Testing among Transgender Women, Men who Have Sex with Men, and Female Entertainment Workers in Cambodia: A Qualitative Analysis	PLOS ONE			English	Article							FEASIBILITY	Background In Cambodia, HIV prevalence is high while HIV testing rates remain low among transgender women (TG women), men who have sex with men (MSM), and female entertainment workers (FEW). Introducing self-testing for HIV to these key populations (KPs) could potentially overcome the under-diagnosis of HIV and significantly increase testing rates and receipt of the results, and thus could decrease transmission. Therefore, this study aimed to determine the acceptability of HIV self-testing (HIVST) among these three categories of KPs. Methods This study was conducted through focus group discussions (FGDs) with TG women, MSM, and FEW in Phnom Penh city, Kampong Cham, Battambang, and Siem Reap provinces of Cambodia. Convenience sampling was used to recruit the participants. Two FGDs (six participants in each FGD) were conducted in each target group in each study site, totaling 24 FGDs (144 participants). Thematic analysis was performed to identify common or divergent patterns across the target groups. Results Almost all participants among the three groups (TG women, MSM, and FEW) had not heard about HIVST, but all of them expressed willingness to try it. They perceived HIVST as confidential, convenient, time-saving, and high-tech. Barriers to obtaining HIVST included cost, access, administration technique, embarrassment, and fear of pain. The majority preferred counseling before and after testing. Conclusions Participants showed high willingness to use and acceptability of HIVST due to its confidentiality/privacy and convenience even if it is not linked to a confirmatory test or care and treatment. Notwithstanding, to increase HIVST, the target groups would need affordable self-test kits, education about how to perform HIVST and read results, assurance about accuracy and reliability of HIVST, and provision of post-test counseling and facilitation of linkage to care and treatment.	[Pal, Khuondyla; Ngin, Chanrith; Tuot, Sovannary; Chhoun, Pheak; Yi, Siyan] KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia; [Minh-Anh Luong; Tatomir, Brent; Yi, Siyan] Touro Univ Calif, Publ Hlth Program, Ctr Global Hlth Res, Vallejo, CA USA; [Ly, Cheaty] PSK, Phnom Penh, Cambodia; [Chhim, Srean] FHI 360, Phnom Penh, Cambodia	Touro University California	Pal, K (corresponding author), KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia.	pkhuondyla@khana.org.kh	Chhoun, Pheak/AAR-3361-2021; Chhim, Srean/E-8829-2016	Chhoun, Pheak/0000-0001-6369-0190; Chhim, Srean/0000-0003-1558-1875	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was supported by the United States Agency for International Development (USAID). The funder had no role in study design, data collection and analysis, decisioin to publish, or preparation of the manuscript.; This study was supported by the United States Agency for International Development (USAID). The authors thank KHANA's senior management for their guidance and support. We gratefully acknowledge the support from our research assistants, implementing partners, outreach workers, and the participants in the data collection and provision.	Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Campbell CH, 1997, AIDS EDUC PREV, V9, P92; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P512; Rosales-Statkus ME, 2014, ENFERM INFEC MICR CL, V32, P302, DOI 10.1016/j.eimc.2013.12.004; Figueroa C, 2015, AIDS BEHAV; Gaydos CA, 2011, ANN EMERG MED, V58, pS74, DOI 10.1016/j.annemergmed.2011.03.029; HIV/AIDS,, 2014, 90 90 90 AMB TREATM; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Joint United Nations Programme on HIV/AIDS (UNAIDS) & the National AIDS Authority (NAA), 2015, CAMB COUNTR PROGR RE; Kassler WJ, 1998, INT J STD AIDS, V9, P134, DOI 10.1258/0956462981921882; Katz DA, 2012, 19 C RETR OPP INF MA; Keenan PA, 2005, POSTGRAD MED, V117, P47, DOI 10.3810/pgm.2005.03.1600; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; Menard D, 2005, J VIROL METHODS, V126, P75, DOI 10.1016/j.jviromet.2005.01.023; National Center for HIV/AIDS Dermatology and STD (NCHADS) & KHANA, NAT POP SIZ EST HIV; Pai NP, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/747619; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Phalkun M, 2013, BEHAV SENTINEL SURVE; Spielberg F, 1996, ANN INTERN MED, V125, P509, DOI 10.7326/0003-4819-125-6-199609150-00014; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; World Health Organisation, 2013, WHO CONS GUID US ANT; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	23	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166129	10.1371/journal.pone.0166129	http://dx.doi.org/10.1371/journal.pone.0166129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829064	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300086
J	Hou, Y; Hossain, GS; Li, JH; Shin, HD; Liu, L; Du, GC; Chen, J				Hou, Ying; Hossain, Gazi Sakir; Li, Jianghua; Shin, Hyun-dong; Liu, Long; Du, Guocheng; Chen, Jian			Two-Step Production of Phenylpyruvic Acid from L-Phenylalanine by Growing and Resting Cells of Engineered Escherichia coli: Process Optimization and Kinetics Modeling	PLOS ONE			English	Article							ALPHA-KETO ACIDS; SUBSTRATE-INHIBITION; PROTEUS-MIRABILIS; AMINO-ACIDS; BIOTRANSFORMATION; DEAMINASE; OXIDASE; FERMENTATION; TRANSFORMATION; DEHYDROGENASE	Phenylpyruvic acid (PPA) is widely used in the pharmaceutical, food, and chemical industries. Here, a two-step bioconversion process, involving growing and resting cells, was established to produce PPA from L-phenylalanine using the engineered Escherichia coli constructed previously. First, the biotransformation conditions for growing cells were optimized (L-phenylalanine concentration 20.0 g.L-1, temperature 35 degrees C) and a two-stage temperature control strategy (keep 20 degrees C for 12 h and increase the temperature to 35 degrees C until the end of biotransformation) was performed. The biotransformation conditions for resting cells were then optimized in 3-L bioreactor and the optimized conditions were as follows: agitation speed 500 rpm, aeration rate 1.5 vvm, and L-phenylalanine concentration 30 g.L-1. The total maximal production (mass conversion rate) reached 29.8 +/- 2.1 g.L-1 (99.3%) and 75.1 +/- 2.5 g.L-1 (93.9%) in the flask and 3-L bioreactor, respectively. Finally, a kinetic model was established, and it was revealed that the substrate and product inhibition were the main limiting factors for resting cell biotransformation.	[Hou, Ying; Hossain, Gazi Sakir; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Peoples R China; [Hou, Ying; Hossain, Gazi Sakir; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology	Liu, L; Du, GC (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Peoples R China.; Liu, L; Du, GC (corresponding author), Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Peoples R China.	longliu@jiangnan.edu.cn; gcdu@jiangnan.edu.cn	Hossain, Gazi Sakir/AAE-5391-2020; li, jianghua/GXG-4735-2022		863 Program [2014AA021200, 2014AA021201]; 111 project [11-2-06]; Fundamental Research Funds for the Central Universities [JUSRP51612A]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021201] Funding Source: NIH RePORTER	863 Program(National High Technology Research and Development Program of China); 111 project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is financially supported by the 863 Program (2014AA021200, 2014AA021201), 111 project (11-2-06) and the Fundamental Research Funds for the Central Universities (JUSRP51612A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the 863 Program (2014AA021200, 2014AA021201).	ALVAREZ-COHEN L, 1991, APPL ENVIRON MICROB, V57, P1031, DOI 10.1128/AEM.57.4.1031-1037.1991; Aymard C, 2000, ENZYME MICROB TECH, V27, P612, DOI 10.1016/S0141-0229(00)00258-1; Binay B, 2007, APPL BIOCHEM BIOTECH, V141, P265, DOI 10.1007/BF02729067; Canovas M, 2002, BIOTECHNOL BIOENG, V77, P764, DOI 10.1002/bit.10157; Carballeira JD, 2009, BIOTECHNOL ADV, V27, P686, DOI 10.1016/j.biotechadv.2009.05.001; Chen C, 2014, APPL ENVIRON MICROB, V80, P3992, DOI 10.1128/AEM.00215-14; CHITNIS A, 1989, BIOTECHNOL BIOENG, V34, P804, DOI 10.1002/bit.260340610; Coban HB, 2016, ACTA ALIMENT HUNG, V45, P1, DOI 10.1556/066.2016.45.1.1; Coban HB, 2016, PREP BIOCHEM BIOTECH, V46, P157, DOI 10.1080/10826068.2014.995813; Coban HB, 2014, BIOPROC BIOSYST ENG, V37, P2343, DOI 10.1007/s00449-014-1212-7; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; des Abbayes H, 2003, DALTON T, P1041, DOI 10.1039/b209103h; Fernandez-Lafuente R, 1998, ENZYME MICROB TECH, V23, P28, DOI 10.1016/S0141-0229(98)00028-3; Geueke B, 2002, ENZYME MICROB TECH, V31, P77, DOI 10.1016/S0141-0229(02)00072-8; Grishko VV, 2013, PROCESS BIOCHEM, V48, P1640, DOI 10.1016/j.procbio.2013.08.012; Hossain GS, 2014, APPL MICROBIOL BIOT, V98, P1507, DOI 10.1007/s00253-013-5444-2; Hou Y, 2016, APPL MICROBIOL BIOT, V100, P2183, DOI 10.1007/s00253-015-7048-5; Hou Y, 2015, APPL MICROBIOL BIOT, V99, P8391, DOI 10.1007/s00253-015-6757-0; Huang WC, 2006, BIOCHEM ENG J, V32, P239, DOI 10.1016/j.bej.2006.10.011; Lang YJ, 2011, EXTREMOPHILES, V15, P303, DOI 10.1007/s00792-011-0360-9; Leese C, 2013, J MOL CATAL B-ENZYM, V85-86, P17, DOI 10.1016/j.molcatb.2012.07.008; Li XF, 2007, BIOTECHNOL LETT, V29, P593, DOI 10.1007/s10529-006-9275-4; Liu L, 2013, J BIOTECHNOL, V164, P97, DOI 10.1016/j.jbiotec.2013.01.005; Liu T, 2013, PROCESS BIOCHEM, V48, P103, DOI 10.1016/j.procbio.2012.11.018; MASSAD G, 1995, J BACTERIOL, V177, P5878, DOI 10.1128/jb.177.20.5878-5883.1995; Pantaleone DP, 2001, J MOL CATAL B-ENZYM, V11, P795, DOI 10.1016/S1381-1177(00)00155-7; Silberbach M, 2003, APPL MICROBIOL BIOT, V62, P92, DOI 10.1007/s00253-003-1222-x; Tobajas M, 2007, BIOCHEM ENG J, V35, P218, DOI 10.1016/j.bej.2007.01.017; Tsuge Y, 2014, APPL MICROBIOL BIOT, V98, P4911, DOI 10.1007/s00253-014-5594-x; Upadhya R, 1999, PROCESS BIOCHEM, V35, P7, DOI 10.1016/S0032-9592(99)00025-4; VILLABLANCA M, 1987, BIOCHIM BIOPHYS ACTA, V926, P224, DOI 10.1016/0304-4165(87)90207-8; Xudong S, 2009, CHINESE J CHEM ENG, V17, P822; Zhang CZ, 2014, FEMS MICROBIOL LETT, V353, P11, DOI 10.1111/1574-6968.12397; Zhang Y, 2012, APPL MICROBIOL BIOT, V94, P1619, DOI 10.1007/s00253-012-3868-8	34	5	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166457	10.1371/journal.pone.0166457	http://dx.doi.org/10.1371/journal.pone.0166457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851793	gold, Green Submitted, Green Published			2022-12-27	WOS:000387909300052
J	Willen, RM; Granhag, PA; Stromwall, LA				Willen, Rebecca M.; Granhag, Par Anders; Stromwall, Leif A.			Factors Affecting Two Types of Memory Specificity: Particularization of Episodes and Details	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; RECURRING EVENTS; SEXUAL-ABUSE; RECALL; INTERVIEW; VIOLENCE; WITNESS; HISTORY	Memory for repeated events is relevant to legal investigations about repeated occurrences. We investigated how two measures of specificity (number of events referred to and amount of detail reported about the events) were influenced by interviewees' age, number of experienced events, interviewer, perceived unpleasantness, and memory rehearsal. Transcribed narratives consisting of over 40.000 utterances from 95 dental patients, and the corresponding dental records, were studied. Amount of detail was measured by categorizing the utterances as generic, specific, or specific-extended. We found that the two measures were affected differently by all five factors. For instance, number of experienced events positively influenced number of referred events but had no effect on amount of detail provided about the events. We make suggestions for future research and encourage reanalysis of the present data set and reuse of the material.	[Willen, Rebecca M.] Univ Gothenburg, Globally Distributed Inst Open Res & Educ, IGDORE, Gothenburg, Sweden; [Granhag, Par Anders; Stromwall, Leif A.] Univ Gothenburg, Dept Psychol, Gothenburg, Sweden; [Granhag, Par Anders] Norwegian Police Univ Coll, Oslo, Norway	University of Gothenburg; University of Gothenburg; Norwegian Police University College	Willen, RM (corresponding author), Univ Gothenburg, Globally Distributed Inst Open Res & Educ, IGDORE, Gothenburg, Sweden.	rebecca.willen@igdore.org	Strömwall, Leif A/H-3984-2011; Willén, Rebecca M./H-7814-2019	Strömwall, Leif A/0000-0002-3039-0252; Willén, Rebecca M./0000-0002-7651-9365	Swedish Crime Victim and Support Authority [252107824]	Swedish Crime Victim and Support Authority	This research was financed by The Swedish Crime Victim and Support Authority (Grant No 252107824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank The Public Dental Care in the Region of Vastra Gotaland, District South; special thanks to the director Anders Ljungne. In addition, we thank Daniel Berntsson for creative programming, all coders and transcribers, and the respondents who enabled the study. This research was financed by The Swedish Crime Victim and Support Authority (Grant No 252107824), and approved by the Regional Ethical Review Board, University of Gothenburg, Sweden (No 1007-11).	Brubacher SP, 2014, PSYCHOL PUBLIC POL L, V20, P325, DOI 10.1037/law0000011; Brubacher SP, 2014, CHILD ABUSE NEGLECT, V38, P202, DOI 10.1016/j.chiabu.2013.06.010; COHEN G, 1995, APPL COGNITIVE PSYCH, V9, P273, DOI 10.1002/acp.2350090402; Cohen J., 1988, STAT POWER ANAL BEHA; Connolly DA, 2006, LAW HUMAN BEHAV, V30, P409, DOI 10.1007/s10979-006-9011-6; Fisher RP, 1992, MEMORY ENHANCING TEC; Gosse LL, 2014, J POLICE CRIM PSYCHO, V29, P36, DOI 10.1007/s11896-013-9118-x; Guadagno BL, 2009, POLICE PRACT RES, V10, P61, DOI 10.1080/15614260802128468; HUDSON JA, 1992, APPL COGNITIVE PSYCH, V6, P483, DOI 10.1002/acp.2350060604; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; JOHNSON MP, 1995, J MARRIAGE FAM, V57, P283, DOI 10.2307/353683; Leins DA, 2014, APPL COGNITIVE PSYCH, V28, P926, DOI 10.1002/acp.3041; Linton M., 1975, EXPLORATIONS COGNITI, P376; MEANS B, 1991, APPL COGNITIVE PSYCH, V5, P297, DOI 10.1002/acp.2350050402; Means B., 1989, VITAL HLTH STAT, V6, P1; NEISSER U, 1981, COGNITION, V9, P1, DOI 10.1016/0010-0277(81)90011-1; Orbach Y, 2001, CHILD ABUSE NEGLECT, V25, P1427, DOI 10.1016/S0145-2134(01)00283-6; Powell M., 2007, CURRENT ISSUES CRIMI, V19, P64, DOI [10.1080/10345329.2007.12036415, DOI 10.1080/10345329.2007.12036415]; Powell MB, 1999, DEV PSYCHOL, V35, P1462, DOI 10.1037/0012-1649.35.6.1462; Rivard JR, 2014, APPL COGNITIVE PSYCH, V28, P917, DOI 10.1002/acp.3026; Roberts KP, 2001, CHILD ABUSE NEGLECT, V25, P1643, DOI 10.1016/S0145-2134(01)00290-3; Schank RC., 1977, SCRIPTS PLANS GOALS; Serrano JP, 2007, INT J CLIN HLTH PSYC, V7, P41; Sharman S.J., 2011, INT J POLICE SCI MAN, V13, P234, DOI [https://doi.org/10.1350/ijps.2011.13.3.243, DOI 10.1350/IJPS.2011.13.3.243]; Surprenant A. M., 2009, PRINCIPLES MEMORY; THOMPSON CP, 1991, APPL COGNITIVE PSYCH, V5, P497, DOI 10.1002/acp.2350050605; Willen RM, 2015, SCAND J PSYCHOL, V56, P28, DOI 10.1111/sjop.12180; Willen RM, 2015, J OPEN PSYCHOL DATA, V3, pe7; Willen RM, 2016, DATABASE OPEN SCI FR; Willen RM, 2015, DATABASE OPEN SCI FR; WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166469	10.1371/journal.pone.0166469	http://dx.doi.org/10.1371/journal.pone.0166469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851775	gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300054
J	Zeng, XL; Pan, YQ; Zhou, H; Yu, S; Liu, XP				Zeng, Xianglong; Pan, Yiqin; Zhou, Han; Yu, Shi; Liu, Xiangping			Exploring Different Patterns of Love Attitudes among Chinese College Students	PLOS ONE			English	Article							SEXUAL ATTITUDES; LOVING STYLES; PERSONALITY; BELIEFS; SCALE	Individual differences in love attitudes and the relationship between love attitudes and other variables in Asian culture lack in-depth exploration. This study conducted cluster analysis with data regarding love attitudes obtained from 389 college students in mainland China. The result of cluster analysis based on love-attitude scales distinguished four types of students: game players, rational lovers, emotional lovers, and absence lovers. These four groups of students showed significant differences in sexual attitudes and personality traits of deliberation and dutifulness but not self-discipline. The study's implications for future studies on love attitudes in certain cultural groups were also discussed.	[Zeng, Xianglong; Pan, Yiqin; Zhou, Han; Yu, Shi; Liu, Xiangping] Beijing Normal Univ, Dept Psychol, Beijing, Peoples R China	Beijing Normal University	Liu, XP (corresponding author), Beijing Normal Univ, Dept Psychol, Beijing, Peoples R China.	Ixp599e@163.com	ZENG, Xianglong/A-1905-2014; Pan, Yiqin/GSN-3496-2022	ZENG, Xianglong/0000-0002-4793-7146; 	Tsinghua University [0020344]	Tsinghua University	This work was supported by the Tsinghua University, Grant number:0020344 to XL. The funder had roles in study design, decision to publish and preparation of the manuscript.	ADLER NL, 1991, J COUNS DEV, V70, P302, DOI 10.1002/j.1556-6676.1991.tb01601.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Berscheid E., 1974, ADV EXPT SOCIAL PSYC, V7, P157, DOI DOI 10.1016/S0065-2601(08)60037-4; BORGEN FH, 1987, J COUNS PSYCHOL, V34, P456, DOI 10.1037/0022-0167.34.4.456; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; [曹慧 CAO Hui], 2007, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V16, P930; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DION KK, 1993, J SOC ISSUES, V49, P53, DOI 10.1111/j.1540-4560.1993.tb01168.x; Ferrer V. A., 2009, PSYCHOL SPAIN, V13, P40; Goodwin R, 1997, PERS RELATIONSHIP, V4, P85, DOI 10.1111/j.1475-6811.1997.tb00132.x; Gordon AD, 1999, CLASSIFICATION; He SS, 2010, J SEX RES, V47, P269, DOI 10.1080/00224490903062241; Heaven PCL, 2004, EUR J PERSONALITY, V18, P103, DOI 10.1002/per.498; Hendrick C, 2004, HANDBOOK OF SEXUALITY IN CLOSE RELATIONSHIPS, P159; Hendrick C, 1998, J SOC PERS RELAT, V15, P147, DOI 10.1177/0265407598152001; Hendrick C, 1986, J PERS SOC PSYCHOL, V5, P161; Hendrick S, 1987, J SEX RES, V23, P502, DOI [10.1080/00224498709551387, DOI 10.1080/00224498709551387]; HENDRICK SS, 1987, J SOC PERS RELAT, V4, P281, DOI 10.1177/026540758700400303; Kline R.B., 2011, PRINCIPLES PRACTICE; Le Gall A, 2002, J SEX RES, V39, P207, DOI 10.1080/00224490209552143; Lee J.A., 1973, COLORS LOVE EXPLORAT; Lee JA, 1988, LOVE STYLES; LESTER D, 1988, PERS INDIV DIFFER, V9, P689, DOI 10.1016/0191-8869(88)90168-7; MALLADIAN I, 1994, PERS INDIV DIFFER, V17, P557, DOI 10.1016/0191-8869(94)90092-2; Neto F, 2000, J CROSS CULT PSYCHOL, V31, P626, DOI 10.1177/0022022100031005005; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; RACITI M, 1992, SEX ROLES, V27, P553, DOI 10.1007/BF00290009; SANGRADOR JL, 1993, PSICOTHEMA, V5, P181; SARWER DB, 1993, ARCH SEX BEHAV, V22, P265, DOI 10.1007/BF01541771; Sprecher S, 2002, SEX ROLES, V46, P131, DOI 10.1023/A:1019780801500; Sternberg R, 1998, PSYCHOL LOVE; STERNBERG RJ, 1986, PSYCHOL REV, V93, P119, DOI 10.1037/0033-295X.93.2.119; Todosijevic, 2009, INTERPERSONA, V3, P55, DOI [10.5964/ijpr.v3i1.32, DOI 10.5964/IJPR.V3I1.32]; Wan WWN, 2000, PERS INDIV DIFFER, V29, P169, DOI 10.1016/S0191-8869(99)00185-3; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; White JK, 2004, PERS INDIV DIFFER, V37, P1519, DOI 10.1016/j.paid.2004.02.019; WOLL SB, 1989, J RES PERS, V23, P480, DOI 10.1016/0092-6566(89)90016-0; YANCEY G, 1991, PSYCHOL REP, V68, P883, DOI 10.2466/PR0.68.3.883-890; Yang Y, 2008, J QIQIHAR MED COLL, V29, P2824, DOI DOI 10.1016/J.RIDD.2014.02.005; Zeng XL, 2010, J YUEYANG VOCATIONAL, V25, P44; Zhang JX, 2003, PAPER PRESENT AT THE; [朱小爽 Zhu Xiaoshuang], 2012, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V20, P535; Zhu XS, 2012, CHINESE J CLIN PSYCH, V20, P542	44	2	2	11	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166410	10.1371/journal.pone.0166410	http://dx.doi.org/10.1371/journal.pone.0166410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851784	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300045
J	Cho, Y; Sinn, DH; Yu, SJ; Gwak, GY; Kim, JH; Yoo, YJ; Jun, DW; Kim, TY; Lee, HY; Cho, EJ; Lee, JH; Kim, YJ; Yoon, JH				Cho, Yuri; Sinn, Dong Hyun; Yu, Su Jong; Gwak, Geum Youn; Kim, Ji Hoon; Yoo, Yang Jae; Jun, Dae Won; Kim, Tae Yeob; Lee, Hyo Young; Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan			Survival Analysis of Single Large (> 5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B	PLOS ONE			English	Article							7 STAGING SYSTEMS; HEPATIC RESECTION; LIVER-TRANSPLANTATION; TRANSARTERIAL CHEMOEMBOLIZATION; SURGICAL-TREATMENT; PROGNOSIS; CIRRHOSIS; INVASION; TUMOR	Background & Aims Single large (>5 cm) hepatocellular carcinoma (HCC) is classified as Barcelona Liver Clinic (BCLC) stage early stage (A). Yet, controversies exist whether single large HCC can be considered as early stage. We have analyzed long-term outcome to see which stage is appropriate for these patients. Methods From 2005 to 2006, 1,546 consecutive patients who were newly diagnosed as HCC (BCLC A or B) at four tertiary hospitals in Korea were analyzed. BCLC A was sub-classified into A1 (single 2-5 cm), A2 (2-3 nodules <= 3 cm), and A3 (single >5 cm). BCLC B1 included patients beyond-Milan criteria, and within up-to-7 criterion. Survival prediction between subgroupings (1: A1 + A2 + A3 vs. B1 and 2: A1 + A2 vs. A3 + B1) was compared based on c-index and Akaike information criterion (AIC). Results The 5-year overall survival (OS) rate was 62.3, 58.6, 36.8, and 42.0% for A1, A2, A3 and B1, respectively. In multivariate Cox-regression analysis, OS was significantly different between A3 + B1 vs. A1 + A2 (hazard ratio [HR] 1.85; P < 0.001), but not between A1 + A2 + A3 vs. B1 (HR 1.19; P = 0.258). For A3, surgical resection showed superior OS over transarterial chemoembolization. Survival prediction was superior in subgrouping 2 (AIC 5727.2; cindex 0.652) than subgrouping 1 (AIC 5766.3; c-index 0.619) even after inverse probability weighting. Conclusions This large scale long-term follow-up data shows that single large tumor should be considered as intermediate stage in terms of prognosis. However, in terms of treatment, resection might be the first line treatment option.	[Cho, Yuri; Yu, Su Jong; Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Yuri; Yu, Su Jong; Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Cho, Yuri] CHA Univ, Dept Internal Med, CHA Gangnam Med Ctr, Seoul, South Korea; [Sinn, Dong Hyun; Gwak, Geum Youn] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr, Seoul, South Korea; [Kim, Ji Hoon; Yoo, Yang Jae] Korea Univ, Coll Med, Guro Hosp, Dept Internal Med, Seoul, South Korea; [Jun, Dae Won; Lee, Hyo Young] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Tae Yeob] Hanyang Univ, Inst Med Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pochon Cha University; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); Hanyang University; Hanyang University	Yu, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Yu, SJ (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	ydoctor2@hanmail.net		KIM, JI HOON/0000-0003-3924-0434; Kim, Yoon Jun/0000-0001-9141-7773; Cho, Eun Ju/0000-0002-2677-3189; Yu, Su Jong/0000-0001-8888-7977; Yoon, Jung-Hwan/0000-0002-9128-3610	Scientific Research Fund of the Korean Liver Cancer Study Group; Seoul National University Hospital Research Fund [04-2013-0830]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1420050]	Scientific Research Fund of the Korean Liver Cancer Study Group; Seoul National University Hospital Research Fund; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by the Scientific Research Fund of the Korean Liver Cancer Study Group 2015, by grant No. 04-2013-0830 from the Seoul National University Hospital Research Fund, and by the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1420050).	BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cho YB, 2007, WORLD J SURG, V31, P795, DOI 10.1007/s00268-006-0359-z; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esnaola NF, 2002, J GASTROINTEST SURG, V6, P224, DOI 10.1016/S1091-255X(01)00015-4; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Fuster J, 1996, ANN SURG, V223, P297, DOI 10.1097/00000658-199603000-00011; Guglielmi A, 2008, AM J GASTROENTEROL, V103, P597, DOI 10.1111/j.1572-0241.2007.01604.x; Hanazaki K, 2001, AM J SURG, V181, P347, DOI 10.1016/S0002-9610(01)00584-0; Jung YK, 2016, J GASTROEN HEPATOL, V31, P467, DOI 10.1111/jgh.13152; Kim JY, 2016, CLIN MOL HEPATOL, V22, P250, DOI 10.3350/cmh.2016.0015; Lee YB, 2015, J VASC INTERV RADIOL, V26, P651, DOI 10.1016/j.jvir.2015.02.004; Liu PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155588; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2008, ANN SURG ONCOL, V15, P1001, DOI 10.1245/s10434-007-9559-5; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; National Cancer Institute: About Cancer, CANC DIAGN STAG; Nonami T, 1997, AM J SURG, V173, P288, DOI 10.1016/S0002-9610(96)00399-6; O'Neil BH, 2007, ONCOLOGIST, V12, P1425, DOI 10.1634/theoncologist.12-12-1425; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Roayaie S, 2002, ANN SURG, V235, P533, DOI 10.1097/00000658-200204000-00012; Shuto T, 1999, HEPATO-GASTROENTEROL, V46, P413; Sinn DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112184; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P64, DOI 10.1016/j.cgh.2010.08.019; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7; Zhong JH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000396; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	36	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165722	10.1371/journal.pone.0165722	http://dx.doi.org/10.1371/journal.pone.0165722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846227	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600018
J	Chuang, PH; Wu, MH; Fan, SY; Lin, KY; Jou, R				Chuang, Pei-Hua; Wu, Mei-Hua; Fan, Shin-Yuan; Lin, Keng-Yu; Jou, Ruwen			Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014	PLOS ONE			English	Article								Objective To determine the extent of drug resistance in multidrug-resistant tuberculosis (MDR-TB) cases, we conducted a retrospective, population-based analysis using drug susceptibility testing (DST) results of MDR Mycobacterium tuberculosis complex isolates obtained from 2007-2014 in Taiwan. Methods M. tuberculosis isolates collected from 1,331 MDR-TB cases were included in this survey. Treatment histories, age, sex, chest radiograph and bacteriological results of patients were analyzed. Standard DST was performed to assess resistance to the following drugs: isoniazid (INH), rifampicin (RIF), streptomycin (SM), ethambutol (EMB), amikacin (AM), kanamycin (KM), capreomycin (CAP), ofloxacin (OFX), moxifloxacin (MOX), levofloxacin (LVX), gatifloxacin (GAT), para-aminosalicylate (PAS), ethionamide (EA), and pyrazinamide (PZA). The Cochran-Armitage trend test was used for statistical analysis. Results We observed a significant increasing trend in portion of new MDR-TB cases, from 59.5% to 80.2% (p < 0.0001), and significant decreasing trend of portion in the 15-44-year-old age group (p < 0.05). Of the MDR M. tuberculosis isolates tested, 6.2% were resistant to AM, 8.6% were resistant to KM, 4.6% were resistant to CAP, 19.5% were resistant to OFX, 17.1% were resistant to MOX, 16.0% were resistant to LVX, 5.8% were resistant to GAT, 9.5% were resistant to PAS, 28.5% were resistant to EA and 33.3% were resistant to PZA. Fifty (3.8%) extensively drug-resistant TB cases were identified. No significant differences were found in drug resistance frequencies between new and previously treated MDR cases. However, we observed significant decreases in the rates of AM resistance (p < 0.05), OFX resistance (p < 0.00001), PAS resistance (p < 0.00001), EA resistance (p < 0.05) and PZA resistance (p < 0.05). Moreover, younger age groups had higher rates of resistance to fluoroquinolones. Conclusion A policy implemented in 2007 to restrict the prescription of fluoroquinolones was shown to be effective. Our survey revealed a decreasing trend of resistance to PZA, OFX and AM, which suggests the feasibility of adopting a short- course regimen and demonstrates the effectiveness of our management program for MDR-TB.	[Chuang, Pei-Hua; Wu, Mei-Hua; Fan, Shin-Yuan; Lin, Keng-Yu; Jou, Ruwen] Ctr Dis Control, TB Res Ctr, Taipei, Taiwan; [Jou, Ruwen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University	Jou, R (corresponding author), Ctr Dis Control, TB Res Ctr, Taipei, Taiwan.; Jou, R (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan.	rwj@cdc.gov.tw			Centers for Disease Control, Ministry of Health and Welfare [MOHW103-CDC-C-315-000405]	Centers for Disease Control, Ministry of Health and Welfare	This study was supported by the Centers for Disease Control, Ministry of Health and Welfare, under the grant number MOHW103-CDC-C-315-000405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Centers for Disease Control, Ministry of Health and Welfare under the grant number MOHW103-CDC-C-315-000405. The authors would like to thank Yu-Ming Deng for his technical assistance and Hsien-Ho Lin for his comments.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; CDC, 2014, TUB CONTR REP 2013; Centers for Disease Control and Prevention (CDC), 2015, ANN REPORT; Chang KC, 2013, ANTIMICROB AGENTS CH, V57, P4097, DOI 10.1128/AAC.00120-13; Cohen T, 2014, DRUG RESIST UPDATE, V17, P105, DOI 10.1016/j.drup.2014.10.001; Fitzpatrick LK, 2001, CLIN INFECT DIS, V33, P1801, DOI 10.1086/323671; Gopal M, 2013, INT J TUBERC LUNG D, V17, P1001, DOI 10.5588/ijtld.12.0144; Mitarai S, 2015, INT J TUBERC LUNG D, V19, P157, DOI 10.5588/ijtld.13.0905; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Stagg HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142425; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; WHO-World Health Organisation, 2016, TUB FACT SHEET; Winters N, 2015, EUR RESPIR J, V46, P1461, DOI 10.1183/13993003.00649-2015; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2015, GUID SURV DRUG RES T; World Health Organization, 2014, MULT RES TUB; World Health organization, 2008, POL GUID DRUG SUSC T; Yu MC, 2008, EMERG INFECT DIS, V14, P849, DOI 10.3201/eid1405.071398; Yu MC, 2015, EUR RESPIR J, V45, P272, DOI 10.1183/09031936.00080614	20	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165222	10.1371/journal.pone.0165222	http://dx.doi.org/10.1371/journal.pone.0165222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846235	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600009
J	Del Rio-Ospina, L; Soto-De Leon, SC; Camargo, M; Sanchez, R; Mancilla, CL; Patarroyo, ME; Patarroyo, MA				Del Rio-Ospina, Luisa; Cecilia Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Lizeth Mancilla, Cindy; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel			The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER PREVENTION; YOUNG-WOMEN; AGE; VARIANTS; COHORT; ASSOCIATION; INTERCOURSE; NEOPLASIA; MY09/11	This study reports six HR-HPV types' infection prevalence discriminated by species and multiple infection in unvaccinated Colombian female adolescents, as well as some factors modulating the risk of infection. HPV DNA for six high-risk viral types was identified in cervical samples taken from 2,134 12-19 year-old females using conventional generic and typespecific PCR. Binomial logistical regression analysis was used for modelling HR-HPV infection and multiple infection risk. The interaction between variables in a stepwise model was also included in such analysis. Viral DNA was detected in 48.97% of the females; 28.52% of them had multiple infections, HPV-16 being the most frequently occurring type (37.44%). Cytological abnormality prevalence was 15.61%. Being over 16 years-old (1.66: 1.01-2.71 95% CI), white ethnicity (4.40: 1.16-16.73 95% CI), having had 3 or more sexual partners (1.77: 1.11-2.81 95% CI) and prior sexually-transmitted infections (STI) (1.65: 1.17-2.32 95% CI) were associated with a greater risk of HPV infection. Having given birth was related to a higher risk of infection by A7 species and antecedent of abortion to less risk of coinfection. Where the females in this study came from also influenced the risk of infection by A7 species as female adolescents from the Andean region had a lower risk of infection (0.42: 0.18-0.99 95% CI). The presence of factors related to risky sexual behaviour in the study population indicated that public health services should pay special attention to female adolescents to modify the risk of infection by high-risk HPV types and decrease their impact on this age group.	[Del Rio-Ospina, Luisa; Cecilia Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Lizeth Mancilla, Cindy; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel] Univ Nacl Colombia, Sch Med, Bogota, Colombia; [Cecilia Soto-De Leon, Sara] Univ Ciencias Aplicadas & Ambientales UDCA, Bogota, Colombia; [Camargo, Milena] Univ Rosario, PhD Programme Biomed & Biol Sci, Bogota, Colombia; [Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario; Universidad del Rosario	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia.; Patarroyo, MA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Leon, Sara Cecilia Soto-De/ABD-3186-2020; De León, Sara Cecilia Soto/AAF-6301-2021; Sanchez, Ricardo/K-8254-2015	Patarroyo, Manuel A/0000-0002-4751-2500; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; De León, Sara Cecilia Soto/0000-0003-4515-6749; Camargo, Milena/0000-0003-0246-0716; Sanchez, Ricardo/0000-0002-7540-4734	Basque Development Cooperation Agency at the Spanish International Development Cooperation Agency (AECID) [10-CAP1-0197]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) [617]	Basque Development Cooperation Agency at the Spanish International Development Cooperation Agency (AECID); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This project was funded by the Basque Development Cooperation Agency at the Spanish International Development Cooperation Agency (AECID) (Project 10-CAP1-0197). The Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) supported MC through PhD training in Colombia within the framework of the Colombian Programme for Promoting Research Training (Convocatoria 617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kalbani Moza, 2015, Asian Pac J Cancer Prev, V16, P6557; Caixeta RCA, 2015, DIAGN CYTOPATHOL, V43, P780, DOI 10.1002/dc.23301; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Camargo M, 2011, J VIROL METHODS, V178, P68, DOI 10.1016/j.jviromet.2011.08.014; Camargo M, 2011, ANN EPIDEMIOL, V21, P204, DOI 10.1016/j.annepidem.2010.11.003; Castellsague X, 2003, SALUD PUBLICA MEXICO, V45, pS345; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Chattopadhyay Koushik, 2011, Indian J Hum Genet, V17, P132, DOI 10.4103/0971-6866.92087; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Ferlay J, 2013, CANC INCIDENCE MORTA; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Franco EL, 2003, CANCER J, V9, P348, DOI 10.1097/00130404-200309000-00004; Ghosh I, 2016, J CLIN DIAGN RES, V10, pXE1, DOI 10.7860/JCDR/2016/15305.7173; Gonzalez-Losa MD, 2004, J CLIN VIROL, V29, P95, DOI 10.1016/S1386-6532(03)00094-5; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Hwang LY, 2009, J ADOLESCENT HEALTH, V44, P103, DOI 10.1016/j.jadohealth.2008.10.006; Jayasinghe YL, 2016, J LOW GENIT TRACT DI, V20, P224, DOI 10.1097/LGT.0000000000000217; Lizano M, 2009, ARCH MED RES, V40, P428, DOI 10.1016/j.arcmed.2009.06.001; Lopera EA, 2014, INFECT GENET EVOL, V28, P339, DOI 10.1016/j.meegid.2014.10.014; Lopez-Hernandez D, 2016, MED CLIN BARC; Louie KS, 2009, BRIT J CANCER, V100, P1191, DOI 10.1038/sj.bjc.6604974; Marek E, 2016, EUR J CANCER CARE, V25, P57, DOI 10.1111/ecc.12332; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Nonato DR, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.003; Pelkofski E, 2016, CLIN THER, V38, P459, DOI 10.1016/j.clinthera.2016.01.024; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; Remschmidt C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1248; Salazar KL, 2015, ACTA CYTOL, V59, P391, DOI 10.1159/000442512; Schiffman M, 2011, CANCER EPIDEM BIOMAR, V20, P1398, DOI 10.1158/1055-9965.EPI-11-0206; Shew ML, 2015, J MED VIROL, V87, P2122, DOI 10.1002/jmv.24284; Smith MA, 2014, CANCER EPIDEM BIOMAR, V23, P812, DOI 10.1158/1055-9965.EPI-13-1255; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Soto-De Leon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014705; Tanton C, 2015, CANCER EPIDEM BIOMAR, V24, P842, DOI 10.1158/1055-9965.EPI-14-1333; Vinodhini K, 2012, ARCH GYNECOL OBSTET, V285, P771, DOI 10.1007/s00404-011-2155-8; Wang Sophia S, 2003, J Natl Cancer Inst Monogr, P35; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297	39	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166502	10.1371/journal.pone.0166502	http://dx.doi.org/10.1371/journal.pone.0166502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846258	gold, Green Published			2022-12-27	WOS:000387794600072
J	Lindblom, A; Wallmenius, K; Sjowall, J; Fryland, L; Wilhelmsson, P; Lindgren, PE; Forsberg, P; Nilsson, K				Lindblom, Anders; Wallmenius, Katarina; Sjowall, Johanna; Fryland, Linda; Wilhelmsson, Peter; Lindgren, Per-Eric; Forsberg, Pia; Nilsson, Kenneth			Prevalence of Rickettsia spp. in Ticks and Serological and Clinical Outcomes in Tick-Bitten Individuals in Sweden and on the Aland Island	PLOS ONE			English	Article							IXODES-RICINUS TICKS; SPOTTED-FEVER; ANAPLASMA-PHAGOCYTOPHILUM; ERYTHEMA MIGRANS; SOUTHERN SWEDEN; HELVETICA; EUROPE; COINFECTIONS; INFECTION; PATIENT	Tick-transmitted diseases are an emerging health problem, and the hard tick Ixodes ricinus is the main vector for Borrelia spp., tick-borne encephalitis virus and most of the spotted fever Rickettsiae in Europe. The aim of the present study was to examine the incidence of rickettsial infection in the southernmost and south central parts of Sweden and the Aland Islands in Finland the risk of infection in humans and its correlation with a bite of a Rickettsia-infected tick, the self-reported symptoms of rickettsial disease, and the prevalence of co-infection between Rickettsia spp. and Borrelia spp. Persons with a recent tick bite were enrolled through public media and asked to answer a questionnaire, provide a blood sample and bring detached ticks at enlistment and at follow-up three months later. Blood samples were previously analysed for Borrelia spp. antibodies and, for this report, analysed for antibodies to Rickettsia spp. by immunofluorescence and in 16 cases also using Western Blot. Ninety-six (44.0%) of the 218 participants were seropositive for IgG antibodies to Rickettsia spp. Forty (18.3%) of the seropositive participants had increased titres at the follow-up, indicating recent/current infection, while four (1.8%) had titres indicating probable recent/current infection (>= 1: 256). Of 472 ticks, 39 (8.3%) were Rickettsia sp. positive. Five (31.3%) of 16 participants bitten by a Rickettsia-infected tick seroconverted. Experience of the selfreported symptoms nausea (p = 0.006) and radiating pain (p = 0.041) was more common among those with recent, current or probable infection compared to those who did not seroconvert. Participants who showed seroreactivity or seroconversion to Rickettsia spp. had more symptoms than those who were seronegative. Seven (3.2%) participants showed seroconversion to Borrelia spp., and three (1.4%) of these showed seroconversion to both Rickettsia spp. and Borrelia spp., in accordance with previous studies in Sweden. Symptoms of rickettsial disease were in most of the cases vague and general that were difficult to differentiate from other tick-borne diseases.	[Lindblom, Anders; Nilsson, Kenneth] Uppsala Univ, Dept Med Sci, Infect Dis Unit, Uppsala, Sweden; [Wallmenius, Katarina; Nilsson, Kenneth] Uppsala Univ, Dept Med Sci, Unit Clin Bacteriol, Uppsala, Sweden; [Sjowall, Johanna] Linkoping Univ, Dept Infect Dis, Linkoping, Sweden; [Fryland, Linda] Linkoping Univ, Dept Clin & Expt Med, Clin Immunol, Linkoping, Sweden; [Wilhelmsson, Peter; Lindgren, Per-Eric] Linkoping Univ, Dept Clin & Expt Med, Med Microbiol, Linkoping, Sweden; [Wilhelmsson, Peter; Lindgren, Per-Eric] Cty Hosp Ryhov, Med Serv, Jonkoping, Sweden; [Forsberg, Pia] Linkoping Univ, Dept Infect Dis, Linkoping, Sweden; [Forsberg, Pia] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lindblom, Anders; Nilsson, Kenneth] Clin Res Ctr, Dalarna, Falun, Sweden	Uppsala University; Uppsala University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Nilsson, K (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Unit, Uppsala, Sweden.; Nilsson, K (corresponding author), Uppsala Univ, Dept Med Sci, Unit Clin Bacteriol, Uppsala, Sweden.; Nilsson, K (corresponding author), Clin Res Ctr, Dalarna, Falun, Sweden.	kenneth.nilsson@medsci.uu.se		Sjowall, Johanna/0000-0001-5622-866X; Wilhelmsson, Peter/0000-0002-9200-2964	Swedish Research Council Branch of Medicine [K2008-58X-14631-06-3]; EU Interreg IV A project ScandTick [167226]; County Council of Ostergotland [L10-56191]; Stiftelsen Olle Engqvist Byggmastare [11877]; Uppsala-Orebro-Regional Research 324 Council [25021]; Center for Clinical Research Dalarna [9028]	Swedish Research Council Branch of Medicine(Swedish Research Council); EU Interreg IV A project ScandTick; County Council of Ostergotland; Stiftelsen Olle Engqvist Byggmastare; Uppsala-Orebro-Regional Research 324 Council; Center for Clinical Research Dalarna	The study was financially supported by grants from the Swedish Research Council Branch of Medicine (grant no. K2008-58X-14631-06-3) (PF); the EU Interreg IV A project ScandTick (grant no. 167226)(PEL); the County Council of Ostergotland (grant no. L10-56191)(PF); Stiftelsen Olle Engqvist Byggmastare (11877)(KN); Uppsala-Orebro-Regional Research 324 Council (25021) (KN); the Center for Clinical Research Dalarna (9028)(KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; CLEMENTS ML, 1983, J INFECT DIS, V148, P876, DOI 10.1093/infdis/148.5.876; Dubourg G, 2014, EUR J CLIN MICROBIOL, V33, P1449, DOI 10.1007/s10096-014-2090-2; Fournier PE, 2004, J CLIN MICROBIOL, V42, P816, DOI 10.1128/JCM.42.2.816-818.2004; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Gray J, 2005, INT J MED MICROBIOL, V295, P567, DOI 10.1016/j.ijmm.2005.05.008; HAMMERSBERGGREN S, 1994, J CLIN MICROBIOL, V32, P1519, DOI 10.1128/JCM.32.6.1519-1525.1994; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Koetsveld J, 2016, TICKS TICK-BORNE DIS, V7, P371, DOI 10.1016/j.ttbdis.2015.12.010; Lindblom A, 2013, EUR J CLIN MICROBIOL, V32, P317, DOI 10.1007/s10096-012-1742-3; Lindblom A, 2010, SCAND J INFECT DIS, V42, P906, DOI 10.3109/00365548.2010.508466; Mancini F, 2014, ANN AGR ENV MED, V21, P723, DOI 10.5604/12321966.1129922; May K, 2014, PARASITOL RES, V113, P2169, DOI 10.1007/s00436-014-3869-x; Nogueras MM, 2015, J CLIN MICROBIOL, V53, P3057, DOI 10.1128/JCM.00457-15; Milhano N, 2010, TICKS TICK-BORNE DIS, V1, P172, DOI 10.1016/j.ttbdis.2010.09.003; Nilsson K, 1999, LANCET, V354, P1169, DOI 10.1016/S0140-6736(99)04093-3; Nilsson K, 2005, APMIS, V113, P126, DOI 10.1111/j.1600-0463.2005.apm1130206.x; Nilsson K, 2014, EUR J NEUROL, V21, P206, DOI 10.1111/ene.12218; Nilsson K, 2009, J INFECTION, V58, P79, DOI 10.1016/j.jinf.2008.06.005; Nilsson K, 2011, CASE REP INFECT DIS, V2011, DOI 10.1155/2011/469194; Nilsson K, 2010, EMERG INFECT DIS, V16, P490, DOI 10.3201/eid1603.090184; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Portillo A, 2015, MICROBES INFECT, V17, P834, DOI 10.1016/j.micinf.2015.09.009; RAOULT D, 1995, FEMS IMMUNOL MED MIC, V11, P13, DOI 10.1111/j.1574-695X.1995.tb00073.x; Saraiva DG, 2014, EMERG INFECT DIS, V20, P1504, DOI 10.3201/eid2009.140189; Severinsson K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-66; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Tijsse-Klasen E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-347; Wallmenius K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-318; Wallmenius K, 2012, TICKS TICK-BORNE DIS, V3, P100, DOI 10.1016/j.ttbdis.2011.11.003; Wilhelmsson P, 2016, TICKS TICK-BORNE DIS, V7, P71, DOI 10.1016/j.ttbdis.2015.08.009; Wilhelmsson P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-362; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433	34	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166653	10.1371/journal.pone.0166653	http://dx.doi.org/10.1371/journal.pone.0166653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846275	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600098
J	Midgard, H; Bramness, JG; Skurtveit, S; Haukeland, JW; Dalgard, O				Midgard, Havard; Bramness, Jorgen G.; Skurtveit, Svetlana; Haukeland, John W.; Dalgard, Olav			Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study	PLOS ONE			English	Article							INNER-CITY RESIDENTS; METHADONE-MAINTENANCE TREATMENT; TODAYS TREATMENT PARADIGM; LIVER-RELATED MORTALITY; COMMUNITY-BASED COHORT; FUTURE DISEASE BURDEN; VIRUS-INFECTION; INJECT DRUGS; SYRINGE PROGRAMS; HCV INFECTION	Background and Aims There is limited data on hepatitis C (HCV) treatment uptake among people who inject drugs including individuals receiving opioid substitution treatment (OST). We aimed to calculate cumulative HCV treatment uptake, estimate annual treatment rates, and identify factors associated with HCV treatment among individuals who have received OST in Norway. Methods This observational study was based on linked data from The Norwegian Prescription Database and The Norwegian Surveillance System for Communicable Diseases between 2004 and 2013. Both registries have national coverage. From a total of 9919 individuals who had been dispensed OST (methadone, buprenorphine or buprenorphine-naloxone), we included 3755 individuals who had been notified with HCV infection. In this population, dispensions of HCV treatment (pegylated interferon and ribavirin), benzodiazepines, selective serotonin reuptake inhibitors and antipsychotics were studied. Results Among 3755 OST patients notified with HCV infection, 539 (14%) had received HCV treatment during the study period. Annual HCV treatment rates during OST ranged between 1.3% (95% confidence interval [CI] 0.7-2.2) in 2005 and 2.6% (95% CI 1.9-3.5) in 2008 with no significant changes over time. HCV treatment uptake was not associated with age or gender, but associated with duration of active OST (adjusted odds ratio [aOR] 1.11 per year; 95% CI 1.07-1.15), high (> 80%) OST continuity (aOR 1.62; 95% CI 1.17-2.25), and heavy benzodiazepine use (aOR 0.65; 95% CI 0.49-0.87). Conclusions Cumulative HCV treatment uptake among OST patients notified with HCV infection in Norway between 2004 and 2013 was 14%. Annual treatment rates during OST remained unchanged below 3% per year. High continuity of OST over time and absence of heavy benzodiazepine use predicted HCV treatment uptake. Increased awareness for HCV among OST patients is needed as tolerable and efficient directly acting antiviral treatment is being introduced.	[Midgard, Havard; Dalgard, Olav] Akershus Univ Hosp, Dept Infect Dis, Lorenskog, Norway; [Midgard, Havard; Dalgard, Olav] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bramness, Jorgen G.; Skurtveit, Svetlana] Univ Oslo, Norwegian Ctr Addict Res, Oslo, Norway; [Skurtveit, Svetlana] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Oslo, Norway; [Haukeland, John W.] Oslo Univ Hosp, Dept Gastroenterol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo	Midgard, H (corresponding author), Akershus Univ Hosp, Dept Infect Dis, Lorenskog, Norway.; Midgard, H (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	havardmi@medisin.uio.no		Skurtveit, Svetlana/0000-0001-7525-9701	Norwegian ExtraFoundation for Health and Rehabilitation	Norwegian ExtraFoundation for Health and Rehabilitation	HM received research funding (PhD scholarship) from the Norwegian ExtraFoundation for Health and Rehabilitation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD-IDSA, 2015, AASLD IDSA REC TEST; Alavi M, 2014, LIVER INT, V34, P1198, DOI 10.1111/liv.12370; Alavi M, 2013, CLIN INFECT DIS, V57, pS62, DOI 10.1093/cid/cit305; Amundsen EJ, 2010, NORDIC STUDIES ALCOH, P27; [Anonymous], NAT GUID OP SUBST TR; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Bell Helge, 2002, Tidsskr Nor Laegeforen, V122, P926; Bramness JG, 2007, DRUG ALCOHOL DEPEN, V90, P203, DOI 10.1016/j.drugalcdep.2007.03.008; Bruggmann P, 2012, J VIRAL HEPATITIS, V19, P829, DOI 10.1111/jvh.12008; Bruggmann P, 2013, CLIN INFECT DIS, V57, pS56, DOI 10.1093/cid/cit271; Bukten A, 2014, ADDICT BEHAV, V39, P1504, DOI 10.1016/j.addbeh.2014.05.007; Dalgard Olav, 2009, Tidsskr Nor Laegeforen, V129, P101, DOI 10.4045/tidsskr.09.35002; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; EASL, 2016, J HEPATOLOGY; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Grebely J, 2011, J VIRAL HEPATITIS, V18, P32, DOI 10.1111/j.1365-2893.2010.01279.x; Grebely J, 2009, J VIRAL HEPATITIS, V16, P352, DOI 10.1111/j.1365-2893.2009.01080.x; Grebely J, 2016, ADDICTION, V111, P311, DOI 10.1111/add.13197; Grebely J, 2015, INT J DRUG POLICY, V26, P1028, DOI 10.1016/j.drugpo.2015.07.005; Grebely J, 2014, ANTIVIR RES, V104, P62, DOI 10.1016/j.antiviral.2014.01.002; Grebely J, 2013, CLIN INFECT DIS, V57, P1014, DOI 10.1093/cid/cit377; Grebely J, 2011, SEMIN LIVER DIS, V31, P331, DOI 10.1055/s-0031-1297922; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hallinan R, 2007, DRUG ALCOHOL DEPEN, V88, P49, DOI 10.1016/j.drugalcdep.2006.09.018; Hatzakis A, 2015, J VIRAL HEPATITIS, V22, P26, DOI 10.1111/jvh.12351; Hickman M, 2015, CURR OPIN INFECT DIS, V28, P576, DOI 10.1097/QCO.0000000000000216; Iversen J, 2013, J VIRAL HEPATITUS, DOI [DOI 10.1111/JVH.12129, 10.1111/jvh.12129]; Kielland KB, 2014, SCAND J GASTROENTERO, V49, P1465, DOI 10.3109/00365521.2014.968860; Kielland KB, 2014, J HEPATOL, V60, P260, DOI 10.1016/j.jhep.2013.09.022; Kielland KB, 2013, J HEPATOL, V58, P31, DOI 10.1016/j.jhep.2012.08.024; Krook AL, 2007, EUR ADDICT RES, V13, P216, DOI 10.1159/000104884; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Lund K. E., SIRUS REPORT 2015; Maeland A, 2015, NORWEGIAN GUIDELINES; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Masson CL, 2013, AM J PUBLIC HEALTH, V103, pE81, DOI 10.2105/AJPH.2013.301458; Mauss S, 2004, HEPATOLOGY, V40, P120, DOI 10.1002/hep.20279; McGowan CE, 2013, HEPATOLOGY, V57, P1325, DOI 10.1002/hep.26246; McGowan CE, 2012, LIVER INT, V32, P151, DOI 10.1111/j.1478-3231.2011.02706.x; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Perlman D. C., 2015, INT J DRUG POLICY; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Sasadeusz JJ, 2011, ADDICTION, V106, P977, DOI 10.1111/j.1360-0443.2010.03347.x; Sulkowski MS, 2011, NAT REV GASTRO HEPAT, V8, P212, DOI 10.1038/nrgastro.2011.21; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Waal H, 2016, ANN ASSESSMENT NORWE; Waal H, 2007, EUR ADDICT RES, V13, P66, DOI 10.1159/000097935; WHO, 2016, MYANM NATL SIMPL TRE; WHO, 2013, GUID ATC CLASS DDD A; Witteck A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13193	51	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166451	10.1371/journal.pone.0166451	http://dx.doi.org/10.1371/journal.pone.0166451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846264	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000387794600064
J	Morciano, C; Basevi, V; Faralli, C; Boon, MH; Tonon, S; Taruscio, D				Morciano, Cristina; Basevi, Vittorio; Faralli, Carla; Boon, Michele Hilton; Tonon, Sabina; Taruscio, Domenico			Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; INTERNATIONAL NETWORK; UNITED-STATES; DISEASE; QUALITY; AUTHORS; MANAGEMENT; STANDARDS; INDUSTRY; SOCIETY	Objective To assess whether organisations that develop health care guidelines have conflict of interest (COI) policies and to review the content of the available COI policies. Methods Survey and content analysis of COI policies available in English, French, Spanish, and Italian conducted between September 2014 and June 2015. A 24-item data abstraction instrument was created on the basis of guideline development standards. Results The survey identified 29 organisations from 19 countries that met the inclusion criteria. From these organisations, 19 policies were eligible for inclusion in the content analysis. Over onethird of the policies (7/19, 37%) did not report or did not clearly report whether disclosure was a prerequisite for membership of the guideline panel. Strategies for the prevention of COI such as divestment were mentioned by only two organisations. Only 21% of policies (4/19) used criteria to determine whether an interest constitutes a COI and to assess the severity of the risk imposed. Conclusions The finding that some organisations, in contradiction of widely available standards, still do not have COI policies publicly available is concerning. Also troubling were the findings that some policies did not clearly report critical steps in obtaining, managing and communicating disclosure of relationships of interest. This in addition to the variability encountered in content and accessibility of COI policies may cause confusion and distrust among guideline users. It is in the interest of guideline users and developers to design an agreed-upon, comprehensive, clear, and accessible COI policy.	[Morciano, Cristina; Taruscio, Domenico] Ist Super Sanita, Ctr Nazl Malattie Rare, Rome, Italy; [Basevi, Vittorio] Ctr Documentazione Salute Perinatale & Riprod, Serv Assistenza Distrettuale Med Gen Pianificaz &, Bologna, Italy; [Faralli, Carla] Ist Super Sanita, Serv Informat Documentaz Biblioteca & Attiv Edito, Rome, Italy; [Boon, Michele Hilton] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Tonon, Sabina] Ist Super Sanita, Ctr Nazl Malattie Rare, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; Istituto Superiore di Sanita (ISS)	Morciano, C (corresponding author), Ist Super Sanita, Ctr Nazl Malattie Rare, Rome, Italy.	cristinamorciano@iss.it	Boon, Michele Hilton/AAB-8745-2021; Taruscio, Domenica/A-6646-2015; Morciano, Cristina/A-6655-2015	Boon, Michele Hilton/0000-0002-2240-7923; Taruscio, Domenica/0000-0001-5403-233X; Morciano, Cristina/0000-0001-5300-9605	European Union's Seventh Framework Programme under the Rare-Bestpractices project [305690]; Medical Research Council [1517742] Funding Source: researchfish	European Union's Seventh Framework Programme under the Rare-Bestpractices project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CM received funds from the European Union's Seventh Framework Programme under the Rare-Bestpractices project www.rarebestpractices.eu; Project Ref.: no 305690. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F. US, 2013, US ADVISORY COMMITTE; Akl EA, 2014, J CLIN EPIDEMIOL, V67, P1222, DOI 10.1016/j.jclinepi.2014.05.006; [Anonymous], 2014, LTD CONFL INT POL; Bindslev JBB, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-19; Boyd Elizabeth A, 2006, Health Res Policy Syst, V4, P16, DOI 10.1186/1478-4505-4-16; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Canadian Task Force on Preventive Health Care, 2014, PROC MAN; Centro National de Excelentia Tecno A logica en Salud, 2007, MET INT GUIAS PRACT; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Conseil Scientifique du Domaine de la Sante A, 2015, PROC ET DIFF REF BON; Davino-Ramaya Carrie, 2012, Perm J, V16, P55; Detsky AS, 2006, CAN MED ASSOC J, V175, P1033, DOI 10.1503/cmaj.061181; Estonian Health Insurance Fund University of Tartu Ministry of Social Affair WHO, 2011, EST HDB GUID DEV; Federaal Kenniscentrum voor de Gezondheidszorg (Belgian Health Care Knowledge Centre), PROC BOOK; Feuerstein JD, 2013, ALIMENT PHARM THER, V37, P937, DOI 10.1111/apt.12290; Finnish Medical Society Duodecim Current Care Guidelines, 2014, FINNISH MED SOC DUOD; German Association of the Scientific Medical Societies (AWMF) Standing Guidelines Commission, 2012, AWMF GUID MAN RUL GU; German Medical Association (GMA) National Association of Statutory Health Insurance Physicians (NASHIP) Association of the Scientific Medical Societies (AWMF), 2010, NAT PROGR DIS MAN GU; Grupo de trabajo sobre GPC Elaboracion de Guio as de Practica Clionica en el Sistema Nacional de Salud, 2007, GRUP TRAB GPC EL GUI; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Hartling L, 2015, AHRQ PUBLICATION; Haute Autorite de Sante, 2015, LAB REC BONN PRAT; Haute Autorite de Sante A, GUID DECL INT GEST C; Holmer HK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075284, DOI 10.1371/JOURNAL.PONE.0075284]; Instituto de Evaluacion Tecnologica en Salud, 2014, GUIO MET EL GUIAS PR; IOM (Institute of Medicine), 2009, CONFLICT OF INTEREST; IOM (Institute of Medicine), 2011, CLIN PRACTICE GUIDEL; Johnson L, 2009, J MED ETHICS, V35, P283, DOI 10.1136/jme.2008.026526; King Saud bin Abdulaziz University for Health Sciences National and Gulf Center for Evidence Based Health Practice, 2008, GUID CLIN PRACT GUID; Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Legido-Quigley H, 2013, OBSERVATORY STUDIES, V30; Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5535; Lenzer J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d4007; McSweegan E, 2008, CLIN INFECT DIS, V47, P1609, DOI 10.1086/595684; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; Ministerio de Salud, 2006, NORM TECN EL GUIAS P; Ministerio de Salud y Proteccion Social, 2010, GUIA MET EL GUIAS AT; Moynihan RN, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001500; National Clinical Effectiveness Committee, 2013, GUID DEV MAN; National Clinical Effectiveness Committee, 2012, POL TRANSP MAN CONFL; National Health and Medical Research Council, 2012, GUID DEV CONFL INT I; National Institute for Health and Care Excellence, 2014, COD PRACT DECL DEAL; National Institute for Health and Care Excellence, 2015, DEV NICE GUID MAN; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037413; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; Schunemann HJ, 2009, AM J RESP CRIT CARE, V180, P564, DOI 10.1164/rccm.200901-0126ST; Schunemann HJ, 2015, ANN INTERN MED, V163, P548, DOI 10.7326/M14-1885; Scottish Intercollegiate Guidelines Network, POL DECL COMP INT; Scottish Intercollegiate Guidelines Network, 2014, GUID DEV HDB; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sistema Nazionale Linee Guida, 2004, PROGR NAZ LIN GUID M; Smith JC, 2009, ANN INTERN MED, V150, P45, DOI 10.7326/0003-4819-150-1-200901060-00009; Sniderman AD, 2012, J CLIN EPIDEMIOL, V65, P705, DOI 10.1016/j.jclinepi.2012.01.009; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Socialstyrelsen (National Board of Health and Welfare), 2015, GUID PROC; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; U.S. Preventive Services Task Force, 2014, AHRQ PUBL; Umscheid CA, HEALTHCARE INFECT CO; Universidad Nacional de Colombia Instituto de Investigaciones clinicas Facultad de Medicina, 2015, GUIA MET EL GUIAS PR; WHO, 2014, HDB GUID DEV	69	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166485	10.1371/journal.pone.0166485	http://dx.doi.org/10.1371/journal.pone.0166485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846255	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000387794600069
J	Gronewold, J; Todica, O; Seidel, UK; Volsek, M; Kribben, A; Bruck, H; Hermann, DM				Gronewold, Janine; Todica, Olga; Seidel, Ulla K.; Volsek, Michaels; Kribben, Andreas; Bruck, Heike; Hermann, Dirk M.			Cognitive Performance Is Highly Stable over a 2-Year-Follow-Up in Chronic Kidney Disease Patients in a Dedicated Medical Environment	PLOS ONE			English	Article							MEMORY COMPLAINTS; DECLINE; IMPAIRMENT; ASSOCIATION; PREVALENCE; DEMENTIA; ALBUMINURIA; DYSFUNCTION; ADULTS; HEALTH	BACKGROUND As kidney and brain functions decline with aging, chronic kidney disease (CKD) and dementia are becoming increasing health burdens worldwide. Among the risk factors for cognitive impairment, CKD is increasingly recognized. The precise impact of CKD on the development of cognitive impairment is poorly understood. METHODS In the New Tools for the Prevention of Cardiovascular Disease in Chronic Kidney Disease (NTCVD) cohort, which was recruited in a dedicated nephrology department, we examined the 2-year course of cognitive performance in 120 patients (73 patients with CKD stages 3-5D, 47 control patients without CKD with similar vascular risk profile) using a comprehensive battery of 10 neuropsychological tests. RESULTS Kidney function, vascular risk factors and cognitive performance were highly stable both in CKD and control patients. The summary score of cognitive performance in CKD patients was very similar at baseline (z = -0.63 +/- 0.76) and follow-up (z = -0.54 +/- 0.79, p = 0.113), as was cognitive performance in control patients (z = -0.01 +/- 0.59 and 0.01 +/- 0.70, p = 0.862, at baseline and follow-up, respectively). Total serum cholesterol (199.6 +/- 36.0 and 186.0 +/- 32.9, p = 0.005 in controls; 194.4 +/- 46.1 and 181.2 +/- 41.2, p = 0.008 in CKD) and common carotid intima-media thickness (0.87 +/- 0.18 and 0.84 +/- 0.17, p = 0.351 in controls; 0.88 +/- 0.21 and 0.82 +/- 0.16, p = 0.002 in CKD) moderately but significantly decreased during the follow-up. In multivariable regression analyses, high age (beta = -0.28, 95%CI = -0.48 to 0.08, p = 0.007) predicted decrease in cognitive performance. CONCLUSIONS In this well-defined cohort receiving state-of-the-art therapy, cognitive performance did not decrease over 2 years. Our data emphasize the aspect of risk factor control, suggesting that dedicated medical care might prevent cognitive decline in CKD patients.	[Gronewold, Janine; Todica, Olga; Seidel, Ulla K.; Hermann, Dirk M.] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany; [Volsek, Michaels; Kribben, Andreas; Bruck, Heike] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Hermann, DM (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany.	dirk.hermann@uk-essen.de	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk/GZB-9350-2022; Hermann, Dirk M/AAP-5538-2020	Hermann, Dirk M./0000-0003-0198-3152; 	Federal Ministry of Education and Research (BMBF/NGFN) [01GR0807]; Heinz Nixdorf Foundation; Dr Werner Jackstadt Foundation	Federal Ministry of Education and Research (BMBF/NGFN); Heinz Nixdorf Foundation; Dr Werner Jackstadt Foundation	This work was supported by the Federal Ministry of Education and Research (BMBF/NGFN 01GR0807), the Heinz Nixdorf Foundation and Dr Werner Jackstadt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Federal Ministry of Education and Research (BMBF/NGFN 01GR0807), the Heinz Nixdorf Foundation and Dr Werner Jackstadt Foundation. We thank Gisela Behrendt for administrative and technical support.	Abdel-Kader K, 2010, CLIN J AM SOC NEPHRO, V5, P1566, DOI 10.2215/CJN.08121109; [Anonymous], 2003, AM J KIDNEY DIS, V41, pS7; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Barzilay JI, 2011, ARCH INTERN MED, V171, P142, DOI 10.1001/archinternmed.2010.502; Baumler G., 1985, FARB WORT INTERFEREN; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Darsie B, 2014, AM J EPIDEMIOL, V180, P68, DOI 10.1093/aje/kwu102; Davey A, 2013, NEPHROL DIAL TRANSPL, V28, P1810, DOI 10.1093/ndt/gfs470; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Etgen T, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0115-4; Etgen T, 2009, NEPHROL DIAL TRANSPL, V24, P3144, DOI 10.1093/ndt/gfp230; Feng L, 2012, J AM GERIATR SOC, V60, P1208, DOI 10.1111/j.1532-5415.2012.04043.x; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Gronewold J, 2016, MOL NEUROBIOL, V53, P3136, DOI 10.1007/s12035-015-9218-y; Harting C, 2000, WECHSLER MEMORY SCAL; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Herrmann-Lingen C., 2005, HADS D HOSP ANXIETY; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Khatri M, 2009, J AM SOC NEPHROL, V20, P2427, DOI 10.1681/ASN.2008101090; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Miwa K, 2014, NEUROLOGY, V82, P1051, DOI 10.1212/WNL.0000000000000251; Nulsen RS, 2008, J REN CARE, V34, P121, DOI 10.1111/j.1755-6686.2008.00028.x; Reitan R, 1992, TRAIL MAKING TEST; Russ M, REY COMPLEX FIGURE T; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Sasaki Y, 2011, J AM GERIATR SOC, V59, P1175, DOI 10.1111/j.1532-5415.2011.03477.x; Schofield PW, 1997, AM J PSYCHIAT, V154, P609; Seidel UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091176; Seidel UK, 2014, KIDNEY INT, V85, P693, DOI 10.1038/ki.2013.366; Slinin Y, 2008, J AM GERIATR SOC, V56, P2082, DOI 10.1111/j.1532-5415.2008.01936.x; Tamura MK, 2011, AM J KIDNEY DIS, V58, P756, DOI 10.1053/j.ajkd.2011.05.027; Thornton WL, 2007, J INT NEUROPSYCH SOC, V13, P344, DOI 10.1017/S1355617707070361; Wang F, 2010, AM J NEPHROL, V32, P117, DOI 10.1159/000315618; Weng SC, 2012, INTERNAL MED, V51, P29, DOI 10.2169/internalmedicine.51.5975; Zehnder Antoinette E, 2007, Am J Alzheimers Dis Other Demen, V22, P416, DOI 10.1177/1533317507302448; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166530	10.1371/journal.pone.0166530	http://dx.doi.org/10.1371/journal.pone.0166530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835681	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200056
J	Le, TQ; Bukkapatnam, STS				Le, Trung Q.; Bukkapatnam, Satish T. S.			Nonlinear Dynamics Forecasting of Obstructive Sleep Apnea Onsets	PLOS ONE			English	Article							PREDICTION; SIGNALS	Recent advances in sensor technologies and predictive analytics are fueling the growth in point-of-care (POC) therapies for obstructive sleep apnea (OSA) and other sleep disorders. The effectiveness of POC therapies can be enhanced by providing personalized and real-time prediction of OSA episode onsets. Previous attempts at OSA prediction are limited to capturing the nonlinear, nonstationary dynamics of the underlying physiological processes. This paper reports an investigation into heart rate dynamics aiming to predict in real time the onsets of OSA episode before the clinical symptoms appear. A prognosis method based on a nonparametric statistical Dirichlet-Process Mixture-Gaussian-Process (DPMG) model to estimate the transition from normal states to an anomalous (apnea) state is utilized to estimate the remaining time until the onset of an impending OSA episode. The approach was tested using three datasets including (1) 20 records from 14 OSA subjects in benchmark ECG apnea databases (Physionet. org), (2) records of 10 OSA patients from the University of Dublin OSA database and (3) records of eight subjects from previous work. Validation tests suggest that the model can be used to track the time until the onset of an OSA episode with the likelihood of correctly predicting apnea onset in 1 min to 5 mins ahead is 83.6 +/- 9.3%, 80 +/- 8.1%, 76.2 +/- 13.3%, 66.9 +/- 15.4%, and 61.1 +/- 16.7%, respectively. The present prognosis approach can be integrated with wearable devices, enhancing proactive treatment of OSA and real-time wearable sensor-based of sleep disorders.	[Le, Trung Q.] Int Univ Vietnam Natl Univ, Dept Biomed Engn, Ho Chi Minh, Vietnam; [Bukkapatnam, Satish T. S.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Bukkapatnam, Satish T. S.] Texas A&M Univ, Ctr Remote Hlth Technol, College Stn, TX USA	Vietnam National University Hochiminh City; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Le, TQ (corresponding author), Int Univ Vietnam Natl Univ, Dept Biomed Engn, Ho Chi Minh, Vietnam.	trung.le@hcmiu.edu.vn		Bukkapatnam, Satish/0000-0003-3312-8222	US National Science Foundation [CM MI: 1543226, 1432914]; Vietnam National University HCM City [1161/QD-DHQG-KHCN]	US National Science Foundation(National Science Foundation (NSF)); Vietnam National University HCM City	This work was supported by US National Science Foundation under grants CM MI: 1543226 and 1432914 and Vietnam National University HCM City under the grant No. 1161/QD-DHQG-KHCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock J, 1998, IEEE T BIO-MED ENG, V45, P1332, DOI 10.1109/10.725330; Bregas SE, 2012, J SLEEP RES, V21, P221, DOI [10.1111/j.1365-2869.2011.00944.x, DOI 10.1111/J.1365-2869.2011.00944.X]; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dingli K, 2003, EUR RESPIR J, V22, P943, DOI 10.1183/09031936.03.00098002; Faure P, 1997, P NATL ACAD SCI USA, V94, P6506, DOI 10.1073/pnas.94.12.6506; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; GRONE R, 1990, SIAM J MATRIX ANAL A, V11, P218, DOI 10.1137/0611016; Hirata Y, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026202; Horner RL, 1996, SLEEP, V19, P827, DOI 10.1093/sleep/19.10.827; Jo JA, 2007, ANN BIOMED ENG, V35, P1425, DOI 10.1007/s10439-007-9299-5; Kantz H., 2004, NONLINEAR TIME SERIE; Karandikar K, 2013, ENG MED BIO SOC EMBC; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kim JW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178104; Le T., 2013, NONLINEAR STOCHASTIC; Le TQ, 2013, IEEE J TRANSL ENG HE, V1, DOI 10.1109/JTEHM.2013.2273354; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Morselli LL, 2012, PFLUG ARCH EUR J PHY, V463, P139, DOI 10.1007/s00424-011-1053-z; Patil SP, 2007, J APPL PHYSIOL, V102, P547, DOI 10.1152/japplphysiol.00282.2006; Penzel T, 2003, NEUROPSYCHOPHARMACOL, V28, pS48, DOI 10.1038/sj.npp.1300146; Penzel T, 2010, ANN INT C IEEE ENG M; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; So P, 1998, BIOPHYS J, V74, P2776, DOI 10.1016/S0006-3495(98)77985-8; Waxman JA, 2010, AM J RESP CRIT CARE, V181, P727, DOI 10.1164/rccm.200907-1146OC	24	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0164406	10.1371/journal.pone.0164406	http://dx.doi.org/10.1371/journal.pone.0164406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835632	Green Submitted, gold, Green Published			2022-12-27	WOS:000387779200001
J	Boete, C; Morand, S				Boete, Christophe; Morand, Serge			Bats and Academics: How Do Scientists Perceive Their Object of Study?	PLOS ONE			English	Article							DIVERSITY	Bats are associated with conflicting perceptions among humans, ranging from affection to disgust. If these attitudes can be associated with various factors among the general public (e.g. social norms, lack of knowledge), it is also important to understand the attitude of scientists who study bats. Such reflexive information on the researchers community itself could indeed help designing adequate mixed communication tools aimed at protecting bats and their ecosystems, as well as humans living in their vicinity that could be exposed to their pathogens. Thus, we conducted an online survey targeting researchers who spend a part of their research activity studying bats. Our aim was to determine (1) how they perceive their object of study, (2) how they perceive the representation of bats in the media and by the general population, (3) how they protect themselves against pathogen infections during their research practices, and (4) their perceptions of the causes underlying the decline in bat populations worldwide. From the 587 completed responses (response rate of 28%) having a worldwide distribution, the heterogeneity of the scientists' perception of their own object of study was highlighted. In the majority of cases, this depended on the type of research they conducted (i.e. laboratory versus field studies) as well as their research speciality. Our study revealed a high level of personal protection equipment being utilised against pathogens during scientific practices, although the role bats play as reservoirs for a number of emerging pathogens remains poorly known. Our results also disclosed the unanimity among specialists in attributing a direct role for humans in the global decline of bat populations, mainly via environmental change, deforestation, and agriculture intensification. Overall, the present study suggests the need for better communication regarding bats and their biology, their role within the scientific community, as well as in the general public population. As a consequence, increased knowledge regarding scientists' perceptions of bats should improve the role scientists play in influencing the perception of bats by the general public.	[Boete, Christophe] Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,INSERM 1207, 27,Bd Jean Moulin, F-13385 Marseille 5, France; [Morand, Serge] CNRS ISEM CIRAD AGIRs, Ctr Infectiol Christophe Merieux Laos, Viangchan, Laos; [Morand, Serge] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Mahidol University	Boete, C (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,INSERM 1207, 27,Bd Jean Moulin, F-13385 Marseille 5, France.	cboete@gmail.com	Morand, Serge/M-5433-2018; BOETE, Christophe/A-7926-2010	Morand, Serge/0000-0003-3986-7659; BOETE, Christophe/0000-0001-9043-8652	French ANR CPAMP;ES BiodivHealthSEA project [ANR 11 CPEL 002]	French ANR CPAMP;ES BiodivHealthSEA project(French National Research Agency (ANR))	This study is supported by the French ANR CP&ES BiodivHealthSEA project (grant ANR 11 CPEL 002; Local impacts and perceptions of global changes: Biodiversity, health and zoonoses in Southeast Asia).r We are really grateful to Ben Holt for allowing us to use the map with the zoogeographic regions that was presented in Holt et al. 2012. An Update of Wallace's Zoogeographic Regions of the World Science 339 (6115), p74-78 (10.1126/science.1228282). We wish to thank Julien Cappelle, Boripat Siriaroonrat, Kevin Olival for helpful comments on the questionnaire. We are extremely grateful to Neil Furey for his many useful suggestions on the design of the survey and insightful comments on a previous version of this manuscript. This study is supported by the French ANR CP&ES BiodivHealthSEA project (grant ANR 11 CPEL 002; Local impacts and perceptions of global changes: Biodiversity, health and zoonoses in Southeast Asia).	Bjerke T, 2004, ANTHROZOOS, P109; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Buttke DE, 2015, J WILDLIFE DIS, V51, P1, DOI 10.7589/2014-01-004; Calcagno V, 2010, J STAT SOFTW, V34, P1; Cunningham AA, 2005, BRIT MED J, V331, P1214, DOI 10.1136/bmj.331.7527.1214; Davey GCL, 1998, BEHAV RES THER, V36, P735, DOI 10.1016/S0005-7967(98)00059-X; Davis C. E., 2012, THESIS; Furey Neil M., 2016, P463; Furey NM, 2010, BIODIVERS CONSERV, V19, P1821, DOI 10.1007/s10531-010-9806-0; Gay Noellie, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P161, DOI 10.1016/j.ijppaw.2014.06.003; Hayes MA, 2012, BIOSCIENCE, V62, P819, DOI 10.1525/bio.2012.62.9.7; Hoffmaster E, 2016, ANIMALS, V6, DOI 10.3390/ani6010006; Kane B, 1939, DETECTIVE COMICS, V1939; Kingston Tigga, 2016, P571; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387; Olival KJ, 2016, ECOHEALTH, V13, P6, DOI 10.1007/s10393-015-1075-7; Prokop P, 2009, ANTHROZOOS, V22, P19, DOI 10.2752/175303708X390446; Robins L.N., 1991, PSYCHIAT DISORDERS A; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Soderbergh S., 2011, CONTAGION, P106; Team RDC, 2019, R LANG ENV STAT COMP; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Voigt C.C., 2016, BATS ANTHROPOCENE CO; Word Medical Association, 1964, BRIT MED J, P177	25	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165969	10.1371/journal.pone.0165969	http://dx.doi.org/10.1371/journal.pone.0165969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832185	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000048
J	Borisev, M; Borisev, I; Zupunski, M; Arsenov, D; Pajevic, S; Curcic, Z; Vasin, J; Djordjevic, A				Borisev, Milan; Borisev, Ivana; Zupunski, Milan; Arsenov, Danijela; Pajevic, Slobodanka; Curcic, Zivko; Vasin, Jovica; Djordjevic, Aleksandar			Drought Impact Is Alleviated in Sugar Beets (Beta vulgaris L.) by Foliar Application of Fullerenol Nanoparticles	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; OXIDATIVE STRESS; LIPID-PEROXIDATION; PLANT; EXPRESSION; C-60(OH)(24); ARABIDOPSIS; INDUCTION; ENZYMES; PROTEIN	Over the past few years, significant efforts have been made to decrease the effects of drought stress on plant productivity and quality. We propose that fullerenol nanoparticles (FNPs, molecular formula C-60(OH)(24)) may help alleviate drought stress by serving as an additional intercellular water supply. Specifically, FNPs are able to penetrate plant leaf and root tissues, where they bind water in various cell compartments. This hydroscopic activity suggests that FNPs could be beneficial in plants. The aim of the present study was to analyse the influence of FNPs on sugar beet plants exposed to drought stress. Our results indicate that intracellular water metabolism can be modified by foliar application of FNPs in drought exposed plants. Drought stress induced a significant increase in the compatible osmolyte proline in both the leaves and roots of control plants, but not in FNP treated plants. These results indicate that FNPs could act as intracellular binders of water, creating an additional water reserve, and enabling adaptation to drought stress. Moreover, analysis of plant antioxidant enzyme activities (CAT, APx and GPx), MDA and GSH content indicate that fullerenol foliar application could have some beneficial effect on alleviating oxidative effects of drought stress, depending on the concentration of nanoparticles applied. Although further studies are necessary to elucidate the biochemical impact of FNPs on plants; the present results could directly impact agricultural practice, where available water supplies are often a limiting factor in plant bioproductivity.	[Borisev, Milan; Zupunski, Milan; Arsenov, Danijela; Pajevic, Slobodanka] Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia; [Borisev, Ivana; Djordjevic, Aleksandar] Univ Novi Sad, Dept Chem Biochem & Environm Protect, Fac Sci, Novi Sad, Serbia; [Curcic, Zivko; Vasin, Jovica] Inst Field & Vegetable Crops, Novi Sad, Serbia	University of Novi Sad; University of Novi Sad	Borisev, M (corresponding author), Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia.	milan.borisev@dbe.uns.ac.rs	Župunski, Milan/U-1696-2017; Arsenov, Danijela D/E-5508-2013; Curcic, Zivko/Y-1459-2019; Arsenov, Danijela/P-5868-2019; Borišev, Ivana/AAK-8961-2020; Borisev, Milan/ABG-7493-2020	Župunski, Milan/0000-0002-8576-1292; Curcic, Zivko/0000-0001-6029-0175; Arsenov, Danijela/0000-0002-1200-5023; Borisev, Milan/0000-0002-1833-002X; , Aleksandar/0000-0003-4120-7318	Ministry of Education, Science and Technological Development of the Republic of Serbia [III 045005]	Ministry of Education, Science and Technological Development of the Republic of Serbia	The authors acknowledge financial support of the Ministry of Education, Science and Technological Development of the Republic of Serbia (grant number III 045005).; Authors acknowledge financial support of the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant number III 045005). We thank dr Edward T. Petri, University of Novi Sad, for editing this manuscript for English language and content. This research was kindly supported by Sanja Muzikravic, chief laboratory technician and Milos I Bokorov, head of the Electron Microscopy Center at the University of Novi Sad, Serbia.	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Bakry R, 2007, INT J NANOMED, V2, P639; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUMONT F, 1990, PLANT SCI, V72, P19, DOI 10.1016/0168-9452(90)90182-N; Bogdanovic V, 2008, J RADIAT RES, V49, P321, DOI 10.1269/jrr.07092; Borsani O, 2001, PLANT SCI, V161, P757, DOI 10.1016/S0168-9452(01)00467-8; Bouwmeester H, 2009, REGUL TOXICOL PHARM, V53, P52, DOI 10.1016/j.yrtph.2008.10.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brant JA, 2006, LANGMUIR, V22, P3878, DOI 10.1021/la053293o; Canas JE, 2008, ENVIRON TOXICOL CHEM, V27, P1922, DOI 10.1897/08-117.1; Arruda SCC, 2015, TALANTA, V131, P693, DOI 10.1016/j.talanta.2014.08.050; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen R, 2010, SMALL, V6, P612, DOI 10.1002/smll.200901911; Clogston JD, 2011, METHODS MOL BIOL, V697, P63, DOI 10.1007/978-1-60327-198-1_6; Da Ros T, 2008, CARBON MATER-CHEM PH, V1, P1; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; Delfine S, 1998, AUST J PLANT PHYSIOL, V25, P395, DOI 10.1071/PP97161; Devasagayam TPA, 2003, INDIAN J BIOCHEM BIO, V40, P300; Djordjevic A, 1998, FULLERENE SCI TECHN, V6, P689, DOI 10.1080/10641229809350229; Djordjevic A, 2015, J NANOMATER, V2015, DOI 10.1155/2015/567073; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; Faisal M, 2013, J HAZARD MATER, V250, P318, DOI 10.1016/j.jhazmat.2013.01.063; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Ghorbanpour M, 2015, CARBON, V94, P749, DOI 10.1016/j.carbon.2015.07.056; Ghormade V, 2011, BIOTECHNOL ADV, V29, P792, DOI 10.1016/j.biotechadv.2011.06.007; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hossain MA, 2014, OXIDATIVE DAMAGE TO PLANTS: ANTIOXIDANT NETWORKS AND SIGNALING, P477, DOI 10.1016/B978-0-12-799963-0.00016-2; Husebo LO, 2004, J AM CHEM SOC, V126, P12055, DOI 10.1021/ja047593o; Husen A, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-16; ICUMSA, 1994, ICUMSA METH BOOK; Inagaki S, 2013, METHODS, V59, P287, DOI 10.1016/j.ymeth.2012.11.006; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; KAPETANOVIC IM, 1979, J PHARMACOL EXP THER, V209, P25; Kertesz A, 2014, INT SOIL WATER CONSE, V2, P91, DOI 10.1016/S2095-6339(15)30016-2; Khodakovskaya M, 2009, ACS NANO, V3, P3221, DOI 10.1021/nn900887m; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Kole C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-37; Letenko DG, 2011, RUSS J APPL CHEM+, V84, P50, DOI 10.1134/S1070427211010083; Lin SJ, 2009, SMALL, V5, P1128, DOI 10.1002/smll.200801556; Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578; Ma HL, 2010, SCI CHINA CHEM, V53, P2233, DOI 10.1007/s11426-010-4118-5; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Miralles P, 2014, J R SOC, V9, P3514; Mirkov SM, 2004, NITRIC OXIDE-BIOL CH, V11, P201, DOI 10.1016/j.niox.2004.08.003; Mondal A, 2011, J NANOPART RES, V13, P4519, DOI 10.1007/s11051-011-0406-z; Nair R, 2010, PLANT SCI, V179, P154, DOI 10.1016/j.plantsci.2010.04.012; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nielsen GD, 2008, BASIC CLIN PHARMACOL, V103, P197, DOI 10.1111/j.1742-7843.2008.00266.x; Nikolic N, 2008, ACTA BIOL CRACOV BOT, V50, P95; Nikravesh F, 2012, RUSS J PLANT PHYSL+, V59, P648, DOI 10.1134/S1021443712030132; Noctor G, 2015, PHYTOCHEMISTRY, V112, P33, DOI 10.1016/j.phytochem.2014.09.002; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; ordevic A., 2008, ARCH ONCOL, V16, P42, DOI [10.2298/AOO0804042D, DOI 10.2298/AOO0804042D, DOI 10.2298/AOO0804042]; Partha R, 2009, INT J NANOMED, V4, P261; Parthasarathy A., 2007, BIOMED ENG, V2, P1; Pitkethly MJ, 2004, MATER TODAY, V7, P20, DOI 10.1016/S1369-7021(04)00627-3; Prylutska S, 2012, J BIOMED NANOTECHNOL, V8, P522, DOI 10.1166/jbn.2012.1404; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Queval G, 2011, PLANT CELL ENVIRON, V34, P21, DOI 10.1111/j.1365-3040.2010.02222.x; Sapsford KE, 2011, ANAL CHEM, V83, P4453, DOI 10.1021/ac200853a; Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Semenov KN, 2011, J CHEM ENG DATA, V56, P230, DOI 10.1021/je100755v; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; SIMON LM, 1974, BIOCHEM PHYSIOL PFL, V166, P387; Singh B., 2012, TXB ANIMAL BIOTECHNO; Song U, 2013, BIOL TRACE ELEM RES, V155, P93, DOI 10.1007/s12011-013-9765-x; Spinoni J, 2015, GLOBAL PLANET CHANGE, V127, P50, DOI 10.1016/j.gloplacha.2015.01.012; Stankov K, 2013, J NANOSCI NANOTECHNO, V13, P105, DOI 10.1166/jnn.2013.6847; Tiwari DK, 2014, APPL NANOSCI, V4, P577, DOI 10.1007/s13204-013-0236-7; Tommerup E.C., 1934, FIELD DESCRIPTION PH, P155; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Vileno B, 2006, ADV FUNCT MATER, V16, P120, DOI 10.1002/adfm.200500425; Villagarcia H, 2012, SMALL, V8, P2328, DOI 10.1002/smll.201102661; Weng MY, 2015, PAK J BOT, V47, P49; Yoshimura K, 2000, PLANT PHYSIOL, V123, P223, DOI 10.1104/pp.123.1.223; YSSS-Yugoslav Soil Science Society, 1966, ISP ZEMLJ, P124; YSSS-Yugoslav Soil Science Society, 1997, PRIR ISP ZEMLJ, P17; Zhao LJ, 2012, ACS NANO, V6, P9615, DOI 10.1021/nn302975u	88	49	49	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166248	10.1371/journal.pone.0166248	http://dx.doi.org/10.1371/journal.pone.0166248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832171	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000084
J	Hsu, CY; Chen, BS				Hsu, Chih-Yuan; Chen, Bor-Sen			Systematic Design of a Metal Ion Biosensor: A Multi-Objective Optimization Approach	PLOS ONE			English	Article							COMBINATORIAL PROMOTER DESIGN; NONLINEAR DYNAMIC-SYSTEMS; TRACKING CONTROL DESIGN; S-ADENOSYLMETHIONINE; WASTE-WATER; GENE; NOISE; IDENTIFICATION; REMOVAL	With the recent industrial expansion, heavy metals and other pollutants have increasingly contaminated our living surroundings. Heavy metals, being non-degradable, tend to accumulate in the food chain, resulting in potentially damaging toxicity to organisms. Thus, techniques to detect metal ions have gradually begun to receive attention. Recent progress in research on synthetic biology offers an alternative means for metal ion detection via the help of promoter elements derived from microorganisms. To make the design easier, it is necessary to develop a systemic design method for evaluating and selecting adequate components to achieve a desired detection performance. A multi-objective (MO) H-2/H-infinity performance criterion is derived here for design specifications of a metal ion biosensor to achieve the H-2 optimal matching of a desired input/output (I/O) response and simultaneous H-infinity optimal filtering of intrinsic parameter fluctuations and external cellular noise. According to the two design specifications, a Takagi-Sugeno (T-S) fuzzy model is employed to interpolate several local linear stochastic systems to approximate the nonlinear stochastic metal ion biosensor system so that the multi-objective H-2/H-infinity design of the metal ion biosensor can be solved by an associated linear matrix inequality (LMI)-constrained multi-objective (MO) design problem. The analysis and design of a metal ion biosensor with optimal I/O response matching and optimal noise filtering ability then can be achieved by solving the multi-objective problem under a set of LMIs. Moreover, a multi-objective evolutionary algorithm (MOEA)-based library search method is employed to find adequate components from corresponding libraries to solve LMI-constrained MO H-2/H-infinity design problems. It is a useful tool for the design of metal ion biosensors, particularly regarding the tradeoffs between the design factors under consideration.	[Hsu, Chih-Yuan; Chen, Bor-Sen] Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu 30013, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu 30013, Taiwan.	bsehen@ee.nthu.edu.tw	Chen, Bor-Sen/D-9114-2017	Chen, Bor-Sen/0000-0003-1644-6106	Ministry of Science and Technology, Taiwan [MOST-103-2745-E-007-001-ASP]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors are grateful for the support provided by the Ministry of Science and Technology, Taiwan through grant no. MOST-103-2745-E-007-001-ASP.; The authors are grateful for the support provided by the Ministry of Science and Technology, Taiwan through grant no. MOST 103-2745-E-007-001-ASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Ayala FJ, 2007, P NATL ACAD SCI USA, V104, P8567, DOI 10.1073/pnas.0701072104; Back T., 1997, IEEE Transactions on Evolutionary Computation, V1, P3, DOI 10.1109/4235.585888; Bajic D., 2012, BMC GENOMICS, P13; Balazsi G, 2007, FEBS J, V274, P258; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chen B.S., 2008, BMC SYSTEMS BIOL, V2; Chen B.S., 2006, BMC BIOINFORMATICS, V7; Chen BS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/304236; Chen BS, 2004, IEEE T AUTOMAT CONTR, V49, P45, DOI 10.1109/TAC.2003.821400; Chen BS, 1999, IEEE T FUZZY SYST, V7, P571, DOI 10.1109/91.797980; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; HARTWIG A, 1995, BIOMETALS, V8, P3; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hobman J.L., 2012, BMC MICROBIOL, P12; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Ngah WSW, 2008, BIORESOURCE TECHNOL, V99, P3935, DOI 10.1016/j.biortech.2007.06.011; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rezvani-Boroujeni A, 2015, IND ENG CHEM RES, V54, P502, DOI 10.1021/ie504106y; Singha AS, 2014, INT J BIOL MACROMOL, V67, P409, DOI 10.1016/j.ijbiomac.2014.03.046; Taghavi S, 1997, RES MICROBIOL, V148, P536, DOI 10.1016/S0923-2508(97)88361-1; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Teodosiu C, 2014, REV CHEM ENG, V30, P403, DOI 10.1515/revce-2013-0036; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tseng CS, 2001, IEEE T FUZZY SYST, V9, P381, DOI 10.1109/91.928735; Tseng CS, 2001, IEEE T FUZZY SYST, V9, P795, DOI 10.1109/91.971729; Val DL, 1998, J BACTERIOL, V180, P2644, DOI 10.1128/JB.180.10.2644-2651.1998; Zhang HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038111; Zhang WH, 2005, IEEE T SIGNAL PROCES, V53, P589, DOI 10.1109/TSP.2004.840724	43	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165911	10.1371/journal.pone.0165911	http://dx.doi.org/10.1371/journal.pone.0165911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832110	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000039
J	Janiszewska, J; Posadas, I; Jativa, P; Bugaj-Zarebska, M; Urbanczyk-Lipkowska, Z; Cena, V				Janiszewska, Jolanta; Posadas, Inmaculada; Jativa, Pablo; Bugaj-Zarebska, Marta; Urbanczyk-Lipkowska, Zofia; Cena, Valentin			Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes	PLOS ONE			English	Article							MEDIATED GENE DELIVERY; SIRNA DELIVERY; DENDRIMERS; PEPTIDE; ACTIVATION; MEMBRANE; POLY(L-LYSINE); TRANSFECTION; HIF-1-ALPHA; APOPTOSIS	Glioblastomas are the most common malignant primary brain tumours in adults and one of the most aggressive and difficult-to-treat cancers. No effective treatment exits actually for this tumour and new therapeutic approaches are needed for this disease. One possible innovative approach involves the nanoparticle-mediated specific delivery of drugs and/or genetic material to glioblastoma cells where they can provide therapeutic benefits. In the present work, we have synthesised and characterised several second generation amphiphilic polylysine dendrons to be used as siRNA carriers. We have found that, in addition to their siRNA binding properties, these new compounds inhibit the proliferation of two glioblastoma cell lines while being nontoxic for non-tumoural central nervous system cells like neurons and glia, cell types that share the anatomical space with glioblastoma cells during the course of the disease. The selective toxicity of these nanoparticles to glioblastoma cells, as compared to neurons and glial cells, involves mitochondrial depolarisation and reactive oxygen species production. This selective toxicity, together with the ability to complex and release siRNA, suggests that these new polylysine dendrons might offer a scaffold in the development of future nanoparticles designed to restrict the proliferation of glioblastoma cells.	[Janiszewska, Jolanta] Inst Ind Res, Warsaw, Poland; [Posadas, Inmaculada; Jativa, Pablo; Cena, Valentin] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Bugaj-Zarebska, Marta; Urbanczyk-Lipkowska, Zofia] PAS, Inst Organ Chem, Warsaw, Poland; [Posadas, Inmaculada; Jativa, Pablo; Cena, Valentin] Univ Castilla La Mancha, Unidad Asociada Neurodeath, Fac Med, Albacete, Spain	CIBERNED; Instituto de Salud Carlos III; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Universidad de Castilla-La Mancha	Cena, V (corresponding author), Inst Salud Carlos III, CIBERNED, Madrid, Spain.; Cena, V (corresponding author), Univ Castilla La Mancha, Unidad Asociada Neurodeath, Fac Med, Albacete, Spain.	valentin.cena@gmail.com	Janiszewska, Jolanta/W-4148-2018; Cena, Valentin/L-1751-2017; Posadas, Inmaculada/M-1124-2014	Janiszewska, Jolanta/0000-0003-0958-8018; Cena, Valentin/0000-0001-8928-3681; Posadas, Inmaculada/0000-0003-1854-3372; Jativa Carbajal, Pablo/0000-0003-0288-9416; Urbanczyk-Lipkowska, Zofia/0000-0003-2043-487X; Bugaj-Zarebska, Marta/0000-0002-8308-0450	MINECO [BFU2014-59009-P]; CYTED [214RT0482]; NCN [UMO-2012/07/B/ST5/01941]	MINECO(Spanish Government); CYTED; NCN	Support was provided by: MINECO Grant no. BFU2014-59009-P to VC; CYTED grant no. 214RT0482 to VC; and NCN grant no UMO-2012/07/B/ST5/01941 to ZU-L.	Agrawal A, 2009, ACS NANO, V3, P2495, DOI 10.1021/nn900201e; Al-Jamal KT, 2010, P NATL ACAD SCI USA, V107, P3966, DOI 10.1073/pnas.0908401107; [Anonymous], 2016, NANOMEDICINE-UK, V11, P833; [Anonymous], 2010, NANOMEDICINE-UK, V5, P1219; Battigelli A, 2013, SMALL, V9, P3610, DOI 10.1002/smll.201300264; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Celardo I, 2014, BRIT J PHARMACOL, V171, P1943, DOI 10.1111/bph.12433; Cho KC, 2005, MACROMOL BIOSCI, V5, P512, DOI 10.1002/mabi.200500018; Coantic S, 2008, INT J PEPT RES THER, V14, P143, DOI 10.1007/s10989-008-9123-6; Cookson MR, 1998, J NEUROCHEM, V70, P501; Curtis Carol D., 2009, V505, P187, DOI 10.1007/978-1-60327-575-0_11; Fruchon S, 2009, J LEUKOCYTE BIOL, V85, P553, DOI 10.1189/jlb.0608371; Ghosh PS, 2008, ACS NANO, V2, P2213, DOI 10.1021/nn800507t; Guerra J, 2012, CARBON, V50, P2832, DOI 10.1016/j.carbon.2012.02.050; Inoue Y, 2008, J CONTROL RELEASE, V126, P59, DOI 10.1016/j.jconrel.2007.10.022; Janiszewska J, 2012, BIOORG MED CHEM LETT, V22, P1388, DOI 10.1016/j.bmcl.2011.12.051; Jobin ML, 2013, BBA-BIOMEMBRANES, V1828, P1457, DOI 10.1016/j.bbamem.2013.02.008; Jordan J, 2004, J NEUROCHEM, V89, P124, DOI 10.1046/j.1471-4159.2003.02299.x; Kaneshiro TL, 2007, MOL PHARMACEUT, V4, P759, DOI 10.1021/mp070036z; Kim WJ, 2009, PHARM RES-DORDR, V26, P657, DOI 10.1007/s11095-008-9774-1; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kwok A, 2013, ACS NANO, V7, P4668, DOI 10.1021/nn400343z; Lipton SA, 1998, CELL CALCIUM, V23, P165, DOI 10.1016/S0143-4160(98)90115-4; Liu XX, 2015, NANOSCALE, V7, P3867, DOI 10.1039/c4nr04759a; Lopez-Hernandez B, 2012, EXP NEUROL, V233, P543, DOI 10.1016/j.expneurol.2011.11.040; Ma D, 2013, J COLLOID INTERF SCI, V405, P305, DOI 10.1016/j.jcis.2013.05.017; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Malhotra S, 2012, BIOMACROMOLECULES, V13, P3087, DOI 10.1021/bm300892v; Malkoch M, 2002, MACROMOLECULES, V35, P8307, DOI 10.1021/ma0205360; Monteagudo S, 2012, NANOMEDICINE-UK, V7, P493, DOI [10.2217/NNM.11.61, 10.2217/nnm.11.61]; Olson JJ, 2014, J NEURO-ONCOL, V118, P427, DOI 10.1007/s11060-014-1431-4; Papadopoulos A, 2012, MOL PHARMACEUT, V9, P394, DOI 10.1021/mp200490b; Parat A, 2015, NANOMEDICINE-UK, V10, P977, DOI [10.2217/NNM.14.196, 10.2217/nnm.14.196]; Perez-Carrion MD, 2013, PHARM RES-DORDR, V30, P2584, DOI 10.1007/s11095-013-1049-9; Perez-Carrion MD, 2012, J NEUROCHEM, V120, P259, DOI 10.1111/j.1471-4159.2011.07556.x; Perez-Martinez FC, 2011, PHARM RES-DORDR, V28, P1843, DOI 10.1007/s11095-010-0364-7; Polcyn P, 2013, MOLECULES, V18, P7120, DOI 10.3390/molecules18067120; Posadas I, 2012, J NEUROCHEM, V120, P515, DOI 10.1111/j.1471-4159.2011.07599.x; Posadas I, 2009, PHARM RES-DORDR, V26, P1181, DOI 10.1007/s11095-009-9839-9; Rekdal O, 2012, J BIOL CHEM, V287, P233, DOI 10.1074/jbc.M111.279281; Rodrigo AC, 2011, BIOMACROMOLECULES, V12, P1205, DOI 10.1021/bm1014987; Sadler Kristen, 2002, J Biotechnol, V90, P195; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shcharbin D, 2014, J CONTROL RELEASE, V181, P40, DOI 10.1016/j.jconrel.2014.02.021; Venur VA, 2015, CANCER TREAT RES, V163, P103, DOI 10.1007/978-3-319-12048-5_7; Weller M, 2014, INT J CANCER, V134, P2437, DOI 10.1002/ijc.28576; Woehrer A, 2014, CURR OPIN NEUROL, V27, P666, DOI 10.1097/WCO.0000000000000144; Wong HL, 2010, ADV DRUG DELIVER REV, V62, P503, DOI 10.1016/j.addr.2009.11.020; Zhao J, 2014, ARCH PHARM, V347, P469, DOI 10.1002/ardp.201300415	50	25	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165704	10.1371/journal.pone.0165704	http://dx.doi.org/10.1371/journal.pone.0165704			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832093	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000028
J	Rienstra, M; Geelhoed, B; Yin, XY; Siland, JE; Vermond, RA; Mulder, BA; Van Der Harst, P; Hillege, HL; Benjamin, EJ; Van Gelder, IC				Rienstra, Michiel; Geelhoed, Bastiaan; Yin, Xiaoyan; Siland, Joylene E.; Vermond, Rob A.; Mulder, Bart A.; Van Der Harst, Pim; Hillege, Hans L.; Benjamin, Emelia J.; Van Gelder, Isabelle C.			Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations	PLOS ONE			English	Article							ASSOCIATION CONSENSUS CONFERENCE; LATENT CLASS ANALYSIS; PROGNOSIS; COHORT	Background Risk prediction of atrial fibrillation (AF) is of importance to improve the early diagnosis and treatment of AF. Latent class analysis takes into account the possible existence of classes of individuals each with shared risk factors, and maybe a better method of incorporating the phenotypic heterogeneity underlying AF. Methods and findings Two prospective community-based cohort studies from Netherlands and United States were used. Prevention of Renal and Vascular End-stage Disease (PREVEND) study, started in 1997, and the Framingham Heart Study (FHS) Offspring cohort started in 1971, both with 10-years follow-up. The main objective was to determine the risk of AF using a latent class analysis, and compare the discrimination and reclassification performance with traditional regression analysis. Mean age in PREVEND was 49 13 years, 49.8% were men. During follow-up, 250(3%) individuals developed AF. We built a latent class model based on 18 risk factors. A model with 7 distinct classes (ranging from 341 to 1517 individuals) gave the optimum tradeoff between a high statistical model-likelihood and a low number of model parameters. All classes had a specific profile. The incidence of AF varied; class 1 0.0%, class 2 0.3%, class 3 7.5%, class 4 0.2%, class 5 1.3%, class 6 4.2%, class 7 21.7% (p<0.001). The discrimination (C-statistic 0.830 vs. 0.842, delta-C -0.013, p = 0.22) and reclassification (IDI-0.028, p<0.001, NRI-0.090, p = 0.049, and category-less-NRI -0.049, p = 0.495) performance of both models was comparable. The results were successfully replicated in a sample of the FHS study (n = 3162; mean age 58 9 years, 46.3% men). Conclusions Latent class analysis to build an AF risk model is feasible. Despite the heterogeneity in number and severity of risk factors between individuals at risk for AF, latent class analysis produces distinguishable groups.	[Rienstra, Michiel; Geelhoed, Bastiaan; Siland, Joylene E.; Vermond, Rob A.; Mulder, Bart A.; Van Der Harst, Pim; Hillege, Hans L.; Van Gelder, Isabelle C.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Yin, Xiaoyan; Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Yin, Xiaoyan; Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Groningen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Boston University; Boston University; Boston University	Rienstra, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	m.rienstra@umcg.nl	Benjamin, Emelia/E-7103-2011; Mulder, Bart/AAU-3871-2020	Benjamin, Emelia/0000-0003-4076-2336; Mulder, Bart/0000-0002-4411-3918; Rienstra, Michiel/0000-0002-2581-070X; Siland, Joylene/0000-0003-4404-1245	Dutch Kidney Foundation [E0.13]; Netherlands Heart Foundation [NHS2010B280]; Netherlands Organization for Scientific Research (Veni) [016.136.055]; EHRA Academic Fellowship program;  [HHSN268201500001I];  [N01-HC 25195];  [2R01HL092577];  [1R01HL128914]	Dutch Kidney Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research (Veni)(Netherlands Organization for Scientific Research (NWO)); EHRA Academic Fellowship program; ; ; ; 	The PREVEND study is supported by the Dutch Kidney Foundation (grant E0.13) and the Netherlands Heart Foundation (grant NHS2010B280). Dr. M. Rienstra is supported by grants from the Netherlands Organization for Scientific Research (Veni grant 016.136.055) and from the EHRA Academic Fellowship program. The FHS is supported by HHSN268201500001I, N01-HC 25195, 2R01HL092577, and 1R01HL128914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Altman RB, 2015, CIRCULATION, V131, P232, DOI 10.1161/CIRCULATIONAHA.114.014106; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Elia J, 2009, PSYCHIAT RES, V170, P192, DOI 10.1016/j.psychres.2008.10.008; Frost L, 2005, AM J MED, V118, P489, DOI 10.1016/j.amjmed.2005.01.031; Ganesalingam J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007107; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kao DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048184; Kirchhof P, 2013, EUROPACE, V15, P1540, DOI 10.1093/europace/eut232; Kirchhof P, 2012, EUROPACE, V14, P8, DOI 10.1093/europace/eur241; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lanza ST, 2013, STRUCT EQU MODELING, V20, P1, DOI 10.1080/10705511.2013.742377; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Vermond RA, 2015, J AM COLL CARDIOL, V66, P1000, DOI 10.1016/j.jacc.2015.06.1314; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165828	10.1371/journal.pone.0165828	http://dx.doi.org/10.1371/journal.pone.0165828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832125	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000036
J	van't Boveneind-Vrubleuskaya, N; Daskapan, A; Kosterink, JGW; van der Wert, TS; van den Hof, S; Alffenaar, JWC				van't Boveneind-Vrubleuskaya, Natasha; Daskapan, Alper; Kosterink, Jos G. W.; van der Wert, Tjip S.; van den Hof, Susan; Alffenaar, Jan-Willem C.			Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting	PLOS ONE			English	Article							INDUCED LIVER-INJURY; DRUG-INDUCED HEPATOTOXICITY; TUBERCULOSIS TREATMENT; SPUTUM SMEAR; PULMONARY TUBERCULOSIS; ANTITUBERCULOSIS TREATMENT; CULTURE CONVERSION; TREATMENT OUTCOMES; FOLLOW-UP; PHARMACOGENETICS	Introduction Standard treatment duration for drug-susceptible tuberculosis (TB) treatment is 6 months. Treatment duration is often extended-and for various different reasons. The aim of this study was to determine the prevalence and to assess risk factors associated with extended TB treatment. Methods A cross-sectional study was conducted. Data including demographic, clinical, radiological and microbiological information from the Netherlands TB Register (NTR) of 90 patients with smear and culture positive pulmonary TB of the region Haaglanden, The Netherlands, was eligible for analysis. Results Treatment was extended to >= 200 days by 46 (51%) patients. Extended TB treatment was associated with a higher frequency of symptoms, presumed to be due to adverse drug reactions (ADR; OR 2.39 95% CI: 1.01-5.69), drug-induced liver injury (DILI) (OR: 13.51; 95% CI: 1.66-109.82) and longer than 2 month smear and culture conversion rate (OR: 11.00; 95% CI: 1.24-97.96 and OR: 8.56; 95% CI: 1.53-47.96). In the multivariable logistic analysis, development of DILI emerged as the single statistically strong risk factor necessitating extension of TB treatment. Conclusion This finding will need further confirmation in a prospective study, exploring the possible mutual role of pharmacokinetic and pharmacogenetic determinants of DILI among TB patients.	[van't Boveneind-Vrubleuskaya, Natasha] Metropolitan Publ Hlth Serv, Dept Publ Hlth TB Control, The Hague, Netherlands; [van't Boveneind-Vrubleuskaya, Natasha; Daskapan, Alper; Kosterink, Jos G. W.; Alffenaar, Jan-Willem C.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [van den Hof, Susan] KNCV TB Fdn, The Hague, Netherlands; [van den Hof, Susan] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [van der Wert, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands	University of Groningen; KNCV Tuberculosis Foundation; University of Groningen	van't Boveneind-Vrubleuskaya, N (corresponding author), Metropolitan Publ Hlth Serv, Dept Publ Hlth TB Control, The Hague, Netherlands.; van't Boveneind-Vrubleuskaya, N (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	natasha.boveneind@ggdhaaglanden.nl		Daskapan, Alper/0000-0003-4744-6619; van der Werf, Tjip/0000-0002-4824-1642; Kosterink, Jos/0000-0001-8358-765X				Azuma J, 2013, EUR J CLIN PHARMACOL, V69, P1091, DOI 10.1007/s00228-012-1429-9; Ben Fredj N, 2017, PHARMACOGENOMICS J, V17, P372, DOI 10.1038/tpj.2016.26; Mota PC, 2012, REV PORT PNEUMOL, V18, P72, DOI 10.1016/j.rppneu.2011.12.005; Chang KC, 2007, EUR RESPIR J, V29, P347, DOI 10.1183/09031936.00090306; Choi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-360; Clancy L., 1990, LUNG DIS, V65, P70; Cojutti P, 2016, J ANTIMICROB CHEMOTH, V71, P1323, DOI 10.1093/jac/dkv490; Gomes NMDF, 2015, PULM MED, V2015, DOI 10.1155/2015/546106; De Vries G, 2014, EURO SURVEILL, V19; Dossing M, 1996, TUBERCLE LUNG DIS, V77, P335, DOI 10.1016/S0962-8479(96)90098-2; Finney L, 2013, EUR RESP J S57, V42, pP4684; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Heysell SK, 2010, EMERG INFECT DIS, V16, P1546, DOI 10.3201/eid1610.100374; Jeong I, 2015, J KOREAN MED SCI, V30, P167, DOI 10.3346/jkms.2015.30.2.167; Kimerling ME, 1998, CHEST, V113, P1178, DOI 10.1378/chest.113.5.1178; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lee J, 2012, INT J TUBERC LUNG D, V16, P1344, DOI 10.5588/ijtld.12.0113; Lienhardt C, 1998, INT J TUBERC LUNG D, V2, P712; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Magis-Escurra C, 2014, INT J ANTIMICROB AG, V44, P229, DOI 10.1016/j.ijantimicag.2014.04.019; Matsumoto T, 2014, PHARMACOGENOMICS, V15, P601, DOI 10.2217/pgs.14.38; Mehta JB, 2001, CHEST, V120, P1520, DOI 10.1378/chest.120.5.1520; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; National Collaborating Centre for Chronic Conditions (UK), 2006, TUB CLIN DIAGN MAN T; Nijland HMJ, 2006, CLIN INFECT DIS, V43, P848, DOI 10.1086/507543; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Pasipanodya JG, 2012, INT J TUBERC LUNG D, V16, P706, DOI 10.5588/ijtld.11.0850; Peloquin CA, 2002, DRUGS, V62, P2169, DOI 10.2165/00003495-200262150-00001; Ramarokoto H, 2002, INT J TUBERC LUNG D, V6, P909; Rieder HL, 1996, TUBERCLE LUNG DIS, V77, P124, DOI 10.1016/S0962-8479(96)90026-X; Salaniponi FML, 1999, INT J TUBERC LUNG D, V3, P1047; Satyaraddi A, 2014, INT J TUBERC LUNG D, V18, P188, DOI 10.5588/ijtld.13.0128; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Singla R, 2003, INT J TUBERC LUNG D, V7, P58; Society AT, 2003, REC REP AM THOR SOC, V52, P1; Sotsuka T, 2011, IN VIVO, V25, P803; Su WJ, 2011, EUR RESPIR J, V37, P376, DOI 10.1183/09031936.00007410; Sun F, 2008, INT J TUBERC LUNG D, V12, P994; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; TSAGAROPOULOUSTINGA H, 1985, PEDIATR INFECT DIS J, V4, P270, DOI 10.1097/00006454-198505000-00013; Valin N, 2009, INT J TUBERC LUNG D, V13, P881; Wang JY, 2009, RESPIROLOGY, V14, P1012, DOI 10.1111/j.1440-1843.2009.01598.x; Wang PY, 2012, INT J TUBERC LUNG D, V16, P589, DOI 10.5588/ijtld.11.0377; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2014, GLOB TUB REP; Yew WW, 2011, EUR RESPIR J, V37, P441, DOI 10.1183/09031936.00033010; Zhang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147744; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	51	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166030	10.1371/journal.pone.0166030	http://dx.doi.org/10.1371/journal.pone.0166030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832142	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000055
J	Nyirenda, M; Omori, R; Tessmer, HL; Arimura, H; Ito, K				Nyirenda, Mayumbo; Omori, Ryosuke; Tessmer, Heidi L.; Arimura, Hiroki; Ito, Kimihito			Estimating the Lineage Dynamics of Human Influenza B Viruses	PLOS ONE			English	Article							SEASONAL INFLUENZA; EPIDEMIC MODEL; CROSS-IMMUNITY; SELECTION; VACCINE	The prediction of the lineage dynamics of influenza B viruses for the next season is one of the largest obstacles for constructing an appropriate influenza trivalent vaccine. Seasonal fluctuation of transmissibility and epidemiological interference between the two major influenza B lineages make the lineage dynamics complicated. Here we construct a parsimonious model describing the lineage dynamics while taking into account seasonal fluctuation of transmissibility and epidemiological interference. Using this model we estimated the epidemiological and evolutional parameters with the time-series data of the lineage specific isolates in Japan from the 2010-2011 season to the 2014-2015 season. The basic reproduction number is similar between Victoria and Yamagata, with a minimum value during one year as 0.82 (95% highest posterior density (HPD): 0.77-0.87) for the Yamagata and 0.83 (95% HPD: 0.74-0.92) for Victoria, the amplitude of seasonal variation of the basic reproduction number is 0.77 (95% HPD: 0.66-0.87) for Yamagata and 1.05 (95% HPD: 0.89-1.02) for Victoria. The duration for which the acquired immunity is effective against infection by the Yamagata lineage is shorter than the acquired immunity for Victoria, 424.1days (95% HPD: 317.4-561.5days). The reduction rate of susceptibility due to immune cross-reaction is 0.51 (95% HPD: 0.084-0.92) for the immunity obtained from the infection with Yamagata against the infection with Victoria and 0.62 (95% HPD: 0.42-0.80) for the immunity obtained from the infection with Victoria against the infection with Yamagata. Using estimated parameters, we predicted the dominant lineage in 2015-2016 season. The accuracy of this prediction is 68.8% if the emergence timings of the two lineages are known and 61.4% if the emergence timings are unknown. Estimated seasonal variation of the lineage specific reproduction number can narrow down the range of emergence timing, with an accuracy of 64.6% if the emergence times are assumed to be the time at which the estimated reproduction number exceeds one.	[Nyirenda, Mayumbo; Arimura, Hiroki] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Omori, Ryosuke; Tessmer, Heidi L.; Ito, Kimihito] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Omori, Ryosuke] JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Omori, R (corresponding author), Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.; Omori, R (corresponding author), JST, PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	omori@czc.hokudai.ac.jp	Ito, Kimihito/E-9975-2012	Ito, Kimihito/0000-0003-4986-1795	CREST, Japan Science and Technology Agency; PRESTO, Japan Science and Technology Agency; PRESTO, JST; Grants-in-Aid for Scientific Research [16J02715] Funding Source: KAKEN	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); PRESTO, JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by CREST, Japan Science and Technology Agency (http:// www.jst.go.jp/kisoken/crest/en/index.html) to RO and KI; PRESTO, Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/presto/en/ index.html) to RO.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by CREST, Japan Science and Technology Agency (JST) to RO and KI, PRESTO, JST to RO. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-38; CASTILLOCHAVEZ C, 1989, J MATH BIOL, V27, P233, DOI 10.1007/BF00275810; Glezen WP, 2014, CLIN INFECT DIS, V59, P1525, DOI 10.1093/cid/ciu668; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Hopping AM, 2016, VACCINE, V34, P1617, DOI 10.1016/j.vaccine.2016.01.042; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025953; Kamo M, 2002, PHYSICA D, V165, P228, DOI 10.1016/S0167-2789(02)00389-5; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Minayev P, 2009, J R SOC INTERFACE, V6, P509, DOI 10.1098/rsif.2008.0333; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Omori R, 2013, J THEOR BIOL, V329, P32, DOI 10.1016/j.jtbi.2013.03.027; Rohani P, 1998, P ROY SOC B-BIOL SCI, V265, P2033, DOI 10.1098/rspb.1998.0537; SCHWARTZ IB, 1983, J MATH BIOL, V18, P233, DOI 10.1007/BF00276090; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Skowronski DM, 2011, PEDIATRICS, V128, pE276, DOI 10.1542/peds.2010-2777; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; Xu CL, 2015, AM J EPIDEMIOL, V182, P705, DOI 10.1093/aje/kwv110	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166107	10.1371/journal.pone.0166107	http://dx.doi.org/10.1371/journal.pone.0166107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829058	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300081
J	Garcia, ES; Swann, ALS; Villegas, JC; Breshears, DD; Law, DJ; Saleska, SR; Stark, SC				Garcia, Elizabeth S.; Swann, Abigail L. S.; Villegas, Juan C.; Breshears, David D.; Law, Darin J.; Saleska, Scott R.; Stark, Scott C.			Synergistic Ecoclimate Teleconnections from Forest Loss in Different Regions Structure Global Ecological Responses	PLOS ONE			English	Article							SCALE DEFORESTATION; BOREAL FOREST; CLIMATE; VEGETATION; DROUGHT; IMPACT; FEEDBACKS; DYNAMICS; MONSOON; FLUXES	Forest loss in hotspots around the world impacts not only local climate where loss occurs, but also influences climate and vegetation in remote parts of the globe through ecoclimate teleconnections. The magnitude and mechanism of remote impacts likely depends on the location and distribution of forest loss hotspots, but the nature of these dependencies has not been investigated. We use global climate model simulations to estimate the distribution of ecologically-relevant climate changes resulting from forest loss in two hotspot regions: western North America (wNA), which is experiencing accelerated dieoff, and the Amazon basin, which is subject to high rates of deforestation. The remote climatic and ecological net effects of simultaneous forest loss in both regions differed from the combined effects of loss from the two regions simulated separately, as evident in three impacted areas. Eastern South American Gross Primary Productivity (GPP) increased due to changes in seasonal rainfall associated with Amazon forest loss and changes in temperature related to wNA forest loss. Eurasia's GPP declined with wNA forest loss due to cooling temperatures increasing soil ice volume. Southeastern North American productivity increased with simultaneous forest loss, but declined with only wNA forest loss due to changes in VPD. Our results illustrate the need for a new generation of local-to-global scale analyses to identify potential ecoclimate teleconnections, their underlying mechanisms, and most importantly, their synergistic interactions, to predict the responses to increasing forest loss under future land use change and climate change.	[Garcia, Elizabeth S.; Swann, Abigail L. S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Swann, Abigail L. S.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Villegas, Juan C.] Univ Antioquia, Escuela Ambiental, Calle 67 53-108, Medellin, Colombia; [Villegas, Juan C.; Breshears, David D.; Law, Darin J.] Univ Arizona, Sch Nat Resources & Environm, ENRII, 1064 E Lowell St,N227, Tucson, AZ 85721 USA; [Breshears, David D.; Saleska, Scott R.] Univ Arizona, Dept Ecol & Evolutionary Biol, 1064 E Lowell St,N227, Tucson, AZ 85721 USA; [Stark, Scott C.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universidad de Antioquia; University of Arizona; University of Arizona; Michigan State University	Garcia, ES (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	esgarcia@uw.edu	Breshears, David D/GSN-3920-2022; Breshears, David D./B-9318-2009; Saleska, Scott R/K-1733-2016	Breshears, David D./0000-0001-6601-0058; Saleska, Scott R/0000-0002-4974-3628; Stark, Scott C/0000-0002-1579-1648; Villegas, Juan Camilo/0000-0001-5048-921X; Swann, Abigail/0000-0001-8513-1074	National Science Foundation [EF-1340649, EF-1340624, EF-1340604, EF-1550641, EF-1550686, EF-1550756]; Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; Estrategia de Sostenibilidad at the Universidad de Antioquia; Direct For Biological Sciences [1340649] Funding Source: National Science Foundation; Division Of Environmental Biology [1550686, 1340624] Funding Source: National Science Foundation; Emerging Frontiers [1550641] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; Estrategia de Sostenibilidad at the Universidad de Antioquia; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported primarily through the National Science Foundation EF-1340649 to the University of Washington, EF-1340624 to the University of Arizona, and EF-1340604 to Michigan State University (www.nsf.gov). Additional support was provided through the National Science foundation EF-1550641 to the University of Washington, EF-1550686 to Michigan State University, EF-1550756 to the University of Arizona, to S.R.S. by the Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona (haury.arizona.edu), and to J.C.V. by the Estrategia de Sostenibilidad 2014-2015 at the Universidad de Antioquia (http./Avww.udea.edu.co/). The Community Earth System Model project is supported by the National Science Foundation and the Office of Science (BER) of the U.S. Department of Energy. Computing resources were provided by the Climate Simulation Laboratory at National Center for Atmospheric Research's Computational and Information Systems Laboratory, sponsored by the National Science Foundation and other agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkama R, 2016, SCIENCE, V351, P600, DOI 10.1126/science.aac8083; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Asner GP, 2016, P NATL ACAD SCI USA, V113, pE249, DOI 10.1073/pnas.1523397113; Avissar R, 2005, J HYDROMETEOROL, V6, P134, DOI 10.1175/JHM406.1; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Betts R, 2008, PHILOS T R SOC B, V363, P1873, DOI 10.1098/rstb.2007.0027; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chen GS, 2012, J CLIMATE, V25, P4511, DOI 10.1175/JCLI-D-11-00317.1; Claussen M, 2001, GEOPHYS RES LETT, V28, P1011, DOI 10.1029/2000GL012471; Cohen J, 1999, GEOPHYS RES LETT, V26, P345, DOI 10.1029/1998GL900321; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Devaraju N, 2015, P NATL ACAD SCI USA, V112, P3257, DOI 10.1073/pnas.1423439112; DICKINSON RE, 1992, GEOPHYS RES LETT, V19, P1947, DOI 10.1029/92GL01905; Donohoe A, 2014, P NATL ACAD SCI USA, V111, P16700, DOI 10.1073/pnas.1412190111; Doughty CE, 2015, NATURE, V519, P78, DOI 10.1038/nature14213; Fisher RA, 2015, GEOSCI MODEL DEV, V8, P3593, DOI 10.5194/gmd-8-3593-2015; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; Frierson DMW, 2012, J CLIMATE, V25, P720, DOI 10.1175/JCLI-D-11-00116.1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Hunke EC, 2012, CICE LOS ALAMOS SEA; Koven CD, 2015, P NATL ACAD SCI USA, V112, P3752, DOI 10.1073/pnas.1415123112; Lawrence, 2013, TECHNICAL DESCRIPTIO, P434, DOI DOI 10.5065/D6RR1W7M; Ma D, 2013, CLIM DYNAM, V41, P2439, DOI 10.1007/s00382-012-1592-9; McCarthy MP, 2012, EARTH SYST DYNAM, V3, P87, DOI 10.5194/esd-3-87-2012; McDowell NG, 2016, NAT CLIM CHANGE, V6, P295, DOI [10.1038/nclimate2873, 10.1038/NCLIMATE2873]; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Medvigy D, 2013, J CLIMATE, V26, P9115, DOI 10.1175/JCLI-D-12-00775.1; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Neale R.B, 2012, TN486STR NCAR; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; Notaro M, 2007, J CLIMATE, V20, P981, DOI 10.1175/JCLI4052.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stark SC, 2016, LANDSCAPE ECOL, V31, P181, DOI 10.1007/s10980-015-0282-5; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Swann ALS, 2014, J CLIMATE, V27, P4857, DOI 10.1175/JCLI-D-13-00690.1; Swann ALS, 2012, P NATL ACAD SCI USA, V109, P712, DOI 10.1073/pnas.1116706108; Trumbore S, 2015, SCIENCE, V349, P814, DOI 10.1126/science.aac6759; United Nations, 2016, C PART ITS 21 SESS H; Voigt A, 2014, J CLIMATE, V27, P1029, DOI 10.1175/JCLI-D-13-00205.1	48	31	31	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165042	10.1371/journal.pone.0165042	http://dx.doi.org/10.1371/journal.pone.0165042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851740	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300008
J	Kogan-Goloborodko, O; Brugmann, E; Repple, J; Habel, U; Clemens, B				Kogan-Goloborodko, Olga; Bruegmann, Elisabeth; Repple, Jonathan; Habel, Ute; Clemens, Benjamin			Experimentally Assessed Reactive Aggression in Borderline Personality Disorder	PLOS ONE			English	Article							PROACTIVE AGGRESSION; COMORBIDITY; IMPULSIVITY; PROVOCATION; VIOLENCE; QUESTIONNAIRE; INDIVIDUALS; COMMUNITY; FEATURES; BEHAVIOR	Approximately 73% of patients suffering from Borderline personality disorder (BPD) exhibit aggressive behaviour, which severely hinders therapeutic work and clinical improvement. Because the underlying mechanisms of aggression in BPD are not yet completely understood, additional research in this domain has a high clinical and scientific relevance. We employed a modified version of the Taylor Aggression Paradigm (mTAP), in order to examine for the first time whether this task can be used to differentiate between BPD patients and healthy controls with regard to reactive aggression. In the mTAP, the amount of money subtracted by a virtual opponent was categorized into 'low' (10-20 cents) and 'high' (80-100 cents) provocations, enabling us to compare how much money BPD patients and healthy controls subtracted (i.e., how aggressively participants responded) following high and low provocation trials. Our results showed that, compared to healthy controls, BPD patients showed higher overall aggression, higher aggression after high provocation trials, as well as a larger difference between high and low provocation trials. This finding was corroborated by a neuropsychological assessment, demonstrating higher levels of aggression and impulsivity in BPD patients. Interestingly, reactive aggression in the mTAP was positively correlated with symptom severity and impulsivity in BPD patients. We suggest that the mTAP provides a valuable tool allowing psychiatrists to quantify reactive aggression in BPD. Therefore, clinicians and researchers might consider this task, as a short experimental measure of reactive aggression, either in future studies or to aid diagnostic assessment during clinical practice.	[Kogan-Goloborodko, Olga; Bruegmann, Elisabeth; Habel, Ute; Clemens, Benjamin] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Repple, Jonathan] Univ Munster, Dept Psychiat, Munster, Germany; [Habel, Ute] JARA, BRAIN Inst 1, Aachen, Germany	RWTH Aachen University; University of Munster	Clemens, B (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	bclemens@ukaachen.de	Repple, Jonathan/I-4948-2015; Clemens, Benjamin/AAW-7273-2021	Repple, Jonathan/0000-0003-1379-9491; Habel, Ute/0000-0003-0703-7722	Interdisciplinary Center for Clinical Research (ICCR) of the Faculty of Medicine, RWTH Aachen [N4-4]	Interdisciplinary Center for Clinical Research (ICCR) of the Faculty of Medicine, RWTH Aachen	This work was funded by the Interdisciplinary Center for Clinical Research (ICCR; N4-4) of the Faculty of Medicine, RWTH Aachen (http://www.inedizin.rwth-aachen.de/cms/Medizin/Die-Fakultaet/Einrichtungen/similar to dgun/IZKF-Aachen/). The funding source had no role in study design, in collection, analysis, and interpretation of data, in	Anderson CA, 1999, CURR DIR PSYCHOL SCI, V8, P3, DOI 10.1111/1467-8721.00002; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Berkowitz L, 2003, SER AFFECTIVE SCI, P804; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Castillo N, 2015, AM J MED GENET B, V9999, P1; Coccaro EF, 2007, BIOL PSYCHIAT, V62, P168, DOI 10.1016/j.biopsych.2006.08.024; Conklin CZ, 2006, J NERV MENT DIS, V194, P69, DOI 10.1097/01.nmd.0000198138.41709.4f; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Dougherty DM, 1999, PSYCHIAT RES, V85, P315, DOI 10.1016/S0165-1781(99)00011-6; First M.B., 1990, USERS GUIDE STRUCTUR; Fossati A, 2004, PSYCHIAT RES, V125, P161, DOI 10.1016/j.psychres.2003.12.001; Gardner KJ, 2012, AGGRESSIVE BEHAV, V38, P403, DOI 10.1002/ab.21437; Giancola PR, 2008, AGGRESSIVE BEHAV, V34, P214, DOI 10.1002/ab.20235; Glenn AL, 2014, NAT REV NEUROSCI, V15, P54, DOI 10.1038/nrn3640; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Haaland VO, 2009, PSYCHOL MED, V39, P1733, DOI 10.1017/S0033291709005285; Herpertz SC, 2014, CURR OPIN PSYCHIATR, V27, P73, DOI 10.1097/YCO.0000000000000026; Hollander E, 2005, AM J PSYCHIAT, V162, P621, DOI 10.1176/appi.ajp.162.3.621; Howard R., 2015, BORDERLINE PERSONAL, V2, P1; Koenigsberg HW, 2009, PSYCHIAT RES-NEUROIM, V172, P192, DOI 10.1016/j.pscychresns.2008.07.010; Kuepper Y, 2013, BEHAV BRAIN RES, V247, P73, DOI 10.1016/j.bbr.2013.03.002; Lehrl S., 2005, MANUAL ZUM MWT B; Leichsenring F., 1997, BORDERLINE PERSONLIC; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Lilienfeld SO., 2005, SOC INFLUENCE, V61, P97; Mancke F, 2015, BORDER PERS DIS EMOT, V2, DOI 10.1186/s40479-015-0028-7; McDermott R, 2009, P NATL ACAD SCI USA, V106, P2118, DOI 10.1073/pnas.0808376106; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pueyo A, 2013, GENES BRAIN BEHAV, V12, P140, DOI [10.1111/j.1601-183X.2012.00868.x, DOI 10.1111/J.1601-183X.2012.00868.X]; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Raine A, 1997, AM J PSYCHIAT, V154, P1265; Reitan R, 1992, TRAIL MAKING TEST; SCHNEIDER F, 1994, PSYCHIAT RES, V51, P19, DOI 10.1016/0165-1781(94)90044-2; Scott LN, 2014, PERSONAL DISORD, V5, P278, DOI 10.1037/per0000070; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Spielberger CD, 1994, STATE TRAIT ANXIETY; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; Tomko RL, 2014, J PERS DISORD, V28, P734, DOI 10.1521/pedi_2012_26_093; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wechsler D., 1984, WMS R WECHSLER MEMOR; Winograd G, 2008, J CHILD PSYCHOL PSYC, V49, P933, DOI 10.1111/j.1469-7610.2008.01930.x; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012	46	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166737	10.1371/journal.pone.0166737	http://dx.doi.org/10.1371/journal.pone.0166737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851804	Green Published, gold			2022-12-27	WOS:000387909300082
J	Chen, C; Geng, ZM; Shen, HX; Song, HW; Zhao, YL; Zhang, GJ; Li, WZ; Ma, L; Wang, L				Chen, Chen; Geng, Zhimin; Shen, Haoxin; Song, Huwei; Zhao, Yaling; Zhang, Guanjun; Li, Wenzhi; Ma, Li; Wang, Lin			Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage	PLOS ONE			English	Article							LYMPH-NODE INVOLVEMENT; SURGICAL RESECTION; BILE-DUCT; AGGRESSIVE SURGERY; ADVANCED-CARCINOMA; RADICAL SURGERY; JAUNDICE; MANAGEMENT; SURVIVAL; IMPACT	Background Radical resection is an effective therapeutic method to increase the survival rate of patients with gallbladder cancer (GBC). In addition to the surgical approach, the relationships between various clinicopathologic factors and the outcome of patients with GBC remain controversial. Methods Clinical and laboratory examination characteristics, pathological and surgical data, and post-operative survival time of 338 patients with advanced GBC who received treatment at the First Affiliated Hospital of Xi'an Jiaotong University, China from January 2008 to December 2012 were analyzed retrospectively. Factors influencing the prognosis of GBC after surgery were analyzed by univariate and multivariate analysis. Results The overall survival rates for curative resection patients were significantly greater than those for non-curative resection patients (1-, 3-, 5-year survival rate and mean-survival time: 59.0%, 47.3%, 44.3% and 22.0 months vs. 12.7%, 8.3%, 7.7% and 3.0 months) (P < 0.001). For the curative resection patients, positive margin, lymph node metastasis, poorly pathological differentiation and the presence of ascites were all independent risk factors for poor prognosis. For patients with T3 stage, neither segmentectomy of IVb and V nor common bile duct resection improved the prognosis (P = 0.867 and P = 0.948). For patients with T4 stage, aggressive curative resection improved the prognosis (P = 0.007). Conclusions An advanced T stage does not preclude curative resection. Positive margin, lymph node metastasis, poorly pathological differentiation and the presence of ascites are all independent risk factors for poor prognosis in the curative intent resection patients. The range of liver resection and whether common bile duct resection is performed do not influence the prognosis as long as R0 resection is achieved.	[Chen, Chen; Geng, Zhimin; Shen, Haoxin; Song, Huwei; Li, Wenzhi; Ma, Li; Wang, Lin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Zhao, Yaling] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China; [Zhang, Guanjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pathol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, L (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China.	jiaodawanglin@163.com			National Natural Science Foundation of China [81572420]; Key Science and Technology Program of Shaanxi Province [2014K11-03-03-12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Program of Shaanxi Province	This work was supported by National Natural Science Foundation of China (81572420, ZG) and Key Science and Technology Program of Shaanxi Province (2014K11-03-03-12, LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2007, J GASTROINTEST SURG, V11, P1722, DOI 10.1007/s11605-007-0320-y; Akyurek N, 2004, J HEPATO-BILIARY-PAN, V11, P357, DOI 10.1007/s00534-004-0910-y; Aloia TA, 2015, HPB, V17, P681, DOI 10.1111/hpb.12444; Andren-Sandberg A, 2014, CURR OPIN GASTROEN, V30, P326, DOI 10.1097/MOG.0000000000000068; Araida T, 2009, J HEPATO-BILIARY-PAN, V16, P204, DOI 10.1007/s00534-009-0044-3; Birnbaum DJ, 2014, EJSO-EUR J SURG ONC, V40, P1008, DOI 10.1016/j.ejso.2013.10.014; Birnbaum DJ, 2015, ANN SURG ONCOL, V22, P811, DOI 10.1245/s10434-014-4044-4; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Chan KM, 2006, SURG ENDOSC, V20, P1867, DOI 10.1007/s00464-005-0195-5; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gani F, 2016, J SURG ONCOL, V114, P176, DOI 10.1002/jso.24283; Gourgiotis S, 2008, AM J SURG, V196, P252, DOI 10.1016/j.amjsurg.2007.11.011; Hawkins WG, 2004, ANN SURG ONCOL, V11, P310, DOI 10.1245/ASO.2004.03.011; Higuchi R, 2014, ANN SURG ONCOL, V21, P4308, DOI 10.1245/s10434-014-3885-1; Hirono S, 2006, WORLD J SURG, V30, P567, DOI 10.1007/s00268-005-0380-7; Hundal R, 2014, CLIN EPIDEMIOL, V6, P99, DOI 10.2147/CLEP.S37357; Kai M, 2007, J GASTROINTEST SURG, V11, P1025, DOI 10.1007/s11605-007-0181-4; Kim Y, 2016, ANN SURG ONCOL, V23, P2998, DOI 10.1245/s10434-016-5262-8; Koerkamp BG, 2014, J SURG ONCOL, V110, P585, DOI 10.1002/jso.23762; Kondo S, 2000, BRIT J SURG, V87, P418, DOI 10.1046/j.1365-2168.2000.01384.x; Kondo S, 2001, J Hepatobiliary Pancreat Surg, V8, P511, DOI 10.1007/s005340100018; Lee SE, 2014, J KOREAN MED SCI, V29, P1333, DOI 10.3346/jkms.2014.29.10.1333; Lim CS, 2012, J GASTROINTEST SURG, V16, P1012, DOI 10.1007/s11605-012-1826-5; Lim H, 2013, J CLIN GASTROENTEROL, V47, P443, DOI 10.1097/MCG.0b013e3182703409; Liu BZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157401; Ma N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1617-y; Mekeel KL, 2007, J GASTROINTEST SURG, V11, P1188, DOI 10.1007/s11605-007-0115-1; Miller G, 2008, EJSO-EUR J SURG ONC, V34, P306, DOI 10.1016/j.ejso.2007.07.206; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; Miyazaki M, 2015, J HEPATO-BIL-PAN SCI, V22, P249, DOI 10.1002/jhbp.233; Murakami Y, 2011, J GASTROINTEST SURG, V15, P1007, DOI 10.1007/s11605-011-1479-9; Muratore A, 2000, EUR J SURG ONCOL, V26, P438, DOI 10.1053/ejso.1999.0918; Nasu Y, 2016, DIGEST SURG, V33, P213, DOI 10.1159/000443842; Nishio H, 2007, J HEPATO-BILIARY-PAN, V14, P351, DOI 10.1007/s00534-006-1187-0; Nishio H, 2011, ANN SURG, V253, P953, DOI 10.1097/SLA.0b013e318216f5f3; Regimbeau JM, 2011, EJSO-EUR J SURG ONC, V37, P505, DOI 10.1016/j.ejso.2011.03.135; Sakamoto Y, 2013, SURGERY, V153, P794, DOI 10.1016/j.surg.2012.11.024; Sasaki R, 2006, WORLD J SURG, V30, P36, DOI 10.1007/s00268-005-0181-z; Sasaki R, 2002, HEPATO-GASTROENTEROL, V49, P912; Shimizu Tetsuya, 2006, J Nippon Med Sch, V73, P136, DOI 10.1272/jnms.73.136; Shirai Y, 2012, WORLD J GASTROENTERO, V18, P2775, DOI 10.3748/wjg.v18.i22.2775; Sikora SS, 2006, J SURG ONCOL, V93, P670, DOI 10.1002/jso.20535; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Taner CB, 2004, J GASTROINTEST SURG, V8, P83, DOI 10.1016/j.gassur.2003.09.022; Vernerey D, 2016, BRIT J CANCER, V115, P281, DOI 10.1038/bjc.2016.212; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Xu Xie-qun, 2013, Chinese Medical Sciences Journal, V28, P102; Yamamoto Y, 2016, SURGERY, V159, P810, DOI 10.1016/j.surg.2015.09.009; Yang XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-652; Yang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051513; Zaydfudim V, 2008, HPB, V10, P420, DOI 10.1080/13651820802320057; Zhang WJ, 2015, INT J CLIN EXP MED, V8, P869	53	46	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166361	10.1371/journal.pone.0166361	http://dx.doi.org/10.1371/journal.pone.0166361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846279	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600049
J	Giraldo, P; Royo, C; Gonzalez, M; Carrillo, JM; Ruiz, M				Giraldo, Patricia; Royo, Conxita; Gonzalez, Mirvana; Carrillo, Jose M.; Ruiz, Magdalena			Genetic Diversity and Association Mapping for Agromorphological and Grain Quality Traits of a Structured Collection of Durum Wheat Landraces Including subsp durum, turgidum and diccocon	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; CARBON-ISOTOPE DISCRIMINATION; WIDE LINKAGE DISEQUILIBRIUM; BREAD-MAKING QUALITY; QTL ANALYSIS; AGRONOMIC PERFORMANCE; TETRAPLOID WHEAT; MAIZE GENOME; KERNEL SIZE; EMMER WHEAT	Association mapping was performed for 18 agromorphological and grain quality traits in a set of 183 Spanish landraces, including subspecies durum, turgidum and dicoccon, genotyped with 749 DArT (Diversity Array Technology) markers. Large genetic and phenotypic variability was detected, being the level of diversity among the chromosomes and genomes heterogeneous, and sometimes complementary, among subspecies. Overall, 356 were monomorphic in at least one subspecies, mainly in dicoccon, and some of them coincidental between subspecies, especially between turgidum and dicoccon. Several of those fixed markers were associated to plant responses to environmental stresses or linked to genes subjected to selection during tetraploid wheat domestication process. A total of 85 stable MTAs (marker trait associations) have been identified for the agromorphological and quality parameters, some of them common among subspecies and others subspecies-specific. For all the traits, we have found MTAs explaining more than 10% of the phenotypic variation in any of the three subspecies. The number of MTAs on the B genome exceeded that on the A genome in subsp. durum, equalled in turgidum and was below in dicoccon. The validation of several adaptive and quality trait MTAs by combining the association mapping with an analysis of the signature of selection, identifying the putative gene function of the marker, or by coincidences with previous reports, showed that our approach was successful for the detection of MTAs and the high potential of the collection to identify marker trait associations. Novel MTAs not previously reported, some of them subspecies specific, have been described and provide new information about the genetic control of complex traits.	[Giraldo, Patricia; Carrillo, Jose M.] Tech Univ Madrid, Sch Agr Engn, Dept Biotechnol Plant Biol, Madrid, Spain; [Royo, Conxita] Inst Food & Agr Res & Technol, Field Crops Program, Lleida, Spain; [Gonzalez, Mirvana] Autonomous Univ Baja California, Engn Inst, Lab Bioinformat & Biofonot, Mexicali, Baja California, Mexico; [Ruiz, Magdalena] Natl Inst Agr & Food Res & Technol, Plant Genet Resources Ctr, Alcala De Henares, Spain	Universidad Politecnica de Madrid; IRTA; Universidad Autonoma de Baja California	Ruiz, M (corresponding author), Natl Inst Agr & Food Res & Technol, Plant Genet Resources Ctr, Alcala De Henares, Spain.	mruiz@inia.es	Royo, Conxita/J-3362-2017; Giraldo, Patricia/AAA-2825-2019; , Mirvana/K-3727-2019; Ruiz, Magdalena/G-1214-2014	Royo, Conxita/0000-0001-7939-1451; Ruiz, Magdalena/0000-0003-3901-703X	Ministerio de Economia y Competitividad, Gobierno de Espana [AGL2012-38345]; Institute nacional de Investigacion y tecnologia Agraria y Alimentaria, Gobierno de Espana [RF2006-00020]	Ministerio de Economia y Competitividad, Gobierno de Espana; Institute nacional de Investigacion y tecnologia Agraria y Alimentaria, Gobierno de Espana	Support was provided by AGL2012-38345: Ministerio de Economia y Competitividad, Gobierno de Espana (to PG, JMC, MR); RF2006-00020: Institute nacional de Investigacion y tecnologia Agraria y Alimentaria, Gobierno de Espana (PG, CR, JMC, MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiriano E, 2008, SPAN J AGRIC RES, V6, P599, DOI 10.5424/sjar/2008064-353; Aguiriano E, 2006, GENET RESOUR CROP EV, V53, P1543, DOI 10.1007/s10722-005-7767-z; [Anonymous], REV DESCR LIST WHEAT; AXFORD DWE, 1978, MILL FEED FERTIL, V161, P18; Blanco A, 1998, THEOR APPL GENET, V97, P721, DOI 10.1007/s001220050948; Blanco A, 1998, PLANT BREEDING, V117, P413, DOI 10.1111/j.1439-0523.1998.tb01965.x; Bordes J, 2014, MOL BREEDING, V33, P755, DOI 10.1007/s11032-013-0004-0; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; Cui F, 2016, THEOR APPL GENET, V129, P469, DOI 10.1007/s00122-015-2641-7; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1989, SOC EXP BIOL SEM SER, V39, P47, DOI 10.1017/CBO9780511661587.005; Federer WT, 2001, AGRON J, V93, P389, DOI 10.2134/agronj2001.932389x; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frankel O, 1984, PLANT GENETIC RESOUR; Furtado A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10446; Gadea M., 1954, TRIGOS ESPANOLES; Graziani M, 2014, CROP PASTURE SCI, V65, P80, DOI 10.1071/CP13349; He HY, 2014, ACTA PHYSIOL PLANT, V36, P581, DOI 10.1007/s11738-013-1444-1; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Kaan F., 1993, Journal of Genetics and Breeding, V47, P151; KATO K, 1992, THEOR APPL GENET, V84, P259, DOI 10.1007/BF00229480; Kosuge K, 2011, EUPHYTICA, V179, P257, DOI 10.1007/s10681-010-0302-0; Kumar V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065535; Laido G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095211; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Li Y, 2009, PLANT BREEDING, V128, P235, DOI 10.1111/j.1439-0523.2008.01578.x; Littel RC, 1996, SAS SYSTEM MIXED MOD; Longin CFH, 2016, CROP SCI, V56, P302, DOI 10.2135/cropsci2015.04.0242; Lopes MS, 2015, J EXP BOT, V66, P3477, DOI 10.1093/jxb/erv122; Luo W, 2016, GENET RESOUR CROP EV, V63, P763, DOI 10.1007/s10722-016-0393-0; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; McIntosh R. A., 1978, Cereal Research Communications, V6, P9; McIntosh RA, 1998, 9 INT WHEAT GEN S; Mora F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0264-y; Moragues M, 2006, GENET RESOUR CROP EV, V53, P993, DOI 10.1007/s10722-004-7367-3; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Nazco R, 2012, EUPHYTICA, V185, P1, DOI 10.1007/s10681-011-0588-6; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Peng JH, 2011, AUST J CROP SCI, V5, P1127; Pfluger LA, 2001, THEOR APPL GENET, V102, P767, DOI 10.1007/s001220051708; Thanh PT, 2013, BIOTECHNOL BIOTEC EQ, V27, P3627, DOI 10.5504/BBEQ.2013.0008; Rebetzke GJ, 2006, EUPHYTICA, V150, P97, DOI 10.1007/s10681-006-9097-4; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Royo C, 2016, J AGR SCI-CAMBRIDGE, V154, P612, DOI 10.1017/S0021859615000507; Royo C, 2014, GENET RESOUR CROP EV, V61, P1345, DOI 10.1007/s10722-014-0116-3; RUIZ M, 1993, THEOR APPL GENET, V87, P353, DOI 10.1007/BF01184923; Ruiz M, 2008, PLANT BREEDING, V127, P20, DOI 10.1111/j.1439-0523.2007.01406.x; RUIZ M, 1995, PLANT BREEDING, V114, P40, DOI 10.1111/j.1439-0523.1995.tb00756.x; Ruiz M, 2012, CROP SCI, V52, P2262, DOI 10.2135/cropsci2012.02.0081; *SAS I INC, 2000, SAS STAT GUID PERS C; Shukla S, 2015, EUPHYTICA, V203, P449, DOI 10.1007/s10681-014-1314-y; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Sukumaran S, WHEAT MAPPING POPULA; Team R. D. C, 2011, R LANG ENV STAT COMP; Tian Jichun, 2015, GENETIC ANAL WHEAT M; Trojan V, 2014, J CEREAL SCI, V59, P48, DOI 10.1016/j.jcs.2013.10.008; UNRAU JOHN, 1950, SCI AGRIC [OTTOWA], V30, P66; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zapotoczny P, 2010, INT J FOOD PROP, V13, P75, DOI 10.1080/10942910802180174; Zeven AC, 1998, EUPHYTICA, V104, P127, DOI 10.1023/A:1018683119237; Zhang J, 2012, THEOR APPL GENET, V125, P1697, DOI 10.1007/s00122-012-1946-z; Zheng GJ, 2014, J INTEGR AGR, V13, P2608, DOI 10.1016/S2095-3119(13)60738-8; Zohary D., 1994, DOMESTICATION OF PLA	88	21	21	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166577	10.1371/journal.pone.0166577	http://dx.doi.org/10.1371/journal.pone.0166577			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846306	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000387794600085
J	Hwong, WY; Bots, ML; Selvarajah, S; Aziz, ZA; Sidek, NN; Spiering, W; Kappelle, LJ; Vaartjes, I				Hwong, Wen Yea; Bots, Michiel L.; Selvarajah, Sharmini; Aziz, Zariah Abdul; Sidek, Norsima Nazifah; Spiering, Wilko; Kappelle, L. Jaap; Vaartjes, Ilonca			Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?	PLOS ONE			English	Article							ACUTE CEREBRAL INFARCTION; SCALE; INHIBITORS; RECEPTORS	Background The increase in angiotensin II (Ang II) formation by selected antihypertensive drugs is said to exhibit neuroprotective properties, but this translation into improvement in clinical outcomes has been inconclusive. We undertook a study to investigate the relationship between types of antihypertensive drugs used prior to a stroke event and ischemic stroke severity. We hypothesized that use of antihypertensive drugs that increase Ang II formation (Ang II increasers) would reduce ischemic stroke severity when compared to antihypertensive drugs that suppress Ang II formation (Ang II suppressors). Methods From the Malaysian National Neurology Registry, we included hypertensive patients with first ischemic stroke who presented within 48 hours from ictus. Antihypertensive drugs were divided into Ang II increasers (angiotensin-I receptor blockers (ARBs), calcium channel blockers (CCBs) and diuretics) and Ang II suppressors (angiotensin-converting-enzyme inhibitors (ACEIs) and beta blockers). We evaluated stroke severity during admission with the National Institute of Health Stroke Scale (NIHSS). We performed a multivariable logistic regression with the score being dichotomized at 15. Scores of less than 15 were categorized as less severe stroke. Results A total of 710 patients were included. ACEIs was the most commonly prescribed antihypertensive drug in patients using Ang II suppressors (74%) and CCBs, in patients prescribed with Ang II increasers at 77%. There was no significant difference in the severity of ischemic stroke between patients who were using Ang II increasers in comparison to patients with Ang II suppressors (OR: 1.32, 95% CI: 0.83-2.10, p = 0.24). Conclusion In our study, we found that use of antihypertensive drugs that increase Ang II formation was not associated with less severe ischemic stroke as compared to use of antihypertensive drugs that suppress Ang II formation.	[Hwong, Wen Yea] Kuala Lumpur Gen Hosp, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Hwong, Wen Yea; Bots, Michiel L.; Selvarajah, Sharmini; Vaartjes, Ilonca] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Aziz, Zariah Abdul] Hosp Sultanah Nur Zahirah, Dept Neurol, Terengganu, Malaysia; [Sidek, Norsima Nazifah] Hosp Sultanah Nur Zahirah, Dept Pharm, Terengganu, Malaysia; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Kappelle, L. Jaap] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Vaartjes, I (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	c.h.vaartjes@umcutrecht.nl	SIDEK, NORSIMA NAZIFAH/AAG-4416-2021	SIDEK, NORSIMA NAZIFAH/0000-0003-1269-7661	Julius Center for Health Sciences and Primary Care under the Honors Track Programme; Dutch Heart Foundation; Ministry of Health Malaysia [NMRR 08-1631-3189]	Julius Center for Health Sciences and Primary Care under the Honors Track Programme; Dutch Heart Foundation(Netherlands Heart Foundation); Ministry of Health Malaysia	WYH is funded by Julius Center for Health Sciences and Primary Care under the Honors Track Programme. IV is funded by the Dutch Heart Foundation for project Facts and Figures. The Honors Track Committee and the Dutch Heart Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The registry is funded by Ministry of Health Malaysia (ID: NMRR 08-1631-3189). Ministry of Health Malaysia had no role in the study design, analysis and preparation of the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; [Anonymous], 2014, R LANG ENV STAT COMP; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; BROWN MJ, 1986, LANCET, V2, P427; Chitravas N, 2007, NEUROLOGY, V68, P1687, DOI 10.1212/01.wnl.0000261914.18101.60; Chrysant SG, 2012, CURR HYPERTENS REP, V14, P202, DOI 10.1007/s11906-012-0257-8; Dai WJ, 1999, STROKE, V30, P2391, DOI 10.1161/01.STR.30.11.2391; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Fournier A, 2004, CURR HYPERTENS REP, V6, P182, DOI 10.1007/s11906-004-0067-8; Fournier A, 2004, J AM COLL CARDIOL, V43, P1343, DOI 10.1016/j.jacc.2003.10.060; Fuentes B, 2010, J HYPERTENS, V28, P575, DOI 10.1097/HJH.0b013e3283350f50; Klungel OH, 2004, J CLIN EPIDEMIOL, V57, P1223, DOI 10.1016/j.jclinepi.2004.03.011; McCarthy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095762; McCarthy CA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0440-1; McCleary L, 2002, NURS RES, V51, P339, DOI 10.1097/00006199-200209000-00012; Miyamoto N, 2012, J STROKE CEREBROVASC, V21, P363, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.011; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Nazifah S Norsima, 2012, Med J Malaysia, V67, P302; Ovbiagele B, 2005, NEUROLOGY, V65, P851, DOI 10.1212/01.wnl.0000175984.29283.6d; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Selim M, 2005, BMC NEUROL, V5, P1, DOI 10.1186/1471-2377-5-10; Stata Corp, 2013, STATA STAT SOFTW REL; Tziomalos K, 2015, J CLIN HYPERTENS, V17, P275, DOI 10.1111/jch.12498	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166524	10.1371/journal.pone.0166524	http://dx.doi.org/10.1371/journal.pone.0166524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846309	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600076
J	Cao, SB; Hu, Y; Gao, X; Liao, Q; Zhao, YP				Cao, Shaobo; Hu, Ya; Gao, Xiang; Liao, Quan; Zhao, Yupei			Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis	PLOS ONE			English	Article							PAPILLARY MUCINOUS NEOPLASMS; POSITRON-EMISSION-TOMOGRAPHY; CARCINOEMBRYONIC ANTIGEN; IMAGING FEATURES; PREDICTORS; SIZE; TRANSFORMATION; EXPERIENCE; MANAGEMENT; ACCURACY	Background Using serum carbohydrate antigen 19-9 (CA 19-9) in discriminating between benign and malignant pancreatic disease remains controversial. We aim to evaluate the diagnostic value of serum CA 19-9 in predicting malignant pancreatic cystic lesions. Methods Eligible studies were identified through searching MEDLINE and EMBASE prior to March 2016. Studies were assessed for quality using the Quality Assessment for Studies of Diagnostic Accuracy, 2nd version (QUADAS-2). Pooled sensitivity and specificity with 95% confidence interval (CI) were calculated using random-effects models. Summary receiver operator characteristic (SROC) curves and the area under curve (AUC) were performed. Results A total of thirteen studies including 1437 patients were enrolled in this meta-analysis. The pooled sensitivity and specificity were 0.47(95% CI: 0.35-0.59), and 0.88(95% CI: 0.86-0.91), respectively, and the AUC was 0.87(95% CI, 0.84-0.90). Meta-regression analysis showed that sample size, region and reference standards were not the main sources of heterogeneity. Conclusions Serum CA 19-9 has satisfying pooled specificity while poor pooled sensitivity for discriminating benign from malignant PCNs. It deserves to be widely used as complementary to other clinical diagnostic methods.	[Zhao, Yupei] Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Zhao, YP (corresponding author), Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	zhao8028@263.net		Hu, Ya/0000-0003-2813-9947				Al-Haddad M, 2010, ENDOSCOPY, V42, P127, DOI 10.1055/s-0029-1215351; Anand N, 2013, CLIN GASTROENTEROL H, V11, P913, DOI 10.1016/j.cgh.2013.02.010; Baba T, 2004, PANCREAS, V29, P212, DOI 10.1097/00006676-200410000-00006; Cecka F, 2016, ANN SURG TREAT RES, V90, P21, DOI 10.4174/astr.2016.90.1.21; Cone MM, 2011, HPB, V13, P112, DOI 10.1111/j.1477-2574.2010.00254.x; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dudeja V, 2015, SEMIN ONCOL, V42, P70, DOI 10.1053/j.seminoncol.2014.12.007; Edirimanne S, 2008, WORLD J SURG, V32, P2028, DOI 10.1007/s00268-008-9633-6; Fritz S, 2011, BRIT J SURG, V98, P104, DOI 10.1002/bjs.7280; Galanis C, 2007, J GASTROINTEST SURG, V11, P820, DOI 10.1007/s11605-007-0157-4; Goh BKP, 2008, J AM COLL SURGEONS, V206, P17, DOI 10.1016/j.jamcollsurg.2007.06.312; Gourgiotis S, 2007, EJSO-EUR J SURG ONC, V33, P678, DOI 10.1016/j.ejso.2006.11.031; Grenacher L, 2015, VISZERALMEDIZIN, V31, P31, DOI 10.1159/000375254; Grobmyer SR, 2009, J SURG ONCOL, V100, P372, DOI 10.1002/jso.21260; Guo XR, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/3546085; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Hong HS, 2010, CLIN NUCL MED, V35, P776, DOI 10.1097/RLU.0b013e3181e4da32; Hwang DW, 2012, LANGENBECK ARCH SURG, V397, P93, DOI 10.1007/s00423-010-0674-6; Hwang DW, 2011, J KOREAN MED SCI, V26, P740, DOI 10.3346/jkms.2011.26.6.740; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Jones NB, 2009, HPB, V11, P664, DOI 10.1111/j.1477-2574.2009.00114.x; Kauhanen S, 2015, J NUCL MED, V56, P1163, DOI 10.2967/jnumed.114.148940; Klibansky DA, 2012, CLIN GASTROENTEROL H, V10, P555, DOI 10.1016/j.cgh.2011.12.029; Ngamruengphong S, 2013, DIGEST LIVER DIS, V45, P920, DOI 10.1016/j.dld.2013.05.002; Ohtsuka T, 2012, SURGERY, V151, P76, DOI 10.1016/j.surg.2011.07.009; Pitt HA, 2003, J GASTROINTEST SURG, V7, P18; Rosman AS, 2007, ADV MED SCI, V52, P76; Sadakari Y, 2010, PANCREAS, V39, P232, DOI 10.1097/MPA.0b013e3181bab60e; Salvia R, 2007, GUT, V56, P1086, DOI 10.1136/gut.2006.100628; Sarr MG, 2000, ANN SURG, V231, P205, DOI 10.1097/00000658-200002000-00009; Shin SH, 2010, WORLD J SURG, V34, P776, DOI 10.1007/s00268-010-0416-5; Sperti C, 2007, ANN SURG, V246, P932, DOI 10.1097/SLA.0b013e31815c2a29; Sultana A, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.60; Suzuki R, 2014, PANCREATOLOGY, V14, P380, DOI 10.1016/j.pan.2014.07.006; Tan L, 2009, WORLD J GASTROENTERO, V15, P4037, DOI 10.3748/wjg.15.4037; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Tomimaru Y, 2010, ONCOL REP, V24, P613, DOI 10.3892/or_00000899; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xu B, 2011, WORLD J SURG, V35, P1103, DOI 10.1007/s00268-011-1003-0; Zaruba P, 2013, Rozhl Chir, V92, P708	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166406	10.1371/journal.pone.0166406	http://dx.doi.org/10.1371/journal.pone.0166406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835676	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200045
J	Kwon, RJ; Han, ME; Kim, JY; Liu, L; Kim, YH; Jung, JS; Oh, SO				Kwon, Ryuk-Jun; Han, Myoung-Eun; Kim, Ji-young; Liu, Liangwen; Kim, Yun-Hak; Jung, Jin-Sup; Oh, Sae-Ock			ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells	PLOS ONE			English	Article							ZINC-FINGERS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROSTATE-CANCER; TARGETS; GROWTH; EGR1	Zinc-fingers and homeoboxes 1 (ZHX1) is a transcription repressor that has been associated with the progressions of hepatocellular carcinoma, gastric cancer, and breast cancer. However, the functional roles of ZHX1 in cholangiocarcinoma (CCA) have not been determined. We investigated the expression and roles of ZHX1 during the proliferation, migration, and invasion of CCA cells. In silico analysis and immunohistochemical studies showed amplification and overexpression of ZHX1 in CCA tissues. Furthermore, ZHX1 knockdown using specific siRNAs decreased CCA cell proliferation, migration, and invasion, whereas ZHX1 overexpression promoted all three characteristics. In addition, results suggested EGR1 might partially mediate the effect of ZHX1 on the proliferation of CCA cells. Taken together, these results show ZHX1 promotes CCA cell proliferation, migration, and invasion, and present ZHX1 as a potential target for the treatment of CCA.	[Kwon, Ryuk-Jun; Han, Myoung-Eun; Kim, Ji-young; Liu, Liangwen; Kim, Yun-Hak; Oh, Sae-Ock] Pusan Natl Univ, Sch Med, Dept Anat, Busandaehak Ro 49, Yangsan 50612, South Korea; [Kwon, Ryuk-Jun; Han, Myoung-Eun; Kim, Ji-young; Liu, Liangwen; Kim, Yun-Hak; Oh, Sae-Ock] Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Busandaehak Ro 49, Yangsan 50612, South Korea; [Jung, Jin-Sup] Pusan Natl Univ, Dept Physiol, Sch Med, Busandaehak Ro 49, Yangsan 50612, South Korea	Pusan National University; Pusan National University; Pusan National University	Oh, SO (corresponding author), Pusan Natl Univ, Sch Med, Dept Anat, Busandaehak Ro 49, Yangsan 50612, South Korea.; Oh, SO (corresponding author), Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Busandaehak Ro 49, Yangsan 50612, South Korea.	hedgehog@pusan.ac.kr		Liu, Liangwen/0000-0003-2918-8142; Kim, Yun Hak/0000-0002-9796-8266	Medical Research Center (MRC) Program [NRF-2015R1A5A2009656]; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST) [NRF-2015R1A1A3A04001322]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	Medical Research Center (MRC) Program; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Medical Research Center (MRC) Program (#NRF-2015R1A5A2009656) and Basic Science Research Foundation (#NRF-2015R1A1A3A04001322) of the National Research Foundation (NRF) funded by the Korean government (MEST), and by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (#0920050). We would like to thank TCGA group providing Cancer Genome Atlas (TCGA) database and tools for data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Medical Research Center (MRC) Program (#NRF-2015R1A5A2009656) and Basic Science Research Foundation (#NRF-2015R1A1A3A04001322) of the National Research Foundation (NRF) funded by the Korean government (MEST), and by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (#0920050). We would like to thank TCGA group providing Cancer Genome Atlas (TCGA) database and tools for data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the Korea Biobank Network. The biospecimens used for this study were provided by the Biobank of Pusan National University Hospital, a member of the Korea Biobank Network.	Adamson E, 2003, CANCER BIOL THER, V2, P617; Armellini A, 2008, BRIT J HAEMATOL, V141, P212, DOI 10.1111/j.1365-2141.2007.06956.x; Barthelemy I, 1996, BIOCHEM BIOPH RES CO, V224, P870, DOI 10.1006/bbrc.1996.1114; Chen SL, 2013, J CELL BIOCHEM, V114, P2323, DOI 10.1002/jcb.24579; Chen Y, 2015, ONCOTARGET, V6, P20419, DOI 10.18632/oncotarget.3983; Cheng JC, 2013, ONCOGENE, V32, P1041, DOI 10.1038/onc.2012.127; de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519; Dokduang H, 2013, TUMOR BIOL, V34, P3519, DOI 10.1007/s13277-013-0930-9; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Han ME, 2013, ANAT CELL BIOL, V46, P8, DOI 10.5115/acb.2013.46.1.8; Kabbach G, 2015, J CLIN TRANSL HEPATO, V3, P169, DOI 10.14218/JCTH.2015.00012; Kim KS, 2012, ANAT CELL BIOL, V45, P17, DOI 10.5115/acb.2012.45.1.17; Kim S. S., 2007, J CHROMATOGR, P1, DOI DOI 10.6133/APJ; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Liu Y, 2015, CANCER GENE THER, V22, P223, DOI 10.1038/cgt.2015.16; Ma XJ, 2016, J CANCER, V7, P60, DOI 10.7150/jca.12973; Maroni L, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.10.04; Meng LQ, 2014, TUMOR BIOL, V35, P12497, DOI 10.1007/s13277-014-2568-7; Nagel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138416; Nagel S, 2011, GENE CHROMOSOME CANC, V50, P996, DOI 10.1002/gcc.20920; Ogata-Kawata H, 2007, FRONT BIOSCI-LANDMRK, V12, P1911, DOI 10.2741/2197; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Segura-Lopez FK, 2015, HELICOBACTER, V20, P223, DOI 10.1111/hel.12195; Shou ZF, 2004, BIOCHEM BIOPH RES CO, V314, P885, DOI 10.1016/j.bbrc.2003.12.162; Sribenja S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-430; Thomas Charles R., 2008, PATHOLOGIC STAGING G, P77; Wang JJ, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313500098; Yamada K, 2002, BIOCHEM BIOPH RES CO, V297, P368, DOI 10.1016/S0006-291X(02)02203-9; Yamada K, 1999, BIOCHEM BIOPH RES CO, V261, P614, DOI 10.1006/bbrc.1999.1087; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhao HL, 2016, J CO2 UTIL, V15, P15, DOI 10.1016/j.jcou.2016.04.004	33	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165516	10.1371/journal.pone.0165516	http://dx.doi.org/10.1371/journal.pone.0165516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835650	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200007
J	Miguchi, M; Hinoi, T; Shimomura, M; Adachi, T; Saito, Y; Niitsu, H; Kochi, M; Sada, H; Sotomaru, Y; Ikenoue, T; Shigeyasu, K; Tanakaya, K; Kitadai, Y; Sentani, K; Oue, N; Yasui, W; Ohdan, H				Miguchi, Masashi; Hinoi, Takao; Shimomura, Manabu; Adachi, Tomohiro; Saito, Yasufumi; Niitsu, Hiroaki; Kochi, Masatoshi; Sada, Haruki; Sotomaru, Yusuke; Ikenoue, Tsuneo; Shigeyasu, Kunitoshi; Tanakaya, Kohji; Kitadai, Yasuhiko; Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru; Ohdan, Hideki			Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation	PLOS ONE			English	Article							TGF-BETA; MICROSATELLITE INSTABILITY; GASTROINTESTINAL-TRACT; GASTRIC-CANCER; COLON-CANCER; MUTATIONS; EXPRESSION; CARCINOMA; GENE; FAMILY	Mutations in TGFBR2, a component of the transforming growth factor (TGF)-beta signaling pathway, occur in high-frequency microsatellite instability (MSI-H) colorectal cancer (CRC). In mouse models, Tgfbr2 inactivation in the intestinal epithelium accelerates the development of malignant intestinal tumors in combination with disruption of the Wnt-beta-catenin pathway. However, no studies have further identified the genes influenced by TGFBR2 inactivation following disruption of the Wnt-beta-catenin pathway. We previously described CDX2P-G19Cre; Apc(flox/flox) mice, which is stochastically null for Apc in the colon epithelium. In this study, we generated CDX2P-G19Cre; Apc(flox/flox); Tgfbr2(flox/flox) mice, with simultaneous loss of Apc and Tgfbr2. These mice developed tumors, including adenocarcinoma in the proximal colon. We compared gene expression profiles between tumors of the two types of mice using microarray analysis. Our results showed that the expression of the murine homolog of GSDMC was significantly upregulated by 9.25-fold in tumors of CDX2P-G19Cre; Apc(flox/flox); Tgfbr2(flox/flox) mice compared with those of CDX2P-G19Cre; Apc(flox/flox) mice. We then investigated the role of GSDMC in regulating CRC tumorigenesis. The silencing of GSDMC led to a significant reduction in the proliferation and tumorigenesis of CRC cell lines, whereas the overexpression of GSDMC enhanced cell proliferation. These results suggested that GSDMC functioned as an oncogene, promoting cell proliferation in colorectal carcinogenesis. In conclusion, combined inactivation of both Apc and Tgfbr2 in the colon epithelium of a CRC mouse model promoted development of adenocarcinoma in the proximal colon. Moreover, GSDMC was upregulated by TGFBR2 mutation in CRC and promoted tumor cell proliferation in CRC carcinogenesis, suggesting that GSDMC may be a promising therapeutic target.	[Miguchi, Masashi; Hinoi, Takao; Shimomura, Manabu; Adachi, Tomohiro; Saito, Yasufumi; Niitsu, Hiroaki; Kochi, Masatoshi; Sada, Haruki; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan; [Hinoi, Takao] Natl Hosp Org Kure Med Ctr, Dept Surg, Inst Clin Res, Hiroshima, Japan; [Hinoi, Takao] Chugoku Canc Ctr, Hiroshima, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Ikenoue, Tsuneo] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Tokyo, Japan; [Shigeyasu, Kunitoshi; Tanakaya, Kohji] Natl Hosp Org Iwakuni Clin Ctr, Dept Surg, Yamaguchi, Japan; [Kitadai, Yasuhiko] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol, Hiroshima, Japan; [Kitadai, Yasuhiko] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Metab, Hiroshima, Japan; [Kitadai, Yasuhiko] Prefectural Univ Hiroshima, Dept Hlth Sci, Program Human Culture & Sci, Hiroshima, Japan; [Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Appl Life Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University; University of Tokyo; Hiroshima University; Hiroshima University; Hiroshima University	Hinoi, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan.; Hinoi, T (corresponding author), Natl Hosp Org Kure Med Ctr, Dept Surg, Inst Clin Res, Hiroshima, Japan.; Hinoi, T (corresponding author), Chugoku Canc Ctr, Hiroshima, Japan.	thinoi@hiroshima-u.ac.jp	Niitsu, Hiroaki/HHZ-1925-2022; Sotomaru, Yusuke/G-5508-2019; Tanakaya, Kohji/AAF-5219-2019; 北台, 靖彦/AAH-1678-2021; Kitadai, Yasuhiko/AAG-4389-2021; Hinoi, Takao/AAI-1443-2020; Ohdan, Hideki/G-4719-2019	北台, 靖彦/0000-0002-8743-3815; Hinoi, Takao/0000-0003-0462-6177; Ohdan, Hideki/0000-0002-9066-1288	Japan Society for the Promotion of Science (JSPS) KAKENHI [22390257, 25293284, 25861190, 15K19892]; Japanese Society of Gastroenterology; Nakayama Cancer Research Institute	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society of Gastroenterology(Japanese Society of Gastroenterology); Nakayama Cancer Research Institute	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (http://www.jsps.go.jp/j-grantsinaid/) (Grant Numbers 22390257 and 25293284) to TH, the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for young Scientists Research (http://www.jsps.go.jp/j-grantsinaid/) (Grant Numbers 25861190 and 15K19892) to MS, the Japanese Society of Gastroenterology Grant-in-Aid 2010, and the Nakayama Cancer Research Institute Grant-in-Aid 2009 for Gastrointestinal Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fernandez-Peralta AM, 2005, CANCER GENET CYTOGEN, V157, P18, DOI 10.1016/j.cancergencyto.2004.05.008; Freshney RI, 1994, CULTURE ANIMAL CELLS; Grady WM, 1998, CANCER RES, V58, P3101; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hatch SB, 2005, CLIN CANCER RES, V11, P2180, DOI 10.1158/1078-0432.CCR-04-0234; Hinoi T, 2003, J BIOL CHEM, V278, P44608, DOI 10.1074/jbc.M307435200; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Kawaguchi Y, 2016, J GASTROENTEROL, V51, P447, DOI 10.1007/s00535-015-1121-9; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Long XC, 2007, J BIOL CHEM, V282, P15941, DOI 10.1074/jbc.R700010200; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Mori Y, 2001, CANCER RES, V61, P6046; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; PARSONS R, 1995, CANCER RES, V55, P5548; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Rigau V, 2003, ARCH PATHOL LAB MED, V127, P694; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Samowitz WS, 2002, GENE CHROMOSOME CANC, V35, P368, DOI 10.1002/gcc.10125; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Sasada T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132435; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Sumida T, 2011, INT J CANCER, V128, P2050, DOI 10.1002/ijc.25812; Takami H, 2012, PATHOBIOLOGY, V79, P154, DOI 10.1159/000335694; Takayama T, 2006, J GASTROENTEROL, V41, P185, DOI 10.1007/s00535-006-1801-6; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Watabe E, 2001, JPN J CANCER RES, V92, P140, DOI 10.1111/j.1349-7006.2001.tb01076.x; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Yu M, 2014, ONCOGENE, V33, P1538, DOI 10.1038/onc.2013.102	46	100	104	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166422	10.1371/journal.pone.0166422	http://dx.doi.org/10.1371/journal.pone.0166422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835699	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200049
J	Xiao, R; Jiang, DW; Christakos, G; Fei, XF; Wu, JP				Xiao, Rui; Jiang, Diwei; Christakos, George; Fei, Xufeng; Wu, Jiaping			Soil Landscape Pattern Changes in Response to Rural Anthropogenic Activity across Tiaoxi Watershed, China	PLOS ONE			English	Article							URBAN SPRAWL; URBANIZATION; IMPACT; CITIES; RIVER; CITY	Soil sealing (loss of soil resources due to extensive land covering for the purpose of house building, road construction etc.) and subsequent soil landscape pattern changes constitute typical environmental problems in many places worldwide. Previous studies concentrated on soil sealing in urbanized regions, whereas rural areas have not been given sufficient attention. Accordingly, this paper studies soil landscape pattern dynamics (i.e., landscape pattern changes in response to rural anthropogenic activities) in the Tiaoxi watershed (Zhejiang province, eastern China), in which surface sealing is by far the predominant component of human forcing with respect to environmental change. A novel approach of quantifying the impacts of rural anthropogenic activities on soil resources is presented. Specifically, quantitative relationships were derived between five soil landscape pattern metrics (patch density, edge density, shape index, Shannon's diversity index and aggregation index) and three rural anthropogenic activity indicators (anthropogenic activity intensity, distance to towns, and distance to roads) at two landscape block scales (3 and 5 km) between 1985 and 2010. The results showed that the Tiaoxi watershed experienced extensive rural settlement expansion and high rates of soil sealing. Soil landscapes became more fragmented, more irregular, more isolated, and less diverse. Relationships between soil landscape pattern changes and rural anthropogenic activities differed with the scale (spatial and temporal) and variable considered. In particular, the anthropogenic activity intensity was found to be the most important indicator explaining social development intensity, whereas the other two proximity indicators had a significant impact at certain temporal interval. In combination with scale effects, spatial dependency (correlation) was shown to play a key role that should be carefully taken into consideration in any relevant environmental study. Overall, the findings of this work suggest that soil sealing can be a critical human forcing issue with considerable consequences deserving serious attention by the experts, the public and the government alike.	[Xiao, Rui; Jiang, Diwei; Christakos, George; Fei, Xufeng; Wu, Jiaping] Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China; [Xiao, Rui] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan, Peoples R China	Zhejiang University; Wuhan University	Wu, JP (corresponding author), Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China.	jw67@zju.edu.cn	Wu, Jiaping/AAD-8800-2022		Ministry of Science and Technology, China [2015DFA01410]	Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This work was supported partially by the Ministry of Science and Technology, China (2015DFA01410).; We are very grateful to the PLoS ONE Editor (Dr. Iratxe Puebla) and the two reviewers for their constructive comments and suggestions, which have substantially improved this paper. Professor Stephen DeGloria of Cornell University (USA) provided valuable comments. This work was supported partially by the Ministry of Science and Technology, China (2015DFA01410).	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Clarke KC, 1998, INT J GEOGR INF SCI, V12, P699, DOI 10.1080/136588198241617; Couch C., 2007, URBAN SPRAWL EUROPE; DARMODY RG, 1982, SOIL SCI SOC AM J, V46, P588, DOI 10.2136/sssaj1982.03615995004600030029x; Donnelly S, 2011, REG ENVIRON CHANGE, V11, P97, DOI 10.1007/s10113-010-0124-6; Jiang ZL, 2012, STOCH ENV RES RISK A, V26, P751, DOI 10.1007/s00477-012-0590-0; Johnson MP, 2001, ENVIRON PLANN A, V33, P717, DOI 10.1068/a3327; Karim Z, 2014, ECOL INDIC, V42, P20, DOI 10.1016/j.ecolind.2013.07.020; Lacombe D, 2004, PUBLIC FINANC REV, V35, P480; Li TH, 2010, ECOL ECON, V69, P1427, DOI 10.1016/j.ecolecon.2008.05.018; Li X, 2004, LANDSCAPE URBAN PLAN, V69, P335, DOI 10.1016/j.landurbplan.2003.10.033; Liu SL, 2008, ECOL ENG, V34, P91, DOI 10.1016/j.ecoleng.2008.07.006; Long HL, 2009, LAND USE POLICY, V26, P322, DOI 10.1016/j.landusepol.2008.04.001; Luo J, 2009, LANDSCAPE URBAN PLAN, V91, P51, DOI 10.1016/j.landurbplan.2008.11.010; McGarigal K, 2002, COMPUTER SOFTWARE PR; McMahon G, 2000, J AM WATER RESOUR AS, V36, P1247, DOI 10.1111/j.1752-1688.2000.tb05724.x; Munsi M, 2010, REG ENVIRON CHANGE, V10, P145, DOI 10.1007/s10113-009-0101-0; Napton DE, 2010, REG ENVIRON CHANGE, V10, P37, DOI 10.1007/s10113-009-0084-x; Nazemi A, 2012, STOCH ENV RES RISK A, V26, P189, DOI 10.1007/s00477-011-0467-7; Pan XZ, 2007, CATENA, V69, P65, DOI 10.1016/j.catena.2006.04.016; Piotrowska-Dlugosz A, 2015, J SOIL SEDIMENT, V15, P47, DOI 10.1007/s11368-014-0963-8; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Rempel R, 2008, PATCH ANAL; Saura S, 2007, ISPRS J PHOTOGRAMM, V62, P201, DOI 10.1016/j.isprsjprs.2007.03.004; Scalenghe R, 2009, LANDSCAPE URBAN PLAN, V90, P1, DOI 10.1016/j.landurbplan.2008.10.011; Schaldach R, 2007, REG ENVIRON CHANGE, V7, P137, DOI 10.1007/s10113-007-0034-4; Seto KC, 2005, LANDSCAPE ECOL, V20, P871, DOI 10.1007/s10980-005-5238-8; Su SL, 2013, ECOL INDIC, V24, P375, DOI 10.1016/j.ecolind.2012.07.015; Su SL, 2011, PHYS CHEM EARTH, V36, P379, DOI 10.1016/j.pce.2010.03.021; Su SL, 2011, REG ENVIRON CHANGE, V11, P651, DOI 10.1007/s10113-010-0197-2; Tan MH, 2005, LAND USE POLICY, V22, P187, DOI 10.1016/j.landusepol.2004.03.003; Tate CM, 2005, AM FISH S S, V47, P291; Wang XW, 2016, STOCH ENV RES RISK A, V30, P137, DOI 10.1007/s00477-015-1043-3; Wei ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109380; Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Wu JiaPing, 2013, Acta Pedologica Sinica, V50, P30; Wu JX, 2009, AGR ECOSYST ENVIRON, V129, P523, DOI 10.1016/j.agee.2008.11.008; Xiao R, 2013, CATENA, V109, P1, DOI 10.1016/j.catena.2013.05.004; Xiao R, 2013, APPL GEOGR, V39, P158, DOI 10.1016/j.apgeog.2013.01.002; Yaalon DH, 2000, NATURE, V407, P301, DOI 10.1038/35030260; Zhang XL, 2007, CATENA, V69, P16, DOI 10.1016/j.catena.2006.04.020	43	5	5	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166224	10.1371/journal.pone.0166224	http://dx.doi.org/10.1371/journal.pone.0166224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832167	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000078
J	Taylor, M; Gozen, I; Patel, S; Jesorka, A; Bertoldi, K				Taylor, Michael; Gozen, Irep; Patel, Samir; Jesorka, Aldo; Bertoldi, Katia			Peridynamic Modeling of Ruptures in Biomembranes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; CRACK-PROPAGATION; MEMBRANE-FLUIDITY; LIPID-BILAYERS; ELASTICITY; FRACTURE; CALCIUM; PORES	We simulate the formation of spontaneous ruptures in supported phospholipid double bilayer membranes, using peridynamic modeling. Experiments performed on spreading double bilayers typically show two distinct kinds of ruptures, floral and fractal, which form spontaneously in the distal (upper) bilayer at late stages of double bilayer formation on high energy substrates. It is, however, currently unresolved which factors govern the occurrence of either rupture type. Variations in the distance between the two bilayers, and the occurrence of interconnections ("pinning sites") are suspected of contributing to the process. Our new simulations indicate that the pinned regions which form, presumably due to Ca2+ ions serving as bridging agent between the distal and the proximal bilayer, act as nucleation sites for the ruptures. Moreover, assuming that the pinning sites cause a non-zero shear modulus, our simulations also show that they change the rupture mode from floral to fractal. At zero shear modulus the pores appear to be circular, subsequently evolving into floral pores. With increasing shear modulus the pore edges start to branch, favoring fractal morphologies. We conclude that the pinning sites may indirectly determine the rupture morphology by contributing to shear stress in the distal membrane.	[Taylor, Michael] Santa Clara Univ, Dept Mech Engn, Santa Clara, CA 95053 USA; [Gozen, Irep; Patel, Samir; Bertoldi, Katia] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Jesorka, Aldo] Chalmers, Dept Chem & Chem Engn, Gothenburg, Sweden	Santa Clara University; Harvard University; Chalmers University of Technology	Bertoldi, K (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	bertoldi@seas.harvard.edu		Gozen, Irep/0000-0002-5379-3273; Taylor, Michael/0000-0002-3702-4191	Santa Clara University; Vetenskapsradet [637-2013-414]; Horizon [664786]; National Science Foundation; Harvard MRSEC [DMR1420570]	Santa Clara University; Vetenskapsradet(Swedish Research Council); Horizon; National Science Foundation(National Science Foundation (NSF)); Harvard MRSEC(National Science Foundation (NSF))	This work was made possible through financial support obtained from the Start-up Funding from the Santa Clara University (MT); Vetenskapsradet 637-2013-414 (IG); Horizon 2020 664786 (AJ), National Science Foundation and Harvard MRSEC DMR1420570 (KB).	Agwai A, 2011, INT J FRACTURE, V171, P65, DOI 10.1007/s10704-011-9628-4; Akashi K, 1998, BIOPHYS J, V74, P2973, DOI 10.1016/S0006-3495(98)78004-X; Ayton G, 2002, BIOPHYS J, V82, P1226, DOI 10.1016/S0006-3495(02)75479-9; Bobaru F, 2012, CENTEURJENG, V2, P551, DOI [10.2478/s13531-012-0020-6, DOI 10.2478/S13531-012-0020-6]; Braverman B, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/262931; Dimova R, 2000, BIOPHYS J, V79, P340, DOI 10.1016/S0006-3495(00)76296-5; Espinosa G, 2011, P NATL ACAD SCI USA, V108, P6008, DOI 10.1073/pnas.1018572108; Falconer K., 2014, FRACTAL GEOMETRY MAT; Fan HF, 2016, INT J IMPACT ENG, V87, P14, DOI 10.1016/j.ijimpeng.2015.08.006; Gerstle W, 2007, NUCL ENG DES, V237, P1250, DOI 10.1016/j.nucengdes.2006.10.002; Gozen I, 2013, SOFT MATTER, V9, P2787, DOI 10.1039/c3sm27429b; Gozen I, 2014, EUR PHYS J-SPEC TOP, V223, P1813, DOI 10.1140/epjst/e2014-02228-5; Gozen I, 2012, SOFT MATTER, V8, P6220, DOI 10.1039/c2sm25629k; Gozen I, 2010, NAT MATER, V9, P908, DOI [10.1038/NMAT2854, 10.1038/nmat2854]; Ha Y, 2010, INT J FRACTURE, V162, P229, DOI 10.1007/s10704-010-9442-4; Hu WK, 2012, COMPUT METHOD APPL M, V217, P247, DOI 10.1016/j.cma.2012.01.016; Hu WK, 2011, INT J MULTISCALE COM, V9, P707, DOI 10.1615/IntJMultCompEng.2011002651; Huang D, 2011, SCI CHINA TECHNOL SC, V54, P591, DOI 10.1007/s11431-011-4306-3; Jadidi Tayebeh, 2014, Front Bioeng Biotechnol, V2, P8, DOI 10.3389/fbioe.2014.00008; Janssen JZ M., 2004, FRACTURE MECH, DOI DOI 10.1529/BIOPHYSJ.107; Kilic B, 2010, THEOR APPL FRACT MEC, V53, P194, DOI 10.1016/j.tafmec.2010.08.001; Lai X, 2015, INT J NUMER ANAL MET, V39, P1304, DOI 10.1002/nag.2356; Liu W, 2012, DISCRETIZED BOND BAS; Liu WY, 2012, INT J NUMER METH ENG, V89, P1028, DOI 10.1002/nme.3278; Madenci E., 2013, PERIDYNAMIC THEORY I; Oterkus E, 2012, OPEN ENG, V2, P523, DOI 10.2478/s13531-012-0025-1; Oterkus E, 2012, J MECH MATER STRUCT, V7, P45, DOI 10.2140/jomms.2012.7.45; Oterkus S, 2014, 55 AIAA ASEM ASCE AH; Pabst G, 2007, BIOPHYS J, V93, P2688, DOI 10.1529/biophysj.107.112615; Parks ML, 2008, COMPUT PHYS COMMUN, V179, P777, DOI 10.1016/j.cpc.2008.06.011; Parks ML, 2011, SANDIA REPORT 2011 8; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Saintyves B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.047801; Seleson P, 2009, MULTISCALE MODEL SIM, V8, P204, DOI 10.1137/09074807X; Silling SA, 2007, J ELASTICITY, V88, P151, DOI 10.1007/s10659-007-9125-1; Silling SA, 2005, COMPUT STRUCT, V83, P1526, DOI 10.1016/j.compstruc.2004.11.026; Silling SA, 2005, INT J NONLIN MECH, V40, P395, DOI 10.1016/j.ijnonlinmec.2004.08.004; Silling SA, 2000, J MECH PHYS SOLIDS, V48, P175, DOI 10.1016/S0022-5096(99)00029-0; Silling SA., COMPUTATIONAL FLUID, P641; Sinn CG, 2006, COLLOID SURFACE A, V282, P410, DOI 10.1016/j.colsurfa.2005.10.014; Smith TG, 1996, J NEUROSCI METH, V69, P123, DOI 10.1016/S0165-0270(96)00080-5; Taylor M, 2015, MATH MECH SOLIDS, V20, P998, DOI 10.1177/1081286513512925; Tupek MR, 2014, J MECH PHYS SOLIDS, V65, P82, DOI 10.1016/j.jmps.2013.12.012; WATANABE H, 1990, FREE RADICAL BIO MED, V8, P507, DOI 10.1016/0891-5849(90)90150-H; Weckner O, 2013, APPL MATH COMPUT, V219, P6039, DOI 10.1016/j.amc.2012.11.090; Zohdi T., 2007, INTRO MODELING SIMUL	46	12	12	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165947	10.1371/journal.pone.0165947	http://dx.doi.org/10.1371/journal.pone.0165947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829001	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300068
J	Gonzalez-Betancor, SM; Lopez-Puig, AJ				Gonzalez-Betancor, Sara M.; Lopez-Puig, Alexis J.			Grade Retention in Primary Education Is Associated with Quarter of Birth and Socioeconomic Status	PLOS ONE			English	Article							CHILD-CARE PREDICTORS; KINDERGARTEN RETENTION; PRESCHOOL EDUCATION; PRE-K; ACHIEVEMENT; STUDENTS; 1ST-GRADE; FAMILY; REPETITION; PROGRAM	Grade retention is still common practice in some countries though longstanding experience tells us that it is a highly criticised practice for its unclear benefits, its important costs for the educational systems and its relation with school dropout. Therefore, the aim of the present study is to analyse which variables increase the probability of being retained in primary education differentiating between being retained in second or in fourth grade, and paying special attention to the role of the socioeconomic status of the families. By knowing which analysed variables are related to grade retention, and how, we may offer some suggestions to reduce it. We use a national dataset with more observations for Spain than any other international ones, called 'Evaluacion General de Diagnostico', conducted in Spain in 2009 with the participation of 28708 students of fourth grade of primary education from 874 schools, considered to be representative for every Spanish autonomous region. This assessment focused on four competences and includes information about the learning context collected through questionnaires for students, families, school management and teachers. Estimating different multilevel random-intercept logistic regressions we obtain the following three main findings: 1) the existence of a 'quarter of birth' effect, that nearly doubles the probability of grade retention in second grade of primary compared to the probability of grade retention in fourth grade, for the youngest students of their same age cohort (OR = 1.93 vs. OR = 1.53, both p<0.001); 2) that the mothers' education level influences more than the fathers' one especially in second grade (OR = 0.20 vs. OR = 0.45, both p<0.001); and 3) that having an unemployed father increases the probability of grade retention much more than having an unemployed mother especially in second grade (OR = 1.48, p<0.005 vs. OR =1.18, p>0.05).	[Gonzalez-Betancor, Sara M.] Univ Las Palmas Gran Canaria, Dept Metodos Cuantitat Econ & Gest, Econ Salud & Polit Publ, Las Palmas Gran Canaria, Spain; [Lopez-Puig, Alexis J.] Univ Las Palmas Gran Canaria, Dept Ingn Elect & Automat, Las Palmas Gran Canaria, Spain; [Lopez-Puig, Alexis J.] ACCUEE, Gobierno De Canarias, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Gonzalez-Betancor, SM (corresponding author), Univ Las Palmas Gran Canaria, Dept Metodos Cuantitat Econ & Gest, Econ Salud & Polit Publ, Las Palmas Gran Canaria, Spain.	sara.gonzalez@ulpgc.es	González-Betancor, Sara M./P-8315-2015	González-Betancor, Sara M./0000-0002-2209-1922; Lopez-Puig, Alexis J./0000-0002-8254-3513				Alivernini F, 2013, EDUC STUD-UK, V39, P399, DOI 10.1080/03055698.2013.767187; Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; Ammermueller A, 2009, J LABOR ECON, V27, P315, DOI 10.1086/603650; [Anonymous], APPL MEAS ED, DOI [10.1080/08957340902754635, DOI 10.1080/08957340902754635]; Barbetta G.P., 2003, ANN PUBLIC COOP ECON, V74, P529, DOI [https://doi.org/10.1111/j.1467-8292.2003.00234.x, DOI 10.1111/J.1467-8292.2003.00234.X, 10.1111/j.1467-8292.2003.00234.x]; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; Borodankova O, 2011, GRADE RETENTION COMP; Bowman-Perrott LJ, 2010, READ WRIT Q, V26, P91, DOI 10.1080/10573560903397064; Brown CA, 2011, EDUC POLICY, V25, P115, DOI 10.1177/0895904810386601; BYRD RS, 1994, PEDIATRICS, V93, P481; Calero J, 2010, REV EDUC-MADRID, P225; Carabaha J., 2015, REV ASOC SOCIOLOGIA, V8, P7; Carabana Morales J, 2011, REV ASOCIACI N SOCIO, V4, P283; Cham HN, 2015, J SCHOOL PSYCHOL, V53, P7, DOI 10.1016/j.jsp.2014.10.001; de Mendizabal AC, 2013, REV EDUC-MADRID, P562, DOI 10.4438/1988-592X-RE-2013-362-242; Conboy J, 2011, INT C ED ED PSYCH 20; Ferrera JMC, 2014, REV EDUC-MADRID, P12, DOI 10.4438/1988-592X-RE-2014-365-263; Ferrera JMC, 2011, REV ECON APL-SPAIN, V19, P117; Corman H, 2003, ECON EDUC REV, V22, P409, DOI 10.1016/S0272-7757(02)00070-5; COSDEN M, 1995, J SCHOOL PSYCHOL, V33, P123, DOI 10.1016/0022-4405(95)00002-4; DANIELS S, 1995, OXFORD REV EDUC, V21, P163, DOI 10.1080/0305498950210203; Downer JT, 2006, SCHOOL PSYCHOL REV, V35, P11; Ehmke T, 2008, Z ERZIEHWISS, V11, P368, DOI 10.1007/s11618-008-0033-3; El-Hassan K, 1998, J EDUC RES, V91, P279, DOI 10.1080/00220679809597555; Elder TE, 2009, J HUM RESOUR, V44, P641; Garcia Montalvo J., 2013, PIRLS TIMSS 2011 EST, VII, P55; Gil-Flores J, 2011, CULT EDUC, V23, P141, DOI 10.1174/113564011794728597; Gonzalez-Betancor SM, 2015, CULT EDUC, V27, P237, DOI 10.1080/11356405.2015.1034533; Gonzalez-Betancor SM, 2015, REV EDUC, V369, P151; Goos M, 2013, J SCHOOL PSYCHOL, V51, P323, DOI 10.1016/j.jsp.2013.03.002; Gormley WT, 2008, SOC SCI QUART, V89, P916, DOI 10.1111/j.1540-6237.2008.00591.x; Guzel CI, 2010, EGIT ARAST, V10, P93; Halpern R., 2013, TEACH COLL REC, V115, P1; Hillmert S, 2013, RES SOC STRAT MOBIL, V32, P7, DOI 10.1016/j.rssm.2013.02.002; Huerta Cuervo MR, 2010, GEST POLIT PUBLICA, V19, P420; Hughes JN, 2013, AM EDUC RES J, V50, P1336, DOI 10.3102/0002831213490784; Hughes JN, 2010, EDUC EVAL POLICY AN, V32, P166, DOI 10.3102/0162373710367682; Hurd S, 2008, BRIT EDUC RES J, V34, P19, DOI 10.1080/01411920701492035; Garcia-Perez JI, 2014, APPL ECON, V46, P1373, DOI 10.1080/00036846.2013.872761; Klapproth F, 2015, EUR J PSYCHOL EDUC, V30, P119, DOI 10.1007/s10212-014-0232-7; Ladd HF, 2012, J POLICY ANAL MANAG, V31, P203, DOI 10.1002/pam.21615; Magnuson KA, 2004, AM EDUC RES J, V41, P115, DOI 10.3102/00028312041001115; Magnuson KA, 2007, EARLY CHILD RES Q, V22, P18, DOI 10.1016/j.ecresq.2006.10.002; MANTZICOPOULOS P, 1992, AM EDUC RES J, V29, P182, DOI 10.2307/1162907; Martin M, PIRLS 20062008; Martin RP, 2004, J LEARN DISABIL-US, V37, P307, DOI 10.1177/00222194040370040301; MCLESKEY J, 1992, EXCEPT CHILDREN, V58, P548, DOI 10.1177/001440299205800609; MECD, 2015, SIST EST IND ED 2015; MECD, 2012, SIST EST IND ED; Ministerio de Educacion, 2010, EV GEN DIAGN 2009 ED; Mwaura PAM, 2008, INT J EARLY YEARS ED, V16, P237, DOI 10.1080/09669760802357121; Pedraja-Chaparro F, 2016, APPL ECON, V48, P1978, DOI 10.1080/00036846.2015.1111989; Pedraja-Chaparro F, 2015, J POLICY MODEL, V37, P820, DOI 10.1016/j.jpolmod.2015.04.004; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Rao N, 2012, EARLY CHILD RES Q, V27, P66, DOI 10.1016/j.ecresq.2011.07.001; REYNOLDS AJ, 1992, EDUC EVAL POLICY AN, V14, P101, DOI 10.3102/01623737014002101; Robertson E, 2011, ECON EDUC REV, V30, P300, DOI 10.1016/j.econedurev.2010.10.005; Roman M, 2011, CEPAL REV, P37; Seyda S, 2009, Z ERZIEHWISS, V12, P233, DOI 10.1007/s11618-009-0073-3; Silberglitt B, 2006, SCHOOL PSYCHOL REV, V35, P134; Stinebrickner R, 2003, J HUM RESOUR, V38, P591, DOI 10.2307/1558769; Stull JC, 2013, RES EDUC, V90, P53, DOI 10.7227/RIE.90.1.4; Verachtert P, 2010, OXFORD REV EDUC, V36, P285, DOI 10.1080/03054981003629896; Winsler A, 2012, DEV PSYCHOL, V48, P1299, DOI 10.1037/a0026985; Wossmann L, 2010, APPL ECON, V42, P2645, DOI 10.1080/00036840801964617	65	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166431	10.1371/journal.pone.0166431	http://dx.doi.org/10.1371/journal.pone.0166431			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851779	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300048
J	Saito, M; Kim, HS; Ito, A; Yokota, T; Maksyutov, S				Saito, Makoto; Kim, Heon-Sook; Ito, Akihiko; Yokota, Tatsuya; Maksyutov, Shamil			Enhanced Methane Emissions during Amazonian Drought by Biomass Burning	PLOS ONE			English	Article							RETRIEVAL ALGORITHM; ERROR-STATISTICS; CO2; INVERSIONS; VALIDATION; SATELLITE; AIRCRAFT; SIBERIA; SURFACE; MODEL	The Amazon is a significant source of atmospheric methane, but little is known about the source response to increasing drought severity and frequency. We investigated satellite observations of atmospheric column-averaged methane for the 2010 drought and subsequent 2011 wet year in the Amazon using an atmospheric inversion scheme. Our analysis indicates an increase in atmospheric methane over the southern Amazon region during the drought, representing an increase in annual emissions relative to the wet year. We attribute the increase to emissions from biomass burning driven by intense drought, combined with carbon monoxide showing seasonal variations corresponding to methane variations. We show that there is probably a strong correspondence between drought and methane emissions in the Amazon.	[Saito, Makoto; Kim, Heon-Sook; Ito, Akihiko; Yokota, Tatsuya; Maksyutov, Shamil] Natl Inst Environm Studies, Ctr Global Environm Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan	National Institute for Environmental Studies - Japan	Saito, M (corresponding author), Natl Inst Environm Studies, Ctr Global Environm Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	saito.makoto@nies.go.jp	Ito, Akihiko/P-2624-2017; Saito, Makoto/AAL-4510-2021; Maksyutov, Shamil S/G-6494-2011	Ito, Akihiko/0000-0001-5265-0791; Maksyutov, Shamil S/0000-0002-1200-9577	Environment Research and Technology Development Fund, Ministry of Environment Japan [A-1202]	Environment Research and Technology Development Fund, Ministry of Environment Japan	This study was supported by Grant A-1202 of Environment Research and Technology Development Fund, Ministry of Environment Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by Grant A-1202 of Environment Research and Technology Development Fund, Ministry of Environment Japan. We thank I. Morino, O. Uchino, Y. Yoshida, T. Machida, M. Sasakawa, the GOSAT project by NIES, CarbonTracker-CH<INF>4</INF>, CRU, EDGAR, GFED, GLOBALVIEW, JCDAS, MOPITT, and WDGCC for providing data. GOSAT data was obtained from the GOSAT User Interface Gateway at http://www.gosat.nies.go.jp/en/. Maptool uses the Generic Mapping Tools, version 5.2.1 (http://gmt.soest.hawaii.edu/).	Arnesen AS, 2013, REMOTE SENS ENVIRON, V130, P51, DOI 10.1016/j.rse.2012.10.035; Berchet A, 2013, ATMOS CHEM PHYS, V13, P7115, DOI 10.5194/acp-13-7115-2013; Bergamaschi P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012287; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bruhwiler L, 2014, ATMOS CHEM PHYS, V14, P8269, DOI 10.5194/acp-14-8269-2014; Bruhwiler LMP, 2005, ATMOS CHEM PHYS, V5, P2691, DOI 10.5194/acp-5-2691-2005; Chapnik B, 2004, Q J ROY METEOR SOC, V130, P2253, DOI 10.1256/qj.03.26; Christensen T. R., 2010, METHANE CLIMATE CHAN, P27; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; Deeter MN, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003186; Dils B, 2014, ATMOS MEAS TECH, V7, P1723, DOI 10.5194/amt-7-1723-2014; Environmental Protection Agency (EPA), 2012, GLOBAL ANTHROPOGENIC; European Commission Joint Research Centre Netherlands Environmental Assessment Agency, 2010, EM DAT GLOB ATM RES; FEARNSIDE PM, 1990, ECOL STU AN, V84, P106; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; Fraser A, 2013, ATMOS CHEM PHYS, V13, P5697, DOI 10.5194/acp-13-5697-2013; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; Ganesan AL, 2014, ATMOS CHEM PHYS, V14, P3855, DOI 10.5194/acp-14-3855-2014; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; GLOBALVIEW-CH4, 2009, COOP ATM DAT INT PRO; Guild LS, 2004, ECOL APPL, V14, pS232; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Ito A, 2012, BIOGEOSCIENCES, V9, P759, DOI 10.5194/bg-9-759-2012; Kim HS, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035201; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/ngeo1955, 10.1038/NGEO1955]; Kuze A, 2009, APPL OPTICS, V48, P6716, DOI 10.1364/AO.48.006716; Law RM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001593; Liu JJ, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.22486; Maksyutov S, 2013, ATMOS CHEM PHYS, V13, P9351, DOI 10.5194/acp-13-9351-2013; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Marengo JA, 2004, J CLIMATE, V17, P2261, DOI 10.1175/1520-0442(2004)017<2261:COTLJE>2.0.CO;2; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Miller JB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029213; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Patra PK, 2011, ATMOS CHEM PHYS, V11, P4163, DOI [10.5194/acp-11-4163-2011, 10.5194/acp-11-12813-2011]; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Potter C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000250; Saeki T, 2013, J GEOPHYS RES-ATMOS, V118, P1100, DOI 10.1002/jgrd.50127; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Sasakawa M, 2013, J GEOPHYS RES-ATMOS, V118, P9489, DOI 10.1002/jgrd.50755; Tsakiris G, 2007, WATER RESOUR MANAG, V21, P821, DOI 10.1007/s11269-006-9105-4; Tsutsumi Y, 2009, TECHNICAL REPORT GLO; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Wilson C, 2016, GLOBAL BIOGEOCHEM CY; Wood TE, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB004014; Yokota T, 2009, SOLA, V5, P160, DOI 10.2151/sola.2009-041; Yoshida Y, 2013, ATMOS MEAS TECH, V6, P1533, DOI 10.5194/amt-6-1533-2013	49	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166039	10.1371/journal.pone.0166039	http://dx.doi.org/10.1371/journal.pone.0166039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851783	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300032
J	Davey, L; Halperin, SA; Lee, SF				Davey, Lauren; Halperin, Scott A.; Lee, Song F.			Mutation of the Streptococcus gordonii Thiol-Disulfide Oxidoreductase SdbA Leads to Enhanced Biofilm Formation Mediated by the CiaRH Two-Component Signaling System	PLOS ONE			English	Article							BINDING-PROTEIN-B; REGULATORY SYSTEM; RESPONSE REGULATOR; ORAL COLONIZATION; IMMUNE-RESPONSES; STRESS TOLERANCE; PNEUMONIAE R6; A ABPA; COMPETENCE; MUTANS	Streptococcus gordonii is a commensal inhabitant of human oral biofilms. Previously, we identified an enzyme called SdbA that played an important role in biofilm formation by S. gordonii. SdbA is thiol-disulfide oxidoreductase that catalyzes disulfide bonds in secreted proteins. Surprisingly, inactivation of SdbA results in enhanced biofilm formation. In this study we investigated the basis for biofilm formation by the Delta sdbA mutant. The results revealed that biofilm formation was mediated by the interaction between the CiaRH and ComDE twocomponent signalling systems. Although it did not affect biofilm formation by the S. gordonii parent strain, CiaRH was upregulated in the Delta sdbA mutant and it was essential for the enhanced biofilm phenotype. The biofilm phenotype was reversed by inactivation of CiaRH or by the addition of competence stimulating peptide, the production of which is blocked by CiaRH activity. Competition assays showed that the enhanced biofilm phenotype also corresponded to increased oral colonization in mice. Thus, the interaction between SdbA, CiaRH and ComDE affects biofilm formation both in vitro and in vivo.	[Davey, Lauren; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Davey, Lauren; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS B3K 6R8, Canada; [Davey, Lauren; Halperin, Scott A.; Lee, Song F.] IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada; [Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Dept Pediat, Fac Med, Halifax, NS B3K 6R8, Canada; [Lee, Song F.] Dalhousie Univ, Dept Appl Oral Sci, Fac Med, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Lee, SF (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS B3K 6R8, Canada.; Lee, SF (corresponding author), IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Dept Pediat, Fac Med, Halifax, NS B3K 6R8, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Dept Appl Oral Sci, Fac Med, Halifax, NS B3H 4R2, Canada.	Song.Lee@Dal.Ca		Halperin, Scott/0000-0003-0525-589X; Davey, Lauren/0000-0002-9541-485X	Natural Sciences and Engineering Research Council of Canada [183712]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Natural Sciences and Engineering Research Council of Canada, grant #183712, to SL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2006, INFECT IMMUN, V74, P1631, DOI 10.1128/IAI.74.3.1631-1642.2006; Anwar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106095; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; Chaudhuri B, 2008, INFECT IMMUN, V76, P4530, DOI 10.1128/IAI.00186-08; Chaudhuri B, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-60; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Davey L, 2016, MOL MICROBIOL, V99, P236, DOI 10.1111/mmi.13227; Davey L, 2016, J BACTERIOL, V198, P321, DOI 10.1128/JB.00800-15; Davey L, 2013, J BIOL CHEM, V288, P16416, DOI 10.1074/jbc.M113.464578; Davis E, 2011, APPL ENVIRON MICROB, V77, P1660, DOI 10.1128/AEM.02178-10; Du LD, 2000, INFECT IMMUN, V68, P4834, DOI 10.1128/IAI.68.8.4834-4837.2000; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Halfmann A, 2011, J MOL MICROB BIOTECH, V20, P96, DOI 10.1159/000324893; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Huang R, 2014, APPL ENVIRON MICROB, V80, P7212, DOI 10.1128/AEM.02395-14; Jack AA, 2015, MICROBIOL-SGM, V161, P411, DOI 10.1099/mic.0.000010; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; Jakubovics NS, 2015, MOL MICROBIOL, V97, P281, DOI 10.1111/mmi.13023; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; Knight JB, 2008, CLIN VACCINE IMMUNOL, V15, P925, DOI 10.1128/CVI.00500-07; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Lee SF, 2003, CURR OPIN INFECT DIS, V16, P231, DOI 10.1097/00001432-200306000-00008; Lee SF, 2002, FEMS MICROBIOL LETT, V208, P175, DOI 10.1016/S0378-1097(02)00457-3; Lee Y, 2008, FEMS MICROBIOL LETT, V278, P213, DOI 10.1111/j.1574-6968.2007.00993.x; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Liu YL, 2009, J BACTERIOL, V191, P7353, DOI 10.1128/JB.01053-09; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Love RM, 1997, INFECT IMMUN, V65, P5157, DOI 10.1128/IAI.65.12.5157-5164.1997; Marchant S, 2001, CARIES RES, V35, P397, DOI 10.1159/000047482; Mascher T, 2006, J BACTERIOL, V188, P1959, DOI 10.1128/JB.188.5.1959-1968.2006; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Pirias GE, 2008, MICROBIOLOGY, V154, P1300, DOI [10.1099/m5.0.2007/015925-0, DOI 10.1099/M5.0.2007/015925-0]; Prudhomme M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006113; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnorpfeil A, 2013, MOL MICROBIOL, V89, P334, DOI 10.1111/mmi.12277; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Tanzer JM, 2003, MICROBIOL-SGM, V149, P2653, DOI 10.1099/mic.0.26022-0; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Trappetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019844; Tremblay YDN, 2009, MICROBIOL-SGM, V155, P2856, DOI 10.1099/mic.0.028456-0; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Wang BY, 2011, J DENT RES, V90, P501, DOI 10.1177/0022034510388808; Wang BY, 2005, APPL ENVIRON MICROB, V71, P354, DOI 10.1128/AEM.71.1.354-362.2005; Zhang Y, 2005, INFECT IMMUN, V73, P3351, DOI 10.1128/IAI.73.6.3351-3357.2005; Zhang YS, 2009, MICROBIOL-SGM, V155, P165, DOI 10.1099/mic.0.023168-0	60	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166656	10.1371/journal.pone.0166656	http://dx.doi.org/10.1371/journal.pone.0166656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846284	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600099
J	Lengyel, B; Lesko, M				Lengyel, Balazs; Lesko, Mariann			International Collaboration and Spatial Dynamics of US Patenting in Central and Eastern Europe 1981-2010	PLOS ONE			English	Article							KNOWLEDGE SPILLOVERS; TERRITORIAL DYNAMICS; GRAVITY MODEL; INNOVATION; STATES; DETERMINANTS; TECHNOLOGY; GOVERNMENT; REGIONS; QUALITY	How did post-socialist transition and a parallel shift in international labor division restructure regional innovation systems in Central and Eastern Europe? This question is increasingly important, because current EU innovation policy is combined with regional development in Smart Specialization Strategies; however, spatial trends of innovation in Central and Eastern Europe are not fully understood which might lead to less than perfectly efficient policy. In this paper we describe the spatial dynamics of inventor activity in the Czech Republic, Hungary, Poland and Slovakia between 1981 and 2010 - a period that covers both the late socialist era and the post-socialist transition. Cleaning and analyzing the publicly available data from the United States Patent and Trademark Office we illustrate that Central and Eastern European patents made in international co-operations with partners outside the region receive more citations than those Central and Eastern European patents that lack international co-operation. Furthermore, the technological portfolio of the former patents has become increasingly independent from the technological portfolio of the latter class. A town-level analysis of the applicant-inventor ties reveals that inventors have started to work for foreign assignees in those towns where no innovation activity had been recorded before. However, the positive effect does not last long and patenting seems to be only periodic in the majority of these towns. Therefore, innovation policy in Central and Eastern European countries, as well as in other less developed regions, shall foster synergies between international and domestic collaborations in order to decrease regional disparities in patenting.	[Lengyel, Balazs] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lengyel, Balazs] Int Business Sch Budapest, Zahony U 3, H-1031 Budapest, Hungary; [Lengyel, Balazs; Lesko, Mariann] Hungarian Acad Sci, Ctr Econ & Reg Studies, Budaorsi Ut 45, H-1112 Budapest, Hungary; [Lesko, Mariann] Univ Amsterdam, Econ, Roetersstr 11, NL-1018 WB Amsterdam, Netherlands	Massachusetts Institute of Technology (MIT); Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies; University of Amsterdam	Lengyel, B (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lengyel, B (corresponding author), Int Business Sch Budapest, Zahony U 3, H-1031 Budapest, Hungary.; Lengyel, B (corresponding author), Hungarian Acad Sci, Ctr Econ & Reg Studies, Budaorsi Ut 45, H-1112 Budapest, Hungary.	blengyel@mit.edu			Polanyi Karoly Foundation for Research and Education; Rosztoczy Fundation; Tempus Public Fundation [MAEO2016_29, 77666]	Polanyi Karoly Foundation for Research and Education; Rosztoczy Fundation; Tempus Public Fundation	Mariann Lesko received financial support from the Polanyi Karoly Foundation for Research and Education. Balks Lengyel was supported by the Rosztoczy Fundation and the Tempus Public Fundation (MAEO2016_29, 77666).	Archibugi D, 1993, CAMB J ECON, V19, P121; Bathelt H, 2004, PROG HUM GEOG, V28, P31, DOI 10.1191/0309132504ph469oa; Beaudry C, 2011, EUROPEAN MANAGEMENT, V9, P362; Blazek J, 2007, EUR PLAN STUD, V15, P871, DOI 10.1080/09654310701356175; Boschma RA, 2005, REG STUD, V39, P61, DOI 10.1080/0034340052000320887; Breschi S., 2001, IND CORP CHANGE, V10, P975, DOI DOI 10.1093/ICC/10.4.975; Chessa A, 2013, SCIENCE, V339, P650, DOI 10.1126/science.1227970; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Crescenzi R, 2007, J ECON GEOGR, V7, P673, DOI 10.1093/jeg/lbm030; Crescenzi R, 2012, J ECON GEOGR, V12, P1055, DOI 10.1093/jeg/lbs020; European Commission, 2016, EUR INN SCOR; Fitjar RD, 2015, J ECON GEOGR, V15, P561, DOI 10.1093/jeg/lbu017; Gao X, 2010, J INFORMETR, V4, P618, DOI 10.1016/j.joi.2010.07.001; Ginarte JC, 1997, RES POLICY, V26, P283, DOI 10.1016/S0048-7333(97)00022-X; Goldfinch S, 2003, SCIENTOMETRICS, V57, P321, DOI 10.1023/A:1025048516769; Grillitsch M, 2015, ANN REGIONAL SCI, V54, P299, DOI 10.1007/s00168-014-0655-8; Guan JC, 2012, INFORM PROCESS MANAG, V48, P170, DOI 10.1016/j.ipm.2011.03.001; Guellec D, 2001, RES POLICY, V30, P1253, DOI 10.1016/S0048-7333(00)00149-9; Hall BH, 2005, RAND J ECON, V36, P16; Hall BH, 2007, PREPRINT; Hall BH, 2012, PREPRINT; Hansen T, 2015, REG STUD, V49, P1672, DOI DOI 10.1080/00343404.2013.873120; Havas A., 2002, J INT RELAT DEV, V5, P380; Hoekman J, 2009, ANN REGIONAL SCI, V43, P721, DOI 10.1007/s00168-008-0252-9; Inzelt A, 2004, RES POLICY, V33, P975, DOI 10.1016/j.respol.2004.03.002; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Lee N, 2015, RES POLICY, V44, P370, DOI 10.1016/j.respol.2014.09.008; LENGYEL B., 2009, TRANSITION STUDIES R, V16, P174, DOI DOI 10.1007/S11300-009-0046-5; Lengyel B, 2015, SCI PUBL POLICY, V42, P1, DOI 10.1093/scipol/sct087; Leydesdorff L, 2004, J AM SOC INF SCI TEC, V55, P991, DOI 10.1002/asi.20045; Leydesdorff L, 2014, SCIENTOMETRICS, V98, P1583, DOI 10.1007/s11192-012-0923-2; Leydesdorff L, 2012, J AM SOC INF SCI TEC, V63, P1442, DOI 10.1002/asi.22666; Lundin P, 2011, NAT BIOTECHNOL, V29, P493, DOI 10.1038/nbt.1885; Marinova D, 2001, TECHNOVATION, V21, P571, DOI 10.1016/S0166-4972(00)00077-8; Marques P, 2015, J ECON GEOGR, V15, P1009, DOI 10.1093/jeg/lbv012; Marzucchi A, 2013, PAPERS REGIONAL SCI, V94, P499; Mccann P, 2015, REG STUD, V49, P1291, DOI 10.1080/00343404.2013.799769; Montobbio F, 2013, WORLD DEV, V44, P281, DOI 10.1016/j.worlddev.2012.11.017; Morgan K, 2015, REG STUD, V49, P480, DOI 10.1080/00343404.2015.1007572; Mowery DC, 2002, RES POLICY, V31, P399, DOI 10.1016/S0048-7333(01)00116-0; Muscio A, 2015, J ECON POLICY REFORM, V18, P153, DOI 10.1080/17487870.2015.1013545; O'Neale DRJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049501; PENROSE E, 1973, ECON J, V83, P768, DOI 10.2307/2230670; Picci L, 2010, RES POLICY, V39, P1070, DOI 10.1016/j.respol.2010.05.007; Radosevic S, 1999, TECHNOL ANAL STRATEG, V11, P95, DOI 10.1080/095373299107609; Radosevic S, 1999, RES POLICY, V28, P351, DOI 10.1016/S0048-7333(98)00124-3; Radosevic S., 2002, J TECHNOLOGY TRANSFE, V27, P87, DOI DOI 10.1023/A:1013152721632; Radosevic S, 2011, SCI PUBL POLICY, V38, P365, DOI 10.3152/030234211X12924093660435; Radosevic Slavo, 2006, KNOWLEDGE BASED EC C, P295; Rodriguez-Pose A, 2015, J ECON GEOGR, V15, P673, DOI 10.1093/jeg/lbu023; Strano E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159465; Suurna M, 2010, SCI PUBL POLICY, V37, P646, DOI 10.3152/030234210X12778118264459; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Tunzelman N. V., 2004, SCI PUBL POLICY, V31, P475; Varblane U, 2007, POST-COMMUNIST ECON, V19, P399, DOI 10.1080/14631370701680048; Varga A, 2004, REG STUD, V38, P977, DOI 10.1080/0034340042000280974; Varga A, 2017, INT REGIONAL SCI REV, V40, P405, DOI 10.1177/0160017616642821; Wagner CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131816	58	2	2	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166034	10.1371/journal.pone.0166034	http://dx.doi.org/10.1371/journal.pone.0166034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846288	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000387794600028
J	Butler, JM; Hirshberg, EL; Hopkins, RO; Wilson, EL; Orme, JF; Beesley, SJ; Kuttler, K; Brown, SM				Butler, Jorie M.; Hirshberg, Eliotte L.; Hopkins, Ramona O.; Wilson, Emily L.; Orme, James F.; Beesley, Sarah J.; Kuttler, Kathryn; Brown, Samuel M.			Preliminary Identification of Coping Profiles Relevant to Surrogate Decision Making in the ICU	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PATIENT-REPORTED MEASURE; OF-LIFE CARE; POSTTRAUMATIC-STRESS; FAMILY-MEMBERS; SYMPTOMS; COLLABORATE; DEPRESSION; INVENTORY; DISCHARGE	Objective The Intensive Care Unit (ICU) is a stressful environment for families of critically ill patients and these individuals are at risk to develop persistent psychological morbidity. Our study objective was to identify individual differences in coping with stress and information presentation preferences of respondents exposed to a simulated ICU experience. Methods Participants were recruited from a university and two community populations. Participants completed questionnaires that measured demographic information and characteristics that may be relevant to an individual's ICU experience. Quality of life was measured by the EQ5D, personality dimensions were examined with the abbreviated Big Five inventory, coping with stress was assessed with Brief COPE. Shared decision making preferences were assessed by the Degner Control Preferences Scale (CPS) and information seeking style was assessed with the Miller Behavioral Style Scale (MBSS). Social support was examined using an abbreviated version of the Social Relationship Index. Participants also completed a vignette-based simulated ICU experience, in which they made a surrogate decision on behalf of a loved one in the ICU. Results Three hundred forty-three participants completed the study. Three distinct coping profiles were identified: adaptive copers, maladaptive copers, and disengaged copers. Profiles differed primarily on coping styles, personality, quality of their closest social relationship, and history of anxiety and depression. Responses to the simulated ICU decision making experience differed across profiles. Disengaged copers (15%) were more likely to elect to refuse dialysis on behalf of an adult sibling compared to adaptive copers (7%) or maladaptive copers (5%) (p = 0.03). Notably, the MBSS and the CPS did not differ by coping profile. Conclusion Distinct coping profiles are associated with differences in responses to a simulated ICU experience. Tailoring communication and support to specific coping profiles may represent an important pathway to improving ICU experience for patients and families.	[Butler, Jorie M.] George E Wahlen Dept Vet Affairs Med Ctr, GRECC, Salt Lake City, UT 84148 USA; [Butler, Jorie M.] Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Butler, Jorie M.; Hirshberg, Eliotte L.; Hopkins, Ramona O.; Wilson, Emily L.; Orme, James F.; Beesley, Sarah J.; Kuttler, Kathryn; Brown, Samuel M.] Intermt Healthcare, Ctr Humanizing Crit Care, Murray, UT USA; [Hirshberg, Eliotte L.; Hopkins, Ramona O.; Wilson, Emily L.; Orme, James F.; Beesley, Sarah J.; Kuttler, Kathryn; Brown, Samuel M.] Intermt Med Ctr, Pulm & Crit Care Div, Dept Med, Murray, UT USA; [Hirshberg, Eliotte L.; Orme, James F.; Beesley, Sarah J.; Brown, Samuel M.] Univ Utah, Dept Internal Med, Div Pulm Med, Salt Lake City, UT 84112 USA; [Hirshberg, Eliotte L.] Univ Utah, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Kuttler, Kathryn] Homer Warner Ctr Informat Res, Murray, UT USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Brigham Young University; Brigham Young University	Butler, JM (corresponding author), George E Wahlen Dept Vet Affairs Med Ctr, GRECC, Salt Lake City, UT 84148 USA.; Butler, JM (corresponding author), Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA.; Butler, JM (corresponding author), Intermt Healthcare, Ctr Humanizing Crit Care, Murray, UT USA.	jorie.butler@hsc.utah.edu	Brown, Samuel/E-6846-2015	Brown, Samuel/0000-0003-1206-6261	Intermountain Research and Medical Foundation	Intermountain Research and Medical Foundation	Intermountain Research and Medical Foundation. https://intermountainhealthcare.org/giving-volunteering/intermountain-foundation/what-we-support/intermountain-research-medical-foundation/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Community Faces of Utah, including Pastor France A. Davis, Doriena Lee, Edwin Napia, Valentine Mukundente, Ana Sanchez-Birkhead, Jeannette Villata, Fahina Tavake-Pasi, Heather Coulter and Louisa Stark, as well as Cathy House at the Osher Lifelong Learning Center for their collaboration and assistance with obtaining survey data. We also thank Jonathan Butner, Jason Watson, and Nathan Story at the Department of Psychology at the University of Utah for assistance in data collection. Heather Gallo at Intermountain Healthcare provided superb support for the REDCAP online survey platform. Thank you to Jacqueline Telonidis for her invaluable assistance with manuscript preparation. Funding for this project was provided by the Intermountain Research and Medical Foundation. The authors declare no competing interests. License is granted to PLOSONE for publication. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0037-5; Barr PJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3085; Braun UK, 2014, PATIENT EDUC COUNS, V94, P334, DOI 10.1016/j.pec.2013.10.013; Brooks R, 2003, MEASUREMENT VALIDATI; Campo RA, 2009, J COMMUNITY PSYCHOL, V37, P471, DOI 10.1002/jcop.20308; Carlson EB, 2015, J CRIT CARE, V30, P557, DOI 10.1016/j.jcrc.2015.01.012; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cassell EJ, 2001, ANN INTERN MED, V134, P1120, DOI 10.7326/0003-4819-134-12-200106190-00012; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Curtis JR, 2016, AM J RESP CRIT CARE, V193, P154, DOI 10.1164/rccm.201505-0900OC; Curtis JR, 2012, CONTEMP CLIN TRIALS, V33, P1245, DOI 10.1016/j.cct.2012.06.010; Degner L F, 1997, Can J Nurs Res, V29, P21; DiGangi JA, 2013, CLIN PSYCHOL REV, V33, P728, DOI 10.1016/j.cpr.2013.05.002; Elwyn G, 2013, PATIENT EDUC COUNS, V93, P102, DOI 10.1016/j.pec.2013.05.009; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hickman RL, 2010, AM J CRIT CARE, V19, P410, DOI 10.4037/ajcc2010354; Jamerson PA, 1996, HEART LUNG, V25, P467, DOI 10.1016/S0147-9563(96)80049-5; Jox RJ, 2012, INT J GERIATR PSYCH, V27, P1045, DOI 10.1002/gps.2820; Khalaila R, 2013, J ADV NURS, V69, P1172, DOI 10.1111/j.1365-2648.2012.06109.x; Kleiber C, 1994, Am J Crit Care, V3, P70; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; McKiernan Margaret, 2010, Intensive Crit Care Nurs, V26, P254, DOI 10.1016/j.iccn.2010.06.004; Miller S. M., 1980, COPING HLTH, P145, DOI DOI 10.1007/978-1-4684-1042-6_8; Myhren H, 2011, PATIENT EDUC COUNS, V85, P237, DOI 10.1016/j.pec.2010.11.005; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Netzer Giora, 2014, Ann Am Thorac Soc, V11, P435, DOI 10.1513/AnnalsATS.201309-308OT; Parslow RA, 2006, PSYCHOL MED, V36, P387, DOI 10.1017/S0033291705006306; Patel SS, 2008, CLIN J AM SOC NEPHRO, V3, P587, DOI 10.2215/CJN.04040907; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Pomey MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122499; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Shaller D., 2007, PATIENT CTR CARE WHA; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Sokol DK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7351; SUHL J, 1994, ARCH INTERN MED, V154, P90, DOI 10.1001/archinte.154.1.90; Team RC, 2014, R LANG ENV STAT COMP; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Turan B, 2011, HEALTH PSYCHOL, V30, P814, DOI 10.1037/a0025664; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; Watson D, 2005, J RES PERS, V39, P46, DOI 10.1016/j.jrp.2004.09.006; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams-Piehota P, 2005, HEALTH PSYCHOL, V24, P58, DOI 10.1037/0278-6133.24.1.58; Zaki M.J., 2014, DATA MINING ANAL FUN; Zoellner LA, 2009, J BEHAV THER EXP PSY, V40, P455, DOI 10.1016/j.jbtep.2009.06.001	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166542	10.1371/journal.pone.0166542	http://dx.doi.org/10.1371/journal.pone.0166542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835704	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200057
J	Guldner, D; Hwang, JK; Cardieri, MCD; Eren, M; Ziaei, P; Norton, MG; Souza, CD				Guldner, Delphine; Hwang, Julianne K.; Cardieri, Maria Clara D.; Eren, Meaghan; Ziaei, Parissa; Norton, M. Grant; Souza, Cleverson D.			In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A	PLOS ONE			English	Article							DENDRITIC CELLS; VACCINE DELIVERY; T-CELLS; NANOTECHNOLOGY; TECHNOLOGY; ENHANCE	Poly (lactic-co-glycolic acid) nanoparticles (PLGA NPs) have been considerably studied as a promising biodegradable delivery system to induce effective immune responses and to improve stability, safety, and cost effectiveness of vaccines. The study aimed at evaluating early inflammatory effects and cellular safety of PLGA NPs, co-encapsulating ovalbumin (PLGA/OVA NPs), as a model antigen and the adjuvant monophosphoryl lipid A (PLGA/MPLA NPs) as an adjuvant, on primary canine macrophages. The PLGA NPs constructs were prepared following the emulsion-solvent evaporation technique and further physicchemically characterized. Peripheral blood mononuclear cells were isolated from canine whole blood by magnetic sorting and further cultured to generate macrophages. The uptake of PLGA NP constructs by macrophages was demonstrated by flow cytometry, transmission electron microscopy and confocal microscopy. Macrophage viability and morphology were evaluated by trypan blue exclusion and light microscopy. Macrophages were immunophenotyped for the expression of MHC-I and MHC-II and gene expression of Interleukin-10 (IL-10), Interleukin-12 (IL-12p40), and tumor necrosis factor alpha (TNF-alpha) were measured. The results showed that incubation of PLGA NP constructs with macrophages revealed effective early uptake of the PLGA NPs without altering the viability of macrophages. PLGA/OVA/MPLA NPs strongly induced TNF-alpha and IL-12p40 expression by macrophages as well as increase relative expression of MHC-I but not MHC-II molecules. Taken together, these results indicated that PLGA NPs with addition of MPLA represent a good model, when used as antigen carrier, for further, in vivo, work aiming to evaluate their potential to induce strong, specific, immune responses in dogs.	[Guldner, Delphine; Hwang, Julianne K.; Cardieri, Maria Clara D.; Eren, Meaghan; Souza, Cleverson D.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Ziaei, Parissa; Norton, M. Grant] Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA	Washington State University; Washington State University	Souza, CD (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA.	souza@vetmed.wsu.edu		Hwang, Julianne/0000-0002-9222-1729	WSU - College of Veterinary Medicine	WSU - College of Veterinary Medicine	Most of this work was supported by WSU - College of Veterinary Medicine, intramural grants.; The authors would like to thank Elizabeth Laws for technical help. This work was supported by WSU-College of Veterinary Medicine, intramural grants.	Balogh L, 2007, NANOMED-NANOTECHNOL, V3, P281, DOI 10.1016/j.nano.2007.09.001; Bergman PJ, 2007, VET CLIN N AM-SMALL, V37, P1111, DOI 10.1016/j.cvsm.2007.06.005; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Cooper DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113558; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Elamanchili P, 2007, J IMMUNOTHER, V30, P378, DOI 10.1097/CJI.0b013e31802cf3e3; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Joshi VB, 2013, HUM VACC IMMUNOTHER, V9, P2584, DOI 10.4161/hv.26136; Keijzer C, 2013, J CONTROL RELEASE, V168, P35, DOI 10.1016/j.jconrel.2013.02.027; Keijzer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026684; Kim H, 2016, CLIN EXP VACCINE RES, V5, P12, DOI 10.7774/cevr.2016.5.1.12; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Ma WX, 2012, INT J NANOMED, V7, P1475, DOI 10.2147/IJN.S29506; McVey S, 2010, VET CLIN N AM-SMALL, V40, P381, DOI 10.1016/j.cvsm.2010.02.001; Minigo G, 2007, VACCINE, V25, P1316, DOI 10.1016/j.vaccine.2006.09.086; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Petrizzo A, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0231-9; Poteet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136862; Proudfoot AG, 2014, IMMUNOL CELL BIOL, V92, P739, DOI 10.1038/icb.2014.73; Romagnani S, 1995, RES IMMUNOL, V146, P457, DOI 10.1016/0923-2494(96)83015-X; Sarti F, 2011, BIOMATERIALS, V32, P4052, DOI 10.1016/j.biomaterials.2011.02.011; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Silva AL, 2015, VACCINE, V33, P847, DOI 10.1016/j.vaccine.2014.12.059; Valle I., 2015, J PREVENTIVE MED HYG, V56, P21; Wagner JL, 2002, TISSUE ANTIGENS, V59, P205, DOI 10.1034/j.1399-0039.2002.590304.x; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Wijewardana V, 2006, VET IMMUNOL IMMUNOP, V114, P37, DOI 10.1016/j.vetimm.2006.07.002; Wu F, 2009, MOL PHARMACEUT, V6, P1506, DOI 10.1021/mp900081y; Zhang N, 2008, BIOCONJUGATE CHEM, V19, P145, DOI 10.1021/bc700227z	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165477	10.1371/journal.pone.0165477	http://dx.doi.org/10.1371/journal.pone.0165477			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835636	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200006
J	Morese, R; Rabellino, D; Sambataro, F; Perussia, F; Valentini, MC; Bare, BG; Bosco, FM				Morese, Rosalba; Rabellino, Daniela; Sambataro, Fabio; Perussia, Felice; Valentini, Maria Consuelo; Bare, Bruno G.; Bosco, Francesca M.			Group Membership Modulates the Neural Circuitry Underlying Third Party Punishment	PLOS ONE			English	Article							MEASURING INDIVIDUAL-DIFFERENCES; VENTROMEDIAL PREFRONTAL DAMAGE; ECONOMIC DECISION-MAKING; ALTRUISTIC PUNISHMENT; PAROCHIAL ALTRUISM; COSTLY PUNISHMENT; INTERGROUP CONFLICT; GENDER-DIFFERENCES; STRONG RECIPROCITY; NORM ENFORCEMENT	This research aims to explore the neural correlates involved in altruistic punishment, parochial altruism and anti-social punishment, using the Third-Party Punishment (TPP) game. In particular, this study considered these punishment behaviors in in-group vs. out-group game settings, to compare how people behave with members of their own national group and with members of another national group. The results showed that participants act altruistically to protect in-group members. This study indicates that norm violation in in-group (but not in out-group) settings results in increased activity in the medial prefrontal cortex and temporo-parietal junction, brain regions involved in the mentalizing network, as the third-party attempts to understand or justify in-group members' behavior. Finally, exploratory analysis during anti-social punishment behavior showed brain activation recruitment of the ventromedial prefrontal cortex, an area associated with altered regulation of emotions.	[Morese, Rosalba; Perussia, Felice; Bare, Bruno G.; Bosco, Francesca M.] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Morese, Rosalba] Univ Svizzera Italiana, Fac Commun Sci, Lugano, Switzerland; [Rabellino, Daniela] Univ Western Ontario, Schulich Sch Med & Dent, Dept Psychiat, London, ON, Canada; [Sambataro, Fabio] Univ Udine, Dept Expt & Clin Med Sci DISM, Udine, Italy; [Valentini, Maria Consuelo] Hosp Citta Salute & Sci Torino, Dept Neuroradiol, Turin, Italy; [Bare, Bruno G.; Bosco, Francesca M.] Univ Turin, Neurosci Inst Turin, Turin, Italy	University of Turin; Universita della Svizzera Italiana; Western University (University of Western Ontario); University of Udine; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Morese, R (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.; Morese, R (corresponding author), Univ Svizzera Italiana, Fac Commun Sci, Lugano, Switzerland.	rosalba.morese@unito.it	Morese, Rosalba/AAI-1008-2019; Morese, Rosalba/B-5444-2014; BOSCO, Francesca Marina/B-6746-2013	Morese, Rosalba/0000-0003-4939-6539; BOSCO, Francesca Marina/0000-0001-6101-8587	University of Turin	University of Turin	This research was supported by the University of Turin through project 2015 Action B "Neural correlates involved in punishment and reward behavior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; Batson CD, 1999, EUR J SOC PSYCHOL, V29, P909, DOI 10.1002/(SICI)1099-0992(199911)29:7<909::AID-EJSP965>3.0.CO;2-L; Baumgartner T, 2012, HUM BRAIN MAPP, V33, P1452, DOI 10.1002/hbm.21298; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bortolotti S, 2015, ECON INQ, V53, P1207, DOI 10.1111/ecin.12187; Bosco FM, 2009, CONSCIOUS COGN, V18, P323, DOI 10.1016/j.concog.2008.12.007; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Bruneau EG, 2012, NEUROPSYCHOLOGIA, V50, P219, DOI 10.1016/j.neuropsychologia.2011.11.008; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Damasio A.R., 2005, DESCARTES ERROR EMOT; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Durham WH., 1991, COEVOLUTION GENES CU; Ellingsen T, 2013, ECON LETT, V118, P470, DOI 10.1016/j.econlet.2012.12.010; Enzi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119150; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Flavell J.H., 1998, HDB CHILD PSYCHOL, P851; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Goette L, 2012, MANAGE SCI, V58, P948, DOI 10.1287/mnsc.1110.1466; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Halevy N, 2012, J BEHAV DECIS MAKING, V25, P188, DOI 10.1002/bdm.726; Hassin RR, 2007, P NATL ACAD SCI USA, V104, P19757, DOI 10.1073/pnas.0704679104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Kirman A, 2010, PHILOS T R SOC B, V365, P303, DOI 10.1098/rstb.2009.0192; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Moretti L, 2009, J COGNITIVE NEUROSCI, V21, P128, DOI 10.1162/jocn.2009.21011; Nosek BA, 2006, PROJECT IMPLICIT ADV; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PREMACK D, 1979, SCIENCE, V206, P1202, DOI 10.1126/science.206.4423.1202; Rabellino D, 2016, J COGN PSYCHOL, V28, P1, DOI [10.1060/204459112016.1136981, DOI 10.1060/204459112016.1136981]; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Robinson JL, 2012, NEUROIMAGE, V60, P117, DOI 10.1016/j.neuroimage.2011.12.010; Saaksvuori L, 2011, P ROY SOC B-BIOL SCI, V278, P3428, DOI 10.1098/rspb.2011.0252; Sambataro F, 2006, EUR J NEUROSCI, V24, P2355, DOI 10.1111/j.1460-9568.2006.05120.x; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Shinada M, 2004, EVOL HUM BEHAV, V25, P379, DOI 10.1016/j.evolhumbehav.2004.08.001; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel J, 1971, EUROPEAN J SOCIAL PS, V1, P149; Tomasello M, 2009, WHY WE COOPERATE, P1; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789	76	21	22	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166357	10.1371/journal.pone.0166357	http://dx.doi.org/10.1371/journal.pone.0166357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835675	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200043
J	Guillot, R; Muriach, B; Rocha, A; Rotllant, J; Kelsh, RN; Cerda-Reverter, JM				Guillot, Raul; Muriach, Borja; Rocha, Ana; Rotllant, Josep; Kelsh, Robert N.; Miguel Cerda-Reverter, Jose			Thyroid Hormones Regulate Zebrafish Melanogenesis in a Gender-Specific Manner	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; NEURAL CREST; CELL; EXPRESSION; PATTERN; FOXD3; MITF	Zebrafish embryos are treated with anti-thyroidal compounds, such as phenylthiourea, to inhibit melanogenesis. However, the mechanism whereby the thyroidal system controls melanin synthesis has not been assessed in detail. In this work, we tested the effect of the administration of diets supplemented with T3 (500 mu g/g food) on the pigment pattern of adult zebrafish. Oral T3 induced a pronounced skin paling in both adult female and male zebrafish that was reversible upon cessation of treatment. The number of visible melanophores was significantly reduced in treated fish. Accordingly, treatment down-regulated expression of tyrosinase-related protein 1 in both sexes. We also found sexually dimorphic regulation of some melanogenic genes, such as Dct/Tyrp2 that was dramatically up-regulated in females after T3 treatment. Thus, we demonstrated that melanogenesis is reversibly inhibited by thyroid hormones in adult zebrafish and make the discovery of gender-specific differences in the response of melanogenic gene expression. Thus, fish gender is now shown to be an important variable that should be controlled in future studies of fish melanogenesis.	[Guillot, Raul; Rocha, Ana; Miguel Cerda-Reverter, Jose] IATS CSIC, Dept Fish Physiol & Biotechnol, Ribera De Cabanes 12595, Castellon, Spain; [Muriach, Borja] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Castellon de La Plana 12006, Spain; [Rotllant, Josep] IIM CSIC, Aquat Mol Pathobiol Grp, Vigo 36208, Spain; [Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Kelsh, Robert N.] Univ Bath, Dev Biol Programme, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Universidad CEU Cardenal Herrera; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Bath; University of Bath	Cerda-Reverter, JM (corresponding author), IATS CSIC, Dept Fish Physiol & Biotechnol, Ribera De Cabanes 12595, Castellon, Spain.	jm.cerda.reverter@csic.es	Cerda-Reverter, Jose Miguel/K-4934-2014; Guillot, Raúl/Z-1884-2019; Rocha, Ana/J-3658-2012; Kelsh, Robert/B-6445-2008; Rotllant, Josep/K-1146-2014	Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Rocha, Ana/0000-0003-2165-5519; Kelsh, Robert/0000-0002-9381-0066; Guillot, Raul/0000-0001-9248-7263; Rotllant, Josep/0000-0001-5331-807X	Ministerio de Economia y Competitividad [AGL2013-46448-C3-3-R, AGL2014-52473R]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L00769X/1]; Medical Research Council (MRC) [MR/J001457/1]; MRC [MR/J001457/1] Funding Source: UKRI; Medical Research Council [MR/J001457/1] Funding Source: researchfish	Ministerio de Economia y Competitividad(Spanish Government); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Ministerio de Economia y Competitividad grant numbers AGL2013-46448-C3-3-R and AGL2014-52473R (http//www.mineco.gob.es), Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/L00769X/1 (http://www.bbsrc.ac.uk), and Medical Research Council (MRC) grant number MR/J001457/1 (http/www.mrc.ac.uk).	Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; Darias MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068844; Dong W., 2014, ENDOCR DISRUPTORS, V2, pe969072, DOI [10.4161/23273739.2014.969072, DOI 10.4161/23273739.2014.969072]; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Agulleiro MJ, 2013, MOL ENDOCRINOL, V27, P1934, DOI 10.1210/me.2013-1099; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; Krauss J, 2014, PIGM CELL MELANOMA R, V27, P827, DOI 10.1111/pcmr.12272; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Mukhi S, 2007, GEN COMP ENDOCR, V150, P486, DOI 10.1016/j.ygcen.2006.11.013; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Robinson KC, 2009, SEMIN CELL DEV BIOL, V20, P111, DOI 10.1016/j.semcdb.2008.11.016; Sarangarajan R, 2001, PIGMENT CELL RES; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457	21	19	21	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166152	10.1371/journal.pone.0166152	http://dx.doi.org/10.1371/journal.pone.0166152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832141	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000069
J	Karlsson, T; Lundholm, M; Widmark, A; Persson, E				Karlsson, Terese; Lundholm, Marie; Widmark, Anders; Persson, Emma			Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation	PLOS ONE			English	Article							DOWN-MODULATE; MICRORNA	Skeletal metastatic disease is a deleterious consequence of dissemination of tumor cells from numerous primary sites, such as prostate, lung and breast. Skeletal metastases are still incurable, resulting in development of clinical complications and decreased survival for cancer patients with metastatic disease. During the last decade, tumor cell-derived microvesicles have been identified and suggested to be involved in cancer disease progression. Whether cancer exosomes are involved in tumor and bone cell interactions in the metastatic site is still, however, a rather unexplored field. Here we show that exosomes isolated from the murine prostate cancer cell line TRAMP-C1 dramatically decrease fusion and differentiation of monocytic osteoclast precursors to mature, multinucleated osteoclasts. The presence of tumor cell-derived exosomes also clearly decreased the expression of established markers for osteoclast fusion and differentiation, including DC-STAMP, TRAP, cathepsin K, and MMP-9. In contrast, exosomes derived from murine fibroblastic cells did not affect osteoclast formation. Our findings suggest that exosomes released from tumor cells in the tumor-bone interface are involved in pathological regulation of bone cell formation in the metastatic site. This further strengthens the role of tumor cell-derived microvesicles in cancer progression and disease aggressiveness.	[Karlsson, Terese; Widmark, Anders; Persson, Emma] Umea Univ, Div Oncol, Dept Radiat Sci, Umea, Sweden; [Lundholm, Marie] Umea Univ, Div Pathol, Dept Med Biosci, Umea, Sweden	Umea University; Umea University	Persson, E (corresponding author), Umea Univ, Div Oncol, Dept Radiat Sci, Umea, Sweden.	emma.e.persson@umu.se		Persson, Emma/0000-0003-4020-1694	AFA Insurance Sweden [120338]; Swedish Cancer Foundation [CAN 2012/743]; Cancer Research Foundation in Northern Sweden [AMP 10-647]; Percy Falk Foundation	AFA Insurance Sweden; Swedish Cancer Foundation; Cancer Research Foundation in Northern Sweden; Percy Falk Foundation	This work received financial support from AFA Insurance Sweden, www.afaforsakring.se (grant no. 120338, EP), The Swedish Cancer Foundation, www.cancerfonden.se (CAN 2012/743, AW), The Cancer Research Foundation in Northern Sweden, www.cancerforskningsfonden.se (AMP 10-647, EP), and The Percy Falk Foundation for research in prostate cancer and breast cancer (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Deng XY, 2014, CANCER TREAT REV, V40, P730, DOI 10.1016/j.ctrv.2014.04.003; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fang J, 2015, CLIN TRANSL ONCOL, V17, P173, DOI 10.1007/s12094-014-1247-x; Federici C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088193; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Gingrich JR, 1996, CANCER RES, V56, P4096; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hensel J, 2016, UROLOGY IN PRESS; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raimondi L, 2015, ONCOTARGET, V6, P13772, DOI 10.18632/oncotarget.3830; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Webber J P, 2015, Oncogene, V34, P290, DOI 10.1038/onc.2013.560; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027; Zhao L, 2015, CANCER LETT, V356, P339, DOI 10.1016/j.canlet.2014.10.027	24	49	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166284	10.1371/journal.pone.0166284	http://dx.doi.org/10.1371/journal.pone.0166284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832183	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000090
J	Loftfield, E; O'Brien, TR; Pfeiffer, RM; Howell, CD; Horst, R; Prokunina-Olsson, L; Weinstein, SJ; Albanes, D; Morgan, TR; Freedman, ND				Loftfield, Erikka; O'Brien, Thomas R.; Pfeiffer, Ruth M.; Howell, Charles D.; Horst, Ron; Prokunina-Olsson, Ludmila; Weinstein, Stephanie J.; Albanes, Demetrius; Morgan, Timothy R.; Freedman, Neal D.			Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; PEGINTERFERON ALPHA-2A; ANTIVIRAL THERAPY; AMERICAN PATIENTS; VIRUS THERAPY; RIBAVIRIN; INTERFERON; INFECTION; MANAGEMENT; CLEARANCE	More than 150 million people worldwide are chronically infected with hepatitis C virus (HCV) and face higher risk of cirrhosis and hepatocellular carcinoma. Highly effective HCV treatments have recently been developed; however, they are costly and therefore poorly suited for application in resource-limited settings where HCV burden is high. Pegylated-interferon alpha (PEG-IFN alpha) and ribavirin (RBV) therapy is far less costly, but also less effective. Vitamin D supplementation has been proposed as an inexpensive adjuvant to treatment, however, prior epidemiological evidence on its effectiveness is inconsistent, with little data available among African Americans who naturally have lower vitamin D concentrations. We thus evaluated associations between baseline vitamin D status, measured by circulating 25-hydroxyvitamin D (25(OH)D), which is considered to be the best marker of vitamin D status in humans, and subsequent response to PEG-IFN alpha/RBV therapy in two large clinical trials that together included 1292 patients infected with HCV genotype 1. We used race-stratified logistic regression models to evaluate multivariable-adjusted associations of 25(OH)D with early virologic response (EVR; 2-log10 HCV RNA decline at week 12) and sustained virologic response (SVR). Among African Americans, we saw no associations. Among European Americans, we saw no association with low vitamin D (<= 20 ng/mL) versus sufficient concentrations (20-<30 ng/mL). However, patients with 25(OH) D >= 30 ng/mL were actually less likely to attain EVR (OR = 0.64, 95% CI = 0.43-0.94) than those with sufficient concentrations, with a similar but non-significant association observed for SVR (OR = 0.49, 95% CI = 0.20-1.17).	[Loftfield, Erikka; O'Brien, Thomas R.; Pfeiffer, Ruth M.; Prokunina-Olsson, Ludmila; Weinstein, Stephanie J.; Albanes, Demetrius; Freedman, Neal D.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Howell, Charles D.] Howard Univ, Coll Med, Dept Med, Washington, DC USA; [Horst, Ron] Heartland Assays, Ames, IA USA; [Morgan, Timothy R.] VA Long Beach Healthcare Syst, Long Beach, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Loftfield, E (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	erikka.loftfield@nih.gov	Weinstein, Stephanie J/P-1627-2017; Loftfield, Erikka/Z-2121-2018; Prokunina-Olsson, Ludmila/A-8240-2019; Freedman, Neal David/B-9741-2015; Prokunina-Olsson, Ludmila/V-7960-2019	Weinstein, Stephanie J/0000-0002-3834-1535; Loftfield, Erikka/0000-0002-3573-8748; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Freedman, Neal David/0000-0003-0074-1098; Prokunina-Olsson, Ludmila/0000-0002-9622-2091	Intramural Research Program of the National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; Department of Health and Human Services; Heartland Assays; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CANCER INSTITUTE [ZIACP010127] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health; Department of Health and Human Services; Heartland Assays; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, and Department of Health and Human Services. Heartland Assays provided support in the form of salaries for author [RH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by the Intramural Research Program of the National Institutes of Health, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services. Heartland Assays provided support in the form of salaries for author [RH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The VIRAHEP-C and HALT-C studies were conducted, respectively, by the VIRAHEP-C and HALT-C Investigators and supported by the National Institute of Diabetes and Digestive and Kidney Diseases. The data and samples from the VIRAHEP-C and HALT-C studies reported here were supplied by the National Institute of Diabetes and Digestive and Kidney Diseases Central Repositories. This manuscript was not prepared in collaboration with the VIRAHEP-C study group or the HALT-C study group and does not necessarily reflect the opinions or views of the VIRAHEP-C Trial and HALT-C Trial, the National Institute of Diabetes and Digestive and Kidney Diseases Central Repositories or the National Institute of Diabetes and Digestive and Kidney Diseases.	Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Aka PV, 2014, J INFECT DIS, V209, P350, DOI 10.1093/infdis/jit433; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bitetto D, 2013, HEPATOLOGY, V57, P925, DOI 10.1002/hep.26186; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; Bitetto D, 2011, TRANSPL INT, V24, P43, DOI 10.1111/j.1432-2277.2010.01141.x; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Butt AA, 2012, CLIN INFECT DIS, V54, P96, DOI 10.1093/cid/cir774; Chan K, 2013, CLIN GASTROENTEROL H, V11, P1503, DOI 10.1016/j.cgh.2013.05.014; Christakos S, 2007, ANN NY ACAD SCI, V1116, P340, DOI 10.1196/annals.1402.070; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Falleti E, 2012, HEPATOLOGY, V56, P1641, DOI 10.1002/hep.25848; Freedman ND, 2011, GASTROENTEROLOGY, V140, P1961, DOI 10.1053/j.gastro.2011.02.061; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gal-Tanamy M, 2011, HEPATOLOGY, V54, P1570, DOI 10.1002/hep.24575; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P10, DOI 10.1093/aje/kwq116; Garcia-Alvarez M, 2014, HEPATOLOGY, V60, P1541, DOI 10.1002/hep.27281; Gibbons JD, 2004, ENCY STAT SCI; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Jeffers LJ, 2004, HEPATOLOGY, V39, P1702, DOI 10.1002/hep.20212; Kitson MT, 2015, HEPATOLOGY, V62, P1642, DOI 10.1002/hep.27797; Kitson MT, 2014, J HEPATOL, V61, P1247, DOI 10.1016/j.jhep.2014.08.004; Kitson MT, 2013, J HEPATOL, V58, P467, DOI 10.1016/j.jhep.2012.11.017; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lee WM, 2004, CONTROL CLIN TRIALS, V25, P472, DOI 10.1016/j.cct.2004.08.003; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Matsumura T, 2012, HEPATOLOGY, V56, P1231, DOI 10.1002/hep.25763; McGowan CE, 2013, HEPATOLOGY, V57, P1325, DOI 10.1002/hep.26246; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Morishima C, 2004, J CLIN MICROBIOL, V42, P421, DOI 10.1128/JCM.42.1.421-425.2004; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; O'Brien TR, 2015, J HEPATOL, V63, P1103, DOI 10.1016/j.jhep.2015.06.035; Pineda-Tenor D, 2015, HEPATOLOGY, V62, P1643, DOI 10.1002/hep.27796; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Rao VB, 2015, LANCET INFECT DIS, V15, P819, DOI 10.1016/S1473-3099(15)00006-7; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Tan A, 2008, LIVER INT, V28, P175, DOI 10.1111/j.1478-3231.2007.01652.x; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Weintraub SJ, 2012, AM J CLIN NUTR, V96, P1025, DOI 10.3945/ajcn.112.039974; WHO, 2015, HEP C 2002; Yano M, 2007, ANTIMICROB AGENTS CH, V51, P2016, DOI 10.1128/AAC.01426-06; Zoulim F, 2015, GUT, V64, P1824, DOI 10.1136/gutjnl-2015-310421	50	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							0166036	10.1371/journal.pone.0166036	http://dx.doi.org/10.1371/journal.pone.0166036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832143	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000056
J	Morten, BC; Scott, RJ; Avery-Kiejda, KA				Morten, Brianna C.; Scott, Rodney J.; Avery-Kiejda, Kelly A.			Comparison of the QuantiGene 2.0 Assay and Real-Time RT-PCR in the Detection of p53 Isoform mRNA Expression in Formalin-Fixed Paraffin-Embedded Tissues-A Preliminary Study	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER	p53 is expressed as multiple smaller isoforms whose functions in cancer are not well understood. The p53 isoforms demonstrate abnormal expression in different cancers, suggesting they are important in modulating the function of full-length p53 (FLp53). The quantification of relative mRNA expression has routinely been performed using real-time PCR (qPCR). However, there are serious limitations when detecting p53 isoforms using this method, particularly for formalin-fixed paraffin-embedded (FFPE) tissues. The use of FFPE tumours would be advantageous to correlate expression of p53 isoforms with important clinical features of cancer. One alternative method of RNA detection is the hybridization-based QuantiGene 2.0 Assay, which has been shown to be advantageous for the detection of RNA from FFPE tissues. In this pilot study, we compared the QuantiGene 2.0 Assay to qPCR for the detection of FLp53 and its isoform Delta 40p53 in matched fresh frozen (FF) and FFPE breast tumours. FLp53 mRNA expression was detected using qPCR in FF and FFPE tissues, but Delta 40p53 mRNA was only detectable in FF tissues. Similar results were obtained for the QuantiGene 2.0 Assay. FLp53 relative mRNA expression was shown to be strongly correlated between the two methods (R-2 = 0.9927, p = 0.0031) in FF tissues, however Delta 40p53 was not (R-2 = 0.4429, p = 0.3345). When comparing the different methods for the detection of FLp53 mRNA from FFPE and FF samples, no correlation (R-2 = 0.0002, p = 0.9863) was shown using the QuantiGene 2.0 Assay, and in contrast, the level of expression was highly correlated between the two tissues using qPCR (R-2 = 0.8753, p = 0.0644). These results suggest that both the QuantiGene 2.0 Assay and qPCR methods are inadequate for the quantification of Delta 40p53 mRNA in FFPE tissues. Therefore, alternative methods of RNA detection and quantification are required to study the relative expression of Delta 40p53 in FFPE samples.	[Morten, Brianna C.; Scott, Rodney J.; Avery-Kiejda, Kelly A.] Hunter Med Res Inst, Med Genet, New Lambton Hts, NSW 2305, Australia; [Morten, Brianna C.; Scott, Rodney J.; Avery-Kiejda, Kelly A.] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Prior Res Ctr Canc, Newcastle, NSW 2308, Australia; [Scott, Rodney J.] John Hunter Hosp, Pathol North, New Lambton Hts, NSW 2305, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; John Hunter Hospital	Avery-Kiejda, KA (corresponding author), Hunter Med Res Inst, Med Genet, New Lambton Hts, NSW 2305, Australia.; Avery-Kiejda, KA (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Prior Res Ctr Canc, Newcastle, NSW 2308, Australia.	kelly.kiejda@newcaste.edu.au	Morten, Brianna C/V-1054-2017; Scott, Rodney/B-2827-2013	Morten, Brianna C/0000-0003-1152-8655; Scott, Rodney/0000-0001-7724-3404; Avery-Kiejda, Kelly/0000-0003-2285-9118	Bloomfield Group Foundation through the Hunter Medical Research Institute [G1200322]; National Breast Cancer Foundation [CG-12-07]; Australian Postgraduate Award (University of Newcastle); MM Sawyer Scholarship (Hunter Medical Research Institute) [G1200615]; Bloomfield Group Foundation through the Hunter Medical Research Institute (HMRI); Australian Postgraduate Award through the University of Newcastle; MM Sawyer Scholarship through the HMRI	Bloomfield Group Foundation through the Hunter Medical Research Institute; National Breast Cancer Foundation; Australian Postgraduate Award (University of Newcastle); MM Sawyer Scholarship (Hunter Medical Research Institute); Bloomfield Group Foundation through the Hunter Medical Research Institute (HMRI); Australian Postgraduate Award through the University of Newcastle; MM Sawyer Scholarship through the HMRI	This study was funded by the Bloomfield Group Foundation through the Hunter Medical Research Institute (G1200322; https://hmri.org.au/) and the National Breast Cancer Foundation (CG-12-07; http://nbcf.org.au/) (KAK, RJS). BCM was financially supported by the Australian Postgraduate Award (University of Newcastle) and the MM Sawyer Scholarship (Hunter Medical Research Institute; G1200615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Australian Breast Cancer Tissue Bank for supplying the FF and matched FFPE breast tumour tissues used in this study. This work was supported by grants from the Bloomfield Group Foundation through the Hunter Medical Research Institute (HMRI) and the National Breast Cancer Foundation; B.C.M was supported by the Australian Postgraduate Award through the University of Newcastle and the MM Sawyer Scholarship through the HMRI.	Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; Avery-Kiejda KA, 2014, CARCINOGENESIS, V35, P586, DOI 10.1093/carcin/bgt411; Avery-Kiejda KA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-203; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Hall JS, 2011, BRIT J CANCER, V104, P971, DOI 10.1038/bjc.2011.66; Kashofer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070714; Knudsen BS, 2008, J MOL DIAGN, V10, P169, DOI 10.2353/jmoldx.2008.070127; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Lu B, 2009, UROLOGY, V74, P1156, DOI 10.1016/j.urology.2009.01.087; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Meng XL, 2012, GENET TEST MOL BIOMA, V16, P689, DOI 10.1089/gtmb.2011.0298; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0	15	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165930	10.1371/journal.pone.0165930	http://dx.doi.org/10.1371/journal.pone.0165930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832134	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000042
J	Soteriades, AD; Stott, AW; Moreau, S; Charroin, T; Blanchard, M; Liu, JY; Faverdin, P				Soteriades, Andreas Diomedes; Stott, Alistair William; Moreau, Sindy; Charroin, Thierry; Blanchard, Melanie; Liu, Jiayi; Faverdin, Philippe			The Relationship of Dairy Farm Eco-Efficiency with Intensification and Self-Sufficiency. Evidence from the French Dairy Sector Using Life Cycle Analysis, Data Envelopment Analysis and Partial Least Squares Structural Equation Modelling	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; ENVIRONMENTAL-IMPACT; MILK-PRODUCTION; TECHNICAL EFFICIENCY; ECONOMIC-PERFORMANCE; SUSTAINABILITY; MANAGEMENT; PLS; SYSTEMS; AGROECOLOGY	We aimed at quantifying the extent to which agricultural management practices linked to animal production and land use affect environmental outcomes at a larger scale. Two practices closely linked to farm environmental performance at a larger scale are farming intensity, often resulting in greater off-farm environmental impacts (land, non-renewable energy use etc.) associated with the production of imported inputs (e.g. concentrates, fertilizer); and the degree of self-sufficiency, i.e. the farm's capacity to produce goods from its own resources, with higher control over nutrient recycling and thus minimization of losses to the environment, often resulting in greater on-farm impacts (eutrophication, acidification etc.). We explored the relationship of these practices with farm environmental performance for 185 French specialized dairy farms. We used Partial Least Squares Structural Equation Modelling to build, and relate, latent variables of environmental performance, intensification and self-sufficiency. Proxy indicators reflected the latent variables for intensification (milk yield/cow, use of maize silage etc.) and self-sufficiency (home-grown feed/total feed use, on-farm energy/total energy use etc.). Environmental performance was represented by an aggregate 'eco-efficiency' score per farm derived from a Data Envelopment Analysis model fed with LCA and farm output data. The dataset was split into two spatially heterogeneous (biophysical conditions, production patterns) regions. For both regions, eco-efficiency was significantly negatively related with milk yield/cow and the use of maize silage and imported concentrates. However, these results might not necessarily hold for intensive yet more self-sufficient farms. This requires further investigation with latent variables for intensification and self-sufficiency that do not largely overlap-a modelling challenge that occurred here. We conclude that the environmental 'sustainability' of intensive dairy farming depends on particular farming systems and circumstances, although we note that more self-sufficient farms may be preferable when they may benefit from relatively low land prices and agri-environment schemes aimed at maintaining grasslands.	[Soteriades, Andreas Diomedes; Stott, Alistair William] Scotlands Rural Coll, Future Farming Syst Grp, Edinburgh, Midlothian, Scotland; [Moreau, Sindy; Charroin, Thierry] Inst Elevage, F-75000 Paris, France; [Blanchard, Melanie] CIRAD INRA Montpellier SupAgro, UMR, SELMET Syst Elevage Mediterraneens & Trop 0868, F-34000 Montpellier, France; [Liu, Jiayi] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Faverdin, Philippe] INRA, UMR PEGASE 1348, F-35590 St Gilles, France; [Faverdin, Philippe] Agrocampus Ouest, UMR PEGASE 1348, F-35000 Rennes, France	Scotland's Rural College; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; James Hutton Institute; INRAE; Institut Agro; Agrocampus Ouest	Soteriades, AD (corresponding author), Scotlands Rural Coll, Future Farming Syst Grp, Edinburgh, Midlothian, Scotland.	andreas.soteriades@sruc.ac.uk	LIU, JIAYI/I-7242-2013	LIU, JIAYI/0000-0002-9194-5338; Soteriades, Andreas Diomedes/0000-0002-5992-9602; Blanchard, Melanie/0000-0002-5166-8719	Scotland's Rural College; Scottish Government Strategic Research Programme; Physiologie Animale et Systeme d'Elevage division of the Institut National de la Recherche Agronomique (French National Institute for Agricultural Research); Project "Efficience Environnementale et productions animales pour le developpement durable, Agence Nationale de la Recherche (French National Research Agency) [ANR-09-STRA-01-01]	Scotland's Rural College; Scottish Government Strategic Research Programme; Physiologie Animale et Systeme d'Elevage division of the Institut National de la Recherche Agronomique (French National Institute for Agricultural Research); Project "Efficience Environnementale et productions animales pour le developpement durable, Agence Nationale de la Recherche (French National Research Agency)(French National Research Agency (ANR))	Funding was obtained from the following sources: 1. Scotland's Rural College (http://www.sruc.ac.uk/) (ADS); 2. Scottish Government Strategic Research Programme 2011-16 (http://www.gov.scot/Topics/Resear/About/EBAR/StrategicResearchStutute-research-strategy) (ADS); 3. Physiologie Animale et Systeme d'Elevage division of the Institut National de la Recherche Agronomique (French National Institute for Agricultural Research; http:/www.inra.fr/en) (ADS); 4. Project "Efficience Environnementale et productions animales pour le developpement durable, ANR-09-STRA-01-01, Agence Nationale de la Recherche (French National Research Agency; http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/) (MB); 5. Scottish Government Strategic Research Programme 2011-16 (http://www.gov.scot/Topics/Research/About/EBAR/StrategicResearch/future-research-strategy) Consultancy for Theme 4 WP4.1 Adaptation to change in land-based and other rural industries (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alba I, 2012, RENEW AGR FOOD SYST, V27, P217, DOI 10.1017/S1742170511000329; Acosta-Alba I, 2012, J CLEAN PROD, V28, P160, DOI 10.1016/j.jclepro.2011.11.061; [Anonymous], 2013, R PACKAGE NOTES; Arsenault N, 2009, INT J AGR SUSTAIN, V7, P19, DOI 10.3763/ijas.2009.0356; Barnes AP, 2006, J ENVIRON MANAGE, V80, P287, DOI 10.1016/j.jenvman.2005.09.020; Barnes AP, 2014, ECOL INDIC, V36, P213, DOI 10.1016/j.ecolind.2013.07.001; Basset-Mens C, 2009, ECOL ECON, V68, P1615, DOI 10.1016/j.ecolecon.2007.11.017; Bava L, 2014, J DAIRY SCI, V97, P4579, DOI 10.3168/jds.2013-7530; Ben Arfa N, 2009, 3 JOURN RECH SCI SOC; Berre D, 2014, J ENVIRON MANAGE, V146, P235, DOI 10.1016/j.jenvman.2014.07.008; Berre D, 2013, EUR J OPER RES, V226, P325, DOI 10.1016/j.ejor.2012.11.017; Bickel U., 2003, IMPACTS SOYBEAN CULT; Casey JW, 2005, J ENVIRON QUAL, V34, P429, DOI 10.2134/jeq2005.0429; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Charroin T., 2005, Rencontres Autour des Recherches sur les Ruminants, V12, P335; Chatellier V, 2006, P FIN SEM GREEN DAIR; Chin W.W., 2010, HDB PARTIAL LEAST SQ, P171; Cooper WW, 2005, J MULTI-CRITERIA DEC, V13, P3, DOI 10.1002/mcda.370; Cooper WW, 1999, J PROD ANAL, V11, P5, DOI 10.1023/A:1007701304281; Cooper WW., 2007, DATA ENVELOPMENT ANA, V2nd; de Boer IJM, 2003, LIVEST PROD SCI, V80, P69, DOI 10.1016/S0301-6226(02)00322-6; de los Campos G, 2006, J ANIM SCI, V84, P2934, DOI 10.2527/jas.2006-016; Del Prado A, 2008, J AGR SCI-CAMBRIDGE, V146, P195, DOI 10.1017/S0021859608007727; Detilleux J, 2012, PREV VET MED, V107, P170, DOI 10.1016/j.prevetmed.2012.06.005; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; Dumont B, 2013, ANIMAL, V7, P1028, DOI 10.1017/S1751731112002418; Eisler MC, 2014, NATURE, V507, P32, DOI 10.1038/507032a; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Gac A., 2010, Rencontres Autour des Recherches sur les Ruminants, V17, P335; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Goodhue DL, 2012, MIS QUART, V36, P981; Government Office for Science, 2011, FOR FUT FOOD FARM; Guerci M, 2013, J DAIRY RES, V80, P300, DOI 10.1017/S0022029913000277; Gyau A, 2011, BRIT FOOD J, V113, P838, DOI 10.1108/00070701111148388; Hair J. F., 2017, ADV ISSUES PARTIAL L; Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6; Hansson H, 2011, LIVEST SCI, V135, P110, DOI 10.1016/j.livsci.2010.06.157; Henseler J, 2016, INT MARKET REV, V33, P405, DOI 10.1108/IMR-09-2014-0304; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Henseler J, 2013, COMPUTATION STAT, V28, P565, DOI 10.1007/s00180-012-0317-1; HOCH I, 1962, ECONOMETRICA, V30, P34, DOI 10.2307/1911286; Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z; Iribarren D, 2011, SCI TOTAL ENVIRON, V409, P1786, DOI 10.1016/j.scitotenv.2011.02.013; Jan P, 2012, INT J LIFE CYCLE ASS, V17, P706, DOI 10.1007/s11367-012-0405-z; Kuosmanen T, 2005, J IND ECOL, V9, P59, DOI 10.1162/108819805775247846; Lebacq T, 2015, ANIMAL, V9, P544, DOI 10.1017/S1751731114002845; Lehuger S, 2009, J CLEAN PROD, V17, P616, DOI 10.1016/j.jclepro.2008.10.005; Lohmoller J.B., 1989, PHYSICA, DOI DOI 10.1007/978-3-642-52512-4; Matthews A, 2013, BIO-BASED APPL ECON, V2, P1; Maulfair D, 2011, FEED EFFICIENCY LACT; Meul M, 2008, AGRON SUSTAIN DEV, V28, P321, DOI 10.1051/agro:2008001; Novo AM, 2013, AGR SYST, V121, P63, DOI 10.1016/j.agsy.2013.06.007; Olesen JE, 2006, AGR ECOSYST ENVIRON, V112, P207, DOI 10.1016/j.agee.2005.08.022; Ondersteijn CJM, 2003, AGR SYST, V78, P31, DOI 10.1016/S0308-521X(03)00031-3; Urdiales MP, 2016, ENVIRON RESOUR ECON, V64, P559, DOI 10.1007/s10640-015-9885-1; Puillet L, 2014, LIVEST SCI, V165, P167, DOI 10.1016/j.livsci.2014.04.001; R Core Team, 2013, R LANG ENV STAT COMP; Reig-Martinez E, 2011, AGR ECON-BLACKWELL, V42, P561, DOI 10.1111/j.1574-0862.2011.00536.x; Richards TJ, 2000, J AGR RESOUR ECON, V25, P232; Ringle CM, 2011, J MARKET THEORY PRAC, V19, P459, DOI 10.2753/MTP1069-6679190407; Rodriguez-Entrena M, 2013, FOOD POLICY, V40, P44, DOI 10.1016/j.foodpol.2013.02.001; Saam H, 2005, AGR SYST, V84, P343, DOI 10.1016/j.agsy.2004.06.020; Salou T, 2017, J CLEAN PROD, V140, P445, DOI 10.1016/j.jclepro.2016.05.019; Santarossa JM, 2004, ANIM SCI, V79, P315, DOI 10.1017/S1357729800090172; Sarstedt M, 2014, J FAM BUS STRATEG, V5, P105, DOI 10.1016/j.jfbs.2014.01.002; Shortall OK, 2013, ECOL INDIC, V29, P478, DOI 10.1016/j.ecolind.2013.01.022; Soteriades AD, 2016, ANIMAL, V10, P1899, DOI 10.1017/S1751731116000707; Soteriades AD, 2015, AGR FOOD SCI, V24, P235, DOI 10.23986/afsci.49446; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Nguyen TTH, 2013, INT J LIFE CYCLE ASS, V18, P1470, DOI 10.1007/s11367-013-0605-1; Tomich TP, 2011, ANNU REV ENV RESOUR, V36, P193, DOI 10.1146/annurev-environ-012110-121302; Torna L, 2013, J DAIRY SCI, V96, P7014, DOI 10.3168/jds.2013-6911; Van Berkum S, 2006, EUROPEAN DAIRY POLIC; van Calker KJ, 2008, ECOL ECON, V65, P407, DOI 10.1016/j.ecolecon.2007.07.010; Voorhees CM, 2016, J ACAD MARKET SCI, V44, P119, DOI 10.1007/s11747-015-0455-4; Wold H., 1975, PATH MODELS LATENT V, P307, DOI [10.1016/B978-0-12-103950-9.50017-4, DOI 10.1016/B978-0-12-103950-9.50017-4]; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X; Zehetmeier M, 2012, ANIMAL, V6, P154, DOI 10.1017/S1751731111001467; Zimmermann A, 2008, J SUSTAIN AGR, V32, P77, DOI 10.1080/10440040802121411	79	22	22	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166445	10.1371/journal.pone.0166445	http://dx.doi.org/10.1371/journal.pone.0166445			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832199	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000126
J	Tachikawa, S; Nakayama, K; Nakamura, S; Mochizuki, A; Iijima, T; Inoue, T				Tachikawa, Satoshi; Nakayama, Kiyomi; Nakamura, Shiro; Mochizuki, Ayako; Iijima, Takehiko; Inoue, Tomio			Coordinated Respiratory Motor Activity in Nerves Innervating the Upper Airway Muscles in Rats	PLOS ONE			English	Article							BRAIN-STEM PREPARATION; IN-SITU; ELECTROMYOGRAPHIC ACTIVITY; GENIOGLOSSUS MUSCLE; EXPIRATORY ACTIVITY; RHYTHM GENERATION; HYOID MUSCLES; HYPOXIA; HYPOGLOSSAL; HYPERCAPNIA	Maintaining the patency of the upper airway during breathing is of vital importance. The activity of various muscles is related to the patency of the upper airway. In the present study, we examined the respiratory motor activity in the efferent nerves innervating the upper airway muscles to determine the movements of the upper airway during respiration under normocapnic conditions (pH = 7.4) and in hypercapnic acidosis (pH = 7.2). Experiments were performed on arterially perfused decerebrate rats aged between postnatal days 21-35. We recorded the efferent nerve activity in a branch of the cervical spinal nerve innervating the infrahyoid muscles (CN), the hypoglossal nerve (HGN), the external branch of the superior laryngeal nerve (SLN), and the recurrent laryngeal nerve (RLN) with the phrenic nerve (PN). Inspiratory nerve discharges were observed in all these nerves under normocapnic conditions. The onset of inspiratory discharges in the CN and HGN was slightly prior to those in the SLN and RLN. When the CO2 concentration in the perfusate was increased from 5% to 8% to prepare for hypercapnic acidosis, the peak amplitudes of the inspiratory discharges in all the recorded nerves were increased. Moreover, hypercapnic acidosis induced pre-inspiratory discharges in the CN, HGN, SLN, and RLN. The onset of pre-inspiratory discharges in the CN, HGN, and SLN was prior to that of discharges in the RLN. These results suggest that the securing of the airway that occurs a certain time before dilation of the glottis may facilitate ventilation and improve hypercapnic acidosis.	[Tachikawa, Satoshi; Nakayama, Kiyomi; Nakamura, Shiro; Mochizuki, Ayako; Inoue, Tomio] Showa Univ, Dept Oral Physiol, Sch Dent, Shinagawa Ku, Tokyo 1428555, Japan; [Tachikawa, Satoshi; Iijima, Takehiko] Showa Univ, Div Anesthesiol, Dept Perioperat Med, Sch Dent,Oota Ku, Tokyo 1458515, Japan	Showa University; Showa University	Nakayama, K (corresponding author), Showa Univ, Dept Oral Physiol, Sch Dent, Shinagawa Ku, Tokyo 1428555, Japan.	nakayamak@dent.showa-u.ac.jp			MEXT/JSPS KAKENHI [25350622, 26293397, 15K15687]; Grants-in-Aid for Scientific Research [26293397, 15K15687, 16K11489, 15H05050, 16K11488] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by MEXT/JSPS KAKENHI (www.jsps.go.jp) Grant number 25350622 (KN), 26293397 (T. Inoue), and 15K15687 (T. Inoue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2009, J PHYSIOL-LONDON, V587, P3539, DOI 10.1113/jphysiol.2008.167502; Adachi T, 1998, OTOLARYNG HEAD NECK, V118, P537, DOI 10.1016/S0194-5998(98)70215-3; Bautista TG, 2016, RESP PHYSIOL NEUROBI, V226, P102, DOI 10.1016/j.resp.2015.07.012; BROUILLETTE RT, 1980, J APPL PHYSIOL, V49, P801, DOI 10.1152/jappl.1980.49.5.801; Chhetri DK, 2014, LARYNGOSCOPE, V124, P2363, DOI 10.1002/lary.24742; COHEN MI, 1979, PHYSIOL REV, V59, P1105, DOI 10.1152/physrev.1979.59.4.1105; Corcoran AE, 2013, RESP PHYSIOL NEUROBI, V186, P214, DOI 10.1016/j.resp.2013.02.015; Curran AK, 2000, EUR RESPIR J, V15, P902, DOI 10.1034/j.1399-3003.2000.15e15.x; Day TA, 2007, J PHYSIOL-LONDON, V578, P843, DOI 10.1113/jphysiol.2006.119594; Dutschmann M, 2000, AUTON NEUROSCI-BASIC, V84, P19, DOI 10.1016/S1566-0702(00)00177-6; FUKUDA Y, 1982, JPN J PHYSIOL, V32, P387; Ghali MGZ, 2015, RESP PHYSIOL NEUROBI, V215, P47, DOI 10.1016/j.resp.2015.05.002; Harris MB, 2001, RESP PHYSIOL, V125, P199, DOI 10.1016/S0034-5687(00)00220-6; Holley HS, 2012, RESP PHYSIOL NEUROBI, V180, P79, DOI 10.1016/j.resp.2011.10.012; Iizuka M, 2007, RESP PHYSIOL NEUROBI, V157, P196, DOI 10.1016/j.resp.2007.01.004; Janczewski WA, 2013, J NEUROSCI, V33, P5454, DOI 10.1523/JNEUROSCI.1595-12.2013; KOBLER JB, 1994, J COMP NEUROL, V349, P129, DOI 10.1002/cne.903490109; Levitt ES, 2015, J PHYSIOL-LONDON, V593, P4453, DOI 10.1113/JP270822; Massey CA, 2015, J NEUROPHYSIOL, V113, P2879, DOI 10.1152/jn.01073.2014; Molkov YI, 2011, J NEUROPHYSIOL, V105, P3080, DOI 10.1152/jn.00070.2011; Molkov YI, 2010, J NEUROPHYSIOL, V104, P2713, DOI 10.1152/jn.00334.2010; MUNTENER M, 1980, ANAT EMBRYOL, V159, P49, DOI 10.1007/BF00299254; OHalloran KD, 1996, EUR RESPIR J, V9, P2323, DOI 10.1183/09031936.96.09112323; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Paton JFR, 2005, J NEUROSCI METH, V147, P138, DOI 10.1016/j.jneumeth.2005.04.003; Paton JFR, 1996, J PHYSIOL-LONDON, V493, P819, DOI 10.1113/jphysiol.1996.sp021425; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Poliacek I, 2003, PHYSIOL RES, V52, P749; Rubin JE, 2011, J COMPUT NEUROSCI, V30, P607, DOI 10.1007/s10827-010-0281-0; SAUERLAND EK, 1976, EXP NEUROL, V51, P160, DOI 10.1016/0014-4886(76)90061-3; SHERREY JH, 1977, ELECTROEN CLIN NEURO, V43, P218, DOI 10.1016/0013-4694(77)90129-8; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; St-John WM, 2004, EXP PHYSIOL, V89, P727, DOI 10.1113/expphysiol.2004.028829; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Stipica I, 2016, PHYSIOL RES, V65, P133, DOI 10.33549/physiolres.933012; STROHL KP, 1980, J APPL PHYSIOL, V49, P638, DOI 10.1152/jappl.1980.49.4.638; SURATT PM, 1985, J APPL PHYSIOL, V58, P1252, DOI 10.1152/jappl.1985.58.4.1252; UEYAMA T, 1988, ANAT EMBRYOL, V177, P445, DOI 10.1007/BF00304742; VANDEGRAAFF WB, 1984, J APPL PHYSIOL, V57, P197, DOI 10.1152/jappl.1984.57.1.197; VANLUNTEREN E, 1987, J APPL PHYSIOL, V62, P582, DOI 10.1152/jappl.1987.62.2.582; Wakai J, 2015, RESP PHYSIOL NEUROBI, V215, P64, DOI 10.1016/j.resp.2015.05.008; WIEGAND DA, 1990, J APPL PHYSIOL, V69, P1262, DOI 10.1152/jappl.1990.69.4.1262; Wilson RJA, 2001, AM J PHYSIOL-REG I, V281, pR528, DOI 10.1152/ajpregu.2001.281.2.R528; Yokoba M, 2003, J APPL PHYSIOL, V95, P810, DOI 10.1152/japplphysiol.00332.2002; ZHOU D, 1989, J APPL PHYSIOL, V67, P1171, DOI 10.1152/jappl.1989.67.3.1171	45	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166436	10.1371/journal.pone.0166436	http://dx.doi.org/10.1371/journal.pone.0166436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832132	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000124
J	Hensch, NR; Karim, ZA; Druey, KM; Tansey, MG; Khasawneh, FT				Hensch, Nicole R.; Karim, Zubair A.; Druey, Kirk M.; Tansey, Malu G.; Khasawneh, Fadi T.			RGS10 Negatively Regulates Platelet Activation and Thrombogenesis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; OUTSIDE-IN; THROMBUS FORMATION; VASCULAR INJURY; KAPPA-B; AGONISTS; PHOSPHORYLATION; SECRETION; NEURONS; COMPLEX	Regulators of G protein signaling (RGS) proteins act as GTPase activating proteins to negatively regulate G protein-coupled receptor (GPCR) signaling. Although several RGS proteins including RGS2, RGS16, RGS10, and RGS18 are expressed in human and mouse platelets, the respective unique function(s) of each have not been fully delineated. RGS10 is a member of the D/R12 subfamily of RGS proteins and is expressed in microglia, macrophages, megakaryocytes, and platelets. We used a genetic approach to examine the role (s) of RGS10 in platelet activation in vitro and hemostasis and thrombosis in vivo. GPCRinduced aggregation, secretion, and integrin activation was much more pronounced in platelets from Rgs10(-/-) mice relative to wild type (WT). Accordingly, these mice had markedly reduced bleeding times and were more susceptible to vascular injury-associated thrombus formation than control mice. These findings suggest a unique, non-redundant role of RGS10 in modulating the hemostatic and thrombotic functions of platelets in mice. RGS10 thus represents a potential therapeutic target to control platelet activity and/or hypercoagulable states.	[Hensch, Nicole R.; Karim, Zubair A.; Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA; [Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, Lab Allerg Dis, NIH, 10 Ctr Dr,Room 11S244B, Bethesda, MD 20892 USA; [Tansey, Malu G.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Karim, Zubair A.; Khasawneh, Fadi T.] Univ Texas El Paso, Sch Pharm, Dept Pharmaceut Sci, 1101 N Campbell St, El Paso, TX 79902 USA	Western University of Health Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; University of Texas System; University of Texas El Paso	Khasawneh, FT (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.; Khasawneh, FT (corresponding author), Univ Texas El Paso, Sch Pharm, Dept Pharmaceut Sci, 1101 N Campbell St, El Paso, TX 79902 USA.	khasawneh@westemu.edu		Hensch, Nicole/0000-0001-9946-0995	College of Pharmacy, Western University of Health Sciences, Pomona, CA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000746] Funding Source: NIH RePORTER	College of Pharmacy, Western University of Health Sciences, Pomona, CA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the College of Pharmacy, Western University of Health Sciences, Pomona, CA (to F.T.K.).	Alshbool FZ, 2015, BIOCHEM BIOPH RES CO, V462, P378, DOI 10.1016/j.bbrc.2015.04.143; Banno F, 2012, J THROMB HAEMOST, V10, P309, DOI 10.1111/j.1538-7836.2011.04575.x; Budnik I, 2015, THROMB RES, V135, P114, DOI 10.1016/j.thromres.2014.10.005; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Delesque-Touchard N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113215; Flor PJ, 2012, BIOCHEM PHARMACOL, V84, P414, DOI 10.1016/j.bcp.2012.04.013; Fong KP, 2016, J BIOL CHEM, V291, P11706, DOI 10.1074/jbc.M116.716613; Gagnon AW, 2002, CELL SIGNAL, V14, P595, DOI 10.1016/S0898-6568(02)00012-8; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Karim ZA, 2016, BBA-MOL CELL RES, V1863, P314, DOI 10.1016/j.bbamcr.2015.11.028; Karim ZA, 2015, ARTERIOSCL THROM VAS, V35, P637, DOI 10.1161/ATVBAHA.114.304509; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Kim SD, 2006, PLATELETS, V17, P493, DOI 10.1080/09537100600758123; LAU LF, 1994, BIOCHEM J, V303, P391, DOI 10.1042/bj3030391; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; Lee JK, 2015, PROG MOL BIOL TRANSL, V133, P153, DOI 10.1016/bs.pmbts.2015.01.005; Lee JK, 2011, J NEUROSCI, V31, P11879, DOI 10.1523/JNEUROSCI.1002-11.2011; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Lin OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087026; Louwette S, 2012, J THROMB HAEMOST, V10, P2215, DOI 10.1111/j.1538-7836.2012.04903.x; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Mao YJ, 2014, PHARMAZIE, V69, P371, DOI 10.1691/ph.2014.3833; Mehrbod M, 2013, BIOPHYS J, V105, P1304, DOI 10.1016/j.bpj.2013.07.055; Mohr K, 2013, ANGEW CHEM INT EDIT, V52, P508, DOI 10.1002/anie.201205315; Mumford AD, 2015, THROMB HAEMOSTASIS, V114, P14, DOI 10.1160/TH14-11-0999; Murad JP, 2012, BIOCHEM BIOPH RES CO, V421, P456, DOI 10.1016/j.bbrc.2012.04.011; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Signarvic RS, 2010, BLOOD, V116, P6092, DOI 10.1182/blood-2010-05-283846; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Tu YP, 2001, J BIOL CHEM, V276, P20160, DOI 10.1074/jbc.M101599200; Vemana HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125764; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0	34	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165984	10.1371/journal.pone.0165984	http://dx.doi.org/10.1371/journal.pone.0165984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829061	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300071
J	Martinez-Martinez, E; Ibarrola, J; Calvier, L; Fernandez-Celis, A; Leroy, C; Cachofeiro, V; Rossignol, P; Lopez-Andres, N				Martinez-Martinez, Ernesto; Ibarrola, Jaime; Calvier, Laurent; Fernandez-Celis, Amaya; Leroy, Celine; Cachofeiro, Victoria; Rossignol, Patrick; Lopez-Andres, Natalia			Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; VALVE-REPLACEMENT; INHIBITION; OUTCOMES; FAILURE; OBESITY; INJURY; PROTEINURIA; PROGRESSION; RISK	Background Galectin-3 (Gal-3), a beta-galactoside-binding lectin, is increased in kidney injury and its pharmacological blockade reduces renal damage in acute kidney injury, hyperaldosteronism or hypertensive nephropathy. We herein investigated the effects of pharmacological Gal-3 inhibition by modified citrus pectin (MCP) in early renal damage associated with obesity and aortic stenosis (AS). Results Gal-3 was upregulated in kidneys from high fat diet (HFD) rats and in animals with partial occlusion of ascending aorta (AS). Urinary and plasma neutrophil gelatinase-associated lipocalin (NGAL) and urinary albumin were enhanced in HFD and AS rats. In kidney from obese rats, fibrotic markers (collagen, TFG-beta), epithelial-mesenchymal transition molecules (a-smooth muscle actin, E-cadherin), inflammatory mediator (osteopontin) and kidney injury marker (kidney injury molecule-1) were modified. In kidney from AS rats, fibrotic markers (collagen, CTGF), epithelial-mesenchymal transition molecules (fibronectin, alpha-smooth muscle actin, beta-catenin, E-cadherin) and kidney injury markers (NGAL, kidney injury molecule 1) were altered. Histologic observations of obese and AS rat kidneys revealed tubulointerstitial fibrosis. The pharmacological inhibition of Gal-3 with MCP normalized renal Gal-3 levels as well as functional, histological and molecular alterations in obese and AS rats. Conclusions In experimental models of mild kidney damage, the increase in renal Gal-3 expression paralleled with renal fibrosis, inflammation and damage, while these alterations were prevented by Gal-3 blockade. These data suggest that Gal-3 could be a new player in renal molecular, histological and functional alterations at early stages of kidney damage.	[Martinez-Martinez, Ernesto; Ibarrola, Jaime; Fernandez-Celis, Amaya; Lopez-Andres, Natalia] Miguel Servet Fdn, Inst Invest Sanitaria Navarra IdiSNA, Cardiovasc Translat Res Navarrabiomed, Pamplona, Spain; [Calvier, Laurent; Leroy, Celine; Rossignol, Patrick; Lopez-Andres, Natalia] Univ Lorraine, CHRU Nancy, UMR 1116, INSERM,Ctr Invest Clin Plurithemat 1433,French Cl, Nancy, France; [Cachofeiro, Victoria] Univ Complutense, Sch Med, Dept Physiol, IiSGM, Madrid, Spain	Navarrabiomed; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Complutense University of Madrid	Lopez-Andres, N (corresponding author), Miguel Servet Fdn, Inst Invest Sanitaria Navarra IdiSNA, Cardiovasc Translat Res Navarrabiomed, Pamplona, Spain.; Lopez-Andres, N (corresponding author), Univ Lorraine, CHRU Nancy, UMR 1116, INSERM,Ctr Invest Clin Plurithemat 1433,French Cl, Nancy, France.	Natalia.lopez.andres@navarra.es	Lopez-Andres, Natalia/B-1276-2017; Martinez-Martinez, Ernesto/M-1376-2017	Lopez-Andres, Natalia/0000-0003-3728-2606; Martinez-Martinez, Ernesto/0000-0002-3011-2041; Ibarrola, Jaime/0000-0003-0604-9289; Fernandez-Celis, Amaya/0000-0002-5627-7653; Cachofeiro, Victoria/0000-0001-6959-6293; Calvier, Laurent/0000-0001-6437-2119	Miguel Servet from the "Instituto de Salud Carlos III-FEDER" [CP13/00221]; Fondo de Investigaciones Sanitarias [P115/02160]; FIBROTARGETS project [602904]; Red de Investigacion Cardiovascular del ISCIII (RIC) [RD12/0042/0033]; Plan Estatal I+D+I; RHU Fight-HF by French National Research Agency (ANR), second "Investissements d'Avenir" programme [ANR-15-RHUS-0004]	Miguel Servet from the "Instituto de Salud Carlos III-FEDER"; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); FIBROTARGETS project; Red de Investigacion Cardiovascular del ISCIII (RIC); Plan Estatal I+D+I; RHU Fight-HF by French National Research Agency (ANR), second "Investissements d'Avenir" programme(French National Research Agency (ANR))	This work was supported by Miguel Servet contract CP13/00221 from the "Instituto de Salud Carlos III-FEDER", Fondo de Investigaciones Sanitarias [P115/02160] "One way to make Europe", FIBROTARGETS project (Grant agreement number FP7 #602904), Red de Investigacion Cardiovascular del ISCIII (RIC; RD12/0042/0033), Plan Estatal I+D+I 2013-2016. PR was supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second "Investissements d'Avenir" programme (reference: ANR-15-RHUS-0004).	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Anderson S, 2009, J AM SOC NEPHROL, V20, P1199, DOI 10.1681/ASN.2008080860; Aregger F, 2009, NEPHROL DIAL TRANSPL, V24, P2175, DOI 10.1093/ndt/gfp036; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Calvier L, 2015, JACC-HEART FAIL, V3, P59, DOI 10.1016/j.jchf.2014.08.002; Chen S.Y., 2016, INT J MOL SCI, V17; Bertocchi APF, 2008, TRANSPL INT, V21, P999, DOI 10.1111/j.1432-2277.2008.00705.x; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Frenay ARS, 2015, AM J PHYSIOL-RENAL, V308, pF500, DOI 10.1152/ajprenal.00461.2014; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Kolatsi-Joannou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018683; Lee HS, 2010, BIOCHEM BIOPH RES CO, V395, P553, DOI 10.1016/j.bbrc.2010.04.065; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Liu HY, 2008, WORLD J GASTROENTERO, V14, P7386, DOI 10.3748/wjg.14.7386; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; Martinez-Martinez E, 2016, INT J OBESITY, V40, P1034, DOI 10.1038/ijo.2016.19; Martinez-Martinez E, 2015, HYPERTENSION, V66, P961, DOI 10.1161/HYPERTENSIONAHA.115.06032; Martinez-Martinez E, 2015, HYPERTENSION, V66, P767, DOI 10.1161/HYPERTENSIONAHA.115.05876; McClellan WM, 2003, J AM SOC NEPHROL, V14, pS65, DOI 10.1097/01.ASN.0000070147.10399.9E; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Najjar M, 2015, INTERACT CARDIOV TH, V21, P499, DOI 10.1093/icvts/ivv196; Nishiyama J, 2000, AM J PATHOL, V157, P815, DOI 10.1016/S0002-9440(10)64595-6; O'Seaghdha CM, 2013, J AM SOC NEPHROL, V24, P1470, DOI 10.1681/ASN.2012090909; Okamura DM, 2011, AM J PHYSIOL-RENAL, V300, pF245, DOI 10.1152/ajprenal.00326.2010; Pugliese G, 2001, FASEB J, V15, P2471, DOI 10.1096/fj.01-0006com; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Tang WHW, 2011, AM J CARDIOL, V108, P385, DOI 10.1016/j.amjcard.2011.03.056; Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075361; Wicks SE, 2016, BIOCHIMIE, V124, P65, DOI 10.1016/j.biochi.2015.08.001; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	32	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166272	10.1371/journal.pone.0166272	http://dx.doi.org/10.1371/journal.pone.0166272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829066	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300102
J	Sove, RJ; Fraser, GM; Goldman, D; Ellis, CG				Sove, Richard J.; Fraser, Graham M.; Goldman, Daniel; Ellis, Christopher G.			Finite Element Model of Oxygen Transport for the Design of Geometrically Complex Microfluidic Devices Used in Biological Studies	PLOS ONE			English	Article							DEFORMATION-INDUCED RELEASE; RED-BLOOD-CELLS; ATP RELEASE; IN-VITRO; RESISTANCE VESSELS; ENDOTHELIAL-CELLS; VASCULAR-TONE; ERYTHROCYTES; GRADIENTS; CULTURE	Red blood cells play a crucial role in the local regulation of oxygen supply in the microcirculation through the oxygen dependent release of ATP. Since red blood cells serve as an oxygen sensor for the circulatory system, the dynamics of ATP release determine the effectiveness of red blood cells to relate the oxygen levels to the vessels. Previous work has focused on the feasibility of developing a microfluidic system to measure the dynamics of ATP release. The objective was to determine if a steep oxygen gradient could be developed in the channel to cause a rapid decrease in hemoglobin oxygen saturation in order to measure the corresponding levels of ATP released from the red blood cells. In the present study, oxygen transport simulations were used to optimize the geometric design parameters for a similar system which is easier to fabricate. The system is composed of a microfluidic device stacked on top of a large, gas impermeable flow channel with a hole to allow gas exchange. The microfluidic device is fabricated using soft lithography in polydimethyl-siloxane, an oxygen permeable material. Our objective is twofold: (1) optimize the parameters of our system and (2) develop a method to assess the oxygen distribution in complex 3D microfluidic device geometries. 3D simulations of oxygen transport were performed to simulate oxygen distribution throughout the device. The simulations demonstrate that micro fluidic device geometry plays a critical role in molecule exchange, for instance, changing the orientation of the short wide microfluidic channel results in a 97.17% increase in oxygen exchange. Since microfluidic devices have become a more prominent tool in biological studies, understanding the transport of oxygen and other biological molecules in microfluidic devices is critical for maintaining a physiologically relevant environment. We have also demonstrated a method to assess oxygen levels in geometrically complex microfluidic devices.	[Sove, Richard J.; Fraser, Graham M.; Goldman, Daniel; Ellis, Christopher G.] Western Univ, Dept Med Biophys, London, ON, Canada; [Fraser, Graham M.] Mem Univ St Johns, Div Biomed Sci, Cardiovasc Res Grp, Fac Med, St Johns, NF, Canada	Western University (University of Western Ontario); Memorial University Newfoundland	Sove, RJ (corresponding author), Western Univ, Dept Med Biophys, London, ON, Canada.	rsove@uwo.ca	Ellis, Christopher G/AAV-2325-2020; Goldman, Daniel/CAF-8020-2022	Goldman, Daniel/0000-0002-8707-5536	Natural Sciences and Engineering Research Council of Canada [R1379A13]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research is funded by the Natural Sciences and Engineering Research Council of Canada (R1379A13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2012, BIOTECHNOL APPL BIOC, V59, P97, DOI 10.1002/bab.1010; Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Bateman RM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1102-7; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BJERKVIG R, 1992, UNDERSEA BIOMED RES, V19, P415; Chen YA, 2011, LAB CHIP, V11, P3626, DOI 10.1039/c1lc20325h; COKELET GR, 1993, MICROVASC RES, V46, P394, DOI 10.1006/mvre.1993.1062; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Dietrich HH, 1996, AM J PHYSIOL-HEART C, V271, pH1109, DOI 10.1152/ajpheart.1996.271.3.H1109; Dietrich HH, 2000, AM J PHYSIOL-HEART C, V278, pH1294, DOI 10.1152/ajpheart.2000.278.4.H1294; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Ellis CG, 2012, MICROCIRCULATION, V19, P440, DOI 10.1111/j.1549-8719.2012.00196.x; Ellis CG, 2010, AM J PHYSIOL-HEART C, V298, pH1661, DOI 10.1152/ajpheart.01239.2009; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Fischer DJ, 2003, ANALYST, V128, P1163, DOI 10.1039/b308225n; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Ghonaim NW, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00260; Ghonaim NW, 2011, MICROCIRCULATION, V18, P646, DOI 10.1111/j.1549-8719.2011.00132.x; Hellums JD, 1996, ANN BIOMED ENG, V24, P1, DOI 10.1007/BF02770991; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Inamdar NK, 2011, CURR OPIN BIOTECH, V22, P681, DOI 10.1016/j.copbio.2011.05.512; Jagger JE, 2001, AM J PHYSIOL-HEART C, V280, pH2833, DOI 10.1152/ajpheart.2001.280.6.H2833; Jiang XY, 2005, ANAL CHEM, V77, P2338, DOI 10.1021/ac048440m; JORNOT L, 1987, J APPL PHYSIOL, V63, P457, DOI 10.1152/jappl.1987.63.2.457; Kang TY, 2013, LANGMUIR, V29, P701, DOI 10.1021/la303552m; Kim MC, 2013, MICROFLUID NANOFLUID, V15, P285, DOI 10.1007/s10404-013-1142-8; Li CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155921; Light DB, 1999, AM J PHYSIOL-CELL PH, V277, pC480, DOI 10.1152/ajpcell.1999.277.3.C480; Moehlenbrock MJ, 2006, ANALYST, V131, P930, DOI 10.1039/b605136g; Oppegard SC, 2013, BIOMED MICRODEVICES, V15, P407, DOI 10.1007/s10544-013-9737-0; PATANKAR SV, 1972, INT J HEAT MASS TRAN, V15, P1787, DOI 10.1016/0017-9310(72)90054-3; Price AK, 2004, ANAL CHEM, V76, P4849, DOI 10.1021/ac0495992; Quinn DJ, 2011, ANN BIOMED ENG, V39, P1041, DOI 10.1007/s10439-010-0232-y; Reddy J.N., 2010, FINITE ELEMENT METHO; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; SANDERS SP, 1993, J CLIN INVEST, V91, P46, DOI 10.1172/JCI116198; Shevkoplyas SS, 2003, MICROVASC RES, V65, P132, DOI 10.1016/S0026-2862(02)00034-1; Sove RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081537; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]; Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744; Wu HK, 2006, J AM CHEM SOC, V128, P4194, DOI 10.1021/ja058530o; Zahorodny-Burke M, 2011, CHEM ENG SCI, V66, P6244, DOI 10.1016/j.ces.2011.09.007	47	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166289	10.1371/journal.pone.0166289	http://dx.doi.org/10.1371/journal.pone.0166289			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829071	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300103
J	Wilcox, RC; Fletcher, RJ				Wilcox, Rebecca C.; Fletcher, Robert J., Jr.			Experimental Test of Preferences for an Invasive Prey by an Endangered Predator: Implications for Conservation	PLOS ONE			English	Article							SNAIL KITE; IMPACTS; DIET; CONSEQUENCES; SPECIALIST; DEMOGRAPHY; SELECTION; BEHAVIOR; HABITAT; MODEL	Identifying impacts of exotic species on native populations is central to ecology and conservation. Although the effects of exotic predators on native prey have received much attention, the role of exotic prey on native predators is poorly understood. Determining if native predators actively prefer invasive prey over native prey has implications for interpreting invasion impacts, identifying the presence of evolutionary traps, and predator persistence. One of the world's most invasive species, Pomacea maculata, has recently established in portions of the endangered Everglade snail kite's (Rostrhamus sociabilis plumbeus) geographic range. Although these exotic snails could provide additional prey resources, they are typically much larger than the native snail, which can lead to lower foraging success and the potential for diminished energetic benefits in comparison to native snails. Nonetheless, snail kites frequently forage on exotic snails. We used choice experiments to evaluate snail kite foraging preference in relation to exotic species and snail size. We found that snail kites do not show a preference for native or exotic snails. Rather, snail kites generally showed a preference for medium-sized snails, the sizes reflective of large native snails. These results suggest that while snail kites frequently forage on exotic snails in the wild, this behavior is likely driven simply by the abundance of exotic snails rather than snail kites preferring exotics. This lack of preference offers insights to hypotheses regarding effects of exotic species, guidance regarding habitat and invasive species management, and illustrates how native-exotic relationships can be misleading in the absence of experimental tests of such interactions.	[Wilcox, Rebecca C.; Fletcher, Robert J., Jr.] Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Zeigler Hall, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Fletcher, RJ (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, 110 Newins Zeigler Hall, Gainesville, FL 32611 USA.	robert.fletcher@ufl.edu			USGS's Greater Everglades Priority Ecosystems Science (GEPES); U.S. Army Corps of Engineers; U.S. Fish and Wildlife Service	USGS's Greater Everglades Priority Ecosystems Science (GEPES); U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army); U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	This project was funded by USGS's Greater Everglades Priority Ecosystems Science (GEPES), the U.S. Army Corps of Engineers, and U.S. Fish and Wildlife Service.; We thank Wiley Kitchens, Peter Frederick, Ellen Robertson and three anonymous reviewers for providing comments on earlier versions of this manuscript. This project was funded by USGS's Greater Everglades Priority Ecosystems Science (GEPES), the U.S. Army Corps of Engineers, and U.S. Fish and Wildlife Service.	Barber NA, 2008, ECOLOGY, V89, P2678, DOI 10.1890/08-0395.1; Barnes MA, 2008, J N AM BENTHOL SOC, V27, P738, DOI 10.1899/08-013.1; BEISSINGER SR, 1994, OECOLOGIA, V100, P54, DOI 10.1007/BF00317130; BEISSINGER SR, 1983, AUK, V100, P84, DOI 10.1093/auk/100.1.84; Bennetts RE, 2000, OIKOS, V91, P459, DOI 10.1034/j.1600-0706.2000.910306.x; Berger-Tal O, 2014, BEHAV ECOL SOCIOBIOL, V68, P1769, DOI 10.1007/s00265-014-1785-9; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CARACO T, 1981, BEHAV ECOL SOCIOBIOL, V8, P213, DOI 10.1007/BF00299833; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; Cattau CE, 2016, ECOL APPL, V26, P1952, DOI 10.1890/15-1020.1; Cattau CE, 2014, J WILDLIFE MANAGE, V78, P620, DOI 10.1002/jwmg.706; Cattau CE, 2010, BIOL CONSERV, V143, P513, DOI 10.1016/j.biocon.2009.11.022; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; D'Amore A, 2009, HERPETOL CONSERV BIO, V4, P325; Darby Philip C., 2007, Florida Field Naturalist, V35, P79; Darby PC, 2008, WETLANDS, V28, P204, DOI 10.1672/07-115.1; Darby PC, 2015, LANDSCAPE ECOL, V30, P1497, DOI 10.1007/s10980-015-0205-5; Donovan TM, 2001, ECOL APPL, V11, P871; ELLIS JE, 1976, J THEOR BIOL, V60, P93, DOI 10.1016/0022-5193(76)90157-0; ELNER RW, 1978, J ANIM ECOL, V47, P103, DOI 10.2307/3925; Fletcher RJ, 2015, P ROY SOC B-BIOL SCI, V282, P40, DOI 10.1098/rspb.2015.1545; Fletcher RJ, 2012, P ROY SOC B-BIOL SCI, V279, P2546, DOI 10.1098/rspb.2012.0139; Hutto R.L., 1990, Studies in Avian Biology, P20; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; LI KT, 1985, ECOLOGY, V66, P1729, DOI 10.2307/2937368; Li YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024299; Martin Julien, 2008, Endangered Species Research, V6, P25, DOI 10.3354/esr00119; Martin J, 2007, CONSERV BIOL, V21, P472, DOI 10.1111/j.1523-1739.2006.00613.x; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; Overton CT, 2014, BIOL INVASIONS, V16, P1897, DOI 10.1007/s10530-013-0634-5; Paxton EH, 2011, CONDOR, V113, P255, DOI 10.1525/cond.2011.090226; Pearson DE, 2008, ECOL APPL, V18, P321, DOI 10.1890/07-0766.1; Pias KE, 2012, WATERBIRDS, V35, P347, DOI 10.1675/063.035.0217; Pintor LM, 2015, ECOL LETT, V18, P1174, DOI 10.1111/ele.12496; R Core Team, 2021, R LANGUAGE ENV STAT; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Reed JM, 1999, CONSERV BIOL, V13, P232, DOI 10.1046/j.1523-1739.1999.013002232.x; Reichert B. E., 2015, SNAIL KITE ROSTRHAMU; Reichert BE, 2016, J ANIM ECOL, V85, P1563, DOI 10.1111/1365-2656.12571; Reichert BE, 2012, ECOLOGY, V93, P2580, DOI 10.1890/12-0233.1; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; Saul WC, 2015, ECOL LETT, V18, P236, DOI 10.1111/ele.12408; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; SNYDER NFR, 1983, AUK, V100, P93, DOI 10.1093/auk/100.1.93; SYKES P W JR, 1987, Colonial Waterbirds, V10, P84, DOI 10.2307/1521235; Sykes PW, 1995, BIRDS N AM, P1; TAKEKAWA JE, 1989, CONSERV BIOL, V3, P302, DOI 10.1111/j.1523-1739.1989.tb00090.x; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; van Gils JA, 2003, AM NAT, V161, P777, DOI 10.1086/374205	54	8	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165427	10.1371/journal.pone.0165427	http://dx.doi.org/10.1371/journal.pone.0165427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829031	gold, Green Submitted, Green Published			2022-12-27	WOS:000387724300045
J	Huang, GH; Chu, C; Huang, T; Kong, XY; Zhang, YH; Zhang, N; Cai, YD				Huang, Guohua; Chu, Chen; Huang, Tao; Kong, Xiangyin; Zhang, Yunhua; Zhang, Ning; Cai, Yu-Dong			Exploring Mouse Protein Function via Multiple Approaches	PLOS ONE			English	Article							AUTOMATED PREDICTION; KISS1 EXPRESSION; ESSENTIAL ROLES; ANNOTATION; ALIGNMENT; BINDING; PHOSPHORYLATION; REGULATOR; KINASE; INTEGRATION	Although the number of available protein sequences is growing exponentially, functional protein annotations lag far behind. Therefore, accurate identification of protein functions remains one of the major challenges in molecular biology. In this study, we presented a novel approach to predict mouse protein functions. The approach was a sequential combination of a similarity-based approach, an interaction-based approach and a pseudo amino acid composition-based approach. The method achieved an accuracy of about 0.8450 for the 1st-order predictions in the leave-one-out and ten-fold cross-validations. For the results yielded by the leave-one-out cross-validation, although the similarity-based approach alone achieved an accuracy of 0.8756, it was unable to predict the functions of proteins with no homologues. Comparatively, the pseudo amino acid composition-based approach alone reached an accuracy of 0.6786. Although the accuracy was lower than that of the previous approach, it could predict the functions of almost all proteins, even proteins with no homologues. Therefore, the combined method balanced the advantages and disadvantages of both approaches to achieve efficient performance. Furthermore, the results yielded by the ten-fold cross-validation indicate that the combined method is still effective and stable when there are no close homologs are available. However, the accuracy of the predicted functions can only be determined according to known protein functions based on current knowledge. Many protein functions remain unknown. By exploring the functions of proteins for which the 1st-order predicted functions are wrong but the 2nd-order predicted functions are correct, the 1st-order wrongly predicted functions were shown to be closely associated with the genes encoding the proteins. The so-called wrongly predicted functions could also potentially be correct upon future experimental verification. Therefore, the accuracy of the presented method may be much higher in reality.	[Huang, Guohua] Shaoyang Univ, Dept Math, Shaoyang 422000, Hunan, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, 99 Shangda Rd, Shanghai 200444, Peoples R China; [Chu, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Huang, Tao; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Zhang, Yunhua] Anhui Agr Univ, Coll Life Sci, Hefei 230036, Anhui, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab Biomed Engn Measurement, Tianjin, Peoples R China	Shaoyang University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Anhui Agricultural University; Tianjin University	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, 99 Shangda Rd, Shanghai 200444, Peoples R China.; Zhang, N (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab Biomed Engn Measurement, Tianjin, Peoples R China.	zhni@tju.edu.cn; cai_yud@126.com	Zhang, Yu-Hang/AAQ-9012-2021; Zhang, Yu-Hang/O-9774-2015; Chu, Chen/J-6527-2019; Huang, Guohua/A-2215-2019	Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yu-Hang/0000-0003-3825-0796; Chu, Chen/0000-0001-8084-0867; Huang, Guohua/0000-0001-6954-3933; cai, yudong/0000-0001-5664-7979; Zhang, Ning/0000-0002-1559-111X	National Natural Science Foundation of China [61401302, 31371335, 81171342, 81201148]; Tianjin Research Program of the Application Foundation and Advanced Technology [14JCQNJC09500]; Innovation Program of the Shanghai Municipal Education Commission [12ZZ087]; National Research Foundation for the Doctoral Program of Higher Education of China [20130032120070, 20120032120073]; Scientific Research Fund of Hunan Provincial Education Department [15B216]; Science and Technology Program of Hunan [2015JC3099]; Seed Foundation of Tianjin University [60302064, 60302069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of the Application Foundation and Advanced Technology; Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Science and Technology Program of Hunan; Seed Foundation of Tianjin University	Funded by National Natural Science Foundation of China (61401302, 31371335, 81171342, 81201148), the Tianjin Research Program of the Application Foundation and Advanced Technology (14JCQNJC09500), the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087), the National Research Foundation for the Doctoral Program of Higher Education of China (20130032120070, 20120032120073), the Scientific Research Fund of Hunan Provincial Education Department (15B216), the Science and Technology Program of Hunan (2015JC3099), and the Seed Foundation of Tianjin University (60302064, 60302069).; This work was supported by grants from the National Natural Science Foundation of China (61401302, 31371335, 81171342, 81201148), the Tianjin Research Program of the Application Foundation and Advanced Technology (14JCQNJC09500), the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087), the National Research Foundation for the Doctoral Program of Higher Education of China (20130032120070, 20120032120073), the Scientific Research Fund of Hunan Provincial Education Department (15B216), the Science and Technology Program of Hunan (2015JC3099), and the Seed Foundation of Tianjin University (60302064, 60302069).	Agrawal PB, 2014, AM J HUM GENET, V95, P218, DOI 10.1016/j.ajhg.2014.07.004; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An JY, 2016, PROTEIN SCI, V25, P1825, DOI 10.1002/pro.2991; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; AWATA H, 1994, GENOMICS, V23, P534, DOI 10.1006/geno.1994.1540; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chi XX, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-437; Chitale M, 2009, BIOINFORMATICS, V25, P1739, DOI 10.1093/bioinformatics/btp309; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Cozzetto D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S1; DEMICHEL P, 1993, PEPTIDES, V14, P1005, DOI 10.1016/0196-9781(93)90078-U; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; Diaz-Martinez LA, 2007, CELL CYCLE, V6, P714, DOI 10.4161/cc.6.6.3935; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Eggers CT, 2009, J BIOL CHEM, V284, P32869, DOI 10.1074/jbc.M109.022582; Erdin S, 2011, CURR OPIN STRUC BIOL, V21, P180, DOI 10.1016/j.sbi.2011.02.001; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fukuda MN, 2008, CELL MOL LIFE SCI, V65, P92, DOI 10.1007/s00018-007-7302-9; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gudmundsdottir K, 2007, ONCOGENE, V26, P7601, DOI 10.1038/sj.onc.1210579; Hawkins T, 2009, PROTEINS, V74, P566, DOI 10.1002/prot.22172; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang YA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1035-4; Jia CZ, 2014, INT J MOL SCI, V15, P10410, DOI 10.3390/ijms150610410; Jin Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030419, 10.1371/journal.pone.0032155]; Khan S, 2003, BIOINFORMATICS, V19, P2484, DOI 10.1093/bioinformatics/btg338; Kikuchi Y, 2015, GENES CELLS, V20, P191, DOI 10.1111/gtc.12210; Kolodny R, 2004, P NATL ACAD SCI USA, V101, P12201, DOI 10.1073/pnas.0404383101; Kostakis ID, 2013, APMIS, V121, P1004, DOI 10.1111/apm.12161; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kroll H, 2011, NEUROENDOCRINOLOGY, V93, P114, DOI 10.1159/000321678; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lai SK, 2011, CELL DEATH DIFFER, V18, P996, DOI 10.1038/cdd.2010.165; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li DL, 2009, PEPTIDES, V30, P130, DOI 10.1016/j.peptides.2008.09.025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JAJ, 2013, P NATL ACAD SCI USA, V110, P2882, DOI 10.1073/pnas.1211747110; Lizama AJ, 2015, INNATE IMMUN-LONDON, V21, P575, DOI 10.1177/1753425914566083; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mollereau C, 2001, BRIT J PHARMACOL, V133, P1, DOI 10.1038/sj.bjp.0704049; Morrison KB, 2002, ONCOGENE, V21, P5684, DOI 10.1038/sj.onc.1205669; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Nishizawa M, 2005, J CELL SCI, V118, P1081, DOI 10.1242/jcs.01667; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Onuma TA, 2012, FASEB J, V26, P2941, DOI 10.1096/fj.11-201095; Pandey G, 2006, COMPUTATIONAL APPROA; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Qiu W, 2014, SCI WORLD J, DOI 10.1155/2014/406154; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruepp A, 2006, NUCLEIC ACIDS RES, V34, pD568, DOI 10.1093/nar/gkj074; Saini HK, 2007, NUCLEIC ACIDS RES, V35, pW499, DOI 10.1093/nar/gkm367; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shatsky M, 2004, NUCLEIC ACIDS RES, V32, pW503, DOI 10.1093/nar/gkh413; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; Sugimoto M, 2008, J CELL BIOL, V183, P19, DOI 10.1083/jcb.200803133; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1055, DOI 10.1152/ajpendo.00516.2004; Tersteeg C, 2014, CIRCULATION, V129, P1320, DOI 10.1161/CIRCULATIONAHA.113.006727; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Wang HH, 2012, AM J PATHOL, V180, P1170, DOI 10.1016/j.ajpath.2011.11.020; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Wong L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010021; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yu J, 2009, INT J ONCOL, V35, P175, DOI 10.3892/ijo_00000326; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Zehetner G, 2003, NUCLEIC ACIDS RES, V31, P3799, DOI 10.1093/nar/gkg555	93	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166580	10.1371/journal.pone.0166580	http://dx.doi.org/10.1371/journal.pone.0166580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846315	gold, Green Submitted, Green Published			2022-12-27	WOS:000387794600087
J	Lin, YH; Chian, CL; Lin, PH; Chang, LR; Ko, CH; Lee, YH; Lin, SH				Lin, Yu-Hsuan; Chian, Chih-Lin; Lin, Po-Hsien; Chang, Li-Ren; Ko, Chih-Hung; Lee, Yang-Han; Lin, Sheng-Hsuan			Proposed Diagnostic Criteria for Smartphone Addiction	PLOS ONE			English	Article							INTERNET GAMING DISORDER; PATHOLOGICAL GAMBLERS; ADOLESCENTS; VALIDITY	Background Global smartphone penetration has led to unprecedented addictive behaviors. The aims of this study are to develop diagnostic criteria of smartphone addiction and to examine the discriminative ability and the validity of the diagnostic criteria. Methods We developed twelve candidate criteria for characteristic symptoms of smartphone addiction and four criteria for functional impairment caused by excessive smartphone use. The participants consisted of 281 college students. Each participant was systematically assessed for smartphone-using behaviors by psychiatrist's structured diagnostic interview. The sensitivity, specificity, and diagnostic accuracy of the candidate symptom criteria were analyzed with reference to the psychiatrists' clinical global impression. The optimal model selection with its cutoff point of the diagnostic criteria differentiating the smartphone addicted subjects from non-addicted subjects was then determined by the best diagnostic accuracy. Results Six symptom criteria model with optimal cutoff point were determined based on the maximal diagnostic accuracy. The proposed smartphone addiction diagnostic criteria consisted of (1) six symptom criteria, (2) four functional impairment criteria and (3) exclusion criteria. Setting three symptom criteria as the cutoff point resulted in the highest diagnostic accuracy (84.3%), while the sensitivity and specificity were 79.4% and 87.5%, respectively. We suggested determining the functional impairment by two or more of the four domains considering the high accessibility and penetration of smartphone use. Conclusion The diagnostic criteria of smartphone addiction demonstrated the core symptoms "impaired control" paralleled with substance related and addictive disorders. The functional impairment involved multiple domains provide a strict standard for clinical assessment.	[Lin, Yu-Hsuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chian, Chih-Lin] Shin Kong Wu Ho Su Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Chian, Chih-Lin] Ctr Drug Evaluat, Div New Drugs, Taipei, Taiwan; [Lin, Po-Hsien] Koo Fdn Sun Yat Sen Canc Ctr, Dept Psychiat, New Taipei, Taiwan; [Chang, Li-Ren] Natl Taiwan Univ, Dept Psychiat, Coll Med, Taipei, Taiwan; [Ko, Chih-Hung] Kaohsiung Med Univ, Dept Psychiat, Kaohsiung, Taiwan; [Ko, Chih-Hung] Kaohsiung Municipal Hsiaokang Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lee, Yang-Han] Tamkang Univ Hosp, Dept & Grad Sch Elect Engn, New Taipei, Taiwan; [Lin, Sheng-Hsuan] Columbia Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA	National Taiwan University; National Taiwan University Hospital; Shin Kong Wu Ho Su Memorial Hospital; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Lin, SH (corresponding author), Columbia Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA.	sh1517@mail.harvard.edu	ko, Chih-Hung/AFH-9581-2022	CHANG, LI-REN/0000-0003-0853-3904; Lin, Sheng-Hsuan/0000-0003-0714-2354				American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Billieux J., 2015, CURR ADDICT REP, V2, P156, DOI [10.1007/s40429-015-0054-y, DOI 10.1007/S40429-015-0054-Y]; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Davey S, 2014, INT J PREVENTIVE MED, V5, P1500; Demirci K, 2014, KLIN PSIKOFARMAKOL B, V24, P226, DOI 10.5455/bcp.20140710040824; Fu KW, 2010, BRIT J PSYCHIAT, V196, P486, DOI 10.1192/bjp.bp.109.075002; Griffiths M, 1996, J Gambl Stud, V12, P471, DOI 10.1007/BF01539190; Hodgins DC, 2001, J CONSULT CLIN PSYCH, V69, P50, DOI 10.1037//0022-006X.69.1.50; Kim SH, 2011, NEUROREPORT, V22, P407, DOI 10.1097/WNR.0b013e328346e16e; Klauer SG, 2014, NEW ENGL J MED, V370, P54, DOI 10.1056/NEJMsa1204142; Ko CH, 2005, J NERV MENT DIS, V193, P728, DOI 10.1097/01.nmd.0000185891.13719.54; Ko CH, 2014, ADDICTION, V109, P1411, DOI 10.1111/add.12565; Ko CH, 2009, COMPR PSYCHIAT, V50, P378, DOI 10.1016/j.comppsych.2007.05.019; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee H, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-0001-1; Lin YH, 2016, J CLIN PSYC IN PRESS; Lin YH, 2015, J PSYCHIATR RES, V65, P139, DOI 10.1016/j.jpsychires.2015.04.003; Lin YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098312; Metcalf O, 2014, CYBERPSYCH BEH SOC N, V17, P147, DOI 10.1089/cyber.2013.0024; Mok JY, 2014, NEUROPSYCH DIS TREAT, V10, P817, DOI 10.2147/NDT.S59293; Petry NA, 2008, J CONSULT CLIN PSYCH, V76, P318, DOI 10.1037/0022-006X.76.2.318; Petry NM, 2006, J CONSULT CLIN PSYCH, V74, P555, DOI 10.1037/0022-006X.74.3.555; Petry NM, 2014, ADDICTION, V109, P1399, DOI 10.1111/add.12457; Potenza M. N., 2014, AM J PSYCHIAT; Slutske WS, 2000, ARCH GEN PSYCHIAT, V57, P666, DOI 10.1001/archpsyc.57.7.666; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; van Rooij AJ, 2011, ADDICTION, V106, P205, DOI 10.1111/j.1360-0443.2010.03104.x; West R, 2001, ADDICTION, V96, P3, DOI 10.1046/j.1360-0443.2001.96131.x	29	83	84	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0163010	10.1371/journal.pone.0163010	http://dx.doi.org/10.1371/journal.pone.0163010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846211	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600001
J	Yu, JM; Hua, H; Liu, Y; Liu, Y				Yu, Jiaming; Hua, Hui; Liu, Yan; Liu, Yang			Distributions of Direct, Reflected, and Diffuse Irradiance for Ocular UV Exposure at Different Solar Elevation Angles	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; ANATOMICAL DISTRIBUTION; SURFACE; BODY	To analyze intensities of ocular exposure to direct (E-o,(dir)), reflected (E-o,(refl)), and diffuse (E-o,E-diff) ultraviolet (UV) irradiance at different solar elevation angles (SEAs), a rotating manikin and dual-detector spectrometer were used to monitor the intensity of ocular exposure to UV irradiation (E-o) and ambient UV radiation (UVR) under clear skies in Sanya, China. E-o,E-dir was derived as the difference between maximum and minimum measured Eo values. E-o,E-refl was converted from the value measured at a height of 160 cm. E-o,E-diff was calculated as the minimum measured E-o value minus E-o,E-refl. Regression curves were fitted to determine distributions of intensities and growth rates at different wavelengths and SEAs. E-o,E-dir differed from ambient UVR exposure. Linear, quadratic, and linear E-o,E-dir distributions were obtained in SEA ranges of 14 degrees-30 degrees, 30 degrees-50 degrees, and 50 degrees-90 degrees, respectively, with maximum E-o,E-dir at 32 degrees-38 degrees SEA. Growth rates of E-o,E-dir with increasing wavelength were fitted with quadratic functions in all SEA ranges. Distributions and growth rate of E-o,(refl) values were fitted with quadratic functions. Maximum E-o,E-diff was achieved at the same SEA for all fitted quadratic functions. Growth rate of E-o,E-diff with increasing wavelength was fitted with a linear function. E-o,E-dir distributions were fitted with linear or quadratic functions in different SEA ranges. All E-o,E-refl and E-o,E-diff distributions were fitted with quadratic functions. As SEA increased, the E-o,E-dir portion of E-o increased and then decreased; the E-o,E-refl portion increased from an initial minimum; and the E-o,E-diff portion first decreased and then increased. The findings may provide data supporting on construction of a mathematical model of ocular UV exposure.	[Yu, Jiaming] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Liaoning, Peoples R China; [Hua, Hui; Liu, Yang] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Liu, Yan] China Med Univ, Dept Biomed Engn, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, Y (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China.	yangliu@cmu.edu.cn			National Natural Science Foundation of China [81273034]; Natural Science Foundation of Liaoning Province, China [2014021009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province)	This work was supported by the National Natural Science Foundation of China, Grant NO:81273034 (https:/isisn.nsfc.gov.cn/egrantindextfuncindex/prisearch-list) to YL and the Natural Science Foundation of Liaoning Province, China, Grant No: 2014021009 (http://kjjh.ininfo.gov.cn/) to JMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baczynska KA, 2013, RADIAT PROT DOSIM, V154, P497, DOI 10.1093/rpd/ncs261; Boulton M, 2001, J PHOTOCH PHOTOBIO B, V64, P144, DOI 10.1016/S1011-1344(01)00227-5; Cullen AP, 2002, INT J TOXICOL, V21, P455, DOI 10.1080/10915810290169882; Fleming DP, 2006, RADIAT PROT DOSIM, V118, P265, DOI 10.1093/rpd/nci346; Gao N, 2012, PHOTOCHEM PHOTOBIOL, V88, P736, DOI 10.1111/j.1751-1097.2012.01094.x; GARRISON LM, 1978, APPL OPTICS, V17, P827, DOI 10.1364/AO.17.000827; Hoeppe P, 2004, INT J BIOMETEOROL, V49, P18, DOI 10.1007/s00484-004-0211-9; Hu LW, 2014, PHOTOCHEM PHOTOBIOL, V90, P925, DOI 10.1111/php.12267; Hu LW, 2013, J OCCUP ENVIRON HYG, V10, P17, DOI 10.1080/15459624.2012.737700; Kim J, 2013, J PHOTOCH PHOTOBIO B, V119, P46, DOI 10.1016/j.jphotobiol.2012.11.007; Kimlin MG, 2003, PHOTOCH PHOTOBIO SCI, V2, P365, DOI 10.1039/b207953d; Liou JC, 2015, MOL VIS, V21; Liu GC, 2014, J PHOTOCH PHOTOBIO B, V141, P106, DOI 10.1016/j.jphotobiol.2014.09.009; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Newkirk KM, 2007, TOXICOL PATHOL, V35, P817, DOI 10.1080/01926230701584197; Oppenrieder A, 2004, J PHOTOCH PHOTOBIO B, V74, P85, DOI 10.1016/j.jphotobiol.2003.11.008; Parisi AV, 2003, J PHOTOCH PHOTOBIO B, V69, P1, DOI 10.1016/S1011-1344(02)00385-8; Pope SJ, 2010, PHOTOCHEM PHOTOBIOL, V86, P457, DOI 10.1111/j.1751-1097.2009.00679.x; Roberts JE, 2001, J PHOTOCH PHOTOBIO B, V64, P136, DOI 10.1016/S1011-1344(01)00196-8; ROSENTHAL FS, 1988, INVEST OPHTH VIS SCI, V29, P649; Serrano D, 2010, TETHYS-J MEDITERR ME, P57, DOI 10.3369/tethys.2010.7.05; Streicher JJ, 2004, PHOTOCHEM PHOTOBIOL, V79, P40, DOI 10.1562/0031-8655(2004)79&lt;40:MTADOS&gt;2.0.CO;2; Sydenham MM, 1997, INVEST OPHTH VIS SCI, V38, P1485; Turner J, 2008, J PHOTOCH PHOTOBIO B, V92, P29, DOI 10.1016/j.jphotobiol.2008.03.006; Turner J, 2009, PHOTOCH PHOTOBIO SCI, V8, P62, DOI 10.1039/b814006e; Vernez D, 2012, BRIT J DERMATOL, V167, P383, DOI 10.1111/j.1365-2133.2012.10898.x; Vernez D, 2011, PHOTOCHEM PHOTOBIOL, V87, P721, DOI 10.1111/j.1751-1097.2011.00895.x; Wang F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050177, 10.1371/journal.pone.0052259]; Weihs P, 2002, INT J BIOMETEOROL, V46, P95, DOI 10.1007/s00484-002-0124-4; Weihs P, 2013, PHOTOCHEM PHOTOBIOL, V89, P1004, DOI 10.1111/php.12085	30	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166729	10.1371/journal.pone.0166729	http://dx.doi.org/10.1371/journal.pone.0166729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846278	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600103
J	Ahmed, A; Haider, SH; Parveen, S; Arshad, M; Alsenaidy, HA; Baaboud, AO; Mobaireek, KF; AlSaadi, MM; Alsenaidy, AM; Sullender, W				Ahmed, Anwar; Haider, Shakir H.; Parveen, Shama; Arshad, Mohammed; Alsenaidy, Hytham A.; Baaboud, Alawi Omar; Mobaireek, Khalid Fahad; AlSaadi, Muslim Mohammed; Alsenaidy, Abdulrahman M.; Sullender, Wayne			Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; G-PROTEIN GENE; MOLECULAR EPIDEMIOLOGY; GENOTYPE ON1; 60-NUCLEOTIDE DUPLICATION; PHYLOGENETIC ANALYSIS; NOSOCOMIAL OUTBREAK; CONSECUTIVE SEASONS; RAPID REPLACEMENT; TRACT INFECTION	Respiratory syncytial virus (RSV) is an important viral pathogen of acute respiratory tract infection (ARI). Limited data are available on molecular epidemiology of RSV from Saudi Arabia. A total of 130 nasopharyngeal aspirates were collected from children less than 5 years of age with ARI symptoms attending the Emergency Department at King Khalid University Hospital and King Fahad Medical City, Riyadh, Saudi Arabia between October and December, 2014. RSV was identified in the 26% of the hospitalized children by reverse transcriptase PCR. Group A RSV (77%) predominated during the study as compared to group B RSV (23%). The phylogenetic analysis of 28 study strains clustered group A RSV in NA1 and ON1 genotypes and group B viruses in BA (BA9) genotype. Interestingly, 26% of the positive samples clustered in genotypes with duplication in the G protein gene (ON1 for group A and BA for group B). Both the genotypes showed enhanced O-linked glycosylation in the duplicated region, with 10 and 2 additional sites in ON1 and BA respectively. Selection pressure analysis revealed purifying selection in both the ON1 and BA genotypes. One codon each in the ON1 (position 274) and BA genotypes (position 219) were positively selected and had high entropy values indicating variations at these amino acid positions. This is the first report describing the presence of ON1 genotype and the first report on co-circulation of two different genotypes of RSV with duplication in the G protein gene from Saudi Arabia. The clinical implications of the simultaneous occurrence of genotypes with duplication in G protein gene in a given population especially in the concurrent infections should be investigated in future. Further, the ongoing surveillance of RSV in this region will reveal the evolutionary trajectory of these two genotypes with duplication in G protein gene from largest country in the Middle East.	[Ahmed, Anwar; Arshad, Mohammed; Alsenaidy, Abdulrahman M.] King Saud Univ, Dept Biochem, Coll Sci, Prot Res Chair, Riyadh, Saudi Arabia; [Ahmed, Anwar] King Saud Univ, Dept Biochem, Coll Sci, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia; [Haider, Shakir H.; Parveen, Shama] Jamia Millie Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Alsenaidy, Hytham A.] Shaqra Univ, Coll Med, Shaqra, Saudi Arabia; [Baaboud, Alawi Omar; Mobaireek, Khalid Fahad] King Fahad Med City, Pediat Emergency Dept, Childrens Hosp, King, WI USA; [AlSaadi, Muslim Mohammed] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Coll Med, Riyadh, Saudi Arabia; [Sullender, Wayne] Colorado Sch Publ Hlth, Sch Med, Ctr Global Hlth, Aurora, CO USA	King Saud University; King Saud University; Jamia Millia Islamia; Shaqra University; Children's Hospital of Wisconsin; King Saud University; King Khalid University Hospital; Colorado School of Public Health	Ahmed, A (corresponding author), King Saud Univ, Dept Biochem, Coll Sci, Prot Res Chair, Riyadh, Saudi Arabia.; Ahmed, A (corresponding author), King Saud Univ, Dept Biochem, Coll Sci, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia.	anahmed@ksu.edu.sa	Ahmed, Anwar/AAL-7789-2021; Ahmed, Anwar/ADH-1445-2022	Ahmed, Anwar/0000-0001-8147-714X	National Plan for Science, Technology and Innovation (MAARIFA), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [12MED-2886-02]	National Plan for Science, Technology and Innovation (MAARIFA), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	The project was funded by the National Plan for Science, Technology and Innovation (MAARIFA), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, URL: http//maanfah.kacst.edu.sa/NSTIPWCPortal/faces/NSTIPHomePage; Award Number 12MED-2886-02, to AA.	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Agoti CN, 2013, INFLUENZA OTHER RESP, V7, P1008, DOI 10.1111/irv.12131; Agrawal AS, 2009, J CLIN VIROL, V45, P358, DOI 10.1016/j.jcv.2009.05.013; Akhter J., 2009, Saudi Pharmaceutical Journal, V17, P177; Al-Ayed MS, 2014, SAUDI MED J, V35, P1348; Al-Hajjar S, 1998, ANN TROP PAEDIATR, V18, P87, DOI 10.1080/02724936.1998.11747933; Al-Majhdi F. N., 2009, International Journal of Virology, V5, P154, DOI 10.3923/ijv.2009.154.163; Al-Shehri Mohammed A, 2005, West Afr J Med, V24, P299; Almajhdi FN, 2014, VIRUS GENES, V48, P252, DOI 10.1007/s11262-013-1030-z; Almajhdi FN, 2014, ARCH VIROL, V159, P73, DOI 10.1007/s00705-013-1792-6; Amer HM, 2015, J MED VIROL; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Avadhanula V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/infdis/jiu473; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Bakir TMF, 1998, J TROP PEDIATRICS, V44, P100, DOI 10.1093/tropej/44.2.100; Balmaks R, 2014, J MED VIROL, V86, P1971, DOI 10.1002/jmv.23855; Ramirez JB, 2014, REV PANAM SALUD PUBL, V36, P101; Bose ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120098; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Choudhary ML, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00165-13; Cui Bin, 2013, Zhongguo Xuexichongbing Fangzhi Zazhi, V25, P598; Cui GL, 2015, INFECT GENET EVOL, V33, P163, DOI 10.1016/j.meegid.2015.04.025; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; De-Paris F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-36; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Esposito S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129369; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; Gimferrer L, 2015, J CLIN VIROL, V66, P27, DOI 10.1016/j.jcv.2015.02.018; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; JAMJOOM GA, 1993, J TROP PEDIATRICS, V39, P346, DOI 10.1093/tropej/39.6.346; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Kouni S, 2013, CLIN MICROBIOL INFEC, V19, P772, DOI 10.1111/1469-0691.12015; Lee WJ, 2012, J VIROL, V86, P13810, DOI 10.1128/JVI.02571-12; Malasao R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142192; Martinez-Roig A, 2015, ARCH BRONCONEUMOL, V51, P5, DOI 10.1016/j.arbres.2014.01.018; Meqdam MM, 2006, FEMS IMMUNOL MED MIC, V47, P129, DOI 10.1111/j.1574-695X.2006.00073.x; Nagai K, 2004, J MED VIROL, V74, P161, DOI 10.1002/jmv.20160; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Parveen S, 2006, J MED VIROL, V78, P659, DOI 10.1002/jmv.20590; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Pierangeli A, 2014, EURO SURVEILL, V19; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Raghuram V. L. N. S., 2015, VirusDisease, V26, P276, DOI 10.1007/s13337-015-0283-7; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; Roca A, 2001, J GEN VIROL, V82, P103, DOI 10.1099/0022-1317-82-1-103; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shier MK, 2005, MINOUFIA MED J, V18, P11; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Taha MK, 2013, EMERG INFECT DIS, V19, P1030, DOI 10.3201/eid1906.120515; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; Viegas M, 2005, J MED VIROL, V77, P302, DOI 10.1002/jmv.20457; Visser A, 2008, J MED VIROL, V80, P724, DOI 10.1002/jmv.21128; Who, 2005, WHOFCHCAH0012; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Yu X., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1016/J.JCV.2015.05.015; Zhang Y, 2007, ARCH VIROL, V152, P1425, DOI 10.1007/s00705-007-0984-3; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	77	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166145	10.1371/journal.pone.0166145	http://dx.doi.org/10.1371/journal.pone.0166145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835664	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200028
J	Holmbom, M; Giske, CG; Fredrikson, M; Balkhed, AO; Claesson, C; Nilsson, LE; Hoffmann, M; Hanberger, H				Holmbom, Martin; Giske, Christian G.; Fredrikson, Mats; Balkhed, Ase Ostholm; Claesson, Carina; Nilsson, Lennart E.; Hoffmann, Mikael; Hanberger, Hakan			14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality	PLOS ONE			English	Article							SEVERE SEPSIS; SECULAR TRENDS; HEALTH-CARE; BURDEN; BACTEREMIA; PATHOGENS	Objectives we assessed the incidence, risk factors and outcome of BSI over a 14-year period (2000-2013) in a Swedish county. Methods retrospective cohort study on culture confirmed BSI among patients in the county ofO E stergo E tland, Sweden, with approximately 440,000 inhabitants. A BSI was defined as either community-onset BSI (CO-BSI) or hospital-acquired BSI (HA-BSI). Results of a total of 11,480 BSIs, 67% were CO-BSI and 33% HA-BSI. The incidence of BSI increased by 64% from 945 to 1,546 per 100,000 hospital admissions per year during the study period. The most prominent increase, 83% was observed within the CO-BSI cohort whilst HA-BSI increased by 32%. Prescriptions of antibiotics in outpatient care decreased with 24% from 422 to 322 prescriptions dispensed/1,000 inhabitants/year, whereas antibiotics prescribed in hospital increased by 67% (from 424 to 709 DDD per 1,000 days of care). The overall 30-day mortality for HA-BSIs was 17.2%, compared to 10.6% for CO-BSIs, with an average yearly increase per 100,000 hospital admissions of 2 and 5% respectively. The proportion of patients with one or more comorbidities, increased from 20.8 to 55.3%. In multivariate analyses, risk factors for mortality within 30 days were: HA-BSI (2.22); two or more comorbidities (1.89); single comorbidity (1.56); CO-BSI (1.21); male (1.05); and high age (1.04). Conclusion this survey revealed an alarming increase in the incidence of BSI over the 14-year study period. Interventions to decrease BSI in general should be considered together with robust antibiotic stewardship programmes to avoid both over-and underuse of antibiotics.	[Holmbom, Martin; Balkhed, Ase Ostholm; Hanberger, Hakan] Linkoping Univ, Div Infect Dis, Dept Clin & Expt Med, Fac Med & Hlth Sci, Linkoping, Sweden; [Holmbom, Martin] Linkoping Univ, Dept Urol, Linkoping, Sweden; [Holmbom, Martin] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Giske, Christian G.] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Giske, Christian G.] Karolinska Univ Hosp, Clin Microbiol, Stockholm, Sweden; [Fredrikson, Mats] Linkoping Univ, Fac Med & Hlth Sci, Dept Clin & Expt Med, Occupat & Environm Med, Linkoping, Sweden; [Fredrikson, Mats] Linkoping Univ, Fac Med & Hlth Sci, Forum Ostergotland, Linkoping, Sweden; [Claesson, Carina; Nilsson, Lennart E.] Linkoping Univ, Fac Med & Hlth Sci, Dept Clin & Expt Med, Div Clin Microbiol, Linkoping, Sweden; [Hoffmann, Mikael] Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, NEPI Fdn,Div Hlth Care Anal, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Hanberger, H (corresponding author), Linkoping Univ, Div Infect Dis, Dept Clin & Expt Med, Fac Med & Hlth Sci, Linkoping, Sweden.	hakan.hanberger@liu.se			Ostergotland County Council (Hakan Hanberger ALF)	Ostergotland County Council (Hakan Hanberger ALF)	This work was supported by Ostergotland County Council (Hakan Hanberger ALF).	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; AL-Rawajfah OM, 2009, INFECT CONT HOSP EP, V30, P1036, DOI 10.1086/606167; Ammerlaan HSM, 2013, CLIN INFECT DIS, V56, P798, DOI 10.1093/cid/cis1006; Damiani E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125827; Deen J, 2012, LANCET INFECT DIS, V12, P480, DOI 10.1016/S1473-3099(12)70028-2; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; ECDC ECfDPaC, 2013, SURV REP POINT PREV; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Gupta RG, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1011-9; Hanberger H, 2014, UPSALA J MED SCI, V119, P154, DOI 10.3109/03009734.2014.909911; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Kaye KS, 2014, J AM GERIATR SOC, V62, P306, DOI 10.1111/jgs.12634; Madsen KM, 1999, APMIS, V107, P346, DOI 10.1111/j.1699-0463.1999.tb01563.x; Martin GS, 2012, EXPERT REV ANTI-INFE, V10, P701, DOI [10.1586/ERI.12.50, 10.1586/eri.12.50]; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mellhammar L C B, 2015, OXFORD J, DOI [10.1093/ofid/ofv161, DOI 10.1093/OFID/OFV161]; Neumark T, 2010, SCAND J INFECT DIS, V42, P90, DOI 10.3109/00365540903352932; Neumark T, 2009, SCAND J PRIM HEALTH, V27, P18, DOI 10.1080/02813430802610784; Nielsen SL, 2016, AM J INFECT CONTROL, V44, P167, DOI 10.1016/j.ajic.2015.09.011; Pittet D, 1997, P ASSOC AM PHYSICIAN, V109, P58; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rodriguez-Bano J, 2010, CLIN MICROBIOL INFEC, V16, P1408, DOI [10.1111/j.1469-0691.2010.03089.x, 10.1111/j.1469-0691.2009.03089.x]; Rodriguez-Creixems M, 2008, MEDICINE, V87, P234, DOI 10.1097/MD.0b013e318182119b; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; SJOBERG L, 1988, EUR J CLIN MICROBIOL, V7, P501; Skogberg K, 2008, EPIDEMIOL INFECT, V136, P108, DOI 10.1017/S0950268807008138; Skogberg K, 2012, CLIN MICROBIOL INFEC, V18, pE170, DOI 10.1111/j.1469-0691.2012.03845.x; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; SWEDRES, 2014, REP SWED ANT UT RES; Tsertsvadze A, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0103-6; Uslan DZ, 2007, ARCH INTERN MED, V167, P834, DOI 10.1001/archinte.167.8.834; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vrijens F, 2010, J HOSP INFECT, V75, P158, DOI 10.1016/j.jhin.2009.12.006; Wilson J, 2011, CLIN MICROBIOL INFEC, V17, P451, DOI 10.1111/j.1469-0691.2010.03262.x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	37	29	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166527	10.1371/journal.pone.0166527	http://dx.doi.org/10.1371/journal.pone.0166527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835663	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200055
J	Milazzo, A; Mnatzaganian, G; Elshaug, AG; Hemphill, SA; Hiller, JE				Milazzo, Adriana; Mnatzaganian, George; Elshaug, Adam G.; Hemphill, Sheryl A.; Hiller, Janet E.		Astute Hlth Study Grp	Depression and Anxiety Outcomes Associated with Failed Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							IN-VITRO FERTILIZATION; QUALITY-OF-LIFE; FOLLOW-UP; INVITRO FERTILIZATION; EMOTIONAL ADJUSTMENT; PSYCHOSOCIAL FACTORS; FERTILITY TREATMENT; COPING STRATEGIES; INFERTILE WOMEN; IVF TREATMENT	Objective Our study examined the psychological outcomes associated with failed ART treatment outcomes in men and women. Search Strategy A systematic search for studies published between January 1980 and August 2015 was performed across seven electronic databases. Inclusion Criteria Studies were included if they contained data on psychosocial outcomes taken pre and post ART treatment. Data Extraction and Synthesis A standardised form was used to extract data and was verified by two independent reviewers. Studies were meta-analysed to determine the association of depression and anxiety with ART treatment outcomes. Narrative synthesis identified factors to explain variations in the size and directions of effects and relationships explored within and between the studies. Main Results Both depression and anxiety increased after a ART treatment failure with an overall pooled standardised mean difference (SMD) of 0.41 (95% CI: 0.27, 0.55) for depression and 0.21 (95% CI: 0.13, 0.29) for anxiety. In contrast, depression decreased after a successful treatment, SMD of -0.24 ( 95% CI: -0.37,-0.11). Both depression and anxiety decreased as time passed from ART procedure. Nonetheless, these remained higher than baseline measures in the group with the failed outcome even six months after the procedure. Studies included in the narrative synthesis also confirmed an association with negative psychological outcomes in relation to marital satisfaction and general well-being following treatment failure. Conclusion Linking ART failure and psychosocial outcomes may elucidate the experience of treatment subgroups, influence deliberations around recommendations for resource allocation and health policy and guide patient and clinician decision making.	[Milazzo, Adriana; Hiller, Janet E.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Mnatzaganian, George] La Trobe Univ, Coll Sci Hlth & Engn, La Trobe Rural Hlth Sch, Bundoora, Vic, Australia; [Elshaug, Adam G.] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Hemphill, Sheryl A.] Australian Catholic Univ, Fac Educ & Arts, Learning Sci Inst Australia, Melbourne, Vic, Australia; [Hemphill, Sheryl A.] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia; [Hiller, Janet E.] Swinburne Univ Technol, Sch Hlth Sci, Melbourne, Vic, Australia	University of Adelaide; La Trobe University; University of Sydney; Australian Catholic University; Australian Catholic University; Swinburne University of Technology	Hiller, JE (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.; Hiller, JE (corresponding author), Swinburne Univ Technol, Sch Hlth Sci, Melbourne, Vic, Australia.	jhiller@swin.edu.au	Hiller, Janet E./A-5633-2008; Milazzo, Adriana/D-9608-2013; Mnatzaganian, George/AAF-7753-2021	Hiller, Janet E./0000-0002-8532-4033; Mnatzaganian, George/0000-0002-7698-5091; Elshaug, Adam/0000-0002-4939-5379				Alesi Rita, 2005, Aust Fam Physician, V34, P135; BEAUREPAIRE J, 1994, J PSYCHOSOM RES, V38, P229, DOI 10.1016/0022-3999(94)90118-X; Bell K, 2006, AUSTR J EMERGING TEC, V4, P15; BERG BJ, 1991, J BEHAV MED, V14, P11, DOI 10.1007/BF00844765; Beutel M, 1999, ANDROLOGIA, V31, P27, DOI 10.1046/j.1439-0272.1999.00231.x; BLACK RB, 1992, SOC WORK HEALTH CARE, V17, P1, DOI 10.1300/J010v17n03_01; Borneskog C, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0154-1; Brandes M, 2009, HUM REPROD, V24, P3127, DOI 10.1093/humrep/dep340; Bryant J., 2004, ASSISTED REPROD TECH; Bryson Caroline A., 2000, Hum Fertil (Camb), V3, P214, DOI 10.1080/1464727002000199011; Carter D, 2013, J BIOETHIC INQ, V10, P79, DOI 10.1007/s11673-012-9415-6; Chochovski J, 2013, J PSYCHOSOM OBST GYN, V34, P122, DOI 10.3109/0167482X.2013.829034; Cooper H, 2009, HDB RES SYNTHESIS ME; Daniluk JC, 2007, J COUNS DEV, V85, P89, DOI 10.1002/j.1556-6678.2007.tb00448.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunson DB, 2004, OBSTET GYNECOL, V103, P51, DOI 10.1097/01.AOG.0000100153.24061.45; Dyer S, 2006, ASSISTED REPROD TECH; Dyer S, 2008, HUM REPROD, V23, P352, DOI 10.1093/humrep/dem279; Fathalla M.F., 2002, CURRENT PRACTICES CO; FREEMAN EW, 1987, ACTA OBSTET GYN SCAN, V66, P517, DOI 10.3109/00016348709015727; Greil AL, 2011, SOC SCI MED, V73, P87, DOI 10.1016/j.socscimed.2011.04.023; Harata T., 2012, Reproductive Medicine and Biology, V11, P143, DOI 10.1007/s12522-012-0124-y; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hodgetts K, 2012, SOC SCI MED, V75, P2191, DOI 10.1016/j.socscimed.2012.08.016; Holter H, 2006, HUM REPROD, V21, P3295, DOI 10.1093/humrep/del288; HYNES GJ, 1992, BRIT J MED PSYCHOL, V65, P269, DOI 10.1111/j.2044-8341.1992.tb01707.x; Johansson M, 2010, ACTA OBSTET GYN SCAN, V89, P683, DOI 10.3109/00016341003657892; Johansson M, 2009, ACTA OBSTET GYN SCAN, V88, P291, DOI 10.1080/00016340802705956; Karlidere T, 2008, ISR J PSYCHIATR REL, V45, P55; Kovacs GT, 2012, AUST NZ J OBSTET GYN, V52, P302, DOI 10.1111/j.1479-828X.2012.01444.x; Kovacs GT, 2003, MED J AUSTRALIA, V179, P536, DOI 10.5694/j.1326-5377.2003.tb05680.x; Lee SH, 2010, SCAND J CARING SCI, V24, P507, DOI 10.1111/j.1471-6712.2009.00742.x; Leeton J, 2004, AUST NZ J OBSTET GYN, V44, P495, DOI 10.1111/j.1479-828X.2004.00305.x; LEIBLUM SR, 1987, J PSYCHOSOM OBST GYN, V6, P165, DOI 10.3109/01674828709019420; Lok IH, 2002, GYNECOL OBSTET INVES, V53, P195, DOI 10.1159/000064560; Luke B, 2012, NEW ENGL J MED, V366, P2483, DOI 10.1056/NEJMoa1110238; Macaldowie A, 2014, ASSISTED REPROD TECH; Maheshwari A, 2008, HUM REPROD, V23, P538, DOI 10.1093/humrep/dem431; Mansour R, 2014, HUM REPROD, V29, P1536, DOI 10.1093/humrep/deu084; Matsubayashi Hidehiko, 2003, Tokai J Exp Clin Med, V28, P9; Merlin T, 2013, INT J TECHNOL ASSESS, V29, P343, DOI 10.1017/S0266462313000287; NEWTON CR, 1990, FERTIL STERIL, V54, P879; Olkin, 1985, STAT MODELS METAANAL; Peronace LA, 2007, J PSYCHOSOM OBST GYN, V28, P105, DOI 10.1080/01674820701410049; Peterson BD, 2009, HUM REPROD, V24, P1656, DOI 10.1093/humrep/dep061; Peterson BD, 2011, FERTIL STERIL, V95, P1759, DOI 10.1016/j.fertnstert.2011.01.125; Rockliff HE, 2014, HUM REPROD UPDATE, V20, P594, DOI 10.1093/humupd/dmu010; Rodgers M., 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643; Rothstein HR, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P1, DOI 10.1002/0470870168; Sina M, 2010, J PSYCHOSOM OBST GYN, V31, P158, DOI 10.3109/0167482X.2010.487952; Slade P, 1997, HUM REPROD, V12, P183, DOI 10.1093/humrep/12.1.183; Spielberger CD, 2003, IJCHP, V3, P209; Stanton AL, 2013, INFERTILITY PERSPECT; Street JM, 2011, INT J TECHNOL ASSESS, V27, P376, DOI 10.1017/S026646231100033X; Su TJ, 2011, J CLIN NURS, V20, P2217, DOI 10.1111/j.1365-2702.2011.03730.x; Sullivan EA, 2013, HUM REPROD, V28, P1375, DOI 10.1093/humrep/det036; Sydsjo G, 2005, HUM REPROD, V20, P1952, DOI 10.1093/humrep/deh882; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Vassard D, 2012, HUM REPROD, V27, P3502, DOI 10.1093/humrep/des353; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Verhaak CM, 2007, HUM REPROD, V22, P305, DOI 10.1093/humrep/del355; Verhaak CM, 2005, J BEHAV MED, V28, P181, DOI 10.1007/s10865-005-3667-0; Verhaak CM, 2001, FERTIL STERIL, V76, P525, DOI 10.1016/S0015-0282(01)01931-8; VISSER AP, 1994, J PSYCHOSOM OBST GYN, V15, P35, DOI 10.3109/01674829409025627; Watt AM, 2011, HEALTH POLICY, V102, P200, DOI 10.1016/j.healthpol.2011.07.007	65	32	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165805	10.1371/journal.pone.0165805	http://dx.doi.org/10.1371/journal.pone.0165805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835654	Green Published, gold			2022-12-27	WOS:000387779200013
J	Tsitoura, MEI; Stavrou, EF; Maraziotis, LA; Sarafidis, K; Athanassiadou, A; Dimitriou, G				Tsitoura, Maria-Eleni I.; Stavrou, Eleana F.; Maraziotis, Loannis A.; Sarafidis, Kosmas; Athanassiadou, Aglaia; Dimitriou, Gabriel			Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates	PLOS ONE			English	Article							ASSOCIATION; VARIANTS; DISEQUILIBRIUM; POPULATION; MORBIDITY; INFANTS; LOCUS	Background and Objectives Newborns delivered late-preterm (between 34(0/7) and 36(6/7) weeks of gestation) are at increased risk of respiratory distress syndrome (RDS). Polymorphisms within the surfactant protein (SP) A and B gene have been shown to predispose to RDS in preterm neonates. The aim of this study was to investigate whether specific SP-A and/or SP-B genetic variants are also associated with RDS in infants born late-preterm. Methods This prospective cross-sectional study included 56 late-preterm infants with and 60 without RDS. Specific SP-A1/SP-A2 haplotypes and SP-B Ile131Thr polymorphic alleles were determined in blood specimens using polymerase-chain-reaction and DNA sequencing. Results The SP-A1 6A(4) and the SP-A2 1A(5) haplotypes were significantly overrepresented in new-borns with RDS compared to controls (OR 2.86, 95% CI 1.20-6.83 and OR 4.68, 95% CI 1.28-17.1, respectively). The distribution of the SP-B Ile131Thr genotypes was similar between the two late-preterm groups. Overall, the SP-A1 6A(4) or/and SP-A2 1A(5) haplotype was present in 20 newborns with RDS (35.7%), resulting in a 4.2-fold (1.60-11.0) higher probability of RDS in carriers. Multivariable regression analysis revealed that the effect of SP-A1 6A(4) and SP-A2 1A(5) haplotypes was preserved when adjusting for known risk or protective factors, such as male gender, smaller gestational age, smaller weight, complications of pregnancy, and administration of antenatal corticosteroids. Conclusions Specific SP-A genetic variants may influence the susceptibility to RDS in late-preterm infants, independently of the effect of other perinatal factors.	[Tsitoura, Maria-Eleni I.; Maraziotis, Loannis A.; Dimitriou, Gabriel] Univ Patras, Dept Pediat, Neonatal Intens Care Unit, Fac Med, Patras, Greece; [Tsitoura, Maria-Eleni I.; Stavrou, Eleana F.; Athanassiadou, Aglaia] Univ Patras, Dept Gen Biol, Fac Med, Patras, Greece; [Sarafidis, Kosmas] Aristotle Univ Thessaloniki, Ippokrat Gen Hosp, Dept Neonatol 1, Thessaloniki, Greece	University of Patras; University of Patras; Aristotle University of Thessaloniki	Dimitriou, G (corresponding author), Univ Patras, Dept Pediat, Neonatal Intens Care Unit, Fac Med, Patras, Greece.	gdimitriou@med.upatras.gr	Dimitriou, Gabriel/AAJ-1946-2020; Sarafidis, Kosmas/R-1266-2019	Sarafidis, Kosmas/0000-0002-6806-6343	European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	European Union (European Social Fund ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	This research has been co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund.	Altman M, 2013, PAEDIATR PERINAT EP, V27, P172, DOI 10.1111/ppe.12035; Ariki S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/532071; DiAngelo S, 1999, DIS MARKERS, V15, P269, DOI 10.1155/1999/961430; Dimitriou G, 2010, EARLY HUM DEV, V86, P587, DOI 10.1016/j.earlhumdev.2010.07.011; Dudell GG, 2006, CLIN PERINATOL, V33, P803, DOI 10.1016/j.clp.2006.09.006; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Floros J, 2001, PEDIATR INT, V43, P567, DOI 10.1046/j.1442-200X.2001.01474.x; Floros J, 2001, CLIN GENET, V60, P178, DOI 10.1034/j.1399-0004.2001.600303.x; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; Haataja R, 2000, HUM MOL GENET, V9, P2751, DOI 10.1093/hmg/9.18.2751; Hawgood S, 2004, BIOL NEONATE, V85, P285, DOI 10.1159/000078169; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hoover RR, 1999, AM J PHYSIOL-LUNG C, V276, pL917, DOI 10.1152/ajplung.1999.276.6.L917; Hoover RR, 1998, AM J RESP CELL MOL, V18, P353, DOI 10.1165/ajrcmb.18.3.3035; Jo HS, 2013, NEONATOLOGY, V103, P44, DOI 10.1159/000342498; KARINCH AM, 1995, AM J RESP CELL MOL, V12, P77, DOI 10.1165/ajrcmb.12.1.7811473; Liu WL, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-13; Marttila R, 2003, AM J RESP CRIT CARE, V168, P1216, DOI 10.1164/rccm.200304-524OC; Marttila R, 2003, HUM GENET, V112, P18, DOI 10.1007/s00439-002-0835-y; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raju TNK, 2012, SEMIN FETAL NEONAT M, V17, P126, DOI 10.1016/j.siny.2012.01.010; Ramet M, 2000, AM J HUM GENET, V66, P1569, DOI 10.1086/302906; Ramet M, 2000, DIS MARKERS, V16, P119; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Silveyra P, 2012, FRONT BIOSCI-LANDMRK, V17, P407, DOI 10.2741/3935	27	7	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166516	10.1371/journal.pone.0166516	http://dx.doi.org/10.1371/journal.pone.0166516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835691	Green Submitted, Green Published, gold			2022-12-27	WOS:000387779200054
J	Baron, K; Neumayer, B; Amerstorfer, E; Scheurer, E; Diwoky, C; Stollberger, R; Sprenger, H; Weinberg, AM				Baron, Katharina; Neumayer, Bernhard; Amerstorfer, Eva; Scheurer, Eva; Diwoky, Clemens; Stollberger, Rudolf; Sprenger, Hanna; Weinberg, Annelie M.			Time-Dependent Changes in T1 during Fracture Healing in Juvenile Rats: A Quantitative MR Approach	PLOS ONE			English	Article							MUSCULOSKELETAL MRI; RELAXATION-TIMES; BONE; AGE	Quantitative magnetic resonance imaging (qMRI) offers several advantages in imaging and determination of soft tissue alterations when compared to qualitative imaging techniques. Although applications in brain and muscle tissues are well studied, its suitability to quantify relaxation times of intact and injured bone tissue, especially in children, is widely unknown. The objective observation of a fracture including its age determination can become of legal interest in cases of child abuse or maltreatment. Therefore, the aim of this study is the determination of time dependent changes in intact and corresponding injured bones in immature rats via qMRI, to provide the basis for an objective and radiation-free approach for fracture dating. Thirty-five MR scans of 7 Sprague-Dawley rats (male, 4 weeks old, 100 5 g) were acquired on a 3T MRI scanner (TimTrio, Siemens AG, Erlangen, Germany) after the surgical infliction of an epiphyseal fracture in the tibia. The images were taken at days 1, 3, 7, 14, 28, 42 and 82 post-surgery. A proton density-weighted and a T1-weighted 3D FLASH sequence were acquired to calculate the longitudinal relaxation time T1 of the fractured region and the surrounding tissues. The calculation of T1 in intact and injured bone resulted in a quantitative observation of bone development in intact juvenile tibiae as well as the bone healing process in the injured tibiae. In both areas, T1 decreased overtime. To evaluate the differences in T1 behaviour between the intact and injured bone, the relative T1 values (bone-fracture) were calculated, showing clear detectable alterations of T1 after fracture occurrence. These results indicate that qMRI has a high potential not only for clinically relevant applications to detect growth defects or developmental alterations in juvenile bones, but also for forensically relevant applications such as the dating of fractures in cases of child abuse or maltreatment.	[Baron, Katharina; Neumayer, Bernhard; Scheurer, Eva; Sprenger, Hanna] LBI CFI, Graz, Austria; [Amerstorfer, Eva] Med Univ Graz, Dept Paediat & Adolescent Surg, Graz, Austria; [Scheurer, Eva] Univ Basel, Hlth Dept Basel, Inst Forens Med, Basel, Switzerland; [Diwoky, Clemens] Graz Univ, Inst Mol Biosci, Graz, Austria; [Stollberger, Rudolf] Graz Univ Technol, Inst Med Engn, Graz, Austria; [Weinberg, Annelie M.] Med Univ Graz, Dept Orthoped & Orthoped Surg, Graz, Austria; [Baron, Katharina; Neumayer, Bernhard; Diwoky, Clemens; Stollberger, Rudolf; Sprenger, Hanna; Weinberg, Annelie M.] BioTechMed Graz, Graz, Austria	Medical University of Graz; University of Basel; University of Graz; Graz University of Technology; Medical University of Graz	Baron, K (corresponding author), LBI CFI, Graz, Austria.; Baron, K (corresponding author), BioTechMed Graz, Graz, Austria.	Katharina.Baron@cfi.lbg.ac.at	Stollberger, Rudolf/AAB-9957-2019; Scheurer, Eva/AAE-6161-2019	Scheurer, Eva/0000-0002-2742-0422; Neumayer, Bernhard/0000-0002-4439-4799; Stollberger, Rudolf/0000-0002-4969-3878	Austrian Science Fund FWF [F3209-18]; AO Research Fund of the AO Research Foundation [S-06-96W]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); AO Research Fund of the AO Research Foundation	This work was funded by the Austrian Science Fund FWF (SFB grant F3209-18, https://www.fwf.ac.at, with RS as Vice-Coordinator) and the AO Research Fund of the AO Research Foundation (project number S-06-96W, https://www.aofoundation.org, to AMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron K, 2016, FORENSIC SCI INT, V261, P61, DOI 10.1016/j.forsciint.2016.01.020; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Cheng S, 1994, BONE MINERAL DENSITY; del Rio Barquero L, 1992, Bone Miner, V18, P159; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fischerauer E, 2011, J MOL HISTOL, V42, P513, DOI 10.1007/s10735-011-9359-x; FUTAMURA Y, 1993, EXP ANIM TOKYO, V42, P643, DOI 10.1538/expanim1978.42.4_643; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; HITTMAIR K, 1994, MAGNET RESON MED, V31, P567, DOI 10.1002/mrm.1910310516; Jordan CD, 2013, EUR J RADIOL, V82, P734, DOI 10.1016/j.ejrad.2011.09.021; Kalfas I H, 2001, Neurosurg Focus, V10, pE1; Kruger K, 1999, ROFO-FORTSCHR RONTG, V170, P262; Lai PH, 1999, AM J ROENTGENOL, V172, P1109, DOI 10.2214/ajr.172.4.10587157; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Merwa R, 2009, P INT SOC MAG RESON, P4661; Morrow JM, 2014, EUR RADIOL, V24, P1610, DOI 10.1007/s00330-014-3145-6; Nunes JS, 2016, ATLAS HISTOLOGY JUVE, P29; Parker GA, 2016, ATLAS HISTOLOGY JUVE, pxi; Piney A, 1922, BRIT MED J, V1922, P792; Pountos I, 2012, SCI WORLD J, DOI 10.1100/2012/606404; Prosser I, 2005, AM J ROENTGENOL, V184, P1282, DOI 10.2214/ajr.184.4.01841282; Prosser I, 2012, AM J ROENTGENOL, V198, P1014, DOI 10.2214/AJR.11.6734; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schoenfeld BJ, 2012, SPORTS MED, V42, P1017, DOI 10.2165/11635190-000000000-00000; Silva JR, 2013, DIAGN INTERV RADIOL, V19, P393, DOI 10.5152/dir.2013.067; Snow-Harter C, 1991, Exerc Sport Sci Rev, V19, P351; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Taha MA, 2013, J MAGN RESON IMAGING, V38, P231, DOI 10.1002/jmri.23876; Wang DT, 2012, J AM OSTEOPATH COLL, V1, P2; Zollinger TJ, 2011, J AVIAN MED SURG, V25, P173, DOI 10.1647/2010-023.1	32	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0164284	10.1371/journal.pone.0164284	http://dx.doi.org/10.1371/journal.pone.0164284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832068	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000003
J	Benito, PJ; Alvarez-Sanchez, M; Diaz, V; Morencos, E; Peinado, AB; Cupeiro, R; Maffulli, N				Benito, Pedro J.; Alvarez-Sanchez, Maria; Diaz, Victor; Morencos, Esther; Peinado, Ana B.; Cupeiro, Rocio; Maffulli, Nicola		PRONAF Study Grp	Cardiovascular Fitness and Energy Expenditure Response during a Combined Aerobic and Circuit Weight Training Protocol	PLOS ONE			English	Article							RESISTANCE EXERCISE; PHYSIOLOGICAL-RESPONSES; OXYGEN-CONSUMPTION; METABOLIC SYSTEM; BENCH PRESS; ENDURANCE; STRENGTH; VALIDITY; RELIABILITY; VALIDATION	Objectives The present study describes the oxygen uptake and total energy expenditure (including both aerobic and anaerobic contribution) response during three different circuit weight training (CWT) protocols of equivalent duration composed of free weight exercises, machine exercises, and a combination of free weight exercises intercalating aerobic exercise. Design Controlled, randomized crossover designs. Methods Subjects completed in a randomized order three circuit weight training protocols of the same duration (3 sets of 8 exercises, 45min 15s) and intensity (70% of 15 repetitions maximum). The circuit protocols were composed of free weight exercises, machine exercises, or a combination of free weight exercises with aerobic exercise. Oxygen consumption and lactate concentration were measured throughout the circuit to estimate aerobic and anaerobic energy expenditure respectively. Results Energy expenditure is higher in the combined exercise protocol (29.9 +/- 3.6 ml/kg/min), compared with Freeweight (24.2 +/- 2.8ml/kg/min) and Machine (20.4 +/- 2.9ml/kg/min). The combined exercise protocol produced the highest total energy expenditure but the lowest lactate concentration and perceived exertion. The anaerobic contribution to total energy expenditure was higher in the machine and free weight protocols compared with the combined exercise protocol (6.2%, 4.6% and 2.3% respectively). Conclusions In the proposed protocols, the combined exercise protocol results in the highest oxygen consumption. Total energy expenditure is related to the type of exercise included in the circuit. Anaerobic contributions to total energy expenditure during circuit weight training may be modest, but lack of their estimation may underestimate total energy expenditure.	[Benito, Pedro J.; Diaz, Victor; Morencos, Esther; Peinado, Ana B.; Cupeiro, Rocio] Tech Univ Madrid, Fac Phys Act & Sport Sci, Dept Hlth & Human Performance, Madrid, Spain; [Alvarez-Sanchez, Maria; Diaz, Victor] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Alvarez-Sanchez, Maria; Diaz, Victor] Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Morencos, Esther] Francisco de Vitoria Univ, Exercise & Sport Sci, Madrid, Spain; [Maffulli, Nicola] Univ Salerno, Sch Med & Surg, Dept Musculoskeletal Disorders, Salerno, Italy; [Maffulli, Nicola] Queen Mary Univ London, Ctr Sport & Exercise Med, Mile End Hosp, 275 Bancroft Rd, London E1 4DG, England	Universidad Politecnica de Madrid; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universidad Francisco de Vitoria; University of Salerno; University of London; Queen Mary University London	Maffulli, N (corresponding author), Univ Salerno, Sch Med & Surg, Dept Musculoskeletal Disorders, Salerno, Italy.; Maffulli, N (corresponding author), Queen Mary Univ London, Ctr Sport & Exercise Med, Mile End Hosp, 275 Bancroft Rd, London E1 4DG, England.	n.maffulli@qmul.ac.uk	Sanchez, Maria/AGT-2170-2022; Loria-Kohen, Viviana/M-7824-2014; Peinado, Pedro Jose Benito/L-3531-2019; Benito, Pedro J/G-1653-2015; Cupeiro, Rocío/B-7817-2015; LOZANO, ANA B PEINADO/L-9316-2017; Maffulli, Nicola/A-1839-2014; PEINADO LOZANO, ANA BELÉN/DNL-8083-2022	Loria-Kohen, Viviana/0000-0001-8686-3306; Peinado, Pedro Jose Benito/0000-0002-1631-8182; Benito, Pedro J/0000-0002-1631-8182; Cupeiro, Rocío/0000-0002-4119-0002; LOZANO, ANA B PEINADO/0000-0002-4871-8682; Maffulli, Nicola/0000-0002-5327-3702; PEINADO LOZANO, ANA BELÉN/0000-0002-4871-8682; Sanchez-Elez, Marcos/0000-0003-1212-3158; Morencos, Esther/0000-0003-3971-7351; Gonzalez-Lamuno, Domingo/0000-0002-7578-241X	Ministerio de Ciencia e Innovacion, Convocatoria de Ayudas I+D, Proyectos de Investigacion Fundamental No Orientada, del VI Plan de Investigacion Nacional [DEP2008-06354-C04-01]	Ministerio de Ciencia e Innovacion, Convocatoria de Ayudas I+D, Proyectos de Investigacion Fundamental No Orientada, del VI Plan de Investigacion Nacional	This article is part of the PRONAF Study, with the financial support of the Ministerio de Ciencia e Innovacion, Convocatoria de Ayudas I+D 2008, Proyectos de Investigacion Fundamental No Orientada, del VI Plan de Investigacion Nacional 2008-2011, (Contrac: DEP2008-06354-C04-01).; This article is part of the PRONAF Study, with the financial support of the Ministerio de Ciencia e Innovacion, Convocatoria de Ayudas I+D 2008, Proyectos de Investigacion Fundamental No Orientada, del VI Plan de Investigacion Nacional 2008-2011, (Contrac: DEP2008-06354-C04-01).	Beckham SG, 2000, J SPORT MED PHYS FIT, V40, P118; Benito PJ, 2012, EUR J APPL PHYSIOL, V112, P3155, DOI 10.1007/s00421-011-2269-5; Benton MJ, 2009, EUR J SPORT SCI, V9, P213, DOI 10.1080/17461390902780429; Brazeau AS, 2011, APPL PHYSIOL NUTR ME, V36, P339, DOI [10.1139/H11-016, 10.1139/h11-016]; Carter J, 2002, EUR J APPL PHYSIOL, V86, P435, DOI 10.1007/s00421-001-0572-2; Davis WJ, 2008, J STRENGTH COND RES, V22, P1487, DOI 10.1519/JSC.0b013e3181739f08; Del Corral P, 2011, OBESITY, V19, P1177, DOI 10.1038/oby.2010.298; Diaz V, 2008, J SPORT SCI MED, V7, P532; Foss O, 2005, INT J SPORTS MED, V26, P569, DOI 10.1055/s-2004-821317; Haltom RW, 1999, MED SCI SPORT EXER, V31, P1613, DOI 10.1097/00005768-199911000-00018; Hamasaki H, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-27; Hunter GR, 2008, OBESITY, V16, P1045, DOI 10.1038/oby.2008.38; Hunter GR, 2010, OBESITY, V18, P690, DOI 10.1038/oby.2009.316; Hunter GR, 2003, J STRENGTH COND RES, V17, P76, DOI 10.1519/00124278-200302000-00013; Kaikkonen H, 2000, SCAND J MED SCI SPOR, V10, P211, DOI 10.1034/j.1600-0838.2000.010004211.x; Kang J, 2005, J STRENGTH COND RES, V19, P305, DOI 10.1519/00124278-200505000-00012; Knuttgen HG, 2007, J STRENGTH COND RES, V21, P973, DOI 10.1519/00124278-200708000-00053; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lagally KM, 2009, J STRENGTH COND RES, V23, P373, DOI 10.1519/JSC.0b013e31818eb1c9; Lander J, 1985, NSCA J, V6, P60; Melanson EL, 2002, MED SCI SPORT EXER, V34, P1793, DOI 10.1097/00005768-200211000-00016; Monteiro AG, 2008, J SPORT MED PHYS FIT, V48, P438; Mukaimoto T, 2012, J SPORT SCI, V30, P79, DOI 10.1080/02640414.2011.616950; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Ortego AR, 2009, J STRENGTH COND RES, V23, P932, DOI 10.1519/JSC.0b013e3181a07884; Peinado AB, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-17; Phillips WI, 2003, J STRENGTH COND RES, V17, P350; Poehlman ET, 2002, J CLIN ENDOCR METAB, V87, P1004, DOI 10.1210/jc.87.3.1004; Robergs RA, 2007, J STRENGTH COND RES, V21, P123, DOI 10.1519/00124278-200702000-00023; Rosdahl H, 2010, EUR J APPL PHYSIOL, V109, P159, DOI 10.1007/s00421-009-1326-9; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Sanal E, 2013, EUR J PHYS REHAB MED, V49, P1; SCALA D, 1987, J STRENGTH COND RES, V1, P48, DOI DOI 10.1519/00124278-198708000-00004; Scott CB, 2005, J SPORT SCI, V23, P15, DOI 10.1080/02640410410001716760; Scott CB, 2006, J STRENGTH COND RES, V20, P404; Scott CB, 2011, J STRENGTH COND RES, V25, P903, DOI 10.1519/JSC.0b013e3181c6a128; Scott CB, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-1; U.S. Department of Health and Human Services, 2008, OKLA NURSE, V53; Vezina JW, 2014, J STRENGTH COND RES, V28, P1026, DOI 10.1519/JSC.0000000000000375; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	41	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0164349	10.1371/journal.pone.0164349	http://dx.doi.org/10.1371/journal.pone.0164349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832062	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000387725000004
J	Vigoder, FM; Parker, DJ; Cook, N; Tourniere, O; Sneddon, T; Ritchie, MG				Vigoder, Felipe M.; Parker, Darren J.; Cook, Nicola; Tourniere, Oceane; Sneddon, Tanya; Ritchie, Michael G.			Inducing Cold-Sensitivity in the Frigophilic Fly Drosophila montana by RNAi	PLOS ONE			English	Article							THERMAL ADAPTATION; GENE-EXPRESSION; TOLERANCE; ACCLIMATION; TEMPERATURE; MYOINOSITOL; SELECTION; DRIVES; TOOLS; FLIES	Cold acclimation is a critical physiological adaptation for coping with seasonal cold. By increasing their cold tolerance individuals can remain active for longer at the onset of winter and can recover more quickly from a cold shock. In insects, despite many physiological studies, little is known about the genetic basis of cold acclimation. Recently, transcriptomic analyses in Drosophila virilis and D. montana revealed candidate genes for cold acclimation by identifying genes upregulated during exposure to cold. Here, we test the role of myo-inositol-1-phosphate synthase (Inos), in cold tolerance in D. montana using an RNAi approach. D. montana has a circumpolar distribution and overwinters as an adult in northern latitudes with extreme cold. We assessed cold tolerance of dsRNA knock-down flies using two metrics: chill-coma recovery time (CCRT) and mortality rate after cold acclimation. Injection of dsRNA/nos did not alter CCRT, either overall or in interaction with the cold treatment, however it did induced cold-specific mortality, with high levels of mortality observed in injected flies acclimated at 5 degrees C but not at 19 degrees C. Overall, injection with dsRNA/nos induced a temperature-sensitive mortality rate of over 60% in this normally cold-tolerant species. qPCR analysis confirmed that dsRNA injection successfully reduced gene expression of Inos. Thus, our results demonstrate the involvement of Inos in increasing cold tolerance in D. montana. The potential mechanisms involved by which Inos increases cold tolerance are also discussed.	[Vigoder, Felipe M.; Parker, Darren J.; Cook, Nicola; Tourniere, Oceane; Sneddon, Tanya; Ritchie, Michael G.] Univ St Andrews, Ctr Biol Divers, Sch Biol, St Andrews, Fife, Scotland; [Vigoder, Felipe M.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Parker, Darren J.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Tourniere, Oceane] Sars Int Ctr Marine Mol Biol, Bergen, Norway	University of St Andrews; Universidade Federal do Rio de Janeiro; University of Jyvaskyla	Vigoder, FM (corresponding author), Univ St Andrews, Ctr Biol Divers, Sch Biol, St Andrews, Fife, Scotland.; Vigoder, FM (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	fvigoder@gmail.com	Cook, Nicola/AGU-9057-2022; Ritchie, Michael G/F-7055-2013	Cook, Nicola/0000-0003-4462-0116; Ritchie, Michael G/0000-0001-7913-8675; Vigoder, Felipe/0000-0003-1037-8851; Parker, Darren James/0000-0003-4027-7779; Tourniere, Oceane/0000-0002-1125-7747	Natural Environment Research Council [NE/J020818/1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; CNPq; NERC Studentship; NERC [NE/J020818/1, NE/P000592/1] Funding Source: UKRI; Natural Environment Research Council [NE/P000592/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NERC Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council-NE/J020818/1 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Venera Tyukmaeva, Liam Dougherty, Emily Burdfield-Steel, Claire Stewart, Jade Green, Jonti Siva-Jothy and Lauren Halliwell for help with CCRT observations. We would also like to thank Dr. Rafaela Bruno for providing a plasmid containing a fragment of lacZ. The work was supported by CNPq (Fellowship to FMV) and a NERC Studentship to DJP. Maaria Kankare, Anneli Hoikkala and Paris Veltsos have contributed help and advice.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BLOCK W, 1983, POLAR BIOL, V2, P109, DOI 10.1007/BF00303176; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; Fassbinder-Orth CA, 2014, INTEGR COMP BIOL, V54, P396, DOI 10.1093/icb/icu023; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kostal V, 1996, CRYO-LETT, V17, P267; Kostal V, 2003, COMP BIOCHEM PHYS B, V135, P407, DOI 10.1016/S1096-4959(03)00117-9; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Overgaard J, 2008, LOW TEMPERATURE BIOL, P276; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; Parker DJ, 2015, HEREDITY, V115, P13, DOI 10.1038/hdy.2015.6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Port F, 2015, G3-GENES GENOM GENET, V5, P1493, DOI 10.1534/g3.115.019083; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Qvarnstrom A, 2016, EVOL APPL, V9, P119, DOI 10.1111/eva.12276; R Core Team, 2021, R LANGUAGE ENV STAT; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; Veltsos P, 2012, ECOL EVOL, V2, P80, DOI 10.1002/ece3.75; Vesala L, 2012, INSECT MOL BIOL, V21, P107, DOI 10.1111/j.1365-2583.2011.01119.x; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948	39	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165724	10.1371/journal.pone.0165724	http://dx.doi.org/10.1371/journal.pone.0165724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832122	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000030
J	Agnvall, B; Jensen, P				Agnvall, Beatrix; Jensen, Per			Effects of Divergent Selection for Fear of Humans on Behaviour in Red Junglefowl	PLOS ONE			English	Article							ANIMAL DOMESTICATION; FEATHER PECKING; GALLUS-GALLUS; ANTIPREDATOR BEHAVIOR; FORAGING STRATEGIES; CHICKENS; MODEL; FOWL; PIGS; EVOLUTION	Domestication has caused a range of similar phenotypic changes across taxa, relating to physiology, morphology and behaviour. It has been suggested that this recurring domesticated phenotype may be a result of correlated responses to a central trait, namely increased tameness. We selected Red Junglefowl, the ancestors of domesticated chickens, during five generations for reduced fear of humans. This caused a marked and significant response in tameness, and previous studies have found correlated effects on growth, metabolism, reproduction, and some behaviour not directly selected for. Here, we report the results from a series of behavioural tests carried out on the initial parental generation (P0) and the fifth selected generation (S5), focusing on behaviour not functionally related to tameness, in order to study any correlated effects. Birds were tested for fear of humans, social reinstatement tendency, open field behaviour at two different ages, foraging/exploration, response to a simulated aerial predator attack and tonic immobility. In S5, there were no effects of selection on foraging/ exploration or tonic immobility, while in the social reinstatement and open field tests there were significant interactions between selection and sex. In the aerial predator test, there were significant main effects of selection, indicating that fear of humans may represent a general wariness towards predators. In conclusion, we found only small correlated effects on behaviours not related to the tameness trait selected for, in spite of them showing high genetic correlations to fear of humans in a previous study on the same population. This suggests that species- specific behaviour is generally resilient to changes during domestication.	[Agnvall, Beatrix; Jensen, Per] Linkoping Univ, IFM Biol, Avian Behav Genom & Physiol Grp, SE-58183 Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, Avian Behav Genom & Physiol Grp, SE-58183 Linkoping, Sweden.	perje@ifm.liu.se			European Research Council [322206]; FORMAS [221-2007-838]; Vetenskapsradet [621-2008-5437]	European Research Council(European Research Council (ERC)European Commission); FORMAS(Swedish Research Council Formas); Vetenskapsradet(Swedish Research Council)	This work is supported by European Research Council 322206 http://erc.europa.eu, FORMAS 221-2007-838 http://www.formas.se/en/ Vetenskapsradet 621-2008-5437 http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agnvall B, 2014, ANIMAL, V8, P1498, DOI 10.1017/S1751731114001426; Agnvall B, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0509; Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; Andersson M, 2001, APPL ANIM BEHAV SCI, V72, P51, DOI 10.1016/S0168-1591(00)00195-7; Belteky J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160033; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Buitenhuis AJ, 2004, BEHAV GENET, V34, P325, DOI 10.1023/B:BEGE.0000017876.82142.73; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DUNCAN IJH, 1978, APPL ANIM ETHOL, V4, P29, DOI 10.1016/0304-3762(78)90091-3; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Francois N, 2000, BEHAV PROCESS, V48, P171, DOI 10.1016/S0376-6357(99)00081-9; Ghareeb K., 2008, International Journal of Poultry Science, V7, P843; Gogoleva SS, 2009, BEHAV PROCESS, V81, P369, DOI 10.1016/j.beproc.2009.03.012; GROMKO MH, 1995, EVOLUTION, V49, P685, DOI 10.1111/j.1558-5646.1995.tb02305.x; Gustafsson M, 1999, APPL ANIM BEHAV SCI, V62, P305, DOI 10.1016/S0168-1591(98)00236-6; Hakansson J, 2008, APPL ANIM BEHAV SCI, V114, P409, DOI 10.1016/j.applanim.2008.04.003; Jensen P, 2005, PHYSIOL BEHAV, V86, P52, DOI 10.1016/j.physbeh.2005.06.029; JENSEN P, 1993, ANIM BEHAV, V45, P351, DOI 10.1006/anbe.1993.1040; JENSEN P, 1991, APPL ANIM BEHAV SCI, V31, P195, DOI 10.1016/0168-1591(91)90005-I; Jensen P, 2015, J EXP BIOL, V218, P32, DOI 10.1242/jeb.106799; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Kagawa H, 2014, BEHAV PROCESS, V106, P91, DOI 10.1016/j.beproc.2014.04.011; Kjaer JB, 2001, APPL ANIM BEHAV SCI, V71, P229, DOI 10.1016/S0168-1591(00)00184-2; Kjaer JB, 2009, BEHAV GENET, V39, P564, DOI 10.1007/s10519-009-9280-1; Malmkvist J, 2001, WELFARE FARMED MINK; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A., 2008, DOG BEHAV EVOLUTION; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; Nicol CJ, BEHAV BIOL CHICKENS; Price EO, 2003, ANIMAL DOMESTICATION; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; STOLBA A, 1989, ANIM PROD, V48, P419, DOI 10.1017/S0003356100040411; Stryjek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040642; Tixier-Boichard M, 2011, CR BIOL, V334, P197, DOI 10.1016/j.crvi.2010.12.012; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070	38	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166075	10.1371/journal.pone.0166075	http://dx.doi.org/10.1371/journal.pone.0166075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851792	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300035
J	Bonneaud, C; Wilson, RS; Seebacher, F				Bonneaud, Camille; Wilson, Robbie S.; Seebacher, Frank			Immune-Challenged Fish Up-Regulate Their Metabolic Scope to Support Locomotion	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; WINTERING GREAT TITS; RAINBOW-TROUT; SICKNESS BEHAVIOR; TRADE-OFFS; LIPOPOLYSACCHARIDE ENDOTOXIN; TERMINAL INVESTMENT; ENERGY-EXPENDITURE; HOUSE SPARROW; SALMO-TRUTTA	Energy-based trade-offs occur when investment in one fitness-related trait diverts energy away from other traits. The extent to which such trade-offs are shaped by limits on the rate of conversion of energy ingested in food (e.g. carbohydrates) into chemical energy (ATP) by oxidative metabolism rather than by the amount of food ingested in the first place is, however, unclear. Here we tested whether the ATP required for mounting an immune response will lead to a trade-off with ATP available for physical activity in mosquitofish (Gambusia hol-brooki). To this end, we challenged fish either with lipopolysaccharide (LPS) from E. coli or with Sheep Red Blood Cells (SRBC), and measured oxygen consumption at rest and during swimming at maximum speed 24h, 48h and 7 days post-challenge in order to estimate metabolic rates. Relative to saline-injected controls, only LPS-injected fish showed a significantly greater resting metabolic rate two days post-challenge and significantly higher maximal metabolic rates two and seven days post-challenge. This resulted in a significantly greater metabolic scope two days post-challenge, with LPS-fish transiently overcompensating by increasing maximal ATP production more than would be required for swimming in the absence of an immune challenge. LPS-challenged fish therefore increased their production of ATP to compensate physiologically for the energetic requirements of immune functioning. This response would avoid ATP shortages and allow fish to engage in an aerobically-challenging activity (swimming) even when simultaneously mounting an immune response. Nevertheless, relative to controls, both LPS- and SRBC-fish displayed reduced body mass gain one week post-injection, and LPS-fish actually lost mass. The concomitant increase in metabolic scope and reduced body mass gain of LPS-challenged fish indicates that immuneassociated trade-offs are not likely to be shaped by limited oxidative metabolic capacities, but may instead result from limitations in the acquisition, assimilation or efficient use of resources.	[Bonneaud, Camille] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn TR10 9FE, Cornwall, England; [Bonneaud, Camille] CNRS, Stn Ecol Expt, USR 2936, F-09200 Moulis, France; [Wilson, Robbie S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Seebacher, Frank] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Exeter; Centre National de la Recherche Scientifique (CNRS); University of Queensland; University of Sydney	Bonneaud, C (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn TR10 9FE, Cornwall, England.; Bonneaud, C (corresponding author), CNRS, Stn Ecol Expt, USR 2936, F-09200 Moulis, France.	c.bonneaud@exeter.ac.uk		Wilson, Robbie/0000-0002-0116-5427; Seebacher, Frank/0000-0002-2281-9311	Marie Curie Reintegration Grant (FP7-PEOPLE-IRG) [239257]; Natural Environment Research Council [NE/M00256X]; Australian Research Council [DP120101215]; Natural Environment Research Council [NE/M00256X/1] Funding Source: researchfish; NERC [NE/M00256X/1] Funding Source: UKRI	Marie Curie Reintegration Grant (FP7-PEOPLE-IRG); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a Marie Curie Reintegration Grant (FP7-PEOPLE-IRG-2008 #239257) to Dr Camille Bonneaud; Natural Environment Research Council (NE/M00256X) to Dr Camille Bonneaud; Australian Research Council Discovery Projects (DP120101215) to Prof Frank Seebacher and Prof Robbie Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2000, J AQUAT ANIM HEALTH, V12, P157, DOI 10.1577/1548-8667(200006)012&lt;0157:PAIEOA&gt;2.0.CO;2; Altringham JD, 1999, J EXP BIOL, V202, P3397; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Barbosa A, 2004, ECOSCIENCE, V11, P305, DOI 10.1080/11956860.2004.11682837; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; Binuramesh C, 2006, BRAIN BEHAV IMMUN, V20, P300, DOI 10.1016/j.bbi.2005.09.002; Bonneaud C, 2004, EVOLUTION, V58, P2823, DOI 10.1111/j.0014-3820.2004.tb01633.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bonneaud C, 2012, MOL ECOL, V21, P4787, DOI 10.1111/j.1365-294X.2012.05736.x; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Burness G, 2010, J EXP BIOL, V213, P1386, DOI 10.1242/jeb.027011; Cherry AD, 2015, ANTIOXID REDOX SIGN, V22, P965, DOI 10.1089/ars.2014.6200; Claireaux G, 2007, PHILOS T R SOC B, V362, P2031, DOI 10.1098/rstb.2007.2099; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; Cutrera AP, 2010, J EXP BIOL, V213, P715, DOI 10.1242/jeb.037887; DERIJK RH, 1993, AM J PHYSIOL, V265, pR1179, DOI 10.1152/ajpregu.1993.265.5.R1179; Einarsdottir IE, 2000, AQUAC RES, V31, P923, DOI 10.1046/j.1365-2109.2000.00506.x; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; Frost R A, 2008, J Anim Sci, V86, pE84, DOI 10.2527/jas.2007-0483; FRY FEJ, 1948, BIOL BULL, V94, P66, DOI 10.2307/1538211; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Goetz FW, 2004, MOL IMMUNOL, V41, P1199, DOI 10.1016/j.molimm.2004.06.005; GRONDEL JL, 1987, J FISH DIS, V10, P35, DOI 10.1111/j.1365-2761.1987.tb00716.x; Horak P, 2003, CAN J ZOOL, V81, P371, DOI [10.1139/z03-020, 10.1139/Z03-020]; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Iliev DB, 2005, MOL IMMUNOL, V42, P1215, DOI 10.1016/j.molimm.2004.11.023; INGRAM GA, 1980, J FISH BIOL, V16, P181, DOI 10.1111/j.1095-8649.1980.tb03698.x; INGRAM GA, 1981, ACTA BIOL MED GER, V40, P317; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Jovanovic B, 2011, J FISH BIOL, V78, P1054, DOI 10.1111/j.1095-8649.2011.02919.x; Kaitetzidou E, 2012, MAR BIOTECHNOL, V14, P605, DOI 10.1007/s10126-012-9469-9; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; KLASING KC, 1984, P SOC EXP BIOL MED, V176, P285; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; MacKenzie S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-141; MacKenzie S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-46; Magnoni Leonardo J., 2015, Biology-Basel, V4, P67, DOI 10.3390/biology4010067; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2008, FUNCT ECOL, V22, P68, DOI 10.1111/j.1365-2435.2007.01347.x; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Nayak SK, 2008, FISH SHELLFISH IMMUN, V24, P394, DOI 10.1016/j.fsi.2007.09.005; Nilsson JA, 2007, J AVIAN BIOL, V38, P488, DOI 10.1111/j.2007.0908-8857.03919.x; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; Owen-Ashley NT, 2008, BRAIN BEHAV IMMUN, V22, P614, DOI 10.1016/j.bbi.2007.12.005; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Owen-Ashley NT, 2006, J EXP BIOL, V209, P3062, DOI 10.1242/jeb.02371; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; SCHULZ R, 1985, STEROIDS, V46, P717, DOI 10.1016/0039-128X(85)90051-0; Seebacher F, 2013, J EXP BIOL, V216, P771, DOI 10.1242/jeb.079756; Seebacher F, 2014, FUNCT ECOL, V28, P137, DOI 10.1111/1365-2435.12156; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Skinner LA, 2010, FISH SHELLFISH IMMUN, V28, P387, DOI 10.1016/j.fsi.2009.11.026; Smith IJ, 2010, INT J BIOCHEM CELL B, V42, P701, DOI 10.1016/j.biocel.2010.01.006; Snoeijs T, 2007, ANIM BIOL, V57, P79, DOI 10.1163/157075607780002041; Swain P, 2008, FISH SHELLFISH IMMUN, V25, P191, DOI 10.1016/j.fsi.2008.04.009; Uller T, 2006, FUNCT ECOL, V20, P873, DOI 10.1111/j.1365-2435.2006.01163.x; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; VLECK D, 1987, J APPL PHYSIOL, V62, P2103, DOI 10.1152/jappl.1987.62.5.2103; Volkoff H, 2004, BRAIN RES, V998, P139, DOI 10.1016/j.brainres.2003.11.011; WEDEMEYER G, 1969, J FISH RES BOARD CAN, V26, P115, DOI 10.1139/f69-010; Wedemeyer G., 1968, J FISH RES BOARD CAN, V26; Zamora-Camacho F. J., BEHAV ECOLOGY, V26, P115	69	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166028	10.1371/journal.pone.0166028	http://dx.doi.org/10.1371/journal.pone.0166028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851769	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300031
J	Thomsen, PF; Moller, PR; Sigsgaard, EE; Knudsen, SW; Jorgensen, OA; Willerslev, E				Thomsen, Philip Francis; Moller, Peter Rask; Sigsgaard, Eva Egelyng; Knudsen, Steen Wilhelm; Jorgensen, Ole Ankjaer; Willerslev, Eske			Environmental DNA from Seawater Samples Correlate with Trawl Catches of Subarctic, Deepwater Fishes	PLOS ONE			English	Article							GREENLAND; EDNA; CATCHABILITY; BIODIVERSITY; UNCERTAINTIES; COMMUNITIES; COLLAPSE; HALIBUT; IMPACT	Remote polar and deepwater fish faunas are under pressure from ongoing climate change and increasing fishing effort. However, these fish communities are difficult to monitor for logistic and financial reasons. Currently, monitoring of marine fishes largely relies on invasive techniques such as bottom trawling, and on official reporting of global catches, which can be unreliable. Thus, there is need for alternative and non-invasive techniques for qualitative and quantitative oceanic fish surveys. Here we report environmental DNA (eDNA) metabarcoding of seawater samples from continental slope depths in Southwest Greenland. We collected seawater samples at depths of 188-918 m and compared seawater eDNA to catch data from trawling. We used Illumina sequencing of PCR products to demonstrate that eDNA reads show equivalence to fishing catch data obtained from trawling. Twenty-six families were found with both trawling and eDNA, while three families were found only with eDNA and two families were found only with trawling. Key commercial fish species for Greenland were the most abundant species in both eDNA reads and biomass catch, and interpolation of eDNA abundances between sampling sites showed good correspondence with catch sizes. Environmental DNA sequence reads from the fish assemblages correlated with biomass and abundance data obtained from trawling. Interestingly, the Greenland shark (Somniosus microcephalus) showed high abundance of eDNA reads despite only a single specimen being caught, demonstrating the relevance of the eDNA approach for large species that can probably avoid bottom trawls in most cases. Quantitative detection of marine fish using eDNA remains to be tested further to ascertain whether this technique is able to yield credible results for routine application in fisheries. Nevertheless, our study demonstrates that eDNA reads can be used as a qualitative and quantitative proxy for marine fish assemblages in deepwater oceanic habitats. This relates directly to applied fisheries as well as to monitoring effects of ongoing climate change on marine biodiversity-especially in polar ecosystems.	[Thomsen, Philip Francis; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Moller, Peter Rask; Sigsgaard, Eva Egelyng; Knudsen, Steen Wilhelm] Univ Copenhagen, Nat Hist Museum Denmark, Sect EvoGen, Copenhagen, Denmark; [Jorgensen, Ole Ankjaer] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Jorgensen, Ole Ankjaer] Greenland Inst Nat Resources, Nuuk, Greenland; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge, England; [Willerslev, Eske] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Greenland Institute of Natural Resources; University of Cambridge; Wellcome Trust Sanger Institute	Thomsen, PF; Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.; Willerslev, E (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.; Willerslev, E (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England.	pfthomsen@snm.ku.dk; ewillerslev@snm.ku.dk	Knudsen, Steen W/C-1072-2015; Thomsen, Philip Francis/AAE-9354-2019; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Sigsgaard, Eva Egelyng/ABB-6275-2021; Knudsen, Steen/X-7948-2019	Knudsen, Steen W/0000-0003-0428-9940; Thomsen, Philip Francis/0000-0002-9867-4366; Willerslev, Eske/0000-0002-7081-6748; Sigsgaard, Eva Egelyng/0000-0002-9396-1550; Knudsen, Steen/0000-0003-0428-9940	Danish National Research Foundation; Greenland Institute of Natural Resources, Greenland Self-government, Department for education and research; Natural History Museum of Denmark and the Danish National Sequencing Centre	Danish National Research Foundation(Danmarks Grundforskningsfond); Greenland Institute of Natural Resources, Greenland Self-government, Department for education and research; Natural History Museum of Denmark and the Danish National Sequencing Centre	Danish National Research Foundation funded the work. Greenland Institute of Natural Resources, Greenland Self-government, Department for education and research funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the crew on R/V Paamiut for their support during the cruises. Peter Frandsen is thanked for a valuable and heroic effort on board. We thank the Natural History Museum of Denmark and the Danish National Sequencing Centre for support in carrying out the work. Pernille Selmer Olsen is thanked for help with the lab work. Marcus Anders Krag is thanked for help with tissue samples. We thank Prof. Pierre Taberlet for design of and permission to use the primer V05F_898. We would like to thank Greenland Institute of Natural Resources, Greenland Self-government, Department for Education and Research for financial support. We thank the Danish National Research Foundation for funding.	Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; [Anonymous], 1942, SAMMENDRAG STAT OPLY, V1, P647; ArreguinSanchez F, 1996, REV FISH BIOL FISHER, V6, P221; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Buch E., 2000, MONOGRAPH PHYS OCEAN; Christiansen JS, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1332-9; Coissac Eric, 2012, Methods Mol Biol, V888, P13, DOI 10.1007/978-1-61779-870-2_2; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Daan N., 2001, ICES CM, V3, P1; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Fraser HM, 2007, ICES J MAR SCI, V64, P1800, DOI 10.1093/icesjms/fsm145; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1569, DOI 10.1139/cjfas-58-8-1569; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Ingvaldsen RB, 2015, NAT CLIM CHANGE, V5, P788, DOI 10.1038/nclimate2761; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jorgensen O.A., 2015, J NW ATLANTIC FISHER, V47, P37, DOI DOI 10.2960/J.V47.M706; Jorgensen OA, 2005, CAN J FISH AQUAT SCI, V62, P1833, DOI 10.1139/F05-101; Jorgensen OA, 1998, 25 NAFO; Jorgensen OA, 2015, SURVEY FOR GREENLAND; Jorgensen OA, 2014, ICES J MAR SCI, V71, P845, DOI 10.1093/icesjms/fst191; Kelly RP, 2016, MOL ECOL RESOUR, V16, P10, DOI 10.1111/1755-0998.12455; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kenchington E, 2017, POLAR BIOL, V40, P321, DOI 10.1007/s00300-016-1957-3; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Lorance P, 2015, IUCN RED LIST THREAT; MacKenzie BR, 2014, GLOBAL CHANGE BIOL, V20, P2484, DOI 10.1111/gcb.12597; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Moller PR, 2010, ZOOTAXA, P1; Moller PR, 2005, COPEIA, P374; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Murray DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124671; Nielsen J, 2014, POLAR BIOL, V37, P37, DOI 10.1007/s00300-013-1408-3; Nygaard R, 2015, BIOMASS ABUNDANCE DE; Olds BP, 2016, ECOL EVOL, V6, P4214, DOI 10.1002/ece3.2186; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; PEDERSEN SA, 1994, POLAR RES, V13, P183, DOI 10.1111/j.1751-8369.1994.tb00448.x; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Shelton AO, 2016, ECOL APPL, V26, P1645, DOI 10.1890/15-1733.1; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Watanabe YY, 2012, J EXP MAR BIOL ECOL, V426, P5, DOI 10.1016/j.jembe.2012.04.021; Wisz MS, 2015, NAT CLIM CHANGE, V5, P790, DOI 10.1038/nclimate2762; Wisz MS, 2015, NAT CLIM CHANGE, V5, P261, DOI [10.1038/nclimate2500, 10.1038/NCLIMATE2500]; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x	71	156	166	7	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165252	10.1371/journal.pone.0165252	http://dx.doi.org/10.1371/journal.pone.0165252			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851757	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300012
J	de Miguel-Diez, J; Lopez-de-Andres, A; Jimenez-Garcia, R; Puente-Maestu, L; Jimenez-Trujillo, I; Hernandez-Barrera, V; Resino, S; Alvaro-Meca, A				de Miguel-Diez, Javier; Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Puente-Maestu, Luis; Jimenez-Trujillo, Isabel; Hernandez-Barrera, Valentin; Resino, Salvador; Alvaro-Meca, Alejandro			Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; RISK-FACTORS; PREVALENCE; MORTALITY; ABNORMALITIES; COMORBIDITY	Purpose The aim of this study was to estimate trends of incidence of hospital admissions and in-hospital mortality (IHM) in HIV-infected patients with COPD in the combination antiretroviral therapy (cART) era in Spain (1997-2012). Methods A retrospective study with data from nationwide population-based COPD diagnoses in the Spanish Minimum Basic Data Set (MBDS) was performed. We established groups according to their HIV and HCV infections: 1) HIV-uninfected patients; 2) HIV-infected patients (with or without HCV coinfection). Results 1,580,207 patients discharge with a COPD diagnosis were included in the study, 8902 of them were HIV-infected patients (5000 HIV-monoinfected patients and 3902 HIV/HCVcoinfected patients). The HIV-infected patients had higher incidence rates of hospital admissions for COPD than the HIV-uninfected patients during the study period. The HIV-monoinfected patients had higher rates of hospitalizations for COPD than the HIV/HCV-coinfected patients in the early-period cART (1997-1999), but these rates decreased in the first group and increased in the second, being even similar in both groups in the late-period cART (2004-2011). On the other hand, the HIV-infected patients with COPD had higher IHM than the HIV-uninfected patients with COPD. The mortality rates were higher in the HIV-monoinfected patients with COPD than in the HIV/HCV-coinfected patients with COPD in the earlyperiod cART; however, in the late-period cART, the mortality rates trends seems higher in the HIV/HCV group. The likelihood of death in HIV/HCV-coinfected patients with COPD was similar to than in HIV-monoinfected patients with COPD. Conclusions Incidence of hospital admissions for COPD and IHM have decreased among HIV-monoinfected individuals but have increased steadily among HIV/HCV-coinfected individuals in the cART era.	[de Miguel-Diez, Javier; Puente-Maestu, Luis] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Fac Med, Inst Invest Sanitaria Gregorio Maranon IiSGM,Pneu, Madrid, Spain; [Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Jimenez-Trujillo, Isabel; Hernandez-Barrera, Valentin; Alvaro-Meca, Alejandro] Univ Rey Juan Carlos, Dept Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain; [Resino, Salvador] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain	Complutense University of Madrid; General University Gregorio Maranon Hospital; Universidad Rey Juan Carlos; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	de Miguel-Diez, J (corresponding author), Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Fac Med, Inst Invest Sanitaria Gregorio Maranon IiSGM,Pneu, Madrid, Spain.	javier.miguel@saluci.madrid.org	Jimenez-Trujillo, Isabel/AAP-7746-2021; Resino, Salvador/B-2430-2008; Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Lopez-de-Andres, Ana/AAD-8703-2019	Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Resino, Salvador/0000-0001-8783-0450; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Lopez-de-Andres, Ana/0000-0001-5551-5181; Alvaro-Meca, Alejandro/0000-0003-1315-4386; de Miguel-Diez, Javier/0000-0003-4543-573X; Hernandez-Barrera, Valentin/0000-0001-5790-1959; Puente-Maestu, Luis/0000-0001-8501-0117	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Institute de Salud Carlos III) [PI11/00245, PI12/00019, PI12/02734]; European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"); Grupo de Excelencia Investigadora URJC-Banco: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE) [30VCPIGI03]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Institute de Salud Carlos III); European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"); Grupo de Excelencia Investigadora URJC-Banco: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE)	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Institute de Salud Carlos III grants no. PI11/00245 to SR, PI12/00019 to MM and PI12/02734 to LPM) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") and by the Grupo de Excelencia Investigadora URJC-Banco Santander No 30VCPIGI03: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE) to RJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias- Health Research Fund, Instituto de Salud Carlos III grants no. PI11/00245 to SR, PI12/00019 to AAM and PI12/02734 to LPM) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") and by the Grupo de Excelencia Investigadora URIC-Banco Santander No 30VCPIGI03: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanbi MO, 2015, J AIDS CLIN RES, V6; Akgun KM, 2013, JAIDS-J ACQ IMM DEF, V62, P52, DOI 10.1097/QAI.0b013e318278f3fa; Alkaline Software Inc, WEBS FREE 2014 MED C; Alvaro-Meca A, 2014, J INFECTION, V68, P355, DOI 10.1016/j.jinf.2013.12.003; [Anonymous], 2001, SUBD GEN DES; Bednasz CJ, 2015, FUTURE VIROL, V10, P981, DOI 10.2217/FVL.15.64; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Diez M, 2014, EURO SURVEILL, V19; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; Erol S, 2009, HEPAT MON, V9, P39; Estebanez-Munoz M, 2012, ARCH BRONCONEUMOL, V48, P126, DOI 10.1016/j.arbres.2011.12.001; Fischer WA, 2014, COPD, V11, P10, DOI 10.3109/15412555.2013.800854; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Gonzalez-Garcia J, 2012, 19 C RETR OPP INF CR; Kanazawa H, 2003, CHEST, V123, P596, DOI 10.1378/chest.123.2.596; Kristoffersen US, 2012, CLIN PHYSIOL FUNCT I, V32, P288, DOI 10.1111/j.1475-097X.2012.01124.x; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; Magalhaes MG, 2007, J AM DENT ASSOC, V138, P1468, DOI 10.14219/jada.archive.2007.0083; Makinson A, 2015, EUR RESPIR J, V45, P828, DOI 10.1183/09031936.00154914; Moorman J, 2005, CHEST, V128, P2882, DOI 10.1378/chest.128.4.2882; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; Norris KA, 2011, IMMUNOL RES, V50, P175, DOI 10.1007/s12026-011-8218-x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petrache I, 2008, THORAX, V63, P463, DOI 10.1136/thx.2007.079111; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Raynaud C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-117; Roca B, 2003, J INFECTION, V47, P117, DOI 10.1016/S0163-4453(03)00067-7; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Schwarcz SK, 2014, AIDS PATIENT CARE ST, V28, P517, DOI 10.1089/apc.2014.0079; Silva DR, 2010, EPIDEMIOL INFECT, V138, P167, DOI 10.1017/S0950268809990276; Simmons RD, 2013, HIV MED, V14, P596, DOI 10.1111/hiv.12045; Simonetti JA, 2014, J AIDS CLIN RES, V5; Soriano V, 2015, CURR OPIN HIV AIDS, V10, P309, DOI 10.1097/COH.0000000000000175; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; UN Joint Programme on HIV/AIDS, 2010, GLOB REP UN REP GLOB; Vallecillo G, 2010, CURR HIV RES, V8, P641, DOI 10.2174/157016210794088272; Yearsley MM, 2005, DIAGN MOL PATHOL, V14, P48, DOI 10.1097/01.pas.0000142168.72253.11	43	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166421	10.1371/journal.pone.0166421	http://dx.doi.org/10.1371/journal.pone.0166421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846297	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600062
J	Penizek, V; Zadorova, T; Kodesova, R; Vanek, A				Penizek, Vit; Zadorova, Tereza; Kodesova, Radka; Vanek, Ales			Influence of Elevation Data Resolution on Spatial Prediction of Colluvial Soils in a Luvisol Region	PLOS ONE			English	Article							YOUNG MORAINIC LANDSCAPES; DEM RESOLUTION; TERRAIN ANALYSIS; ORGANIC-CARBON; MODELS; SCALE; IDENTIFICATION; ATTRIBUTES; TOPOGRAPHY; TRUNCATION	The development of a soil cover is a dynamic process. Soil cover can be altered within a few decades, which requires updating of the legacy soil maps. Soil erosion is one of the most important processes quickly altering soil cover on agriculture land. Colluvial soils develop in concave parts of the landscape as a consequence of sedimentation of eroded material. Colluvial soils are recognised as important soil units because they are a vast sink of soil organic carbon. Terrain derivatives became an important tool in digital soil mapping and are among the most popular auxiliary data used for quantitative spatial prediction. Prediction success rates are often directly dependent on raster resolution. In our study, we tested how raster resolution (1, 2, 3, 5, 10, 20 and 30 meters) influences spatial prediction of colluvial soils. Terrain derivatives (altitude, slope, plane curvature, topographic position index, LS factor and convergence index) were calculated for the given raster resolutions. Four models were applied (boosted tree, neural network, random forest and Classification/Regression Tree) to spatially predict the soil cover over a 77 ha large study plot. Models training and validation was based on 111 soil profiles surveyed on a regular sampling grid. Moreover, the predicted real extent and shape of the colluvial soil area was examined. In general, no clear trend in the accuracy prediction was found without the given raster resolution range. Higher maximum prediction accuracy for colluvial soil, compared to prediction accuracy of total soil cover of the study plot, can be explained by the choice of terrain derivatives that were best for Colluvial soils differentiation from other soil units. Regarding the character of the predicted Colluvial soils area, maps of 2 to 10 m resolution provided reasonable delineation of the colluvial soil as part of the cover over the study area.	[Penizek, Vit; Zadorova, Tereza; Kodesova, Radka; Vanek, Ales] Czech Univ Life Sci Prague, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic	Czech University of Life Sciences Prague	Penizek, V (corresponding author), Czech Univ Life Sci Prague, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic.	penizek@af.czu.cz	Kodešová, Radka/F-5671-2019; Penížek, Vít/O-6418-2019; Zádorová, Tereza/Z-1202-2019; Vanek, Ales/M-7058-2013	Kodešová, Radka/0000-0001-7236-8064; Penížek, Vít/0000-0001-6131-7608; Zádorová, Tereza/0000-0002-5541-2155; Vanek, Ales/0000-0002-6156-3419	Czech Science Foundation [13-07516P]	Czech Science Foundation(Grant Agency of the Czech Republic)	The study was funded by Czech Science Foundation by grant nr. 13-07516P.	Adhikari K, 2014, GEODERMA, V214, P101, DOI 10.1016/j.geoderma.2013.09.023; Ariza-Villaverde AB, 2015, GEOMORPHOLOGY, V241, P243, DOI 10.1016/j.geomorph.2015.03.040; Cavazzi S, 2013, GEODERMA, V195, P111, DOI 10.1016/j.geoderma.2012.11.020; Chaplot V, 2005, J HYDROL, V312, P207, DOI 10.1016/j.jhydrol.2005.02.017; Chaplot V, 2000, GEODERMA, V97, P405, DOI 10.1016/S0016-7061(00)00048-3; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; de Forges A.R., 2014, GLOBALSOILMAP BASIS; Debella-Gilo M, 2009, CATENA, V77, P8, DOI 10.1016/j.catena.2008.12.001; Feder F, 2013, CATENA, V110, P215, DOI 10.1016/j.catena.2013.06.019; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; FRIDLAND VM, 1972, PATTERN SOIL COVER; Gallant JC, 1997, MATH COMPUT SIMULAT, V43, P313, DOI 10.1016/S0378-4754(97)00015-3; Gillin CP, 2015, PHOTOGRAMM ENG REM S, V81, P387, DOI 10.14358/PERS.81.5.387; Greve MH, 2012, SOIL SCI SOC AM J, V76, P2116, DOI 10.2136/sssaj2010.0354; Guth J., 1964, KOMPLEXNI PRUZKUM ZE; Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Heung B, 2016, GEODERMA, V265, P62, DOI 10.1016/j.geoderma.2015.11.014; Heung B, 2014, GEODERMA, V214, P141, DOI 10.1016/j.geoderma.2013.09.016; Jenny H., 1941, FACTORS SOIL FORMATI; Kempen B, 2012, SOIL SCI SOC AM J, V76, P2097, DOI 10.2136/sssaj2011.0424; Kempen B, 2009, GEODERMA, V151, P311, DOI 10.1016/j.geoderma.2009.04.023; Kerry R, 2012, GEODERMA, V170, P347, DOI 10.1016/j.geoderma.2011.10.007; Laamrani A, 2014, FOREST ECOL MANAG, V330, P144, DOI 10.1016/j.foreco.2014.07.013; Lacoste M, 2011, GEOMORPHOLOGY, V133, P90, DOI 10.1016/j.geomorph.2011.06.026; Lassueur T, 2006, ECOL MODEL, V198, P139, DOI 10.1016/j.ecolmodel.2006.04.004; Lemercier B, 2012, GEODERMA, V171, P75, DOI 10.1016/j.geoderma.2011.03.010; Mashimbye ZE, 2014, GEODERMA, V213, P312, DOI 10.1016/j.geoderma.2013.08.023; Maynard JJ, 2014, GEODERMA, V230, P29, DOI 10.1016/j.geoderma.2014.03.021; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Mukherjee S, 2013, INT J APPL EARTH OBS, V21, P205, DOI 10.1016/j.jag.2012.09.004; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; Napieralski J, 2010, COMPUT GEOSCI-UK, V36, P222, DOI 10.1016/j.cageo.2009.06.003; Park SJ, 2001, GEODERMA, V103, P249, DOI 10.1016/S0016-7061(01)00042-8; Shi X, 2012, GEODERMA, V170, P217, DOI 10.1016/j.geoderma.2011.11.020; Smith MP, 2006, GEODERMA, V137, P58, DOI 10.1016/j.geoderma.2006.07.002; Sorensen R, 2007, J HYDROL, V347, P79, DOI 10.1016/j.jhydrol.2007.09.001; StatSoftInc, 2015, STATISTICA; Sulaeman Y, 2013, GEODERMA, V192, P77, DOI 10.1016/j.geoderma.2012.08.005; Sun XL, 2015, EUR J SOIL SCI, V66, P1012, DOI 10.1111/ejss.12295; Switoniak M, 2016, CATENA, V137, P583, DOI 10.1016/j.catena.2014.09.005; Switoniak M, 2014, CATENA, V116, P173, DOI 10.1016/j.catena.2013.12.015; Tarolli P, 2009, GEOMORPHOLOGY, V113, P47, DOI 10.1016/j.geomorph.2009.02.006; Taylor JA, 2013, GEODERMA, V193, P83, DOI 10.1016/j.geoderma.2012.09.009; Thompson JA, 2001, GEODERMA, V100, P67, DOI 10.1016/S0016-7061(00)00081-1; Vaze J, 2010, ENVIRON MODELL SOFTW, V25, P1086, DOI 10.1016/j.envsoft.2010.03.014; Vianello A, 2009, CATENA, V76, P97, DOI 10.1016/j.catena.2008.09.012; Wilson J.P., 2000, TERRAIN ANAL PRINCIP, P133; Wu S, 2008, APPL GEOGR, V28, P210, DOI 10.1016/j.apgeog.2008.02.006; Wu S, 2007, ENVIRON MODELL SOFTW, V22, P1250, DOI 10.1016/j.envsoft.2006.08.001; Wu W, 2008, AGR ECOSYST ENVIRON, V126, P209, DOI 10.1016/j.agee.2008.01.026; Zadorova T, 2015, GEODERMA, V253, P122, DOI 10.1016/j.geoderma.2015.04.012; Zadorova T, 2013, GEODERMA, V195, P56, DOI 10.1016/j.geoderma.2012.11.012; Zadorova T, 2011, CATENA, V85, P22, DOI 10.1016/j.catena.2010.11.006	54	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165699	10.1371/journal.pone.0165699	http://dx.doi.org/10.1371/journal.pone.0165699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846230	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600017
J	Zuo, HY; Zhang, JF; Zhang, LG; Ren, XX; Chen, XL; Hao, HS; Zhao, XM; Wang, D				Zuo, Haiyang; Zhang, Junfang; Zhang, Liuguang; Ren, Xiaoxia; Chen, Xiaoli; Hao, Haisheng; Zhao, Xueming; Wang, Dong			Transcriptomic Variation during Spermiogenesis in Mouse Germ Cells	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; SPERMATOGENESIS; NUCLEAR; RNA; TESTIS; GENE; OVEREXPRESSION	To explore variations in the transcription activity during spermiogenesis, round and elongated spermatids were collected from ICR/CD1 model mice using laser capture microdissection (LCM) and cauda epididymal sperm samples. The transcripts were sequenced using RNA-seq, and the reads were mapped to mm9. The majority of the reads (70%) in the round and elongated spermatids were mappable to known and predicted exons, but that in sperm was only 9%. The results of the distribution of reads suggested that alternative splicing was more complicated in sperm than in round and elongated spermatids. In the 19,127 genes, we detected the expression of 5,104 de novo genes and 91,112 alternative splicing events, and 12,105 were differentially expressed. Gene ontology (GO), InterPro domains, and KEGG revealed changes in gene transcription, mitochondrial protein translation, cellular components, and energy metabolism during spermiogenesis. The results provided considerable information about alternative splicing events, differentiallly expressed genes (DEGs), and novel transcriptions during spermiogenesis in mice.	[Zuo, Haiyang; Zhang, Junfang; Zhang, Liuguang; Ren, Xiaoxia; Chen, Xiaoli; Hao, Haisheng; Zhao, Xueming; Wang, Dong] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet & Utilizat, Beijing 100193, Peoples R China; [Zuo, Haiyang] JiLin Agr Univ Anim Sci & Technol, Changchun 130118, Peoples R China; [Zhang, Liuguang] HaiKou Mary Hosp, Reprod Med Ctr, Haikou 570100, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Wang, D (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet & Utilizat, Beijing 100193, Peoples R China.	dwangcn2002@vip.sina.com			National Natural Science Foundation of China [31372296]; Beijing Innovation Team of Technology System in Dairy Industry; National Science and Technology Support Program of China [2011BAD19B02]; Agricultural Science and Technology Innovation Program (ASTIP) [cxgc-ias-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Innovation Team of Technology System in Dairy Industry; National Science and Technology Support Program of China; Agricultural Science and Technology Innovation Program (ASTIP)	This work was supported by grants from the National Natural Science Foundation of China (No. 31372296), Beijing Innovation Team of Technology System in Dairy Industry, the National Science and Technology Support Program of China (No. 2011BAD19B02) and the Agricultural Science and Technology Innovation Program (ASTIP) (cxgc-ias-06).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dadoune JP, 1995, MICRON, V26, P323, DOI 10.1016/0968-4328(95)00007-0; DAOUST R, 1955, AM J ANAT, V96, P255, DOI 10.1002/aja.1000960204; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Escalier D, 2003, MOL REPROD DEV, V65, P298, DOI 10.1002/mrd.10290; Gannon JR, 2014, ADV EXP MED BIOL, V791, P53, DOI 10.1007/978-1-4614-7783-9_4; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; HINRICHSENKOHANE AC, 1984, ANDROLOGIA, V16, P321; Hokari M, 2010, NEUROPATHOLOGY, V30, P401, DOI 10.1111/j.1440-1789.2009.01086.x; Hosken DJ, 2014, TRENDS ECOL EVOL, V29, P451, DOI 10.1016/j.tree.2014.05.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Lassalle B, 1999, HUM REPROD, V14, P388, DOI 10.1093/humrep/14.2.388; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Sutovsky P, 2000, INT REV CYTOL, V195, P1; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Woop M, 2015, BIOPHYS J, V108, p393A, DOI 10.1016/j.bpj.2014.11.2156; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7	31	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0164874	10.1371/journal.pone.0164874	http://dx.doi.org/10.1371/journal.pone.0164874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835637	Green Submitted, gold, Green Published			2022-12-27	WOS:000387779200003
J	Kim, HJ; Kim, SY; Kwon, JY; Kim, YJ; Kang, SH; Jang, WH; Lee, JH; Seo, MW; Song, JJ; Seo, YR; Park, MK				Kim, Hyo Jeong; Kim, So Young; Kwon, Jee Young; Kim, Yeo Jin; Kang, Seung Hun; Jang, Won-Hee; Lee, Jun Ho; Seo, Myung-Whan; Song, Jae -Jun; Seo, Young Rok; Park, Moo Kyun			Identification of Potential Novel Biomarkers and Signaling Pathways Related to Otitis Media Induced by Diesel Exhaust Particles Using Transcriptomic Analysis in an In Vivo System	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; MIDDLE-EAR; INFLAMMATION; ACETYLCHOLINE; EXPRESSION; AIRWAY; APOPTOSIS; CHILDREN; SOS1	Introduction Air pollutants are associated with inflammatory diseases such as otitis media (OM). Significantly higher incidence rates of OM are reported in regions with air pollution. Diesel exhaust particles (DEPs) comprise a major class of contaminants among numerous air pollutants, and they are characterized by a carbonic mixture of polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs, and small amounts of sulfate, nitrate, metals and other trace elements. DEP exposure is a risk factor for inflammatory diseases. Our previous study identified potential biomarkers using gene expression microarray and pathway analyses in an in vitro system. Although in vitro investigations have been conducted to elucidate plausible biomarkers and molecular mechanisms related to DEP exposure, in vivo studies are necessary to identify the exact biological relevance regarding the incidence of OM caused by DEP exposure. In this study, we identified potential molecular biomarkers and pathways triggered by DEP exposure in a rodent model. Methods Transcriptomic analysis was employed to identify novel potential biomarkers in the middle ear of DEP-exposed mice. Results A total of 697 genes were differentially expressed in the DEP-exposed mice; 424 genes were upregulated and 273 downregulated. In addition, signaling pathways among the differentially expressed genes mediated by DEP exposure were predicted. Several key molecular biomarkers were identified including cholinergic receptor muscarinic 1 (CHRM1), erythropoietin (EPO), son of sevenless homolog 1 (SOS1), estrogen receptor 1 (ESR1), cluster of differentiation 4 (CD4) and interferon alpha-1 (IFNA1). Conclusions Our results shed light on the related cell processes and gene signaling pathways affected by DEP exposure. The identified biomarkers might be potential candidates for determining early diagnoses and effective treatment strategies for DEP-mediated disorders.	[Kim, Hyo Jeong; Kwon, Jee Young; Kim, Yeo Jin; Kang, Seung Hun; Jang, Won-Hee; Seo, Young Rok; Park, Moo Kyun] Dongguk Univ, Dept Life Sci, Biomedi Campus,32 Dongguk Ro, Goyang Si 410820, Gyeonggi Do, South Korea; [Kim, Hyo Jeong; Kwon, Jee Young; Kim, Yeo Jin; Kang, Seung Hun; Seo, Young Rok; Park, Moo Kyun] Dongguk Univ, Inst Environm Med, Seoul, South Korea; [Kim, So Young] CHA Univ, Dept Otorhinolaryngol Head & Neck Surg, Bundang CHA Med Ctr, Songnam, South Korea; [Lee, Jun Ho; Seo, Myung-Whan; Park, Moo Kyun] Seoul Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Song, Jae -Jun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Dongguk University; Dongguk University; Pochon Cha University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Seo, YR; Park, MK (corresponding author), Dongguk Univ, Dept Life Sci, Biomedi Campus,32 Dongguk Ro, Goyang Si 410820, Gyeonggi Do, South Korea.; Seo, YR; Park, MK (corresponding author), Dongguk Univ, Inst Environm Med, Seoul, South Korea.; Park, MK (corresponding author), Seoul Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	seoyr1@naver.com; aseptic@snu.ac.kr		Jang, Wonhee/0000-0003-2470-8137; Park, Moo Kyun/0000-0002-8635-797X; Kim, Yeo Jin/0000-0001-9122-914X	Korea Ministry of the Environment under 'Environmental Health Action Program' [2016001360009]; Research Resettlement Fund for the new faculty of Seoul National University	Korea Ministry of the Environment under 'Environmental Health Action Program'; Research Resettlement Fund for the new faculty of Seoul National University	This work was supported by the Korea Ministry of the Environment (grant no. 2016001360009) under the auspices of the 'Environmental Health Action Program.' This work was supported by Research Resettlement Fund for the new faculty of Seoul National University.	Amin K, 1999, INFLAMM RES, V48, P626, DOI 10.1007/s000110050513; Boland S, 1999, AM J PHYSIOL-LUNG C, V276, pL604, DOI 10.1152/ajplung.1999.276.4.L604; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Churg A, 1997, AM J RESP CRIT CARE, V155, P2109, DOI 10.1164/ajrccm.155.6.9196123; GENDELMAN HE, 1991, J EXP MED, V173, P277, DOI 10.1084/jem.173.1.277; Guittard G, 2015, EUR J IMMUNOL, V45, P2389, DOI 10.1002/eji.201445226; KOYAMA S, 1992, AM J PHYSIOL, V262, pL466, DOI 10.1152/ajplung.1992.262.4.L466; Landvik NE, 2007, TOXICOLOGY, V231, P159, DOI 10.1016/j.tox.2006.12.009; Li N, 2006, EUR RESPIR J, V27, P667, DOI 10.1183/09031936.06.00025006; Li N, 2002, J IMMUNOL, V169, P4531, DOI 10.4049/jimmunol.169.8.4531; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Mazzarella G, 2007, RESP MED, V101, P1155, DOI 10.1016/j.rmed.2006.11.011; Metzen J, 2003, LIFE SCI, V72, P2075, DOI 10.1016/S0024-3205(03)00086-9; Nemmar A, 2010, TOXICOL LETT, V194, P58, DOI 10.1016/j.toxlet.2010.02.001; Nguyen LHP, 2004, J ALLERGY CLIN IMMUN, V114, P1110, DOI 10.1016/j.jaci.2004.07.061; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026749; Polanczyk M, 2004, AM J PATHOL, V164, P1915, DOI 10.1016/S0002-9440(10)63752-2; Polosa R, 2002, ARCH ENVIRON HEALTH, V57, P188, DOI 10.1080/00039890209602935; Poltorak M, 2014, EUR J IMMUNOL, V44, P1535, DOI 10.1002/eji.201344046; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; SAGAI M, 1993, FREE RADICAL BIO MED, V14, P37, DOI 10.1016/0891-5849(93)90507-Q; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Scariano JK, 2008, J RECEPT SIG TRANSD, V28, P285, DOI [10.1080/10799890802084614, 10.1080/10799890802084614 ]; Sharma SK, 2011, J INFECT DIS, V204, P645, DOI 10.1093/infdis/jir340; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Song JJ, 2013, INT J PEDIATR OTORHI, V77, P1760, DOI 10.1016/j.ijporl.2013.08.012; Song JJ, 2012, INT J PEDIATR OTORHI, V76, P334, DOI 10.1016/j.ijporl.2011.12.003; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; Takizawa H, 2000, Respirology, V5, P197, DOI 10.1046/j.1440-1843.2000.00245.x; Wan JX, 2007, INHAL TOXICOL, V19, P177, DOI 10.1080/08958370701496145; WEBB GC, 1993, GENOMICS, V18, P14, DOI 10.1006/geno.1993.1421	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166044	10.1371/journal.pone.0166044	http://dx.doi.org/10.1371/journal.pone.0166044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832168	Green Published, gold			2022-12-27	WOS:000387725000058
J	de Leon-Bautista, MP; Cardenas-Aguayo, MD; Casique-Aguirre, D; Almaraz-Salinas, M; Parraguirre-Martinez, S; Olivo-Diaz, A; Thompson-Bonilla, MD; Vargas, M				Piedad de Leon-Bautista, Mercedes; del Carmen Cardenas-Aguayo, Maria; Casique-Aguirre, Diana; Almaraz-Salinas, Manuel; Parraguirre-Martinez, Sara; Olivo-Diaz, Angelica; del Rocio Thompson-Bonilla, Maria; Vargas, Miguel			Immunological and Functional Characterization of RhoGDI3 and Its Molecular Targets RhoG and RhoB in Human Pancreatic Cancerous and Normal Cells	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; EPIDERMAL-GROWTH-FACTOR; GTP-BINDING PROTEINS; FACTOR RECEPTOR; EXPRESSION; GTPASES; CARCINOMA; RAS; METASTASIS; INVASION	RhoGDI proteins have been implicated in several human cancers; changes in their expression levels have shown pro-or anti-tumorigenic effects. Pancreatic Ductal Adenocarcinoma (PDAC) is a complex pathology, with poor prognosis, and most patients die shortly after diagnosis. Efforts have been focused on understanding the role of RhoGDI's in PDAC, specially, RhoGDI1 and RhoGDI2. However, the role of RhoGDI3 has not been studied in relation to cancer or to PDAC. Here, we characterized the expression and functionality of RhoGDI3 and its target GTPases, RhoG and RhoB in pancreatic cell lines from both normal pancreatic tissue and tissue in late stages of PDAC, and compared them to human biopsies. Through immunofluorescences, pulldown assays and subcellular fractionation, we found a reduction in RhoGDI3 expression in the late stages of PDAC, and this reduction correlates with tumor progression and aggressiveness. Despite the reduction in the expression of RhoGDI3 in PDAC, we found that RhoB was underexpressed while RhoG was overexpressed, suggesting that cancerous cells preserve their capacity to activate this pathway, thus these cells may be more eager to response to the stimuli needed to proliferate and become invasive unlike normal cells. Surprisingly, we found nuclear localization of RhoGDI3 in non -cancerous pancreatic cell line and normal pancreatic tissue biopsies, which could open the possibility of novel nuclear functions for this protein, impacting gene expression regulation and cellular homeostasis.	[Piedad de Leon-Bautista, Mercedes; Casique-Aguirre, Diana; Vargas, Miguel] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Ave Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico; [del Carmen Cardenas-Aguayo, Maria] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Ave Univ 3000, Delegacion Coyoacan 04510, Mexico; [Almaraz-Salinas, Manuel] Inst Tecnol Milpa Alta, Fac Bioquim, Independencia 36, Mexico City 12300, DF, Mexico; [Parraguirre-Martinez, Sara] Hosp Gen Doctor Manuel Gea Gonzalez, Dept Anat Patol, Av Calzada Tlalpan 4800,Sect 16, Mexico City 14080, DF, Mexico; [Olivo-Diaz, Angelica] Hosp Doctor Manuel Gea Gonzalez, Dept Biol Mol & Histocompatibilidad, Av Calzada Tlalpan 4800,Sect 16, Mexico City 14080, DF, Mexico; [del Rocio Thompson-Bonilla, Maria] Hosp 1 Octubre, ISSSTE, Lab Med Genom, Invest Biomed Traslac, Av Inst Politecn Nacl 1669, Mexico City 07760, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Vargas, M (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Ave Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico.	mavargas@cinvestav.mx	Casique Aguirre, Diana/E-8650-2019; del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020	Casique Aguirre, Diana/0000-0001-5580-2551; del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161; VARGAS, MIGUEL/0000-0002-3031-9798	CONACyT Mexico Grant ANR-CONAGyT [140364]; CONACYT [153334]; ISSSTE [002.2015]	CONACyT Mexico Grant ANR-CONAGyT(French National Research Agency (ANR)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ISSSTE	This work was supported by CONACyT Mexico Grant ANR-CONAGyT 140364, CONACYT 153334 and ISSSTE 002.2015.	Abiatari I, 2009, MOL CANCER THER, V8, P1494, DOI 10.1158/1535-7163.MCT-08-0755; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Adnane J, 2002, CLIN CANCER RES, V8, P2225; Adra CN, 1998, GENOMICS, V53, P104, DOI 10.1006/geno.1998.5482; ADRA CN, 1993, GENE CHROMOSOME CANC, V8, P253, DOI 10.1002/gcc.2870080408; Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065; Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Bousquet E, 2016, ONCOGENE, V35, P1760, DOI 10.1038/onc.2015.240; Brunet N, 2002, TRAFFIC, V3, P342, DOI 10.1034/j.1600-0854.2002.30504.x; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gildea JJ, 2002, CANCER RES, V62, P6418; Golovanov AP, 2001, J MOL BIOL, V305, P121, DOI 10.1006/jmbi.2000.4262; Guillemot JC, 1996, BLOOD, V88, P2722, DOI 10.1182/blood.V88.7.2722.bloodjournal8872722; Hu LD, 2007, ONCOL REP, V17, P1383; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Jones MB, 2002, PROTEOMICS, V2, P76, DOI 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.3.CO;2-F; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Keep NH, 1997, STRUCTURE, V5, P623, DOI 10.1016/S0969-2126(97)00218-9; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Krieser RJ, 1999, CELL DEATH DIFFER, V6, P412, DOI 10.1038/sj.cdd.4400515; Li WD, 2013, INT J CLIN EXP PATHO, V6, P2535; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Lu W, 2008, CHINA FRONTIERS ENV, V2, P15, DOI [10.1007/s11783-008-006-z, DOI 10.1007/S11010-008-9713-9]; Morin A, 2011, SMALL GTPASES, V1, P142, DOI DOI 10.4161/SGTP.1.3.15112; OHGA N, 1989, BIOCHEM BIOPH RES CO, V163, P1523, DOI 10.1016/0006-291X(89)91153-4; Paulo JA, 2013, BBA-PROTEINS PROTEOM, V1834, P791, DOI 10.1016/j.bbapap.2013.01.011; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Reimer J, 2007, ANTI-CANCER DRUG, V18, P333, DOI 10.1097/CAD.0b013e328011fd7f; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120076; [王世和 Wang Shihe], 2003, [中国给水排水, China Water & Wastewater], V19, P9; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106; Yi B, 2014, INT J MOL MED, V34, P205, DOI 10.3892/ijmm.2014.1765; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang Y-Y, 2006, PROG MODERN BIOMED, V6, P8, DOI DOI 10.1158/0008-5472.CAN-05-; Zhang YQ, 2009, J BIOL CHEM, V284, P12956, DOI 10.1074/jbc.M807845200; Zheng Z, 2013, ONCOL LETT, V5, P255, DOI 10.3892/ol.2012.949	57	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166370	10.1371/journal.pone.0166370	http://dx.doi.org/10.1371/journal.pone.0166370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832197	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000112
J	Teilmann, AC; Rozell, B; Kalliokoski, O; Hau, J; Abelson, KSP				Teilmann, Anne Charlotte; Rozell, Bjorn; Kalliokoski, Otto; Hau, Jann; Abelson, Klas S. P.			Carotid Catheterization and Automated Blood Sampling Induce Systemic IL-6 Secretion and Local Tissue Damage and Inflammation in the Heart, Kidneys, Liver and Salivary Glands in NMRI Mice	PLOS ONE			English	Article							VOLUNTARILY-INGESTED BUPRENORPHINE; CHRONIC VASCULAR CATHETERIZATION; CORTICOSTERONE LEVELS; PERMANENT CATHETERIZATION; PLASMA INTERLEUKIN-6; BODY-WEIGHT; STRESS; CYTOKINES; RAT; ACTIVATION	Automated blood sampling through a vascular catheter is a frequently utilized technique in laboratory mice. The potential immunological and physiological implications associated with this technique have, however, not been investigated in detail. The present study compared plasma levels of the cytokines IL-1 beta, IL-2, IL-6, IL-10, IL-17A, GM-CSF, IFN-gamma and TNF-alpha in male NMRI mice that had been subjected to carotid artery catheterization and subsequent automated blood sampling with age-matched control mice. Body weight and histopathological changes in the surgical area, including the salivary glands, the heart, brain, spleen, liver, kidneys and lungs were compared. Catheterized mice had higher levels of IL-6 than did control mice, but other cytokine levels did not differ between the groups. No significant difference in body weight was found. The histology revealed inflammatory and regenerative ( healing) changes at surgical sites of all catheterized mice, with mild inflammatory changes extending into the salivary glands. Several catheterized mice had multifocal degenerative to necrotic changes with inflammation in the heart, kidneys and livers, suggesting that thrombi had detached from the catheter tip and embolized to distant sites. Thus, catheterization and subsequent automated blood sampling may have physiological impact. Possible confounding effects of visceral damage should be assessed and considered, when using catheterized mouse models.	[Teilmann, Anne Charlotte; Kalliokoski, Otto; Hau, Jann; Abelson, Klas S. P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark; [Rozell, Bjorn] Karolinska Inst, Dept Comparat Med, SE-17177 Stockholm, Sweden	University of Copenhagen; Karolinska Institutet	Teilmann, AC (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark.	annete@sund.ku.dk	Kalliokoski, Otto/I-3828-2019; Hau, Jann/C-8692-2012	Kalliokoski, Otto/0000-0001-6531-3487; Hau, Jann/0000-0001-8586-5705; Abelson, Klas/0000-0002-4986-7882				Abelson KSP, 2012, LAB ANIM-UK, V46, P349, DOI 10.1258/la.2012.012028; Anderson G, 2002, THEORY PRACTICE HIST, P85; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; BLAHA MD, 2008, J AM ASSOC LAB ANIM, V47, P8; Blanchard AA, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0068-3; Chappell MG, 2011, J AM ASSOC LAB ANIM, V50, P227; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Fonseca UNK, 2010, LAB ANIM-UK, V44, P46, DOI 10.1258/la.2009.008122; Frazier KS, 2012, TOXICOL PATHOL, V40, P14, DOI 10.1177/0192623312438736; Goldkuhl R, 2010, IN VIVO, V24, P131; Grouzmann E, 2003, PFLUG ARCH EUR J PHY, V447, P254, DOI 10.1007/s00424-003-1140-x; Hagan CE, 2012, COMP ANATOMY HISTOLO, P339; Harada T., 1999, PATHOLOGY MOUSE, P119; Haschek WM, 2010, FUNDAMENTALS OF TOXICOLOGIC PATHOLOGY, 2ND EDITION, P197, DOI 10.1016/B978-0-12-370469-6.00009-X; Hayes KE, 2000, CONTEMP TOP LAB ANIM, V39, P18; Hovard AMB, 2015, LAB ANIM-UK, V49, P40, DOI 10.1177/0023677214551108; Hsing Chung-Hsi, 2015, Acta Anaesthesiol Taiwan, V53, P23, DOI 10.1016/j.aat.2015.03.002; Jacobsen KR, 2011, ANIM WELFARE, V20, P591; Jacobsen KR, 2013, COMPARATIVE MED, V63, P105; Jokinen MP, 2005, CARDIOVASC TOXICOL, V5, P227, DOI 10.1385/CT:5:2:227; Kalliokoski O, 2010, IN VIVO, V24, P641; Kaplan H. M., 1983, MOUSE BIOMEDICAL RES, V111, P248; Lin E, 2000, SURGERY, V127, P117, DOI 10.1067/msy.2000.101584; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; McInnes E.F., 2011, BACKGROUND LESIONS L; Mirantes C, 2014, EXP CELL RES; MOKHTARIAN A, 1993, PHYSIOL BEHAV, V54, P895, DOI 10.1016/0031-9384(93)90298-T; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nukina K, 2001, J NEUROIMMUNOL, V115, P46, DOI 10.1016/S0165-5728(01)00260-0; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954; Shebusky RJ, 2001, J PHARMACOL EXP THER, V300, P729; Sheeran P, 1997, BRIT J ANAESTH, V78, P201, DOI 10.1093/bja/78.2.201; Sinno MCN, 2012, ECHOCARDIOGR-J CARD, V29, pE56, DOI 10.1111/j.1540-8175.2011.01582.x; Siswanto H, 2008, IN VIVO, V22, P435; Sundbom R, 2011, IN VIVO, V25, P335; Tan RHH, 2003, AUST VET J, V81, P136, DOI 10.1111/j.1751-0813.2003.tb11074.x; Teilmann AC, 2014, LAB ANIM-UK, V48, P278, DOI 10.1177/0023677214541438; Teilmann AC, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-33; Teilmann AC, 2014, LAB ANIMAL, V43, P397, DOI 10.1038/laban.570; Teilmann AC, 2012, IN VIVO, V26, P577; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7; Yang J, 2005, LAB ANIM-UK, V39, P259, DOI 10.1258/0023677054307033; YOBURN BC, 1984, PHYSIOL BEHAV, V33, P89, DOI 10.1016/0031-9384(84)90018-0; Zhong Q., 2015, J APPL STAT, V1, P1, DOI DOI 10.1007/S00500-015-1789-Z; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	48	4	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166353	10.1371/journal.pone.0166353	http://dx.doi.org/10.1371/journal.pone.0166353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832170	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000108
J	Archidona-Yuste, A; Navas-Cortes, JA; Cantalapiedra-Navarrete, C; Palomares-Rius, JE; Castillo, P				Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo			Remarkable Diversity and Prevalence of Dagger Nematodes of the Genus Xiphinema Cobb, 1913 (Nematoda: Longidoridae) in Olives Revealed by Integrative Approaches	PLOS ONE			English	Article							SP-N NEMATODA; AMERICANUM-GROUP; COMPLEX NEMATODA; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR CHARACTERIZATION; SPECIES DELIMITATION; PARASITIC NEMATODES; IDENTIFICATION; PACHTAICUM; POPULATIONS	The genus Xiphinema includes a remarkable group of invertebrates of the phylum Nematoda comprising ectoparasitic animals of many wild and cultivated plants. Damage is caused by direct feeding on root cells and by vectoring nepoviruses that cause diseases on several crops. Precise identification of Xiphinema species is critical for launching appropriate control measures. We make available the first detailed information on the diversity and distribution of Xiphinema species infesting wild and cultivated olive in a wide-region in southern Spain that included 211 locations from which 453 sampling sites were analyzed. The present study identified thirty-two Xiphinema spp. in the rhizosphere of olive trees, ten species belonging to Xiphinema americanum-group, whereas twenty-two were attributed to Xiphinema non-americanum-group. These results increase our current knowledge on the biodiversity of Xiphinema species identified in olives and include the description of four new species (Xiphinema andalusiense sp. nov., Xiphinema celtiense sp. nov., Xiphinema iznajarense sp. nov., and Xiphinema mengibarense sp. nov.), and two new records for cultivate olives (X. cadavalense and X. conurum). We also found evidence of remarkable prevalence of Xiphinema spp. in olive trees, viz. 85.0% (385 out of 453 sampling sites), and they were widely distributed in both wild and cultivated olives, with 26 and 17 Xiphinema spp., respectively. Diversity indexes (Richness, Hill 's diversity, Hill 's reciprocal of D and Hill' s evenness) were significantly affected by olive type. We also developed a comparative morphological and morphometrical study together with molecular data from three nuclear ribosomal RNA genes (D2-D3 expansion segments of 28S, ITS1, and partial 18S). Molecular characterization and phylogenetic analyses allowed the delimitation and discrimination of four new species of the genus described herein and three known species. Phylogenetic analyses of Xiphinema spp. resulted in a general consensus of these species groups. This study is the most complete phylogenetic analysis for Xiphinema non-americanum-group species to date.	[Archidona-Yuste, Antonio; Navas-Cortes, Juan A.; Cantalapiedra-Navarrete, Carolina; Palomares-Rius, Juan E.; Castillo, Pablo] CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Castillo, P (corresponding author), CSIC, IAS, Ave Menendez Pidal S-N, Cordoba 14004, Spain.	p.castillo@csic.es	Navas-Cortes, Juan A/H-3381-2014; , Antonio/ABF-4935-2020; Archidona-Yuste, Antonio/GRS-2729-2022; Castillo, Pablo/L-3397-2019; Navas-Cortes, Juan A./M-2060-2019; Castillo, Pablo/A-1445-2011; Archidona-Yuste, Antonio/C-2406-2018; Palomares-Rius, Juan/K-8004-2015	Navas-Cortes, Juan A/0000-0001-6480-1104; , Antonio/0000-0003-4446-0642; Archidona-Yuste, Antonio/0000-0003-4446-0642; Castillo, Pablo/0000-0001-6657-6385; Castillo, Pablo/0000-0003-0256-876X; Archidona-Yuste, Antonio/0000-0003-4446-0642; Palomares-Rius, Juan/0000-0003-1776-8131	Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P12-AGR-1486]; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262]; 'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; FEDER from the European Union	Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); 'Ministerio de Economia y Competitividad' of Spain; FEDER from the European Union	Financial support was received by Project P12-AGR-1486 from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, the grant 219262 ArimNET_ERANET FP7 2012-2015 Project PESTOLIVE 'Contribution of olivehistory for the management of soilborne parasites in the Mediterranean basin' from Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA), Project AGL-2012-37521 from 'Ministerio de Economia y Competitividad' of Spain, and FEDER financial support from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archidona-Yuste A, 2016, INVERTEBR SYST, V30, P547, DOI 10.1071/IS16002; Archidona-Yuste A, 2016, ZOOL J LINN SOC-LOND, V176, P231, DOI 10.1111/zoj.12316; Archidona-Yuste A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147689; ARIAS M, 1987, Revue de Nematologie, V10, P377; Arias M., 1973, Nematologia Mediterranea, V1, P28; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Brown D.J.F., 1994, Nematologia Mediterranea, V22, P253; Brown D.J.F., 1993, Nematologia Mediterranea, V20, P251; Cantalapiedra-Navarrete C, 2013, ZOOL ANZ, V252, P246, DOI 10.1016/j.jcz.2012.08.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cherry T, 1997, J NEMATOL, V29, P23; Cobb N. A., 1913, J Acad Sci, V3; COOMANS A, 1985, AGR ECOSYST ENVIRON, V12, P335, DOI 10.1016/0167-8809(85)90006-4; Coomans A, 2000, NEMATOLOGY, V2, P3, DOI 10.1163/156854100508845; Coomans A, 2001, ANN SCI ZOOLOGIQUES, V287, P1; Coomans August, 1996, Russian Journal of Nematology, V4, P51; Dalmasso A., 1969, MEMOIRES MUSEUM NATL, VLXI; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Decaens T, 2006, EUR J SOIL BIOL, V42, pS23, DOI 10.1016/j.ejsobi.2006.07.001; Decraemer W, 2006, PLANT NEMATOLOGY, P3, DOI [10.1079/9781845930561.0003, 10.1079/9781780641515.0003]; Decraemer W, 2007, J NEMATOL, V39, P295; Groza M, 2013, HELMINTHOLOGIA, V50, P215, DOI 10.2478/s11687-013-0133-3; Guesmi-Mzoughi I, 2017, EUR J PLANT PATHOL, V147, P389, DOI 10.1007/s10658-016-1011-x; Gutierrez-Gutierrez C, 2013, ZOOL J LINN SOC-LOND, V169, P548, DOI 10.1111/zoj.12071; Gutierrez-Gutierrez C, 2012, EUR J PLANT PATHOL, V134, P561, DOI 10.1007/s10658-012-0039-9; Gutierrez-Gutierrez C, 2011, PHYTOPATHOLOGY, V101, P1168, DOI 10.1094/PHYTO-07-10-0194; Gutierrez-Gutierrez C, 2011, EUR J PLANT PATHOL, V129, P427, DOI 10.1007/s10658-010-9705-y; Gutierrez-Gutierrez C, 2010, ZOOL SCR, V39, P483, DOI 10.1111/j.1463-6409.2010.00437.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hashim Z., 1979, Nematologia Mediterranea, V7, P177; Hashim Z., 1983, Nematologia Mediterranea, V11, P27; He Y, 2005, NEMATOLOGY, V7, P111, DOI 10.1163/1568541054192108; HEYNS J, 1971, Phytophylactica, V3, P107; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kirjanova E. S, 1951, TRUDY ZOOL INST AKAD, V9, P625; Koenning SR, 1999, J NEMATOL, V31, P587; Lal A., 1982, Nematologia Mediterranea, V10, P217; Lamberti F., 2004, Nematologia Mediterranea, V32, P53; Lamberti F., 1993, Nematologia Mediterranea, V21, P215; Lamberti F., 1983, Nematologia Mediterranea, V11, P49; Lamberti F, 2000, RUSS J NEMATOL, V8, P65; Lamberti F., 1992, Nematologia Mediterranea, V20, P125; Lamberti F., 1986, Nematologia Mediterranea, V14, P101; Lamberti F., 1993, EPPO B, V23, P481, DOI DOI 10.1111/J.1365-2338.1993.TB01356.X; Lamberti F, 1979, NEMATOLOGIA MEDITERR, V7, P51; Lamberti F, 1990, NEMATOLOGIA MEDITERR, V17, P115; Linnaeus C, 1766, SYSTEMA NATURAE REGN; LOOF PAA, 1990, SYST PARASITOL, V16, P35, DOI 10.1007/BF00009600; LOOF PAA, 1972, NEMATOLOGICA, V18, P92, DOI 10.1163/187529272X00458; LUC M, 1985, Revue de Nematologie, V8, P85; LUC M, 1982, Revue de Nematologie, V5, P233; Luc M., 1964, Nematologica, V10, P151; Luc M., TROIS NOUVEAUX XIPHI; Macfarlane SA, 2003, MOL PLANT PATHOL, V4, P211, DOI 10.1046/j.1364-3703.2003.00164.x; MacFarlane SA, 2002, ADV BOT RES, V36, P169, DOI 10.1016/S0065-2296(02)36063-4; Martelli GP, 1990, ADV DIS VECTOR RES, V6, P144; MCELROY FD, 1972, J NEMATOL, V4, P16; Meyl AH., 1953, Z MORPHOLOGIE OKOL T; MICOLETZKY H., 1927, ZOOL ANZEIGER, V73, P113; NAVAS A, 1988, NEMATOLOGICA, V34, P314, DOI 10.1163/002825988X00170; Navas A., 1993, Nematologia Mediterranea, V21, P71; Navas A., 1990, Nematologia Mediterranea, V18, P103; Oliveira CMG, 2006, J NEMATOL, V38, P418; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palomares-Rius JE, 2008, NEMATOLOGY, V10, P87, DOI 10.1163/156854108783360186; Palomares-Rius JE, 2016, MOL ECOL, V25, P6225, DOI 10.1111/mec.13904; Palomares-Rius JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116890; Palomares-Rius JE, 2014, NEMATOLOGY, V16, P1105, DOI 10.1163/15685411-00002831; Palomares-Rius JE, 2012, SOIL BIOL BIOCHEM, V45, P168, DOI 10.1016/j.soilbio.2011.11.009; PENA-SANTIAGO R, 1990, Revue de Nematologie, V13, P113; Pereira M. J., 1992, NEMATOLOGICA, V38, P428; Robbins Robert T., 1996, Russian Journal of Nematology, V4, P163; ROBBINS RT, 1995, SYST PARASITOL, V32, P33, DOI 10.1007/BF00009466; ROCA F, 1994, FUND APPL NEMATOL, V17, P79; ROCA F, 1993, FUND APPL NEMATOL, V16, P543; ROCA F, 1993, FUND APPL NEMATOL, V16, P515; ROCA F, 1991, Revue de Nematologie, V14, P597; ROCA F, 1993, FUND APPL NEMATOL, V16, P455; Roca F., 1988, Nematologia Mediterranea, V16, P87; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Moreno S, 2015, AGRON SUSTAIN DEV, V35, P691, DOI 10.1007/s13593-014-0266-x; Sasanelli N., 1999, Nematologia Mediterranea, V27, P253; Schindler AF, 1957, MARYLAND FLORIST, V47, P1; Schuurmans Stekhoven Jr JH, 1938, NEMATODES LIBRES TER; Siddiqi M. R., 1961, Zeitschrift fuer Parasitenkunde, V20, P457, DOI 10.1007/BF00572848; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; STURHAN D, 1983, NEMATOLOGICA, V29, P270, DOI 10.1163/187529283X00032; STURHAN D, 1984, NEMATOLOGICA, V30, P305, DOI 10.1163/187529284X00211; STURHAN D, 1978, NEMATOLOGICA, V24, P19, DOI 10.1163/187529278X00029; Subbotin SA, 2006, PLANT NEMATOLOGY, P33, DOI 10.1079/9781845930561.0033; Tarjan A. C., 1964, FAO PLANT PROTECTION, V12, P49; Taylor C.E., 1997, NEMATODE VECTORS PLA; Teliz D, 2007, PLANT DIS, V91, P1147, DOI 10.1094/PDIS-91-9-1147; Thome G., 1939, V Proc helminth Soc Washington, V6, P30; THORNE G, 1950, P HELM SOC WASH, V17, P27; THORNE GERALD, 1935, PROC HELMINTH SOC WASHINGTON, V2, P96; Tulaganov A. T, 1938, T UZBEKSKOGO GOSUDAR, V12, P1; Tzortzakakis EA, 2015, NEMATOLOGY, V17, P231, DOI 10.1163/15685411-00002865; Tzortzakakis EA, 2014, EUR J PLANT PATHOL, V140, P563, DOI 10.1007/s10658-014-0488-4; WILLIAMS TD, 1961, CAN J ZOOLOG, V39, P407, DOI 10.1139/z61-044; Wolters V, 2001, EUR J SOIL BIOL, V37, P221, DOI 10.1016/S1164-5563(01)01088-3; Wyss U, 1997, DEV PLANT PATHOL, V10, P5; Ye WM, 2004, J NEMATOL, V36, P14; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X	105	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165412	10.1371/journal.pone.0165412	http://dx.doi.org/10.1371/journal.pone.0165412			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829048	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300043
J	Hamedi, Y; Sharifi-Sarasiabi, K; Dehghan, F; Safari, R; To, S; Handayuni, I; Trimarsanto, H; Price, RN; Auburn, S				Hamedi, Yaghoob; Sharifi-Sarasiabi, Khojasteh; Dehghan, Farzaneh; Safari, Reza; To, Sheren; Handayuni, Irene; Trimarsanto, Hidayat; Price, Ric N.; Auburn, Sarah			Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1	PLOS ONE			English	Article							RESISTANT PLASMODIUM-VIVAX; SINGLE-NUCLEOTIDE POLYMORPHISMS; LOCAL-POPULATION STRUCTURE; MALARIA CONTROL; TRANSMISSION DYNAMICS; GENETIC DIVERSITY; CRT-O; AREAS; INFECTIONS; MYANMAR	Background Malaria remains endemic at low levels in the south-eastern provinces of Iran bordering Afghanistan and Pakistan, with the majority of cases attributable to P. vivax. The national guidelines recommend chloroquine (CQ) as blood-stage treatment for uncomplicated P. vivax, but the large influx of imported cases enhances the risk of introducing CQ resistance (CQR). Methodology and Principal Findings The genetic diversity at pvmdr1, a putative modulator of CQR, and across nine putatively neutral short tandem repeat (STR) markers were assessed in P. vivax clinical isolates collected between April 2007 and January 2013 in Hormozgan Province, south-eastern Iran. One hundred blood samples were collected from patients with microscopy-confirmed P. vivax enrolled at one of five district clinics. In total 73 (73%) were autochthonous cases, 23 (23%) imported cases from Afghanistan or Pakistan, and 4 (4%) with unknown origin. 97% (97/100) isolates carried the F1076L mutation, but none carried the Y976F mutation. STR genotyping was successful in 71 (71%) isolates, including 57(57%) autochthonous and 11 (11%) imported cases. Analysis of population structure revealed 2 major sub-populations, K1 and K2, with further sub-structure within K2. The K1 sub-population had markedly lower diversity than K2 (H-E = 0.06 vs H-E = 0.82) suggesting that the sub-populations were sustained by distinct reservoirs with differing transmission dynamics, possibly reflecting local versus imported/introduced populations. No notable separation was observed between the local and imported cases although the sample size was limited. Conclusions The contrasting low versus high diversity in the two sub-populations (K1 and K2) infers that a combination of local transmission and cross-border malaria from higher transmission regions shape the genetic make-up of the P. vivax population in south-eastern Iran. There was no molecular evidence of CQR amongst the local or imported cases, but ongoing clinical surveillance is warranted.	[Hamedi, Yaghoob; Sharifi-Sarasiabi, Khojasteh] Hormozgan Univ Med Sci, Infect & Trop Dis Res Ctr, Bandar Abbas, Hormozgan Provi, Iran; [Dehghan, Farzaneh] Hormozgan Univ Med Sci, Mol Med Res Ctr, Bandar Abbas, Hormozgan Provi, Iran; [Safari, Reza] Hormozgan Univ Med Sci, Bandar Abbas, Hormozgan Provi, Iran; [To, Sheren; Handayuni, Irene; Price, Ric N.; Auburn, Sarah] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [To, Sheren; Handayuni, Irene; Price, Ric N.; Auburn, Sarah] Charles Darwin Univ, Darwin, NT, Australia; [Trimarsanto, Hidayat] Eijkman Inst Mol Biol, Bioinformat Lab, Jakarta, Indonesia; [Trimarsanto, Hidayat] Minist Res & Technol RISTEK, Jakarta, Indonesia; [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jakarta, Indonesia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Eijkman Institute; Agency for the Assessment & Application of Technology (BPPT); University of Oxford	Sharifi-Sarasiabi, K (corresponding author), Hormozgan Univ Med Sci, Infect & Trop Dis Res Ctr, Bandar Abbas, Hormozgan Provi, Iran.; Auburn, S (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia.; Auburn, S (corresponding author), Charles Darwin Univ, Darwin, NT, Australia.	Shariisarasiabi@gmail.com; Sarah.Aubum@menzies.edu.au	Sharifi-Sarasiabi, Khojasteh/G-2037-2017; Hamedi, Yaghoob/G-7447-2017; Auburn, Sarah/N-2266-2013	Sharifi-Sarasiabi, Khojasteh/0000-0003-3615-5285; Hamedi, Yaghoob/0000-0003-4224-3118; Price, Richard/0000-0003-2000-2874; Auburn, Sarah/0000-0002-4638-536X; Trimarsanto, Hidayat/0000-0003-2436-8283	Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Iran; Wellcome Trust [091625]	Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Iran; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported financially by the Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Iran. SA and RNP were supported by the Wellcome Trust; Senior Fellowship in Clinical Science awarded to RNP (091625). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082553; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Barry AE, 2015, PATHOG GLOB HEALTH, V109, P142, DOI 10.1179/2047773215Y.0000000012; Basseri H R, 2010, Bull Soc Pathol Exot, V103, P340, DOI 10.1007/s13149-010-0050-3; Battle KE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-144; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Chavshin Ali Reza, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P47, DOI 10.1016/S2221-1691(14)60207-0; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-412; Cui LW, 2003, TRENDS PARASITOL, V19, P220, DOI 10.1016/S1471-4922(03)00085-0; del Carmen R, 2012, AM J TROP MED HYG, V87, P813, DOI 10.4269/ajtmh.2012.12-0094; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edrissian G., 2006, IRAN J PARASITOL, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Getachew S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140780; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Hamedi Y., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P512; Hastings IM, 1996, PARASITOLOGY, V112, P155, DOI 10.1017/S0031182000084717; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Kim JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151514; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Marfurt J, 2008, J INFECT DIS, V198, P409, DOI 10.1086/589882; Nateghpour M, 2007, IRAN J PUBLIC HEALTH, V36, P60; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09; PALMQUIST EE, 1954, PUBLIC HEALTH REP, V69, P976, DOI 10.2307/4588935; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pava Z, 2016, ANTIMICROB AGENTS CH, V60, P361, DOI 10.1128/AAC.02207-15; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Price RN, 2012, TRENDS PARASITOL, V28, P522, DOI 10.1016/j.pt.2012.08.005; Pritchard JK, 2000, GENETICS, V155, P945; Raeisi A, 2013, IRAN J PUBLIC HEALTH, V42, P326; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schousboe ML, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-392; Suwanarusk R, 2008, J INFECT DIS, V198, P1558, DOI 10.1086/592451; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; Wangchuk S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1320-8; Wangdi K, 2015, ADV PARASIT, V89, P79, DOI 10.1016/bs.apar.2015.04.002; White NJ, 2012, ADV PARASIT, V80, P113, DOI 10.1016/B978-0-12-397900-1.00002-5; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, WORLD MAL REP 2015; ZAIM M, 1987, J AM MOSQUITO CONTR, V3, P392; Zakeri S, 2006, AM J TROP MED HYG, V74, P394, DOI 10.4269/ajtmh.2006.74.394; Zakeri S, 2010, PARASITOL INT, V59, P15, DOI 10.1016/j.parint.2009.06.006	57	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166124	10.1371/journal.pone.0166124	http://dx.doi.org/10.1371/journal.pone.0166124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829067	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300085
J	Hirasawa, K; Okano, K; Koshiji, R; Funaki, W; Shoji, N				Hirasawa, Kazunori; Okano, Kana; Koshiji, Risako; Funaki, Wakana; Shoji, Nobuyuki			Smaller Fixation Target Size Is Associated with More Stable Fixation and Less Variance in Threshold Sensitivity	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPE; MACULAR DEGENERATION; GAZE TRACKING; MICROPERIMETER MP-1; HUMPHREY PERIMETRY; NIDEK MP-1; STABILITY; GLAUCOMA; NEOVASCULARIZATION; LOCATION	The aims of this randomized observational case control study were to quantify fixation behavior during standard automated perimetry (SAP) with different fixation targets and to evaluate the relationship between fixation behavior and threshold variability at each test point in healthy young participants experienced with perimetry. SAP was performed on the right eyes of 29 participants using the Octopus 900 perimeter, program 32, dynamic strategy. The fixation targets of Point, Cross, and Ring were used for SAP. Fixation behavior was recorded using a wearable eye-tracking glass. All participants underwent SAP twice with each fixation target in a random fashion. Fixation behavior was quantified by calculating the bivariate contour ellipse area (BCEA) and the frequency of deviation from the fixation target. The BCEAs (deg(2)) of Point, Cross, and Ring targets were 1.11, 1.46, and 2.02, respectively. In all cases, BCEA increased significantly with increasing fixation target size (p < 0.05). The logarithmic value of BCEA demonstrated the same tendency (p < 0.05). A positive correlation was identified between fixation behavior and threshold variability for the Point and Cross targets (rho = 0.413-0.534, p < 0.05). Fixation behavior increased with increasing fixation target size. Moreover, a larger fixation behavior tended to be associated with a higher threshold variability. A small fixation target is recommended during the visual field test.	[Hirasawa, Kazunori; Okano, Kana; Koshiji, Risako; Funaki, Wakana] Kitasato Univ, Sch Allied Hlth Sci, Dept Orthopt & Visual Sci, Sagamihara, Kanagawa, Japan; [Shoji, Nobuyuki] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan; [Hirasawa, Kazunori; Okano, Kana; Koshiji, Risako; Funaki, Wakana; Shoji, Nobuyuki] Kitasato Univ, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan	Kitasato University; Kitasato University; Kitasato University	Hirasawa, K (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Dept Orthopt & Visual Sci, Sagamihara, Kanagawa, Japan.; Hirasawa, K (corresponding author), Kitasato Univ, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	hirasawa@kitasato-u.ac.jp		Hirasawa, Kazunori/0000-0001-5100-005X	Kitasato University	Kitasato University	This study was supported by a research fund at Kitasato University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore FM, 2013, OPHTHAL PHYSL OPT, V33, P611, DOI 10.1111/opo.12048; Anderson DR., 1999, AUTOMATED STATIC PER; Bedell HE, 2015, INVEST OPHTH VIS SCI, V56, P2624, DOI 10.1167/iovs.15-16511; Bellmann C, 2004, OPHTHALMOLOGY, V111, P2265, DOI 10.1016/j.ophtha.2004.06.019; Cesareo M, 2015, INT OPHTHALMOL, V35, P11, DOI 10.1007/s10792-014-9924-x; Crossland MD, 2009, RETINA-J RET VIT DIS, V29, P651, DOI 10.1097/IAE.0b013e318196bd65; Demirel S, 1994, J Glaucoma, V3, P28; Dunbar HMP, 2010, INVEST OPHTH VIS SCI, V51, P4346, DOI 10.1167/iovs.09-4556; Fujii GY, 2003, AM J OPHTHALMOL, V136, P1067, DOI 10.1016/S0002-9394(03)00663-9; Gonzalez EG, 2011, INVEST OPHTH VIS SCI, V52, P4208, DOI 10.1167/iovs.10-7026; Grenga PL, 2013, CAN J OPHTHALMOL, V48, P394, DOI 10.1016/j.jcjo.2013.04.006; HEIJL A, 1977, ACTA OPHTHALMOL, V55, P854; Ishiyama Y, 2015, INVEST OPHTH VIS SCI, V56, P7801, DOI 10.1167/iovs.15-17988; Ishiyama Y, 2015, INVEST OPHTH VIS SCI, V56, P6233, DOI 10.1167/iovs.15-17661; Ishiyama Y, 2014, INVEST OPHTH VIS SCI, V55, P8149, DOI 10.1167/iovs.14-15541; Kameda T, 2009, JPN J OPHTHALMOL, V53, P580, DOI 10.1007/s10384-009-0735-y; Lin SR, 2015, J GLAUCOMA, V24, P100, DOI 10.1097/IJG.0b013e31829d9b41; Longhin E, 2013, CAN J OPHTHALMOL, V48, P375, DOI 10.1016/j.jcjo.2013.05.021; Mori F, 2001, AM J OPHTHALMOL, V132, P897, DOI 10.1016/S0002-9394(01)01216-8; Nilsson UL, 1998, OPTOMETRY VISION SCI, V75, P873, DOI 10.1097/00006324-199812000-00009; Rohrschneider K, 2005, AM J OPHTHALMOL, V139, P125, DOI 10.1016/j.ajo.2004.08.060; Rohrschneider K, 1995, Ger J Ophthalmol, V4, P197; Shi Y, 2013, J GLAUCOMA, V22, P169, DOI 10.1097/IJG.0b013e3182311dce; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; Tarita-Nistor L, 2009, INVEST OPHTH VIS SCI, V50, P84, DOI 10.1167/iovs.08-2342; Tezel TH, 1996, OPHTHALMOLOGY, V103, P1829, DOI 10.1016/S0161-6420(96)30419-3; Thaler L, 2013, VISION RES, V76, P31, DOI 10.1016/j.visres.2012.10.012	27	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165046	10.1371/journal.pone.0165046	http://dx.doi.org/10.1371/journal.pone.0165046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829030	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300027
J	Machado, DE; Rodrigues-Baptista, KC; Alessandra-Perini, J; de Moura, RS; dos Santos, TA; Pereira, KG; da Silva, YM; Souza, PJC; Nasciutti, LE; Perini, JA				Machado, Daniel Escorsim; Rodrigues-Baptista, Karina Cristina; Alessandra-Perini, Jessica; de Moura, Roberto Soares; dos Santos, Thiago Alves; Pereira, Kariny Gomes; da Silva, Yasmin Marinho; Cunha Souza, Pergentino Jose; Nasciutti, Luiz Eurico; Perini, Jamila Alessandra			Euterpe oleracea Extract (Acai) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AMAZONIAN PALM BERRY; MART. ACAI; PHYTOCHEMICAL COMPOSITION; ECTOPIC ENDOMETRIUM; DOWN-REGULATION; IN-VITRO; ANGIOGENESIS; EXPRESSION; CYCLOOXYGENASE-2	This study investigated the therapeutic potential of Euterpe oleracea extract (acai) on the growth and survival of endometriotic lesions using an experimental model. Twenty female Sprague-Dawley rats were randomized into two groups after the implantation and establishment of autologous endometrium onto the peritoneum abdominal wall and treated with 200 mg/kg hydroalcoholic solution extract from acai stone or vehicle via gastric tube for 30 consecutive days. Body weight, lesion surface areas, histological and immunohistochemistry analyses of vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), metalloproteinase-9 (MMP-9), cyclooxygenase-2 (COX-2) and F4-80 were performed. Levels of VEGF, VEGFR-2, MMP-9 and COX-2 mRNA were measured. Flow cytometry of F4-80 was performed, and ELISA immunoassays measured prostaglandin E2 (PGE2), VEGF and nitric oxide (NO) and concentrations. Macrophage cell line J774. G8 was treated with 10, 20, and 40 mu g/mL of acai for 24, 48 and 72 h, and cell viability was measured using 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Acai treatment significantly decreased the implant size, and histological examination indicated atrophy and regression. A reduction in immunostaining and mRNA expression of VEGF, MMP-9 and COX-2 was observed, and F4-80 was lower in the treated group than the control group. The treated group also exhibited lower concentrations of PGE2, VEGF and NO compared to the control group. Macrophages cells treated with 20 and 40 mu g/ml of Acai reduced cell viability in about 50% after 24, 48 and 72 h. Our results suggest that Acai effectively suppressed the establishment and growth of endometriotic lesions, and this agent is a promising novel pharmacological therapeutic treatment for endometriosis.	[Machado, Daniel Escorsim; Rodrigues-Baptista, Karina Cristina; Alessandra-Perini, Jessica; dos Santos, Thiago Alves; Pereira, Kariny Gomes; da Silva, Yasmin Marinho; Perini, Jamila Alessandra] Ctr Univ Estadual Zona Oeste, Unidade Farm, Rio De Janeiro, RJ, Brazil; [Rodrigues-Baptista, Karina Cristina; Alessandra-Perini, Jessica; Perini, Jamila Alessandra] Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, RJ, Brazil; [de Moura, Roberto Soares] Univ Estado Rio De Janeiro, Dept Farmacol & Psicobiol, Rio De Janeiro, RJ, Brazil; [dos Santos, Thiago Alves] Univ Estadual Norte Fluminense, Programa Posgrad Biociencias & Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Cunha Souza, Pergentino Jose] Fed Univ Para, Dept Farm, Belem, PA, Brazil; [Nasciutti, Luiz Eurico] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil	Centro Universitario Estadual da Zona Oeste; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Federal do Para; Universidade Federal do Rio de Janeiro	Perini, JA (corresponding author), Ctr Univ Estadual Zona Oeste, Unidade Farm, Rio De Janeiro, RJ, Brazil.; Perini, JA (corresponding author), Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, RJ, Brazil.	jamilaperini@yahoo.com.br		Machado, Daniel/0000-0002-2640-8579	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Riode Janeiro - FAPERJ, Brazil [E-26/010.002619/2014, E-26/010.002644/2014]; Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Brazil [E-26/010.002619/2014, E-26/010.002644/2014]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Riode Janeiro - FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Brazil	This work was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Riode Janeiro - FAPERJ, Brazil (E-26/010.002619/2014 and E-26/010.002644/2014).; This study was supported by the Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Brazil (E-26/010.002619/2014 and E-26/010.002644/2014).	Becker CM, 2007, MICROVASC RES, V74, P121, DOI 10.1016/j.mvr.2007.04.008; Becker CM, 2011, AM J PATHOL, V178, P1782, DOI 10.1016/j.ajpath.2010.12.037; Castro MM, 2009, FREE RADICAL BIO MED, V46, P1298, DOI 10.1016/j.freeradbiomed.2009.02.011; Chishima F, 2002, AM J REPROD IMMUNOL, V48, P50, DOI 10.1034/j.1600-0897.2002.01101.x; da Costa CA, 2012, N-S ARCH PHARMACOL, V385, P1199, DOI 10.1007/s00210-012-0798-z; de Moura RS, 2012, PHYTOMEDICINE, V19, P262, DOI 10.1016/j.phymed.2011.11.004; de Moura RS, 2011, FOOD CHEM TOXICOL, V49, P855, DOI 10.1016/j.fct.2010.12.007; de Souza MO, 2012, NUTR RES, V32, P976, DOI 10.1016/j.nutres.2012.10.001; Del Pozo-Insfran D, 2006, J AGR FOOD CHEM, V54, P1222, DOI 10.1021/jf052132n; Del Pozo-Insfran D, 2004, J AGR FOOD CHEM, V52, P1539, DOI 10.1021/jf035189n; Di Carlo C, 2009, FERTIL STERIL, V91, P2315, DOI 10.1016/j.fertnstert.2008.03.079; Ergenoglu AM, 2013, REPROD SCI, V20, P1230, DOI 10.1177/1933719113483014; Fang XX, 2015, EUR J CANCER, V51, P2820, DOI 10.1016/j.ejca.2015.09.010; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Fragoso MF, 2013, FOOD CHEM TOXICOL, V58, P68, DOI 10.1016/j.fct.2013.04.011; GALLE PC, 1989, OBSTET GYN CLIN N AM, V16, P29; Ghosh D, 2009, MOL NUTR FOOD RES, V53, P322, DOI 10.1002/mnfr.200800182; Gilabert-Estelles J, 2007, HUM REPROD, V22, P2120, DOI 10.1093/humrep/dem149; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Guo SW, 2007, GYNECOL OBSTET INVES, V64, P24, DOI 10.1159/000098413; Heinrich M, 2011, PHYTOCHEM LETT, V4, P10, DOI 10.1016/j.phytol.2010.11.005; Jackson LW, 2005, HUM REPROD, V20, P2014, DOI 10.1093/humrep/dei001; Jana S, 2012, BIOCHEM PHARMACOL, V83, P797, DOI 10.1016/j.bcp.2011.12.030; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Kang J, 2010, FOOD CHEM, V122, P610, DOI 10.1016/j.foodchem.2010.03.020; Kong Sai, 2014, Evid Based Complement Alternat Med, V2014, P146383, DOI 10.1155/2014/146383; Kumar S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.017; Laschke MW, 2008, HUM REPROD, V23, P2308, DOI 10.1093/humrep/den245; Laschke MW, 2007, FERTIL STERIL, V87, P163, DOI 10.1016/j.fertnstert.2006.05.068; Laschke MW, 2007, HUM REPROD UPDATE, V13, P331, DOI 10.1093/humupd/dmm006; Lichtenthaler R, 2005, INT J FOOD SCI NUTR, V56, P53, DOI 10.1080/09637480500082082; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Machado DE, 2008, FERTIL STERIL, V90, P148, DOI 10.1016/j.fertnstert.2007.05.076; Machado DE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/751460; Machado DE, 2014, HISTOL HISTOPATHOL, V29, P903, DOI 10.14670/HH-29.903; Machado DE, 2010, FERTIL STERIL, V93, P2674, DOI 10.1016/j.fertnstert.2009.11.037; Marques ES, 2016, FOOD CHEM TOXICOL, V93, P13, DOI 10.1016/j.fct.2016.04.018; Matsuzaki S, 2004, FERTIL STERIL, V82, P1309, DOI 10.1016/j.fertnstert.2004.03.059; McLaren J, 2000, HUM REPROD UPDATE, V6, P45, DOI 10.1093/humupd/6.1.45; Melin A, 2006, HUM REPROD, V21, P1237, DOI 10.1093/humrep/dei462; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Olivares C, 2008, HUM REPROD, V23, P2701, DOI 10.1093/humrep/den315; Ota H, 2001, HUM REPROD, V16, P561, DOI 10.1093/humrep/16.3.561; Pacheco-Palencia LA, 2009, FOOD CHEM, V115, P1199, DOI 10.1016/j.foodchem.2009.01.034; Perini JA, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0745-x; Perini JA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-117; Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516; Poulose SM, 2012, J AGR FOOD CHEM, V60, P1084, DOI 10.1021/jf203989k; Ribeiro JC, 2010, MUTAT RES-GEN TOX EN, V695, P22, DOI 10.1016/j.mrgentox.2009.10.009; Rocha APM, 2007, VASC PHARMACOL, V46, P97, DOI 10.1016/j.vph.2006.08.411; Rodrigues RB, 2006, J AGR FOOD CHEM, V54, P4162, DOI 10.1021/jf058169p; Ruhland B, 2011, Minerva Ginecol, V63, P247; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8604, DOI 10.1021/jf0609779; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8598, DOI 10.1021/jf060976g; Silva DF, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-175; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Stoner GD, 2009, CANCER PREV RES, V2, P187, DOI 10.1158/1940-6207.CAPR-08-0226; Sudo RT, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0724-2; Swarnakar S, 2009, INDIAN J BIOCHEM BIO, V46, P59; Taylor RN, 2004, GYNECOL OBSTET INVES, V57, P54; Tekin YB, 2015, EUR J OBSTET GYN R B, V184, P1, DOI 10.1016/j.ejogrb.2014.10.041; Tosti C, 2015, REPROD SCI, V22, P1053, DOI 10.1177/1933719115592713; VERNON MW, 1985, FERTIL STERIL, V44, P684; Wang CC, 2013, ANGIOGENESIS, V16, P59, DOI 10.1007/s10456-012-9299-4; Wu Meng-Hsing, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700021X; Xu H, 2009, HUM REPROD, V24, P608, DOI 10.1093/humrep/den417; Xu H, 2011, FERTIL STERIL, V96, P1021, DOI 10.1016/j.fertnstert.2011.07.008; Zanini S, 2015, CRIT REV FOOD SCI, V55, P1870, DOI 10.1080/10408398.2012.732126; Zhang Y, 2011, INT J MOL MED, V27, P87, DOI 10.3892/ijmm.2010.552	70	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166059	10.1371/journal.pone.0166059	http://dx.doi.org/10.1371/journal.pone.0166059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851787	gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300033
J	Mazzuoli, S; Tricarico, D; Demma, F; Furneri, G; Guglielmi, FW				Mazzuoli, S.; Tricarico, D.; Demma, F.; Furneri, G.; Guglielmi, F. W.			Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort Study in IBD Patients	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; CROHNS-DISEASE; MAINTENANCE THERAPY; TOLERABILITY; DRUG	Background Standard Infliximab infusion consists of a 2-hour intravenous administration. Recently, Infliximab shortened infusion has been included in the Infliximab label as possible maintenance regimen for patients tolerating Infliximab induction therapy. Aim To verify if accelerated 1-hour Infliximab infusions are as safe as standard administrations, in patients with Inflammatory Bowel Disease. Methods Seventy-four patients treated between September 2008 and November 2014 were evaluated. Patients were eligible for 1-hour infusion if they had no history of infusion reactions during the previous 2-hour infusions. Results Twenty-three patients received 2-hour infusions, 16 patients received 1-hour infusions, 35 patients received 2-hour infusions followed by 1-hour infusions. A total of 1,123 Infliximab infusions were administered. The proportion of patients experiencing infusion reaction was: 4% over the 1-hour infusions and 9% over the 2-hour (P = 0.318). Adverse reaction/infusion rate was 0.55% over the 1-hour infusions and 0.66% over the 2-hour (P = 0.835). In the logistic model, accelerated infusion was the only statistically significant predictor of infusion reaction risk reduction (-90%; P = 0.024). Mean satisfaction was 8/10 (0.84) with 1-hour regimen and 6/10 (0.56) with 2-hour infusions (P = 0.000). The mean total cost was reduced by 47% with the 1-hour regimen (133.54 and 250.86 for 1-hour and 2-hour infusions, respectively). Conclusions Accelerated Infliximab infusion does not increase the acute infusion reaction incidence. In patients with inflammatory bowel disease, the 1-hour regimen should be preferred to 2-hour protocol also due to positive effects on indirect costs and patient's satisfaction.	[Mazzuoli, S.; Guglielmi, F. W.] San Nicola Pellegrino Hosp, Gastroenterol & Artificial Dept, Trani, BT, Italy; [Tricarico, D.] Univ Bari Aldo Moro, Dept Pharmacol & Pharmaceut Sci, Bari, Italy; [Demma, F.; Furneri, G.] EBMA Consulting, Hlth Econ & Outcome Res Dept, Milan, Italy	Universita degli Studi di Bari Aldo Moro	Guglielmi, FW (corresponding author), San Nicola Pellegrino Hosp, Gastroenterol & Artificial Dept, Trani, BT, Italy.	guglielmifw@libero.it			Merck	Merck(Merck & Company)	Merck provided funding for the editorial support of this article and to EBMA. The funder provided support in the form of salaries for authors GF and FD but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, REM INFL FULL PRESCR; Babouri A, 2013, J CROHNS COLITIS, V7, P129, DOI 10.1016/j.crohns.2012.03.007; Belhassan M, 2013, CLIN RES HEPATOL GAS, V37, P189, DOI 10.1016/j.clinre.2012.07.004; Breynaert C, 2011, AM J GASTROENTEROL, V106, P778, DOI 10.1038/ajg.2011.61; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Colombo GL, 2003, FARMECONOMIA PERCORS, V4; Doessegger L, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.14; European Medicine Agency, 2015, INFL SUMM PROD CHAR; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; ISTAT, 2015, REV CALC; Karsten CM, 2012, IMMUNOBIOLOGY, V217, P1067, DOI 10.1016/j.imbio.2012.07.015; Lee TW, 2011, ALIMENT PHARM THER, V34, P181, DOI 10.1111/j.1365-2036.2011.04699.x; Lichtenstein L, 2015, J CROHNS COLITIS, V9, P806, DOI 10.1093/ecco-jcc/jjv096; Urbano PCM, 2014, BIOL-TARGETS THER, V8, P211, DOI 10.2147/BTT.S57253; Mazzuoli S, 2013, DIGEST LIVER DIS, V45, P969, DOI 10.1016/j.dld.2013.06.010; National Coordination of chronic patients Associations, 2014, DIAGN MED ASS PATW C; Neef HC, 2013, ALIMENT PHARM THER, V38, P365, DOI 10.1111/apt.12389; OECD, 2014, AV SAL; Ollendorf Daniel A, 2006, Am J Ther, V13, P502, DOI 10.1097/01.mjt.0000245223.43783.45; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Saxena P, 2014, EXPERT OPIN BIOL TH, V14, P277, DOI 10.1517/14712598.2014.866649; Van Assche G, 2010, J CROHNS COLITIS, V4, P329, DOI 10.1016/j.crohns.2009.12.012; Vermeire S, 2007, GUT, V56, P1226, DOI 10.1136/gut.2006.099978; Wong BJ, 2011, J MANAGE CARE PHARM, V17, P313	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166443	10.1371/journal.pone.0166443	http://dx.doi.org/10.1371/journal.pone.0166443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851772	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300049
J	Jebena, MG; Lindstrom, D; Belachew, T; Hadley, C; Lachat, C; Verstraeten, R; De Cock, N; Kolsteren, P				Jebena, Mulusew G.; Lindstrom, David; Belachew, Tefera; Hadley, Craig; Lachat, Carl; Verstraeten, Roos; De Cock, Nathalie; Kolsteren, Patrick			Food Insecurity and Common Mental Disorders among Ethiopian Youth: Structural Equation Modeling	PLOS ONE			English	Article							SELF-REPORTING QUESTIONNAIRE; FREQUENCY QUESTIONNAIRE; MEDIATION ANALYSIS; FAMILY INCOME; JIMMA ZONE; HEALTH; INSUFFICIENCY; VALIDATION; DEPRESSION; VALIDITY	Background Although the consequences of food insecurity on physical health and nutritional status of youth living have been reported, its effect on their mental health remains less investigated in developing countries. The aim of this study was to examine the pathways through which food insecurity is associated with poor mental health status among youth living in Ethiopia. Methods We used data from Jimma Longitudinal Family Survey of Youth (JLFSY) collected in 2009/ 10. A total of 1,521 youth were included in the analysis. We measured food insecurity using a 5-items scale and common mental disorders using the 20-item Self-Reporting Questionnaire (SRQ-20). Structural and generalized equation modeling using maximum likelihood estimation method was used to analyze the data. Results The prevalence of common mental disorders was 30.8% (95% CI: 28.6, 33.2). Food insecurity was independently associated with common mental disorders (beta = 0.323, P<0.05). Most (91.8%) of the effect of food insecurity on common mental disorders was direct and only 8.2% of their relationship was partially mediated by physical health. In addition, poor self-rated health (beta = 0.285, P< 0.05), high socioeconomic status (beta = -0.076, P< 0.05), parental education (beta = 0.183, P< 0.05), living in urban area (beta=0.139, P< 0.05), and female-headed household (beta = 0.192, P< 0.05) were associated with common mental disorders. Conclusions Food insecurity is directly associated with common mental disorders among youth in Ethiopia. Interventions that aim to improve mental health status of youth should consider strategies to improve access to sufficient, safe and nutritious food.	[Jebena, Mulusew G.; Belachew, Tefera] Jimma Univ, Populat & Family Hlth, Jimma, Ethiopia; [Lindstrom, David] Brown Univ, Dept Sociol, Providence, RI 02912 USA; [Hadley, Craig] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Jebena, Mulusew G.; Lachat, Carl; De Cock, Nathalie; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, Ghent, Belgium; [Verstraeten, Roos] Inst Trop Med, Dept Publ Hlth, Nutr & Child Hlth Unit, Antwerp, Belgium	Jimma University; Brown University; Emory University; Ghent University; Institute of Tropical Medicine (ITM)	Jebena, MG (corresponding author), Jimma Univ, Populat & Family Hlth, Jimma, Ethiopia.; Jebena, MG (corresponding author), Univ Ghent, Dept Food Safety & Food Qual, Ghent, Belgium.	mulusew.gerbaba@gmail.com	lachat, carl/AAH-9764-2020; Belachew, Tefera/AAO-5877-2020	lachat, carl/0000-0002-1389-8855; Gerbaba, Mulusew/0000-0002-0383-7012	Packard Foundation; Campton Foundation; National Institutes of Health; National Science Foundation (NSF Grant) [0717608]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041020] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); Campton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF Grant)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Packard Foundation, Campton Foundation, the National Institutes of Health, and the National Science Foundation (NSF Grant #0717608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2001, HEALTH POLICY PLANN, V16, P206, DOI 10.1093/heapol/16.2.206; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; Alaimo K, 2001, PEDIATRICS, V108, P44; Alaimo K, 2001, AM J PUBLIC HEALTH, V91, P781, DOI 10.2105/AJPH.91.5.781; Alemu WG, 2013, PREVALENCE ASS FACTO, V2, P43; Allen J, 2014, INT REV PSYCHIATR, V26, P392, DOI 10.3109/09540261.2014.928270; Almeida Alessandro de Moura, 2007, J. bras. psiquiatr., V56, P245, DOI 10.1590/S0047-20852007000400002; Ashiabi GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000940; Ashiabi GS, 2007, IS HOUSEHOLD FOOD IN, V5, P76; Belachew T, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-55; Belachew T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057643; Belachew T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-604; Belachew T, 2011, PEDIATRICS, V127, pE398, DOI 10.1542/peds.2010-0944; Belachew T, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-29; Beusenberg M, 1994, USERS GUIDE SELF REP; Bhattacharya J, 2004, J HEALTH ECON, V23, P839, DOI 10.1016/j.jhealeco.2003.12.008; Bronte-Tinkew J, 2007, J NUTR, V137, P2160, DOI 10.1093/jn/137.9.2160; CAMPBELL CC, 1991, J NUTR, V121, P408, DOI 10.1093/jn/121.3.408; Carta MG, 2000, PSYCHOPATHOLOGY, V33, P240, DOI 10.1159/000029152; Carter KN, 2009, J EPIDEMIOL COMMUN H, V63, P221, DOI 10.1136/jech.2008.079483; Cheng Y, 2008, ASIA PAC J CLIN NUTR, V17, P166; Chilton M, 2009, AM J PUBLIC HEALTH, V99, P556, DOI 10.2105/AJPH.2008.144394; Coates J, 2006, J NUTR, V136, P1438, DOI 10.1093/jn/136.5.1438S; Cole SM, 2011, SOC SCI MED, V73, P1071, DOI 10.1016/j.socscimed.2011.07.012; Collins L., 2009, J ASS RES MOTHERING, V11, P251; Cook JT, 2004, J NUTR, V134, P1432; Dachew BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119464; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; Dessie Y, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.95.2173; Fao, STAT FOOD INS WORLD2; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Fernandes AC, 2013, SOC PSYCH PSYCH EPID, V48, P515, DOI 10.1007/s00127-012-0614-6; Gelaye Bizu, 2012, Clin Pract Epidemiol Ment Health, V8, P126, DOI 10.2174/1745017901208010126; Giang KB, 2006, INT J SOC PSYCHIATR, V52, P175, DOI 10.1177/0020764006061251; Gunzler Douglas, 2013, Shanghai Arch Psychiatry, V25, P390, DOI 10.3969/j.issn.1002-0829.2013.06.009; Hackett M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-175; Hadley C, 2008, J EPIDEMIOL COMMUN H, V62, P980, DOI 10.1136/jech.2007.068460; Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025; Hadley C, 2007, PUBLIC HEALTH NUTR, V10, P544, DOI 10.1017/S1368980007246725; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Harpham T, 2005, BRIT J PSYCHIAT, V187, P161, DOI 10.1192/bjp.187.2.161; Harpham T, 2003, HEALTH POLICY PLANN, V18, P344, DOI 10.1093/heapol/czg041; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heflin CM, 2005, SOC SCI MED, V61, P1971, DOI 10.1016/j.socscimed.2005.04.014; Huang J, 2010, SOC SERV REV, V84, P381, DOI 10.1086/655821; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jackson MD, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-28; Jacob KS, 2014, LANCET, V383, P1433, DOI 10.1016/S0140-6736(13)62382-X; Johnson JG, 1999, J ABNORM PSYCHOL, V108, P490, DOI 10.1037/0021-843X.108.3.490; Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kulkarni AA, 2015, EUR J CLIN NUTR, V69, P79, DOI 10.1038/ejcn.2014.130; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Liu L, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-49; Lund C, 2014, SOC SCI MED, V111, P134, DOI 10.1016/j.socscimed.2014.04.010; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; Marques-Vidal P, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.5905; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Oddy WH, 2009, PREV MED, V49, P39, DOI 10.1016/j.ypmed.2009.05.009; Olson CM, 1999, J NUTR, V129, p504S, DOI 10.1093/jn/129.2.504S; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Psid ID, 2010, DOES HOUSEHOLD FOOD; Quizan T, 2007, FASEB J, V21, pA312; Rose D, 1997, AM J PUBLIC HEALTH, V87, P1956, DOI 10.2105/AJPH.87.12.1956; Roustit C, 2010, EUR CHILD ADOLES PSY, V19, P597, DOI 10.1007/s00787-010-0094-8; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Sanchez-Villegas A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-208; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Siefert K, 2004, J HEALTH SOC BEHAV, V45, P171, DOI 10.1177/002214650404500204; Solar O, 2010, CONCEPTUAL FRAMEWORK, P79; Sorsdahl K, 2011, J EPIDEMIOL COMMUN H, V65, P426, DOI 10.1136/jech.2009.091462; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; Tampubolon G, 2014, SOC SCI MED, V106, P20, DOI 10.1016/j.socscimed.2014.01.012; Tarasuk V, 2007, J NUTR, V137, P1980, DOI 10.1093/jn/137.8.1980; Tarasuk V, 2013, J NUTR, V143, P1785, DOI 10.3945/jn.113.178483; Tesfaye A, 2009, PREVALENCE CORRELATE, P85; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Vozoris NT, 2003, J NUTR, V133, P120, DOI 10.1093/jn/133.1.120; Weaver LJ, 2009, ECOL FOOD NUTR, V48, P263, DOI 10.1080/03670240903001167; Webb Patrick, 2006, J Nutr, V136, p1404S; Weinreb L, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e41; World Health Organization N, 2008, GLOB BURD DIS 2004 U, V2010, P146	84	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165931	10.1371/journal.pone.0165931	http://dx.doi.org/10.1371/journal.pone.0165931			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846283	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600023
J	Pevnick, JM; Fuller, G; Duncan, R; Spiegel, BMR				Pevnick, Joshua M.; Fuller, Garth; Duncan, Ray; Spiegel, Brennan M. R.			A Large-Scale Initiative Inviting Patients to Share Personal Fitness Tracker Data with Their Providers: Initial Results	PLOS ONE			English	Article								Background Personal fitness trackers (PFT) have substantial potential to improve healthcare. Objective To quantify and characterize early adopters who shared their PFT data with providers. Methods We used bivariate statistics and logistic regression to compare patients who shared any PFT data vs. patients who did not. Results A patient portal was used to invite 79,953 registered portal users to share their data. Of 66,105 users included in our analysis, 499 (0.8%) uploaded data during an initial 37-day study period. Bivariate and regression analysis showed that early adopters were more likely than non-adopters to be younger, male, white, health system employees, and to have higher BMIs. Neither comorbidities nor utilization predicted adoption. Conclusion Our results demonstrate that patients had little intrinsic desire to share PFT data with their providers, and suggest that patients most at risk for poor health outcomes are least likely to share PFT data. Marketing, incentives, and/or cultural change may be needed to induce such data-sharing.	[Pevnick, Joshua M.] Cedars Sinai Med Ctr, Dept Med, Div Gen Internal Med, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Pevnick, Joshua M.; Duncan, Ray] Dept Biomed Sci, Div Informat, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Fuller, Garth; Spiegel, Brennan M. R.] Cedars Sinai Med Ctr, Ctr Outcomes Res & Educ, 8700 Beverly Blvd, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Pevnick, JM (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Gen Internal Med, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.; Pevnick, JM (corresponding author), Dept Biomed Sci, Div Informat, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Joshua.Pevnick@cshs.org	Pevnick, Joshua M/AAH-6105-2021		National Institute On Aging; National Center for Advancing Translational Science of the National Institutes of Health [K23AG049181, UCLA CTSI KL2TR000122]; NATIONAL INSTITUTE ON AGING [K23AG049181] Funding Source: NIH RePORTER	National Institute On Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Science of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Joshua Pevnick was supported by the National Institute On Aging and the National Center for Advancing Translational Science of the National Institutes of Health under awards K23AG049181 and UCLA CTSI KL2TR000122. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. There were no other relevant funding sources, and the authors have no conflicts of interest with this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancker JS, 2011, J GEN INTERN MED, V26, P1117, DOI 10.1007/s11606-011-1749-y; de Veer AJE, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0765-8; Fox S, 2012, MOBILE HLTH 2012; Goldzweig CL, 2013, ANN INTERN MED, V159, P677, DOI 10.7326/0003-4819-159-10-201311190-00006; Kohnke Anne, 2014, Journal of Technology Management & Innovation, V9, P29, DOI 10.4067/S0718-27242014000200003; Lee J, 2013, HEALTHC INFORM RES, V19, P167, DOI 10.4258/hir.2013.19.3.167; Palen TE, 2012, JAMA-J AM MED ASSOC, V308, P2012, DOI 10.1001/jama.2012.14126; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Pew Research Center, 2015, SMARTPH DIFF; Shaw RJ, 2016, J AM MED INFORM ASSN, V23, P462, DOI 10.1093/jamia/ocv186; Venkatesh V, 2012, MIS QUART, V36, P157	11	30	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165908	10.1371/journal.pone.0165908	http://dx.doi.org/10.1371/journal.pone.0165908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846287	Green Submitted, gold, Green Published			2022-12-27	WOS:000387794600022
J	Molino, CDRC; Romano-Lieber, NS; Ribeiro, E; de Melo, DO				Rezende Costa Molino, Caroline de Godoi; Romano-Lieber, Nicolina Silvana; Ribeiro, Eliane; de Melo, Daniela Oliveira			Non-Communicable Disease Clinical Practice Guidelines in Brazil: A Systematic Assessment of Methodological Quality and Transparency	PLOS ONE			English	Article							AGREE II; PRIMARY-CARE; MULTIMORBIDITY; MANAGEMENT; APPRAISAL; CHINA; INSTRUMENT	Background Annually, non-communicable diseases (NCDs) kill 38 million people worldwide, with low and middle-income countries accounting for three-quarters of these deaths. High-quality clinical practice guidelines (CPGs) are fundamental to improving NCD management. The present study evaluated the methodological rigor and transparency of Brazilian CPGs that recommend pharmacological treatment for the most prevalent NCDs. Methods We conducted a systematic search for CPGs of the following NCDs: asthma, atrial fibrillation, benign prostatic hyperplasia, chronic obstructive pulmonary disease, congestive heart failure, coronary artery disease and/or stable angina, dementia, depression, diabetes, gastroesophageal reflux disease, hypercholesterolemia, hypertension, osteoarthritis, and osteoporosis. CPGs comprising pharmacological treatment recommendations were included. No language or year restrictions were applied. CPGs were excluded if they were merely for local use and referred to NCDs not listed above. CPG quality was independently assessed by two reviewers using the Appraisal of Guidelines Research and Evaluation instrument, version II (AGREE II). Main Findings "Scope and purpose" and "clarity and presentation" domains received the highest scores. Sixteen of 26 CPGs were classified as low quality, and none were classified as high overall quality. No CPG was recommended without modification (77% were not recommended at all). After 2009, 2 domain scores ("rigor of development" and "clarity and presentation") increased (61% and 73%, respectively). However, "rigor of development" was still rated <30%. Conclusion Brazilian healthcare professionals should be concerned with CPG quality for the treatment of selected NCDs. Features that undermined AGREE II scores included the lack of a multidisciplinary team for the development group, no consideration of patients' preferences, insufficient information regarding literature searches, lack of selection criteria, formulating recommendations, authors' conflict of interest disclosures, and funding body influence.	[Rezende Costa Molino, Caroline de Godoi] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, Sao Paulo, Brazil; [Romano-Lieber, Nicolina Silvana] Univ Sao Paulo, Sch Publ Hlth, Dept Publ Hlth Practice, Sao Paulo, Brazil; [Ribeiro, Eliane] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, Univ Sao Paulo Hosp, Sao Paulo, Brazil; [de Melo, Daniela Oliveira] Univ Fed Sao Paulo, Inst Environm Sci Chem & Pharmaceut, Dept Biol Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	de Melo, DO (corresponding author), Univ Fed Sao Paulo, Inst Environm Sci Chem & Pharmaceut, Dept Biol Sci, Sao Paulo, Brazil.	melo.daniela@unifesp.br	de G. R. C. Molino, Caroline/J-9504-2015; de Melo, Daniela Oliveira/C-8328-2017; Ribeiro, Eliane/D-8308-2012	de G. R. C. Molino, Caroline/0000-0001-6925-1201; de Melo, Daniela Oliveira/0000-0001-8613-7953; Ribeiro, Eliane/0000-0003-0886-368X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [164700/2015-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CGRCM is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), process number 164700/2015-3. The funding source did not influence the content of this study.	Agency for Healthcare Research and Quality (AHRQ), NAT GUID CLEAR; AGREE Next Steps Consortium, 2009, AGREE 2 INSTR EL VER; Al-Ansary LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053744; Bancos I, 2012, J CLIN EPIDEMIOL, V65, P520, DOI 10.1016/j.jclinepi.2011.07.014; Bocchi EA, 2012, ARQ BRAS CARDIOL, V98, P1, DOI 10.1590/S0066-782X2012000700001; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bower P, 2011, FAM PRACT, V28, P579, DOI 10.1093/fampra/cmr018; Brazil. Ministry of Health, 2014, CLIN PROT THER GUID; Brazil. Ministry of Health, 2013, CLIN PROT THER GUID; Brazil. Ministry of Health, 2013, CLIN PROT HER GUID A; Brazil. Ministry of Health, CLIN PROT THER GUID; Brazil Ministry of Health, 2015, CLIN PROT THER GUID; Brazilian Society of Diabetes, GUID BRAZ SOC DIAB; Brazilian Society of Pneumology and Tisiology, 2012, J BRASILEIRO PNEU S1, V38, pS1; Brazilian Society of Pneumology and Tisiology, 2004, J BRAS PNEUMOL, V30, pS1; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cavalcanti A, 2006, BENIGN PROSTATIC HYP; Cesar LA, 2014, ARQ BRAS CARDIOL, V103, P1, DOI 10.5935/abc.2014S004; Chen YL, 2012, CHINESE MED J-PEKING, V125, P3660, DOI 10.3760/cma.j.issn.0366-6999.2012.20.011; Chen Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008099; Chui Sin Yan, 2007, Journal of Pharmacy Practice and Research, V37, P124; Coimbra I, 2011, USE NONSTEROIDAL ANT; Khan GSC, 2014, CAD SAUDE PUBLICA, V30, P1111, DOI 10.1590/0102-311X00174912; Dlyernois J-F, 2014, REV EPIDEMIOL SANTE, V62, P305, DOI [10.1016/j.respe.2014.09.002, DOI 10.1016/J.RESPE.2014.09.002]; Fleck M, 2011, UNIPOLAR DEPRESSION; Fretheim Atle, 2006, Health Res Policy Syst, V4, P15, DOI 10.1186/1478-4505-4-15; Gich I, 2010, QUAL SAF HEALTH CARE, V19, pe58, DOI [10.1136/qshc.2010.042077, DOI 10.1136/QSHC.2010.042077]; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Guiding principles for the care of older adults with multimorbidity: an approach for clinicians, 2012, J Am Geriatr Soc, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; HAINES A, 1994, BMJ-BRIT MED J, V308, P1488, DOI 10.1136/bmj.308.6942.1488; da Mota LMH, 2012, REV BRAS REUMATOL, V52, P135; Hu J, 2013, J EVAL CLIN PRACT, V19, P961, DOI 10.1111/j.1365-2753.2012.01893.x; Hudon C, 2012, PATIENT EDUC COUNS, V88, P170, DOI 10.1016/j.pec.2012.01.009; Jardim J, 2012, CHRONIC OBSTRUCTIVE; Jayaraman S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123780; Jiang M, 2015, CHEST, V148, P759, DOI 10.1378/chest.14-3201; Knai C, 2012, HEALTH POLICY, V107, P157, DOI 10.1016/j.healthpol.2012.06.004; Kryworuchko J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-49; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Kunz Regina, 2012, Proc Am Thorac Soc, V9, P229, DOI 10.1513/pats.201208-056ST; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004; Lopes L, 2011, ALZHEIMERS DIS PREVE; Lorgunpai SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089447; Lowry R, VASSARSTATS WEBSITE; Macedo G, 2011, TYPE 2 DIABETES MELL; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Martins D, 2004, DIABETES MELLITUS TR; McMaster University, MCMASTER AGREE 2 SCO; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Murthy L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009401.pub2; Nasy A, 2011, GASTROESOPHAGEAL REF; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; *PAN AM HLTH ORG, 2012, HEALTH IN THE AMERIC; Piano V, 2013, PAIN PRACT, V13, P349, DOI 10.1111/j.1533-2500.2012.00602.x; Poitras S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2339; Rayess ZAI, 2014, GIN C MELB; Ronsoni RD, 2015, CAD SAUDE PUBLICA, V31, P1157, DOI 10.1590/0102-311X00118814; Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027; Seron P, 2015, J CARDIOPULM REHABIL, V35, P1, DOI 10.1097/HCR.0000000000000075; Sgarbi J, 2004, DIABETES MELLITUS PH; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Siering U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082915; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001; Soeiro A de M, 2014, ARQ BRAS CARDIOL, V102, P1; Tudor KI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069877; U. S. National Library of Medicine, MEDLINE PUBMED; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027; Wagner E H, 1996, Manag Care Q, V4, P12; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; World Health Organization (WHO), 2015, WHO MEDIACENTRE D FA; Xavier HT, 2013, ARQ BRAS CARDIOL, V101, P1, DOI 10.5935/abc.2013S010; Yan JP, 2013, J EVAL CLIN PRACT, V19, P626, DOI 10.1111/j.1365-2753.2012.01873.x; Zhang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111796; Zimerman LI, 2009, ARQ BRAS CARDIOL, V92, P1	81	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166367	10.1371/journal.pone.0166367	http://dx.doi.org/10.1371/journal.pone.0166367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846245	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600052
J	Sonderegger, K; Tschopp, M; Taube, W				Sonderegger, Karin; Tschopp, Markus; Taube, Wolfgang			The Challenge of Evaluating the Intensity of Short Actions in Soccer: A New Methodological Approach Using Percentage Acceleration	PLOS ONE			English	Article							LOCAL POSITION MEASUREMENT; SPEED; PLAYERS; SYSTEM; LPM; PROFILES; ACCURACY	Purpose There are several approaches to quantifying physical load in team sports using positional data. Distances in different speed zones are most commonly used. Recent studies have used acceleration data in addition in order to take short intense actions into account. However, the fact that acceleration decreases with increasing initial running speed is ignored and therefore introduces a bias. The aim of our study was to develop a new methodological approach that removes this bias. For this purpose, percentage acceleration was calculated as the ratio of the maximal acceleration of the action (a(max, action)) and the maximal voluntary acceleration (a(max)) that can be achieved for a particular initial running speed (percentage acceleration [%] = a(max, action) /a(max) * 100). Methods To define a(max), seventy-two highly trained junior male soccer players (17.1 +/- 0.6 years) completed maximal sprints from standing and three different constant initial running speeds (vinit; trotting: similar to 6.0 km .h(-1); jogging: similar to 10.8 km.h(-1); running: similar to 15.0 km.h(-1)). Results The a(max) was 6.01 +/- 0.55 from a standing start, 4.33 +/- 0.40 from trotting, 3.20 +/- 0.49 from jogging and 2.29 +/- 0.34 m.s(-2) from running. The amax correlated significantly with v(init) (r = -0.98) and the linear regression equation of highly-trained junior soccer players was: a(max) = -0.23 * v(init) + 5.99. Conclusion Using linear regression analysis, we propose to classify high-intensity actions as accelerations > 75% of the a(max), corresponding to acceleration values for our population of > 4.51 initiated from standing, > 3.25 from trotting, > 2.40 from jogging, and > 1.72 m.s(-2) from running. The use of percentage acceleration avoids the bias of underestimating actions with high and overestimating actions with low initial running speed. Furthermore, percentage acceleration allows determining individual intensity thresholds that are specific for one population or one single player.	[Sonderegger, Karin; Tschopp, Markus] SFISM, Sect Elite Sport, Magglingen, Switzerland; [Sonderegger, Karin; Taube, Wolfgang] Univ Fribourg, Dept Med Movement & Sport Sci, Fribourg, Switzerland	University of Fribourg	Sonderegger, K (corresponding author), SFISM, Sect Elite Sport, Magglingen, Switzerland.; Sonderegger, K (corresponding author), Univ Fribourg, Dept Med Movement & Sport Sci, Fribourg, Switzerland.	karin.sonderegger@baspo.admin.ch	Taube, Wolfgang/E-4018-2012	Taube, Wolfgang/0000-0002-8802-2065				Akenhead R, 2013, J SCI MED SPORT, V16, P556, DOI 10.1016/j.jsams.2012.12.005; Arsac LM, 2002, J APPL PHYSIOL, V92, P1781, DOI 10.1152/japplphysiol.00754.2001; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P367, DOI 10.1123/ijspp.6.3.367; Aughey RJ, 2010, INT J SPORT PHYSIOL, V5, P394, DOI 10.1123/ijspp.5.3.394; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Bradley PS, 2010, J STRENGTH COND RES, V24, P2343, DOI 10.1519/JSC.0b013e3181aeb1b3; Buchheit M, 2014, J SPORT SCI, V32, P1271, DOI 10.1080/02640414.2014.884721; Buchheit M, 2012, INT J SPORT PHYSIOL, V7, P76, DOI 10.1123/ijspp.7.1.76; Cohen J.E., 1988, STAT POWER ANAL BEHA; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Duthie GM, 2006, J STRENGTH COND RES, V20, P208, DOI 10.1519/R-16784.1; Dwyer DB, 2012, J STRENGTH COND RES, V26, P818, DOI 10.1519/JSC.0b013e3182276555; Frencken WGP, 2010, J SCI MED SPORT, V13, P641, DOI 10.1016/j.jsams.2010.04.003; Gaudino P, 2013, INT J SPORTS MED, V34, P963, DOI 10.1055/s-0033-1337943; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; Hodgson C, 2014, HUM MOVEMENT SCI, V33, P25, DOI 10.1016/j.humov.2013.12.002; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; McFarlane B. A, 1993, NATL STR COND ASS J, V15, P57; Ogris G, 2012, J SPORT SCI, V30, P1503, DOI 10.1080/02640414.2012.712712; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Stelzer A, 2004, IEEE T MICROW THEORY, V52, P2664, DOI 10.1109/TMTT.2004.838281; Stevens TGA, 2014, INT J SPORT PHYSIOL, V9, P446, DOI [10.1123/IJSPP.2013-0340, 10.1123/ijspp.2013-0340]; Varley MC, 2013, INT J SPORTS MED, V34, P34, DOI 10.1055/s-0032-1316315; Young W, 2001, STRENGTH COND J, V23, P7, DOI 10.1519/1533-4295(2001)023<0007:RTFSSA>2.0.CO;2	24	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166534	10.1371/journal.pone.0166534	http://dx.doi.org/10.1371/journal.pone.0166534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846308	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600079
J	Heo, SK; Noh, EK; Gwon, GD; Kim, JY; Joe, JC; Choi, Y; Kohl, S; Baek, JH; Min, YJ; Kim, H				Heo, Sook-Kyoung; Noh, Eui-Kyu; Gwon, Gi-Dong; Kim, Jeong Yi; Joe, Jae-Cheol; Choi, Yunsuk; Kohl, SuJin; Baek, Jin Ho; Min, Young Joo; Kim, Hawk			LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; SOLUBLE DECOY RECEPTOR-3; VIRUS ENTRY MEDIATOR; STROMAL CELLS; METHODOLOGICAL APPROACH; CO-STIMULATION; TRANSPLANTATION; LYMPHOTOXIN/LIGHT; THERAPY	LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus glycoprotein D for herpes virus entry mediator (HVEM)/tumor necrosis factor (TNF)-related 2, is a member of the TNF superfamily. It is expressed as a homotrimer on activated T cells and dendritic cells (DCs), and has three receptors: HVEM, LT-beta receptor (LT beta R), and decoy receptor 3 (DcR3). So far, three receptors with distinct cellular expression patterns are known to interact with LIGHT. Follicular DCs and stromal cells bind LIGHT through LT beta R. We monitored the effects of LIGHT on human bone marrow-derived mesenchymal stem cells (BM-MSCs). At first, we checked the negative and positive differentiation markers of BM-MSCs. And we confirmed the quality of MSCs by staining cells undergoing adipogenesis (Oil Red O staining), chondrogenesis (Alcian blue staining), and osteogenesis (Alizarin red staining). After rhLIGHT treatment, we monitored the count, viability, and proliferation of cells and cell cycle distribution. PDGF and TGF beta production by rhLIGHT was examined by ELISA, and the underlying biological mechanisms were studied by immunoblotting by rhLIGHT treatment. LT beta R was constitutively expressed on the surface of human BM-MSCs. Cell number and viability increased after rhLIGHT treatment. BM-MSC proliferation was induced by an increase in the S/G2/M phase. The expression of not only diverse cyclins such as cyclin B1, D1, D3, and E, but also CDK1 and CDK2, increased, while that of p27 decreased, after rhLIGHT treatment. RhLIGHT-induced PDGF and TGF beta production mediated by STAT3 and Smad3 activation accelerated BM-MSC proliferation. Thus, LIGHT and LT beta R interaction increases the survival and proliferation of human BM-MSCs, and therefore, LIGHT might play an important role in stem cell therapy.	[Heo, Sook-Kyoung; Gwon, Gi-Dong; Kim, Jeong Yi; Kim, Hawk] Univ Ulsan, Coll Med, Biomed Res Ctr, Ulsan Univ Hosp, Ulsan 682060, South Korea; [Noh, Eui-Kyu; Joe, Jae-Cheol; Choi, Yunsuk; Kohl, SuJin; Baek, Jin Ho; Min, Young Joo; Kim, Hawk] Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan 682714, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Kim, H (corresponding author), Univ Ulsan, Coll Med, Biomed Res Ctr, Ulsan Univ Hosp, Ulsan 682060, South Korea.; Kim, H (corresponding author), Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan 682714, South Korea.	kimhawkmd@gmail.com		Choi, Yunsuk/0000-0002-7983-8089	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0094050]; Basic Science Research Program through the NRF - Ministry of Education [NRF-2014R1A1A3051393]; Basic Science Research Program through the Biomedical Research Center - Ulsan University Hospital [UUHBRC-2016-001]	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Basic Science Research Program through the NRF - Ministry of Education; Basic Science Research Program through the Biomedical Research Center - Ulsan University Hospital	This work was supported by the Priority Research Center Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2009-0094050), and by the Basic Science Research Program through the NRF, funded by the Ministry of Education (NRF-2014R1A1A3051393). This research was supported by Basic Science Research Program through the Biomedical Research Center, funded by the Ulsan University Hospital (UUHBRC-2016-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bamias G, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/2637010; Brunetti G, 2014, ONCOTARGET, V5, P12950, DOI 10.18632/oncotarget.2633; Chang PMH, 2008, INT J ONCOL, V33, P549, DOI 10.3892/ijo_00000039; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Colucci S, 2009, LEUKEMIA, V23, P2139, DOI 10.1038/leu.2009.136; De Miguel MP, 2012, CURR MOL MED, V12, P574; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Heo SK, 2006, J LEUKOCYTE BIOL, V79, P330, DOI 10.1189/jlb.1104694; Heo SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129853; Heo SK, 2012, EXP MOL MED, V44, P149, DOI 10.3858/emm.2012.44.2.010; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jung HW, 2003, EXP MOL MED, V35, P501, DOI 10.1038/emm.2003.65; Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lin WW, 2011, BIOCHEM PHARMACOL, V81, P838, DOI 10.1016/j.bcp.2011.01.011; Liu CX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-114; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Martinez HR, 2012, CELL TRANSPLANT, V21, P1899, DOI 10.3727/096368911X582769; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Najar M, 2016, J IMMUNOTHER, V39, P45, DOI 10.1097/CJI.0000000000000108; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Nicolay NH, 2015, CANCER LETT, V366, P133, DOI 10.1016/j.canlet.2015.06.012; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Suk KT, 2016, HEPATOLOGY; Tamada K, 2000, NAT MED, V6, P283; van der Garde M, 2015, STEM CELLS DEV, V24, P2649, DOI 10.1089/scd.2015.0138; Wang J, 2004, IMMUNOL RES, V30, P201, DOI 10.1385/IR:30:2:201; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3	43	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166589	10.1371/journal.pone.0166589	http://dx.doi.org/10.1371/journal.pone.0166589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835685	gold, Green Submitted, Green Published			2022-12-27	WOS:000387779200062
J	Kambach, S; Kuhn, I; Castagneyrol, B; Bruelheide, H				Kambach, Stephan; Kuehn, Ingolf; Castagneyrol, Bastien; Bruelheide, Helge			The Impact of Tree Diversity on Different Aspects of Insect Herbivory along a Global Temperature Gradient - A Meta-Analysis	PLOS ONE			English	Article							ASSOCIATIONAL SUSCEPTIBILITY; HOST-SPECIFICITY; HYPOTHESIS; PRESSURE; DAMAGE; RICHNESS; PATTERNS; DEFENSES; FOLIVORY; DENSITY	Forests with higher tree diversity are often assumed to be more resistant to insect herbivores but whether this effect depends on climatic conditions is so far poorly understood. In particular, a forest's resistance to herbivory may depend on mean annual temperature (MAT) as a key driver of plant and insect phenology. We carried out a global meta-analysis on regression coefficients between tree diversity and four aspects of insect herbivory, namely herbivore damage, abundance, incidence rate and species richness. To test for a potential shift of tree diversity effects along a global gradient of MAT we applied mixed-effects models and estimated grand mean effect sizes and the influence of MAT, experimental vs. observational studies and herbivores diet breadth. There was no overall effect of tree diversity on the pooled effect sizes of insect herbivore damage, abundance and incidence rate. However, when analysed separately, we found positive grand mean effect sizes for herbivore abundance and species richness. For herbivore damage and incidence rate we found a significant but opposing shift along a gradient of MAT indicating that with increasing MAT diversity effects on herbivore damage tend towards associational resistance whereas diversity effects on incidence rates tend towards associational susceptibility. Our results contradict previous meta-analyses reporting overall associational resistance to insect herbivores in mixed forests. Instead, we report that tree diversity effects on insect herbivores can follow a biogeographic pattern calling for further in-depth studies in this field.	[Kambach, Stephan; Kuehn, Ingolf] Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saale, Germany; [Kambach, Stephan; Kuehn, Ingolf; Bruelheide, Helge] Martin Luther Univ Halle Wittenberg, Inst Biol Geobot, Halle, Saale, Germany; [Kambach, Stephan; Kuehn, Ingolf; Bruelheide, Helge] Martin Luther Univ Halle Wittenberg, Bot Garden, Halle, Saale, Germany; [Kuehn, Ingolf; Bruelheide, Helge] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Castagneyrol, Bastien] Univ Bordeaux, INRA, BIOGECO, F-33610 Cestas, France	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Kambach, S (corresponding author), Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saale, Germany.; Kambach, S (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biol Geobot, Halle, Saale, Germany.; Kambach, S (corresponding author), Martin Luther Univ Halle Wittenberg, Bot Garden, Halle, Saale, Germany.	stephan.kambach@ufz.de	Kühn, Ingolf/B-9756-2009; Bruelheide, Helge/G-3907-2013	Kühn, Ingolf/0000-0003-1691-8249; Bruelheide, Helge/0000-0003-3135-0356; Castagneyrol, Bastien/0000-0001-8795-7806; Kambach, Stephan/0000-0003-3585-5837	Helmholtz Centre for Environmental Research - UFZ; Helmholtz Research School for Ecosystem Services under Changing Land-use and Climate (ESCALATE); Martin Luther University Halle-Wittenberg	Helmholtz Centre for Environmental Research - UFZ(Helmholtz Association); Helmholtz Research School for Ecosystem Services under Changing Land-use and Climate (ESCALATE); Martin Luther University Halle-Wittenberg	The work of SK was funded by the Helmholtz Centre for Environmental Research - UFZ, the Helmholtz Research School for Ecosystem Services under Changing Land-use and Climate (ESCALATE) and the Martin Luther University Halle-Wittenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work of S. Kambach was funded by the Helmholtz Centre for Environmental Research - UFZ, the Helmholtz Research School for Ecosystem Services under Changing Land-use and Climate (ESCALATE) and the Martin Luther University Halle-Wittenberg. We are indebted to the researchers who shared their raw data with us. Publications and researches that provided data for this meta-analysis are listened in S1 File.	Adams JM, 2009, ECOL RES, V24, P1381, DOI 10.1007/s11284-009-0623-4; Adams JM, 2009, J ECOL, V97, P933, DOI 10.1111/j.1365-2745.2009.01523.x; Andrew NR, 2005, OIKOS, V108, P176, DOI 10.1111/j.0030-1299.2005.13457.x; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Borenstein M., 2009, INTRO METAANALYSIS; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; BROWN BJ, 1987, ECOLOGY, V68, P108, DOI 10.2307/1938810; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Champagne E, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1371; Clissold FJ, 2013, J EXP BIOL, V216, P2089, DOI 10.1242/jeb.078782; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; del-Val E, 2010, BIOTROPICA, V42, P174, DOI 10.1111/j.1744-7429.2009.00554.x; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Gillman LN, 2015, GLOBAL ECOL BIOGEOGR, V24, P107, DOI 10.1111/geb.12245; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Harzing A. W., 2007, PUBLISH PERISH; Hijmans RJ, 2013, R PACKAGE VERSION; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jactel H, 2011, OECOLOGIA, V166, P703, DOI 10.1007/s00442-011-1918-z; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jeffries JM, 2006, ECOL APPL, V16, P901, DOI 10.1890/1051-0761(2006)016[0901:FAIOIH]2.0.CO;2; Kim TN, 2015, ECOLOGY, V96, P1431, DOI 10.1890/14-1097.1; Koricheva J., 2013, HDB METAANALYSIS ECO, P195, DOI DOI 10.23943/PRINCETON/9780691137285.001.0001; Kozlov MV, 2008, CLIMATIC CHANGE, V87, P107, DOI 10.1007/s10584-007-9348-y; Kozlov MV, 2015, GLOBAL ECOL BIOGEOGR, V24, P1126, DOI 10.1111/geb.12347; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lemoine Nathan P, 2014, PeerJ, V2, pe376, DOI 10.7717/peerj.376; Marquis RJ, 2012, OECOLOGIA, V169, P811, DOI 10.1007/s00442-012-2249-4; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Otway SJ, 2005, J ANIM ECOL, V74, P234, DOI 10.1111/j.1365-2656.2005.00913.x; Pearse IS, 2012, EVOLUTION, V66, P2272, DOI 10.1111/j.1558-5646.2012.01591.x; Pennings SC, 2009, ECOLOGY, V90, P183, DOI 10.1890/08-0222.1; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Price PW, 1998, J BIOGEOGR, V25, P581, DOI 10.1046/j.1365-2699.1998.2530581.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rasband WS, 2011, IMAGEJ; Raubenheimer D, 1999, ENTOMOL EXP APPL, V91, P67, DOI 10.1023/A:1003682921131; Rhainds M, 2003, ECOL ENTOMOL, V28, P348, DOI 10.1046/j.1365-2311.2003.00508.x; Rodriguez-Castaneda G, 2013, GLOBAL ECOL BIOGEOGR, V22, P118, DOI 10.1111/j.1466-8238.2012.00795.x; Salazar D, 2012, P NATL ACAD SCI USA, V109, P12616, DOI 10.1073/pnas.1202907109; Schuldt A, 2015, J ECOL, V103, P563, DOI 10.1111/1365-2745.12396; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P99; Stoepler TM, 2012, FUNCT ECOL, V26, P1205, DOI 10.1111/j.1365-2435.2012.02033.x; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; van Asch M, 2007, ANNU REV ENTOMOL, V52, P37, DOI 10.1146/annurev.ento.52.110405.091418; Verheyen K, 2016, AMBIO, V45, P29, DOI 10.1007/s13280-015-0685-1; Verschut TA, 2016, FUNCT ECOL, V30, P1826, DOI 10.1111/1365-2435.12670; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; White JA, 2000, ECOLOGY, V81, P1795, DOI 10.1890/0012-9658(2000)081[1795:ASOCTA]2.0.CO;2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	62	35	35	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165815	10.1371/journal.pone.0165815	http://dx.doi.org/10.1371/journal.pone.0165815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835651	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200014
J	Nora, S; Aparicio, A; Albaladejo, RG				Nora, Sofia; Aparicio, Abelardo; Albaladejo, Rafael G.			High Correlated Paternity Leads to Negative Effects on Progeny Performance in Two Mediterranean Shrub Species	PLOS ONE			English	Article							ECOLOGICAL MATERNAL NEIGHBORHOOD; LIFE-HISTORY TRAITS; PISTACIA-LENTISCUS; MATING PATTERNS; MYRTUS-COMMUNIS; FRAGMENTED LANDSCAPES; HABITAT FRAGMENTATION; GENETIC DIVERSITY; POLLEN LIMITATION; DISPERSAL	Anthropogenic habitat deterioration can promote changes in plant mating systems that subsequently may affect progeny performance, thereby conditioning plant recruitment for the next generation. However, very few studies yet tested mating system parameters other than outcrossing rates; and the direct effects of the genetic diversity of the pollen received by maternal plants (i.e. correlated paternity) has often been overlooked. In this study, we investigated the relation between correlated paternity and progeny performance in two common Mediterranean shrubs, Myrtus communis and Pistacia lentiscus. To do so, we collected open-pollinated progeny from selected maternal plants, calculated mating system parameters using microsatellite genotyping and conducted sowing experiments under greenhouse and field conditions. Our results showed that some progeny fitness components were negatively affected by the high correlated paternity of maternal plants. In Myrtus communis, high correlated paternity had a negative effect on the proportion and timing of seedling emergence in the natural field conditions and in the greenhouse sowing experiment, respectively. In Pistacia lentiscus, seedling emergence time under field conditions was also negatively influenced by high correlated paternity and a progeny survival analysis in the field experiment showed greater mortality of seedlings from maternal plants with high correlated paternity. Overall, we found effects of correlated paternity on the progeny performance of Myrtus communis, a self-compatible species. Further, we also detected effects of correlated paternity on the progeny emergence time and survival in Pistacia lentiscus, an obligate out-crossed species. This study represents one of the few existing empirical examples which highlight the influence that correlated paternity may exert on progeny performance in multiple stages during early seedling growth.	[Nora, Sofia; Aparicio, Abelardo; Albaladejo, Rafael G.] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain	University of Sevilla	Nora, S (corresponding author), Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain.	sofianora@us.es	Albaladejo, Rafael G/K-2204-2014	Albaladejo, Rafael G/0000-0003-2101-5204	Spanish Ministerio de Ciencia en Innovacion [CGL2008-00938, CGL2011-23721]; pre-doctoral FPI studentship [BES-2009-026244]	Spanish Ministerio de Ciencia en Innovacion; pre-doctoral FPI studentship	This study was funded by projects from the Spanish Ministerio de Ciencia en Innovacion (CGL2008-00938 and CGL2011-23721) and by a pre-doctoral FPI studentship for S.N. (BES-2009-026244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaladejo RG, 2008, MOL ECOL RESOUR, V8, P904, DOI 10.1111/j.1755-0998.2008.02110.x; Albaladejo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049012; Albaladejo RG, 2010, AM J BOT, V97, pE23, DOI 10.3732/ajb.1000060; Albaladejo RG, 2009, MOL ECOL, V18, P5195, DOI 10.1111/j.1365-294X.2009.04415.x; Aparicio A, 2008, BIODIVERS CONSERV, V17, P2219, DOI 10.1007/s10531-007-9295-y; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Armbruster WS, 2004, AM J BOT, V91, P1939, DOI 10.3732/ajb.91.11.1939; Breed MF, 2015, HEREDITY, V115, P100, DOI 10.1038/hdy.2012.72; Breed MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090478; Breed MF, 2012, MOL ECOL, V21, P5955, DOI 10.1111/mec.12056; Breed MF, 2012, ECOL LETT, V15, P444, DOI 10.1111/j.1461-0248.2012.01752.x; Byrne M, 2007, MOL ECOL, V16, P1303, DOI 10.1111/j.1365-294X.2006.03204.x; Coates DJ, 2007, AUST J BOT, V55, P239, DOI 10.1071/BT06142; Coulon A, 2010, MOL ECOL RESOUR, V10, P167, DOI 10.1111/j.1755-0998.2009.02731.x; COX DR, 1972, J R STAT SOC B, V34, P187; De-Lucas AI, 2008, HEREDITY, V100, P390, DOI 10.1038/sj.hdy.6801090; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; Franceschinelli EV, 2000, HEREDITY, V84, P116, DOI 10.1046/j.1365-2540.2000.00636.x; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Garcia-Fayos P, 1998, ACTA OECOL, V19, P357, DOI 10.1016/S1146-609X(98)80040-4; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gomez-Aparicio L, 2008, J ECOL, V96, P1128, DOI 10.1111/j.1365-2745.2008.01431.x; Gonzalez-Varo JP, 2012, PERSPECT PLANT ECOL, V14, P111, DOI 10.1016/j.ppees.2011.11.002; Gonzalez-Varo JP, 2010, ANN BOT-LONDON, V106, P999, DOI 10.1093/aob/mcq200; Gonzalez-Varo JP, 2010, J APPL ECOL, V47, P1242, DOI 10.1111/j.1365-2664.2010.01879.x; Gonzalez-Varo JP, 2010, ECOGRAPHY, V33, P185, DOI 10.1111/j.1600-0587.2009.06021.x; Gonzalez-Varo JP, 2009, PLANT ECOL, V203, P207, DOI 10.1007/s11258-008-9534-7; Gonzalez-Varo JP, 2009, BIOL CONSERV, V142, P1058, DOI 10.1016/j.biocon.2009.01.017; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy OJ, 2004, GENETICS, V168, P1601, DOI 10.1534/genetics.104.027714; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; IZHAKI I, 1991, J ECOL, V79, P575, DOI 10.2307/2260654; JORDANO P, 1989, OIKOS, V55, P375, DOI 10.2307/3565598; JORDANO P, 1988, Anales del Jardin Botanico de Madrid, V45, P213; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Llorens TM, 2013, MOL ECOL, V164, P129, DOI 10.1016/ j. biocon. 2013.05.011; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; Neal PR, 2005, PLANT SYST EVOL, V250, P173, DOI 10.1007/s00606-004-0229-9; Nora S, 2015, PLANT BIOLOGY, V17, P311, DOI 10.1111/plb.12242; Oddou-Muratorio S, 2006, AM J BOT, V93, P1650, DOI 10.3732/ajb.93.11.1650; Pannell JR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0051; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rocha OJ, 2001, AM J BOT, V88, P1600, DOI 10.2307/3558404; Skogsmyr I, 2002, BIOL REV, V77, P537, DOI 10.1017/S1464793102005973; Traveset A, 2003, J ECOL, V91, P427, DOI 10.1046/j.1365-2745.2003.00780.x; Valbuena-Carabana M, 2010, REV PALAEOBOT PALYNO, V162, P492, DOI 10.1016/j.revpalbo.2009.11.003; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Verdu M, 2002, REV CHIL HIST NAT, V75, P57; Verdu M, 2006, EVOLUTION, V60, P2056, DOI 10.1111/j.0014-3820.2006.tb01843.x; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	54	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166023	10.1371/journal.pone.0166023	http://dx.doi.org/10.1371/journal.pone.0166023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835658	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200020
J	Yanishi, K; Nakamura, T; Nakanishi, N; Yokota, I; Zen, K; Yamano, T; Shiraishi, H; Shirayama, T; Shiraishi, J; Sawada, T; Kohno, Y; Kitamura, M; Furukawa, K; Matoba, S				Yanishi, Kenji; Nakamura, Takeshi; Nakanishi, Naohiko; Yokota, Ise; Zen, Kan; Yamano, Tetsuhiro; Shiraishi, Hirokazu; Shirayama, Takeshi; Shiraishi, Jun; Sawada, Takahisa; Kohno, Yoshio; Kitamura, Makoto; Furukawa, Keizo; Matoba, Satoaki			A Simple Risk Stratification Model for ST-Elevation Myocardial Infarction (STEMI) from the Combination of Blood Examination Variables: Acute Myocardial Infarction-Kyoto Multi-Center Risk Study Group	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; C-REACTIVE PROTEIN; HOSPITAL CARDIAC-ARREST; MORTALITY; HYPERGLYCEMIA; ASSOCIATION; PREDICTORS; THERAPY; ANGIOPLASTY; DYSFUNCTION	Background Many mortality risk scoring tools exist among patients with ST-elevation Myocardial Infarction (STEMI). A risk stratification model that evaluates STEMI prognosis more simply and rapidly is preferred in clinical practice. Methods and Findings We developed a simple stratification model for blood examination by using the STEMI data of AMI-Kyoto registry in the derivation set (n = 1,060) and assessed its utility for mortality prediction in the validation set (n = 521). We selected five variables that significantly worsen in-hospital mortality: white blood cell count, hemoglobin, C-reactive protein, creatinine, and blood sugar levels at >10,000/mu L, <10 g/dL, >1.0 mg/dL, >1.0 mg/dL, and >200 mg/dL, respectively. In the derivation set, each of the five variables significantly worsened inhospital mortality (p < 0.01). We developed the risk stratification model by combining laboratory variables that were scored based on each beta coefficient obtained using multivariate analysis and divided three laboratory groups. We also found a significant trend in the inhospital mortality rate for three laboratory groups. Therefore, we assessed the utility of this model in the validation set. The prognostic discriminatory capacity of our laboratory stratification model was comparable to that of the full multivariable model (c-statistic: derivation set vs validation set, 0.81 vs 0.74). In addition, we divided all cases (n = 1,581) into three thrombolysis in myocardial infarction (TIMI) risk index groups based on an In TIME II sub-study; the cases were further subdivided based on this laboratory model. The high laboratory group had significantly high in-hospital mortality rate in each TIMI risk index group (trend of in-hospital mortality; p < 0.01). Conclusions This laboratory stratification model can predict in-hospital mortality of STEMI simply and rapidly and might be useful for predicting in-hospital mortality of STEMI by further subdividing the TIMI risk index.	[Yanishi, Kenji; Nakamura, Takeshi; Nakanishi, Naohiko; Zen, Kan; Yamano, Tetsuhiro; Shiraishi, Hirokazu; Shirayama, Takeshi; Matoba, Satoaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan; [Yokota, Ise] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biostat, Kyoto, Japan; [Shiraishi, Jun; Sawada, Takahisa; Kohno, Yoshio] Kyoto First Red Cross Hosp, Dept Cardiol, Kyoto, Japan; [Kitamura, Makoto] Kyoto Second Red Cross Hosp, Dept Cardiol, Kyoto, Japan; [Furukawa, Keizo] Tanabe Cent Hosp, Dept Cardiol, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Nakamura, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto, Japan.	tnak@koto.kpu-m.ac.jp	Yokota, Isao/AAB-2910-2021	Yokota, Isao/0000-0001-6254-2225; Yamano, Tetsuhiro/0000-0002-2123-6122				Berger AK, 2003, J AM COLL CARDIOL, V42, P201, DOI 10.1016/S0735-1097(03)00572-2; Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/j.jacc.2003.06.001; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Ishihara M, 2005, AM HEART J, V150, P814, DOI 10.1016/j.ahj.2004.12.020; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kinjo K, 2005, AM J CARDIOL, V96, P617, DOI 10.1016/j.amjcard.2005.04.030; Kinjo K, 2003, AM J CARDIOL, V91, P931, DOI 10.1016/S0002-9149(03)00106-1; Kosuge M, 2005, CIRC J, V69, P375, DOI 10.1253/circj.69.375; Kosuge M, 2005, CIRC J, V69, P23, DOI 10.1253/circj.69.23; Maekawa Y, 2002, J AM COLL CARDIOL, V39, P241, DOI 10.1016/S0735-1097(01)01721-1; Magadle R, 2004, CLIN CARDIOL, V27, P163, DOI 10.1002/clc.4960270314; Matsue Y, 2013, HEART VESSELS, V28, P19, DOI 10.1007/s00380-011-0209-2; Moriyama N, 2014, CIRC J, V78, P1475, DOI 10.1253/circj.CJ-14-0117; Morrow DA, 2001, LANCET, V358, P1571, DOI 10.1016/S0140-6736(01)06649-1; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Nakanishi N, 2011, AM J EMERG MED, V29, P1037, DOI 10.1016/j.ajem.2010.06.018; Nakanishi N, 2011, PREHOSP EMERG CARE, V15, P271, DOI 10.3109/10903127.2010.545475; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Shiraishi J, 2008, CIRC J, V72, P1225, DOI 10.1253/circj.72.1225; Shiraishi J, 2010, CIRC J, V74, P1152, DOI 10.1253/circj.CJ-09-0774; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Wison S, 2003, AM J CARDIOL, V91, P1051, DOI 10.1016/S0002-9149(03)00147-4; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007	23	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166391	10.1371/journal.pone.0166391	http://dx.doi.org/10.1371/journal.pone.0166391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835698	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200044
J	de Beer, M; Vrijkotte, TGM; Fall, CHD; van Eijsden, M; Osmond, C; Gemke, RJBJ				de Beer, Marieke; Vrijkotte, Tanja G. M.; Fall, Caroline H. D.; van Eijsden, Manon; Osmond, Clive; Gemke, Reinoud J. B. J.			Associations of Infant Feeding and Timing of Weight Gain and Linear Growth during Early Life with Childhood Blood Pressure: Findings from a Prospective Population Based Cohort Study	PLOS ONE			English	Article							POSTNATAL-GROWTH; YOUNG ADULTHOOD; BIRTH-WEIGHT; RISK-FACTORS; CHILDREN; HEIGHT; HEALTH; INCOME; AGE; HYPERTENSION	Objective Small birth size and rapid postnatal growth have been associated with higher future blood pressure. The timing of these effects, the relative importance of weight gain and linear growth and the role of infant feeding need to be clarified. Methods We assessed how blood pressure relates to birth weight, infant and childhood growth and infant feeding (duration of exclusive breastfeeding and timing of introduction of complementary feeding) in 2227 children aged 5 years from a prospective cohort study (Amsterdam Born Children and their Development). Postnatal growth was represented by statistically independent measures of relative weight gain (weight gain independent of height) and linear growth in four age periods during infancy (0-1 month; 1-3 months; 3-6 months; 6-12 months) and from 12 months to 5 years. Results Lower birth weight was associated with higher childhood diastolic blood pressure (-0.38 mm Hg.SD-1; P = 0.007). Faster relative weight gain and linear growth after 1 month were positively associated with systolic and diastolic blood pressure. Associations of linear growth with systolic blood pressure ranged from 0.47 to 1.49 mm Hg.SD-1; P< 0.01 for all. Coefficients were similar for different periods of infancy and also for relative weight gain and linear growth. Compared to breastfeeding < 1 month, breastfeeding > 1 month was associated with lower blood pressure (e.g. > 6 months -1.56 mm Hg systolic blood pressure; P<0.001). Compared to > 6 months, introduction of complementary feeding < 6 months was associated with higher blood pressure (e.g. 4-6 months 0.91 mm Hg systolic blood pressure; P = 0.004). Conclusions After the age of one month faster growth in either weight or height is associated with higher childhood blood pressure. It is unknown whether faster weight gain and linear growth carry the same risk for adult hypertension and cardiovascular morbidity. Longer breastfeeding and delayed introduction of complementary feeding may be associated with lower adult blood pressure.	[de Beer, Marieke; Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam, Dept Pediat, Med Ctr, Amsterdam, Netherlands; [Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, Amsterdam, Netherlands; [Fall, Caroline H. D.; Osmond, Clive] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [van Eijsden, Manon] Publ Hlth Serv, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Southampton; Public Health Service Amsterdam	de Beer, M (corresponding author), Vrije Univ Amsterdam, Dept Pediat, Med Ctr, Amsterdam, Netherlands.	m.debeer@vumc.nl		Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organisation for Health Research and Development [92003489]; Medical Research Council [MC_UU_12011/3, MC_UP_A620_1016, U1475000003] Funding Source: researchfish; MRC [MC_UU_12011/3, MC_UP_A620_1016] Funding Source: UKRI	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Netherlands Organisation for Health Research and Development (http://www.zonmw.nl), Grand nr: 92003489, MDB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Ben-Shlomo Y, 2008, HYPERTENSION, V52, P638, DOI 10.1161/HYPERTENSIONAHA.108.114256; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chiolero A, 2014, AM J EPIDEMIOL, V179, P4, DOI 10.1093/aje/kwt228; de Beer M, 2015, INT J OBESITY, V39, P586, DOI 10.1038/ijo.2014.200; de Beer M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-23; de Jonge LL, 2013, J NUTR, V143, P1959, DOI 10.3945/jn.113.174326; de Onis M, 2003, ACTA PAEDIATR, V92, P413, DOI 10.1111/j.1651-2227.2003.tb00570.x; Dotsch J, 2009, HYPERTENS RES, V32, P238, DOI 10.1038/hr.2009.4; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Erlingsdottir A, 2010, PEDIATR NEPHROL, V25, P323, DOI 10.1007/s00467-009-1350-3; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; HEBERT PR, 1993, CIRCULATION, V88, P1437, DOI 10.1161/01.CIR.88.4.1437; HEINIG MJ, 1993, ACTA PAEDIATR, V82, P999, DOI 10.1111/j.1651-2227.1993.tb12798.x; Heys M, 2013, PEDIATRICS, V131, pE62, DOI 10.1542/peds.2012-0574; Jones A, 2012, HYPERTENSION, V59, P919, DOI 10.1161/HYPERTENSIONAHA.111.187716; Kaakinen M, 2014, J EPIDEMIOL COMMUN H, V68, P1161, DOI 10.1136/jech-2013-203661; Kark M, 2009, PAEDIATR PERINAT EP, V23, P245, DOI 10.1111/j.1365-3016.2008.01007.x; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kwok MK, 2013, AM J EPIDEMIOL, V178, P928, DOI 10.1093/aje/kwt076; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Martin RM, 2005, AM J EPIDEMIOL, V161, P15, DOI 10.1093/aje/kwh338; Martin RM, 2004, CIRCULATION, V109, P1259, DOI 10.1161/01.CIR.0000118468.76447.CE; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Organization WH, 2009, GLOB HLTH RISKS MORT; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Pomeranz A, 2002, J HYPERTENS, V20, P203, DOI 10.1097/00004872-200202000-00009; Regnault N, 2014, INT J EPIDEMIOL, V43, P149, DOI 10.1093/ije/dyt248; Robinson S, 2012, NUTRIENTS, V4, P859, DOI 10.3390/nu4080859; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Tu YK, 2013, INT J EPIDEMIOL, V42, P1327, DOI 10.1093/ije/dyt157; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Verduci E, 2014, NUTRIENTS, V6, P1711, DOI 10.3390/nu6041711; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; Wuhl E, 2002, J HYPERTENS, V20, P1995, DOI 10.1097/00004872-200210000-00019	44	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166281	10.1371/journal.pone.0166281	http://dx.doi.org/10.1371/journal.pone.0166281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832113	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000089
J	Moreno, CL; Yang, LD; Decks, PA; Soda, F; van Deursen, JMA; Mobbs, CV				Moreno, Cesar L.; Yang, Linda; Decks, Penny A.; Soda, Fumiko; van Deursen, Jan M. A.; Mobbs, Charles V.			Role of Hypothalamic Creb-Binding Protein in Obesity and Molecular Reprogramming of Metabolic Substrates	PLOS ONE			English	Article							INDIRECT CALORIMETRY; MESSENGER-RNA; FOOD-INTAKE; GLUCOSE; CBP; EXPRESSION; NEURONS; INHIBITION; HORMONE; NUCLEUS	We have reported a correlation between hypothalamic expression of Creb-binding protein (Cbp) and lifespan, and that inhibition of Cbp prevents protective effects of dietary restriction during aging, suggesting that hypothalamic Cbp plays a role in responses to nutritional status and energy balance. Recent GWAS and network analyses have also implicated Cbp as the most connected gene in protein-protein interactions in human Type 2 diabetes. The present studies address mechanisms mediating the role of Cbp in diabetes by inhibiting hypothalamic Cbp using a Cre-lox strategy. Inhibition of hypothalamic Cbp results in profound obesity and impaired glucose homeostasis, increased food intake, and decreased body temperature. In addition, these changes are accompanied by molecular evidence in the hypothalamus for impaired leptin and insulin signaling, a shift from glucose to lipid metabolism, and decreased Pomc mRNA, with no effect on locomotion. Further assessment of the significance of the metabolic switch demonstrated that enhanced expression of hypothalamic Cptl a, which promotes lipid metabolism, similarly resulted in increased body weight and reduced Pomc mRNA.	[Moreno, Cesar L.; Yang, Linda; Decks, Penny A.; Soda, Fumiko; Mobbs, Charles V.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Moreno, Cesar L.; Yang, Linda; Decks, Penny A.; Soda, Fumiko; Mobbs, Charles V.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [van Deursen, Jan M. A.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Mayo Clinic	Mobbs, CV (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Mobbs, CV (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	Charles.mobbs@mssm.edu	Moreno, Cesar/Q-4822-2017	Moreno, Cesar/0000-0002-0876-0341; Dacks, Penny/0000-0003-1149-4192	National Institute of Aging of the National Institute of Health [FAG042299A, R01 AG019934]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG042299] Funding Source: NIH RePORTER	National Institute of Aging of the National Institute of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute of Aging of the National Institute of Health under award number FAG042299A, and R01 AG019934. The funder in the study had no role in the study design, data collection, analysis, or preparation of this manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; James WPT, 2008, INT J OBESITY, V32, pS120, DOI 10.1038/ijo.2008.247; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; Kang L, 2006, DIABETES, V55, P412, DOI 10.2337/diabetes.55.02.06.db05-1229; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lavrentyev EN, 2004, BIOCHEM BIOPH RES CO, V315, P174, DOI 10.1016/j.bbrc.2004.01.040; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MAYER J, 1953, NEW ENGL J MED, V249, P13, DOI 10.1056/NEJM195307022490104; Mera P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097195; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mizuno TM, 2003, DIABETES, V52, P2675, DOI 10.2337/diabetes.52.11.2675; Moreno C, 2013, ENDOCRIN METAB CLIN, V42, P67, DOI 10.1016/j.ecl.2012.11.007; Moreno CL, 2016, NEUROBIOL DIS, V85, P25, DOI 10.1016/j.nbd.2015.09.012; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Poplawski MM, 2010, ENDOCRINOLOGY, V151, P5206, DOI 10.1210/en.2010-0702; Shu I-W, 2002, KEYSTONE S J, VJ3/J4, P98; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Stromberg H, 1999, BRAIN RES, V818, P510, DOI 10.1016/S0006-8993(98)01219-0; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Vincent M, 2014, J NEUROSCI METH, V235, P189, DOI 10.1016/j.jneumeth.2014.07.005; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763; Yang XJ, 2004, DIABETES, V53, P67, DOI 10.2337/diabetes.53.1.67; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166381	10.1371/journal.pone.0166381	http://dx.doi.org/10.1371/journal.pone.0166381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832201	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000116
J	Neveu, R; Neveu, D; Barbalat, G; Schmidt, U; Coricelli, G; Nicolas, A				Neveu, Remi; Neveu, Dorine; Barbalat, Guillaume; Schmidt, Ulrike; Coricelli, Giorgio; Nicolas, Alain			The Sequential Binge, a New Therapeutic Approach for Binge Eating: A Pilot Study	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; SENSORY-SPECIFIC SATIETY; BULIMIA-NERVOSA PATIENTS; RESPONSE-INHIBITION; FOOD SELECTION; OBESE WOMEN; DISORDER; PREDICTORS; ATTENTION; IMPULSIVITY	Background and Objectives A sizeable proportion of patients experiencing binge eating do not respond to cognitive behavioral therapy (CBT). We present the sequential binge (SB), a new behavioral intervention that complements CBT, and preliminary results of its effects. SB breaks up the binge into repeated identical sequences of eating separated by incremental pauses. This pattern of ingestion aims at facilitating boredom toward the ingested foods and at turning cognitive control away from binge food restriction. SB is hypothesized to reduce food intake during the binge and the number of daily binges. Methods Prospective pilot study. Fifteen binging patients with previous unsuccessful intensive CBT were given SB as an adjunct to their treatment and were followed up for 16 weeks from admission. All patients were reassessed 47 weeks on average after discharge. Results SB was associated with a 44% relative reduction in the planned food intake (p<0.001), a longer consecutive binge refractory period compared to regular binges (median: 48 hours versus 4 hours, p = 0.002) and an average relative reduction by 26% of binge number the day after each SB (p = 0.004). 47% of patients reached binge abstinence for four consecutive weeks 16 weeks after the first SB. Conclusion This case series shows promising evidence for the use of SB in patients with refractory binge eating. Further evaluation in a prospective randomized controlled trial would be justified.	[Neveu, Remi] Univ Lyon 1, Team Olfact Coding Memory, Neurosci Res Ctr, CNRS,UMR5292,INSERM,U1028, F-69366 Lyon, France; [Neveu, Dorine] Univ Montpellier I, Montpellier, France; [Neveu, Dorine] INSERM, U1058, Montpellier, France; [Neveu, Dorine] CHU Montpellier, Dept Informat Med, Montpellier, France; [Barbalat, Guillaume] Greenlane Clin Ctr, Reg Eating Disorders Serv, Auckland, New Zealand; [Schmidt, Ulrike] Kings Coll London, Inst Psychiat, Sect Eating Disorders PO59, De Crespigny Pk, London SE5 8AF, England; [Coricelli, Giorgio] Univ Southern Calif, Los Angeles, CA USA; [Coricelli, Giorgio] Univ Trento, Interdept Ctr Mind Brain Sci CIMeC, Trento, Italy; [Nicolas, Alain] Hop Vinatier, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of London; King's College London; University of Southern California; University of Trento	Neveu, R (corresponding author), Univ Lyon 1, Team Olfact Coding Memory, Neurosci Res Ctr, CNRS,UMR5292,INSERM,U1028, F-69366 Lyon, France.	remi.neveu@isc.cnrs.fr		Barbalat, Guillaume/0000-0002-8212-8053	Praxis and European Research Council (ERC Consolidator) grant [617629]; CNRS (Centre National de la Recherche Scientifique); Montpellier hospital	Praxis and European Research Council (ERC Consolidator) grant; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Montpellier hospital	This work was funded by Praxis and European Research Council (ERC Consolidator grant 617629) grant, and supported by CNRS (Centre National de la Recherche Scientifique) and Montpellier hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agras WS, 2000, AM J PSYCHIAT, V157, P1302, DOI 10.1176/appi.ajp.157.8.1302; AGRAS WS, 1995, J CONSULT CLIN PSYCH, V63, P356, DOI 10.1037/0022-006X.63.3.356; Alvarez-Moya EM, 2009, J INT NEUROPSYCH SOC, V15, P302, DOI 10.1017/S1355617709090377; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010; Bacaltchuk J, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003385; Baer RA., 2005, J RATION-EMOT COGN-B, V23, P281, DOI [10.1007/s10942-005-0015-9, DOI 10.1007/S10942-005-0015-9]; Bartholome LT, 2013, EUR J NUTR, V52, P193, DOI 10.1007/s00394-012-0302-z; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bellisle F, 2003, PHYSIOL BEHAV, V79, P183, DOI 10.1016/S0031-9384(03)00088-X; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Brondel L, 2009, APPETITE, V53, P203, DOI 10.1016/j.appet.2009.06.009; Brownstone LM, 2013, INT J EAT DISORDER, V46, P66, DOI 10.1002/eat.22066; Bulik CM, 1999, INT J EAT DISORDER, V26, P137, DOI 10.1002/(SICI)1098-108X(199909)26:2<137::AID-EAT2>3.3.CO;2-E; Byrne SM, 2011, BEHAV RES THER, V49, P219, DOI 10.1016/j.brat.2011.01.006; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Duggan C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-335; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fairburn CG, 1993, BINGE EATING NATURE; Fairburn CG, 2008, COGNITIVE BEHAV THER; Fairburn CG., 1995, OVERCOMING BINGE EAT; Fay SH, 2011, APPETITE, V56, P284, DOI 10.1016/j.appet.2011.01.006; Fernandez-Aranda F, 2015, CYBERPSYCH BEH SOC N, V18, P744, DOI 10.1089/cyber.2015.0265; Flament MF, 2012, INT J NEUROPSYCHOPH, V15, P189, DOI 10.1017/S1461145711000381; Goldstein M, 2014, EUR EAT DISORD REV, V22, P217, DOI 10.1002/erv.2281; HADIGAN CM, 1989, AM J CLIN NUTR, V50, P759, DOI 10.1093/ajcn/50.4.759; Hay PPJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000562.pub3; HETHERINGTON M, 1989, APPETITE, V12, P57, DOI 10.1016/0195-6663(89)90068-8; Hetherington MM, 1996, NEUROSCI BIOBEHAV R, V20, P113, DOI 10.1016/0149-7634(95)00048-J; Johansson Linda, 2005, Eat Behav, V6, P271, DOI 10.1016/j.eatbeh.2004.11.001; Kahn BE, 2004, J CONSUM RES, V30, P519, DOI 10.1086/380286; Keel PK, 1997, AM J PSYCHIAT, V154, P313; Kissileff HR, 2008, PHYSIOL BEHAV, V93, P481, DOI 10.1016/j.physbeh.2007.10.007; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; McClelland A, 2006, J CLIN PSYCHOL, V62, P355, DOI 10.1002/jclp.20216; Meister R, 2016, J CLIN EPIDEMIOL, V71, P97, DOI 10.1016/j.jclinepi.2015.10.007; Neef NA, 2001, J APPL BEHAV ANAL, V34, P397, DOI 10.1901/jaba.2001.34-397; Neveu R, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00065; Neveu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105657; NICE, 2004, EAT DIS COR INT TREA; Perroud A, 2001, FAIRE FACE BOULIMIE; Piqueras-Fiszman B, 2014, COLOUR PLEASANTNESS; Polivy J, 2005, INT J EAT DISORDER, V38, P301, DOI 10.1002/eat.20195; Raymond NC, 2007, INT J EAT DISORDER, V40, P67, DOI 10.1002/eat.20312; Rigaud DJ, 2011, JPEN-PARENTER ENTER, V35, P356, DOI 10.1177/0148607110382422; Rosval L, 2006, INT J EAT DISORDER, V39, P590, DOI 10.1002/eat.20296; Vansteelandt S, 2009, EPIDEMIOLOGY, V20, P851, DOI 10.1097/EDE.0b013e3181b6f4c9; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621; Wilkinson LL, 2013, APPETITE, V60, P175, DOI 10.1016/j.appet.2012.10.001; Wilson GT, 1999, J CONSULT CLIN PSYCH, V67, P451, DOI 10.1037/0022-006X.67.4.451; Wilson GT, 1996, BEHAV RES THER, V34, P197, DOI 10.1016/0005-7967(95)00068-2	52	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165696	10.1371/journal.pone.0165696	http://dx.doi.org/10.1371/journal.pone.0165696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832121	Green Published, gold			2022-12-27	WOS:000387725000026
J	Shen, J; Xia, JB; Dong, SF; Zhang, XY; Fu, K				Shen, Jian; Xia, Jingbo; Dong, Shufu; Zhang, Xiaoyan; Fu, Kai			Universal Feature Extraction for Traffic Identification of the Target Category	PLOS ONE			English	Article							REGRESSION; FRAMEWORK	Traffic identification of the target category is currently a significant challenge for network monitoring and management. To identify the target category with pertinence, a feature extraction algorithm based on the subset with highest proportion is presented in this paper. The method is proposed to be applied to the identification of any category that is assigned as the target one, but not restricted to certain specific category. We divide the process of feature extraction into two stages. In the stage of primary feature extraction, the feature subset is extracted from the dataset which has the highest proportion of the target category. In the stage of secondary feature extraction, the features that can distinguish the target and interfering categories are added to the feature subset. Our theoretical analysis and experimental observations reveal that the proposed algorithm is able to extract fewer features with greater identification ability of the target category. Moreover, the universality of the proposed algorithm proves to be available with the experiment that every category is set to be the target one.	[Shen, Jian; Dong, Shufu; Zhang, Xiaoyan; Fu, Kai] Air Force Engn Univ, Inst Informat & Nav, Xian, Shaanxi, Peoples R China; [Xia, Jingbo] Xiamen Univ, Tan KahKee Coll, Xiamen, Fujian, Peoples R China	Air Force Engineering University; Xiamen University	Shen, J (corresponding author), Air Force Engn Univ, Inst Informat & Nav, Xian, Shaanxi, Peoples R China.	shenjian2018@126.com			Shaanxi Province Natural Science Foundation [2012JZ8005]; Aero-Science Foundation [20141996018]	Shaanxi Province Natural Science Foundation(Natural Science Foundation of Shaanxi Province); Aero-Science Foundation	Project supported by the Shaanxi Province Natural Science Foundation (Grant No. 2012JZ8005), Aero-Science Foundation (Grant No. 20141996018).	Alibeigi M, 2012, DATA KNOWL ENG, V81-82, P67, DOI 10.1016/j.datak.2012.08.001; [Anonymous], 1999, CORRELATION BASED FE; Bonfiglio D, 2006, ACM SIGCOMM COMPUTER; Bonfiglio D, 2009, IEEE T MULTIMEDIA, V11, P117, DOI 10.1109/TMM.2008.2008927; Cai X., 2013, PROC 23 INT JOINT C, P1; Callado A, 2010, J NETW COMPUT APPL, V33, P433, DOI 10.1016/j.jnca.2010.02.002; Callado A, 2009, IEEE COMMUN SURV TUT, V11, P37, DOI 10.1109/SURV.2009.090304; Chen H X, 2009, ELECTROOPTIC TECHNOL; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Gui J, 2014, IEEE T IMAGE PROCESS, V23, P3126, DOI 10.1109/TIP.2014.2326001; Gui J, 2014, IEEE T CIRC SYST VID, V24, P211, DOI 10.1109/TCSVT.2013.2273652; Gui J, 2012, PATTERN RECOGN, V45, P2884, DOI 10.1016/j.patcog.2012.02.005; Gui J, 2010, ARTIF INTELL MED, V50, P181, DOI 10.1016/j.artmed.2010.05.004; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; He HT, 2008, LECT NOTES COMPUT SC, V5227, P449; He HB, 2010, IMBALANCED LEARNING, VVII; Hou C, 2016, DISCRIMINATIVE VANIS, P1666; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Huang KZ, 2004, PROC CVPR IEEE, P558; Jeffrey C M, 1992, ACM T COMPUT SYST, V10, P81; Jin Y, 2012, ACM T KNOWL DISCOV D, V6, DOI 10.1145/2133360.2133364; Kalfut A, 2006, P 6 ACM SIGCOMM C IN; Liu T, 2003, P INT C MACH LEARN A; Manevitz LM, 2002, J MACH LEARN RES, V2, P139, DOI 10.1162/15324430260185574; Masnadi-Shirazi H, 2007, MACH LEARN P 24 INT, P609; Nie F., 2008, P 23 NAT C ART INT, P671; Nie F., 2010, ADV NEURAL INFORM PR, V23, DOI DOI 10.1007/978-3-319-10690-8_12; Padmaja TM., 2008, IEEE REG 10 ANN INT; Sen S, 2004, IEEE ACM T NETWORK, V12, P219, DOI 10.1109/TNET.2004.826277; Stefanowski J, 2008, LECT NOTES COMPUT SC, V5182, P283, DOI 10.1007/978-3-540-85836-2_27; Street W N, 2001, ACM SIGKDD INT C KNO, P1152; Trang DD, 2000, THESIS; Wald R, 2013, STABILITY FILTER WRA, P374; Wang D, 2015, IEEE T KNOWL DATA EN, V27, P2743, DOI 10.1109/TKDE.2015.2426703; Wang H., 2003, P 9 ACM SIGKDD INT C, P226, DOI DOI 10.1145/956750.956778; Wasikowski M, 2010, IEEE T KNOWL DATA EN, V22, P1388, DOI 10.1109/TKDE.2009.187; Weicai Zhong, 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P3548, DOI 10.1109/IJCNN.2009.5178804; Williamson C, 2001, IEEE INTERNET COMPUT, V5, P70, DOI 10.1109/4236.968834; Witten IH, 2011, MOR KAUF D, P61, DOI 10.1016/B978-0-12-374856-0.00003-1; Zhang HL, 2010, SKYPE TRAFFIC IDENTI, V12, P149	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165993	10.1371/journal.pone.0165993	http://dx.doi.org/10.1371/journal.pone.0165993			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832103	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000053
J	Yu, SL; Zhou, WY; Cheng, XQ; Fang, HL; Zhang, RP; Cheng, Q; Han, JH; Su, W; Xia, LY; Qiu, L				Yu, Songlin; Zhou, Weiyan; Cheng, Xinqi; Fang, Huiling; Zhang, Ruiping; Cheng, Qian; Han, Jianhua; Su, Wei; Xia, Liangyu; Qiu, Ling			Blood Collection Tubes and Storage Temperature Should Be Evaluated when Using the Siemens ADVIA Centaur XP for Measuring 25-Hydroxyvitamin D	PLOS ONE			English	Article							IMMUNOASSAYS	A significant bias was found when using the Siemens ADVIA Centaur XP system for measurement of 25-hydroxyvitamin D (250HD) with VACUETTE (R) tubes with Serum Clot Activator and Gel. Here, we examined whether other commonly used tubes or temperatures affected 250HD results obtained with the Siemens ADVIA Centaur XP system. Serum was collected into five types of vacuum blood collection tubes from three manufacturers, and 250HD was analyzed using the Siemens ADVIA Centaur XP system and liquid chromatography tandem mass spectrometry (LC-MS/MS) immediately or after storage at 4 degrees C or -80 degrees C for 48 h. Significantly higher 250HD values were found when using the Siemens ADVIA Centaur XP system with VACUETTE (R) tubes with serum clot activator and gel and VACUETTE (R) tubes with clot activator but no gel compared with VACUETTE (R) tubes with no additives. The 250HD values in all of these tubes were not significantly different from those obtained by LC-MS/MS. Moreover, after storage at-80 degrees C for 48 h, the values obtained in IMPROVEVACUTER (R) tubes with serum clot activator and gel significantly increased, with a mean bias of 74.6% compared with the values before storage, on analysis with the Siemens ADVIA Centaur XP system. VACUETTE (R) tubes containing additives significantly affect the accuracy of 250HD results obtained using the Siemens ADVIA Centaur XP system. Additionally, the composition of serum collected in IMPROVEVACUTER (R) tubes was affected by freezing, resulting in different measurements when using the Siemens 250HD assay platform.	[Yu, Songlin; Cheng, Xinqi; Fang, Huiling; Cheng, Qian; Han, Jianhua; Su, Wei; Xia, Liangyu; Qiu, Ling] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Zhou, Weiyan] Beijing Hosp, Natl Ctr Clin Labs, Minist Hlth, Beijing 100730, Peoples R China; [Zhang, Ruiping] China Japan Friendship Hosp, Dept Clin Lab, Beijing 100029, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Beijing Hospital; China-Japan Friendship Hospital	Qiu, L (corresponding author), Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	lingqiubj@163.com	Zhang, Rui/GXN-3801-2022; Zhou, Weiyan/GPW-9289-2022	Zhou, Weiyan/0000-0003-4174-6047	China National Clinical Key Subject Program; National Natural Science Foundation of China [81201337]; National High Technology Research and Development Program of China (863 Program) [2014AA022304]	China National Clinical Key Subject Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was funded by the China National Clinical Key Subject Program and by research grants from the National Natural Science Foundation of China (81201337) (http://www.nsfc.gov.cn/), and the National High Technology Research and Development Program of China (863 Program, 2014AA022304) (http://program.most.gov.cn/). The funding bodies were not involved in conducting or analyzing this work, and were not involved in the decision to publish.	Ajuria-Morentin I, 2013, SCAND J CLIN LAB INV, V73, P82, DOI 10.3109/00365513.2012.743165; Antoniucci DM, 2005, CLIN CHEM, V51, P258; Bowen RAR, 2014, CLIN BIOCHEM, V47, P150, DOI 10.1016/j.clinbiochem.2013.11.003; Bowen RAR, 2010, CLIN BIOCHEM, V43, P4, DOI 10.1016/j.clinbiochem.2009.10.001; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fraser CG, 2012, CLIN CHEM LAB MED, V50, P807, DOI 10.1515/CCLM.2011.733; Labonte J, 2013, VITAMIN D TESTING ME; Stankovic AK, 2006, CLIN CHEM, V52, P1627, DOI 10.1373/clinchem.2006.069997; Tanner M, 2008, ANN CLIN BIOCHEM, V45, P375, DOI 10.1258/acb.2007.007183; Viljoen A, 2011, J CLIN LAB ANAL, V25, P130, DOI 10.1002/jcla.20446; Yu SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14636	11	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166327	10.1371/journal.pone.0166327	http://dx.doi.org/10.1371/journal.pone.0166327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832181	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000099
J	Chenausky, K; Norton, A; Tager-Flusberg, H; Schlaug, G				Chenausky, Karen; Norton, Andrea; Tager-Flusberg, Helen; Schlaug, Gottfried			Auditory-Motor Mapping Training: Comparing the Effects of a Novel Speech Treatment to a Control Treatment for Minimally Verbal Children with Autism	PLOS ONE			English	Article							LANGUAGE-ASSOCIATION CORTEX; MELODIC INTONATION THERAPY; PHONOLOGICAL DISORDERS; NONVERBAL CHILDREN; ARCUATE FASCICULUS; ORAL-MOTOR; SPECTRUM; ASYMMETRY; REPRESENTATION; SKILLS	This study compared Auditory-Motor Mapping Training (AMMT), an intonation-based treatment for facilitating spoken language in minimally verbal children with autism spectrum disorder (ASD), to a matched control treatment, Speech Repetition Therapy (SRT). 23 minimally verbal children with ASD (20 male, mean age 6; 5) received at least 25 sessions of AMMT. Seven (all male) were matched on age and verbal ability to seven participants (five male) who received SRT. Outcome measures were Percent Syllables Approximated, Percent Consonants Correct (of 86), and Percent Vowels Correct (of 61) produced on two sets of 15 bisyllabic stimuli. All subjects were assessed on these measures several times at baseline and after 10, 15, 20, and 25 sessions. The post-25 session assessment timepoint, common to all participants, was compared to Best Baseline performance. Overall, after 25 sessions, AMMT participants increased by 19.4% Syllables Approximated, 13.8% Consonants Correct, and19.1% Vowels Correct, compared to Best Baseline. In the matched AMMT-SRT group, after 25 sessions, AMMT participants produced 29.0% more Syllables Approximated (SRT 3.6%); 17.9% more Consonants Correct (SRT 0.5); and 17.6% more Vowels Correct (SRT 0.8%). Chi-square tests showed that significantly more AMMT than SRT participants in both the overall and matched groups improved significantly in number of Syllables Approximated per stimulus and number of Consonants Correct per stimulus. Pretreatment ability to imitate phonemes, but not chronological age or baseline performance on outcome measures, was significantly correlated with amount of improvement after 25 sessions. Intonation-based therapy may offer a promising new interventional approach for teaching spoken language to minimally verbal children with ASD.	[Chenausky, Karen; Norton, Andrea; Schlaug, Gottfried] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Mus & Neuroimaging Lab, Boston, MA USA; [Chenausky, Karen; Tager-Flusberg, Helen] Boston Univ, Ctr Autism Res Excellence, Dept Psychol & Brain Sci, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University	Schlaug, G (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Mus & Neuroimaging Lab, Boston, MA USA.	gschlaug@bidmc.harvard.edu			Nancy Lurie Marks Family Foundation; Autism Speaks; NIH [P50 DC 13027]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010290, P50DC013027] Funding Source: NIH RePORTER	Nancy Lurie Marks Family Foundation; Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding for this study was provided by the Nancy Lurie Marks Family Foundation, Autism Speaks, and NIH P50 DC 13027. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Binkofski F, 2004, BRAIN LANG, V89, P362, DOI 10.1016/S0093-934X(03)00358-4; Caruso A, 1999, CLIN MANAGEMENT MOTO, P1; Catani M, 2016, BRAIN, V139, P616, DOI 10.1093/brain/awv351; DAVIS BL, 1995, J SPEECH HEAR RES, V38, P1199, DOI 10.1044/jshr.3806.1199; De Fosse L, 2004, ANN NEUROL, V56, P757, DOI 10.1002/ana.20275; Dominick KC, 2007, RES DEV DISABIL, V28, P145, DOI 10.1016/j.ridd.2006.02.003; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fenson L., 2007, MACARTHUR BATES COMM, V2nd; Fletcher PT, 2010, NEUROIMAGE, V51, P1117, DOI 10.1016/j.neuroimage.2010.01.083; Floris DL, 2016, HUM BRAIN MAPP, V37, P230, DOI 10.1002/hbm.23023; Fritz J, 2013, STRUNGMANN FORUM REP, P417; Gentilucci M, 2000, EXP BRAIN RES, V133, P468, DOI 10.1007/s002210000431; Gernsbacher MA, 2008, J CHILD PSYCHOL PSYC, V49, P43, DOI 10.1111/j.1469-7610.2007.01820.x; HAIRSTON MJP, 1990, J MUSIC THER, V27, P137; Heaton P, 2008, BRIT J DEV PSYCHOL, V26, P171, DOI 10.1348/026151007X206776; Heaton P, 2007, J AUTISM DEV DISORD, V37, P1355, DOI 10.1007/s10803-006-0283-y; Herbert MR, 2002, ANN NEUROL, V52, P588, DOI 10.1002/ana.10349; Hoelzley P., 1993, CANADIAN J MUSIC THE, V1, P54; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Iverson JM, 2007, J AUTISM DEV DISORD, V37, P158, DOI 10.1007/s10803-006-0339-z; Iverson JM, 2004, CHILD DEV, V75, P1053, DOI 10.1111/j.1467-8624.2004.00725.x; Kasari C, 2013, AUTISM RES, V6, P479, DOI 10.1002/aur.1334; Kaufman N., 1995, KAUFMAN SPEECH PRAXI; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Knaus TA, 2010, BRAIN LANG, V112, P113, DOI 10.1016/j.bandl.2009.11.005; KOEGEL RL, 1987, J AUTISM DEV DISORD, V17, P187, DOI 10.1007/BF01495055; Koegel RL, 1999, SCHOOL PSYCHOL REV, V28, P576; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Leonard HC, 2015, RES AUTISM SPECT DIS, V13-14, P15, DOI 10.1016/j.rasd.2014.12.012; Lo YC, 2011, PSYCHIAT RES-NEUROIM, V192, P60, DOI 10.1016/j.pscychresns.2010.09.008; Lord C., 1999, AUTISM DIAGNOSTIC OB; LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3; Marchina S, 2011, STROKE, V42, P2251, DOI 10.1161/STROKEAHA.110.606103; Matson JL, 2009, J DEV PHYS DISABIL, V21, P253, DOI 10.1007/s10882-009-9140-1; Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3; MILLER SB, 1979, J CLIN PSYCHIAT, V40, P201; Mullen E. M, 1995, MULLEN SCALES EARLY; Newmeyer AJ, 2007, CLIN PEDIATR, V46, P604, DOI 10.1177/0009922807299545; Norton A, 2009, ANN NY ACAD SCI, V1169, P431, DOI 10.1111/j.1749-6632.2009.04859.x; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Paldino MJ, 2016, AM J NEURORADIOL, V37, P169, DOI 10.3174/ajnr.A4461; Paul R, 2008, CHILD ADOL PSYCH CL, V17, P835, DOI 10.1016/j.chc.2008.06.011; Paul R, 2013, J AUTISM DEV DISORD, V43, P418, DOI 10.1007/s10803-012-1583-z; Prizant BM, 2000, COMM LANG INTERVEN, V9, P193; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rogers SJ, 2006, J AUTISM DEV DISORD, V36, P1007, DOI 10.1007/s10803-006-0142-x; Ross DE, 2003, RES DEV DISABIL, V24, P58, DOI 10.1016/S0891-4222(02)00167-1; Rvachew S., 2012, DEV PHONOLOGICAL DIS; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Saporta ASD, 2011, PEDIATR NEUROL, V44, P270, DOI 10.1016/j.pediatrneurol.2010.11.006; Schopler E., 1988, CHILDHOOD AUTISM RAT; SHRIBERG LD, 1982, J SPEECH HEAR DISORD, V47, P256, DOI 10.1044/jshd.4703.256; SHRIBERG LD, 1993, J SPEECH HEAR RES, V36, P105, DOI 10.1044/jshr.3601.105; SHRIBERG LD, 1994, J SPEECH HEAR RES, V37, P1127, DOI 10.1044/jshr.3705.1127; Square P, 1999, CLIN MANAGEMENT MOTO, P149; Tager-Flusberg H., 2005, HDB AUTISM PERVASIVE, P335, DOI DOI 10.1002/9780470939345.CH12; Tager-Flusberg H, 2013, AUTISM RES, V6, P468, DOI 10.1002/aur.1329; Tager-Flusberg H, 2011, NEUROPSYCHOLOGIST HB, P127; Tokimura H, 1996, ANN NEUROL, V40, P628, DOI 10.1002/ana.410400413; Trevarthen C, 1996, CHILDREN WITH AUTISM; Uozumi T, 2004, NEUROLOGY, V62, P757, DOI 10.1212/01.WNL.0000113731.75479.25; VENTER A, 1992, J CHILD PSYCHOL PSYC, V33, P489, DOI 10.1111/j.1469-7610.1992.tb00887.x; Wan CY, 2012, ANN NY ACAD SCI, V1252, P332, DOI 10.1111/j.1749-6632.2012.06446.x; Wan CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025505; Wan CY, 2010, FUTUR NEUROL, V5, P797, DOI 10.2217/FNL.10.55; Wetherby A. M, 2002, COMMUNICATION SYMBOL, DOI 10.1037/t11529-000; Wing L., 1985, AUTISTIC CHILDREN; WOLF M, 1964, BEHAV RES THER, V1, P305; Yeatman J, 2012, J OF COGNITIVE, V23, P3304; Yoder P, 2006, J CONSULT CLIN PSYCH, V74, P426, DOI 10.1037/0022-006X.74.3.426	72	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164930	10.1371/journal.pone.0164930	http://dx.doi.org/10.1371/journal.pone.0164930			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829034	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300022
J	Christensen, MA; Bettencourt, L; Kaye, L; Moturu, ST; Nguyen, KT; Olgin, JE; Pletcher, MJ; Marcus, GM				Christensen, Matthew A.; Bettencourt, Laura; Kaye, Leanne; Moturu, Sai T.; Nguyen, Kaylin T.; Olgin, Jeffrey E.; Pletcher, Mark J.; Marcus, Gregory M.			Direct Measurements of Smartphone Screen-Time: Relationships with Demographics and Sleep	PLOS ONE			English	Article							DURATION; SEVERITY; RISK; METAANALYSIS; TECHNOLOGY; DEPRESSION; VALIDITY; QUALITY; LIGHT	Background Smartphones are increasingly integrated into everyday life, but frequency of use has not yet been objectively measured and compared to demographics, health information, and in particular, sleep quality. Aims The aim of this study was to characterize smartphone use by measuring screen-time directly, determine factors that are associated with increased screen-time, and to test the hypothesis that increased screen-time is associated with poor sleep. Methods We performed a cross-sectional analysis in a subset of 653 participants enrolled in the Health eHeart Study, an internet-based longitudinal cohort study open to any interested adult (>= 18 years). Smartphone screen-time (the number of minutes in each hour the screen was on) was measured continuously via smartphone application. For each participant, total and average screen-time were computed over 30-day windows. Average screen-time specifically during self-reported bedtime hours and sleeping period was also computed. Demographics, medical information, and sleep habits (Pittsburgh Sleep Quality Index-PSQI) were obtained by survey. Linear regression was used to obtain effect estimates. Results Total screen-time over 30 days was a median 38.4 hours (IQR 21.4 to 61.3) and average screen-time over 30 days was a median 3.7 minutes per hour (IQR 2.2 to 5.5). Younger age, self-reported race/ethnicity of Black and "Other" were associated with longer average screen-time after adjustment for potential confounders. Longer average screen-time was associated with shorter sleep duration and worse sleep-efficiency. Longer average screen-times during bedtime and the sleeping period were associated with poor sleep quality, decreased sleep efficiency, and longer sleep onset latency. Conclusions These findings on actual smartphone screen-time build upon prior work based on self-report and confirm that adults spend a substantial amount of time using their smartphones. Screen-time differs across age and race, but is similar across socio-economic strata suggesting that cultural factors may drive smartphone use. Screen-time is associated with poor sleep. These findings cannot support conclusions on causation. Effect-cause remains a possibility: poor sleep may lead to increased screen-time. However, exposure to smartphone screens, particularly around bedtime, may negatively impact sleep.	[Christensen, Matthew A.; Nguyen, Kaylin T.; Olgin, Jeffrey E.; Marcus, Gregory M.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Bettencourt, Laura; Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kaye, Leanne; Moturu, Sai T.] Ginger Io Inc, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.	marcusg@medicine.ucsf.edu	Marcus, Gregory/AAN-8584-2021	Marcus, Gregory/0000-0001-5197-7696; Christensen, Matthew/0000-0002-6021-8680; Kaye, Leanne/0000-0002-5345-7026	Office of Behavioral Social Sciences (OBSSR); National Institute of Biomedical Imaging and Bioengineering (NIBIB); National Institute of Neurological Disorders and Stroke (NINDS); National Heart Lung and Blood Institute (NHLBI); National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health [1U2CEB021881]; Sarnoff Cardiovascular Research Foundation; National Institute on Minority Health and Health Disparities (NIM HD) [R25MD006832]	Office of Behavioral Social Sciences (OBSSR); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health; Sarnoff Cardiovascular Research Foundation; National Institute on Minority Health and Health Disparities (NIM HD)	Research reported in this publication was supported by the Office of Behavioral Social Sciences (OBSSR), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute of Neurological Disorders and Stroke (NINDS), National Heart Lung and Blood Institute (NHLBI), and National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health under award number 1U2CEB021881 (https://grants.nih.govigrants/oer.htm). MAC is a research fellow supported by the Sarnoff Cardiovascular Research Foundation (http://samofffoundation.com). KTN is a fellow supported by National Institute on Minority Health and Health Disparities (NIM HD) under award number R25MD006832 (http.//www.nimhd.nih.gov/). Ginger.io Incorporated (https://ginger.io) provided support in the form of salaries for authors LK and STM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors (LK, STM) are articulated in the 'author contributions' section. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buysse DJ, 1989, RES PSYCHIAT, V193, P213, DOI DOI 10.1016/0165-1781(89)90047-4; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Cajochen C, 2011, J APPL PHYSIOL, V110, P1432, DOI 10.1152/japplphysiol.00165.2011; Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chang A. - M., 2014, P NATL ACAD SCI USA, V112; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Demirci K, 2015, J BEHAV ADDICT, V4, P85, DOI 10.1556/2006.4.2015.010; Dixit S, 2016, HEART RHYTHM, V13, P3, DOI 10.1016/j.hrthm.2015.08.004; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Falbe J, 2015, PEDIATRICS, V135, pE367, DOI 10.1542/peds.2014-2306; Gibss N., 2012, YOUR LIFE IS FULLY M; Gradisar M, 2013, J CLIN SLEEP MED, V9, P1291, DOI 10.5664/jcsm.3272; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Grandner MA, 2012, J SLEEP RES, V21, P427, DOI 10.1111/j.1365-2869.2011.00990.x; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hixon T., 2014, FORBES; Holzman DC, 2010, ENVIRON HEALTH PERSP, V118, pA22, DOI 10.1289/ehp.118-a22; Howden LM, 2011, AGE SEX COMPOSITION, P1; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Knutson KL, 2006, SLEEP, V29, P1503, DOI 10.1093/sleep/29.11.1503; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lin YH, 2015, J PSYCHIATR RES, V65, P139, DOI 10.1016/j.jpsychires.2015.04.003; Patyar S, 2015, J STROKE CEREBROVASC, V24, P905, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.038; Saeb S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4273; Smith A, 2011, 35 AM ADULTS OWN SMA; Smith A., 2015, SMARTPHONE DIFFERENC; Smith A., 2013, SMARTPHONE OWNERSHIP	28	101	107	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165331	10.1371/journal.pone.0165331	http://dx.doi.org/10.1371/journal.pone.0165331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829040	gold, Green Submitted, Green Published			2022-12-27	WOS:000387724300038
J	Lindstrand, A; Kalyango, J; Alfven, T; Darenberg, J; Kadobera, D; Bwanga, F; Peterson, S; Henriques-Normark, B; Kallander, K				Lindstrand, Ann; Kalyango, Joan; Alfven, Tobias; Darenberg, Jessica; Kadobera, Daniel; Bwanga, Freddie; Peterson, Stefan; Henriques-Normark, Birgitta; Kallander, Karin			Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; ANTIBIOTIC-RESISTANCE; SEROTYPE DISTRIBUTION; INVASIVE-DISEASE; PREVALENCE; SURVEILLANCE; VACCINATION; POPULATION	Background Pneumonia is the major cause of death in children globally, with more than 900,000 deaths annually in children under five years of age. Streptococcus pneumoniae causes most deaths, most often in the form of community acquired pneumonia. Pneumococcal conjugate vaccines (PCVs) are currently being implemented in many low-income countries. PCVs decrease vaccine-type pneumococcal carriage, a prerequisite for invasive pneumococcal disease, and thereby affects pneumococcal disease and transmission. In Uganda, PCV was launched in 2014, but baseline data is lacking for pneumococcal serotypes in carriage. Objectives To study pneumococcal nasopharyngeal carriage and serotype distribution in children under 5 years of age prior to PCV introduction in Uganda Methods Three cross-sectional pneumococcal carriage surveys were conducted in 2008, 2009 and 2011, comprising respectively 150, 587 and 1024 randomly selected children aged less than five years from the lganga/Mayuge Health and Demographic Surveillance Site. The caretakers were interviewed about illness history of the child and 1723 nasopharyngeal specimens were collected. From these, 927 isolates of S. pneumoniae were serotyped. Results Overall, the carriage rate of S. pneumoniae was 56% (957/1723). Pneumococcal carriage was associated with illness on the day of the interview (OR = 1.50, p = 0.04). The most common pneumococcal serotypes were in descending order 19F (16%), 23F (9%), 6A (8%), 29 (7%) and 6B (7%). One percent of the strains were non-typeable. The potential serotype coverage rate for PCV10 was 42% and 54% for PCV13. Conclusion About half of circulating pneumococcal serotypes in carriage in the Ugandan under-five population studied was covered by available PCVs.	[Lindstrand, Ann; Alfven, Tobias; Peterson, Stefan; Kallander, Karin] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lindstrand, Ann; Darenberg, Jessica; Henriques-Normark, Birgitta] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Kalyango, Joan; Kadobera, Daniel; Peterson, Stefan; Kallander, Karin] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Alfven, Tobias] Sachs Children & Youth Hosp, Stockholm, Sweden; [Bwanga, Freddie] Makerere Univ, Fac Med, Kampala, Uganda; [Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, Sweden; [Henriques-Normark, Birgitta] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Kallander, Karin] Malaria Consortium, London, England; [Peterson, Stefan] Uppsala Univ, Dept Int Maternal & Child Hlth Womens & Childrens, Uppsala, Sweden; [Kadobera, Daniel] Minist Hlth, Kampala, Uganda; [Kadobera, Daniel] Hlth & Demog Surveillance Site, Iganga Mayuge, Uganda	Karolinska Institutet; Public Health Agency of Sweden; Makerere University; Makerere University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Lindstrand, A (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Lindstrand, A (corresponding author), Publ Hlth Agcy Sweden, Stockholm, Sweden.	Ann.Lindstrand@folkhalsomyndigheten.se		Kallander, Karin/0000-0002-5778-5780; Lindstrand, Ann/0000-0002-8271-9486; Alfven, Tobias/0000-0002-2328-3512	Swedish International Development Agency [SWE-2008-228]; Karolinska Institutet (KI) Strategic Research Program in Epidemiology; KI Public International Health Network (KIPIH) [228/2008-607]	Swedish International Development Agency; Karolinska Institutet (KI) Strategic Research Program in Epidemiology; KI Public International Health Network (KIPIH)	This study was funded by the Swedish International Development Agency (SWE-2008-228) (www.sida.se), the Karolinska Institutet (KI) Strategic Research Program in Epidemiology (http://ki.se/en/research/the-strategic-research-area-in-epidemiology-sfoepi), the KI Public International Health Network (228/2008-607) (KIPIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293; Ba F, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0627-8; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220; Blossom DB, 2006, INT J INFECT DIS, V10, P458, DOI 10.1016/j.ijid.2006.05.010; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Donkor ES, 2013, INT J GEN MED, V6, P757, DOI 10.2147/IJGM.S45842; Galanis I, 2016, EUR RESPIR J, V47, P1208, DOI 10.1183/13993003.01451-2015; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Goldblatt D, 2013, VACCINE, V32, P146, DOI 10.1016/j.vaccine.2013.06.040; Hackel M, 2013, VACCINE, V31, P4881, DOI 10.1016/j.vaccine.2013.07.054; Hammitt LL, 2014, LANCET GLOB HEALTH, V2, pE397, DOI 10.1016/S2214-109X(14)70224-4; Hammitt LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085459; Hausdorff WP, 2007, VACCINE, V25, P2406, DOI 10.1016/j.vaccine.2006.09.009; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kallander K, 2016, LANCET GLOB HEALTH, V4, pE12, DOI 10.1016/S2214-109X(15)00272-7; Kalyango JN, 2012, AM J TROP MED HYG, V87, P36, DOI 10.4269/ajtmh.2012.11-0733; Kisakye A, 2009, CLIN INFECT DIS, V48, pS153, DOI 10.1086/596495; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mackenzie GA, 2016, LANCET INFECT DIS; Mudhune S, 2009, CLIN INFECT DIS, V48, pS147, DOI 10.1086/596494; Muema DM, 2015, CLIN EXP IMMUNOL, V181, P297, DOI 10.1111/cei.12637; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; Normark BH, 2003, MICROB DRUG RESIST, V9, P337, DOI 10.1089/107662903322762761; Normark BH, 2001, SCAND J INFECT DIS, V33, P848, DOI 10.1080/713933757; Nunes MC, 2013, PEDIATR INFECT DIS J, V32, pE192, DOI 10.1097/INF.0b013e31828683a3; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Oliwa JN, PAEDIAT RESP REV; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Rutebemberwa E, 2015, UPSALA J MED SCI, V120, P249, DOI 10.3109/03009734.2015.1072606; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sankoh O, 2012, INT J EPIDEMIOL, V41, P579, DOI 10.1093/ije/dys081; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Sharma D, 2013, PEDIATR INFECT DIS J, V32, pE45, DOI 10.1097/INF.0b013e3182788fdd; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tate JE, 2011, VACCINE, V29, P3329, DOI 10.1016/j.vaccine.2010.12.122; Usuf E, 2015, TROP MED INT HLTH; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; von Gottberg A, 2014, NEW ENGL J MED, V371, P1889, DOI 10.1056/NEJMoa1401914; Weinberger DM, 2013, AM J EPIDEMIOL, V178, P1488, DOI 10.1093/aje/kwt156; World Health Organization, 2003, MANUAL LAB IDENTIFIC; World Health Organization, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166018	10.1371/journal.pone.0166018	http://dx.doi.org/10.1371/journal.pone.0166018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829063	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300075
J	Chiang, MH; Chen, PH; Chen, YK; Chen, CH; Ho, ML; Wang, YH				Chiang, Min-Hsuan; Chen, Ping-Ho; Chen, Yuk-Kwan; Chen, Chia-Hsin; Ho, Mei-Ling; Wang, Yan-Hsiung			Characterization of a Novel Dermal Fibrosis Model Induced by Areca Nut Extract that Mimics Oral Submucous Fibrosis	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; COLLAGEN-SYNTHESIS; IN-VITRO; FIBROBLASTS; STIMULATION; BLEOMYCIN; MECHANISM; CYTOTOXICITY; INHIBITION; ACTIVATION	Oral submucous fibrosis (OSF) is an oral potentially malignant disorder and areca quid chewing is the main etiological factor. However, the molecular mechanism underlying OSF remains unclear, partly due to the lack of an appropriate animal model. The present study aimed to establish and characterize an animal model of areca nut extract (ANE)-induced skin fibrosis that mimics OSF. Mice were divided into 4 groups: the control group; the bleomycin group; and the ANE10 and ANE20 groups, which received 10mg/ml and 20mg/ml subcutaneous (SC) injection of ANE, respectively. Skin fibrosis was evaluated by histological analyses. Additionally, the expression levels of the fibrotic marker genes were determined by immunohistochemical staining and immunoblotting. ANE administration significantly increased dermal thickness and collagen deposition compared with the control group. Moreover, ANE induced the expression of the fibrotic marker genes alpha smooth muscle actin (alpha-SMA) and connective tissue growth factor (CTGF) in the skin lesions. The SC injection of ANE successfully induced skin fibrosis, exhibiting characteristics similar to those of OSF. This model may facilitate future studies of the mechanism underlying OSF.	[Chiang, Min-Hsuan; Chen, Ping-Ho; Chen, Yuk-Kwan; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Chiang, Min-Hsuan; Chen, Chia-Hsin; Ho, Mei-Ling; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Chen, Ping-Ho] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Chen, Ping-Ho] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chen, Ping-Ho] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res CICAR, Kaohsiung, Taiwan; [Chen, Yuk-Kwan] Kaohsiung Med Univ, Oral & Maxillofacial Imaging Ctr, Kaohsiung, Taiwan; [Chen, Yuk-Kwan] Kaohsiung Med Univ Hosp, Dept Dent, Div Oral Pathol & Maxillofacial Radiol, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Ho, Mei-Ling] Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Wang, YH (corresponding author), Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan.; Wang, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan.	yhwang@kmu.edu.tw	Chen, Yuk-Kwan/C-8773-2009; Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Chen, Chia-Hsin/0000-0002-6557-9848; Ho, Mei-Ling/0000-0001-8064-8488	Ministry of Science and Technology [MOST-104-2314-B-037-059-]; Kaohsiung Medical University Aim for the Top Universities Grants [KMU-TP103B08, KM U-TP104B11]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University Aim for the Top Universities Grants	The authors gratefully acknowledge the support of research grant from the Ministry of Science and Technology (MOST-104-2314-B-037-059-) and Kaohsiung Medical University Aim for the Top Universities Grants (KMU-TP103B08 and KM U-TP104B11).	ADAMSON IYR, 1984, ENVIRON HEALTH PERSP, V55, P25, DOI 10.1289/ehp.845525; Angadi PV, 2011, ORAL MAXILLOFAC SURG, V15, P1, DOI 10.1007/s10006-010-0219-8; ASO Y, 1976, LAB INVEST, V35, P558; CANNIFF JP, 1981, INT J ORAL MAXILLOF, V10, P163; CHANDLER DB, 1990, CLIN CHEST MED, V11, P21; Chang MC, 2004, J BIOL CHEM, V279, P50676, DOI 10.1074/jbc.M404465200; Chang YC, 2014, J CELL MOL MED, V18, P698, DOI 10.1111/jcmm.12219; Dai JP, 2015, MOLECULES, V20, P6794, DOI 10.3390/molecules20046794; Dai JP, 2014, J ORAL PATHOL MED, V43, P464, DOI 10.1111/jop.12158; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Ham SA, 2015, J DERMATOL SCI, V80, P186, DOI 10.1016/j.jdermsci.2015.10.005; Jeng JH, 1999, J ORAL PATHOL MED, V28, P64; Khan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051806; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; MA RH, 1995, J ORAL PATHOL MED, V24, P407, DOI 10.1111/j.1600-0714.1995.tb01210.x; MAHER R, 1994, J ORAL PATHOL MED, V23, P65, DOI 10.1111/j.1600-0714.1994.tb00258.x; MEGHJI S, 1987, ARCH ORAL BIOL, V32, P213, DOI 10.1016/0003-9969(87)90138-5; Meier JKH, 2011, INFLAMM BOWEL DIS, V17, P202, DOI 10.1002/ibd.21344; Mukherjee S, 2012, ORAL ONCOL, V48, pE27, DOI 10.1016/j.oraloncology.2012.05.018; Mukherjee S, 2012, J ORAL PATHOL MED, V41, P292, DOI 10.1111/j.1600-0714.2011.01097.x; MURTI PR, 1985, COMMUNITY DENT ORAL, V13, P340, DOI 10.1111/j.1600-0528.1985.tb00468.x; Perera MWS, 2007, J ORAL PATHOL MED, V36, P273, DOI 10.1111/j.1600-0714.2007.00523.x; PINDBORG JJ, 1984, SCAND J DENT RES, V92, P224; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; SCUTT A, 1987, EXPERIENTIA, V43, P391, DOI 10.1007/BF01940422; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Tilakaratne WM, 2006, ORAL ONCOL, V42, P561, DOI 10.1016/j.oraloncology.2005.08.005; Tsai CC, 1999, J ORAL PATHOL MED, V28, P59; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yang SC, 2003, J ORAL PATHOL MED, V32, P600, DOI 10.1034/j.1600-0714.2003.00199.x	33	11	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166454	10.1371/journal.pone.0166454	http://dx.doi.org/10.1371/journal.pone.0166454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851781	gold, Green Submitted, Green Published			2022-12-27	WOS:000387909300051
J	Costanzo, A; Panseri, S; Giorgi, A; Romano, A; Caprioli, M; Saino, N				Costanzo, Alessandra; Panseri, Sara; Giorgi, Annamaria; Romano, Andrea; Caprioli, Manuela; Saino, Nicola			The Odour of Sex: Sex-Related Differences in Volatile Compound Composition among Barn Swallow Eggs Carrying Embryos of Either Sex	PLOS ONE			English	Article							UROPYGIAL GLAND SECRETION; PLUMAGE COLOR; DOSAGE COMPENSATION; YOLK ANDROGENS; BEGGING CALLS; RATIO; RECOGNITION; ALLOCATION; GROWTH; BIRDS	Avian communication has been traditionally believed to be mainly mediated by visual and auditory channels. However, an increasing number of studies are disclosing the role of olfaction in the interaction of birds with their social environment and with other species, as well as in other behaviors such as nest recognition, food location and navigation. Olfaction has also been suggested to play a role in parent-offspring communication not only in the post-but also in the pre-hatching period. Volatile compounds produced during embryogenesis and passively released through the eggshell pores may indeed represent the only cue at parents' disposal to assess offspring quality, including the sex composition of their clutch before hatching. In turn, sex identification before hatching may mediate adaptive strategies of allocation to either sex. In the present study, we analyzed odour composition of barn swallow eggs incubated in their nest in order to identify any sex-related differences in volatile compounds emitted. For the first time in any bird species, we also investigated whether odour composition is associated with relatedness. The evidence of differences in odour composition among eggs containing embryos of either sex indicates that parents have a cue to identify their brood sex composition even before hatching which can be used to modulate their behavior accordingly. Moreover, odour similarity within nests may represent the prerequisite for kin recognition in this species.	[Costanzo, Alessandra; Romano, Andrea; Caprioli, Manuela; Saino, Nicola] Univ Milan, Dept Biosci, Milan, Italy; [Panseri, Sara] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Giorgi, Annamaria] Univ Milan, Ctr Appl Studies Sustainable Management & Protect, Ge S Di Mt, Brescia, Italy	University of Milan; University of Milan; University of Milan	Costanzo, A (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	alessandra.costanzo@unimi.it	costanzo, alessandra/AAF-8987-2020; Romano, Andrea/A-2780-2017; Romano, Andrea/B-3930-2012	costanzo, alessandra/0000-0003-3781-0798; Romano, Andrea/0000-0002-0945-6018; giorgi, annamaria/0000-0001-5386-7378; Panseri, Sara/0000-0001-6970-2009; Saino, Nicola/0000-0002-0230-3967				Amo L, 2012, J ANIM ECOL, V81, P605, DOI 10.1111/j.1365-2656.2011.01940.x; Appleby BM, 1997, P ROY SOC B-BIOL SCI, V264, P1111, DOI 10.1098/rspb.1997.0153; Badyaev AV, 2006, J EVOLUTION BIOL, V19, P1044, DOI 10.1111/j.1420-9101.2006.01106.x; Balbontin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1197, DOI 10.1007/s00265-009-0752-3; BALTHAZART J, 1979, NATURWISSENSCHAFTEN, V66, P55, DOI 10.1007/BF00369365; Bang B.G., 1985, P195; BANG BG, 1968, AUK, V85, P55; BANG BG, 1960, NATURE, V188, P547, DOI 10.1038/188547a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardi ML, 1996, HUM REPROD, V11, P621, DOI 10.1093/HUMREP/11.3.621; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Boncoraglio G, 2008, BEHAV ECOL SOCIOBIOL, V62, P729, DOI 10.1007/s00265-007-0498-8; Bonisoli-Alquati A, 2011, P ROY SOC B-BIOL SCI, V278, P1273, DOI 10.1098/rspb.2010.1741; Booksmythe I, 2017, BIOL REV, V92, P108, DOI 10.1111/brv.12220; CAREY C, 1980, BIOSCIENCE, V30, P819, DOI 10.2307/1308374; Caro SP, 2010, J COMP PHYSIOL A, V196, P751, DOI 10.1007/s00359-010-0534-4; CHARNOV E L, 1982; COHEN J, 1981, BIOCHEM SYST ECOL, V9, P351, DOI 10.1016/0305-1978(81)90022-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cordero PJ, 2001, J EVOLUTION BIOL, V14, P829, DOI 10.1046/j.1420-9101.2001.00320.x; Costanzo A, 2017, BEHAV ECOL, V28, P204, DOI 10.1093/beheco/arw147; Cramp S, 1998, COMPLETE BIRDS W PAL; Deeming DC, 2002, OX ORN SER, V13, P63; Dijkstra C, 1998, BEHAV ECOL, V9, P287, DOI 10.1093/beheco/9.3.287; DuRant SE, 2010, J EXP BIOL, V213, P45, DOI 10.1242/jeb.034488; Fisher, 1930, GENETICAL THEORY NAT; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Gil D, 2006, J EVOLUTION BIOL, V19, P123, DOI 10.1111/j.1420-9101.2005.00981.x; Gilbert L, 2005, NATURWISSENSCHAFTEN, V92, P178, DOI 10.1007/s00114-004-0603-z; Goluke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155513; GRUBB TC, 1972, NATURE, V237, P404, DOI 10.1038/237404a0; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; Hirao A, 2009, BEHAV PROCESS, V80, P115, DOI 10.1016/j.beproc.2008.10.006; Hubbard JK, 2015, ECOL EVOL, V5, P3436, DOI 10.1002/ece3.1602; JACOB J, 1978, J LIPID RES, V19, P148; Jacob J., 1982, AVIAN BIOL, DOI [10.1016/B978-0-12-249406-2.50013-7, DOI 10.1016/B978-0-12-249406-2.50013-7]; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Johnsen A, 2003, P ROY SOC B-BIOL SCI, V270, P1263, DOI 10.1098/rspb.2003.2375; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Komdeur J, 2012, EVOLUTION OF PARENTAL CARE, P171; Krause ET, 2014, BEHAV ECOL SOCIOBIOL, V68, P1819, DOI 10.1007/s00265-014-1791-y; Mainwaring MC, 2012, J ORNITHOL, V153, P1011, DOI 10.1007/s10336-012-0828-0; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; Manzo A, 2014, MOLECULES, V19, P7913, DOI 10.3390/molecules19067913; Menezo YJR, 1999, FERTIL STERIL, V72, P221, DOI 10.1016/S0015-0282(99)00256-3; Moller AP., 1994, SEXUAL SELECTION BAR; Monk DS, 1997, WILSON BULL, V109, P328; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; PAGANELLI CV, 1980, AM ZOOL, V20, P329; Panseri S, 2011, FOOD CHEM, V127, P886, DOI 10.1016/j.foodchem.2010.12.150; Parejo D, 2012, BIOL LETTERS, V8, P502, DOI 10.1098/rsbl.2012.0124; PEIPPO J, 1995, MOL REPROD DEV, V40, P56, DOI 10.1002/mrd.1080400108; Romano A, 2015, J EVOLUTION BIOL, V28, P1234, DOI 10.1111/jeb.12650; Romano A, 2016, BEHAV ECOL, V27, P1198, DOI 10.1093/beheco/arw040; Romano A, 2012, EVOL ECOL, V26, P1041, DOI 10.1007/s10682-011-9543-1; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Roulin A, 1998, EVOLUTION, V52, P1451, DOI 10.1111/j.1558-5646.1998.tb02026.x; Saino N, 2003, ANIM BEHAV, V66, P1003, DOI 10.1006/anbe.2003.2295; Saino N, 2003, J EVOLUTION BIOL, V16, P516, DOI 10.1046/j.1420-9101.2003.00534.x; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2008, ANIM BEHAV, V75, P1375, DOI 10.1016/j.anbehav.2007.09.011; Soler JJ, 2014, J EVOLUTION BIOL, V27, P1265, DOI 10.1111/jeb.12377; Spurr E. B., 1999, Science for Conservation, P1; Stager KE, 1964, LOS ANGELES COUNTY M, V81, P1; Steiger SS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-117; STREHL CE, 1986, OECOLOGIA, V70, P178, DOI 10.1007/BF00379237; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Tagirov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114625; Tillmann H, 2002, GENE, V291, P57, DOI 10.1016/S0378-1119(02)00627-3; Tinbergen JM, 2002, OX ORN SER, V13, P299; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tschirren B, 2012, P ROY SOC B-BIOL SCI, V279, P1233, DOI 10.1098/rspb.2011.1543; Turner A., 2006, BARN SWALLOW; Uller T, 2006, BIOL REV, V81, P207, DOI 10.1017/S1464793105006962; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vleck CM, 1998, AVIAN GROWTH DEV EVO, P89; Webster B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116345; Wenzel B.M., 1973, P389; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Whittaker DJ, 2011, BEHAV ECOL, DOI [10.1093/beheco/, DOI 10.1093/BEHECO/]; Williams Joseph B., 1996, P375; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997; Zhang SBO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-13; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	93	9	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165055	10.1371/journal.pone.0165055	http://dx.doi.org/10.1371/journal.pone.0165055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851741	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300009
J	Martinez, LM; Estebaranz-Sanchez, F; Galbany, J; Perez-Perez, A				Monica Martinez, Laura; Estebaranz-Sanchez, Ferran; Galbany, Jordi; Perez-Perez, Alejandro			Testing Dietary Hypotheses of East African Hominines Using Buccal Dental Microwear Data	PLOS ONE			English	Article							UNDERGROUND-STORAGE ORGANS; FLK 22 ZINJANTHROPUS; LATE PLIOCENE HOMO; OLDUVAI GORGE; FALLBACK FOODS; QUANTITATIVE-ANALYSIS; PARANTHROPUS-BOISEI; EARLY PLEISTOCENE; ISOTOPIC EVIDENCE; MOLAR MICROWEAR	There is much debate on the dietary adaptations of the robust hominin lineages during the Pliocene-Pleistocene transition. It has been argued that the shift from C3 to C4 ecosystems in Africa was the main factor responsible for the robust dental and facial anatomical adaptations of Paranthropus taxa, which might be indicative of the consumption of fibrous, abrasive plant foods in open environments. However, occlusal dental microwear data fail to provide evidence of such dietary adaptations and are not consistent with isotopic evidence that supports greater C4 food intake for the robust clades than for the gracile australopithecines. We provide evidence from buccal dental microwear data that supports softer dietary habits than expected for P. aethiopicus and P. boisei based both on masticatory apomorphies and isotopic analyses. On one hand, striation densities on the buccal enamel surfaces of paranthropines teeth are low, resembling those of H. habilis and clearly differing from those observed on H. ergaster, which display higher scratch densities indicative of the consumption of a wide assortment of highly abrasive foodstuffs. Buccal dental microwear patterns are consistent with those previously described for occlusal enamel surfaces, suggesting that Paranthropus consumed much softer diets than previously presumed and thus calling into question a strict interpretation of isotopic evidence. On the other hand, the significantly high buccal scratch densities observed in the H. ergaster specimens are not consistent with a highly specialized, mostly carnivorous diet; instead, they support the consumption of a wide range of highly abrasive food items.	[Monica Martinez, Laura; Estebaranz-Sanchez, Ferran; Perez-Perez, Alejandro] Univ Barcelona, Seccio Zool & Antropol, Dept Biol Evolut Ecol & Ciencies Ambientals, Fac Biol, Barcelona, Spain; [Galbany, Jordi] George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC USA	University of Barcelona; George Washington University	Perez-Perez, A (corresponding author), Univ Barcelona, Seccio Zool & Antropol, Dept Biol Evolut Ecol & Ciencies Ambientals, Fac Biol, Barcelona, Spain.	martinez.perez-perez@ub.edu	Martínez, Laura Mónica/J-7148-2017; Sánchez, Ferran Estebaranz/K-7434-2017; Pérez-Pérez, Alejandro/K-6715-2014; Galbany, Jordi/K-8609-2017	Martínez, Laura Mónica/0000-0002-1166-4799; Sánchez, Ferran Estebaranz/0000-0002-9736-3953; Pérez-Pérez, Alejandro/0000-0002-1442-1397; Galbany, Jordi/0000-0001-6724-3451	Spanish "Ministerio de Ciencia e Innovacion" [CGL2011-22999, CGL2014-52611-C2-1-P]	Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research was funded by the Spanish "Ministerio de Ciencia e Innovacion" (http://www.id.mineco.gob.es/portal/site/MICINN/), grant numbers CGL2011-22999 and CGL2014-52611-C2-1-P, both to APP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bamford MK, 2008, PALAEOGEOGR PALAEOCL, V257, P280, DOI 10.1016/j.palaeo.2007.09.003; Bauchop T, 1978, ECOLOGY ARBOREAL FOL, P195; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; BERNSTEIN PL, 1978, Z TIERPSYCHOL, V46, P268; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe R, 2002, J HUM EVOL, V42, P475, DOI 10.1006/jhev.2001.0535; Brown F. H., 1991, KOOBI FORA RES PROJE, V3, P1; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10507, DOI 10.1073/pnas.1222571110; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; CHISHOLM BS, 1983, J ARCHAEOL SCI, V10, P355, DOI 10.1016/0305-4403(83)90073-0; Constantino PJ, 2011, J HUM EVOL, V61, P89, DOI 10.1016/j.jhevol.2011.02.009; Constantino PJ, 2010, BIOL LETTERS, V6, P826, DOI 10.1098/rsbl.2010.0304; Constantino PJ, 2009, AM J PHYS ANTHROPOL, V140, P599, DOI 10.1002/ajpa.20978; Copeland SR, 2007, J HUM EVOL, V53, P146, DOI 10.1016/j.jhevol.2007.03.002; Curnoe D, 2006, J HUM EVOL, V50, P36, DOI 10.1016/j.jhevol.2005.07.008; Cuthbert MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107358; Daegling DJ, 2013, AM J PHYS ANTHROPOL, V151, P356, DOI 10.1002/ajpa.22281; DASILVA GL, 1994, INT J PRIMATOL, V15, P655, DOI 10.1007/BF02737426; Davis M, 2016, ECOL EVOL, V6, P1883, DOI 10.1002/ece3.2054; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Deocampo DM, 2009, AM J SCI, V309, P834, DOI 10.2475/09.2009.03; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Estebaranz F, 2009, J HUM EVOL, V57, P739, DOI 10.1016/j.jhevol.2009.07.007; Estebaranz F, 2012, J ANTHROPOL SCI, V90, P163, DOI [10.4436/JASS.90006, 10.4436/jass.90006]; Finlayson C., 2014, IMPROBABLE PRIMATE W; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; FOX CL, 1993, J HUM EVOL, V24, P29, DOI 10.1006/jhev.1993.1004; Galbany J, 2006, MICROSC RES TECHNIQ, V69, P246, DOI 10.1002/jemt.20296; Galbany J, 2005, FOLIA PRIMATOL, V76, P325, DOI 10.1159/000089531; Galbany J, 2005, SCANNING, V27, P23; Galbany J., 2004, ANTHROPOLOGIE, V42, P5; Galbany J., 2004, ANTHROPOLOGIE, V42, P13; Galbany J, 2009, PRIMATES, V50, P221, DOI 10.1007/s10329-009-0139-0; GORDON KD, 1983, AM J PHYS ANTHROPOL, V60, P109, DOI 10.1002/ajpa.1330600115; GORDON KD, 1982, AM J PHYS ANTHROPOL, V59, P195, DOI 10.1002/ajpa.1330590208; Grine F. E., 1988, AUSTRALOPITHECUS PAR, P3; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; Grine FE, 2010, J HUM EVOL, V58, P293, DOI 10.1016/j.jhevol.2009.12.001; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOSHINO J, 1985, Primates, V26, P248, DOI 10.1007/BF02382401; Hylander W.L., 1988, P55; IWAMOTO T, 1983, J ANIM ECOL, V52, P357, DOI 10.2307/4559; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; King T, 1999, AM J PHYS ANTHROPOL, V108, P359, DOI 10.1002/(SICI)1096-8644(199903)108:3<359::AID-AJPA10>3.0.CO;2-9; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; LAHM SA, 1986, AM J PRIMATOL, V11, P9, DOI 10.1002/ajp.1350110103; Lalueza C, 1996, AM J PHYS ANTHROPOL, V101, P101; Lalueza C, 1996, AM J PHYS ANTHROPOL, V100, P367, DOI 10.1002/(SICI)1096-8644(199607)100:3<367::AID-AJPA5>3.0.CO;2-R; Lambert JE, 2007, EVOLUTION HUMAN DIET, P324; Lee JJW, 2011, BIOL REV, V86, P959, DOI 10.1111/j.1469-185X.2011.00181.x; LEONARD WR, 1994, AM J HUM BIOL, V6, P77, DOI 10.1002/ajhb.1310060111; Lieberman DE, 1996, J HUM EVOL, V30, P97, DOI 10.1006/jhev.1996.0008; LUCAS PW, 1995, FOLIA PRIMATOL, V64, P30, DOI 10.1159/000156829; MAAS MC, 1991, AM J PHYS ANTHROPOL, V85, P31, DOI 10.1002/ajpa.1330850106; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Macho GA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084942, 10.1371/journal.pone.0102794]; Mahoney P, 2006, J HUM EVOL, V50, P452, DOI 10.1016/j.jhevol.2005.11.003; Marlowe FW, 2009, AM J PHYS ANTHROPOL, V140, P751, DOI 10.1002/ajpa.21040; Martinez L. M., 2004, ANTHROPOLOGY, VXLII, P37; McGraw WS, 2016, J HUM EVOL, V98, P90, DOI 10.1016/j.jhevol.2015.06.001; McGraw WS, 2012, AM J PHYS ANTHROPOL, V147, P326, DOI 10.1002/ajpa.21634; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Mirazon-Lahr M, 2010, OUT OF AFRICA; MITANI M, 1989, PRIMATES, V30, P307, DOI 10.1007/BF02381257; O'Connell JF, 1999, J HUM EVOL, V36, P461, DOI 10.1006/jhev.1998.0285; Oates John F., 1994, P45; Pazol K, 2005, BEHAV ECOL SOCIOBIOL, V58, P566, DOI 10.1007/s00265-005-0953-3; Perez-Perez A, 2003, J HUM EVOL, V44, P497, DOI 10.1016/S0047-2484(03)00030-7; Perez-Perez A, 1999, AM J PHYS ANTHROPOL, V108, P433, DOI 10.1002/(SICI)1096-8644(199904)108:4<433::AID-AJPA5>3.0.CO;2-5; Perez-Perez A, 1990, EVOLUCION DIETA BALE; Perez-Perez A, 2004, ANTHROPOLOGIE, V42, P1; PEREZPEREZ A, 1994, AM J PHYS ANTHROPOL, V94, P175, DOI 10.1002/ajpa.1330940203; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; Pinilla Perez B, 2011, ANTHR REV, V74, P25, DOI DOI 10.2478/V10044-010-0005-0; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Potts R, 2012, CURR ANTHROPOL, V53, pS299, DOI 10.1086/667704; Prat S, 2005, J HUM EVOL, V49, P230, DOI 10.1016/j.jhevol.2005.03.009; PUECH PF, 1985, CR ACAD SCI II, V301, P59; PUECH PF, 1984, CURR ANTHROPOL, V25, P349, DOI 10.1086/203146; PUECH PF, 1983, J HUM EVOL, V12, P721, DOI 10.1016/S0047-2484(83)80127-4; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Remis MJ, 2001, INT J PRIMATOL, V22, P807, DOI 10.1023/A:1012021617737; Romero A, 2009, AM J PHYS ANTHROPOL, P223; Romero A, 2007, NEW PERSPECTIVES PRO; Romero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084804; Romero A, 2012, AM J PHYS ANTHROPOL, V148, P467, DOI 10.1002/ajpa.22054; Shabel A, 2009, CRANIODENTAL MORPHOL; Shabel A.B., 2010, HUMAN BRAIN EVOL INF, P173, DOI 10.1002/9780470609880.ch9; Shultz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076750; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Sponheimer M, 2009, AM J PHYS ANTHROPOL, V140, P661, DOI 10.1002/ajpa.21111; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Stewart K.M., 2010, HUMAN BRAIN EVOLUTIO, P137, DOI [10.1002/9780470609880.ch8, DOI 10.1002/9780470609880.CH8]; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1167; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P73, DOI 10.1002/ajpa.1330800109; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Tobias P, 1991, O GORGE SKULLS ENDOC, V4; Tobias PV, 2010, HUMAN BRAIN EVOLUTIO, pvii; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; Ungar Peter S., 2009, P121, DOI 10.1007/978-1-4020-9980-9_11; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; Ungar PS, 2006, J HUM EVOL, V50, P78, DOI 10.1016/j.jhevol.2005.08.007; Ungar PS, 1996, AM J PHYS ANTHROPOL, V100, P101; Ungar PS, 1999, AM J PHYS ANTHROPOL, V109, P387, DOI 10.1002/(SICI)1096-8644(199907)109:3&lt;387::AID-AJPA7&gt;3.0.CO;2-F; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; Vaneechoutte Mario, 2000, Human Evolution, V15, P243, DOI 10.1007/BF02437448; WALKER A, 1981, PHILOS T ROY SOC B, V292, P57, DOI 10.1098/rstb.1981.0013; Waters N E, 1980, Symp Soc Exp Biol, V34, P99; White EC, 2010, INT J PRIMATOL, V31, P627, DOI 10.1007/s10764-010-9417-3; WHITEN A, 1991, PHILOS T ROY SOC B, V334, P187, DOI 10.1098/rstb.1991.0108; Wood B, 2001, AM J PHYS ANTHROPOL, V116, P13, DOI 10.1002/ajpa.1097; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1998, AM J PHYS ANTHROPOL, V105, P523, DOI 10.1002/(SICI)1096-8644(199804)105:4<523::AID-AJPA9>3.0.CO;2-O; Wood B. A., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; Wood Bernard, 1993, P485; Wood Bernard A., 2009, P17, DOI 10.1007/978-1-4020-9980-9_3; Wrangham R, 2009, AM J PHYS ANTHROPOL, V140, P630, DOI 10.1002/ajpa.21122; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; XHONGA FA, 1977, J ORAL REHABIL, V4, P65, DOI 10.1111/j.1365-2842.1977.tb00967.x; Yamagiwa Juichi, 2012, P385	146	13	13	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165447	10.1371/journal.pone.0165447	http://dx.doi.org/10.1371/journal.pone.0165447			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851745	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300016
J	Poremski, D; Vathsala; Wang, P; Lum, A; Subramaniam, M; Ann, CS				Poremski, Daniel; Vathsala; Wang, Peizhi; Lum, Alvin; Subramaniam, Mythily; Ann, Chong Siow			The Impact of Stakeholder Preferences on Service User Adherence to Treatments for Schizophrenia and Metabolic Comorbidities	PLOS ONE			English	Article							ILLNESS; SAMPLE; HEALTH; FOCUS; PEOPLE; RATES	Objective To determine how stakeholder opinions of treatments influence service user decisions to adhere to courses of actions necessary to treat metabolic conditions. Methods Qualitative open-ended interviews were conducted with 20 service providers, 25 service users, and 9 caregivers. Grounded theory was used to generate an understanding that linked preferences of care with adherence to follow-up treatments. Results Participants spoke about several considerations when discussing adherence: Resource limitations were the predominant consideration. Social considerations such as stigma and support surfaced in caregiver and service-user interviews. The influence of symptoms, especially their absence could reduce adherence, and organizational considerations related to the opinions they had about the qualifications of professionals. Discussion A rational patient model partially organizes our findings, but emotional components related to stigma and the opinion of service providers do not fit well into such a model. If service providers do not consider components of the decision making process which fall outside of the rational patient model, they may incorrectly be leveraging suboptimal values to bring about adherence to treatment plans. Being sensitive to the values of service users and their caregivers may allow service providers to better act on points that may bring about change in non-compliant service users with schizophrenia and metabolic comorbidities.	[Poremski, Daniel; Vathsala; Wang, Peizhi; Lum, Alvin; Subramaniam, Mythily; Ann, Chong Siow] Inst Mental Hlth, Div Res, Singapore, Singapore		Poremski, D (corresponding author), Inst Mental Hlth, Div Res, Singapore, Singapore.	daniel_poremski@imh.com.sg			Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme [NMRC/CG/004/2013]	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme	This research was supported by the Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme (Grant No.: NMRC/CG/004/2013) awarded to the Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111882; AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Broadbent E, 2011, DIABETES CARE, V34, P338, DOI 10.2337/dc10-1779; Carr VJ, 2004, SOC PSYCH PSYCH EPID, V39, P78, DOI 10.1007/s00127-004-0703-2; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Citrome Leslie, 2008, J Psychopharmacol, V22, P90, DOI 10.1177/0269881107087373; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Corrigan PW, 2014, REHABIL PSYCHOL, V59, P85, DOI 10.1037/a0034935; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; DiBonaventura M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-20; Eiring O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007848; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gorczynski P, 2014, CLIN SCHIZOPHR RELAT, V4, P1; Greene JA, 2016, PSYCHIAT SERV, V67, P485, DOI 10.1176/appi.ps.201400591; Hewitt J, 2005, J ADV NURS, V52, P561, DOI 10.1111/j.1365-2648.2005.03623.x; Hysong SJ, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-125; MacDougall C, 2001, QUAL HEALTH RES, V11, P117, DOI 10.1177/104973201129118975; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Nasrallah HA, 2006, SCHIZOPHR RES, V86, P15, DOI 10.1016/j.schres.2006.06.026; Domecq JP, 2015, J CLIN ENDOCR METAB, V100, P363, DOI 10.1210/jc.2014-3421; Polednak AP, 2014, SOC PSYCH PSYCH EPID, V49, P1083, DOI 10.1007/s00127-014-0846-8; Raney LE, 2015, AM J PSYCHIAT, V172, P721, DOI 10.1176/appi.ajp.2015.15010017; Rich A, 2015, J BEHAV MED, V38, P673, DOI 10.1007/s10865-015-9644-3; Rojo LE., 2015, PHARM RES; Stahl S.M., 2021, ESSENTIAL PSYCHOPHAR; Stubbs B., 2015, ACTA PSYCHIAT SCAND; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Weiss KA, 2002, SCHIZOPHRENIA BULL, V28, P341, DOI 10.1093/oxfordjournals.schbul.a006943; Werner FM, 2014, EXPERT OPIN DRUG SAF, V13, P1031, DOI 10.1517/14740338.2014.935761; Young SL, 2015, J PSYCHOPHARMACOL, V29, P353, DOI 10.1177/0269881114562090	32	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166171	10.1371/journal.pone.0166171	http://dx.doi.org/10.1371/journal.pone.0166171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851771	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300039
J	Uceyler, N; Schroter, N; Kafke, W; Kramer, D; Wanner, C; Weidemann, F; Sommer, C				Ueceyler, Nurcan; Schroeter, Nils; Kafke, Waldemar; Kramer, Daniela; Wanner, Christoph; Weidemann, Frank; Sommer, Claudia			Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; PAIN SYMPTOM INVENTORY; SMALL FIBER NEUROPATHY; AGALSIDASE-BETA; DIAGNOSIS; NEPHROPATHY; BIOPSIES; EFFICACY; SAFETY; TRIAL	Background The X-chromosomally linked life-limiting Fabry disease (FD) is associated with deposits of the sphingolipid globotriaosylceramide 3 (Gb3) in various tissues. Skin is easily accessible and may be used as an additional diagnostic and follow-up medium. Our aims were to visualize skin Gb3 deposits in FD patients applying immunofluorescence and to determine if cutaneous Gb3 load correlates with disease severity. Methods At our Fabry Center for Interdisciplinary Therapy we enrolled 84 patients with FD and 27 healthy controls. All subjects underwent 5-mm skin punch biopsy at the lateral lower leg and the back. Skin samples were processed for immunohistochemistry using antibodies against CD77 (i.e. Gb3). Cutaneous Gb3 deposition was quantified in a blinded manner and correlated to clinical data. Results We found that Gb3 load was higher in distal skin of male FD patients compared to healthy controls (p<0.05). Men (p<0.01) and women (p<0.05) with a classic FD phenotype had higher distal skin Gb3 load than healthy controls. Men with advanced disease as reflected by impaired renal function, and men and women with small fiber neuropathy had more Gb3 deposits in distal skin samples than males with normal renal function (p<0.05) and without small fiber neuropathy. Gb3 deposits were not different between patients with and without enzyme replacement therapy. Conclusions Immunofluorescence on minimally invasive skin punch biopsies may be useful as a tool for assessment and follow-up in FD patients.	[Ueceyler, Nurcan; Schroeter, Nils; Kafke, Waldemar; Kramer, Daniela; Sommer, Claudia] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Wanner, Christoph; Weidemann, Frank] Univ Wurzburg, Dept Internal Med, Wurzburg, Germany; [Ueceyler, Nurcan; Schroeter, Nils; Kafke, Waldemar; Kramer, Daniela; Wanner, Christoph; Weidemann, Frank; Sommer, Claudia] Univ Wurzburg, Wurzburg Fabry Ctr Interdisciplinary Therapy FAZI, Wurzburg, Germany; [Weidemann, Frank] Katharinen Hosp Unna, Innere Klin 2, Obere Husemannstr 2, D-59423 Unna, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Uceyler, N (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.; Uceyler, N (corresponding author), Univ Wurzburg, Wurzburg Fabry Ctr Interdisciplinary Therapy FAZI, Wurzburg, Germany.	ueceyler_n@ukw.de	Schröter, Nils/ABE-4090-2020; Sommer, Claudia/A-9820-2010	Schröter, Nils/0000-0002-3833-9822; Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428	intramural research funds of the University of Wurzburg; European Union's Seventh Framework Programme ("ncRNAPain") [602133]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Sonderforschungsbereich 581]	intramural research funds of the University of Wurzburg; European Union's Seventh Framework Programme ("ncRNAPain"); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The study was supported by intramural research funds of the University of Wurzburg and by an unrestricted grant to the University of Wurzburg by Genzyme Corp. The sponsor had no knowledge of the study design and the results and also had no influence on the conductance of the project. Claudia Sommer and Nurcan Uceyler received funding by the European Union's Seventh Framework Programme ("ncRNAPain", grant agreement number 602133). This work was part of the doctoral theses of Nils Schroter, who received a six-months scholarship form the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; Sonderforschungsbereich 581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Kanekura T, 2005, BRIT J DERMATOL, V153, P544, DOI 10.1111/j.1365-2133.2005.06732.x; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; Lakoma J, 2016, J CELL PHYSIOL, V231, P192, DOI 10.1002/jcp.25072; Lao LM, 1998, J DERMATOL SCI, V18, P109, DOI 10.1016/S0923-1811(98)00032-2; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848; Navarro C, 2006, ACTA NEUROPATHOL, V111, P178, DOI 10.1007/s00401-005-0026-8; Palungwachira Piti, 2002, J Med Assoc Thai, V85, P842; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rozenfeld PA, 2006, CLIN EXP OPHTHALMOL, V34, P689, DOI 10.1111/j.1442-9071.2006.01318.x; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104; Tahir H, 2007, J AM SOC NEPHROL, V18, P2609, DOI 10.1681/ASN.2006121400; Tetaud C, 2003, J BIOL CHEM, V278, P45200, DOI 10.1074/jbc.M303868200; Thurberg BL, 2004, J INVEST DERMATOL, V122, P900, DOI 10.1111/j.0022-202X.2004.22425.x; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Uceyler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087054; Uceyler N, 2012, J ULTRAS MED, V31, P463; Uceyler N, 2011, J PERIPHER NERV SYST, V16, P304, DOI 10.1111/j.1529-8027.2011.00365.x; Valbuena C, 2012, VIRCHOWS ARCH, V460, P211, DOI 10.1007/s00428-011-1182-y; van der Tol L, 2016, BRIT J OPHTHALMOL, V100, P3, DOI 10.1136/bjophthalmol-2014-306433; van der Tol L, 2015, MOL GENET METAB, V114, P242, DOI 10.1016/j.ymgme.2014.08.007; van Mullem P J, 1972, Arch Belg Dermatol Syphiligr, V28, P41; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Wijburg FA, 2015, PLOS ONE, V10, DOI [DOI 10.1371/journal.pone.0124987, 10.1371/JOUMALPONE.0124987]; Wraith JE, 2008, J PEDIATR-US, V152, P563, DOI 10.1016/j.jpeds.2007.09.007	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166484	10.1371/journal.pone.0166484	http://dx.doi.org/10.1371/journal.pone.0166484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851774	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300055
J	Amaya, R; Cancel, LM; Tarbell, JM				Amaya, Ronny; Cancel, Limary M.; Tarbell, John M.			Interaction between the Stress Phase Angle (SPA) and the Oscillatory Shear Index (OSI) Affects Endothelial Cell Gene Expression	PLOS ONE			English	Article							WALL SHEAR; ATHEROSCLEROTIC PLAQUE; CAROTID BIFURCATION; CORONARY-ARTERY; PULSATILE FLOW; SIMULATION; RECEPTOR	Hemodynamic forces play an important role in the non-uniform distribution of atherosclerotic lesions. Endothelial cells are exposed simultaneously to fluid wall shear stress (WSS) and solid circumferential stress (CS). Due to variations in impedance (global factors) and geometric complexities (local factors) in the arterial circulation a time lag arises between these two forces that can be characterized by the temporal phase angle between CS and WSS (stress phase angle-SPA). Asynchronous flows (SPA close to -180 degrees) that are most prominent in coronary arteries have been associated with localization of atherosclerosis. Reversing oscillatory flows characterized by an oscillatory shear index (OSI) that is great than zero are also associated with atherosclerosis localization. In this study we examined the relationship between asynchronous flows and reversing flows in altering the expression of 37 genes relevant to atherosclerosis development. In the case of reversing oscillatory flow, we observed that the asynchronous condition upregulated 8 genes compared to synchronous hemodynamics, most of them proatherogenic. Upregulation of the pro-inflammatory transcription factor NF kappa B p65 was confirmed by western blot, and nuclear translocation of NF kappa B p65 was confirmed by immunofluorescence staining. A comparative study between non reversing flow and reversing flow found that in the case of synchronous hemodynamics, reversing flow altered the expression of 11 genes, while in the case of asynchronous hemodynamics, reversing flow altered the expression of 17 genes. Reversing flow significantly upregulated protein expression of NFKB p65 for both synchronous and asynchronous conditions. Nuclear translocation of NF kappa B p65 was confirmed for synchronous and asynchronous conditions in the presence of flow reversal. These data suggest that asynchronous hemodynamics and reversing flow can elicit proatherogenic responses in endothelial cells compared to synchronous hemodynamics without shear stress reversal, indicating that SPA as well as reversal flow (OSI) are important parameters characterizing arterial susceptibility to disease.	[Amaya, Ronny; Cancel, Limary M.; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Tarbell, JM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu			National Institutes of Health [HL 086543]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant HL 086543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129952; Bradley MT, 2016, PSYCHOL REP, V119, P487, DOI 10.1177/0033294116662659; CARO CG, 1971, PROC R SOC SER B-BIO, V177, P109, DOI 10.1098/rspb.1971.0019; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Ishino S, 2007, ATHEROSCLEROSIS, V195, P48, DOI 10.1016/j.atherosclerosis.2006.11.031; Joshi AK, 2004, ARTERIOSCL THROM VAS, V24, P2408, DOI 10.1161/01.ATV.0000147118.97474.4b; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Nam D., 2010, J VIS EXP, V2010, P1861, DOI DOI 10.3791/1861; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Qiu YC, 2000, J BIOMECH ENG-T ASME, V122, P77, DOI 10.1115/1.429629; Qiu YC, 1996, ASAIO J, V42, pM702, DOI 10.1097/00002480-199609000-00078; Qiu YC, 2000, J VASC RES, V37, P147, DOI 10.1159/000025726; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Tada S, 2005, ANN BIOMED ENG, V33, P1202, DOI 10.1007/s10439-005-5630-1; Tada S, 2007, BIOPHYS J, V93, P3026, DOI 10.1529/biophysj.106.100685; Torii R, 2009, AM J PHYSIOL-HEART C, V296, pH765, DOI 10.1152/ajpheart.01166.2007; van der Giessen AG, 2010, INT J CARDIOVAS IMAG, V26, P781, DOI 10.1007/s10554-009-9546-y; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217	24	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166569	10.1371/journal.pone.0166569	http://dx.doi.org/10.1371/journal.pone.0166569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846267	Green Published, gold			2022-12-27	WOS:000387794600083
J	Gucyetmez, B; Atalan, HK; Cakar, N				Gucyetmez, Bulent; Atalan, Hakan Korkut; Cakar, Nahit		Turkish Tracheotomy Survey Grp	Elective Tracheotomy Practices in Turkey	PLOS ONE			English	Article							PERCUTANEOUS DILATATIONAL TRACHEOSTOMY; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; SURGICAL TRACHEOSTOMY; ICU PATIENTS; NATIONWIDE SURVEY; POSTAL SURVEY; METAANALYSIS; TRIALS; INTUBATION	Objectives Elective tracheotomy (ET) procedures in intensive care units (ICU) might be different in accordance with countries and ICUs' features. The aim of the present study was to search the epidemiology of ET procedures in Turkey. Methods A questionnaire which consists of 43 questions was sent by e-mail to 238 ICUs which were officially recognized by The Turkish Ministry of Health. All answers were obtained between August 1, 2015 and August 31, 2015. Results Two hundred and three ICUs (85.3%) participated in this study. 177 (87.2%) and 169 (83.4%) of ICU's were level III and mixed ICUs respectively. Anesthesiologists were the director of 189 (93.0%) ICUs. Estimated total count of admitted, mechanically ventilated and tracheotomized patients in 2014 were 126282, 80569 (63.8%) and 8989 (7.1%) respectively. Most common indication for ET was prolonged mechanical ventilation (76.9%). The first choice for ET procedure was percutaneous in 162 (79.8%) ICUs. Griggs guide wire dilatational forceps (GWDF) technique was used as the first choice for elective percutaneous tracheotomy (EPT) by 143 (70.4%) ICUs. Most common early EPT complication was bleeding (68.0%) and late EPT complication was stenosis (35.0%). While facilitation of weaning was most important advantage (26.1%), bleeding and tracheal complications were most important disadvantages for EPT (29.1%). Conclusions Most common indications for ET are prolonged MV and coma in Turkish ICUs. EPT is the preferred procedure for ET and GWDF is the most common technique. Bronchoscopy and USG are rarely used as a guide.	[Gucyetmez, Bulent; Cakar, Nahit] Acibadem Univ, Dept Anesthesiol, Sch Med, Istanbul, Turkey; [Atalan, Hakan Korkut] Atasehir Mem Hosp, Dept Anesthesiol, Istanbul, Turkey	Acibadem University; Memorial Healthcare Group	Gucyetmez, B (corresponding author), Acibadem Univ, Dept Anesthesiol, Sch Med, Istanbul, Turkey.	bulentgucyetmez@gmail.com	Kavrut Ozturk, Nilgun/P-3404-2016; YAPICI, Nihan/A-9114-2018; Atalan, Hakan Korkut/I-1384-2018; Mutlu, Nevzat Mehmet/AIB-3959-2022; Gucyetmez, Bulent/D-1033-2016	Kavrut Ozturk, Nilgun/0000-0002-9320-0778; YAPICI, Nihan/0000-0002-7684-8177; Atalan, Hakan Korkut/0000-0001-9306-3657; Mutlu, Nevzat Mehmet/0000-0001-7981-3060; Gucyetmez, Bulent/0000-0002-4464-4591; Cakar, Nahit/0000-0002-1302-9596				Angel LF, 2003, CLIN CHEST MED, V24, P423, DOI 10.1016/S0272-5231(03)00053-4; Anon JM, 2004, INTENS CARE MED, V30, P1212, DOI 10.1007/s00134-004-2276-7; Blot F, 2005, CHEST, V127, P1347, DOI 10.1378/chest.127.4.1347; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Byhahn C, 2000, ANAESTHESIST, V49, P202, DOI 10.1007/s001010050815; Cabrini L, 2014, ACTA ANAESTH SCAND, V58, P135, DOI 10.1111/aas.12213; CIAGLIA P, 1985, CHEST, V87, P715, DOI 10.1378/chest.87.6.715; Delaney A, 2006, CRIT CARE, V10, DOI 10.1186/cc4887; Dosemeci L, 2002, INTENS CARE MED, V28, P63, DOI 10.1007/s00134-001-1161-x; Dulguerov P, 1999, CRIT CARE MED, V27, P1617, DOI 10.1097/00003246-199908000-00041; Fantoni A, 1997, INTENS CARE MED, V23, P386, DOI 10.1007/s001340050345; Fikkers BG, 2003, INTENS CARE MED, V29, P1390, DOI 10.1007/s00134-003-1824-x; Fischler L, 2000, INTENS CARE MED, V26, P1428, DOI 10.1007/s001340000634; Freeman BD, 2000, CHEST, V118, P1412, DOI 10.1378/chest.118.5.1412; Frova G, 2002, INTENS CARE MED, V28, P299, DOI 10.1007/s00134-002-1218-5; GRIGGS WM, 1990, SURG GYNECOL OBSTET, V170, P543; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Jackson LM, 2011, J TRAUMA, V71, P1553, DOI 10.1097/TA.0b013e31823ba29e; Kluge S, 2008, ANESTH ANALG, V107, P1639, DOI 10.1213/ane.0b013e318188b818; Krishnan K, 2005, ANAESTHESIA, V60, P360, DOI 10.1111/j.1365-2044.2004.04106.x; Mallick A, 2010, EUR J ANAESTH, V27, P676, DOI 10.1097/EJA.0b013e32833b1ba0; Maziak DE, 1998, CHEST, V114, P605, DOI 10.1378/chest.114.2.605; Nates JL, 2000, CRIT CARE MED, V28, P3734, DOI 10.1097/00003246-200011000-00034; Oliver ER, 2007, LARYNGOSCOPE, V117, P1570, DOI 10.1097/MLG.0b013e318093edae; Putensen C, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0544-7; Rudas M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0514-0; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Sollid SJM, 2008, EUR J ANAESTH, V25, P925, DOI 10.1017/S0265021508004791; Van Heurn LWE, 2001, INTENS CARE MED, V27, P292, DOI 10.1007/s001340000743; vanHeurn LWE, 1996, J LARYNGOL OTOL, V110, P723; Vargas M, 2013, MINERVA ANESTESIOL, V79, P156; Walz MK, 1998, INTENS CARE MED, V24, P685, DOI 10.1007/s001340050645	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166097	10.1371/journal.pone.0166097	http://dx.doi.org/10.1371/journal.pone.0166097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846248	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600032
J	Li, L; Zhang, JY; Deng, QS; Li, JM; Li, ZF; Xiao, Y; Hu, SW; Li, TT; Tan, QX; Li, XF; Luo, BS; Mo, H				Li, Li; Zhang, Jiangyu; Deng, Qingshan; Li, Jieming; Li, Zhengfen; Xiao, Yao; Hu, Shuiwang; Li, Tiantian; Tan, Qiuxiao; Li, Xiaofang; Luo, Bingshu; Mo, Hui			Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CELL-SURVIVAL; ANDROGEN EXCESS; GRANULOSA-CELLS; HSP90; PHOSPHORYLATION; DIAGNOSIS; MECHANISM; CANCER; PREVALENCE	Objectives To identify differential protein expression pattern associated with polycystic ovary syndrome (PCOS). Methods Twenty women were recruited for the study, ten with PCOS as a test group and ten without PCOS as a control group. Differential in-gel electrophoresis (DIGE) analysis and mass spectroscopy were employed to identify proteins that were differentially expressed between the PCOS and normal ovaries. The differentially expressed proteins were further validated by western blot (WB) and immunohistochemistry (IHC). Results DIGE analysis revealed eighteen differentially expressed proteins in the PCOS ovaries of which thirteen were upregulated, and five downregulated. WB and IHC confirmed the differential expression of membrane-associated progesterone receptor component 1 (PGRMC1), retinol-binding protein 1 (RBP1), heat shock protein 90B1, calmodulin 1, annexin A6, and tropomyosin 2. Also, WB analysis revealed significantly (P<0.05) higher expression of PGRMC1 and RBP1 in PCOS ovaries as compared to the normal ovaries. The differential expression of the proteins was also validated by IHC. Conclusions The present study identified novel differentially expressed proteins in the ovarian tissues of women with PCOS that can serve as potential biomarkers for the diagnosis and development of novel therapeutics for the treatment of PCOS using molecular interventions.	[Li, Li; Deng, Qingshan; Li, Jieming; Li, Tiantian; Tan, Qiuxiao; Li, Xiaofang; Luo, Bingshu] Guangdong Women & Children Hosp, Dept Obstet & Gynecol, Guangzhou 510010, Guangdong, Peoples R China; [Zhang, Jiangyu] Guangdong Women & Children Hosp, Dept Pathol, Guangzhou 510010, Guangdong, Peoples R China; [Li, Zhengfen] Southern Med Univ, Affiliated Hosp 3, Guangzhou 510515, Guangdong, Peoples R China; [Xiao, Yao; Mo, Hui] Macau Univ Sci & Technol, Lab Chinese Med Qual Res, Macau 00853, Peoples R China; [Hu, Shuiwang] Southern Med Univ, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Macau University of Science & Technology; Southern Medical University - China	Mo, H (corresponding author), Macau Univ Sci & Technol, Lab Chinese Med Qual Res, Macau 00853, Peoples R China.	lili-1406@163.com			Science and Technology Planning Project of Guangdong Province [2014A020212237]; Guangdong Natural Science Foundation [S2013010011984]; Guangdong provincial population and family planning commission [20133071]; Guangzhou Municipal Science and Technology Innovation Council [201510010290]	Science and Technology Planning Project of Guangdong Province; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong provincial population and family planning commission; Guangzhou Municipal Science and Technology Innovation Council	The study was supported by Science and Technology Planning Project of Guangdong Province (2014A020212237); Guangdong Natural Science Foundation (S2013010011984); Guangdong provincial population and family planning commission (20133071); and Guangzhou Municipal Science and Technology Innovation Council (201510010290).	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chehab M, 2015, ONCOTARGET, V6, P8454, DOI 10.18632/oncotarget.3502; Chittenden BG, 2009, REPROD BIOMED ONLINE, V19, P398, DOI 10.1016/S1472-6483(10)60175-7; Choi DH, 2010, J PROTEOME RES, V9, P4329, DOI 10.1021/pr100008e; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; Engmann L, 2006, J CLIN ENDOCR METAB, V91, P4962, DOI 10.1210/jc.2006-1128; Ernst A, 2015, CANCER LETT, V365, P211, DOI 10.1016/j.canlet.2015.05.024; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gao M, 2015, ASIAN PAC J TROP MED, V8, P305, DOI 10.1016/S1995-7645(14)60335-7; Gerdes D, 1998, BIOL CHEM, V379, P907; Gerst F, 2015, DIABETOLOGIA, V58, P2819, DOI 10.1007/s00125-015-3744-z; Ghosh S, 2015, ACS CHEM BIOL, V10, P577, DOI 10.1021/cb5008713; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Haoula Z, 2012, HUM REPROD, V27, P1327, DOI 10.1093/humrep/des042; Hart R, 2006, BEST PRACT RES CL OB, V20, P751, DOI 10.1016/j.bpobgyn.2006.04.006; Hart R, 2015, J CLIN ENDOCR METAB, V100, P911, DOI 10.1210/jc.2014-3886; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Insenser M, 2013, MOL CELL ENDOCRINOL, V370, P65, DOI 10.1016/j.mce.2013.02.009; Lee KH, 2015, AM J RESP CELL MOL, V53, P412, DOI 10.1165/rcmb.2014-0186OC; Li L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152837; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Lim GE, 2013, DIABETOLOGIA, V56, P825, DOI 10.1007/s00125-012-2820-x; Ma X, 2007, MOL HUM REPROD, V13, P527, DOI 10.1093/molehr/gam036; Matharoo-Ball B, 2007, J PROTEOME RES, V6, P3321, DOI 10.1021/pr070124b; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Misiti S, 2010, J ENDOCRINOL INVEST, V33, P156, DOI [10.1007/BF03346575, 10.3275/6544]; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Mori M, 2015, INT J ONCOL, V46, P47, DOI 10.3892/ijo.2014.2727; Neukamm SS, 2013, J BIOL CHEM, V288, P16403, DOI 10.1074/jbc.M113.474593; Park JK, 2008, PLACENTA, V29, P584, DOI 10.1016/j.placenta.2008.03.007; Peluso JJ, 2004, BIOL REPROD, V71, P1870, DOI 10.1095/biolreprod.104.031716; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Peluso JJ, 2006, BIOL REPROD, V75, P2, DOI 10.1095/biolreprod.105.049924; Peluso JJ, 2009, J CLIN ENDOCR METAB, V94, P2644, DOI 10.1210/jc.2009-0147; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Sanchon R, 2012, HUM REPROD, V27, P1209, DOI 10.1093/humrep/des028; Sun YF, 2015, ACTA BIOCH BIOPH SIN, V47, P451, DOI 10.1093/abbs/gmv034; Teede HJ, 2007, TRENDS ENDOCRIN MET, V18, P273, DOI 10.1016/j.tem.2007.08.001; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	46	13	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0164538	10.1371/journal.pone.0164538	http://dx.doi.org/10.1371/journal.pone.0164538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846214	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600005
J	Powner, MB; Salt, TE; Hogg, C; Jeffery, G				Powner, Michael B.; Salt, Thomas E.; Hogg, Chris; Jeffery, Glen			Improving Mitochondrial Function Protects Bumblebees from Neonicotinoid Pesticides	PLOS ONE			English	Article							NEAR-INFRARED LIGHT; THERAPY; SYSTEM; EYE	Global pollination is threatened by declining insect pollinator populations that may be linked to neonicotinoid pesticide use. Neonicotinoids over stimulate neurons and depolarize their mitochondria, producing immobility and death. However, mitochondrial function can be improved by near infrared light absorbed by cytochrome c oxidase in mitochondrial respiration. In flies, daily exposure to 670nm light throughout life increases average lifespan and aged mobility, and reduces systemic inflammation. Here we treat bumble bees with Imidacloprid a common neonicotinoid. This undermined ATP and rapidly induced immobility and reduced visual function and survival. Bees exposed to insecticide and daily to 670nm light showed corrected ATP levels and significantly improved mobility allowing them to feed. Physiological recordings from eyes revealed that light exposure corrected deficits induced by the pesticide. Overall, death rates in bees exposed to insecticide but also given 670nm light were indistinguishable from controls. When Imidacloprid and light exposure were withdrawn, survival was maintained. Bees and insects generally cannot see deep red light so it does not disturb their behaviour. Hence, we show that deep red light exposure that improves mitochondrial function, reverses the sensory and motor deficits induced by Imidacloprid. These results may have important implications as light delivery is economic and can be placed in hives/colonies.	[Salt, Thomas E.; Hogg, Chris; Jeffery, Glen] UCL, London, England; [Powner, Michael B.] City Univ London, London, England; [Salt, Thomas E.] Neurexpert Ltd, London, England	University of London; University College London; City University London	Jeffery, G (corresponding author), UCL, London, England.	g.jeffery@ucl.ac.uk	Salt, Thomas E/A-6405-2009; Powner, Michael/CAG-7455-2022	Powner, Michael/0000-0003-4913-1004	Biotechnology and Biological Sciences Research Council, UK [BB/N000250/1]; Biotechnology and Biological Sciences Research Council [BB/N000250/1] Funding Source: researchfish; BBSRC [BB/N000250/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Biotechnology and Biological Sciences Research Council, UK, BB/N000250/1.; This research was supported by the BBSRC BB/N000250/1.	Begum R, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0073; Begum R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057828; Darlot F, 2016, ANN NEUROL, V79, P59, DOI 10.1002/ana.24542; Dyer AG, 2011, P ROY SOC B-BIOL SCI, V278, P952, DOI 10.1098/rspb.2010.2412; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Gkotsi D, 2014, EXP EYE RES, V122, P50, DOI 10.1016/j.exer.2014.02.023; GOLDSMITH TH, 1960, J GEN PHYSIOL, V43, P775, DOI 10.1085/jgp.43.4.775; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Moffat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24764; Moffat C, 2015, FASEB J, V29, P2112, DOI 10.1096/fj.14-267179; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Vos M, 2013, PLOS ONE; Wilson M, 1970, BIOCHEM J, V116, P17	20	20	20	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166531	10.1371/journal.pone.0166531	http://dx.doi.org/10.1371/journal.pone.0166531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846310	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000387794600077
J	Bonfrer, I; Breebaart, L; Van de Poel, E				Bonfrer, Igna; Breebaart, Lyn; Van de Poel, Ellen			The Effects of Ghana's National Health Insurance Scheme on Maternal and Infant Health Care Utilization	PLOS ONE			English	Article							PROPENSITY SCORE; IMPLEMENTATION; PERCEPTIONS	Increasing equitable access to health care is a main challenge African policy makers are facing. The Ghanaian government implemented the National Health Insurance Scheme in 2004 and the aim of this study is to evaluate its early effects on maternal and infant healthcare use. We exploit data on births before and after the intervention and apply propensity score matching to limit the bias arising from self-selection into the health insurance. About forty percent of children had a mother who is enrolled in this insurance. The scheme significantly increased the proportion of pregnancies with at least four antenatal care visits with 7 percentage points and had a significant effect on attended deliveries (10 percentage points). Caesarean sections increased (6 percentage points) and the number of children born from an unwanted pregnancy decreased (7 percentage points). Insurance enrollment had almost no effect on child vaccinations. Among the poorest forty percent of the sample, the effects of the scheme on antenatal care and attended deliveries were similar. However, the effects of the scheme on caesarean sections were about half the size (3 percentage points) and the reduction in unwanted pregnancies was larger (10 percentage points) compared to the effects in the full sample. We conclude that in the first years of operation, the National Health Insurance Scheme had a modest impact on the use of antenatal and delivery care. This is important for other African countries currently introducing or considering a national health insurance as a means towards universal health coverage.	[Bonfrer, Igna; Breebaart, Lyn; Van de Poel, Ellen] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, South Holland, Netherlands; [Bonfrer, Igna] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA	Erasmus University Rotterdam; Harvard University; Harvard T.H. Chan School of Public Health	Bonfrer, I (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, South Holland, Netherlands.; Bonfrer, I (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.	bonfrer@bmg.eur.nl		Bonfrer, Igna/0000-0002-8570-0393	Netherland Organization for Scientific Research, Rubicon fellowship; Beleid en Management van de Gezondheidszorg Innovationfund; Netherlands Organization for Scientific Research [451-11-031]	Netherland Organization for Scientific Research, Rubicon fellowship; Beleid en Management van de Gezondheidszorg Innovationfund; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Support was provided by: Netherland Organization for Scientific Research, Rubicon fellowship (to IB); Beleid en Management van de Gezondheidszorg Innovationfund, [www.bmg.eurnl] (to IB); and Netherlands Organization for Scientific Research, Veni project 451-11-031 [http://www.nwo.nl/actueel/nieuws//2011/Toekenningen+Verrieuwingsimpuls+Veri+bij+MaGW.html] (to EVdP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Amporfu E, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-4; Arhin A. A., 2013, Developing Country Studies, V3, P151; Arthur E., 2012, HLTH EC REV, V2, P214; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Blanchet N J, 2012, Ghana Med J, V46, P76; Dalinjong PA, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-13; De Allegri M, 2009, TROP MED INT HEALTH, V14, P586, DOI 10.1111/j.1365-3156.2009.02262.x; Dionne K. Y., 2013, GLOB HLTH, V4, P1; Dixon J., 2011, AFRICANPORTAL BACKGR, V8, P1; Dixon J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-35; Escobar ML, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P1; Fenenga C., 2015, A MATTER OF TRUST; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gajate-Garrido G, 2013, EFFECT PARENTS INSUR; Gajate-Garrido G, 2013, NATL HLTH INSURANCE, P1; Ghana Statistical Service, 2009, DEM HLTH SURV 2008 R; Giedion U, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P13; Global Alliance for Vaccines and Immunization, 2005, PROGR REP GAVI VACC; Gobah FF., 2011, GLOBAL J HLTH SCI, V3, P90, DOI [10.5539/gjhs.v3n2p90, DOI 10.5539/GJHS.V3N2P90]; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Koch S, 2010, SOC SCI MED, V70, P175, DOI 10.1016/j.socscimed.2009.10.015; Leuven E, 2014, PSMATCH2 STATA MODUL; Mensah J, 2010, HEALTH ECON, V19, P95, DOI 10.1002/hec.1633; Ministry of Health Ghana, 2009, IND REV HLTH SECT PR; National Health Insurance Authority, 2009, NAT HLTH INS AUTH 20; National Health Insurance Authority, 2013, NAT HLTH INS AUTH 20; National Health Insurance Authority, 2008, PROV FREE MAT NEON H; National Health Insurance Scheme, 2014, PREM REG FEE; Ofori-Adjei David, 2007, Ghana Med J, V41, P94; Oxfam, 2014, ACH SHAR GOAL FREE U; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Saleh K., 2012, HLTH SECTOR TRANSITI; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, GLOB NUMB COSTS ADD; Witter S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-16; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20	40	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165623	10.1371/journal.pone.0165623	http://dx.doi.org/10.1371/journal.pone.0165623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835639	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200009
J	Carreras-Sureda, A; Rubio-Moscardo, F; Olvera, A; Argilaguet, J; Kiefer, K; Mothe, B; Meyerhans, A; Brander, C; Vicente, R				Carreras-Sureda, Amado; Rubio-Moscardo, Fanny; Olvera, Alex; Argilaguet, Jordi; Kiefer, Kerstin; Mothe, Beatriz; Meyerhans, Andreas; Brander, Christian; Vicente, Ruben			Lymphocyte Activation Dynamics Is Shaped by Hereditary Components at Chromosome Region 17q12-q21	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; CELL-DIFFERENTIATION; ORMDL3; EXPRESSION; ASTHMA; SUSCEPTIBILITY; RISK; LOCI; IDENTIFICATION	Single nucleotide polymorphisms (SNPs) located in the chromosome region 17q12-q21 are risk factors for asthma. Particularly, there are cis-regulatory haplotypes within this region that regulate differentially the expression levels of ORMDL3, GSDMB and ZPBP2 genes. Remarkably, ORMDL3 has been shown to modulate lymphocyte activation parameters in a heterologous expression system. In this context, it has been shown that Th2 and Th17 cytokine production is affected by SNPs in this region. Therefore, we aim to assess the impact of hereditary components within region 17q12-q21 on the activation profile of human T lymphocytes, focusing on the haplotype formed by allelic variants of SNPs rs7216389 and rs12936231. We measured calcium influx and activation markers, as well as the proliferation rate upon T cell activation. Haplotype-dependent differences in mRNA expression levels of IL-2 and INF-gamma were observed at early times after activation. In addition, the allelic variants of these SNPs impacted on the extent of calcium influx in resting lymphocytes and altered proliferation rates in a dose dependent manner. As a result, the asthma risk haplotype carriers showed a lower threshold of saturation during activation. Finally, we confirmed differences in activation marker expression by flow cytometry using phytohemagglutinin, a strong polyclonal stimulus. Altogether, our data suggest that the genetic component of pro-inflammatory pathologies present in this chromosome region could be explained by different T lymphocyte activation dynamics depending on individual allelic heredity.	[Carreras-Sureda, Amado; Rubio-Moscardo, Fanny; Kiefer, Kerstin; Vicente, Ruben] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol, Barcelona, Spain; [Carreras-Sureda, Amado] Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile; [Carreras-Sureda, Amado] Univ Chile, Inst Biomed Sci, Program Cellular & Mol Biol, Ctr Mol Studies Cell, Santiago, Chile; [Olvera, Alex; Mothe, Beatriz; Brander, Christian] Hosp Germans Trias i Pujol, AIDS Res Inst, IrsiCaixa HIVACAT, Badalona, Spain; [Argilaguet, Jordi; Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Infect Biol Grp, Barcelona, Spain; [Mothe, Beatriz; Brander, Christian] Univ Vic Univ Cent Catalunya UVic UCC, Vic, Spain; [Meyerhans, Andreas; Brander, Christian] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Pompeu Fabra University; Universidad de Chile; Universidad de Chile; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Pompeu Fabra University; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); ICREA	Vicente, R (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol, Barcelona, Spain.	ruben.vicente@upf.edu	Argilaguet, Jordi/E-5109-2016; García, Rubén Vicente/L-1097-2014; Rubio-Moscardó, Francisca/L-6247-2014	Argilaguet, Jordi/0000-0001-5924-2774; García, Rubén Vicente/0000-0003-0401-4808; Rubio-Moscardó, Francisca/0000-0002-3609-9992; Carreras Sureda, Amado/0000-0002-9032-5639; Mothe, Beatriz/0000-0001-9975-407X; Olvera, Alex/0000-0002-9934-5759	Spanish Ministry of Economy and Competitiveness [SAF2010-16725, SAF2013-46077-R, SAF2014-52228-R, BES-2011-043839]; Fondo de Investigacion Sanitaria [Red HERACLES RD12/0042/0014]; Fundacio la Marato de TV3 [20134030]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 3150113]; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacio la Marato de TV3; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2010-16725, SAF2013-46077-R, SAF2014-52228-R, BES-2011-043839), Fondo de Investigacion Sanitaria (Red HERACLES RD12/0042/0014), Fundacio la Marato de TV3 (20134030) and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 3150113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Berlivet S, 2012, HUM GENET, V131, P1161, DOI 10.1007/s00439-012-1142-x; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carreras-Sureda A, 2013, HUM MOL GENET, V22, P519, DOI 10.1093/hmg/dds450; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Kalies K, 2006, J IMMUNOL, V176, P741, DOI 10.4049/jimmunol.176.2.741; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lluis A, 2011, J ALLERGY CLIN IMMUN, V127, P1587, DOI 10.1016/j.jaci.2011.03.015; Mcgovern DPB, 2011, GENOME WIDE ASS IDEN, V42, P332; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Orban C, 2014, CYTOM PART A, V85A, P636, DOI 10.1002/cyto.a.22479; Qiu R, 2013, SCAND J RHEUMATOL, V42, P469, DOI 10.3109/03009742.2013.786755; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rebollo A, 2001, J IMMUNOL, V167, P6366, DOI 10.4049/jimmunol.167.11.6366; Schedel M, 2015, J ALLERGY CLIN IMMUN, V136, P893, DOI 10.1016/j.jaci.2015.03.014; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stamm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067746; Tkach KE, 2014, ELIFE, V3, DOI 10.7554/eLife.01944; Toldi G, 2012, IMMUNOBIOLOGY, V217, P37, DOI 10.1016/j.imbio.2011.08.007; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Waysbort N, 2013, J IMMUNOL, V191, P5822, DOI 10.4049/jimmunol.1301575	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166414	10.1371/journal.pone.0166414	http://dx.doi.org/10.1371/journal.pone.0166414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835674	Green Published, gold			2022-12-27	WOS:000387779200046
J	Arulmozhiraja, S; Matsuo, N; Ishitsubo, E; Okazaki, S; Shimano, H; Tokiwa, H				Arulmozhiraja, Sundaram; Matsuo, Naoya; Ishitsubo, Erika; Okazaki, Seiji; Shimano, Hitoshi; Tokiwa, Hiroaki			Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERFACES; GLUCAGON-LIKE PEPTIDE-1; HIGHLY POTENT; RI-MP2 METHOD; ACTIVE-SITE; IN-VITRO; INHIBITOR; DEGRADATION; POLYPEPTIDE; CHEMISTRY	Dipeptidyl peptidase IV (DPP-4) enzyme is responsible for the degradation of incretins that stimulates insulin secretion and hence inhibition of DPP-4 becomes an established approach for the treatment of type 2 diabetics. We studied the interaction between DPP-4 and its inhibitor drugs (sitagliptin 1, linagliptin 2, alogliptin 3, and teneligliptin 4) quantitatively by using fragment molecular orbital calculations at the RI-MP2/cc-pVDZ level to analyze the inhibitory activities of the drugs. Apart from having common interactions with key residues, inhibitors encompassing the DPP-4 active site extensively interact widely with the hydrophobic pocket by their hydrophobic inhibitor moieties. The cumulative hydrophobic interaction becomes stronger for these inhibitors and hence linagliptin and teneligliptin have larger interaction energies, and consequently higher inhibitory activities, than their alogliptin and sitagliptin counterparts. Though effective interaction for both 2 and 3 is at S-2' subsite, 2 has a stronger binding to this subsite interacting with Trp629 and Tyr547 than 3 does. The presence of triazolopiperazine and piperazine moiety in 1 and 4, respectively, provides the interaction to the S-2 extensive subsite; however, the latter's superior inhibitory activity is not only due to a relatively tighter binding to the S2 extensive subsite, but also due to the interactions to the S-1 subsite. The calculated hydrophobic interfragment interaction energies correlate well with the experimental binding affinities (K-D) and inhibitory activities (IC50) of the DPP-4 inhibitors.	[Arulmozhiraja, Sundaram; Matsuo, Naoya; Ishitsubo, Erika; Okazaki, Seiji; Tokiwa, Hiroaki] Rikkyo Univ, Dept Chem, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan; [Arulmozhiraja, Sundaram; Okazaki, Seiji; Tokiwa, Hiroaki] Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan; [Shimano, Hitoshi] Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Tsukuba, Ibaraki 3058575, Japan; [Tokiwa, Hiroaki] AMED CREST, Tokyo, Japan	Rikkyo University; Rikkyo University; University of Tsukuba	Tokiwa, H (corresponding author), Rikkyo Univ, Dept Chem, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.; Tokiwa, H (corresponding author), Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.; Tokiwa, H (corresponding author), AMED CREST, Tokyo, Japan.	tokiwa@rikkyo.ac.jp	Shimano, Hitoshi/AAI-5648-2020; Arulmozhiraja, Sundaram/ABB-9551-2021; Shimano, Hitoshi/V-1761-2019	Shimano, Hitoshi/0000-0002-5562-5572; Sundaram, Arulmozhiraja/0000-0002-7150-560X; TOKIWA, Hiroaki/0000-0002-3790-1799	Rikkyo SFR project; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Supported Program for the Strategic Research Foundation at Private Universities; Japanese Agency for Medical Research and Development (AMED-CREST); MEXT of Japan [25460157]; Boehringer Ingelheim (Japan)	Rikkyo SFR project; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Supported Program for the Strategic Research Foundation at Private Universities; Japanese Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Boehringer Ingelheim (Japan)	This work was supported by Rikkyo SFR project, 2014-2016, and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Supported Program for the Strategic Research Foundation at Private Universities, 2013-2018. This work is partly supported by the Japanese Agency for Medical Research and Development (AMED-CREST), by a Grant-in-aid for Scientific Research (C) (grant no. 25460157) from the MEXT of Japan, and by Boehringer Ingelheim (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL MOL GRAPH SYST; Bernholdt DE, 1996, CHEM PHYS LETT, V250, P477, DOI 10.1016/0009-2614(96)00054-1; Bruger AT, 1997, METHOD ENZYMOL, V277, P366, DOI [10.1016/S0076-6879(97)77021-6, DOI 10.1016/S0076-6879(97)77021-6]; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Eckhardt M, 2007, J MED CHEM, V50, P6450, DOI 10.1021/jm701280z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erijman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110085; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; Fedorov DG, 2016, J PHYS CHEM A, V120, P2218, DOI 10.1021/acs.jpca.6b00163; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; FEYEREISEN M, 1993, CHEM PHYS LETT, V208, P359, DOI 10.1016/0009-2614(93)87156-W; Guo WX, 2014, BIOORG MED CHEM LETT, V24, P2546, DOI 10.1016/j.bmcl.2014.03.095; Heifetz A, 2016, J MED CHEM, V59, P4352, DOI 10.1021/acs.jmedchem.6b00045; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Ishikawa T, 2009, CHEM PHYS LETT, V474, P195, DOI 10.1016/j.cplett.2009.04.045; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Kimata H, 2012, MED CONSULT NEW REME, V49, P9; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Metzler WJ, 2008, PROTEIN SCI, V17, P240, DOI 10.1110/ps.073253208; Minami A, 2013, FEBS OPEN BIO, V3, P231, DOI 10.1016/j.fob.2013.05.002; Molecular Operating Environment (MOE), 2016, MOL OP ENV MOE; Morita D, NAT COMMUN, V7, P10356, DOI [10.1038/ncornms10356, DOI 10.1038/NCORNMS10356]; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nabeno M, 2013, BIOCHEM BIOPH RES CO, V434, P191, DOI 10.1016/j.bbrc.2013.03.010; Otuka T, 2015, J COMPUT CHEM, V36, P2209, DOI [10.1002/jcc.24055, DOI 10.1002/JCC.24055]; Rosenstock Julio, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P98, DOI 10.1097/MED.0b013e3280a02f65; SCAPIN G, 2015, CHEM BIOL MULTIFACET, P53, DOI DOI 10.1007/978-94-017-9719-1_5; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schnapp G, 2016, J MED CHEM, V59, P7466, DOI 10.1021/acs.jmedchem.6b00475; Shoombuatong W, 2015, DRUG DES DEV THER, V9, P4515, DOI 10.2147/DDDT.S86529; Sriwilaijaroen N, 2016, J MED CHEM, V59, P4563, DOI 10.1021/acs.jmedchem.5b01863; Thomas L, 2008, J PHARMACOL EXP THER, V325, P175, DOI 10.1124/jpet.107.135723; Touw WG, 2016, J MOL BIOL, V428, P1375, DOI 10.1016/j.jmb.2016.02.002; VAHTRAS O, 1993, CHEM PHYS LETT, V213, P514, DOI 10.1016/0009-2614(93)89151-7; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida T, 2012, BIOORGAN MED CHEM, V20, P5705, DOI 10.1016/j.bmc.2012.08.012; Zhang ZY, 2011, J MED CHEM, V54, P510, DOI 10.1021/jm101016w	46	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166275	10.1371/journal.pone.0166275	http://dx.doi.org/10.1371/journal.pone.0166275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832184	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000088
J	Fujiwara, M; Zhou, C; Acres, C; Martinez-Andrade, F				Fujiwara, Masami; Zhou, Can; Acres, Chelsea; Martinez-Andrade, Fernando			Interaction between Penaeid Shrimp and Fish Populations in the Gulf of Mexico: Importance of Shrimp as Forage Species	PLOS ONE			English	Article							BROWN SHRIMP; RED DRUM; SCIAENOPS-OCELLATA; GALVESTON BAY; TIME-SERIES; AZTECUS; SALINITY; GROWTH; TEXAS; PREY	This study investigated the contribution of shrimp stocks in supporting the production of valuable predator species. Fishery-independent data on white shrimp, brown shrimp, and selected fish species (spotted seatrout, red drum, and southern flounder) were collected from 1986 to 2014 by the Texas Parks and Wildlife Department, and converted to catch-perunit effort (CPUE). Here, the associations between the CPUEs of fish species as predators and those of shrimp species as prey in each sampled bay and sampling season were analyzed using co-integration analysis and Partial Least Squares Regression (PLSR). Co-integration analysis revealed significant associations between 31 of 70 possible fish/shrimp pairings. The analysis also revealed discernible seasonal and spatial patterns. White shrimp in August and brown shrimp in May were associated with fish CPUEs in bays located along the lower coast of Texas, whereas white shrimp in November was more strongly associated with fish CPUEs in bays located on the upper coast. This suggests the possible influence of latitudinal environmental gradient. The results of the PLSR, on the other hand, were not conclusive. This may reflect the high statistical error rates inherent to the analysis of short non-stationary time series. Co-integration is a robust method when analyzing non-stationary time series, and a majority of time series in this study was non-stationary. Based on our co-integration results, we conclude that the CPUE data show significant associations between shrimp abundance and the three predator fish species in the tested regions.	[Fujiwara, Masami; Acres, Chelsea] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Zhou, Can] Chinese Acad Fisheries Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Zhou, Can] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Martinez-Andrade, Fernando] Texas Parks & Wildlife Dept, Coastal Fisheries Div, Corpus Christi, TX USA	Texas A&M University System; Texas A&M University College Station; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Virginia Polytechnic Institute & State University	Fujiwara, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	fujiwara@tamu.edu	Fujiwara, Masami/C-3115-2012; Zhou, Can/AAZ-9771-2020	Fujiwara, Masami/0000-0002-9255-6043; Zhou, Can/0000-0003-4533-5333	Institutional Grant from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce [NA140AR4170102]	Institutional Grant from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce	This work was supported by an Institutional Grant (NA140AR4170102) to the Texas Sea Grant College Program from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce.	Adamack AT, 2012, MAR ECOL PROG SER, V444, P155, DOI 10.3354/meps09431; Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204; [Anonymous], 2015, MATLAB VER 8 5; BOOTHBY RN, 1971, T AM FISH SOC, V100, P290, DOI 10.1577/1548-8659(1971)100<290:FHLRAC>2.0.CO;2; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Fujiwara M, 2008, ECOLOGY, V89, P4, DOI 10.1890/07-1270.1; Fujiwara M, 2009, OIKOS, V118, P1712, DOI 10.1111/j.1600-0706.2009.17570.x; GARTHWAITE PH, 1994, J AM STAT ASSOC, V89, P122, DOI 10.2307/2291207; Green LM, 2010, MANAGEMENT DATA SERI, V57; Haas HL, 2001, CAN J FISH AQUAT SCI, V58, P2258, DOI 10.1139/cjfas-58-11-2258; Hart R. A., 2012, NMFSSEFSC638 NOAA; Hart RA, 2012, NOAA TECHNICAL MEMOR, P36; Hart Rick A., 2013, U S National Marine Fisheries Service Marine Fisheries Review, V75, P43; KLIMA EF, 1982, MAR FISH REV, V44, P16; Lassuy D.R., 1983, FWSOBS8211 US ARM CO; Martinez-Andrade F., 2015, MARINE RESOURCE MONI; MINELLO TJ, 1984, CONTRIB MAR SCI, V27, P159; MINELLO TJ, 1989, T AM FISH SOC, V118, P693, DOI 10.1577/1548-8659(1989)118<0693:MOYBSP>2.3.CO;2; MINELLO TJ, 1985, ESTUAR COAST SHELF S, V20, P707, DOI 10.1016/0272-7714(85)90027-7; Muncy R. J., 1984, FWSOBS821120 US ARM; MURDOCH WW, 1970, ECOLOGY, V51, P497, DOI 10.2307/1935385; Nance JM, 1993, NMFSSEFSC323 NOAA; National Marine Fisheries Service, 2016, NMFSFSPO163 NOAA US; OVERSTREET RM, 1978, GULF RES REP, V6, P131; Rosas C, 1999, J CRUSTACEAN BIOL, V19, P244, DOI 10.2307/1549230; Rozas LP, 2007, MAR ECOL PROG SER, V344, P119, DOI 10.3354/meps06945; Rozas LP, 2011, J EXP MAR BIOL ECOL, V397, P196, DOI 10.1016/j.jembe.2010.12.003; Rozas LP, 2001, WETLANDS, V21, P327, DOI 10.1672/0277-5212(2001)021[0327:MTAAWR]2.0.CO;2; Saoud IP, 2003, ESTUARIES, V26, P970, DOI 10.1007/BF02803355; Scharf FS, 2000, ESTUARIES, V23, P128, DOI 10.2307/1353230; Simonsen KA, 2013, B MAR SCI, V89, P657, DOI 10.5343/bms.2012.1013; SOLOW AR, 1994, BIOMETRICS, V50, P556, DOI 10.2307/2533401; Stokes GM, 1977, LIFE HIST STUDIES SO; TPWD, 2002, TEX SHRIMP FISH REP; VanderKooy S, 2001, GULF STATES MARINE F, V87; VanderKooy S, 2000, GULF STATES MARINE F, V83; ZEINELDIN ZP, 1965, BIOL BULL-US, V129, P199, DOI 10.2307/1539778; Zhou C, 2016, ENVIRON ECOL STAT, V23, P181, DOI 10.1007/s10651-015-0334-7; Zimmerman RJ, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P293; Zimmerman RJ, 2002, SALT MARSH LINKAGES, P293	40	12	13	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166479	10.1371/journal.pone.0166479	http://dx.doi.org/10.1371/journal.pone.0166479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832213	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000129
J	Huang, CH; Wang, CH; Tsai, MS; Hsu, NT; Chiang, CY; Wang, TD; Chang, WT; Chen, HW; Chen, WJ				Huang, Chien-Hua; Wang, Chih-Hung; Tsai, Min-Shan; Hsu, Nai-Tan; Chiang, Chih-Yen; Wang, Tzung-Dau; Chang, Wei-Tien; Chen, Huei-Wen; Chen, Wen-Jone			Urocortin Treatment Improves Acute Hemodynamic Instability and Reduces Myocardial Damage in Post-Cardiac Arrest Myocardial Dysfunction	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; AMERICAN-HEART-ASSOCIATION; RESUSCITATION; CARDIOPULMONARY; ACTIVATION; MODEL; DOBUTAMINE; MANAGEMENT; COMMITTEE; SURVIVAL	Aims Hemodynamic instability occurs following cardiac arrest and is associated with high mortality during the post-cardiac period. Urocortin is a novel peptide and a member of the corticotrophin-releasing factor family. Urocortin has the potential to improve acute cardiac dysfunction, as well as to reduce the myocardial damage sustained after ischemia reperfusion injury. The effects of urocortin in post-cardiac arrest myocardial dysfunction remain unclear. Methods and Results We developed a preclinical cardiac arrest model and investigated the effects of urocortin. After cardiac arrest induced by 6.5 min asphyxia, male Wistar rats were resuscitated and randomized to either the urocortin treatment group or the control group. Urocortin (10 mu g/kg) was administrated intravenously upon onset of resuscitation in the experimental group. The rate of return of spontaneous circulation (ROSC) was similar between the urocortin group (76%) and the control group (72%) after resuscitation. The left ventricular systolic (dP/dt(40)) and diastolic (maximal negative dP/dt) functions, and cardiac output, were ameliorated within 4 h after ROSC in the urocortin-treated group compared to the control group (P<0.01). The neurological function of surviving animals was better at 6 h after ROSC in the urocortin-treated group (p = 0.023). The 72-h survival rate was greater in the urocortintreated group compared to the control group (p = 0.044 by log-rank test). Cardiomyocyte apoptosis was lower in the urocortin-treated group (39.9 +/- 8.6 vs. 17.5 +/- 4.6% of TUNEL positive nuclei, P<0.05) with significantly increased Akt, ERK and STAT-3 activation and phosphorylation in the myocardium (P<0.05). Conclusions Urocortin treatment can improve acute hemodynamic instability as well as reducing myocardial damage in post-cardiac arrest myocardial dysfunction.	[Huang, Chien-Hua; Wang, Chih-Hung; Tsai, Min-Shan; Hsu, Nai-Tan; Chang, Wei-Tien; Chen, Wen-Jone] Natl Taiwan Univ, Med Coll & Hosp, Dept Emergency Med, Taipei, Taiwan; [Huang, Chien-Hua; Wang, Tzung-Dau] Natl Taiwan Univ, Med Coll & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chiang, Chih-Yen] Cardinal Tien Hosp, Yunghe Branch, Dept Internal Med, Div Cardiol, New Taipei, Taiwan; [Chen, Huei-Wen] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan; [Chen, Wen-Jone] Lotung Poh Ai Hosp, Dept Internal Med, Div Cardiol, Luodong Township, Yilan County, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chen, WJ (corresponding author), Natl Taiwan Univ, Med Coll & Hosp, Dept Emergency Med, Taipei, Taiwan.; Chen, WJ (corresponding author), Lotung Poh Ai Hosp, Dept Internal Med, Div Cardiol, Luodong Township, Yilan County, Taiwan.	wjchen1955@ntu.edu.tw	TSAI, MIN-SHAN/AHE-3825-2022	TSAI, MIN-SHAN/0000-0002-2862-7572; CHANG, WEI-TIEN/0000-0002-1880-7932; HUANG, CHIEN-HUA/0000-0003-2981-4537; CHEN, HUEI-WEN/0000-0001-5051-9896; CHEN, WEN-JONE/0000-0002-2098-5922; WANG, TZUNG-DAU/0000-0002-7180-3607; WANG, CHIH-HUNG/0000-0003-0802-7825	National Science Council [101-2628-B-002-004-MY3]; National Taiwan University Hospital [101MSN04]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the National Science Council, 101-2628-B-002-004-MY3, and the National Taiwan University Hospital, 101MSN04.	Adao R, 2015, DRUG DISCOV TODAY, V20, P906, DOI 10.1016/j.drudis.2015.02.012; Bale TL, 2004, P NATL ACAD SCI USA, V101, P3697, DOI 10.1073/pnas.0307324101; Barry SP, 2010, J MOL ENDOCRINOL, V45, P69, DOI 10.1677/JME-09-0148; Bigham BL, 2011, RESUSCITATION, V82, P979, DOI 10.1016/j.resuscitation.2011.03.024; Brar BK, 2004, ENDOCRINOLOGY, V145, P24, DOI 10.1210/en.2003-0689; Chanalaris A, 2005, BIOCHEM BIOPH RES CO, V328, P442, DOI 10.1016/j.bbrc.2005.01.001; Davis ME, 2007, EUR HEART J, V28, P2589, DOI 10.1093/eurheartj/ehm340; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hsuchou H, 2010, ENDOCRINOLOGY, V151, P1221, DOI 10.1210/en.2009-1039; Huang C., 2007, TEXT RES J, V28, P53, DOI DOI 10.1097/SHK.0B013E31802F0218; Huang CH, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0516-3; Huang Chien-Hua, 2011, Resuscitation, V82 Suppl 2, pS41, DOI 10.1016/S0300-9572(11)70150-2; Huang HY, 2011, NEUROBIOL AGING, V32, P1662, DOI 10.1016/j.neurobiolaging.2009.09.010; Huang L, 2005, CRIT CARE MED, V33, P487, DOI 10.1097/01.ccm.0000156241.55872.15; Kakavas S, 2011, EUR J PHARMACOL, V667, P32, DOI 10.1016/j.ejphar.2011.06.002; Kern KB, 1996, J AM COLL CARDIOL, V28, P232, DOI 10.1016/0735-1097(96)00130-1; Kimura Y, 2002, J CLIN ENDOCR METAB, V87, P340, DOI 10.1210/jc.87.1.340; Kuizon E, 2009, INT J CARDIOL, V137, P189, DOI 10.1016/j.ijcard.2009.03.112; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Leary S, 2013, AVMA GUIDELINES EUTH; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; Madathil RJ, 2016, RESUSCITATION, V105, P85, DOI 10.1016/j.resuscitation.2016.04.009; Meili-Butz S, 2010, EUR J HEART FAIL, V12, P797, DOI 10.1093/eurjhf/hfq054; Morimura N, 2011, RESUSCITATION, V82, P10, DOI 10.1016/j.resuscitation.2010.08.032; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Overgaard CB, 2008, CIRCULATION, V118, P1047, DOI 10.1161/CIRCULATIONAHA.107.728840; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Rademaker MT, 2015, INT J CARDIOL, V197, P56, DOI 10.1016/j.ijcard.2015.06.011; Rademaker MT, 2002, J AM COLL CARDIOL, V40, P1495, DOI 10.1016/S0735-1097(02)02170-8; Smani T, 2011, CLIN EXP PHARMACOL P, V38, P71, DOI 10.1111/j.1440-1681.2010.05466.x; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Tsai MS, 2015, AM J EMERG MED, V33, P1374, DOI 10.1016/j.ajem.2015.07.030; Vasquez A, 2004, RESUSCITATION, V61, P199, DOI 10.1016/j.resuscitation.2004.01.002; Walther S, 2014, AM J PHYSIOL-HEART C, V307, pH689, DOI 10.1152/ajpheart.00694.2013; Weihong P, 2007, J MOL NEUROSCI, V33, P232, DOI 10.1007/s12031-007-0071-y; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Yang LZ, 2011, BRIT J PHARMACOL, V162, P544, DOI 10.1111/j.1476-5381.2010.01067.x; Zhou Y, 2016, J CARDIOVASC PHARM T, V21, P296, DOI 10.1177/1074248415604463	41	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166324	10.1371/journal.pone.0166324	http://dx.doi.org/10.1371/journal.pone.0166324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832152	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000098
J	Lee, SY; Ro, HJ; Chung, SG; Kang, SH; Seo, KM; Kim, DK				Lee, Sang Yoon; Ro, Hee Joon; Chung, Sun G.; Kang, Si Hyun; Seo, Kyung Mook; Kim, Don-Kyu			Low Skeletal Muscle Mass in the Lower Limbs Is Independently Associated to Knee Osteoarthritis	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; VITAMIN-D DEFICIENCY; LEAN BODY-MASS; SARCOPENIC OBESITY; HIP OSTEOARTHRITIS; PROSPECTIVE COHORT; CARTILAGE LOSS; OLDER PERSONS; RISK-FACTORS; BONE LOSS	Objectives It has been reported that low skeletal muscle mass correlates with knee osteoarthritis in obese individuals. This study aimed to investigate whether lower limb skeletal muscle mass is independently associated with knee osteoarthritis in the general population. Materials and Methods This cross-sectional study used public data from the Fourth and Fifth Korean National Health and Nutrition Examination Survey. Subjects included 4924 community-dwelling adults aged >= 50 years (821 subjects with knee osteoarthritis and 4,103 controls). Skeletal muscle mass index (SMI) was calculated from the appendicular skeletal muscle mass measured by dual energy X-ray absorptiometry. Independent effects of total and lower limb SMI values on knee osteoarthritis were determined using odds ratios (OR) adjusted for age, sex, obesity, total femur bone mineral density, serum vitamin D level, diabetes mellitus status, and physical activity on multivariate logistic regression analysis. Results The adjusted logistic regression model revealed that older age, female sex, and obesity were significantly associated with knee osteoarthritis. A higher serum vitamin D level was also positively correlated with knee osteoarthritis (OR, 1.015; 95% CI, 1.003-1.027; P = 0.010). Although total SMI was not significantly associated with knee osteoarthritis (OR, 0.976; 95% CI, 0.946-1.007; P = 0.127), a low lower limb SMI had an independent effect on knee osteoarthritis (OR, 0.941; 95% CI, 0.900-0.983; P = 0.006). Conclusions Low skeletal muscle mass in the lower limbs but not in the whole body was independently associated with knee osteoarthritis.	[Lee, Sang Yoon; Ro, Hee Joon; Kang, Si Hyun; Seo, Kyung Mook; Kim, Don-Kyu] Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, 102 Heukseok Ro, Seoul 156755, South Korea; [Chung, Sun G.] Seoul Natl Univ, Coll Med, Dept Rehabil Med, 101 Daehang Ro, Seoul 110744, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU)	Kim, DK (corresponding author), Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, 102 Heukseok Ro, Seoul 156755, South Korea.	donkim21@gmail.com			National Research Foundation of Korea [2011-0030135]; Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MEST) [2011-0030135]	National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MEST)	This work was supported by the National Research Foundation of Korea, 2011-0030135, to Sun G. Chung.; This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government (MEST) (No. 2011-0030135).	Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; [Anonymous], 1988, STAT POWER ANAL BEHA; Apold H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-217; Baert IAC, 2013, CLIN BIOMECH, V28, P40, DOI 10.1016/j.clinbiomech.2012.10.007; Becker R, 2004, J ORTHOPAED RES, V22, P768, DOI 10.1016/j.orthres.2003.11.004; Burger H, 1996, ARTHRITIS RHEUM, V39, P81, DOI 10.1002/art.1780390111; Candow DG, 2005, J GERONTOL A-BIOL, V60, P148, DOI 10.1093/gerona/60.2.148; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dannhauer T, 2014, MAGN RESON MATER PHY, V27, P339, DOI 10.1007/s10334-013-0418-z; Ding C, 2009, ARTHRITIS RHEUM-US, V60, P1381, DOI 10.1002/art.24486; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P129, DOI 10.1002/art.22292; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Frediani B, 2003, BONE, V33, P575, DOI 10.1016/S8756-3282(03)00208-4; Glass NA, 2013, OSTEOARTHR CARTILAGE, V21, P1154, DOI 10.1016/j.joca.2013.05.016; Grineva EN, 2013, AGING-US, V5, P575; Harding GT, 2012, OSTEOARTHR CARTILAGE, V20, P1234, DOI 10.1016/j.joca.2012.08.004; Hart DJ, 1999, ARTHRITIS RHEUM, V42, P17, DOI 10.1002/1529-0131(199901)42:1<17::AID-ANR2>3.0.CO;2-E; HEIM G, 1990, Z ERNAHRUNGSWISS, V29, P178, DOI 10.1007/BF02021556; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Hu PF, 2011, MOL BIOL REP, V38, P873, DOI 10.1007/s11033-010-0179-y; Hunter DJ, 2008, ANN RHEUM DIS, V67, P1545, DOI 10.1136/ard.2007.076810; Hwang B, 2012, J KOREAN MED SCI, V27, P748, DOI 10.3346/jkms.2012.27.7.748; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karlsson MK, 2015, CLIN ORTHOP RELAT R, V473, P258, DOI 10.1007/s11999-014-3973-3; Laiguillon MC, 2015, OSTEOARTHR CARTILAGE, V23, P1513, DOI 10.1016/j.joca.2015.04.026; Lane NE, 1999, ARTHRITIS RHEUM-US, V42, P854, DOI 10.1002/1529-0131(199905)42:5&lt;854::AID-ANR3&gt;3.0.CO;2-I; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Le Graverand MPH, 2009, ANN RHEUM DIS, V68, P1734, DOI 10.1136/ard.2007.085530; Lee S, 2012, ARTHRITIS RHEUM-US, V64, P3947, DOI 10.1002/art.37696; Liikavainio T, 2010, KNEE, V17, P69, DOI 10.1016/j.knee.2009.05.003; Lohmander LS, 2009, ANN RHEUM DIS, V68, P490, DOI 10.1136/ard.2008.089748; Maly MR, 2013, ARTHRIT CARE RES, V65, P44, DOI 10.1002/acr.21868; McAlindon T, 2013, JAMA-J AM MED ASSOC, V309, P155, DOI 10.1001/jama.2012.164487; O'Reilly Sheila, 1997, Current Opinion in Rheumatology, V9, P259, DOI 10.1097/00002281-199705000-00014; Papalia R, 2014, Musculoskelet Surg, V98, P9, DOI 10.1007/s12306-014-0311-6; Powell A, 2005, BRIT J SPORT MED, V39, P4, DOI 10.1136/bjsm.2004.011841; Roberson JR, 2000, J AM VET MED ASSOC, V216, P1115, DOI 10.2460/javma.2000.216.1115; Roberson JR, 2000, J AM VET MED ASSOC, V216, P1075; Sanghi D, 2013, CLIN ORTHOP RELAT R, V471, P3556, DOI 10.1007/s11999-013-3201-6; Segal NA, 2012, OSTEOARTHR CARTILAGE, V20, P1534, DOI 10.1016/j.joca.2012.08.019; Toda Y, 2000, J RHEUMATOL, V27, P2449; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Wang YY, 2012, ARTHRITIS RHEUM-US, V64, P3917, DOI 10.1002/art.34681; Wilder FV, 2003, OSTEOARTHR CARTILAGE, V11, P29, DOI 10.1053/joca.2002.0857; Zhang YQ, 2001, ARTHRITIS RHEUM, V44, P2065, DOI 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	50	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166385	10.1371/journal.pone.0166385	http://dx.doi.org/10.1371/journal.pone.0166385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832208	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000118
J	Shenoy, VK; Beaver, KM; Fisher, FM; Singhal, G; Dushay, JR; Maratos-Flier, E; Flier, SN				Shenoy, Vivek K.; Beaver, Kristin M.; Fisher, Ffolliott M.; Singhal, Garima; Dushay, Jody R.; Maratos-Flier, Eleftheria; Flier, Sarah N.			Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC REGULATOR; CIRCULATING FGF21; FGF-21; FIBROBLAST-GROWTH-FACTOR-21; MICE	Background The metabolic regulator Fibroblast Growth Factor 21 (FGF21) is highly expressed in the acinar pancreas, but its role in pancreatic function is obscure. It appears to play a protective role in acute experimental pancreatitis in mice. The aim of this study was to define an association between FGF21 and the course and resolution of acute pancreatitis in humans. Methods and Principal Findings Twenty five subjects with acute pancreatitis admitted from May to September 2012 to the Beth Israel Deaconess Medical Center (BIDMC) were analyzed. Serial serum samples were collected throughout hospitalization and analyzed for FGF21 levels by ELISA. Twenty healthy subjects sampled three times over a four week period were used as controls. We found that, in patients with pancreatitis, serum FGF21 rises significantly and peaks four to six days after the maximum lipase level, before slowly declining. Maximum FGF21 levels were significantly greater than baseline levels for acute pancreatitis subjects (1733 vs. 638 pg/mL, P = 0.003). This maximum value was significantly greater than the highest value observed for our control subjects (1733 vs. 322 pg/mL, P = 0.0002). The ratio of active to total FGF21 did not change during the course of the disease (42.5% vs. 44.4%, P = 0.58). Fold increases in FGF21 were significantly greater in acute pancreatitis subjects than the fold difference seen in healthy subjects (4.7 vs. 2.0, P = 0.01). Higher fold changes were also seen in severe compared to mild pancreatitis (18.2 vs. 4.4, P = 0.01). The timing of maximum FGF21 levels correlated with day of successful return to oral intake (R-2 = 0.21, P = 0.04). Conclusions Our results demonstrate that serum FGF21 rises significantly in humans with acute pancreatitis. The pancreas may be contributing to increased FGF21 levels following injury and FGF21 may play a role in the recovery process.	[Shenoy, Vivek K.; Beaver, Kristin M.; Fisher, Ffolliott M.; Singhal, Garima; Dushay, Jody R.; Maratos-Flier, Eleftheria; Flier, Sarah N.] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Beaver, Kristin M.] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA; [Shenoy, Vivek K.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Stanford University; University of California System; University of California San Francisco	Flier, SN (corresponding author), Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	Sflier1@bidmc.harvarvd.edu			NCATS NIH HHS [UL1 TR001102] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Hansen JS, 2015, MOL METAB, V4, P551, DOI 10.1016/j.molmet.2015.06.001; Johnson CL, 2014, AM J PHYSIOL-ENDOC M, V306, pE916, DOI 10.1152/ajpendo.00559.2013; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Novotny D, 2015, CLIN LAB, V61, P1119, DOI 10.7754/Clin.Lab.2015.141251; Singhal G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148252; Suomalainen Anu, 2013, Expert Opin Med Diagn, V7, P313, DOI 10.1517/17530059.2013.812070; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Zhang W, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/417432	25	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0164351	10.1371/journal.pone.0164351	http://dx.doi.org/10.1371/journal.pone.0164351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832059	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000005
J	Stallman, HM; Kohler, M				Stallman, Helen M.; Kohler, Mark			Prevalence of Sleepwalking: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SLEEP DISORDERS; DISTURBED SLEEP; SCHOOL-CHILDREN; CHILDHOOD; PARASOMNIAS; POPULATION; SCHOOLCHILDREN; PARENTS; DIFFICULTIES; COMORBIDITY	Sleepwalking is thought to be a common arousal disorder; however, the epidemiology of this disorder has not yet been systematically examined. A systematic search of MEDLINE, CINAHL, EMBASE, PsycINFO, PubMed, and ScienceDirect was conducted for 'sleepwalking' OR 'somnambulism' in any field, to identify studies that reported the epidemiology of sleepwalking or sleepwalking disorders. Fifty-one studies assessed the prevalence rates of sleepwalking in a total sample of 100 490. The meta-analysis showed the estimated lifetime prevalence of sleepwalking was 6.9% (95% CI 4.6%-10.3%). The current prevalence rate of sleepwalking within the last 12 months was significantly higher in children 5.0% (95% CI 3.8%-6.5%) than adults 1.5% (95% CI 1.0%-2.3%). There was no evidence of developmental trends in sleepwalking across childhood. The significant risk of bias across all studies suggests these results should be used cautiously. Further epidemiological research that addresses methodological problems found in studies of sleepwalking to date is needed.	[Stallman, Helen M.; Kohler, Mark] Univ South Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia	University of South Australia	Stallman, HM (corresponding author), Univ South Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia.	helen.stallman@unisa.edu.au	Stallman, Helen/AAP-3932-2021; Kohler, Mark/F-4538-2013	Stallman, Helen/0000-0001-7830-0781; Kohler, Mark/0000-0001-7265-6242				Abdel-Khalek AM, 2001, PERCEPT MOTOR SKILL, V93, P901, DOI 10.2466/pms.2001.93.3.901; ABE K, 1966, PSYCHIAT NEUROL, V152, P306; ABE K, 1982, ACTA PAEDOPSYCHIATR, V48, P185; Agargun MY, 2004, SLEEP, V27, P701, DOI 10.1093/sleep/27.4.701; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, DOI DOI 10.1176/APPI.BOOKS.9780890425596.893619; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anders TF, 2000, HDB INFANT MENTAL HL; Archbold KH, 2002, J PEDIATR-US, V140, P97, DOI 10.1067/mpd.2002.119990; Australian Bureau of Statistics, 2012, 3303 0 CAUS DEATH AU; Australian Bureau of Statistics, 2014, 3303 0 CAUS DEATH AU; Australian Bureau of Statistics, 2015, 3303 0 CAUS DEATH AU; Australian Bureau of Statistics, 2013, 3303 0 CAUS DEATH AU; Bharti B, 2006, INDIAN PEDIATR, V43, P35; BIXLER EO, 1979, AM J PSYCHIAT, V136, P1257; Bjorvatn B, 2010, SLEEP MED, V11, P1031, DOI 10.1016/j.sleep.2010.07.011; Black R, 2020, MEMORY, V28, P1014, DOI 10.1080/09658211.2020.1811347; Blader JC, 1997, ARCH PEDIAT ADOL MED, V151, P473, DOI 10.1001/archpedi.1997.02170420043007; Borenstein M., 2009, INTRO METAANALYSIS; Boyle MH, 1998, EVID-BASED MENT HEAL, V1, P37; BROUGHTON RJ, 1968, SCIENCE, V159, P1070, DOI 10.1126/science.159.3819.1070; BUHLER M, 1981, HELV PAEDIATR ACTA, V36, P533; Cai Yi-Min, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P353; Cicogna P, 2013, BEHAV BRAIN SCI, V36, P611, DOI 10.1017/S0140525X13001246; Colrain IM, 2011, NEUROPSYCHOL REV, V21, P5, DOI 10.1007/s11065-010-9155-5; Ramirez MMC, 2008, IATREIA, V21, P113; Davis E, 1942, LANCET, V1, P186; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eysenck MW, 1979, LEVELS PROCESSING HU; FISHER BE, 1987, PERCEPT MOTOR SKILL, V64, P1147, DOI 10.2466/pms.1987.64.3c.1147; Fisher HL, 2014, SLEEP, V37, P475, DOI 10.5665/sleep.3478; Frauscher B, 2014, J CLIN SLEEP MED, V10, P623, DOI 10.5664/jcsm.3784; Furet Oscar, 2011, Southwest J Pulm Crit Care, V2, P93; Ghalebandi Mirfarhad, 2011, Iran J Psychiatry, V6, P75; Goodwin JL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-14; Greene G, 2015, J SLEEP RES, V24, P19, DOI 10.1111/jsr.12200; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirotsu C, 2014, SLEEP SCI, V7, P135, DOI 10.1016/j.slsci.2014.08.001; Hunt RR, 2011, J MEM LANG, V65, P378, DOI 10.1016/j.jml.2011.06.003; Ipsiroglu OS, 2002, J ADOLESCENT HEALTH, V31, P436, DOI 10.1016/S1054-139X(02)00423-8; Kilincaslan A, 2014, PEDIATR INT, V56, P594, DOI 10.1111/ped.12287; KLACKENB.G, 1971, ACTA PAEDIATR SCAND, P1; KLACKENBERG G, 1982, ACTA PAEDIATR SCAND, V71, P495, DOI 10.1111/j.1651-2227.1982.tb09458.x; Klackenberg G, 1987, SLEEP ITS DISORDERS, P99; Koch HJ, 2015, BIOL RHYTHM RES, V46, P287, DOI 10.1080/09291016.2014.994856; Laberge L, 2000, PEDIATRICS, V106, P67, DOI 10.1542/peds.106.1.67; Lehmkuhl G, 2008, DTSCH ARZTEBL INT, V105, P809, DOI 10.3238/arztebl.2008.0809; Light R.J., 1984, SUMMING SCI REV RES; Liu X, 2003, SLEEP, V26; Liu XC, 2005, PEDIATRICS, V115, P266, DOI 10.1542/peds.2004-0815I; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mume CO, 2010, LIBYAN J MED, V5, DOI [10.3402/ljm.v5i0.2143, 10.4176/090907]; Neveus T, 2001, ACTA PAEDIATR, V90, P1450; Ohayon MM, 2012, NEUROLOGY, V78, P1583, DOI 10.1212/WNL.0b013e3182563be5; Ohayon MM, 1999, J CLIN PSYCHIAT, V60, P268, DOI 10.4088/JCP.v60n0413; Oluwole OSA, 2010, J NEUROL, V257, P1141, DOI 10.1007/s00415-010-5479-6; ORME JE, 1967, ACTA PSYCHIAT SCAND, V43, P279, DOI 10.1111/j.1600-0447.1967.tb05764.x; Ozgun N, 2016, PEDIATR INT, V58, P1014, DOI 10.1111/ped.12954; Panda S, 2012, NEUROL INDIA, V60, P68, DOI 10.4103/0028-3886.93601; Petit D, 2007, PEDIATRICS, V119, pE1016, DOI 10.1542/peds.2006-2132; Petit D, 2015, JAMA PEDIATR, V169, P653, DOI 10.1001/jamapediatrics.2015.127; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Poryazova R, 2007, ARCH NEUROL-CHICAGO, V64, P1524, DOI 10.1001/archneur.64.10.1524; Qiu SF, 2016, STAT METHODS MED RES, V25, P37, DOI 10.1177/0962280212439576; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Shang CY, 2006, J SLEEP RES, V15, P63, DOI 10.1111/j.1365-2869.2006.00492.x; Sheldon SH, 2007, SLEEP DISORDERS NEUR, P59; SIMONDS JF, 1982, J AM ACAD CHILD PSY, V21, P383, DOI 10.1016/S0002-7138(09)60942-0; Smedje H, 1999, ACTA PAEDIATR, V88, P858; Smedje H, 2001, EUR CHILD ADOLES PSY, V10, P1, DOI 10.1007/s007870170041; Stallman HM, 2016, SLEEP MED, V25, P1, DOI 10.1016/j.sleep.2016.06.024; Stallman HM, 2016, SLEEP HYPNOSIS, DOI [10.5350/Sleep.Hypn.2016.18.0122, DOI 10.5350/SLEEP.HYPN.2016.18.0122]; Stallman HM, SLEEP MED R IN PRESS; Steinsbekk S, 2015, J DEV BEHAV PEDIATR, V36, P243, DOI 10.1097/DBP.0000000000000134; Steinsbekk S, 2013, J DEV BEHAV PEDIATR, V34, P633, DOI 10.1097/01.DBP.0000437636.33306.49; STEPANSKY R, 1999, SOMNOLOGIE, V3, P78, DOI DOI 10.1007/S11818-999-0014-7; THOMAS C B, 1963, J Chronic Dis, V16, P1099, DOI 10.1016/0021-9681(63)90044-4; Vaher H, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-200; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vela-Bueno A, 1999, Gac Sanit, V13, P441; VILA MT, 2008, AN PEDIATR, V68, P250; Wiechers S, 2011, SOMNOLOGIE, V15, P243; Wilson S, 2008, SLEEP DISORDERS; Woodward M., 2014, EPIDEMIOLOGY STUDY D; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Xie Q, 2016, DAILY MAIL AUST 0530; Xiong Fei, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P1014; YANG LL, 1987, J CHILD PSYCHOL PSYC, V28, P167, DOI 10.1111/j.1469-7610.1987.tb00660.x	88	40	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0164769	10.1371/journal.pone.0164769	http://dx.doi.org/10.1371/journal.pone.0164769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832078	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000387725000006
J	Wise, RA; Holbrook, JT; Criner, G; Sethi, S; Rayapudi, S; Sudini, KR; Sugar, EA; Burke, A; Thimmulappa, R; Singh, A; Talalay, P; Fahey, JW; Berenson, CS; Jacobs, MR; Biswal, S				Wise, Robert A.; Holbrook, Janet T.; Criner, Gerard; Sethi, Sanjay; Rayapudi, Sobharani; Sudini, Kuladeep R.; Sugar, Elizabeth A.; Burke, Alyce; Thimmulappa, Rajesh; Singh, Anju; Talalay, Paul; Fahey, Jed W.; Berenson, Charles S.; Jacobs, Michael R.; Biswal, Shyam		Broccoli Sprout Extract Trial Res	Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; BROCCOLI; RESPONSES; PATHWAY; CANCER; MICE	Background COPD patients have high pulmonary and systemic oxidative stress that correlates with severity of disease. Sulforaphane has been shown to induce expression of antioxidant genes via activation of a transcription factor, nuclear factor erythroid-2 related factor 2 (Nrf2). Methods This parallel, placebo-controlled, phase 2, randomized trial was conducted at three US academic medical centers. Patients who met GOLD criteria for COPD and were able to tolerate bronchoscopies were randomly assigned (1:1:1) to receive placebo, 25 pmoles, or 150 pmoles sulforaphane daily by mouth for four weeks. The primary outcomes were changes in Nrf2 target gene expression (NQ01, HO1, AKR1C1 and AKR1C3) in alveolar macrophages and bronchial epithelial cells. Secondary outcomes included measures of oxidative stress and airway inflammation, and pulmonary function tests. Results Between July 2011 and May 2013, 89 patients were enrolled and randomized. Sulforaphane was absorbed in the patients as evident from their plasma metabolite levels. Changes in Nrf2 target gene expression relative to baseline ranged from 0.79 to 1.45 and there was no consistent pattern among the three groups; the changes were not statistically significantly different from baseline. Changes in measures of inflammation and pulmonary function tests were not different among the groups. Sulforaphane was well tolerated at both dose levels. Conclusion Sulforaphane administered for four weeks at doses of 25 pmoles and 150 pmoles to patients with COPD did not stimulate the expression of Nrf2 target genes or have an effect on levels of other anti-oxidants or markers of inflammation.	[Wise, Robert A.; Talalay, Paul; Fahey, Jed W.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Holbrook, Janet T.; Rayapudi, Sobharani; Sudini, Kuladeep R.; Sugar, Elizabeth A.; Burke, Alyce; Thimmulappa, Rajesh; Singh, Anju; Biswal, Shyam] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Criner, Gerard; Jacobs, Michael R.] Temple Univ, Philadelphia, PA 19122 USA; [Sethi, Sanjay; Berenson, Charles S.] Univ Buffalo SUNY, Buffalo, NY USA; [Sethi, Sanjay; Berenson, Charles S.] VA WNY Healthcare Syst, Buffalo, NY USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wise, RA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	rwise@jhmi.edu	Thimmulappa, Rajesh/AAW-5013-2021; Jacobs, Michael R/E-7010-2011	Thimmulappa, Rajesh/0000-0001-6050-1323; Wise, Robert/0000-0002-8353-2349	National Heart, Lung, and Blood Institute [5U01HL105569]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105569] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung, and Blood Institute, 5U01HL105569.	Alumkal JJ, 2015, INVEST NEW DRUG, V33, P480, DOI 10.1007/s10637-014-0189-z; Bauman JE, 2016, CANCER PREV RES, V9, P547, DOI 10.1158/1940-6207.CAPR-15-0290; Bocci V, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00004; Boutten A, 2011, TRENDS MOL MED, V17, P363, DOI 10.1016/j.molmed.2011.02.006; Bowler Russell P, 2004, COPD, V1, P255, DOI 10.1081/COPD-200027031; Centers for Disease Control and Prevention, 2010, NAT VIT STAT REP DEA, P61; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Egner PA, 2014, CANCER PREV RES, V7, P813, DOI 10.1158/1940-6207.CAPR-14-0103; Fahey JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140963; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Heber D, 2014, FOOD FUNCT, V5, P35, DOI 10.1039/c3fo60277j; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Langen RCJ, 2003, FREE RADICAL BIO MED, V35, P226, DOI 10.1016/S0891-5849(03)00316-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugade AA, 2011, AM J RESP CELL MOL, V45, P557, DOI 10.1165/rcmb.2010-0321OC; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; MacNee W, 2000, CHEST, V117, p303S, DOI 10.1378/chest.117.5_suppl_1.303S-a; Mercado N, 2011, BIOCHEM BIOPH RES CO, V406, P292, DOI 10.1016/j.bbrc.2011.02.035; Noah TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098671; Rahman I, 2012, CURR OPIN PHARMACOL, V12, P256, DOI 10.1016/j.coph.2012.01.015; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Yageta Y, 2011, J VIROL, V85, P4679, DOI 10.1128/JVI.02456-10; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	31	77	79	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0163716	10.1371/journal.pone.0163716	http://dx.doi.org/10.1371/journal.pone.0163716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832073	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000002
J	Bacchi, E; Bonin, C; Zanolin, ME; Zambotti, F; Livornese, D; Dona, S; Tosi, F; Baldisser, G; Ihnatava, T; Di Sarra, D; Sonora, E; Moghetti, P				Bacchi, Elisabetta; Bonin, Cecilia; Zanolin, Maria Elisabetta; Zambotti, Francesca; Livornese, Dario; Dona, Silvia; Tosi, Flavia; Baldisser, Giulia; Ihnatava, Tatsiana; Di Sarra, Daniela; Sonora, Enzo; Moghetti, Paolo			Physical Activity Patterns in Normal-Weight and Overweight/Obese Pregnant Women	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; RISK; PREECLAMPSIA	The aims of the present study were to assess the volume of physical activity (PA) throughout pregnancy in normal-weight vs overweight/obese women, and to investigate which factors may predict compliance to PA recommendations in these women throughout gestation. In 236 pregnant women, 177 normal-weight and 59 overweight/obese (median [IQR] BMI 21.2[19.9-22.8] vs 26.5[25.5-29.0] kg/m2, respectively), medical history, anthropometry and clinical data, including glucose tolerance, were recorded. In addition, pre-pregnancy PA was estimated by the Kaiser questionnaire, while total, walking and fitness/sport PA during pregnancy were assessed by the Physical Activity Scale for the Elderly (PASE) modified questionnaire, at 14-16, 24-28 and 30-32 weeks of gestation. PA volume was very low in the first trimester of pregnancy in both groups of women. However, it increased in the second and third trimester in normal-weight, but not in overweight/ obese subjects. Higher pre-pregnancy PA was a statistically significant predictor of being physically active (>150 minutes of PA per week) during all trimesters of gestation. In conclusion, physical activity volume is low in pregnant women, especially in overweight/obese subjects. PA volume increases during pregnancy only in normal-weight women. Pre-pregnancy PA is an independent predictor of achieving a PA volume of at least 150 min per week during pregnancy.	[Bacchi, Elisabetta; Zambotti, Francesca; Livornese, Dario; Dona, Silvia; Tosi, Flavia; Baldisser, Giulia; Di Sarra, Daniela; Sonora, Enzo; Moghetti, Paolo] Univ Verona, Dept Med, Endocrinol Diabet & Metab, Verona, Italy; [Bacchi, Elisabetta; Zambotti, Francesca; Livornese, Dario; Dona, Silvia; Tosi, Flavia; Baldisser, Giulia; Di Sarra, Daniela; Sonora, Enzo; Moghetti, Paolo] AOUI Verona, Verona, Italy; [Bonin, Cecilia; Ihnatava, Tatsiana] AOUI Verona, Miniinvas Pelv Surg Unit, Verona, Italy; [Zanolin, Maria Elisabetta] Univ Verona, Dept Diagnost & Publ Hlth, Epidemiol & Med Stat, Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Moghetti, P (corresponding author), Univ Verona, Dept Med, Endocrinol Diabet & Metab, Verona, Italy.; Moghetti, P (corresponding author), AOUI Verona, Verona, Italy.	paolo.moghetti@univr.it	Moghetti, Paolo/K-1138-2016; Tosi, Flavia/AAB-4855-2022	Moghetti, Paolo/0000-0003-3951-0297; Tosi, Flavia/0000-0003-3495-4411				Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036; Campbell CG, 2012, J DEV ORIG HLTH DIS, V3, P159, DOI 10.1017/S2040174412000025; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Domingues MR, 2007, REV SAUDE PUBL, V41, P173, DOI 10.1590/s0034-89102007000200002; Evenson KR, 2014, AM J LIFESTYLE MED, V8, P102, DOI 10.1177/1559827613498204; Evenson KR, 2004, PAEDIATR PERINAT EP, V18, P400, DOI 10.1111/j.1365-3016.2004.00595.x; Hegaard HK, 2007, ACTA OBSTET GYN SCAN, V86, P1290, DOI 10.1080/00016340701647341; Hegaard HK, 2011, MATERN CHILD HLTH J, V15, P806, DOI 10.1007/s10995-010-0647-y; Liu JH, 2011, EUR J EPIDEMIOL, V26, P237, DOI 10.1007/s10654-010-9538-1; Lof M, 2006, BRIT J NUTR, V95, P296, DOI 10.1079/BJN20051497; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nascimento SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128953; Ning Y, 2003, J Matern Fetal Neonatal Med, V13, P385, DOI 10.1080/713605926; Pivarnik JM, 2006, MED SCI SPORT EXER, V38, P989, DOI 10.1249/01.mss.0000218147.51025.8a; Renault K, 2010, ACTA OBSTET GYN SCAN, V89, P956, DOI 10.3109/00016341003792459; Rousham EK, 2006, EUR J CLIN NUTR, V60, P393, DOI 10.1038/sj.ejcn.1602329; Schmidt MD, 2006, MED SCI SPORT EXER, V38, P42, DOI 10.1249/01.mss.0000181301.07516.d6; Sui ZX, 2013, HEALTH PROMOT J AUST, V24, P206, DOI 10.1071/HE13054; Tobias DK, 2011, DIABETES CARE, V34, P223, DOI 10.2337/dc10-1368; Walsh JM, 2011, INT J GYNECOL OBSTET, V114, P154, DOI 10.1016/j.ijgo.2011.02.016; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zhang CL, 2006, ARCH INTERN MED, V166, P543, DOI 10.1001/archinte.166.5.543	23	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166254	10.1371/journal.pone.0166254	http://dx.doi.org/10.1371/journal.pone.0166254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829017	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300100
J	Dalhatu, I; Onotu, D; Odafe, S; Abiri, O; Debem, H; Agolory, S; Shiraishi, RW; Auld, AF; Swaminathan, M; Dokubo, K; Ngige, E; Asadu, C; Abatta, E; Ellerbrock, TV				Dalhatu, Ibrahim; Onotu, Dennis; Odafe, Solomon; Abiri, Oseni; Debem, Henry; Agolory, Simon; Shiraishi, Ray W.; Auld, Andrew F.; Swaminathan, Mahesh; Dokubo, Kainne; Ngige, Evelyn; Asadu, Chukwuemeka; Abatta, Emmanuel; Ellerbrock, Tedd V.			Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; TERM IMMUNOLOGICAL RESPONSE; FOLLOW-UP; PATIENTS LOST; CELL COUNT; 1ST YEAR; THERAPY; MORTALITY; CD4; COHORT	Background The Nigerian Antiretroviral therapy (ART) program started in 2004 and now ranks among the largest in Africa. However, nationally representative data on outcomes have not been reported. Methods We evaluated retrospective cohort data from a nationally representative sample of adults aged >= 15 years who initiated ART during 2004 to 2012. Data were abstracted from 3,496 patient records at 35 sites selected using probability-proportional-to-size (PPS) sampling. Analyses were weighted and controlled for the complex survey design. The main outcome measures were mortality, loss to follow-up (LTFU), and retention (the proportion alive and on ART). Potential predictors of attrition were assessed using competing risk regression models. Results At ART initiation, 66.4 percent (%) were females, median age was 33 years, median weight 56 kg, median CD4 count 161 cells/mm(3), and 47.1% had stage III/IV disease. The percentage of patients retained at 12, 24, 36 and 48 months was 81.2%, 74.4%, 67.2%, and 61.7%, respectively. Over 10,088 person-years of ART, mortality, LTFU, and overall attrition (mortality, LTFU, and treatment stop) rates were 1.1 (95% confidence interval (CI): 0.7-1.8), 12.3 (95% CI: 8.9-17.0), and 13.9 (95% CI: 10.4-18.5) per 100 person-years (py) respectively. Highest attrition rates of 55.4/100py were witnessed in the first 3 months on ART. Predictors of LTFU included: lower-than-secondary level education (reference: Tertiary), care in North-East and South-South regions (reference: North-Central), presence of moderate/severe anemia, symptomatic functional status, and baseline weight <45kg. Predictor of mortality was WHO stage higher than stage I. Male sex, severe anemia, and care in a small clinic were associated with both mortality and LTFU. Conclusion Moderate/Advanced HIV disease was predictive of attrition; earlier ART initiation could improve program outcomes. Retention interventions targeting men and those with lower levels of education are needed. Further research to understand geographic and clinic size variations with outcome is warranted.	[Dalhatu, Ibrahim; Onotu, Dennis; Odafe, Solomon; Debem, Henry] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Abuja, Nigeria; [Abiri, Oseni; Dokubo, Kainne] Univ Texas Houston, Sch Biomed Informat, Houston, TX USA; [Agolory, Simon; Shiraishi, Ray W.; Auld, Andrew F.; Swaminathan, Mahesh; Ellerbrock, Tedd V.] US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Atlanta, GA USA; [Ngige, Evelyn; Asadu, Chukwuemeka; Abatta, Emmanuel] Fed Minist Hlth, Natl AIDS & STIs Control Program, Abuja, Nigeria	University of Texas System; University of Texas Health Science Center Houston; Centers for Disease Control & Prevention - USA	Odafe, S (corresponding author), US Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV AIDS, Abuja, Nigeria.	wsp7@cdc.gov	Odafe, Solomon/AAJ-2390-2020	Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the United States Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam RR, 2015, T ROY SOC TROP MED H, V109, P325, DOI 10.1093/trstmh/trv018; Anguzu R, 2015, VALUE HEALTH, V18, pA590, DOI 10.1016/j.jval.2015.09.1515; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Auld AF, 2014, MMWR-MORBID MORTAL W, V63, P1097; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bognounou R, 2015, Bull Soc Pathol Exot, V108, P197, DOI 10.1007/s13149-015-0424-7; Bonner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113813; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Eddings W, 2012, STATA J, V12, P353, DOI 10.1177/1536867X1201200301; Federal Ministry of Health, 2010, TECHN REP 2010 NAT H, P16; Federal Ministry of Health (FMOH), 2007, NAT GUID HIV AIDS TR, P12; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Fine J, 1991, JAMSTATASSOC, V94, P496; FMOH, 2010, NAT GUID HIV AIDS TR, P12; FMOH, 2007, NAT GUID HIV AIDS TR, P65; FMOH, 2014, INT NAT GUIEL HIV PR, P1; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Gazzard B, 2014, J INT AIDS SOC, V17, P167, DOI 10.7448/IAS.17.4.19767; Gonzalez PJ, 2016, F1000RESEARCH, V5, P983, DOI [10.7490/f1000research.1111966.1, DOI 10.7490/F1000RESEARCH.1111966.1]; Hao Lianzheng, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P466; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Imaz A, 2013, ANTIVIR THER, V18, P125, DOI 10.3851/IMP2249; Ioannidis JPA, 1997, J ACQ IMMUN DEF SYND, V16, P22, DOI 10.1097/00042560-199709010-00004; Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007; Kousignian I, 2008, CLIN INFECT DIS, V46, P296, DOI 10.1086/524753; Landman R, 2014, ANTIVIR THER, V19, P51, DOI 10.3851/IMP2675; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Mdege ND, 2013, HEALTH POLICY PLANN, V28, P223, DOI 10.1093/heapol/czs058; Meloni ST, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu055; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nasidi A, 1986, 2 INT C AIDS JUN 23; National Agency for the Control of AIDS (NACA), 2007, STRAT PLANN RES, P20; National Agency for the Control of AIDS (NACA), 2014, GLOB AIDS RESP COUNT, P14; National Agency for the Control of AIDS (NACA) Federal Republic of Nigeria, 2012, GLOB AIDS RESP COUNT; National Centre for AIDS and STD Control, 2020, RETENTION HIV CARE N; Nuesch Reto, 2009, Open AIDS J, V3, P38, DOI 10.2174/1874613600903010038; Odafe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051254; Odafe S, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17424; Oladepo DK, 2009, CLIN VACCINE IMMUNOL, V16, P1374, DOI 10.1128/CVI.00378-08; Olsen CH, 2007, HIV MED, V8, P96, DOI 10.1111/j.1468-1293.2007.00436.x; Palacios R, 2009, EUR J CLIN MICROBIOL, V28, P399, DOI 10.1007/s10096-008-0636-x; Patrick Royston, 2011, J STAT SOFTWARE, V45; Ramjan R, 2014, TROP MED INT HEALTH, V19, P501, DOI 10.1111/tmi.12297; Reepalu A, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu039; Renaud-Thery F, ADULT ANTIRETROVIRAL; Reynolds SJ, 2014, AIDS PATIENT CARE ST, V28, P575, DOI 10.1089/apc.2014.0086; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rubin DB, 2004, MULTIPLE IMPUTATION; Sabapathy K, 2012, JAIDS-J ACQ IMM DEF, V60, pE53, DOI 10.1097/QAI.0b013e31824d5689; Schaubel DE, 2005, STAT MED, V24, P3037, DOI 10.1002/sim.2157; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; StataCorp, 2013, REL 13 STAT SOFTW REL 13 STAT SOFTW; StataCorp, 2013, TEST TEST LIN HYP ES; StataCorp, 2013, IT LIF TABL SURV DAT; StataCorp, 2013, STPTIM CALC PERS TIM; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tafese Zelalem, 2012, Ethiop Med J, V50, P75; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; UNAIDS, 2014, HIV AIDS EST; UNAIDS, 2012, NIG HIV AIDS EST; Verguet S, 2013, J INFECT DIS, V207, P72, DOI 10.1093/infdis/jis635; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Wang HL, 2012, AIDS, V26, P1755, DOI 10.1097/QAD.0b013e328355ced2; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2011, WHO UNICEF EST ROT C, P2; *WHO, TEXTB 7 3 MON RESP A; WHO, 2004, SUBST MAINT THER MAN, P11; WHO, 2013, GLOB UPD HIV TREATM; WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level, 2004, STRAT FRAM MAL PREV, P9; World Health Organization (WHO) HIV/AIDS, 2006, PAT MON GUID HIV CAR, P30; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	86	36	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165528	10.1371/journal.pone.0165528	http://dx.doi.org/10.1371/journal.pone.0165528			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829033	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300048
J	Karat, AS; Omar, T; von Gottberg, A; Tlali, M; Chihota, VN; Churchyard, GJ; Fielding, KL; Johnson, S; Martinson, NA; McCarthy, K; Wolter, N; Wong, EB; Charalambous, S; Grant, AD				Karat, Aaron S.; Omar, Tanvier; von Gottberg, Anne; Tlali, Mpho; Chihota, Violet N.; Churchyard, Gavin J.; Fielding, Katherine L.; Johnson, Suzanne; Martinson, Neil A.; McCarthy, Kerrigan; Wolter, Nicole; Wong, Emily B.; Charalambous, Salome; Grant, Alison D.			Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; POSTMORTEM BACTERIOLOGY; HOSPITALIZED ADULTS; DEATH; MORTALITY; TB; VALIDATION; ROUTINE; PEOPLE; NEED	Background Early mortality among HIV-positive adults starting antiretroviral therapy (ART) remains high in resource-limited settings, with tuberculosis (TB) the leading cause of death. However, current methods to estimate TB-related deaths are inadequate and most autopsy studies do not adequately represent those attending primary health clinics (PHCs). This study aimed to determine the autopsy prevalence of TB and other infections in adults enrolled at South African PHCs in the context of a pragmatic trial of empiric TB treatment ("TB Fast Track"). Methods and Findings Adults with CD4 <= 150 cells/mu L, not on ART or TB treatment, were enrolled to TB Fast Track and followed up for at least six months. Minimally invasive autopsy (MIA) was conducted as soon as possible after death. Lungs, liver, and spleen were biopsied; blood, CSF, and urine aspirated; and bronchoalveolar lavage fluid obtained. Samples underwent mycobacterial, bacterial, and fungal culture; molecular testing (including Xpert (R) MTB/RIF); and histological examination. 34 MIAs were conducted: 18 (53%) decedents were female; median age was 39 (interquartile range 33-44) years; 25 (74%) deaths occurred in hospitals; median time from death to MIA was five (IQR 3-6) days. 16/34 (47%) had evidence of TB (14/16 [88%] with extrapulmonary disease; 6/16 [38%] not started on treatment antemortem); 23 (68%) had clinically important bacterial infections; four (12%) cryptococcal disease; three (9%) non-tuberculous mycobacterial disease; and two (6%) Pneumocystis pneumonia. Twenty decedents (59%) had evidence of two or more concurrent infections; 9/ 16 (56%) individuals with TB had evidence of bacterial disease and two (13%) cryptococcal disease. Conclusions TB, followed by bacterial infections, were the leading findings at autopsy among adults with advanced HIV enrolled from primary care clinics. To reduce mortality, strategies are needed to identify and direct those at highest risk into a structured pathway that includes expedited investigation and/or treatment of TB and other infections.	[Karat, Aaron S.; Churchyard, Gavin J.; Fielding, Katherine L.; Grant, Alison D.] London Sch Hyg & Trop Med, TB Ctr, London, England; [Omar, Tanvier] Natl Hlth Lab Serv, Dept Anat Pathol, Johannesburg, South Africa; [Omar, Tanvier] Univ Witwatersrand, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Tlali, Mpho; Chihota, Violet N.; Churchyard, Gavin J.; McCarthy, Kerrigan; Charalambous, Salome] Aurum Inst, Johannesburg, South Africa; [Chihota, Violet N.; Churchyard, Gavin J.; Fielding, Katherine L.; McCarthy, Kerrigan; Charalambous, Salome; Grant, Alison D.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Johnson, Suzanne] Fdn Profess Dev, Pretoria, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Med Res Council, Soweto Matlosana Collaborating Ctr HIV AIDS & TB, Johannesburg, South Africa; [Martinson, Neil A.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Martinson, Neil A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn, Ctr Excellence Biomed TB Res, Johannesburg, South Africa; [McCarthy, Kerrigan] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Wong, Emily B.] Africa Hlth Res Inst, Durban, South Africa; [Wong, Emily B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Grant, Alison D.] Univ KwaZulu Natal, Durban, South Africa	University of London; London School of Hygiene & Tropical Medicine; National Health Laboratory Service; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; University of Witwatersrand; Johns Hopkins University; National Research Foundation - South Africa; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Africa Health Research Institute; Harvard University; Massachusetts General Hospital; University of Kwazulu Natal	Karat, AS (corresponding author), London Sch Hyg & Trop Med, TB Ctr, London, England.	aaron.karat@lshtm.ac.uk	Chihota, Violet/DWH-9372-2022	Karat, Aaron/0000-0001-9643-664X; McCarthy, Kerrigan/0000-0001-8958-9795; Tlali, Mpho/0000-0003-0283-2022; Charalambous, Salome/0000-0001-7143-1009; von Gottberg, Anne/0000-0002-0243-7455; Churchyard, Gavin/0000-0002-4269-3699; Chihota, Violet/0000-0003-1444-9266	Bill and Melinda Gates Foundation [OPP1083118]; Medical Research Council [MR/K012126/1, G1100689] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI118538] Funding Source: NIH RePORTER; MRC [G1100689] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Bill and Melinda Gates Foundation (Global Health Grant number OPP1083118; http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett I V., 2016, JAIDS J ACQUIR I APR; Bates M, 2015, LANCET INFECT DIS, V3099, P1; Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007; Cain KP, 2015, INT J TUBERC LUNG D, V19, P1270, DOI 10.5588/ijtld.15.0782; Christoffersen S, 2015, FORENSIC SCI INT, V250, P27, DOI 10.1016/j.forsciint.2015.02.020; Cox JA, 2014, JAIDS-J ACQ IMM DEF, V67, P169, DOI 10.1097/QAI.0000000000000290; Cox JA, 2011, TROP MED INT HEALTH, V16, P1015, DOI 10.1111/j.1365-3156.2011.02798.x; Fielding KL, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0650-0; Ford N, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20714; Garcia-Basteiro AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20703; Gerston KF, 2004, HUM PATHOL, V35, P571, DOI 10.1016/j.humpath.2004.01.009; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Guerra I, 2001, PATHOL RES PRACT, V197, P165, DOI 10.1078/0344-0338-00028; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Hanifa Y, 2012, INT J TUBERC LUNG D, V16, P1252, DOI 10.5588/ijtld.11.0733; Karat AS, 2015, 22 C RETR OPP INF; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Lawn SD, 2008, AIDS, V22; Lawn SD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0432-2; Liu TT, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/937013; Lucas S., 2007, CURR DIAGN PATHOL, V13, P375, DOI DOI 10.1016/J.CDIP.2007.06.001; Martinez MJ, 2016, DIAGN MICR INFEC DIS, V84, P80, DOI 10.1016/j.diagmicrobio.2015.10.002; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Maujean G, 2013, J FORENSIC SCI, V58, P1069, DOI 10.1111/1556-4029.12155; Morris JA, 2006, J CLIN PATHOL, V59, P1, DOI 10.1136/jcp.2005.028183; Morris JA, 2007, CURR DIAGN PATHOL, V13, P65, DOI DOI 10.1016/J.CDIP.2006.07.005; Mudenda V, 2012, J INFECT DIS, V205, pS340, DOI 10.1093/infdis/jir859; Murithi S, 2015, 46 UN WORLD C LUNG H; Omar T, 2015, INT J TUBERC LUNG D, V19, P1320, DOI 10.5588/ijtld.15.0222; Palmiere C, 2015, J FORENSIC LEG MED, V30, P21, DOI 10.1016/j.jflm.2014.12.012; Popovic T, 2011, INT J EPIDEMIOL, P71; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; South African National Department of Health, 2014, NAT TUB MAN GUID; Statistics South Africa, 2015, MORT CAUS DEATH S AF; Streatfield PK, 2014, GLOB HLTH ACTION, P1; Tatti KM, 2011, J CLIN MICROBIOL, V49, P4059, DOI 10.1128/JCM.00601-11; Thurman KA, 2011, DIAGN MICR INFEC DIS, V70, P1, DOI 10.1016/j.diagmicrobio.2010.11.014; Tsokos M, 2001, Leg Med (Tokyo), V3, P15, DOI 10.1016/S1344-6223(01)00002-5; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Weber MA, 2010, FORENSIC SCI INT, V198, P121, DOI 10.1016/j.forsciint.2010.02.002; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; WHO, 2015, END TB STRAT GLOB ST; WHO, 2007, IMPR DIAGN TREATM SM; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2015, IMPL TUB DIAGN POL F; World Health Organization, 2016, CONS GUID US ANT DRU	47	37	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166158	10.1371/journal.pone.0166158	http://dx.doi.org/10.1371/journal.pone.0166158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829072	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000387724300092
J	Xu, D; Hou, Y; Zheng, YF; Zheng, Y; Li, MT; Zeng, XF				Xu, Dong; Hou, Yong; Zheng, Yuanfang; Zheng, Yue; Li, Mengtao; Zeng, Xiaofeng			The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR Center	PLOS ONE			English	Article							PERFORMANCE	Objectives To evaluate the performance of the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) in clinical practice in a Chinese patient cohort, and to compare outcomes with the 1980 ACR criteria. Methods Patients clinically diagnosed with SSc between September 2013 and May 2015 were prospectively recruited from the EUSTAR database of the Peking Union Medical College Hospital. Diagnosis of SSc was based on the evaluation of three experienced rheumatologists. Patients diagnosed with other connective tissue diseases were recruited as disease controls. The 1980 ACR and 2013 ACR/EULAR criteria were applied to the cohort, and patients who fulfilled the criteria were classified as definite SSc patients. Sensitivity and specificity were analyzed for the 2013 and 1980 criteria. Results A total of 143 SSc patients and 87 patients with other connective diseases were recruited. 41 (28.7%) and 102 (71.3%) cases were diffuse cutaneous SSc and limited cutaneous SSc, respectively. Although the sensitivity of the 2013 criteria (94.4%) exceeded the 1980 criteria (72.7%) (P<0.001), the 1980 and 2013 criteria sets showed no significant difference in specificity (97.7% and 93.1%, respectively, P = 0.278). The sensitivity of the 2013 criteria was significantly higher than the 1980 criteria in some SSc subgroups (e.g., lcSSc, abnormal pattern of nailfold videocapillaroscopy [NVC] and presence of Raynaud's phenomenon [RP]) compared to others. Conclusions Relative to the 1980 ACR criteria, in Chinese SSc patients the new 2013 ACR/EULAR criteria had similar specificity and higher sensitivity, especially for patients with mild skin thickening or prominent microvascular diseases.	[Li, Mengtao; Zeng, Xiaofeng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, MT; Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China.	mengtao.li@cstar.org.cn; xiaofeng.zeng@cstar.org.cn	meng, li/GVT-2063-2022		EULAR Scleroderma Trial & Research group (EUSTAR); National Natural Science Foundation of China [81571597]; Funding scientific research special clinical medicine of the Chinese medical association [12040740374]	EULAR Scleroderma Trial & Research group (EUSTAR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding scientific research special clinical medicine of the Chinese medical association	This work was supported by the EULAR Scleroderma Trial & Research group (EUSTAR); National Natural Science Foundation of China [81571597]; and Funding scientific research special clinical medicine of the Chinese medical association [12040740374]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhajeri H, 2015, ARTHRIT CARE RES, V67, P582; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Hoffmann-Vold AM, 2015, J RHEUMATOL, V42, P60, DOI 10.3899/jrheum.140047; Jordan S, 2015, RHEUMATOLOGY, V54, P1454, DOI 10.1093/rheumatology/keu530; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; LEROY EC, 1992, CLIN EXP RHEUMATOL, V10, P485; Melchor S, 2016, SEMIN ARTHRITIS RHEU; Pamuk ON, 2016, CLIN RHEUMATOL, V35, P357, DOI 10.1007/s10067-015-3138-0; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Zhang X, 1999, CHINESE J RHEUMATOLO, V1, P5; Zhang X, 1999, CHINESE RHEUMATOLOGY, V3, P247	11	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166629	10.1371/journal.pone.0166629	http://dx.doi.org/10.1371/journal.pone.0166629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851803	gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300075
J	Pan, YZ; Wang, XQ; Sun, GL; Lie, FS; Gong, X				Pan, Yuezhi; Wang, Xueqin; Sun, Guiling; Lie, Fusheng; Gong, Xun			Application of RAD Sequencing for Evaluating the Genetic Diversity of Domesticated Panax notoginseng (Araliaceae)	PLOS ONE			English	Article							POPULATION-STRUCTURE; NATURAL-POPULATIONS; SNP DISCOVERY; DE-NOVO; HISTORY; EVOLUTIONARY; LOCI; POLYMORPHISM; INFERENCE; PHYLOGENY	Panax notoginseng, a traditional Chinese medicinal plant, has been cultivated and domesticated for approximately 400 years, mainly in Yunnan and Guangxi, two provinces in southwest China. This species was named according to cultivated rather than wild individuals, and no wild populations had been found until now. The genetic resources available on farms are important for both breeding practices and resource conservation. In the present study, the recently developed technology RADseq, which is based on next-generation sequencing, was used to analyze the genetic variation and differentiation of P. notoginseng. The nucleotide diversity and heterozygosity results indicated that P. notoginseng had low genetic diversity at both the species and population levels. Almost no genetic differentiation has been detected, and all populations were genetically similar due to strong gene flow and insufficient splitting time. Although the genetic diversity of P. notoginseng was low at both species and population levels, several traditional plantations had relatively high genetic diversity, as revealed by the He and p values and by the private allele numbers. These valuable genetic resources should be protected as soon as possible to facilitate future breeding projects. The possible geographical origin of Sanqi domestication was discussed based on the results of the genetic diversity analysis.	[Pan, Yuezhi; Gong, Xun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China; [Pan, Yuezhi; Lie, Fusheng] Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Peoples R China; [Wang, Xueqin] Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou, Peoples R China; [Sun, Guiling] Yunnan Key Lab Wild Plant Resources, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Agricultural University; Zhoukou Normal University	Gong, X (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China.; Lie, FS (corresponding author), Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Peoples R China.	Ifs810@sina.com; gongxun@mail.kib.ac.cn			National Natural Science Foundation of China [31570339]; Natural Science Foundation of Yunnna province, China [2011FZ207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnna province, China	This project was supported by grant 31570339 from the National Natural Science Foundation of China and grant 2011FZ207 from Natural Science Foundation of Yunnna province, China (YP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artyukova EV, 2004, RUSS J GENET+, V40, P178, DOI 10.1023/B:RUGE.0000016992.55458.3f; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Bruneaux M, 2013, MOL ECOL, V22, P565, DOI 10.1111/j.1365-294X.2012.05749.x; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105064; Chen Z, 2001, CHINESE TRADITIONAL, V32, P357; Cornille A, 2014, TRENDS GENET, V30, P57, DOI 10.1016/j.tig.2013.10.002; DaCosta JM, 2016, MOL PHYLOGENET EVOL, V94, P122, DOI 10.1016/j.ympev.2015.07.026; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2003, GENETICS, V164, P1567; Frankel OH, 1995, CONSERVATION PLANT D; FRANKEL OH, 1975, CROP GENETIC RESOURC; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Freeland J. R., 2011, MOL ECOLOGY; Grubbs HJ, 2004, CONSERV GENET, V5, P13, DOI 10.1023/B:COGE.0000014064.44592.bc; Guo HB, 2010, GENET RESOUR CROP EV, V57, P453, DOI 10.1007/s10722-010-9531-2; Guo YM, 2014, J HERED, V105, P555, DOI 10.1093/jhered/esu021; Hamilton M.B., 2009, POPULATION GENETICS; Han YP, 2016, NEW PHYTOL, V209, P871, DOI 10.1111/nph.13626; Hartl Daniel L., 1997; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang RS, 2007, LISHIZHEN MED MAT ME, V18, P1610; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Liu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135390; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Meegahakumbura MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155369; Miao ZuoQing, 2006, Scientia Agricultura Sinica, V39, P1371; Migicovsky Z, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2834-8; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Mutegi E, 2011, THEOR APPL GENET, V122, P989, DOI 10.1007/s00122-010-1504-5; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ogden R, 2013, MOL ECOL, V22, P3112, DOI 10.1111/mec.12234; Pan Yue-Zhi, 2014, Plant Diversity and Resources, V36, P233, DOI 10.7677/ynzwyj201413084; Pritchard JK, 2000, GENETICS, V155, P945; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Shi FX, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0669-0; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tiwari G, 2016, IND CROP PROD, V86, P1, DOI 10.1016/j.indcrop.2016.03.031; Wang D, 2013, PHYTOCHEMISTRY, V93, P88, DOI 10.1016/j.phytochem.2013.03.007; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069; Wen J., 2001, UTILIZATION BIOTECHN, P67; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1978, P580; Wright SI, 2003, MOL ECOL, V12, P1247, DOI 10.1046/j.1365-294X.2003.01743.x; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xiao Hui, 2008, Southwest China Journal of Agricultural Sciences, V21, P147; Xiao JH, 2015, THESIS; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; Yao XH, 2012, CONSERV GENET, V13, P1499, DOI 10.1007/s10592-012-0393-3; Yi TS, 2004, TAXON, V53, P987, DOI 10.2307/4135565; Zhang JJ, 2013, BOT J LINN SOC, V173, P775, DOI 10.1111/boj.12116; Zheng GZ, 1994, BIOL PANAX NOTOGINSE; Zhou SL, 2005, J INTEGR PLANT BIOL, V47, P107, DOI 10.1111/j.1744-7909.2005.00013.x; Zhuravlev YN, 2008, ACTA PHARMACOL SIN, V29, P1127, DOI 10.1111/j.1745-7254.2008.00866.x	78	15	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166419	10.1371/journal.pone.0166419	http://dx.doi.org/10.1371/journal.pone.0166419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846268	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600061
J	Schnurr, TM; Gjesing, AP; Sandholt, CH; Jonsson, A; Mahendran, Y; Have, CT; Ekstrom, CT; Bjerregaard, AL; Brage, S; Witte, DR; Jorgensen, ME; Aadahl, M; Thuesen, BH; Linneberg, A; Eiberg, H; Pedersen, O; Grarup, N; Kilpelainen, TO; Hansen, T				Schnurr, Theresia M.; Gjesing, Anette P.; Sandholt, Camilla H.; Jonsson, Anna; Mahendran, Yuvaraj; Have, Christian T.; Ekstrom, Claus T.; Bjerregaard, Anne-Louise; Brage, Soren; Witte, Daniel R.; Jorgensen, Marit E.; Aadahl, Mette; Thuesen, Betina H.; Linneberg, Allan; Eiberg, Hans; Pedersen, Oluf; Grarup, Niels; Kilpelainen, Tuomas O.; Hansen, Torben			Genetic Correlation between Body Fat Percentage and Cardiorespiratory Fitness Suggests Common Genetic Etiology	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEART-RATE; OBESITY; EXERCISE; COHORT; MASS	Objectives It has long been discussed whether fitness or fatness is a more important determinant of health status. If the same genetic factors that promote body fat percentage (body fat%) are related to cardiorespiratory fitness (CRF), part of the concurrent associations with health outcomes could reflect a common genetic origin. In this study we aimed to 1) examine genetic correlations between body fat% and CRF; 2) determine whether CRF can be attributed to a genetic risk score (GRS) based on known body fat% increasing loci; and 3) examine whether the fat mass and obesity associated (FTO) locus associates with CRF. Methods Genetic correlations based on pedigree information were examined in a family based cohort (n = 230 from 55 families). For the genetic association analyses, we examined two Danish population-based cohorts (n(total) = 3206). The body fat% GRS was created by summing the alleles of twelve independent risk variants known to associate with body fat%. We assessed CRF as maximal oxygen uptake expressed in millilitres of oxygen uptake per kg of body mass (VO(2)max), per kg fat-free mass (VO(2)max(FFM)), or per kg fat mass (VO(2)max(FM)). All analyses were adjusted for age and sex, and when relevant, for body composition. Results We found a significant negative genetic correlation between VO(2)max and body fat% (rho G = -0.72 (SE +/- 0.13)). The body fat% GRS associated with decreased VO(2)max (beta = -0.15 mL/kg/min per allele, p = 0.0034, age and sex adjusted). The body fat%-increasing FTO allele was associated with a 0.42 mL/kg/min unit decrease in VO(2)max per allele (p = 0.0092, age and sex adjusted). Both associations were abolished after additional adjustment for body fat %. The fat% increasing GRS and FTO risk allele were associated with decreased VO(2)max(FM) but not with VO(2)max(FFM). Conclusions Our findings suggest a shared genetic etiology between whole body fat% and CRF.	[Schnurr, Theresia M.; Gjesing, Anette P.; Sandholt, Camilla H.; Jonsson, Anna; Mahendran, Yuvaraj; Have, Christian T.; Pedersen, Oluf; Grarup, Niels; Kilpelainen, Tuomas O.; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Ekstrom, Claus T.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Biostat Sect, Copenhagen, Denmark; [Aadahl, Mette; Thuesen, Betina H.; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Eiberg, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Bjerregaard, Anne-Louise; Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Brage, Soren] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England; [Jorgensen, Marit E.] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, Gentofte, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Southern Denmark; Steno Diabetes Center	Schnurr, TM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark.	tmschnurr@sund.ku.dk	Brage, Soren/C-6415-2013; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015; Gjesing, Anette/ACC-7521-2022; Witte, Daniel/AAF-9535-2019; Pedersen, Oluf/AAG-8015-2020; Kilpeläinen, Tuomas/F-8569-2012; Schnurr, Theresia M./AAY-9287-2020	Brage, Soren/0000-0002-1265-7355; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Gjesing, Anette/0000-0003-4580-1576; Witte, Daniel/0000-0002-0769-2922; Kilpeläinen, Tuomas/0000-0002-8349-3028; Schnurr, Theresia M./0000-0002-6573-4959; Thuesen, Betina/0000-0001-9772-4344; Jorgensen, Marit Eika/0000-0001-8356-5565; Aadahl, Mette/0000-0001-5904-9747; Linneberg, Allan/0000-0002-0994-0184; Jonsson, Anna/0000-0003-1252-8673; Ekstrom, Claus Thorn/0000-0003-1191-373X; Bjerregaard, Anne-Louise/0000-0001-9844-5531; Hansen, Torben/0000-0001-8748-3831	Danish Diabetes Academy - Novo Nordisk Foundation; University of Copenhagen Excellence Programme for Interdisciplinary Research; Danish Medical Research Council; European Foundation [74550801]; Danish Council for Strategic Research; Steno Diabetes Center; UK Medical Research Council [MC_UU_12015/3]; Velux Foundation; Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health; Capital Region of Denmark; Novo Nordisk Foundation; MRC [MC_UU_12015/3] Funding Source: UKRI; Lundbeck Foundation [R140-2013-13313] Funding Source: researchfish; Medical Research Council [MC_UU_12015/3] Funding Source: researchfish	Danish Diabetes Academy - Novo Nordisk Foundation; University of Copenhagen Excellence Programme for Interdisciplinary Research; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Foundation(European Science Foundation (ESF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Steno Diabetes Center; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Velux Foundation(Velux Fonden); Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health; Capital Region of Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project was supported by the Danish Diabetes Academy supported by the Novo Nordisk Foundation, the research programme "Governing Obesity" funded by the University of Copenhagen Excellence Programme for Interdisciplinary Research (www.go.ku.dk) as well as the Danish Medical Research Council. The ADDITION-PRO study was funded by an unrestricted grant from the European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801), by the Danish Council for Strategic Research and by internal research and equipment funds from Steno Diabetes Center. The work of SB was funded by the UK Medical Research Council (MC_UU_12015/3). The Health2006 study was financially supported by grants from the Velux Foundation; the Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; the Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories (Denmark) and Research Centre for Prevention and Health, the Capital Region of Denmark. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.kudk).; The authors thank A. Forman, B. Andersen and G.J. Klaysen from the Novo Nordisk Foundation Center for Basic Metabolic Research for their dedicated and careful technical assistance and G. Lademann for secretarial support. The project was supported by the Danish Diabetes Academy supported by the Novo Nordisk Foundation, the research programme "Governing Obesity" funded by the University of Copenhagen Excellence Programme for Interdisciplinary Research (www.go.ku.dk) as well as the Danish Medical Research Council. The ADDITION PRO study was funded by an unrestricted grant from the European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801), by the Danish Council for Strategic Research and by internal research and equipment funds from Steno Diabetes Center. The work of SB was funded by the UK Medical Research Council (MC_UU_12015/3). The Health2006 study was financially supported by grants from the Velux Foundation; the Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; the Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories (Denmark) and Research Centre for Prevention and Health, the Capital Region of Denmark. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk).	Aadahl M, 2013, EUR J PREV CARDIOL, V20, P1088, DOI 10.1177/2047487312462825; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; BOUCHARD C, 1988, INT J OBESITY, V12, P205; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gjesing AP, 2015, DIABETOLOGIA, V58, P1006, DOI 10.1007/s00125-015-3516-9; Gjesing AP, 2014, DIABETOLOGIA, V57, P1173, DOI 10.1007/s00125-014-3207-y; Goran M, 2000, INT J OBESITY, V24, P841, DOI 10.1038/sj.ijo.0801241; Hamer M, 2007, PREV MED, V44, P3, DOI 10.1016/j.ypmed.2006.09.005; Hinriksdottir G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130597; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johansen NB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1078; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnson W, 2015, BEHAV GENET, V45, P84, DOI 10.1007/s10519-014-9690-6; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Knab AM, 2010, INT J BIOL SCI, V6, P133; Knab AM, 2009, BEHAV BRAIN RES, V204, P147, DOI 10.1016/j.bbr.2009.05.034; Laukkanen JA, 2009, AM J CARDIOL, V103, P1598, DOI 10.1016/j.amjcard.2009.01.371; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Rankinen T, 2010, OBESITY, V18, P322, DOI 10.1038/oby.2009.205; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Thuesen BH, 2014, INT J EPIDEMIOL, V43, P568, DOI 10.1093/ije/dyt009	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166738	10.1371/journal.pone.0166738	http://dx.doi.org/10.1371/journal.pone.0166738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846319	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600105
J	Castro-Castro, A; Muriel, O; del Pozo, MA; Bustelo, XR				Castro-Castro, Antonio; Muriel, Olivia; del Pozo, Miguel A.; Bustelo, Xose R.			Characterization of Novel Molecular Mechanisms Favoring Rac1 Membrane Translocation	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; SMALL GTPASE RAC; G-BETA-GAMMA; CELL-MIGRATION; PLASMA-MEMBRANE; CORONIN 1A; SIGNAL-TRANSDUCTION; LIPID RAFTS; ACTIVATION; DISSOCIATION	The Rac1 GTPase plays key roles in cytoskeletal organization, cell motility and a variety of physiological and disease-linked responses. Wild type Rac1 signaling entails dissociation of the GTPase from cytosolic Rac1-Rho GDP dissociation inhibitor (GDI) complexes, translocation to membranes, activation by exchange factors, effector binding, and activation of downstream signaling cascades. Out of those steps, membrane translocation is the less understood. Using transfections of a expression cDNA library in cells expressing a Rac1 bioreporter, we previously identified a cytoskeletal feedback loop nucleated by the F-actin binding protein coronin 1A (Coro1A) that promotes Rac1 translocation to the plasma membrane by facilitating the Pak-dependent dissociation of Rac1-Rho GDI complexes. This screening identified other potential regulators of this process, including WDR26, basigin, and TMEM8A. Here, we show that WDR26 promotes Rac1 translocation following a Coro1A-like and Coro1A-dependent mechanism. By contrast, basigin and TMEM8A stabilize Rac1 at the plasma membrane by inhibiting the internalization of caveolin-rich membrane subdomains. This latter pathway is F-actin-dependent but Coro1A-, Pak- and Rho GDI-independent.	[Castro-Castro, Antonio; Bustelo, Xose R.] Ctr Invest Canc, Salamanca, Spain; [Castro-Castro, Antonio; Bustelo, Xose R.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca, Spain; [Muriel, Olivia; del Pozo, Miguel A.] Ctr Nacl Invest Cardiovasc, Vasc Pathophysiol Dept, Madrid, Spain; [Bustelo, Xose R.] Carlos III Hlth Inst, Ctr Invest Biorned Red Oncol, Madrid, Spain; [Castro-Castro, Antonio] Inst Pasteur, Cell Polar Migrat & Invas Unit, Paris, France; [Muriel, Olivia] Univ Geneva, Dept Biochem, Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva	Castro-Castro, A; Bustelo, XR (corresponding author), Ctr Invest Canc, Salamanca, Spain.; Castro-Castro, A; Bustelo, XR (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca, Spain.; Bustelo, XR (corresponding author), Carlos III Hlth Inst, Ctr Invest Biorned Red Oncol, Madrid, Spain.; Castro-Castro, A (corresponding author), Inst Pasteur, Cell Polar Migrat & Invas Unit, Paris, France.	antonio.castro@pasteur.fr; xbustelo@usal.es	del Pozo, Miguel Angel/L-2861-2014; Bustelo, Xose R./A-9526-2010; Bustelo, Xose R./AAD-2081-2022	del Pozo, Miguel Angel/0000-0001-9077-391X; Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072; Muriel, Olivia/0000-0003-2640-2342	Spanish Ministry of Economy and Competitiveness [RD12/0036/0002, SAF2015-64556-R]; Worldwide Cancer Research [14-1248]; Ramon Areces Foundation, Consejeria de Educacion of the Junta de Castilla y Leon [CSI049U16]; Fundacion Cientifica Asociacion Espanola contra el Cancer [GD16173472GARC]; Junta de Castilla y Leon	Spanish Ministry of Economy and Competitiveness(Spanish Government); Worldwide Cancer Research; Ramon Areces Foundation, Consejeria de Educacion of the Junta de Castilla y Leon; Fundacion Cientifica Asociacion Espanola contra el Cancer; Junta de Castilla y Leon(Junta de Castilla y Leon)	XRB has been supported by grants from the Spanish Ministry of Economy and Competitiveness (RD12/0036/0002, SAF2015-64556-R), Worldwide Cancer Research (14-1248), Ramon Areces Foundation, Consejeria de Educacion of the Junta de Castilla y Leon (CSI049U16), and Fundacion Cientifica Asociacion Espanola contra el Cancer (GD16173472GARC). Funding from both the Spanish Ministry of Economy and Competitiveness and Junta de Castilla y Leon is partially contributed by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2012, BIOESSAYS, V34, P748, DOI 10.1002/bies.201200041; Bustelo XR, 2012, SMALL GTPASES, V3, P1; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chao WT, 2010, J CELL BIOL, V190, P247, DOI 10.1083/jcb.200911110; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Chuang HW, 2015, PLANT SCI, V241, P23, DOI 10.1016/j.plantsci.2015.09.024; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Cordova-Palomera A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.49; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Fei F, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-48; Feng YS, 2012, FREE RADICAL RES, V46, P777, DOI 10.3109/10715762.2012.678840; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Gandhi Meghal, 2008, V48, P72, DOI 10.1007/978-0-387-09595-0_7; Gandhi PN, 2004, BIOCHEM J, V378, P409, DOI 10.1042/BJ20030979; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Goto T, 2016, FEBS LETT, V590, P1291, DOI 10.1002/1873-3468.12180; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Maruta Hiroshi, 2002, Methods Mol Biol, V189, P75; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Norambuena A, 2011, MOL BIOL CELL, V22, P3456, DOI 10.1091/mbc.E11-04-0361; Ojeda V, 2015, MOL BIOL CELL, V26, P2895, DOI 10.1091/mbc.E15-01-0052; Ojeda V, 2014, MOL CELL BIOL, V34, P3388, DOI 10.1128/MCB.00347-14; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Porter Andrew P, 2016, Small GTPases, V7, P123, DOI 10.1080/21541248.2016.1173767; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rebres RA, 2005, J CELL PHYSIOL, V205, P182, DOI 10.1002/jcp.20379; Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007; Runne C, 2013, CELL ADHES MIGR, V7, P214, DOI 10.4161/cam.22940; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun ZZ, 2013, J BIOL CHEM, V288, P16715, DOI 10.1074/jbc.M113.462564; Sun ZZ, 2011, J BIOL CHEM, V286, P43902, DOI 10.1074/jbc.M111.301382; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Ye Y, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7439; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yoshida H, 2000, BLOOD, V96, P234, DOI 10.1182/blood.V96.1.234.013k06_234_241; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232; Zhao J, 2009, NEUROSCI LETT, V460, P66, DOI 10.1016/j.neulet.2009.05.024; Zhu Y, 2004, J CELL BIOCHEM, V93, P579, DOI 10.1002/jcb.20175	72	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166715	10.1371/journal.pone.0166715	http://dx.doi.org/10.1371/journal.pone.0166715			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835684	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200065
J	Liu, X; Han, Q; Wang, J; Wang, X; Xu, JH; Shi, JR				Liu, Xin; Han, Qi; Wang, Jian; Wang, Xin; Xu, Jianhong; Shi, Jianrong			Two FgLEU2 Genes with Different Roles in Leucine Biosynthesis and Infection-Related Morphogenesis in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RESISTANCE; VIRULENCE; SYNTHASE; TRANSFORMATION; PATHOGENESIS; METABOLISM; MUTATIONS; SURVIVAL; MUTANTS	3-isopropylmalate dehydrogenase (IPMD) encoded by LEU2 is a key enzyme in leucine (Leu) biosynthetic pathway. Analysis of the genome sequence of Fusarium graminearum revealed two paralogous LEU2 genes (designated as FgLEU2A and FgLEU2B) in this fungus and the deduced amino acid sequences of FgLeu2A and FgLeu2B share 45% identity. Targeted disruption of individual FgLEU2A/B gene in F. graminearum assigned a more crucial role of FgLeu2A in Leu biosynthesis as disruption of FgLEU2A resulted in mutant (Delta FgLeu2A-10) that was Leu-auxotrophic and could not grow in minimal medium limited for amino acids, whereas FgLEU2B deletion mutant Delta FgLeu2B-2 was morphologically indistinguishable from the wild type strain PH-1. The growth defects of Delta FgLeu2A-10 could be overcome by exogenous addition of Leu at 0.25 mM. Double deletion of FgLEU2A and FgLEU2B (Delta FgLeu2AB-8) caused a more severe Leu-auxotrophic phenotype as the concentration of Leu exogenously added to medium to rescue the growth defect of Delta FgLeu2AB-8 should be raised to 1.25 mM, indicating a less important but nonnegligible role of FgLeu2B in Leu biosynthesis. Disturb of Leu biosynthesis caused by FgLEU2A deletion leads to slower growth rate, reduced aerial hyphal formation and red pigmentation on PDA plates and completely blocked conidial production and germination. All of the defects above could be overcome by Leu addition or complementation of the full-length FgLEU2A gene. Delta FgLeu2A-10 also showed significantly increased sensitivity to osmotic and oxidative stresses. Pathogenicity assay results showed that virulence of mutants lacking FgLEU2A were dramatically impaired on wheat heads and non-host cherry tomatoes. Additionally, a low level of deoxynivalenol (DON) production of Delta FgLeu2A-10 and Delta FgLeu2AB-8 in wheat kernels was also detected. Taken together, results of this study indicated a crucial role of FgLeu2A and a less important role of FgLeu2B in Leu biosynthesis and fungal infection-related morphogenesis in F. graminearum and FgLeu2A may serve as a potential target for novel antifungal development.	[Liu, Xin; Han, Qi; Wang, Jian; Wang, Xin; Xu, Jianhong; Shi, Jianrong] Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] Minist Agr, Key Lab Control Technol & Stand Agroprod Safety &, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] Minist Agr, Key Lab Agroprod Safety Risk Evaluat Nanjing, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Xu, JH; Shi, JR (corresponding author), Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), Minist Agr, Key Lab Control Technol & Stand Agroprod Safety &, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), Minist Agr, Key Lab Agroprod Safety Risk Evaluat Nanjing, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China.	xujianhongnj@126.com; shiji@jaas.ac.cn	Shi, Jianrong/AAQ-1805-2020; xu, jianhong/AAQ-4773-2021	shi, jianrong/0000-0001-8650-248X	National Natural Science Foundation of China [31301623, 31300128]; Jiangsu Provincial Natural Science Foundation [BK20130704]; Jiangsu Agricultural Science and Technology Innovation Fund [CX(13)5050]; Special Fund for Agro-scientific Research in the Public Interest [201303016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Agricultural Science and Technology Innovation Fund; Special Fund for Agro-scientific Research in the Public Interest	The research was supported by National Natural Science Foundation of China (31301623 and 31300128), Jiangsu Provincial Natural Science Foundation (BK20130704) and Jiangsu Agricultural Science and Technology Innovation Fund (CX(13)5050) to Xin Liu; and Special Fund for Agro-scientific Research in the Public Interest (201303016) to Jianrong Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by National Natural Science Foundation of China (31301623 and 31300128), Jiangsu Provincial Natural Science Foundation (BK20130704) and Jiangsu Agricultural Science and Technology Innovation Fund (CX(13)5050) to Xin Liu, Special Fund for Agro-scientific Research in the Public Interest (201303016) to Jianrong Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthy D, 2009, MICROBIOL-SGM, V155, P2978, DOI 10.1099/mic.0.029884-0; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Davey ML, 2009, MYCOL RES, V113, P1254, DOI 10.1016/j.mycres.2009.08.001; Du Y, 2014, FUNGAL GENET BIOL, V73, P53, DOI 10.1016/j.fgb.2014.10.001; Du Y, 2013, MOL PLANT PATHOL, V14, P870, DOI 10.1111/mpp.12053; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Ilgen P, 2008, CEREAL RES COMMUN, V36, P421, DOI 10.1556/CRC.36.2008.Suppl.B.35; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2006, EUKARYOT CELL, V5, P816, DOI 10.1128/EC.5.5.816-824.2006; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leslie JF, WILEY INTERSCIENCE O, Vxii; Liu HJ, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/324502; Liu XR, 2014, TRANSL STROKE RES, V5, P692, DOI 10.1007/s12975-014-0359-5; Liu X, 2015, CURR GENET, V61, P55, DOI 10.1007/s00294-014-0444-z; Liu X, 2011, MICROBIOL-SGM, V157, P1665, DOI 10.1099/mic.0.045690-0; Liu X, 2011, FUNGAL GENET BIOL, V48, P113, DOI 10.1016/j.fgb.2010.10.004; Liu ZH, 2012, METHODS MOL BIOL, V835, P365, DOI 10.1007/978-1-61779-501-5_21; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; MCCUSKER JH, 1990, MOL CELL BIOL, V10, P2941, DOI 10.1128/MCB.10.6.2941; Oliver JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043559; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Sasanya JJ, 2008, J FOOD PROTECT, V71, P1205, DOI 10.4315/0362-028X-71.6.1205; SIMON JR, 1990, MOL GEN GENET, V223, P241, DOI 10.1007/BF00265060; Soleimany F, 2012, FOOD CHEM, V130, P1055, DOI 10.1016/j.foodchem.2011.07.131; Swinnen S, 2015, EUKARYOT CELL, V14, P884, DOI 10.1128/EC.00053-15; Williams BA, 1996, CURR GENET, V30, P305, DOI 10.1007/s002940050137; Wu AB, 2005, MYCOPATHOLOGIA, V160, P75, DOI 10.1007/s11046-005-1153-4; Yoshizawa F, 2004, BIOCHEM BIOPH RES CO, V313, P417, DOI 10.1016/j.bbrc.2003.07.013; Zhan J, 2001, PHYTOPATHOLOGY, V91, P1011, DOI 10.1094/PHYTO.2001.91.10.1011	37	7	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165927	10.1371/journal.pone.0165927	http://dx.doi.org/10.1371/journal.pone.0165927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835660	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200016
J	Paege, N; Jung, S; Schape, P; Muller-Hagen, D; Ouedraogo, JP; Heiderich, C; Jedamzick, J; Nitsche, BM; van den Hondel, CA; Ram, AF; Meyer, V				Paege, Norman; Jung, Sascha; Schape, Paul; Muller-Hagen, Dirk; Ouedraogo, Jean-Paul; Heiderich, Caroline; Jedamzick, Johanna; Nitsche, Benjamin M.; van den Hondel, Cees A.; Ram, Arthur F.; Meyer, Vera			A Transcriptome Meta-Analysis Proposes Novel Biological Roles for the Antifungal Protein AnAFP in Aspergillus niger	PLOS ONE			English	Article							GUILT-BY-ASSOCIATION; FILAMENTOUS FUNGI; PENICILLIUM-CHRYSOGENUM; GENOME DATABASE; MULTISPECIES CURATION; STRESS-RESPONSE; PYRG-GENE; CELL-WALL; EXPRESSION; REVEALS	Understanding the genetic, molecular and evolutionary basis of cysteine-stabilized antifungal proteins (AFPs) from fungi is important for understanding whether their function is mainly defensive or associated with fungal growth and development. In the current study, a transcriptome meta-analysis of the Aspergillus niger.-core protein AnAFP was performed to explore co-expressed genes and pathways, based on independent expression profiling microarrays covering 155 distinct cultivation conditions. This analysis uncovered that anafp displays a highly coordinated temporal and spatial transcriptional profile which is concomitant with key nutritional and developmental processes. Its expression profile coincides with early starvation response and parallels with genes involved in nutrient mobilization and autophagy. Using fluorescence-and luciferase reporter strains we demonstrated that the anafp promoter is active in highly vacuolated compartments and foraging hyphal cells during carbon starvation with CreA and FlbA, but not BrlA, as most likely regulators of anafp. A co-expression network analysis supported by luciferase-based reporter assays uncovered that anafp expression is embedded in several cellular processes including allorecognition, osmotic and oxidative stress survival, development, secondary metabolism and autophagy, and predicted StuA and VelC as additional regulators. The transcriptomic resources available for A. niger provide unparalleled resources to investigate the function of proteins. Our work illustrates how transcriptomic meta-analyses can lead to hypotheses regarding protein function and predict a role for AnAFP during slow growth, allorecognition, asexual development and nutrient recycling of A. niger and propose that it interacts with the autophagic machinery to enable these processes.	[Paege, Norman; Jung, Sascha; Schape, Paul; Muller-Hagen, Dirk; Ouedraogo, Jean-Paul; Nitsche, Benjamin M.; Meyer, Vera] Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, Berlin, Germany; [Ouedraogo, Jean-Paul; Heiderich, Caroline; Jedamzick, Johanna; van den Hondel, Cees A.; Ram, Arthur F.] Leiden Univ, Inst Biol Leiden, Dept Mol Microbiol & Biotechnol, Leiden, Netherlands; [van den Hondel, Cees A.; Ram, Arthur F.; Meyer, Vera] HiTexaCoat, Gouda, Netherlands	Technical University of Berlin; Leiden University; Leiden University - Excl LUMC	Meyer, V (corresponding author), Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, Berlin, Germany.; Meyer, V (corresponding author), HiTexaCoat, Gouda, Netherlands.	vera.meyer@tu-berlin.de	Ram, Arthur FJ/S-4648-2017	Ram, Arthur FJ/0000-0002-2487-8016; Jung, Sascha/0000-0003-4970-6904; Meyer, Vera/0000-0002-2298-2258; Ouedraogo, Jean-Paul/0000-0002-9735-6235; Van den Hondel, Kees/0000-0003-4782-2725	Marie Curie Integration grant [CIG 303684]; Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Marie Curie Integration grant; Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was partly funded by the Marie Curie Integration grant to VM (CIG 303684) and supported by the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2002, AFF MICR SUIT 5 0 US; Allen A, 2008, PLANTA, V227, P331, DOI 10.1007/s00425-007-0620-1; Arentshorst M., 2014, FUNGAL BIOL, V1, P263, DOI DOI 10.1007/978-3-319-10142-2_; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Baroni A, 2009, PEPTIDES, V30, P267, DOI 10.1016/j.peptides.2008.11.001; Batta G, 2009, FEBS J, V276, P2875, DOI 10.1111/j.1742-4658.2009.07011.x; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bennett JW, 1991, MORE GENE MANIPULATI; Benoit I, 2015, ENVIRON MICROBIOL, V17, P2099, DOI 10.1111/1462-2920.12564; Bleichrodt R, 2013, STUD MYCOL, P31, DOI 10.3114/sim0007; Braaksma M, 2009, MICROBIOL-SGM, V155, P3430, DOI 10.1099/mic.0.031062-0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cairns TC, 2016, TRENDS MICROBIOL, V24, P35, DOI 10.1016/j.tim.2015.09.008; CAMPOSOLIVAS R, 1995, BIOCHEMISTRY-US, V34, P3009, DOI 10.1021/bi00009a032; Carvalho NDSP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-350; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Choudhary M, 2015, PHYSIOL MOL BIOL PLA, V21, P187, DOI 10.1007/s12298-015-0287-1; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; de Bekker C, 2011, APPL ENVIRON MICROB, V77, P1263, DOI 10.1128/AEM.02134-10; DERUITERJACOBS YMJT, 1989, CURR GENET, V16, P159, DOI 10.1007/BF00391472; Fiedler Markus Rm, 2014, Fungal Biol Biotechnol, V1, P5, DOI 10.1186/s40694-014-0005-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Girgi M, 2006, TRANSGENIC RES, V15, P313, DOI 10.1007/s11248-006-0001-8; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Gruben BS, 2014, APPL MICROBIOL BIOT, V98, P5531, DOI 10.1007/s00253-014-5607-9; Gruben BS, 2012, FEBS LETT, V586, P3980, DOI 10.1016/j.febslet.2012.09.029; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Han SJ, 2011, PROTEIN CELL, V2, P784, DOI 10.1007/s13238-011-1104-4; Hegedus N, 2013, FUNGAL BIOL REV, V26, P132, DOI 10.1016/j.fbr.2012.07.002; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hu PJ, 2015, FUNGAL GENET BIOL, V83, P26, DOI 10.1016/j.fgb.2015.08.003; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jorgensen TR, 2010, APPL ENVIRON MICROB, V76, P5344, DOI 10.1128/AEM.00450-10; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Jung S, 2012, J BIOL CHEM, V287, P14246, DOI 10.1074/jbc.M111.336495; Kaiserer L, 2003, ARCH MICROBIOL, V180, P204, DOI 10.1007/s00203-003-0578-8; Klomp Jeff A, 2012, BMC Res Notes, V5, P370, DOI 10.1186/1756-0500-5-370; Kovacs B, 2014, ACTA MICROBIOL IMM H, V61, P379, DOI 10.1556/AMicr.61.2014.3.10; Kovacs L, 2011, PEPTIDES, V32, P1724, DOI 10.1016/j.peptides.2011.06.022; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Krijgsheld P, 2013, FUNGAL GENOM BIOL, V3; Krijgsheld P, 2013, J PROTEOME RES, V12, P1808, DOI 10.1021/pr301154w; Krijgsheld P, 2012, J PROTEOME RES, V11, P2807, DOI 10.1021/pr201157b; Kwon MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-701; Lee DG, 1999, BIOCHEM BIOPH RES CO, V263, P646, DOI 10.1006/bbrc.1999.1428; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Martens-Uzunova ES, 2008, FUNGAL GENET BIOL, V45, P1449, DOI 10.1016/j.fgb.2008.08.002; Meyer V, 2008, FUNGAL GENET BIOL, V45, P152, DOI 10.1016/j.fgb.2007.07.006; Meyer V, 2008, APPL MICROBIOL BIOT, V78, P17, DOI 10.1007/s00253-007-1291-3; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Meyer V, 2015, ADV BIOCHEM ENG BIOT, V149, P91, DOI 10.1007/10_2014_297; Meyer V, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P318; Meyer V, 2009, EUKARYOT CELL, V8, P1677, DOI 10.1128/EC.00050-09; Nitsche BM, 2013, APPL MICROBIOL BIOT, V97, P8205, DOI 10.1007/s00253-013-4971-1; Nitsche BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-380; Nitsche BM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-486; Nitsche BM, 2014, FUNGAL GENOMICS, V13, P209, DOI DOI 10.1007/978-3-642-45218-5_; Normile D, 2010, SCIENCE, V327, P807, DOI 10.1126/science.327.5967.807; Novodvorska M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-246; OLSON BH, 1965, APPL MICROBIOL, V13, P314, DOI 10.1128/AEM.13.3.314-321.1965; Ouedraogo JP, 2011, J BIOL CHEM, V286, P13859, DOI 10.1074/jbc.M110.203588; Paramythiotou E, 2014, MOLECULES, V19, P1085, DOI 10.3390/molecules19011085; Park BC, 2014, J MICROBIOL, V52, P940, DOI 10.1007/s12275-014-4517-y; Park HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10199; Park HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089883; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J, 2001, MOL CLONING LAB MANU, P2588; Schachtschabel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078102; SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Sheppard DC, 2005, MOL BIOL CELL, V16, P5866, DOI 10.1091/mbc.E05-07-0617; Sigl C, 2011, APPL ENVIRON MICROB, V77, P972, DOI 10.1128/AEM.01557-10; Skouri-Gargouri H, 2008, PEPTIDES, V29, P1871, DOI 10.1016/j.peptides.2008.07.005; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; van der Veen D, 2009, APPL ENVIRON MICROB, V75, P2414, DOI 10.1128/AEM.02270-08; Van Diepeningen AD, 2009, MYCOL RES, V113, P222, DOI 10.1016/j.mycres.2008.10.003; van Leeuwen MR, 2013, STUD MYCOL, P71, DOI 10.3114/sim0013; van Munster JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116269; van Munster JM, 2013, MICROBIOL-SGM, V159, P1853, DOI 10.1099/mic.0.067967-0; VANHARTINGSVELDT W, 1987, MOL GEN GENET, V206, P71, DOI 10.1007/BF00326538; Wanka F, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0543-2; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yount NY, 2006, BBA-BIOMEMBRANES, V1758, P1373, DOI 10.1016/j.bbamem.2006.03.027; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Yuan XL, 2008, MOL GENET GENOMICS, V279, P11, DOI 10.1007/s00438-007-0290-5	102	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165755	10.1371/journal.pone.0165755	http://dx.doi.org/10.1371/journal.pone.0165755			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835655	Green Published, gold			2022-12-27	WOS:000387779200010
J	Calegario, G; Pollier, J; Arendt, P; de Oliveira, LS; Thompson, C; Soares, AR; Pereira, RC; Goossens, A; Thompson, FL				Calegario, Gabriela; Pollier, Jacob; Arendt, Philipp; de Oliveira, Louisi Souza; Thompson, Cristiane; Soares, Angelica Ribeiro; Pereira, Renato Crespo; Goossens, Alain; Thompson, Fabiano L.			Cloning and Functional Characterization of Cycloartenol Synthase from the Red Seaweed Laurencia dendroidea	PLOS ONE			English	Article							ISOPRENOID BIOSYNTHESIS; OXIDOSQUALENE CYCLASES; HALOGENATED COMPOUNDS; TRITERPENOIDS; PATHWAY; PLANTS; ALGAE; EXPRESSION; BIOLOGY; GENES	The red seaweed Laurencia dendroidea belongs to the Rhodophyta, a phylum of eukaryotic algae that is widely distributed across the oceans and that constitute an important source of bioactive specialized metabolites. Laurencia species have been studied since 1950 and were found to contain a plethora of specialized metabolites, mainly halogenated sesquiterpenes, diterpenes and triterpenes that possess a broad spectrum of pharmacological and ecological activities. The first committed step in the biosynthesis of triterpenes is the cyclization of 2,3-oxidosqualene, an enzymatic reaction carried out by oxidosqualene cyclases (OSCs), giving rise to a broad range of different compounds, such as the sterol precursors cycloartenol and lanosterol, or triterpene precursors such as cucurbitadienol and beta-amyrin. Here, we cloned and characterized the first OSC from a red seaweed. The OSC gene was identified through mining of a L. dendroidea transcriptome dataset and subsequently cloned and heterologously expressed in yeast for functional characterization, which indicated that the corresponding enzyme cyclizes 2,3-oxidosqualene to the sterol precursor cycloartenol. Accordingly, the gene was named L. dendroidea cycloartenol synthase (LdCAS). A phylogenetic analysis using OSCs genes from plants, fungi and algae revealed that LdCAS grouped together with OSCs from other red algae, suggesting that cycloartenol could be the common product of the OSC in red seaweeds. Furthermore, profiling of L. dendroidea revealed cholesterol as the major sterol accumulating in this species, implicating red seaweeds contain a 'hybrid' sterol synthesis pathway in which the phytosterol precursor cycloartenol is converted into the major animal sterol cholesterol.	[Calegario, Gabriela; Pereira, Renato Crespo] Univ Fed Fluminense, Dept Marine Biol, Niteroi, RJ, Brazil; [Calegario, Gabriela; de Oliveira, Louisi Souza; Thompson, Cristiane; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio de Janeiro, Brazil; [Calegario, Gabriela; de Oliveira, Louisi Souza; Thompson, Cristiane; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, Brazil; [Pollier, Jacob; Arendt, Philipp; Goossens, Alain] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Pollier, Jacob; Arendt, Philipp; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Soares, Angelica Ribeiro] UFRJ, Nucleo Estudos Ecol & Desenvolvimento Socioambien, GPNOA, Macae, Brazil	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Flanders Institute for Biotechnology (VIB); Ghent University; Universidade Federal do Rio de Janeiro	Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio de Janeiro, Brazil.; Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, Brazil.	fabianothompson1@gmail.com	Pollier, Jacob/B-3091-2012; Soares, Angelica/AAW-6611-2021; Van Breusegem, Frank/AAJ-2647-2020; Pereira, Renato Crespo/AAA-7832-2020	Pollier, Jacob/0000-0002-1134-9238; Soares, Angelica/0000-0001-9126-3778; Van Breusegem, Frank/0000-0002-3147-0860; Calegario, Gabriela/0000-0002-3772-8447; Thompson, Fabiano/0000-0002-7562-1683	CNPq; CAPES; FAPERJ; CAPES scholarship; VIB International Fellowship Program	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); VIB International Fellowship Program	We thank CNPq, CAPES and FAPERJ for financial support. This work is part of GC's PhD thesis in the graduate course of Dinamica dos Oceanos e da Terra, supported by CAPES scholarship. JP is postdoctoral fellow of the Research Foundation Flanders. PA is indebted to the VIB International Fellowship Program for a predoctoral fellowship. RCP and FLT thank CNPq by Productivity Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank CNPq, CAPES and FAPERJ for financial support. This work is part of G.C. PhD thesis in the graduate course of Dinamica dos Oceanos e da Terra, supported by CAPES scholarship. J.P. is postdoctoral fellow of the Research Foundation Flanders. P.A. is indebted to the VIB International Fellowship Program for a predoctoral fellowship. RCP and FLT thank CNPq by Productivity Fellowships.	Abe I, 1996, J AM CHEM SOC, V118, P9180, DOI 10.1021/ja961643a; ABE I, 1995, P NATL ACAD SCI USA, V92, P9274, DOI 10.1073/pnas.92.20.9274; Acimovic J, 2013, MOLECULES, V18, P4002, DOI 10.3390/molecules18044002; Andre CM, 2016, NEW PHYTOL, V211, P1279, DOI 10.1111/nph.13996; Arendt P, 2016, PLANT J, V87, P16, DOI 10.1111/tpj.13138; Babiychuk E, 2008, P NATL ACAD SCI USA, V105, P3163, DOI 10.1073/pnas.0712190105; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Cardenas PD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10654; CATTEL L, 1986, LIPIDS, V21, P31, DOI 10.1007/BF02534300; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cock PJA, 2013, PEERJ, V1, DOI 10.7717/peerj.167; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; Davidovich-Rikanati R, 2015, YEAST, V32, P103, DOI 10.1002/yea.3049; de Oliveira LS, 2015, MAR DRUGS, V13, P879, DOI 10.3390/md13020879; Dhar N, 2014, J BIOL CHEM, V289, P17249, DOI 10.1074/jbc.M114.571919; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dong YZ, 2011, NAT PROD REP, V28, P529, DOI 10.1039/c0np00035c; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Fernandez JJ, 1998, BIOORGAN MED CHEM, V6, P2237, DOI 10.1016/S0968-0896(98)80004-7; Fiallos-Jurado J, 2016, PLANT SCI, V250, P188, DOI 10.1016/j.plantsci.2016.05.015; Gas-Pascual E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109156; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Iliopoulou D, 2002, TETRAHEDRON, V58, P6749, DOI 10.1016/S0040-4020(02)00687-7; IRIE T, 1965, TETRAHEDRON LETT, P1091; IRIE T, 1970, TETRAHEDRON, V26, P3271, DOI 10.1016/S0040-4020(01)92906-0; Ji NY, 2008, HELV CHIM ACTA, V91, P1940, DOI 10.1002/hlca.200890207; Ji NY, 2014, PHYTOCHEM REV, V13, P653, DOI 10.1007/s11101-013-9326-0; Khakimov B, 2015, PLANT J, V84, P478, DOI 10.1111/tpj.13012; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li YX, 2013, MOLECULES, V18, P7886, DOI 10.3390/molecules18077886; Lin YL, 2015, J NAT PROD, V78, P1556, DOI 10.1021/acs.jnatprod.5b00020; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Masse G, 2004, P NATL ACAD SCI USA, V101, P4413, DOI 10.1073/pnas.0400902101; Moses T, 2015, PLANT CELL, V27, P286, DOI 10.1105/tpc.114.134486; Moses T, 2014, P NATL ACAD SCI USA, V111, P1634, DOI 10.1073/pnas.1323369111; Nasir M, 2011, PHARMACOGN MAG, V7, P97, DOI 10.4103/0973-1296.80663; Pereira R. C., 2003, Braz. J. Biol., V63, P665, DOI 10.1590/S1519-69842003000400013; Sambamurty AVSS, 2005, A TXB ALGAE; Sawai S, 2014, PLANT CELL, V26, P3763, DOI 10.1105/tpc.114.130096; Schwender J, 2001, PLANTA, V212, P416, DOI 10.1007/s004250000409; Schwender J, 1997, FEBS LETT, V414, P129, DOI 10.1016/S0014-5793(97)01002-8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058833; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Thimmappa R, 2014, ANNU REV PLANT BIOL, V65, P225, DOI 10.1146/annurev-arplant-050312-120229; Vairappan CS, 2010, J APPL PHYCOL, V22, P305, DOI 10.1007/s10811-009-9460-7; Vairappan CS, 2004, PLANTA MED, V70, P1087, DOI 10.1055/s-2004-832653; Vairappan CS, 2001, PHYTOCHEMISTRY, V58, P291, DOI 10.1016/S0031-9422(01)00243-6; Wang BG, 2013, CHEM REV, V113, P3632, DOI 10.1021/cr9002215; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Yang DC, 2012, IEEE PES TRANSM DIST, V2012, P7, DOI [DOI 10.1371/J0URNAL.P0NE.0042076, DOI 10.1371/J0URNAL.P0NE.0033596]	58	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165954	10.1371/journal.pone.0165954	http://dx.doi.org/10.1371/journal.pone.0165954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832119	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000046
J	Fortuna, TM; Snirc, A; Badouin, H; Gouzy, J; Siguenza, S; Esquerre, D; Le Prieur, S; Shykoff, JA; Giraud, T				Fortuna, Taiadjana M.; Snirc, Alodie; Badouin, Helene; Gouzy, Jerome; Siguenza, Sophie; Esquerre, Diane; Le Prieur, Stephanie; Shykoff, Jacqui A.; Giraud, Tatiana			Polymorphic Microsatellite Markers for the Tetrapolar Anther-Smut Fungus Microbotryum saponariae Based on Genome Sequencing	PLOS ONE			English	Article							MATING-TYPE CHROMOSOMES; VIOLACEUM USTILAGO-VIOLACEA; WITHIN-HOST COMPETITION; SILENE-LATIFOLIA; POPULATION-STRUCTURE; LYCHNIDIS-DIOICAE; PATHOGEN; PLANT; DIVERGENCE; LOCI	Background Anther-smut fungi belonging to the genus Microbotryum sterilize their host plants by aborting ovaries and replacing pollen by fungal spores. Sibling Microbotryum species are highly specialized on their host plants and they have been widely used as models for studies of ecology and evolution of plant pathogenic fungi. However, most studies have focused, so far, on M. lychnidis-dioicae that parasitizes the white campion Silene latifolia. Microbotryum saponariae, parasitizing mainly Saponaria officinalis, is an interesting anther-smut fungus, since it belongs to a tetrapolar lineage (i.e., with two independently segregating mating-type loci), while most of the anther-smut Microbotryum fungi are bipolar (i.e., with a single mating-type locus). Saponaria officinalis is a widespread long-lived perennial plant species with multiple flowering stems, which makes its anther-smut pathogen a good model for studying phylogeography and within-host multiple infections. Principal Findings Here, based on a generated genome sequence of M. saponariae we developed 6 multiplexes with a total of 22 polymorphic microsatellite markers using an inexpensive and efficient method. We scored these markers in fungal individuals collected from 97 populations across Europe, and found that the number of their alleles ranged from 2 to 11, and their expected heterozygosity from 0.01 to 0.58. Cross-species amplification was examined using nine other Microbotryum species parasitizing hosts belonging to Silene, Dianthus and Knautia genera. All loci were successfully amplified in at least two other Microbotryum species. Significance These newly developed markers will provide insights into the population genetic structure and the occurrence of within-host multiple infections of M. saponariae. In addition, the draft genome of M. saponariae, as well as one of the described markers will be useful resources for studying the evolution of the breeding systems in the genus Microbotryum and the evolution of specialization onto different plant species.	[Fortuna, Taiadjana M.; Snirc, Alodie; Badouin, Helene; Le Prieur, Stephanie; Shykoff, Jacqui A.; Giraud, Tatiana] Univ Paris Saclay, Lab Ecol Systemat Evolut, Univ Paris Sud, CNRS,AgroParisTech, F-91400 Orsay, France; [Gouzy, Jerome; Siguenza, Sophie] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Gouzy, Jerome; Siguenza, Sophie] CNRS, LIPM, UMR2594, F-31326 Castanet Tolosan, France; [Esquerre, Diane] Univ Toulouse, INRA, INPT, GenPhySE,ENVT, F-31326 Castanet Tolosan, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Fortuna, TM (corresponding author), Univ Paris Saclay, Lab Ecol Systemat Evolut, Univ Paris Sud, CNRS,AgroParisTech, F-91400 Orsay, France.	taadjanafortuna@gmail.com	Gouzy, Jerome/AAH-4977-2020	Gouzy, Jerome/0000-0001-5695-4557; Giraud, Tatiana/0000-0002-2685-6478; Badouin, Helene/0000-0002-2456-5968	MULTIVIR [ANR-13-BSV7-0008]; Agence Nationale de Recherche; GenomeFun [309403]; European Reserach Council	MULTIVIR; Agence Nationale de Recherche(French National Research Agency (ANR)); GenomeFun; European Reserach Council	Funded by MULTIVIR ANR-13-BSV7-0008, Agence Nationale de Recherche, (JAS) and GenomeFun 309403, European Reserach Council, (TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonovics J, 2002, AM NAT, V160, pS40, DOI 10.1086/342143; Badouin H, 2015, GENETICS, V200, P1275, DOI 10.1534/genetics.115.177709; Bucheli E, 2000, J EVOLUTION BIOL, V13, P188, DOI 10.1046/j.1420-9101.2000.00160.x; Bucheli E, 2001, MOL ECOL, V10, P285, DOI 10.1046/j.1365-294x.2001.01146.x; Bueker B, 2016, MOL ECOL, V25, P811, DOI 10.1111/mec.13512; Cryer NC, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-3; DAY AW, 1968, GENET RES, V11, P63, DOI 10.1017/S0016672300011204; Devier B, 2009, GENETICS, V181, P209, DOI 10.1534/genetics.108.093708; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Fontaine MC, 2013, NEW PHYTOL, V198, P946, DOI 10.1111/nph.12177; Fontanillas E, 2015, MOL BIOL EVOL, V32, P928, DOI 10.1093/molbev/msu396; Garber ED, 2002, ADV APPL MICROBIOL, V51, P107, DOI 10.1016/S0065-2164(02)51003-0; Giraud T, 2008, MOL ECOL RESOUR, V8, P387, DOI 10.1111/j.1471-8286.2007.01967.x; Giraud T, 2004, HEREDITY, V93, P559, DOI 10.1038/sj.hdy.6800554; Giraud T, 2005, INT J PLANT SCI, V166, P649, DOI 10.1086/430098; Giraud T, 2002, MOL ECOL NOTES, V2, P142, DOI 10.1046/j.1471-8286.2002.00172.x; Gladieux P, 2015, MOL ECOL, V24, P1969, DOI 10.1111/mec.13028; Gladieux P, 2014, MOL ECOL, V23, P753, DOI 10.1111/mec.12631; Gladieux P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P59, DOI 10.1016/B978-0-12-384890-1.00004-2; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; Hood ME, 2000, HEREDITY, V85, P231, DOI 10.1046/j.1365-2540.2000.00748.x; Hood ME, 2002, GENETICS, V160, P457; Hood ME, 2015, EVOLUTION, V69, P2561, DOI 10.1111/evo.12765; Hood ME, 2013, GENETICS, V193, P309, DOI 10.1534/genetics.112.146266; Hood ME, 2010, NEW PHYTOL, V187, P217, DOI 10.1111/j.1469-8137.2010.03268.x; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kemler M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-35; Kemler M, 2009, SYST BIODIVERS, V7, P297, DOI 10.1017/S1477200009990028; Kniep H, 1919, Z BOT, V11, P257; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Lutz Matthias, 2005, Mycological Progress, V4, P225, DOI 10.1007/s11557-006-0126-4; Lutz M, 2008, MYCOL RES, V112, P1280, DOI 10.1016/j.mycres.2008.04.010; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nieuwenhuis BPS, 2013, HEREDITY, V111, P445, DOI 10.1038/hdy.2013.67; Perlin MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1660-8; POON NH, 1976, CAN J MICROBIOL, V22, P495, DOI 10.1139/m76-076; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Refregier G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-100; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Thrall PH, 1995, AM NAT, V73, pS1249; Tollenaere C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052492; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vercken E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001229; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu L, 2016, HEREDITY, V116, P44, DOI 10.1038/hdy.2015.68	51	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165656	10.1371/journal.pone.0165656	http://dx.doi.org/10.1371/journal.pone.0165656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832131	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000022
J	Jonkers, ART; Sharkey, KJ				Jonkers, Art R. T.; Sharkey, Kieran J.			The Differential Warming Response of Britain's Rivers (1982-2011)	PLOS ONE			English	Article							SALMON SALMO-SALAR; CLIMATE-CHANGE; WATER TEMPERATURE; CHINOOK SALMON; FRESH-WATER; STREAM; FISH; VARIABILITY; POPULATIONS; IMPACTS	River water temperature is a hydrological feature primarily controlled by topographical, meteorological, climatological, and anthropogenic factors. For Britain, the study of freshwater temperatures has focussed mainly on observations made in England and Wales; similar comprehensive data sets for Scotland are currently unavailable. Here we present a model for the whole of mainland Britain over three recent decades (1982-2011) that incorporates geographical extrapolation to Scotland. The model estimates daily mean freshwater temperature for every river segment and for any day in the studied period, based upon physico-geographical features, daily mean air and sea temperatures, and available freshwater temperature measurements. We also extrapolate the model temporally to predict future warming of Britain's rivers given current observed trends. Our results highlight the spatial and temporal diversity of British freshwater temperatures and warming rates. Over the studied period, Britain's rivers had a mean temperature of 9.84 degrees C and experienced a mean warming of +0.22 degrees C per decade, with lower rates for segments near lakes and in coastal regions. Model results indicate April as the fastest-warming month (+0.63 degrees C per decade on average), and show that most rivers spend on average ever more days of the year at temperatures exceeding 10 degrees C, a critical threshold for several fish pathogens. Our results also identify exceptional warming in parts of the Scottish Highlands (in April and September) and pervasive cooling episodes, in December throughout Britain and in July in the southwest of England (in Wales, Cornwall, Devon, and Dorset). This regional heterogeneity in rates of change has ramifications for current and future water quality, aquatic ecosystems, as well as for the spread of waterborne diseases.	[Jonkers, Art R. T.; Sharkey, Kieran J.] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England; [Jonkers, Art R. T.] Westfalische Wilhelms Univ, Inst Geophys, Munster, Germany	University of Liverpool; University of Munster	Jonkers, ART (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England.; Jonkers, ART (corresponding author), Westfalische Wilhelms Univ, Inst Geophys, Munster, Germany.	jonkers@earth.uni-muenster.de		Sharkey, Kieran/0000-0002-7210-9246	BBSRC/NERC [BB/M026434/1]; Biotechnology and Biological Sciences Research Council [BB/M026434/1] Funding Source: researchfish; BBSRC [BB/M026434/1] Funding Source: UKRI	BBSRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC/NERC grant reference BB/M026434/1. URL: http://www.bbsrc.ac.uk/innovation/collaboration/collaborative-programmes/uk-aquaculture-initiative/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell A, 2014, ENERG ECON, V46, P510, DOI 10.1016/j.eneco.2013.12.016; Broadmeadow SB, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1354; Brown LE, 2008, HYDROL PROCESS, V22, P954, DOI 10.1002/hyp.6982; Buchan J, 2014, MON WEATHER REV, V142, P922, DOI 10.1175/MWR-D-13-00104.1; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Chen Z, 2013, CAN J ZOOL, V91, P265, DOI 10.1139/cjz-2012-0300; Cianfrani C, 2015, ECOL MODEL, V313, P1, DOI 10.1016/j.ecolmodel.2015.06.023; Des Clers S, 2010, SR070035 UK ENV AG; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Elliott JM, 2010, J FISH BIOL, V77, P1793, DOI 10.1111/j.1095-8649.2010.02762.x; Garner G, 2014, HYDROL PROCESS, V28, P5583, DOI 10.1002/hyp.9992; Graham DA, 2008, J FISH DIS, V31, P859, DOI 10.1111/j.1365-2761.2008.00946.x; Gurney WSC, 2008, CAN J FISH AQUAT SCI, V65, P2606, DOI 10.1139/F08-149; Hammond D, 2007, SC060017SR UK ENV AG; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Hawley LM, 2008, DIS AQUAT ORGAN, V82, P171, DOI 10.3354/dao01998; Hrachowitz M, 2010, HYDROL PROCESS, V24, P3374, DOI 10.1002/hyp.7756; Jenkins GJ, 2008, UKCP09 MET OFF HADL; Jeppesen E, 2012, HYDROBIOLOGIA, V694, P1, DOI 10.1007/s10750-012-1182-1; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Keery J, 2007, J HYDROL, V336, P1, DOI 10.1016/j.jhydrol.2006.12.003; Lisi PJ, 2015, GEOPHYS RES LETT, V42, P3380, DOI 10.1002/2015GL064083; Malcolm IA, 2008, HYDROL PROCESS, V22, P968, DOI 10.1002/hyp.6996; Mantua NJ, 2015, NAT CLIM CHANGE, V5, P613, DOI 10.1038/nclimate2670; Marcos-Lopez M, 2010, TRANSBOUND EMERG DIS, V57, P293, DOI 10.1111/j.1865-1682.2010.01150.x; Moore A, 2012, FISHERIES MANAG ECOL, V19, P518, DOI 10.1111/j.1365-2400.2011.00833.x; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P615, DOI 10.1038/nclimate2671; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P163, DOI 10.1038/NCLIMATE2473; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Okamura B, 2011, FRESHWATER BIOL, V56, P735, DOI 10.1111/j.1365-2427.2010.02465.x; Orr H. G., 2010, ROLE HYDROLOGY MANAG; Orr HG, 2015, HYDROL PROCESS, V29, P752, DOI 10.1002/hyp.10181; Pletterbauer F, 2015, HYDROBIOLOGIA, V744, P235, DOI 10.1007/s10750-014-2079-y; Quigley JT, 2006, J THERM BIOL, V31, P429, DOI 10.1016/j.jtherbio.2006.02.003; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Salama NKG, 2013, AQUACULT ENV INTERAC, V4, P91, DOI 10.3354/aei00077; Segura C, 2015, HYDROL PROCESS, V29, P2178, DOI 10.1002/hyp.10357; Solomon DJ, 2008, SCHO0808BOLVEP UK EN; Thrush MA, 2013, TRANSBOUND EMERG DIS, V60, P460, DOI 10.1111/j.1865-1682.2012.01368.x; van Vliet MTH, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009198; van Vliet MTH, 2013, GLOBAL ENVIRON CHANG, V23, P450, DOI 10.1016/j.gloenvcha.2012.11.002; VHSV Expert Panel & Working Grp, 2010, PREV VET MED, V94, P128, DOI 10.1016/j.prevetmed.2009.11.020; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Webb BW, 2007, HYDROLOG SCI J, V52, P74, DOI 10.1623/hysj.52.1.74; Webb BW, 1996, HYDROL PROCESS, V10, P205, DOI 10.1002/(SICI)1099-1085(199602)10:2&lt;205::AID-HYP358&gt;3.0.CO;2-1; Wehrly KE, 2007, T AM FISH SOC, V136, P365, DOI 10.1577/T06-163.1; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101	49	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166247	10.1371/journal.pone.0166247	http://dx.doi.org/10.1371/journal.pone.0166247			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832108	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000083
J	Kim, N; Choi, J; Kim, S; Gwon, YD; Cho, Y; Yang, JM; Oh, YK; Kim, YB				Kim, Nayoung; Choi, Jiwon; Kim, Sehyun; Gwon, Yong-Dae; Cho, Yeondong; Yang, Jae Myung; Oh, Yu-Kyoung; Kim, Young Bong			Transmission of Porcine Endogenous Retrovirus Produced from Different Recipient Cells In Vivo	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; ISLET XENOTRANSPLANTATION; INFECTION; EXPRESSION; VIRUS; PERV; VITRO; PIGS	Humanized pigs have been developed to reduce the incidence of immune rejection in xeno-transplantation, but significant concerns remain, such as transmission of viral zoonosis. Porcine endogenous retroviruses (PERV), which exist in the genome of pigs, are produced as infectious virions from all porcine cells and cause zoonosis. Here, we examined the possibility of zoonosis of hosts under conditions of immune suppression or xenotransplantation of cells producing host-adapted viruses. Upon transplantation of PERV-producing porcine cells into mice, no transmission of PERV was detected, whereas, transmission of PERV from mice transplanted with mouse-adapted PERV-producing cells was detected. In addition, the frequency of PERV transmission was increased in CsA treated mice transplanted with PERV-producing murine cells, compared with PERV-producing porcine cells. Transmission of PERV to host animals did not affect weight but immune responses, in particular, the number of T cells from PERV-transmitted mice, were notably reduced. The observed risk of PERV zoonosis highlights the requirement for thorough evaluation of viral zoonosis under particular host conditions, such as immunosuppressive treatment and transplantation with host-adapted virus-producing cells.	[Kim, Nayoung; Yang, Jae Myung] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Choi, Jiwon; Kim, Sehyun; Gwon, Yong-Dae; Cho, Yeondong; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea; [Oh, Yu-Kyoung] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Oh, Yu-Kyoung] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea	Sogang University; Konkuk University; Seoul National University (SNU); Seoul National University (SNU)	Kim, YB (corresponding author), Konkuk Univ, Dept Bioind Technol, Seoul, South Korea.	kimera@konkuk.ac.kr	Oh, Yu Kyoung/G-8754-2013	Gwon, Yong-Dae/0000-0002-0703-4188; Oh, Yu-Kyoung/0000-0002-0969-3339	Konkuk University	Konkuk University	This work was supported by the Konkuk University in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Konkuk University in 2015.	Atluri VSR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00212; Bach FH, 1998, ANNU REV MED, V49, P301; BACH FH, 1995, NAT MED, V1, P869, DOI 10.1038/nm0995-869; Bertera S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/856386; Bertin J, 2014, VIROLOGY, V454, P128, DOI 10.1016/j.virol.2014.02.007; Blusch JH, 2002, XENOTRANSPLANTATION, V9, P242, DOI 10.1034/j.1399-3089.2002.01110.x; Boneva RS, 2001, CLIN MICROBIOL REV, V14, P1, DOI 10.1128/CMR.14.1.1-14.2001; Cooper DKC, 2000, J HEART LUNG TRANSPL, V19, P1125, DOI 10.1016/S1053-2498(00)00224-2; Deng YM, 2000, TRANSPLANTATION, V70, P1010, DOI 10.1097/00007890-200010150-00004; Di Nicuolo G, 2005, XENOTRANSPLANTATION, V12, P286, DOI 10.1111/j.1399-3089.2005.00226.x; Dorling A, 1997, LANCET, V349, P867, DOI 10.1016/S0140-6736(96)09404-4; Dufrane D, 2012, TRANSPLANT REV-ORLAN, V26, P183, DOI 10.1016/j.trre.2011.07.004; Gunzburg WH, 2000, MOL MED TODAY, V6, P199, DOI 10.1016/S1357-4310(00)01708-1; Hermida-Prieto M, 2007, TRANSPLANTATION, V84, P548, DOI 10.1097/01.tp.0000275203.91841.23; Karlas A, 2010, ANN TRANSPL, V15, P45; Kim NY, 2009, VIRUS GENES, V39, P210, DOI 10.1007/s11262-009-0377-7; Koch KS, 2006, IMMUNOLOGY, V119, P98, DOI 10.1111/j.1365-2567.2006.02412.x; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee Jung Eun, 2009, Journal of Bacteriology and Virology, V39, P137; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Martin U, 1998, LANCET, V352, P692, DOI 10.1016/S0140-6736(98)07144-X; Martina Y, 2006, J VIROL, V80, P3135, DOI 10.1128/JVI.80.7.3135-3146.2006; Martina Y, 2005, AM J TRANSPLANT, V5, P1837, DOI 10.1111/j.1600-6143.2005.00978.x; Mendoza R, 2011, J VIROL, V85, P9247, DOI 10.1128/JVI.05137-11; Pal N, 2011, TRANSBOUND EMERG DIS, V58, P344, DOI 10.1111/j.1865-1682.2011.01210.x; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Popp SK, 2007, IMMUNOL CELL BIOL, V85, P238, DOI 10.1038/sj.icb.7100028; Sakuma K, 2005, ACTA NEUROPATHOL, V110, P269, DOI 10.1007/s00401-005-1049-x; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Scheef G, 2001, J VIROL, V75, P6933, DOI 10.1128/JVI.75.15.6933-6940.2001; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998; Yang YG, 2004, J CLIN INVEST, V114, P695, DOI 10.1172/JCI200421946; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165156	10.1371/journal.pone.0165156	http://dx.doi.org/10.1371/journal.pone.0165156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832080	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000011
J	Choi, EPH; Wong, JYH; Lo, HHM; Wong, W; Chio, JHM; Fong, DYT				Choi, Edmond Pui-Hang; Wong, Janet Yuen-Ha; Lo, Herman Hay-Ming; Wong, Wendy; Chio, Jasmine Hin-Man; Fong, Daniel Yee-Tak			The Impacts of Using Smartphone Dating Applications on Sexual Risk Behaviours in College Students in Hong Kong	PLOS ONE			English	Article							LOS-ANGELES; ORAL SEX; INTERNET; MEN; GAY; TRANSMISSION; HEALTH; APPS	Dating applications (apps) on smartphones have become increasingly popular. The aim of this study was to explore the association between the use of dating apps and risky sexual behaviours. Data were collected in four university campuses in Hong Kong. Subjects completed a structured questionnaire asking about the use of dating apps, sexual behaviours, and sociodemographics. Multiple linear and logistics regressions were used to explore factors associated with sexual risk behaviours. Six hundred sixty-six subjects were included in the data analysis. Factors associated with having unprotected sexual intercourse with more lifetime sexual partners included use of dating apps (beta = 0.93, p<0.01), having one's first sexual intercourse before 16 years of age (beta = 1.74, p< 0.01), being older (beta = 0.4, p< 0.01), currently being in a relationship (= 0.69, p< 0.05), having a monthly income at least HKD $5,000 (beta = 1.34, p< 0.01), being a current smoker (beta = 1.52, p< 0.01), and being a current drinker (beta=0.7, p< 0.01). The results of a multiple logistic regression analysis found that users of dating apps (adjust odds ratio: 0.52, p< 0.05) and current drinkers (adjust odds ratio: 0.40, p< 0.01) were less likely to have consistent condom use. Users of dating apps (adjust odds ratio: 1.93, p< 0.05), bisexual/homosexual subjects (adjust odds ratio: 2.57, p< 0.01) and female subjects (adjust odds ratio: 2.00, p< 0.05) were more likely not to have used condoms the last time they had sexual intercourse. The present study found a robust association between using dating apps and sexual risk behaviours, suggesting that app users had greater sexual risks. Interventions that can target app users so that they can stay safe when seeking sexual partners through dating apps should be developed.	[Choi, Edmond Pui-Hang; Wong, Janet Yuen-Ha; Fong, Daniel Yee-Tak] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Lo, Herman Hay-Ming] Hong Kong Polytech Univ, Dept Appl Social Sci, Hong Kong, Hong Kong, Peoples R China; [Wong, Wendy] Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Wendy] Chinese Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Chio, Jasmine Hin-Man] Hong Kong Shue Yan Univ, Dept Counselling & Psychol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Hong Kong Polytechnic University; Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Shue Yan University	Wong, JYH (corresponding author), Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	janetyh@hku.hk	Choi, Edmond/H-4187-2019; Wong, Janet Yuen Ha/F-4433-2011; Fong, Daniel YT/C-4269-2009; Choi, Edmond/HDN-8462-2022; Wong, Wendy/H-3939-2016; Chio, Jasmine/ABD-5351-2020; Konrad, Kerstin/H-7747-2013	Choi, Edmond/0000-0001-9062-3540; Wong, Janet Yuen Ha/0000-0002-3000-4577; Fong, Daniel YT/0000-0001-7365-9146; Wong, Wendy/0000-0001-8731-0498; LO, Hay Ming Herman/0000-0002-5053-6837; Konrad, Kerstin/0000-0001-9039-2615; CHIO, Jasmine H.M./0000-0002-9467-6129	Small Project Funding [201309176196]; University of Hong Kong	Small Project Funding; University of Hong Kong(University of Hong Kong)	This study was supported by the Small Project Funding (201309176196), the University of Hong Kong.	Benotsch EG, 2013, J ADOLESCENT HEALTH, V52, P307, DOI 10.1016/j.jadohealth.2012.06.011; Besoain F, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0010-z; Beymer MR, 2014, SEX TRANSM INFECT, V90, P567, DOI 10.1136/sextrans-2013-051494; Breyer BN, 2010, J SEX MED, V7, P2391, DOI 10.1111/j.1743-6109.2010.01794.x; Carey MP, 1997, COMMUNITY MENT HLT J, V33, P133, DOI 10.1023/A:1022423417304; Cherry A. L., 2014, INT HDB ADOLESCENT P; Chiasson MA, 2006, J URBAN HEALTH, V83, P73, DOI 10.1007/s11524-005-9008-3; Coker TR, 2010, ANNU REV PUBL HEALTH, V31, P457, DOI 10.1146/annurev.publhealth.012809.103636; Cooper A, 2002, J SEX MARITAL THER, V28, P105, DOI 10.1080/00926230252851861; Couch D, 2008, QUAL HEALTH RES, V18, P268, DOI 10.1177/1049732307312832; Daneback K, 2007, CYBERPSYCHOL BEHAV, V10, P100, DOI 10.1089/cpb.2006.9986; Doring NM, 2009, COMPUT HUM BEHAV, V25, P1089, DOI 10.1016/j.chb.2009.04.003; Downing MJ, 2012, AM J MENS HEALTH, V6, P18, DOI 10.1177/1557988311407906; Edwards S, 1998, SEX TRANSM INFECT, V74, P6, DOI 10.1136/sti.74.1.6; Edwards S, 1998, SEX TRANSM INFECT, V74, P95, DOI 10.1136/sti.74.2.95; Finer LB, 1999, FAM PLANN PERSPECT, V31, P228, DOI 10.2307/2991570; Goodenow C, 2006, PSYCHOL SCHOOLS, V43, P573, DOI 10.1002/pits.20173; Grosskopf NA, 2014, AM J MENS HEALTH, V8, P510, DOI 10.1177/1557988314527311; Grov C, 2007, AIDS BEHAV, V11, P527, DOI 10.1007/s10461-007-9234-7; Holloway Ian W, 2015, AIDS Behav, V19 Suppl 2, P112, DOI 10.1007/s10461-014-0989-3; Howard DE, 2004, AM J HEALTH BEHAV, V28, P3, DOI 10.5993/AJHB.28.1.1; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; Lehmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086603; Ma QQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-111; Miller B, 2015, COMPUT HUM BEHAV, V51, P476, DOI 10.1016/j.chb.2015.05.023; Nahom D, 2001, J SCHOOL HEALTH, V71, P153, DOI 10.1111/j.1746-1561.2001.tb01314.x; O'Donnell L, 2001, FAM PLANN PERSPECT, V33, P268, DOI 10.2307/3030194; Poon MKL, 2005, ETHNIC HEALTH, V10, P145, DOI 10.1080/13557850500071202; Valois RF, 1999, J ADOLESCENT HEALTH, V25, P328, DOI 10.1016/S1054-139X(99)00051-8	31	40	43	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165394	10.1371/journal.pone.0165394	http://dx.doi.org/10.1371/journal.pone.0165394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27828997	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300042
J	Johnson, ML; Saffrey, MJ; Taylor, VJ				Johnson, Michelle L.; Saffrey, M. Jill; Taylor, Victoria J.			Plasma Ghrelin Concentrations Were Altered with Oestrous Cycle Stage and Increasing Age in Reproductively Competent Wistar Females	PLOS ONE			English	Article							MESSENGER-RNA; RATS; EXPRESSION; ESTRADIOL; APPETITE; STOMACH	Changes in appetite occur during the ovarian cycle in female mammals. Research on appetite -regulatory gastrointestinal peptides in females is limited, because reproductive changes in steroid hormones present additional experimental factors to control for. This study aimed to explore possible changes in the orexigenic (appetite-stimulating) gastrointestinal peptide hormone ghrelin during the rodent oestrous cycle. Fed and fasted plasma and stomach tissue samples were taken from female Wistar rats (32-44 weeks of age) at each stage of the oestrous cycle for total ghrelin quantification using radioimmunoassay. Sampling occurred during the dark phase when most eating takes place in rats. Statistical analysis was by paired-samples t-test, one-way ANOVA on normally distributed data, with Tukey post-hoc tests, or Kruskal-Wallis if not. GLM univariate analysis was used to assess main effects and interactions in ghrelin concentrations in the fed or fasted state and during different stages of the ovarian cycle, with age as a covariate. No consistent fed to fasted ghrelin increases were measured in matched plasma samples from the same animals, contrary to expectations. Total ghrelin concentrations did not significantly change between cycle stages with ANOVA, in either fed or fasted plasma or in stomach tissue. This was despite significantly decreased fasted stomach contents at oestrus (P= 0.028), suggesting decreased food intake. There was however a significant interaction in ghrelin plasma concentrations between fed and fasted proestrus rats and a direct effect of age with rats over 37 weeks old having lower circulating concentrations of ghrelin in both fed and fasted states. The biological implications of altered ghrelin plasma concentrations from 37 weeks of age are as yet unknown, but warrant further investigation. Exploring peripheral ghrelin regulatory factor changes with increasing age in reproductively competent females may bring to light potential effects on offspring development and nutritional metabolic programming.	[Johnson, Michelle L.; Saffrey, M. Jill; Taylor, Victoria J.] Open Univ, Sch Life Hlth & Chem Sci, Fac Sci Technol Engn & Math, Milton Keynes, Bucks, England; [Johnson, Michelle L.] Univ Leeds, Leeds Inst Canc & Pathol, Fac Med & Hlth, Leeds, W Yorkshire, England	Open University - UK; University of Leeds	Taylor, VJ (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Fac Sci Technol Engn & Math, Milton Keynes, Bucks, England.	vicky.taylor@open.ac.uk	Taylor, Victoria Jane/AAE-2568-2021	Taylor, Victoria Jane/0000-0001-9864-4979; Johnson, Michelle/0000-0002-6252-610X	Department of Life, Health and Chemical Sciences (LHCS), The Open University	Department of Life, Health and Chemical Sciences (LHCS), The Open University	This work was funded by the Department of Life, Health and Chemical Sciences (LHCS), The Open University. The Open University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Butera PC, 2010, PHYSIOL BEHAV, V99, P175, DOI 10.1016/j.physbeh.2009.06.010; Clegg DJ, 2007, DIABETES, V56, P1051, DOI 10.2337/db06-0015; Dye L, 1997, HUM REPROD, V12, P1142; Eckel LA, 2000, PHYSIOL BEHAV, V70, P397, DOI 10.1016/S0031-9384(00)00278-X; Fang FG, 2012, SYST BIOL REPROD MED, V58, P116, DOI 10.3109/19396368.2011.637607; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Martin JR, 2011, ENDOCRINOLOGY, V152, P2060, DOI 10.1210/en.2010-1485; Sakata I, 2006, J ENDOCRINOL, V190, P749, DOI 10.1677/joe.1.06808; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Slupecka M, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/5739763; Spivak H, 2012, SURG ENDOSC, V26, P1909, DOI 10.1007/s00464-011-2125-z; Stengel A, 2009, ENDOCRINOLOGY, V150, P5113, DOI 10.1210/en.2009-0697; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; WHO, OB OV 2015; Zhao Z, 2008, J ENDOCRINOL, V196, P529, DOI 10.1677/JOE-07-0300	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166229	10.1371/journal.pone.0166229	http://dx.doi.org/10.1371/journal.pone.0166229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829021	Green Accepted, Green Published, gold			2022-12-27	WOS:000387724300097
J	Labandeira, CC; Kustatscher, E; Wappler, T				Labandeira, Conrad C.; Kustatscher, Evelyn; Wappler, Torsten			Floral Assemblages and Patterns of Insect Herbivory during the Permian to Triassic of Northeastern Italy	PLOS ONE			English	Article							PRA-DELLA-VACCA; FOREST-NATIONAL-PARK; NORTH-CENTRAL TEXAS; PLANT-ARTHROPOD INTERACTIONS; NEW-SOUTH-WALES; COAL MEASURES; SEED-FERNS; TREE FERN; MIDDLE; DOLOMITES	To discern the effect of the end-Permian (P-Tr) ecological crisis on land, interactions between plants and their insect herbivores were examined for four time intervals containing ten major floras from the Dolomites of northeastern Italy during a Permian-Triassic interval. These floras are: (i) the Kungurian Tregiovo Flora; (ii) the Wuchiapingian Bletterbach Flora; (iii) three Anisian floras; and (iv) five Ladinian floras. Derived plant-insect interactional data is based on 4242 plant specimens (1995 Permian, 2247 Triassic) allocated to 86 fossil taxa (32 Permian, 56 Triassic), representing lycophytes, sphenophytes, pteridophytes, pterido-sperms, ginkgophytes, cycadophytes and coniferophytes from 37 million-year interval (23 m. yr. Permian, 14 m. yr. Triassic). Major Kungurian herbivorized plants were unaffiliated taxa and pteridosperms; later during the Wuchiapingian cycadophytes were predominantly consumed. For the Anisian, pteridosperms and cycadophytes were preferentially consumed, and subordinately pteridophytes, lycophytes and conifers. Ladinian herbivores overwhelming targeted pteridosperms and subordinately cycadophytes and conifers. Throughout the interval the percentage of insect-damaged leaves in bulk floras, as a proportion of total leaves examined, varied from 3.6% for the Kungurian (N = 464 leaves), 1.95% for the Wuchiapingian (N = 1531), 11.65% for the pooled Anisian (N = 1324), to 10.72% for the pooled Ladinian (N = 923), documenting an overall herbivory rise. The percentage of generalized consumption, equivalent to external foliage feeding, consistently exceeded the level of specialized consumption from internal feeding. Generalized damage ranged from 73.6% (Kungurian) of all feeding damage, to 79% (Wuchiapingian), 65.5% (pooled Anisian) and 73.2% (pooled Ladinian). Generalized-to-specialized ratios show minimal change through the interval, although herbivore component community structure (herbivore species feeding on a single plant-host species) increasingly was partitioned from Wuchiapingian to Ladinian. The Paleozoic plant with the richest herbivore component community, the coniferophyte Pseudovoltzia liebeana, harbored four damage types (DTs), whereas its Triassic parallel, the pteridosperm Scytophyllum bergeri housed 11 DTs, almost four times that of P. liebeana. Although generalized DTs of P. liebeana were similar to S. bergeri, there was expansion of Triassic specialized feeding types, including leaf mining. Permian-Triassic generalized herbivory remained relatively constant, but specialized herbivores more finely partitioned plant- host tissues via new feeding modes, especially in the Anisian. Insect-damaged leaf percentages for Dolomites Kungurian and Wuchiapingian floras were similar to those of lower Permian, north-central Texas, but only one-third that of southeastern Brazil. Global herbivore patterns for Early Triassic plant-insect interactions remain unknown.	[Labandeira, Conrad C.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Labandeira, Conrad C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Labandeira, Conrad C.] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Kustatscher, Evelyn] Museum Nat South Tyrol, Bindergasse 1, I-39100 Bozen Bolzano, Italy; [Kustatscher, Evelyn] Ludwig Maximilians Univ & Bayer Staatssammlung Pa, Dept Geo & Umweltwissensch, Palaontol & Geobiol, Richard Wagner Str 10, D-80333 Munich, Germany; [Wappler, Torsten] Univ Bonn, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany	Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Capital Normal University; University of Munich; University of Bonn	Wappler, T (corresponding author), Univ Bonn, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany.	twappler@uni-bonn.de	Wappler, Torsten/P-6831-2019; Kustatscher, Evelyn/I-3085-2019	Wappler, Torsten/0000-0003-1592-0988; 	Deutsche Forschungsgemeinschaft (DFG) [WA 1496/8-1]; Promotion of Educational Policies, University; Research Department of the Autonomous Province of Bolzano-South Tyrol; Euregio Tirol-SiAtirol-Trentino Science Fund	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Promotion of Educational Policies, University; Research Department of the Autonomous Province of Bolzano-South Tyrol; Euregio Tirol-SiAtirol-Trentino Science Fund	This research was possible thanks to grants of the Deutsche Forschungsgemeinschaft (DFG, Heisenberg grant WA 1496/8-1) to TW. The study of the material has been partly carried out within the project "The Permian-Triassic ecological crisis in the Dolomites: extinction and recovery dynamics in Terrestrial Ecosystems" financed by the Promotion of Educational Policies, University and Research Department of the Autonomous Province of Bolzano-South Tyrol and by the "The end-Permian mass extinction in the Southern and Eastern Alps: extinction rates vs taphonomic biases in different depositional environments" financed by the Euregio Tirol-SiAtirol-Trentino Science Fund.	Adami-Rodrigues K, 2008, SIMPOSIO BRASILEIRO, V12, P1; Adami-Rodrigues Karen, 2004, Fossils and Strata, V51, P106; Adami-Rodrigues Karen, 2004, Revista Brasileira de Paleontologia, V7, P93; Anderson JM, 2016, EVOL STUD I IN PRESS, V1; [Anonymous], 1997, J AUST GEOL GEOPHYS; Araya Jaime E., 2000, Boletin de Sanidad Vegetal Plagas, V26, P65; Aristov DS, 2013, PALEONTOL J+, V47, P641, DOI 10.1134/S0031030113070010; Ash S, 1996, LETHAIA, V29, P237, DOI 10.1111/j.1502-3931.1996.tb01657.x; Ash S, 1999, INT J PLANT SCI, V160, P208, DOI 10.1086/314115; Ash S, 2000, J PALEONTOL, V74, P1065, DOI 10.1666/0022-3360(2000)074<1065:EOOMHI>2.0.CO;2; ASH S R, 1972, Palaeontology (Oxford), V15, P598; Ash Sidney, 2005, Paleobios, V25, P17; Ash S, 2009, PALAEONTOGR ABT B, V282, P1; Ash SR, 2004, IAWA J, V25, P349, DOI 10.1163/22941932-90000371; Avanzini M., 2004, STUD TRENT SCI NAT A, V79, P1; Avanzini M, 2011, EARTH AND ENVIRONMENTAL SCIENCES, P591; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Banerjee M, 1988, IND BIOL, V30, P58; Bauer K, 2014, RIV ITAL PALEONTOL S, V120, P271, DOI 10.13130/2039-4942/6071; Beattie R, 2007, AFR INVERTEBR, V48, P41; Beck AL, 1998, PALAEOGEOGR PALAEOCL, V142, P139, DOI 10.1016/S0031-0182(98)00060-1; Bethoux O, 2008, J IBER GEOL, V34, P109; Blanckenhorn M., 1885, PALAEONTOGRAPHICA, V32, P117; CALANCHI N, 1978, TSCHER MINER PETROG, V25, P131, DOI 10.1007/BF01082858; Calanchi N, 1977, MINEROLOGICA PETROGR, V21, P221; Cariglino B, 2011, AMEGHINIANA, V48, P103, DOI 10.5710/AMGH.v48i1(321); Carpenter FM, 1969, P 1 N AM PAL CONV CH, V2, P1236; Cassinis G., 1999, FIELD TRIP GUID INT; Cassinis G, 2012, INT J EARTH SCI, V101, P129, DOI 10.1007/s00531-011-0642-6; CEOLONI P, 1988, Z GEOL WISSENSCHAFT, V16, P895; CHALONER WG, 1991, PHILOS T ROY SOC B, V333, P177, DOI 10.1098/rstb.1991.0066; CHAUHAN D K, 1985, Bionature, V5, P5; Clement-Westerhof J.A, 1986, FORSCHUNGSINSTITUT S, V86, P89; CLEMENTW.JA, 1974, REV PALAEOBOT PALYNO, V17, P63, DOI 10.1016/0034-6667(74)90092-X; CLEMENTWESTERHOF JA, 1984, REV PALAEOBOT PALYNO, V41, P51, DOI 10.1016/0034-6667(84)90043-5; CLEMENTWESTERHOF JA, 1987, REV PALAEOBOT PALYNO, V52, P375, DOI 10.1016/0034-6667(87)90066-2; Conti M. A., 1975, MEMORIE GEOPALEONTOL, V3, P141; Conti MA, 1977, PALAEONTOGR ITAL, V70, P1; Conti MA, 1979, MEM SOC GEOL ITAL, V20, P357; Creber GT, 2004, PALAEONTOLOGY, V47, P21, DOI 10.1111/j.0031-0239.2004.00345.x; D'Rozario A, 2011, PALAEOGEOGR PALAEOCL, V306, P127, DOI 10.1016/j.palaeo.2011.04.009; Pinheiro ERD, 2012, REV PALAEOBOT PALYNO, V174, P113, DOI 10.1016/j.revpalbo.2012.01.002; De Zanche V., 1993, MEM SCI GEOL, V45, P1; Delfrati L., 2000, CARTA GEOLOGICA DITA, V3, P89; DEZANCHE V, 1992, ECLOGAE GEOL HELV, V85, P127; ECALE CL, 1995, ENTOMOL EXP APPL, V77, P121, DOI 10.1007/BF02383025; Erwin D. H., 2006, EXTINCTION LIFE EART; Feng Z, 2014, GEOLOGY, V42, P407, DOI 10.1130/G35369.1; Feng Z, 2010, PALAEOGEOGR PALAEOCL, V288, P54, DOI 10.1016/j.palaeo.2010.01.035; Fischer TC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-337; Florin, 1945, PALAEONTOGR ABT B, V85, P1, DOI [10.1515/9783111561752-001, DOI 10.1515/9783111561752-001]; Fois E., 1984, Palaeontographica Americana, P191; Frentzen K., 1933, PALAEONTOL Z, V15, P30; Gallego J, 2014, GEOBIOS-LYON, V47, P101, DOI 10.1016/j.geobios.2014.01.002; Gallego O., 2003, COMUNICACIONES CIENT; Gastaldo RA, 2005, PALAIOS, V20, P479, DOI 10.2110/palo.2004.P04-62; Geyer G., 1987, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V174, P331; Ghosh AK, 2015, ALCHERINGA, V39, P92, DOI 10.1080/03115518.2015.958285; Gianolla P, 1999, THESIS; Glasspool I, 2003, REV PALAEOBOT PALYNO, V127, P125, DOI 10.1016/S0034-6667(03)00107-6; Gnaedinger SC, 2014, GEOBIOS-LYON, V47, P221, DOI 10.1016/j.geobios.2014.06.003; Goth Kurt, 1992, Senckenbergiana Lethaea, V72, P1; Grauvogel-Stamm Lea, 1996, Paleontologia Lombarda, V5, P5; Guerra-Sommer M, FITOFAGIA GLOSSOPTER; Hering EM, 1951, BIOL LEAF MINERS; Hilton J, 2002, REV PALAEOBOT PALYNO, V120, P301, DOI 10.1016/S0034-6667(02)00084-2; Hilton J, 2001, PALAEONTOLOGY, V44, P811, DOI 10.1111/1475-4983.00202; Hoernes R., 1912, SITZUNGSBERICHTE KON, V121, P3; Holmes W. B. K., 1995, GLOBAL ENV DIVERSIFI, P123; Holmes WBK, 2003, P LINN SOC N S W, V124, P53; Hudspith V, 2012, INT J COAL GEOL, V89, P13, DOI 10.1016/j.coal.2011.07.009; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Isaias R.M.S., 2014, NEOTROPICAL INSECT G, P51; Italian International Geological Correlation Program Project 203 Group, 1986, FIELD GUID FIELD C S, P91; Josten, 1973, COMPT REND SEPT C IN, V2, P2, DOI [10.1007/s15033-021-2690-3, DOI 10.1134/S0031030107020116]; Kelber K.A., 1988, NEUE FORSCHUNGEN ERD, V1, P166; Kelber K.P., 1989, COURIER FORSCHUNGSIN, V109, P165; Kelber KP., 1999, TRIAS GANZ ANDERE WE, P355; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Konijnenburg-Van Cittert JAV, 2006, PALAEONTOLOGY, V49, P943; Krassilov Valentin, 2008, Alavesia, V2, P247; Krassilov V, 2009, PALAEOGEOGR PALAEOCL, V284, P326, DOI 10.1016/j.palaeo.2009.10.012; Kustatscher E, 2006, REV PALAEOBOT PALYNO, V140, P79, DOI 10.1016/j.revpalbo.2006.03.003; Kustatscher E., 2005, GEO ALP, V2, P31; Kustatscher E., 2004, GEOL ALPINE, V1, P57; Kustatscher E., 2004, ACTA NATURALIA ALTEN, V40, P95; Kustatscher E, 2007, PALAEONTOLOGY, V50, P1277, DOI 10.1111/j.1475-4983.2007.00707.x; Kustatscher E, 2006, MICROPALEONTOLOGY, V52, P223, DOI 10.2113/gsmicropal.52.3.223; Kustatscher E, 2014, ACTA PALAEONTOL POL, V59, P741, DOI 10.4202/app.2012.0076; Kustatscher E, 2014, REV PALAEOBOT PALYNO, V208, P65, DOI 10.1016/j.revpalbo.2014.05.003; Kustatscher E, 2014, PALAEOBIO PALAEOENV, V94, P237, DOI 10.1007/s12549-014-0161-0; Kustatscher E, 2012, REV PALAEOBOT PALYNO, V183, P32, DOI 10.1016/j.revpalbo.2012.06.011; Kustatscher E, 2012, REV PALAEOBOT PALYNO, V182, P1, DOI 10.1016/j.revpalbo.2012.06.001; Kustatscher E, 2010, PALAEOGEOGR PALAEOCL, V290, P71, DOI 10.1016/j.palaeo.2009.07.001; Kustatscher E, 2010, PALAEONTOLOGY, V53, P595, DOI 10.1111/j.1475-4983.2010.00948.x; Labandeira CC, 1997, PALAIOS, V12, P319, DOI 10.2307/3515334; Labandeira CC, 2012, GEOL SOC AM ABSTR, p[44, 290]; Labandeira CC, 2007, GUIDE INSECTS OTHER; Labandeira Conrad, 2006, Arthropod Systematics & Phylogeny, V64, P53; Labandeira CC, 2007, PALAEOGEOGR PALAEOCL, V247, P197, DOI 10.1016/j.palaeo.2006.10.015; Labandeira CC, 2013, NATURWISSENSCHAFTEN, V100, P355, DOI 10.1007/s00114-013-1035-4; Labandeira CC, 2014, INT J PALEOPATHOL, V4, P1, DOI 10.1016/j.ijpp.2013.10.002; Labandeira CC, 2013, ANNU REV EARTH PL SC, V41, P287, DOI 10.1146/annurev-earth-050212-124139; Labandeira Conrad C., 2012, P269; Labandeira Conrad C., 2005, American Entomologist, V51, P14; Labandeira Conrad C., 2002, P26; Leonardi P, FLORA PERMIANA ORTIS; Leonardi P., 1968, DOLOMITI GEOLOGIA MO; Linck O., 1949, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart B, V4-6, P180; Loriga CB, 2002, RIV ITAL PALEONTOL S, V108, P381, DOI 10.13130/2039-4942/5483; Lozovsky VR, 2016, STRATIGR GEO CORREL+, V24, P364, DOI 10.1134/S0869593816040043; Lucchini F., 1982, GUIDA GEOLOGIA SUDAL, P221; Maheshwari H.K., 1990, Geophytology, V20, P45; Marchetti L, 2015, PALAEOGEOGR PALAEOCL, V440, P180, DOI 10.1016/j.palaeo.2015.08.021; Marocchi M, 2008, J GEOL, V116, P480, DOI 10.1086/590135; Massari F., 1988, SCI GEOL MEM U PADOV, V60, P229; Massari F., 1994, SCI GEOL MEM U PADOV, V46, P119; Massari F., 1999, STRATIGRAPHY FACIES, P111; McLoughlin S., 1994, PALAEONTOGR ABT B, V228, P105; McLoughlin Stephen, 1992, Palaeontographica Abteilung B Palaeophytologie, V228, P105; McLoughlin Stephen, 1994, Palaeontographica Abteilung B Palaeophytologie, V231, P1; McLoughlin S, 2011, AUST J BOT, V59, P156, DOI 10.1071/BT10297; Meller B, 2011, PALAEONTOLOGY, V54, P97, DOI 10.1111/j.1475-4983.2010.01009.x; Mendonca Jr M. S., 2014, NEOTROPICAL INSECT G, P221; Mietto P, 1995, B SOC GEOL FR, V166, P539; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Morelli C., 2007, MITT OSTERR MINER GE, V153, P195; Naugolnykh SV, 2010, PALEONTOL J+, V44, P468, DOI 10.1134/S0031030110040131; Noll R., 2005, VEROFF MUS NATURK CH, V28, P29; Ori G.C., 1988, PERMIAN PERMIAN TRIA, V34, P155; Pant D D, 1995, P INT C GLOB ENV DIV, P317; Pinheiro E.R.S., 2012, Palaeobotanist (Lucknow), V61, P67; Pisa G, 1978, MEM SOC GEOL ITAL, V18, P63; PLUMSTEAD EDNA P., 1963, S AFRICAN JOUR SCI, V59, P147; Ponomarenko AG, 2016, PALEONTOL J+, V50, P174, DOI 10.1134/S0031030116020052; Pott C, 2008, J PALEONTOL, V82, P778, DOI 10.1666/06-094.1; Prevec R, 2009, REV PALAEOBOT PALYNO, V156, P454, DOI 10.1016/j.revpalbo.2009.04.012; Remy W., 1978, ARGUMENTA PALAEOBOT, V5, P57; Roopnarine PD, 2007, P ROY SOC B-BIOL SCI, V274, P2077, DOI 10.1098/rspb.2007.0515; Rossler R, 2000, REV PALAEOBOT PALYNO, V108, P55, DOI 10.1016/S0034-6667(99)00033-0; Rossler R, 2011, VEROFF MUS NATURK CH, V37, P55; Rossler R., 1996, VEROFFENTLICHUNGEN M, V19, P27; ROZEFELDS AC, 1987, ALCHERINGA, V11, P51, DOI 10.1080/03115518708618979; Schachat SR, 2015, PALAEOGEOGR PALAEOCL, V440, P830, DOI 10.1016/j.palaeo.2015.10.001; Schachat SR, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1266-7; Schachat SR, 2014, INT J PLANT SCI, V175, P855, DOI 10.1086/677679; Schmidt G, 2000, J TROP ECOL, V16, P829, DOI 10.1017/S0266467400001747; Scott AC, 2004, J GEOL SOC LONDON, V161, P401, DOI 10.1144/0016-764903-118; Senowbari-Daryan B, 1933, FACIES, V28, P181; Shcherbakov DE, 2008, PALEONTOL J+, V42, P15, DOI 10.1134/S0031030108010036; Shcherbakov Dmitry E., 2009, Russian Entomological Journal, V18, P7; Sidor CA, 2013, P NATL ACAD SCI USA, V110, P8129, DOI 10.1073/pnas.1302323110; Sidorchuk EA, 2015, J SYST PALAEONTOL, V13, P129, DOI 10.1080/14772019.2013.867373; Slater BJ, 2012, PALAEOGEOGR PALAEOCL, V363, P109, DOI 10.1016/j.palaeo.2012.08.018; Smith DM, 2004, BIOTROPICA, V36, P318, DOI 10.1111/j.1744-7429.2004.tb00323.x; Srivastava AK, 2011, PALEONTOL J+, V45, P200, DOI 10.1134/S0031030111020171; Srivastava A.K., 1987, PALAEOBOTANIST, V36, P138; Srivastava AK, 1996, GONDWANA NINE - NINTH INTERNATIONAL GONDWANA SYMPOSIUM, VOLS 1 AND 2, P549; Stull GW, 2013, J PALEONTOL, V87, P217, DOI 10.1666/12-063R.1; Tapanila L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031668; Testa B, 2013, GEOHERITAGE, V5, P151, DOI 10.1007/s12371-013-0079-3; Tillyard R. J., 1922, Proceedings of the Linnean Society of New South Wales, V47, P447; Todesco Rossana, 2008, Geo.Alp, V5, P121; Uhl D, 2005, PALAEOGEOGR PALAEOCL, V218, P205, DOI 10.1016/j.palaeo.2004.12.015; Uhl D, 2014, PALAEOBIO PALAEOENV, V94, P271, DOI 10.1007/s12549-014-0155-y; Uhl D, 2012, RIV ITAL PALEONTOL S, V118, P223, DOI 10.13130/2039-4942/6002; Vasilenko DV, 2007, PALEONTOL J+, V41, P207, DOI 10.1134/S0031030107020116; VIEL G, 1979, Rivista Italiana di Paleontologia e Stratigrafia, V85, P297; Viel G., 1979, RIV ITAL PALEONTOL S, V85, P85; VINCENT JFV, 1990, ADV BOT RES, V17, P235, DOI 10.1016/S0065-2296(08)60135-4; Visscher H., 2001, REGIONAL REPORTS COR, V25, P117; Walker JD, 2013, GEOL SOC AM BULL, V125, P259, DOI 10.1130/B30712.1; WALKER M. V., 1938, PROC U S NATION MUS, V85, P137; Wang J, 2009, REV PALAEOBOT PALYNO, V156, P277, DOI 10.1016/j.revpalbo.2009.03.006; Wappler T, 2015, PEERJ, V3, DOI 10.7717/peerj.921; WEBB JA, 1982, ALCHERINGA, V6, P79, DOI 10.1080/03115518208566988; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Wopfner H, 1999, SCHLERN, V73, P23; Wopfner H., 1988, MEM SOC GEOL ITAL, V34, P161; ZAVADA MS, 1992, AM MIDL NAT, V127, P1, DOI 10.2307/2426316	181	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165205	10.1371/journal.pone.0165205	http://dx.doi.org/10.1371/journal.pone.0165205			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829032	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300031
J	Cruz, MJ; Menezes, G; Machete, M; Silva, MA				Cruz, Maria Joao; Menezes, Gui; Machete, Miguel; Silva, Monica A.			Predicting Interactions between Common Dolphins and the Pole-and-Line Tuna Fishery in the Azores	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERIES; TROPICAL PACIFIC-OCEAN; BOTTLE-NOSED DOLPHINS; NORTHEAST ATLANTIC; DELPHINUS-DELPHIS; NE ATLANTIC; SPATIAL-DISTRIBUTION; MITIGATION DEVICE; CATCH RATES; DEPREDATION	Common dolphins (Delphinus delphis) are responsible for the large majority of interactions with the pole-and-line tuna fishery in the Azores but the underlying drivers remain poorly understood. In this study we investigate the influence of various environmental and fisheries-related factors in promoting the interaction of common dolphins with this fishery and estimate the resultant catch losses. We analysed 15 years of fishery and cetacean interaction data (1998-2012) collected by observers placed aboard tuna fishing vessels. Dolphins interacted in less than 3% of the fishing events observed during the study period. The probability of dolphin interaction varied significantly between years with no evident trend over time. Generalized additive modeling results suggest that fishing duration, sea surface temperature and prey abundance in the region were the most important factors explaining common dolphin interaction. Dolphin interaction had no impact on the catches of albacore, skipjack and yellowfin tuna but resulted in significantly lower catches of bigeye tuna, with a predicted median annual loss of 13.5% in the number of fish captured. However, impact on bigeye catches varied considerably both by year and fishing area. Our work shows that rates of common dolphin interaction with the pole-and-line tuna fishery in the Azores are low and showed no signs of increase over the study period. Although overall economic impact was low, the interaction may lead to significant losses in some years. These findings emphasize the need for continued monitoring and for further research into the consequences and economic viability of potential mitigation measures.	[Cruz, Maria Joao; Menezes, Gui] Univ Acores, Dept Oceanog & Pescas, P-9901862 Horta, Portugal; [Cruz, Maria Joao; Menezes, Gui; Machete, Miguel; Silva, Monica A.] Univ Azores, MARE Marine & Environm Sci Ctr, P-9901862 Horta, Portugal; [Cruz, Maria Joao; Menezes, Gui; Machete, Miguel; Silva, Monica A.] Univ Azores, Ctr Inst Marine Res IMAR, P-9901862 Horta, Portugal; [Silva, Monica A.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Universidade dos Acores; Universidade dos Acores; Universidade dos Acores; Woods Hole Oceanographic Institution	Cruz, MJ (corresponding author), Univ Acores, Dept Oceanog & Pescas, P-9901862 Horta, Portugal.; Cruz, MJ (corresponding author), Univ Azores, MARE Marine & Environm Sci Ctr, P-9901862 Horta, Portugal.; Cruz, MJ (corresponding author), Univ Azores, Ctr Inst Marine Res IMAR, P-9901862 Horta, Portugal.	mjoaocruz@uac.pt	Silva, Mónica/D-1893-2012; Menezes, Gui M./A-3956-2009	Silva, Mónica/0000-0002-2683-309X; Menezes, Gui M./0000-0003-0781-4579	Fundacao para a Ciencia e a Tecnologia (FCT) though FEDER; DRCT/SRCTE, though FEDER; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Portuguese Ministry for Science and Education [PTDC/MAR/74071/2006, IF/00943/2013/CP1199/CT0001, M2.1.2/F/012/2011]; Fundacao para a Ciencia e Tecnologia (FCT) [UID/MAR/04292/2013]; Azorean Regional Government; Shipowners Association; Association of the Tuna Canning Industries; DRCT [M3.1.2/F/008/2009]; POPH; QREN; European Social Fund; Portuguese Ministry for Science and Education, through an FCT [IF/00943/2013]; FCT [IF/00943/2013/CP1199/CT0001]; SMRCT/DRCT	Fundacao para a Ciencia e a Tecnologia (FCT) though FEDER; DRCT/SRCTE, though FEDER; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Portuguese Ministry for Science and Education(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Azorean Regional Government; Shipowners Association; Association of the Tuna Canning Industries; DRCT; POPH; QREN; European Social Fund(European Social Fund (ESF)); Portuguese Ministry for Science and Education, through an FCT; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); SMRCT/DRCT	This work was funded by Fundacao para a Ciencia e a Tecnologia (FCT) and DRCT/SRCTE, though FEDER, the Competitiveness Factors Operational (COMPETE), QREN European Social Fund, the Portuguese Ministry for Science and Education, under research projects TRACE (PTDC/MAR/74071/2006), FCT Exploratory Project (IF/00943/2013/CP1199/CT0001), and MAPCET (M2.1.2/F/012/2011). We acknowledge the support of Fundacao para a Ciencia e Tecnologia (FCT), through the strategic project UID/MAR/04292/2013 granted to MARE. We thank the Azorean Regional Government for funding POPA, the Shipowners Association and the Association of the Tuna Canning Industries for their support to the program. MJC was supported by a DRCT doctoral grant (M3.1.2/F/008/2009). MAS was supported by POPH, QREN, European Social Fund and Portuguese Ministry for Science and Education, through an FCT Investigator grant (IF/00943/2013). Publication fees for this open access publication were supported the FCT Exploratory Project (IF/00943/2013/CP1199/CT0001) and by SMRCT/DRCT.	[Anonymous], 2014, 2 IPNLF; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; AU DWK, 1986, CONDOR, V88, P304, DOI 10.2307/1368877; Auge AA, 2012, FISHERIES MANAG ECOL, V19, P426, DOI 10.1111/j.1365-2400.2012.00861.x; Bonizzoni S, 2014, AQUAT CONSERV, V24, P696, DOI 10.1002/aqc.2401; Brill RW, 2001, AM FISH S S, V25, P179; Brotons JM, 2008, MAR MAMMAL SCI, V24, P112, DOI 10.1111/j.1748-7692.2007.00164.x; Brown S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104468; Carretta JV, 2011, MAR TECHNOL SOC J, V45, P7, DOI 10.4031/MTSJ.45.5.3; Chilvers BL, 2003, CAN J ZOOL, V81, P1947, DOI 10.1139/Z03-195; Clua E, 2001, AQUAT LIVING RESOUR, V14, P11, DOI 10.1016/S0990-7440(00)01097-4; Correia AM, 2015, J MARINE SYST, V143, P73, DOI 10.1016/j.jmarsys.2014.10.016; Cruz MJ, 2014, ICES J MAR SCI, V71, P2608, DOI 10.1093/icesjms/fsu073; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Damaso C, 2007, THESIS; Das K, 2000, MAR POLLUT BULL, V40, P102, DOI 10.1016/S0025-326X(99)00178-2; Edwards E.F., 2007, INT J COMP PSYCHOL, V20, P217; EDWARDS EF, 1992, FISH B-NOAA, V90, P678; Erzini K, 2005, FISH OCEANOGR, V14, P195, DOI 10.1111/j.1365-2419.2005.00332.x; FAO. Fisheries and Aquaculture Department, 2015, GLOB TUN CATCH STOCK; Fertl D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P219; Food and Agriculture Organization, 2015, STAT WORLD FISH AQ 2; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gilman E, 2012, AQUAT CONSERV, V22, P446, DOI 10.1002/aqc.2237; Gosliner Michael L., 1999, P120; Hall MA, 1998, REV FISH BIOL FISHER, V8, P1, DOI 10.1023/A:1008854816580; Hamer DJ, 2015, ICES J MAR SCI, V72, P1691, DOI 10.1093/icesjms/fsv013; Hassani Sami, 1997, Journal of Northwest Atlantic Fishery Science, V22, P119; Hastie GD, 2005, ICES J MAR SCI, V62, P760, DOI 10.1016/j.icesjms.2005.02.004; ICES, 2012, ICES CM 2012 ACOM; ISSF, 2015, 201503 ISSF; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; Lopez BD, 2012, MAR BIOL, V159, P2161, DOI 10.1007/s00227-012-2002-x; Lotacor, 2014, PESC DESC NA RAA; Lourenco N, 1998, MAR GEOPHYS RES, V20, P141, DOI 10.1023/A:1004505401547; Machete M, 2007, P 5 INT FISH OBS C V, P114; Majkowski J, 2007, FAO FISHERIES TECHNI; Meynier L, 2008, MAR ECOL PROG SER, V354, P277, DOI 10.3354/meps07246; Miyake M.P., 2010, 543 FAO, P125; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Neumann Dirk R., 2001, Aquatic Mammals, V27, P121; O'Connell V, 2015, ICES J MAR SCI, V72, P1667, DOI 10.1093/icesjms/fsv014; Peterson MJ, 2013, ICES J MAR SCI, V70, P1220, DOI 10.1093/icesjms/fst045; Pham CK, 2013, ICES J MAR SCI, V70, P564, DOI 10.1093/icesjms/fst024; Pusineri C, 2007, MAR MAMMAL SCI, V23, P30, DOI 10.1111/j.1748-7692.2006.00088.x; Rabearisoa N, 2015, ICES J MAR SCI, V72, P1682, DOI 10.1093/icesjms/fsu252; Rabearisoa N, 2012, J EXP MAR BIOL ECOL, V432, P55, DOI 10.1016/j.jembe.2012.07.004; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Santos RS, 1995, AQUAT CONSERV, V5, P311, DOI 10.1002/aqc.3270050406; Scott MD, 2012, MAR ECOL PROG SER, V458, P283, DOI 10.3354/meps09740; Silva MA, 2002, MAR MAMMAL SCI, V18, P893, DOI 10.1111/j.1748-7692.2002.tb01080.x; Silva Monica A., 2003, Aquatic Mammals, V29, P77, DOI 10.1578/016754203101024095; Silva MA, 2014, MAR BIOL RES, V10, P123, DOI 10.1080/17451000.2013.793814; Silva MA, 2011, AQUAT CONSERV, V21, P17, DOI 10.1002/aqc.1158; Tixier P, 2010, CCAMLR SCI, V17, P179; Tixier P, 2015, ICES J MAR SCI, V72, P1673, DOI 10.1093/icesjms/fsu166; YOUNG DD, 1994, J ZOOL, V234, P41, DOI 10.1111/j.1469-7998.1994.tb06055.x; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	60	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0164107	10.1371/journal.pone.0164107	http://dx.doi.org/10.1371/journal.pone.0164107			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851763	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300004
J	Greibe, E; Nexo, E				Greibe, Eva; Nexo, Ebba			Forms and Amounts of Vitamin B12 in Infant Formula: A Pilot Study	PLOS ONE			English	Article							BREAST-FED INFANTS; HUMAN-MILK; HAPTOCORRIN; COBALAMINS; PROTEINS; SERUM	Purpose Infant formula is based on cow's milk and designed to mimic breast milk for substitution. Vitamin B12 (B12) is bound to proteins in both breast milk and cow's milk, and in milk from both species the vitamin occurs mainly in its natural form such as hydroxo-B12 with little or no synthetic B12 (cyano-B12). Here we test commercially available infant formulas. Methods Eleven commercially available infant formulas were measured for content of B12 and analyzed for the presence of B12-binding proteins and forms of B12 using size exclusion chromatography and HPLC. Results All infant formulas contained B12 by and large in accord with the informations given on the package inserts. None of the formulas contained protein-bound B12, and cyano-B12 accounted for 19-78% of the total amount of B12 present, while hydroxo-B12 constituted more or less the rest. Conclusions This pilot study shows that infant formula differs from breast milk in providing the infant with free B12, rather than protein-bound B12, and by a relative high content of cyano-B12. The consequence of supplying the infant with synthetic cyano-B12 remains to be elucidated.	[Greibe, Eva; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Aarhus University	Greibe, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark.	greibe@clin.au.dk	Greibe, Eva/E-3375-2018	Greibe, Eva/0000-0002-0417-1195; Nexo, Ebba/0000-0001-9406-9081	Innovation Fund Denmark [12-132437]	Innovation Fund Denmark	The work is part of the TRIM project (www.trirm-project.dk), headed by Associate Professor Christian Heegaard and financed by Innovation Fund Denmark (http://innovationsfonden.dkten) (Grant No. 12-132437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Y, 2002, J PEDIATR GASTR NUTR, V35, P192, DOI 10.1097/00005176-200208000-00016; CRAFT IL, 1971, J CLIN PATHOL, V24, P449, DOI 10.1136/jcp.24.5.449; DIPALMA J, 1991, GASTROENTEROLOGY, V101, P116, DOI 10.1016/0016-5085(91)90467-Y; FARQUHARSON J, 1976, BRIT J NUTR, V36, P127, DOI 10.1079/BJN19760063; Fedosov SN, 1996, BBA-PROTEIN STRUCT M, V1292, P113, DOI 10.1016/0167-4838(95)00173-5; FORD JE, 1974, BRIT J NUTR, V31, P243, DOI 10.1079/BJN19740030; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Greibe E, 2013, AM J CLIN NUTR, V98, P389, DOI 10.3945/ajcn.113.058479; GULLBERG R, 1973, SCAND J GASTROENTERO, V8, P497; Hardlei TF, 2010, CLIN CHEM, V56, P432, DOI 10.1373/clinchem.2009.131524; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Institue of Medicine Food and Nutrition Board, 1998, DIET REF INT THIAM R; KELLY EJ, 1992, EARLY HUM DEV, V31, P163, DOI 10.1016/0378-3782(92)90043-G; Kornerup LS, 2016, BIOCHIMIE, V126, P57, DOI 10.1016/j.biochi.2015.11.024; Lildballe DL, 2009, CLIN CHEM LAB MED, V47, P182, DOI 10.1515/CCLM.2009.047; Matte JJ, 2012, BRIT J NUTR, V107, P61, DOI 10.1017/S0007114511002364; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Russell RM, 2001, J NUTR, V131, P291, DOI 10.1093/jn/131.2.291; SPECKER BL, 1990, AM J CLIN NUTR, V51, P209, DOI 10.1093/ajcn/51.2.209; Vogiatzoglou A, 2009, AM J CLIN NUTR, V89, P1078, DOI 10.3945/ajcn.2008.26598	20	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165458	10.1371/journal.pone.0165458	http://dx.doi.org/10.1371/journal.pone.0165458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851744	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300017
J	Kwan, JM; Hajjiri, Z; Metwally, A; Finn, PW; Perkins, DL				Kwan, Jennifer M.; Hajjiri, Zahraa; Metwally, Ahmed; Finn, Patricia W.; Perkins, David L.			Effect of the Obesity Epidemic on Kidney Transplantation: Obesity Is Independent of Diabetes as a Risk Factor for Adverse Renal Transplant Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; ADIPOSE-TISSUE; WEIGHT-LOSS; INFLAMMATION; SURVIVAL; CELLS; OVERWEIGHT	Background Obesity is a growing epidemic in most developed countries including the United States resulting in an increased number of obese patients with end-stage renal disease. A previous study has shown that obese patients with end-stage renal disease have a survival benefit with transplantation compared with dialysis. However, due to serious comorbidities, many centers place restrictions on the selection of obese patients for transplantation. Further, due to obese patients having an increased risk of diabetes, it is unclear whether obesity can be an independent risk, independent of diabetes for increasing adverse renal transplant outcomes. Methods To investigate the role of obesity in kidney transplantation, we used the Scientific Registry of Transplant Recipients database. After filtering for subjects that had the full set of covariates including age, gender, graft type, ethnicity, diabetes, peripheral vascular disease, dialysis time and time period of transplantation for our analysis, 191,091 subjects were included in the analyses. Using multivariate logistic regression analyses adjusted for covariates we determined whether obesity is an independent risk factor for adverse outcomes such as delayed graft function, acute rejection, urine protein and graft failure. Cox regression modeling was used to determine hazard ratios of graft failure. Results Using multivariate model analyses, we found that obese patients have significantly increased risk of adverse transplant outcomes, including delayed graft function, graft failure, urine protein and acute rejection. Cox regression modeling hazard ratios showed that obesity also increased risk of graft failure. Life-table survival curves showed that obesity may be a risk factor independent of diabetes mellitus for a shorter time to graft failure. Conclusions A key observation in our study is that the risks for adverse outcome of obesity are progressive with increasing body mass index. Furthermore, pre-obese overweight recipients compared with normal weight recipients also had increased risks of adverse outcomes related to kidney transplantation.	[Kwan, Jennifer M.; Hajjiri, Zahraa; Finn, Patricia W.; Perkins, David L.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Metwally, Ahmed; Perkins, David L.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Perkins, David L.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Finn, PW (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	pwfinn@uic.edu		Abdelhadi Metwally, Ahmed/0000-0002-0155-7412				[Anonymous], 1995, SURV AN US SAS; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Blackburn GL, 2010, AM J CLIN NUTR, V91, p289S, DOI 10.3945/ajcn.2009.28473D; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; CDC, AD OB FACTS 2014; Chicago UoIa, 2012, SCIENCEDAILYCOM; de las Fuentes L, 2009, J AM COLL CARDIOL, V54, P2376, DOI 10.1016/j.jacc.2009.07.054; Ditonno P, 2011, TRANSPL P, V43, P367, DOI 10.1016/j.transproceed.2010.12.022; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Friedman AN, 2003, AM J KIDNEY DIS, V41, P480, DOI 10.1053/ajkd.2003.50059; Fujioka K, 2010, DIABETES OBES METAB, V12, P186, DOI 10.1111/j.1463-1326.2009.01155.x; Gerriets VA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00379; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Gill JS, 2013, AM J TRANSPLANT, V13, P2083, DOI 10.1111/ajt.12331; Gore JL, 2006, AM J TRANSPLANT, V6, P357, DOI 10.1111/j.1600-6143.2005.01198.x; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hill CJ, 2015, NEPHROL DIAL TRANSPL, V30, P1403, DOI 10.1093/ndt/gfv214; Kalantar-Zadeh K, 2006, ANN INTERN MED, V144, P701, DOI 10.7326/0003-4819-144-9-200605020-00021; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kucharska AM, 2015, ADV EXP MED BIOL, V866, P35, DOI 10.1007/5584_2015_147; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Liu LL, 2010, PEDIATR DIABETES, V11, P4, DOI 10.1111/j.1399-5448.2009.00519.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Nicoletto F N, 2014, TRANSPLANTATION; Ortiz J, 2012, CLIN TRANSPLANT, V26, pE284, DOI 10.1111/j.1399-0012.2012.01649.x; Port FK, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341061; Segev DL, 2008, J AM SOC NEPHROL, V19, P349, DOI 10.1681/ASN.2007050610; Seijkens T, 2014, DIABETES, V63, P3982, DOI 10.2337/db14-0272; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; Zoccali C, 2005, J RENAL NUTR, V15, P125, DOI 10.1053/j.jrn.2004.09.036	31	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165712	10.1371/journal.pone.0165712	http://dx.doi.org/10.1371/journal.pone.0165712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851743	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300023
J	Black, RJ; Hill, CL; Lester, S; Dixon, WG				Black, Rachel J.; Hill, Catherine L.; Lester, Susan; Dixon, William G.			The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							POSTERIOR SUBCAPSULAR CATARACTS; TERM CORTICOSTEROID-THERAPY; PLACEBO-CONTROLLED TRIAL; AGE-RELATED CATARACTS; DOUBLE-BLIND; LENS OPACITIES; SPARSE DATA; DISEASE; EYE; EFFICACY	Objective Glucocorticoids (GCs) are often used to treat Rheumatoid Arthritis (RA) despite their many side effects and the availability of other effective therapies. Cataract and glaucoma are known side effects of GCs but the risk of them developing in the setting of GC use for RA is unknown. The aim was to perform a systematic review and meta-analysis to determine the association between GCs and the risk of developing cataract and/or glaucoma in RA. Methods A systematic search was carried out using MEDLINE, EMBASE, and Web of Science. All RCTs comparing GC use to non-use in RA populations were sought. Observational studies reporting cataract and/or glaucoma amongst GC users and non-users were also included. Data extracted included incidence/prevalence of cataract and/or glaucoma in each arm, dose and duration of therapy. Two independent reviewers performed quality assessment. Results 28 RCTs met eligibility criteria, however only 3 reported cataracts and glaucoma, suggesting significant under-reporting. An association between GC use and the development of cataracts in RA patients was seen in observational studies but not RCTs. There was no statistically significant association between GC use and the development of glaucoma, although data were sparse. There were insufficient data to determine the impact of dose and duration of therapy. Conclusion The current literature suggests a possible association between GC use and the development of cataract. However, this risk cannot be accurately quantified in RA from the available evidence. RCTs have not adequately captured these outcomes and well-designed observational research is required.	[Black, Rachel J.; Dixon, William G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England; [Black, Rachel J.; Hill, Catherine L.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Hill, Catherine L.; Lester, Susan] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA, Australia; [Dixon, William G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Farr Inst Hlth Informat Res, Hlth e Res Ctr, Manchester, Lancs, England; [Dixon, William G.] Salford Royal NHS Fdn Trust, Dept Rheumatol, Salford, Lancs, England	University of Manchester; University of Adelaide; University of Manchester; Salford Royal NHS Foundation Trust	Black, RJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England.; Black, RJ (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	rachel.black2@sa.gov.au	Dixon, William/L-8408-2019; Black, Rachel/GSN-5905-2022; Hill, Catherine L/AAE-7152-2019	Dixon, William/0000-0001-5881-4857; Hill, Catherine L/0000-0001-8289-4922; Black, Rachel J/0000-0001-6600-7430	Ken Muirden Overseas Training Fellowship; Arthritis Australia; Roche Products Pty Ltd; Australian Postgraduate Award (The University of Adelaide); Arthritis South Australia/Australian Rheumatology Association (South Australian Branch) Postgraduate Grant; MRC Clinician Scientist Fellowship [G0902272]; Arthritis Research UK [20380]; Medical Research Council [MR/K006665/1, MC_PC_13042, G0902272] Funding Source: researchfish; MRC [G0902272, MR/K006665/1] Funding Source: UKRI	Ken Muirden Overseas Training Fellowship; Arthritis Australia; Roche Products Pty Ltd; Australian Postgraduate Award (The University of Adelaide); Arthritis South Australia/Australian Rheumatology Association (South Australian Branch) Postgraduate Grant; MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RJB was the recipient of the 2013 Ken Muirden Overseas Training Fellowship, an educational research grant jointly funded by Arthritis Australia and Roche Products Pty Ltd. RJB was also supported by an Australian Postgraduate Award (The University of Adelaide) and an Arthritis South Australia/Australian Rheumatology Association (South Australian Branch) Postgraduate Grant. WGD was supported by a MRC Clinician Scientist Fellowship (G0902272). We thank the Arthritis Research UK for their support: Arthritis Research UK grant number 20380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker MF, 2012, ANN INTERN MED, V156, P329, DOI 10.7326/0003-4819-156-5-201203060-00004; Black RJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0895-8; BLACK RL, 1960, JAMA-J AM MED ASSOC, V174, P166, DOI 10.1001/jama.1960.63030020005014; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; CALDWELL JR, 1991, SEMIN ARTHRITIS RHEU, V21, P1, DOI 10.1016/0049-0172(91)90051-Z; Carnahan M C, 2000, Curr Opin Ophthalmol, V11, P478, DOI 10.1097/00055735-200012000-00016; CREWS SJ, 1963, BRIT MED J, P1644; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Fardet L, 2011, RHEUMATOLOGY, V50, P1982, DOI 10.1093/rheumatology/ker017; FURST C, 1966, ANN RHEUM DIS, V25, P364; GILES CL, 1962, JAMA-J AM MED ASSOC, V182, P719, DOI 10.1001/jama.1962.03050460011003; GULLBERG R, 1973, Scandinavian Journal of Rheumatology, V2, P113; HENCH PS, 1950, ARCH INTERN MED, V85, P545, DOI 10.1001/archinte.1950.00230100002001; Hodge WG, 1995, EPIDEMIOL REV, V17, P336, DOI 10.1093/oxfordjournals.epirev.a036197; Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157; Huscher D, 2009, ANN RHEUM DIS, V68, P1119, DOI 10.1136/ard.2008.092163; Jacobs JW, 2013, KELLEYS TXB RHEUMATO, P894; Kanthan GL, 2008, OPHTHALMOLOGY, V115, P808, DOI 10.1016/j.ophtha.2007.07.008; Kersey JP, 2006, EYE, V20, P407, DOI 10.1038/sj.eye.6701895; Kirwan JR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006356; Klein BEK, 2001, OPHTHALMOLOGY, V108, P1670, DOI 10.1016/S0161-6420(01)00656-X; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; MARAINI G, 1991, AM J EPIDEMIOL, V133, P541; MATSUNAMI C, 1994, AUST NZ J OPHTHALMOL, V22, P53, DOI 10.1111/j.1442-9071.1994.tb01696.x; Mazzantini M, 2010, J RHEUMATOL, V37, P2232, DOI 10.3899/jrheum.100461; MCDOUGALL R, 1994, J RHEUMATOL, V21, P1207; R Core Team, 2013, R LANG ENV STAT COMP; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; SAAG KG, 1994, AM J MED, V96, P115, DOI 10.1016/0002-9343(94)90131-7; STERN JJ, 1953, AM J OPHTHALMOL, V36, P389, DOI 10.1016/0002-9394(53)91389-0; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Taylor HR, 2005, MED J AUSTRALIA, V182, P565, DOI 10.5694/j.1326-5377.2005.tb06815.x; TOOGOOD JH, 1993, J ALLERGY CLIN IMMUN, V91, P571, DOI 10.1016/0091-6749(93)90263-F; van Everdingen AA, 2002, ANN INTERN MED, V136, P1, DOI 10.7326/0003-4819-136-1-200201010-00006; Wang JJ, 2009, OPHTHALMOLOGY, V116, P652, DOI 10.1016/j.ophtha.2008.12.001; Wassenberg S, 2005, ARTHRITIS RHEUM-US, V52, P3371, DOI 10.1002/art.21421; WILLIAMS IA, 1982, LANCET, V2, P237; WILLIAMSON J, 1969, BRIT J OPHTHALMOL, V53, P361, DOI 10.1136/bjo.53.6.361	41	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166468	10.1371/journal.pone.0166468	http://dx.doi.org/10.1371/journal.pone.0166468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846316	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600068
J	Crank, MC; Wilson, EMP; Novik, L; Enama, ME; Hendel, CS; Gu, WJ; Nason, MC; Bailer, RT; Nabel, GJ; McDermott, AB; Mascola, JR; Koup, RA; Ledgerwood, JE; Graham, BS				Crank, Michelle C.; Wilson, Eleanor M. P.; Novik, Laura; Enama, Mary E.; Hendel, Cynthia S.; Gu, Wenjuan; Nason, Martha C.; Bailer, Robert T.; Nabel, Gary J.; McDermott, Adrian B.; Mascola, John R.; Koup, Richard A.; Ledgerwood, Julie E.; Graham, Barney S.		VRC012 Study Team	Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)	PLOS ONE			English	Article							T-CELL RESPONSES; TEST-OF-CONCEPT; DNA CANDIDATE VACCINE; IMMUNE-RESPONSES; ADENOVIRUS VECTORS; 1ST-IN-HUMAN EVALUATION; NONHUMAN-PRIMATES; PROSTATE-CANCER; PHASE-1 SAFETY; EFFICACY TRIAL	Background VRC 012 was a Phase I study of a prototype recombinant adenoviral-vector serotype-35 (rAd35) HIV vaccine, the precursor to two recently published clinical trials, HVTN 077 and 083. On the basis of prior evaluation of multiclade rAd5 HIV vaccines, Envelope A (EnvA) was selected as the standard antigen for a series of prototype HIV vaccines to compare various vaccine platforms. In addition, prior studies of rAd5-vectored vaccines suggested preexisting human immunity may be a confounding factor in vaccine efficacy. rAd35 is less seroprevalent across human populations and was chosen for testing alone and in combination with a rAd5-EnvA vaccine in the present two-part phase I study. Methods First, five subjects each received a single injection of 10(9), 10(10), or 10(11) particle units (PU) of rAd35-EnvA in an open-label, dose-escalation study. Next, 20 Ad5/Ad35-seronegative subjects were randomized to blinded, heterologous prime-boost schedules combining rAd5-EnvA and rAd35-EnvA with a three month interval. rAd35-EnvA was given at 10(10) or 10(11) PU to ten subjects each; all rAd5-EnvA injections were 10(10) PU. EnvA-specific immunogenicity was assessed four weeks post-injection. Solicited reactogenicity and clinical safety were followed after each injection. Results Vaccinations were well tolerated at all dosages. Antibody responses measured by ELISA were detected at 4 weeks in 30% and 50% of subjects after single doses of 10(10) or 10(11) PU rAd35, respectively, and in 89% after a single rAd5-EnvA 10(10) PU injection. EnvA-specific IFN-Upsilon ELISpot responses were detected at four weeks in 0%, 70%, and 50% of subjects after the respective rAd35-EnvA dosages compared to 89% of subjects after rAd5. T cell responses were higher after a single rAd5-EnvA 10(10) PU injection than after a single rAd35-EnvA 10(10) PU injection, and humoral responses were low after a single dose of either vector. Of those completing the vaccine schedule, 100% of rAd5-EnvA recipients and 90% of rAd35-EnvA recipients had both T cell and humoral responses after boosting with the heterologous vector. ELISpot response magnitude was similar in both regimens and comparable to a single dose of rAd5. A trend toward more robust CD8 T cell responses using rAd5-EnvA prime and rAd35-EnvA boost was observed. Humoral response magnitude was also similar after either heterologous regimen, but was several fold higher than after a single dose of rAd5. Adverse events (AEs) related to study vaccines were in general mild and limited to one episode of hematuria, Grade two. Activated partial thromboplastin time (aPTT) AEs were consistent with an in vitro effect on the laboratory assay for aPTT due to a transient induction of anti-phospholipid antibody, a phenomenon that has been reported in other adenoviral vector vaccine trials. Conclusions Limitations of the rAd vaccine vectors, including the complex interactions among pre-existing adenoviral immunity and vaccine-induced immune responses, have prompted investigators to include less seroprevalent vectors such as rAd35-EnvA in prime-boost regimens. The rAd35-EnvA vaccine described here was well tolerated and immunogenic. While it effectively primed and boosted antibody responses when given in a reciprocal prime-boost regimen with rAd5-EnvA using a three-month interval, it did not significantly improve the frequency or magnitude of T cell responses above a single dose of rAd5. The humoral and cellular immunogenicity data reported here may inform future vaccine and study design.	[Crank, Michelle C.; Wilson, Eleanor M. P.; Novik, Laura; Enama, Mary E.; Hendel, Cynthia S.; Bailer, Robert T.; Nabel, Gary J.; McDermott, Adrian B.; Mascola, John R.; Koup, Richard A.; Ledgerwood, Julie E.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gu, Wenjuan] Leidos Biomed Res Inc, Clin Monitoring Res Program, Clin Res Directorate, NCI Campus,Frederick, Frederick, MD 21702 USA; [Wilson, Eleanor M. P.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Nabel, Gary J.] Sanofi US, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; Sanofi-Aventis	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853; McDermott, Adrian/0000-0003-0616-9117; Wilson, Eleanor/0000-0002-4855-514X	National Institute of Allergy and Infectious Diseases (NIAID) intramural research program; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) intramural research program; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the conduct of this clinical trial was provided by the National Institute of Allergy and Infectious Diseases (NIAID) intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wenjuan Gu: Ms. Gu is an employee of Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Maryland 21702. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Baden LR, 2016, ANN INTERN MED, V164, P313, DOI 10.7326/M15-0880; Baden LR, 2015, J INFECT DIS, V211, P518, DOI 10.1093/infdis/jiu485; Baden LR, 2014, J INFECT DIS, V210, P1052, DOI 10.1093/infdis/jiu217; Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Barouch DH, 2014, NAT REV MICROBIOL, V12, P765, DOI 10.1038/nrmicro3360; Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Bart PA, 2014, J CLIN INVEST, V124, P4843, DOI 10.1172/JCI75894; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Capone S, 2014, MOL THER, V22, P1039, DOI 10.1038/mt.2014.15; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Chakrabarti BK, 2002, J VIROL, V76, P5357, DOI 10.1128/JVI.76.11.5357-5368.2002; Chen RF, 2014, INT REV IMMUNOL, V33, P45, DOI 10.3109/08830185.2013.823420; Chmielewska AM, 2014, J VIROL, V88, P5502, DOI 10.1128/JVI.03574-13; Churchyard GJ, 2015, VACCINE, V33, P1890, DOI 10.1016/j.vaccine.2015.02.004; Creech CB, 2013, HUM VACC IMMUNOTHER, V9, P2548, DOI 10.4161/hv.26038; Enama ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091366; Enama ME, 2011, 14 ANN C VACC RES 20; Fuchs JD, 2015, J AIDS CLIN RES, V6, DOI [10.4172/2155-6113.1000461, DOI 10.4172/2155-6113.1000461]; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Graham BSL, 2010, SAFETY IMMUNOGENICTY; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoft DF, 2012, VACCINE, V30, P2098, DOI 10.1016/j.vaccine.2012.01.048; Johnson MJ, 2012, J IMMUNOL, V188, P6109, DOI 10.4049/jimmunol.1103717; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Kibuuka H, 2015, LANCET, V385, P1545, DOI 10.1016/S0140-6736(14)62385-0; Kimani D, 2014, MOL THER, V22, P1992, DOI 10.1038/mt.2014.109; Koeneman KS, 2000, WORLD J UROL, V18, P102, DOI 10.1007/s003450050181; Kopycinski J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090378; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037; Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]; Lore K, 2007, J IMMUNOL, V179, P1721, DOI 10.4049/jimmunol.179.3.1721; Malaeb BS, 2005, UROLOGY, V66, P830, DOI 10.1016/j.urology.2005.04.041; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; McCoy K, 2007, J VIROL, V81, P6594, DOI 10.1128/JVI.02497-06; McMichael A, 2013, NAT MED, V19, P1576, DOI 10.1038/nm.3413; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Omosa-Manyonyi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125954; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078679; Paris RM, 2010, EXPERT REV VACCINES, V9, P1055, DOI 10.1586/ERV.10.106; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Perdiguero B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074831; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Quinn KM, 2015, J CLIN INVEST, V125, P1129, DOI 10.1172/JCI78280; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reynaud JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00174; Sellin CI, 2009, CURR TOP MICROBIOL, V330, P111; Sheets RL, 2008, J IMMUNOTOXICOL, V5, P315, DOI 10.1080/15376510802312464; Walsh SR, 2016, J INFECT DIS, V213, P541, DOI 10.1093/infdis/jiv496	61	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166393	10.1371/journal.pone.0166393	http://dx.doi.org/10.1371/journal.pone.0166393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846256	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600056
J	Esposito, S; Di Gangi, M; Cardinale, F; Baraldi, E; Corsini, I; Da Dale, L; Tovo, PA; Correre, A; Villani, A; Sacco, O; Tenero, L; Dones, P; Gambino, M; Zampiero, A; Principi, N				Esposito, Susanna; Di Gangi, Maria; Cardinale, Fabio; Baraldi, Eugenio; Corsini, Ilaria; Da Dale, Liviana; Tovo, Pier Angelo; Correre, Antonio; Villani, Alberto; Sacco, Oliviero; Tenero, Laura; Dones, Piera; Gambino, Monia; Zampiero, Alberto; Principi, Nicola		Ita-CAP Study Grp	Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM PROCALCITONIN; CLINICAL-FEATURES; CHILDREN; DIAGNOSIS; BACTEREMIA; CHILDHOOD; MARKER; TERM; BIOMARKERS	Study Design This study aimed to evaluate the diagnostic accuracy of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1), midregional proatrial natriuretic peptide (MR-proANP) and midregional proadrenomedullin (MR-proADM) to distinguish bacterial from viral community-acquired pneumonia (CAP) and to identify severe cases in children hospitalized for radiologically confirmed CAP. Index test results were compared with those derived from routine diagnostic tests, i.e., white blood cell (WBC) counts, neutrophil percentages, and serum C-reactive protein (CRP) and procalcitonin (PCT) levels. Methods This prospective, multicenter study was carried out in the most important children's hospitals (n = 11) in Italy and 433 otherwise healthy children hospitalized for radiologically confirmed CAP were enrolled. Among cases for whom etiology could be determined, CAP was ascribed to bacteria in 235 (54.3%) children and to one or more viruses in 111 (25.6%) children. A total of 312 (72.2%) children had severe disease. Results CRP and PCT had the best performances for both bacterial and viral CAP identification. The cut-off values with the highest combined sensitivity and specificity for the identification of bacterial and viral infections using CRP were >= 7.98 mg/L and <= 7.5 mg/L, respectively. When PCT was considered, the cut-off values with the highest combined sensitivity and specificity were >= 0.188 ng/mL for bacterial CAP and <= 0.07 ng/mL for viral CAP. For the identification of severe cases, the best results were obtained with evaluations of PCT and MR-proANP. However, in both cases, the biomarker cut-off with the highest combined sensitivity and specificity (>= 0.093 ng/mL for PCT and <= 33.8 pmol/L for proANP) had a relatively good sensitivity (higher than 70%) but a limited specificity (of approximately 55%). Conclusions This study indicates that in children with CAP, sTREM-1, MR-proANP, and MR-proADM blood levels have poor abilities to differentiate bacterial from viral diseases or to identify severe cases, highlighting that PCT maintains the main role at this regard.	[Esposito, Susanna; Gambino, Monia; Zampiero, Alberto; Principi, Nicola] Univ Milan, Fdn IRCCS Ca Grande, Osped Maggiore Policlin, Pediat Highly Intens Care Unit,Dept Pathophysiol, Milan, Italy; [Di Gangi, Maria; Dones, Piera] G Cristina Hosp, Pediat Infect Dis Unit, Palermo, Italy; [Cardinale, Fabio] Giovanni XXIII Hosp, Pediat Unit, Bari, Italy; [Baraldi, Eugenio] Univ Padua, Childrens Hosp, Pediat Pulmonol Unit, Padua, Italy; [Corsini, Ilaria] Univ Bologna, Pediat Emergency Unit, Policlin St Orsola, Bologna, Italy; [Da Dale, Liviana] Univ Padua, Treviso Hosp, Pediat Unit, Padua, Italy; [Tovo, Pier Angelo] Univ Turin, Regina Margherita Hosp, Pediat Clin, Turin, Italy; [Correre, Antonio] Santobono Hosp, Pediat Unit, Naples, Italy; [Villani, Alberto] IRCCS Bambino Gesu Hosp, Gen Pediat & Infect Dis, Rome, Italy; [Sacco, Oliviero] IRCCS Giannina Gaslini Hosp, Pulmonol Unit, Genoa, Italy; [Tenero, Laura] Univ Verona, Pediat Clin, Verona, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Padua; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Padua; A.O.U. Citta della Salute e della Scienza di Torino; Ospedale Infantile Regina Margherita; University of Turin; IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Grande, Osped Maggiore Policlin, Pediat Highly Intens Care Unit,Dept Pathophysiol, Milan, Italy.	susanna.esposito@unimi.it	Villani, Alberto/K-9844-2018; Sacco, Oliviero/AAB-1907-2021; Esposito, Susanna/AAA-8275-2022; baraldi, eugenio/AAC-5233-2022; CARDINALE, FABIO/AAL-4357-2020; Esposito, Susanna/K-3475-2016	Sacco, Oliviero/0000-0002-9350-9134; CARDINALE, FABIO/0000-0002-6774-6152; Esposito, Susanna/0000-0003-4103-2837	Italian Ministry of Health [2014850/03]	Italian Ministry of Health(Ministry of Health, Italy)	This study was financially supported by the Italian Ministry of Health (Progetto a concorso 2014850/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study has been registred by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (registry number 200913-850) and the full study protocol is available upon request in the Scientific Direction website of Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (www.formazione.eu.com). This study was financially supported by the Italian Ministry of Health (Progetto a concorso 2014 850/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adly AAM, 2014, CYTOKINE, V65, P184, DOI 10.1016/j.cyto.2013.11.004; Agnello L, 2016, CLIN BIOCHEM, V49, P47, DOI 10.1016/j.clinbiochem.2015.09.008; Alan M, 2015, J INTERN MED, V278, P174, DOI 10.1111/joim.12341; Bender MT, 2016, CURR OPIN PULM MED; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cohen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036927; Cohen R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-52; Don M, 2007, SCAND J INFECT DIS, V39, P129, DOI 10.1080/00365540600951283; Esposito S, 2013, PEDIATR INFECT DIS J, V32, P1199, DOI 10.1097/INF.0b013e31829ec274; Esposito S, 2012, PEDIATR INFECT DIS J, V31, P705, DOI 10.1097/INF.0b013e31825384ae; Esposito S, 2012, CURR OPIN INFECT DIS, V25, P286, DOI 10.1097/QCO.0b013e328352b60c; Esposito S, 2011, RESP MED, V105, P1939, DOI 10.1016/j.rmed.2011.09.003; Galetto-Lacour A, 2013, PEDIATR INFECT DIS J, V32, P1175, DOI 10.1097/INF.0b013e31829ba62a; Gibot S, 2005, CRIT CARE MED, V33, P1787, DOI 10.1097/01.CCM.0000172614.36571.75; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gordo-Remartinez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125212; Guinard-Barbier S, 2011, BIOMARKERS, V16, P637, DOI 10.3109/1354750X.2011.620629; Guinard-Barbier S, 2011, BIOMARKERS, V16, P355, DOI 10.3109/1354750X.2011.576769; Guo WL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006766; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Korppi M, 2001, EUR RESPIR J, V17, P623, DOI 10.1183/09031936.01.17406230; Korppi M, 2008, ACTA PAEDIATR, V97, P943, DOI 10.1111/j.1651-2227.2008.00789.x; Kruger S, 2010, THORAX, V65, P208, DOI 10.1136/thx.2009.121178; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Masekela R, 2015, PEDIATR PULM, V50, P333, DOI 10.1002/ppul.23121; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P644, DOI 10.3109/00365541003796775; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; ORTQVIST A, 1995, SCAND J INFECT DIS, V27, P457, DOI 10.3109/00365549509047046; Oudhuis GJ, 2009, INTENS CARE MED, V35, P1265, DOI 10.1007/s00134-009-1463-y; Palazzo SJ, 2012, RESP CARE, V57, P2052, DOI 10.4187/respcare.01703; Pasternak Y, 2016, ACTA PAEDIATR, V105, pE17, DOI 10.1111/apa.13226; PONKA A, 1983, EUR J RESPIR DIS, V64, P360; Principi Nicola, 2001, Clinical Infectious Diseases, V32, P1281, DOI 10.1086/319981; Rambaud-Althaus C, 2015, LANCET INFECT DIS, V15, P439, DOI 10.1016/S1473-3099(15)70017-4; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Shi JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054054, 10.1371/journal.pone.0077651]; Spuesens EBM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001444; Williams DJ, 2015, PEDIATR INFECT DIS J, V34, P792, DOI 10.1097/INF.0000000000000724	43	27	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0163262	10.1371/journal.pone.0163262	http://dx.doi.org/10.1371/journal.pone.0163262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846213	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600002
J	Guo, BS; Lei, C; Ito, T; Jiang, YY; Ozeki, Y; Goda, K				Guo, Baoshan; Lei, Cheng; Ito, Takuro; Jiang, Yiyue; Ozeki, Yasuyuki; Goda, Keisuke			High-Throughput Accurate Single-Cell Screening of Euglena gracilis with Fluorescence-Assisted Optofluidic Time-Stretch Microscopy	PLOS ONE			English	Article							NITROGEN STARVATION; BIOFUEL PRODUCTION; MICROALGAE; CLASSIFICATION; ACCUMULATION; RICH	The development of reliable, sustainable, and economical sources of alternative fuels is an important, but challenging goal for the world. As an alternative to liquid fossil fuels, algal biofuel is expected to play a key role in alleviating global warming since algae absorb atmospheric CO2 via photosynthesis. Among various algae for fuel production, Euglena gracilis is an attractive microalgal species as it is known to produce wax ester (good for biodiesel and aviation fuel) within lipid droplets. To date, while there exist many techniques for inducing microalgal cells to produce and accumulate lipid with high efficiency, few analytical methods are available for characterizing a population of such lipid-accumulated microalgae including E. gracilis with high throughout, high accuracy, and single-cell resolution simultaneously. Here we demonstrate high-throughput, high-accuracy, single-cell screening of E. gracilis with fluorescence-assisted optofluidic time-stretch microscopy-a method that combines the strengths of microfluidic cell focusing, optical time-stretch microscopy, and fluorescence detection used in conventional flow cytometry. Specifically, our fluorescence-assisted optofluidic time-stretch microscope consists of an optical time-stretch microscope and a fluorescence analyzer on top of a hydrodynamically focusing microfluidic device and can detect fluorescence from every E. gracilis cell in a population and simultaneously obtain its image with a high throughput of 10,000 cells/s. With the multi-dimensional information acquired by the system, we classify nitrogen-sufficient (ordinary) and nitrogen-deficient (lipid-accumulated) E. gracilis cells with a low false positive rate of 1.0%. This method holds promise for evaluating cultivation techniques and selective breeding for microalgae-based biofuel production.	[Guo, Baoshan; Lei, Cheng; Jiang, Yiyue; Goda, Keisuke] Univ Tokyo, Dept Chem, Tokyo 1130033, Japan; [Lei, Cheng] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China; [Ito, Takuro; Goda, Keisuke] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Ozeki, Yasuyuki] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Goda, Keisuke] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA	University of Tokyo; Tsinghua University; Japan Science & Technology Agency (JST); University of Tokyo; University of California System; University of California Los Angeles	Lei, C; Goda, K (corresponding author), Univ Tokyo, Dept Chem, Tokyo 1130033, Japan.; Lei, C (corresponding author), Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China.; Goda, K (corresponding author), Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan.; Goda, K (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA.	leicheng@chem.s.u-tokyo.ac.jp; goda@chems.s.u-tokyo.ac.jp	GODA, KEISUKE/G-4997-2014; Guo, Baoshan/AAM-9544-2020	Guo, Baoshan/0000-0003-2508-7424; Goda, Keisuke/0000-0001-6302-6038; Ito, Takuro/0000-0001-5043-1886	ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); International Postdoctoral Exchange Fellowship Program of the Office of the China Postdoctoral Council; Burroughs Wellcome Fund; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); International Postdoctoral Exchange Fellowship Program of the Office of the China Postdoctoral Council; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). CL and KG were partly supported by the International Postdoctoral Exchange Fellowship Program 2014 of the Office of the China Postdoctoral Council and Burroughs Wellcome Fund, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). C. Lei and K. Goda were partly supported by the International Postdoctoral Exchange Fellowship Program 2014 of the Office of the China Postdoctoral Council and Burroughs Wellcome Fund, respectively. The fabrication of the microfluidic device was conducted at the Centre for Nano Lithography & Analysis, The University of Tokyo, supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Andersen R. A., 2005, ALGAL CULTURING TECH; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Chen CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21471; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Goda K, 2013, NAT PHOTONICS, V7, P102, DOI [10.1038/NPHOTON.2012.359, 10.1038/nphoton.2012.359]; Goda K, 2009, NATURE, V458, P1145, DOI 10.1038/nature07980; Goda K, 2012, P NATL ACAD SCI USA, V109, P11630, DOI 10.1073/pnas.1204718109; Hessen DO, 1997, FRESHWATER BIOL, V38, P513, DOI 10.1046/j.1365-2427.1997.00223.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Lamers PP, 2012, J BIOTECHNOL, V162, P21, DOI 10.1016/j.jbiotec.2012.04.018; LATASA M, 1994, J PLANKTON RES, V16, P83, DOI 10.1093/plankt/16.1.83; Lau AKS, 2016, LAB CHIP, V16, P1743, DOI 10.1039/c5lc01458a; Lei C, 2016, BIOMED OPT EXPRESS, V7, P2703, DOI 10.1364/BOE.7.002703; Lei C, 2016, APPL PHYS REV, V3, DOI 10.1063/1.4941050; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mujtaba G, 2012, BIORESOURCE TECHNOL, V123, P279, DOI 10.1016/j.biortech.2012.07.057; Narayanan A, 2006, LECT NOTES COMPUT SC, V3852, P335; Ogawa T, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0264-5; Ooka H, 2014, RSC ADV, V4, P20693, DOI 10.1039/c4ra02101k; Shapiro HM, 2005, PRACTICAL FLOW CYTOM; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Thoroddsen ST, 2008, ANNU REV FLUID MECH, V40, P257, DOI 10.1146/annurev.fluid.40.111406.102215; Ugawa M, 2015, OPT LETT, V40, P4803, DOI 10.1364/OL.40.004803; Watson J., 1991, FLUID FLOW DYNAMICS; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yamada K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26327	30	21	21	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166214	10.1371/journal.pone.0166214	http://dx.doi.org/10.1371/journal.pone.0166214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846239	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600040
J	Zhang, YL; Li, ZF; Feng, ZL; Feng, HJ; Shi, YQ; Zhao, LH; Zhang, XL; Zhu, HQ				Zhang, Ya-Lin; Li, Zhi-Fang; Feng, Zi-Li; Feng, Hong-Jie; Shi, Yong-Qiang; Zhao, Li-Hong; Zhang, Xi-Ling; Zhu, He-Qin			Functional Analysis of the Pathogenicity-Related Gene VdPR1 in the Vascular Wilt Fungus Verticillium dahliae	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; PROTEIN-KINASE GENE; MOLECULAR CHARACTERIZATION; MICROSCLEROTIA FORMATION; FUSARIUM-OXYSPORUM; HYDROPHOBIN GENE; V-DAHLIAE; EXPRESSION; VIRULENCE; TOOL	Verticillium dahliae Kleb., the causal agent of vascular wilt, can seriously diminish the yield and quality of many crops, including cotton. The pathogenic mechanism to cotton is complicated and unclear now. To screen pathogencity related genes and identify their function is the reliable way to explain the mechanism. In this study, we obtained a low-pathogenicity mutant vdpr1 from a T-DNA insertional library of the highly virulent isolate of V. dahliae Vd080, isolated from cotton. The tagged gene was named pathogenicity-related gene (VdPR1). The deletion mutant Delta VdPR1 did not form microsclerotia and showed a drastic reduction in spore yield and mycelial growth, compared to wild type. Also, Delta VdPR1 showed significantly lower protease and cellulase activities than those of wild type. Complementation of the mutant strain with VdPR1 (strain Delta VdPR1-C) almost completely rescued the attributes described above to wild-type levels. The knockout mutant Delta VdPR1 showed delayed infection, caused mild disease symptoms, formed a smaller biomass in roots of the host, and showed compromised systemic invasive growth in the xylem. These results suggest that VdPR1 is a multifaceted gene involved in regulating the growth development, early infection and pathogenicity of V. dahliae.	[Zhang, Ya-Lin; Li, Zhi-Fang; Feng, Zi-Li; Feng, Hong-Jie; Shi, Yong-Qiang; Zhao, Li-Hong; Zhang, Xi-Ling; Zhu, He-Qin] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, XL; Zhu, HQ (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China.	hainan1571@163.com; heqinanyang@163.com		Zhang, Yalin/0000-0002-3296-0239	Special Fund for Agro-scientific Research in the Public Interest [201503109]	Special Fund for Agro-scientific Research in the Public Interest	The Special Fund for Agro-scientific Research in the Public Interest (201503109). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank The Special Fund for Agro-scientific Research in the Public Interest (201503109) for the financial support.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; [邓晟 Deng Sheng], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3382; Dobinson KF, 1997, CAN J MICROBIOL, V43, P227, DOI 10.1139/m97-031; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Gao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015319; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Linder T, 2008, FUNGAL GENET BIOL, V45, P485, DOI 10.1016/j.fgb.2007.08.002; Liu SY, 2013, GENE, V529, P307, DOI 10.1016/j.gene.2013.06.089; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; [刘义杰 Liu Yijie], 2015, [植物病理学报, Acta Phytopathologica Sinica], V45, P258; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo XM, 2014, APPL MICROBIOL BIOT, V98, P6921, DOI 10.1007/s00253-014-5863-8; Mullins ED, 2001, CELL MOL LIFE SCI, V58, P2043, DOI 10.1007/PL00000835; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; ODonnell K, 1997, MYCOLOGIA, V89, P48, DOI 10.2307/3761172; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Pataky NR, 1997, REPORT PLANT DIS VER, P1010; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Rauyaree P, 2005, CURR GENET, V48, P109, DOI 10.1007/s00294-005-0586-0; Sambrook J, 2001, MOL CLONING LAB MANU, V999; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P278, DOI 10.1094/MPMI-09-12-0222-R; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P249, DOI 10.1094/MPMI-08-12-0198-R; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tian LL, 2014, GENE, V550, P238, DOI 10.1016/j.gene.2014.08.035; Tjamos EC, 1989, VASCULAR WILT DIS PL, P51; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Tzima A, 2010, FUNGAL GENET BIOL, V47, P406, DOI 10.1016/j.fgb.2010.01.007; Tzima AK, 2012, FUNGAL GENET BIOL, V49, P271, DOI 10.1016/j.fgb.2012.02.005; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Tran VT, 2014, NEW PHYTOL, V202, P565, DOI 10.1111/nph.12671; Wang JY, 2004, APPL ENVIRON MICROB, V70, P4989, DOI 10.1128/AEM.70.8.4989-4995.2004; Yajima W, 2006, PROTEOMICS, V6, P5995, DOI 10.1002/pmic.200600424; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang YL, 2015, CURR GENET, V61, P555, DOI 10.1007/s00294-015-0476-z; Zhou BJ, 2012, MOL PLANT MICROBE IN, V25, P964, DOI 10.1094/MPMI-12-11-0319; Zhou FF, 2012, ACTA AGR BOREALI OCC, V8, P004; Zhou L, 2013, J GENET GENOMICS, V40, P421, DOI 10.1016/j.jgg.2013.04.006; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402; Zhu HQ, 2013, J PHYTOPATHOL, V161, P70, DOI 10.1111/jph.12027	50	12	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166000	10.1371/journal.pone.0166000	http://dx.doi.org/10.1371/journal.pone.0166000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846253	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600027
J	Lima, L; Gaiteiro, C; Peixoto, A; Soares, J; Neves, M; Santos, LL; Ferreira, JA				Lima, Luis; Gaiteiro, Cristiana; Peixoto, Andreia; Soares, Janine; Neves, Manuel; Santos, Lucio Lara; Ferreira, Jose Alexandre			Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies	PLOS ONE			English	Article							HOUSEKEEPING GENES; INDUCIBLE FACTOR-1-ALPHA; PROSTATE-CANCER; QRT-PCR; RT-PCR; VALIDATION; SELECTION; IDENTIFICATION; NORMALIZATION; HIF-1	Highly aggressive, rapidly growing tumors contain significant areas of hypoxia or anoxia as a consequence of inadequate and/or irregular blood supply. During oxygen deprivation, tumor cells withstand a panoply of adaptive responses, including a shift towards anaerobic metabolism and the reprogramming of the transcriptome. One of the major mediators of the transcriptional hypoxic response is the hypoxia-inducible factor 1 (HIF-1), whose stabilization under hypoxia acts as an oncogenic stimulus contributing to chemotherapy resistance, invasion and metastasis. Gene expression analysis by qRT-PCR is a powerful tool for cancer cells phenotypic characterization. Nevertheless, as cells undergo a severe transcriptome remodeling. in response to oxygen deficit, the precise identification of reference genes poses a significant challenge for hypoxic studies. Herein, we aim to establish the best reference genes for studying the effects of hypoxia on bladder cancer cells. Accordingly, three bladder cancer cell lines (T24, 5637, and HT1376) representative of two distinct carcinogenesis pathways to invasive cancer (FGFR3/CCND1 and E2F3/RB1) were used. Additionally, we have explored the most suitable control gene when addressing the influence of Deferoxamine Mesilate salt (DFX), an iron chelator often used to avoid the proteasomal degradation of HIF-1 alpha, acting as an hypoxia-mimetic agent. Using bioinformatics tools (GeNorm and NormFinder), we have elected B2M and HPRT as the most stable genes for all cell lines and experimental conditions out of a panel of seven putative candidates (HPRT, ACTB, 18S, GAPDH, TBP, B2M, and SDHA). These observations set the molecular basis for future studies addressing the effect of hypoxia and particularly HIF-1 alpha in bladder cancer cells.	[Lima, Luis; Gaiteiro, Cristiana; Peixoto, Andreia; Soares, Janine; Neves, Manuel; Santos, Lucio Lara; Ferreira, Jose Alexandre] Portuguese Inst Oncol Porto IPO Porto, Expt Pathol & Therapeut Grp, Res Ctr, P-4200072 Oporto, Portugal; [Lima, Luis; Peixoto, Andreia; Ferreira, Jose Alexandre] Univ Porto, I3S, Oporto, Portugal; [Lima, Luis; Ferreira, Jose Alexandre] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4200135 Oporto, Portugal; [Peixoto, Andreia; Neves, Manuel; Ferreira, Jose Alexandre] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, P-4050313 Oporto, Portugal; [Santos, Lucio Lara] Hlth Sch Univ Fernando Pessoa, P-4249004 Oporto, Portugal; [Santos, Lucio Lara] Portuguese Inst Oncol Porto IPO Porto, Dept Surg Oncol, P-4200072 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Lima, L (corresponding author), Portuguese Inst Oncol Porto IPO Porto, Expt Pathol & Therapeut Grp, Res Ctr, P-4200072 Oporto, Portugal.; Lima, L (corresponding author), Univ Porto, I3S, Oporto, Portugal.; Lima, L (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4200135 Oporto, Portugal.	luis.carlos.lima@ipoporto.min-saude.pt	Santos, Lúcio Lara/AAE-2822-2021; Ferreira, José Alexandre/ABM-1695-2022; Peixoto, Andreia/AAG-4757-2021; Gaiteiro, Cristiana/M-1544-2014	Santos, Lúcio Lara/0000-0002-0521-5655; Ferreira, José Alexandre/0000-0002-0097-6148; Peixoto, Andreia/0000-0001-9514-0775; Lima, Luis/0000-0001-8152-9237; Soares, Eliana/0000-0002-1586-7120; Gaiteiro, Cristiana/0000-0001-5438-1679	Portuguese Foundation for Science and Technology [SFRH/BPD/66288/2009, SFRH/BPD/101827/2014, SFRH/BD/111242/2015]; European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF)	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF)	Some authors have postdoctoral grants SFRH/BPD/66288/2009 (JAF), SFRH/BPD/101827/2014 (LL), and PhD grants SFRH/BD/111242/2015 (AP) supported by Portuguese Foundation for Science and Technology (FCT - www.fct.pt). FCT is co-financed by European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Azevedo R, 2015, J CONTROL RELEASE, V214, P40, DOI 10.1016/j.jconrel.2015.07.002; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Chouaib S, 2017, ONCOGENE, V36, P439, DOI 10.1038/onc.2016.225; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Ferreira JA, 2016, DRUG RESIST UPDATE, V24, P34, DOI 10.1016/j.drup.2015.11.003; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Gadkar VJ, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0952-4; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Higashimura Y, 2011, ARCH BIOCHEM BIOPHYS, V509, P1, DOI 10.1016/j.abb.2011.02.011; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Kuwai T, 2003, INT J CANCER, V105, P176, DOI 10.1002/ijc.11068; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lima L, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.05.009; Lima L, 2014, UROL ONCOL-SEMIN ORI, V32, P449, DOI 10.1016/j.urolonc.2013.10.012; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Maltseva Diana V, 2013, J Clin Bioinforma, V3, P13, DOI 10.1186/2043-9113-3-13; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Mucaj V, 2012, INT J HEMATOL, V95, P464, DOI 10.1007/s12185-012-1070-5; Nascimento CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127935; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Pinto-Leite R, 2014, TUMOR BIOL, V35, P4599, DOI 10.1007/s13277-013-1604-3; Riemer AB, 2012, EXP DERMATOL, V21, P625, DOI 10.1111/j.1600-0625.2012.01537.x; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Said Harun M, 2009, BMC Res Notes, V2, P8, DOI 10.1186/1756-0500-2-8; Schmid T, 2004, J CELL MOL MED, V8, P423, DOI 10.1111/j.1582-4934.2004.tb00467.x; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Theodoropoulos VE, 2005, BJU INT, V95, P425, DOI 10.1111/j.1464-410X.2005.05314.x; Theodoropoulos VE, 2004, EUR UROL, V46, P200, DOI 10.1016/j.eururo.2004.04.008; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vajda A, 2013, PROSTATE, V73, P382, DOI 10.1002/pros.22578; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HJ, 2015, EXP MOL PATHOL, V98, P375, DOI 10.1016/j.yexmp.2014.10.014; Woo KJ, 2006, BIOCHEM BIOPH RES CO, V343, P8, DOI 10.1016/j.bbrc.2006.02.116; Wu C, 2013, ACTA BIOCH BIOPH SIN, V45, P780, DOI 10.1093/abbs/gmt072; Yao L, 2012, MOL BIOL REP, V39, P569, DOI 10.1007/s11033-011-0772-8; Zhao JD, 2015, CANCER TREAT REV, V41, P623, DOI 10.1016/j.ctrv.2015.05.004; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	54	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166120	10.1371/journal.pone.0166120	http://dx.doi.org/10.1371/journal.pone.0166120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835695	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200025
J	Das, A; Mahapatra, S; Mala, GS; Chaudhuri, I; Mahapatra, T				Das, Aritra; Mahapatra, Sanchita; Mala, Guntur Sai; Chaudhuri, Indrajit; Mahapatra, Tanmay			Association of Frontline Worker-Provided Services with Change in Block-Level Complementary Feeding Indicators: An Ecological Analysis from Bihar, India	PLOS ONE			English	Article							YOUNG-CHILDREN; DETERMINANTS; URBAN; NUTRITION; GROWTH	Background Insufficiencies in complementary feeding put infants and young children at increased risk of undernutrition. Till now, most Indian studies have looked at the individual level determinants of complementary feeding practices. We aimed to evaluate the association of frontline worker (FLW) provided nutritional counselling services, with change in community level indicators of complementary feeding practices among 9-11 month old children over time. Methods The study data was obtained from five rounds of 'Lot Quality Assurance Sampling' survey in eight districts of Bihar, an impoverished Indian state. The surveys were conducted as evaluation exercises for the 'Integrated Family Health Initiative (IFHI)'-a multi-faceted program aimed at improving the maternal and child health outcomes in Bihar. The main outcome indicators were-current breastfeeding, age-appropriate minimum frequency of semi-solid food, age-appropriate minimum quantity of semi-solid food, initiation of complementary feeding at the right age, and dietary diversity. Repeated measures analysis was performed to determine the association of changes in the outcome indicators with coverage of FLW-provided counselling services. Results Visits by FLW, advices on age-appropriate frequency and handwashing were significant predictors of receiving age-appropriate frequency of feeding. The determinants of receiving age-appropriate quantity were-advices on age appropriate frequency and advices on handwashing. Receiving food support from AWC and FLW visits were significantly associated with initiating complementary feeding at the right age. Conclusions The present study identified the critical elements among the different types of FLW-provided services. The study findings, from an economically and socially underdeveloped region of India, would inform the relevant programs about the nutritional counselling services that need to be emphasized upon for reducing the burden of childhood malnutrition.	[Das, Aritra; Mala, Guntur Sai; Chaudhuri, Indrajit; Mahapatra, Tanmay] CARE India Solut Sustainable Dev, H 14,Patliputra Colony, Patna, Bihar 800013, India; [Mahapatra, Sanchita] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, 650 Charles Young Dr South,Box 951772, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Mahapatra, T (corresponding author), CARE India Solut Sustainable Dev, H 14,Patliputra Colony, Patna, Bihar 800013, India.	drtanmaymahapatra@yahoo.com	Das, Aritra/C-9076-2014	Das, Aritra/0000-0002-7033-1441; Chaudhuri, Indrajit/0000-0002-8248-4402	Bill and Melinda Gates Foundation [OPP1016872CARE]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study, under Integrated Family Health Initiative (IFHI) project, was financially supported by a grant from the Bill and Melinda Gates Foundation (Grant ID# OPP1016872CARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; [Anonymous], 2010, HINDU; [Anonymous], 2001, DESCR COMP METH CLUS; [Anonymous], 2013, CAT CHANG HLTH COMM; Bhandari N, 2004, J NUTR, V134, P2342; Black MM, 2015, ADV NUTR, V6, P852, DOI 10.3945/an.115.010348; BROWN KH, 1998, COMPLEMENTARY FEEDIN; Das A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161186; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; Dewey KG., 2003, GUIDING PRINCIPLES C; Dodge H.F., 1959, SAMPLING INSPECTION; Hawkes C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0383-7; Huff-Rousselle M, 2007, ASSESSMENT DECENTRAL; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Kapur D, 2005, INDIAN PEDIATR, V42, P351; Khan M E, 1990, Asia Pac Popul J, V5, P71; Kimani-Murage EW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-396; Kristiansen AL, 2010, PUBLIC HEALTH NUTR, V13, P2087, DOI 10.1017/S1368980010002156; Kumar Sanjiv, 2016, Indian J Community Med, V41, P1, DOI 10.4103/0970-0218.170955; LANATA C F, 1991, World Health Statistics Quarterly, V44, P133; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; National Guidelines on Infant and Young Child Feeding, 2004, NAT GUID INF YOUNG C; Oommen A, 2009, INDIAN PEDIATR, V46, P891; PAHO, 2003, GUID PRINC COMPL FEE; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Patel A, 2010, FOOD NUTR BULL, V31, P314, DOI 10.1177/156482651003100221; Pezzoli L, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21921; Reinke WA, 1988, IND SAMPLING PLANS P; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; Roig AO, 2010, REV LAT-AM ENFERM, V18, P373, DOI 10.1590/S0104-11692010000300012; Sethi Vani, 2003, Indian Journal of Pediatrics, V70, P463; Steinmann P, 2015, J WATER SANIT HYG DE, V5, P474, DOI 10.2166/washdev.2015.101; UNICEF Uzbekistan, 2020, YOUTH UZB CHALL PROS; VALADEZ JJ, 1995, AM J PUBLIC HEALTH, V85, P1165, DOI 10.2105/AJPH.85.8_Pt_1.1165-a; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; WHO, 1996, WHOVRDTRAM9601; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166511	10.1371/journal.pone.0166511	http://dx.doi.org/10.1371/journal.pone.0166511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832211	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000132
J	Dolezal, AG; Hendrix, SD; Scavo, NA; Carrillo-Tripp, J; Harris, MA; Wheelock, MJ; O'Neal, ME; Toth, AL				Dolezal, Adam G.; Hendrix, Stephen D.; Scavo, Nicole A.; Carrillo-Tripp, Jimena; Harris, Mary A.; Wheelock, M. Joseph; O'Neal, Matthew E.; Toth, Amy L.			Honey Bee Viruses in Wild Bees: Viral Prevalence, Loads, and Experimental Inoculation	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; ACUTE PARALYSIS VIRUS; BOMBUS-TERRESTRIS; POLLINATORS; INFECTION; PATHOGEN; BUMBLEBEES; DECLINE; TRENDS	Evidence of inter-species pathogen transmission from managed to wild bees has sparked concern that emerging diseases could be causing or exacerbating wild bee declines. While some pathogens, like RNA viruses, have been found in pollen and wild bees, the threat these viruses pose to wild bees is largely unknown. Here, we tested 169 bees, representing 4 families and 8 genera, for five common honey bee (Apis mellifera) viruses, finding that more than 80% of wild bees harbored at least one virus. We also quantified virus titers in these bees, providing, for the first time, an assessment of viral load in a broad spectrum of wild bees. Although virus detection was very common, virus levels in the wild bees were minimal D similar to or lower than foraging honey bees and substantially lower than honey bees collected from hives. Furthermore, when we experimentally inoculated adults of two different bee species (Megachile rotundata and Colletes inaequalis) with a mixture of common viruses that is lethal to honey bees, we saw no effect on short term survival. Overall, we found that honey bee RNA viruses can be commonly detected at low levels in many wild bee species, but we found no evidence that these pathogens cause elevated short-term mortality effects. However, more work on these viruses is greatly needed to assess effects on additional bee species and life stages.	[Dolezal, Adam G.; Scavo, Nicole A.; Carrillo-Tripp, Jimena; Toth, Amy L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Hendrix, Stephen D.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Carrillo-Tripp, Jimena] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Harris, Mary A.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA; [Wheelock, M. Joseph; O'Neal, Matthew E.; Toth, Amy L.] Iowa State Univ, Dept Entomol, Ames, IA USA	Iowa State University; University of Iowa; Iowa State University; Iowa State University; Iowa State University	Dolezal, AG (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	adolezal@gmail.com			USDA-AFRI (United States Department of Agriculture, Agriculture and Food Research Initiative, Iowa State University Center for Virus-Insect Interactions) [2011-04894]; USDA-AFRI [2011-04894]; Iowa State University Center for Virus-Insect Interactions	USDA-AFRI (United States Department of Agriculture, Agriculture and Food Research Initiative, Iowa State University Center for Virus-Insect Interactions); USDA-AFRI(United States Department of Agriculture (USDA)); Iowa State University Center for Virus-Insect Interactions	Funded by USDA-AFRI (United States Department of Agriculture, Agriculture and Food Research Initiative, 2011-04894 Iowa State University Center for Virus-Insect Interactions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like the Iowa Lakeside Laboratory and the Friends of Lakeside Lab, the Iowa State University Horticulture Research Station, and the Iowa Agriculture and Home Economics Experiment Station. We also thank Steve J. Hanlin and the USDA-ARS North Central Region Plant Introduction Station for providing M. rotundata and advisement on their care and the Toth laboratory for comments on the manuscript. Amy Geffre provided bee illustrations for the figures. This work was supported by USDA-AFRI 2011-04894 and the Iowa State University Center for Virus-Insect Interactions.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Caron DM, 2009, HONEY BEE BIOL BEEKE; Carrillo-Tripp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22265; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Yanping, 2011, P105; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Database TPC, 2011, DAT TPC; Daughenbaugh KF, 2015, VIRUSES-BASEL, V7, P3285, DOI 10.3390/v7062772; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; Droege S, VERY HANDY MANUAL CA; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Gill KA, 2015, ENVIRON ENTOMOL, V44, P488, DOI 10.1093/ee/nvv001; Gisder S, 2015, VIRUSES-BASEL, V7, P5603, DOI 10.3390/v7102885; Goulson D, 2003, J FOOD AGRIC ENVIRON, V1, P142; Graystock P, INT J PARASITOLOGY P; Graystock P, 2016, INT J PARASITOL-PAR, V5, P64, DOI 10.1016/j.ijppaw.2015.10.001; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Graystock P, 2014, PEERJ, V2, DOI 10.7717/peerj.522; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hedtke SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130560; Hendrix SD, 2010, BIODIVERS CONSERV, V19, P1699, DOI 10.1007/s10531-010-9797-x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Manley R, 2015, J APPL ECOL, V52, P331, DOI 10.1111/1365-2664.12385; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Meeus I, 2014, J INVERTEBR PATHOL, V121, P64, DOI 10.1016/j.jip.2014.06.011; Michener CD, 2000, BEES WORLD, Vxiv; Michener CD, 1994, BEE GENERA N CENTRAL, Vviii; Mitchell T.B., 1960, BEES E US; Mitchell T.B., 1962, BEES E US; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sachman-Ruiz B, 2015, BIOL INVASIONS, V17, P2043, DOI 10.1007/s10530-015-0859-6; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Tehel A, 2016, CURR OPIN VIROL, V19, P16, DOI 10.1016/j.coviro.2016.06.006; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Yanez O, 2012, APIDOLOGIE, V43, P587, DOI 10.1007/s13592-012-0128-y; Zhang X, 2012, J INVERTEBR PATHOL, V109, P156, DOI 10.1016/j.jip.2011.09.010	53	54	54	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166190	10.1371/journal.pone.0166190	http://dx.doi.org/10.1371/journal.pone.0166190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832169	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000074
J	Ma, JP; Sun, Y; Yuan, XM; Kurths, J; Zhan, M				Ma, Jinpeng; Sun, Yong; Yuan, Xiaoming; Kurths, Juergen; Zhan, Meng			Dynamics and Collapse in a Power System Model with Voltage Variation: The Damping Effect	PLOS ONE			English	Article							STABILITY; SYNCHRONIZATION; BIFURCATIONS; ATTRACTORS; CRISES; CHAOS; GRIDS	Complex nonlinear phenomena are investigated in a basic power system model of the single-machine-infinite-bus (SMIB) with a synchronous generator modeled by a classical third order differential equation including both angle dynamics and voltage dynamics, the so-called flux decay equation. In contrast, for the second-order differential equation considering the angle dynamics only, it is the classical swing equation. Similarities and differences of the dynamics generated between the third-order model and the second-order one are studied. We mainly find that, for positive damping, these two models show quite similar behavior, namely, stable fixed point, stable limit cycle, and their coexistence for different parameters. However, for negative damping, the second-order system can only collapse, whereas for the third-order model, more complicated behavior may happen, such as stable fixed point, limit cycle, quasi-periodicity, and chaos. Interesting partial collapse phenomena for angle instability only and not for voltage instability are also found here, including collapse from quasi-periodicity and from chaos etc. These findings not only provide a basic physical picture for power system dynamics in the third-order model incorporating voltage dynamics, but also enable us a deeper understanding of the complex dynamical behavior and even leading to a design of oscillation damping in electric power systems.	[Ma, Jinpeng; Sun, Yong] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Ma, Jinpeng; Sun, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yuan, Xiaoming; Zhan, Meng] Huazhong Univ Sci & Technol, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China; [Kurths, Juergen] Potsdam Inst Climate Impact Res PIK, Potsdam, Germany; [Kurths, Juergen] Humboldt Univ, Dept Phys, Berlin, Germany; [Kurths, Juergen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen, Scotland	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong University of Science & Technology; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin; University of Aberdeen	Zhan, M (corresponding author), Huazhong Univ Sci & Technol, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China.	zhanmeng@hust.edu.cn	Zhan, Meng/A-9926-2008	Zhan, Meng/0000-0002-2331-2002	National Natural Science Foundation of China [11475253]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant No. 11475253. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABED EH, 1984, INT J ELEC POWER, V6, P37, DOI 10.1016/0142-0615(84)90034-6; Anderson PM, 2012, POWER SYSTEM CONTROL; ARAPOSTATHIS A, 1982, IEEE T CIRCUITS SYST, V29, P673, DOI 10.1109/TCS.1982.1085086; Bergen A R, 1986, POWER SYSTEMS ANAL; Caliskan SY, 2015, IEEE DECIS CONTR P, P6662, DOI 10.1109/CDC.2015.7403268; Carareto R, 2013, COMMUN NONLINEAR SCI, V18, P1035, DOI 10.1016/j.cnsns.2012.08.030; Carter G. K., 1941, T AM I ELECT ENG, V60, P116, DOI [10.1109/T-AIEE1941.5058292, DOI 10.1109/T-AIEE1941.5058292]; Chen HK, 2005, CHAOS SOLITON FRACT, V24, P1307, DOI 10.1016/j.chaos.2004.09.081; Chiang H. D., 2011, DIRECT METHODS STABI; CHUA LO, 1986, IEEE T CIRCUITS SYST, V33, P1072, DOI 10.1109/TCS.1986.1085869; DEMELLO FP, 1969, IEEE T POWER AP SYST, VPA88, P316, DOI 10.1109/TPAS.1969.292452; Dhooge A., 2011, MATCONT 150 MATCONT; DOBSON I, 1989, SYST CONTROL LETT, V13, P253, DOI 10.1016/0167-6911(89)90072-8; Dobson I., 2001, CIRCUITS SYSTEMS 1 F, V48, P349; Dorfler F, 2013, P NATL ACAD SCI USA, V110, P2005, DOI 10.1073/pnas.1212134110; Du-Qu Wei, 2011, Proceedings of the Fourth International Workshop on Chaos-Fractals Theories and Applications (IWCFTA 2011), P295, DOI 10.1109/IWCFTA.2011.8; Gajduk A, 2014, EUR PHYS J-SPEC TOP, V223, P2387, DOI 10.1140/epjst/e2014-02212-1; GREBOGI C, 1983, PHYSICA D, V7, P181, DOI 10.1016/0167-2789(83)90126-4; Ji W, 1996, INT J ELEC POWER, V18, P279, DOI 10.1016/0142-0615(95)00066-6; Ji WJ, 1995, PROCEEDINGS OF THE 34TH IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-4, P3465, DOI 10.1109/CDC.1995.479121; Kundur P., 2007, POWER SYSTEM STABILI, V10; Liwschitz M M, 1941, ELECTRON ENG, V60, P210, DOI [10.1109/T-AIEE.1941.5058316, DOI 10.1109/T-AIEE.1941.5058316]; Lu JH, 2006, INT J BIFURCAT CHAOS, V16, P775, DOI 10.1142/S0218127406015179; Lu Q, 1982, OPTIMAL CONTROL TRAN; Ma ML, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/3/030501; Machowski J., 2008, POWER SYSTEM DYNAMIC, V2nd; Mahmud MA, 2012, INT J ELEC POWER, V41, P54, DOI 10.1016/j.ijepes.2012.03.007; Manjarekar NS, 2010, INT J ELEC POWER, V32, P63, DOI 10.1016/j.ijepes.2009.06.010; Menck PJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4969; Monshizadeh P, 2016, ARXIV160307440; Motter AE, 2013, NAT PHYS, V9, P191, DOI 10.1038/nphys2535; Ni Y.X., 2002, DYNAMIC THEORY ANAL; Nishikawa T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/015012; Paganini F, 2002, IEEE T CIRCUITS SYST, V46, P760; Quattrociocchi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087986; Rohden M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.064101; Rongxiang Yuan, 2012, Journal of Control Theory and Applications, V10, P554, DOI 10.1007/s11768-012-0168-x; Schmietendorf K, 2014, EUR PHYS J-SPEC TOP, V223, P2577, DOI 10.1140/epjst/e2014-02209-8; Sen Gupta D. P., 1985, IEE Proceedings C (Generation, Transmission and Distribution), V132, P109, DOI 10.1049/ip-c.1985.0023; Simpson-Porco JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10790; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Subbarao D, 2004, IEEE T POWER SYST, V19, P1918, DOI 10.1109/TPWRS.2004.836203; Sun YZ, 2001, ELECTR POW SYST RES, V57, P123, DOI 10.1016/S0378-7796(01)00085-2; Susuki Y, 2011, J NONLINEAR SCI, V21, P403, DOI 10.1007/s00332-010-9087-5; van der Schaft A, 2016, ANNU REV CONTROL, V41, P119, DOI 10.1016/j.arcontrol.2016.04.017; VARAIYA P, 1985, P IEEE, V73, P1703, DOI 10.1109/PROC.1985.13366; Venkatasubramanian V, 1999, IEEE T CIRCUITS-I, V46, P405, DOI 10.1109/81.751316; WANG HO, 1994, IEEE T CIRCUITS-I, V41, P294, DOI 10.1109/81.285684; Wang X., 2014, B PATIENTS RHEUM ART, V2014, P1; Wang XD, 2015, APPL MATH MODEL, V39, P2951, DOI 10.1016/j.apm.2014.11.018; Wei DQ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/50008; Wei DQ, 2010, NONLINEAR DYNAM, V61, P477, DOI 10.1007/s11071-010-9663-0	52	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165943	10.1371/journal.pone.0165943	http://dx.doi.org/10.1371/journal.pone.0165943			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832098	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000044
J	Szigeti, A; Ecsedy, M; Schneider, M; Lenart, L; Lesch, B; Nagy, ZZ; Fekete, A; Recsan, Z				Szigeti, Andrea; Ecsedy, Monika; Schneider, Miklos; Lenart, Lilla; Lesch, Balazs; Nagy, Zoltan Zsolt; Fekete, Andrea; Recsan, Zsuzsanna			Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHEMOKINE GENE VARIANT; FACTOR-I; OCULAR NEOVASCULARIZATION; EXPRESSION; CELLS; ADHESION; CXCR4; RETINOPATHY; MIGRATION	Background Stromal cell-derived factor 1 (SDF1) has crucial role in the regulation of angiogenesis and ocular neovascularisation (NV). The purpose of this study was to evaluate the association Methods 130 patients with RVO (median age: 69.0, range 35-93 years; male/female-58/72; 55 patients had central RVO, 75 patients had branch RVO) were enrolled in this study. In the RVO group, 40 (30.8%) patients were diagnosed with NV complications of RVO and 90 (69.2%) patients without NVs. The median follow up period was 40.3 months (range: 18-57 months). The SDF1-3'G(801) A polymorphism was detected by PCR-RFLP. Allelic prevalence was related to reference values obtained in the control group consisted of 125 randomly selected, age and gender matched, unrelated volunteers (median age: 68.0, range 36-95 years; male/female -53/72). Statistical analysis of the allele and genotype differences between groups (RVO patients vs controls; RVO patients with NV vs RVO patients without NV) was determined by chi-squared test. P value of <0.05 was considered statistically significant. Results Hardy-Weinberg criteria was fulfilled in all groups. The SDF1-3'G(801) A allele and genotype frequencies of RVO patients were similar to controls (SDF1-3'A allele: 22.3% vs 20.8%; SDF1-3'(801) AA: 5.4% vs 4.8%, SDF1-3'(801) GG: 60.8% vs 63.2%). The frequency of SDF1-3'(801) AA and SDF1-3'(801) GA genotypes, as well as the SDF1-3'(801) A allele frequency were higher in RVO patients with NV versus in patients without NV complication (SDF1-3'(801) AA+AG genotypes: 57.5% vs 31.1%, p = 0.008; SDF1-3'(801) A allele: 35.0% vs 16.7%, p = 0.002) or versus controls (SDF1-3'(801) AA+AG genotypes 57.5% vs 36.8%, p = 0.021; SDF1-3'(801) A allele: 35.0% vs 20.8% p = 0.01). Carrying of SDF1-3'(801) A allele increased the risk of neovascularisation complications of RVO by 2.69 ( OR, 95% CI = 1.47-4.93). Conclusion These findings suggest that carrying SDF1-3'( 801) A allele plays a role in the development of neovascular complications in retinal vein occlusion.	[Szigeti, Andrea; Ecsedy, Monika; Schneider, Miklos; Lesch, Balazs; Nagy, Zoltan Zsolt; Recsan, Zsuzsanna] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Lenart, Lilla; Fekete, Andrea] Hungarian Acad Sci, MTA SE Lendulet Diabet Res Grp, Res Lab Pediat & Nephrol, Budapest, Hungary; [Lenart, Lilla; Fekete, Andrea] Semmelweis Univ, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Recsan, Z (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	zsrecsan@gmail.com	Schneider, Miklos/E-7128-2018; Nagy, Zoltan Zsolt/T-6180-2017	Schneider, Miklos/0000-0003-1488-4743; 	OTKA [K112629]; MTA-SE Lendulet Diabetes Research Grant [LP-008/2015]; BELSZEM MED Kft	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA-SE Lendulet Diabetes Research Grant; BELSZEM MED Kft	This study was founded by grants of OTKA K112629- and MTA-SE Lendulet Diabetes Research Grant (LP-008/2015) and BELSZEM MED Kft. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors have no financial or proprietary interest in any material or method mentioned.; This study was founded by grants of OTKA K112629- and MTA-SE Lendulet Diabetes Research Grant (LP-008/2015) and BELSZEMMED Kft.	Abu El-Asrar AM, 2006, EUR CYTOKINE NETW, V17, P155, DOI 10.1684/ecn.2006.0033; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Browning DJ., 2012, RETINAL VEIN OCCLUSI; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Butler JM., 2006, THESIS U FLORIDA; Cardones AR, 2003, CANCER RES, V63, P6751; Chen LY, 2010, CHINESE MED J-PEKING, V123, P984, DOI 10.3760/cma.j.issn.0366-6999.2010.08.002; Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x; Djuric Z, 2010, ACTA DIABETOL, V47, P79, DOI 10.1007/s00592-009-0119-2; Dubois-Laforgue D, 2001, DIABETES, V50, P1211, DOI 10.2337/diabetes.50.5.1211; FUNDERBURK RL, 1989, ANN OPHTHALMOL, V21, P65; Glass TJ, 2011, BLOOD, V118, P766, DOI 10.1182/blood-2011-01-328476; Gu XL, 2014, BIOCHEM BIOPH RES CO, V443, P932, DOI 10.1016/j.bbrc.2013.12.065; Hayreh SS, 2007, PROG RETIN EYE RES, V26, P470, DOI 10.1016/j.preteyeres.2007.06.001; Hayreh SS, 2012, RETINA-J RET VIT DIS, V32, P1553, DOI 10.1097/IAE.0b013e318246912c; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P488; Ide A, 2003, HUM IMMUNOL, V64, P973, DOI 10.1016/S0198-8859(03)00176-9; Joussen A. M., 2007, RETINAL VASCULAR DIS; Ki-I Y, 2007, CURR EYE RES, V32, P1065, DOI 10.1080/02713680701758727; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Lam FC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008732.pub2; Luan B, 2010, MOL BIOL REP, V37, P399, DOI 10.1007/s11033-009-9845-3; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj.gt.3301723; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; ROSENBERG N, 1986, ARCH OPHTHALMOL-CHIC, V104, P34; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Santiago JG, 2009, INVEST OPHTHALMOL, V50, P3720; SHILLING JS, 1976, BRIT J OPHTHALMOL, V60, P810, DOI 10.1136/bjo.60.12.810; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; Sonmez K, 2008, OPHTHALMOLOGY, V115, P1065, DOI 10.1016/j.ophtha.2007.08.050; Warchol T, 2010, MOL BIOL REP, V37, P3121, DOI 10.1007/s11033-009-9890-y; Yannuzzi LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P545	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166544	10.1371/journal.pone.0166544	http://dx.doi.org/10.1371/journal.pone.0166544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832196	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000387725000134
J	Tu, CY; Carr, J; Suweis, S				Tu, Chengyi; Carr, Joel; Suweis, Samir			A Data Driven Network Approach to Rank Countries Production Diversity and Food Specialization	PLOS ONE			English	Article							COMPETITION; NESTEDNESS; LAND; WEB	The easy access to large data sets has allowed for leveraging methodology in network physics and complexity science to disentangle patterns and processes directly from the data, leading to key insights in the behavior of systems. Here we use country specific food production data to study binary and weighted topological properties of the bipartite country food production matrix. This country-food production matrix can be: 1) transformed into overlap matrices which embed information regarding shared production of products among countries, and or shared countries for individual products, 2) identify subsets of countries which produce similar commodities or subsets of commodities shared by a given country allowing for visualization of correlations in large networks, and 3) used to rank country fitness (the ability to produce a diverse array of products weighted on the type of food commodities) and food specialization (quantified on the number of countries producing a specific food product weighted on their fitness). Our results show that, on average, countries with high fitness produce both low and high specializion food commodities, whereas nations with low fitness tend to produce a small basket of diverse food products, typically comprised of low specializion food commodities.	[Tu, Chengyi; Suweis, Samir] Univ Padua, Dept Phys & Astron, I-35131 Padua, Italy; [Carr, Joel] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA	University of Padua; University of Virginia	Suweis, S (corresponding author), Univ Padua, Dept Phys & Astron, I-35131 Padua, Italy.	suweis@pd.infn.it		Carr, Joel/0000-0002-9164-4156; Suweis, Samir/0000-0002-1603-8375				Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Azaele S, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035003; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bustos S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049393; Caldarelli G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047278; Carr JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055825; Cristelli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117174; Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726; Davis KF, 2015, SCI TOTAL ENVIRON, V538, P817, DOI 10.1016/j.scitotenv.2015.08.126; Davis KF, 2015, NAT GEOSCI, V8, P772, DOI [10.1038/ngeo2540, 10.1038/NGEO2540]; Dominguez-Garcia V, 2015, SCI REP-UK, V5, DOI 10.1038/srep08182; Eurostat, 2015, EUR QUIN MARK CONT F; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Konar M, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010307; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman M, 2010, NETWORKS INTRO, DOI 10.1093/acprof:oso/9780199206650.001.0001; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; O'Bannon C, 2014, HYDROL EARTH SYST SC, V18, P503, DOI 10.5194/hess-18-503-2014; Ricardo D., 1891, PRINCIPLES POLITICAL; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Seaquist JW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114006; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Suweis S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046837; Suweis S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10179; Suweis S, 2015, P NATL ACAD SCI USA, V112, P6902, DOI 10.1073/pnas.1507366112; Suweis S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101851; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Tacchella A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00723; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	34	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165941	10.1371/journal.pone.0165941	http://dx.doi.org/10.1371/journal.pone.0165941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832118	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000043
J	Zhou, W; Zhang, X; Zhu, CL; He, ZY; Liang, JP; Song, ZC				Zhou, Wei; Zhang, Xuan; Zhu, Cai-Lian; He, Zhi-Yan; Liang, Jing-Ping; Song, Zhong-Chen			Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response	PLOS ONE			English	Article							OXIDATIVE STRESS; IL-8 PRODUCTION; P. GINGIVALIS; FIBROBLASTS; BACTERIAL; LIPOPOLYSACCHARIDE; ANTIOXIDANT; EXPRESSION; BIOFILMS; GENES	Aim "Perioceutics" including antimicrobial therapy and host modulatory therapy has emerged as a vital adjunctive treatment of periodontal disease. Melatonin level was significantly reduced in patients with periodontal diseases suggesting melatonin could be applied as a potential "perioceutics" treatment of periodontal diseases. This study aims to investigate the effects of melatonin receptor agonists (melatonin and ramelteon) on Porphyromonas gingivalis virulence and Porphyromonas gingivalis-derived lipopolysaccharide (Pg-LPS)-induced inflammation. Methods Effects of melatonin receptor agonists on Porphyromonas gingivalis planktonic cultures were determined by microplate dilution assays. Formation, reduction, and viability of Porphyromonas gingivalis biofilms were detected by crystal violet staining and MTT assays, respectively. Meanwhile, biofilms formation was also observed by confocal laser scanning microscopy (CLSM). The effects on gingipains and hemolytic activities of Porphyromonas gingivalis were evaluated using chromogenic peptides and sheep erythrocytes. The mRNA expression of virulence and iron/heme utilization was assessed using RT-PCR. In addition, cell viability of melatonin receptor agonists on human gingival fibroblasts (HGFs) was evaluated by MTT assays. After pretreatment of melatonin receptor agonists, HGFs were stimulated with Pg-LPS and then release of cytokines (IL-6 and lL-8) was measured by enzyme-linked immunosorbent assay (ELISA). Results Melatonin and ramelteon did exhibit antimicrobial effects against planktonic culture. Importantly, they inhibited biofilm formation, reduced the established biofilms, and decreased biofilm viability of Porphyromonas gingivalis. Furthermore, they at sub-minimum inhibitory concentration (sub-MIC) concentrations markedly inhibited the proteinase activities of gingipains and hemolysis in a dose-dependent manner. They at sub-MIC concentrations significantly inhibited the mRNA expression of virulence factors (kgp, rgpA, rgpB, hagA, and ragA), while increasing the mRNA expression of ferritin (ftn) or hemolysin (hem). They did not show obvious cytotoxicity toward HGFs. They inhibited Pg-LPS-induced IL-6 and IL-8 secretion, which was reversed by luzindole, the melatonin receptor antagonist. Conclusion Melatonin receptor agonists can inhibit planktonic and biofilm growth of Porphyromonas gingivalis by affecting the virulent properties, as well as Pg-LPS-induced inflammatory response. Our study provides new evidence that melatonin receptor agonists might be useful as novel "perioceutics" agents to prevent and treat Porphyromonas gingivalis-associated periodontal diseases.	[Zhou, Wei; Song, Zhong-Chen] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Periodontol,Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Zhou, Wei; Zhu, Cai-Lian; He, Zhi-Yan; Liang, Jing-Ping] Shanghai Jiao Tong Univ, Shanghai Res Inst Stomatol, Peoples Hosp 9, Shanghai Key Lab Stomatol,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 1, Peoples R China; [Zhang, Xuan] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Pharm, Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Song, ZC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Periodontol,Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Liang, JP (corresponding author), Shanghai Jiao Tong Univ, Shanghai Res Inst Stomatol, Peoples Hosp 9, Shanghai Key Lab Stomatol,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 1, Peoples R China.	liangjpdentist@126.com; szhongchen@sina.com			National Natural Science Foundation of China [81271156, 81670992]; Shanghai Municipal Education Commission - Summit & Plateau Disciplines [20152523]; Shanghai Jiao Tong University Cooperation Grant of Medicine, Science, Engineering [YG2015007, YG2015M504]; Chinese Stomatological Association Grant [CSA-Y2015-01]; Shanghai Cooperation of Industry, University and Research Institute; Shanghai Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission - Summit & Plateau Disciplines; Shanghai Jiao Tong University Cooperation Grant of Medicine, Science, Engineering; Chinese Stomatological Association Grant; Shanghai Cooperation of Industry, University and Research Institute; Shanghai Education Commission	This work was supported by the National Natural Science Foundation of China (No.81271156, No.81670992), Shanghai Municipal Education Commission - Summit & Plateau Disciplines (No.20152523), Shanghai Jiao Tong University Cooperation Grant of Medicine, Science, Engineering (YG2015007, YG2015M504), Chinese Stomatological Association Grant (CSA-Y2015-01), Shanghai Cooperation of Industry, University and Research Institute by Shanghai Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolsamadi Hamidreza, 2014, J Dent Res Dent Clin Dent Prospects, V8, P160, DOI 10.5681/joddd.2014.029; Belanger M, 2012, ANAEROBE, V18, P128, DOI 10.1016/j.anaerobe.2011.10.005; Bodet C, 2006, J ANTIMICROB CHEMOTH, V57, P685, DOI 10.1093/jac/dkl031; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Carocci A, 2014, CLIN PHARMACOL-ADV A, V6, P127, DOI 10.2147/CPAA.S36600; Chava VK, 2012, INT J DENT, V2012, DOI 10.1155/2012/720185; Choi EY, 2011, J PINEAL RES, V50, P197, DOI 10.1111/j.1600-079X.2010.00829.x; CHU L, 1991, INFECT IMMUN, V59, P1932, DOI 10.1128/IAI.59.6.1932-1940.1991; Cogo K, 2012, J PERIODONTAL RES, V47, P766, DOI 10.1111/j.1600-0765.2012.01494.x; CURTIS MA, 1991, ORAL MICROBIOL IMMUN, V6, P321, DOI 10.1111/j.1399-302X.1991.tb00502.x; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Cutando A, 2014, ODONTOLOGY, V102, P290, DOI 10.1007/s10266-013-0122-5; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Ghallab NA, 2016, AUST DENT J, V61, P53, DOI 10.1111/adj.12294; Gomez-Florit M, 2013, BIOCHEM PHARMACOL, V86, P1784, DOI 10.1016/j.bcp.2013.10.009; Graziano TS, 2014, J PERIODONTAL RES, V49, P660, DOI 10.1111/jre.12148; Gulati Minkle, 2014, J Indian Soc Periodontol, V18, P282, DOI 10.4103/0972-124X.134559; Gulle K, 2014, J PERIODONTAL RES, V49, P736, DOI 10.1111/jre.12156; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hiratsuka K, 2010, MICROB PATHOGENESIS, V48, P116, DOI 10.1016/j.micpath.2010.01.001; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Kadowaki T, 2003, CURR PROTEIN PEPT SC, V4, P451, DOI 10.2174/1389203033486992; Kara A, 2013, FREE RADICAL BIO MED, V55, P21, DOI 10.1016/j.freeradbiomed.2012.11.002; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Konar V, 2000, BIOORG CHEM, V28, P214, DOI 10.1006/bioo.2000.1173; Kong LX, 2015, ARCH ORAL BIOL, V60, P12, DOI 10.1016/j.archoralbio.2014.08.019; Elmahallawy EK, 2014, CHEM-BIOL INTERACT, V220, P84, DOI 10.1016/j.cbi.2014.06.016; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lepine G, 1996, INFECT IMMUN, V64, P1467; Li JY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/909870; Limson J, 1998, J PINEAL RES, V24, P15, DOI 10.1111/j.1600-079X.1998.tb00361.x; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Lo A, 2010, J BACTERIOL, V192, P1332, DOI 10.1128/JB.01211-09; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Mathes AM, 2008, CRIT CARE MED, V36, P2863, DOI 10.1097/CCM.0b013e318187b863; Murakami Yukio, 2012, ISRN Dent, V2012, P350859, DOI 10.5402/2012/350859; Nakayama K, 2003, CURR PROTEIN PEPT SC, V4, P389, DOI 10.2174/1389203033486983; Olsen I, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.24800; Ozturk AI, 2000, CELL BIOCHEM FUNCT, V18, P117; Pandi-Perumal SR, 2009, ADV THER, V26, P613, DOI 10.1007/s12325-009-0041-6; Patel M., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/624089; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Reiter RJ, 2015, J PERIODONTAL RES, V50, P9, DOI 10.1111/jre.12176; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Ryan Maria Emanuel, 2005, Dent Clin North Am, V49, P611, DOI 10.1016/j.cden.2005.03.010; Saito T, 2011, ARCH ORAL BIOL, V56, P244, DOI 10.1016/j.archoralbio.2010.09.014; Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608; Schuck DC, 2014, EUR J MED CHEM, V78, P375, DOI 10.1016/j.ejmech.2014.03.055; Slots J, 2000, PERIODONTOL 2000, V22, P7; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Tang HJ, 2012, J ANTIMICROB CHEMOTH, V67, P944, DOI 10.1093/jac/dkr535; Tekbas OF, 2008, J PINEAL RES, V44, P222, DOI 10.1111/j.1600-079X.2007.00516.x; Thurnheer T, 2014, ARCH ORAL BIOL, V59, P977, DOI 10.1016/j.archoralbio.2014.05.023; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Vanterpool E, 2004, INFECT IMMUN, V72, P5555, DOI 10.1128/IAI.72.10.5555-5564.2004; Wang HX, 2001, COMP BIOCHEM PHYS C, V130, P379, DOI 10.1016/S1532-0456(01)00264-2; Wang Q, 2016, ARCH ORAL BIOL, V62, P28, DOI 10.1016/j.archoralbio.2015.11.007; Wei GX, 2006, J ANTIMICROB CHEMOTH, V57, P1100, DOI 10.1093/jac/dkl120; Wendell KJ, 2001, J PERIODONTOL, V72, P1038, DOI 10.1902/jop.2001.72.8.1038; Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79; Zhang D., 2013, THESIS	68	24	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166442	10.1371/journal.pone.0166442	http://dx.doi.org/10.1371/journal.pone.0166442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832188	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000125
J	Lin, MT; Wang, CC; Cheng, YF; Eng, HL; Yen, YH; Tsai, MC; Tseng, PL; Chang, KC; Wu, CK; Hu, TH				Lin, Ming-Tsung; Wang, Chih-Chi; Cheng, Yu-Fan; Eng, Hock-Liew; Yen, Yi-Hao; Tsai, Ming-Chao; Tseng, Po-Lin; Chang, Kuo-Chin; Wu, Cheng-Kun; Hu, Tsung-Hui			Comprehensive Comparison of Multiple Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis	PLOS ONE			English	Article							CIRRHOTIC LIVER; ADENOMATOUS HYPERPLASIA; SPIRAL CT; PHASE; TUMOR; GUIDELINE; RISK	Background & Aims Liver computed tomography and dynamic magnetic resonance imaging play an important role in the early detection of hepatocellular carcinoma. However, the American Association for the Study of Liver Diseases (AASLD) recommend the use of applied imaging studies for HCC diagnosis only in cirrhotic patients. This study aimed to comprehensively compare liver CT and dynamic MRI for HCC diagnosis before surgical resection over years in clinical practice, and also to compare the diagnostic differences between liver CT and dynamic MRI in HCCs with varying degrees of fibrosis. Methods 841 patients with liver tumor who had liver CT or dynamic MRI examinations followed by surgical resection were included in the study. We defined typical HCC imaging characteristics as early enhancement in the artery phase and early washout in the venous phase. The tumor size was recorded based on pathological examination after surgery. The pathologic fibrosis score was verified by the METAVIR scoring classification. Results Among the 841 patients, 756 underwent liver CT and 204 underwent dynamic liver MRI before surgery. The etiologies of chronic liver disease included hepatitis B virus, hepatitis C virus, hepatitis B and C virus, and non-hepatitis B or C virus. The sensitivity and accuracy of liver CT or MRI for HCC diagnosis was approximately 80%similar to 90%. Liver CT had a diagnostic accuracy for HCC similar to that of dynamic MRI, and liver fibrosis stage did not influence their diagnostic efficacies. Conclusions The application of 4-phase dynamic CT and MRI exhibit similar diagnostic accuracy for hepatocellular carcinoma, in tumors of sizes 1 to 2 cm and >2 cm. Liver fibrosis status did not affect the diagnostic accuracy of liver CT or MRI for HCC. The AASLD and EASL restrictions of dynamic imaging studies for HCC diagnosis to cirrhotic patients alone are unnecessary.	[Lin, Ming-Tsung; Yen, Yi-Hao; Tsai, Ming-Chao; Tseng, Po-Lin; Chang, Kuo-Chin; Wu, Cheng-Kun; Hu, Tsung-Hui] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Wang, Chih-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan; [Eng, Hock-Liew] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Lin, Ming-Tsung; Hu, Tsung-Hui] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hu, TH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan.; Hu, TH (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.	dr.hu@msa.hinet.net	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051				BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Brancatelli G, 2001, RADIOLOGY, V219, P69, DOI 10.1148/radiology.219.1.r01ap3269; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; BUKH J, 1993, P NATL ACAD SCI USA, V90, P1848, DOI 10.1073/pnas.90.5.1848; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Davis Gary L, 2008, Proc (Bayl Univ Med Cent), V21, P266; Furlan A, 2011, BRIT J RADIOL, V84, P403, DOI 10.1259/bjr/18329080; Iavarone M, 2010, HEPATOLOGY, V52, P1723, DOI 10.1002/hep.23903; IKEDA K, 1993, HEPATOLOGY, V18, P47, DOI 10.1016/0270-9139(93)90505-H; Izumi N, 2010, ONCOLOGY-BASEL, V78, P78, DOI 10.1159/000315234; Jiang Yuan-yuan, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P767; Kageyama F, 1998, AM J GASTROENTEROL, V93, P2588, DOI 10.1016/S0002-9270(98)00608-X; Kim SE, 2011, LIVER INT; Kim TK, 1998, RADIOLOGY, V208, P597, DOI 10.1148/radiology.208.3.9722834; Kojiro Masamichi, 2004, Liver Transpl, V10, pS3, DOI 10.1002/lt.20042; Krinsky GA, 1998, RADIOLOGY, V209, P461, DOI 10.1148/radiology.209.2.9807574; Lee DH, 2009, INVEST RADIOL, V44, P311, DOI 10.1097/RLI.0b013e31819c9f44; Lee KHY, 2004, AM J ROENTGENOL, V182, P643, DOI 10.2214/ajr.182.3.1820643; Lencioni Riccardo, 2008, Expert Rev Gastroenterol Hepatol, V2, P697, DOI 10.1586/17474124.2.5.697; Lin MT, 2015, J GASTROEN HEPATOL, V30, P345, DOI 10.1111/jgh.12699; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; McMahon BJ, 2000, HEPATOLOGY, V32, P842, DOI 10.1053/jhep.2000.17914; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062; Sofue K, 2010, EUR J RADIOL; Stigliano R, 2007, CANCER TREAT REV, V33, P437, DOI 10.1016/j.ctrv.2007.04.001; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Wong LL, 2000, LIVER TRANSPLANT, V6, P320, DOI 10.1053/lv.2000.4875; 2009, HEPATOLOGY, V49, P658, DOI DOI 10.1002/HEP.22709	33	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166157	10.1371/journal.pone.0166157	http://dx.doi.org/10.1371/journal.pone.0166157			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829060	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300091
J	Chen, HM; Lin, HF; Huang, MF; Chang, CW; Yeh, YC; Lo, YC; Yen, CF; Chen, CS				Chen, Hui-Mei; Lin, Hsiu-Fen; Huang, Mei-Feng; Chang, Chun-Wei; Yeh, Yi-Chun; Lo, Yi-Ching; Yen, Cheng-Fang; Chen, Cheng-Sheng			Validation of Taiwan Performance-Based Instrumental Activities of Daily Living (TPIADL), a Performance- Based Measurement of Instrumental Activities of Daily Living for Patients with Vascular Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OLDER-ADULTS; DEMENTIA	Objective Patients with cerebrovascular diseases often presented both cognitive and physical impairment. Disability in everyday functioning involving cognitive impairment among patients may be hard to completely rely on informants' reports, as their reports may be confounded with physical impairment. The aim of this study was to validate a performance-based measure of functional assessment, the Taiwan Performance-Based Instrumental Activities of Daily Living (TPIADL), for vascular cognitive impairment (VCI) by examining its psychometric properties and diagnostic accuracy. Methods Ninety-seven patients with cerebrovascular diseases, including 30 with vascular dementia (VaD), 28 with mild cognitive impairment and 39 with no cognitive impairment, and 49 healthy control adults were recruited during study period. The TPIADL, as well as the Mini Mental State Examination (MMSE), Lawton-IADL and Barthel Index (BI), were performed. The internal consistency, convergent and criteria validity of the TPIADL were examined. Results Cronbach's alpha of the TPIADL test was 0.84. The TPIADL scores were significantly correlated with the Lawton IADL (r = -0.587, p <0.01). Notably, the TPIADL had a higher correlation coefficient with the cognitive domain of Lawton IADL (r = -0.663) than with physical domain of Lawton IADL (r = -0.541). The area under the relative operating characteristic curve was 0.888 (95% CI = 0.812 -0.965) to differentiate VaD from other groups. The optimal cut-off point of the TPIADL for detecting VaD was 6/7, which gives a sensitivity of 73.3% and a specificity of 84.5%. Conclusion The TPIADL is a brief and sensitive tool for the detection of IADL impairment in patients with VaD.	[Chen, Hui-Mei; Chang, Chun-Wei] Kaohsiung Med Univ, Dept Occupat Therapy, Coll Hlth Sci, Kaohsiung, Taiwan; [Lin, Hsiu-Fen] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Huang, Mei-Feng; Yeh, Yi-Chun; Yen, Cheng-Fang; Chen, Cheng-Sheng] Kaohsiung Med Univ Hosp, Dept Psychiat 3, Kaohsiung, Taiwan; [Chen, Hui-Mei; Huang, Mei-Feng; Yeh, Yi-Chun] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Lin, Hsiu-Fen] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Huang, Mei-Feng; Yeh, Yi-Chun; Yen, Cheng-Fang; Chen, Cheng-Sheng] Kaohsiung Med Univ, Dept Psychiat, Coll Med, Kaohsiung, Taiwan; [Lo, Yi-Ching] Kaohsiung Med Univ, Dept Pharmacol, Coll Med, Kaohsiung, Taiwan; [Lo, Yi-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yen, CF; Chen, CS (corresponding author), Kaohsiung Med Univ Hosp, Dept Psychiat 3, Kaohsiung, Taiwan.; Yen, CF; Chen, CS (corresponding author), Kaohsiung Med Univ, Dept Psychiat, Coll Med, Kaohsiung, Taiwan.	chfaye@cc.kmu.edu.tw; sheng@kmu.edu.tw		Lin, Hsiu-Fen/0000-0001-6343-826X; Chen, Hui-Mei/0000-0002-3712-5144	Kaohsiung Medical University Hospital [KMUH102-M204]	Kaohsiung Medical University Hospital	This research was supported by grants from the Kaohsiung Medical University Hospital (KMUH102-M204).	Canavan M, 2014, GERONTOLOGY, V60, P212, DOI 10.1159/000356744; Chen HM, 2015, PSYCHOGERIATRICS, V15, P227, DOI 10.1111/psyg.12096; den Ouden MEM, 2014, EXP GERONTOL, V58, P1, DOI 10.1016/j.exger.2014.06.002; Donoghue OA, 2014, ARCH PHYS MED REHAB, V95, P1954, DOI 10.1016/j.apmr.2014.06.008; Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598; Guo NW, 1988, TAIWAN J PHYS MED RE, V16, P52; Gure TR, 2010, J GERONTOL A-BIOL, V65, P434, DOI 10.1093/gerona/glp197; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hamel R, 2015, PSYCHOL MED, V45, P1509, DOI 10.1017/S0033291714002645; Hamilton JM, 2014, ALZHEIMERS DEMENT, V10, P171, DOI 10.1016/j.jalz.2013.04.003; Harvey PD, 2007, SCHIZOPHRENIA BULL, V33, P1138, DOI 10.1093/schbul/sbm040; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jekel K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0099-0; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kim YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/852784; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MAHONEY F I, 1965, Md State Med J, V14, P61; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Moore DJ, 2007, J PSYCHIATR RES, V41, P97, DOI 10.1016/j.jpsychires.2005.10.008; Ng TP, 2006, J GERONTOL A-BIOL, V61, P726, DOI 10.1093/gerona/61.7.726; Ni JN, 2015, INT J GERIATR PSYCH, V30, P888, DOI 10.1002/gps.4317; Reppermund S, 2011, INT J GERIATR PSYCH, V26, P843, DOI 10.1002/gps.2612; Rockwood K, 2002, STROKE, V33, P1605, DOI 10.1161/01.STR.0000017878.85274.44; Rockwood K, 2007, J NEUROL SCI, V252, P106, DOI 10.1016/j.jns.2006.10.015; Rodakowski J, 2014, J AM GERIATR SOC, V62, P1347, DOI 10.1111/jgs.12878; Sadek JR, 2011, J INT NEUROPSYCH SOC, V17, P832, DOI 10.1017/S1355617711000841; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Tolea MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122878; Vasquez BP, 2015, J NEUROPSYCHOL, V9, P109, DOI 10.1111/jnp.12039; Wilms HU, 2007, COMPR PSYCHIAT, V48, P95, DOI 10.1016/j.comppsych.2006.04.001; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	31	2	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166546	10.1371/journal.pone.0166546	http://dx.doi.org/10.1371/journal.pone.0166546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851810	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300064
J	Brzobohata, H; Krajicek, V; Horak, Z; Veleminska, J				Brzobohata, Hana; Krajicek, Vaclav; Horak, Zdenek; Veleminska, Jana			Sexual Dimorphism of the Human Tibia through Time: Insights into Shape Variation Using a Surface-Based Approach	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; FUNCTIONAL ADAPTATION; POSTCRANIAL ROBUSTICITY; MORPHOMETRIC-ANALYSIS; PROXIMAL TIBIA; CENTRAL-EUROPE; DISTAL FEMUR; BRONZE-AGE; KNEE-JOINT; BODY-MASS	In this paper we present a three-dimensional (3D) morphometrical assessment of human tibia sexual dimorphism based on whole bone digital representation. To detect shape-size and shape differences between sexes, we used geometric morphometric tools and colourcoded surface deviation maps. The surface-based methodology enabled analysis of sexually dimorphic features throughout the shaft and articular ends of the tibia. The overall study dataset consisted of 183 3D models of adult tibiae from three Czech population subsets, dating to the early medieval (9-10 th century) (N = 65), early 20 th century (N = 61) and 21 st century (N = 57). The time gap between the chronologically most distant and contemporary datasets was more than 1200 years. The results showed that, in all three datasets, sexual dimorphism was pronounced. There were some sex-dimorphic characteristics common to all three samples, such as tuberosity protrusion, anteriorly bowed shaft and relatively larger articular ends in males. Diachronic comparisons also revealed substantial shape variation related to the most dimorphic area. Male/female distinctions showed a consistent temporal trend regarding the location of dimorphic areas (shifting distally with time), while the maximal deviation between male and female digitized surfaces fluctuated and reached the lowest level in the 21 st-century sample. Sex determination on a whole-surface basis yielded the lowest return of correct sex assignment in the 20 th-century group, which represented the lowest socioeconomic status. The temporal variation could be attributed to changes in living conditions, the decreasing lower limb loading/labour division in the last 12 centuries having the greatest effect. Overall, the results showed that a surface-based approach is successful for analysing complex long bone geometry.	[Brzobohata, Hana] Inst Archaeol Acad Sci, Dept Prehistor Archaeol, Prague, Czech Republic; [Krajicek, Vaclav] Charles Univ Prague, Fac Math & Phys, Dept Software & Comp Sci Educ, Prague, Czech Republic; [Krajicek, Vaclav; Veleminska, Jana] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic; [Horak, Zdenek] Czech Tech Univ, Fac Mech Engn, Lab Biomech, Prague, Czech Republic	Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Prague; Charles University Prague; Charles University Prague; Czech Technical University Prague	Brzobohata, H (corresponding author), Inst Archaeol Acad Sci, Dept Prehistor Archaeol, Prague, Czech Republic.	brzobohata@arup.cas.cz	Brzobohata, Hana/G-6684-2014	/0000-0003-4538-5859; Veleminska, Jana/0000-0002-5213-951X	Programme for perspective human resources	Programme for perspective human resources	HB was supported by Programme for perspective human resources - support for postdoctoral research of Czech Academy of Sciences during the preparation of the manuscript.	Adams JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139800; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Bejdova S, 2012, J CRANIO MAXILL SURG, V40, P201, DOI 10.1016/j.jcms.2011.04.013; Berner M, 2012, AM J PHYS ANTHROPOL, V147, P98; Betti L, 2012, HUM BIOL, V84, P139, DOI 10.3378/027.084.0203; Bigoni L, 2013, AM J PHYS ANTHROPOL, V150, P349, DOI 10.1002/ajpa.22210; Borgognini Tarli S.M., 1986, HUM EVOL, V1, P51, DOI [DOI 10.1007/BF02437285, 10.1007/BF02437285]; Boyer DM, 2015, ANAT REC, V298, P249, DOI 10.1002/ar.23084; Brauer G. W., 1982, SEXUAL DIMORPHISM HO, P245; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Brzobohata H, 2015, J FORENSIC SCI, V60, P29, DOI 10.1111/1556-4029.12641; Brzobohata H, 2014, ANTHROPOL ANZ, V71, P219, DOI 10.1127/0003-5548/2014/0336; Brzobohata H, 2012, COLLEGIUM ANTROPOL, V36, P801; Buikstra JE, 1994, ARKANSAS ARCHEOLOGIC, DOI DOI 10.1016/j.jasrep.2017.10.033; Campbell GR, 2009, SCI JUSTICE, V49, P2, DOI 10.1016/j.scijus.2008.09.001; Carlson KJ, 2014, RECONSTRUCTING MOBIL, P1; Costello AK, 2015, AM J PHYS ANTHROPOL, V156, P111; Danubio ME, 2008, J ANTHROPOL SCI, V86, P91; Dargel J, 2011, J ARTHROPLASTY, V26, P346, DOI 10.1016/j.arth.2009.12.019; Duyar I, 2003, AM J PHYS ANTHROPOL, V122, P23, DOI 10.1002/ajpa.10257; Eckstein F, 2002, OSTEOARTHR CARTILAGE, V10, P44, DOI 10.1053/joca.2001.0480; Fatah EEA, 2012, AM J PHYS ANTHROPOL, V149, P547, DOI 10.1002/ajpa.22156; Frelat MA, 2012, AM J PHYS ANTHROPOL, V149, P628, DOI 10.1002/ajpa.22177; Frelat MA, 2011, AM J HUM BIOL, V23, P796, DOI 10.1002/ajhb.21217; Gonzalez-Reimers E, 2000, FORENSIC SCI INT, V108, P165, DOI 10.1016/S0379-0738(99)00205-4; GRAY JP, 1980, AM J PHYS ANTHROPOL, V53, P441, DOI 10.1002/ajpa.1330530314; Hammond P, 2007, ARCH DIS CHILD, V92, P1120, DOI 10.1136/adc.2006.103507; HOLLAND TD, 1991, AM J PHYS ANTHROPOL, V85, P221, DOI 10.1002/ajpa.1330850210; Hrdlicka A, 1898, AM ANTHROPOL, V11, P307, DOI DOI 10.1525/AA.1898.11.10.02A00010; Hutton TJ, 2003, IEEE T MED IMAGING, V22, P747, DOI 10.1109/TMI.2003.814784; ISCAN MY, 1994, J FORENSIC SCI, V39, P785; Karell MA, 2016, INT J LEGAL MED, V130, P1315, DOI 10.1007/s00414-016-1334-3; Krajicek V, 2015, THESIS; Krajicek V., 2012, J WSCG, V20, P65; Kranioti EF, 2009, FORENSIC SCI INT, V189, P111, DOI 10.1016/j.forsciint.2009.04.013; Kujanova M, 2008, INT J OSTEOARCHAEOL, V18, P476, DOI 10.1002/oa.958; Larsen CS, 2015, BIOARCHAEOLOGY INTER, P241; Lazenby RA, 2001, AM J PHYS ANTHROPOL, P96; Lee UY, 2015, FORENSIC SCI INT, V253, DOI 10.1016/j.forsciint.2015.05.017; Lieberman DE, 2001, AM J PHYS ANTHROPOL, V116, P266, DOI 10.1002/ajpa.1123; Macintosh AA, 2014, J ARCHAEOL SCI, V52, P376, DOI 10.1016/j.jas.2014.09.001; Mahfouz M. R., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P447, DOI 10.1080/10255840701552093; Matthews T, 2016, PALAEONTOL ELECTRON, V19; Pachner P., 1937, POHLAVN ROZDILY LIDS; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Polly P.D., 2008, PALAEONTOL ELECTRON, V11, p10A; R Core Team, 2018, R LANG ENV STAT COMP; Radzi S, 2014, MED ENG PHYS, V36, P1618, DOI 10.1016/j.medengphy.2014.09.007; Ramsthaler F, 2010, FORENSIC SCI INT, V195, P148, DOI 10.1016/j.forsciint.2009.12.010; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; RUFF C, 1987, J HUM EVOL, V16, P391, DOI 10.1016/0047-2484(87)90069-8; RUFF CB, 1988, J ORTHOP RES, V6, P886, DOI 10.1002/jor.1100060613; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P383, DOI 10.1002/ajpa.1330600309; RUFF CB, 1991, AM J PHYS ANTHROPOL, V86, P397, DOI 10.1002/ajpa.1330860306; Ruff CB, 2015, P NATL ACAD SCI USA, V112, P7147, DOI 10.1073/pnas.1502932112; Scheuer L, 2002, CLIN ANAT, V15, P297, DOI 10.1002/ca.10028; Schmitt A, 2002, J FORENSIC SCI, V47, P1203; Sievwright H, 2012, ZOOL J LINN SOC-LOND, V165, P390, DOI 10.1111/j.1096-3642.2012.00818.x; Sladek V, 2006, J ARCHAEOL SCI, V33, P470, DOI 10.1016/j.jas.2005.09.004; Sladek V, 2005, AM J PHYS ANTHROPOL, P192; Slaus M., 2013, FORENSIC SCI INT, V226, P302, DOI DOI 10.1016/J.F0RSCIINT.2013.01.025; Squyres N, 2015, AM J PHYS ANTHROPOL, V158, P198, DOI 10.1002/ajpa.22789; Stevens SD, 2008, INT J OSTEOARCHAEOL, V18, P352, DOI 10.1002/oa.954; Stock JT, 2006, AM J PHYS ANTHROPOL, V131, P194, DOI 10.1002/ajpa.20398; Svoboda J., 2003, VELKA KNIHA KLIMATU; Vance VL, 2010, FORENSIC SCI INT, V199, DOI 10.1016/j.forsciint.2010.02.036; Veleminska J, 2012, HOMO, V63, P81, DOI 10.1016/j.jchb.2012.02.002; von Cramon-Taubadel N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1337; Wang H, 2013, PHYS MED BIOL, V58, P465, DOI 10.1088/0031-9155/58/3/465; Webb EA, 2008, ECON HUM BIOL, V6, P228, DOI 10.1016/j.ehb.2008.03.001	71	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166461	10.1371/journal.pone.0166461	http://dx.doi.org/10.1371/journal.pone.0166461			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846265	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600067
J	Koorevaar, RCT; van't Riet, E; Gerritsen, MJJ; Madden, K; Bulstra, SK				Koorevaar, Rinco C. T.; van't Riet, Esther; Gerritsen, Marleen J. J.; Madden, Kim; Bulstra, Sjoerd K.			The Influence of Preoperative and Postoperative Psychological Symptoms on Clinical Outcome after Shoulder Surgery: A Prospective Longitudinal Cohort Study	PLOS ONE			English	Article							ROTATOR CUFF REPAIR; QUALITY-OF-LIFE; QUESTIONNAIRE 4DSQ; MUSCULOSKELETAL PAIN; PERCEIVED DISABILITY; DEPRESSIVE SYMPTOMS; DISTRESS; ANXIETY; VALIDATION; ARM	Background Psychological symptoms are highly prevalent in patients with shoulder complaints. Psychological symptoms in patients with shoulder complaints might play a role in the aetiology, perceived disability and pain and clinical outcome of treatment. The aim of this study was to assess whether preoperative symptoms of distress, depression, anxiety and somatisation were associated with a change in function after shoulder surgery and postoperative patient perceived improvement of pain and function. In addition, the change of psychological symptoms after shoulder surgery was analyzed and the influence of postoperative symptoms of psychological disorders after surgery on the change in function after shoulder surgery and perceived postoperative improvement of pain and function. Methods and Findings A prospective longitudinal cohort study was performed in a general teaching hospital. 315 consecutive patients planned for elective shoulder surgery were included. Outcome measures included change of Disabilities of the Arm, Shoulder and Hand (DASH) score and anchor questions about improvement in pain and function after surgery. Psychological symptoms were identified before and 12 months after surgery with the validated FourDimensional Symptom Questionnaire (4DSQ). Psychological symptoms were encountered in all the various shoulder diagnoses. Preoperative symptoms of psychological disorders persisted after surgery in 56% of patients, 10% of patients with no symptoms of psychological disorders before surgery developed new psychological symptoms. Preoperative symptoms of psychological disorders were not associated with the change of DASH score and perceived improvement of pain and function after shoulder surgery. Patients with symptoms of psychological disorders after surgery were less likely to improve on the DASH score. Postoperative symptoms of distress and depression were associated with worse perceived improvement of pain. Postoperative symptoms of distress, depression and somatisation were associated with worse perceived improvement of function. Conclusions Preoperative symptoms of distress, depression, anxiety and somatisation were not associated with worse clinical outcome 12 months after shoulder surgery. Symptoms of psychological disorders before shoulder surgery persisted in 56% of patients after surgery. Postoperative symptoms of psychological disorders 12 months after shoulder surgery were strongly associated with worse clinical outcome.	[Koorevaar, Rinco C. T.] Deventer Hosp, Dept Orthopaed, Deventer, Netherlands; [van't Riet, Esther] Deventer Hosp, Res Dept, Deventer, Netherlands; [Gerritsen, Marleen J. J.] Deventer Hosp, Dept Psychol, Deventer, Netherlands; [Madden, Kim] Mc Master Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Bulstra, Sjoerd K.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands	Deventer Hospital; Deventer Hospital; Deventer Hospital; McMaster University; University of Groningen	Koorevaar, RCT (corresponding author), Deventer Hosp, Dept Orthopaed, Deventer, Netherlands.	C.T.Koorevaar@dz.nl	Madden, Kim/N-5761-2015	Madden, Kim/0000-0002-2861-9636				Alizadehkhaiyat O, 2007, CLIN J PAIN, V23, P482, DOI 10.1097/AJP.0b013e31805f70fa; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Cho CH, 2015, CLIN ORTHOP RELAT R, V473, P3494, DOI 10.1007/s11999-015-4258-1; Cho CH, 2013, J SHOULDER ELB SURG, V22, P1160, DOI 10.1016/j.jse.2013.02.006; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; De Vet HCW, 2011, MEASUREMENT MED, P246; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Desai AS, 2010, ANN ROY COLL SURG, V92, P9, DOI 10.1308/003588410X12518836440522; Duivenvoorden T, 2013, OSTEOARTHR CARTILAGE, V21, P1834, DOI 10.1016/j.joca.2013.08.022; George SZ, 2016, ARTHRIT CARE RES, V68, P1671, DOI 10.1002/acr.22876; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jorgensen CK, 2000, BRIT J GEN PRACT, V50, P537; Karels CH, 2007, J CLIN EPIDEMIOL, V60, P839, DOI 10.1016/j.jclinepi.2006.11.012; Koorevaar RCT, 2016, J ORTHOP RES, V34, P683, DOI 10.1002/jor.23051; Lindenhovius ALC, 2008, J BONE JOINT SURG AM, V90A, P2090, DOI 10.2106/JBJS.G.00793; Pakarinen M, 2014, SPINE J, V14, P2392, DOI 10.1016/j.spinee.2014.01.047; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Potter MQ, 2015, CLIN ORTHOP RELAT R, V473, P3501, DOI 10.1007/s11999-015-4513-5; Ring D, 2004, J BONE JOINT SURG AM, V86A, P1387, DOI 10.2106/00004623-200407000-00005; Ring D, 2006, J BONE JOINT SURG AM, V88A, P1983, DOI 10.2106/JBJS.E.00932; Roh YH, 2012, CLIN ORTHOP RELAT R, V470, P3470, DOI 10.1007/s11999-012-2503-4; Roh YH, 2012, ARCH ORTHOP TRAUM SU, V132, P1251, DOI 10.1007/s00402-012-1545-0; Rosenberger PH, 2006, J AM ACAD ORTHOP SUR, V14, P397, DOI 10.5435/00124635-200607000-00002; Tashjian RZ, 2008, J SHOULDER ELB SURG, V17, P853, DOI 10.1016/j.jse.2008.04.003; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; Terluin B, 2014, EUR J GEN PRACT, V20, P320, DOI 10.3109/13814788.2014.905826; Terluin B, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-58; Veehof Martine M, 2002, J Hand Ther, V15, P347; Vranceanu AM, 2009, J BONE JOINT SURG AM, V91A, P2014, DOI 10.2106/JBJS.H.01512	29	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166555	10.1371/journal.pone.0166555	http://dx.doi.org/10.1371/journal.pone.0166555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846296	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600080
J	Willwacher, S; Herrmann, V; Heinrich, K; Funken, J; Strutzenberger, G; Goldmann, JP; Braunstein, B; Brazil, A; Irwin, G; Potthast, W; Bruggemann, GP				Willwacher, Steffen; Herrmann, Volker; Heinrich, Kai; Funken, Johannes; Strutzenberger, Gerda; Goldmann, Jan-Peter; Braunstein, Bjoern; Brazil, Adam; Irwin, Gareth; Potthast, Wolfgang; Brueggemann, Gert-Peter			Sprint Start Kinetics of Amputee and Non-Amputee Sprinters	PLOS ONE			English	Article							PERFORMANCE; MECHANICS; POWER; PUSH	The purpose of this study was to explore the relationship between the forces applied to the starting blocks and the start performances (SPs) of amputee sprinters (ASs) and non-amputee sprinters (NASs). SPs of 154 male and female NASs (100-m personal records [PRs], 9.58 - 14.00 s) and 7 male ASs (3 unilateral above knee, 3 unilateral below knee, 1 bilateral below knee; 100 m PRs, 11.70 - 12.70 s) with running specific prostheses (RSPs) were analysed during full-effort sprint starts using instrumented starting blocks that measured the applied forces in 3D. Using the NAS dataset and a combination of factor analysis and multiple regression techniques, we explored the relationship between force characteristics and SP (quantified by normalized average horizontal block power). Start kinetics were subsequently compared between ASs and NASs who were matched based on their absolute 100 m PR and their 100 m PR relative to the world record in their starting class. In NASs, 86% of the variance in SP was shared with five latent factors on which measured parameters related to force application to the rear and front blocks and the respective push-off directions in the sagittal plane of motion were loaded. Mediolateral force application had little influence on SP. The SP of ASs was significantly reduced compared to that of NASs matched on the basis of relative 100-m PR (-33.8%; d = 2.11, p < 0.001), while a non-significant performance reduction was observed when absolute 100-m PRs were used (-17.7%; d = 0.79, p = 0.09). These results are at least partially explained by the fact that force application to the rear block was clearly impaired in the affected legs of ASs.	[Willwacher, Steffen; Herrmann, Volker; Heinrich, Kai; Funken, Johannes; Goldmann, Jan-Peter; Braunstein, Bjoern; Potthast, Wolfgang; Brueggemann, Gert-Peter] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Strutzenberger, Gerda; Brazil, Adam; Irwin, Gareth] Cardiff Metropolitan Univ, Sch Sport, Cardiff, S Glam, Wales; [Strutzenberger, Gerda] Salzburg Univ, Dept Sport Sci & Kinesiol, Salzburg, Austria; [Goldmann, Jan-Peter; Braunstein, Bjoern] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany	German Sport University Cologne; Cardiff Metropolitan University; Salzburg University; German Sport University Cologne	Willwacher, S (corresponding author), German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany.	s.willwacher@dshs-koeln.de	Funken, Johannes/AAR-8238-2020; Heinrich, Kai/ABA-3038-2020; Goldmann, Jan-Peter/AAS-7638-2021; Braunstein, Bjoern/D-7142-2013; Mourot, Laurent/M-2114-2019	Funken, Johannes/0000-0002-0093-8686; Heinrich, Kai/0000-0001-9417-9619; Goldmann, Jan-Peter/0000-0003-2552-5762; Braunstein, Bjoern/0000-0002-5173-8916; Mourot, Laurent/0000-0001-9486-3090; Brazil, Adam/0000-0003-1850-9852; Strutzenberger, Gerda/0000-0001-5218-6183	International Association of Athletics Federations (IAAF)	International Association of Athletics Federations (IAAF)	SW, VH, KH, and GB received funding for the study for collecting data from non-amputee athletes from the International Association of Athletics Federations (IAAF). The funder was not involved in data collection and analysis, the decision to publish or the preparation of the manuscript.; The authors are grateful for the work of Martin Kusel-Feldker, Jurgen Geyermann and Thomas Forster in building the instrumented starting blocks used in this study. Parts of the study were funded by the International Association of Athletics Federations (IAAF).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Basilevsky A, 1981, CANADIAN J STAT, V9, P109, DOI DOI 10.2307/3315301; Bezodis NE, 2010, SPORT BIOMECH, V9, P258, DOI 10.1080/14763141.2010.538713; Bezodis NE, 2015, EUR J SPORT SCI, V15, P118, DOI 10.1080/17461391.2014.928915; Bruggemann Gert-Peter., 2008, SPORTS TECHNOLOGY, V1, P220, DOI [10.1002/jst.63, DOI 10.1002/JST.63, DOI 10.1080/19346182.2008.9648476]; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CAVAGNA GA, 1971, J PHYSIOL-LONDON, V217, P709, DOI 10.1113/jphysiol.1971.sp009595; Charalambous L, 2012, J SPORT SCI, V30, P1, DOI 10.1080/02640414.2011.616948; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Debaere S, 2013, J SPORT SCI, V31, P137, DOI 10.1080/02640414.2012.722225; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Harland MJ, 1997, SPORTS MED, V23, P11, DOI 10.2165/00007256-199723010-00002; HOF AL, 1996, GAIT POSTURE, V4, P222; James G., 2014, INTRO STAT LEARNING; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; McGowan CP, 2012, J ROYAL SOC INTERFAC; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; Morin JB, 2015, J BIOMECH, V48, P3149, DOI 10.1016/j.jbiomech.2015.07.009; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Taboga P, 2014, J APPL BIOMECH, V30, P381, DOI 10.1123/jab.2013-0113; Tellez T., 1984, TRACK TECHNIQUE, V88, P2802; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Weyand PG, 2010, J APPL PHYSIOL, V108, P1011, DOI [10.1152/japplphysiol.01238.2009, 10.1152/japplphysiol.01238.2009a]; Willwacher S, 2013, PROCEDIA ENGINEER, V60, P124, DOI 10.1016/j.proeng.2013.07.073; Zatsiorsky VM, 2012, BIOMECHANICS SKELETA	28	40	40	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166219	10.1371/journal.pone.0166219	http://dx.doi.org/10.1371/journal.pone.0166219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846241	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600042
J	Wu, YS; Chen, YT; Bao, YT; Li, ZM; Zhou, XJ; He, JN; Dai, SJ; Li, CY				Wu, Yang Sheng; Chen, Yi-Tao; Bao, Yu-Ting; Li, Zhe-Ming; Zhou, Xiao-Jie; He, Jia-Na; Dai, Shi-Jie; Li, Chang Yu			Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; AGC PROTEIN-KINASES; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; CELLS; DEFICIENCY; THERAPIES; SECRETION; DISEASE; CANCER	Background Berberine is used to treat diabetes and dyslipidemia. However, the effect of berberine on specific diabetes treatment targets is unknown. In the current study, we investigated the effect of berberine on the random plasma glucose, glycated hemoglobin (HbA1C), AST, ALT, BUN and CREA levels of Zucker diabetic fatty (ZDF) rats, and we identified and verified the importance of potential therapeutic target genes to provide molecular information for further investigation of the mechanisms underlying the anti-diabetic effects of berberine. Methods ZDF rats were randomly divided into control (Con), diabetic (DM) and berberine-treated (300 mg center dot kg(-1), BBR) groups. After the ZDF rats were treated with BBR for 12 weeks, its effect on the random plasma glucose and HbA1C levels was evaluated. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), CREA and OGTT were measured from blood, respectively. The levels of gene expression in liver samples were analyzed using an Agilent rat gene expression 4x44K microarray. The differentially expressed genes (DEGs) were screened as those with log2 (Con vs DM) >= 1 and log2 (BBR vs DM) >= 1 expression levels, which were the genes with up-regulated expression, and those with log2 (Con vs DM) <= -1 and log2 (BBR vs DM) <= -1 expression levels, which were the genes with down-regulated expression; the changes in gene expression were considered significant at P<0.05. The functions of the DEGs were determined using gene ontology (GO) and pathway analysis. Furthermore, a protein-protein interaction (PPI) network was constructed using STRING and Cytoscape software. The expression levels of the key node genes in the livers of the ZDF rats were also analyzed using qRT-PCR. Results We found that 12 weeks of berberine treatment significantly decreased the random plasma glucose, HbA1 C levels and improved glucose tolerance. There was a tendency for berberine to reduce AST, ALT, BUN except increase CREA levels. In the livers of the BBR group, we found 154 DEGs, including 91 genes with up-regulated expression and 63 genes with down-regulated expression. In addition, GO enrichment analysis showed significant enrichment of the DEGs in the following categories: metabolic process, localization, cellular process, biological regulation and response to stimulus process. After the gene screening, KEGG pathway analysis showed that the target genes are involved in multiple pathways, including the lysine degradation, glycosaminoglycan biosynthesischondroitin sulfate/dermatan sulfate and pyruvate metabolism pathways. By combining the results of PPI network and KEGG pathway analyses, we identified seven key node genes. The qRT-PCR results confirmed that the expression of the RHOA, MAPK4 and DLAT genes was significantly down-regulated compared with the levels in DM group, whereas the expression of the SgK494, DOT1 L, SETD2 and ME3 genes was significantly up-regulated in the BBR group. Conclusion Berberine can significantly improve glucose metabolism and has a protective effects of liver and kidney function in ZDF rats. The qRT-PCR results for the crucial DEGs validated the microarray results. These results suggested that the RHOA, MAPK4, SGK494, DOT1 L, SETD2, ME3 and DLAT genes are potential therapeutic target genes for the treatment of diabetes.	[Wu, Yang Sheng; Bao, Yu-Ting; Li, Zhe-Ming; Zhou, Xiao-Jie; He, Jia-Na; Dai, Shi-Jie; Li, Chang Yu] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Zhejiang, Peoples R China; [Chen, Yi-Tao] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Li, CY (corresponding author), Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Zhejiang, Peoples R China.	lcyzcmu@sina.com			Project of National Great New Drug Research and Development [2012ZX09503001-001]; Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University [752223A00201/005/019]	Project of National Great New Drug Research and Development; Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University	This work was supported by the Project of National Great New Drug Research and Development (No. 2012ZX09503001-001), and Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University (No. 752223A00201/005/019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Project of National Great New Drug Research and Development (No. 2012ZX09503001-001), and Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University (No. 752223A00201/005/019). We are grateful to Ms Yuanxiao Yang, Ms Ying He for constructive discussion, Ms Ling Xuan, Ms Jie Ying Zhang and Mr Xue Ming Chen for literature search.	Al Sarakbi W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-290; Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010; Bragoszewski P, 2007, ACTA BIOCHIM POL, V54, P341, DOI 10.18388/abp.2007_3255; Bruder-Nascimento T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162731; Chen JL, 2014, EXP THER MED, V8, P836, DOI 10.3892/etm.2014.1843; Ciara E, 2016, MOL GENET METAB REP, V7, P70, DOI 10.1016/j.ymgmr.2016.03.004; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Di Pierro F, 2013, CLIN PHARMACOL-ADV A, V5, P167, DOI 10.2147/CPAA.S54308; Dong Y, 2016, PHYTOTHER RES, V30, P823, DOI 10.1002/ptr.5587; Goguet-Rubio P, 2016, P NATL ACAD SCI USA, V113, P11004, DOI 10.1073/pnas.1602751113; Guo WG, 2013, EUR REV MED PHARMACO, V17, P1509; Hasan NM, 2015, MOL ENDOCRINOL, V29, P396, DOI 10.1210/me.2014-1249; Head RA, 2005, ANN NEUROL, V58, P234, DOI 10.1002/ana.20550; Iyer A, 2012, IMMUNOL CELL BIOL, V90, P39, DOI 10.1038/icb.2011.99; Jiang GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154028; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Knipe RS, 2015, PHARMACOL REV, V67, P103, DOI 10.1124/pr.114.009381; Lan AP, 2015, NEPHROL DIAL TRANSPL, V30, P385, DOI 10.1093/ndt/gfu196; Lan JR, 2015, J ETHNOPHARMACOL, V161, P69, DOI 10.1016/j.jep.2014.09.049; Lee MH, 2010, EARLY HUM DEV, V86, P45, DOI 10.1016/j.earlhumdev.2010.01.001; Li F, 2016, J HUAZHONG U SCI-MED, V36, P64, DOI 10.1007/s11596-016-1543-5; Liu C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/313808; Martinez-Abundis E, 2016, WORLD J DIABETES, V7, P142, DOI 10.4239/wjd.v7.i7.142; Pan DN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002761; Pang B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/905749; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Rousseau J, 2010, MOL CELL BIOL, V30, P5752, DOI 10.1128/MCB.01147-10; Scarda A, 2010, INT J OBESITY, V34, P1319, DOI 10.1038/ijo.2010.47; Suzuki MG, 2014, INT J MOL SCI, V15, P6772, DOI 10.3390/ijms15046772; Tang YH, 2012, PLANTA MED, V78, P18, DOI 10.1055/s-0031-1280268; Tasdelen I, 2013, BIOCHEM J, V451, P45, DOI 10.1042/BJ20121113; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Wei SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152097; Wu H., 2013, J NANOMATER, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0053342; Xie X, 2013, MOL CELL ENDOCRINOL, V381, P56, DOI 10.1016/j.mce.2013.07.019; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Xu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103702; Zhang Q, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-188; Zhou H, 2011, DIABETES-METAB RES, V27, P318, DOI 10.1002/dmrr.1182; Zhou Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360	41	14	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166378	10.1371/journal.pone.0166378	http://dx.doi.org/10.1371/journal.pone.0166378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846294	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600053
J	Kim, MS; Min, HG; Lee, SH; Kim, JG				Kim, Min-Suk; Min, Hyun-Gi; Lee, Sang-Hwan; Kim, Jeong-Gyu			The Effects of Various Amendments on Trace Element Stabilization in Acidic, Neutral, and Alkali Soil with Similar Pollution Index	PLOS ONE			English	Article							HEAVY-METALS; CONTAMINATED SOILS; AVAILABILITY; MOBILITY; HYPERACCUMULATOR; BIOAVAILABILITY; TOXICITY; BIOCHAR; LEAD; PH	Many studies have examined the application of soil amendments, including pH change-induced immobilizers, adsorbents, and organic materials, for soil remediation. This study evaluated the effects of various amendments on trace element stabilization and phytotoxicity, depending on the initial soil pH in acid, neutral, and alkali conditions. As in all types of soils, Fe and Ca were well stabilized on adsorption sites. There was an effect from pH control or adsorption mechanisms on the stabilization of cationic trace elements from inorganic amendments in acidic and neutral soil. Furthermore, acid mine drainage sludge has shown great potential for stabilizing most trace elements. In a phytotoxicity test, the ratio of the bioavailable fraction to the pseudo-total fraction significantly affected the uptake of trace elements by bok choy. While inorganic amendments efficiently decreased the bioavailability of trace elements, significant effects from organic amendments were not noticeable due to the short-term cultivation period. Therefore, the application of organic amendments for stabilizing trace elements in agricultural soil requires further study.	[Kim, Min-Suk; Kim, Jeong-Gyu] Korea Univ, O Jeong Ecoresilience Inst, Seoul, South Korea; [Min, Hyun-Gi; Kim, Jeong-Gyu] Korea Univ, Div Environm Sci & Ecol Engn, Coll Life & Environm Sci, Seoul, South Korea; [Lee, Sang-Hwan] Mine Reclamat Corp, Soil Remediat Team, Wonju, South Korea	Korea University; Korea University; Mine Reclamation Corporation	Kim, JG (corresponding author), Korea Univ, O Jeong Ecoresilience Inst, Seoul, South Korea.; Kim, JG (corresponding author), Korea Univ, Div Environm Sci & Ecol Engn, Coll Life & Environm Sci, Seoul, South Korea.	lemonkim@korea.ac.kr			National Research Foundation of Korea (NRF) [2015R1D1A1A01057594]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was funded by the National Research Foundation of Korea (NRF) [2015R1D1A1A01057594] http://nrf.re.kr/nri_tot_cms/indexisppmnsso-return2=none (to MS Kim). Mine Reclamation Corporation, Wonju, Republic of Korea, a commercial company, provided support in the form of salaries for authors SH Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contribution section.	Adriano DC, 2001, J ENVIRON QUAL, V30, P596, DOI 10.2134/jeq2001.302596x; ALLOWAY BJ, 1988, SCI TOTAL ENVIRON, V75, P41, DOI 10.1016/0048-9697(88)90159-3; BERNSTEIN L, 1975, ANNU REV PHYTOPATHOL, V13, P295, DOI 10.1146/annurev.py.13.090175.001455; Cao XD, 2003, ENVIRON POLLUT, V126, P157, DOI 10.1016/S0269-7491(03)00208-2; Chuan MC, 1996, WATER AIR SOIL POLL, V90, P543, DOI 10.1007/BF00282668; Comerford NB, 2005, ECOL STU AN, V181, P1; Davies NA, 2002, ENVIRON TOXICOL CHEM, V21, P2685, DOI 10.1897/1551-5028(2002)021<2685:CITABO>2.0.CO;2; Hettiarachchi GM, 2004, ENVIRON PROG, V23, P78, DOI 10.1002/ep.10004; 양주경, 2011, [Journal of the Korean Society of Water and Wastewater, 상하수도학회지], V25, P419; Karhu K, 2011, AGR ECOSYST ENVIRON, V140, P309, DOI 10.1016/j.agee.2010.12.005; Kim KR, 2012, J ENVIRON MANAGE, V102, P88, DOI 10.1016/j.jenvman.2012.02.001; Kim MS, 2014, J ENVIRON MANAGE, V146, P124, DOI 10.1016/j.jenvman.2014.07.001; Koo N, 2012, ENVIRON GEOCHEM HLTH, V34, P337, DOI 10.1007/s10653-011-9419-x; Korea Ministry of Environment, 2011, SOIL ENV STAND TEST; Lee S.-H., 2011, INT ATOMIC ENERGY AG, V43, P1; Lee SH, 2014, J ENVIRON MANAGE, V139, P15, DOI 10.1016/j.jenvman.2014.02.019; Li ZB, 1997, ENVIRON POLLUT, V95, P219, DOI 10.1016/S0269-7491(96)00077-2; Liu XY, 2012, ECOL ENG, V42, P168, DOI 10.1016/j.ecoleng.2012.01.016; Lopes C, 2012, ENVIRON POLLUT, V166, P17, DOI 10.1016/j.envpol.2012.02.017; LUCAS R. E., 1961, SOIL SCI, V92, P177, DOI 10.1097/00010694-196109000-00005; Martins Adão Luiz Castanheiro, 2003, Sci. agric. (Piracicaba, Braz.), V60, P747; McCauley A., 2009, SOIL PH ORGANIC MATT, V8, P4449; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Priha O, 1999, SOIL BIOL BIOCHEM, V31, P965, DOI 10.1016/S0038-0717(99)00006-1; SALTER PJ, 1969, EUR J SOIL SCI, V20, P126; SMITH SR, 1994, ENVIRON POLLUT, V85, P321, DOI 10.1016/0269-7491(94)90054-X; Suk Kim Min, 2014, [Korean Journal of Environmental Agriculture, 한국환경농학회지], V33, P78, DOI 10.5338/KJEA.2014.33.2.78; Tordoff GM, 2000, CHEMOSPHERE, V41, P219, DOI 10.1016/S0045-6535(99)00414-2; Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014; WOOLSON EA, 1973, SOIL SCI SOC AM J, V37, P254, DOI 10.2136/sssaj1973.03615995003700020028x; Zeng FR, 2011, ENVIRON POLLUT, V159, P84, DOI 10.1016/j.envpol.2010.09.019; Zhang XC, 2012, J HAZARD MATER, V229, P361, DOI 10.1016/j.jhazmat.2012.06.013; 윤정기, 2009, [The Journal of Korean Society of Soil and Groundwater Environment, 지하수토양환경], V14, P32	34	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166335	10.1371/journal.pone.0166335	http://dx.doi.org/10.1371/journal.pone.0166335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835687	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200040
J	Lu, Y; Liu, YL; Nie, JJ; Liang, XF; Yan, L; Wang, FZ; Zhai, XJ; Liu, JX; Zhu, FC; Chang, ZJ; Li, J				Lu, Ying; Liu, Ya-Lin; Nie, Jing-Jing; Liang, Xiao-Feng; Yan, Ling; Wang, Fu-Zhen; Zhai, Xiang-Jun; Liu, Jian-Xun; Zhu, Feng-Cai; Chang, Zhan-Jun; Li, Jie			Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CHILDREN BORN; SURFACE-ANTIGEN; VACCINATION; ASSAY; DNA	Objective Occult HBV infection (OBI) has been reported in infants born to HBsAg-positive mothers despite immunization. This study aims to determine the maintenance of this status in a prospective birth cohort. Methods A total of 158 neonates born to HBsAg-positive mothers were enrolled. All received passive-active immunization against HBV according to a 0-1-6 schedule. Sera were collected at 7 months of age. Those diagnosed with OBI were serially followed up at 12, 24 and 36 months of age. HBV serological markers were determined by Abbott i2000 system. HBV DNA was quantitated by Abbott m2000 system. Standard PCR followed by direct sequencing were applied for mother-child HBV pairs. Homology and phylogenetic comparisons were done by BLAST and Mega 5. Results All the 158 neonates were HBsAg-negative and anti-HBs-positive at 7 months of age, and 32 (20.3%) of them were diagnosed with OBI, with a median HBV DNA level of 1.97 (1.20-3.71) log IU/mL. Of them, HBV DNA was positive in 25.0%, 21.9% and 7.7% at 12, 24 and 36 months of age, respectively. HBV DNA disappeared at one of the follow-up points in 31 neonates, however, rebounded to low levels in 6 of them thereafter. HBV DNA persisted at low levels during follow-ups in the other one neonate apart from the above 31. All remained negative for HBsAg. Only two (6.3%) neonates were positive for anti-HBc after 24 months of age. HBV showed close homology and phylogenetic relationships for mother-child pairs. S-escape mutant, G145R, was not discovered. The first vaccine dose within 6 hours of birth significantly reduced the occurrence of OBI (59.4% vs. 83.3%, p = 0.003). Conclusions HBV may be controlled in immunized neonates of HBsAg-positive mothers, after being diagnosed with OBI. Timely vaccination against HBV may provide the utmost protection. Longterm and close monitorings are needed.	[Lu, Ying; Liu, Ya-Lin; Nie, Jing-Jing; Yan, Ling; Li, Jie] Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Lu, Ying; Liu, Ya-Lin; Nie, Jing-Jing; Yan, Ling; Li, Jie] Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Liang, Xiao-Feng; Wang, Fu-Zhen] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China; [Zhai, Xiang-Jun; Zhu, Feng-Cai] Jiangsu Prov Ctr Dis Control & Prevent, Dept Infect Dis, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Jian-Xun; Chang, Zhan-Jun] Zhengzhou Municipal Ctr Dis Control & Prevent, Dept Major Projects, Zhengzhou 450053, Peoples R China	Peking University; Peking University; Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing 100191, Peoples R China.; Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing 100191, Peoples R China.	jieli@bjmu.edu.cn			National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period [2012ZX10002001-001]	National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period	This study was supported by National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period (2012ZX10002001-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio Bertoletti, 2010, CELLULAR MOL IMMUNOL, V12, P258; Bertoletti A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00441; Ciotti M, 2008, J CLIN MICROBIOL, V46, P1517, DOI 10.1128/JCM.02046-07; Deguchi M, 2004, J VIROL METHODS, V115, P217, DOI 10.1016/j.jviromet.2003.10.002; Foaud H, 2015, INFECTION, V43, P307, DOI 10.1007/s15010-015-0733-6; Friedt M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-11; [金晖 JIN Hui], 2008, [中华流行病学杂志, Chinese Journal of Epidemiology], V29, P1235; Mulrooney-Cousins PM, 2007, WORLD J GASTROENTERO, V13, P5682, DOI 10.3748/wjg.v13.i43.5682; Nie JJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-121; Pande C, 2013, J VIRAL HEPATITIS, V20, P801, DOI 10.1111/jvh.12102; Pollicino T, 2014, J HEPATOL, V61, P688, DOI 10.1016/j.jhep.2014.04.036; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Sadeghi A, 2016, J VIRAL HEPATITIS, V23, P282, DOI 10.1111/jvh.12490; Shahmoradi S, 2012, J HEPATOL, V57, P515, DOI 10.1016/j.jhep.2012.04.021; Su HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070768; Wang JS, 2005, WORLD J GASTROENTERO, V11, P3582, DOI 10.3748/wjg.v11.i23.3582; Yeh CT, 2012, J HEPATOL, V57, P484, DOI 10.1016/j.jhep.2012.06.003; Zhou YH, 2016, J VIRAL HEPATITIS, V23, P830, DOI 10.1111/jvh.12559	19	12	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166317	10.1371/journal.pone.0166317	http://dx.doi.org/10.1371/journal.pone.0166317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835694	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200037
J	Peng, H; Chen, L; Li, WF; Zhang, Y; Liu, LZ; Tian, L; Lin, AH; Sun, Y; Ma, J				Peng, Hao; Chen, Lei; Li, Wen-Fei; Zhang, Yuan; Liu, Li-Zhi; Tian, Li; Lin, Ai-Hua; Sun, Ying; Ma, Jun			Prognostic Correlations between ABO Blood Group and Pre-Treatment Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SURVIVAL; RISK; POPULATION; CANCER	Purpose The objective of this study is to assess the prognostic value of ABO blood group in nasopharyngeal carcinoma (NPC) treated by intensity-modulated radiotherapy (IMRT). Patients and Methods We retrospectively reviewed the data on 1397 patients with non-metastatic, newly diagnosed NPC treated using IMRT. Patient survival between different ABO blood groups were compared using log-rank test. Cox hazards model was adopted to establish independent prognostic factors. Results In our study, the distribution of the A, B, AB and O blood groups was 26.6% (372/1397), 26.2% (366/1397), 5.2% (73/1397) and 42.0% (586/1397), respectively. The cut-off value of pre-treatment Epstein-Barr virus (EBV) DNA based on disease-free survival (DFS) was 1355 copies/ml (area under curve [AUC], 0.649; sensitivity, 0.76; specificity, 0.496) for the whole cohort. Estimated four-year DFS, overall survival (OS), distant metastasis-free survival (DMFS) and locoregional relapse-free survival (LRRFS) rates were 81.7%, 89.2%, 89.4% and 92.3% for blood group A; 82.1%, 89.3%, 89.0% and 92.0% for group B; 83.3%, 88.1%, 86.2% and 95.5% for group AB, 80.9%, 90.7%, 88.4% and 90.2% for group O (P > 0.05 for all rates). Multivariate analysis revealed ABO blood group was not an independent prognostic factor for DFS, OS, DMFS or LRRFS (P > 0.05 for all rates) after adjusting for plasma EBV DNA in either the whole cohort or subgroup analysis by gender. Conclusions The prognostic value of ABO blood group may be limited for patients with NPC in the era of IMRT, and no substantial correlation between ABO blood group and plasma EBV DNA was observed.	[Peng, Hao; Chen, Lei; Li, Wen-Fei; Zhang, Yuan; Sun, Ying; Ma, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Liu, Li-Zhi; Tian, Li] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Imaging Diag & Intervent Ctr,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Sch Publ Hlth, Guangzhou 510080, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	majun2@mail.sysu.edu.cn			Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]; Sun Yat-sen University Clinical Research 5010 Program [2012011]; Science and Technology Project of Guangzhou City, China [14570006]; Planned Science and Technology Project of Guangdong Province [20136020400004]	Health & Medical Collaborative Innovation Project of Guangzhou City, China; Sun Yat-sen University Clinical Research 5010 Program; Science and Technology Project of Guangzhou City, China; Planned Science and Technology Project of Guangdong Province	This work was supported by grants from the Health & Medical Collaborative Innovation Project of Guangzhou City, China (No. 201400000001), the Sun Yat-sen University Clinical Research 5010 Program (No. 2012011), the Science and Technology Project of Guangzhou City, China (No. 14570006), and the Planned Science and Technology Project of Guangdong Province (No. 20136020400004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Health & Medical Collaborative Innovation Project of Guangzhou City, China (No. 201400000001), the Sun Yat-sen University Clinical Research 5010 Program (No. 2012011), the Science and Technology Project of Guangzhou City, China (No. 14570006), and the Planned Science and Technology Project of Guangdong Province (No. 2013B020400004).	Adam SI, 2012, J LARYNGOL OTOL, V126, P180, DOI 10.1017/S0022215111002507; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chan KCA, 2014, CHIN J CANCER, V33, P598, DOI 10.5732/cjc.014.10192; CHANG YS, 1990, J CLIN MICROBIOL, V28, P2398, DOI 10.1128/JCM.28.11.2398-2402.1990; CHEN CL, 1993, INTERVIROLOGY, V36, P91, DOI 10.1159/000150327; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Engin H, 2012, ASIAN PAC J CANCER P, V13, P131, DOI 10.7314/APJCP.2012.13.1.131; Hou X, 2011, CLIN ONCOL-UK, V23, P128, DOI 10.1016/j.clon.2010.09.001; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lin JC, 2007, INT J RADIAT ONCOL, V68, P1342, DOI 10.1016/j.ijrobp.2007.02.012; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; Lu X, 2013, CHIN J CANCER, V32, P283, DOI 10.5732/cjc.012.10058; Miao SY, 2014, ASIA-PAC J CLIN ONCO, V10, P101, DOI 10.1111/ajco.12083; OuYang PY, 2013, BRIT J CANCER, V109, P2462, DOI 10.1038/bjc.2013.559; Rahbari NN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-319; Shao JY, 2004, ANTICANCER RES, V24, P4059; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Sheng LM, 2013, INT J CANCER, V133, P893, DOI 10.1002/ijc.28087; Sun P, 2014, TUMOR BIOL, V35, P7201, DOI 10.1007/s13277-014-1960-7; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Xu LY, 2010, RADIOTHER ONCOL, V96, P94, DOI 10.1016/j.radonc.2010.04.006; Yang X, 2014, INT J CLIN EXP MED, V7, P2214; Yi JL, 2006, INT J RADIAT ONCOL, V65, P161, DOI 10.1016/j.ijrobp.2005.12.003; Zhang YX, 2014, ASIAN PAC J CANCER P, V15, P7459, DOI 10.7314/APJCP.2014.15.17.7459	26	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166194	10.1371/journal.pone.0166194	http://dx.doi.org/10.1371/journal.pone.0166194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835689	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200031
J	Yu, J; Li, DQ; Lei, DS; Yuan, F; Pei, F; Zhang, HF; Yu, AM; Wang, K; Chen, H; Chen, L; Wu, XL; Tong, XL; Wang, YF				Yu, Jing; Li, Dongqing; Lei, Dansheng; Yuan, Feng; Pei, Feng; Zhang, Huifeng; Yu, Anming; Wang, Kun; Chen, Hu; Chen, Liang; Wu, Xianglei; Tong, Xianli; Wang, Yefu			Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; FIRST EPISODE; CANCER; BEVACIZUMAB; LEVEL	D-dimer level in cancer patients is associated with risk of venous thromboembolism and deep venous thrombosis. Most cancer patients have "\abnormal" D-dimer levels based on the current normal reference range. To investigate tumor-specific D-dimer reference range, we compared D-dimer levels for nine different tumour types with healthy controls by using simultaneous quantile regression and constructing a median, 5th percentile, and 95th percentile model of normal tumour D-dimer concentration. Associations with tumour primary site, stage, pathological type, and treatment were also explored. Additionally, 190 patients were tracked to reveal the relevance of initial D-dimer levels to cancer prognosis. D-dimer ranges (median, 5th, 95th) in various cancers (mg/L) were: liver 1.12, 0.27, 5.25; pancreatic 0.96, 0.23, 4.81; breast 0.44, 0.2, 2.17; gastric 0.65, 0.22, 5.03; colorectal 0.73, 0.22, 4.45; lung 0.7, 0.25, 4.0; gynaecological 0.61, 0.22, 3.98; oesophageal 0.23, 0.7, 3.45; and head and neck 0.22, 0.44, 2.19. All were significantly higher than that of healthy controls (0.18, 0.07, 0.57). D-dimer peaked 1-2 days postoperatively but had decreased to the normal range by 1 week. Additionally, cancer patients with high initial D-dimer were shown a tendency of poor prognosis in survival rate. In conclusion, D-dimer levels in cancer depend on patient age, tumour primary site, and tumour stage. Thrombosis prevention is necessary if D-dimer has not decreased to the tumor-specific baseline a week after surgery.	[Yu, Jing; Wang, Yefu] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Lei, Dansheng; Yuan, Feng; Pei, Feng; Zhang, Huifeng; Wang, Kun; Chen, Hu; Tong, Xianli] Hubei Canc Hosp, Dept Lab, Wuhan, Peoples R China; [Li, Dongqing] Wuhan Univ, Sch Basic Med Sci, Dept Microbiol, Wuhan, Peoples R China; [Yu, Anming] Stago Diag Co, Wuhan, Peoples R China; [Chen, Liang] Wuhan Univ, Dept Orthopaed, Renmin Hosp, Wuhan, Peoples R China; [Wu, Xianglei] Univ Lorraine, Immunol Lab, Lorraine, France	Wuhan University; Wuhan University; Wuhan University; Universite de Lorraine	Wang, YF (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	wangyefu2014@sina.com	Yu, Aimin/B-3848-2010	Yu, Aimin/0000-0001-9606-6255	National Natural Science Foundation of China [30901356]; Fundamental Research Funds for the Central Universities [3082008]; Ph.D. Programs Foundation of Ministry of Education of China [20090141120014]; Research Foundation of Health Department of Hubei Province [JX4B67]; Stago Diagnosis Company	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Research Foundation of Health Department of Hubei Province; Stago Diagnosis Company	This work was funded by grants from the National Natural Science Foundation of China (No. 30901356), Fundamental Research Funds for the Central Universities (No.3082008), Ph.D. Programs Foundation of Ministry of Education of China (No.20090141120014), and Research Foundation of Health Department of Hubei Province (No. JX4B67). The study sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anming Yu is employed by Stago Diagnosis Company. Stago Diagnosis Company provided support by the supply of partial D-dimer testing reagents and some technic support and paid the salary for author AY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anming Yu is the one who supported technical support. This specific role of this author is articulated in the 'author contributions' section.	Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Aishima K, 2013, BRIT J NEUROSURG, V27, P348, DOI 10.3109/02688697.2012.737958; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Desciak MC, 2011, J CLIN ANESTH, V23, P153, DOI 10.1016/j.jclinane.2010.06.011; Di Nisio M, 2005, J THROMB HAEMOST, V3, P1239, DOI 10.1111/j.1538-7836.2005.01323.x; Diao DM, 2013, J SURG ONCOL, V108, P34, DOI 10.1002/jso.23339; Durczynski A, 2014, WORLD J GASTROENTERO, V20, P13167, DOI 10.3748/wjg.v20.i36.13167; Favaloro EJ, 2010, SEMIN THROMB HEMOST, V36, P458, DOI 10.1055/s-0030-1254055; Fernandez-Ros N, 2015, LIVER INT, V35, P1590, DOI 10.1111/liv.12592; Fijalkowska Anna, 2012, Pneumonol Alergol Pol, V80, P101; Haase C, 2013, THROMB RES, V132, P676, DOI 10.1016/j.thromres.2013.09.033; Hu QL, 2014, BIOCHEM CELL BIOL, V92, P547, DOI 10.1139/bcb-2014-0062; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kline JA, 2005, CLIN CHEM, V51, P825, DOI 10.1373/clinchem.2004.044883; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090547; Liu P, 2015, CANCER CHEMOTH PHARM, V76, P1163, DOI 10.1007/s00280-015-2900-y; Misch M, 2013, ANTICANCER RES, V33, P2093; Ota S, 2005, AM J HEMATOL, V79, P274, DOI 10.1002/ajh.20396; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Paneesha S, 2006, BRIT J HAEMATOL, V135, P85, DOI 10.1111/j.1365-2141.2006.06260.x; Pinede L, 2001, CIRCULATION, V103, P2453; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Simonetti G, 2014, NEUROL SCI, V35, P83, DOI 10.1007/s10072-013-1583-6; Soares AA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-54; Tomimaru Y, 2006, J AM COLL SURGEONS, V202, P139, DOI 10.1016/j.jamcollsurg.2005.08.008; Wang YZ, 2015, ONCOTARGETS THER, V8, P805, DOI 10.2147/OTT.S78154; Zhang PP, 2013, EJSO-EUR J SURG ONC, V39, P951, DOI 10.1016/j.ejso.2013.06.008	28	19	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165390	10.1371/journal.pone.0165390	http://dx.doi.org/10.1371/journal.pone.0165390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835633	Green Published, gold			2022-12-27	WOS:000387779200005
J	Chen, FA; Chien, CC; Chen, YW; Wu, YT; Lin, CC				Chen, Fu-An; Chien, Chih-Chiang; Chen, Yu-Wei; Wu, Yu-Te; Lin, Chih-Ching			Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis	PLOS ONE			English	Article							FAILING DIALYSIS-ACCESS; NEOINTIMAL HYPERPLASIA; ARTERIOVENOUS-FISTULA; BALLOON ANGIOPLASTY; GRAFT PATENCY; STENT GRAFT; OUTCOMES; VEIN; SURVIVAL	Background Vascular access failure is a huge burden for patients undergoing hemodialysis. Many efforts have been made to maintain vascular access patency, including pharmacotherapy. Angiotensin converting enzyme inhibitor (ACE-I), angiotensin receptor blocker (ARB), and calcium channel blocker (CCB) are known for their antihypertensive and cardio-protective effects, however, their effects on long-term vascular access patency are still inconclusive. Design, setting, participants and measurements We retrospectively enrolled patients commencing maintenance hemodialysis between January 1, 2000, and December 31, 2006 by using National Health Insurance Research Database in Taiwan. Primary patency was defined as the date of first arteriovenous fistula (AVF) or arteriovenous graft (AVG) creation to the time of access thrombosis or any intervention aimed to maintain or re-establish vascular access patency. Cox proportional hazards models were used to adjust the influences of patient characteristics, co-morbidities and medications. Results Total 42244 patients were enrolled in this study, 37771 (89.4%) used AVF, 4473 (10.6%) used AVG as their first long term dialysis access. ACE-I, ARB, and CCB use were all associated with prolonged primary patency of AVF [hazard ratio (HR) 0.586, 95% confidence interval (CI) 0.557-0.616 for ACE-I use; HR 0.532, CI 0.508-0.556 for ARB use; HR 0.485, CI 0.470-0.501 for CCB use] and AVG (HR 0.557, CI 0.482-0.643 for ACE-I use, HR 0.536, CI 0.467-0.614 for ARB use, HR 0.482, CI 0.442-0.526 for CCB use). Conclusions In our analysis, ACE-I, ARB, and CCB were strongly associated with prolonged primary patency of both AVF and AVG. Further prospective randomized studies are still warranted to prove the causality.	[Chen, Fu-An; Chen, Yu-Wei; Wu, Yu-Te; Lin, Chih-Ching] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Fu-An] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan; [Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Chen, Yu-Wei; Wu, Yu-Te; Lin, Chih-Ching] Taipei Vet Gen Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Chi Mei Hospital; Taipei Veterans General Hospital	Lin, CC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Lin, CC (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.	lincc2@vghtpe.gov.tw			Taipei Veterans General Hospital [V100C1-050, V101C-188, V102C-060, V102E2-001, V103C-043, V104C-026, V105C-075]; National Science Council [NSC101-2314-B-010-024-MY3]; Ministry of Science and Technology in Taiwan [MOST 104-2314-B-010-032-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural grants (V100C1-050, V101C-188, V102C-060, V102E2-001, V103C-043, V104C-026, V105C-075) from Taipei Veterans General Hospital, and grants from the National Science Council (NSC101-2314-B-010-024-MY3) and the Ministry of Science and Technology (MOST 104-2314-B-010-032-MY3) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Bashar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119958; Brauner R, 1997, J THORAC CARDIOV SUR, V114, P53, DOI 10.1016/S0022-5223(97)70117-X; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Doi S, 2008, THER APHER DIAL, V12, P232, DOI 10.1111/j.1744-9987.2008.00579.x; Dolmatch BL, 2010, J VASC ACCESS, V11, P89, DOI 10.1177/112972981001100201; Gradzki R, 2001, AM J KIDNEY DIS, V38, P1240, DOI 10.1053/ajkd.2001.29220; Haskal ZJ, 2010, NEW ENGL J MED, V362, P494, DOI 10.1056/NEJMoa0902045; Huang P, 2001, AM J SURG, V181, P492, DOI 10.1016/S0002-9610(01)00615-8; Hung YN, 2010, CLIN J AM SOC NEPHRO, V5, P1029, DOI 10.2215/CJN.08181109; Jackson RS, 2011, J VASC SURG, V54, P1706, DOI 10.1016/j.jvs.2011.06.028; Lin CC, 2007, J AM SOC NEPHROL, V18, P985, DOI 10.1681/ASN.2006050534; Mihmanli I, 2001, J ULTRAS MED, V20, P217; Ng LJ, 2011, NEPHROL DIAL TRANSPL, V26, P3659, DOI 10.1093/ndt/gfr063; Ocak G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-79; ODONOHOE MK, 1991, ANN SURG, V214, P727, DOI 10.1097/00000658-199112000-00014; Osborn G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002786.pub2; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; Sajgure A, 2007, NEPHROL DIAL TRANSPL, V22, P1390, DOI 10.1093/ndt/gfl821; Saran R, 2002, AM J KIDNEY DIS, V40, P1255, DOI 10.1053/ajkd.2002.36895; Taber T E, 1995, ASAIO J, V41, P842; USRDS, 2014, US REN DAT SYST 2014; Wasse H, 2007, CLIN J AM SOC NEPHRO, V2, P708, DOI 10.2215/CJN.00170107; Yagi S, 2004, HYPERTENS RES, V27, P129, DOI 10.1291/hypres.27.129; Yamada T, 2007, ARTERIOSCL THROM VAS, V27, P2363, DOI 10.1161/ATVBAHA.107.147124	25	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166362	10.1371/journal.pone.0166362	http://dx.doi.org/10.1371/journal.pone.0166362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832203	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000110
J	Joshi, R; Buchanan, JC; Paruchuri, S; Morris, N; Tavana, H				Joshi, Ramila; Buchanan, James Carlton; Paruchuri, Sailaja; Morris, Nathan; Tavana, Hossein			Molecular Analysis of Stromal Cells-Induced Neural Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; TYROSINE-HYDROXYLASE; CORTICAL DEVELOPMENT; PROGENITOR CELLS; NEURONAL DIFFERENTIATION; DOPAMINERGIC-NEURONS; SELF-RENEWAL; ES CELLS; EXPRESSION; INDUCTION	Deriving specific neural cells from embryonic stem cells (ESCs) is a promising approach for cell replacement therapies of neurodegenerative diseases. When co-cultured with certain stromal cells, mouse ESCs (mESCs) differentiate efficiently to neural cells. In this study, a comprehensive gene and protein expression analysis of differentiating mESCs is performed over a two-week culture period to track temporal progression of cells from a pluripotent state to specific terminally-differentiated neural cells such as neurons, astrocytes, and oligoden-drocytes. Expression levels of 26 genes consisting of marker genes for pluripotency, neural progenitors, and specific neuronal, astroglial, and oligodendrocytic cells are tracked using real time q-PCR. The time-course gene expression analysis of differentiating mESCs is combined with the hierarchal clustering and functional principal component analysis (FPCA) to elucidate the evolution of specific neural cells from mESCs at a molecular level. These statistical analyses identify three major gene clusters representing distinct phases of transition of stem cells from a pluripotent state to a terminally-differentiated neuronal or glial state. Temporal protein expression studies using immunohistochemistry demonstrate the generation of neural stem/progenitor cells and specific neural lineages and show a close agreement with the gene expression profiles of selected markers. Importantly, parallel gene and protein expression analysis elucidates long-term stability of certain proteins compared to those with a quick turnover. Describing the molecular regulation of neural cells commitment of mESCs due to stromal signaling will help identify major promoters of differentiation into specific cell types for use in cell replacement therapy applications.	[Joshi, Ramila; Buchanan, James Carlton; Tavana, Hossein] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Morris, Nathan] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Akron; University of Akron; Case Western Reserve University	Tavana, H (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.	tavana@uakron.edu	Joshi, Ramila/U-5982-2019		National Science Foundation [1264562]; Ohio Third Frontier [TECG20140954]	National Science Foundation(National Science Foundation (NSF)); Ohio Third Frontier	This research is supported by the National Science Foundation, grant 1264562 and from Ohio Third Frontier, grant TECG20140954. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by grant 1264562 from National Science Foundation and grant TECG20140954 from Ohio Third Frontier.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Akanuma Hiromi, 2012, Frontiers in Genetics, V3, P141, DOI 10.3389/fgene.2012.00141; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai C, 2007, DEV DYNAM, V236, P3255, DOI 10.1002/dvdy.21306; Chen XS, 2013, INT J MOL MED, V32, P25, DOI 10.3892/ijmm.2013.1372; Ding YC, 2002, NEUROL RES, V24, P829, DOI 10.1179/016164102101200816; Erceg S, 2009, STEM CELLS, V27, P78, DOI 10.1634/stemcells.2008-0543; Faigle R, 2012, BIOCHIM BIOPHYS ACTA, V1830, P2435, DOI DOI 10.1016/J.BBAGEN.2012.09.002; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Goldman S A., 1995, NEUROSCIENTIST, V1, P338; Haque A, 2012, BIOMATERIALS, V33, P5094, DOI 10.1016/j.biomaterials.2012.04.003; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; James G, 2000, BIOMETRIKA, V1, P1; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kan LX, 2007, DEV BIOL, V310, P85, DOI 10.1016/j.ydbio.2007.07.026; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kaufmann M, 2015, J BIOMOL SCREEN, V20, P1101, DOI 10.1177/1087057115588287; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kitajima H, 2005, J NEUROSCI RES, V80, P467, DOI 10.1002/jnr.20469; Kondeti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071536; Kuegler PB, 2005, ENV PROT, P17; Kumar M, 2007, STEM CELLS DEV, V16, P667, DOI 10.1089/scd.2006.0115; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Liao Mei-Chih, 2014, World J Stem Cells, V6, P248, DOI 10.4252/wjsc.v6.i2.248; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Lindvall Olle, 2004, NeuroRx, V1, P379, DOI 10.1007/BF03206624; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Melchitzky DS, 2000, NEUROPSYCHOPHARMACOL, V22, P466, DOI 10.1016/S0893-133X(99)00139-6; Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; PAPALOPULU N, 1991, DEVELOPMENT, V113, P1145; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Paul D, 2009, ANN STAT, V37, P1229, DOI 10.1214/08-AOS608; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rosskothen-Kuhl N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092624; Sancho-Martinez I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10743; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Sweeney CL, 2016, STEM CELLS, V34, P1513, DOI 10.1002/stem.2332; Taha MF, 2014, J BIOTECHNOL, V172, P1, DOI 10.1016/j.jbiotec.2013.11.028; Tavana H, 2011, BIOTECHNOL BIOENG, V108, P2509, DOI 10.1002/bit.23190; Tavana H, 2010, ADV MATER, V22, P2628, DOI 10.1002/adma.200904271; Tchorz JS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.65; Vazin T, 2008, STEM CELLS, V26, P1517, DOI 10.1634/stemcells.2008-0039; Venere M, 2012, DEVELOPMENT, V139, P3938, DOI 10.1242/dev.081133; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walsh FS, 2003, NEURAL CELL ADHESION; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745; Yin Dezhong, 2012, Methods Mol Biol, V873, P247, DOI 10.1007/978-1-61779-794-1_16; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7	67	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166316	10.1371/journal.pone.0166316	http://dx.doi.org/10.1371/journal.pone.0166316			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832161	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000095
J	Lim, L; Hart, H; Mehta, MA; Simmons, A; Mirza, K; Rubia, K				Lim, Lena; Hart, Heledd; Mehta, Mitul A.; Simmons, Andrew; Mirza, Kah; Rubia, Katya			Neurofunctional Abnormalities during Sustained Attention in Severe Childhood Abuse	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; POSTTRAUMATIC STRESS SYMPTOMS; SCHOOL-AGED CHILDREN; ADULT MENTAL-HEALTH; EARLY-LIFE STRESS; SEXUAL-ABUSE; MALTREATED CHILDREN; PHYSICAL ABUSE; EARLY DEPRIVATION; NEGLECT	Childhood maltreatment is associated with adverse affective and cognitive consequences including impaired emotion processing, inhibition and attention. However, the majority of functional magnetic resonance imaging (fMRI) studies in childhood maltreatment have examined emotion processing, while very few studies have tested the neurofunctional substrates of cognitive functions and none of attention. This study investigated the association between severe childhood abuse and fMRI brain activation during a parametric sustained attention task with a progressively increasing load of sustained attention in 21 medication-naive, drug-free young people with a history of childhood abuse controlling for psychiatric comorbidities by including 19 psychiatric controls matched for psychiatric diagnoses, and 27 healthy controls. Behaviorally, the participants exposed to childhood abuse showed increased omission errors in the task which correlated positively trend-wise with the duration of their abuse. Neurofunctionally, the participants with a history of childhood abuse, but not the psychiatric controls, displayed significantly reduced activation relative to the healthy controls during the most challenging attention condition only in typical attention regions including left inferior and dorsolateral prefrontal cortex, insula and temporal areas. We therefore show for the first time that severe childhood abuse is associated with neurofunctional abnormalities in key ventral frontal-temporal sustained attention regions. The findings represent a first step towards the delineation of abuse-related neurofunctional abnormalities in sustained attention, which may help in the development of effective treatments for victims of childhood abuse.	[Lim, Lena; Hart, Heledd; Mirza, Kah; Rubia, Katya] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England; [Mehta, Mitul A.; Simmons, Andrew] Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London, England; [Simmons, Andrew] South London & Maudsley Fdn NHS Trust, NIHR Biomed Res Ctr, London, England	University of London; King's College London; University of London; King's College London	Lim, L (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England.	lena.lim@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Hassan, Randa/AAW-3624-2021; Rubia, Katya/H-7497-2012	Simmons, Andrew/0000-0003-2306-5811; Rubia, Katya/0000-0002-1410-7701; Lim, Lena/0000-0002-3301-923X	Reta Lila Weston Trust for Medical Research; National Medical Research Council; UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London	Reta Lila Weston Trust for Medical Research; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London	This study, HH and LL were supported by the Reta Lila Weston Trust for Medical Research. LL was also supported by the National Medical Research Council. AS and KR were supported by the UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and the Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London.; This study, HH and LL were supported by the Reta Lila Weston Trust for Medical Research. LL was also supported by the National Medical Research Council. AS and KR were supported by the UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and the Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London. We thank all the individuals and their families who participated in this study. We also thank Dr. Kaylita Chantiluke and Miss Sinead King for their assistance with data collection as well as the staff of Kids Company London for their help with recruitment.	Ackerman PT, 1998, CHILD ABUSE NEGLECT, V22, P759, DOI 10.1016/S0145-2134(98)00062-3; Ardekani BA, 2002, COGNITIVE BRAIN RES, V14, P347, DOI 10.1016/S0926-6410(02)00137-4; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; Bucker J, 2012, COMPR PSYCHIAT, V53, P758, DOI 10.1016/j.comppsych.2011.12.006; Carrion VG, 2008, DEPRESS ANXIETY, V25, P514, DOI 10.1002/da.20346; Choi J, 2012, NEUROIMAGE, V59, P1071, DOI 10.1016/j.neuroimage.2011.09.033; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; CLAUSSEN AH, 1991, CHILD ABUSE NEGLECT, V15, P5, DOI 10.1016/0145-2134(91)90085-R; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Currie CE, 1997, HEALTH EDUC RES, V12, P385, DOI 10.1093/her/12.3.385; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2009, J INT NEUROPSYCH SOC, V15, P868, DOI 10.1017/S1355617709990464; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DePrince AP, 2009, CHILD ABUSE NEGLECT, V33, P353, DOI 10.1016/j.chiabu.2008.08.002; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Elton A, 2014, HUM BRAIN MAPP, V35, P1654, DOI 10.1002/hbm.22280; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Feiring C, 1996, CHILD ABUSE NEGLECT, V20, P767, DOI 10.1016/0145-2134(96)00064-6; FINKELHOR D, 1985, AM J ORTHOPSYCHIAT, V55, P530, DOI 10.1111/j.1939-0025.1985.tb02703.x; Fonzo GA, 2013, PSYCHIAT RES-NEUROIM, V211, P93, DOI 10.1016/j.pscychresns.2012.08.006; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Fuller-Thomson E, 2014, J AGGRESS MALTREAT T, V23, P188, DOI 10.1080/10926771.2014.873510; Geoffroy MC, 2016, J AM ACAD CHILD PSY, V55, P33, DOI 10.1016/j.jaac.2015.10.012; Gibb BE, 2009, CHILD MALTREATMENT, V14, P148, DOI 10.1177/1077559508326358; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Hanson JL, 2012, J NEUROSCI, V32, P7917, DOI 10.1523/JNEUROSCI.0307-12.2012; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heim CM, 2013, AM J PSYCHIAT, V170, P616, DOI 10.1176/appi.ajp.2013.12070950; Herrenkohl TI, 2013, J FAM VIOLENCE, V28, P191, DOI 10.1007/s10896-012-9474-9; Huang H, 2012, NEUROPSYCHOPHARMACOL, V37, P2693, DOI 10.1038/npp.2012.133; Kremer I, 2016, ARCH SUICIDE RES, P1; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lewis T, 2016, CHILD ABUSE NEGLECT, V51, P31, DOI 10.1016/j.chiabu.2015.11.016; Lim L, 2015, AM J PSYCHIAT, V172, P892, DOI 10.1176/appi.ajp.2015.14081042; Lim L, 2014, AM J PSYCHIAT, V171, P854, DOI 10.1176/appi.ajp.2014.13101427; Loman MM, 2013, J CHILD PSYCHOL PSYC, V54, P37, DOI 10.1111/j.1469-7610.2012.02602.x; Lopez-Castroman J, 2013, WORLD PSYCHIATRY, V12, P149, DOI 10.1002/wps.20039; MacMillan HL, 2013, CHILD ABUSE NEGLECT, V37, P14, DOI 10.1016/j.chiabu.2012.06.005; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; Masten CL, 2008, CHILD ABUSE NEGLECT, V32, P139, DOI 10.1016/j.chiabu.2007.09.006; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; McCrory E, 2010, J CHILD PSYCHOL PSYC, V51, P1079, DOI 10.1111/j.1469-7610.2010.02271.x; McCrory EJ, 2013, BRIT J PSYCHIAT, V202, P269, DOI 10.1192/bjp.bp.112.116624; McCrory EJ, 2011, CURR BIOL, V21, pR947, DOI 10.1016/j.cub.2011.10.015; McDermott JM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00167; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mills R, 2011, PEDIATRICS, V127, P4, DOI 10.1542/peds.2009-3479; Miyake Y, 2004, ACTA NEUROBIOL EXP, V64, P415; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Murphy CM, 2014, AM J PSYCHIAT, V171, P1107, DOI 10.1176/appi.ajp.2014.12030352; National Society for the Prevention of Cruelty to Children (NSPCC), 2011, CHILD ABUSE NEGLECT; NEY PG, 1994, CHILD ABUSE NEGLECT, V18, P705, DOI 10.1016/0145-2134(94)00037-9; Nolin P, 2007, CHILD ABUSE NEGLECT, V31, P631, DOI 10.1016/j.chiabu.2006.12.009; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Ouyang LJ, 2008, J PEDIATR-US, V153, P851, DOI 10.1016/j.jpeds.2008.06.002; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; Pollak SD, 2005, CHILD DEV, V76, P968, DOI 10.1111/j.1467-8624.2005.00890.x; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Raine A, 2001, AGGRESSIVE BEHAV, V27, P111, DOI 10.1002/ab.4; Read J, 2003, PSYCHOL PSYCHOTHER-T, V76, P1, DOI 10.1348/14760830260569210; Rubia K, 1998, NEUROPSYCHOLOGIA, V36, P1283, DOI 10.1016/S0028-3932(98)00038-4; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shackman JE, 2007, EMOTION, V7, P838, DOI 10.1037/1528-3542.7.4.838; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Smith AB, 2011, NEUROIMAGE, V56, P1693, DOI 10.1016/j.neuroimage.2011.01.072; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sugaya L, 2012, J TRAUMA STRESS, V25, P384, DOI 10.1002/jts.21719; Tana MG, 2010, COMPUTATIONAL INTELL; Taylor SE, 2006, BIOL PSYCHIAT, V60, P296, DOI 10.1016/j.biopsych.2005.09.027; Teicher MH, 1997, ANN NY ACAD SCI, V821, P160, DOI 10.1111/j.1749-6632.1997.tb48277.x; Tekin A, 2016, NORD J PSYCHIAT, V70, P88, DOI 10.3109/08039488.2015.1053097; Tottenham N, 2011, DEVELOPMENTAL SCI, V14, P190, DOI 10.1111/j.1467-7687.2010.00971.x; Trickett PK, 2011, CHILD ABUSE NEGLECT, V35, P876, DOI 10.1016/j.chiabu.2011.08.001; TRICKETT PK, 1995, DEV REV, V15, P311, DOI 10.1006/drev.1995.1012; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weierich MR, 2008, J CONSULT CLIN PSYCH, V76, P39, DOI 10.1037/0022-006X.76.1.39; White MG, 2012, GENES BRAIN BEHAV, V11, P869, DOI 10.1111/j.1601-183X.2012.00837.x; Young JC, 2014, CHILD ABUSE NEGLECT, V38, P1369, DOI 10.1016/j.chiabu.2014.03.008; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005	97	18	18	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165547	10.1371/journal.pone.0165547	http://dx.doi.org/10.1371/journal.pone.0165547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832090	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000019
J	Ma, XW; Wang, L; Wu, H; Feng, YM; Han, XB; Bu, HR; Zhu, Q				Ma, Xiaowen; Wang, Le; Wu, Hao; Feng, Yuemin; Han, Xibiao; Bu, Haoran; Zhu, Qiang			Spleen Stiffness Is Superior to Liver Stiffness for Predicting Esophageal Varices in Chronic Liver Disease: A Meta-Analysis	PLOS ONE			English	Article							SIGNIFICANT PORTAL-HYPERTENSION; TRANSIENT ELASTOGRAPHY; GASTROESOPHAGEAL VARICES; DIAGNOSTIC-ACCURACY; CIRRHOTIC-PATIENTS; SHEAR-WAVE; NONINVASIVE ASSESSMENT; ARFI ELASTOGRAPHY; HEPATITIS; RISK	Background and Aims Liver stiffness (LS) and spleen stiffness (SS) are two most widely accessible non-invasive parameters for predicting esophageal varices (EV), but the reported accuracy of the two predictors have been inconsistent across studies. This meta-analysis aims to evaluate the diagnostic performance of LS and SS measurement for detecting EV in patients with chronic liver disease (CLD), and compare their accuracy. Methods Pubmed/Medline, Embase, Cochrane Library and Ovid were searched for all studies assessing SS and LS simultaneously in EV diagnosis. A total of 16 studies including 1892 patients were included in this meta-analysis, and the pooled statistical parameters were calculated using the bivariate mixed effects models. Results In detection of any EV, for LS measurement, the summary sensitivity was 0.83 (95% confidence interval [CI]: 0.78-0.87), and the specificity was 0.66 (95% CI: 0.60-0.72). While for SS measurement, the pooled sensitivity and specificity was 0.88 (95% CI: 0.83-0.92) and 0.78 (95% CI: 0.73-0.83). The summary receiver operating characteristic (SROC) curve values of LS and SS were 0.81 (95% CI: 0.77-0.84) and 0.88 (95% CI: 0.85-0.91) respectively, and the results had statistical significance (P<0.01). The diagnostic odds ratio (DOR) of SS (25.73) was significantly higher than that of LS (9.54), with the relative DOR value was 2.48 (95% CI: 1.10-5.60), P<0.05. Conclusions Under current techniques, SS is significantly superior to LS for identifying the presence of EV in patients with CLD. SS measurement may help to select patients for endoscopic screening.	[Ma, Xiaowen; Wang, Le; Wu, Hao; Feng, Yuemin; Bu, Haoran; Zhu, Qiang] Shandong Univ, Shandong Prov Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China; [Ma, Xiaowen; Wang, Le; Wu, Hao; Feng, Yuemin; Bu, Haoran; Zhu, Qiang] Shandong Prov Engn & Technol Res Ctr Liver Dis Pr, Jinan, Shandong, Peoples R China; [Han, Xibiao] Shandong Univ, Shandong Prov Hosp, Dept Pharm, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhu, Q (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China.; Zhu, Q (corresponding author), Shandong Prov Engn & Technol Res Ctr Liver Dis Pr, Jinan, Shandong, Peoples R China.	zhuqiang@medmail.com.cn	Wijarnpreecha, Karn/J-3296-2019	Wijarnpreecha, Karn/0000-0002-6232-6343	National Natural Science Foundation of China [81370554]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (Grant No.81370554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraldes JG, 2013, HEPATOLOGY, V57, P1278, DOI 10.1002/hep.26239; Al-Dahshan Magdy, 2012, J Egypt Soc Parasitol, V42, P79; Alsebaey A, 2015, HEPATOLOGY, V62, p1126A; Attia D, 2015, ULTRASCHALL MED, V36, P603, DOI 10.1055/s-0041-107971; Berzigotti A, 2014, HEPATOLOGY, V59, P729, DOI 10.1002/hep.26652; Berzigotti A, 2013, GASTROENTEROLOGY, V144, P102, DOI 10.1053/j.gastro.2012.10.001; Bolognesi M, 2002, DIGEST LIVER DIS, V34, P144, DOI 10.1016/S1590-8658(02)80246-8; Bota S, 2013, LIVER INT, V33, P1138, DOI 10.1111/liv.12240; Bota S, 2012, ANN HEPATOL, V11, P519, DOI 10.1016/S1665-2681(19)31466-8; Calvaruso V, 2013, J VIRAL HEPATITIS, V20, P867, DOI 10.1111/jvh.12114; Calvaruso V, 2010, J HEPATOL, V52, pS159, DOI 10.1016/S0168-8278(10)60390-X; Colecchia A, 2012, GASTROENTEROLOGY, V143, P646, DOI 10.1053/j.gastro.2012.05.035; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; de Franchis R, 2014, CLIN LIVER DIS, V18, P293, DOI 10.1016/j.cld.2013.12.002; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deng H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001795; Elkrief L, 2015, RADIOLOGY, V275, P589, DOI 10.1148/radiol.14141210; Fraquelli M, 2014, J VIRAL HEPATITIS, V21, P90, DOI 10.1111/jvh.12119; Garcia-Tsao G, 2007, AM J GASTROENTEROL, V102, P2086, DOI 10.1111/j.1572-0241.2007.01481.x; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Grgurevic I, 2015, CROAT MED J, V56, P470, DOI 10.3325/cmj.2015.56.470; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Lim JK, 2007, HEPATOLOGY, V45, P1087, DOI 10.1002/hep.21731; Liu Fang, 2013, Zhonghua Gan Zang Bing Za Zhi, V21, P840, DOI 10.3760/cma.j.issn.1007-3418.2013.11.010; Morisaka H, 2015, J MAGN RESON IMAGING, V41, P117, DOI 10.1002/jmri.24505; Procopet B, 2015, J HEPATOL, V62, P1068, DOI 10.1016/j.jhep.2014.12.007; Rosolowski M, 2014, PRZ GASTROENTEROL, V9, P63, DOI 10.5114/pg.2014.42497; Sharma P, 2013, AM J GASTROENTEROL, V108, P1101, DOI 10.1038/ajg.2013.119; Shi KQ, 2013, LIVER INT, V33, P62, DOI 10.1111/liv.12003; Shin SU, 2014, RADIOLOGY, V272, P143, DOI 10.1148/radiol.14130916; Singh S, 2014, CLIN GASTROENTEROL H, V12, P935, DOI 10.1016/j.cgh.2013.09.013; Stefanescu H, 2015, LIVER INT, V35, P317, DOI 10.1111/liv.12687; Stefanescu H, 2011, J GASTROEN HEPATOL, V26, P164, DOI 10.1111/j.1440-1746.2010.06325.x; Takuma Y, 2011, ACTA HEPATOLOGICA JA, V52, P258; Takuma Y, 2013, GASTROENTEROLOGY, V144, P92, DOI 10.1053/j.gastro.2012.09.049; Tripathi D, 2015, GUT, V64, P1680, DOI 10.1136/gutjnl-2015-309262; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Ye XP, 2012, J ULTRAS MED, V31, P1245; Zykus R, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0414-z	41	66	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165786	10.1371/journal.pone.0165786	http://dx.doi.org/10.1371/journal.pone.0165786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829057	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300060
J	Tang, Y; Liu, MY; Wu, JH				Tang, Yi; Liu, Ming-yu; Wu, Jin-hua			Effects of Thinning and Water Supply Manipulation on the Productivity of Pinus sylvestris var. mongolica in Northeastern China	PLOS ONE			English	Article							EUROPEAN BEECH; SEED NUMBER; IMPACTS; FORESTS; STANDS; MODEL	Management is an effective tool for increasing the productivity of Mongolian pine (Pinus sylvestris var. mongolica). This species has been widely planted in China, especially in sandy lands. However, optimization of management practices had not been fully explored. We established a system dynamic model to evaluate the effects of thinning and of manipulation of water supply on the productivity and population density of a Mongolian pine forest (17 scenarios in total). Different levels of thinning increased the mean biomass of Mongolian pine over no-management to a range from 202 to 256 t.ha(-1). Increasing water supply decreased the mean biomass of Mongolian pine to a range from 176 to 199 t.ha(-1). These results indicated that thinning at different levels may lead to an increase in biomass accumulation, while manipulating water supply may decrease biomass. Further, thinning appeared more effective than increasing water supply in efforts at maintaining high productivity of Mongolian pine forests. Moreover, the highest biomass occurred in a scenario with a thinning intensity of 30% in over-mature trees, indicating that this thinning intensity was the most effective choice for to the maintenance of the highest biomass in Mongolian pine forests. This study informs about the interactions between Mongolian pine and forest management, and provides guidelines for the practice of management of this forest type.	[Tang, Yi; Liu, Ming-yu; Wu, Jin-hua] Liaoning Univ, Sch Life Sci, Shenyang, Peoples R China	Liaoning University	Tang, Y (corresponding author), Liaoning Univ, Sch Life Sci, Shenyang, Peoples R China.	tangyi@lnu.edu.cn	Tang, Yi/AAG-3642-2021	Tang, Yi/0000-0002-4374-6334	National Basic Research Program of China [2013CB429905]; National Natural Science Foundation of China [41201052]; Scientific Research Program of the education department of Liaoning province [LYB201613]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Program of the education department of Liaoning province	This work was supported by the National Basic Research Program of China (2013CB429905), the National Natural Science Foundation of China (41201052) and the Scientific Research Program of the education department of Liaoning province (LYB201613).	Armolaitis K, 2013, BIOMASS BIOENERG, V54, P250, DOI 10.1016/j.biombioe.2013.03.034; Carvajal DE, 2015, AM J BOT, V102, P1552, DOI 10.3732/ajb.1500097; Chu Jian-min, 2011, Shengtaixue Zazhi, V30, P2672; Cienciala E, 2006, TREES-STRUCT FUNCT, V20, P483, DOI 10.1007/s00468-006-0064-4; Dulamsuren C, 2013, PLANT ECOL, V214, P139, DOI 10.1007/s11258-012-0152-z; Dyck W. J., 1994, IMPACTS FOREST HARVE; Forrester DI, 2013, FOREST ECOL MANAG, V288, P21, DOI 10.1016/j.foreco.2011.11.024; Gambin BL, 2010, ANN APPL BIOL, V156, P91, DOI 10.1111/j.1744-7348.2009.00367.x; Guo H, 2010, J ECOL, V98, P1232, DOI 10.1111/j.1365-2745.2010.01688.x; Huang XH., 2012, RUAL PRACT TECH INFO, V18, P39; Jiang F, 1996, MANAGEMENT REASONABL; Jiao ShuRen, 2001, Scientia Silvae Sinicae, V37, P131; [康宏樟 Kang Hongzhang], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P799; [李华 Li Hua], 2010, [生态学报, Acta Ecologica Sinica], V21, P3654; Lopez-Serrano FR, 2015, EUR J FOREST RES, V134, P167, DOI 10.1007/s10342-014-0841-3; Luan KZ, 2012, FOREST SCI TECH, V37, P35; Luo L. Y., 2008, THESIS; McKnight US, 2013, ENVIRON MODELL SOFTW, V40, P35, DOI 10.1016/j.envsoft.2012.07.007; Molina AJ, 2012, FOREST ECOL MANAG, V269, P206, DOI 10.1016/j.foreco.2011.12.037; Nzunda EF, 2011, PLANT ECOL, V212, P1991, DOI 10.1007/s11258-011-9991-2; Pretzsch H, 2013, EUR J FOREST RES, V132, P263, DOI 10.1007/s10342-012-0673-y; Sharma RP, 2016, FOREST ECOL MANAG, V366, P208, DOI 10.1016/j.foreco.2016.01.040; Song LN, 2015, AGROFOREST SYST, V89, P477, DOI 10.1007/s10457-014-9784-4; Tang Y, 2018, AGROFOREST SYST, V92, P1, DOI 10.1007/s10457-016-0004-2; Tang Y, 2015, BIOCELL, V39, P15; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043531; Wang QF, 2009, THE SYSTEM DYNAMICS; Wei SK, 2012, EUR J OPER RES, V221, P248, DOI 10.1016/j.ejor.2012.03.014; Wei X, 2000, FOREST ECOL MANAG, V133, P217, DOI 10.1016/S0378-1127(99)00234-0; Wu CR, 2003, PROTECTION FOREST SC, V1, P59; Wu YX, 1997, J LIAONING FOREST SC, V24, P27; Xu Wei, 2008, Journal of Zhejiang University (Agriculture and Life Sciences), V34, P649; You GC, 2002, PROTECT FOREST SCI T, V10, P11; Zeng DH, 2000, ACTA ECOL SIN, V20, P235, DOI DOI 10.3321/J.ISSN:1000-0933.2000.02.011; Zhang ZJ., 2014, PROTECT FOREST SCI T, V23, P73; Zheng DeHui, 1996, Chinese Journal of Applied Ecology, V7, P134; Zheng X, 2012, AGR WATER MANAGE, V109, P94, DOI 10.1016/j.agwat.2012.02.010; Zhu Jiao-jun, 2003, Journal of Forestry Research (Harbin), V14, P103, DOI 10.1007/BF02856774; Zhu JJ, 2006, J FOREST RES-JPN, V11, P319, DOI 10.1007/s10310-006-0214-y	40	2	2	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166109	10.1371/journal.pone.0166109	http://dx.doi.org/10.1371/journal.pone.0166109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829012	gold, Green Submitted, Green Published			2022-12-27	WOS:000387724300082
J	Ree, XM; Zuo, GF; Wu, W; Luo, J; Ye, P; Chen, SL; Hu, ZY				Ree, Xiao-min; Zuo, Guang-feng; Wu, Wen; Luo, Jie; Ye, Peng; Chen, Shao-liang; Hu, Zuo-ying			Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3 beta-PP2Ac-NF-kappa B Signaling Axis	PLOS ONE			English	Article							NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3; GLUCOSE-INDUCED APOPTOSIS; PROTEIN PHOSPHATASE-2A; OXIDATIVE STRESS; MUSCLE-CELLS; CARDIOMYOCYTES; ACTIVATION; EXPRESSION; HEART	Recent studies reported that atorvastatin (ATOR) alleviated progression of experimental diabetic cardiomyopathy (DCM), possibly by protecting against apoptosis. However, the underlying mechanisms of this protective effect remain unclear. Therefore, our study investigated the role of the glycogen synthase kinase (GSK)-3 beta-protein phosphatase 2A(PP2A)-NF-kappa B signaling pathway in the anti-apoptotic and cardioprotective effects of ATOR on cardiomyocytes cultured in high glucose (HG) and in DCM. Our results showed that, in HG-cultured cardiomyocytes, phosphorylation of GSK-3 beta was decreased, while that of the PP2A catalytic subunit C (PP2Ac) and IKK/I kappa Ba was increased, followed by NF-kappa B nuclear translocation and apoptosis. IKK/I kappa B alpha phosphorylation and NF-kappa B nuclear translocation were also increased by treatment of cells with okadaic acid (OA), a selective PP2A inhibitor, or by silencing PP2Ac expression. The opposite results were obtained by silencing GSK-3 beta expression, which resulted in PP2Ac activation. Furthermore, IKK/I kappa Ba phosphorylation and NF-kappa B nuclear translocation were markedly inhibited and apoptosis attenuated in cells treated with ATOR. These effects occurred through inactivation of GSK-3 beta and subsequent activation of PP2Ac. They were abolished by treatment of cells with OA or PP2Ac siRNA. In mice with type 1 diabetes mellitus, treatment with ATOR, at 10 mg-kg(-1)-d(-1), significantly suppressed GSK-3 beta activation, IKK/I kappa Ba phosphorylation, NF-kappa B nuclear translocation and caspase-3 activation, while also activating PP2Ac. Finally, improvements in histological abnormalities, fibrosis, apoptosis and cardiac dysfunction were observed in diabetic mice treated with ATOR. These findings demonstrated that ATOR protected against HG-induced apoptosis in cardiomyocytes and alleviated experimental DCM by regulating the GSK-3 beta-PP2A-NF-kappa B signaling pathway.	[Ree, Xiao-min; Zuo, Guang-feng; Wu, Wen; Luo, Jie; Ye, Peng; Chen, Shao-liang; Hu, Zuo-ying] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing 210006, Jiangsu, Peoples R China	Nanjing Medical University	Chen, SL; Hu, ZY (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing 210006, Jiangsu, Peoples R China.	chen_s_l0931@sina.com; huzy0073@163.com			National Natural Science Foundation of China [NSFC-91439118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We acknowledge the National Natural Science Foundation of China (NSFC-91439118) for supporting completion of this study. Shao-liang Chen is the grant recipient and one of the corresponding authors in this manuscript.	Abdel-Hamid AAM, 2015, J MOL HISTOL, V46, P337, DOI 10.1007/s10735-015-9625-4; Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007; Barone E, 2014, BIOCHEM PHARMACOL, V88, P605, DOI 10.1016/j.bcp.2013.10.030; Bertoni AG, 2003, DIABETES CARE, V26, P2791, DOI 10.2337/diacare.26.10.2791; Cai Lu, 2003, Cardiovasc Toxicol, V3, P219, DOI 10.1385/CT:3:3:219; Chen SL, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-150; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dandapat S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0621-1; Fang D, 2014, EUR REV MED PHARMACO, V18, P242; Franke WW, 2007, EUR J CELL BIOL, V86, P127, DOI 10.1016/j.ejcb.2006.11.003; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Khan S, 2016, MOL CELL ENDOCRINOL, V428, P101, DOI 10.1016/j.mce.2016.03.025; Liu GP, 2008, NEUROBIOL AGING, V29, P1348, DOI 10.1016/j.neurobiolaging.2007.03.012; Mandosi E, 2010, J ATHEROSCLER THROMB, V17, P539, DOI 10.5551/jat.2956; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; Nizamutdinova IT, 2013, J CELL PHYSIOL, V228, P380, DOI 10.1002/jcp.24142; Obulesu M, 2014, NEUROCHEM RES, V39, P2301, DOI 10.1007/s11064-014-1454-4; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Ouyang CH, 2014, J MOL CELL CARDIOL, V71, P71, DOI 10.1016/j.yjmcc.2013.10.014; Palomer X, 2013, INT J CARDIOL, V168, P3160, DOI 10.1016/j.ijcard.2013.07.150; Pan Y, 2014, DIABETES, V63, P3497, DOI 10.2337/db13-1577; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Shirpoor A, 2009, J DIABETES COMPLICAT, V23, P310, DOI 10.1016/j.jdiacomp.2008.02.009; Somaratne JB, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-29; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Xu JJ, 2014, CRIT CARE MED, V42, pE583, DOI 10.1097/CCM.0000000000000415; Yao XQ, 2011, BIOCHEM J, V437, P335, DOI 10.1042/BJ20110347; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8	32	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166740	10.1371/journal.pone.0166740	http://dx.doi.org/10.1371/journal.pone.0166740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851811	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300083
J	Bi, JR; Yang, J; Wang, Y; Yao, CJ; Mei, J; Liu, Y; Cao, JY; Lu, YJ				Bi, Jirui; Yang, Jin; Wang, Ying; Yao, Cijiang; Mei, Jing; Liu, Ying; Cao, Jiyu; Lu, Youjin			Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis	PLOS ONE			English	Review							INTENSIVE-CARE-UNIT; ANTIBIOTIC-THERAPY; PREDICTION RULE; GLUCOCORTICOIDS; HYDROCORTISONE; DEXAMETHASONE; MANAGEMENT; LENGTH; STAY	Background Adjunctive corticosteroids therapy is an attractive option for community-acquired pneumonia (CAP) treatment. However, the effectiveness of adjunctive corticosteroids on mortality of CAP remains inconsistent, especially in severe CAP. We performed a meta-analysis to evaluate the efficacy and safety of adjunctive corticosteroids in severe CAP patients. Methods Three databases of PubMed, EMBASE and Cochrane Library were searched for related studies published in English up to December, 2015. Randomized controlled trials (RCTs) of corticosteroids in hospitalized adults with severe CAP were included. Meta-analysis was performed by a random-effect model with STATA 11.0 software. We estimated the summary risk ratios (RRs) or effect size (ES) with its corresponding 95% confidence interval (95% CI) to assess the outcomes. Results We included 8 RCTs enrolling 528 severe CAP patients. Adjunctive corticosteroids significantly reduced all-cause mortality (RR = 0.46, 95% CI: 0.28 to 0.77, p = 0.003), risk of adult respiratory distress syndrome (ARDS) (RR = 0.23, 95% CI: 0.07 to 0.80, p = 0.02) and need for mechanical ventilation (RR = 0.50, 95% CI: 0.27 to 0.92, p = 0.026). Adjunctive corticosteroids did not increase frequency of hyperglycemia requiring treatment (RR = 1.03, 95% CI: 0.61 to 1.72, p = 0.91) or gastrointestinal hemorrhage (RR = 0.66, 95% CI: 0.19 to 2.31, p = 0.52). In subgroup analysis by duration of corticosteroids, we found that prolonged corticosteroids therapy significantly reduced all-cause mortality (RR = 0.41, 95% CI: 0.20 to 0.83, p = 0.01) and length of hospital stay (-4.76 days, 95% CI:-8.13 to -1.40, p = 0.006). Conclusions Results from this meta-analysis suggested that adjunctive corticosteroids therapy was safe and beneficial for severe CAP. In addition, prolonged corticosteroids therapy was more effective. These results should be confirmed by adequately powered studies in the future.	[Bi, Jirui; Yang, Jin; Wang, Ying; Mei, Jing; Lu, Youjin] Anhui Med Univ, Affiliated Hosp 2, Dept Resp Med, Hefei, Peoples R China; [Yao, Cijiang; Liu, Ying] Anhui Med Univ, Sch Publ Hlth, Hefei, Peoples R China; [Cao, Jiyu] Anhui Med Univ, Sch Publ Hlth, Teaching Ctr Prevent Med, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Lu, YJ (corresponding author), Anhui Med Univ, Affiliated Hosp 2, Dept Resp Med, Hefei, Peoples R China.	luyougolden@hotmail.com						Aliberti S, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-27; Alvarez-Lerma Francisco, 2004, Curr Opin Crit Care, V10, P369; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Blum CA, 2015, LANCET, V385, P1511, DOI 10.1016/S0140-6736(14)62447-8; Carratala J, 2012, ARCH INTERN MED, V172, P922, DOI 10.1001/archinternmed.2012.1690; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Chen YJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007720.pub2; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; El-Ghamrawy AH., 2006, EGYPT J CHEST DIS TU, V55, P91; Endeman H, 2011, EUR RESPIR J, V37, P1431, DOI 10.1183/09031936.00074410; Fernandez-Botran R, 2014, INFLAMMATION, V37, P1158, DOI 10.1007/s10753-014-9840-2; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gusmao-Flores D, 2014, RESP CARE, V59, pE118, DOI 10.4187/respcare.03444; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Horita N, 2015, SCI REP-UK, V5, DOI 10.1038/srep14061; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mandell LA, 2015, POSTGRAD MED, V127, P607, DOI 10.1080/00325481.2015.1074030; MARIK P, 1993, CHEST, V104, P389, DOI 10.1378/chest.104.2.389; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Marti C, 2012, CRIT CARE, V16, DOI 10.1186/cc11447; Martinez R, 2011, EUR RESPIR J, V37, P393, DOI 10.1183/09031936.00040710; MCHARDY VU, 1972, BRIT MED J, V4, P569, DOI 10.1136/bmj.4.5840.569; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Mikami K, 2007, LUNG, V185, P249, DOI 10.1007/s00408-007-9020-3; Nafae RM, 2013, EGYPT J CHEST DIS TU, V62, P439, DOI 10.1016/j.ejcdt.2013.03.009; Nie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047926; Rello J, 2009, CRIT CARE MED, V37, P456, DOI 10.1097/CCM.0b013e318194b021; Remmelts HHF, 2012, J INFECTION, V65, P25, DOI 10.1016/j.jinf.2012.03.008; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rodriguez A, 2007, CRIT CARE MED, V35, P1493, DOI 10.1097/01.CCM.0000266755.75844.05; Sabry NA, 2011, PHARM PHARM, V2, P73, DOI DOI 10.4236/PP.2011.22009; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Salluh J, 2006, INTENS CARE MED, V32, P595, DOI 10.1007/s00134-005-0046-9; Salluh JIF, 2008, CHEST, V134, P947, DOI 10.1378/chest.08-1382; Salluh JIF, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2010.03.004; Shafiq M, 2013, J HOSP MED, V8, P68, DOI 10.1002/jhm.1992; Sibila O, 2008, EUR RESPIR J, V32, P1037, DOI 10.1183/09031936.00009208; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Siempos II, 2008, J ANTIMICROB CHEMOTH, V62, P661, DOI 10.1093/jac/dkn283; Sligl WI, 2013, CRIT CARE CLIN, V29, P563, DOI 10.1016/j.ccc.2013.03.009; Snijders D, 2010, AM J RESP CRIT CARE, V181, P975, DOI 10.1164/rccm.200905-0808OC; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Tagami T, 2015, EUR RESPIR J, V45, P463, DOI 10.1183/09031936.00081514; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; WAGNER HN, 1956, B JOHNS HOPKINS HOSP, V98, P197; Wan YD, 2016, CHEST, V149, P209, DOI 10.1378/chest.15-1733; Woodhead M, 2006, CRIT CARE, V10, DOI 10.1186/cc4927; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869	55	36	37	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165942	10.1371/journal.pone.0165942	http://dx.doi.org/10.1371/journal.pone.0165942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846240	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600025
J	Fukano, Y; Tanaka, Y; Farkhary, SI; Kurachi, T				Fukano, Yuya; Tanaka, Yosuke; Farkhary, Sayed Ibrahim; Kurachi, Takuma			Flower-Visiting Butterflies Avoid Predatory Stimuli and Larger Resident Butterflies: Testing in a Butterfly Pavilion	PLOS ONE			English	Article							BUMBLEBEES BOMBUS-IGNITUS; LOCAL ENHANCEMENT; STINGLESS BEES; PLANT FITNESS; NET CAGE; POLLINATION; CONSPECIFICS; REDUCE; INFORMATION; VISITATION	The flower-visiting behaviors of pollinator species are affected not only by flower traits but also by cues of predators and resident pollinators. There is extensive research into the effects of predator cues and resident pollinators on the flower-visiting behaviors of bee pollinators. However, there is relatively little research into their effects on butterfly pollinators probably because of the difficulty in observing a large number of butterfly pollination events. We conducted a dual choice experiment using artificial flowers under semi-natural conditions in the butterfly pavilion at Tama Zoological Park to examine the effects of the presence of a dead mantis and resident butterflies have on the flower-visiting behavior of several butterfly species. From 173 hours of recorded video, we observed 3235 visitations by 16 butterfly species. Statistical analysis showed that (1) butterflies avoided visiting flowers occupied by a dead mantis, (2) butterflies avoided resident butterflies that were larger than the visitor, and (3) butterflies showed greater avoidance of a predator when the predator was present together with the resident butterfly than when the predator was located on the opposite flower of the resident. Finally, we discuss the similarities and differences in behavioral responses of butterfly pollinators and bees.	[Fukano, Yuya] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Tanaka, Yosuke] Tokyo Zool Pk Soc, Ueno Zool Gardens, Tokyo, Japan; [Farkhary, Sayed Ibrahim; Kurachi, Takuma] Tokyo Univ Agr & Technol, Dept Vet Med, Fac Agr, Tokyo, Japan	University of Tokyo; Tokyo University of Agriculture & Technology	Fukano, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	yuya.fukano@gmail.com			 [26-3225]		This work was supported in part by Grant-in-Aid for JSPS (Japanese society for promotion of science) Fellows (no. 26-3225). https://www.jsps.go.jp/english/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; ALM J, 1990, OECOLOGIA, V84, P53, DOI 10.1007/BF00665594; Baude M, 2011, P ROY SOC B-BIOL SCI, V278, P2806, DOI 10.1098/rspb.2010.2659; Cembrowski AR, 2014, AM NAT, V183, P133, DOI 10.1086/674101; Craig CL, 2001, EVOLUTION, V55, P986, DOI 10.1554/0014-3820(2001)055[0986:SPITWD]2.0.CO;2; Dawson EH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3174; Dukas R, 2005, ECOLOGY, V86, P1401, DOI 10.1890/04-1663; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Hirota SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085601; Kawaguchi LG, 2006, FUNCT ECOL, V20, P239, DOI 10.1111/j.1365-2435.2006.01086.x; Kawaguchi LG, 2007, P ROY SOC B-BIOL SCI, V274, P2661, DOI 10.1098/rspb.2007.0860; KIKUCHI TOSHIHIDE, 1965, SCI REP TOHOKU UNTV SER IV BIOL, V31, P275; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Makino TT, 2004, BEHAV ECOL SOCIOBIOL, V56, P155, DOI 10.1007/s00265-004-0773-x; Makino TT, 2005, BEHAV ECOL SOCIOBIOL, V57, P617, DOI 10.1007/s00265-004-0877-3; MORSE DH, 1982, INSECT SOC, V29, P445, DOI 10.1007/BF02226159; MORSE DH, 1986, OIKOS, V46, P223, DOI 10.2307/3565470; Munoz AA, 2004, OECOLOGIA, V138, P66, DOI 10.1007/s00442-003-1405-2; Otis GW, 2006, J INSECT BEHAV, V19, P685, DOI 10.1007/s10905-006-9049-9; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Rader R, 2016, P NATL ACAD SCI USA, V113, P146, DOI 10.1073/pnas.1517092112; Robertson IC, 2005, OIKOS, V109, P577, DOI 10.1111/j.0030-1299.2005.13903.x; Romero GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020689; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Slaa EJ, 2003, ECOL ENTOMOL, V28, P369, DOI 10.1046/j.1365-2311.2003.00512.x; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Suttle KB, 2003, ECOL LETT, V6, P688, DOI 10.1046/j.1461-0248.2003.00490.x; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1983, NATURE, V302, P422, DOI 10.1038/302422a0; Willmer P., 2011, POLLINATION FLORAL E; ZIMMERMAN M, 1982, OIKOS, V38, P381, DOI 10.2307/3544681	35	1	1	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166365	10.1371/journal.pone.0166365	http://dx.doi.org/10.1371/journal.pone.0166365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846252	gold, Green Submitted, Green Published			2022-12-27	WOS:000387794600050
J	Le, CHH				Le, Chi Huu Hong			The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012)	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; PHYSICAL PERFORMANCE; HEMOGLOBIN LEVELS; UNITED-STATES; MORTALITY; IMPAIRMENT; DISABILITY; PREGNANCY; AMERICAN; SYMPTOMS	Since anemia is associated with poor health outcomes, the prevalence of anemia is a significant public health indicator. Even though anemia is primarily caused by iron deficiency, low oxygen-carrying capacity may result from other conditions such as chronic diseases, which remain a relevant health concern in the United States. However, studies examining current rates of anemia in the total US population and in more specific subgroups are limited. Data from five National Health and Nutrition Examination Surveys (NHANES) from 2003 to 2012 were analyzed to assess two outcomes: anemia and moderate-severe anemia, which were based upon serum hemoglobin levels (Hb) as per World Health Organization (WHO) definitions. Statistical analysis using SAS examined temporal trends and the prevalence of anemia among sexes, age groups, and races/ethnicities. The study estimated that an average of 5.6% of the U. S. population met the criteria for anemia and 1.5% for moderate-severe anemia during this 10-year period. High-risk groups such as pregnant women, elderly persons, women of reproductive age, non-Hispanic blacks, and Hispanics were identified, and relationships between multiple risk factors were examined. Rates of anemia in men increased monotonically with age, while that of women increased bimodally with peaks in age group 40-49 years and 80-85 years. The effect of risk factors was observed to compound. For instance, the prevalence of anemia in black women aged 80-85 years was 35.6%, 6.4 times higher than the population average. Moreover, anemia is a growing problem because of the increased prevalence of anemia (4.0% to 7.1%) and moderate-severe anemia (1.0% to 1.9%), which nearly doubled from 2003-2004 to 2011-2012. Thus, these results augment the current knowledge on anemia prevalence, severity, and distribution among subgroups in the US and raised anemia as an issue that requires urgent public health intervention.	[Le, Chi Huu Hong] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Le, CHH (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	chi.le@emory.edu						Adebisi OY, 2005, FAM MED, V37, P655; [Anonymous], 2011, HAEMOGLOBIN CONCENTR; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Brotanek JM, 2007, PEDIATRICS, V120, P568, DOI 10.1542/peds.2007-0572; Brunner Christian, 2010, Ther Umsch, V67, P219, DOI 10.1024/0040-5930/a000040; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Carter RC, 2010, PEDIATRICS, V126, pE427, DOI 10.1542/peds.2009-2097; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; Cusick SE, 2008, AM J CLIN NUTR, V88, P1611, DOI 10.3945/ajcn.2008.25926; DeMaeyer E, 1985, World Health Stat Q, V38, P302; Ezekowitz JA, 2003, CIRCULATION, V107, P223, DOI 10.1161/01.CIR.0000052622.51963.FC; Frith-Terhune AL, 2000, AM J CLIN NUTR, V72, P963; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; KLEBANOFF MA, 1991, AM J OBSTET GYNECOL, V164, P59, DOI 10.1016/0002-9378(91)90626-3; LEVY A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI DOI 10.1016/J.EJ0GRB.2005.02.015; Mahoney DH, 2008, AM J CLIN NUTR, V88, P1457, DOI 10.3945/ajcn.2008.26965; McClellan W, 2004, CURR MED RES OPIN, V20, P1501, DOI 10.1185/030079904X2763; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; NORDENBERG D, 1990, JAMA-J AM MED ASSOC, V264, P1556, DOI 10.1001/jama.264.12.1556; Ostchega Y, 2013, NATL HLTH NUTR EXAMI; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P719, DOI 10.1111/j.1532-5415.2004.52208.x; Penninx BWJH, 2003, AM J MED, V115, P104, DOI 10.1016/S0002-9343(03)00263-8; SALIVE ME, 1992, J AM GERIATR SOC, V40, P489, DOI 10.1111/j.1532-5415.1992.tb02017.x; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Viteri F E, 1994, SCN News, P14; WALTER T, 1989, PEDIATRICS, V84, P7; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2007, ASS IR STAT POP INCL; World Health Organization, 2008, WHO GLOBAL DATABASE; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zakai NA, 2009, AM J EPIDEMIOL, V169, P355, DOI 10.1093/aje/kwn355	35	156	160	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166635	10.1371/journal.pone.0166635	http://dx.doi.org/10.1371/journal.pone.0166635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846276	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600095
J	Scalone, R; Lemke, A; Stefanic, E; Kolseth, AK; Rasic, S; Andersson, L				Scalone, Romain; Lemke, Andreas; Stefanic, Edita; Kolseth, Anna-Karin; Rasic, Sanda; Andersson, Lars			Phenological Variation in Ambrosia artemisiifolia L. Facilitates Near Future Establishment at Northern Latitudes	PLOS ONE			English	Article							INTER-POPULATION VARIATION; COMMON RAGWEED; RANGE SHIFTS; INVASIVE POPULATIONS; PERENNIAL RYEGRASS; RAPID EVOLUTION; SPECIES RANGE; FRANCE; POLLEN; LIMITS	The invasive weed Ambrosia artemisiifolia (common ragweed) constitutes a great threat to public health and agriculture in large areas of the globe. Climate change, characterized by higher temperatures and prolonged vegetation periods, could increase the risk of establishment in northern Europe in the future. However, as the species is a short-day plant that requires long nights to induce bloom formation, it might still fail to produce mature seeds before the onset of winter in areas at northern latitudes characterized by short summer nights. To survey the genetic variation in flowering time and study the effect of latitudinal origin on this trait, a reciprocal common garden experiment, including eleven populations of A. artemisiifolia from Europe and North America, was conducted. The experiment was conducted both outside the range limit of the species, in Sweden and within its invaded range, in Croatia. Our main hypothesis was that the photoperiodic-thermal requirements of A. artemisiifolia constitute a barrier for reproduction at northern latitudes and, thus, halts the northern range shift despite expected climate change. Results revealed the presence of a north-south gradient in flowering time at both garden sites, indicating that certain European populations are pre-adapted to photoperiodic and thermal conditions at latitudes up to, at least, 60 degrees N. This was confirmed by phenological recordings performed in a region close to the northern range limit, the north of Germany. Thus, we conclude that there exists a high risk for establishment and spread of A. artemisiifolia in FennoScandinavia in the near future. The range shift might occur independently of climate change, but would be accelerated by it.	[Scalone, Romain; Kolseth, Anna-Karin; Andersson, Lars] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Lemke, Andreas] Tech Univ Berlin, Dept Ecol Plant Ecol & Ecosyst Sci, Berlin, Germany; [Stefanic, Edita; Rasic, Sanda] Univ Josip Juraj Strossmayer, Fac Agr, Osijek, Croatia	Swedish University of Agricultural Sciences; Technical University of Berlin; University of JJ Strossmayer Osijek	Andersson, L (corresponding author), Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden.	lars.andersson@slu.se		SCALONE, Romain/0000-0002-9687-8584	Svenska Forskningsradet Formas [217 - 2012-994]	Svenska Forskningsradet Formas(Swedish Research Council Formas)	The work was funded by Svenska Forskningsradet Formas (http://www.formas.se), grant number 217 - 2012-994. LA and AK received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SUST MAN REGW EUR; [Anonymous], [No title captured]; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; BIANCHI D. E., 1959, BOT GAZ, V120, P235, DOI 10.1086/336030; Brandes D., 2006, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V58, P286; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Chapman DS, 2014, GLOBAL CHANGE BIOL, V20, P192, DOI 10.1111/gcb.12380; Chauvel B, 2011, ACTA BOT GALLICA, V158, P309, DOI 10.1080/12538078.2011.10516276; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chun YJ, 2011, MOL ECOL, V20, P1378, DOI 10.1111/j.1365-294X.2011.05013.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Dahl A., 1999, AEROBIOLOGIA, V15, P293, DOI [DOI 10.1023/A:1007678107552, 10.1023/A:1007678107552]; Deen W, 1998, WEED SCI, V46, P555, DOI 10.1017/S0043174500091098; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dullinger S, 2009, BIOL INVASIONS, V11, P2401, DOI 10.1007/s10530-009-9424-5; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Essl F, 2015, J ECOL, V103, P1069, DOI 10.1111/1365-2745.12424; Fumanal B, 2007, ANN AGR ENV MED, V14, P233; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Genton BJ, 2005, MOL ECOL NOTES, V5, P381, DOI 10.1111/j.1471-8286.2005.00934.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Groom QJ, 2013, PEERJ, V1, DOI 10.7717/peerj.77; Gruvberger B, 2002, CONTACT DERMATITIS, V47, P157; Hargreaves AL, 2014, AM NAT, V183, P157, DOI 10.1086/674525; Hodgins KA, 2011, J EVOLUTION BIOL, V24, P2731, DOI 10.1111/j.1420-9101.2011.02404.x; Hodgins KA, 2013, MOL ECOL, V22, P2496, DOI 10.1111/mec.12179; Kasprzyk I, 2011, INT J BIOMETEOROL, V55, P633, DOI 10.1007/s00484-010-0376-3; Kazinczi G., 2008, Herbologia, V9, P119; Leiblein-Wild MC, 2014, BIOL INVASIONS, V16, P2003, DOI 10.1007/s10530-014-0644-y; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Li XM, 2015, OECOLOGIA, V177, P669, DOI 10.1007/s00442-014-3127-z; Martin MD, 2014, MOL ECOL, V23, P1701, DOI 10.1111/mec.12675; Miguel A., 2011, ECOL LETT, V14, P511, DOI [10.1111/j.1461-0248.2011.01601.x, DOI 10.1111/J.1461-0248.2011.01601.X]; Moller H, 2002, CONTACT DERMATITIS, V47, P157, DOI 10.1034/j.1600-0536.2002.470306.x; Moloney KA, 2009, PERSPECT PLANT ECOL, V11, P311, DOI 10.1016/j.ppees.2009.05.002; Novy A, 2013, J EVOLUTION BIOL, V26, P443, DOI 10.1111/jeb.12047; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Sikoparija B, 2013, AGR FOREST METEOROL, V180, P112, DOI 10.1016/j.agrformet.2013.05.014; Sikoparija B, 2009, INT J BIOMETEOROL, V53, P263, DOI 10.1007/s00484-009-0212-9; Smith M, 2013, ENVIRON INT, V61, P115, DOI 10.1016/j.envint.2013.08.005; Storkey J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088156; Thalmann DJK, 2015, BIOL INVASIONS, V17, P1041, DOI 10.1007/s10530-014-0774-2; THOMAS RL, 1969, HEREDITY, V24, P91, DOI 10.1038/hdy.1969.9; THOMAS RL, 1967, HEREDITY, V22, P481, DOI 10.1038/hdy.1967.65; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Zink K, 2012, INT J BIOMETEOROL, V56, P669, DOI 10.1007/s00484-011-0468-8; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	53	17	17	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166510	10.1371/journal.pone.0166510	http://dx.doi.org/10.1371/journal.pone.0166510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846312	Green Submitted, gold, Green Published			2022-12-27	WOS:000387794600073
J	Ling, QH; Song, YQ; Han, F; Yang, D; Huang, DS				Ling, Qing-Hua; Song, Yu-Qing; Han, Fei; Yang, Dan; Huang, De-Shuang			An Improved Ensemble of Random Vector Functional Link Networks Based on Particle Swarm Optimization with Double Optimization Strategy	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; FUNCTION APPROXIMATION; ALGORITHM	For ensemble learning, how to select and combine the candidate classifiers are two key issues which influence the performance of the ensemble system dramatically. Random vector functional link networks (RVFL) without direct input-to-output links is one of suitable base-classifiers for ensemble systems because of its fast learning speed, simple structure and good generalization performance. In this paper, to obtain a more compact ensemble system with improved convergence performance, an improved ensemble of RVFL based on attractive and repulsive particle swarm optimization (ARPSO) with double optimization strategy is proposed. In the proposed method, ARPSO is applied to select and combine the candidate RVFL. As for using ARPSO to select the optimal base RVFL, ARPSO considers both the convergence accuracy on the validation data and the diversity of the candidate ensemble system to build the RVFL ensembles. In the process of combining RVFL, the ensemble weights corresponding to the base RVFL are initialized by the minimum norm least-square method and then further optimized by ARPSO. Finally, a few redundant RVFL is pruned, and thus the more compact ensemble of RVFL is obtained. Moreover, in this paper, theoretical analysis and justification on how to prune the base classifiers on classification problem is presented, and a simple and practically feasible strategy for pruning redundant base classifiers on both classification and regression problems is proposed. Since the double optimization is performed on the basis of the single optimization, the ensemble of RVFL built by the proposed method outperforms that built by some single optimization methods. Experiment results on function approximation and classification problems verify that the proposed method could improve its convergence accuracy as well as reduce the complexity of the ensemble system.	[Ling, Qing-Hua; Song, Yu-Qing; Han, Fei; Yang, Dan] Jiangsu Univ, Sch Comp Sci & Commun Engn, Zhenjiang, Peoples R China; [Ling, Qing-Hua] Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Peoples R China; [Huang, De-Shuang] Tongji Univ, Sch Elect & Informat Engn, Shanghai, Peoples R China	Jiangsu University; Jiangsu University of Science & Technology; Tongji University	Ling, QH (corresponding author), Jiangsu Univ, Sch Comp Sci & Commun Engn, Zhenjiang, Peoples R China.; Ling, QH (corresponding author), Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Peoples R China.	lingee_2000@163.com			National Natural Science Foundation of China [61271385, 61572241, 61572239, 61520106006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos.61271385, 61572241, 61572239, 61520106006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Wahab MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122827; AEBERHARD S, 1994, PATTERN RECOGN, V27, P1065, DOI 10.1016/0031-3203(94)90145-7; Cai Q, 2014, NEURAL NETWORKS, V58, P4, DOI 10.1016/j.neunet.2014.04.006; Chen HH, 2010, IEEE T KNOWL DATA EN, V22, P1738, DOI 10.1109/TKDE.2010.26; Chyzhyk D, 2015, NEURAL NETWORKS, V68, P23, DOI 10.1016/j.neunet.2015.04.002; Escandell-Montero P, 2014, EUR S ART NEUR NETW, P129; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Gastaldo P, 2016, NEURAL NETWORKS, V74, P22, DOI 10.1016/j.neunet.2015.10.011; Han B, 2015, MATH PROBL ENG, V3, P273; Han F, 2006, NEUROCOMPUTING, V69, P2369, DOI 10.1016/j.neucom.2006.02.013; Han F, 2015, IEEE IJCNN; Han F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097530; Han F, 2013, INT J INTELL SYST, V28, P271, DOI 10.1002/int.21569; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Huang G, 2015, NEURAL NETWORKS, V70, P1, DOI 10.1016/j.neunet.2015.06.002; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huixin Tian, 2010, 2010 IEEE Fifth International Conference on Bio-Inspired Computing: Theories and Applications (BIC-TA), P1076, DOI 10.1109/BICTA.2010.5645111; IGELNIK B, 1995, IEEE T NEURAL NETWOR, V6, P1320, DOI 10.1109/72.471375; Inoue H, 2004, 2004 47TH MIDWEST SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL III, CONFERENCE PROCEEDINGS, P85; Jeong SY, 2000, NEUROCOMPUTING, V35, P73, DOI 10.1016/S0925-2312(00)00296-4; Kabeya Shutaro, 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P1476, DOI 10.1109/IJCNN.2009.5178979; Kausar A, 2010, LECT NOTES ENG COMP, P671; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Lan Y, 2009, NEUROCOMPUTING, V72, P3391, DOI 10.1016/j.neucom.2009.02.013; Lang K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143175; Lian C, 2014, NEURAL COMPUT APPL, V24, P99, DOI 10.1007/s00521-013-1446-3; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liu N, 2010, IEEE SIGNAL PROC LET, V17, P754, DOI 10.1109/LSP.2010.2053356; Mansourvar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138493; Nabavi-Kerizi SH, 2010, COMPUT ELECTR ENG, V36, P886, DOI 10.1016/j.compeleceng.2008.04.006; Noel MM, 2012, APPL SOFT COMPUT, V12, P353, DOI 10.1016/j.asoc.2011.08.037; PAO YH, 1992, INT J CONTROL, V56, P263, DOI 10.1080/00207179208934315; Quinlan JR, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P725; Riget J, 200202 AARH U DEP CO; SCHMIDT WF, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL II, P1, DOI 10.1109/ICPR.1992.201708; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Soria-Olivas E, 2011, IEEE T NEURAL NETWOR, V22, P505, DOI 10.1109/TNN.2010.2103956; Tian HX, 2010, IEEE T AUTOM SCI ENG, V7, P73, DOI 10.1109/TASE.2008.2005640; Wang DH, 2013, NEUROCOMPUTING, V102, P98, DOI 10.1016/j.neucom.2011.12.046; Wang S, 2013, IEEE T KNOWL DATA EN, V25, P206, DOI 10.1109/TKDE.2011.207; Yan DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129157; Yang D, 2014, LECT NOTES COMPUT SC, V8588, P213, DOI 10.1007/978-3-319-09333-8_23; Zhang L, 2016, INFORM SCIENCES, V367, P1094, DOI 10.1016/j.ins.2015.09.025; Zhang R, 2012, IEEE T NEUR NET LEAR, V23, P365, DOI 10.1109/TNNLS.2011.2178124; Zhang X, 2007, IEEE INTL CONF CONTR, P260; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X	47	8	8	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165803	10.1371/journal.pone.0165803	http://dx.doi.org/10.1371/journal.pone.0165803			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835638	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200012
J	Lu, J; Cui, J; Li, XH; Wang, X; Zhou, Y; Yang, WJ; Chen, M; Zhao, J; Pei, G				Lu, Jing; Cui, Jin; Li, Xiaohang; Wang, Xin; Zhou, Yue; Yang, Wenjuan; Chen, Ming; Zhao, Jian; Pei, Gang			An Anti-Parkinson's Disease Drug via Targeting Adenosine A(2A) Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; A-BETA; PROTEIN; COMPLEX; MODULATORS; APP; ISTRADEFYLLINE; FLUORESCENCE; ANTAGONISTS; INHIBITORS	gamma-secretase mediates the intramembranous proteolysis of amyloid precursor protein (APP) and determines the generation of A beta which is associated with Alzheimer's disease (AD). Here we identified that an anti-Parkinson's disease drug, Istradefylline, could enhance A beta generation in various cell lines and primary neuronal cells of APP/PS1 mouse. Moreover, the increased generation of A beta 42 was detected in the cortex of APP/PS1 mouse after chronic treatment with Istradefylline. Istradefylline promoted the activity of gamma-secretase which could lead to increased A beta production. These effects of Istradefylline were reduced by the knockdown of A(2A)R but independent of A(2A)R-mediated G protein- or beta-arrestin-dependent signal pathway. We further observed that A(2A)R colocalized with gamma-secretase in endosomes and physically interacted with the catalytic subunit presenilin-1 (PS1). Interestingly, Istradefylline attenuated the interaction in time-and dosage-dependent manners. Moreover the knockdown of A(2A)R which in theory would release PS1 potentiated both A beta generation and gamma-secretase activity. Thus, our study implies that the association of A(2A)R could modulate gamma-secretase activity. Istradefylline enhance A beta generation and gamma-secretase activity possibly via modulating the interaction between A(2A)R and gamma-secretase, which may bring some undesired effects in the central nervous system (CNS).	[Lu, Jing; Cui, Jin; Li, Xiaohang; Wang, Xin; Zhou, Yue; Yang, Wenjuan; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Cui, Jin; Li, Xiaohang; Wang, Xin; Yang, Wenjuan] Univ Chinese Acad Sci, Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Yang, Wenjuan] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Chen, Ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Chem Biol Core Facil, Shanghai 200031, Peoples R China; [Zhao, Jian] Tongji Univ, Shanghai East Hosp, Sch Med, Translat Med Ctr Stem Cell Therapy, Shanghai 200120, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.; Pei, G (corresponding author), Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China.	gpei@sibs.ac.cn	Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Li, Xiaohang/0000-0002-7316-2196; Wang, Xin/0000-0001-6250-910X	Ministry of Science and Technology of China [2011CB910202]; National Natural Science Foundation of China [31371419]; Science and Technology Commission of Shanghai Municipality [13401900600]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by the Ministry of Science and Technology of China (2011CB910202), the National Natural Science Foundation of China (31371419), Science and Technology Commission of Shanghai Municipality (13401900600).; We thank X. Xie (Shanghai Institute of Materia Medica) for the A2AR plasmid; Y. Shi for the pMLink vector (Tsinghua University); P. Wang (East China Normal University) for Rab5, Rab7 and Rab11 plasmids. We also thank Y. Wang, Y. Yu and National Center for Protein Science Shanghai for FRET and imaging technical support. We appreciate all the lab members for sharing reagents and advice. This research was supported by the Ministry of Science and Technology of China, the National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.	Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Chavant F, 2011, BRIT J CLIN PHARMACO, V72, P898, DOI 10.1111/j.1365-2125.2011.04009.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Compta Y, 2014, NEURODEGENER DIS, V13, P154, DOI 10.1159/000354670; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Cui J, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.21; Davis AA, 2010, J NEUROSCI, V30, P4190, DOI 10.1523/JNEUROSCI.6393-09.2010; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Dolev I, 2013, NAT NEUROSCI, V16, P587, DOI 10.1038/nn.3376; Dungo RT, 2013, DRUGS, V73, P1503, DOI 10.1007/s40265-013-0111-6; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fuxe K, 2007, MOVEMENT DISORD, V22, P1990, DOI 10.1002/mds.21440; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Horita TK, 2013, PSYCHOPHARMACOLOGY, V230, P345, DOI 10.1007/s00213-013-3158-x; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jastrzebska J, 2014, NEUROPHARMACOLOGY, V81, P318, DOI 10.1016/j.neuropharm.2014.03.002; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Komatsu H, 2015, INT J MOL SCI, V16, P14109, DOI 10.3390/ijms160614109; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Levitan D, 2001, P NATL ACAD SCI USA, V98, P12186, DOI 10.1073/pnas.211321898; Li W, 2015, NEUROBIOL DIS, V80, P93, DOI 10.1016/j.nbd.2015.05.002; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Milligan G, 1997, TRENDS PHARMACOL SCI, V18, P468, DOI 10.1016/S0165-6147(97)90685-4; MIZOGUCHI K, 1994, BRAIN RES, V662, P255, DOI 10.1016/0006-8993(94)90821-4; Moscoso-Castro M, 2016, EUR NEUROPSYCHOPHARM, V26, P1227, DOI 10.1016/j.euroneuro.2016.04.003; Nelson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074680; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nickols HH, 2014, NEUROBIOL DIS, V61, P55, DOI 10.1016/j.nbd.2013.09.013; Pinna A, 2014, CNS DRUGS, V28, P455, DOI 10.1007/s40263-014-0161-7; Richard CL, 2006, INT J CANCER, V119, P2044, DOI 10.1002/ijc.22084; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shen HY, 2009, CURR NEUROPHARMACOL, V7, P195, DOI 10.2174/157015909789152191; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; UKENA D, 1993, BIOCHEM PHARMACOL, V45, P847, DOI 10.1016/0006-2952(93)90168-V; Valadas JS, 2012, J NEUROCHEM, V123, P1030, DOI 10.1111/jnc.12050; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wang X, 2015, J ALZHEIMERS DIS, V47, P927, DOI 10.3233/JAD-150313; Wei CJ, 2011, BBA-BIOMEMBRANES, V1808, P1358, DOI 10.1016/j.bbamem.2010.12.018; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	58	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166415	10.1371/journal.pone.0166415	http://dx.doi.org/10.1371/journal.pone.0166415			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835671	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200047
J	Kambire, D; Soeters, HM; Ouedraogo-Traore, R; Medah, I; Sangare, L; Yameogo, I; Sawadogo, G; Ouedraogo, AS; Hema-Ouangraoua, S; McGee, L; Srinivasan, V; Ake, F; Congo-Ouedraogo, M; Sanou, S; Ba, AK; Novak, RT; Van Beneden, C				Kambire, Dinanibe; Soeters, Heidi M.; Ouedraogo-Traore, Rasmata; Medah, Isaie; Sangare, Lassana; Yameogo, Issaka; Sawadogo, Guetawende; Ouedraogo, Abdoul-Salem; Hema-Ouangraoua, Soumeya; McGee, Lesley; Srinivasan, Velusamy; Ake, Flavien; Congo-Ouedraogo, Malika; Sanou, Soufian; Ba, Absatou Ky; Novak, Ryan T.; Van Beneden, Chris		MenAfriNet Consortium	Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013	PLOS ONE			English	Article							TIME PCR ASSAYS; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR SEROTYPES; CHILDREN; BURDEN; SURVEILLANCE; EPIDEMICS; OUTBREAK	Background Following introduction of Haemophilus influenzae type b vaccine in 2006 and serogroup A meningococcal conjugate vaccine in 2010, Streptococcus pneumoniae (Sp) became the leading cause of bacterial meningitis in Burkina Faso. We describe bacterial meningitis epidemiology, focusing on pneumococcal meningitis, before 13-valent pneumococcal conjugate vaccine (PCV13) introduction in the pediatric routine immunization program in October 2013. Methods Nationwide population-based meningitis surveillance collects case-level demographic and clinical information and cerebrospinal fluid (CSF) laboratory results. Sp infections are confirmed by culture, real-time polymerase chain reaction (rt-PCR), or latex agglutination, and CSF serotyped using real-time and conventional PCR. We calculated incidence rates in cases per 100,000 persons, adjusting for age and proportion of cases with CSF tested at national reference laboratories, and case fatality ratios (CFR). Results During 2011-2013, 1,528 pneumococcal meningitis cases were reported. Average annual adjusted incidence rates were 26.9 (<1 year), 5.4 (1-4 years), 7.2 (5-14 years), and 3.0 (>= 15 years). Overall CFR was 23% and highest among children aged <1 year (32%) and adults >= 30 years (30%). Of 1,528 cases, 1,036 (68%) were serotyped: 71% were PCV13-associated serotypes, 14% were non-PCV13-associated serotypes, and 15% were non typeable by PCR. Serotypes 1 (45%) and 12F/12A/12B/44/46 (8%) were most common. Among children aged <1 year, serotypes 5 (15%), 6A/6B (13%) and 1 (12%) predominated. Conclusions In Burkina Faso, the highest morbidity and mortality due to pneumococcal meningitis occurred among children aged <1 year. The majority of cases were due to PCV13-associated serotypes; introduction of PCV13 should substantially decrease this burden.	[Kambire, Dinanibe; Ouedraogo-Traore, Rasmata] Ctr Hosp Univ Pediat Charles de Gaulle, Ouagadougou, Burkina Faso; [Soeters, Heidi M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Soeters, Heidi M.; McGee, Lesley; Srinivasan, Velusamy; Novak, Ryan T.; Van Beneden, Chris] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Medah, Isaie; Yameogo, Issaka; Sawadogo, Guetawende] Minist Sante, Ouagadougou, Burkina Faso; [Sangare, Lassana; Congo-Ouedraogo, Malika] Ctr Hosp Univ Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Ouedraogo, Abdoul-Salem] Ctr Hosp Univ Souro Sanou, Bobo Dioulasso, Burkina Faso; [Hema-Ouangraoua, Soumeya] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Ake, Flavien] CDC Fdn, Ouagadougou, Burkina Faso; [Ba, Absatou Ky] Lab Natl Sante Publ, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centre Muraz	Kambire, D (corresponding author), Ctr Hosp Univ Pediat Charles de Gaulle, Ouagadougou, Burkina Faso.; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.	dinanibekambire@yahoo.fr; hzx8@cdc.gov	Soeters, Heidi/H-3271-2019	Soeters, Heidi/0000-0002-9415-9340	Bill and Melinda Gates Foundation; Gavi; U.S. Centers for Disease Control and Prevention, World Health Organization; Agence de Medecine Preventive	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gavi; U.S. Centers for Disease Control and Prevention, World Health Organization; Agence de Medecine Preventive	This work was supported by the MenAfriNet Consortium, a partnership between the U.S. Centers for Disease Control and Prevention, World Health Organization, and Agence de Medecine Preventive, through a grant from the Bill and Melinda Gates Foundation, and a grant from Gavi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; Blumental S, 2015, CLIN VACCINE IMMUNOL, V22, P404, DOI 10.1128/CVI.00758-14; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7; Cibrelus L, 2015, EMERG INFECT DIS, V21, P2063, DOI 10.3201/eid2111.150304; Collard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060432; Decosas J, 2002, LANCET INFECT DIS, V2, P763, DOI 10.1016/S1473-3099(02)00455-3; Djingarey Mamoudou, 2012, Morbidity and Mortality Weekly Report, V61, P1025; Djingarey MH, 2008, 16 INT PATH NEISS C, pP166; Gessner BD, 2012, VACCINE, V30, pG41, DOI 10.1016/j.vaccine.2012.10.052; Janoff EN., 2015, MANDELL DOUGLAS BENN, V2; Kornelisse RF, 1995, CLIN INFECT DIS, V21, P1390, DOI 10.1093/clinids/21.6.1390; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Molesworth AM, 2003, EMERG INFECT DIS, V9, P1287; Mueller JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052464; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Ritchie ND, 2012, FUTURE MICROBIOL, V7, P33, DOI [10.2217/fmb.11.146, 10.2217/FMB.11.146]; Sanou I, 2014, J MED MICROB DIAGN, V3, P130, DOI [10.4172/2161-0703.1000130, DOI 10.4172/2161-0703.1000130]; Sie A, 2008, TROP MED INT HEALTH, V13, P861, DOI 10.1111/j.1365-3156.2008.02056.x; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Tunkel AR, 2015, MANDELL DOUGLAS BENN, P1097; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; WHO-AFRO, 2009, STAND OP PROC ENH ME; World Health Organization, 2010, TECHN GUID INT DIS S; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	30	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166384	10.1371/journal.pone.0166384	http://dx.doi.org/10.1371/journal.pone.0166384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832151	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000387725000117
J	Lim, CH; Lin, CH; Chen, DY; Chen, YM; Chao, WC; Liao, TL; Chen, HH				Lim, Chong-Hong; Lin, Ching-Heng; Chen, Der-Yuan; Chen, Yi-Ming; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Hsin-Hua			One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							INFECTION; DISEASE; METAANALYSIS	Objective To investigate the risk of tuberculosis (TB) among rheumatoid arthritis (RA) patients within 1 year after initiation of tumor necrosis factor inhibitor (TNFi) therapy from 2008 to 2012. Methods We used the 2003-2013 Taiwanese National Health Insurance Research Database to identify RA patients who started any RA-related medical therapy from 2008 to 2012. Those who initiated etanercept or adalimumab therapy during 2008-2012 were selected as the TNFi group and those who never received biologic disease-modifying anti-rheumatic drug therapy were identified as the comparison group after excluding the patients who had a history of TB or human immunodeficiency virus infection/acquired immune deficiency syndrome. We used propensity score matching (1: 6) for age, sex, and the year of the drug index date to re-select the TNFi group and the non-TNFi controls. After adjusting for potential confounders, hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to examine the 1-year TB risk in the TNFi group compared with the non-TNFi controls. Subgroup analyses according to the year of treatment initiation and specific TNFi therapy were conducted to assess the trend of 1-year TB risk in TNFi users from 2008 to 2012. Results This study identified 5,349 TNFi-treated RA patients and 32,064 matched non-TNFi-treated controls. The 1-year incidence rates of TB were 1,513 per 10 5 years among the TNFi group and 235 per 10 5 years among the non-TNFi controls (incidence rate ratio, 6.44; 95% CI, 4.69-8.33). After adjusting for age, gender, disease duration, comoridities, history of TB, and concomitant medications, TNFi users had an increased 1-year TB risk (HR, 7.19; 95% CI, 4.18-12.34) compared with the non-TNFi-treated controls. The 1-year TB risk in TNFi users increased from 2008 to 2011 and deceased in 2012 when the Food and Drug Administration in Taiwan announced the Risk Management Plan for patients scheduled to receive TNFi therapy. Conclusion This study showed that the 1-year TB risk in RA patients starting TNFi therapy was significantly higher than that in non-TNFi controls in Taiwan from 2008 to 2012.	[Lim, Chong-Hong] Pulau Pinang Gen Hosp, Dept Internal Med, Rheumatol Unit, Georgetown, Malaysia; [Lim, Chong-Hong; Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Ching-Heng; Chen, Yi-Ming; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Liao, Tsai-Ling; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Liao, Tsai-Ling; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.	shc5555@hatmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Lim, Chong Hong/0000-0003-0752-2154				Ai JW, 2015, J RHEUMATOL, V42, P2229, DOI 10.3899/jrheum.150057; [Anonymous], 2012, RISK MAN PLAN TUM NE; ANTONUCCI G, 1995, JAMA-J AM MED ASSOC, V274, P143, DOI 10.1001/jama.274.2.143; Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; Carmona L, 2003, J RHEUMATOL, V30, P1436; Centers for Disease Control Ministry of Health and Welfare R.O.C. (Taiwan), 2015, 2015 CTR DIS CONTR A; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Chen DY, 2011, FORMOSAN J RHEUMATOL, V25, P5; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen YH, 2012, FORMOSAN J RHEUMATOL, V26, P7; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chia S, 1998, INT J TUBERC LUNG D, V2, P989; Chiu YM, 2014, INT J RHEUM DIS, V17, P9, DOI 10.1111/1756-185X.12539; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Hu HY, 2014, EPIDEMIOL INFECT, V142, P191, DOI 10.1017/S0950268813000551; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; JUNG Seung, 2015, INT J RHEUM DIS, V18, P323, DOI [10.1111/1756-185X.12530, DOI 10.1111/1756-185X.12530]; Ke WM, 2013, INT J TUBERC LUNG D, V17, P1590, DOI 10.5588/ijtld.13.0368; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lee CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-194; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Ministry of the Interior, 2015, STUD OLD TAIP PRIS; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Tam LS, 2010, CLIN EXP RHEUMATOL, V28, P679; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; World Health Organization, GLOB TUB REP 2016; Wu VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069556; Yamada T, 2006, ANN RHEUM DIS, V65, P1661, DOI 10.1136/ard.2005.047274; Yasui K, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-45; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110922	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166339	10.1371/journal.pone.0166339	http://dx.doi.org/10.1371/journal.pone.0166339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832150	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000101
J	Liu, M; Wang, P; Zhao, M; Liu, D				Liu, Mei; Wang, Peng; Zhao, Min; Liu, Dy			Intestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; IMMUNE-RESPONSES; INVARIANT CHAIN; LIVER-DISEASE; LYMPH-NODES; CHEMOKINE; MIGRATION; LIGANDS; CCL21; CCR7	Fulminant hepatic failure (FHF) is defined as rapid acute liver injury, often complicated with spontaneous bacterial peritonitis (SBP). The precise onset of FHF with SBP is still unknown, but it is thought that SBP closely correlates with a weakened intestinal barrier. Dendritic cells (DCs) play a crucial role in forming the intestinal immune barrier, therefore the number, maturity and chemotactic ability of intestinal DCs were studied in FHF. Mouse intestinal and spleen DCs were isolated by magnetic-activated cell sorting (MACS) and surface markers of DCs, namely CD11c, CD74, CD83 and CD86, were identified using flow cytometry. Immunohistochemistry and Western blotting were performed to detect the distribution and expression of CC-chemokine receptor 7 (CCR7) and CC-chemokine receptor 9 (CCR9), as well as their ligands-CC-chemokine ligand 21 (CCL21) and CC-chemokine ligand 25 (CCL25). Real-time PCR was used to detect CCR7 and CCR9 mRNA, along with their ligands-CCL21 and CCL25 mRNA. Flow cytometry analysis showed that the markers CD74, CD83 and CD86 of CD11c(+)DCs were lower in the D-galactosamine (D-GalN) group and were significantly decreased in the FHF group, while there were no significant changes in the expression of these markers in the lipopolysaccharide (LPS) group. Immunohistochemistry results showed that staining for CCR7 and CCR9, as well as their ligands-CCL21 and CCL25, was significantly weaker in the D-GalN and FHF groups compared with the normal saline (NS) group or the LPS group; the FHF group even showed completely unstained parts. Protein expression of CCR7 and CCR9, as well as their ligands-CCL21 and CCL25, was also lower in the D-GalN group and decreased even more significantly in the FHF group. At the gene level, CCR7 and CCR9, along with CCL21 and CCL25 mRNA expression, was lower in the D-GalN group and significantly decreased in the FHF group compared to the NS and LPS groups, consisting with the protein expression. Our study indicated that intestinal DCs were decreased in number, maturity and chemotactic ability in FHF and might contribute to a decreased function of the intestinal immune barrier in FHF.	[Liu, Mei; Zhao, Min; Liu, Dy] China Med Univ, Shengjing Hosp, Med Res Ctr, Shenyang, Liaoning Provin, Peoples R China; [Wang, Peng] China Med Univ, Shengjing Hosp, Dept Urol 2, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Liu, D (corresponding author), China Med Univ, Shengjing Hosp, Med Res Ctr, Shenyang, Liaoning Provin, Peoples R China.	liudy19701010@sina.com			National Natural Science Foundation of China [30871158, 81170604]; Education Department Foundation of Liaoning Province [LK201620]; Outstanding Scientific Fund of Shengjing Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department Foundation of Liaoning Province; Outstanding Scientific Fund of Shengjing Hospital	This study was supported by the National Natural Science Foundation of China (#30871158, #81170604), the Education Department Foundation of Liaoning Province (#LK201620), and the Outstanding Scientific Fund of Shengjing Hospital.	Acton SE, 2016, IMMUNOL REV, V271, P221, DOI 10.1111/imr.12414; Bekker P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628340; Bin Younis B, 2015, PAK J MED SCI, V31, P1009, DOI 10.12669/pjms.314.7618; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Cao X, 2015, WORLD J GASTROENTERO, V21, P4883, DOI 10.3748/wjg.v21.i16.4883; Ericsson A, 2004, EUR J IMMUNOL, V34, P2720, DOI 10.1002/eji.200425125; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Frolich D, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3767; Giannelli V, 2014, WORLD J GASTROENTERO, V20, P16795, DOI 10.3748/wjg.v20.i45.16795; Granucci F, 2008, CELL MOL LIFE SCI, V65, P1683, DOI 10.1007/s00018-008-8009-2; Gupta P, 2014, ONCOTARGET, V5, P10170, DOI 10.18632/oncotarget.2526; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Karakikes I, 2012, FASEB J, V26, P4886, DOI 10.1096/fj.12-211466; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Li GZ, 2012, WORLD J GASTROENTERO, V18, P5042, DOI 10.3748/wjg.v18.i36.5042; Li J, 2013, ARCH IMMUNOL THER EX, V61, P237, DOI 10.1007/s00005-013-0223-4; Liu DY, 2011, BRAZ J MED BIOL RES, V44, P477, DOI 10.1590/S0100-879X2011007500051; Lutz P, 2015, WORLD J HEPATOL, V7, P304, DOI 10.4254/wjh.v7.i3.304; Mandorfer M, 2014, GASTROENTEROLOGY, V146, P1680, DOI 10.1053/j.gastro.2014.03.005; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Moschovakis GL, 2012, EUR J IMMUNOL, V42, P1949, DOI 10.1002/eji.201242614; Noor S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-77; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pande C, 2009, ALIMENT PHARM THER, V29, P1273, DOI 10.1111/j.1365-2036.2009.03994.x; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Raju R, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav106; Reiberger T, 2013, J HEPATOL, V58, P911, DOI 10.1016/j.jhep.2012.12.011; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Rochereau N, 2011, VACCINE, V29, P3655, DOI 10.1016/j.vaccine.2011.03.012; Rosenkilde MM, 2008, BRIT J PHARMACOL, V153, pS154, DOI 10.1038/sj.bjp.0707660; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166165	10.1371/journal.pone.0166165	http://dx.doi.org/10.1371/journal.pone.0166165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832135	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000071
J	Stojic-Vukanic, Z; Pilipovic, I; Vujnovic, I; Nacka-Aleksic, M; Petrovic, R; Arsenovic-Ranin, N; Dimitrijevic, M; Leposavic, G				Stojic-Vukanic, Zorica; Pilipovic, Ivan; Vujnovic, Ivana; Nacka-Aleksic, Mirjana; Petrovic, Raisa; Arsenovic-Ranin, Nevena; Dimitrijevic, Mirjana; Leposavic, Gordana			GM-CSF-Producing Th Cells in Rats Sensitive and Resistant to Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; MYELOID CELLS; T(H)17 CELLS; IN-VIVO; EAE; INDUCTION; INFLAMMATION	Given that granulocyte macrophage colony-stimulating factor (GM-CSF) is identified as the key factor to endow auto-reactive Th cells with the potential to induce neuroinflammation in experimental autoimmune encephalomyelitis (EAE) models, the frequency and phenotype of GM-CSF-producing (GM-CSF+) Th cells in draining lymph nodes (dLNs) and spinal cord (SC) of Albino Oxford (AO) and Dark Agouti (DA) rats immunized for EAE were examined. The generation of neuroantigen-specific GM-CSF+ Th lymphocytes was impaired in dLNs of AO rats (relatively resistant to EAE induction) compared with their DA counterparts (susceptible to EAE) reflecting impaired CD4+ lymphocyte proliferation and less supportive of GM-CSF+ Th cell differentiation dLN cytokine microenvironment. Immunophenotyping of GM-CSF+ Th cells showed their phenotypic heterogeneity in both strains and revealed lower frequency of IL-17+ IFN-gamma+, IL-17+ IFN-gamma-, and IL-17-IFN-gamma+ cells accompanied by higher frequency of IL-17-IFN-gamma- cells among them in AO than in DA rats. Compared with DA, in AO rats was also found (i) slightly lower surface density of CCR2 (drives accumulation of highly pathogenic GM-CSF+ IFN-gamma+ Th17 cells in SC) on GM-CSF+ IFN-gamma+ Th17 lymphocytes from dLNs, and (ii) diminished CCL2 mRNA expression in SC tissue, suggesting their impaired migration into the SC. Moreover, dLN and SC cytokine environments in AO rats were shown to be less supportive of GM-CSF+ IFN-gamma+ Th17 cell differentiation (judging by lower expression of mRNAs for IL-1 beta, IL-6 and IL-23/p19). In accordance with the (i) lower frequency of GM-CSF+ Th cells in dLNs and SC of AO rats and their lower GM-CSF production, and (ii) impaired CCL2 expression in the SC tissue, the proportion of proinflammatory monocytes among peripheral blood cells and their progeny (CD45(hi) cells) among the SC CD11b+ cells were reduced in AO compared with DA rats. Collectively, the results indicate that the strain specificities in efficacy of several mechanisms controlling (auto) reactive CD4+ lymphocyte expansion/differentiation into the cells with pathogenic phenotype and migration of the latter to the SC contribute to AO rat resistance to EAE.	[Stojic-Vukanic, Zorica; Arsenovic-Ranin, Nevena] Univ Belgrade, Fac Pharm, Dept Microbiol & Immunol, Belgrade, Serbia; [Pilipovic, Ivan; Vujnovic, Ivana; Petrovic, Raisa; Leposavic, Gordana] Inst Virol Vaccines & Sera Torlak, Immunol Res Ctr Branislav Jankovic, Belgrade, Serbia; [Nacka-Aleksic, Mirjana; Leposavic, Gordana] Univ Belgrade, Fac Pharm, Dept Physiol, Belgrade, Serbia; [Dimitrijevic, Mirjana] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Immunol, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Leposavic, G (corresponding author), Inst Virol Vaccines & Sera Torlak, Immunol Res Ctr Branislav Jankovic, Belgrade, Serbia.; Leposavic, G (corresponding author), Univ Belgrade, Fac Pharm, Dept Physiol, Belgrade, Serbia.	Gordana.Leposavic@pharmacy.bg.ac.rs	Dimitrijević, Mirjana/B-9236-2016	Dimitrijević, Mirjana/0000-0002-9094-5248; Nacka-Aleksic, Mirjana/0000-0003-0750-9347	Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije [175050]; MNTR of the Republic of Serbia [175050]	Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije; MNTR of the Republic of Serbia	Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije (http://www.mpn.gov.rs/), Grant Number 175050 (GL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is supported by the grant 175050 (MNTR of the Republic of Serbia). http://www.nature.com/nrd/journal/v1/n1/authors/nrd705.html	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bufan B, 2014, GENETIKA-BELGRADE, V46, P287, DOI 10.2298/GENSR1401287B; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Codarri L, 2013, TRENDS IMMUNOL, V34, P114, DOI 10.1016/j.it.2012.09.007; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; deLuca LES, 2010, J IMMUNOL, V184, P3174, DOI 10.4049/jimmunol.0902881; Di Rosa F, 2000, INT IMMUNOL, V12, P711, DOI 10.1093/intimm/12.5.711; Djikic J, 2014, EXP GERONTOL, V58, P179, DOI 10.1016/j.exger.2014.08.005; Dogan RNE, 2008, J IMMUNOL, V180, P7376, DOI 10.4049/jimmunol.180.11.7376; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ghosh D, 2016, J LEUKOCYTE BIOL, V100, P747, DOI 10.1189/jlb.3A0815-359R; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grifka-Walk HM, 2015, EUR J IMMUNOL, V45, P2780, DOI 10.1002/eji.201545800; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Kara EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9644; Kinetics M., 2008, NEUROSCI LETT, V447, P148, DOI [10.1016/j.neulet.2008.09.082, DOI 10.1016/J.NEULET.2008.09.082]; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; KUMAR V, 1993, J EXP MED, V178, P909, DOI 10.1084/jem.178.3.909; Kurschus FC, 2015, BIOMED J, V38, P183, DOI 10.4103/2319-4170.155590; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Lukic ML, 2003, NATO SCI SERIES, VI, P29; Markovic M, 2009, MOL IMMUNOL, V47, P141, DOI 10.1016/j.molimm.2009.01.012; MATSUMOTO Y, 1992, J NEUROIMMUNOL, V37, P23, DOI 10.1016/0165-5728(92)90152-B; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Miljkovic D, 2006, J NEUROSCI RES, V84, P379, DOI 10.1002/jnr.20883; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; MOSTARICASTOJKOVIC M, 1982, CLIN EXP IMMUNOL, V50, P311; Nacka-Aleksic M, 2015, BRAIN BEHAV IMMUN, V49, P101, DOI 10.1016/j.bbi.2015.04.017; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Pachner AR, 2011, CURR OPIN NEUROL, V24, P291, DOI 10.1097/WCO.0b013e328346c226; Potzl J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002951; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Shiomi A, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0014-5; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Siojc-Vukanic Z, 2015, IMMUN AGEING, V12, P16, DOI [10.1186/s12979-015-0044-x, DOI 10.1186/S12979-015-0044-X]; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; Varona R, 2006, LEUKEMIA LYMPHOMA, V47, P1469, DOI 10.1080/10428190500513819; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; VUKMANOVIC S, 1989, CELL IMMUNOL, V121, P237, DOI 10.1016/0008-8749(89)90022-1; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Zhang GX, 2002, EXP MOL PATHOL, V73, P35, DOI 10.1006/exmp.2002.2441	64	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166498	10.1371/journal.pone.0166498	http://dx.doi.org/10.1371/journal.pone.0166498			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832210	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000131
J	Tabata, N; Sueta, D; Akasaka, T; Arima, Y; Sakamoto, K; Yamamoto, E; Izumiya, Y; Yamamuro, M; Tsujita, K; Kojima, S; Kaikita, K; Morita, K; Oniki, K; Saruwatari, J; Nakagawa, K; Hokimoto, S				Tabata, Noriaki; Sueta, Daisuke; Akasaka, Tomonori; Arima, Yuichiro; Sakamoto, Kenji; Yamamoto, Eiichiro; Izumiya, Yasuhiro; Yamamuro, Megumi; Tsujita, Kenichi; Kojima, Sunao; Kaikita, Koichi; Morita, Kazunori; Oniki, Kentaro; Saruwatari, Junji; Nakagawa, Kazuko; Hokimoto, Seiji			Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CAG PATHOGENICITY ISLAND; SYSTEMIC INFLAMMATION; HEART-DISEASE; MANAGEMENT; INFECTION; STRAINS; RISK; SUSCEPTIBILITY; SECRETION	Background Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients. Methods We recruited consecutive acute coronary syndrome patients, and 101 non-ST-segment elevation acute coronary syndrome patients and 103 ST-segment elevation myocardial infarction patients were enrolled. Interleukin-1 polymorphism analyses were performed for single nucleotide polymorphism in interleukin-1 beta-511 and the variable number of tandem repeats polymorphism in the interleukin-1 receptor antagonist by polymerase chain reaction. Immunoglobulin G antibodies against Helicobacter pylori and high sensitivity C-reactive protein were also measured. Results The rates of the simultaneous presence of interleukin-1 polymorphisms and Helicobacter pylori-seropositivity between non-ST-segment elevation acute coronary syndrome and ST-segment elevation myocardial infarction groups were 25.7% and 42.7%, respectively (P = 0.012). Helicobacter pylori-seropositive subjects with interleukin-1 polymorphisms showed significantly higher levels of high sensitivity C-reactive protein (0.04-0.12 vs. 0.02-0.05; P< 0.001). Multivariate logistic regression analysis revealed that the carriage of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with STsegment elevation myocardial infarction (odds ratio, 2.32; 95% confidence interval, 1.23-4.37; P = 0.009). The C-statistic of conventional risk factors was 0.68 (P<0.001) and that including Helicobacter pylori-seropositivity and interleukin- 1 polymorphisms was 0.70 (P< 0.001); continuous net reclassification improvement was 34% (P = 0.0094) and integrated discrimination improvement was 3.0% (P = 0.014). Conclusions The coincidence of Helicobacter pylori-seropositivity and interleukin- 1 polymorphisms was significantly associated with higher levels of high sensitivity C-reactive protein and the increased risk of ST-segment elevation myocardial infarction.	[Tabata, Noriaki; Sueta, Daisuke; Akasaka, Tomonori; Arima, Yuichiro; Sakamoto, Kenji; Yamamoto, Eiichiro; Izumiya, Yasuhiro; Yamamuro, Megumi; Tsujita, Kenichi; Kojima, Sunao; Kaikita, Koichi; Hokimoto, Seiji] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Morita, Kazunori; Oniki, Kentaro; Saruwatari, Junji; Nakagawa, Kazuko] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan	Kumamoto University; Kumamoto University	Hokimoto, S (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan.	shokimot@kumamoto-u.ac.jp	Saruwatari, Junji/Q-7748-2019; Tsujita, Kenichi/AAG-4562-2021	Saruwatari, Junji/0000-0001-6266-1347; Kojima, Sunao/0000-0002-1916-7252				Abbott JD, 2007, AM J CARDIOL, V100, P190, DOI 10.1016/j.amjcard.2007.02.083; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Barua RS, 2010, THROMB RES, V126, P426, DOI 10.1016/j.thromres.2010.07.021; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; D'Aiuto F, 2004, CYTOKINE, V28, P29, DOI 10.1016/j.cyto.2004.06.005; Daida H, 2013, CIRC J, V77, P934, DOI 10.1253/circj.CJ-13-0174; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Dong L, 2015, AM J CARDIOL, V115, P860, DOI 10.1016/j.amjcard.2015.01.008; El-Omar EM, 2001, GUT, V48, P743, DOI 10.1136/gut.48.6.743; Folsom AR, 1998, CIRCULATION, V98, P845, DOI 10.1161/01.CIR.98.9.845; Fujioka T, 2000, JPN J MED PHARM SCI, V43, P573; Gabrielli M, 2004, EUR HEART J, V25, P64, DOI 10.1016/j.ehj.2003.10.004; Georges JL, 2003, AM J CARDIOL, V92, P515, DOI 10.1016/S0002-9149(03)00717-3; Hamajima N, 2001, JPN J CANCER RES, V92, P383, DOI 10.1111/j.1349-7006.2001.tb01106.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hong YJ, 2010, J CARDIOL, V56, P15, DOI 10.1016/j.jjcc.2010.01.010; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Ikeda A, 2013, ATHEROSCLEROSIS, V230, P67, DOI 10.1016/j.atherosclerosis.2013.06.013; Liu J, 2015, HELICOBACTER, V20, P176, DOI 10.1111/hel.12188; Maeda S, 1999, GUT, V44, P336, DOI 10.1136/gut.44.3.336; Mather AN, 2013, INT J CARDIOL, V166, P458, DOI 10.1016/j.ijcard.2011.11.004; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mazurkiewicz L, 2009, ANN NONINVAS ELECTRO, V14, P4, DOI 10.1111/j.1542-474X.2008.00267.x; Pasceri V, 1998, CIRCULATION, V97, P1675, DOI 10.1161/01.CIR.97.17.1675; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pietroiusti A, 2002, CIRCULATION, V106, P580, DOI 10.1161/01.CIR.0000023894.10871.2F; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Reibis R, 2014, CLIN CARDIOL, V37, P213, DOI 10.1002/clc.22241; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Ridker PM, 2001, ANN INTERN MED, V135, P184, DOI 10.7326/0003-4819-135-3-200108070-00010; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Shimoda A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18346; Sousa H, 2013, ARCH ORAL BIOL, V58, P1040, DOI 10.1016/j.archoralbio.2013.02.004; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tabata N, 2016, CLIN TRIALS REGUL SC, V17, P9; Tabata N, 2016, INT J CARDIOL, V212, P54, DOI 10.1016/j.ijcard.2016.03.034; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2011, POL ARCH MED WEWN, V121, P310, DOI 10.20452/pamw.1083; Wu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059996; Zhu JH, 2002, AM J CARDIOL, V89, P155, DOI 10.1016/S0002-9149(01)02192-0	45	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166240	10.1371/journal.pone.0166240	http://dx.doi.org/10.1371/journal.pone.0166240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832202	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000082
J	Caron-Lormier, G; Harvey, ND; England, GCW; Asher, L				Caron-Lormier, Geoffrey; Harvey, Naomi D.; England, Gary C. W.; Asher, Lucy			A New Metric for Quantifying the Relative Impact of Risk Factors on Loss of Working Life Illustrated in a Population of Working Dogs	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACVD TASK-FORCE; SEPARATION ANXIETY; GUIDE DOGS; EPIDEMIOLOGY; BEHAVIOR	In a resource-limited world, organisations attempting to reduce the impact of health or behaviour issues need to choose carefully how to allocate resources for the highest overall impact. However, such choices may not always be obvious. Which has the biggest impact? A large change to a small number of individuals, or a small change to a large number of individuals? The challenge is identifying the issues that have the greatest impact on the population so potential interventions can be prioritised. We addressed this by developing a score to quantify the impact of health conditions and behaviour problems in a population of working guide dogs using data from Guide Dogs, UK. The cumulative incidence of different issues was combined with information about their impact, in terms of reduction in working life, to create a work score. The work score was created at population-level to illustrate issues with the greatest impact on the population and to understand contributions of breeds or crossbreeds to the workforce. An individual work deficit score was also created and means of this score used to illustrate the impact on working life within a subgroup of the population such as a breed, or crossbreed generation. The work deficit scores showed that those removed for behavioural issues had a greater impact on the overall workforce than those removed for health reasons. Additionally trends over time illustrated the positive influence of interventions Guide Dogs have made to improve their workforce. Information highlighted by these scores is pertinent to the effort of Guide Dogs to ensure partnerships are lasting. Recognising that the scores developed here could be transferable to a wide variety of contexts and species, most notably human work force decisions; we discuss possible uses and adaptations such as reduction in lifespan, quality of life and yield in production animals.	[Caron-Lormier, Geoffrey; Harvey, Naomi D.; England, Gary C. W.] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Nottingham, Leics, England; [Asher, Lucy] Newcastle Univ, Ctr Behav & Evolut, Henry Wellcome Bldg, Newcastle Upon Tyne, Tyne & Wear, England	University of Nottingham; Newcastle University - UK	Harvey, ND (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Nottingham, Leics, England.	Naomi.Harvey@nottingham.ac.uk	PAN, ZEQIANG/X-6341-2018; Harvey, Naomi D./H-6435-2019; England, Gary C.W./G-5432-2011	Harvey, Naomi D./0000-0002-9208-7734; Asher, Lucy/0000-0001-9729-7856; England, Gary/0000-0001-5800-3106	Guide Dogs, UK [CR2012-01a]	Guide Dogs, UK	This study was supported by Guide Dogs, UK (www.guideclogs.org.uk), Grant Code: CR2012-01a. The funders provided access to the data (no new data was collected) and approved of the project through ethical review. The funders approved this manuscript for publication but had no role in study design, analysis or manuscript preparation.r We would like to thank Guide Dogs UK for funding this study, for their cooperation throughout the project and for comments on earlier versions of this manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; Arvelius P, 2014, J VET BEHAV, V9, P281, DOI 10.1016/j.jveb.2014.06.008; Belshaw Z, 2015, VET J, V206, P203, DOI 10.1016/j.tvjl.2015.07.016; Caron-Lormier G, 2016, VET J, V207, P124, DOI 10.1016/j.tvjl.2015.10.046; Caron-Lormier G, 2016, SCI REP-UK, V6, DOI 10.1038/srep23860; Cohen JD, 2006, J HEALTHC MANAG, V51, P233, DOI 10.1097/00115514-200607000-00006; Collins LM, 2010, ANIM WELFARE, V19, P67; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; Devinsky O, 1999, EPILEPSIA, V40, P1715, DOI 10.1111/j.1528-1157.1999.tb01588.x; Flannigan G, 2001, J AM VET MED ASSOC, V219, P460, DOI 10.2460/javma.2001.219.460; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; Green LE, 2002, J DAIRY SCI, V85, P2250, DOI 10.3168/jds.S0022-0302(02)74304-X; Grierson J, 2011, VET COMP ORTHOPAED, V24, P192, DOI 10.3415/VCOT-10-03-0030; Hill PB, 2001, VET IMMUNOL IMMUNOP, V81, P169, DOI 10.1016/S0165-2427(01)00298-7; King JN, 2000, APPL ANIM BEHAV SCI, V67, P255, DOI 10.1016/S0168-1591(99)00127-6; Konok V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118375; Langford FM, 2012, ANIM WELFARE, V21, P41, DOI 10.7120/096272812X13345905673647; Macht M, 2013, CRIT CARE, V17, DOI 10.1186/cc12791; Nielsen TD, 2014, VET REC; Pierce JP, 2007, J CLIN ONCOL, V25, P2345, DOI 10.1200/JCO.2006.08.6819; Robinson NJ, 2015, VET REC, V176, P463, DOI 10.1136/vr.102751; SIMON GE, 1995, ARCH GEN PSYCHIAT, V52, P850; Sousa CA, 2001, VET IMMUNOL IMMUNOP, V81, P153, DOI 10.1016/S0165-2427(01)00297-5; Takeuchi Y, 2001, APPL ANIM BEHAV SCI, V70, P297, DOI 10.1016/S0168-1591(00)00156-8; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012	26	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165414	10.1371/journal.pone.0165414	http://dx.doi.org/10.1371/journal.pone.0165414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829045	Green Published, gold			2022-12-27	WOS:000387724300044
J	McFadden, BR				McFadden, Brandon R.			Examining the Gap between Science and Public Opinion about Genetically Modified Food and Global Warming	PLOS ONE			English	Article							CLIMATE-CHANGE; COGNITIVE REFLECTION; INFORMATION; RISK; KNOWLEDGE; GENDER; BIASES	There is great uncertainty due to challenges of escalating population growth and climate change. Public perception that diverges from the scientific community may decrease the effectiveness of scientific inquiry and innovation as tools to solve these challenges. The objective of this study was to identify the factors associated with the divergence of public opinion from scientific consensus regarding the safety of genetically modified (GM) foods and human involvement in global warming (GW). Results indicate that the effects of knowledge on public opinion are complex and non-uniform across types of knowledge (i.e., perceived and actual) or issues. Political affiliation affects agreement with science; Democrats were more likely to agree that GM food is safe and human actions cause GW. Respondents who had relatively higher cognitive function or held illusionary correlations about GM food or GW were more likely to have an opinion that differed from the scientific community.	[McFadden, Brandon R.] Univ Florida, Dept Food & Resource Econ, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	McFadden, BR (corresponding author), Univ Florida, Dept Food & Resource Econ, Gainesville, FL 32611 USA.	brandon.mcfadden@ufl.edu						Bensaude-Vincent B, 2001, PUBLIC UNDERST SCI, V10, P99, DOI 10.1088/0963-6625/10/1/307; Bord RJ, 2000, PUBLIC UNDERST SCI, V9, P205, DOI 10.1088/0963-6625/9/3/301; CHAPMAN LJ, 1967, J VERB LEARN VERB BE, V6, P151, DOI 10.1016/S0022-5371(67)80066-5; Davidson DJ, 1996, ENVIRON BEHAV, V28, P302, DOI 10.1177/0013916596283003; DeStefano F, 2013, J PEDIATR-US, V163, P561, DOI 10.1016/j.jpeds.2013.02.001; Douglas M, 1983, RISK CULTURE ESSAY S; Dunlap RE, 2008, ENVIRONMENT, V50, P26, DOI 10.3200/ENVT.50.5.26-35; EVANS G, 1995, PUBLIC UNDERST SCI, V0004; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Funk C., 2015, PUBLIC SCI VIEWS SCI; Greene H., 2003, ECONOMETRIC ANAL; Gross A. G., 1994, PUBLIC UNDERST SCI, V3, P3, DOI DOI 10.1088/0963-6625/3/1/001; Hallman W. K, 2003, PUBLIC PERCEPTIONS G; Hamilton LC, 2012, POLAR GEOGR, V35, P155, DOI 10.1080/1088937X.2012.684155; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hoppe EI, 2011, ECON LETT, V110, P97, DOI 10.1016/j.econlet.2010.11.015; Hossain F, 2003, J INT FOOD AGRIBUS M, V15, P53; Kahan D.M., 2012, HDB RISK THEORY EPIS, P725, DOI [DOI 10.1007/978-94-007-1433-5_28, 10.1007/978-94-007-1433-5_28]; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McCright AM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044029; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; McFadden BR, 2015, FOOD POLICY, V54, P35, DOI 10.1016/j.foodpol.2015.04.010; McMillan GS, 2000, RES POLICY, V29, P1, DOI 10.1016/s0048-7333(99)00030-x; Mooney C., 2012, REPUBLICAN BRAIN SCI; Mooney Chris, 2005, REPUBLICAN WAR SCI; Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9; Owens S, 2000, ENVIRON PLANN A, V32, P1141, DOI 10.1068/a3330; Phillips DM, 2013, PSYCHOL MARKET, V30, P739, DOI 10.1002/mar.20642; Rabin M, 1999, Q J ECON, V114, P37, DOI 10.1162/003355399555945; Shaw A, 2002, PUBLIC UNDERST SCI, V11, P273, DOI 10.1088/0963-6625/11/3/305; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Shwom RachaelL., 2015, CLIMATE CHANGE SOC S, P269, DOI 10.1093/acprof:oso/9780199356102.003.0009; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Wynne B., 1992, PUBLIC UNDERST SCI, V1, P281, DOI [10.1088/0963-6625/1/3/004, DOI 10.1088/0963-6625/1/3/004]; ZIMAN J, 1991, SCI TECHNOL HUM VAL, V16, P99, DOI 10.1177/016224399101600106	37	29	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166140	10.1371/journal.pone.0166140	http://dx.doi.org/10.1371/journal.pone.0166140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829008	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300088
J	Nolte, A; Gawalek, P; Koerte, S; Wei, H; Schumann, R; Werckenthin, A; Krieger, J; Stengl, M				Nolte, Andreas; Gawalek, Petra; Koerte, Sarah; Wei, HongYing; Schumann, Robin; Werckenthin, Achim; Krieger, Juergen; Stengl, Monika			No Evidence for Ionotropic Pheromone Transduction in the Hawkmoth Manduca sexta	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; DROSOPHILA ODORANT RECEPTORS; SENSITIVE TRICHOID SENSILLA; ION CHANNELS; AMILORIDE DERIVATIVES; ANTHERAEA-POLYPHEMUS; MEMBRANE TOPOLOGY; CATION CHANNELS; ANTENNA; CURRENTS	Insect odorant receptors (ORs) are 7-transmembrane receptors with inverse membrane topology. They associate with the conserved ion channel Orco. As chaperon, Orco maintains ORs in cilia and, as pacemaker channel, Orco controls spontaneous activity in olfactory receptor neurons. Odorant binding to ORs opens OR-Orco receptor ion channel complexes in heterologous expression systems. It is unknown, whether this also occurs in vivo. As an alternative to this ionotropic transduction, experimental evidence is accumulating for metabotropic odor transduction, implicating that insect ORs couple to G-proteins. Resulting second messengers gate various ion channels. They generate the sensillum potential that elicits phasic-tonic action potentials (APs) followed by late, long-lasting pheromone responses. Because it is still unclear how and when Orco opens after odor-OR-binding, we used tip recordings to examine in vivo the effects of the Orco antagonist OLC15 and the amilorides MIA and HMA on bombykal transduction in the hawkmoth Manduca sexta. In contrast to OLC15 both amilorides decreased the pheromone-dependent sensillum potential amplitude and the frequency of the phasic AP response. Instead, OLC15 decreased spontaneous activity, increased latencies of phasic-, and decreased frequencies of late, long-lasting pheromone responses Zeitgebertime-dependently. Our results suggest no involvement for Orco in the primary transduction events, in contrast to amiloride-sensitive channels. Instead of an odor-gated ionotropic receptor, Orco rather acts as a voltage- and apparently second messenger-gated pacemaker channel controlling the membrane potential and hence threshold and kinetics of the pheromone response.	[Nolte, Andreas; Gawalek, Petra; Koerte, Sarah; Wei, HongYing; Schumann, Robin; Werckenthin, Achim; Stengl, Monika] Univ Kassel, Dept Anim Physiol, FB Biol 10, Heinrich Plett Str 40, D-34132 Kassel, Germany; [Krieger, Juergen] Martin Luther Univ Halle Wittenberg, Dept Anim Physiol, Inst Biol Zool, Hoher Weg 8, D-06108 Halle, Saale, Germany; [Koerte, Sarah] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoell Str 8, D-07749 Jena, Germany	Universitat Kassel; Martin Luther University Halle Wittenberg; Max Planck Society	Stengl, M (corresponding author), Univ Kassel, Dept Anim Physiol, FB Biol 10, Heinrich Plett Str 40, D-34132 Kassel, Germany.	stengl@uni-kassel.de			Deutsche Forschungsgesellschaft [STE531/20-1, STE531/20-2, SPP 1392]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschungsgesellschaft STE531/20-1,2 and SPP 1392 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahk S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0306-x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Bobkov YV, 2007, CHEM SENSES, V32, P149, DOI 10.1093/chemse/bjl041; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dolzer J, 2003, J EXP BIOL, V206, P1575, DOI 10.1242/jeb.00302; Dolzer J, 2001, J EXP BIOL, V204, P2781; Dolzer J, 2008, CHEM SENSES, V33, P803, DOI 10.1093/chemse/bjn043; Elmore T, 2003, J NEUROSCI, V23, P9906; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Getahun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058889; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nolte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062648; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schendzielorz T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121230; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; SCHWEITZER ES, 1976, J INSECT PHYSIOL, V22, P955, DOI 10.1016/0022-1910(76)90078-0; STENGL M, 1993, J EXP BIOL, V178, P125; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; STENGL M, 1990, J NEUROSCI, V10, P837; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 1990, THESIS; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Szyszka P, 2014, P NATL ACAD SCI USA, V111, P16925, DOI 10.1073/pnas.1412051111; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wei HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108757; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217; ZUFALL F, 1991, J EXP BIOL, V161, P455	49	16	16	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166060	10.1371/journal.pone.0166060	http://dx.doi.org/10.1371/journal.pone.0166060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829053	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300076
J	Ribeiro, BR; Sales, LP; De Marco, P; Loyola, R				Ribeiro, Bruno R.; Sales, Lilian P.; De Marco, Paulo, Jr.; Loyola, Rafael			Assessing Mammal Exposure to Climate Change in the Brazilian Amazon	PLOS ONE			English	Article							RANGE SHIFTS; DISTRIBUTIONS; VULNERABILITY; BIODIVERSITY; IMPACTS; CONSERVATION; GEOGRAPHY; BEHAVIOR; HEAT; SIZE	Human-induced climate change is considered a conspicuous threat to biodiversity in the 21st century. Species' response to climate change depends on their exposition, sensitivity and ability to adapt to novel climates. Exposure to climate change is however uneven within species' range, so that some populations may be more at risk than others. Identifying the regions most exposed to climate change is therefore a first and pivotal step on determining species' vulnerability across their geographic ranges. Here, we aimed at quantifying mammal local exposure to climate change across species' ranges. We identified areas in the Brazilian Amazon where mammals will be critically exposed to non-analogue climates in the future with different variables predicted by 15 global circulation climate forecasts. We also built a null model to assess the effectiveness of the Amazon protected areas in buffering the effects of climate change on mammals, using an innovative and more realistic approach. We found that 85% of species are likely to be exposed to non-analogue climatic conditions in more than 80% of their ranges by 2070. That percentage is even higher for endemic mammals; almost all endemic species are predicted to be exposed in more than 80% of their range. Exposure patterns also varied with different climatic variables and seem to be geographically structured. Western and northern Amazon species are more likely to experience temperature anomalies while northeastern species will be more affected by rainfall abnormality. We also observed an increase in the number of critically-exposed species from 2050 to 2070. Overall, our results indicate that mammals might face high exposure to climate change and that protected areas will probably not be efficient enough to avert those impacts.	[Ribeiro, Bruno R.; Sales, Lilian P.; Loyola, Rafael] Univ Fed Goias, Dept Ecol, Lab Biogeog Conservacao, Goiania, Go, Brazil; [Ribeiro, Bruno R.; Sales, Lilian P.] Univ Fed Goias, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil; [De Marco, Paulo, Jr.] Univ Fed Goias, Lab Metacomunidades & Ecol Paisagens, Dept Ecol, Goiania, Go, Brazil; [De Marco, Paulo, Jr.; Loyola, Rafael] Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias; Instituto Nacional de Pesquisas Espaciais (INPE)	Loyola, R (corresponding author), Univ Fed Goias, Dept Ecol, Lab Biogeog Conservacao, Goiania, Go, Brazil.; Loyola, R (corresponding author), Inst Nacl Pesquisas Espaciais, Brazilian Res Network Climate Change Rede Clima, Sao Jose Dos Campos, SP, Brazil.	loyola@ufg.br	Sales, Lillian P./C-2300-2016; Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008; De Marco, Paulo/B-2209-2009; Ribeiro, Bruno R./Z-2123-2018	Sales, Lillian P./0000-0003-1159-6412; Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; De Marco, Paulo/0000-0002-3628-6405; Ribeiro, Bruno R./0000-0002-7755-6715	Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico; Coordenagao de Aperfeicoamento de Nivel Superior; CNPq [308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9, 437167/2016-0]; O Boticario Group Foundation for the Protection of Nature [PROG_0008_2013]; CNCFlora; FINEP [01.13.0353.00]	Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenagao de Aperfeicoamento de Nivel Superior; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); O Boticario Group Foundation for the Protection of Nature; CNCFlora; FINEP(Financiadora de Inovacao e Pesquisa (Finep))	BRR and LPS are supported by Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) and Coordenagao de Aperfeicoamento de Nivel Superior (www.capes.gov.br) scholarships, respectively. RL research has been constantly funded by CNPq (grants #308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9), O Boticario Group Foundation for the Protection of Nature (grant #PROG_0008_2013), and CNCFlora. This paper is a contribution of the Brazilian Network on Global Climate Change Research funded by CNPq (grant #437167/2016-0) and FINEP (grant #01.13.0353.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Juarez EIAY, 2013, CONSERV LETT, V6, P145, DOI 10.1111/j.1755-263X.2012.00306.x; Juarez EIAY, 2012, TRENDS ECOL EVOL, V27, P272, DOI 10.1016/j.tree.2011.11.005; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berry Pam, 2013, Biology - Basel, V2, P872, DOI 10.3390/biology2030872; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Buckley LB, 2012, GLOBAL ECOL BIOGEOGR, V21, P873, DOI 10.1111/j.1466-8238.2011.00737.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cruz-McDonnell KK, 2016, GLOBAL CHANGE BIOL, V22, P237, DOI 10.1111/gcb.13092; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Ferro VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107792; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Khaliq I, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1097; Lemes P, 2014, BIODIVERS CONSERV, V23, P357, DOI 10.1007/s10531-013-0605-2; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Mccain CM, 2014, GLOBAL CHANGE BIOL, V20, P1760, DOI 10.1111/gcb.12499; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Oswald SA, 2011, J BIOGEOGR, V38, P430, DOI 10.1111/j.1365-2699.2010.02435.x; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Paglia A.P., 2012, OCCASIONAL PAPERS CO, V2nd; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; R Core Team, 2013, R LANG ENV STAT COMP; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sheth SN, 2014, EVOLUTION, V68, P2917, DOI 10.1111/evo.12494; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Standards IUCN and Subcommittee Petitions, 2016, GUIDELINES FOR USING, V12; Stocker T.F., 2013, CLIMATE CHANGE 2013; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Verissimo A, 2011, PROTECTED AREAS BRAZ, V92; Vilela B, 2015, METHODS ECOL EVOL, V6, P1229, DOI 10.1111/2041-210X.12401; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	54	30	30	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165073	10.1371/journal.pone.0165073	http://dx.doi.org/10.1371/journal.pone.0165073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829036	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300029
J	Topczewska, JM; Shoela, RA; Tomaszewski, JP; Mirmira, RB; Gosain, AK				Topczewska, Jolanta M.; Shoela, Ramy A.; Tomaszewski, Joanna P.; Mirmira, Rupa B.; Gosain, Arun K.			The Morphogenesis of Cranial Sutures in Zebrafish	PLOS ONE			English	Article							MOUSE CORONAL SUTURE; OSTEOBLAST DIFFERENTIATION; CRANIOFACIAL DEVELOPMENT; SKULL VAULT; COLLAGEN-FIBERS; CALVARIAL BONE; MODEL SYSTEM; DANIO-RERIO; CRANIOSYNOSTOSIS; EXPRESSION	Using morphological, histological, and TEM analyses of the cranium, we provide a detailed description of bone and suture growth in zebrafish. Based on expression patterns and localization, we identified osteoblasts at different degrees of maturation. Our data confirm that, unlike in humans, zebrafish cranial sutures maintain lifelong patency to sustain skull growth. The cranial vault develops in a coordinated manner resulting in a structure that protects the brain. The zebrafish cranial roof parallels that of higher vertebrates and contains five major bones: one pair of frontal bones, one pair of parietal bones, and the supraoccipital bone. Parietal and frontal bones are formed by intramembranous ossification within a layer of mesenchyme positioned between the dermal mesenchyme and meninges surrounding the brain. The supraoccipital bone has an endochondral origin. Cranial bones are separated by connective tissue with a distinctive architecture of osteogenic cells and collagen fibrils. Here we show RNA in situ hybridization for col1a1a, col2a1a, col10a1, bglap/osteocalcin, fgfr1a, fgfr1b, fgfr2, fgfr3, foxq1, twist2, twist3, runx2a, runx2b, sp7/osterix, and spp1/osteopontin, indicating that the expression of genes involved in suture development in mammals is preserved in zebrafish. We also present methods for examining the cranium and its sutures, which permit the study of the mechanisms involved in suture patency as well as their pathological obliteration. The model we develop has implications for the study of human disorders, including craniosynostosis, which affects 1 in 2,500 live births.	[Topczewska, Jolanta M.; Shoela, Ramy A.; Tomaszewski, Joanna P.; Mirmira, Rupa B.; Gosain, Arun K.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Plast Surg,Stanley Manne Childrens Res, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Topczewska, JM (corresponding author), Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Plast Surg,Stanley Manne Childrens Res, Chicago, IL 60611 USA.	j-topczewska@northwestern.edu		Topczewska, Jolanta M/0000-0003-1876-5039	AO Foundation [S-09-102G]	AO Foundation	AO Foundation supported this work through No. S-09-102G [https://www.aeans.aotoundation.org/Structure/research/research-funding/Pages/Start-up-agrants.aspx].	Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bhat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025990; Bieller A, 2001, DNA CELL BIOL, V20, P555, DOI 10.1089/104454901317094963; Boonrungsiman S, 2012, P NATL ACAD SCI USA, V109, P14170, DOI 10.1073/pnas.1208916109; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Clendenning DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036789; Cohen MM, 2012, J CRANIOFAC SURG, V23, P338, DOI 10.1097/SCS.0b013e318241dbc4; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Eames BF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-27; Feng WG, 2013, GENESIS, V51, P677, DOI 10.1002/dvg.22416; Filipek-Gorniok B, 2013, DEV DYNAM, V242, P964, DOI 10.1002/dvdy.23981; FURUYA Y, 1984, J NEUROSURG, V61, P53, DOI 10.3171/jns.1984.61.1.0053; Geurtzen K, 2014, DEVELOPMENT, V141, P2225, DOI 10.1242/dev.105817; Hatch NE, 2010, CRIT REV EUKAR GENE, V20, P295, DOI 10.1615/CritRevEukarGeneExpr.v20.i4.20; Hermann CD, 2012, CALCIFIED TISSUE INT, V91, P255, DOI 10.1007/s00223-012-9632-3; Irie K, 1998, ANAT RECORD, V252, P554; Iseki S, 1999, DEVELOPMENT, V126, P5611; Ishii M, 2015, CURR TOP DEV BIOL, V115, P131, DOI 10.1016/bs.ctdb.2015.07.004; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Jasinoski SC, 2010, J BIOMECH, V43, P3104, DOI 10.1016/j.jbiomech.2010.08.007; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Johnson D, 2000, MECH DEVELOP, V91, P341, DOI 10.1016/S0925-4773(99)00278-6; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kabbani H, 2004, AM FAM PHYSICIAN, V69, P2863; Kague E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047394; Kapp-Simon KA, 2016, J NEUROSURG PEDIAT, P1, DOI [DOI 10.3171/2015.9.PEDS15238, 10.3171/2015.9.PEDS15238]; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Khonsari RH, 2012, AM J MED GENET A, V158A, P2797, DOI 10.1002/ajmg.a.35598; Kimmel CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009475; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Kolar JC, 2011, J CRANIOFAC SURG, V22, P47, DOI 10.1097/SCS.0b013e3181f6c2fb; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Levi B, 2012, J CRANIOFAC SURG, V23, P13, DOI 10.1097/SCS.0b013e318240c6c0; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; McGee-Lawrence ME, 2013, J BIOL CHEM, V288, P5291, DOI 10.1074/jbc.M112.414995; Merrill AE, 2006, HUM MOL GENET, V15, P1319, DOI 10.1093/hmg/ddl052; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Moursi AM, 2002, CLEFT PALATE-CRAN J, V39, P487, DOI 10.1597/1545-1569(2002)039<0487:FGFIIC>2.0.CO;2; Muenke M, 2011, MONOGR HUM GENET, V19, P1; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Quarto N, 2005, CELLS TISSUES ORGANS, V181, P109, DOI 10.1159/000091100; Renn J, 2013, DEV BIOL, V381, P134, DOI 10.1016/j.ydbio.2013.05.030; Rice DPC, 2003, EUR J ORTHODONT, V25, P139, DOI 10.1093/ejo/25.2.139; Rice DPC, 2000, DEVELOPMENT, V127, P1845; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Slater BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003914; Sousa S, 2012, BIOL OPEN, V1, P915, DOI 10.1242/bio.2012877; Spiesz EM, 2011, J STRUCT BIOL, V176, P302, DOI 10.1016/j.jsb.2011.09.009; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Twigg SRF, 2015, HUM MOL GENET, V24, pR50, DOI 10.1093/hmg/ddv228; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Warren SM, 2008, J CRANIOFAC SURG, V19, P198, DOI 10.1097/scs.0b013e31815c8a9a; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Yelick PC, 2002, CRIT REV ORAL BIOL M, V13, P308, DOI 10.1177/154411130201300402; Yoshida T, 2005, J ANAT, V206, P437, DOI 10.1111/j.1469-7580.2005.00411.x; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	68	27	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165775	10.1371/journal.pone.0165775	http://dx.doi.org/10.1371/journal.pone.0165775			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829009	Green Submitted, gold, Green Published			2022-12-27	WOS:000387724300058
J	McDaniel, J; Piner, K; Lee, HH; Hill, K				McDaniel, Jenny; Piner, Kevin; Lee, Hui-Hua; Hill, Kevin			Evidence that the Migration of the Northern Subpopulation of Pacific Sardine (Sardinops sagax) off the West Coast of the United States Is Age-Based	PLOS ONE			English	Article							CALIFORNIA CURRENT; STOCK ASSESSMENT; SOUTHERN CALIFORNIA; BAJA-CALIFORNIA; ATLANTIC COD; POPULATION; FISH; DISCRIMINATION; SELECTIVITY; MANAGEMENT	Analysis of fish movements has been an important area of study for fisheries ecology and population dynamics for decades. Pacific sardine, Sardinops sagax, along the west coast of the United States exhibit a well-defined large-scale seasonal migration. Larger and older fish are found in the northern reaches of their range during summer and contract to southerly offshore areas for spawning during spring. Because of the close correlation between fish size and age it has not yet been determined if movements are size- or age-based. Measuring spatial changes in the age structure conditioned on individual lengths was used to determine the roles of age versus length in the seasonal migration. S. sagax have a pattern of increasing age-at-length with seasonal northward movements and offshore movements for spawning. The pattern of increasing age-at-length with distance from the origin eliminates a solely length-based process of movement and supports age-based movement. Patterns in the size and age when fish first show migratory behaviors, coupled with the patterns observed during the spawning season, support a hypothesis that migratory behaviors are linked to age-based ontogenetic changes associated with maturation.	[McDaniel, Jenny; Piner, Kevin; Lee, Hui-Hua; Hill, Kevin] NOAA, Fisheries Resources Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92038 USA	National Oceanic Atmospheric Admin (NOAA) - USA	McDaniel, J (corresponding author), NOAA, Fisheries Resources Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92038 USA.	Jenny.McDaniel@noaa.gov						Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Clark F. N., 1945, Fishery Bulletin Sacramento, VNo. 61, P63; Clark F. N., 1945, Fishery Bulletin Sacramento, VNo. 61, P7; Clark F. N., 1955, Progress Reports California Ocean Fish Invest, V1953-55, P11; Corten A, 1999, ICES J MAR SCI, V56, P207, DOI 10.1006/jmsc.1998.0429; Demer DA, 2014, ICES J MAR SCI, V71, P328, DOI 10.1093/icesjms/fst135; Demer DA, 2012, FISH B-NOAA, V110, P52; Dorval E, 2013, CAL COOP OCEAN FISH, V54, P192; Felix-Uraga R, 2005, CAL COOP OCEAN FISH, V46, P113; Felix-Uraga R, 2004, CAL COOP OCEAN FISH, V45, P146; Flostrand L, 2014, CAN SCI ADVIS SEC RE, V113, P1; Francis RICC, 2016, FISH RES, V180, P77, DOI 10.1016/j.fishres.2015.02.018; Garcia-Morales R., 2012, CURR DEV OCEANOGR, V5, P23; Hill Kevin T., 2015, NOAA Technical Memorandum NMFS-SWFSC, V546, P1; Hoyle Simon D., 2006, Inter-American Tropical Tuna Commission Stock Assessment Report, V6, P3; Humston R, 2000, FISH OCEANOGR, V9, P136, DOI 10.1046/j.1365-2419.2000.00132.x; Humston R, 2004, T AM FISH SOC, V133, P1304, DOI 10.1577/T03-040.1; Jacobson LD, 1996, CAN J FISH AQUAT SCI, V53, P600, DOI 10.1139/f95-207a; Janssen J. F., 1945, Fishery Bulletin Sacramento, VNo. 61, P43; JANSSEN JOHN F., 1937, CALIFORNIA FISH AND GAME, V23, P190; JANSSEN JOHN F., 1938, CALIFORNIA FISH AND GAME, V24, P376; Jorgensen C, 2009, EVOL APPL, V2, P356, DOI 10.1111/j.1752-4571.2009.00075.x; KRAMER D, 1971, COMMER FISH REV, V33, P7; Le Bris A, 2013, ICES J MAR SCI, V70, P793, DOI 10.1093/icesjms/fst068; Lee HH, 2017, J FISH BIOL, V90, P222, DOI 10.1111/jfb.13177; Leggett W.C., 1985, Contributions in Marine Science, V27, P277; Lluch-B. D., 1991, P293; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; Lo NCH, 2011, B MAR SCI, V87, P395, DOI 10.5343/bms.2010.1077; Lo NCH, 2010, FISH B-NOAA, V108, P174; MacCall AD, 2012, ICES J MAR SCI, V69, P267, DOI 10.1093/icesjms/fss008; Maunder MN, 2015, ICES J MAR SCI, V72, P7, DOI 10.1093/icesjms/fsu015; McClatchie S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150628; McFarlane GA, 2002, AM FISH S S, V32, P195; McFarlane GA, 1999, PICES S SIDN CAN; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; PARRISH RH, 1989, CAN J FISH AQUAT SCI, V46, P2019, DOI 10.1139/f89-251; Piner KR, 2016, FISH RES, V180, P128, DOI 10.1016/j.fishres.2015.05.024; Polovina JJ, 1996, FISH OCEANOGR, V5, P114, DOI 10.1111/j.1365-2419.1996.tb00110.x; Radovich J., 1982, CALCOFI REPORTS, V23, P56; Robichaud D, 2004, FISH FISH, V5, P185, DOI 10.1111/j.1467-2679.2004.00141.x; Sampson DB, 2014, FISH RES, V158, P5, DOI 10.1016/j.fishres.2013.10.004; Schueller AM, 2014, FISH RES, V158, P26, DOI 10.1016/j.fishres.2013.10.023; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Smith PE, 2005, CAL COOP OCEAN FISH, V46, P75; Taylor NG, 2005, CAN J FISH AQUAT SCI, V62, P215, DOI 10.1139/F04-189; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; VROOMAN AM, 1964, J FISH RES BOARD CAN, V21, P691, DOI 10.1139/f64-062; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Yaremko ML, 1996, NOAATMNMFSSWFSC223, V223, P39	51	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166780	10.1371/journal.pone.0166780	http://dx.doi.org/10.1371/journal.pone.0166780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851805	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300085
J	Alfano, G; Kruczek, PM; Shah, AZ; Kramarz, B; Jeffery, G; Zelhof, AC; Bhattacharya, SS				Alfano, Giovanna; Kruczek, Przemyslaw M.; Shah, Amna Z.; Kramarz, Barbara; Jeffery, Glen; Zelhof, Andrew C.; Bhattacharya, Shomi S.			EYS Is a Protein Associated with the Ciliary Axoneme in Rods and Cones	PLOS ONE			English	Article							MUTATIONS; EYES; DIFFERENTIATION; DYSTROPHY; CELLS	Purpose Mutations in the EYS gene are a common cause of autosomal recessive retinitis pigmentosa (arRP), yet the role of the EYS protein in humans is presently unclear. The aim of this study was to investigate the isoform structure, expression and potential function of EYS in the mammalian retina in order to better understand its involvement in the pathogenesis of arRP. Methods To achieve the objective, we examined the expression of mRNA transcripts of EYS isoforms in human tissues and cell lines by RT-PCR. We also investigated the localisation of EYS in cultured cells and retinal cryo-sections by confocal fluorescence microscopy and Western blot analysis. Results RT-PCR analysis confirmed that EYS has at least four isoforms. In addition to the previously reported EYS isoforms 1 and 4, we present the experimental validation of two smaller variants referred to as EYS isoforms 2 and 3. All four isoforms are expressed in the human retina and Y79 cells and the short variants were additionally detected in the testis. Immunofluorescent confocal microscopy and Western blot analysis revealed that all EYS isoforms preferentially localise to the cytoplasm of Y79 and HeLa cells. Moreover, an enrichment of the endogenous protein was observed near the centrosomes in Y79 cells. Interestingly, EYS was observed at the ciliary axoneme in Y79 ciliated cells. In macaque retinal cryosections, EYS was found to localise in the region of the photoreceptor ciliary axoneme in both rods and cones as well as in the cytoplasm of the ganglion cells. Conclusion The results obtained in this study lead us to speculate that, in photoreceptor cells, EYS could be a protein involved in maintaining the stability of the ciliary axoneme in both rods and cones. The variability of its isoform structure suggests that other roles are also possible and yet to be established.	[Alfano, Giovanna; Kruczek, Przemyslaw M.; Shah, Amna Z.; Kramarz, Barbara; Jeffery, Glen; Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Zelhof, Andrew C.] Indiana Univ, Dept Biol, 1001 East Third St, Bloomington, IN 47405 USA	University of London; University College London; Indiana University System; Indiana University Bloomington	Alfano, G (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	g.alfano@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Zelhof, Andrew/0000-0001-7085-822X; Kramarz, Barbara/0000-0002-3898-1727	British Eye Research Foundation (Fight for Sight) [1111438, 1933/ST1107D]; Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust) [298582, M233-CD1]; Special Trustees of Moorfields Eye Hospital General Fund [228064]; Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust) [1140679]; National Institute for Health Research personal award; National Institute of Health [R21 EY024125]; NATIONAL EYE INSTITUTE [R21EY024125] Funding Source: NIH RePORTER	British Eye Research Foundation (Fight for Sight); Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust); Special Trustees of Moorfields Eye Hospital General Fund; Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust); National Institute for Health Research personal award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the British Eye Research Foundation (Fight for Sight; charity number 1111438, PhD Studentship 1933/ST1107D to SSB); the Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust; charity number 298582) [Grant Number M233-CD1 to AZS, GA, and SSB]; the Special Trustees of Moorfields Eye Hospital General Fund (Charity Number 228064) personal award to SSB for infrastructure; the Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust; charity number 1140679) personal award to SSB for infrastructure; and the National Institute for Health Research personal award to SSB for infrastructure. ACZ was supported by National Institute of Health (R21 EY024125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Dr. Naushin Waseem and Beverley Scott for their support with DNA sequencing. This work was supported by the British Eye Research Foundation (Fight for Sight; charity number 1111438, PhD Studentship 1933/ST1107D to SSB]; the Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust; charity number 298582) [Grant Number M233-CD1 to AZS, GA, and SSB]; the Special Trustees Of Moorfields Eye Hospital General Fund (Charity Number 228064) personal award to SSB for infrastructure; the Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust; charity number 1140679) personal award to SSB for infrastructure; and the National Institute for Health Research personal award to SSB for infrastructure. ACZ was supported by National Institute of Health (R21 EY024125).	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Anasagasti A, 2012, VISION RES, V75, P117, DOI 10.1016/j.visres.2012.09.012; Arai Y, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/819760; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bonilha VL, 2015, GRAEF ARCH CLIN EXP, V253, P295, DOI 10.1007/s00417-014-2868-z; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Iwanami M, 2012, INVEST OPHTH VIS SCI, V53, P1033, DOI 10.1167/iovs.11-9048; Katagiri S, 2014, DOC OPHTHALMOL, V128, P211, DOI 10.1007/s10633-014-9435-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kowal TJ, 2015, CELL BIOL INT, V39, P1341, DOI 10.1002/cbin.10500; KYRITSIS A, 1984, EXP EYE RES, V38, P411, DOI 10.1016/0014-4835(84)90196-9; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Liu MM, 2013, CLIN GENET, V84, P142, DOI 10.1111/cge.12181; Nie J, 2012, DEV BIOL, V371, P312, DOI 10.1016/j.ydbio.2012.08.024; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; TSOKOS M, 1986, AM J PATHOL, V123, P542; Vento R, 1997, MOL CELL BIOCHEM, V170, P163, DOI 10.1023/A:1006813705101; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang PB, 2015, PROTEOMICS, V15, P836, DOI 10.1002/pmic.201400397	26	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166397	10.1371/journal.pone.0166397	http://dx.doi.org/10.1371/journal.pone.0166397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846257	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600057
J	Eichberg, C; Wohde, M; Muller, K; Rausch, A; Scherrmann, C; Scheuren, T; During, RA; Donath, TW				Eichberg, Carsten; Wohde, Manuel; Mueller, Kerstin; Rausch, Anja; Scherrmann, Christina; Scheuren, Theresa; Duering, Rolf-Alexander; Donath, Tobias W.			The Anthelmintic Ingredient Moxidectin Negatively Affects Seed Germination of Three Temperate Grassland Species	PLOS ONE			English	Article							MACROCYCLIC LACTONES; DISPERSAL; IVERMECTIN; RESTORATION; TOXICITY; IMPACT; SHEEP; DUNG; PHARMACOKINETICS; CONSEQUENCES	In animal farming, anthelmintics are regularly applied to control gastrointestinal nematodes. There is plenty of evidence that also non-target organisms, such as dung beetles, are negatively affected by residues of anthelmintics in faeces of domestic ungulates. By contrast, knowledge about possible effects on wild plants is scarce. To bridge this gap of knowledge, we tested for effects of the common anthelmintic formulation Cydectin and its active ingredient moxidectin on seed germination. We conducted a feeding experiment with sheep and germination experiments in a climate chamber. Three wide-spread plant species of temperate grasslands (Centaurea jacea, Galium verum, Plantago lanceolate) were studied. We found significant influences of both, Cydectin and moxidectin, on germination of the tested species. Across species, both formulation and active ingredient solely led to a decrease in germination percentage and synchrony of germination and an increase in mean germination time with the formulation showing a more pronounced response pattern. Our study shows for the first time that anthelmintics have the potential to negatively affect plant regeneration. This has practical implications for nature conservation since our results suggest that treatments of livestock with anthelmintics should be carefully timed to not impede endozoochorous seed exchange between plant populations.	[Eichberg, Carsten; Mueller, Kerstin; Rausch, Anja; Scherrmann, Christina; Scheuren, Theresa] Univ Trier, Reg & Environm Sci, Geobot, Trier, Germany; [Wohde, Manuel; Duering, Rolf-Alexander] Justus Liebig Univ, Inst Soil Sci & Soil Conservat, Giessen, Germany; [Donath, Tobias W.] Christian Albrechts Univ Kiel, Inst Nat Resource Conservat, Dept Landscape Ecol, Kiel, Germany	Universitat Trier; Justus Liebig University Giessen; University of Kiel	Eichberg, C (corresponding author), Univ Trier, Reg & Environm Sci, Geobot, Trier, Germany.	eichberg@uni-trier.de	Donath, Tobias W./B-2856-2012; Eichberg, Carsten/J-1970-2014	Donath, Tobias W./0000-0003-1874-1096; 				AFZAL J, 1994, J AGR FOOD CHEM, V42, P1767, DOI 10.1021/jf00044a037; Albert A, 2015, OIKOS, V124, P1109, DOI 10.1111/oik.02512; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Bartikova H, 2016, CHEMOSPHERE, V144, P2290, DOI 10.1016/j.chemosphere.2015.10.137; Bartuszevige AM, 2008, J ARID ENVIRON, V72, P904, DOI 10.1016/j.jaridenv.2007.11.007; Baskin CC, 2014, SEEDS ECOLOGY BIOGGE; Beynon SA, 2012, VET PARASITOL, V189, P113, DOI 10.1016/j.vetpar.2012.03.040; Cobb R, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S2-S5; Coop R. L., 2002, P303, DOI 10.1079/9780851996172.0303; Cosyns E, 2005, J ECOL, V93, P353, DOI 10.1111/j.0022-0477.2005.00982.x; D'hondt B, 2011, PLANT BIOLOGY, V13, P118, DOI 10.1111/j.1438-8677.2010.00335.x; Eichberg C, 2007, FLORA, V202, P3, DOI 10.1016/j.flora.2006.01.004; Elter A, 2007, J BIOL CHEM, V282, P8786, DOI 10.1074/jbc.M607241200; Faust C, 2011, BASIC APPL ECOL, V12, P215, DOI 10.1016/j.baae.2011.02.009; FDAH (Fort Dodge Animal Health), 2001, ENV ASS CYDECTIN MOX, P1; Floate KD, 2002, B ENTOMOL RES, V92, P471, DOI 10.1079/BER2002201; Freund L, 2014, APPL VEG SCI, V17, P74, DOI 10.1111/avsc.12052; Ghassali F, 1998, EXP AGR, V34, P391, DOI 10.1017/S0014479798004086; Hempel H, 2006, ENVIRON TOXICOL CHEM, V25, P3155, DOI 10.1897/06-022R2.1; Iwasa M, 2008, APPL ENTOMOL ZOOL, V43, P271, DOI 10.1303/aez.2008.271; Jager E, 2011, ROTHMALER EXKURSIONS; Kadiri N, 1999, ANN SOC ENTOMOL FR, V35, P222; Kiehl K, 2010, BASIC APPL ECOL, V11, P285, DOI 10.1016/j.baae.2009.12.004; Kuiters AT, 2010, APPL VEG SCI, V13, P163, DOI 10.1111/j.1654-109X.2009.01058.x; Lifschitz A, 2005, J VET PHARMACOL THER, V28, P411, DOI 10.1111/j.1365-2885.2005.00674.x; Lloberas M, 2013, INT J PARASITOL-DRUG, V3, P20, DOI 10.1016/j.ijpddr.2012.11.001; Lumaret JP, 2012, CURR PHARM BIOTECHNO, V13, P1004, DOI 10.2174/138920112800399257; MALO JE, 1995, OECOLOGIA, V104, P246, DOI 10.1007/BF00328589; Mancilla-Leyton JM, 2012, SMALL RUMINANT RES, V107, P12, DOI 10.1016/j.smallrumres.2012.04.001; Martin R. J., 2002, P125, DOI 10.1079/9780851996172.0125; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Pakeman RJ, 2002, FUNCT ECOL, V16, P296, DOI 10.1046/j.1365-2435.2002.00625.x; Perez R, 2001, VET J, V161, P85, DOI 10.1053/tvjl.2000.0521; Prichard R, 2012, INT J PARASITOL-DRUG, V2, P134, DOI 10.1016/j.ijpddr.2012.04.001; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; Ranal Marli A., 2009, Braz. J. Bot., V32, P849, DOI 10.1590/S0100-84042009000400022; Ranal Marli A., 2006, Braz. J. Bot., V29, P1, DOI 10.1590/S0100-84042006000100002; Rendell D, 1996, AUST VET J, V73, P35, DOI 10.1111/j.1751-0813.1996.tb09954.x; Rosas CA, 2008, J VEG SCI, V19, P769, DOI 10.3170/2008-8-18447; Rosenthal G, 2012, TUEXENIA, P167; Ruhl AT, 2016, SEED SCI RES, V26, P93, DOI 10.1017/S0960258516000106; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Suarez VH, 2009, ECOTOX ENVIRON SAFE, V72, P1551, DOI 10.1016/j.ecoenv.2007.11.009; Sutherland I., 2010, GASTROINTESTINAL NEM; Traveset A, 1998, ECOL EVOL SYST, V1, P151, DOI DOI 10.1078/1433-8319-00057; Ulyatt M. J., 1986, Control of digestion and metabolism in ruminants. Proceedings of the Sixth International Symposium on Ruminant Physiology held at Banff, Canada, September 10th-14th, 1984, P498; Vercruysse J, 2002, MACROCYCLIC LACTONES; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	50	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166366	10.1371/journal.pone.0166366	http://dx.doi.org/10.1371/journal.pone.0166366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846249	gold, Green Published			2022-12-27	WOS:000387794600051
J	Chen, WH; Zheng, LR; Li, KY; Wang, Q; Liu, GZ; Jiang, Q				Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing			A Novel and Effective Method for Congestive Heart Failure Detection and Quantification Using Dynamic Heart Rate Variability Measurement	PLOS ONE			English	Article							SENSITIVITY; SYSTEM	Risk assessment of congestive heart failure (CHF) is essential for detection, especially helping patients make informed decisions about medications, devices, transplantation, and end-of- life care. The majority of studies have focused on disease detection between CHF patients and normal subjects using short-/long-term heart rate variability (HRV) measures but not much on quantification. We downloaded 116 nominal 24-hour RR interval records from the MIT/BIH database, including 72 normal people and 44 CHF patients. These records were analyzed under a 4-level risk assessment model: no risk (normal people, N), mild risk (patients with New York Heart Association (NYHA) class I-II, P1), moderate risk (patients with NYHA III, P2), and severe risk (patients with NYHA III-IV, P3). A novel multistage classification approach is proposed for risk assessment and rating CHF using the non-equilibrium decision-tree-based support vector machine classifier. We propose dynamic indices of HRV to capture the dynamics of 5-minute short term HRV measurements for quantifying autonomic activity changes of CHF. We extracted 54 classical measures and 126 dynamic indices and selected from these using backward elimination to detect and quantify CHF patients. Experimental results show that the multistage risk assessment model can realize CHF detection and quantification analysis with total accuracy of 96.61%. The multistage model provides a powerful predictor between predicted and actual ratings, and it could serve as a clinically meaningful outcome providing an early assessment and a prognostic marker for CHF patients.	[Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing] Sun Yat Sen Univ, Sch Engn, Guangzhou, Guangdong, Peoples R China; [Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing] Sci & Technol Planning Project Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing] Guangdong Prov Engn & Technol Ctr Adv & Portable, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, GZ; Jiang, Q (corresponding author), Sun Yat Sen Univ, Sch Engn, Guangzhou, Guangdong, Peoples R China.; Liu, GZ; Jiang, Q (corresponding author), Sci & Technol Planning Project Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Liu, GZ; Jiang, Q (corresponding author), Guangdong Prov Engn & Technol Ctr Adv & Portable, Guangzhou, Guangdong, Peoples R China.	liugzh3@163.com; qjiang@mail.sysu.edu.cn			natural science foundation of China [61401521]; natural science foundation of Guangdong province [2014A030310163]	natural science foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by the natural science foundation of China (61401521), the natural science foundation of Guangdong province (2014A030310163).	Asyali MH, 2003, P ANN INT IEEE EMBS, V25, P200, DOI 10.1109/IEMBS.2003.1279568; BAIM DS, 1986, J AM COLL CARDIOL, V7, P661, DOI 10.1016/S0735-1097(86)80478-8; Bradley BD, 2013, CRIT CARE MED, V41, P433, DOI 10.1097/CCM.0b013e31826a47de; Camm AJ, 1996, CIRCULATION, V93, P1043; Cirugeda-Roldan E, 2014, ENTROPY-SWITZ, V16, P5901, DOI 10.3390/e16115901; D'Addio G, 2003, COMPUT CARDIOL, V30, P449, DOI 10.1109/CIC.2003.1291189; De Jong Marla J, 2005, J Cardiovasc Nurs, V20, P186; Duda R.O., 2006, PATTERN CLASSIFICATI; Flavell C, 2001, CIRCULATION, V104, pE89, DOI 10.1161/hc4301.099136; Fleg JL, 2000, CIRCULATION, V102, P1591, DOI 10.1161/01.CIR.102.13.1591; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Isler Y, 2007, COMPUT BIOL MED, V37, P1502, DOI 10.1016/j.compbiomed.2007.01.012; Kishi T, 2012, J CARDIOL, V59, P117, DOI 10.1016/j.jjcc.2011.12.006; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Liu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093399; Madzarov G, 2009, INFORM-J COMPUT INFO, V33, P225; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Mao KZ, 2004, IEEE T SYST MAN CY B, V34, P629, DOI 10.1109/TSMCB.2002.804363; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Melillo P, 2013, IEEE J BIOMED HEALTH, V17, P727, DOI 10.1109/JBHI.2013.2244902; Mortara A, 1997, CIRCULATION, V96, P246; Pecchia L, 2011, IEEE T BIO-MED ENG, V58, P800, DOI 10.1109/TBME.2010.2092776; Pecchia L, 2011, IEEE T INF TECHNOL B, V15, P40, DOI 10.1109/TITB.2010.2091647; Provost F, 1998, MACH LEARN, V30, P127, DOI 10.1023/A:1007442505281; Rao AM, 2002, PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P167, DOI 10.1109/NEBC.2002.999518; Raphael C, 2007, HEART, V93, P476, DOI 10.1136/hrt.2006.089656; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Takahashi F, 2002, ICONIP'02: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, P1418; Verkerk AO, 2003, CIRCULATION, V108, P760, DOI 10.1161/01.CIR.0000083719.51661.B9; Xue H, 2011, IEEE T NEURAL NETWOR, V22, P573, DOI 10.1109/TNN.2011.2108315; YBae BJ, 2001, TUBERCULOSIRESP DI, V71, P46; Yu SN, 2012, COMPUT BIOL MED, V42, P816, DOI 10.1016/j.compbiomed.2012.06.005; Zhou SX, 2009, EUROPACE, V11, P245, DOI 10.1093/europace/eun383; Zhu Y, 2014, IEEE T BIO-MED ENG, V61, P938, DOI 10.1109/TBME.2013.2292693	34	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165304	10.1371/journal.pone.0165304	http://dx.doi.org/10.1371/journal.pone.0165304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835634	gold, Green Submitted, Green Published			2022-12-27	WOS:000387779200004
J	Godbout, R; Legare, S; Auger, M; Carpentier, C; Otis, F; Auger, M; Lague, P; Voyer, N				Godbout, Raphael; Legare, Sebastien; Auger, Maud; Carpentier, Claudia; Otis, Francois; Auger, Michele; Lague, Patrick; Voyer, Normand			Membrane Assembly and Ion Transport Ability of a Fluorinated Nanopore	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; AMINO-ACIDS; HALOGEN-BOND; FORCE-FIELD; CHANNEL; DESIGN; CHEMISTRY; MODELS; CHARMM; STABILITY	A novel 21-residue peptide incorporating six fluorinated amino acids was prepared. It was designed to fold into an amphiphilic alpha helical structure of nanoscale length with one hydrophobic face and one fluorinated face. The formation of a fluorous interface serves as the main vector for the formation of a superstructure in a bilayer membrane. Fluorescence assays showed this ion channel's ability to facilitate the translocation of alkali metal ions through a phospholipid membrane, with selectivity for sodium ions. Computational studies showed that a tetramer structure is the most probable and stable supramolecular assembly for the active ion channel structure. The results illustrate the possibility of exploiting multiple F delta(-):M+ interactions for ion transport and using fluorous interfaces to create functional nanostructures.	[Godbout, Raphael; Carpentier, Claudia; Otis, Francois; Voyer, Normand] Univ Laval, Dept Chim, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Quebec City, PQ, Canada; [Legare, Sebastien; Lague, Patrick] Univ Laval, Dept Biochim Microbiol & Bioinformat, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Quebec City, PQ, Canada; [Auger, Maud; Auger, Michele] Univ Laval, Dept Chim, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Ctr Rech Mat Avances CERMA,Ctr Quebecois Mat Fonc, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Voyer, N (corresponding author), Univ Laval, Dept Chim, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Quebec City, PQ, Canada.	normand.voyer@chm.ulaval.ca		Lague, Patrick/0000-0002-5236-4979	Fond de recherche du Quebec-Nature et technologic [182605-NV]	Fond de recherche du Quebec-Nature et technologic	This work was supported by Fond de recherche du Quebec-Nature et technologic (182605-NV), www.frqnt.gouv.qc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERFELDT KS, 1993, ACCOUNTS CHEM RES, V26, P191, DOI 10.1021/ar00028a009; Benachir T, 1996, BIOPHYS J, V70, P831, DOI 10.1016/S0006-3495(96)79622-4; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bilgicer B, 2001, J AM CHEM SOC, V123, P4393, DOI 10.1021/ja002961j; Buer BC, 2012, P NATL ACAD SCI USA, V109, P4810, DOI 10.1073/pnas.1120112109; Chan TY, 1996, TETRAHEDRON LETT, V37, P8097, DOI 10.1016/0040-4039(96)01849-7; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; Curran DP, 2008, J FLUORINE CHEM, V129, P898, DOI 10.1016/j.jfluchem.2008.05.025; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fyles TM, 2007, CHEM SOC REV, V36, P335, DOI 10.1039/b603256g; Gokel GW, 2013, ACCOUNTS CHEM RES, V46, P2824, DOI 10.1021/ar400026x; Gottler LM, 2008, BIOCHEMISTRY-US, V47, P4484, DOI 10.1021/bi702476f; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; Jentzsch AV, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1902; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JULLIEN L, 1988, TETRAHEDRON LETT, V29, P3803, DOI 10.1016/S0040-4039(00)82119-X; Kaucher MS, 2006, J AM CHEM SOC, V128, P38, DOI 10.1021/ja056888e; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krishnamurthy VM, 2013, METHODS MOL BIOL, V1063, P227, DOI 10.1007/978-1-62703-583-5_13; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Marsh ENG, 2014, ACCOUNTS CHEM RES, V47, P2878, DOI 10.1021/ar500125m; MONTAL M, 1995, ANNU REV BIOPH BIOM, V24, P31, DOI 10.1146/annurev.bb.24.060195.000335; Montenegro J, 2013, ACCOUNTS CHEM RES, V46, P2955, DOI 10.1021/ar400061d; Moszynski JM, 2010, ORG BIOMOL CHEM, V8, P5139, DOI 10.1039/c0ob00194e; Naarmann N, 2006, ANGEW CHEM INT EDIT, V45, P2588, DOI 10.1002/anie.200503567; Nyakatura EK, 2013, RSC ADV, V3, P6319, DOI 10.1039/c3ra41110a; Otis F, 2011, J AM CHEM SOC, V133, P6481, DOI 10.1021/ja110336s; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Priimagi A, 2013, ACCOUNTS CHEM RES, V46, P2686, DOI 10.1021/ar400103r; Sakai N, 2003, CHEM-EUR J, V9, P223, DOI 10.1002/chem.200390016; Salwiczek M, 2012, CHEM SOC REV, V41, P2135, DOI 10.1039/c1cs15241f; Salwiczek M, 2009, CHEM-EUR J, V15, P7628, DOI 10.1002/chem.200802136; Schrey A, 2000, ANGEW CHEM INT EDIT, V39, P900, DOI 10.1002/(SICI)1521-3773(20000303)39:5<900::AID-ANIE900>3.0.CO;2-D; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHARPE AG, 1990, J CHEM EDUC, V67, P309, DOI 10.1021/ed067p309; SMITH DW, 1977, J CHEM EDUC, V54, P540, DOI 10.1021/ed054p540; Son S, 2006, CHEMBIOCHEM, V7, P1251, DOI 10.1002/cbic.200500420; TABUSHI I, 1982, TETRAHEDRON LETT, V23, P4601, DOI 10.1016/S0040-4039(00)85664-6; Tomalia DA, 2003, NAT MATER, V2, P711, DOI 10.1038/nmat1004; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wang W, 2009, CHEM-EUR J, V15, P10543, DOI 10.1002/chem.200900898; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yoder NC, 2002, CHEM SOC REV, V31, P335, DOI 10.1039/b201097f; Zheng J, 2015, HDB ION CHANNELS	47	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166587	10.1371/journal.pone.0166587	http://dx.doi.org/10.1371/journal.pone.0166587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835700	Green Submitted, Green Published, gold			2022-12-27	WOS:000387779200061
J	Kim, BR; Choi, SH; Yun, TJ; Lee, ST; Park, CK; Kim, TM; Kim, JH; Park, SW; Sohn, CH; Park, SH; Kim, IH				Kim, Bo Ram; Choi, Seung Hong; Yun, Tae Jin; Lee, Soon-Tae; Park, Chui-Kee; Kim, Tae Min; Kim, Ji-Hoon; Park, Sun-Won; Sohn, Chui-Ho; Park, Sung-Hye; Kim, Il Han			MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction	PLOS ONE			English	Article							TEMOZOLOMIDE; RECURRENCE; PATTERNS; BRAIN; RADIOTHERAPY; GLIOMAS; BEVACIZUMAB; ADJUVANT; INVASION; CRITERIA	Purpose To analyze the enhancement patterns and apparent diffusion coefficient (ADC) values of non-measurable surgical cavity wall enhancement pattern, newly appearing after completion of standard concurrent chemoradiotherapy (CCRT) with temozolomide in glioblastoma patients for the prognosis prediction. Materials and Methods From January 2010 to April 2014, among 190 patients with histopathologically confirmed glioblastoma, a total of 33 patients with non-measurable wall enhancement on post-CCRT MR imaging were enrolled and divided into two subgroups: non-progression (n = 18) and progression groups (n = 15). We analyzed the wall enhancement patterns, which were categorized into three patterns: thin, thick and nodular enhancement. ADC values were measured in the enhancing portions of the walls. The progression-free survival (PFS) related to the wall enhancement was analyzed by Kaplan-Meier analysis, and survival curves were compared using the log-rank test. Results Statistically significant differences in the surgical cavity wall enhancement patterns was shown between the progression and non-progression groups (P = 0.0032). Thin wall enhancement was more frequently observed in the non-progression group, and thick or nodular wall enhancement were observed in the progression group (P = 0.0016). There was no statistically significant difference in the mean ADC values between the progression and non-progression groups. The mean PFS was longer in patients with thin wall enhancement than in those with nodular or thick wall enhancement (35.5 months vs. 15.8 months, P = 0.008). Conclusion Pattern analysis of non-measurable surgical cavity wall enhancement on post-CCRT MR imaging might be useful tool for predicting prognosis of GBM patient before clear progression of non-measurable disease.	[Kim, Bo Ram; Choi, Seung Hong; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chui-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Lee, Soon-Tae] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Park, Chui-Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Kim, Tae Min] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Park, Sun-Won] Boramae Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Sung-Hye] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Kim, Il Han] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Park, Chul-Kee/O-7842-2019; Sohn, ChulHo/AAV-4565-2021; Park, Chul-Kee/J-5499-2012	Park, Chul-Kee/0000-0002-2350-9876; Kim, Bo Ram/0000-0002-5968-3884; Lee, Soon-Tae/0000-0003-4767-7564	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [HI16C1111]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016M3C7A1914002]; Creative-Pioneering Researchers Program through Seoul National University (SNU);  [IBS-R006-D1]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Creative-Pioneering Researchers Program through Seoul National University (SNU); 	The scientific guarantor of this publication is Seung Hong Choi. The authors of this manuscript declare no relationships with any companies. This study has received funding by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (HI16C1111); by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), by Creative-Pioneering Researchers Program through Seoul National University (SNU),; and by Project Code (IBS-R006-D1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The scientific guarantor of this publication is Seung Hong Choi. The authors of this manuscript declare no relationships with any companies. This study has received funding by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (HI16C1111); by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), by Creative-Pioneering Researchers Program through Seoul National University (SNU),; and by Project Code (IBS-R006-D1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dobelbower MC, 2011, J MED IMAG RADIAT ON, V55, P77, DOI 10.1111/j.1754-9485.2010.02232.x; Does MD, 1999, MAGNET RESON MED, V41, P236, DOI 10.1002/(SICI)1522-2594(199902)41:2<236::AID-MRM4>3.0.CO;2-3; Ekinci G, 2003, EUR J RADIOL, V45, P99, DOI 10.1016/S0720-048X(02)00027-X; Ellingson BM, 2011, J NEURO-ONCOL, V105, P91, DOI 10.1007/s11060-011-0567-8; Farace P, 2013, J NEURO-ONCOL, V111, P177, DOI 10.1007/s11060-012-0997-y; Gzell CE, 2016, J NEURO-ONCOL, V128, P67, DOI 10.1007/s11060-016-2074-4; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; Hwang EJ, 2013, J NEURO-ONCOL, V112, P427, DOI 10.1007/s11060-013-1072-z; Jeon HJ, 2009, CLIN NEUROL NEUROSUR, V111, P679, DOI 10.1016/j.clineuro.2009.06.013; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Majos C, 2015, EUROPEAN RADIOLOGY, P1; Milano MT, 2010, INT J RADIAT ONCOL, V78, P1147, DOI 10.1016/j.ijrobp.2009.09.018; Nagashima G, 1999, SURG NEUROL, V51, P292, DOI 10.1016/S0090-3019(98)00056-1; Oh J, 2011, CAN J NEUROL SCI, V38, P621, DOI 10.1017/S0317167100012166; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Petrecca K, 2013, J NEURO-ONCOL, V111, P19, DOI 10.1007/s11060-012-0983-4; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Sherriff J, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120414; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick W, 2008, NEURO-ONCOLOGY, V10, P1019, DOI 10.1215/15228517-2008-058	26	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166096	10.1371/journal.pone.0166096	http://dx.doi.org/10.1371/journal.pone.0166096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835666	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200024
J	Bell, AR; Ward, PS; Killilea, ME; Tamal, MEH				Bell, Andrew Reid; Ward, Patrick S.; Killilea, Mary E.; Tamal, Md. Ehsanul Haque			Real-Time Social Data Collection in Rural Bangladesh via a 'Microtasks for Micropayments' Platform on Android Smartphones	PLOS ONE			English	Article								The advent of cheap smartphones in rural areas across the globe presents an opportunity to change the mode with which researchers engage hard-to-reach populations. In particular, smartphones allow researchers to connect with respondents more frequently than standard household surveys, opening a new window into important short-term variability in key measures of household and community wellbeing. In this paper, we present early results from a pilot study in rural Bangladesh using a 'microtasks for micropayments' model to collect a range of community and household living standards data using Android smartphones. We find that more frequent task repetition with shorter recall periods leads to more inclusive reporting, improved capture of intra-seasonal variability, and earlier signals of events such as illness. Payments in the form of mobile talk time and data provide a positive development externality in the form of expanded access to mobile internet and social networks. Taken to scale, programs such as this have potential to transform data collection in rural areas, providing near-real-time windows into the development of markets, the spread of illnesses, or the diffusion of ideas and innovations.	[Bell, Andrew Reid; Killilea, Mary E.] NYU, Dept Environm Studies, 285 Mercer St, New York, NY 10003 USA; [Ward, Patrick S.] IFPRI, 2033 K St NW, Washington, DC 20006 USA; [Tamal, Md. Ehsanul Haque] IFPRI, Dhaka Off, House 10A,Rd 35,Gulshan 2, Dhaka 1212, Bangladesh	New York University; CGIAR; International Food Policy Research Institute (IFPRI)	Bell, AR (corresponding author), NYU, Dept Environm Studies, 285 Mercer St, New York, NY 10003 USA.	andrew.reid.bell@nyu.edu		Ward, Patrick S/0000-0001-8793-1200; Tamal, Md. Ehsanul Haque/0000-0002-1331-0732	Cereal Systems Initiative for South Asia (CSISA) of the Consultative Group on International Agricultural Research (CGIAR); United States Agency for International Development (USAID); Bill and Melinda Gates Foundation	Cereal Systems Initiative for South Asia (CSISA) of the Consultative Group on International Agricultural Research (CGIAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Cereal Systems Initiative for South Asia (CSISA) of the Consultative Group on International Agricultural Research (CGIAR), with generous funding provided by the United States Agency for International Development (USAID) and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Ahmed, 2013, BANGLADESH PARLIAMEN; Anokwa Y, 2009, COMPUTER, V42, P97, DOI 10.1109/MC.2009.328; Bangladesh Bureau of Statistics, 2011, INT INF MAN SYST BBS; Brunette W., 2013, P 14 WORKSH MOB COMP, DOI 10.1145/2444776.2444790; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Cartwright Jon, 2016, Nature, V531, P669; Chander R, 1980, LIVING STANDARDS MEA; CIA, 2016, CIA WORLD FACTB BANG; Deaton A., 1997, The analysis of household surveys: a microeconometric approach to development policy.; Deaton A., 1980, MEASUREMENT WELFARE; Enenkel M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142030; Flanagin AJ, 2008, GEOJOURNAL, V72, P137, DOI 10.1007/s10708-008-9188-y; Husain I., 2016, DHAKA TRIBUNE   0124, P1; ICT, 2015, ICT FACTS FIG 2015; Kittur A, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P453; Piot P, 2014, LANCET INFECT DIS, V14, P1034, DOI 10.1016/S1473-3099(14)70956-9; Raja A, 2014, Online J Public Health Inform, V5, P228, DOI 10.5210/ojphi.v5i3.4996; Rajput ZA, 2012, J AM MED INFORM ASSN, V19, P655, DOI 10.1136/amiajnl-2011-000476; Reis S, 2015, ENVIRON MODELL SOFTW, V74, P238, DOI 10.1016/j.envsoft.2015.06.003; Sadoulet E., 1995, QUANTITATIVE DEV POL; Strauss J., 1995, HDB DEV EC, V3, P1883; Tomori O, 2016, EBOLA UNPREPARED AFR, P1; UN Global Pulse, 2015, FEAS STUD CROWDS HIG	25	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165924	10.1371/journal.pone.0165924	http://dx.doi.org/10.1371/journal.pone.0165924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832116	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000041
J	Bellomo, G; Marcocci, F; Bianchini, D; Mezzenga, E; D'Errico, V; Menghi, E; Zannoli, R; Sarnelli, A				Bellomo, Giovanni; Marcocci, Francesco; Bianchini, David; Mezzenga, Emilio; D'Errico, Vincenzo; Menghi, Enrico; Zannoli, Romano; Sarnelli, Anna			MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; EPITHELIAL-CELLS; SEMINAL FLUID; BASIS-SET; QUANTITATION; CITRATE; BIOPSY; LOCALIZATION; SIMULATIONS; LCMODEL	Prostate cancer (PCa) is the most common non-cutaneous cancer in male subjects and the second leading cause of cancer-related death in developed countries. The necessity of a non-invasive technique for the diagnosis of PCa in early stage has grown through years. Proton magnetic resonance spectroscopy (H-1-MRS) and proton magnetic resonance spectroscopy imaging (H-1-MRSI) are advanced magnetic resonance techniques that can mark the presence of metabolites such as citrate, choline, creatine and polyamines in a selected voxel, or in an array of voxels (in MRSI) inside prostatic tissue. Abundance or lack of these metabolites can discriminate between pathological and healthy tissue. Although the use of magnetic resonance spectroscopy (MRS) is well established in brain and liver with dedicated software for spectral analysis, quantification of metabolites in prostate can be very difficult to achieve, due to poor signal to noise ratio and strong J-coupling of the citrate. The aim of this work is to develop a software prototype for automatic quantification of citrate, choline and creatine in prostate. Its core is an original fitting routine that makes use of a fixed step gradient descent minimization algorithm (FSGD) and MRS simulations developed with the GAMMA libraries in C++. The accurate simulation of the citrate spin systems allows to predict the correct J-modulation under different NMR sequences and under different coupling parameters. The accuracy of the quantifications was tested on measurements performed on a Philips Ingenia 3T scanner using homemade phantoms. Some acquisitions in healthy volunteers have been also carried out to test the software performance in vivo.	[Bellomo, Giovanni; Marcocci, Francesco; Bianchini, David; Mezzenga, Emilio; D'Errico, Vincenzo; Menghi, Enrico; Sarnelli, Anna] Ist Sci Romagnolo Studio & Cura Tumori IRCCS, Med Phys Unit, Meldola, FC, Italy; [Zannoli, Romano] Univ Bologna, Expt Diagnost & Specialty Med Dept DIMES, Bologna, Italy	IRCCS Meldola (IRST); University of Bologna	Marcocci, F (corresponding author), Ist Sci Romagnolo Studio & Cura Tumori IRCCS, Med Phys Unit, Meldola, FC, Italy.	francesco.marcocci@irst.emr.it	Bellomo, Giovanni/AAE-1090-2021; Mezzenga, Emilio/Q-1018-2018; Sarnelli, Anna/V-4284-2018	Bellomo, Giovanni/0000-0003-0456-5650; Mezzenga, Emilio/0000-0002-0150-7757; Sarnelli, Anna/0000-0001-5986-3845				Ackerstaff E, 2001, CANCER RES, V61, P3599; Basharat M, 2014, NMR BIOMED, V27, P459, DOI 10.1002/nbm.3082; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Caivano R, 2012, J MED IMAG RADIAT ON, V56, P606, DOI 10.1111/j.1754-9485.2012.02449.x; Costello LC, 1997, UROLOGY, V50, P3, DOI 10.1016/S0090-4295(97)00124-6; Garcia-Martin ML, 2011, MAGN RESON MED, V65, P329, DOI 10.1002/mrm.22631; Giskeodegard GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062375; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Jung AJ, 2014, J MAGN RESON IMAGING, V40, P314, DOI 10.1002/jmri.24383; KAVANAGH JP, 1985, J REPROD FERTIL, V75, P35; Keevil SF, 2006, PHYS MED BIOL, V51, pR579, DOI 10.1088/0031-9155/51/16/R01; Kobus T, 2014, NMR BIOMED, V27, P39, DOI 10.1002/nbm.2973; Kurhanewicz J, 2000, NEOPLASIA, V2, P166, DOI 10.1038/sj.neo.7900081; Levitt M. H., 2013, SPIN DYNAMICS BASICS; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; Mullerad M, 2005, J UROLOGY, V174, P2158, DOI 10.1097/01.ju.0000181224.95276.82; Nagarajan R, 2013, MAGN RESON INSIGHTS, V6, P51, DOI 10.4137/MRI.S10861; Nagarajan R, 2012, J MAGN RESON IMAGING, V36, P697, DOI 10.1002/jmri.23676; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Ouzzane A, 2015, J UROLOGY, V194, P350, DOI 10.1016/j.juro.2015.02.2938; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Reynolds G, 2006, MAGN RESON MED, V56, P1211, DOI 10.1002/mrm.21081; Sarkar BK, 2014, FRONT BIOSCI-LANDMRK, V19, P1186, DOI 10.2741/4275; Schipper RG, 2003, BIOCHEM SOC T, V31, P375, DOI 10.1042/BST0310375; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Stables LA, 1999, J MAGN RESON, V140, P305, DOI 10.1006/jmre.1998.1850; StarLack J, 1997, MAGN RESON MED, V38, P311, DOI 10.1002/mrm.1910380222; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Thompson RB, 1999, MAGNET RESON MED, V41, P1162, DOI 10.1002/(SICI)1522-2594(199906)41:6<1162::AID-MRM12>3.0.CO;2-N; vanderGraaf M, 1996, J MAGN RESON SER B, V112, P58, DOI 10.1006/jmrb.1996.0109; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wang P, 2008, KOREAN J RADIOL, V9, P432, DOI 10.3348/kjr.2008.9.5.432; Ward JF, 2005, BJU INT, V95, P751, DOI 10.1111/j.1464-410X.2005.05394.x	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165730	10.1371/journal.pone.0165730	http://dx.doi.org/10.1371/journal.pone.0165730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832096	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000032
J	Das Gupta, S; Mackenzie, MD				Das Gupta, Sanatan; Mackenzie, M. Derek			Spatial Patterns of Soil Respiration Links Above and Belowground Processes along a Boreal Aspen Fire Chronosequence	PLOS ONE			English	Article							CARBON-DIOXIDE EFFLUX; COARSE WOODY DEBRIS; BLACK SPRUCE; MICROBIAL BIOMASS; FOREST SOIL; CO2 EFFLUX; ECOSYSTEM RESPIRATION; SEASONAL-VARIATION; ENZYME-ACTIVITIES; ROOT RESPIRATION	Fire in boreal ecosystems is known to affect CO2 efflux from forest soils, which is commonly termed soil respiration (Rs). However, there is limited information on how fire and recovery from this disturbance affects spatial variation in Rs. The main objective of this study was to quantify the spatial variability of Rs over the growing season in a boreal aspen (Populus tremuloides Michx.) fire chronosequence. The chronosequence included three stands in northern Alberta; a post fire stand (1 year old, PF), a stand at canopy closure (9 years old, CC), and a mature stand (72 years old, MA). Soil respiration, temperature and moisture were measured monthly from May to August using an intensive spatial sampling protocol (n = 42, minimum lag = 2 m). Key aboveground and belowground properties were measured one time at each sampling point. No spatial structure was detected in Rs of the PF stand during the peak growing season (June and July), whereas Rs was auto-correlated at a scale of < 6 m in the CC and MA stands. The PF stand had the lowest mean Rs (4.60 pmol C m(-2) s(-1)) followed by the CC (5.41 pmol C m(-2) s(-1)), and the MA (7.32 pmol C m(-2) s(-1)) stand. Forest floor depth was the only aboveground factor that influenced the spatial pattern of Rs in all three stands and was strongest in the PF stand. Enzyme activity and fine root biomass, on the other hand, were the significant belowground factors driving the spatial pattern of Rs in the CC and MA stands. Persistent joint aboveground and belowground control on Rs in the CC and MA stands indicates a tight spatial coupling, which was not observed in the PF stand. Overall, the current study suggests that fire in the boreal aspen ecosystem alters the spatial structure of Rs and that fine scale heterogeneity develops quickly as stands reach the canopy closure phase (<10 years).	[Das Gupta, Sanatan] Nat Resources Canada, Northern Forestry Ctr, Canadian Forest Serv, Edmonton, AB, Canada; [Mackenzie, M. Derek] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	Natural Resources Canada; Canadian Forest Service; University of Alberta	Das Gupta, S (corresponding author), Nat Resources Canada, Northern Forestry Ctr, Canadian Forest Serv, Edmonton, AB, Canada.	sanatan@ualberta.ca			Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development (CONRAD); National Science and Engineering Research Council of Canada (NSERC); National Science and Engineering Research Council of Canada	Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development (CONRAD); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development (CONRAD) and the National Science and Engineering Research Council of Canada (NSERC). No specific permissions were required for the studied locations; however, research activities on these sites were reported back to the ERRG committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development, and the National Science and Engineering Research Council of Canada for providing funding. Special thanks go to Dr. Fangliang He for logistic support and suggestion in spatial data analysis. We would also like to thank a number of field technicians for helping to collect data, including Megan Lewis, Mark Howell, Sawyer Desaulniers, and Nicole Filipow.	Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Amiro BD, 2003, AGR FOREST METEOROL, V115, P91, DOI 10.1016/S0168-1923(02)00170-3; [Anonymous], 2006, MICROBIOLOGICAL METH; ANSELIN L, 1988, GEOGR ANAL, V20, P1, DOI 10.1111/j.1538-4632.1988.tb00159.x; Anselin L., 2004, URBANA, V51, P61801; AZZALINI A, 1994, J R STAT SOC C-APPL, V43, P505; Bach CE, 2013, SOIL BIOL BIOCHEM, V67, P183, DOI 10.1016/j.soilbio.2013.08.022; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Bond-Lamberty B, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000839; Bond-Lamberty B, 2004, TREE PHYSIOL, V24, P1387, DOI 10.1093/treephys/24.12.1387; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bond-Lamberty B, 2009, GLOBAL CHANGE BIOL, V15, P1242, DOI 10.1111/j.1365-2486.2008.01776.x; Bouma TJ, 1997, PLANT SOIL, V195, P221, DOI 10.1023/A:1004278421334; Brassard BW, 2010, STAND STRUCTURE COMP; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Canadian Forest Service, 2013, NAT FIR DAT AG FIR D; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chen J, 2000, GLOBAL BIOGEOCHEM CY, V14, P839, DOI 10.1029/1999GB001207; Chen WJ, 2004, PLANT SOIL, V265, P31, DOI 10.1007/s11104-005-8503-3; CLAYTON MK, 1995, J AM STAT ASSOC, V90, P753, DOI 10.2307/2291088; Crown PH, 1970, M702 U ALB ALB I PED; Czimczik CI, 2005, EUR J SOIL SCI, V56, P417, DOI 10.1111/j.1365-2389.2004.00665.x; Czimczik CI, 2006, GLOBAL CHANGE BIOL, V12, P957, DOI 10.1111/j.1365-2486.2006.01107.x; Desrochers A, 2002, TREE PHYSIOL, V22, P725, DOI 10.1093/treephys/22.10.725; Dilly O, 2001, BIOL FERT SOILS, V34, P64, DOI 10.1007/s003740100375; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Fajardo A, 2007, AM NAT, V169, P647, DOI 10.1086/513492; Fang C, 1998, PLANT SOIL, V205, P135, DOI 10.1023/A:1004304309827; Finer L, 1997, CAN J FOREST RES, V27, P304, DOI 10.1139/x96-170; Fioretto A, 2005, APPL VEG SCI, V8, P13, DOI 10.1111/j.1654-109X.2005.tb00624.x; Flannigan M. D, 2008, COLD REGION ATMOSPHE, V1, P403; Foti Szilvia, 2009, Ekologia (Bratislava), V28, P389, DOI 10.4149/ekol_2009_04_389; FRITZE H, 1993, CAN J FOREST RES, V23, P1286, DOI 10.1139/x93-164; Gaumont-Guay D, 2008, TREE PHYSIOL, V28, P161, DOI 10.1093/treephys/28.2.161; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P203, DOI 10.1016/j.agrformet.2006.08.002; Gimeno-Garcia E, 2004, GEODERMA, V118, P17, DOI 10.1016/S0016-7061(03)00167-8; Gonzalez-Perez JA, 2004, ENVIRON INT, V30, P855, DOI 10.1016/j.envint.2004.02.003; Grant RF, 2007, TREE PHYSIOL, V27, P115, DOI 10.1093/treephys/27.1.115; Griffis TJ, 2004, AGR FOREST METEOROL, V125, P207, DOI 10.1016/j.agrformet.2004.04.006; Gross HL, 1981, DIS ASPEN SUCKES NO; Gulledge J, 2000, ECOSYSTEMS, V3, P269, DOI 10.1007/s100210000025; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; Hely C, 2000, CAN J FOREST RES, V30, P674, DOI 10.1139/cjfr-30-5-674; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Isaaks E.H., 1989, ISA; Jarvis PG, 1997, J GEOPHYS RES-ATMOS, V102, P28953, DOI 10.1029/97JD01176; KASISCHKE ES, 1995, ECOL APPL, V5, P437, DOI 10.2307/1942034; Kasischke ES, 2012, CLIMATE CHANGE CARBO; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kelsey KC, 2012, ARCT ANTARCT ALP RES, V44, P457, DOI 10.1657/1938-4246-44.4.457; Khomik M, 2006, AGR FOREST METEOROL, V140, P244, DOI 10.1016/j.agrformet.2006.08.006; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lavigne MB, 2003, CAN J FOREST RES, V33, P1744, DOI 10.1139/X03-090; Lavoie M, 2012, BIOGEOCHEMISTRY, V107, P227, DOI 10.1007/s10533-010-9547-x; Lee P, 1998, FOREST ECOL MANAG, V105, P263, DOI 10.1016/S0378-1127(97)00286-7; MacKenzie MD, 2006, PLANT SOIL, V287, P257, DOI 10.1007/s11104-006-9074-7; MacKenzie MD, 2008, SOIL SCI SOC AM J, V72, P1774, DOI 10.2136/sssaj2007.0363; Mariani L, 2006, SOIL BIOL BIOCHEM, V38, P1734, DOI 10.1016/j.soilbio.2005.11.029; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; O'Neill KP, 2006, BIOGEOCHEMISTRY, V80, P1, DOI 10.1007/s10533-005-5964-7; O'Neill KP, 2002, CAN J FOREST RES, V32, P1525, DOI [10.1139/x02-077, 10.1139/X02-077]; Pedlar JH, 2002, FOREST ECOL MANAG, V158, P189, DOI 10.1016/S0378-1127(00)00711-8; Pietikainen J, 1996, SOIL MICROBIAL BIOMA, P337; Prokushkin A. S., 2001, Eurasian Journal of Forest Research, V2, P45; Quideau SA, 2013, SOIL SCI SOC AM J, V77, P145, DOI 10.2136/sssaj2012.0202; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Rayment MB, 2000, SOIL BIOL BIOCHEM, V32, P35, DOI 10.1016/S0038-0717(99)00110-8; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Richter DD, 2000, POSTFIRE STIMULATION, P197; Ruess RW, 1996, CAN J FOREST RES, V26, P1326, DOI 10.1139/x26-148; Russell CA, 1998, CAN J SOIL SCI, V78, P301, DOI 10.4141/S97-054; Saiz G, 2006, PLANT SOIL, V287, P161, DOI 10.1007/s11104-006-9052-0; Scott-Denton LE, 2003, SOIL BIOL BIOCHEM, V35, P525, DOI 10.1016/S0038-0717(03)00007-5; Shackle VJ, 2000, SOIL BIOL BIOCHEM, V32, P1935, DOI 10.1016/S0038-0717(00)00169-3; Shibata H, 2003, SOIL SCI PLANT NUTR, V49, P25, DOI 10.1080/00380768.2003.10409975; Shibistova O, 2002, TELLUS B, V54, P552, DOI 10.1034/j.1600-0889.2002.01348.x; Singh S, 2008, CAN J FOREST RES, V38, P647, DOI 10.1139/X07-200; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Smithwick EAH, 2005, BIOGEOCHEMISTRY, V76, P517, DOI 10.1007/s10533-005-0031-y; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, P12, DOI 10.1029/2001jd000484; STRONG WL, 1985, FOREST ECOL MANAG, V12, P233, DOI 10.1016/0378-1127(85)90093-3; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Van Cleve K., 1971, ARCTIC ALPINE RES, V3, P17, DOI [DOI 10.2307/1550380, doi:10.2307/1550380]; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vogel E., 2013, THESIS LUND U SWEDEN; Wang C, 2002, J GEOPHYS RES-ATMOS, V107; WEBER MG, 1990, FOREST ECOL MANAG, V31, P1, DOI 10.1016/0378-1127(90)90107-M; Wickland KP, 2010, CAN J FOREST RES, V40, P2123, DOI 10.1139/X10-163; Yang PC, 1999, J GEOPHYS RES-ATMOS, V104, P27653, DOI 10.1029/1999JD900295; Yates SR., 2002, SOIL SCI SOC AM BOOK, V5, P81; Yuan ZY, 2012, FUNCT ECOL, V26, P991, DOI 10.1111/j.1365-2435.2012.02007.x; Zhao HM, 2012, GEODERMA, V189, P532, DOI 10.1016/j.geoderma.2012.05.013; Zhou W, 2016, BIOGEOSCIENCES DISCU	104	9	9	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e165602	10.1371/journal.pone.0165602	http://dx.doi.org/10.1371/journal.pone.0165602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832089	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000021
J	Liu, Z; Fan, SH; Liu, HP; Yu, J; Qiao, R; Zhou, M; Yang, YT; Zhou, J; Xie, P				Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng			Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; BIOMARKER DISCOVERY; PROTEOMIC ANALYSIS; CARDIOVASCULAR-DISEASE; QUANTITATIVE-ANALYSIS; SAMPLE PREPARATION; HUMAN SERUM; SEPARATION; PRECIPITATION; DEPTH	The enormous depth complexity of the human plasma proteome poses a significant challenge for current mass spectrometry-based proteomic technologies in terms of detecting low-level proteins in plasma, which is essential for successful biomarker discovery efforts. Typically, a single-step analytical approach cannot reduce this intrinsic complexity. Current simplex immunodepletion techniques offer limited capacity for detecting low-abundance proteins, and integrated strategies are thus desirable. In this respect, we developed an improved strategy for analyzing the human plasma proteome by integrating polyethylene glycol (PEG) fractionation with immunoaffinity depletion. PEG fractionation of plasma proteins is simple, rapid, efficient, and compatible with a downstream immunodepletion step. Compared with immunodepletion alone, our integrated strategy substantially improved the proteome coverage afforded by PEG fractionation. Coupling this new protocol with liquid chromatography-tandem mass spectrometry, 135 proteins with reported normal concentrations below 100 ng/mL were confidently identified as common low-abundance proteins. A side-by-side comparison indicated that our integrated strategy was increased by average 43.0% in the identification rate of low-abundance proteins, relying on an average 65.8% increase of the corresponding unique peptides. Further investigation demonstrated that this combined strategy could effectively alleviate the signal-suppressive effects of the major high-abundance proteins by affinity depletion, especially with moderate-abundance proteins after incorporating PEG fractionation, thereby greatly enhancing the detection of low abundance proteins. In sum, the newly developed strategy of incorporating PEG fractionation to immunodepletion methods can potentially aid in the discovery of plasma biomarkers of therapeutic and clinical interest.	[Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yang, Yongtao; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng] Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China; [Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Xie, Peng] Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.; Zhou, J; Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.; Zhou, J; Xie, P (corresponding author), Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China.; Zhou, J; Xie, P (corresponding author), Chongqing Key Lab Neurobiol, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China.	zhou_jian0615@163.com; xiepeng@cqmu.edu.cn	Fan, Song-Hua/E-1612-2017	Fan, Song-Hua/0000-0002-5456-2725	National Basic Research Program of China ("973 program") [2009CB918300]; National Natural Science Foundation of China [31570826, 81101009]; Foundation and Cutting-edge Research Plan Item of Chongqing [cstc2015jcyjA10052]; Fund for Young Backbone Teachers in Chongqing Colleges and Universities	National Basic Research Program of China ("973 program")(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation and Cutting-edge Research Plan Item of Chongqing; Fund for Young Backbone Teachers in Chongqing Colleges and Universities	This work was supported by the National Basic Research Program of China ("973 program", 2009CB918300), the National Natural Science Foundation of China (31570826, 81101009), the Foundation and Cutting-edge Research Plan Item of Chongqing (cstc2015jcyjA10052), and the Fund for Young Backbone Teachers in Chongqing Colleges and Universities.; We thank Dr. Rui Wang (Shanghai Institute for Biological Sciences, Chinese Academy of Sciences) for his assistance with the MS analysis. This work was supported by grants from the National Basic Research Program of China ("973 program", 2009CB918300), the National Natural Science Foundation of China (31570826, 81101009), the Foundation and Cutting-edge Research Plan Item of Chongqing (cstc2015jcyjA10052), and the Fund for Young Backbone Teachers in Chongqing Colleges and Universities.	Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; ATHA DH, 1981, J BIOL CHEM, V256, P2108; Bast RC, 2011, GYNECOL ONCOL, V121, P429, DOI 10.1016/j.ygyno.2011.04.032; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Cao ZJ, 2012, J PROTEOME RES, V11, P3090, DOI 10.1021/pr201068b; Chan R, 2004, BIOTECHNOL BIOENG, V85, P190, DOI 10.1002/bit.10866; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; Ernoult E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927917; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Fernandez C, 2011, ELECTROPHORESIS, V32, P2966, DOI 10.1002/elps.201100183; Fukao Y, 2013, PLANT CELL PHYSIOL, V54, P808, DOI 10.1093/pcp/pct033; Gretzer MB, 2004, PROSTATE, V60, P325, DOI 10.1002/pros.20066; Guipaud O, 2013, ADV EXP MED BIOL, V990, P61, DOI 10.1007/978-94-007-5896-4_4; Hoffman SA, 2007, J CHROMATOGR B, V849, P43, DOI 10.1016/j.jchromb.2006.10.069; Hu Y., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1155/2013/175616; Huang L, 2005, PROTEOMICS, V5, P3314, DOI 10.1002/pmic.200401277; Irizarry Michael C, 2004, NeuroRx, V1, P226; Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kovacs A, 2013, CURR MED CHEM, V20, P483; Lee HJ, 2006, CURR OPIN CHEM BIOL, V10, P42, DOI 10.1016/j.cbpa.2006.01.007; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Mahn A, 2011, J CHROMATOGR B, V879, P3645, DOI 10.1016/j.jchromb.2011.09.024; Mehrani Hossein, 2011, Clin Proteomics, V8, P2, DOI 10.1186/1559-0275-8-2; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Polaskova V, 2010, ELECTROPHORESIS, V31, P471, DOI 10.1002/elps.200900286; POLSON A, 1972, VOX SANG, V23, P107, DOI 10.1111/j.1423-0410.1972.tb03818.x; Qian WJ, 2008, MOL CELL PROTEOMICS, V7, P1963, DOI 10.1074/mcp.M800008-MCP200; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shi TJ, 2012, METHODS, V56, P246, DOI 10.1016/j.ymeth.2011.09.001; Sriyam S, 2007, J CHROMATOGR B, V849, P91, DOI 10.1016/j.jchromb.2006.10.065; Sun BJ, 2011, ELECTROPHORESIS, V32, P2091, DOI 10.1002/elps.201000657; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Velasco C, 2003, J COLLOID INTERF SCI, V266, P148, DOI 10.1016/S0021-9797(03)00613-1; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu HB, 2012, INT J NEUROPSYCHOPH, V15, P1413, DOI 10.1017/S1461145712000302; Yang Y, 2013, NEUROSCIENCE, V247, P191, DOI 10.1016/j.neuroscience.2013.05.031; Zhan Y, 2014, EUR PSYCHIAT, V29, P307, DOI 10.1016/j.eurpsy.2014.03.004; Zhou J, 2011, J CHROMATOGR B, V879, P2957, DOI 10.1016/j.jchromb.2011.08.017	51	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166306	10.1371/journal.pone.0166306	http://dx.doi.org/10.1371/journal.pone.0166306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832179	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000093
J	Zeng, XJ; Shi, J; Zhao, M; Chen, QW; Wang, LP; Jiang, HY; Luo, FF; Zhu, LJ; Lu, LL; Wang, XC; Liu, ZQ				Zeng, Xuejun; Shi, Jian; Zhao, Min; Chen, Qingwei; Wang, Liping; Jiang, Huangyu; Luo, Feifei; Zhu, Lijun; Lu, Linlin; Wang, Xinchun; Liu, Zhongqiu			Regioselective Glucuronidation of Diosmetin and Chrysoeriol by the Interplay of Glucuronidation and Transport in UGT1A9-Overexpressing HeLa Cells	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; UDP-GLUCURONOSYLTRANSFERASES UGTS; ENZYMES REACTION-KINETICS; TANDEM MASS-SPECTROMETRY; ORAL BIOAVAILABILITY; SPECIES-DIFFERENCES; IN-VIVO; LUTEOLIN; METABOLISM; INHIBITION	This study aimed to determine the reaction kinetics of the regioselective glucuronidation of diosmetin and chrysoeriol, two important methylated metabolites of luteolin, by human liver microsomes (HLMs) and uridine-50-diphosphate glucuronosyltransferase (UGTs) enzymes. This study also investigated the effects of breast cancer resistance protein (BCRP) on the efflux of diosmetin and chrysoeriol glucuronides in HeLa cells overexpressing UGT1A9 (HeLa D UGT1A9). After incubation with HLMs in the presence of UDP-glucuronic acid, diosmetin and chrysoeriol gained two glucuronides each, and the OH D in each B ring of diosmetin and chrysoeriol was the preferable site for glucuronidation. Screening assays with 12 human expressed UGT enzymes and chemical-inhibition assays demonstrated that glucuronide formation was almost exclusively catalyzed by UGT1A1, UGT1A6, and UGT1A9. Importantly, in HeLa D UGT1A9, Ko143 significantly inhibited the efflux of diosmetin and chrysoeriol glucuronides and increased their intracellular levels in a dose-dependent manner. This observation suggested that BCRP-mediated excretion was the predominant pathway for diosmetin and chrysoeriol disposition. In conclusion, UGT1A1, UGT1A6, and UGT1A9 were the chief contributors to the regioselective glucuronidation of diosmetin and chrysoeriol in the liver. Moreover, cellular glucuronidation was significantly altered by inhibiting BCRP, revealing a notable interplay between glucuronidation and efflux transport. Diosmetin and chrysoeriol possibly have different effects on anti-cancer due to the difference of UGT isoforms in different cancer cells.	[Zeng, Xuejun; Chen, Qingwei; Wang, Xinchun] Shihezi Univ, Hosp Affiliated 1, Dept Pharm, Shihezi 832002, Xinjiang, Peoples R China; [Zeng, Xuejun; Shi, Jian; Zhao, Min; Chen, Qingwei; Wang, Liping; Jiang, Huangyu; Luo, Feifei; Zhu, Lijun; Lu, Linlin; Liu, Zhongqiu] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China	Shihezi University; Guangzhou University of Chinese Medicine	Wang, XC (corresponding author), Shihezi Univ, Hosp Affiliated 1, Dept Pharm, Shihezi 832002, Xinjiang, Peoples R China.; Liu, ZQ (corresponding author), Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China.	cwjwxc@163.com; liuzq@gzucm.edu.cn	Liu, Zhongqiu/AHC-9661-2022; lu, Linlin/K-6600-2016	Liu, Zhongqiu/0000-0001-6986-9677; lu, Linlin/0000-0002-9943-2422	National Natural Science Foundation of China [U1203204, 81460638, 81360671]; Science and Technology Project of Guangzhou City [201509010004]; Guangdong Natural Science Foundation Province [2015AD030312012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangzhou City; Guangdong Natural Science Foundation Province	This research was supported by the joint fund set up by the National Natural Science Foundation of China (No. U1203204), the National Natural Science Foundation of China (No. 81460638, 81360671), Science and Technology Project of Guangzhou City (201509010004) and Guangdong Natural Science Foundation Province (2015AD030312012).	Androutsopoulos VP, 2013, J NUTR BIOCHEM, V24, P496, DOI 10.1016/j.jnutbio.2012.01.012; Balyan R, 2015, CHEM-BIOL INTERACT, V240, P208, DOI 10.1016/j.cbi.2015.08.011; Bonifacio MJ, 2009, BIOCHEM PHARMACOL, V78, P1043, DOI 10.1016/j.bcp.2009.05.036; Brand W, 2008, DRUG METAB DISPOS, V36, P1794, DOI 10.1124/dmd.107.019943; Chan BCL, 2013, PHYTOMEDICINE, V20, P611, DOI 10.1016/j.phymed.2013.02.007; Chen ZJ, 2013, MOL NUTR FOOD RES, V57, P877, DOI 10.1002/mnfr.201200584; Chen ZJ, 2012, FITOTERAPIA, V83, P1616, DOI 10.1016/j.fitote.2012.09.011; Chen ZJ, 2011, DRUG METAB DISPOS, V39, P667, DOI 10.1124/dmd.110.037333; Coughlin JL, 2012, DRUG METAB DISPOS, V40, P481, DOI 10.1124/dmd.111.042366; Dai PM, 2015, BIOPHARM DRUG DISPOS, V36, P622, DOI 10.1002/bdd.1989; Dong RH, 2012, PHYTOTHER RES, V26, P86, DOI 10.1002/ptr.3525; Ge A, 2015, ACTA BIOCH BIOPH SIN, V47, P604, DOI 10.1093/abbs/gmv052; Harbourt DE, 2012, ANAL CHEM, V84, P98, DOI 10.1021/ac201704a; Jiang W, 2012, DRUG METAB DISPOS, V40, P336, DOI 10.1124/dmd.111.041467; Kato R, 2014, BIOL PHARM BULL, V37, P1782, DOI 10.1248/bpb.b14-00438; Kiang TKL, 2005, PHARMACOL THERAPEUT, V106, P97, DOI 10.1016/j.pharmthera.2004.10.013; Konieczna A, 2015, Klin Onkol, V28, P431; Qiang L, 2015, J CHROMATOGR A, V1395, P116, DOI 10.1016/j.chroma.2015.03.069; Liu HM, 2014, XENOBIOTICA, V44, P696, DOI 10.3109/00498254.2014.891780; Liu HX, 2008, DRUG METAB DISPOS, V36, P1562, DOI 10.1124/dmd.108.020560; Liu ZQ, 2006, PHARM RES-DORDR, V23, P2768, DOI 10.1007/s11095-006-9100-8; Mishra B, 2003, BIOORGAN MED CHEM, V11, P2677, DOI 10.1016/S0968-0896(03)00232-3; Oda S, 2015, DRUG METAB PHARMACOK, V30, P30, DOI 10.1016/j.dmpk.2014.12.001; ORTMANN R, 1970, FEBS LETT, V7, P164, DOI 10.1016/0014-5793(70)80146-6; Pattanawongsa A, 2015, DRUG METAB DISPOS; Pick A, 2011, BIOORGAN MED CHEM, V19, P2090, DOI 10.1016/j.bmc.2010.12.043; Poor M, 2014, J PHOTOCH PHOTOBIO B, V132, P1, DOI 10.1016/j.jphotobiol.2014.01.016; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Seo KA, 2014, DRUG METAB DISPOS, V42, P1803, DOI 10.1124/dmd.114.058818; Sun H, 2015, J PHARM SCI-US, V104, P2369, DOI 10.1002/jps.24464; Sun H, 2014, EXPERT OPIN DRUG MET, V10, P1325, DOI 10.1517/17425255.2014.954548; Tang L, 2014, PHARM RES-DORDR, V31, P847, DOI 10.1007/s11095-013-1207-0; Uchaipichat V, 2006, DRUG METAB DISPOS, V34, P449, DOI 10.1124/dmd.105.007369; Wu BJ, 2013, CURR TOP MED CHEM, V13, P1343; Wu BJ, 2012, PHARM RES-DORDR, V29, P3199, DOI 10.1007/s11095-012-0817-2; Wu BJ, 2011, DRUG METAB REV, V43, P440, DOI 10.3109/03602532.2011.615320; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Wu J, 2016, J ETHNOPHARMACOL; Wu ZF, 2015, J PHARM PHARMACOL, V67, P583, DOI 10.1111/jphp.12351; Xu HY, 2009, MOL PHARMACEUT, V6, P1703, DOI 10.1021/mp900013d; Zhang L, 2013, CHEM RES TOXICOL, V26, P1570, DOI 10.1021/tx400268q; Zhou GY, 2011, J MED CHEM, V54, P7220, DOI 10.1021/jm200791z; Zhu L., 2015, WORLD J TRADIT CHIN, V1, P1	43	10	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166239	10.1371/journal.pone.0166239	http://dx.doi.org/10.1371/journal.pone.0166239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832172	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000081
J	Cheok, J; Pressey, RL; Weeks, R; Andrefouet, S; Moloney, J				Cheok, Jessica; Pressey, Robert L.; Weeks, Rebecca; Andrefouet, Serge; Moloney, James			Sympathy for the Devil: Detailing the Effects of Planning-Unit Size, Thematic Resolution of Reef Classes, and Socioeconomic Costs on Spatial Priorities for Marine Conservation	PLOS ONE			English	Article							PROTECTED AREAS; BIODIVERSITY CONSERVATION; OPPORTUNITY COSTS; RESERVE SELECTION; LAND CLASSES; SCALE; REPRESENTATION; ECOREGIONS; SURROGATES; DESIGN	Spatial data characteristics have the potential to influence various aspects of prioritising bio-diversity areas for systematic conservation planning. There has been some exploration of the combined effects of size of planning units and level of classification of physical environments on the pattern and extent of priority areas. However, these data characteristics have yet to be explicitly investigated in terms of their interaction with different socioeconomic cost data during the spatial prioritisation process. We quantify the individual and interacting effects of three factors-planning-unit size, thematic resolution of reef classes, and spatial variability of socioeconomic costs-on spatial priorities for marine conservation, in typical marine planning exercises that use reef classification maps as a proxy for biodiversity. We assess these factors by creating 20 unique prioritisation scenarios involving combinations of different levels of each factor. Because output data from these scenarios are analogous to ecological data, we applied ecological statistics to determine spatial similarities between reserve designs. All three factors influenced prioritisations to different extents, with cost variability having the largest influence, followed by planning-unit size and thematic resolution of reef classes. The effect of thematic resolution on spatial design depended on the variability of cost data used. In terms of incidental representation of conservation objectives derived from finer-resolution data, scenarios prioritised with uniform cost outperformed those prioritised with variable cost. Following our analyses, we make recommendations to help maximise the spatial and cost efficiency and potential effectiveness of future marine conservation plans in similar planning scenarios. We recommend that planners: employ the smallest planning-unit size practical; invest in data at the highest possible resolution; and, when planning across regional extents with the intention of incidentally representing fine-resolution features, prioritise the whole region with uniform costs rather than using coarse-resolution data on variable costs.	[Cheok, Jessica; Pressey, Robert L.; Weeks, Rebecca] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Andrefouet, Serge] Univ Reunion, CNRS, Inst Rech Dev, Lab Excellence CORAIL,UMR ENTROPIE 9220, Noumea, New Caledonia; [Cheok, Jessica; Moloney, James] James Cook Univ, Coll Sci & Engn, Townsville, Qld 4811, Australia	James Cook University; Institut de Recherche pour le Developpement (IRD); James Cook University	Cheok, J (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.; Cheok, J (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld 4811, Australia.	jessica.cheok@my.jcu.edu.au		Weeks, Rebecca/0000-0002-0867-1007	Australian Research Council; James Cook University; US National Aeronautics and Space Administration (NASA); University of South Florida (USF, Institute for Marine Remote Sensing); Institut de Recherche Pour le Developpement (IRD) [UMR 9220 ENTROPIE]	Australian Research Council(Australian Research Council); James Cook University; US National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); University of South Florida (USF, Institute for Marine Remote Sensing); Institut de Recherche Pour le Developpement (IRD)	This study was funded by the Australian Research Council, and James Cook University. Millennium mapping products were funded by the US National Aeronautics and Space Administration (NASA), University of South Florida (USF, Institute for Marine Remote Sensing) and by Institut de Recherche Pour le Developpement (IRD, UMR 9220 ENTROPIE). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JC thanks Phil Bright from the Secretariat of the Pacific Community (SPC) for access to invaluable district-level population data and GIS shapefiles of census areas, Collin Storlie for help and advice on using the High Performance Computing facility at James Cook University, and Loic Thibaut for statistical advice. RLP and RW acknowledge funding from the Australian Research Council.	Adams VM, 2011, BIOL CONSERV, V144, P350, DOI 10.1016/j.biocon.2010.09.012; Adams VM, 2010, BIOL CONSERV, V143, P439, DOI 10.1016/j.biocon.2009.11.011; Alpine JE, 2007, MAR FRESHWATER RES, V58, P558, DOI 10.1071/MF06214; Andrefouet S., 2006, P 10 INT COR REEF S; [Anonymous], 2013, SPARCL PERFORM SPARS; [Anonymous], 2014, R LANG ENV STAT COMP; Ardron JA, 2010, CJ MARXAN GOOD PRACT, P165; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban NC, 2013, FRONT ECOL ENVIRON, V11, P194, DOI 10.1890/110205; Ban NC, 2009, MAR POLICY, V33, P794, DOI 10.1016/j.marpol.2009.02.011; Ban NC, 2009, CONSERV BIOL, V23, P899, DOI 10.1111/j.1523-1739.2009.01185.x; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Beger M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9208; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Bridge TCL, 2016, CONSERV BIOL, V30, P154, DOI 10.1111/cobi.12557; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; CNMI Department of Commerce, 2010, NO MAR ISL 2010 CENS; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Deas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097409; Delavenne J, 2012, ICES J MAR SCI, V69, P75, DOI 10.1093/icesjms/fsr180; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Federated States of Micronesia Division of Statistics, 2010, 2010 CENS POP HOUS; Fiji Bureau of Statistics, 2007, 2007 CENS POP; Fjeldsa J, 2007, CONSERV BIOL, V21, P659, DOI 10.1111/j.1523-1739.2007.00706.x; Giakoumi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076449; Green A., 2013, DESIGNING MARINE PRO; Green A, 2009, ORYX, V43, P488, DOI 10.1017/S0030605309990342; Hamel MA, 2013, CONSERV LETT, V6, P46, DOI 10.1111/j.1755-263X.2012.00285.x; Horigue V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135789; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Justus J, 2008, CONSERV BIOL, V22, P673, DOI 10.1111/j.1523-1739.2008.00928.x; Juutinen A, 2004, FOREST SCI, V50, P527; KIRKPATRICK JB, 1994, CONSERV BIOL, V8, P217, DOI 10.1046/j.1523-1739.1994.08010217.x; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Larsen FW, 2003, BIODIVERS CONSERV, V12, P599, DOI 10.1023/A:1022448928753; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lombard AT, 2003, BIOL CONSERV, V112, P45, DOI 10.1016/S0006-3207(02)00422-6; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mazor T, 2014, ECOL APPL, V24, P1115, DOI 10.1890/13-1249.1; Miclat EFB, 2006, OCEAN COAST MANAGE, V49, P597, DOI 10.1016/j.ocecoaman.2006.06.019; Mills M, 2010, CONSERV LETT, V3, P291, DOI 10.1111/j.1755-263X.2010.00134.x; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nhancale BA, 2011, BIODIVERS CONSERV, V20, P1821, DOI 10.1007/s10531-011-0063-7; Office of Planning and Statistics, 2005, 2005 CENS POP HOUS R; Oksanen J., **DATA OBJECT**; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Payet K, 2010, AUSTRAL ECOL, V35, P121, DOI 10.1111/j.1442-9993.2009.02014.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Poiani KA, 2000, BIOSCIENCE, V50, P133, DOI 10.1641/0006-3568(2000)050[0133:BCAMSF]2.3.CO;2; Pressey RL, 1998, BIOL CONSERV, V85, P305, DOI 10.1016/S0006-3207(97)00146-8; Pressey RL, 1995, CONSERV BIOL, V9, P1506, DOI 10.1046/j.1523-1739.1995.09061506.x; Pressey RL, 1999, J BIOGEOGR, V26, P179, DOI 10.1046/j.1365-2699.1999.00258.x; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Republic of the Marshall Islands, 1999, CENS POP HOUS; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Rouget M, 2003, BIOL CONSERV, V112, P217, DOI 10.1016/S0006-3207(02)00415-9; Scholes RJ, 2013, CURR OPIN ENV SUST, V5, P16, DOI 10.1016/j.cosust.2013.01.004; Schroter M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112557; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898; Shriner SA, 2006, ECOL APPL, V16, P1660, DOI 10.1890/1051-0761(2006)016[1660:RNBORH]2.0.CO;2; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; U.S. Census Bureau, 2010, 2010 CENS FOR GUAM; Van Wynsberge S, 2015, OCEAN COAST MANAGE, V116, P37, DOI 10.1016/j.ocecoaman.2015.06.031; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136, DOI [DOI 10.1002/9781444390001.CH6, 10.1002/9781444390001.ch6]; Weeks R, 2010, CONSERV LETT, V3, P445, DOI 10.1111/j.1755-263X.2010.00131.x; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031	77	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0164869	10.1371/journal.pone.0164869	http://dx.doi.org/10.1371/journal.pone.0164869			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829042	Green Published, Green Accepted, gold			2022-12-27	WOS:000387724300021
J	Iigaya, K; Jolivald, A; Jitkrittum, W; Gilchrist, ID; Dayan, P; Paul, E; Mendl, M				Iigaya, Kiyohito; Jolivald, Aurelie; Jitkrittum, Wittawat; Gilchrist, Iain D.; Dayan, Peter; Paul, Elizabeth; Mendl, Michael			Cognitive Bias in Ambiguity Judgements: Using Computational Models to Dissect the Effects of Mild Mood Manipulation in Humans	PLOS ONE			English	Article							ANIMAL EMOTION; DEPRESSION; BEHAVIOR; WELFARE; REWARD; ANXIETY; STRESS; STATE; MECHANISMS; DISORDERS	Positive and negative moods can be treated as prior expectations over future delivery of rewards and punishments. This provides an inferential foundation for the cognitive (judgement) bias task, now widely-used for assessing affective states in non-human animals. In the task, information about affect is extracted from the optimistic or pessimistic manner in which participants resolve ambiguities in sensory input. Here, we report a novel variant of the task aimed at dissecting the effects of affect manipulations on perceptual and value computations for decision-making under ambiguity in humans. Participants were instructed to judge which way a Gabor patch (250ms presentation) was leaning. If the stimulus leant one way (e.g. left), pressing the REWard key yielded a monetary WIN whilst pressing the SAFE key failed to acquire the WIN. If it leant the other way (e.g. right), pressing the SAFE key avoided a LOSS whilst pressing the REWard key incurred the LOSS. The size (0-100 UK pence) of the offered WIN and threatened LOSS, and the ambiguity of the stimulus (vertical being completely ambiguous) were varied on a trial-by-trial basis, allowing us to investigate how decisions were affected by differing combinations of these factors. Half the subjects performed the task in a 'Pleasantly' decorated room and were given a gift (bag of sweets) prior to starting, whilst the other half were in a bare 'Unpleasant' room and were not given anything. Although these treatments had little effect on self-reported mood, they did lead to differences in decision-making. All subjects were risk averse under ambiguity, consistent with the notion of loss aversion. Analysis using a Bayesian decision model indicated that Unpleasant Room subjects were ('pessimistically') biased towards choosing the SAFE key under ambiguity, but also weighed WINS more heavily than LOSSes compared to Pleasant Room subjects. These apparently contradictory findings may be explained by the influence of affect on different processes underlying decision-making, and the task presented here offers opportunities for further dissecting such processes.	[Iigaya, Kiyohito; Jitkrittum, Wittawat; Dayan, Peter] UCL, Gatsby Computat Neurosci Unit, London W1T 4JG, England; [Jolivald, Aurelie; Paul, Elizabeth; Mendl, Michael] Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Langford BS40 5DU, England; [Gilchrist, Iain D.] Univ Bristol, Sch Expt Psychol, Bristol BS8 1TU, Avon, England	University of London; University College London; University of Bristol; University of Bristol	Iigaya, K (corresponding author), UCL, Gatsby Computat Neurosci Unit, London W1T 4JG, England.; Mendl, M (corresponding author), Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Langford BS40 5DU, England.	kiigaga@gatsby.ucl.ac.uk; mike.mendl@bristol.ac.uk	Jitkrittum, Wittawat/U-6881-2019; Mendl, Michael/D-7220-2016	Gilchrist, Iain D./0000-0003-2070-6679; Mendl, Michael/0000-0002-5302-1871	UK National Centre for the Replacement Refinement and Reduction of Animals in Research [K/00008X/1]; Gatsby Charitable Foundation; UK Medical Research Council; National Centre for the Replacement [NC/K00008X/1] Funding Source: researchfish	UK National Centre for the Replacement Refinement and Reduction of Animals in Research; Gatsby Charitable Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement	This work was funded by the UK National Centre for the Replacement Refinement and Reduction of Animals in Research (Grant number K/00008X/1 to MM, EP, PD), and the Gatsby Charitable Foundation (PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Gatsby Charitable Foundation, and the UK National Centre for the Replacement Refinement and Reduction of Animals in Research (Grant number K/00008X/1 to MM, EP, PD) who receive core funding from the UK Medical Research Council, for supporting the collaboration between Mendl, Paul and Dayan. We are grateful to Ralph Thompson for assisting with data collection, and to Sam Gershman and an anonymous referee for helpful comments on an earlier version.	Anderson MH, 2012, COGN AFFECT BEHAV NE, V12, P373, DOI 10.3758/s13415-011-0076-4; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Baciadonna L, 2015, USE JUDGEMENT BIAS A; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Berridge KC, 2003, COGNITION EMOTION, V17, P181, DOI 10.1080/02699930302289; Bethell EJ, 2012, ANIM WELFARE, V21, P185, DOI 10.7120/09627286.21.2.185; Bethell EJ, 2015, J APPL ANIM WELF SCI, V18, pS18, DOI 10.1080/10888705.2015.1075833; Bongers P, 2013, APPETITE, V67, P74, DOI 10.1016/j.appet.2013.03.017; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012; Crockett MJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2244, DOI 10.1038/npp.2012.75; Doyle RE, 2011, PSYCHONEUROENDOCRINO, V36, P279, DOI 10.1016/j.psyneuen.2010.07.018; Eldar E, 2016, TRENDS COGN SCI, V20, P15, DOI 10.1016/j.tics.2015.07.010; Gibson EL, 2012, BEHAV PHARMACOL, V23, P442, DOI 10.1097/FBP.0b013e328357bd4e; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Guitart-Masip M, 2012, NEUROIMAGE, V62, P154, DOI 10.1016/j.neuroimage.2012.04.024; Gygax L, 2014, ANIM BEHAV, V95, P59, DOI 10.1016/j.anbehav.2014.06.013; Hales CA, 2014, BRIT J PHARMACOL, V171, P4524, DOI 10.1111/bph.12603; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hernandez CE, 2015, APPL ANIM BEHAV SCI, V163, P135, DOI 10.1016/j.applanim.2014.12.002; Huys QJM, 2015, ANNU REV NEUROSCI, V38, P1, DOI 10.1146/annurev-neuro-071714-033928; Huys QJM, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-12; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; Iigaya K, 2016, ELIFE, V5, DOI 10.7554/eLife.13747; ISEN AM, 1984, J PERS SOC PSYCHOL, V47, P1206, DOI 10.1037/0022-3514.47.6.1206; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Nesse RM, 2000, ARCH GEN PSYCHIAT, V57, P14, DOI 10.1001/archpsyc.57.1.14; Nettle D, 2012, CURR BIOL, V22, pR712, DOI 10.1016/j.cub.2012.06.020; Nygren TE, 1996, ORGAN BEHAV HUM DEC, V66, P59, DOI 10.1006/obhd.1996.0038; Papciak J, 2013, BEHAV BRAIN RES, V256, P305, DOI 10.1016/j.bbr.2013.08.036; Paul ES, 2011, EVOL HUM BEHAV, V32, P21, DOI 10.1016/j.evolhumbehav.2010.07.005; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; Schick A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00272; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Van der Horst JE, 2007, ANIM WELFARE, V16, P67; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whiteley L, 2008, J VISION, V8, DOI 10.1167/8.3.2; Willner P, 1998, PSYCHOPHARMACOLOGY, V136, P272, DOI 10.1007/s002130050566; Zhang X, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00689	49	18	18	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165840	10.1371/journal.pone.0165840	http://dx.doi.org/10.1371/journal.pone.0165840			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829041	gold, Green Submitted, Green Published			2022-12-27	WOS:000387724300063
J	Li, NL; Yu, BL; Hung, CF				Li, Nai-Liang; Yu, Ben-Long; Hung, Chen-Fang			Paravertebral Block Plus Thoracic Wall Block versus Paravertebral Block Alone for Analgesia of Modified Radical Mastectomy: A Retrospective Cohort Study	PLOS ONE			English	Article							BREAST-CANCER SURGERY; BRACHIAL-PLEXUS BLOCK; GENERAL-ANESTHESIA; POSTOPERATIVE NAUSEA; EPIDURAL ANALGESIA; SURGICAL ANATOMY; LEVOBUPIVACAINE; RECONSTRUCTION; ROPIVACAINE; SUFENTANIL	Background and Objectives Paravertebral block placement was the main anesthetic technique for modified radical mastectomy in our hospital until February 2014, when its combination with blocks targeting the pectoral musculature was initiated. We compared the analgesic effects of paravertebral blocks with or without blocks targeting the pectoral musculature for modified radical mastectomy. Methods We retrospectively collected data from a single surgeon and anesthesiologist from June 1, 2012, to May 31, 2015. lntraoperative sedatives and analgesic requirements, time to the first analgesic request, postoperative analgesic doses, patient satisfaction, and complications were compared. Results Fifty-four patients received a paravertebral block alone (PECS 0), and 46 received a paravertebral block combined with blocks targeting the pectoral musculature (PECS 1). The highest intraoperative effect site concentration of propofol was significantly lower in the PECS 1 group than in the PECS 0 group [2.3 (1.5, 2.8) vs 2.5 (1.5, 4) mu g/mL, p = 0.0014]. The intraoperative rescue analgesic dose was significantly lower in the PECS 1 group [0 (0, 25) vs 0 (0, 75) mg of ketamine, p = 0.0384]. Furthermore, the PECS 1 group had a significantly longer time to the first analgesic request [636.5 (15, 720) vs 182.5 (14, 720) min, p = 0.0001]. After further adjustment for age, body mass index, American Society of Anesthesiologists Physical Status classification, chronic pain history, incidence of a superficial cervical plexus block placement, and operation duration, blocks targeting the pectoral musculature were determined to be the only significant factor (hazard ratio, 0.36; 95% confidence interval, 0.23-0.58; p < 0.0001). Very few patients used potent analgesics including morphine and ketorolac; the cumulative use of morphine or ketorolac was similar in the study groups. However, the incidence of all analgesic use, namely morphine, ketorolac, acetaminophen, and celecoxib, was significantly lower in the PECS 1 group [3.5 (0, 6) vs 5 (0, 12), p < 0.0001]. Conclusions Compared with the placement of a paravertebral block alone, combining blocks targeting the pectoral musculature with a paravertebral block for modified radical mastectomy reduced the sedative and analgesic requirements during operation and provided more effective postoperative analgesia.	[Li, Nai-Liang] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Anesthesiol, Taipei, Taiwan; [Yu, Ben-Long] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Surg, Taipei, Taiwan; [Hung, Chen-Fang] Koo Fdn, Sun Yat Sen Canc Ctr, Off Clin Res, Biostat Sect, Taipei, Taiwan		Li, NL (corresponding author), Koo Fdn, Sun Yat Sen Canc Ctr, Dept Anesthesiol, Taipei, Taiwan.	lnl@kfsyscc.org						Aiyama S, 1973, Kaibogaku Zasshi, V48, P179; Apfel CC, 1999, ANESTHESIOLOGY, V91, P693, DOI 10.1097/00000542-199909000-00022; Blanco R, 2012, REV ESP ANEST REANIM, V59, P470, DOI 10.1016/j.redar.2012.07.003; Blanco R, 2011, ANAESTHESIA, V66, P847, DOI 10.1111/j.1365-2044.2011.06838.x; Burlacu CL, 2006, ANAESTHESIA, V61, P932, DOI 10.1111/j.1365-2044.2006.04793.x; Channabasappa Shivakumar M, 2016, Anesth Essays Res, V10, P77, DOI 10.4103/0259-1162.167844; CHERNIK DA, 1990, J CLIN PSYCHOPHARM, V10, P244; De Cosmo G, 2007, ANAESTHESIA, V62, P994, DOI 10.1111/j.1365-2044.2007.05184.x; De Cosmo G, 2008, EUR J ANAESTH, V25, P1020, DOI 10.1017/S0265021508004638; De Cosmo G, 2009, MINERVA ANESTESIOL, V75, P393; Desroches J, 2013, CLIN ANAT, V26, P49, DOI 10.1002/ca.22117; Erdogmus S, 2004, NEUROANATOMY, V3, P2; Gan TJ, 2003, ANESTH ANALG, V97, P62, DOI 10.1213/01.ANE.0000068580.00245.95; Gautier P, 2011, ANESTH ANALG, V113, P951, DOI 10.1213/ANE.0b013e31822b876f; Guay J, 2011, CLIN ANAT, V24, P202, DOI 10.1002/ca.21085; Herring AA, 2012, AM J EMERG MED, V30, P1263, DOI 10.1016/j.ajem.2011.06.023; Kairaluoma PM, 2004, ANESTH ANALG, V99, P1837, DOI 10.1213/01.ANE.0000136775.15566.87; Layeeque R, 2004, ANN SURG, V240, P608, DOI 10.1097/01.sla.000014156.56314.lf; Li Nai-Liang, 2011, Acta Anaesthesiol Taiwan, V49, P91, DOI 10.1016/j.aat.2011.08.006; Lou FF, 2016, PLAST RECONSTR SURG, V137, p502E, DOI 10.1097/01.prs.0000479933.75887.82; Loukas M, 2006, CLIN ANAT, V19, P685, DOI 10.1002/ca.20315; Macéa José Rafael, 2006, Int. J. Morphol., V24, P691, DOI 10.4067/S0717-95022006000500030; Moller JF, 2007, ANESTH ANALG, V105, P1848, DOI 10.1213/01.ane.0000286135.21333.fd; MOORE DC, 1951, JAMA-J AM MED ASSOC, V146, P803, DOI 10.1001/jama.1951.03670090035011; Naja MZ, 2003, EUR J ANAESTH, V20, P897, DOI 10.1097/00003643-200311000-00007; Naja ZM, 2006, REGION ANESTH PAIN M, V31, P196, DOI 10.1016/j.rapm.2005.12.004; Najarian MM, 2003, AM SURGEON, V69, P213; Porzionato A, 2012, CLIN ANAT, V25, P559, DOI 10.1002/ca.21301; Prakash KG, 2014, J CLIN DIAGN RES, V8, pAC1, DOI 10.7860/JCDR/2014/8631.4545; Renes SH, 2010, REGION ANESTH PAIN M, V35, P212, DOI 10.1097/AAP.0b013e3181c75a8b; Riazi S, 2008, BRIT J ANAESTH, V101, P549, DOI 10.1093/bja/aen229; Sarhadi NS, 1997, CLIN ANAT, V10, P283, DOI 10.1002/(SICI)1098-2353(1997)10:4<283::AID-CA12>3.0.CO;2-G; Sopena-Zubiria LA, 2012, REV ESP ANEST REANIM, V59, P12, DOI 10.1016/j.redar.2011.10.001; Vilhegas S, 2015, VET REC, V177, DOI 10.1136/vr.102993; Wahba SS, 2014, EGYPT J ANAESTH, V30, P129, DOI 10.1016/j.egja.2013.10.006; Wheatley RG, 2001, BRIT J ANAESTH, V87, P47, DOI 10.1093/bja/87.1.47; Zin T, 2012, ECANCERMEDICALSCIENC, V6, DOI 10.3332/ecancer.2012.255	37	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166227	10.1371/journal.pone.0166227	http://dx.doi.org/10.1371/journal.pone.0166227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829018	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300096
J	Padder, BA; Kamfwa, K; Awale, HE; Kelly, JD				Padder, Bilal A.; Kamfwa, Kelvin; Awale, Halima E.; Kelly, James D.			Transcriptome Profiling of the Phaseolus vulgaris - Colletotrichum lindemuthianum Pathosystem	PLOS ONE			English	Article							WESTERN HIMALAYAN REGION; ANTHRACNOSE RESISTANCE; MOLECULAR DIVERSITY; GENE-EXPRESSION; BZIP PROTEIN; NEMATODE RESISTANCE; DEFENSE RESPONSES; BASAL RESISTANCE; HIMACHAL-PRADESH; CO-4 LOCUS	Bean (Phaseolus vulgaris) anthracnose caused by the hemi-biotrophic pathogen Colletotrichum lindemuthianum is a major factor limiting production worldwide. Although sources of resistance have been identified and characterized, the early molecular events in the host-pathogen interface have not been investigated. In the current study, we conducted a comprehensive transcriptome analysis using Illumina sequencing of two near isogenic lines (NILs) differing for the presence of the Co-1 gene on chromosome Pv01 during a time course following infection with race 73 of C. lindemuthianum. From this, we identified 3,250 significantly differentially expressed genes (DEGs) within and between the NILs over the time course of infection. During the biotrophic phase the majority of DEGs were up regulated in the susceptible NIL, whereas more DEGs were up-regulated in the resistant NIL during the necrotrophic phase. Various defense related genes, such as those encoding PR proteins, peroxidases, lipoxygenases were up regulated in the resistant NIL. Conversely, genes encoding sugar transporters were up-regulated in the susceptible NIL during the later stages of infection. Additionally, numerous transcription factors (TFs) and candidate genes within the vicinity of the Co-1 locus were differentially expressed, suggesting a global reprogramming of gene expression in and around the Co-1 locus. Through this analysis, we reduced the previous number of candidate genes reported at the Co-1 locus from eight to three. These results suggest the dynamic nature of P. vulgaris-C. lindemuthianum interaction at the transcriptomic level and reflect the role of both pathogen and effector triggered immunity on changes in plant gene expression.	[Padder, Bilal A.; Kamfwa, Kelvin; Awale, Halima E.; Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA; [Padder, Bilal A.] Sher E Kashmir Univ Agr Sci & Technol Kashmir, Srinagar 190025, Jammu & Kashmir, India; [Kamfwa, Kelvin] Univ Zambia, Sch Agr Sci, Dept Plant Sci, POB 32379,Great East Rd, Lusaka, Zambia	Michigan State University; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); University of Zambia	Kelly, JD (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA.	kellyj@msu.edu		Padder, Bilal A/0000-0001-8842-2432	MSU AgBioResearch Project GREEEN [GR15-015]; University Grants Commission, India	MSU AgBioResearch Project GREEEN; University Grants Commission, India(University Grants Commission, India)	Research was supported by MSU AgBioResearch Project GREEEN Proposal #GR15-015, with financial support acknowledged from the University Grants Commission, India for providing RAMAN Fellowship to BAP.	AFANADOR LK, 1994, THEOR APPL GENET, V88, P337, DOI 10.1007/BF00223642; Albani D, 1997, PLANT CELL, V9, P171, DOI 10.1105/tpc.9.2.171; Alkan N, 2015, NEW PHYTOL, V205, P801, DOI 10.1111/nph.13087; Alves MS, 2015, FUNCT INTEGR GENOMIC, V15, P685, DOI 10.1007/s10142-015-0445-0; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Borges A, 2012, J PLANT PHYSIOL, V169, P1216, DOI 10.1016/j.jplph.2012.04.003; Brown SH, 2008, MOL PLANT PATHOL, V9, P171, DOI 10.1111/J.1364-3703.2007.00454.X; Burkhardt A, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0069; Burt AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139450; Cai DG, 1997, SCIENCE, V275, P832, DOI 10.1126/science.275.5301.832; Camehl I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002051; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Casado-Diaz A, 2006, PHYSIOL PLANTARUM, V128, P633, DOI 10.1111/j.1399-3054.2006.00798.x; Chern MS, 1996, PLANT J, V10, P135, DOI 10.1046/j.1365-313X.1996.10010135.x; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; Denance N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00155; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Dongfang YF, 2008, CAN J PLANT SCI, V88, P771, DOI 10.4141/CJPS07145; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dufresne M, 2000, PLANT CELL, V12, P1579, DOI 10.1105/tpc.12.9.1579; Fernandez MT, 2000, EUPHYTICA, V114, P143, DOI 10.1023/A:1003937812700; Ferreira JJ, TRANSLATIONAL GENOMI, VI, P151; FOUILLOUX G, 1976, ANN AMELIOR PLANT, V26, P443; Fountain JC, 2015, PHYSIOL MOL PLANT P, V89, P31, DOI 10.1016/j.pmpp.2014.11.005; Fraire-Velazquez S, 2003, PHYSIOL MOL PLANT P, V63, P79, DOI 10.1016/j.pmpp.2003.10.004; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Garcia AV, 2012, CELL MOL LIFE SCI, V69, P3259, DOI 10.1007/s00018-012-1093-3; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Goodwin PH, 2004, PLANT SCI, V167, P481, DOI 10.1016/j.plantsci.2004.04.014; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Herbert C, 2004, FUNGAL GENET BIOL, V41, P140, DOI 10.1016/j.fgb.2003.09.008; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; KELLY JD, 1994, PLANT DIS, V78, P892, DOI 10.1094/PD-78-0892; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kelly JD, 2001, CROP SCI, V41, P1647, DOI 10.2135/cropsci2001.4151647x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kim KC, 2006, PLANT PHYSIOL, V142, P1180, DOI 10.1104/pp.106.082487; Kim KH, 2004, PHYTOPATHOLOGY, V94, P1295, DOI 10.1094/PHYTO.2004.94.12.1295; Li Chun-Yu, 2012, BMC Genomics, V13, P374, DOI 10.1186/1471-2164-13-374; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lingner U, 2011, J BIOL CHEM, V286, P20913, DOI 10.1074/jbc.M110.213678; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe RGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103098; Ludwig N, 2014, MOL PLANT MICROBE IN, V27, P315, DOI 10.1094/MPMI-09-13-0267-R; Mahuku GS, 2004, EUR J PLANT PATHOL, V110, P253, DOI 10.1023/B:EJPP.0000019795.18984.74; Mahuku GS, 2002, PLANT DIS, V86, P1383, DOI 10.1094/PDIS.2002.86.12.1383; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsui H, 2010, PLANT CELL PHYSIOL, V51, P1731, DOI 10.1093/pcp/pcq132; Melotto M, 2001, THEOR APPL GENET, V103, P508, DOI 10.1007/s001220100609; MENEZES JR, 1988, PHYTOPATHOLOGY, V78, P650, DOI 10.1094/Phyto-78-650; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; Miles TD, 2011, MOL PLANT PATHOL, V12, P463, DOI 10.1111/j.1364-3703.2010.00687.x; Muencha S, 2008, J PLANT PHYSIOL, V165, P41, DOI 10.1016/j.jplph.2007.06.008; Nakagawa H, 1996, PLANT J, V9, P217, DOI 10.1046/j.1365-313X.1996.09020217.x; Oblessuc PR, 2015, THEOR APPL GENET, V128, P1193, DOI 10.1007/s00122-015-2500-6; Oblessuc PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043161; Padder BA, 2007, PHYSIOL MOL PLANT P, V70, P8, DOI 10.1016/j.pmpp.2007.05.003; Padder BA, 2008, APPL BIOL RES, V10, P6; Padder B. A., 2009, Archives of Phytopathology and Plant Protection, V42, P610, DOI 10.1080/03235400701287305; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; PASTORCORRALES MA, 1995, PLANT DIS, V79, P63, DOI 10.1094/PD-79-0063; Pathania A, 2006, EUPHYTICA, V149, P97, DOI 10.1007/s10681-005-9057-4; Pereira MF, 2013, J MICROBIOL, V51, P70, DOI 10.1007/s12275-013-2393-5; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Prusky D, 2000, COLLETOTRICHUM, P232; Que YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106476; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; SHAO FM, 1985, TROP PEST MANAGE, V31, P60, DOI 10.1080/09670878509370947; Sharma PN, 2007, AUSTRALAS PLANT PATH, V36, P191, DOI 10.1071/AP07013; Sharma P. N., 2008, Indian Phytopathology, V61, P323; Sharma PN, 1999, J PHYTOPATHOL, V147, P41, DOI 10.1046/j.1439-0434.1999.147001041.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Thurau T, 2003, PLANT MOL BIOL, V52, P643, DOI 10.1023/A:1024887516581; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Ooijen G, 2010, PLANT J, V63, P563, DOI 10.1111/j.1365-313X.2010.04260.x; Vazin MA, 2014, ANN REPT BEAN IMPROV, V57, P161; Vos P, 1998, NAT BIOTECHNOL, V16, P1365, DOI 10.1038/4350; Wang N., 2016, PLANT GENE, V5, P22, DOI [10.1016/j.plgene.2015.11.003, DOI 10.1016/J.PLGENE.2015.11.003]; WIJESUNDERA RLC, 1989, PHYSIOL MOL PLANT P, V34, P403, DOI 10.1016/0885-5765(89)90067-2; Yin YH, 1997, EMBO J, V16, P5247, DOI 10.1093/emboj/16.17.5247; Zhuang XF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-668; Zuiderveen GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156391	99	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165823	10.1371/journal.pone.0165823	http://dx.doi.org/10.1371/journal.pone.0165823			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829044	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300062
J	Yamauchi, H; Bando, M; Baba, T; Kataoka, K; Yamada, Y; Yamamoto, H; Miyamoto, A; Ikushima, S; Johkoh, T; Sakai, F; Terasaki, Y; Hebisawa, A; Kawabata, Y; Sugiyama, Y; Ogura, T				Yamauchi, Hiroyoshi; Bando, Masashi; Baba, Tomohisa; Kataoka, Kensuke; Yamada, Yoshihito; Yamamoto, Hiroshi; Miyamoto, Atsushi; Ikushima, Soichiro; Johkoh, Takeshi; Sakai, Fumikazu; Terasaki, Yasuhiro; Hebisawa, Akira; Kawabata, Yoshinori; Sugiyama, Yukihiko; Ogura, Takashi			Clinical Course and Changes in High Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis without Honeycombing	PLOS ONE			English	Article							NONSPECIFIC INTERSTITIAL PNEUMONIA; CT FINDINGS; CLASSIFICATION; DIAGNOSIS; SOCIETY; DISEASE; PATTERN	Some patients with idiopathic pulmonary fibrosis (IPF) do not have honeycombing on high resolution computed tomography (HRCT) at their initial evaluation. The clinical course and sequential changes in HRCT findings in these patients are not fully understood. We reviewed the cases of 43 patients with IPF without honeycombing on initial HRCT from institutions throughout Japan. All patients were diagnosed with IPF based on a surgical lung biopsy. Multidisciplinary discussions were held five times between 2011 and 2014, to exclude alternative etiologies. We evaluated the sequential changes in HRCT findings in 30 patients with IPF. We classified these 30 patients into three groups based on their HRCT patterns and clarified the clinical characteristics and prognosis among the groups. The patterns of all 30 patients on initial HRCT corresponded to a possible usual interstitial pneumonia (UIP) pattern which was described in the 2011 International Statement. On long-term follow-up (71.0 +/- 38.7 standard deviation [SD] months), honeycombing was seen in 16 patients (53%, the HoneyCo group); traction bronchiectasis or cysts without honeycombing was observed in 12 patients (40%, the NoHoneyCo group), and two patients showed no interval change (7%, the NoChange group) on HRCT. The mean survival periods of the HoneyCo and NoHoneyCo groups were 67.1 and 61.2 months, respectively (p = 0.76). There are some patients with IPF whose conditions chronically progress without honeycombing on HRCT. The appearance of honeycombing on HRCT during the follow-up might not be related to prognosis.	[Yamauchi, Hiroyoshi; Bando, Masashi; Sugiyama, Yukihiko] Jichi Med Univ, Dept Med, Shimotsuke, Tochigi, Japan; [Baba, Tomohisa; Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan; [Kataoka, Kensuke] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi, Japan; [Yamada, Yoshihito] East Japan Railway Co, JR Tokyo Gen Hosp, Dept Resp Med, Tokyo, Japan; [Yamamoto, Hiroshi] Shinshu Univ, Sch Med, Dept Internal Med 1, Nagano, Japan; [Miyamoto, Atsushi] Toranomon Gen Hosp, Dept Resp Med, Tokyo, Japan; [Ikushima, Soichiro] Japanese Red Cross Med Ctr, Dept Resp Med, Tokyo, Japan; [Johkoh, Takeshi] Mutual Aid Assoc Publ Sch Teachers, Kinki Cent Hosp, Dept Radiol, Itami, Hyogo, Japan; [Sakai, Fumikazu] Saitama Med Univ, Dept Diagnost Radiol, Int Med Ctr, Moroyama, Saitama, Japan; [Terasaki, Yasuhiro] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo, Japan; [Hebisawa, Akira] Natl Hosp Org, Dept Clin Res, Tokyo Natl Hosp, Tokyo, Japan; [Kawabata, Yoshinori] Saitama Prefectural Cardiovasc & Resp Ctr, Div Diagnost Pathol, Kumagaya, Saitama, Japan	Jichi Medical University; Kanagawa Cardiovascular & Respiratory Center; Tosei General Hospital; Shinshu University; Toranomon Hospital; Japanese Red Cross Medical Center; University of Tokyo; Saitama Medical University; Nippon Medical School	Bando, M (corresponding author), Jichi Med Univ, Dept Med, Shimotsuke, Tochigi, Japan.	bando034@jichi.ac.jp		Terasaki, Yasuhiro/0000-0003-4495-7982				Akira M, 2011, THORAX, V66, P61, DOI 10.1136/thx.2010.140574; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Bando M, 2015, RESPIR INVESTIG, V53, P51, DOI 10.1016/j.resinv.2014.11.001; Battista Giuseppe, 2003, Radiol Med, V105, P2; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Flaherty KR, 2002, EUR RESPIR J, V19, P275, DOI 10.1183/09031936.02.00182002; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Lee HY, 2012, AM J ROENTGENOL, V199, P982, DOI 10.2214/AJR.11.8192; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; RAGHU G, 1987, CHEST, V92, P148, DOI 10.1378/chest.92.1.148; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2014, LANCET RESP MED, V2, P277, DOI 10.1016/S2213-2600(14)70011-6; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Schettino IAL, 2002, PATHOL RES PRACT, V198, P347, DOI 10.1078/0344-0338-00265; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Silva CIS, 2008, RADIOLOGY, V247, P251, DOI 10.1148/radiol.2471070369; Sumikawa H, 2014, RADIOLOGY, V272, P549, DOI 10.1148/radiol.14130853; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tristan JH, 2015, RESP INVESTIG, V53, P88; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309	22	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166168	10.1371/journal.pone.0166168	http://dx.doi.org/10.1371/journal.pone.0166168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829068	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300093
J	Aberg, KC; Doell, KC; Schwartz, S				Aberg, Kristoffer Carl; Doell, Kimberly C.; Schwartz, Sophie			Linking Individual Learning Styles to Approach-Avoidance Motivational Traits and Computational Aspects of Reinforcement Learning	PLOS ONE			English	Article							REWARD QUESTIONNAIRE SPSRQ; DECISION-MAKING; BEHAVIORAL ACTIVATION; PREDICTION ERRORS; SENSITIVITY; DOPAMINE; PUNISHMENT; ANXIETY; PERSONALITY; SCALES	Learning how to gain rewards (approach learning) and avoid punishments (avoidance learning) is fundamental for everyday life. While individual differences in approach and avoidance learning styles have been related to genetics and aging, the contribution of personality factors, such as traits, remains undetermined. Moreover, little is known about the computational mechanisms mediating differences in learning styles. Here, we used a probabilistic selection task with positive and negative feedbacks, in combination with computational modelling, to show that individuals displaying better approach (vs. avoidance) learning scored higher on measures of approach (vs. avoidance) trait motivation, but, paradoxically, also displayed reduced learning speed following positive (vs. negative) outcomes. These data suggest that learning different types of information depend on associated reward values and internal motivational drives, possibly determined by personality traits.	[Aberg, Kristoffer Carl; Doell, Kimberly C.; Schwartz, Sophie] Univ Geneva, Fac Med, Dept Neurosci, Geneva, Switzerland; [Aberg, Kristoffer Carl; Doell, Kimberly C.; Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Aberg, Kristoffer Carl; Doell, Kimberly C.; Schwartz, Sophie] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Aberg, KC (corresponding author), Univ Geneva, Fac Med, Dept Neurosci, Geneva, Switzerland.; Aberg, KC (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.; Aberg, KC (corresponding author), Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland.	kc.aberg@gmail.com	Doell, Kim/AAF-4852-2021	Doell, Kim/0000-0002-0043-9609; Schwartz, Sophie/0000-0001-7718-4053	Swiss National Science Foundation [320030_135653, 320030-159862, 51NF40-104897]; Swiss Center for Affective Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Center for Affective Sciences	This work was supported by the Swiss National Science Foundation (grant numbers: 320030_135653, 320030-159862, and 51NF40-104897) awarded to SS, and by the Swiss Center for Affective Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2015, J NEUROSCI, V35, P14491, DOI 10.1523/JNEUROSCI.1859-15.2015; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Aupperle Robin L, 2010, Dialogues Clin Neurosci, V12, P517; Baker TE, 2013, COGN AFFECT BEHAV NE, V13, P417, DOI 10.3758/s13415-013-0164-8; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Browning M, 2015, NAT NEUROSCI, V18, P590, DOI 10.1038/nn.3961; Caci H, 2007, PERS INDIV DIFFER, V42, P987, DOI 10.1016/j.paid.2006.09.008; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Caseras X, 2003, PERS INDIV DIFFER, V34, P999, DOI 10.1016/S0191-8869(02)00084-3; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; Cox SML, 2015, NEUROIMAGE, V109, P95, DOI 10.1016/j.neuroimage.2014.12.070; Frank MJ, 2008, PSYCHOL AGING, V23, P392, DOI 10.1037/0882-7974.23.2.392; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; Indovina I, 2011, NEURON, V69, P563, DOI 10.1016/j.neuron.2010.12.034; Itzhak Y, 2014, IUBMB LIFE, V66, P559, DOI 10.1002/iub.1310; Kim SH, 2015, SOC COGN AFFECT NEUR, V10, P1219, DOI 10.1093/scan/nsv007; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lardi C, 2008, PERS INDIV DIFFER, V45, P722, DOI 10.1016/j.paid.2008.07.019; Maia TV, 2011, NAT NEUROSCI, V14, P154, DOI 10.1038/nn.2723; Maril S, 2013, NEUROPSYCHOLOGICA, P818; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Olsson A, 2013, EMOTION, V13, P616, DOI 10.1037/a0033150; Palminteri S, 2012, BIOL PSYCHIAT, V72, P244, DOI 10.1016/j.biopsych.2011.12.028; Paulus MP, 2012, TRENDS COGN SCI, V16, P476, DOI 10.1016/j.tics.2012.07.009; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Sharot T, 2011, NAT NEUROSCI, V14, P1475, DOI 10.1038/nn.2949; Smillie LD, 2005, PERS INDIV DIFFER, V38, P981, DOI 10.1016/j.paid.2004.09.013; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Stephens DN, 2010, ADDICT BIOL, V15, P145, DOI 10.1111/j.1369-1600.2009.00193.x; Tomer R, 2014, J COGNITIVE NEUROSCI, V26, P1039, DOI 10.1162/jocn_a_00544; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5	40	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166675	10.1371/journal.pone.0166675	http://dx.doi.org/10.1371/journal.pone.0166675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851807	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300077
J	Iwanowicz, DD; Vandergast, AG; Cornman, RS; Adams, CR; Kohn, JR; Fisher, RN; Brehme, CS				Iwanowicz, Deborah D.; Vandergast, Amy G.; Cornman, Robert S.; Adams, Cynthia R.; Kohn, Joshua R.; Fisher, Robert N.; Brehme, Cheryl S.			Metabarcoding of Fecal Samples to Determine Herbivore Diets: A Case Study of the Endangered Pacific Pocket Mouse	PLOS ONE			English	Article							FOOD; SELECTION; PREY; DNA; IDENTIFICATION; SEQUENCES; ALIGNMENT; ACCURACY; AMPLICON; RODENT	Understanding the diet of an endangered species illuminates the animal's ecology, habitat requirements, and conservation needs. However, direct observation of diet can be difficult, particularly for small, nocturnal animals such as the Pacific pocket mouse (Heteromyidae: Perognathus longimembris pacificus). Very little is known of the dietary habits of this federally endangered rodent, hindering management and restoration efforts. We used a metabarcoding approach to identify source plants in fecal samples (N = 52) from the three remaining populations known. The internal transcribed spacers (ITS) of the nuclear ribosomal loci were sequenced following the Illumina MiSeq amplicon strategy and processed reads were mapped to reference databases. We evaluated a range of threshold mapping criteria and found the best-performing setting generally recovered two distinct mock communities in proportions similar to expectation. We tested our method on captive animals fed a known diet and recovered almost all plant sources, but found substantial heterogeneity among fecal pellets collected from the same individual at the same time. Observed richness did not increase with pooling of pellets from the same individual. In field-collected samples, we identified 4-14 plant genera in individual samples and 74 genera overall, but over 50 percent of reads mapped to just six species in five genera. We simulated the effects of sequencing error, variable read length, and chimera formation to infer taxon-specific rates of misassignment for the local flora, which were generally low with some exceptions. Richness at the species and genus levels did not reach a clear asymptote, suggesting that diet breadth remained underestimated in the current pool of samples. Large numbers of scat samples are therefore needed to make inferences about diet and resource selection in future studies of the Pacific pocket mouse. We conclude that our minimally invasive method is promising for determining herbivore diets given a library of sequences from local plants.	[Iwanowicz, Deborah D.; Adams, Cynthia R.] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA; [Vandergast, Amy G.; Fisher, Robert N.; Brehme, Cheryl S.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA; [Cornman, Robert S.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Kohn, Joshua R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of California System; University of California San Diego	Iwanowicz, DD (corresponding author), US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA.	diwanowicz@usgs.gov	Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240; Adams, Cynthia/0000-0003-4383-530X; Brehme, Cheryl/0000-0001-8904-3354	Environmental Security Department, Resource Branch Management, Marine Corps Base Camp Pendleton, California - MIPR [M3320013MPFE026]; USGS Ecosystems Mission Area; USGS Wildlife Research Program; ResMed Incorporated; San Diego Barcode of Life; Hattie Ettinger Conservation Fund; Consulate of Canada in San Diego	Environmental Security Department, Resource Branch Management, Marine Corps Base Camp Pendleton, California - MIPR; USGS Ecosystems Mission Area; USGS Wildlife Research Program; ResMed Incorporated; San Diego Barcode of Life; Hattie Ettinger Conservation Fund; Consulate of Canada in San Diego	This work was funded by the Environmental Security Department, Resource Branch Management, Marine Corps Base Camp Pendleton, California - MIPR# M3320013MPFE026; USGS Ecosystems Mission Area; USGS Wildlife Research Program; ResMed Incorporated; San Diego Barcode of Life; Hattie Ettinger Conservation Fund; Consulate of Canada in San Diego.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ando H, 2013, ECOL EVOL, V3, P4057, DOI 10.1002/ece3.773; Angly Florent E, 2012, Nucleic Acids Res, V40, pe94, DOI 10.1093/nar/gks251; BAILEY VERNON, 1939, JOUR MAMMAL, V20, P325, DOI 10.2307/1374258; BARKER RD, 1986, AUST WILDLIFE RES, V13, P559; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; BELOVSKY GE, 1986, OECOLOGIA, V70, P35, DOI 10.1007/BF00377109; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Belovsky GE, 1984, P NATL ACAD SCI USA, V105, P1977; BERGERON JM, 1991, CAN J ZOOL, V69, P1496, DOI 10.1139/z91-209; Bloeker J. C. von., 1931, Journal of Mammalogy, V12, P369; Boyer S, 2013, PLOS ONE, V8; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Brehme CSS, 2014, PACIFIC POCKET MOUSE; Brehme CST, 2011, PACIFIC POCKET MOUSE; Calflora, 2016, INF WILD CAL PLANTS; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clarke K. R., 2001, CHANGES MARINE COMMU; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Cornman RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145365; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Deakin CT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRANK CL, 1988, PHYSIOL ZOOL, V61, P527, DOI 10.1086/physzool.61.6.30156161; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; Hammer O, 2001, PAST PALEONTOLOGICAL, V4; Heise W, 2015, BOT J LINN SOC, V177, P576, DOI 10.1111/boj.12261; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Kempel A, 2015, ECOLOGY, V96, P2923, DOI 10.1890/14-2125.1; Khanam S, 2016, INTEGR ZOOL, V11, P98, DOI 10.1111/1749-4877.12172; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latinne A, 2014, J CAVE KARST STUD, V76, P139, DOI 10.4311/2013LSC0100; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McArthur C, 2014, OECOLOGIA, V176, P677, DOI 10.1007/s00442-014-3076-6; McClenaghan B, 2015, ECOL EVOL, V5, P3046, DOI 10.1002/ece3.1585; MESERVE PL, 1976, J MAMMAL, V57, P300, DOI 10.2307/1379690; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; Minnich RA, 2008, CALIFORNIA'S FADING WILDFLOWERS: LOST LEGACY AND BIOLOGICAL INVASIONS, P1; Ostoja SM, 2013, OIKOS, V122, P563, DOI 10.1111/j.1600-0706.2012.19969.x; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; Purcell M, 2004, FISH B-NOAA, V102, P213; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; REICHMAN OJ, 1977, ECOLOGY, V58, P454, DOI 10.2307/1935622; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tollit DJ, 2003, MAR MAMMAL SCI, V19, P724, DOI 10.1111/j.1748-7692.2003.tb01127.x; USFWS, 2010, PAC POCK MOUS PER LO; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Williams DF, 1973, AM SOC MAMMAL; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	64	22	23	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165366	10.1371/journal.pone.0165366	http://dx.doi.org/10.1371/journal.pone.0165366			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851756	gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300014
J	Shi, XF; Yang, JC; Cui, XY; Huang, JS; Long, ZB; Zhou, YL; Liu, P; Tao, LL; Ruan, Z; Xiao, B; Zhang, W; Li, DY; Dai, KS; Mao, JH; Xi, XD				Shi, Xiaofeng; Yang, Jichun; Cui, Xiongying; Huang, Jiansong; Long, Zhangbiao; Zhou, Yulan; Liu, Ping; Tao, Lanlan; Ruan, Zheng; Xiao, Bing; Zhang, Wei; Li, Dongya; Dai, Kesheng; Mao, Jianhua; Xi, Xiaodong			Functional Effect of the Mutations Similar to the Cleavage during Platelet Activation at Integrin beta 3 Cytoplasmic Tail when Expressed in Mouse Platelets	PLOS ONE			English	Article							OUTSIDE-IN; INSIDE-OUT; CALPAIN CLEAVAGE; SIGNALING PATHWAY; BETA(3) SUBUNIT; CELL-ADHESION; SRC-KINASE; GPIIB-IIIA; ALPHA-IIB-BETA-3; DOMAIN	Previous studies in Chinese hamster ovary cells showed that truncational mutations of beta 3 at sites of F-754 and Y-759 mimicking calpain cleavage regulate integrin signaling. The roles of the sequence from F-754 to C-terminus and the conservative N-756 ITY759 motif in platelet function have yet to be elaborated. Mice expressing beta 3 with F-754 and Y-759 truncations, or NITY deletion (beta 3-Delta TNITYRGT, beta 3-Delta RGT, or beta 3-Delta NITY) were established through transplanting the homozygous beta 3-deficient mouse bone marrow cells infected by the GFP tagged MSCV MigR1 retroviral vector encoding different beta 3 mutants into lethally radiated wild-type mice. The platelets were harvested for soluble fibrinogen binding and platelet spreading on immobilized fibrinogen. Platelet adhesion on fibrinogen-and collagen-coated surface under flow was also tested to assess the ability of the platelets to resist hydrodynamic drag forces. Data showed a drastic inhibition of the beta 3-Delta TNITYRGT platelets to bind soluble fibrinogen and spread on immobilized fibrinogen in contrast to a partially impaired fibrinogen binding and an almost unaffected spreading exhibited in the beta 3-Delta NITY platelets. Behaviors of the beta 3-Delta RGT platelets were consistent with the previous observations in the beta 3-Delta RGT knock-in platelets. The adhesion impairment of platelets with the beta 3 mutants under flow was in different orders of magnitude shown as: beta 3-Delta TNITYRGT> beta 3-Delta RGT> beta 3-Delta NITY to fibrinogencoated surface, and beta 3-Delta TNITYRGT> beta 3-Delta NITY> beta 3-Delta RGT to collagen-coated surface. To evaluate the interaction of the beta 3 mutants with signaling molecules, GST pull-down and immunofluorescent assays were performed. Results showed that beta 3-Delta RGT interacted with kindlin but not c-Src, beta 3-Delta NITY interacted with c-Src but not kindlin, while beta 3-Delta TNITYRGT did not interact with both proteins. This study provided evidence in platelets at both static and flow conditions that the calpain cleavage-related sequences of integrin beta 3, i.e. T(755)NITYRGT(762), R(760)GT(762), and (NITY759)-I-756 participate in bidirectional, outside-in, and inside-out signaling, respectively and the association of c-Src or kindlin with beta 3 integrin may regulate these processes.	[Shi, Xiaofeng; Yang, Jichun; Cui, Xiongying; Huang, Jiansong; Long, Zhangbiao; Zhou, Yulan; Liu, Ping; Tao, Lanlan; Ruan, Zheng; Xiao, Bing; Zhang, Wei; Li, Dongya; Mao, Jianhua; Xi, Xiaodong] Shanghai Jiao Tong Univ, Sino French Res Ctr Life Sci & Genom, Collaborat Innovat Ctr Hematol, State Key Lab Med Genom,Sch Med,Ruijin Hosp,Shang, Shanghai 200025, Peoples R China; [Shi, Xiaofeng; Li, Dongya] Jiangsu Univ, Affiliated Hosp, Dept Hematol, Zhenjiang, Peoples R China; [Huang, Jiansong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol,Inst Hematol, Hangzhou, Zhejiang, Peoples R China; [Dai, Kesheng] Soochow Univ, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol, Affiliated Hosp 1,Minist Hlth, Suzhou 215006, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Jiangsu University; Zhejiang University; Soochow University - China	Mao, JH; Xi, XD (corresponding author), Shanghai Jiao Tong Univ, Sino French Res Ctr Life Sci & Genom, Collaborat Innovat Ctr Hematol, State Key Lab Med Genom,Sch Med,Ruijin Hosp,Shang, Shanghai 200025, Peoples R China.	maojianhua110@163.com; xixiaodong@shsmu.edu.cn	Stefanadis, Christodoulos/ABH-2232-2020; Huang, Jiansong/AAI-1682-2019; Mao, Jianhua/GOK-2713-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Huang, Jiansong/0000-0003-0821-2801	National Natural Science Foundation of China [81670127, 81270594]; Basic Research Program of China [2013CB966800, 2012CB518000]; Science and Technology Commission of Shanghai Municipality of China [16PJ1406100, 16ZR1421000]; Science and Technology Department of Jiangsu Province of China [SBK2015043674]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of China(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Department of Jiangsu Province of China	This work was supported by the research grants (grant number: 81670127 and 81270594, http://www.nsfc.gov.cn) from the National Natural Science Foundation of China, (grant number: 2013CB966800 and 2012CB518000, http://www.most.gov.cn/) from the National Basic Research Program of China to XX, (grant number: 16PJ1406100, 16ZR1421000, http://www.stcsm.gov.cn/) from the Science and Technology Commission of Shanghai Municipality of China to JM, and the research grant (grant number: SBK2015043674, http://www.jstd.gov.cn) from the Science and Technology Department of Jiangsu Province of China to XS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablooglu AJ, 2009, BLOOD, V113, P3585, DOI 10.1182/blood-2008-09-180687; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Basani RB, 2009, BLOOD, V113, P902, DOI 10.1182/blood-2008-09-177337; Benoit MR, 2010, APPL ENVIRON MICROB, V76, P4136, DOI 10.1128/AEM.03065-09; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Blue R, 2009, BLOOD, V114, P195, DOI 10.1182/blood-2008-08-169243; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Conant CG, 2010, J BIOMOL SCREEN, V15, P102, DOI 10.1177/1087057109353789; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Fan XM, 2014, BLOOD, V124, P2421, DOI 10.1182/blood-2014-03-557645; Fitzpatrick P, 2014, J BIOL CHEM, V289, P11183, DOI 10.1074/jbc.M113.535369; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; Giuliano S, 2003, BIOCHEM J, V372, P163, DOI 10.1042/BJ20020868; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huang JS, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0159-8; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Kroll MH, 1996, BLOOD, V88, P1525; Kuchay SM, 2012, J THROMB HAEMOST, V10, P1120, DOI 10.1111/j.1538-7836.2012.04715.x; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mao YX, 2009, EMBO J, V28, P1831, DOI 10.1038/emboj.2009.155; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Moskowitz KA, 1998, THROMB HAEMOSTASIS, V79, P824, DOI 10.1055/s-0037-1615072; Nesbitt WS, 2002, J BIOL CHEM, V277, P2965, DOI 10.1074/jbc.M110070200; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ohmori T, 2010, BIOCHEM BIOPH RES CO, V400, P323, DOI 10.1016/j.bbrc.2010.08.056; Passacquale G, 2011, BRIT J CLIN PHARMACO, V72, P604, DOI 10.1111/j.1365-2125.2011.03906.x; Patel S, 2012, CIRCULATION, V126, P1385, DOI 10.1161/CIRCULATIONAHA.112.105452; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; PIDARD D, 1986, BLOOD, V67, P604; Pouwels J, 2012, J CELL SCI, V125, P3271, DOI 10.1242/jcs.093641; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503; Tousoulis D, 2010, PHARMACOL THERAPEUT, V127, P108, DOI 10.1016/j.pharmthera.2010.05.001; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; Valera MC, 2012, BLOOD, V120, P1703, DOI 10.1182/blood-2012-01-405498; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	60	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166136	10.1371/journal.pone.0166136	http://dx.doi.org/10.1371/journal.pone.0166136			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851790	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300038
J	Zhang, L; Wang, LL; Tian, P; Tian, SY				Zhang, Lei; Wang, Linlin; Tian, Pu; Tian, Suyan			Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method	PLOS ONE			English	Article							MICROARRAY DATA; SET ENRICHMENT; EXPRESSION; SELECTION; CLASSIFICATION; NETWORK; TOOL	The focus of analyzing data from microarray experiments has shifted from the identification of associated individual genes to that of associated biological pathways or gene sets. In bioinformatics, a feature selection algorithm is usually used to cope with the high dimensionality of microarray data. In addition to those algorithms that use the biological information contained within a gene set as a priori to facilitate the process of feature selection, various gene set analysis methods can be applied directly or modified readily for the purpose of feature selection. Significance analysis of microarray to gene-set reduction analysis (SAM-GSR) algorithm, a novel direction of gene set analysis, is one of such methods. Here, we explore the feature selection property of SAM-GSR and provide a modification to better achieve the goal of feature selection. In a multiple sclerosis (MS) microarray data application, both SAM-GSR and our modification of SAM-GSR perform well. Our results show that SAM-GSR can carry out feature selection indeed, and modified SAM-GSR outperforms SAM-GSR. Given pathway information is far from completeness, a statistical method capable of constructing biologically meaningful gene networks is of interest. Consequently, both SAM-GSR algorithms will be continuously revaluated in our future work, and thus better characterized.	[Zhang, Lei; Wang, Linlin; Tian, Pu] Jilin Univ, Coll Life Sci, 2699 Qianjin St, Changchun 130012, Jilin, Peoples R China; [Zhang, Lei] Jilin Univ, Dept Neurol, Hosp 2, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China; [Tian, Suyan] Jilin Univ, Div Clin Res, Hosp 1, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Tian, P (corresponding author), Jilin Univ, Coll Life Sci, 2699 Qianjin St, Changchun 130012, Jilin, Peoples R China.; Tian, SY (corresponding author), Jilin Univ, Div Clin Res, Hosp 1, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China.	tianpu@jlu.edu.cn; stian@rockefeller.edu	Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542; Zhang, Lei/0000-0002-2414-0505; Wang, Linlin/0000-0002-2805-7514	Natural Science Foundation of China [31401123, 31270758]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (No 31401123 for ST and No 31270758 for PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker N, 2009, BIOINFORMATICS, V25, P1711, DOI 10.1093/bioinformatics/btp286; Boulesteix AL, 2010, BIOINFORMATICS, V26, P437, DOI 10.1093/bioinformatics/btp648; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fontoura P, 2010, RESULTS PROBL CELL D, V51, P259, DOI 10.1007/400_2010_36; FRIEDMAN JH, 2004, GRADIENT DIRECTED RE; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100052; Huang J, 2009, BIOMETRIKA, V96, P339, DOI 10.1093/biomet/asp020; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kemppinen AK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000053; Kim S, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-21; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Lauria M., 2013, SYSTEMS BIOMEDICINE, V1, P35; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lim K, 2014, BIOINFORMATICS, V30, P189, DOI 10.1093/bioinformatics/btt625; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Ma SG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-60; Ma SG, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-271; Ma SG, 2009, STAT INTERFACE, V2, P1; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-369; Meyer P, 2012, BIOINFORMATICS, V28, P1193, DOI 10.1093/bioinformatics/bts116; Mycko MP, 2003, BRAIN, V126, P1048, DOI 10.1093/brain/awg107; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajouri L, 2007, CURR GENOMICS, V8, P181, DOI 10.2174/138920207780833829; Tarca AL, 2013, SYST BIOMED, V1, P1; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tian SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078302; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsai CA, 2009, BIOINFORMATICS, V25, P897, DOI 10.1093/bioinformatics/btp098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Zhang HH, 2006, BIOINFORMATICS, V22, P88, DOI 10.1093/bioinformatics/bti736; Zhao C, 2013, SYST BIOMED, V1, P247	45	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165543	10.1371/journal.pone.0165543	http://dx.doi.org/10.1371/journal.pone.0165543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846233	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600013
J	Zhao, CJ; Wang, SG; Li, DY				Zhao, Chuanjun; Wang, Suge; Li, Deyu			Determining Fuzzy Membership for Sentiment Classification: A Three-Layer Sentiment Propagation Model	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; ALGORITHMS	Enormous quantities of review documents exist in forums, blogs, twitter accounts, and shopping web sites. Analysis of the sentiment information hidden in these review documents is very useful for consumers and manufacturers. The sentiment orientation and sentiment intensity of a review can be described in more detail by using a sentiment score than by using bipolar sentiment polarity. Existing methods for calculating review sentiment scores frequently use a sentiment lexicon or the locations of features in a sentence, a paragraph, and a document. In order to achieve more accurate sentiment scores of review documents, a three-layer sentiment propagation model (TLSPM) is proposed that uses three kinds of interrelations, those among documents, topics, and words. First, we use nine relationship pairwise matrices between documents, topics, and words. In TLSPM, we suppose that sentiment neighbors tend to have the same sentiment polarity and similar sentiment intensity in the sentiment propagation network. Then, we implement the sentiment propagation processes among the documents, topics, and words in turn. Finally, we can obtain the steady sentiment scores of documents by a continuous iteration process. Intuition might suggest that documents with strong sentiment intensity make larger contributions to classification than those with weak sentiment intensity. Therefore, we use the fuzzy membership of documents obtained by TLSPM as the weight of the text to train a fuzzy support vector machine model (FSVM). As compared with a support vector machine (SVM) and four other fuzzy membership determination methods, the results show that FSVM trained with TLSPM can enhance the effectiveness of sentiment classification. In addition, FSVM trained with TLSPM can reduce the mean square error (MSE) on seven sentiment rating prediction data sets.	[Zhao, Chuanjun; Wang, Suge; Li, Deyu] Shanxi Univ, Sch Comp & Informat Technol, Taiyuan 030006, Shanxi, Peoples R China; [Wang, Suge; Li, Deyu] Minist Educ, Key Lab Computat Intelligence & Chinese Informat, Taiyuan 030006, Shanxi, Peoples R China	Shanxi University	Wang, SG (corresponding author), Shanxi Univ, Sch Comp & Informat Technol, Taiyuan 030006, Shanxi, Peoples R China.; Wang, SG (corresponding author), Minist Educ, Key Lab Computat Intelligence & Chinese Informat, Taiyuan 030006, Shanxi, Peoples R China.	wsg@sxu.edu.cn		Wang, Suge/0000-0002-1553-2937; Li, Deyu/0000-0003-2489-9404	National High-tech R&D Program (863 Program) [2015AA011808]; National Natural Science Foundation of China [61573231, 61632011, 61272095, 61432011, U1435212, 61672331]; Shanxi Province Science and Technology Basic Platform Construction Project [2015091001-0102]; Shanxi Province Graduate Student Education Innovation Project [2016BY004]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011808] Funding Source: NIH RePORTER	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Province Science and Technology Basic Platform Construction Project; Shanxi Province Graduate Student Education Innovation Project; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by: the National High-tech R&D Program (863 Program) (2015AA011808), the URL is http://program.most.gov.cn/; the National Natural Science Foundation of China (61573231, 61632011, 61272095, 61432011, U1435212, 61672331), the URL is http://www.nsfagov.cn/; the Shanxi Province Science and Technology Basic Platform Construction Project (2015091001-0102), the URL is http://jctj.sxinfo.net/; and Shanxi Province Graduate Student Education Innovation Project (2016BY004), the URL is http://www.sxedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: the National High-tech R&D Program (863 Program) (2015AA011808), the URL is http://program.most.gov.cn/; the National Natural Science Foundation of China (61573231, 61632011, 61272095, 61432011, U1435212, 61672331), the URL is http://www.nsfc.gov.cn/; the Shanxi Province Science and Technology Basic Platform Construction Project (2015091001-0102), the URL is http://jctj.sxinfo.net/. Shanxi Province Graduate Student Education Innovation Project (2016BY004), the URL is ha://www.sxedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/715730; Austin D, 2006, AM MATH SOC FEATURE, V10, P1; Baccianella S., 2010, P 7 INT C LANG RES O, V10, P2200; Batuwita R, 2010, IEEE T FUZZY SYST, V18, P558, DOI 10.1109/TFUZZ.2010.2042721; Blitzer J., 2007, ANN M ASS COMP LING, P440, DOI DOI 10.1109/IRPS.2011.5784441; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Kanayama H., 2006, P 2006 C EMP METH NA, P355, DOI DOI 10.3115/1610075.1610125; Li FT, 2010, AAAI CONF ARTIF INTE, P1371; Li SS, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P414; Liang JG, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P63, DOI 10.1145/2740908.2742741; Lin CF, 2004, PATTERN RECOGN LETT, V25, P1647, DOI 10.1016/j.patrec.2004.06.009; Lin CH, 2012, IEEE T KNOWL DATA EN, V24, P1134, DOI 10.1109/TKDE.2011.48; Lin CJ, 2002, IEEE T NEURAL NETWOR, V13, P1045, DOI 10.1109/TNN.2002.1031937; Liu D, 2014, INT J APPROX REASON, V55, P197, DOI 10.1016/j.ijar.2013.02.013; Liu D, 2012, FUND INFORM, V115, P173, DOI 10.3233/FI-2012-648; Liu X, 2010, PHYSICA A, V389, P1493, DOI 10.1016/j.physa.2009.12.019; Liu Y, 2013, P 2013 INT WORKSH MI, P39; Long C., 2010, P 23 INT C COMP LING, P766; Mei Q., 2007, P 16 INT C WORLD WID, P171, DOI DOI 10.1145/1242572.1242596; Meng H, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS I-V, CONFERENCE PROCEEDINGS, P88, DOI 10.1109/ICMA.2007.4303521; Neagu DC, 2007, ATLA-ALTERN LAB ANIM, V35, P25, DOI 10.1177/026119290703500119; Novak PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144296; Ohana B., 2009, 9 IT T C, P13, DOI DOI 10.21427/D77S56; Pang Bo, 2005, CS0506075 ARXIV, P115, DOI DOI 10.3115/1219840.1219855; Qu L., 2010, P 23 INT C COMP LING, P913; Ramage D., 2009, P 2009 C EMP METH NA, V1, P248, DOI DOI 10.3115/1699510.1699543; Ranco G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138441; Shields MD, 2015, RELIAB ENG SYST SAFE, V142, P310, DOI 10.1016/j.ress.2015.05.023; Snyder Benjamin, 2007, P HUM LANG TECHN C N, P300; Tan S., 2009, P HUM LANG TECHN 200, P181; Tang D., 2015, PROC C EMPIRICAL MET, P1422, DOI DOI 10.18653/V1/D15-1167; Vo DT, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P1347; Wan X. J., 2009, P JOINT C 47 ANN M A, V1, P235, DOI DOI 10.3115/1687878.1687913; Wang H., 2011, P 17 ACM SIGKDD INT, P618, DOI DOI 10.1145/2020408.2020505; Wang H, 2010, P 16 ACM SIGKDD INT, P783, DOI DOI 10.1145/1835804.1835903; Wang SG, 2013, KNOWL-BASED SYST, V37, P451, DOI 10.1016/j.knosys.2012.09.003; Wang SG, 2011, EXPERT SYST APPL, V38, P8696, DOI 10.1016/j.eswa.2011.01.077; Ye Q, 2009, EXPERT SYST APPL, V36, P6527, DOI 10.1016/j.eswa.2008.07.035; You QZ, 2016, PROCEEDINGS OF THE NINTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'16), P13, DOI 10.1145/2835776.2835779; Yu H, 2016, KNOWL-BASED SYST, V91, P189, DOI 10.1016/j.knosys.2015.05.028; Yu H, 2014, INT J APPROX REASON, V55, P101, DOI 10.1016/j.ijar.2013.03.018; Yu ZW, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SMART CITY/SOCIALCOM/SUSTAINCOM (SMARTCITY), P339, DOI 10.1109/SmartCity.2015.94; Zhao CJ, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P1191, DOI 10.1109/ICDMW.2014.137; Zhou B, 2014, INT J APPROX REASON, V55, P211, DOI 10.1016/j.ijar.2013.04.006; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	48	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165560	10.1371/journal.pone.0165560	http://dx.doi.org/10.1371/journal.pone.0165560			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846225	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600014
J	Henke, PK; Park, YJ; Hans, S; Bove, P; Cuff, R; Kazmers, A; Schreiber, T; Gurm, HS; Grossman, PM				Henke, Peter K.; Park, Yeo Jung; Hans, Sachinder; Bove, Paul; Cuff, Robert; Kazmers, Andris; Schreiber, Theodore; Gurm, Hitinder S.; Grossman, P. Michael			The Association of Peri-Procedural Blood Transfusion with Morbidity and Mortality in Patients Undergoing Percutaneous Lower Extremity Vascular Interventions: Insights from BMC2 VIC	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINE; CELL TRANSFUSION; RISK-FACTOR; OUTCOMES; MULTICENTER; INFECTION; ANEMIA; SURGERY; IMPACT; BYPASS	Objective To determine the predictors of periprocedural blood transfusion and the association of transfusion on outcomes in high risk patients undergoing endoluminal percutaneous vascular interventions (PVI) for peripheral arterial disease. Methods/Results Between 2010-2014 at 47 hospitals participating in a statewide quality registry, 4.2% (n = 985) of 23,273 patients received a periprocedural blood transfusion. Transfusion rates varied from 0 to 15% amongst the hospitals in the registry. Using multiple logistic regression, factors associated with increased transfusion included female gender (OR = 1.9; 95% CI: 1.6-2.1), low creatinine clearance (1.3; 1.1-1.6), pre-procedural anemia (4.7; 3.9-5.7), family history of CAD (1.2; 1.1-1.5), CHF (1.4; 1.2-1.6), COPD (1.2; 1.1-1.4), CVD or TIA (1.2; 1.1-1.4), renal failure CRD (1.5; 1.2-1.9), pre-procedural heparin use (1.8; 1.4-2.3), warfarin use (1.2; 1.0-1.5), critical limb ischemia (1.7; 1.5-2.1), aorta-iliac procedure (1.9; 1.5-2.5), below knee procedure (1.3; 1.1-1.5), urgent procedure (1.7; 1.3-2.2), and emergent procedure (8.3; 5.6-12.4). Using inverse weighted propensity matching to adjust for confounders, transfusion was a significant risk factor for death (15.4; 7.5-31), MI (67; 29-150), TIA/stroke (24; 8-73) and ARF (19; 6.2-57). A focused QI program was associated with a 28% decrease in administration of blood transfusion (p = 0.001) over 4 years. Conclusion In a large statewide PVI registry, post procedure transfusion was highly correlated with a specific set of clinical risk factors, and with in-hospital major morbidity and mortality. However, using a focused QI program, a significant reduction in transfusion is possible.	[Henke, Peter K.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Park, Yeo Jung; Gurm, Hitinder S.; Grossman, P. Michael] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Hans, Sachinder] Henry Ford Malcomb Hosp, Wyndott, MI USA; [Bove, Paul] Beaumont Hlth Syst, Royal Oak, MI USA; [Cuff, Robert] Spectrum Hlth Syst, Grand Rapids, MI USA; [Kazmers, Andris] McLaren Northern Michigan Hlth Syst, Traverse City, MI USA; [Schreiber, Theodore] Detroit Med Ctr, Detroit, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Beaumont Health; Detroit Medical Center	Henke, PK (corresponding author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.	henke@umich.edu		Gurm, Hitinder/0000-0002-1646-0218	Blue Cross Blue Shield of Michigan (BCBSM); Blue Care Network (BCN)	Blue Cross Blue Shield of Michigan (BCBSM); Blue Care Network (BCN)	Financial support for the Blue Cross Blue Shield Cardiovascular Consortium is provided by Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN). BCBSM/BCN has not formally contributed to this manuscript or reviewed it prior to submission. We also greatly appreciate the assistance of Dr Scott Grey, biostatistical support.	Amin M, 2003, TRANSFUSION MED, V13, P275, DOI 10.1046/j.1365-3148.2003.00454.x; Ardati AK, 2012, CIRC-CARDIOVASC INTE, V5, P850, DOI 10.1161/CIRCINTERVENTIONS.112.975862; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Bertges DJ, 2010, J VASC SURG, V52, P674, DOI 10.1016/j.jvs.2010.03.031; Bilgin YM, 2010, CRIT CARE MED, V38, P546, DOI 10.1097/CCM.0b013e3181c0de7b; Bursi F, 2009, EUR J VASC ENDOVASC, V37, P311, DOI 10.1016/j.ejvs.2008.12.002; Bush RL, 1997, AM J SURG, V174, P143, DOI 10.1016/S0002-9610(97)00073-1; Carson JL, 2013, JAMA-J AM MED ASSOC, V309, P83, DOI 10.1001/jama.2012.50429; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Chang H, 2000, VOX SANG, V78, P13, DOI 10.1046/j.1423-0410.2000.7810013.x; Cote C., 2014, J THORACIC CARDIOVAS, P1; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Jani SM, 2007, CLIN CARDIOL, V30, P49, DOI 10.1002/clc.20236; Kadakia MB, 2015, JACC-CARDIOVASC INTE, V8, P1868, DOI 10.1016/j.jcin.2015.07.028; Kasapis C, 2010, CIRC-CARDIOVASC INTE, V3, P593, DOI 10.1161/CIRCINTERVENTIONS.110.957381; Klein HG, 1999, ANESTHESIOLOGY, V91, P861, DOI 10.1097/00000542-199909000-00040; Krishnamurthy V, 2014, VASC MED, V19, P491, DOI 10.1177/1358863X14552013; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Kuy S, 2014, ANN VASC SURG, V28, P53, DOI 10.1016/j.avsg.2013.08.002; LaPar DJ, 2013, J THORAC CARDIOV SUR, V145, P796, DOI 10.1016/j.jtcvs.2012.12.041; Madjdpour C, 2006, MINERVA ANESTESIOL, V72, P283; McKechnie RS, 2004, CIRCULATION, V110, P271, DOI 10.1161/01.CIR.0000134964.01697.C7; Mukherjee D, 2005, AM HEART J, V149, P1003, DOI 10.1016/j.ahj.2004.08.015; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; OPELZ G, 1973, TRANSPLANT P, V5, P253; Plaisance BR, 2011, JACC-CARDIOVASC INTE, V4, P694, DOI 10.1016/j.jcin.2011.03.012; Qaseem A, 2013, ANN INTERN MED, V159, P770, DOI 10.7326/0003-4819-159-11-201312030-00009; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Sherwood MW, 2014, JAMA-J AM MED ASSOC, V311, P836, DOI 10.1001/jama.2014.980; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tan TW, 2013, J AM COLL SURGEONS, V216, P1005, DOI 10.1016/j.jamcollsurg.2013.01.006; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Wu WT, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5730; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Wu WC, 2012, ANN SURG, V255, P708, DOI 10.1097/SLA.0b013e31824a55b9	38	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165796	10.1371/journal.pone.0165796	http://dx.doi.org/10.1371/journal.pone.0165796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835656	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200011
J	Pires-Neto, RC; Bernardi, FD; de Araujo, PA; Mauad, T; Dolhnikoff, M				Pires-Neto, Ruy Camargo; Bernardi, Fabiola Del Carlo; de Araujo, Priscila Alves; Mauad, Thais; Dolhnikoff, Marisa			The Expression of Water and Ion Channels in Diffuse Alveolar Damage Is Not Dependent on DAD Etiology	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; FLUID CLEARANCE; PULMONARY-EDEMA; K-ATPASE; AQUAPORINS; EPITHELIUM; RESOLUTION; RAT; NA	Introduction Aquaporins and ion channels are membrane proteins that facilitate the rapid movement of water and solutes across biological membranes. Experimental and in vitro studies reported that the function of these channels and pulmonary edema resolution are impaired in acute lung injury (ALI). Although current evidence indicates that alveolar fluid clearance is impaired in patients with ALI/diffuse alveolar damage (DAD), few human studies have addressed the alterations in pulmonary channels in this clinical condition. Additionally, it is not known whether the primary cause of DAD is a relevant variable for the channel dysfunction. Methods Autopsied lungs of 43 patients with acute respiratory failure (ARF) due to DAD of three different etiologies, non-pulmonary sepsis, H1N1 viral infection and leptospirosis, were compared to 18 normal lungs. We quantified the expression of aquaporin (AQP) 1, AQP3, AQP5, epithelial Na+ channel (ENaC) and sodium potassium ATPase (Na-K-ATPase) in the alveolar septum using immunohistochemistry and image analysis. Results The DAD group presented with increased expression of AQP3, AQP5 and Na-K-ATPase and decreased expression of ENaC compared to controls. However, there was no difference in protein expression within the DAD groups of different etiologies. Conclusion Water and ion channels are altered in patients with ARF due to DAD. The cause of DAD does not seem to influence the level of impairment of these channels.	[Pires-Neto, Ruy Camargo; Bernardi, Fabiola Del Carlo; de Araujo, Priscila Alves; Mauad, Thais; Dolhnikoff, Marisa] Univ Sao Paulo, Dept Patol, Fac Med, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Dolhnikoff, M (corresponding author), Univ Sao Paulo, Dept Patol, Fac Med, Sao Paulo, SP, Brazil.	maridol@usp.br	Dolhnikoff, Marisa/B-9019-2013	Dolhnikoff, Marisa/0000-0002-9073-9989	Laboratorio de Investigagao Mica (LIM) 05 da Faculdade de Medicina da Universidade de Sao Paulo (FMUSP); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPQ)	Laboratorio de Investigagao Mica (LIM) 05 da Faculdade de Medicina da Universidade de Sao Paulo (FMUSP); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Laboratorio de Investigagao Mica (LIM) 05 da Faculdade de Medicina da Universidade de Sao Paulo (FMUSP). Thais Mauad and Marisa Dolhnikoff are funded by Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; De Brito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071743; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Dolhnikoff M, 2007, CURR OPIN PULM MED, V13, P230, DOI 10.1097/MCP.0b013e3280f9df74; Hasan B, 2014, RESP PHYSIOL NEUROBI, V200, P40, DOI 10.1016/j.resp.2014.05.008; He J, 2015, EXP CELL RES, V331, P164, DOI 10.1016/j.yexcr.2014.09.024; Helenius Iiro T, 2010, Proc Am Thorac Soc, V7, P65, DOI 10.1513/pats.200907-082JS; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Jang AS, 2004, INTENS CARE MED, V30, P489, DOI 10.1007/s00134-003-2129-9; Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103; Katzenstein ALA., 2006, KATZENSTEIN ASKINS S, P446; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Liu Y, 2007, BIOPHYS CHEM, V131, P1, DOI 10.1016/j.bpc.2007.08.007; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Morales MMB, 2011, CRIT CARE, V15, DOI 10.1186/cc9401; Pires-Neto RC, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.05.013; Song YL, 2000, J PHYSIOL-LONDON, V525, P771, DOI 10.1111/j.1469-7793.2000.00771.x; Sun CY, 2014, J RADIAT RES, V55, P683, DOI 10.1093/jrr/rru008; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; Uhlig C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-56; Vadasz I, 2007, INTENS CARE MED, V33, P1243, DOI 10.1007/s00134-007-0661-8; Verkman AS, 2007, RESP PHYSIOL NEUROBI, V159, P324, DOI 10.1016/j.resp.2007.02.012; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; Zemans RL, 2004, CRIT CARE, V8, P469, DOI 10.1186/cc2906	27	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166184	10.1371/journal.pone.0166184	http://dx.doi.org/10.1371/journal.pone.0166184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835672	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200030
J	An, CI; Ichihashi, Y; Peng, J; Sinha, NR; Hagiwara, N				An, Chung-Il; Ichihashi, Yasunori; Peng, Jie; Sinha, Neelima R.; Hagiwara, Nobuko			Transcriptome Dynamics and Potential Roles of Sox6 in the Postnatal Heart	PLOS ONE			English	Article							FETAL GENE PROGRAM; IN-VIVO; CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE; HISTONE H3; CELL-DEATH; FIBER-TYPE; CYCLIN D1; MICE; GROWTH	The postnatal heart undergoes highly coordinated developmental processes culminating in the complex physiologic properties of the adult heart. The molecular mechanisms of postnatal heart development remain largely unexplored despite their important clinical implications. To gain an integrated view of the dynamic changes in gene expression during postnatal heart development at the organ level, time-series transcriptome analyses of the postnatal hearts of neonatal through adult mice (P1, P7, P14, P30, and P60) were performed using a newly developed bioinformatics pipeline. We identified functional gene clusters by principal component analysis with self-organizing map clustering which revealed organized, discrete gene expression patterns corresponding to biological functions associated with the neonatal, juvenile and adult stages of postnatal heart development. Using weighted gene co-expression network analysis with bootstrap inference for each of these functional gene clusters, highly robust hub genes were identified which likely play key roles in regulating expression of co-expressed, functionally linked genes. Additionally, motivated by the role of the transcription factor Sox6 in the functional maturation of skeletal muscle, the role of Sox6 in the postnatal maturation of cardiac muscle was investigated. Differentially expressed transcriptome analyses between Sox6 knockout (KO) and control hearts uncovered significant upregulation of genes involved in cell proliferation at postnatal day 7 (P7) in the Sox6 KO heart. This result was validated by detecting mitotically active cells in the P7 Sox6 KO heart. The current report provides a framework for the complex molecular processes of postnatal heart development, thus enabling systematic dissection of the developmental regression observed in the stressed and failing adult heart.	[An, Chung-Il; Hagiwara, Nobuko] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Ichihashi, Yasunori; Sinha, Neelima R.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Peng, Jie] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Ichihashi, Yasunori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Ichihashi, Yasunori] JST, PRESTO, Kawaguchi, Saitama, Japan	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; RIKEN; Japan Science & Technology Agency (JST)	An, CI; Hagiwara, N (corresponding author), Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA.; Ichihashi, Y (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.; Ichihashi, Y (corresponding author), RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan.; Ichihashi, Y (corresponding author), JST, PRESTO, Kawaguchi, Saitama, Japan.	can95616@gmail.com; yasunori.ichihashi@riken.jp; nhagiwara@ucdavis.edu	Ichihashi, Yasunori/D-1503-2017	Ichihashi, Yasunori/0000-0003-1935-4397	American Heart Association [063507N]; National Institutes of Health [AR055209]; National Science Foundation [IOS-0820854]; RIKEN Special Postdoctoral Researchers Program; Ministry of Education, Culture, Sports, Science and Technology, Japan [15K18589]; PRESTO, Japan Science and Technology Agency	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); RIKEN Special Postdoctoral Researchers Program; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by American Heart Association Scientist Development Grant (063507N to N.H.), the National Institutes of Health (AR055209 to N.H.), a National Science Foundation grant (IOS-0820854 to N.R.S. and J.P.), the RIKEN Special Postdoctoral Researchers Program (to Y.I.), Grant-in-Aid for Young Scientists (B; grant no. 15K18589) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Y.I.), and PRESTO, Japan Science and Technology Agency (to Y.I.).	Adams GN, 2013, BLOOD, V122, P1522, DOI 10.1182/blood-2012-10-460360; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; An CI, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-59; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Chen IY, 2006, J BIOL CHEM, V281, P19369, DOI 10.1074/jbc.M601443200; Chitwood DH, 2013, PLANT PHYSIOL, V162, P537, DOI 10.1104/pp.112.213546; Cohen-Barak O, 2003, NUCLEIC ACIDS RES, V31, P5941, DOI 10.1093/nar/gkg807; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; Dumitriu B, 2006, GENESIS, V44, P219, DOI 10.1002/dvg.20210; Dunning M., ILLUMINAMOUSEV2 DB I; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fernandez E, 2001, DEV DYNAM, V221, P302, DOI 10.1002/dvdy.1139; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Gan JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133288; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; Hagiwara N, 2007, DEV DYNAM, V236, P2062, DOI 10.1002/dvdy.21223; Hagiwara N, 2011, DEV DYNAM, V240, P1311, DOI 10.1002/dvdy.22639; Hamaguchi T, 2008, INT J ONCOL, V33, P725, DOI 10.3892/ijo_00000058; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hetheridge C, 2012, J CELL SCI, V125, P1420, DOI 10.1242/jcs.091066; Hew KW, 2003, BIRTH DEFECTS RES B, V68, P309, DOI 10.1002/bdrb.10034; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hsu SC, 2013, CARDIOVASC RES, V100, P222, DOI 10.1093/cvr/cvt190; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Huang ZQ, 2009, CELL PHYSIOL BIOCHEM, V24, P17, DOI 10.1159/000227809; Ichihashi Y, 2014, P NATL ACAD SCI USA, V111, pE2616, DOI 10.1073/pnas.1402835111; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Ishida T, 2003, J BIOL CHEM, V278, P34598, DOI 10.1074/jbc.M304890200; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kim MS, 2012, BBA-MOL CELL BIOL L, V1821, P800, DOI 10.1016/j.bbalip.2011.10.001; Klose T, 2012, PANCREATOLOGY, V12, P350, DOI 10.1016/j.pan.2012.05.012; Kohonen T, 1997, SELF ORGANIZING MAPS; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li S, 2013, ANN APPL STAT, V7, P391, DOI 10.1214/12-AOAS589; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074504; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu QQ, 1996, CIRC RES, V79, P716, DOI 10.1161/01.RES.79.4.716; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; Martin OJ, 2014, CIRC RES, V114, P626, DOI 10.1161/CIRCRESAHA.114.302562; Matsunaga S, 2012, CELL REP, V1, P299, DOI 10.1016/j.celrep.2012.02.005; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Ohnuki H, 2012, BLOOD, V119, P2688, DOI 10.1182/blood-2011-03-345306; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; SCHIAFFINO S, 1989, CIRC RES, V64, P937, DOI 10.1161/01.RES.64.5.937; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Smit A, REPEATMASKER OPEN 4; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Sung MM, 2015, CARDIOVASC RES, V107, P235, DOI 10.1093/cvr/cvv166; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; VANGRONINGEN JP, 1991, ANAT EMBRYOL, V184, P65; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wehrens R, 2007, J STAT SOFTW, V21, P1; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yazdi PG, 2013, CTS-CLIN TRANSL SCI, V6, P347, DOI 10.1111/cts.12083; Yeghiazarians Y, 2014, J CARDIOVASC PHARM, V63, P406, DOI 10.1097/FJC.0000000000000061; ZHANG B, 1989, ANN NY ACAD SCI, V573, P130, DOI 10.1111/j.1749-6632.1989.tb14991.x; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	121	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166574	10.1371/journal.pone.0166574	http://dx.doi.org/10.1371/journal.pone.0166574			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832192	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000135
J	Heidlmayr, K; Dore-Mazars, K; Aparicio, X; Isel, F				Heidlmayr, Karin; Dore-Mazars, Karine; Aparicio, Xavier; Isel, Frederic			Multiple Language Use Influences Oculomotor Task Performance: Neurophysiological Evidence of a Shared Substrate between Language and Motor Control	PLOS ONE			English	Article							HIGHLY PROFICIENT BILINGUALS; ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; EXECUTIVE CONTROL; INHIBITORY CONTROL; ANTISACCADE TASK; INDIVIDUAL-DIFFERENCES; CORTICAL POTENTIALS; CONFLICT-RESOLUTION; VOLUNTARY CONTROL	In the present electroencephalographical study, we asked to which extent executive control processes are shared by both the language and motor domain. The rationale was to examine whether executive control processes whose efficiency is reinforced by the frequent use of a second language can lead to a benefit in the control of eye movements, i.e. a non-linguistic activity. For this purpose, we administrated to 19 highly proficient late French-German bilingual participants and to a control group of 20 French monolingual participants an antisaccade task, i.e. a specific motor task involving control. In this task, an automatic saccade has to be suppressed while a voluntary eye movement in the opposite direction has to be carried out. Here, our main hypothesis is that an advantage in the antisaccade task should be observed in the bilinguals if some properties of the control processes are shared between linguistic and motor domains. ERP data revealed clear differences between bilinguals and monolinguals. Critically, we showed an increased N2 effect size in bilinguals, thought to reflect better efficiency to monitor conflict, combined with reduced effect sizes on markers reflecting inhibitory control, i.e. cue-locked positivity, the target-locked P3 and the saccade-locked presaccadic positivity (PSP). Moreover, effective connectivity analyses (dynamic causal modelling; DCM) on the neuronal source level indicated that bilinguals rely more strongly on ACC-driven control while monolinguals rely on PFC-driven control. Taken together, our combined ERP and effective connectivity findings may reflect a dynamic interplay between strengthened conflict monitoring, associated with subsequently more efficient inhibition in bilinguals. Finally, L2 proficiency and immersion experience constitute relevant factors of the language background that predict efficiency of inhibition. To conclude, the present study provided ERP and effective connectivity evidence for domain-general executive control involvement in handling multiple language use, leading to a control advantage in bilingualism.	[Heidlmayr, Karin; Dore-Mazars, Karine] Paris Descartes Sorbonne Paris Cite Univ, Inst Psychol, Lab Vis Act Cognit EA 7326, Paris, France; [Heidlmayr, Karin; Isel, Frederic] Paris Lumieres Paris Ouest Nanterre La Def Univ, Lab MoDyCo UMR 7114, CNRS, Paris, France; [Aparicio, Xavier] Paris Est Creteil Univ, Lab CHArt EA 4004, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Isel, F (corresponding author), Paris Lumieres Paris Ouest Nanterre La Def Univ, Lab MoDyCo UMR 7114, CNRS, Paris, France.	fisel@u-paris10.fr		Heidlmayr, Karin/0000-0002-0550-1598	French National Research Agency (ANR), program "Investissements d'Avenir" [ANR-10-LABX-0083]; Paris Descartes-Sorbonne Paris Cite University	French National Research Agency (ANR), program "Investissements d'Avenir"(French National Research Agency (ANR)); Paris Descartes-Sorbonne Paris Cite University	This research has been supported by a public grant overseen by the French National Research Agency (ANR) as part of the program "Investissements d'Avenir" (reference: ANR-10-LABX-0083) and by internal funding from the Paris Descartes-Sorbonne Paris Cite University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Abutalebi J, 2013, BRAIN LANG, V125, P307, DOI 10.1016/j.bandl.2012.03.009; Aichert DS, 2012, PSYCHOPHYSIOLOGY, V49, P345, DOI 10.1111/j.1469-8986.2011.01306.x; Alahyane N, 2014, NEUROIMAGE, V98, P103, DOI 10.1016/j.neuroimage.2014.03.008; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Bialystok E, 2006, J EXP PSYCHOL LEARN, V32, P1341, DOI 10.1037/0278-7393.32.6.1341; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Blumenfeld HK, 2013, J COGN PSYCHOL, V25, P547, DOI 10.1080/20445911.2013.812093; Bocquillon P, 2014, NEUROSCIENCE, V271, P9, DOI 10.1016/j.neuroscience.2014.04.014; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brysbaert M, 2003, MASKED PRIMING STATE; Buchholz VN, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00446; Calabria M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00399; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chen AT, 2008, HUM BRAIN MAPP, V29, P1028, DOI 10.1002/hbm.20449; Collins T, 2008, J NEUROPHYSIOL, V99, P2708, DOI 10.1152/jn.01082.2007; Cordones I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063751; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Costa A, 2008, BILING-LANG COGN, V11, P121, DOI 10.1017/S1366728907003252; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; De Baene W, 2015, J COGNITIVE NEUROSCI, V27, P1752, DOI 10.1162/jocn_a_00817; de Bruin A, 2014, NEUROIMAGE, V90, P348, DOI 10.1016/j.neuroimage.2013.12.049; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dijkstra T, 2002, BILING LANG COGN, V5; Dijkstra Ton, 2005, HDB BILINGUALISM PSY, P179; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Evdokimidis I, 1996, ELECTROEN CLIN NEURO, V98, P377, DOI 10.1016/0013-4694(96)94699-4; Everling S, 1997, ELECTROEN CLIN NEURO, V102, P356, DOI 10.1016/S0013-4694(96)96569-4; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Festman J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00115; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Gathercole VCM, 2010, INT J BILING EDUC BI, V13, P617, DOI 10.1080/13670050.2010.488289; Gentilucci M, 2000, EXP BRAIN RES, V133, P468, DOI 10.1007/s002210000431; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Green DW, 2014, APPL PSYCHOLINGUIST, V35, P910, DOI 10.1017/S0142716414000228; Green DW, 2013, J COGN PSYCHOL, V25, P515, DOI 10.1080/20445911.2013.796377; Green DW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00103; Greenhill P, 2010, FAIRY TALE FILMS: VISIONS OF AMBIGUITY, P1; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hamm JP, 2012, EXP BRAIN RES, V221, P123, DOI 10.1007/s00221-012-3167-8; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; Harper J, 2014, CLIN NEUROPHYSIOL, V125, P124, DOI 10.1016/j.clinph.2013.06.025; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Heidlmayr K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00821; Heidlmayr K, 2014, BILING-LANG COGN, V17, P630, DOI 10.1017/S1366728913000539; Hernandez M, 2010, BILING-LANG COGN, V13, P315, DOI 10.1017/S1366728909990010; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hoshino N, 2011, BRAIN RES, V1371, P100, DOI 10.1016/j.brainres.2010.11.053; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jackson SR, 1999, NEUROREPORT, V10, P861, DOI 10.1097/00001756-199903170-00035; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Jiang JF, 2014, CEREB CORTEX, V24, P1793, DOI 10.1093/cercor/bht029; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; Keppel G., 1991, DESIGN AND ANAL, V3rd; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Kossowska M, 2014, NEUROSCI LETT, V570, P38, DOI 10.1016/j.neulet.2014.04.002; Kousaie S, 2012, BRAIN RES, V1446, P71, DOI 10.1016/j.brainres.2012.01.052; Kovacs AM, 2009, SCIENCE, V325, P611, DOI 10.1126/science.1173947; Kroll JF, 2013, J COGN PSYCHOL, V25, P497, DOI 10.1080/20445911.2013.799170; Kutas M, 2008, LIT STUD, V1, P153, DOI 10.1007/978-0-387-74980-8_6; Li P, 2014, CORTEX, V58, P301, DOI 10.1016/j.cortex.2014.05.001; Li SC, 2013, NEUROSCI BIOBEHAV R, V37, P2201, DOI 10.1016/j.neubiorev.2013.07.019; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Luck S, 2014, APA HDB RES METHODS, P1; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Marshall TR, 2015, J NEUROSCI, V35, P1638, DOI 10.1523/JNEUROSCI.3116-14.2015; Martensson J, 2012, NEUROIMAGE, V63, P240, DOI 10.1016/j.neuroimage.2012.06.043; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Mueller SC, 2009, NEUROIMAGE, V45, P191, DOI 10.1016/j.neuroimage.2008.11.019; Muhle-Karbe PS, 2014, NEUROIMAGE, V99, P332, DOI 10.1016/j.neuroimage.2014.05.058; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nieuwenhuis S, 2004, BRAIN COGNITION, V56, P198, DOI 10.1016/j.bandc.2003.12.002; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Paap KR, 2015, AIMS NEUROSCI, V2, P1, DOI 10.3934/Neuroscience.2015.1.1; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Prior A, 2011, J INT NEUROPSYCH SOC, V17, P682, DOI 10.1017/S1355617711000580; Prior A, 2010, BILING-LANG COGN, V13, P253, DOI 10.1017/S1366728909990526; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Runnqvist E, 2012, J MEM LANG, V66, P850, DOI 10.1016/j.jml.2012.02.007; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Segalowitz N., 2010, ANAL CELL PATHOL, DOI [10.4324/9780203851357, DOI 10.1155/2010/519498]; Segalowitz N., 2005, HDB BILINGUALISM PSY, P371; Singh N, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01481; Stein M, 2012, CORTEX, V48, P458, DOI 10.1016/j.cortex.2010.10.007; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stocco A, 2014, INT J BILINGUAL, V18, P67, DOI 10.1177/1367006912456617; Valian V, 2015, BILING-LANG COGN, V18, P3, DOI 10.1017/S1366728914000522; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Weissberger GH, 2015, NEUROPSYCHOLOGIA, V66, P193, DOI 10.1016/j.neuropsychologia.2014.10.037	112	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165029	10.1371/journal.pone.0165029	http://dx.doi.org/10.1371/journal.pone.0165029			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832065	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000007
J	Kruer, TL; Dougherty, SM; Reynolds, L; Long, E; de Silva, T; Lockwood, WW; Clem, BF				Kruer, Traci L.; Dougherty, Susan M.; Reynolds, Lindsey; Long, Elizabeth; de Silva, Tanya; Lockwood, William W.; Clem, Brian F.			Expression of the IncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway	PLOS ONE			English	Article							NONCODING RNA MEG3; TGF-BETA; TUMOR-SUPPRESSOR; HYPERMETHYLATION; PROGRESSION; ACTIVATION; MECHANISMS; REGION; ROLES; P53	Maternally expressed gene 3 (MEG3, mouse homolog GtI2 encodes a long noncoding RNA (IncRNA) that is expressed in many normal tissues, but is suppressed in various cancer cell lines and tumors, suggesting it plays a functional role as a tumor suppressor. Hyper-methylation has been shown to contribute to this loss of expression. We now demonstrate that MEG3 expression is regulated by the retinoblastoma protein (Rb) pathway and correlates with a change in cell proliferation. Microarray analysis of mouse embryonic fibroblasts (MEFs) isolated from mice with genetic deletion of all three Rb family members (TKO) revealed a significant silencing of GtI2/MEG3 expression compared to WT MEFs, and re expression of GtI2/MEG3 caused decrease in cell proliferation and increased apoptosis. MEG3 levels also were suppressed in A549 lung cancer cells compared with normal human bronchial epithelial (NHBE) cells, and, similar to the TKO cells, re-constitution of MEG3 led to a decrease in cell proliferation and elevated apoptosis. Activation of pRb by treatment of A549 and SK-MES-1 cells with palbociclib, a CDK4/6 inhibitor, increased the expression of MEG3 in a dose-dependent manner, while knockdown of pRb/p107 attenuated this effect. In addition, expression of phosphorylation-deficient mutant of pRb increased MEG3 levels in both lung cancer cell types. Treatment of these cells with palbociclib also decreased the expression of pRb-regulated DNA methyltransferase 1 (DNMT1), while conversely, knockdown of DNMT1 resulted in increased expression of MEG3. As gene methylation has been suggested for MEG3 regulation, we found that palbociclib resulted in decreased methylation of the MEG3 locus similar to that observed with 5-aza-deoxycytidine. Anti-sense oligonucleotide silencing of drug-induced MEG3 expression in A549 and SK-MES-1 cells partially rescued the palbociclib-mediated decrease in cell proliferation, while analysis of the TCGA database revealed decreased MEG3 expression in human lung tumors harboring a disrupted RB pathway. Together, these data suggest that disruption of the pRb-DNMT1 pathway leads to a decrease in MEG3 expression, thereby contributing to the pro-proliferative state of certain cancer cells.	[Kruer, Traci L.; Dougherty, Susan M.; Reynolds, Lindsey; Long, Elizabeth; Clem, Brian F.] Univ Louisville, James Graham Brown Canc Ctr, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [de Silva, Tanya; Lockwood, William W.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [de Silva, Tanya; Lockwood, William W.] BC Canc Res Ctr, Integrat Oncol, Vancouver, BC, Canada	University of Louisville; University of British Columbia; British Columbia Cancer Agency	Clem, BF (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Biochem & Mol Genet, Louisville, KY 40292 USA.	bfclem01@louisville.edu		Kruer, Traci/0000-0002-9211-6304; Conroy, Lindsey/0000-0003-4593-0896	National Cancer Institute [CM166327]; American Cancer Society [RSG-13-139-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA166327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute, CM166327 (BFC), www.cancer.gov, and American Cancer Society, RSG 13-139-01-CNE (BFC), www.cancer.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Sabine Weigel and the James Brown Cancer Center Genomics Core Facility for performing and analyzing the microarray study and would like to thank Dr. Levi Beverly for insightful discussions regarding this work and Drs. Alan Kerr, Sucheta Telang, and Yoannis Imbert-Fernandez for critical reading of the manuscript. This work was supported by the National Cancer Institute (CA166327) and the American Cancer Society (RSG-13-139-01-CNE) to B.F.C.	Angus SP, 2012, ONCOGENE, V31, P4709, DOI 10.1038/onc.2011.622; Anwar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049462; Balik V, 2013, J NEURO-ONCOL, V112, P1, DOI 10.1007/s11060-012-1038-6; Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Gejman R, 2008, J CLIN ENDOCR METAB, V93, P4119, DOI 10.1210/jc.2007-2633; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; He Y, 2014, BBA-MOL BASIS DIS, V1842, P2204, DOI 10.1016/j.bbadis.2014.08.015; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114586; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Mangini NS, 2015, ANN PHARMACOTHER, V49, P1252, DOI 10.1177/1060028015602273; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Witkiewicz AK, 2014, ONCOGENE, V33, P3980, DOI 10.1038/onc.2013.367; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	30	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166363	10.1371/journal.pone.0166363	http://dx.doi.org/10.1371/journal.pone.0166363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832204	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000111
J	Martinez-Castillo, M; Bonilla-Moreno, R; Aleman-Lazarini, L; Meraz-Rios, MA; Orozco, L; Cedillo-Barron, L; Cordova, EJ; Villegas-Sepulveda, N				Martinez-Castillo, Macario; Bonilla-Moreno, Raul; Aleman-Lazarini, Leticia; Antonio Meraz-Rios, Marco; Orozco, Lorena; Cedillo-Barron, Leticia; Cordova, Emilio J.; Villegas-Sepulveda, Nicolas			A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; NF-KAPPA-B; DNA-DAMAGE; APOPTOSIS; INHIBITION; ACTIVATION; KINASE; ABL; PROLIFERATION; PATHOGENESIS	Curcumin is extensively investigated as a good chemo-preventive agent in the development of many cancers and particularly in leukemia, including treatment of chronic myelogenous leukemia and it has been proposed as an adjuvant for leukemia therapies. Human chronic myeloid leukemia cells (K562), were treated with 20 mu M of curcumin, and we found that a subpopulation of these cells were arrested and accumulate in the G2/M phase of the cell cycle. Characterization of this cell subpopulation showed that the arrested cells presented nuclear morphology changes resembling those described for mitotic catastrophe. Mitotic cells displayed abnormal chromatin organization, collapse of the mitotic spindle and abnormal chromosome segregation. Then, these cells died in an apoptosis dependent manner and showed diminution in the protein levels of BCL-2 and XIAP. Moreover, our results shown that a transient activation of the nuclear factor kappa B (NF kappa B) occurred early in these cells, but decreased after 6 h of the treatment, explaining in part the diminution of the antiapoptotic proteins. Additionally, P73 was translocated to the cell nuclei, because the expression of the C/EBP alpha, a cognate repressor of the P73 gene, was decreased, suggesting that apoptosis is trigger by elevation of P73 protein levels acting in concert with the diminution of the two anti-apoptotic molecules. In summary, curcumin treatment might produce a P73-dependent apoptotic cell death in chronic myelogenous leukemia cells (K562), which was triggered by mitotic catastrophe, due to sustained BAX and survivin expression and impairment of the anti-apoptotic proteins BCL-2 and XIAP.	[Martinez-Castillo, Macario; Bonilla-Moreno, Raul; Aleman-Lazarini, Leticia; Antonio Meraz-Rios, Marco; Cedillo-Barron, Leticia; Villegas-Sepulveda, Nicolas] Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Orozco, Lorena; Cordova, Emilio J.] Inst Nacl Med Genom, Lab Inmunogen & Enfermedades Metab, Secretaria Salud, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Nacional de Medicina Genomica	Villegas-Sepulveda, N (corresponding author), Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico.; Cordova, EJ (corresponding author), Inst Nacl Med Genom, Lab Inmunogen & Enfermedades Metab, Secretaria Salud, Mexico City, DF, Mexico.	ecordova@inmegen.gob.mx; nvillega@cinvestav.mx	MERAZ RIOS, MARCO ANTONIO/F-4194-2016	MERAZ RIOS, MARCO ANTONIO/0000-0001-6748-8117; Villegas-Sepulveda, Nicolas/0000-0001-9489-2545; Orozco, Lorena/0000-0002-5801-9180	CONACyT, Mexico; CINVESTAV; INMEGEN; CONACyT [128686]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CINVESTAV; INMEGEN; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	MMC is indebted to CONACyT, Mexico for a doctoral fellowship. This work was supported in part by funds allocated to NVS and EJC by CINVESTAV and INMEGEN, respectively, and by grant 128686 from CONACyT.	Ara SA, 2016, J CANCER RES THER, V12, P175, DOI 10.4103/0973-1482.171370; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bose S, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0012-z; Boyanapalli Sarandeep S S, 2015, Curr Pharmacol Rep, V1, P129; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Chen M, 2013, JNCI-J NATL CANCER I, V105, P405, DOI 10.1093/jnci/djt006; Chereda B, 2015, ANN HEMATOL, V94, pS107, DOI 10.1007/s00277-015-2325-z; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Jang SY, 2015, BIOCHEM BIOPH RES CO, V465, P71, DOI 10.1016/j.bbrc.2015.07.131; Jobin C, 1999, J IMMUNOL, V163, P3474; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Konig H, 2008, BLOOD, V111, P2329, DOI 10.1182/blood-2007-05-092056; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Li WJ, 2016, CHEM RES TOXICOL, V29, P694, DOI 10.1021/acs.chemrestox.6b00016; Li Y, 2015, J AGR FOOD CHEM, V63, P7731, DOI 10.1021/acs.jafc.5b02011; Li YQ, 2012, J CELL BIOCHEM, V113, P3165, DOI 10.1002/jcb.24194; Marabese M, 2003, NUCLEIC ACIDS RES, V31, P6624, DOI 10.1093/nar/gkg869; Matassov Demetrius, 2004, Methods Mol Biol, V282, P1; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Polishchuk L. A., 2014, Experimental Oncology, V36, P138; Rajitha B, 2016, CANCER LETT, V373, P227, DOI 10.1016/j.canlet.2016.01.052; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rudiger H., 2012, BLOOD, V120, P737, DOI [10.1182/blood-2012-03-380147, DOI 10.1182/BLOOD-2012-03-380147]; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Rumpold H, 2011, CURR CANCER DRUG TAR, V11, P3, DOI 10.2174/156800911793743619; Saussele S, 2015, ANN HEMATOL, V94, pS159, DOI 10.1007/s00277-015-2324-0; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Taylor William R, 2004, Methods Mol Biol, V281, P293; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Wolanin K, 2006, MOL CANCER RES, V4, P457, DOI 10.1158/1541-7786.MCR-05-0172; Wu LX, 2014, ACTA PHARMACOL SIN, V35, P401, DOI 10.1038/aps.2013.180; Xia YQ, 2014, ASIAN PAC J CANCER P, V15, P6893, DOI 10.7314/APJCP.2014.15.16.6893; Zhou QY, 2016, CLIN EXP PHARMACOL P, V43, P394, DOI 10.1111/1440-1681.12546	39	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165971	10.1371/journal.pone.0165971	http://dx.doi.org/10.1371/journal.pone.0165971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832139	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000049
J	Marzotto, M; Bonafini, C; Olioso, D; Baruzzi, A; Bettinetti, L; Di Leva, F; Galbiati, E; Bellavite, P				Marzotto, Marta; Bonafini, Clara; Olioso, Debora; Baruzzi, Anna; Bettinetti, Laura; Di Leva, Francesca; Galbiati, Elisabetta; Bellavite, Paolo			Arnica montana Stimulates Extracellular Matrix Gene Expression in a Macrophage Cell Line Differentiated to Wound-Healing Phenotype	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-1; IN-VITRO; SESQUITERPENE LACTONES; QUANTITATIVE-ANALYSIS; L.; FIBRONECTIN; PLANT; SENSITIVITY; ACTIVATION; REGULATOR	Arnica montana (Arnica m.) is used for its purported anti-inflammatory and tissue healing actions after trauma, bruises, or tissue injuries, but its cellular and molecular mechanisms are largely unknown. This work tested Arnica m. effects on gene expression using an in vitro model of macrophages polarized towards a "wound-healing" phenotype. The monocyte-macrophage human THP-1 cell line was cultured and differentiated with phorbol-myristate acetate and Interleukin-4, then exposed for 24h to Arnica m. centesimal (c) dilutions 2c, 3c, 5c, 9c, 15c or Control. Total RNA was isolated and cDNA libraries were sequenced with a NextSeq500 sequencer. Genes with significantly positive (up-regulated) or negative (downregulated) fold changes were defined as differentially expressed genes (DEGs). A total of 20 DEGs were identified in Arnica m. 2c treated cells. Of these, 7 genes were up-regulated and 13 were down-regulated. The most significantly up-regulated function concerned 4 genes with a conserved site of epidermal growth factor-like region (p<0.001) and three genes of proteinaceous extracellular matrix, including heparin sulphate proteoglycan 2 (HSPG2), fibrillin 2 (FBN2), and fibronectin (FN1) (p<0.01). Protein assay confirmed a statistically significant increase of fibronectin production (p<0.05). The down-regulated transcripts derived from mitochondrial genes coding for some components of electron transport chain. The same groups of genes were also regulated by increasing dilutions of Arnica m. (3c, 5c, 9c, 15c), although with a lower effect size. We further tested the healing potential of Arnica m. 2c in a scratch model of wound closure based on the motility of bone marrow-derived macrophages and found evidence of an accelerating effect on cell migration in this system. The results of this work, taken together, provide new insights into the action of Arnica m. in tissue healing and repair, and identify extracellular matrix regulation by macrophages as a therapeutic target.	[Marzotto, Marta; Bonafini, Clara; Olioso, Debora; Baruzzi, Anna; Bellavite, Paolo] Univ Verona, Dept Med, Str Le Grazie 8, I-37134 Verona, Italy; [Bettinetti, Laura; Di Leva, Francesca] Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy; [Galbiati, Elisabetta] Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 3, I-20126 Milan, Italy	University of Verona; University of Verona; University of Milano-Bicocca	Bellavite, P (corresponding author), Univ Verona, Dept Med, Str Le Grazie 8, I-37134 Verona, Italy.	paola.bellavite@univr.it			Boiron Laboratoires Lyon	Boiron Laboratoires Lyon	This work was supported by Boiron Laboratoires Lyon, www.boiron.fr. The funder had no role in data collection and analysis, interpretation, decision to publish, or writing the manuscript.	Alonso D, 2002, DERMATOL SURG, V28, P686, DOI 10.1046/j.1524-4725.2002.02011.x; Babot M, 2014, BBA-BIOENERGETICS, V1837, P1083, DOI 10.1016/j.bbabio.2014.02.018; Balleza E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002456; Baruzzi A, 2015, J IMMUNOL, V195, P4900, DOI 10.4049/jimmunol.1500579; Bell IR, 2015, HOMEOPATHY, V104, P123, DOI 10.1016/j.homp.2014.11.003; Bell IR, 2014, DOSE-RESPONSE, V12, P202, DOI 10.2203/dose-response.13-025.Bell; Bell Iris R, 2013, Front Biosci (Schol Ed), V5, P685; Bellavite P, 2015, HOMEOPATHY, V104, P139, DOI 10.1016/j.homp.2015.02.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bhattacharyya SS, 2008, EXP BIOL MED, V233, P1591, DOI 10.3181/0805-RM-181; Bigagli E, 2016, DOSE-RESPONSE, V14, DOI 10.1177/1559325815626685; Bresler A, 2007, IND J RES HOM, V2, P7; Brinkhaus B, 2006, COMPLEMENT THER MED, V14, P237, DOI 10.1016/j.ctim.2006.04.004; Budovsky A, 2015, WOUND REPAIR REGEN, V23, P171, DOI 10.1111/wrr.12274; Castro FCB, 2012, HOMEOPATHY, V101, P147, DOI 10.1016/j.homp.2012.05.006; Chanput W, 2012, FOOD FUNCT; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; Chikramane PS, 2010, HOMEOPATHY, V99, P231, DOI 10.1016/j.homp.2010.05.006; Conforti Anita, 2007, BMC Complement Altern Med, V7, P1, DOI 10.1186/1472-6882-7-1; Craciunescu O, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-97; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Das Durba, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P752; Das Sreemanti, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P337, DOI 10.3736/jcim20120314; De Arnab, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P210; de Camargo RA, 2013, HOMEOPATHY, V102, P49, DOI 10.1016/j.homp.2012.11.001; Douglas JA, 2004, PLANTA MED, V70, P166, DOI 10.1055/s-2004-815495; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fleck D, 2013, J NEUROSCI, V33, P7856, DOI 10.1523/JNEUROSCI.3372-12.2013; Ganzera M, 2008, ANAL CHIM ACTA, V614, P196, DOI 10.1016/j.aca.2008.03.023; Gaultier A, 2010, MATRIX BIOL, V29, P22, DOI 10.1016/j.matbio.2009.08.003; GELBERMAN RH, 1991, J HAND SURG-AM, V16A, P686, DOI 10.1016/0363-5023(91)90195-H; Gonias SL, 2004, THROMB HAEMOSTASIS, V91, P1056, DOI 10.1160/TH04-01-0023; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hostanska K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iannitti T, 2016, AM J THER, V23, pE184, DOI 10.1097/MJT.0000000000000036; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Juneja SC, 2013, CONNECT TISSUE RES, V54, P218, DOI 10.3109/03008207.2013.787418; Karow JH, 2008, J ALTERN COMPLEM MED, V14, P17, DOI 10.1089/acm.2007.0560; Kawakami AP, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/917541; Kennedy JM, 2014, J EXP MED, V211, P2519, DOI 10.1084/jem.20140455; Khuda-Bukhsh A., 1997, COMPLEMENT THER MED, V5, P43; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klaas CA, 2002, PLANTA MED, V68, P385, DOI 10.1055/s-2002-32067; Lawrence WT, 2003, PLAST RECONSTR SURG, V112, P1164, DOI 10.1097/01.PRS.0000075161.89940.81; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lussignoli S, 1999, Complement Ther Med, V7, P225, DOI 10.1016/S0965-2299(99)80006-5; Lyss G, 1997, BIOL CHEM, V378, P951, DOI 10.1515/bchm.1997.378.9.951; Macedo S B, 2004, Homeopathy, V93, P84, DOI 10.1016/j.homp.2004.02.006; Mantle David, 2001, Adverse Drug Reactions and Toxicological Reviews, V20, P89; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Marzotto M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-104; Maurer E, 2015, THROMB HAEMOSTASIS, V114, P1175, DOI 10.1160/TH14-11-0958; Maver T, 2015, INT J DERMATOL, V54, P740, DOI 10.1111/ijd.12766; May P, 2013, CURR OPIN LIPIDOL, V24, P134, DOI 10.1097/MOL.0b013e32835e809c; Meldolesi J, 2016, PHARMACOL RES, V107, P430, DOI 10.1016/j.phrs.2015.10.019; Mu JY, 2014, MOL NUTR FOOD RES, V58, P1561, DOI 10.1002/mnfr.201300729; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Olioso D, 2016, HOMEOPATHY, V105, P131, DOI 10.1016/j.homp.2016.02.001; Olioso D, 2014, J ETHNOPHARMACOL, V153, P535, DOI 10.1016/j.jep.2014.02.048; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-5; Ramo P, 2006, J THEOR BIOL, V242, P164, DOI 10.1016/j.jtbi.2006.02.011; Reddy KK, 2013, J AM ACAD DERMATOL, V68, pE127, DOI 10.1016/j.jaad.2011.06.030; Sharma S, 2016, J SCI FOOD AGR, V96, P1500, DOI 10.1002/jsfa.7252; Staneva J, 2011, J PHARMACEUT BIOMED, V54, P94, DOI 10.1016/j.jpba.2010.08.018; Strickland DK, 2014, ARTERIOSCL THROM VAS, V34, P487, DOI 10.1161/ATVBAHA.113.301924; Suen PW, 1999, J CELL SCI, V112, P4067; Sutovska M, 2014, INT J BIOL MACROMOL, V69, P214, DOI 10.1016/j.ijbiomac.2014.05.051; Theocharis AD, 2015, ADV DRUG DELIV REV; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Verma N, 2010, MOL CELL BIOCHEM, V336, P127, DOI 10.1007/s11010-009-0263-6; Widrig R, 2007, RHEUMATOL INT, V27, P585, DOI 10.1007/s00296-007-0304-y; Wijeratne SS, 2016, MATRIX BIOL, V50, P27, DOI 10.1016/j.matbio.2015.11.001; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671	80	28	28	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166340	10.1371/journal.pone.0166340	http://dx.doi.org/10.1371/journal.pone.0166340			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832158	Green Published, gold			2022-12-27	WOS:000387725000102
J	Rodrigues, NCP; Lino, VTS; Daumas, RP; Andrade, MKD; O'Dwyer, G; Monteiro, DLM; Gerardi, A; Fernandes, GHBV; Ramos, JA; Ferreira, CEG; Leitelf, LD				Pinheiro Rodrigues, Nadia Cristina; Saraiva Lino, Valeria Teresa; Daumas, Regina Paiva; de Noronha Andrade, Monica Kramer; O'Dwyer, Gisele; Maia Monteiro, Denise Leite; Gerardi, Alyssa; Barroso Viana Fernandes, Gabriel Henrique; Sapienza Ramos, Jose Augusto; Goncalves Ferreira, Carlos Eduardo; Leite, Luri da Costa			Temporal and Spatial Evolution of Dengue Incidence in Brazil, 2001-2012	PLOS ONE			English	Article							AEDES-AEGYPTI; VIRUS TYPE-4; SAO-PAULO; STATE; CLIMATE	Background In Brazil, the incidence of dengue greatly increased in the last two decades and there are several factors impeding the control of the disease. The present study focused on describing the space-time evolution of dengue in Brazil from 2001 to 2012 and analyzing the relationship of the reported cases with socio-demographic and environmental factors. Methods The analytic units used in the preparation of thematic maps were municipalities. Statistical tests and multilevel regression models were used to evaluate the association between dengue incidence and the following factors: climate, diagnostic period, demographic density, percentage of people living in rural areas, Gross Domestic Product, Gini index, percentage of garbage collection and the rate of households with a sewage network. Results The largest accumulation of dengue cases in Brazil was concentrated on the Atlantic coast and in the interior part of Sao Paulo State. The risk of dengue in subtropical and tropical climates was 1.20-11 times lower than that observed in semi-arid climates. In 2009-2010 and 2011-2012, the risks were ten and six times higher than in 2003-2004, respectively. Conclusion Dengue is a common infection in the Brazilian population, with the largest accumulation of dengue cases concentrated on the Atlantic coast and in the interior area of Sao Paulo State.The high dengue rates observed in the Brazilian coastal region suggest that the cases imported from neighboring countries contribute to the spread of the disease in the country. Our results suggest that several socio-demographic and environmental factors resulted in the increase of dengue in the country over time. This is likely applicable to the occurrence of other arboviruses like Zika and chikungunya. To reverse the situation, Brazil must implement effective public policies that offer basic services such as garbage collection and sanitation networks as well as reduce vector populations.	[Pinheiro Rodrigues, Nadia Cristina; Saraiva Lino, Valeria Teresa; Daumas, Regina Paiva; de Noronha Andrade, Monica Kramer; O'Dwyer, Gisele; Leite, Luri da Costa] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil; [Pinheiro Rodrigues, Nadia Cristina; Maia Monteiro, Denise Leite] Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil; [de Noronha Andrade, Monica Kramer] Vital Brazil Inst, Ctr Studies & Res Ageing, Rio De Janeiro, Brazil; [Gerardi, Alyssa] Georgetown Univ, Washington, DC USA; [Barroso Viana Fernandes, Gabriel Henrique; Sapienza Ramos, Jose Augusto; Goncalves Ferreira, Carlos Eduardo] Univ Estado Rio De Janeiro, Sch Geol, Rio De Janeiro, Brazil; [Pinheiro Rodrigues, Nadia Cristina] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Germano Sinval Faria, Rio De Janeiro, Brazil; [Pinheiro Rodrigues, Nadia Cristina] Univ Estado Rio de Janeiro, Fac Med, Dept Tecnol Informacao & Educ Saude, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Georgetown University; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Germano Sinval Faria, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio de Janeiro, Fac Med, Dept Tecnol Informacao & Educ Saude, Rio De Janeiro, Brazil.	nadiacristinapr@gmail.com	Monteiro, Denise LM/G-2652-2012; DAUMAS, REGINA P/M-9387-2013; Lino, Valeria/ADI-4254-2022; kar, paritosh kumar/U-6713-2019	Monteiro, Denise LM/0000-0003-4679-1859; DAUMAS, REGINA P/0000-0002-8923-7711; 				Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804; [Anonymous], 2015, PLOS NEGLECTED TROPI; Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285; Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005; Bertolacci-Rocha LG, 2014, CAD SAUDE PUBLICA, V30, P1789, DOI 10.1590/0102-311X00003914; Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009; Chahad-Ehlers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052559; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; DATASUS, 2015, HLTH INF; de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439; FIOCRUZ FOC, 2016, AED AEG MOSQ PART HI; FUNASA BHM, 2011, HIST PUBL HLTH CHRON; Gelman A., 2007, DATA ANAL USING REGR; Gentile C, 2013, MEM I OSWALDO CRUZ, V108, P80, DOI 10.1590/0074-0276130471; Glasser CM, 2002, REV SAUDE PUBL, V36, P166, DOI 10.1590/S0034-89102002000200008; Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280; HM BHM, 2009, DENG BRAS INF EP 17; HM BHM, 2012, EP B DENG EP SIT; HM BHM, 2016, COMP PROB CAS DENG 2; IBGE, 2010, SUBN CLUST TERR INF; IBGE, 2015, IBGE MALH DIG; IBGE BIoGaS, 2014, EST RES POP BRAZ FED; IPEA, 2016, EC APPL RES; Ismail N., 2007, CASUALTY ACTUARIAL S, V2007, P103; Jacobi P., 2004, URBAN ENV IMPACTS RI; Jaenisch Thomas, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2010.140487; Mendonça Francisco de Assis, 2009, Soc. nat., V21, P257, DOI 10.1590/S1982-45132009000300003; Muhamad M, 2010, INT J BIOL SCI, V6, P294; Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001; Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376; Ribeiro AF, 2006, REV SAUDE PUBL, V40, P671, DOI 10.1590/S0034-89102006000500017; RIPSA RIdIpS, 2012, IND DAD BAS BRAS 201; Rocco Iray Maria, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P55, DOI 10.1590/S0036-46652001000100011; Rolim Glauco de Souza, 2007, Bragantia, V66, P711, DOI 10.1590/S0006-87052007000400022; Sampaio MdS, 2011, AN 15 S BRAS SENS RE, P8857; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Teixeira MG, 2012, REV INST MED TROP SP, V54, pS1, DOI 10.1590/S0036-46652012000700002; UJVARI SC, 2003, REV INST MED TROP SP, V45, P212; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; World Bank, 2006, EQ DEV; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, GLOB STRAT DENG PREV	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165945	10.1371/journal.pone.0165945	http://dx.doi.org/10.1371/journal.pone.0165945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832129	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000045
J	Huang, Z; Zhong, XJ; He, J; Jin, SH; Quo, HD; Yu, XF; Zhou, YJ; Li, X; Ma, MD; Chen, QB; Long, H				Huang, Zhuo; Zhong, Xiao-Juan; He, Jiao; Jin, Si-Han; Quo, Han-Du; Yu, Xiao-Fang; Zhou, Yu-Jue; Li, Xi; Ma, Ming-Dong; Chen, Qi-Bing; Long, Hai			Genome-Wide Identification, Characterization, and Stress-Responsive Expression Profiling of Genes Encoding LEA (Late Embryogenesis Abundant) Proteins in Moso Bamboo (Phyllostachys edulis)	PLOS ONE			English	Article							FREEZING TOLERANCE; WATER-DEFICIT; ARABIDOPSIS; DROUGHT; FAMILY; SALT; PHYLOGENY; EVOLUTION; SEQUENCE; ELEMENTS	Late embryogenesis abundant (LEA) proteins have been identified in a wide range of organisms and are believed to play a role in the adaptation of plants to stress conditions. In this study, we performed genome-wide identification of LEA proteins and their coding genes in Moso bamboo (Phyllostachys edulis) of Poaceae. A total of 23 genes encoding LEA proteins (PeLEAs) were found in P. edulis that could be classified to six groups based on Pfam protein family and homologous analysis. Further in silico analyses of the structures, gene amount, and biochemical characteristics were conducted and compared with those of O. sativa (OsLEAs), B. distachyon (BdLEAs), Z. mays (ZmLEAs), S. bicolor (SbLEAs), Arabidopsis, and Populus trichocarpa. The less number of PeLEAs was found. Evolutionary analysis revealed orthologous relationship and colinearity between P. edulis, O. sativa, B. distachyon, Z. mays, and S. bicolor. Analyses of the non-synonymous (Ka) and synonymous (Ks) substitution rates and their ratios indicated that the duplication of PeLEAs may have occurred around 18.8 million years ago (MYA), and divergence time of LEA family among the P. edulis-O. sativa and P. edulis-B. distachyon, P. edulis-S. bicolor, and P. edulis-Z. mays was approximately 30 MYA, 36 MYA, 48 MYA, and 53 MYA, respectively. Almost all PeLEAs contain ABA-and (or) stress-responsive regulatory elements. Further RNA-seq analysis revealed approximately 78% of PeLEAs could be up-regulated by dehydration and cold stresses. The present study makes insights into the LEA family in P. edulis and provides inventory of stress-responsive genes for further functional validation and transgenic research aiming to plant genetic improvement of abiotic stress tolerance.	[Huang, Zhuo; Zhong, Xiao-Juan; He, Jiao; Jin, Si-Han; Quo, Han-Du; Yu, Xiao-Fang; Zhou, Yu-Jue; Li, Xi; Ma, Ming-Dong; Chen, Qi-Bing] Sichuan Agr Univ, Coll Landscape Architecture, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China; [Long, Hai] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China	Sichuan Agricultural University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Huang, Z (corresponding author), Sichuan Agr Univ, Coll Landscape Architecture, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.; Long, H (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China.	duoduo609@sina.com; hailong@cib.ac.cn		Qibing, Chen/0000-0001-6466-2618	Department of Science and Technology of Sichuan Province, China [2015JY0085]; Science and Technology Support Project of Sichuan Province, China [16ZC2871]	Department of Science and Technology of Sichuan Province, China; Science and Technology Support Project of Sichuan Province, China	This work was Financially supported by Department of Science and Technology of Sichuan Province, China (2015JY0085) and Science and Technology Support Project of Sichuan Province, China (16ZC2871).	BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Battaglia M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00190; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Brini F, 2007, PLANT CELL REP, V26, P2017, DOI 10.1007/s00299-007-0412-x; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; Filiz E, 2013, PLANT OMICS, V6, P433; GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Imai R, 1996, GENE, V170, P243, DOI 10.1016/0378-1119(95)00868-3; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ismail AM, 1999, PLANT PHYSIOL, V120, P237, DOI 10.1104/pp.120.1.237; Kim HS, 2005, GENE, V344, P115, DOI 10.1016/j.gene.2004.09.012; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Lan T, 2013, TREE GENET GENOMES, V9, P253, DOI 10.1007/s11295-012-0551-2; Liang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083056; Liang JJ, 2012, MOL BREEDING, V30, P441, DOI 10.1007/s11032-011-9633-3; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MAITRA N, 1994, PLANT PHYSIOL, V106, P805, DOI 10.1104/pp.106.2.805; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; Peng ZH, 2013, NAT GENET, V45, P456, DOI 10.1038/ng.2569; PIATKOWSKI D, 1990, PLANT PHYSIOL, V94, P1682, DOI 10.1104/pp.94.4.1682; Shih MD, 2008, ADV BOT RES, V48, P211, DOI 10.1016/S0065-2296(08)00404-7; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang MZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0290-7; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wu HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126657; Wu ZQ, 2012, MOL PHYLOGENET EVOL, V62, P573, DOI 10.1016/j.ympev.2011.10.019; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yang ZF, 2008, J MOL EVOL, V67, P266, DOI 10.1007/s00239-008-9143-z; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	46	32	37	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165953	10.1371/journal.pone.0165953	http://dx.doi.org/10.1371/journal.pone.0165953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829056	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300069
J	Li, LJ; Velumian, AA; Samoilova, M; Fehlings, MG				Li, Lijun; Velumian, Alexander A.; Samoilova, Marina; Fehlings, Michael G.			A Novel Approach for Studying the Physiology and Pathophysiology of Myelinated and Non-Myelinated Axons in the CNS White Matter	PLOS ONE			English	Article							SPINAL-CORD AXONS; COMPOUND ACTION-POTENTIALS; VISUAL CALLOSAL AXONS; CORPUS-CALLOSUM; ISCHEMIC-INJURY; ANOXIC INJURY; IMPULSE CONDUCTION; UNMYELINATED AXONS; RAT; BRAIN	Advances in brain connectomics set the need for detailed knowledge of functional properties of myelinated and non-myelinated (if present) axons in specific white matter pathways. The corpus callosum (CC), a major white matter structure interconnecting brain hemispheres, is extensively used for studying CNS axonal function. Unlike another widely used CNS white matter preparation, the optic nerve where all axons are myelinated, the CC contains also a large population of non-myelinated axons, making it particularly useful for studying both types of axons. Electrophysiological studies of optic nerve use suction electrodes on nerve ends to stimulate and record compound action potentials (CAPs) that adequately represent its axonal population, whereas CC studies use microelectrodes (MEs), recording from a limited area within the CC. Here we introduce a novel robust isolated "whole" CC preparation comparable to optic nerve. Unlike ME recordings where the CC CAP peaks representing myelinated and non-myelinated axons vary broadly in size, "whole" CC CAPs show stable reproducible ratios of these two main peaks, and also reveal a third peak, suggesting a distinct group of smaller caliber non-myelinated axons. We provide detailed characterization of "whole" CC CAPs and conduction velocities of myelinated and non-myelinated axons along the rostro-caudal axis of CC body and show advantages of this preparation for comparing axonal function in wild type and dysmyelinated shiverer mice, studying the effects of temperature dependence, bath-applied drugs and ischemia modeled by oxygen-glucose deprivation. Due to the isolation from gray matter, our approach allows for studying CC axonal function without possible "contamination" by reverberating signals from gray matter. Our analysis of "whole" CC CAPs revealed higher complexity of myelinated and non-myelinated axonal populations, not noticed earlier. This preparation may have a broad range of applications as a robust model for studying myelinated and non-myelinated axons of the CNS in various experimental models.	[Li, Lijun; Velumian, Alexander A.; Samoilova, Marina; Fehlings, Michael G.] Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Velumian, Alexander A.; Fehlings, Michael G.] Univ Hlth Network, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada; [Velumian, Alexander A.] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON, Canada; [Velumian, Alexander A.; Fehlings, Michael G.] Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Fehlings, MG (corresponding author), Univ Hlth Network, Krembil Res Inst, Div Genet & Dev, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Div Neurosurg, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada.; Fehlings, MG (corresponding author), Univ Toronto, Fac Med, Dept Surg, Toronto, ON, Canada.	michael.fehlings@uhn.ca		Fehlings, Michael/0000-0002-5722-6364	Ontario Brain Institute; NeuroDevNet Canadian Network of Centres of Excellence; Halbert Chair in Neural Repair and Regeneration; DeZwirek Foundation	Ontario Brain Institute; NeuroDevNet Canadian Network of Centres of Excellence; Halbert Chair in Neural Repair and Regeneration; DeZwirek Foundation	No specific funding was received for this work but Michael G. Fehlings is supported by the Ontario Brain Institute, NeuroDevNet Canadian Network of Centres of Excellence, Halbert Chair in Neural Repair and Regeneration and the DeZwirek Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Agrawal SK, 1997, J NEUROSCI, V17, P1055; Alix JJP, 2009, ANN NEUROL, V66, P682, DOI 10.1002/ana.21767; Allen L, 2006, J NEUROPHYSIOL, V95, P1917, DOI 10.1152/jn.00637.2005; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Bakker R, 2015, NEUROINFORMATICS, V13, P353, DOI 10.1007/s12021-014-9258-x; Baltan Selva, 2006, Critical Reviews in Neurobiology, V18, P95; Baltan S, 2008, J NEUROSCI, V28, P1479, DOI 10.1523/JNEUROSCI.5137-07.2008; Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010; Bando Y, 2008, EUR J NEUROSCI, V28, P1731, DOI 10.1111/j.1460-9568.2008.06474.x; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; BERGJOHNSEN J, 1992, BRAIN RES, V576, P319, DOI 10.1016/0006-8993(92)90696-7; BERRY RL, 1990, J NEUROSCI METH, V33, P171, DOI 10.1016/0165-0270(90)90021-7; Black JA, 2002, MOL BRAIN RES, V105, P19, DOI 10.1016/S0169-328X(02)00385-6; Bolton Sally, 2005, Journal of Pharmacological and Toxicological Methods, V51, P221, DOI 10.1016/j.vascn.2004.08.010; Calabrese E, 2015, CEREB CORTEX, V25, P4628, DOI 10.1093/cercor/bhv121; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; Crawford DK, 2009, NEUROSCIENCE, V164, P1407, DOI 10.1016/j.neuroscience.2009.09.069; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Devaux J, 2003, J NEUROSCI, V23, P4509; Devaux J, 2008, J CELL BIOL, V183, P909, DOI 10.1083/jcb.200808034; DiLeonardi AM, 2012, J NEUROPATHOLOGY EXP, V71; Eftekharpour E, 2005, EXP NEUROL, V193, P334, DOI 10.1016/j.expneurol.2005.01.019; Eftekharpour E, 2007, J NEUROSCI, V27, P3416, DOI 10.1523/JNEUROSCI.0273-07.2007; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fehlings MG, 1997, J NEUROSCI METH, V71, P215, DOI 10.1016/S0165-0270(96)00147-1; FERN R, 1995, J NEUROPHYSIOL, V74, P369, DOI 10.1152/jn.1995.74.1.369; Fern R, 1998, J NEUROPHYSIOL, V79, P95, DOI 10.1152/jn.1998.79.1.95; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; FOSTER RE, 1982, DEV BRAIN RES, V3, P371, DOI 10.1016/0165-3806(82)90005-0; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Goncharenko K, 2014, J NEUROPHYSIOL, V112, P2067, DOI 10.1152/jn.00037.2013; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Huff TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017176; Innocenti GM, 2014, CEREB CORTEX, V24, P2178, DOI 10.1093/cercor/bht070; Jbabdi S, 2015, NAT NEUROSCI, V18, P1546, DOI 10.1038/nn.4134; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; KOCSIS JD, 1985, EXP BRAIN RES, V57, P620; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; LEE MR, 1993, EXP NEUROL, V119, P140, DOI 10.1006/exnr.1993.1015; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Mitchell BD, 2005, J COMP NEUROL, V482, P17, DOI 10.1002/cne.20428; Moore S, 2014, J NEUROSCI RES, V92, P1621, DOI 10.1002/jnr.23440; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Olmos-Serrano JL, 2016, NEURON, V89, P1208, DOI 10.1016/j.neuron.2016.01.042; Ouardouz M, 2006, J PHYSL LOND, V577, P191; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Patel R, 2013, BRAIN PATHOL, V23, P462, DOI 10.1111/bpa.12029; Pinto V, 2008, J NEUROPHYSIOL, V99, P617, DOI 10.1152/jn.00944.2007; PRESTON RJ, 1983, EXP NEUROL, V79, P808, DOI 10.1016/0014-4886(83)90044-4; Pryor J, 2006, SPINAL CORD, V44, P653, DOI 10.1038/sj.sc.3101901; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reeves TM, 2012, SPRINGER PROTOCOLS H, P313, DOI DOI 10.1007/978-1-61779-782-8_30; REMAHL S, 1990, J NEUROCYTOL, V19, P313, DOI 10.1007/BF01188401; REMAHL S, 1982, J NEUROL SCI, V54, P33, DOI 10.1016/0022-510X(82)90216-7; Ritter JS, 2012, THESIS; Ruff CA, 2013, J NEUROSCI, V33, P11899, DOI 10.1523/JNEUROSCI.1131-13.2013; Sahel A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00077; Schultke E, 2005, J NEUROTRAUM, V22, P1475, DOI 10.1089/neu.2005.22.1475; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Sinha K, 2005, J NEUROTRAUM, V22, P1239; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stidworthy MF, 2003, BRAIN PATHOL, V13, P329; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; STYS PK, 1992, J CEREBR BLOOD F MET, V12, P977, DOI 10.1038/jcbfm.1992.135; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; STYS PK, 1991, BRAIN RES, V546, P18, DOI 10.1016/0006-8993(91)91154-S; SWADLOW HA, 1976, EXP NEUROL, V53, P128, DOI 10.1016/0014-4886(76)90288-0; SWADLOW HA, 1975, P NATL ACAD SCI USA, V72, P5156, DOI 10.1073/pnas.72.12.5156; SWADLOW HA, 1978, EXP BRAIN RES, V33, P455; Swanson L, 2016, ANN REV NEUROSCI; Swanson TH, 1998, BRAIN RES, V784, P188, DOI 10.1016/S0006-8993(97)01323-1; Tekkok SB, 2005, NEUROSCI LETT, V382, P275, DOI 10.1016/j.neulet.2005.03.054; Tekkok SB, 2004, NEUROCHEM RES, V29, P2163; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Tekkok SB, 2003, J CEREBR BLOOD F MET, V23, P1340, DOI 10.1097/01.WCB.0000091763.61714.B7; Van Essen DC, 2013, NEURON, V80, P775, DOI 10.1016/j.neuron.2013.10.027; Velumian AA, 2011, J NEUROPHYSIOL, V105, P929, DOI 10.1152/jn.00435.2010; Velumian AA, 2010, J NEUROSCI METH, V187, P33, DOI 10.1016/j.jneumeth.2009.12.006; Vincze A, 2008, INT J DEV NEUROSCI, V26, P575, DOI 10.1016/j.ijdevneu.2008.05.003; VOGT BA, 1982, J NEUROPHYSIOL, V48, P1257, DOI 10.1152/jn.1982.48.6.1257; WAXMAN SG, 1976, BRAIN RES, V113, P179, DOI 10.1016/0006-8993(76)90017-2; WAXMAN SG, 1990, ANN NEUROL, V28, P335, DOI 10.1002/ana.410280306; WAXMAN SG, 1977, PROG NEUROBIOL, V8, P297, DOI 10.1016/0301-0082(77)90009-0; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Zhang CL, 2004, J NEUROPHYSIOL, V91, P1025, DOI 10.1152/jn.00769.2003; Zhang JD, 2013, J NEUROSCI RES, V91, P240, DOI 10.1002/jnr.23150; Zhou J, 2013, P NATL ACAD SCI USA, V110, pE2714, DOI 10.1073/pnas.1310233110; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	94	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165637	10.1371/journal.pone.0165637	http://dx.doi.org/10.1371/journal.pone.0165637			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829055	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300053
J	Vazquez, E; Barranco, A; Ramirez, M; Gruart, A; Delgado-Garcia, JM; Jimenez, ML; Buck, R; Rueda, R				Vazquez, Enrique; Barranco, Alejandro; Ramirez, Maria; Gruart, Agnes; Delgado-Garcia, Jose M.; Jimenez, Maria L.; Buck, Rachael; Rueda, Ricardo			Dietary 2 '-Fucosyllactose Enhances Operant Conditioning and Long-Term Potentiation via Gut-Brain Communication through the Vagus Nerve in Rodents	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; FUCOSYL GLYCOPROTEINS; MICROBIOTA; STIMULATION; HIPPOCAMPUS; EXPRESSION; PLASTICITY; BENEFITS; MEMORY; MOUSE	2'-fucosyllactose (2'-FL) is an abundant human milk oligosaccharide (HMO) in human milk with diverse biological effects. We recently reported ingested 2'-FL stimulates central nervous system (CNS) function, such as hippocampal long term potentiation (LTP) and learning and memory in rats. Conceivably the effect of 2'-FL on CNS function may be via the gutbrain axis (GBA), specifically the vagus nerve, and L-fucose (Fuc) may play a role. This study had two aims: (1) determine if the effect of ingested 2'-FL on the modulation of CNS function is dependent on the integrity of the molecule; and (2) confirm if oral 2'-FL modified hippocampal LTP and associative learning related skills in rats submitted to bilateral subdiaphragmatic vagotomy. Results showed that 2'-FL but not Fuc enhanced LTP, and vagotomy inhibited the effects of oral 2'-FL on LTP and associative learning related paradigms. Taken together, the data show that dietary 2'-FL but not its Fuc moiety affects cognitive domains and improves learning and memory in rats. This effect is dependent on vagus nerve integrity, suggesting GBA plays a role in 2'-FL-mediated cognitive benefits.	[Vazquez, Enrique; Barranco, Alejandro; Ramirez, Maria; Jimenez, Maria L.; Rueda, Ricardo] Abbott Nutr, Strateg R&D Dept, Granada 18004, Spain; [Buck, Rachael] Abbott Nutr, Strateg R&D Dept, Columbus, OH USA; [Gruart, Agnes; Delgado-Garcia, Jose M.] Pablo de Olavide Univ, Div Neurosci, Seville 41013, Spain	Universidad Pablo de Olavide	Vazquez, E (corresponding author), Abbott Nutr, Strateg R&D Dept, Granada 18004, Spain.	Enrique.vazquez@abbott.com	Delgado-Garcia, Jose M./V-1567-2019		Abbott Nutrition	Abbott Nutrition(Abbott Laboratories)	The study has been exclusively funded by Abbott Nutrition. The funder provided support in the form of salaries for authors [EV, AB, MR, MLJ, RB, RR] as well as budget for expenses associated with experimental work. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bienenstock J, 2015, NUTR REV, V73, P28, DOI 10.1093/nutrit/nuv019; Bienenstock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076236; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Bode L, 2015, EARLY HUM DEV, V91, P619, DOI 10.1016/j.earlhumdev.2015.09.001; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Castanys-Munoz E, 2013, NUTR REV, V71, P773, DOI 10.1111/nure.12079; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Gallaher ZR, 2012, NEUROSCI LETT, V513, P31, DOI 10.1016/j.neulet.2012.01.079; German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322; Goehring KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101692; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; GURD JW, 1979, BIOCHIM BIOPHYS ACTA, V555, P221, DOI 10.1016/0005-2736(79)90162-7; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Jantscher-Krenn E, 2012, MINERVA PEDIATR, V64, P83; Jantscher-Krenn E, 2013, BRIT J NUTR, V110, P640, DOI 10.1017/S0007114512005727; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; JORK R, 1986, PHARMACOL BIOCHEM BE, V25, P1137, DOI 10.1016/0091-3057(86)90100-0; Keightley P, 2015, AUSTRALAS PSYCHIATRY, V23, P403, DOI 10.1177/1039856215590033; Keightley PC, 2015, AUST NZ J PSYCHIAT, V49, P207, DOI 10.1177/0004867415569801; Knowles CH, 2013, NAT REV GASTRO HEPAT, V10, P206, DOI 10.1038/nrgastro.2013.18; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; KRUG M, 1994, BRAIN RES, V643, P130, DOI 10.1016/0006-8993(94)90018-3; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Matthies H, 1996, BRAIN RES, V725, P276, DOI 10.1016/0006-8993(96)00406-4; Matthies H, 2000, LEARN MEMORY, V7, P227, DOI 10.1101/lm.7.4.227; Matthies H, 1999, NEUROSCIENCE, V91, P175, DOI 10.1016/S0306-4522(98)00628-9; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Murrey HE, 2009, BIOCHEMISTRY-US, V48, P7261, DOI 10.1021/bi900640x; Oliveros E, 2016, J NUTR BIOCHEM, V31, P20, DOI 10.1016/j.jnutbio.2015.12.014; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters JH, 2013, J COMP NEUROL, V521, P3584, DOI 10.1002/cne.23374; Pickard JM, 2015, J IMMUNOL, V194, P5588, DOI 10.4049/jimmunol.1500395; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rudloff S, 2006, GLYCOBIOLOGY, V16, P477, DOI 10.1093/glycob/cwj092; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Sanchez-Campusano R, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00039; Santos-Fandila A, 2014, TALANTA, V118, P137, DOI 10.1016/j.talanta.2013.10.013; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Sherman MP, 2015, PEDIATR RES, V77, P127, DOI 10.1038/pr.2014.161; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; SUKUMAR R, 1980, J NEUROCHEM, V34, P1000, DOI 10.1111/j.1471-4159.1980.tb09677.x; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; Udit S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00134; Urashima T, 2013, BIOSCI BIOTECH BIOCH, V77, P455, DOI 10.1271/bbb.120810; Vazquez E, 2015, J NUTR BIOCHEM, V26, P455, DOI 10.1016/j.jnutbio.2014.11.016; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Wu SA, 2011, J PROTEOME RES, V10, P856, DOI 10.1021/pr101006u; Wu SA, 2010, J PROTEOME RES, V9, P4138, DOI 10.1021/pr100362f; ZATZ M, 1971, J NEUROCHEM, V18, P1125, DOI 10.1111/j.1471-4159.1971.tb12041.x; Zuo YT, 2007, PHYSIOL BEHAV, V90, P583, DOI 10.1016/j.physbeh.2006.11.009	58	36	39	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166070	10.1371/journal.pone.0166070	http://dx.doi.org/10.1371/journal.pone.0166070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851789	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300034
J	Abera, B; Kibret, M; Mulu, W				Abera, Bayeh; Kibret, Mulugeta; Mulu, Wondemagegn			Extended-Spectrum beta (beta)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESISTANT; LACTAMASES; HEALTH	Background The spread of Extended-Spectrum beta (beta)-Lactamases (ESBL)-producing Enterobacteriaceae has become a serious global problem. ESBL-producing Enterobacteriaceae vary based on differences in antibiotic use, nature of patients and hospital settings. This study was aimed at determining ESBL and antibiogram in Enterobacteriaceae isolates from clinical and drinking water sources in Bahir Dar City, Northwest Ethiopia. Methods Enterobacteriaceae species were isolated from clinical materials and tap water using standard culturing procedures from September 2013 to March 2015. ESBL-producing-Enterobacteriaceae were detected using double-disk method by E-test Cefotaxim/cefotaxim+ clavulanic acid and Ceftazidime/ceftazidime+ clavulanic acid (BioMerieux SA, France) on Mueller Hinton agar (Oxoid, UK). Results Overall, 274 Enterobacteriaceae were isolated. Of these, 210 (44%) were from patients and 64 (17.1%) were from drinking water. The median age of the patients was 28 years. Urinary tract infection and blood stream infection accounted for 60% and 21.9% of Enterobacteriaceae isolates, respectively. Klebsiella pneumoniae was isolated from 9 (75%) of neonatal sepsis. The overall prevalence of ESBL-producing Enterobacteriaceae in clinical and drinking water samples were 57.6% and 9.4%, respectively. The predominant ESBL-producers were K. pneumoniae 34 (69.4%) and Escherichia coli 71 (58.2%). Statistically significant associations were noted between ESBL-producing and non-producing Enterobacteriaceae with regard to age of patients, infected body sites and patient settings (P = 0.001). ESBLproducing Enterobacteriaceae showed higher levels of resistance against chloramphenicol, ciprofloxacin and cotrimoxazole than non-ESBL producers (P = 0.001) Conclusions ESBL-producing Enterobacteriaceae coupled with high levels of other antimicrobials become a major concern for treatment of patients with invasive infections such as blood stream infections, neonatal sepsis and urinary tract infections. ESBL-producing Enterobacteriaceae were also detected in drinking water sources.	[Abera, Bayeh; Mulu, Wondemagegn] Bahir Dar Univ, Dept Microbiol Immunol & Parasitol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Kibret, Mulugeta] Bahir Dar Univ, Dept Biol, Coll Sci, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Abera, B (corresponding author), Bahir Dar Univ, Dept Microbiol Immunol & Parasitol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	bayeabera15@gmail.com	Mulu, Wondemagegn/X-3190-2019; Abera, Bayeh/AAU-8754-2020		Biotechnology Research Institute of Bahir University [1/339/1.11.10]	Biotechnology Research Institute of Bahir University	The authors cordially acknowledge the Biotechnology Research Institute of Bahir University for the financial support on grant number 1/339/1.11.10.; The authors cordially acknowledge the Biotechnology Research Institute of Bahir University for the financial support on grant number 1/339/1.11.10. We also acknowledge the technical support of the staff of the Bahir Dar Regional Health Research Laboratory Centre.	Abera B, 2014, J WATER SANIT HYG DE, V4, P384, DOI 10.2166/washdev.2014.105; Alzahrani AM, 2011, AFR J MICROBIOL RES, V5, P123; [Anonymous], 2003, BASIC LAB PROCEDURES; Aruna K, 2012, EXCLI J, V11, P363; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Brolund Alma, 2014, Infection Ecology & Epidemiology, V4, P24555, DOI 10.3402/iee.v4.24555; Chesbrougn M, 2000, MANUAL MED MICROBIOL, P251; Clinical Laboratory Standards Institute, 2013, M100S21 CLSI; De Boeck H, 2012, EMERG INFECT DIS, V18, P1019, DOI 10.3201/eid1806.111214; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; Johnson JR, 2002, J INFECT DIS, V186, P859, DOI 10.1086/342490; Kateregga JN, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0013-1; Mehrgan H, 2010, J INFECT DEV COUNTR, V4, P132, DOI 10.3855/jidc.488; Mulualem Yohannes, 2012, East Afr J Public Health, V9, P58; Odumosu B, 2014, AFR J CLIN EXPT MICR, V16, P28; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rashid Mahmudur, 2015, Infection Ecology & Epidemiology, V5, P26712, DOI 10.3402/iee.v5.26712; Sahoo KC, 2012, INT J ENV RES PUB HE, V9, P746, DOI 10.3390/ijerph9030746; Seid J, 2005, ACTA TROP, V95, P143, DOI 10.1016/j.actatropica.2005.05.009; Sethaphanich N, 2016, PEDIATR INT, V58, P338, DOI 10.1111/ped.12845; Somily AM, 2014, J INFECT DEV COUNTR, V8, P1129, DOI 10.3855/jidc.4292; Teferra Abula, 2004, Ethiopian Journal of Health Development, V18, P35; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization, 2004, GUID DRINK WAT QUAL, P1, DOI DOI 10.1037/E333612004-001	27	19	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166519	10.1371/journal.pone.0166519	http://dx.doi.org/10.1371/journal.pone.0166519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846254	Green Submitted, gold, Green Published			2022-12-27	WOS:000387794600074
J	Pilishvili, T; Loo, JD; Schrag, S; Stanistreet, D; Christensen, B; Yip, F; Nyagol, R; Quick, R; Sage, M; Bruce, N				Pilishvili, Tamara; Loo, Jennifer D.; Schrag, Stephanie; Stanistreet, Debbi; Christensen, Bryan; Yip, Fuyuen; Nyagol, Ronald; Quick, Robert; Sage, Mike; Bruce, Nigel			Effectiveness of Six Improved Cookstoves in Reducing Household Air Pollution and Their Acceptability in Rural Western Kenya	PLOS ONE			English	Article							PARTICULATE MATTER; GLOBAL BURDEN; INDOOR; STOVES; RISK; GUATEMALA; PNEUMONIA; KEROSENE; EXPOSURE	Background Household air pollution (HAP) from biomass fuel burning is linked to poor health outcomes. Improved biomass cookstoves (ICS) have the potential to improve HAP. Objectives A pre-/post-intervention study assessed the impact of six ICS on indoor air quality and acceptability of ICS to local users in rural Western Kenya. Methods We measured mean personal and kitchen level concentrations of particulate matter <2.5 mu m in diameter (PM2.5, mu g/m(3)) and carbon monoxide (CO, ppm) during the 48-hour period of each ICS use in 45 households. We compared these levels to those observed with traditional 3-stone fire (TSF) use. We assessed ICS acceptability through interviews and focus groups. We evaluated association of stove type, fuel use, and factors related to cooking practices with mean kitchen PM2.5 and CO using multivariable regression. Results Stove type, exclusive ICS use (vs. concurrent TSF use), and the amount of fuel used were independently associated with kitchen PM2.5 and CO levels. Reductions (95% CI) in mean PM2.5 compared to TSF, ranged by ICS from 11.9% (-2.8-24.5) to 42.3% (32.3-50.8). Reductions in kitchen CO compared to TSF, ranged by ICS from -5.8% (-21.9-8.2) to 34.5% (23.2-44.1). Mean kitchen PM2.5 ranged from 319 mu g/m(3) to 518 mu g/m(3) by ICS. Women thought ICS were easy to use, more efficient, produced less smoke, and cooked faster, compared to TSF. Women also reported limitations for each ICS. Conclusions We documented reductions in HAP from ICS compared to TSF. The PM2.5 levels with ICS use were still considerably higher than WHO indoor air quality guidelines. Achieving maximal potential of ICS requires adherence to more exclusive use and addressing user reported ICS limitations.	[Pilishvili, Tamara; Loo, Jennifer D.; Schrag, Stephanie; Christensen, Bryan; Yip, Fuyuen; Quick, Robert; Sage, Mike] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Stanistreet, Debbi; Bruce, Nigel] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England; [Nyagol, Ronald] Safe Water & AIDS Project, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; University of Liverpool	Pilishvili, T (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	tpilishvili@cdc.gov		Stanistreet, Debbi/0000-0003-3738-1727	Centers for Disease Control and Prevention; Morgan Stanley Foundation	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Morgan Stanley Foundation	Funding for the study was provided by the Centers for Disease Control and Prevention and The Morgan Stanley Foundation. The study was approved by the Institutional Review Boards of the Kenya Medical Research Institute (protocol number 2075) and the Centers for Disease Control and Prevention (protocol number 6155).	Apple J, 2010, INDOOR AIR, V20, P399, DOI 10.1111/j.1600-0668.2010.00664.x; Balakrishnan K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-77; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bruce N, 2004, J EXPO ANAL ENV EPID, V14, pS26, DOI 10.1038/sj.jea.7500355; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Jetter JJ, 2009, BIOMASS BIOENERG, V33, P294, DOI 10.1016/j.biombioe.2008.05.014; Lam NL, 2012, J TOXICOL ENV HEAL B, V15, P396, DOI 10.1080/10937404.2012.710134; Loo JD, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020167; Lozier M, 2015, OBJECTIVE ASSE UNPUB, DOI 10.1038/sj.jea.7500355; Naeher LP, 2000, INDOOR AIR, V10, P200; Po JYT, 2011, THORAX, V66, P232, DOI 10.1136/thx.2010.147884; Puzzolo E, 2013, FACTORS INFLUENCING; Smith KR, 2014, ANNU REV PUBL HEALTH, V35, P185, DOI 10.1146/annurev-publhealth-032013-182356; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; Stokes D, 2012, DESIGN TESTING THERM; WHO, 2014, IND AIR QUAL GUID HO; Zuk M, 2007, J EXPO SCI ENV EPID, V17, P224, DOI 10.1038/sj.jes.7500499	19	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165529	10.1371/journal.pone.0165529	http://dx.doi.org/10.1371/journal.pone.0165529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846224	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600012
J	Sumimoto, H; Takano, A; Teramoto, K; Daigo, Y				Sumimoto, Hidetoshi; Takano, Atsushi; Teramoto, Koji; Daigo, Yataro			RAS-Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers	PLOS ONE			English	Article							TARGETED THERAPY; IMMUNE EVASION; IFN-GAMMA; B7-H1; PATHWAY; METASTASIS; MELANOMA; CELLS; INFECTION; MIGRATION	Ectopic programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancers (NSCLCs) is related to immune evasion by cancer, and it is a molecular target of immune checkpoint therapies. Although some altered signals in NSCLCs are responsible for ectopic PD-L1 expression, the precise mechanisms remain obscure. Because we found a higher frequency of EGFR/KRAS mutations in NSCLC cell lines with high PD-L1 expression (p < 0.001), we evaluated the relationships between downstream signals and PD-L1 expression, particularly in three KRAS-mutant adenocarcinoma cell lines. The MEK inhibitor U0126 (20 mu M) significantly decreased the surface PD-L1 levels by 50-60% compared with dimethyl sulfoxide (p < 0.0001). Phorbol 12-myristate 13-acetate stimulation (100 nM, 15 min) increased (p < 0.05) and two ERK2 siRNAs as well as KRAS siRNAs decreased (p < 0.05) PD-L1 expression. The transcriptional activity of the potential AP-1 site (+ 4785 to + 5056 from the transcription start site) in the PD-L1 gene was demonstrated by luciferase assays, which was inhibited by U0126. The chromatin immunoprecipitation assay demonstrated the binding of cJUN to the AP-1 site. Two STAT3 siRNAs decreased PD-L1 expression by 10 +/- 32% in two of the three KRAS-mutant lung adenocarcinoma cell lines (p < 0.05), while the PI3K inhibitor LY294002 (40 mu M) did not change the expression level. Supervised cluster analysis and gene set enrichment analysis between the PD-L1-high and-low NSCLCs revealed a correlation between PD-L1 expression and genes/pathways related to cell motility/adhesion. These results indicate that MAPK signaling is the dominant downstream signal responsible for ectopic PD-L1 expression, in which STAT3 is also involved to some extent. Furthermore, MAPK signaling may control the expression of PD-L1 and several genes related to enhanced cell motility. Our findings suggest that MAPK, along with STAT3, is important for determining PD-L1 expression, which could be useful for targeted therapies against lung cancers.	[Sumimoto, Hidetoshi; Takano, Atsushi; Teramoto, Koji; Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga, Japan; [Sumimoto, Hidetoshi; Takano, Atsushi; Teramoto, Koji; Daigo, Yataro] Shiga Univ Med Sci, Ctr Canc, Otsu, Shiga, Japan; [Takano, Atsushi; Daigo, Yataro] Univ Tokyo, Res Hosp, Inst Med Sci, Ctr Antibody & Vaccine Therapy, Tokyo, Japan	Shiga University of Medical Science; Shiga University of Medical Science; University of Tokyo	Daigo, Y (corresponding author), Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga, Japan.; Daigo, Y (corresponding author), Shiga Univ Med Sci, Ctr Canc, Otsu, Shiga, Japan.; Daigo, Y (corresponding author), Univ Tokyo, Res Hosp, Inst Med Sci, Ctr Antibody & Vaccine Therapy, Tokyo, Japan.	ydago@ims.u-tokyo.ac.jp	Sumimoto, Hidetoshi/AAE-6873-2020	Daigo, Yataro/0000-0002-0915-3025	Japan Society for the Promotion of Science; JSPS KAKENHI [15H04761, 16H06277]; Shiga Prefecture (Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Shiga Prefecture (Japan)	This work was supported in part by Grant-in-Aid for Scientific Research (B) and Grant in-Aid for Scientific Research on Innovative Areas from The Japan Society for the Promotion of Science to Y.D. (JSPS KAKENHI Grant Number JP: 15H04761 and 16H06277). Y.D. is a member of Shiga Cancer Treatment Project supported by Shiga Prefecture (Japan).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; CAMIENER GW, 1965, BIOCHEM PHARMACOL, V14, P1405, DOI 10.1016/0006-2952(65)90175-9; Campbell LM, 2013, PHARMACEUTICALS, V6, P929, DOI 10.3390/ph6080929; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Yamamoto R, 2009, CANCER SCI, V100, P2093, DOI 10.1111/j.1349-7006.2009.01302.x; Yao X, 2014, UROL ONCOL-SEMIN ORI, V32, P162, DOI 10.1016/j.urolonc.2012.12.006	30	111	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166626	10.1371/journal.pone.0166626	http://dx.doi.org/10.1371/journal.pone.0166626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846317	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600092
J	Peoples, BK; Midway, SR; Sackett, D; Lynch, A; Cooney, PB				Peoples, Brandon K.; Midway, Stephen R.; Sackett, Dana; Lynch, Abigail; Cooney, Patrick B.			Twitter Predicts Citation Rates of Ecological Research	PLOS ONE			English	Article							METRICS; TWEETS; IMPACT; ALTMETRICS; JOURNALS; SCIENCE; SCOPUS	The relationship between traditional metrics of research impact (e.g., number of citations) and alternative metrics (altmetrics) such as Twitter activity are of great interest, but remain imprecisely quantified. We used generalized linear mixed modeling to estimate the relative effects of Twitter activity, journal impact factor, and time since publication on Web of Science citation rates of 1,599 primary research articles from 20 ecology journals published from 2012-2014. We found a strong positive relationship between Twitter activity (i.e., the number of unique tweets about an article) and number of citations. Twitter activity was a more important predictor of citation rates than 5-year journal impact factor. Moreover, Twitter activity was not driven by journal impact factor; the 'highest-impact' journals were not necessarily the most discussed online. The effect of Twitter activity was only about a fifth as strong as time since publication; accounting for this confounding factor was critical for estimating the true effects of Twitter use. Articles in impactful journals can become heavily cited, but articles in journals with lower impact factors can generate considerable Twitter activity and also become heavily cited. Authors may benefit from establishing a strong social media presence, but should not expect research to become highly cited solely through social media promotion. Our research demonstrates that altmetrics and traditional metrics can be closely related, but not identical. We suggest that both altmetrics and traditional citation rates can be useful metrics of research impact.	[Peoples, Brandon K.] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA; [Midway, Stephen R.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Sackett, Dana] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Lynch, Abigail] US Geol Survey, Natl Climate Change & Wildlife Sci Ctr, 959 Natl Ctr, Reston, VA 22092 USA; [Cooney, Patrick B.] Smith Root Inc, Vancouver, WA USA	Louisiana State University System; Louisiana State University; Auburn University System; Auburn University; United States Department of the Interior; United States Geological Survey	Peoples, BK (corresponding author), Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA.	peoples@clemson.edu	Lynch, Abigail J./H-5059-2019	Lynch, Abigail J./0000-0001-8449-8392	Smith-Root Inc	Smith-Root Inc	Smith-Root Inc provided support in the form of salaries for author Patrick B. Cooney, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie E, 2013, LEARN PUBL, V26, P11, DOI 10.1087/20130103; Ajiferuke I, 2015, J INFORMETR, V9, P499, DOI 10.1016/j.joi.2015.05.001; Alcaraz C, 2012, NATURE, V483, P36, DOI 10.1038/483036d; [Anonymous], 2015, R LANG ENV STAT COMP; Bar-Ilan Judit, 2012, ARXIV12055611; Bik HM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001535; Branch TA, 2016, FISH FISH, V17, P1094, DOI 10.1111/faf.12160; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; Buela-Casal G, 2014, EUR J PSYCHOL APPL L, V6, P91, DOI 10.1016/j.ejpal.2014.06.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; de Winter JCF, 2015, SCIENTOMETRICS, V102, P1773, DOI 10.1007/s11192-014-1445-x; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Fenner M., 2014, ALTMETRICS OTHER NOV, P179; Galligan F, 2013, SERIALS REV, V39, P56, DOI 10.1016/j.serrev.2013.01.003; Haustein S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120495; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; Holmberg Kim, 2014, Scientometrics, V101, P1027, DOI 10.1007/s11192-014-1229-3; Maflahi N, 2016, J ASSOC INF SCI TECH, V67, P191, DOI 10.1002/asi.23369; Piwowar H, 2013, NATURE, V493, P159, DOI 10.1038/493159a; Priem J., 2010, ALTMETRICS MANIFESTO; Priem J., 2012, ARXIV12034745; Priem J, 2013, NATURE, V495, P437, DOI 10.1038/495437a; Ringelhan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134389; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Seglen PO, 1997, BRIT MED J, V314, P498; Shema H, 2014, J ASSOC INF SCI TECH, V65, P1018, DOI 10.1002/asi.23037; Shuai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047523; Sud P, 2014, SCIENTOMETRICS, V98, P1131, DOI 10.1007/s11192-013-1117-2; Thelwall M, 2012, P 17 INT C SCI TECHN; Thelwall M, 2016, ASLIB J INFORM MANAG, V68, P2, DOI 10.1108/AJIM-09-2015-0146; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Waltman L, 2011, J INFORMETR, V5, P37, DOI 10.1016/j.joi.2010.08.001; Zahedi Z, 2014, ALTM 14 WORKSH WEB S	35	107	107	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166570	10.1371/journal.pone.0166570	http://dx.doi.org/10.1371/journal.pone.0166570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835703	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200059
J	Burri, A; Marinova, Z; Robinson, MD; Kuhnel, B; Waldenberger, M; Wahl, S; Kunze, S; Gieger, C; Livshits, G; Williams, F				Burri, Andrea; Marinova, Zoya; Robinson, Mark D.; Kuehnel, Brigitte; Waldenberger, Melanie; Wahl, Simone; Kunze, Sonja; Gieger, Christian; Livshits, Gregory; Williams, Frances			Are Epigenetic Factors Implicated in Chronic Widespread Pain?	PLOS ONE			English	Article							MONOAMINE-OXIDASE-B; DNA METHYLATION; FIBROMYALGIA SYNDROME; COLLAGEN; COMORBIDITIES; ASSOCIATION; INVOLVEMENT	Background Chronic widespread musculoskeletal pain (CWP) is the cardinal symptom of fibromyalgia and affects about 12% of the general population. Familial aggregation of CWP has been repeatedly demonstrated with estimated heritabilities of around 50%, indicating a genetic susceptibility. The objective of the study was to explore genome-wide disease-differentially methylated positions (DMPs) for chronic widespread pain (CWP) in a sample of unrelated individuals and a subsample of discordant monozygotic (MZ) twins. Methodology/Principle Findings A total of N = 281 twin individuals from the TwinsUK registry, including N = 33 MZ twins discordant for self-reported CWP, were part of the discovery sample. The replication sample included 729 men and 756 women from a subsample of the KORA S4 survey-an independent population-based cohort from Southern Germany. Epigenome-wide analysis of DNA methylation was conducted using the Illumina Infinium HumanMethylation 450 DNA Bead-Chip in both the discovery and replication sample. Of our 40 main loci that were carried forward for replication, three CPGs reached significant p-values in the replication sample, including malate dehydrogenase 2 (MDH2; p-value 0.017), tetranectin (CLEC3B; p-value 0.039), and heat shock protein beta-6 (HSPB6; p-value 0.016). The associations between the collagen type I, alpha 2 chain (COL1A2) and monoamine oxidase B (MAOB) observed in the discovery sample-both of which have been previously reported to be biological candidates for pain-could not be replicated. Conclusion/Significance Our results may serve as a starting point to encourage further investigation in large and independent population-based cohorts of DNA methylation and other epigenetic changes as possible disease mechanisms in CWP. Ultimately, understanding the key mechanisms underlying CWP may lead to new treatments and inform clinical practice.	[Burri, Andrea] Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand; [Burri, Andrea] North Shore Hosp, Dept Anaesthesia & Perioperat Med, Waitemata Pain Serv, Auckland, New Zealand; [Burri, Andrea] Univ Zurich, Dept Psychol, Binzmuhlestr 14, CH-8050 Zurich, Switzerland; [Marinova, Zoya] Clin Barmelweid, Dept Psychosomat Med, CH-5017 Barmelweid, Switzerland; [Robinson, Mark D.] Univ Zurich, Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland; [Robinson, Mark D.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Kuehnel, Brigitte; Waldenberger, Melanie; Wahl, Simone; Kunze, Sonja; Gieger, Christian] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany; [Kuehnel, Brigitte; Waldenberger, Melanie; Wahl, Simone; Kunze, Sonja; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Munich, Germany; [Livshits, Gregory] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Livshits, Gregory; Williams, Frances] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, Westminster Bridge Rd, London SE1 7EH, England	Auckland University of Technology; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; University of Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Tel Aviv University; Sackler Faculty of Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Burri, A (corresponding author), Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand.; Burri, A (corresponding author), North Shore Hosp, Dept Anaesthesia & Perioperat Med, Waitemata Pain Serv, Auckland, New Zealand.; Burri, A (corresponding author), Univ Zurich, Dept Psychol, Binzmuhlestr 14, CH-8050 Zurich, Switzerland.	a.burri@psychologie.uzh.ch	Livshits, Gregory/AAG-7051-2019; Waldenberger, Melanie/B-5355-2014; Robinson, Mark D./O-2254-2019	Livshits, Gregory/0000-0003-3766-7493; Waldenberger, Melanie/0000-0003-0583-5093; Robinson, Mark D./0000-0002-3048-5518; Burri, Andrea/0000-0002-4705-3551; Kunze, Sonja/0000-0002-9685-2675; Williams, Frances/0000-0002-2998-2744	Arthritis Research UK [20682]; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)- funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's; St Thomas' NHS Foundation Trust; Helmholtz Zentrum Munchen German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; European Union Seventh Framework Programme (FP7) [603288, HEALTH-F2-2013-602736]; European Union's Seventh Framework Programme (FP7-Health-F5) [305280]; Swiss National Science Foundation; Swisslife Jubilaumsstiftung; Swiss National Science Foundation [143883]; European Commission through the 7th Framework Collaborative Project RADIANT [305626]; Versus Arthritis [20682] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)- funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's; St Thomas' NHS Foundation Trust; Helmholtz Zentrum Munchen German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; European Union Seventh Framework Programme (FP7); European Union's Seventh Framework Programme (FP7-Health-F5); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swisslife Jubilaumsstiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission through the 7th Framework Collaborative Project RADIANT; Versus Arthritis(Versus Arthritis)	The study was supported by Arthritis Research UK (grant 20682). TwinsUK: the cohort was supported by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)- funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The authors declare no conflict of interest. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health (https://www.helmholtz-muenchen.de/), which is funded by the German Federal Ministry of Education and Research (BMBF; https://www.bmbf.de/en/) and by the State of Bavaria. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreements no 603288 (SysVasc), HEALTH-F2-2013-602736 (PAIN-OMICS) and European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement 305280 (MIMOmics). AB reports an Ambizione personal career fellowship by the Swiss National Science Foundation and a project grant from the Swisslife Jubilaumsstiftung. FW has grant support from Arthritis Research UK (grant 20682). MDR acknowledges funding from a Swiss National Science Foundation project grant (143883) and from the European Commission through the 7th Framework Collaborative Project RADIANT (grant agreement number 305626).; AB reports an Ambizione personal career fellowship by the Swiss National Science Foundation and a project grant from the Swisslife Jubilaumsstiftung. FW has grant support from Arthritis Research UK (grant 20682). MDR acknowledges funding from a Swiss National Science Foundation project grant (143883) and from the European Commission through the 7th Framework Collaborative Project RADIANT (grant agreement number 305626). The KORA-Study Group consists of A. Peters, J. Heinrich, R. Holle, R. Leidl, C. Meisinger, K. Strauch, and their co-workers, who are responsible for the design and conduct of the KORA studies.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Burri A, 2015, PAIN, V156, P1458, DOI 10.1097/j.pain.0000000000000182; Choi WJ, 2014, FOOT ANKLE INT, V35, P1045, DOI 10.1177/1071100714540885; COQUOZ D, 1993, CLIN PHARMACOL THER, V54, P339, DOI 10.1038/clpt.1993.156; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Genc H, 2003, YONSEI MED J, V44, P619, DOI 10.3349/ymj.2003.44.4.619; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gronemann ST, 2004, RHEUMATOLOGY, V43, P27, DOI 10.1093/rheumatology/keg452; Hauser W, 2009, JAMA-J AM MED ASSOC, V301, P198, DOI 10.1001/jama.2008.944; Hansen KD, 2014, PACKAGE MINFI ANAL I; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Limer KL, 2008, RHEUMATOLOGY, V47, P572, DOI 10.1093/rheumatology/ken027; Livshits G, 2014, ANN HUM GENET, V78, P357, DOI [10.1111/ahg.12074, DOI 10.1111/AHG.12074]; Lu CE, 2015, J NEUROL SCI, V352, P48, DOI 10.1016/j.jns.2015.03.018; Malkin I, 2015, PAIN, V156, P1845, DOI [10.1097/j.pain.0000000000000200, DOI 10.1097/J.PAIN.0000000000000200]; Mansfield KE, 2016, PAIN, V157, P55, DOI 10.1097/j.pain.0000000000000314; Menzies V, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/795784; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Olson GB, 2000, CRANIO, V18, P135, DOI 10.1080/08869634.2000.11746125; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Pirildar Sebnem, 2003, Psychopharmacol Bull, V37, P127; R Core Team, 2020, R LANG ENV STAT COMP; Ribel-Madsen S, 2005, INT J TISSUE REACT, V27, P75; Schreiber S, 1998, NEUROSCI LETT, V253, P183, DOI 10.1016/S0304-3940(98)00638-7; Sery O, 2006, NEUROENDOCRINOL LETT, V27, P333; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Szyf M, 2013, CHILD DEV, V84, P49, DOI 10.1111/j.1467-8624.2012.01793.x; Tort S, 2012, COCHRANE DB SYST REV, V8; Treister R, 2009, PAIN, V147, P187, DOI 10.1016/j.pain.2009.09.001; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Villarinho JG, 2012, EUR J PHARMACOL, V690, P107, DOI 10.1016/j.ejphar.2012.06.042; von Wurmb-Schwark Nicole, 2004, Leg Med (Tokyo), V6, P125, DOI 10.1016/j.legalmed.2003.12.002; Wade J. B, 2000, PERSONALITY CHARACTE, P89; White KP, 1999, J RHEUMATOL, V26, P885; Willis DE, 2015, NEUROSCI LETT; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165548	10.1371/journal.pone.0165548	http://dx.doi.org/10.1371/journal.pone.0165548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832094	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000387725000020
J	Ding, YJ; Ma, Q; Liu, F; Zhao, L; Wei, WQ				Ding, Yuanjie; Ma, Qing; Liu, Fen; Zhao, Lei; Wei, Wenqiang			The Potential Use of Salivary miRNAs as Promising Biomarkers for Detection of Cancer: A Meta-Analysis	PLOS ONE			English	Article							DIAGNOSTIC-TEST ACCURACY; SYSTEMATIC REVIEWS; ESOPHAGEAL CANCER; CLINICAL UTILITY; BODY-FLUIDS; ORAL-CANCER; MICRORNAS; CARE	Background Accumulating evidence has demonstrated that microRNAs (miRNAs) could serve as promising molecular biomarkers for cancer detection. This study aims to systematically assess the diagnostic performance of salivary miRNAs in detection of cancer through a comprehensive meta-analysis. Methods Eligible studies were identified using PubMed and other computerized databases up to October 31, 2015, supplemented by a manual search of references from retrieved articles. The pooled sensitivity, specificity, and other measurements of accuracy of salivary miRNAs in the diagnosis of cancer were analyzed using the bivariate binomial mixed model. Results Seventeen studies from 8 articles with 694 subjects were included in this meta-analysis. All studies have a relatively high score of quality assessment. The overall sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) of salivary miRNAs in detection of cancer were 0.77 (95% confidence intervals [CI]: 0.69-0.84), 0.77 (95%CI: 0.65-0.88), 3.37 (95%CI: 2.26-5.02), 0.29 (95%CI: 0.23-0.38), and 11.41 (95%CI: 7.35-17.73), respectively. The AUC was 0.84 (95%CI: 0.80-0.87). Moreover, both whole saliva and saliva supernatant could be used as sources of clinical specimens for miRNAs detection. Conclusions Our meta-analysis demonstrated that salivary miRNAs may serve as potential noninvasive biomarkers for cancer detection. The findings need to be confirmed with further research before it can be applied in the clinic.	[Ding, Yuanjie; Liu, Fen] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Ma, Qing; Wei, Wenqiang] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Canc Epidemiol, Beijing, Peoples R China; [Ma, Qing; Wei, Wenqiang] Peking Union Med Coll, Beijing, Peoples R China; [Zhao, Lei] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA USA	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Iowa	Liu, F (corresponding author), Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.; Wei, WQ (corresponding author), Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Canc Epidemiol, Beijing, Peoples R China.; Wei, WQ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	liufen05@ccmu.edu.cn; weiwq@cicams.ac.cn	Liu, Fen/R-7749-2019		National Natural Science Foundation of China [81473056, 81573224, 30901239]; Beijing Natural Science Foundation [7132023]; Importation and Development of High Caliber Talents Project of Beijing Municipal Institutions [CITTCD201404183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Importation and Development of High Caliber Talents Project of Beijing Municipal Institutions	This work was partly supported by grants from the National Natural Science Foundation of China (81473056, 81573224 and 30901239), Beijing Natural Science Foundation (7132023) and the Importation and Development of High Caliber Talents Project of Beijing Municipal Institutions to FL (CIT&TCD201404183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by grants from the National Natural Science Foundation of China (81473056, 81573224 and 30901239), Beijing Natural Science Foundation (7132023) and the Importation and Development of High Caliber Talents Project of Beijing Municipal Institutions to FL (CIT&TCD201404183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Handy B, 2009, LABMEDICINE, V40, P99, DOI 10.1309/LMTRKSKYW4GI6SBJ; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Humeau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130996; Igaz I, 2015, EXPERIENTIA SUPPL, V106, P245, DOI 10.1007/978-3-0348-0955-9_11; Kim T, 2011, J SURG ONCOL, V103, P179, DOI 10.1002/jso.21784; Lee J, 2015, KOREAN J RADIOL, V16, P1188, DOI 10.3348/kjr.2015.16.6.1188; Lee YH, 2009, AM J DENT, V22, P241; Li W, 2015, CHONGQING YIXUE, P1894; Momen-Heravi F, 2014, J DENT RES, V93, P86, DOI 10.1177/0022034514531018; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Patel RS, 2011, ARCH ORAL BIOL, V56, P1506, DOI 10.1016/j.archoralbio.2011.05.015; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wu Weidong, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1783; Xie ZJ, 2012, ASIAN PAC J CANCER P, V13, P6145, DOI 10.7314/APJCP.2012.13.12.6145; Xie ZJ, 2015, CANCER PREV RES, V8, P165, DOI 10.1158/1940-6207.CAPR-14-0192; Xie ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057502; Ye Minhua, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P885; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	27	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166303	10.1371/journal.pone.0166303	http://dx.doi.org/10.1371/journal.pone.0166303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832115	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000092
J	Enciso, M; Meftahi, N; Walker, ML; Smith, BJ				Enciso, Marta; Meftahi, Nastaran; Walker, Michael L.; Smith, Brian J.			BioPPSy: An Open-Source Platform for QSAR/QSPR Analysis	PLOS ONE			English	Article							POLAR SURFACE-AREA; AQUEOUS SOLUBILITY; DRUG DISCOVERY; ORGANIC-COMPOUNDS; ADME EVALUATION; DIVERSE SET; PREDICTION; PERMEABILITY; TRANSPORT; MOLECULES	The reliability of quantitative structure-property relationship (QSPR) and quantitative structure-activity relationship (QSAR) models is often difficult to assess due to the problems of accessing the tools and data used to build the models. We present here BioPPSy, which aims to fill this gap by providing an easy-to-use open-source software platform. We demonstrate the program capabilities by calculating three key properties used in drug discovery, aqueous solubility, Caco-2 cell permeability and blood-brain barrier permeability. A comparison is made with a number of previously reported methods, taken from the literature, for each property.	[Enciso, Marta; Meftahi, Nastaran; Walker, Michael L.; Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem & Phys, Bundoora, Vic 3086, Australia	La Trobe University	Smith, BJ (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem & Phys, Bundoora, Vic 3086, Australia.	brian.smith@latrobe.edu.au	Enciso, Marta/AAZ-2849-2021; Smith, Brian J/F-8282-2011	Enciso, Marta/0000-0002-3426-3752; Smith, Brian J/0000-0003-0498-1910; Meftahi, Nastaran/0000-0003-2664-4368	Australian Research Council [DP130100998]; VLSCI's Life Sciences Computation Centre; University of Melbourne; Monash University; La Trobe University	Australian Research Council(Australian Research Council); VLSCI's Life Sciences Computation Centre; University of Melbourne(University of Melbourne); Monash University(Monash University); La Trobe University	This work was supported financially through grants from Australian Research Council (DP130100998) and from the VLSCI's Life Sciences Computation Centre, a collaboration between The University of Melbourne, Monash University and La Trobe University, and an initiative of the Victorian Government, Australia.; This work was supported financially through grants from the Australian Research Council (DP130100998) and from the VLSCI's Life Sciences Computation Centre, a collaboration between The University of Melbourne, Monash University and La Trobe University, and an initiative of the Victorian Government, Australia. We are endebted to Eden Duthie, Jocelyn Penington, Nicholas Smith and Jakub Szarlat for their contributions.	Artursson P, 2012, ADV DRUG DELIVER REV, V64, P280, DOI 10.1016/j.addr.2012.09.005; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; Delaney JS, 2004, J CHEM INF COMP SCI, V44, P1000, DOI 10.1021/ci034243x; Di L, 2009, CURR PHARM DESIGN, V15, P2184, DOI 10.2174/138161209788682479; Duchowicz PR, 2009, INT J MOL SCI, V10, P2558, DOI 10.3390/ijms10062558; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Fan Y, 2010, J CHEM INF MODEL, V50, P1123, DOI 10.1021/ci900384c; Feher M, 2000, INT J PHARMACEUT, V201, P239, DOI 10.1016/S0378-5173(00)00422-1; Garg P, 2006, J CHEM INF MODEL, V46, P289, DOI 10.1021/ci050303i; Gozalbes R, 2011, BIOORGAN MED CHEM, V19, P2615, DOI 10.1016/j.bmc.2011.03.011; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Hou TJ, 2004, J CHEM INF COMP SCI, V44, P266, DOI 10.1021/ci034184n; Hou TJ, 2002, J MOL MODEL, V8, P337, DOI 10.1007/s00894-002-0101-1; Howard PH, 2000, PHYSPROP DATABASE; Huuskonen J, 2000, J CHEM INF COMP SCI, V40, P773, DOI 10.1021/ci9901338; Khan MTH, 2010, CURR DRUG METAB, V11, P285; Klopman G, 2001, J CHEM INF COMP SCI, V41, P439, DOI 10.1021/ci000152d; Lipinski C., 2002, AM PHARM REV, V5, P82; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu PX, 2009, INT J MOL SCI, V10, P1978, DOI 10.3390/ijms10051978; McElroy NR, 2001, J CHEM INF COMP SCI, V41, P1237, DOI 10.1021/ci010035y; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Nantasenamat C, 2009, EXCLI J, V8, P74; Osterberg T, 2000, J CHEM INF COMP SCI, V40, P1408, DOI 10.1021/ci000065l; Palm K, 1996, J PHARM SCI, V85, P32, DOI 10.1021/js950285r; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Sushko I, 2011, J COMPUT AID MOL DES, V25, P533, DOI 10.1007/s10822-011-9440-2; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1488, DOI 10.1021/ci000392t; Todeschini R., 2000, WILEY VCH, V11, P688; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; VANDEWATERBEEMD H, 1992, CHIMIA, V46, P299; vandeWaterbeemd H, 1996, QUANT STRUCT-ACT REL, V15, P480, DOI 10.1002/qsar.19960150604; Walker T, 2010, BIOINFORMATICS, V26, P3000, DOI 10.1093/bioinformatics/btq556; Yalkowsky S.H., 1992, AQUASOL DATABASE AQU	38	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166298	10.1371/journal.pone.0166298	http://dx.doi.org/10.1371/journal.pone.0166298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832156	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000091
J	Hurnakova, J; Hulejova, H; Zavada, J; Komarc, M; Hanova, P; Klein, M; Mann, H; Sleglova, O; Olejarova, M; Forejtova, S; Ruzickova, O; Vencovsky, J; Pavelka, K; Senolt, L				Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Komarc, Martin; Hanova, Petra; Klein, Martin; Mann, Herman; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav			Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; POWER DOPPLER ULTRASOUND; SYNOVIAL INFLAMMATION; DAMAGE; PROTEINS; SCORES; JOINTS; ULTRASONOGRAPHY; DETERIORATION; METHOTREXATE	Objective Clinical remission in some patients with rheumatoid arthritis (RA) may be associated with ongoing synovial inflammation that is not always detectable on clinical examination or reflected by laboratory tests but can be visualized by musculoskeletal ultrasound. The goal of our study was to determine the levels of serum calprotectin, a major leukocyte protein, in patients with RA in clinical remission and to investigate the ability of serum calprotectin levels to distinguish patients in ultrasound-defined remission from those with residual ultrasound subclinical inflammation. Methods Seventy RA patients in clinical remission underwent clinical and ultrasound examination. Ultrasound examination was performed according to the German US7 score. Ultrasound remission was defined as grey scale (GS) range 0-1 and power Doppler (PD) range 0. The levels of serum calprotectin and C-reactive protein (CRP) were determined. The discriminatory capacity of calprotectin and CRP in detecting residual ultrasound inflammation was assessed using ROC curves. Results The total number of patients fulfilling the DAS28-ESR, DAS28-CRP, SDAI and CDAI remission criteria was 58, 67, 32 and 31, respectively. Residual synovial inflammation was found in 58-67% of the patients who fulfilled at least one set of clinical remission criteria. Calprotectin levels were significantly higher in patients with residual synovial inflammation than in those with ultrasound-defined remission (mean 2.5 +/- 1.3 vs. 1.7 +/- 0.8 mu g/mL, p<0.005). Using ultrasound-defined remission criteria, calprotectin had an AUC of 0.692, p<0.05 using DAS28-ESR remission criteria and an AUC of 0.712, p<0.005 using DAS28-CRP remission criteria. Calprotectin correctly distinguished ultrasound remission from subclinical activity in 70% of patients. CRP (AUC DAS28-ESR = 0.494, p = NS; AUC DAS28-CRP = 0.498, p = NS) had lower and insignificant discriminatory capacity. Conclusion The present study demonstrates the potential of calprotectin to distinguish RA patients in both clinical and ultrasound-defined remission from patients in clinical remission but with residual subclinical disease activity.	[Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Klein, Martin; Mann, Herman; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Inst Rheumatol, Prague, Czech Republic; [Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Klein, Martin; Mann, Herman; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Charles Univ Prague, Dept Rheumatol, Fac Med 1, Prague, Czech Republic; [Komarc, Martin] Charles Univ Prague, Dept Methodol, Fac Phys Educ & Sport, Prague, Czech Republic	Institute of Rheumatology; Charles University Prague; Charles University Prague	Senolt, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.; Senolt, L (corresponding author), Charles Univ Prague, Dept Rheumatol, Fac Med 1, Prague, Czech Republic.	senolt@revma.cz	Hulejová, Hana/H-1909-2019; Komarc, Martin/A-7308-2017; Hurnakova, Jana/P-1932-2017; Olejárová, Marta/O-8800-2017; Vencovsky, Jiri/G-6094-2017; Klein, Martin/N-6958-2017; Hanova, Petra/O-6675-2017; Mann, Herman Felix/G-5871-2014; Komarc, Martin/O-2575-2019; Šenolt, Ladislav/O-6097-2017; Závada, Jakub/N-3159-2017; Ruzickova, Olga/O-4214-2017; Šléglová, Olga/N-3022-2017; Forejtova, Sarka/N-7448-2017; Pavelka, Karel/E-6578-2017	Hulejová, Hana/0000-0002-2335-6996; Komarc, Martin/0000-0003-4106-5217; Hurnakova, Jana/0000-0002-1139-539X; Olejárová, Marta/0000-0002-0586-361X; Vencovsky, Jiri/0000-0002-0851-0713; Klein, Martin/0000-0002-1027-0923; Hanova, Petra/0000-0003-4473-9766; Mann, Herman Felix/0000-0002-4243-235X; Komarc, Martin/0000-0003-4106-5217; Šenolt, Ladislav/0000-0001-5500-7312; Závada, Jakub/0000-0002-9802-6545; Ruzickova, Olga/0000-0003-4284-1003; Šléglová, Olga/0000-0003-1764-5852; Forejtova, Sarka/0000-0002-7510-7895; Pavelka, Karel/0000-0003-1952-8422	Ministry of Health of the Czech Republic [023728]; Internal grant agency of the Ministry of Health of the Czech Republic [NT12437]; Charles University Grant Agency (GAUK); Czech Republic [1010213]; Specific Academy Research Projects [260 031]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Internal grant agency of the Ministry of Health of the Czech Republic; Charles University Grant Agency (GAUK); Czech Republic(Czech Republic Government); Specific Academy Research Projects	This work was supported by a project of the Ministry of Health of the Czech Republic for conceptual research development by organization [023728], Internal grant agency of the Ministry of Health of the Czech Republic [NT12437], Charles University Grant Agency (GAUK), Czech Republic [1010213] and Specific Academy Research Projects (SW) [260 031]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; Backhaus M, 2013, ARTHRITIS RHEUM-US, V65, pS829; Balsa A, 2010, RHEUMATOLOGY, V49, P683, DOI 10.1093/rheumatology/kep442; BERNTZEN HB, 1989, J RHEUMATOL, V16, P1416; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; Cohen G, 2007, ANN RHEUM DIS, V66, P358, DOI 10.1136/ard.2006.057497; EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foltz V, 2012, ARTHRITIS RHEUM-US, V64, P67, DOI 10.1002/art.33312; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hammer HB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3503; Hurnakova J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0764-5; Inciarte-Mundo J, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1032-z; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Korpela M, 2004, ARTHRITIS RHEUM, V50, P2072, DOI 10.1002/art.20351; Molenaar ETH, 2004, ARTHRITIS RHEUM, V50, P36, DOI 10.1002/art.11481; Mulherin D, 1996, BRIT J RHEUMATOL, V35, P1263; Naredo E, 2005, ANN RHEUM DIS, V64, P375, DOI 10.1136/ard.2004.023929; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ohrndorf S, 2013, ANN RHEUM DIS, V72, P69, DOI 10.1136/annrheumdis-2012-202197; Ozgocmen S, 2008, SOUTH MED J, V101, P240, DOI 10.1097/SMJ.0b013e318164e16a; Padovano I, 2016, ANN RHEUM DIS, V75, P1819, DOI 10.1136/annrheumdis-2015-208103; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ramirez J, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0970-9; Saleem B, 2011, ANN RHEUM DIS, V70, P792, DOI 10.1136/ard.2010.134445; Saleem B, 2009, ARTHRITIS RHEUM-US, V60, P1915, DOI 10.1002/art.24596; Scire CA, 2009, RHEUMATOLOGY, V48, P1092, DOI 10.1093/rheumatology/kep171; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Szkudlarek M, 2012, RHEUMATOLOGY, V51, P6, DOI 10.1093/rheumatology/kes334; Witt M, 2013, ARTHRITIS RHEUM-US, V65, P1694, DOI 10.1002/art.37954; Youssef P, 1999, J RHEUMATOL, V26, P2523	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165498	10.1371/journal.pone.0165498	http://dx.doi.org/10.1371/journal.pone.0165498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832086	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000015
J	Pang, LJ; Yan, XX; Zhao, HY; Hu, YF; Li, HX				Pang, Liaojun; Yan, Xuxia; Zhao, Huiyang; Hu, Yufei; Li, Huixian			A Novel Multi-Receiver Signcryption Scheme with Complete Anonymity	PLOS ONE			English	Article							IDENTITY-BASED ENCRYPTION; KEY AGREEMENT PROTOCOL; PROVABLY SECURE; EFFICIENT; CRYPTANALYSIS	Anonymity, which is more and more important to multi-receiver schemes, has been taken into consideration by many researchers recently. To protect the receiver anonymity, in 2010, the first multi-receiver scheme based on the Lagrange interpolating polynomial was proposed. To ensure the sender's anonymity, the concept of the ring signature was proposed in 2005, but afterwards, this scheme was proven to has some weakness and at the same time, a completely anonymous multi-receiver signcryption scheme is proposed. In this completely anonymous scheme, the sender anonymity is achieved by improving the ring signature, and the receiver anonymity is achieved by also using the Lagrange interpolating polynomial. Unfortunately, the Lagrange interpolation method was proven a failure to protect the anonymity of receivers, because each authorized receiver could judge whether anyone else is authorized or not. Therefore, the completely anonymous multi-receiver signcryption mentioned above can only protect the sender anonymity. In this paper, we propose a new completely anonymous multi-receiver signcryption scheme with a new polynomial technology used to replace the Lagrange interpolating polynomial, which can mix the identity information of receivers to save it as a ciphertext element and prevent the authorized receivers from verifying others. With the receiver anonymity, the proposed scheme also owns the anonymity of the sender at the same time. Meanwhile, the decryption fairness and public verification are also provided.	[Pang, Liaojun; Yan, Xuxia; Zhao, Huiyang; Hu, Yufei] Xidian Univ, Sch Life Sci & Technol, State Key Lab Integrated Serv Networks, Xian 710071, Shaanxi, Peoples R China; [Pang, Liaojun] Wayne State Univ, Dept Comput Sci, Detroit, MI 48202 USA; [Li, Huixian] Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Shaanxi, Peoples R China	Xidian University; Wayne State University; Northwestern Polytechnical University	Pang, LJ (corresponding author), Xidian Univ, Sch Life Sci & Technol, State Key Lab Integrated Serv Networks, Xian 710071, Shaanxi, Peoples R China.; Pang, LJ (corresponding author), Wayne State Univ, Dept Comput Sci, Detroit, MI 48202 USA.; Li, HX (corresponding author), Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Shaanxi, Peoples R China.	ljpang@mail.xidian.edu.cn; lihuixian@nwpu.edu.cn			Natural Science Foundation of China [61103178]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM6002, 2015JM6294]; Fundamental Research Funds for the Central Universities [3102015JSJ0003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China (61103178), Natural Science Basic Research Plan in Shaanxi Province of China (2016JM6002 & 2015JM6294), and Fundamental Research Funds for the Central Universities (3102015JSJ0003).	Baek J, 2005, LECT NOTES COMPUT SC, V3386, P380; Bellare M, 2003, LECT NOTES COMPUT SC, V2567, P85; Bellare M, 2000, LECT NOTES COMPUT SC, V1807, P259; Cao XF, 2010, INFORM SCIENCES, V180, P2895, DOI 10.1016/j.ins.2010.04.002; Chatterjee S, 2006, LECT NOTES COMPUT SC, V4329, P394; Duan SS, 2006, LECT NOTES COMPUT SC, V4058, P195; Elkamchouchi Hassan, 2009, 2009 International Conference on Networking and Media Convergence (ICNM'09), P70, DOI 10.1109/ICNM.2009.4907192; Fan CI, 2010, IEEE T COMPUT, V59, P1239, DOI 10.1109/TC.2010.23; Huang XY, 2005, AINA 2005: 19TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOL 2, P649; Islam SKH, 2013, INT J COMPUT MATH, V90, P2244, DOI 10.1080/00207160.2013.776674; Islam SKH, 2012, ANN TELECOMMUN, V67, P547, DOI 10.1007/s12243-012-0296-9; Jianhong Zhang, 2012, 2012 4th International Conference on Intelligent Networking and Collaborative Systems (INCoS 2012), P473, DOI 10.1109/iNCoS.2012.117; Khullar S., 2013, INT J ADV RES TECHNO, V2, P189; Kurosawa K., 2002, Public Key Cryptography. 4th International Workshop on Practice and Theory in Public Key Cryptosystems, PKC 2002. Proceedings (Lecture Notes in Computer Science Vol.2274), P48; Lal S, 2009, IACR CRYPTOLOGY EPRI, P345; Li Fagen, 2007, Wuhan University Journal of Natural Sciences, V12, P17, DOI 10.1007/s11859-006-0133-y; Li FG, 2013, CONCURR COMP-PRACT E, V25, P2112, DOI 10.1002/cpe.2826; Li F, 2012, J NETW COMPUT APPL, V35, P340, DOI 10.1016/j.jnca.2011.08.001; Li FG, 2011, IETE TECH REV, V28, P265, DOI 10.4103/0256-4602.81236; Li FG, 2012, FUTURE GENER COMP SY, V28, P306, DOI 10.1016/j.future.2010.11.004; Li FG, 2009, 2009 INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CIRCUITS AND SYSTEMS PROCEEDINGS, VOLUMES I & II, P296, DOI 10.1109/ICCCAS.2009.5250510; Li HX, 2014, IET INFORM SECUR, V8, P8, DOI 10.1049/iet-ifs.2012.0354; Li Z, NCIS 2012, P388, DOI [10.1007/978-3-642-35211-9_51, DOI 10.1007/978-3-642-35211-9_51]; Pang LJ, 2015, IET INFORM SECUR, V9, P194, DOI 10.1049/iet-ifs.2014.0360; Pang LJ, 2013, COMPUT INFORM, V32, P441; Pang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063562; Park J.-H., 2008, PROC ACM S INF COMPU, P373; Qin HW, 2011, SECUR COMMUN NETW, V4, P1331, DOI 10.1002/sec.259; Qin L, 2008, 2008 IEEE GLOB TEL C; Selvi SSD, 2009, LECT NOTES COMPUT SC, V5824, P71, DOI 10.1007/978-3-642-04846-3_6; Wang H, 2012, IET INFORM SECUR, V6, P20, DOI 10.1049/iet-ifs.2010.0252; Yang Ming, 2010, Proceedings of the 2010 International Conference of Information Science and Management Engineering. ISME 2010, P382, DOI 10.1109/ISME.2010.28; Yang XY, 2008, HPCC 2008: 10TH IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS, PROCEEDINGS, P1042, DOI 10.1109/HPCC.2008.82; Yu Y, 2007, LECT NOTES COMPUT SC, V4610, P13; Zhang B, 2010, LECT NOTES COMPUT SC, V6059, P15, DOI 10.1007/978-3-642-13577-4_2; Zhang JH, 2009, LECT NOTES COMPUT SC, V5446, P604, DOI 10.1007/978-3-642-00672-2_58; Zheng YL, 1997, LECT NOTES COMPUT SC, V1294, P165	37	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166173	10.1371/journal.pone.0166173	http://dx.doi.org/10.1371/journal.pone.0166173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832105	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000072
J	Yashiro, H; Takagahara, S; Tamura, YO; Miyahisa, I; Matsui, J; Suzuki, H; Ikeda, S; Watanabe, M				Yashiro, Hiroaki; Takagahara, Shuichi; Tamura, Yumiko Okano; Miyahisa, Ikuo; Matsui, Junji; Suzuki, Hideo; Ikeda, Shota; Watanabe, Masanori			A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ADIPOSE-TISSUE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; GENE-EXPRESSION; PLASMA; RATIO; OMEGA-3-FATTY-ACIDS; HYPERTENSION; CONTRIBUTES	Obesity is now recognized as a state of chronic low-grade inflammation and is called as metabolic inflammation. Delta-5 desaturase (D5D) is an enzyme that metabolizes dihomo-gamma-linolenic acid (DGLA) to arachidonic acid (AA). Thus, D5D inhibition increases DGLA (precursor to anti-inflammatory eicosanoids) while decreasing AA (precursor to pro-inflammatory eicosanoids), and could result in synergistic improvement in the low-grade inflammatory state. Here, we demonstrate reduced insulin resistance and the anti-obesity effect of a D5D selective inhibitor (compound-326), an orally active small-molecule, in a high-fat dietinduced obese (DIO) mouse model. In vivo D5D inhibition was confirmed by determining changes in blood AA/DGLA profiles. In DIO mice, chronic treatment with compound-326 lowered insulin resistance and caused body weight loss without significant impact on cumulative calorie intake. Decreased macrophage infiltration into adipose tissue was expected from mRNA analysis. Increased daily energy expenditure was also observed following administration of compound-326, in line with sustained body weight loss. These data indicate that the novel D5D selective inhibitor, compound-326, will be a new class of drug for the treatment of obese and diabetic patients.	[Yashiro, Hiroaki; Takagahara, Shuichi; Tamura, Yumiko Okano; Miyahisa, Ikuo; Matsui, Junji; Suzuki, Hideo; Ikeda, Shota; Watanabe, Masanori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Tokyo, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Yashiro, H (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Tokyo, Kanagawa, Japan.	hiroaki.yashiro@takeda.com		Ikeda, Shota/0000-0003-1358-524X	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. Employees of Takeda played roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorg P, 2008, EUR J CLIN NUTR, V62, P1155, DOI 10.1038/sj.ejcn.1602836; Baugh SDP, 2015, BIOORG MED CHEM LETT, V25, P3836, DOI 10.1016/j.bmcl.2015.07.066; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Covington MB, 2004, AM FAM PHYSICIAN, V70, P133; Domei T, 2012, CIRC J, V76, P423, DOI 10.1253/circj.CJ-11-0941; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Haidar Yarah M, 2011, Clin Colon Rectal Surg, V24, P205, DOI 10.1055/s-0031-1295684; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Inoue K, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-25; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KIRTLAND SJ, 1988, PROSTAG LEUKOTR ESS, V32, P165, DOI 10.1016/0952-3278(88)90168-8; KNAPP HR, 1978, LIPIDS, V13, P804, DOI 10.1007/BF02533480; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Miyahisa I, 2016, ACS MED CHEM LETT, V7, P868, DOI 10.1021/acsmedchemlett.6b00241; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Pan A, 2012, CIRCULATION, V126, P163, DOI 10.1161/CIRCULATIONAHA.112.115923; Park H, 2010, CLIN CHIM ACTA, V411, P1735, DOI 10.1016/j.cca.2010.07.012; Perwitz N, 2010, DIABETES OBES METAB, V12, P158, DOI 10.1111/j.1463-1326.2009.01133.x; Pisani DF, 2014, MOL METAB, V3, P834, DOI 10.1016/j.molmet.2014.09.003; Powell DR, 2016, DIABETES METAB SYNDR, V9, P185, DOI 10.2147/DMSO.S106653; Rimoldi OJ, 2001, BIOCHEM BIOPH RES CO, V283, P323, DOI 10.1006/bbrc.2001.4785; Russo C, 1997, HYPERTENSION, V29, P1058, DOI 10.1161/01.HYP.29.4.1058; Saito E, 2013, PROSTAG LEUKOTR ESS, V88, P307, DOI 10.1016/j.plefa.2013.01.005; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2004, WORLD REV NUTR DIET, V93, P1; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Stoffel W, 2014, EMBO REP, V15, P110, DOI 10.1002/embr.201338041; Suzuki H, [No title captured], Patent No. [WO 2010087467 A1, 2010087467]; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Verty ANA, 2009, OBESITY, V17, P254, DOI 10.1038/oby.2008.509; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Zhang L., 2012, AEROSP MAT TECHNOL, V6, P20; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZURIER RB, 1991, ADV PROSTAG THROMB L, V21, P947	47	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166198	10.1371/journal.pone.0166198	http://dx.doi.org/10.1371/journal.pone.0166198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832159	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000075
J	Yu, SH; Dubey, NK; Li, WS; Liu, MC; Chiang, HS; Leu, SJ; Shieh, YH; Tsai, FC; Deng, WP				Yu, Sung-Hsun; Dubey, Navneet Kumar; Li, Wei-Shan; Liu, Ming-Che; Chiang, Han-Sun; Leu, Sy-Jye; Shieh, Ying-Hua; Tsai, Feng-Chou; Deng, Win-Ping			Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; FRUITING BODY; KIDNEY; INSULIN; PATHOGENESIS; CHOLESTEROL; PROGRESSION; ANTIFUNGAL; THERAPY; GLUCOSE	Diabetic nephropathy is derived from long-term effects of high blood glucose on kidney function in type 2 diabetic patients. Several antidiabetic drugs and herbal medications have failed to prevent episodes of DN. Hence, this study aimed to further investigate the renal injury-reducing effect of antidiabetic CmNo1, a novel combination of powders of fruiting bodies and mycelia of Cordyceps militaris. After being administered with streptozotocin-nicotinamide and high-fat-diet, the diabetic nephropathy mouse model displayed elevated blood glucose and renal dysfunction markers including serum creatinine and kidney-to-body weight ratio. These elevated markers were significantly mitigated following 8 weeks CmNo1 treatment. Moreover, the chronic hyperglycemia-induced pathological alteration in renal tissue were also ameliorated. Besides, immunohistochemical study demonstrated a substantial reduction in elevated levels of carboxymethyl lysine, an advanced glycation end product. Elevated collagenous deposition in DN group was also attenuated through CmNo1 administration. Moreover, the enhanced levels of transforming growth factor-beta 1, a fibrosis-inducing protein in glomerulus were also markedly dampened. Furthermore, auxiliary risk factors in DN like serum triglycerides and cholesterol were found to be increased but were decreased by CmNo1 treatment. Conclusively, the results suggests that CmNo1 exhibit potent and efficacious renoprotective action against hyperglycemia-induced DN.	[Yu, Sung-Hsun; Leu, Sy-Jye] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Yu, Sung-Hsun; Dubey, Navneet Kumar; Li, Wei-Shan; Deng, Win-Ping] Taipei Med Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Dubey, Navneet Kumar; Liu, Ming-Che; Deng, Win-Ping] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan; [Liu, Ming-Che] Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Ming-Che] Taipei Med Univ, Sch Med, Dept Urol, Coll Med, Taipei, Taiwan; [Chiang, Han-Sun] Cathay Gen Hosp, Div Urol, Dept Surg, New Taipei, Taiwan; [Chiang, Han-Sun; Deng, Win-Ping] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan; [Leu, Sy-Jye] Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Shieh, Ying-Hua] Taipei Med Univ, Wan Fang Hosp, Dept Family Med, Taipei, Taiwan; [Tsai, Feng-Chou] Cosmet Clin Grp, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Deng, WP (corresponding author), Taipei Med Univ, Stem Cell Res Ctr, Taipei, Taiwan.; Deng, WP (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan.; Deng, WP (corresponding author), Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan.	wpdeng@tmu.edu.tw	Dubey, Navneet Kumar/H-3870-2019; 黎, 伟/GXM-4040-2022; Yu, Sung-Hsun/H-7601-2019; wei, li/GSD-3630-2022	Dubey, Navneet Kumar/0000-0002-3540-5281; 	National Science Council, Taiwan [NSC 99-2628-B-038-010-MY3, 101-2314-B-038-023, 102-2314-B-038-058, 102-2314-B-038-015]; Department of Health, Taiwan [DOH102-TD-PB-111-NSC009]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	Supported by the following agencies (grant no.): National Science Council, Taiwan (NSC 99-2628-B-038-010-MY3, 101-2314-B-038-023, 102-2314-B-038-058 and 102-2314-B-038-015) and Department of Health, Taiwan. (DOH102-TD-PB-111-NSC009). URL NSC: https://www.most.gov.tw/en/public. URL DoH Taiwan: http://www mohw.gov.tw/EN/Ministry/Index.aspx.	Agarwal Pankaj, 2013, Indian J Endocrinol Metab, V17, pS55, DOI 10.4103/2230-8210.119506; Akpan EE, 2015, CASE REP MED, V2015, DOI 10.1155/2015/150204; Alaveras AEG, 1997, NEPHROL DIAL TRANSPL, V12, P71; Almquist T, 2014, EUR J CLIN INVEST, V44, P276, DOI 10.1111/eci.12230; Awazu M, 2003, J AM SOC NEPHROL, V14, P699, DOI 10.1097/01.ASN.0000051726.41601.C0; Batlle D, 2003, KIDNEY INT, V63, P2319, DOI 10.1046/j.1523-1755.2003.00053.x; Berg TJ, 1997, METABOLISM, V46, P661, DOI 10.1016/S0026-0495(97)90010-X; BUNDSCHUH I, 1992, EUR J CLIN CHEM CLIN, V30, P651; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Cho EJ, 2007, APPL MICROBIOL BIOT, V75, P1257, DOI 10.1007/s00253-007-0972-2; Choi YE, 2010, EVID-BASED COMPL ALT, V7, P433, DOI 10.1093/ecam/nen021; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; Deshpande SD, 2013, DIABETES, V62, P3151, DOI 10.2337/db13-0305; Dong Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160980; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; Gao SM, 2012, FASEB J, V26; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Hong In-Pyo, 2010, Mycobiology, V38, P128, DOI 10.4489/MYCO.2010.38.2.128; Hosten AO, 1990, BUN CREATININE 1990; Hsu Chia-Hsiu, 2008, Pediatrics and Neonatology, V49, P171, DOI 10.1016/S1875-9572(09)60004-8; Hsu SHJ, 2015, INTERNAL MED, V54, P2291, DOI 10.2169/internalmedicine.54.4308; Hur Hyun, 2008, Mycobiology, V36, P233, DOI 10.4489/MYCO.2008.36.4.233; Jeong MH, 2013, ONCOL REP, V30, P1996, DOI 10.3892/or.2013.2660; Pang J, 2014, WORLD J DIABETES, V5, P165, DOI 10.4239/wjd.v5.i2.165; Kang J, 2005, ACTA DIABETOL, V42, P110, DOI 10.1007/s00592-005-0188-9; LARKINS RG, 1992, DIABETOLOGIA, V35, P499, DOI 10.1007/BF00400475; Lee HS, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S9-008; Li A, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/691594; Lin S, 2016, APPL BIOCHEM BIOTECH, V179, P633, DOI 10.1007/s12010-016-2020-0; Liu Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/575063; Lo HC, 2004, LIFE SCI, V74, P2897, DOI 10.1016/j.lfs.2003.11.003; MULEC H, 1993, AM J KIDNEY DIS, V22, P196, DOI 10.1016/S0272-6386(12)70186-5; Nagai R, 2002, DIABETES, V51, P2833, DOI 10.2337/diabetes.51.9.2833; Nagai R, 1997, BIOCHEM BIOPH RES CO, V234, P167, DOI 10.1006/bbrc.1997.6608; Nagai R, 2010, BIOCHEM BIOPH RES CO, V393, P118, DOI 10.1016/j.bbrc.2010.01.095; Nasri H, 2015, J RES MED SCI, V20, P1112, DOI 10.4103/1735-1995.172845; Norlin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152315; Olatunji OJ, 2016, ENVIRON TOXICOL PHAR, V44, P53, DOI 10.1016/j.etap.2016.02.009; Peng J, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/678214; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Rave K, 2001, DIABETES CARE, V24, P886, DOI 10.2337/diacare.24.5.886; Raz I, 2003, NEPHROL DIAL TRANSPL, V18, P1293, DOI 10.1093/ndt/gfg170; Reis FS, 2013, FOOD CHEM TOXICOL, V62, P91, DOI 10.1016/j.fct.2013.08.033; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Rosario Rey F, 2006, Curr Diab Rep, V6, P455, DOI 10.1007/s11892-006-0079-7; Saito T, 1997, TOHOKU J EXP MED, V181, P321, DOI 10.1620/tjem.181.321; Schena FP, 2005, J AM SOC NEPHROL, V16, P30, DOI DOI 10.1681/ASN.2004110970; Sugar AM, 1998, ANTIMICROB AGENTS CH, V42, P1424, DOI 10.1128/AAC.42.6.1424; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; TRIGG PI, 1971, T ROY SOC TROP MED H, V65, P514, DOI 10.1016/0035-9203(71)90162-3; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; Wang H., 2014, AM J MAR SCI, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE.0088779; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Won KJ, 2009, J PHARMACOL SCI, V109, P403, DOI 10.1254/jphs.08308FP; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yokozawa T, 2004, NEPHRON EXP NEPHROL, V97, pE38, DOI 10.1159/000078405; Yokozawa T, 2001, EXP TOXICOL PATHOL, V53, P359, DOI 10.1078/0940-2993-00203; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yun YunHa, 2003, Natural Product Sciences, V9, P291; Zhang GQ, 2006, APPL MICROBIOL BIOT, V72, P1152, DOI 10.1007/s00253-006-0411-9; Zhang YW, 2007, J ETHNOPHARMACOL, V114, P387, DOI 10.1016/j.jep.2007.08.024	63	27	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166342	10.1371/journal.pone.0166342	http://dx.doi.org/10.1371/journal.pone.0166342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832180	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000103
J	Das, P; Bansal, A; Rao, SN; Deodhar, K; Mahantshetty, U; Shrivastava, SK; Sivaraman, K; Mulherkar, R				Das, Poulami; Bansal, Akanksha; Rao, Sudha Narayan; Deodhar, Kedar; Mahantshetty, Umesh; Shrivastava, Shyam K.; Sivaraman, Karthikeyan; Mulherkar, Rita			Somatic Variations in Cervical Cancers in Indian Patients	PLOS ONE			English	Article							MUTATIONS; GENOME; GENE; ACTIVATION; HETEROGENEITY; PATHWAY; BREAST; TUMORS; RISK; HPV	There are very few reports that describe the mutational landscape of cervical cancer, one of the leading cancers in Indian women. The aim of the present study was to investigate the somatic mutations that occur in cervical cancer. Whole exome sequencing of 10 treatment naive tumour biopsies with matched blood samples, from a cohort of Indian patients with locally advanced disease, was performed. The data revealed missense mutations across 1282 genes, out of 1831 genes harbouring somatic mutations. These missense mutations (nonsynonymous + stop-gained) when compared with pre-existing mutations in the COSMIC database showed that 272 mutations in 250 genes were already reported although from cancers other than cervical cancer. More than 1000 novel somatic variations were obtained in matched tumour samples. Pathways / genes that are frequently mutated in various other cancers were found to be mutated in cervical cancers. A significant enrichment of somatic mutations in the MAPK pathway was observed, some of which could be potentially targetable. This is the first report of whole exome sequencing of well annotated cervical cancer samples from Indian women and helps identify trends in mutation profiles that are found in an Indian cohort of cervical cancer.	[Das, Poulami; Bansal, Akanksha; Mulherkar, Rita] Tata Mem Hosp, ACTREC, Mulherkar Lab, Kharghar 410210, Navi Mumbai, India; [Rao, Sudha Narayan] Genotyp Technol Pvt Ltd, 259 Apoorva 4th Cross,80 Ft Rd,RMV 2 Stage, Bengaluru 560094, India; [Deodhar, Kedar] Tata Mem Hosp, Dept Pathol, Bombay 400012, Maharashtra, India; [Mahantshetty, Umesh; Shrivastava, Shyam K.] Tata Mem Hosp, Dept Radiat Oncol, Bombay 400012, Maharashtra, India; [Sivaraman, Karthikeyan] Dhiti Technol Pvt Ltd, 2-10,5th Floor,80 Feet Rd,RMV 2nd Stage, Bengaluru 560094, Karnataka, India; [Das, Poulami] Univ Texas Austin, Ctr Infect Dis, Dept Mol Biosci, Austin, TX 78712 USA; [Mulherkar, Rita] A 103,Pk Dew,Sect 20, Kharghar 410210, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Texas System; University of Texas Austin	Mulherkar, R (corresponding author), Tata Mem Hosp, ACTREC, Mulherkar Lab, Kharghar 410210, Navi Mumbai, India.; Mulherkar, R (corresponding author), A 103,Pk Dew,Sect 20, Kharghar 410210, Navi Mumbai, India.	rmulherkar@gmail.com	DAS, POULAMI/ABC-6544-2020	Bansal, Akanksha/0000-0002-4501-2094; DAS, POULAMI/0000-0002-8100-7962	Department of Science and Technology (DST) [SR/SO/HS-22/2009]; Genotypic Technology Pvt. Ltd.; Dhitiomics Technologies Pvt. Ltd.	Department of Science and Technology (DST)(Department of Science & Technology (India)); Genotypic Technology Pvt. Ltd.; Dhitiomics Technologies Pvt. Ltd.	The work was funded by Department of Science and Technology (DST No: SR/SO/HS-22/2009), a grant sanctioned to RM. Genotypic Technology Pvt. Ltd. and Dhitiomics Technologies Pvt. Ltd. provided support in the form of salaries/consultation fees for authors SNR and KS respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SNR provided services which included exomesequencing using Illumina platform and providing the raw data. KS, an independent consultant, was specifically brought in by Dhitiomics Technologies Pvt. Ltd., for handling the data analysis part. The specific roles of these authors are articulated in the 'author contributions' section.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Chandrani P, 2015, BRIT J CANCER, V112, P1958, DOI 10.1038/bjc.2015.121; Christiansen IK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119566; Chung TK, 2015, INT J CANC; Courts C, 2008, J NEUROPATH EXP NEUR, V67, P720, DOI 10.1097/NEN.0b013e31817dd02d; Cui B, 2009, INT J ONCOL, V34, P409, DOI 10.3892/ijo_00000164; Das P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041012; EllingerZiegelbauer H, 1997, J BIOL CHEM, V272, P2668, DOI 10.1074/jbc.272.5.2668; FRIEDMAN E, 1993, NAT GENET, V5, P242, DOI 10.1038/ng1193-242; GLOBOCAN, 2012, SECT CANC SURV; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hildesheim A, 1998, CANCER EPIDEM BIOMAR, V7, P1035; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Horvath A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02256; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lou H, 2015, CLIN CANCER RES, V21, P5360, DOI 10.1158/1078-0432.CCR-14-1837; Madeleine MM, 2002, J INFECT DIS, V186, P1565, DOI 10.1086/345285; Muller E, 2015, CANCER MED-US, V4, P1484, DOI 10.1002/cam4.492; Narayan G, 2010, FUTURE ONCOL, V6, P1643, DOI 10.2217/FON.10.114; Nichols Anthony C, 2012, ISRN Oncol, V2012, P809370, DOI 10.5402/2012/809370; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Ouyang LM, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-2; Parfenov M, 2014, P NATL ACAD SCI USA, V111, P15544, DOI 10.1073/pnas.1416074111; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rusan M, 2015, CLIN CANCER RES, V21, P2009, DOI 10.1158/1078-0432.CCR-14-1101; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Sharma V, 2011, CANCER RES, V71, P6438, DOI 10.1158/0008-5472.CAN-11-1645; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; TOMMERUP N, 1995, GENOMICS, V27, P259, DOI 10.1006/geno.1995.1040; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Wang WP, 2012, HUM MUTAT, V33, P480, DOI 10.1002/humu.22014; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; WONG YF, 1995, CANCER LETT, V95, P29, DOI 10.1016/0304-3835(95)03857-S; Xu L, 2015, CANCER-AM CANCER SOC, V121, P2367, DOI 10.1002/cncr.29381; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165878	10.1371/journal.pone.0165878	http://dx.doi.org/10.1371/journal.pone.0165878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829003	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300064
J	Ip, V; Toth, Z; Chibnall, J; McBride-Gagyi, S				Ip, Victoria; Toth, Zacharie; Chibnall, John; McBride-Gagyi, Sarah			Remnant Woven Bone and Calcified Cartilage in Mouse Bone: Differences between Ages/Sex and Effects on Bone Strength	PLOS ONE			English	Article							RAT CORTICAL BONE; MECHANICAL-PROPERTIES; LONG BONES; MICE; AGE; RESISTANCE; SENESCENCE; INTEGRITY; FRACTURE; GROWTH	Introduction Mouse models are used frequently to study effects of bone diseases and genetic determinates of bone strength. Murine bones have an intracortical band of woven bone that is not present in human bones. This band is not obvious under brightfield imaging and not typically analyzed. Due to the band's morphology and location it has been theorized to be remnant bone from early in life. Furthermore, lamellar and woven bone are well known to have differing mechanical strengths. The purpose of this study was to determine (i) if the band is from early life and (ii) if the woven bone or calcified cartilage contained within the band affect whole bone strength. Woven Bone Origin Studies In twelve to fourteen week old mice, doxycycline was used to label bone formed prior to 3 weeks old. Doxycycline labeling and woven bone patterns on contralateral femora matched well and encompassed an almost identical cross-sectional area. Also, we highlight for the first time in mice the presence of calcified cartilage exclusively within the band. However, calcified cartilage could not be identified on high resolution cone-beam microCT scans when examined visually or by thresholding methods. Mechanical Strength Studies Subsequently, three-point bending was used to analyze the effects of woven bone and calcified cartilage on whole bone mechanics in a cohort of male and female six and 13 week old Balb/C mice. Three-point bending outcomes were correlated with structural and compositional measures using multivariate linear regression. Woven bone composed a higher percent of young bones than older bones. However, calcified cartilage in older bones was twice that of younger bones, which was similar when normalized by area. Area and/or tissue mineral density accounted for >75% of variation for most strength outcomes. Percent calcified cartilage added significant predictive power to maximal force and bending stress. Calcified cartilage and woven bone could have more influence in genetic models where calcified cartilage percent is double our highest value.	[Ip, Victoria] Cornell Univ, Sch Operat Res & Informat Engn, Ithaca, NY USA; [Toth, Zacharie; McBride-Gagyi, Sarah] St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA; [Chibnall, John] St Louis Univ, Dept Psychiat, St Louis, MO 63103 USA	Cornell University; Saint Louis University; Saint Louis University	McBride-Gagyi, S (corresponding author), St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA.	smcbrid9@slu.edu			NIAMS NIH HHS [P30 AR057235] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bach-Gansmo FL, 2013, CALCIFIED TISSUE INT, V92, P330, DOI 10.1007/s00223-012-9682-6; BECK TJ, 1993, CALCIFIED TISSUE INT, V53, pS41, DOI 10.1007/BF01673401; DANIELSEN CC, 1992, CALCIFIED TISSUE INT, V50, P169, DOI 10.1007/BF00298796; DANIELSEN CC, 1993, CALCIFIED TISSUE INT, V52, P26, DOI 10.1007/BF00675623; FAULKNER KG, 1993, J BONE MINER RES, V8, P1211, DOI 10.1002/jbmr.5650081008; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Hayer PS, 2016, J CLIN DIAGN RES, V10, pRC9, DOI 10.7860/JCDR/2016/19267.7629; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; McBride-Gagyi SH, 2015, BONE, V81, P533, DOI 10.1016/j.bone.2015.09.003; Pautke C, 2010, J ORAL MAXIL SURG, V68, P125, DOI 10.1016/j.joms.2009.05.442; Price C, 2005, J BONE MINER RES, V20; Shipov A, 2013, J STRUCT BIOL, V183, P132, DOI 10.1016/j.jsb.2013.04.010; Silva MJ, 2006, J BONE MINER RES, V21, P78, DOI 10.1359/JBMR.050909; Silva MJ, 2002, J BONE MINER RES, V17, P1597, DOI 10.1359/jbmr.2002.17.9.1597; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Tseng KF, 1996, J ORTHOPAED RES, V14, P598, DOI 10.1002/jor.1100140414; Vanleene M, 2008, MED ENG PHYS, V30, P1049, DOI 10.1016/j.medengphy.2007.12.010; Vardakastani V, 2014, INCREASED INTRACORTI, V69; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y; Zimmermann EA, 2015, J BONE MINER RES, V30, P264, DOI 10.1002/jbmr.2340	22	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166476	10.1371/journal.pone.0166476	http://dx.doi.org/10.1371/journal.pone.0166476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829059	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300109
J	Greene, SB; Dago, AE; Leitz, LJ; Wang, YP; Lee, J; Werner, SL; Gendreau, S; Patel, P; Jia, SD; Zhang, LX; Tucker, EK; Malchiodi, M; Graf, RP; Dittamore, R; Marrinucci, D; Landers, M				Greene, Stephanie B.; Dago, Angel E.; Leitz, Laura J.; Wang, Yipeng; Lee, Jerry; Werner, Shannon L.; Gendreau, Steven; Patel, Premal; Jia, Shidong; Zhang, Liangxuan; Tucker, Eric K.; Malchiodi, Michael; Graf, Ryon P.; Dittamore, Ryan; Marrinucci, Dena; Landers, Mark			Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; CIRCULATING TUMOR-CELLS; INTRATUMOR HETEROGENEITY; ANDROGEN RECEPTOR; BREAST-CANCER; EVOLUTION; PTEN; HYBRIDIZATION; AMPLIFICATION; EXPRESSION	Genomic instability is a hallmark of cancer often associated with poor patient outcome and resistance to targeted therapy. Assessment of genomic instability in bulk tumor or biopsy can be complicated due to sample availability, surrounding tissue contamination, or tumor heterogeneity. The Epic Sciences circulating tumor cell (CTC) platform utilizes a non-enrichment based approach for the detection and characterization of rare tumor cells in clinical blood samples. Genomic profiling of individual CTCs could provide a portrait of cancer heterogeneity, identify clonal and sub-clonal drivers, and monitor disease progression. To that end, we developed a single cell Copy Number Variation (CNV) Assay to evaluate genomic instability and CNVs in patient CTCs. For proof of concept, prostate cancer cell lines, LNCaP, PC3 and VCaP, were spiked into healthy donor blood to create mock patient-like samples for downstream single cell genomic analysis. In addition, samples from seven metastatic castration resistant prostate cancer (mCRPC) patients were included to evaluate clinical feasibility. CTCs were enumerated and characterized using the Epic Sciences CTC Platform. Identified single CTCs were recovered, whole genome amplified, and sequenced using an Illumina NextSeq 500. CTCs were then analyzed for genome-wide copy number variations, followed by genomic instability analyses. Large-scale state transitions (LSTs) were measured as surrogates of genomic instability. Genomic instability scores were determined reproducibly for LNCaP, PC3, and VCaP, and were higher than white blood cell (WBC) controls from healthy donors. A wide range of LST scores were observed within and among the seven mCRPC patient samples. On the gene level, loss of the PTEN tumor suppressor was observed in PC3 and 5/7 (71%) patients. Amplification of the androgen receptor (AR) gene was observed in VCaP cells and 5/7 (71%) mCRPC patients. Using an in silico down-sampling approach, we determined that DNA copy number and genomic instability can be detected with as few as 350K sequencing reads. The data shown here demonstrate the feasibility of detecting genomic instabilities at the single cell level using the Epic Sciences CTC Platform. Understanding CTC heterogeneity has great potential for patient stratification prior to treatment with targeted therapies and for monitoring disease evolution during treatment.	[Greene, Stephanie B.; Dago, Angel E.; Leitz, Laura J.; Wang, Yipeng; Lee, Jerry; Werner, Shannon L.; Tucker, Eric K.; Malchiodi, Michael; Graf, Ryon P.; Dittamore, Ryan; Marrinucci, Dena; Landers, Mark] Epic Sci Inc, San Diego, CA 92121 USA; [Gendreau, Steven; Patel, Premal; Jia, Shidong; Zhang, Liangxuan] Genentech Inc, Roche, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Jia, Shidong] Predicine Holdings Ltd, Palo Alto, CA USA	Roche Holding; Genentech	Landers, M (corresponding author), Epic Sci Inc, San Diego, CA 92121 USA.	mark.landers@epicsciences.com	t, lf/AAJ-4924-2020	Graf, Ryon/0000-0002-8065-4148	Genentech, Inc./ Roche	Genentech, Inc./ Roche	SBG, AED, LJL, YW, JL, SLW, EKT, MM, RPG, RD, DM, ML are employees of Epic Sciences, Inc. SG, PP, SJ, LZ are employees of Genentech, Inc./ Roche. Epic Sciences, Inc., and Genentech, Inc./ Roche provided support in the form of salaries for authors, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Andor N., 2015, NAT MED; [Anonymous], 2011, CURR PROB CANCER, V35, P7, DOI 10.1016/j.currproblcancer.2010.12.002; Attard G, 2011, CLIN CANCER RES, V17, P3048, DOI 10.1158/1078-0432.CCR-10-3234; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chen Y, 2001, CANCER RES, V61, P4112; Ciuffreda Ludovica, 2014, Advances in Biological Regulation, V56, P66, DOI 10.1016/j.jbior.2014.07.002; Crockford A, 2014, J PATHOL, V232, P264, DOI 10.1002/path.4270; Dago AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101777; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Fox JJ, 2011, J NUCL MED, V52, P1727, DOI 10.2967/jnumed.111.089326; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ha S, 2011, ENDOCR-RELAT CANCER, V18, P245, DOI 10.1530/ERC-10-0204; Hayes JL, 2013, GENOMICS, V102, P174, DOI 10.1016/j.ygeno.2013.04.006; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Lotan TL, 2011, CLIN CANCER RES, V17, P6563, DOI 10.1158/1078-0432.CCR-11-1244; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Mateo J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0448-5; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Perkins G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047020; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Punnoose EA, 2015, BR J CANC; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Schmitt M.W., 2015, NAT REV CLIN ONCOL; Seol H, 2012, MODERN PATHOL, V25, P938, DOI 10.1038/modpathol.2012.36; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Watkins JA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3670; Weiss MM, 1999, J CLIN PATHOL-MOL PA, V52, P243; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]; Werner SL, 2015, J CIRCULATING BIOMAR, V4; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Xu HT, 2015, J CANCER, V6, P247, DOI 10.7150/jca.10747; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yap TA, 2014, CLIN CANCER RES, V20, P2553, DOI 10.1158/1078-0432.CCR-13-2664; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zafarana G, 2012, CANCER-AM CANCER SOC, V118, P4053, DOI 10.1002/cncr.26729; Zhang S, 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1155/2014/302702; Zhang X, 2015, ONCOL LETT, V9, P2617, DOI 10.3892/ol.2015.3114	49	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165089	10.1371/journal.pone.0165089	http://dx.doi.org/10.1371/journal.pone.0165089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851748	Green Submitted, Green Published, gold			2022-12-27	WOS:000387909300010
J	Naess, M; Holmen, TL; Langaas, M; Bjorngaard, JH; Kvaloy, K				Naess, Marit; Holmen, Turid Lingaas; Langaas, Mette; Bjorngaard, Johan Hakon; Kvaloy, Kirsti			Intergenerational Transmission of Overweight and Obesity from Parents to Their Adolescent Offspring - The HUNT Study	PLOS ONE			English	Article							BODY-MASS INDEX; ASSORTATIVE WEIGHT-GAIN; FATHER-SON PAIRS; WAIST CIRCUMFERENCE; CHILDHOOD OVERWEIGHT; MOTHER-DAUGHTER; TRENDS; CHILDREN; ASSOCIATIONS; PREVALENCE	Purpose The main aim of this study was to examine weight associations between parents and offspring at two time points: 1995-97 and 2006-08, taking into account body mass index (BMI) and waist circumference. Methods The study included 8425 parent-offspring trios who participated in the population based Health Study of Nord Tr phi ndelag (the HUNT Study), Norway, at either the HUNT2 (1995-97) or the HUNT3 (2006-08) survey. We used linear mixed effects models with siblings clustered within mothers to analyze the associations between 1) parental grouped BMI and offspring BMI z-scores and 2) parental grouped waist circumference and offspring waist circumference z-scores. Results Adolescent and adult overweight and obesity were higher in 2006-08 than in 1995-97, with the greatest increase observed in waist circumference. Both mother's and father's BMI and waist circumference were strongly associated with corresponding measures in offspring. Compared with both parents being normal weight (BMI < 25 kg/m(2)), having two overweight or obese parents (BMI<25 kg/m(2)) was associated with a higher offspring BMI z-score of 0.76 (95% CI; 0.65, 0.87) and 0.64 (95% CI; 0.48, 0.80) in daughters, and 0.76 (95% CI; 0.65, 0.87) and 0.69 (95% CI; 0.53, 0.80) in sons, in 1995-97 and 2006-08 respectively. Offspring with one parent being overweight/obese had BMI z-scores of approximately half of offspring with two parents categorized as overweight/obese. The results of the waist circumference based analyses did not differ substantially from the BMI based analyses. Conclusions Parental overweight was strongly positively associated with offspring weight both in 1995-97 and 2006-08 where both parents being overweight/obese gave the largest effect. This seemingly stable association, strongly address the importance of public health initiatives towards preventing obesity in parents of both sexes to decrease further obesity expansion in offspring.	[Naess, Marit; Holmen, Turid Lingaas; Kvaloy, Kirsti] NTNU Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Naess, Marit; Kvaloy, Kirsti] Nord Trondelag Hlth Trust, Levanger Hosp, Dept Res & Dev, Levanger, Norway; [Langaas, Mette] NTNU Norwegian Univ Sci & Technol, Dept Math Sci, Trondheim, Norway; [Bjorngaard, Johan Hakon] NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Fac Med, Trondheim, Norway; [Bjorngaard, Johan Hakon] St Olays Univ Hosp Trondheim, Forens Dept, Trondheim, Norway; [Bjorngaard, Johan Hakon] St Olays Univ Hosp Trondheim, Res Ctr Broset, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Naess, M (corresponding author), NTNU Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Trondheim, Norway.; Naess, M (corresponding author), Nord Trondelag Hlth Trust, Levanger Hosp, Dept Res & Dev, Levanger, Norway.	marit.nass@ntnu.no	Langaas, Mette/G-7423-2012; Langaas, Mette/AAD-5948-2020	Langaas, Mette/0000-0002-5714-0288	Liaison Committee; NTNU - Norwegian University of Science and Technology [2013/7511]; Norwegian Research Council	Liaison Committee; NTNU - Norwegian University of Science and Technology; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Liaison Committee between the Norwegian University of Science and Technology and Helse Midt-Norge, and the NTNU - Norwegian University of Science and Technology grant number 2013/7511 and The Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 2015, EUR J PUBLIC HEALTH, V25, P28, DOI 10.1093/eurpub/ckv016; Ajala O, 2011, INT J PEDIATR OBES, V6, P223, DOI 10.3109/17477166.2011.583662; Ajslev TA, 2015, OBESITY, V23, P1279, DOI 10.1002/oby.21060; Andersen LF, 2005, SCAND J PUBLIC HEALT, V33, P99, DOI 10.1080/140349404100410019172; Bahk J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2616-2; Bjelland M, 2010, SCAND J PUBLIC HEALT, V38, P19, DOI 10.1177/1403494810385036; Bjornelv S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-279; Brannsether B, 2011, ACTA PAEDIATR, V100, P1576, DOI 10.1111/j.1651-2227.2011.02370.x; Chau JY, 2014, J SCI MED SPORT, V17, P78, DOI 10.1016/j.jsams.2013.03.004; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holmen T. L, 2013, INT J EPIDEMIOL; Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150; Kohn Michael, 2003, Adolesc Med, V14, P1; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Livingstone M B, 2001, Public Health Nutr, V4, P109; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Midthjell K, 2013, CLIN OBES, V3, P12, DOI 10.1111/cob.12009; Miqueleiz E, 2014, EUR J CLIN NUTR, V68, P209, DOI 10.1038/ejcn.2013.255; Mostazir M, 2014, PEDIATR OBES, V9, P176, DOI 10.1111/j.2047-6310.2013.00157.x; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Perez-Pastor EM, 2009, INT J OBESITY, V33, P727, DOI 10.1038/ijo.2009.76; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Rangul V, 2011, J ADOLESCENT HEALTH, V48, P616, DOI 10.1016/j.jadohealth.2010.09.013; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; SSB, 2003, NORW STAND CLASS ED; Walls HL, 2011, OBESITY, V19, P216, DOI 10.1038/oby.2010.149; Wardle J, 2008, INT J OBESITY, V32, P527, DOI 10.1038/sj.ijo.0803740; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; World Health Organization, 2000, OB PREV MAN GLOB EP, Vxii; Xi B, 2014, PEDIATRICS, V134, pE334, DOI 10.1542/peds.2014-0970	36	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166585	10.1371/journal.pone.0166585	http://dx.doi.org/10.1371/journal.pone.0166585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851798	Green Published, gold, Green Submitted			2022-12-27	WOS:000387909300071
J	Almawi, WY; Gammoh, E; Malalla, ZH; Al-Madhi, SA				Almawi, Wassim Y.; Gammoh, Emily; Malalla, Zainab H.; Al-Madhi, Safa A.			Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE POLYMORPHISMS; DIAGNOSTIC-CRITERIA; BLOOD-FLOW; WOMEN; RISK; PREECLAMPSIA; POPULATION; PREVALENCE; FAMILY	Background Vascular endothelial growth factor (VEGF) contributes to the pathogenesis of polycystic ovary syndrome (PCOS), and genetic variations in VEGFA gene were suggested to contribute to VEGF secretion and PCOS. Aim To evaluate the association of altered VEGF levels, stemming from the presence of specific VEGFA variants, with altered risk of PCOS. Subjects and Methods Retrospective case-control study, performed between 2012-2015. Study subjects comprised 382 women with PCOS, and 393 control subjects. ELISA measured VEGF levels; genotyping of VEGFA variants was done by allelic exclusion. Results Among the 12 tested VEGFA SNPs, minor allele frequency of only rs3025020 was significantly higher in PCOS cases than control women. Increased and reduced PCOS risk was seen with rs3025020 and rs2010963 genotypes, respectively. Increases and reduction in VEGF levels were associated with rs3025020 and rs2010963, respectively. Increased fasting insulin and HOMA-IR, and bioactive testosterone were linked with rs3025020, while carriage of rs2010963 was linked with reduction in fasting insulin, and free and bioactive testosterone. Of the 12 VEGFA variants, 9 were in LD, thus allowing construction of 9-locus haplotypes. Increased frequency of CAACAGCGA haplotype was seen in PCOS cases, after controlling for BMI, free and bioactive testosterone, SHBG, free insulin and HOMA-IR. Conclusion This study confirms the contribution of altered VEGF secretion, resulting from genetic variation in VEGFA gene into the pathogenesis of PCOS. This supports a role for VEGF as PCOS candidate locus.	[Almawi, Wassim Y.; Gammoh, Emily; Malalla, Zainab H.; Al-Madhi, Safa A.] Arabian Gulf Univ, Dept Med Biochem, Manama, Bahrain	Arabian Gulf University	Almawi, WY (corresponding author), Arabian Gulf Univ, Dept Med Biochem, Manama, Bahrain.	wassim@agu.edu.bh	Almawi, Wassim/FGW-0821-2022					Abd El Aal DEM, 2005, EUR J OBSTET GYN R B, V118, P219, DOI 10.1016/j.ejogrb.2004.07.024; Agrawal R, 1998, HUM REPROD, V13, P651, DOI 10.1093/humrep/13.3.651; Al-Habboubi HH, 2011, EUR CYTOKINE NETW, V22, P154, DOI 10.1684/ecn.2011.0289; Al-Habboubi HH, 2012, EUR J HAEMATOL, V89, P403, DOI 10.1111/ejh.12003; Almawi WY, 2013, HUM REPROD, V28, P2628, DOI 10.1093/humrep/det308; Andraweera PH, 2013, J MATERN-FETAL NEO M, V26, P532, DOI 10.3109/14767058.2012.743520; Artini PG, 2009, HUM FERTIL, V12, P40, DOI 10.1080/14647270802621358; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Banyasz I, 2006, MOL HUM REPROD, V12, P233, DOI 10.1093/molehr/gal024; Carmina E, 2013, FRONT HORM RES, V40, P40, DOI 10.1159/000341840; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641; Geva E, 2000, FERTIL STERIL, V74, P429, DOI 10.1016/S0015-0282(00)00670-1; Guruvaiah P, 2014, J ASSIST REPROD GEN, V31, P1383, DOI 10.1007/s10815-014-0310-4; Hefler LA, 2007, CLIN CANCER RES, V13, P898, DOI 10.1158/1078-0432.CCR-06-1008; Houck K. A., 1991, ENDOCRINOLOGY, V5, P1806, DOI [10.1210/mend-5-12-1806, DOI 10.1210/MEND-5-12-1806]; Hurd WW, 2011, FERTIL STERIL, V96, P1043, DOI 10.1016/j.fertnstert.2011.07.002; Korytkowski M., 2000, WOMEN HLTH PRIM CARE, V3, P55; Lee EJ, 2008, FERTIL STERIL, V89, P1751, DOI 10.1016/j.fertnstert.2007.06.049; Locke JM, 2011, DIABETOLOGIA, V54, P3078, DOI 10.1007/s00125-011-2290-6; Luo L, 2013, J MATERN-FETAL NEO M, V26, P686, DOI 10.3109/14767058.2012.746305; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Menon MC, 2015, J CLIN INVEST, V125, P208, DOI 10.1172/JCI76902; Nagy B, 2008, CLIN CHIM ACTA, V389, P126, DOI 10.1016/j.cca.2007.12.003; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Peitsidis P, 2010, REPROD BIOMED ONLINE, V20, P444, DOI 10.1016/j.rbmo.2010.01.007; Resende AV, 2001, GYNECOL OBSTET INVES, V52, P153, DOI 10.1159/000052964; Ruggiero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016982; Stevens A, 2003, CANCER RES, V63, P812; Tulandi T, 2000, FERTIL STERIL, V74, P585, DOI 10.1016/S0015-0282(00)00684-1; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Vural P, 2009, EUR J OBSTET GYN R B, V147, P57, DOI 10.1016/j.ejogrb.2009.06.026; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Zidi S, 2015, CYTOKINE, V74, P108, DOI 10.1016/j.cyto.2014.11.009	35	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165636	10.1371/journal.pone.0165636	http://dx.doi.org/10.1371/journal.pone.0165636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846231	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600016
J	Domazet-Loso, M; Domazet-LoSo, T				Domazet-Loso, Mirjana; Domazet-Loso, Tomislav			gmos: Rapid Detection of Genome Mosaicism over Short Evolutionary Distances	PLOS ONE			English	Article							RECOMBINATION; SEQUENCE; INFERENCE; ALIGNMENT; SEARCH; BLAST; MODEL	Prokaryotic and viral genomes are often altered by recombination and horizontal gene transfer. The existing methods for detecting recombination are primarily aimed at viral genomes or sets of loci, since the expensive computation of underlying statistical models often hinders the comparison of complete prokaryotic genomes. As an alternative, alignment-free solutions are more efficient, but cannot map (align) a query to subject genomes. To address this problem, we have developed gmos (Genome MOsaic Structure), a new program that determines the mosaic structure of query genomes when compared to a set of closely related subject genomes. The program first computes local alignments between query and subject genomes and then reconstructs the query mosaic structure by choosing the best local alignment for each query region. To accomplish the analysis quickly, the program mostly relies on pairwise alignments and constructs multiple sequence alignments over short overlapping subject regions only when necessary. This fine-tuned implementation achieves an efficiency comparable to an alignment-free tool. The program performs well for simulated and real data sets of closely related genomes and can be used for fast recombination detection; for instance, when a new prokaryotic pathogen is discovered. As an example, gmos was used to detect genome mosaicism in a pathogenic Enterococcus faecium strain compared to seven closely related genomes. The analysis took less than two minutes on a single 2.1 GHz processor. The output is available in fasta format and can be visualized using an accessory program, gmosDraw (freely available with gmos).	[Domazet-Loso, Mirjana] Univ Zagreb, Fac Elect Engn & Comp, Dept Appl Comp, Zagreb, Croatia; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Lab Evolutionary Genet, Zagreb, Croatia; [Domazet-Loso, Tomislav] Catholic Univ Croatia, Zagreb, Croatia	University of Zagreb; Rudjer Boskovic Institute	Domazet-Loso, M (corresponding author), Univ Zagreb, Fac Elect Engn & Comp, Dept Appl Comp, Zagreb, Croatia.	mirjana.domazet@fer.hr			University of Zagreb [TP1.13]; Adris Foundation; City of Zagreb grant	University of Zagreb; Adris Foundation; City of Zagreb grant	This research was supported by the University of Zagreb research grant TP1.13 (2014) to MDL. TDL is supported by Adris Foundation and the City of Zagreb grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Bulla I, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-205; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cartwright RA, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bti1200; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041; Didelot X, 2010, GENETICS, V186, P1435, DOI 10.1534/genetics.110.120121; Diemer GS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-13; Domazet-Loso Mirjana, 2011, Mob Genet Elements, V1, P230; Domazet-Loso M, 2011, BIOINFORMATICS, V27, P1466, DOI 10.1093/bioinformatics/btr176; Gertz EM, 2005, BLAST SCORING PARAME; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Haubold B, 2009, J COMPUT BIOL, V16, P1487, DOI 10.1089/cmb.2009.0106; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Korf I., 2003, BLAST; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Manzini G, 2004, ALGORITHMICA, V40, P33, DOI 10.1007/s00453-004-1094-1; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Marttinen P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr928; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Mori Y., 2008, LIBDIVSUFSORT LIGHTW; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Peng J, 2011, PROTEINS, V79, P1930, DOI 10.1002/prot.23016; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Repizo GD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-489; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Sung, 2010, ALGORITHMS BIOINFORM; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Yahara K, 2014, MOL BIOL EVOL, V31, P1593, DOI 10.1093/molbev/msu082; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	38	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166602	10.1371/journal.pone.0166602	http://dx.doi.org/10.1371/journal.pone.0166602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846272	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600089
J	Errea, A; Cayet, D; Marchetti, P; Tang, C; Kluza, J; Offermanns, S; Sirard, JC; Rumbo, M				Errea, Agustina; Cayet, Delphine; Marchetti, Philippe; Tang, Cong; Kluza, Jerome; Offermanns, Stefan; Sirard, Jean-Claude; Rumbo, Martin			Lactate Inhibits the Pro-Inflammatory Response and Metabolic Reprogramming in Murine Macrophages in a GPR81-Independent Manner	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; LACTIC-ACID; INNATE IMMUNITY; POLARIZATION; GLYCOLYSIS; CANCER; INJURY; CELLS; COLON; LUNG	Lactate is an essential component of carbon metabolism in mammals. Recently, lactate was shown to signal through the G protein coupled receptor 81 (GPR81) and to thus modulate inflammatory processes. This study demonstrates that lactate inhibits pro-inflammatory signaling in a GPR81-independent fashion. While lipopolysaccharide (LPS) triggered expression of IL-6 and IL-12 p40, and CD40 in bone marrow-derived macrophages, lactate was able to abrogate these responses in a dose dependent manner in Gpr81(-/-) cells as well as in wild type cells. Macrophage activation was impaired when glycolysis was blocked by chemical inhibitors. Remarkably, lactate was found to inhibit LPS-induced glycolysis in wild type as well as in Gpr81(-/-) cells. In conclusion, our study suggests that lactate can induce GPR81-independent metabolic changes that modulate macrophage pro-inflammatory activation.	[Errea, Agustina; Rumbo, Martin] Univ Nacl La Plata, CONICET, Inst Estudios Inmunol & Fisiopatol, RA-1900 La Plata, Buenos Aires, Argentina; [Cayet, Delphine; Sirard, Jean-Claude] Univ Lille, CHU Lille, CIIL U1019 UMR8204, Inst Pasteur Lille,INSERM,CNRS, F-59000 Lille, France; [Marchetti, Philippe; Kluza, Jerome] Univ Lille, INSERM, CHU Lille,JPArc, Ctr Rech JeanPierre AUBERT Neurosci & Ctr,UMR,S 1, F-59000 Lille, France; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Offermanns, Stefan] Goethe Univ Frankfurt, Fac Med, D-60590 Frankfurt, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Goethe University Frankfurt	Rumbo, M (corresponding author), Univ Nacl La Plata, CONICET, Inst Estudios Inmunol & Fisiopatol, RA-1900 La Plata, Buenos Aires, Argentina.	martinr@biol.unlp.edu.ar	Sirard, Jean-Claude/B-5932-2011; Kluza, Jérome/B-6312-2012; Offermanns, Stefan/L-3313-2017	Sirard, Jean-Claude/0000-0001-9854-4652; Kluza, Jérome/0000-0002-7346-1305; CAYET, Delphine/0000-0003-1720-0845; MARCHETTI, Philippe/0000-0002-4663-6800; Offermanns, Stefan/0000-0001-8676-6805; Tang, Cong/0000-0002-5228-3052	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille; CONICET-DAAD; Argentinian Ministry of Science, Technology and Innovation; French Ministry for Research and Higher Education [EGOS A12803]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille; CONICET-DAAD; Argentinian Ministry of Science, Technology and Innovation; French Ministry for Research and Higher Education; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT), INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille, CONICET-DAAD and the Argentinian Ministry of Science, Technology and Innovation and the French Ministry for Research and Higher Education (grant EGOS A12803). AE received a Bernardo Houssay fellowship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AE and MR are members of the Argentinian National Research Council (CONICET), and JCS a member of INSERM. AE received a Bernardo Houssay fellowship from CONICET. The work was supported by grants from Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCYT), INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille, CONICET-DAAD and the Argentinian Ministry of Science, Technology and Innovation and the French Ministry for Research and Higher Education (grant EGOS A12B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Garrote GL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00629; Goodwin ML, 2014, CANCER CELL, V26, P851, DOI 10.1016/j.ccell.2014.10.003; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hoque R, 2014, GASTROENTEROLOGY, V146, P1763, DOI 10.1053/j.gastro.2014.03.014; HOVE H, 1995, DIGEST DIS SCI, V40, P320, DOI 10.1007/BF02065417; Hur H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098581; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Luc R, 2015, MOL BIOL REP, V42, P835, DOI 10.1007/s11033-015-3859-9; Nasi A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26744; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; O'Neill LAJ, 2015, IMMUNITY, V42, P393, DOI 10.1016/j.immuni.2015.02.017; Offermanns S, 2014, ANNU REV PHARMACOL, V54, P407, DOI 10.1146/annurev-pharmtox-011613-135945; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Shi LB, 2015, SCI REP-UK, V5, DOI 10.1038/srep18176; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Tan Z, 2015, J BIOL CHEM, V290, P46, DOI 10.1074/jbc.M114.603589; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Wang AS, 2014, NMR BIOMED, V27, P1361, DOI 10.1002/nbm.3198; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008	33	83	84	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0163694	10.1371/journal.pone.0163694	http://dx.doi.org/10.1371/journal.pone.0163694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846210	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600003
J	Kim, D; Choi, Y; Ireland, J; Foreman, O; Tam, RN; Patel, R; Schleifman, EB; Motlhabi, M; French, D; Wong, CV; Peters, E; Molinero, L; Raja, R; Amler, LC; Hampton, GM; Lackner, MR; Kabbarah, O				Kim, Doris; Choi, YounJeong; Ireland, James; Foreman, Oded; Tam, Rachel N.; Patel, Rajesh; Schleifman, Erica B.; Motlhabi, Maipelo; French, Dorothy; Wong, Cheryl V.; Peters, Eric; Molinero, Luciana; Raja, Rajiv; Amler, Lukas C.; Hampton, Garret M.; Lackner, Mark R.; Kabbarah, Omar			Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; EXTRACELLULAR DOMAIN; PROGNOSTIC-FACTORS; MUTATIONS; CARCINOMA; FGFR3; GENE; CLASSIFICATION; PROGRESSION; EXPRESSION	In the age of personalized medicine stratifying tumors into molecularly defined subtypes associated with distinctive clinical behaviors and predictable responses to therapies holds tremendous value. Towards this end, we developed a custom microfluidics-based bladder cancer gene expression panel for characterization of archival clinical samples. In silico analysis indicated that the content of our panel was capable of accurately segregating bladder cancers from several public datasets into the clinically relevant basal and luminal subtypes. On a technical level, our bladder cancer panel yielded robust and reproducible results when analyzing formalin-fixed, paraffin-embedded (FFPE) tissues. We applied our panel in the analysis of a novel set of 204 FFPE samples that included non-muscle invasive bladder cancers (NMIBCs), muscle invasive disease (MIBCs), and bladder cancer metastases (METs). We found NMIBCs to be mostly luminal-like, MIBCs to include both luminal-and basal-like types, and METs to be predominantly of a basal-like transcriptional profile. Mutational analysis confirmed the expected enrichment of FGFR3 mutations in luminal samples, and, consistently, FGFR3 IHC showed high protein expression levels of the receptor in these tumors. Our bladder cancer panel enables basal/luminal characterization of FFPE tissues and with further development could be used for stratification of bladder cancer samples in the clinic.	[Kim, Doris; Tam, Rachel N.; Patel, Rajesh; Schleifman, Erica B.; Motlhabi, Maipelo; Wong, Cheryl V.; Peters, Eric; Molinero, Luciana; Raja, Rajiv; Amler, Lukas C.; Hampton, Garret M.; Lackner, Mark R.; Kabbarah, Omar] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Choi, YounJeong] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Ireland, James] Alternate Allele Consulting, Orinda, CA USA; [Foreman, Oded; French, Dorothy] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kabbarah, O (corresponding author), Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA.	kabbaraa@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	DK, YC, OF, RNT, RP, EBS, MM, DF, CVVV, EP, LM, RR, LCA, GMH, MRL, and OK are current or former employees of Genentech, Inc. Genentech, Inc. provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JI is an employee of Alternative Allele Consulting. Alternative Allele Consulting provided support in the form of salary for this author but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al-Ahmadie HA, 2011, J PATHOL, V224, P270, DOI 10.1002/path.2892; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Dudoit S, 2002, GENOME BIOL, V3; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; George B, 2007, J CLIN ONCOL, V25, P5352, DOI 10.1200/JCO.2006.10.4125; Gust KM, 2013, MOL CANCER THER, V12, P1245, DOI 10.1158/1535-7163.MCT-12-1150; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; HENEY NM, 1992, UROL CLIN N AM, V19, P429; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juanpere N, 2012, HUM PATHOL, V43, P1573, DOI 10.1016/j.humpath.2011.10.026; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Knowles MA, 2007, FRONT BIOSCI-LANDMRK, V12, P2233, DOI 10.2741/2226; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Liu X, 2014, GENET MOL RES, V13, P1109, DOI 10.4238/2014.February.20.12; Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039; Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282; McConkey DJ, 2016, EUR UROL, V69, P855, DOI 10.1016/j.eururo.2015.08.034; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Millan-Rodriguez F, 2000, J UROLOGY, V163, P73, DOI 10.1016/S0022-5347(05)67975-X; Nargund VH, 2012, SEMIN ONCOL, V39, P559, DOI 10.1053/j.seminoncol.2012.08.001; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rebouissou S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008970; Resnick MJ, 2013, CURR OPIN ONCOL, V25, P281, DOI 10.1097/CCO.0b013e32835eb583; Ross JS, 2014, CLIN CANCER RES, V20, P68, DOI 10.1158/1078-0432.CCR-13-1992; Sanchez-Carbayo M, 2007, SEMIN ONCOL, V34, P75, DOI 10.1053/j.seminoncol.2006.12.013; Schleifman EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090761; Schleifman EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088401; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Team RDC, 2006, R LANG ENV STAT COMP; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tukey JW, 1977, EXPLORATORY DATA ANA; van Rhijn BWG, 2002, J PATHOL, V198, P245, DOI 10.1002/path.1202; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165856	10.1371/journal.pone.0165856	http://dx.doi.org/10.1371/journal.pone.0165856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846280	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600021
J	Baba, S; Iso, H; Fujiwara, T				Baba, Sachiko; Iso, Hiroyasu; Fujiwara, Takeo			Area-Level and Individual-Level Factors for Teenage Motherhood: A Multilevel Analysis in Japan	PLOS ONE			English	Article							POPULATION; PREGNANCY; RISK; CONSEQUENCES; COHORT; OUTCOMES; POVERTY; PEOPLE; AGE	Background Teenage motherhood is strongly associated with a range of disadvantages for both the mother and the child. No epidemiological studies have examined related factors for teenage motherhood at both area and individual levels among Japanese women. Therefore, we performed a multilevel analysis of nationwide data in Japan to explore the association of area- and individual-level factors with teenage motherhood. Methods The study population comprised 21,177 mothers living in 47 prefectures who had their first, singleton baby between 10 and 17 January or between 10 and 17 July, 2001. Information on the prefecture in which the mothers resided was linked to prefecture-level variables. Primary outcomes were area-level characteristics (single-mother households, three-generation households, college enrollment, abortions, juvenile crime, and per capita income) and individual-level characteristics, and divided into tertiles or quintiles based on their variable distributions. Multilevel logistic regression analysis was then performed. Results There were 440 teenage mothers (2.1%) in this study. In addition to individual low level of education [adjusted odds ratio (OR), 7.40; 95% confidence interval (CI), 5.59-9.78], low income [4.23 (2.95-6.08)], and smoking [1.65 (1.31-2.07)], high proportions of single-mother households [1.72 (1.05-2.80)] and three-generation household [1.81 (1.17-2.78)], and per capita income [2.19 (1.06-3.81)] at an area level were positively associated, and high level of college enrollment [0.46 (0.25-0.83)] and lower crime rate [0.62 (0.40-0.98)] at area level were inversely associated with teenage motherhood compared with the corresponding women living in prefectures with the lowest levels of these variables. Conclusions Our findings suggest that encouraging the completion of higher education and reducing the number of single-mother household at an area level may be important public health strategies to reduce teenage motherhood.	[Baba, Sachiko] Osaka Univ, Grad Sch Med, Ctr Int Relat, Suita, Osaka, Japan; [Baba, Sachiko; Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka, Japan; [Fujiwara, Takeo] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Tokyo, Japan	Osaka University; National Center for Child Health & Development - Japan; Osaka University; Tokyo Medical & Dental University (TMDU)	Baba, S (corresponding author), Osaka Univ, Grad Sch Med, Ctr Int Relat, Suita, Osaka, Japan.; Baba, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	baba@cir.med.osaka-u.ac.jp		Baba, Sachiko/0000-0002-6213-8115	Japan Society for the Promotion of Science [26870331]; Grants-in-Aid for Scientific Research [26870331] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Young Scientist (B) from the Japan Society for the Promotion of Science (grant 26870331) (https://www.jsps.go.english/e-grants/grants01.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2014, J OBSTET GYNAECOL RE, V40, P125, DOI 10.1111/jog.12138; Baba Sachiko, 2005, Environmental Health and Preventive Medicine, V10, P9, DOI 10.1265/ehpm.10.9; BARKER DJP, 1986, LANCET, V1, P1077; Burack R, 1999, BRIT J FAM PLAN, V24, P145; Cabinet Office Government of Japan, 2001, ANN REP PREF ACC FIS; Chang Z, 2014, INT J EPIDEMIOL, V43, P1815, DOI 10.1093/ije/dyu204; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Gaudie J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-63; Hardy R, 2009, J EPIDEMIOL COMMUN H, V63, P99, DOI 10.1136/jech.2008.076943; Harrison Ayanna T., 2012, Morbidity and Mortality Weekly Report, V61, P25; Hobcraft J, 2001, BRIT J SOCIOL, V52, P495; Hogan DP, 2000, AM J PUBLIC HEALTH, V90, P1421; Johns SE, 2011, HEALTH PLACE, V17, P122, DOI 10.1016/j.healthplace.2010.09.006; Kane JB, 2013, DEMOGRAPHY, V50, P2129, DOI 10.1007/s13524-013-0238-9; Kirby D, 2001, FAM PLANN PERSPECT, V33, P63, DOI 10.2307/2673751; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Lipman EL, 2011, J AM ACAD CHILD PSY, V50, P232, DOI 10.1016/j.jaac.2010.12.007; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Ministry of Education Culture Sports Science and Technology, REP SCH REF DROP HIG; Ministry of education culture sports science and technology, 2001, SCH BAS SURV FISC YE; Ministry of Education Culture Sports Science and Technology, FY 2014 SCH BAS SURV; Ministry of health labour and welfare., 2001, VIT STAT SPEC ISS 20; Ministry of health labour and welfare, 2001, REP PUBL HLTH ADM SE; Nanchahal K, 2005, J EPIDEMIOL COMMUN H, V59, P828, DOI 10.1136/jech.2004.026021; National Police Agency, 2001, OV JUV DEL PROT 2000; Noll JG, 2013, PEDIATRICS, V131, pE1181, DOI 10.1542/peds.2012-3072; OECD, 2013, ED IND FOC; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Patel PH, 2012, MATERN CHILD HLTH J, V16, P1063, DOI 10.1007/s10995-011-0829-2; Paul C, 2000, J ADOLESCENT HEALTH, V27, P136, DOI 10.1016/S1054-139X(99)00095-6; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Saito E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-93; Silverstein M, 2006, J GERONTOL B-PSYCHOL, V61, pS256, DOI 10.1093/geronb/61.5.S256; Smith Debbie M, 2006, Psychol Health Med, V11, P399, DOI 10.1080/13548500500429353; Statistics Bureau Ministry of Internal Affairs and Communications, PORT SIT OFF STAT JA PORT SIT OFF STAT JA; Thornberry TP, 2014, CHILD ABUSE NEGLECT, V38, P706, DOI 10.1016/j.chiabu.2013.08.009; UNICEF, 2001, LEAGUE TABLE TEENAGE; Uren Zoe, 2007, Health Stat Q, P34; Webb RT, 2011, PSYCHOL MED, V41, P1867, DOI 10.1017/S0033291711000055	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166345	10.1371/journal.pone.0166345	http://dx.doi.org/10.1371/journal.pone.0166345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832177	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000105
J	Parker, ML; Houston, S; Wetherell, C; Cameron, CE; Boulanger, MJ				Parker, Michelle L.; Houston, Simon; Wetherell, Charmaine; Cameron, Caroline E.; Boulanger, Martin J.			The Structure of Treponema pallidum Tp0624 Reveals a Modular Assembly of Divergently Functionalized and Previously Uncharacterized Domains	PLOS ONE			English	Article							BACTERIAL FLAGELLAR MOTOR; PEPTIDOGLYCAN; PROTEIN; MECHANISM; RMPM	Treponema pallidum subspecies pallidum is the causative agent of syphilis, a chronic, multistage, systemic infection that remains a major global health concern. The molecular mechanisms underlying T. pallidum pathogenesis are incompletely understood, partially due to the phylogenetic divergence of T. pallidum. One aspect of T. pallidum that differentiates it from conventional Gram-negative bacteria, and is believed to play an important role in pathogenesis, is its unusual cell envelope ultrastructure; in particular, the T. pallidum peptidoglycan layer is chemically distinct, thinner and more distal to the outer membrane. Established functional roles for peptidoglycan include contributing to the structural integrity of the cell envelope and stabilization of the flagellar motor complex, which are typically mediated by the OmpA domain-containing family of proteins. To gain insight into the molecular mechanisms that govern peptidoglycan binding and cell envelope biogenesis in T. pallidum we report here the structural characterization of the putative OmpA-like domain-containing protein, Tp0624. Analysis of the 1.70 A resolutionp0624 crystal structure reveals a multi-modular architecture comprised of three distinct domains including a C-terminal divergent OmpA-like domain, which we show is unable to bind the conventional peptidoglycan component diaminopimelic acid, and a previously uncharacterized tandem domain unit. Intriguingly, bioinformatic analysis indicates that the three domains together are found in all orthologs from pathogenic treponemes, but are not observed together in genera outside Treponema. These findings provide the first structural insight into a multi-modular treponemal protein containing an OmpA-like domain and its potential role in peptidoglycan coordination and stabilization of the T. pallidum cell envelope.	[Parker, Michelle L.; Houston, Simon; Wetherell, Charmaine; Cameron, Caroline E.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Victoria	Cameron, CE; Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	caroc@uvic.ca; mboulang@uvic.ca	Cameron, Caroline/HIR-2880-2022	Cameron, Caroline/0000-0002-8786-4359; Houston, Simon/0000-0001-5961-5227	Natural Sciences and Engineering Research Council of Canada; Canada Chairs Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051334, R01AI051334] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Chairs Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Natural Sciences and Engineering Research Council of Canada grants to MJB and CEC. MJB and CEC gratefully acknowledge the Canada Chairs Research Program for salary support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Artola-Recolons C, 2014, ACS CHEM BIOL, V9, P2058, DOI 10.1021/cb500439c; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bouveret E, 1999, J BACTERIOL, V181, P6306, DOI 10.1128/JB.181.20.6306-6311.1999; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLT SC, 1978, MICROBIOL REV, V42, P114, DOI 10.1128/MMBR.42.1.114-160.1978; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; JOSEPH R, 1973, J BACTERIOL, V115, P426, DOI 10.1128/JB.115.1.426-435.1973; Kelkar YD, 2013, GENETICS, V193, P303, DOI 10.1534/genetics.112.145656; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen O, 2003, STRUCTURE, V11, P1547, DOI 10.1016/j.str.2003.11.003; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Lukehart Sheila A, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12a01s7; Maharjan S, 2016, MICROBIOL-SGM, V162, P364, DOI 10.1099/mic.0.000227; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Nash RP, 2010, NUCLEIC ACIDS RES, V38, P5929, DOI 10.1093/nar/gkq303; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Nguyen CC, 1996, RES MICROBIOL, V147, P317, DOI 10.1016/0923-2508(96)84707-3; Nusbaum Margaret R H, 2004, J Am Osteopath Assoc, V104, P527; Organization WH., 2011, PREV INC SEX TRANSM; Osbak KK, 2016, PLOS NEGL T IN PRESS; Park JS, 2012, FASEB J, V26, P219, DOI 10.1096/fj.11-188425; Parker ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139407; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Reboul CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018981; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smajs D, 2005, J BACTERIOL, V187, P1866, DOI 10.1128/JB.187.5.1866-1874.2005; Tonkin ML, 2013, J BIOL CHEM, V288, P12805, DOI 10.1074/jbc.M113.455667; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; UMEMOTO T, 1981, INFECT IMMUN, V31, P767, DOI 10.1128/IAI.31.2.767-774.1981; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; YANAGIHARA Y, 1984, MICROBIOL IMMUNOL, V28, P535, DOI 10.1111/j.1348-0421.1984.tb00706.x	49	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166274	10.1371/journal.pone.0166274	http://dx.doi.org/10.1371/journal.pone.0166274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832149	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000087
J	Piszter, G; Kertesz, K; Balint, Z; Biro, LP				Piszter, Gabor; Kertesz, Krisztian; Balint, Zsolt; Biro, Laszlo Peter			Variability of the Structural Coloration in Two Butterfly Species with Different Prezygotic Mating Strategies	PLOS ONE			English	Article							WING SCALES; SEXUAL SELECTION; PHOTONIC NANOARCHITECTURES; EVOLUTION; CRYSTALS; SIGNALS; GREEN; MOTH	Structural coloration variability was investigated in two Blue butterfly species that are common in Hungary. The males of Polyommatus icarus (Common Blue) and Plebejus argus (Silver -studded Blue) use their blue wing coloration for conspecific recognition. Despite living in the same type of habitat, these two species display differences in prezygotic mating strategy: the males of P. icarus are patrolling, while P. argus males have sedentary behavior. Therefore, the species-specific photonic nanoarchitecture, which is the source of the structural coloration, may have been subjected to different evolutionary effects. Despite the increasing interest in photonic nanoarchitectures of biological origin, there is a lack of studies focused on the biological variability of structural coloration that examine a statistically relevant number of individuals from the same species. To investigate possible structural color variation within the same species in populations separated by large geographical distances, climatic differences, or applied experimental conditions, one has to be able to compare these variations to the normal biological variability within a single population. The structural coloration of the four wings of 25 male individuals (100 samples for each species) was measured and compared using different light-collecting setups: perpendicular and with an integrating sphere. Significant differences were found in the near UV wavelength region that are perceptible by these polyommatine butterflies but are invisible to human observers. The differences are attributed to the differences in the photonic nanoarchitecture in the scales of these butterflies. Differences in the intensity of structural coloration were also observed and were tentatively attributed to the different prezygotic mating strategies of these insects. Despite the optical complexity of the scale covered butterfly wings, for sufficiently large sample batches, the averaged normal incidence measurements and the averaged measurements using an integrating sphere are in agreement.	[Piszter, Gabor; Kertesz, Krisztian; Biro, Laszlo Peter] Inst Tech Phys & Mat Sci, Energy Res Ctr, Budapest, Hungary; [Balint, Zsolt] Hungarian Nat Hist Museum, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Hungarian Research Centre for Natural Sciences	Piszter, G (corresponding author), Inst Tech Phys & Mat Sci, Energy Res Ctr, Budapest, Hungary.	piszter@mfa.kfki.hu	Biro, Laszlo/GRO-3819-2022	Balint, Zsolt/0000-0001-8174-878X; Piszter, Gabor/0000-0001-7155-4025	Hungarian Scientific Research Fund [OTKA K 111741, OTKA K 115724]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (http://www.otka.hu/en) OTKA K 111741 and OTKA K 115724 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Balint Z, 2012, J R SOC INTERFACE, V9, P1745, DOI 10.1098/rsif.2011.0854; Balinti Zsolt, 2010, Genus (Wroclaw), V21, P163; Bateson P., 1983, MATE CHOICE; Biro LP, 2011, LASER PHOTONICS REV, V5, P27, DOI 10.1002/lpor.200900018; Biro LP, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021907; Burghardt F, 2000, NATURWISSENSCHAFTEN, V87, P304, DOI 10.1007/s001140050726; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Ghiradella H, 2010, ADV INSECT PHYSIOL, V38, P135, DOI 10.1016/S0065-2806(10)38006-4; Ghiradella HT, 2009, J R SOC INTERFACE, V6, pS243, DOI 10.1098/rsif.2008.0372.focus; Han ZW, 2014, RSC ADV, V4, P45214, DOI 10.1039/c4ra06117a; Kertesz K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021922; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Levin SA, 2013, ENCY BIODIVERSITY; Lewis OT, 1997, ECOL ENTOMOL, V22, P283, DOI 10.1046/j.1365-2311.1997.00074.x; Mafuku M., 2013, EUR J ENTOMOL, V110, P435; Meadows MG, 2011, BEHAV ECOL SOCIOBIOL, V65, P1317, DOI 10.1007/s00265-010-1135-5; Michielsen K, 2008, J R SOC INTERFACE, V5, P85, DOI 10.1098/rsif.2007.1065; Michielsen K, 2010, J R SOC INTERFACE, V7, P765, DOI 10.1098/rsif.2009.0352; Mitesser O, 2015, INT J ELECTR COMPUT, V6, P29; Piszter G, 2014, OPT EXPRESS, V22, P22649, DOI 10.1364/OE.22.022649; Piszter G, 2011, ANAL METHODS-UK, V3, P78, DOI 10.1039/c0ay00410c; Sison-Mangus MP, 2008, J EXP BIOL, V211, P361, DOI 10.1242/jeb.012617; Stavenga DG, 2006, OPT EXPRESS, V14, P4880, DOI 10.1364/OE.14.004880; Stavenga DG, 2009, OPT EXPRESS, V17, P193, DOI 10.1364/OE.17.000193; Thomas J., 2010, BUTTERFLIES BRITAIN; Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794; Wasik BR, 2014, P NATL ACAD SCI USA, V111, P12109, DOI 10.1073/pnas.1402770111; White TE, 2015, EVOLUTION, V69, P14, DOI 10.1111/evo.12551; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wilts BD, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0160-9; Wilts BD, 2009, J R SOC INTERFACE, V6, pS185, DOI 10.1098/rsif.2008.0299.focus; Yoshioka S, 2007, OPT EXPRESS, V15, P2691, DOI 10.1364/OE.15.002691; Zhang D, 2015, PROG MATER SCI, V68, P67, DOI 10.1016/j.pmatsci.2014.10.003	36	17	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165857	10.1371/journal.pone.0165857	http://dx.doi.org/10.1371/journal.pone.0165857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832120	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000037
J	Schreeg, ME; Marr, HS; Tarigo, JL; Cohn, LA; Bird, DM; Scholl, EH; Levy, MG; Wiegmann, BM; Birkenheuer, AJ				Schreeg, Megan E.; Marr, Henry S.; Tarigo, Jaime L.; Cohn, Leah A.; Bird, David M.; Scholl, Elizabeth H.; Levy, Michael G.; Wiegmann, Brian M.; Birkenheuer, Adam J.			Mitochondrial Genome Sequences and Structures Aid in the Resolution of Piroplasmida phylogeny	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; BABESIA-MICROTI; SOUTHERN EUROPE; THEILERIA-PARVA; SP NOV.; APICOMPLEXAN PARASITES; CYTAUXZOON-FELIS; STRAY CATS; EVOLUTION; DNA	The taxonomy of the order Piroplasmida, which includes a number of clinically and economically relevant organisms, is a hotly debated topic amongst parasitologists. Three genera (Babesia, Theileria, and Cytauxzoon) are recognized based on parasite life cycle characteristics, but molecular phylogenetic analyses of 18S sequences have suggested the presence of five or more distinct Piroplasmida lineages. Despite these important advancements, a few studies have been unable to define the taxonomic relationships of some organisms (e.g. C. felis and T. equi) with respect to other Piroplasmida. Additional evidence from mitochondrial genome sequences and synteny should aid in the inference of Piroplasmida phylogeny and resolution of taxonomic uncertainties. In this study, we have amplified, sequenced, and annotated seven previously uncharacterized mitochondrial genomes (Babesia canis, Babesia vogeli, Babesia rossi, Babesia sp. Coco, Babesia conradae, Babesia microti-like sp., and Cytauxzoon felis) and identified additional ribosomal fragments in ten previously characterized mitochondrial genomes. Phylogenetic analysis of concatenated mitochondrial and 18S sequences as well as cox1 amino acid sequence identified five distinct Piroplasmida groups, each of which possesses a unique mitochondrial genome structure. Specifically, our results confirm the existence of four previously identified clades (B. microti group, Babesia sensu stricto, Theileria equi, and a Babesia sensu latu group that includes B. conradae) while supporting the integration of Theileria and Cytauxzoon species into a single fifth taxon. Although known biological characteristics of Piroplasmida corroborate the proposed phylogeny, more investigation into parasite life cycles is warranted to further understand the evolution of the Piroplasmida. Our results provide an evolutionary framework for comparative biology of these important animal and human pathogens and help focus renewed efforts toward understanding the phylogenetic relationships within the group.	[Schreeg, Megan E.; Marr, Henry S.; Tarigo, Jaime L.; Levy, Michael G.; Birkenheuer, Adam J.] North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Tarigo, Jaime L.] Univ Georgia, Coll Vet Med, Athens, GA USA; [Cohn, Leah A.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Bird, David M.; Scholl, Elizabeth H.; Wiegmann, Brian M.] North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University	Birkenheuer, AJ (corresponding author), North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.; Wiegmann, BM (corresponding author), North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC 27695 USA.	bwiegman@ncsu.edu; ajbirken@ncsu.edu		Birkenheuer, Adam/0000-0002-2617-2252; Bird, David/0000-0002-1041-6769; Wiegmann, Brian/0000-0002-1869-9759	charitable organization	charitable organization	This work was funded by a charitable organization that wishes to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MTEP, 2006, ANN NY ACAD SCI, V1081, P509, DOI 10.1196/annals.1373.076; ALLSOPP MTEP, 1994, PARASITOLOGY, V108, P147, DOI 10.1017/S0031182000068232; Andre MR, 2015, TICKS TICK-BORNE DIS, V6, P779, DOI 10.1016/j.ttbdis.2015.07.004; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bajer A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0572-9; Baneth G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0830-5; Birkenheuer AJ, 2004, VET PARASITOL, V124, P151, DOI 10.1016/j.vetpar.2004.07.008; Bishop R, 2004, PARASITOLOGY, V129, pS271, DOI 10.1017/S0031182003004748; BLOUIN EF, 1987, J WILDLIFE DIS, V23, P499, DOI 10.7589/0090-3558-23.3.499; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bosman AM, 2010, J CLIN MICROBIOL, V48, P2703, DOI 10.1128/JCM.02266-09; Carli E, 2012, VET PARASITOL, V183, P343, DOI 10.1016/j.vetpar.2011.07.025; Chantangsi C, 2008, MOL PHYLOGENET EVOL, V49, P979, DOI 10.1016/j.ympev.2008.09.017; Chauvin A, 2009, VET RES, V40, DOI 10.1051/vetres/2009020; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Cornillot E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072657; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Criado-Fornelio A, 2003, VET PARASITOL, V113, P189, DOI 10.1016/S0304-4017(03)00078-5; Criado-Fornelio A, 2003, VET PARASITOL, V114, P173, DOI 10.1016/S0304-4017(03)00141-9; Criado-Fornelio A, 2003, VET MICROBIOL, V93, P307, DOI 10.1016/S0378-1135(03)00044-0; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; Feagin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038320; Giadinis ND, 2012, VET REC, V170, p155B, DOI 10.1136/vr.100394; Goethert HK, 2003, PARASITOLOGY, V127, P301, DOI 10.1017/S0031182003003822; Gohil S, 2013, INT J PARASITOL, V43, P125, DOI 10.1016/j.ijpara.2012.09.008; GORENFLOT A, 1991, PARASITOL RES, V77, P3, DOI 10.1007/BF00934377; Gou HT, 2012, ACTA TROP, V124, P92, DOI 10.1016/j.actatropica.2012.07.001; GROOTENHUIS JG, 1979, RES VET SCI, V27, P59, DOI 10.1016/S0034-5288(18)32860-1; Hagiwara K, 1997, INT J PARASITOL, V27, P1375, DOI 10.1016/S0020-7519(97)00092-1; Harris DJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1567-5; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; He L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-82; Hikosaka K, 2013, MOL BIOCHEM PARASIT, V188, P26, DOI 10.1016/j.molbiopara.2013.02.006; Hikosaka K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-622; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1052-6; Irwin PJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S4; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Ketz-Riley CJ, 2003, J WILDLIFE DIS, V39, P424, DOI 10.7589/0090-3558-39.2.424; Kher CP, 2011, PROTIST, V162, P2, DOI 10.1016/j.protis.2010.03.004; Kjemtrup AM, 2006, VET PARASITOL, V138, P103, DOI 10.1016/j.vetpar.2006.01.044; Kjemtrup AM, 2000, PARASITOLOGY, V120, P487, DOI 10.1017/S003118209900582X; Kjemtrup AM, 2001, J PARASITOL, V87, P373, DOI 10.1645/0022-3395(2001)087[0373:DAEOTY]2.0.CO;2; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1501, DOI 10.1016/S0020-7519(00)00120-X; Kjemtrup AM, 2006, VET PARASITOL, V138, P112, DOI 10.1016/j.vetpar.2006.01.045; Lack JB, 2012, INT J PARASITOL, V42, P353, DOI 10.1016/j.ijpara.2012.02.005; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Le TH, 2000, ACTA TROP, V77, P243, DOI 10.1016/S0001-706X(00)00157-1; Leclaire S, 2015, PARASITOLOGY, V142, P543, DOI 10.1017/S0031182014001504; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LEVINE ND, 1971, T AM MICROSC SOC, V90, P2, DOI 10.2307/3224894; Levine ND., 1988, PROTOZOAN PHYLUM API; Maia C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-115; MEHLHORN H, 1986, DEUT TIERARZTL WOCH, V93, P400; Mehlhorn H, 1998, PARASITOL RES, V84, P467, DOI 10.1007/s004360050431; Meinkoth JH, 2005, VET CLIN N AM-SMALL, V35, P89, DOI 10.1016/j.cvsm.2004.08.003; Merino S, 1998, J PARASITOL, V84, P422, DOI 10.2307/3284504; Millan J, 2007, PARASITOLOGY, V134, P995, DOI 10.1017/S003118200700248X; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; MOTZEL SL, 1990, VET PARASITOL, V35, P131, DOI 10.1016/0304-4017(90)90122-R; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; NEITZ W. O., 1948, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V23, P63; Nijhof AM, 2005, J CLIN MICROBIOL, V43, P5907, DOI 10.1128/JCM.43.12.5907-5911.2005; Nijhof AM, 2003, J CLIN MICROBIOL, V41, P2249, DOI 10.1128/JCM.41.5.2249-2254.2003; Ogedengbe JD, 2011, INT J PARASITOL, V41, P843, DOI 10.1016/j.ijpara.2011.03.007; Paparini A, 2015, PROTIST, V166, P609, DOI 10.1016/j.protis.2015.10.001; Paparini A, 2014, PARASITOL RES, V113, P4407, DOI 10.1007/s00436-014-4118-z; QUICK RE, 1993, ANN INTERN MED, V119, P284, DOI 10.7326/0003-4819-119-4-199308150-00006; Ramsay JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076996; Reichard MV, 2005, J PARASITOL, V91, P420, DOI 10.1645/GE-384R; SANKOFF D, 1992, P NATL ACAD SCI USA, V89, P6575, DOI 10.1073/pnas.89.14.6575; SATO M, 1993, J VET MED SCI, V55, P571, DOI 10.1292/jvms.55.571; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schnittger L, 2012, INFECT GENET EVOL, V12, P1788, DOI 10.1016/j.meegid.2012.07.004; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sikorski LE, 2010, J VET INTERN MED, V24, P127, DOI 10.1111/j.1939-1676.2009.0440.x; Sivakumar T, 2014, INFECT GENET EVOL, V27, P250, DOI 10.1016/j.meegid.2014.07.013; Soares JF, 2015, VET PARASITOL, V210, P98, DOI 10.1016/j.vetpar.2015.03.013; Solano-Gallego L, 2011, VET PARASITOL, V181, P48, DOI 10.1016/j.vetpar.2011.04.023; SPOONER RL, 1988, PARASITE IMMUNOL, V10, P619, DOI 10.1111/j.1365-3024.1988.tb00249.x; SPOONER RL, 1989, IMMUNOLOGY, V66, P284; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Susta L, 2009, VET PATHOL, V46, P1197, DOI 10.1354/vp.08-VP-0132-B-FL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarigo JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071233; THOMAS SE, 1982, ONDERSTEPOORT J VET, V49, P163; Tian Z, 2012, INFECT GENET EVOL; UILENBERG G, 1987, VET PARASITOL, V26, P21, DOI 10.1016/0304-4017(87)90073-2; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; Wilson RJM, 1997, MICROBIOL MOL BIOL R, V61, P1; Wise LN, 2013, J VET INTERN MED, V27, P1334, DOI 10.1111/jvim.12168; Yabsley Michael J., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P18, DOI 10.1016/j.ijppaw.2012.11.003; Yabsley MJ, 2006, J PARASITOL, V92, P423, DOI 10.1645/GE-617R.1; YOUNG AS, 1980, PARASITOLOGY, V81, P129, DOI 10.1017/S0031182000055104; Zahler M, 2000, PARASITOL RES, V86, P642, DOI 10.1007/PL00008545; Zahler M, 2000, PARASITOLOGY, V120, P365, DOI 10.1017/S0031182099005557	102	69	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165702	10.1371/journal.pone.0165702	http://dx.doi.org/10.1371/journal.pone.0165702			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832128	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000027
J	El-Battrawy, I; Lang, S; Zhao, Z; Akin, I; Yucel, G; Meister, S; Patocskai, B; Behnes, M; Rudic, B; Tulumen, E; Liebe, V; Tiburcy, M; Dworacek, J; Zimmermann, WH; Utikal, J; Wieland, T; Borggrefe, M; Zhou, XB				El-Battrawy, Ibrahim; Lang, Siegfried; Zhao, Zhihan; Akin, Ibrahim; Yuecel, Goekhan; Meister, Sophie; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Liebe, Volker; Tiburcy, Malte; Dworacek, Jennifer; Zimmermann, Wolfram-Hubertus; Utikal, Jochen; Wieland, Thomas; Borggrefe, Martin; Zhou, Xiao-Bo			Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							BRUGADA-SYNDROME; MOLECULAR CHARACTERIZATION; ATRIAL-FIBRILLATION; LIDOCAINE; CURRENTS; FEVER; TEMPERATURE; RANOLAZINE; MUTATION; DEPENDENCE	Introduction Fever can increase the susceptibility to supraventricular and ventricular arrhythmias, in which sodium channel dysfunction has been implicated. Whether fever influences the efficacy of sodium channel blocking drugs is unknown. The current study was designed to investigate the temperature dependent effects of distinct sodium channel blocking drugs on the sodium currents in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Methods and Results hiPSC-CMs were generated from human skin fibroblasts of a healthy donor. The peak and late sodium currents (I-Na), steady-state activation, inactivation and recovery from inactivation of INa in hiPSC-CMs were analyzed using the whole-cell patch clamp technique. The effects of different concentrations of the antiarrhythmic drugs flecainide, lidocaine, ajmaline and the antianginal drug ranolazine on INa were tested at 36 degrees C and 40 degrees C. Increasing the temperature of the bath solution from 36 degrees C to 40 degrees C enhanced the inhibition of peak INa but reduced the inhibition of late INa by flecainide and lidocaine. By contrast, increasing the temperature reduced the effect of ajmaline and ranolazine on the peak INa but not late INa. None of the tested drugs showed temperature-dependent effects on the steady-state activation and inactivation as well as on the recovery from inactivation of INa in hiPSC-CMs. Conclusions Temperature variation from the physiological to the febrile range apparently influences the effects of sodium channel blockers on the sodium currents. This may influence their antiarrhythmic efficacy in patients suffering from fever.	[El-Battrawy, Ibrahim; Lang, Siegfried; Zhao, Zhihan; Akin, Ibrahim; Yuecel, Goekhan; Meister, Sophie; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Liebe, Volker; Borggrefe, Martin; Zhou, Xiao-Bo] Heidelberg Univ, Med Fac Mannheim, Dept Med 1, Mannheim, Germany; [El-Battrawy, Ibrahim; Lang, Siegfried; Akin, Ibrahim; Yuecel, Goekhan; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Tiburcy, Malte; Dworacek, Jennifer; Zimmermann, Wolfram-Hubertus; Utikal, Jochen; Wieland, Thomas; Borggrefe, Martin; Zhou, Xiao-Bo] DZHK German Ctr Cardiovasc Res, Heidelberg, Germany; [El-Battrawy, Ibrahim; Lang, Siegfried; Akin, Ibrahim; Yuecel, Goekhan; Patocskai, Bence; Behnes, Michael; Rudic, Boris; Tueluemen, Erol; Tiburcy, Malte; Dworacek, Jennifer; Zimmermann, Wolfram-Hubertus; Utikal, Jochen; Wieland, Thomas; Borggrefe, Martin; Zhou, Xiao-Bo] DZHK German Ctr Cardiovasc Res, Gottingen, Germany; [Tiburcy, Malte; Zimmermann, Wolfram-Hubertus] Univ Gottingen, Inst Pharmacol & Toxicol, Gottingen, Germany; [Dworacek, Jennifer; Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Dworacek, Jennifer; Utikal, Jochen] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany; [Wieland, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, Mannheim, Germany; [Zhou, Xiao-Bo] Southwest Med Univ, Inst Cardiovasc Res, Luzhou, Sichuan, Peoples R China	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research; University of Gottingen; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Southwest Medical University	El-Battrawy, I; Zhou, XB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Med 1, Mannheim, Germany.; El-Battrawy, I; Zhou, XB (corresponding author), DZHK German Ctr Cardiovasc Res, Heidelberg, Germany.; El-Battrawy, I; Zhou, XB (corresponding author), DZHK German Ctr Cardiovasc Res, Gottingen, Germany.; Zhou, XB (corresponding author), Southwest Med Univ, Inst Cardiovasc Res, Luzhou, Sichuan, Peoples R China.	lbrahim.El-Battrawy@medma.uni-heidelberg.de; Xiaoba.zhou@medma.uni-heidelberg.de	Tulumen, Erol/AAI-2331-2019; Zimmermann, Wolfram-Hubertus H/I-6838-2012; Rudic, Boris/AAG-9404-2020; Akin, Ibrahim/AAF-1356-2020; Wieland, Thomas/Q-1506-2019; Zhou, Xiaobo/AAH-4320-2019; Yücel, Gökhan/GZL-1223-2022; Wieland, Thomas/G-1772-2012; Rudic, Boris/X-6703-2019	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261; Rudic, Boris/0000-0002-2275-7149; Utikal, Jochen/0000-0001-5316-0241; Yucel, Gokhan/0000-0002-1803-2663; El-Battrawy, Ibrahim/0000-0002-0139-1045	DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)	DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This study was supported by the DZHK (German Center for Cardiovascular Research), the BMBF (German Ministry of Education and Research) (grants to MB, JU, TW and WZ).	Amin AS, 2005, ACTA PHYSIOL SCAND, V185, P291, DOI 10.1111/j.1365-201X.2005.01496.x; Antzelevitch C, 2002, PACE, V25, P1537, DOI 10.1046/j.1460-9592.2002.01537.x; Barajas-Martinez HM, 2008, CIRC RES, V103, P396, DOI 10.1161/CIRCRESAHA.108.172619; Bebarova M, 2005, GEN PHYSIOL BIOPHYS, V24, P311; Benito B, 2008, PROG CARDIOVASC DIS, V51, P1, DOI 10.1016/j.pcad.2008.05.002; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; Brugada R, 2000, CIRCULATION, V101, P510, DOI 10.1161/01.CIR.101.5.510; Burrell Christopher, 2007, J Infect, V54, pe13, DOI 10.1016/j.jinf.2006.03.020; Chaitman BR, 2006, CIRCULATION, V113, P2462, DOI 10.1161/CIRCULATIONAHA.105.597500; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Hoekstra M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00346; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; JOHNS JA, 1989, J CARDIOVASC PHARM, V13, P826, DOI 10.1097/00005344-198906000-00004; Kane C, 2016, BIOPHYS J, V110, P281, DOI 10.1016/j.bpj.2015.08.052; Keller DI, 2005, CARDIOVASC RES, V67, P510, DOI 10.1016/j.cardiores.2005.03.024; Larribere L, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12369; LEE HC, 1993, J CLIN INVEST, V91, P693, DOI 10.1172/JCI116250; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MAKIELSKI JC, 1991, AM J PHYSIOL, V260, pH681, DOI 10.1152/ajpheart.1991.260.3.H681; MANZ M, 1988, DEUT MED WOCHENSCHR, V113, P1317, DOI 10.1055/s-2008-1067813; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Mok NS, 2003, J CARDIOVASC ELECTR, V14, P407, DOI 10.1046/j.1540-8167.2003.02379.x; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Morita H, 2002, J CARDIOVASC ELECTR, V13, P816, DOI 10.1046/j.1540-8167.2002.00816.x; Novak A, 2012, J CELL MOL MED, V16, P468, DOI 10.1111/j.1582-4934.2011.01476.x; Pasquie JL, 2004, J CARDIOVASC ELECTR, V15, P1271, DOI 10.1046/j.1540-8167.2004.04388.x; Polytarchou Kali, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P31; Porres JM, 2002, PACE, V25, P1646, DOI 10.1046/j.1460-9592.2002.01646.x; Saura D, 2002, PACE, V25, P856, DOI 10.1046/j.1460-9592.2002.t01-1-00856.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu W, 2000, J CARDIOVASC ELECTR, V11, P1320, DOI 10.1046/j.1540-8167.2000.01320.x; Sossalla S, 2010, J AM COLL CARDIOL, V55, P2330, DOI 10.1016/j.jacc.2009.12.055; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tiburcy M, 2014, TRENDS CARDIOVAS MED, V24, P7, DOI 10.1016/j.tcm.2013.05.003; WANG ZG, 1995, J PHARMACOL EXP THER, V272, P184; WELLENS HJJ, 1980, AM J CARDIOL, V45, P130, DOI 10.1016/0002-9149(80)90230-1; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	43	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166143	10.1371/journal.pone.0166143	http://dx.doi.org/10.1371/journal.pone.0166143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829006	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300089
J	Landsheer, JA				Landsheer, Johannes A.			Interval of Uncertainty: An Alternative Approach for the Determination of Decision Thresholds, with an Illustrative Application for the Prediction of Prostate Cancer	PLOS ONE			English	Article							LOGISTIC-REGRESSION; DIAGNOSTIC-TESTS; MODELS; ZONE	Often, for medical decisions based on test scores, a single decision threshold is determined and the test results are dichotomized into positive and negative diagnoses. It is therefore important to identify the decision threshold with the least number of misclassifications. The proposed method uses trichotomization: it defines an Uncertain Interval around the point of intersection between the two distributions of individuals with and without the targeted disease. In this Uncertain Interval the diagnoses are intermixed and the numbers of correct and incorrect diagnoses are (almost) equal. This Uncertain Interval is considered to be a range of test scores that is inconclusive and does not warrant a decision. It is expected that defining such an interval with some precision, prevents a relatively large number of false decisions, and therefore results in an increased accuracy or correct classifications rate (CCR) for the test scores outside this Uncertain Interval. Clinical data and simulation results confirm this. The results show that the CCR is systematically higher outside the Uncertain Interval when compared to the CCR of the decision threshold based on the maximized You den index. For strong tests with a very small overlap between the two distributions, it can be difficult to determine an Uncertain Interval. In simulations, the comparison with an existing method for test-score trichotomization, the Two-graph Receiver Operating Characteristic (TG-ROC), showed smaller differences between the two distributions for the Uncertain Interval than for TG-ROC's Intermediate Range and consequently a more improved CCR outside the Uncertain Interval. The main conclusion is that the Uncertain Interval method offers two advantages: 1. Identification of patients for whom the test results are inconclusive; 2. A higher estimated rate of correct decisions for the remaining patients.	[Landsheer, Johannes A.] Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands	Utrecht University	Landsheer, JA (corresponding author), Univ Utrecht, Dept Methodol & Stat, Utrecht, Netherlands.	j.a.landsheer@uu.nl		Landsheer, Hans/0000-0001-5117-7031	University of Utrecht	University of Utrecht	All costs were covered by the author's employer, the University of Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayer T, 2010, RADIOGRAPHICS, V30, P13, DOI 10.1148/rg.301095057; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Brasil P, 2010, DIAGNOSISMED DIAGNOS; Briggs WM, 2008, BIOMETRICS, V64, P250, DOI 10.1111/j.1541-0420.2007.00781_1.x; Cammann H, 2011, CLIN CHEM, V57, P1490, DOI 10.1373/clinchem.2011.166959; Coste J, 2003, INT J EPIDEMIOL, V32, P304, DOI 10.1093/ije/dyg054; Coste J, 2006, CLIN CHEM, V52, P2229, DOI 10.1373/clinchem.2006.072280; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P109, DOI 10.1016/0895-4356(90)90064-V; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; FREI H, 1988, MUTAT RES, V203, P297, DOI 10.1016/0165-1161(88)90019-2; Goncalves L, 2014, REVSTAT-STAT J, V12, P1; Greiner M, 1996, J IMMUNOL METHODS, V191, P93, DOI 10.1016/0022-1759(96)00013-0; GREINER M, 1995, J IMMUNOL METHODS, V185, P145, DOI 10.1016/0022-1759(95)00078-O; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; HANLEY JA, 1988, MED DECIS MAKING, V8, P197, DOI 10.1177/0272989X8800800308; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lopez-Raton M, 2014, J STAT SOFTW, V61, P1; R Development Core Team, 2014, R LANG ENV STAT COMP; Shinkins B, 2013, BRIT J GEN PRACT, V63, P122, DOI 10.3399/bjgp13X664090; Simundic AM, 2008, MED BIOL SCI, V22, P61; SOMOZA E, 1994, MED DECIS MAKING, V14, P157, DOI 10.1177/0272989X9401400208; Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210; Tyagi A, 2015, INT J MED RES HEALTH, V4, P208, DOI 10.5958/2319-5886.2015.00034.X; Woolever Donald R, 2008, Fam Pract Manag, V15, P31	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166007	10.1371/journal.pone.0166007	http://dx.doi.org/10.1371/journal.pone.0166007			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829010	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300074
J	Liu, W; Zhu, W; Liao, B; Chen, XT				Liu, Wei; Zhu, Wen; Liao, Bo; Chen, Xiangtao			Gene Regulatory Network Inferences Using a Maximum-Relevance and Maximum-Significance Strategy	PLOS ONE			English	Article							BAYESIAN NETWORK; BOOLEAN NETWORKS; EXPRESSION DATA; ALGORITHM; TOPOLOGY; MODEL	Recovering gene regulatory networks from expression data is a challenging problem in systems biology that provides valuable information on the regulatory mechanisms of cells. A number of algorithms based on computational models are currently used to recover network topology. However, most of these algorithms have limitations. For example, many models tend to be complicated because of the "large p, small n" problem. In this paper, we propose a novel regulatory network inference method called the maximum-relevance and maximum-significance network (MRMSn) method, which converts the problem of recovering networks into a problem of how to select the regulator genes for each gene. To solve the latter problem, we present an algorithm that is based on information theory and selects the regulator genes for a specific gene by maximizing the relevance and significance. A first-order incremental search algorithm is used to search for regulator genes. Eventually, a strict constraint is adopted to adjust all of the regulatory relationships according to the obtained regulator genes and thus obtain the complete network structure. We performed our method on five different datasets and compared our method to five state-of-the-art methods for network inference based on information theory. The results confirm the effectiveness of our method.	[Liu, Wei; Zhu, Wen; Liao, Bo; Chen, Xiangtao] Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China	Hunan University	Liao, B (corresponding author), Hunan Univ, Coll Informat Sci & Engn, Changsha 410082, Hunan, Peoples R China.	dragonbw@163.com		chen, xiangtao/0000-0002-5102-1472	National Nature Science Foundation of China [11171369, 61272395, 61370171, 61300128, 61472127, 61572178]; National Nature Science Foundation of Hunan Province [12JJ2041]; Planned Science and Technology Project of Hunan Province [2014FJ3079]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Hunan Province; Planned Science and Technology Project of Hunan Province	This study is supported by the National Nature Science Foundation of China (Grant Nos. 11171369, 61272395, 61370171, 61300128, 61472127 and 61572178), National Nature Science Foundation of Hunan Province (Grant No. 12JJ2041) and the Planned Science and Technology Project of Hunan Province (Grant Nos. 2014FJ3079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acid S, 2004, ARTIF INTELL MED, V30, P215, DOI 10.1016/j.artmed.2003.11.002; Aijo T, 2009, BIOINFORMATICS, V25, P2937, DOI 10.1093/bioinformatics/btp511; Banga JR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-47; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Butte A J, 2000, Pac Symp Biocomput, P418; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Chen CC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S19; Chen XW, 2008, IEEE T KNOWL DATA EN, V20, P628, DOI 10.1109/TKDE.2007.190732; De Campos LM, 1998, J EXP THEOR ARTIF IN, V10, P511, DOI 10.1080/095281398146743; de Campos LM, 2000, INT J APPROX REASON, V24, P11, DOI 10.1016/S0888-613X(99)00042-0; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 1998, NATO ADV SCI I D-BEH, V89, P421; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Iba H, 2002, INFORM SCIENCES, V145, P225, DOI 10.1016/S0020-0255(02)00234-7; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KAUFFMAN S, 1974, J THEOR BIOL, V44, P167, DOI 10.1016/S0022-5193(74)80037-8; Keedwell E, 2005, IEEE ACM T COMPUT BI, V2, P231, DOI 10.1109/TCBB.2005.40; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Maetschke SR, 2014, BRIEF BIOINFORM, V15, P195, DOI 10.1093/bib/bbt034; Maji P, 2011, INT J APPROX REASON, V52, P408, DOI 10.1016/j.ijar.2010.09.006; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Meyer P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-13; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Ocone A, 2013, BIOINFORMATICS, V29, P910, DOI 10.1093/bioinformatics/btt069; Pal R, 2005, BIOINFORMATICS, V21, P4021, DOI 10.1093/bioinformatics/bti664; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Samoilov M., 1997, THESIS; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Steck H., 2012, ARXIV12063287; Vasic B, 2012, IEEE ACM T COMPUT BI, V9, P52, DOI 10.1109/TCBB.2011.61; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Villaverde Alejandro F, 2013, Cells, V2, P306, DOI 10.3390/cells2020306; Wai Lam, 1994, Computational Intelligence, V10, P269, DOI 10.1111/j.1467-8640.1994.tb00166.x; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Watanabe Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S12; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626	42	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166115	10.1371/journal.pone.0166115	http://dx.doi.org/10.1371/journal.pone.0166115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829000	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300083
J	Markovic, D; Nikolic, N; Glinwood, R; Seisenbaeva, G; Ninkovic, V				Markovic, Dimitrije; Nikolic, Neda; Glinwood, Robert; Seisenbaeva, Gulaim; Ninkovic, Velemir			Plant Responses to Brief Touching: A Mechanism for Early Neighbour Detection?	PLOS ONE			English	Article							GLANDULAR TRICHOMES; VOLATILE COMMUNICATION; PHENOTYPIC PLASTICITY; BIOMASS ALLOCATION; PUBESCENCE DENSITY; LEAVES; STRESS; WIND; HERBIVORES; RESISTANCE	In natural habitats plants can be exposed to brief and light contact with neighbouring plants. This mechanical stimulus may represent a cue that induces responses to nearby plants. However, little is known about the effect of touching on plant growth and interaction with insect herbivores. To simulate contact between plants, a soft brush was used to apply light and brief mechanical stimuli to terminal leaves of potato Solanum tuberosum L. The number of non-glandular trichomes on the leaf surface was counted on images made by light microscope while glandular trichomes and pavement cells were counted on images made under scanning electronic microscope. Volatile compounds were identified and quantified using coupled gas chromatography-mass spectrometry (GC-MS). Treated plants changed their pattern of biomass distribution; they had lower stem mass fraction and higher branch and leaf mass fraction than untouched plants. Size, weight and number of tubers were not significantly affected. Touching did not cause trichome damage nor change their total number on touched terminal leaves. However, on primary leaves the number of glandular trichomes and pavement cells was significantly increased. Touching altered the volatile emission of treated plants; they released higher quantities of the sesquiterpenes (E)-beta-caryophyllene, germacrene D-4-ol and (E)-nerolidol, and lower quantities of the terpenes (E)-ocimene and linalool, indicating a systemic effect of the treatment. The odour of touched plants was significantly less preferred by the aphids Macrosiphum euphorbiae and Myzus persicae compared to odour of untouched plants. The results suggest that light contact may have a potential role in the detection of neighbouring plants and may affect plant-insect interactions.	[Markovic, Dimitrije; Nikolic, Neda; Glinwood, Robert; Ninkovic, Velemir] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Markovic, Dimitrije] Univ Banja Luka, Fac Agr, Banja Luka, Bosnia & Herceg; [Seisenbaeva, Gulaim] Swedish Univ Agr Sci, Dept Chem & Biotechnol, Uppsala, Sweden	Swedish University of Agricultural Sciences; University of Banja Luka (UNIBL); Swedish University of Agricultural Sciences	Ninkovic, V (corresponding author), Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden.	velemir.ninkovic@slu.se	Seisenbaeva, Gulaim/Y-8024-2019; Ninkovic, Velemir/E-7677-2011; Markovic, Dimitrije/A-2513-2019	Seisenbaeva, Gulaim/0000-0003-0072-6082; Ninkovic, Velemir/0000-0001-9276-7169; Markovic, Dimitrije/0000-0003-3030-4155; Glinwood, Robert/0000-0001-5082-5076	Swedish Research Council [2012-581]; Svenska Forskningsradet Formas [2014-225]; Carl Tryggers Foundation for Scientific Research [CTS KF14:7]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Svenska Forskningsradet Formas(Swedish Research Council Formas); Carl Tryggers Foundation for Scientific Research	This study was financially supported by the Swedish Research Council (Formas) grants 2012-581 (Dr. Gulaim Seisenbaeva) and Svenska Forskningsradet Formas 2014-225 Dr. Velemir Ninkovic. This work was also supported by Carl Tryggers Foundation for Scientific Research, grant CTS KF14:7 (Dr. Velemir Ninkovic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; [Anonymous], 2010, CORELDRAW X5; Anten NPR, 2010, NEW PHYTOL, V188, P554, DOI 10.1111/j.1469-8137.2010.03379.x; Anten NPR, 2005, AM NAT, V166, P650, DOI 10.1086/497442; AVE DA, 1987, ENTOMOL EXP APPL, V44, P131, DOI 10.1007/BF00367620; Baldwin IT, 2010, CURR BIOL, V20, pR392, DOI 10.1016/j.cub.2010.02.052; Benikhlef L, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-133; Benz BW, 2006, J PLANT PHYSIOL, V163, P648, DOI 10.1016/j.jplph.2005.05.008; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; BRAAM J, 1990, CELL, V60, P357, DOI 10.1016/0092-8674(90)90587-5; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Choh Y, 2004, J CHEM ECOL, V30, P1305, DOI 10.1023/B:JOEC.0000037741.13402.19; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Coutand C, 2008, ANN BOT-LONDON, V101, P1421, DOI 10.1093/aob/mcn054; Dahlin I, 2013, J APPL ECOL, V50, P1281, DOI 10.1111/1365-2664.12115; de Wit M, 2012, P NATL ACAD SCI USA, V109, P14705, DOI 10.1073/pnas.1205437109; Defauw S.L., 2012, SUSTAINABLE POTATO P, P3, DOI [10.1007/978-94-007-4104-1_1, DOI 10.1007/978-94-007-4104-1_1]; Dell Inc, 2015, DELL STAT VERS; ELLER BM, 1977, OECOLOGIA, V29, P179, DOI 10.1007/BF00345796; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Farmer EE, 2014, LEAF DEFENCE, P47; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; Galmes J, 2007, ENVIRON EXP BOT, V60, P105, DOI 10.1016/j.envexpbot.2006.08.001; Glas JJ, 2012, INT J MOL SCI, V13, P17077, DOI 10.3390/ijms131217077; Glinwood R, 2011, PHYTOCHEMISTRY, V72, P1683, DOI 10.1016/j.phytochem.2011.02.010; Gonzalez WL, 2008, ACTA OECOL, V33, P128, DOI 10.1016/j.actao.2007.10.004; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Izaguirre MM, 2006, P NATL ACAD SCI USA, V103, P7170, DOI 10.1073/pnas.0509805103; Jaffe MJ, 2002, AM J BOT, V89, P375, DOI 10.3732/ajb.89.3.375; Jeffries C., 2006, HDB POTATO PRODUCTIO, P387; Kaplan I, 2009, ECOL APPL, V19, P864, DOI 10.1890/07-1566.1; Karban R, 2014, ECOL LETT, V17, P44, DOI 10.1111/ele.12205; Kegge W, 2015, ANN BOT-LONDON, V115, P961, DOI 10.1093/aob/mcv036; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kos M, 2013, PEST MANAG SCI, V69, P302, DOI 10.1002/ps.3391; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; Markovic D, 2014, ARTHROPOD-PLANT INTE, V8, P171, DOI 10.1007/s11829-014-9303-6; Montgomery JA, 2004, J AM SOC HORTIC SCI, V129, P339, DOI 10.21273/JASHS.129.3.0339; Moran PJ, 1999, J PHYTOPATHOL, V147, P313, DOI 10.1046/j.1439-0434.1999.147005313.x; Moulia B, 2006, AM J BOT, V93, P1477, DOI 10.3732/ajb.93.10.1477; Niklas KJ, 1998, ANN BOT-LONDON, V82, P147, DOI 10.1006/anbo.1998.0658; Ninkovic V, 2003, J EXP BOT, V54, P1931, DOI 10.1093/jxb/erg192; Ninkovic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069431; Peiffer M, 2009, NEW PHYTOL, V184, P644, DOI 10.1111/j.1469-8137.2009.03002.x; Perez-Estrada LB, 2000, TREE PHYSIOL, V20, P629; Pettersson J, 2007, APHIDS AS CROP PESTS, P87, DOI 10.1079/9780851998190.0087; Pickett JA, 2007, APHIDS AS CROP PESTS, P235, DOI 10.1079/9780851998190.0235; Pieczynski M, 2013, PLANT BIOTECHNOL J, V11, P459, DOI 10.1111/pbi.12032; Pigliucci M, 2002, INT J PLANT SCI, V163, P399, DOI 10.1086/339158; Poorter H, 2015, NEW PHYTOL, V208, P736, DOI 10.1111/nph.13571; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Ren Q, 2000, EUPHYTICA, V111, P191, DOI 10.1023/A:1003833230859; Saidi I, 2010, PLANT SIGNAL BEHAV, V5, P122, DOI 10.4161/psb.5.2.10302; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sato Y, 2014, EVOL ECOL, V28, P545, DOI 10.1007/s10682-013-9686-3; Stolarz M, 2009, PLANT SIGNAL BEHAV, V4, P380, DOI 10.4161/psb.4.5.8293; Szafranek B, 2005, J AGR FOOD CHEM, V53, P2817, DOI 10.1021/jf040437g; Telewski FW, 2006, AM J BOT, V93, P1466, DOI 10.3732/ajb.93.10.1466; Traw MB, 2002, ENVIRON ENTOMOL, V31, P714, DOI 10.1603/0046-225X-31.4.714; Valkama E, 2005, TREES-STRUCT FUNCT, V19, P191, DOI 10.1007/s00468-004-0380-5; Webster B, 2012, PHYSIOL ENTOMOL, V37, P10, DOI 10.1111/j.1365-3032.2011.00791.x; Weissbecker B, 2000, J CHEM ECOL, V26, P1433, DOI 10.1023/A:1005535708866; Whippo CW, 2006, PLANT CELL, V18, P1110, DOI 10.1105/tpc.105.039669; WOODMAN RL, 1991, OIKOS, V60, P11, DOI 10.2307/3544986; ZHANG JH, 1992, CROP SCI, V32, P641, DOI 10.2135/cropsci1992.0011183X003200030013x; Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082256	69	18	19	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165742	10.1371/journal.pone.0165742	http://dx.doi.org/10.1371/journal.pone.0165742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828995	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300057
J	Aslam, MN; Bassis, CM; Zhang, L; Zaidi, S; Varani, J; Bergin, IL				Aslam, Muhammad Nadeem; Bassis, Christine M.; Zhang, Li; Zaidi, Sameer; Varani, James; Bergin, Ingrid L.			Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles	PLOS ONE			English	Article							VITAMIN-D; HEPATOCELLULAR-CARCINOMA; MILK-PRODUCTS; ANIMAL-MODELS; OBESITY; DISEASE; COLON; METABOLISM; C57BL/6; SALMONELLA	A high-fat "Western-style" diet (HFWD) promotes obesity-related conditions including nonalcoholic steatohepatitis (NASH), the histologic manifestation of non-alcoholic fatty liver disease (NAFLD). In addition to high saturated fat and processed carbohydrates, the typical HFWD is deficient in calcium. Calcium-deficiency is an independent risk factor for many conditions associated with the Western-style diet. However, calcium has not been widely evaluated in the context of NAFLD. The goal of the present study was to determine if dietary calcium supplementation could protect mice fed a HFWD from NAFLD, specifically by decreasing non-alcoholic steatohepatitis (NASH) and its down-stream consequences. Male C57BL/6NCrl mice were maintained for 18-months on a HFWD containing dietary calcium at either 0.41 gm/kg feed (unsupplemented) or 5.25 gm/kg feed (supplemented). Although there was no difference in body weight or steatosis, calcium-supplemented mice were protected against downstream consequences of hepatic steatosis, manifested by lower inflammation, less fibrosis, and by lower overall histologic NAFLD activity scores (NAS). Calcium supplementation correlated with distinctly segregating gut fecal and cecal microbial communities as defined by 16S rRNA gene sequence. Further, calcium supplementation also correlated with decreased hepatic concentration of the major conjugated murine primary bile acid, tauro-beta-muricholic acid (as well as a decrease in the parent unconjugated bile acid). Thus, calcium was protective against progression of diet-induced hepatic steatosis to NASH and end-stage liver disease, suggesting that calcium supplementation may effectively protect against adverse hepatic consequences of HFWD in cases where overall diet modification cannot be sustained. This protective effect occurred in concert with calcium-mediated gut microbial community shifts and alterations of the hepatic bile acid pool.	[Aslam, Muhammad Nadeem; Zaidi, Sameer; Varani, James] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bassis, Christine M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhang, Li] Univ Michigan, Michigan Reg Comprehens Metabol Resource Ctr, Ann Arbor, MI 48109 USA; [Bergin, Ingrid L.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aslam, MN (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	mnaslam@med.umich.edu	Aslam, Muhammad/GRS-8220-2022; Aslam, Muhammad Nadeem/I-7314-2012	Aslam, Muhammad/0000-0002-6071-5468; Aslam, Muhammad Nadeem/0000-0003-1361-5357; Bassis, Christine/0000-0001-6047-0678	Association for International Cancer Research [11-0577]; NIH Common Funds Project [U24 DK097153]; Host Microbiome Initiative (HMI) of the University of Michigan Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153] Funding Source: NIH RePORTER	Association for International Cancer Research; NIH Common Funds Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Host Microbiome Initiative (HMI) of the University of Michigan Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by grant 11-0577 from the Association for International Cancer Research (http://www.worldwidecancerresearch.org/), St. Andrews, Fife, Scotland (JV). Bile acid analysis was performed at the Michigan Regional Comprehensive Metabolomics Resource Core (MRC2), funded by grant U24 DK097153 of NIH Common Funds Project to the University of Michigan. Work represented in this paper was supported by the Host Microbiome Initiative (HMI) of the University of Michigan Medical School.; This study was supported in part by grant 11-0577 from the Association for International Cancer Research, St. Andrews, Fife, Scotland (W). Bile acid analysis was performed at the Michigan Regional Comprehensive Metabolomics Resource Core (MRC<SUP>2</SUP>), funded by grant U24 DK097153 of NIH Common Funds Project to the University of Michigan (ILB). Microbial work represented in this paper was supported by the Host Microbiome Initiative (HMI) of the University of Michigan Medical School (ILB & MNA). Microbial community 16S sequencing was performed through the Microbial Systems Molecular Biology Lab of the HMI of the University of Michigan Medical School.	Alba LM, 2003, ALIMENT PHARM THER, V17, P977, DOI 10.1046/j.1365-2036.2003.01493.x; Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Aslam MN, 2012, CALCIFIED TISSUE INT, V86, P313; Aslam MN, 2012, NUTR CANCER, V64, P1020, DOI 10.1080/01635581.2012.713160; Aslam MN, 2012, BIOL TRACE ELEM RES, V147, P267, DOI 10.1007/s12011-011-9316-2; Aslam MN, 2010, INTEGR CANCER THER, V9, P93, DOI 10.1177/1534735409360360; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bastie CC, 2012, J NUTR, V142, P859, DOI 10.3945/jn.111.149914; BoveeOudenhoven I, 1996, GUT, V38, P59, DOI 10.1136/gut.38.1.59; BoveeOudenhoven IMJ, 1997, GASTROENTEROLOGY, V113, P550, DOI 10.1053/gast.1997.v113.pm9247475; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Cani PD, 2014, J HEPATOL, V61, P5, DOI 10.1016/j.jhep.2014.04.006; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; DELZENNE NM, 1992, TOXICOL LETT, V61, P291, DOI 10.1016/0378-4274(92)90156-E; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Ervin R Bethene, 2004, Adv Data, P1; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Gerard Philippe, 2013, Pathogens, V3, P14, DOI 10.3390/pathogens3010014; Gomes JMG, 2015, BRIT J NUTR, V114, P1756, DOI 10.1017/S0007114515003608; Govers MJAP, 1996, CANCER RES, V56, P3270; Green CJ, 2014, NUTRIENTS, V6, P5018, DOI 10.3390/nu6115018; Griffiths WJ, 2010, J LIPID RES, V51, P23, DOI 10.1194/jlr.R001941-JLR200; Hashimoto E, 2012, HEPATOL RES, V42, P1, DOI 10.1111/j.1872-034X.2011.00872.x; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kahle M, 2013, MOL METAB, V2, P435, DOI 10.1016/j.molmet.2013.07.009; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kudlacek S, 2003, EUR J CLIN INVEST, V33, P323, DOI 10.1046/j.1365-2362.2003.01127.x; Kwok RM, 2013, HEPATOLOGY, V58, P1166, DOI 10.1002/hep.26390; Laraichi S, 2013, LIPIDS, V48, P817, DOI 10.1007/s11745-013-3798-y; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Moore-Schiltz L, 2015, BRIT J NUTR, V114, P924, DOI 10.1017/S0007114515002482; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Newmark HL, 2009, CARCINOGENESIS, V30, P88, DOI 10.1093/carcin/bgn229; Newmark HL, 2001, CARCINOGENESIS, V22, P1871, DOI 10.1093/carcin/22.11.1871; Pais P, 2014, DRUGS R&D, V14, P291, DOI 10.1007/s40268-014-0068-2; Pannu Poonam K, 2016, Adv Food Nutr Res, V77, P57, DOI 10.1016/bs.afnr.2015.11.001; Paolella G, 2014, WORLD J GASTROENTERO, V20, P15518, DOI 10.3748/wjg.v20.i42.15518; Parra P, 2008, J NUTR BIOCHEM, V19, P109, DOI 10.1016/j.jnutbio.2007.01.009; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Piguet AC, 2015, J HEPATOL, V62, P1296, DOI 10.1016/j.jhep.2015.01.017; Pilvi TK, 2007, BRIT J NUTR, V98, P900, DOI 10.1017/S0007114507764760; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sass DA, 2005, DIGEST DIS SCI, V50, P171, DOI 10.1007/s10620-005-1267-z; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Seekatz AM, 2015, INFECT IMMUN, V83, P3838, DOI 10.1128/IAI.00459-15; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Vajro P, 2013, J PEDIATR GASTR NUTR, V56, P461, DOI 10.1097/MPG.0b013e318284abb5; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; VanderMeer R, 1997, CANCER LETT, V114, P75, DOI 10.1016/S0304-3835(97)04629-6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	71	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166178	10.1371/journal.pone.0166178	http://dx.doi.org/10.1371/journal.pone.0166178			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851786	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300040
J	Flood, A; Estrada, M; McAdams, D; Ji, YH; Chen, DX				Flood, Alexander; Estrada, Marcus; McAdams, David; Ji, Yuhua; Chen, Dexiang			Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation	PLOS ONE			English	Article							RATIONAL DESIGN; STABILITY; POWDER; LYOPHILIZATION; STABILIZATION; HEMAGGLUTININ; TECHNOLOGY; CHALLENGES; STORAGE; STEP	An influenza pandemic remains a major public health concern. A key strategy to prevent a pandemic is to stockpile and pre-position stable influenza vaccine to allow rapid deployment in response to an outbreak. However, most influenza vaccines today are formulated as liquids that are stable only within a temperature range of 2 degrees C to 8 degrees C and require use of a cold chain, making vaccine transportation, distribution, and storage complicated and expensive, particularly for developing countries. To support the National Strategy for Pandemic Influenza preparedness in the United States and internationally, we developed two lead dry formulations of stable H1N1 influenza subunit vaccines using freeze-drying technology. The stable formulations contain an excipient combination of a disaccharide, such as sucrose or trehalose, and glycine, in addition to a surfactant and phosphate buffer. The freeze-dried vaccines were shown to be safe and remained immunogenic in an in vivo study in mice. Moreover, the lead formulations demonstrated no significant loss of activity after 40 months at storage temperatures of 25 degrees C and 37 degrees C. This stability can be particularly attractive as it could eliminate the need to use a cold chain for vaccine deployment and facilitate integration of vaccine distribution with general drug distribution where appropriate. These freeze-dried thermostable influenza subunit vaccines could also reduce the frequency of vaccine stockpile turnover, offering a cost-effective option for pandemic preparedness.	[Flood, Alexander; Estrada, Marcus; McAdams, David; Chen, Dexiang] PATH, Devices & Tools Program, Seattle, WA 98109 USA; [Ji, Yuhua] PATH, Drug Dev Program, Seattle, WA USA		Chen, DX (corresponding author), PATH, Devices & Tools Program, Seattle, WA 98109 USA.	dchen@path.org			Biomedical Advanced Research and Development Authority (BARDA) [HHSO1002011000040C]	Biomedical Advanced Research and Development Authority (BARDA)	The authors received funding from the Biomedical Advanced Research and Development Authority (BARDA) for this work, under grant contract number HHSO1002011000040C (http://www.phe.gov/about/BARDA/Pages/default.aspx). Novartis Pharmaceuticals (East Hanover, NJ) provided the generous supply of two lots of influenza H1N1 subunit bulk vaccine. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.; This work was made possible by a grant from Biomedical Advanced Research and Development Authority (BARDA, Contract Number HHSO100201000040C, http://www.phe.gov/about/barda). The authors wish to thank the following organization and people: Novartis Pharmaceuticals (East Hanover, NJ) for the generous supply of two lots of influenza H1N1 subunit bulk vaccine; scientific advisors Dr. Philip Dormitzer from Novartis and Dr. George Robertson and Ms. Debra Kristensen from PATH; Professor Thomas G. Voss and his team at Tulane University School of Medicine for performing the immunogenicity study reported in this paper; and Mr. John Ballenot and Mr. Clint Posey at PATH for editing the manuscript.	Allison SD, 2000, BBA-BIOMEMBRANES, V1468, P127, DOI 10.1016/S0005-2736(00)00251-0; Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Anamur C, 2015, INT J PHARMACEUT, V483, P131, DOI 10.1016/j.ijpharm.2015.01.053; Carpenter JF, 1997, PHARMACEUT RES, V14, P969, DOI 10.1023/A:1012180707283; CARPENTER JF, 1989, BIOCHEMISTRY-US, V28, P3916, DOI 10.1021/bi00435a044; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Chang BS, 1996, ARCH BIOCHEM BIOPHYS, V331, P249, DOI 10.1006/abbi.1996.0305; Chang BS, 1996, PHARMACEUT RES, V13, P243, DOI 10.1023/A:1016043114998; Chang LQ, 2005, J PHARM SCI-US, V94, P1427, DOI 10.1002/jps.20364; Chen DX, 2009, EXPERT REV VACCINES, V8, P547, DOI [10.1586/erv.09.20, 10.1586/ERV.09.20]; Coenen F, 2006, VACCINE, V24, P525, DOI 10.1016/j.vaccine.2005.07.081; Homeland Security Council, 2006, NAT STRAT PAND INFL; Huang J, 2004, VACCINE, V23, P794, DOI 10.1016/j.vaccine.2004.06.049; Johnson RE, 2002, J PHARM SCI, V91, P914, DOI 10.1002/jps.10094; Kamerzell TJ, 2011, ADV DRUG DELIVER REV, V63, P1118, DOI 10.1016/j.addr.2011.07.006; Kasraian K, 1998, Pharm Dev Technol, V3, P233, DOI 10.3109/10837459809028500; Kawai K, 2007, PHARM RES-DORDR, V24, P1883, DOI 10.1007/s11095-007-9312-6; Liu W, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060223; Luykx DMAM, 2004, EUR J PHARM SCI, V23, P65, DOI 10.1016/j.ejps.2004.05.007; Maa YF, 2004, J PHARM SCI-US, V93, P1912, DOI 10.1002/jps.20104; Molina MD, 2004, J PHARM SCI-US, V93, P2259, DOI 10.1002/jps.20138; Ohtake S, 2011, ADV DRUG DELIVER REV, V63, P1053, DOI 10.1016/j.addr.2011.06.011; Orszag PR, 2008, US POLICY REGARDING, P25; Pikal-Cleland KA, 2002, J PHARM SCI, V91, P1969, DOI 10.1002/jps.10184; Rasband W., 2006, IMAGEJ; Tang XL, 2004, PHARM RES-DORDR, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; The Department of Health and Human Services (DHHS), 2009, PAND INFL PREP SPEND; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3	29	20	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0164692	10.1371/journal.pone.0164692	http://dx.doi.org/10.1371/journal.pone.0164692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851765	gold, Green Submitted, Green Published			2022-12-27	WOS:000387909300005
J	Morehouse, AT; Graves, TA; Mikle, N; Boyce, MS				Morehouse, Andrea T.; Graves, Tabitha A.; Mikle, Nate; Boyce, Mark S.			Nature vs. Nurture: Evidence for Social Learning of Conflict Behaviour in Grizzly Bears	PLOS ONE			English	Article							FORAGING BEHAVIOR; BLACK BEARS; PARENTAGE ANALYSIS; NORTH-AMERICA; AGRICULTURAL LANDS; SIBSHIP INFERENCE; NATIONAL-PARK; URSUS-ARCTOS; BRAIN SIZE; POPULATION	The propensity for a grizzly bear to develop conflict behaviours might be a result of social learning between mothers and cubs, genetic inheritance, or both learning and inheritance. Using non-invasive genetic sampling, we collected grizzly bear hair samples during 2011-2014 across southwestern Alberta, Canada. We targeted private agricultural lands for hair samples at grizzly bear incident sites, defining an incident as an occurrence in which the grizzly bear caused property damage, obtained anthropogenic food, or killed or attempted to kill livestock or pets. We genotyped 213 unique grizzly bears (118 M, 95 F) at 24 micro-satellite loci, plus the amelogenin marker for sex. We used the program COLONY to assign parentage. We evaluated 76 mother-offspring relationships and 119 father-offspring relationships. We compared the frequency of problem and non-problem offspring from problem and non-problem parents, excluding dependent offspring from our analysis. Our results support the social learning hypothesis, but not the genetic inheritance hypothesis. Offspring of problem mothers are more likely to be involved in conflict behaviours, while offspring from non-problem mothers are not likely to be involved in incidents or human-bear conflicts themselves (Barnard's test, p = 0.05, 62.5% of offspring from problem mothers were problem bears). There was no evidence that offspring are more likely to be involved in conflict behaviour if their fathers had been problem bears (Barnard's test, p = 0.92, 29.6% of offspring from problem fathers were problem bears). For the mother-offspring relationships evaluated, 30.3% of offspring were identified as problem bears independent of their mother's conflict status. Similarly, 28.6% of offspring were identified as problem bears independent of their father's conflict status. Proactive mitigation to prevent female bears from becoming problem individuals likely will help prevent the perpetuation of conflicts through social learning.	[Morehouse, Andrea T.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Graves, Tabitha A.; Mikle, Nate] US Geol Survey, Northern Rocky Mt Sci Ctr, West Glacier, MT USA	University of Alberta; United States Department of the Interior; United States Geological Survey	Morehouse, AT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	morehous@ualberta.ca	Boyce, Mark S/A-2620-2014	Boyce, Mark S/0000-0001-5811-325X; Morehouse, Andrea/0000-0002-2015-9938	Alberta Conservation Association Grants in Biodiversity; Alberta Ecotrust; Alberta Environment and Parks; Alberta Innovates Bio Solutions; Alberta Sport Recreation Parks and Wildlife Foundation; Disney Worldwide Conservation Fund; Drywood Yarrow Conservation Partnership; Environment Canada Science Horizons; Glacier National Park Conservancy; International Association for Bear Research and Management; Minister's Special License; Miistakis Institute; Nature Conservancy of Canada; Natural Sciences and Engineering Research Council of Canada; National Science Foundation Division of Environmental Biology; DEB [0919239]; Parks Canada; Safari Club International Foundation; Safari Club International Northern Alberta Chapter; Shell Canada; TD Friends of the Environment Foundation; University of Alberta; US Geological Survey; US Bureau of Land Management; US Forest Service; Waterton Biosphere Reserve Association; Yellowstone to Yukon; Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; US Fish and Wildlife Service	Alberta Conservation Association Grants in Biodiversity; Alberta Ecotrust; Alberta Environment and Parks; Alberta Innovates Bio Solutions; Alberta Sport Recreation Parks and Wildlife Foundation; Disney Worldwide Conservation Fund; Drywood Yarrow Conservation Partnership; Environment Canada Science Horizons; Glacier National Park Conservancy; International Association for Bear Research and Management; Minister's Special License; Miistakis Institute; Nature Conservancy of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); DEB; Parks Canada; Safari Club International Foundation; Safari Club International Northern Alberta Chapter; Shell Canada; TD Friends of the Environment Foundation; University of Alberta(University of Alberta); US Geological Survey(United States Geological Survey); US Bureau of Land Management; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Waterton Biosphere Reserve Association; Yellowstone to Yukon; Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; US Fish and Wildlife Service(US Fish & Wildlife Service)	This study was funded by the organizations listed below, including: Alberta Conservation Association Grants in Biodiversity: http//www.ab-conservation.com/go/default/index.cfm/grants/grant-eligible-conservation-fund/overview/; Alberta Ecotrust: http://albertaecotrust.com/; Alberta Environment and Parks: http://aep.alberta.ca/; Alberta Innovates Bio Solutions: http://bio.albertainnovates.ca/; Alberta Sport Recreation Parks and Wildlife Foundation; Disney Worldwide Conservation Fund: https//thewaltdisneycompany.com/environment#disney-conservation-fund; Drywood Yarrow Conservation Partnership: Environment Canada Science Horizons: http://www.ec.gc.caiscitech/default.asp? lang.En & Glacier National Park Conservancy: https://mw.glacierconservancy.org/; International Association for Bear Research and Management: http://www.bearbiology.com/; Minister's Special License: http://www.afga.org/ministers-special-licence/html; Miistakis Institute: http://www.rockies.ca/; Nature Conservancy of Canada: http://www.natureconservancy.ca/en/; Natural Sciences and Engineering Research Council of Canada: http://www.nserc-crsng.gc.ca/index_eng.asp; National Science Foundation Division of Environmental Biology: https://www. nsf.gov/funding/pgm_list.isp?org DEB, Grant # 0919239; Parks Canada: http://www.pc.gc.ca/eng/index.aspx; Safari Club International Foundation: http://safariclubfoundation.og Safari Club International Northern Alberta Chapter: http://sci-northern.ab.ca/; Shell Canada: http://www.shell.ca/; TD Friends of the Environment Foundation: https://fettd.com/; University of Alberta: https://galberta.ca/; US Geological Survey: http://www.usgs.govt, US Bureau of Land Management: http://www.blm.gov/wo/st/en.html; US Forest Service: http://www.fs.fed.us/; Waterton Biosphere Reserve Association: http://www.watertonbiosphere.com/; Yellowstone to Yukon: https://y2y.net/. Additional in-kind support came from the Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; and the US Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the agencies and organizations that provided funding for this research: Alberta Conservation Association Grants in Biodiversity, Alberta Ecotrust, Alberta Environment and Parks, Alberta Innovates-Bio Solutions, Alberta Sport Recreation Parks and Wildlife Foundation, Disney Worldwide Conservation Fund, Drywood Yarrow Conservation Partnership, Environment Canada Science Horizons, Glacier National Park Conservancy, International Association for Bear Research and Management, Minister's Special License, Miistakis Institute, Nature Conservancy of Canada, Natural Sciences and Engineering Research Council of Canada, National Science Foundation Division of Environmental Biology, Parks Canada, Safari Club International Foundation, Safari Club International Northern Alberta Chapter, Shell Canada, TD Friends of the Environment Foundation, University of Alberta, US Geological Survey, US Bureau of Land Management, US Forest Service, Waterton Biosphere Reserve Association, and Yellowstone to Yukon. Additional in-kind and logistical support was provided by the Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; and the US Fish and Wildlife Service. Over 200 people assisted in the collection of grizzly bear hair samples; this project would not have been possible without their contributions. In particular, we thank M. Urmson, A. Loosen, S. Rettler, and T. Malish who worked on the Alberta portion of the project for multiple seasons and assisted with field work as well as data entry and management. Over 70 landowners provided land access and/or collected opportunistic hair samples; we are thankful for their support. In particular, we thank the Waterton Biosphere Reserve's Carnivore Working Group for supporting the project and helping to facilitate communication with landowners. We thank Alberta Environment and Parks, British Columbia Ministry of Forests, Lands, and Natural Resource Operations, and the Foothills Research Institute Grizzly Bear Program for the DNA data sets provided. Thanks to Lori Roberts for sharing conflict history from Montana grizzly bears. We thank Kate Kendall, Garth Mowat and Gord Stenhouse for leading hair collection in neighboring study areas. Finally, Garth Mowat and Gord Stenhouse also provided helpful comments on earlier versions of our manuscript.	Alberta Environment and Parks, 2016, ALB GRIZZL BEAR UR A, V38; Alberta Government, 2009, GRIZZL BEAR RESP GUI; Alberta Grizzly Bear Inventory Team, 2008, GRIZZL BEAR POP DENS; Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; Anderson CR, 2002, URSUS, V13, P247; [Anonymous], 2008, ALB GRIZZL BEAR REC; Arnold S.J., 1981, P409; BARNARD GA, 1945, NATURE, V156, P177, DOI 10.1038/156177a0; Baruch-Mordo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085122; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Bino G, 2010, J APPL ECOL, V47, P1262, DOI 10.1111/j.1365-2664.2010.01882.x; BLANCHARD BM, 1995, J WILDLIFE MANAGE, V59, P560, DOI 10.2307/3802463; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Breck SW, 2008, J MAMMAL, V89, P428, DOI 10.1644/07-MAMM-A-028R2.1; Breed M., 2010, NATURE ED KNOWLEDGE, V3, P68; Brown L, 2014, 23 INT C BEAR RES MA; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Fonturbel FE, 2011, WILDLIFE BIOL, V17, P217, DOI 10.2981/10-091; Galef BG, 2001, ANIM BEHAV, V62, P41, DOI 10.1006/anbe.2000.1721; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galton F., 1874, P ROYAL I, V7, P227; Galton F., 1983, INQUIRY HUMAN FACULT; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; GILBERT BK, 1999, MAMMALIAN SOCIAL LEA, P225; Gillin C.M., 1994, INT C BEAR RES MANAG, V9, P503, DOI DOI 10.2307/3872738; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; *GOV ALB, 2010, GRIZZL BEAR CONS ALB; Harris R.B., 2006, WILDL MONOGR, V161, P44; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; HEDRICK AV, 1989, OECOLOGIA, V80, P533, DOI 10.1007/BF00380078; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hopkins JB, 2013, J MAMMAL, V94, P1214, DOI 10.1644/13-MAMM-A-009.1; Hopkins JB, 2010, URSUS, V21, P154, DOI 10.2192/URSUS-D-10-00005.1; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Laland KN, 2004, LEARN BEHAV, V32, P4; Launchbaugh KL, 1999, GRAZING BEHAV LIVEST, P28; Lefebvre Louis, 1996, P107, DOI 10.1016/B978-012273965-1/50007-8; Leigh Jennifer, 2008, Human-Wildlife Conflicts, V2, P175; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Lydersen S, 2009, RECOMMENDED TESTS AS, V28, P1159, DOI [10.1002/sim.3531, DOI 10.1002/SIM.3531]; Mace RD, 2012, J WILDLIFE MANAGE, V76, P119, DOI 10.1002/jwmg.250; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mazur R, 2008, ANIM BEHAV, V75, P1503, DOI 10.1016/j.anbehav.2007.10.027; Mazur RL, 2010, J WILDLIFE MANAGE, V74, P48, DOI 10.2193/2008-163; MCLELLAN B, 1994, INT BEAR MS, P15; Mikle N, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1467; MOREHOUSE A.T., 2016, THESIS; Morehouse AT, 2016, J WILDLIFE MANAGE, V80, P1152, DOI 10.1002/jwmg.21104; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mowat G., 2013, SO ROCKIES FLATHEAD; Nielsen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053721; Northrup JM, 2012, ANIM CONSERV, V15, P369, DOI 10.1111/j.1469-1795.2012.00525.x; Paetkau D, 2004, J WILDLIFE MANAGE, V68, P449, DOI 10.2193/0022-541X(2004)068[0449:TONOMI]2.0.CO;2; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Page RE, 1995, ANIM BEHAV, V50, P1617, DOI 10.1016/0003-3472(95)80015-8; Pokrovskaya L, 2015, MAMM BIOL, V80, P355, DOI 10.1016/j.mambio.2015.02.007; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Riley SJ., 1994, URSUS, V9, P567, DOI [10.2307/3872745, DOI 10.2307/3872745]; Sameroff A, 2010, CHILD DEV, V81, P6, DOI 10.1111/j.1467-8624.2009.01378.x; Shivik JA, 2006, CONS BIOL, V17, P1531; SKULASON S, 1993, ANIM BEHAV, V45, P1179, DOI 10.1006/anbe.1993.1140; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; U.S. Fish and Wildlife Service, 1993, GRIZZL BEAR REC PLAN; van Manen FT, 2014, CONSERV LETT, V7, P323, DOI 10.1111/conl.12095; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2014, MOL ECOL RESOUR, V14, P541, DOI 10.1111/1755-0998.12210; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wilson SM, 2006, BIOL CONSERV, V130, P47, DOI 10.1016/j.biocon.2005.12.001; Wilson SM, 2005, URSUS, V16, P117, DOI 10.2192/1537-6176(2005)016[0117:NLFHAA]2.0.CO;2	78	35	35	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165425	10.1371/journal.pone.0165425	http://dx.doi.org/10.1371/journal.pone.0165425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851753	Green Published, gold			2022-12-27	WOS:000387909300015
J	Nyiro, JU; Sande, CJ; Mutunga, M; Kiyuka, PK; Munywoki, PK; Scott, JAG; Nokes, DJ				Nyiro, Joyce Uchi; Sande, Charles Jumba; Mutunga, Martin; Kiyuka, Patience Kerubo; Munywoki, Patrick Kioo; Scott, John Anthony G.; Nokes, David James			Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus ( RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya	PLOS ONE			English	Article							MATERNAL ANTIBODY; KILIFI DISTRICT; IMMUNE GLOBULIN; YOUNG-CHILDREN; BIRTH COHORT; INFECTION; RISK; IGG; PNEUMONIA; VACCINE	Background The target group for severe respiratory syncytial virus (RSV) disease prevention is infants under 6 months of age. Vaccine boosting of antibody titres in pregnant mothers could protect these young infants from severe respiratory syncytial virus (RSV) associated disease. Quantifying protective levels of RSV-specific maternal antibody at birth would inform vaccine development. Methods A case control study nested in a birth cohort (2002-07) was conducted in Kilifi, Kenya; where 30 hospitalised cases of RSV-associated severe disease were matched to 60 controls. Participants had a cord blood and 2 subsequent 3-monthly blood samples assayed for RSV-specific neutralising antibody by the plaque reduction neutralisation test (PRNT). Two sample paired t test and conditional logistic regression were used in analyses of log(2)PRNT titres. Results The mean RSV log2PRNT titre at birth for cases and controls were not significantly different (P = 0.4) and remained so on age-stratification. Cord blood PRNT titres showed considerable overlap between cases and controls. The odds of RSV disease decreased with increase in log(2)PRNT cord blood titre. There was a 30% reduction in RSV disease per unit increase in log(2)PRNT titre (< 3months age group) but not significant (P = 0.3). Conclusions From this study, there is no strong evidence of protection by maternal RSV specific antibodies from severe RSV disease. Cord antibody levels show wide variation with considerable overlap between cases and controls. It is likely that, there are additional factors to specific PRNT antibody levels which determine susceptibility to severe RSV disease. In addition, higher levels of neutralizing antibody beyond the normal range may be required for protection; which it is hoped can be achieved by a maternal RSV vaccine.	[Nyiro, Joyce Uchi; Sande, Charles Jumba; Mutunga, Martin; Kiyuka, Patience Kerubo; Munywoki, Patrick Kioo; Scott, John Anthony G.; Nokes, David James] Kenya Med Res Inst KEMRI, Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Scott, John Anthony G.] London Sch Hyg & Trop Med, London, England; [Nokes, David James] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Nokes, David James] Univ Warwick, WIDER Ctr, Coventry, W Midlands, England; [Sande, Charles Jumba] Univ Oxford, Oxford, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; University of Warwick; University of Oxford	Nyiro, JU (corresponding author), Kenya Med Res Inst KEMRI, Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya.	Jnyiro@kemri-wellcome.org	Munywoki, Patrick K./GQP-4775-2022	Munywoki, Patrick K./0000-0001-9419-7155; Sande, Charles/0000-0002-8364-6063; Kiyuka, Patience/0000-0002-3257-5920	PATH [R.LFJN.3003]; Wellcome Trust [077092, 084633, 098532]	PATH; Wellcome Trust(Wellcome TrustEuropean Commission)	DJN received funding from PATH [Grant ref:R.LFJN.3003]; and the Wellcome Trust [077092], [084633] while JAGS recieved funding from the Wellcome Trust [098532]. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.; We thank all the study participants for their contribution of study samples. We are grateful to field, laboratory and data management staff of the KEMRI Wellcome Trust Research Programme for collection and storage of the samples and data retrieval, and specifically the support of Lilian Mwango and Anne Bett. Finally, we acknowledge the funding support from PATH [Grant ref: R.LFJN.3003] and the Wellcome Trust [077092], [084633], [098532]. This paper is published with the permission of the Director of KEMRI.	Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bulkow LR, 2002, PEDIATRICS, V109, P210, DOI 10.1542/peds.109.2.210; Chu HY, 2014, J INFECT DIS; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; English M, 2003, AM J TROP MED HYG, V69, P228, DOI 10.4269/ajtmh.2003.69.228; Englund J, 1998, VACCINE, V16, P1456, DOI 10.1016/S0264-410X(98)00108-X; Glenn GM, 2015, J INFECT DIS; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Graham BS, 2014, J INFECT DIS, V209, P1679, DOI 10.1093/infdis/jiu075; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Karron RA, 2013, CURR TOP MICROBIOL, V372, P259, DOI 10.1007/978-3-642-38919-1_13; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; LAMPRECHT CL, 1976, J INFECT DIS, V134, P211, DOI 10.1093/infdis/134.3.211; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; Munoz FM, 2003, PEDIATRICS, V111, P218, DOI 10.1542/peds.111.1.218; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894, DOI 10.1128/JCM.24.5.894-898.1986; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Nyiro JU, 2015, VACCINE, V33, P1797, DOI 10.1016/j.vaccine.2015.02.039; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Okiro EA, 2008, J CLIN MICROBIOL, V46, P1659, DOI 10.1128/JCM.02190-07; Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x; Raghunandan R, 2014, VACCINE, V32, P6485, DOI 10.1016/j.vaccine.2014.09.030; Roca A, 2002, J MED VIROL, V67, P616, DOI 10.1002/jmv.10148; Rodriguez WJ, 1997, PEDIATRICS, V100, P937, DOI 10.1542/peds.100.6.937; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Sande CJ, 2013, J MED VIROL, V85, P2020, DOI 10.1002/jmv.23696; Sande CJ, 2013, J INFECT DIS, V207, P489, DOI 10.1093/infdis/jis700; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	35	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166706	10.1371/journal.pone.0166706	http://dx.doi.org/10.1371/journal.pone.0166706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851799	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000387909300079
J	Thompson, SJ; Handel, CM; Richardson, RM; McNew, LB				Thompson, Sarah J.; Handel, Colleen M.; Richardson, Rachel M.; McNew, Lance B.			When Winners Become Losers: Predicted Nonlinear Responses of Arctic Birds to Increasing Woody Vegetation	PLOS ONE			English	Article							SPECIES RICHNESS; NORTHERN ALASKA; COMMUNITY; PLANT; ABUNDANCE; INFERENCE; SELECTION; HABITAT; MODELS; HETEROGENEITY	Climate change is facilitating rapid changes in the composition and distribution of vegetation at northern latitudes, raising questions about the responses of wildlife that rely on arctic ecosystems. One widely observed change occurring in arctic tundra ecosystems is an increasing dominance of deciduous shrub vegetation. Our goals were to examine the tolerance of arctic-nesting bird species to existing gradients of vegetation along the boreal forest-tundra ecotone, to predict the abundance of species across different heights and densities of shrubs, and to identify species that will be most or least responsive to ongoing expansion of shrubs in tundra ecosystems. We conducted 1,208 point counts on 12 study blocks from 2012-2014 in northwestern Alaska, using repeated surveys to account for imperfect detection of birds. We considered the importance of shrub height, density of low and tall shrubs (i.e. shrubs >0.5 m tall), percent of ground cover attributed to shrubs (including dwarf shrubs <0.5 m tall), and percent of herbaceous plant cover in predicting bird abundance. Among 17 species considered, only gray-cheeked thrush (Catharus minimus) abundance was associated with the highest values of all shrub metrics in its top predictive model. All other species either declined in abundance in response to one or more shrub metrics or reached a threshold where further increases in shrubs did not contribute to greater abundance. In many instances the relationship between avian abundance and shrubs was nonlinear, with predicted abundance peaking at moderate values of the co-variate, then declining at high values. In particular, a large number of species were responsive to increasing values of average shrub height with six species having highest abundance at near-zero values of shrub height and abundance of four other species decreasing once heights reached moderate values <= 33 cm). Our findings suggest that increases in shrub cover and density will negatively affect abundance of only a few bird species and may potentially be beneficial for many others. As shrub height increases further, however, a considerable number of tundra bird species will likely find habitat increasingly unsuitable.	[Thompson, Sarah J.; Handel, Colleen M.; Richardson, Rachel M.; McNew, Lance B.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [McNew, Lance B.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA	United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman	Thompson, SJ (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	sjthompson@usgs.gov	Batova, Olga/A-7438-2017	Batova, Olga/0000-0002-7822-6507	U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area	U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area	Funding was received by CMH from U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative and this work is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area.; This work is part of the U.S. Geological Survey (USGS) Changing Arctic Ecosystem Initiative and is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. We are grateful to everyone who helped collect bird and habitat data for this project: C. Anderson, C. Davis, A. Emrie, M. McDermott, M. Milligan, N. Okun, L. Pajot, J. Peterson, R. Roth, J. Terenzi, M. Trainor, C. Van Hemert, and S. Vold. We thank S. Matsuoka for helpful comments on an earlier draft of this paper and C. Amundson for guidance with data analysis.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Ballantyne K, 2011, WATERBIRDS, V34, P151, DOI 10.1675/063.034.0203; Batova ON, 2011, BIOL BULL+, V38, P259, DOI 10.1134/S1062359011030022; Boelman NT, 2015, GLOBAL CHANGE BIOL, V21, P1508, DOI 10.1111/gcb.12761; Buckland S. T., 2005, ENCY BIOSTATISTICS, V2, P1, DOI [10. 1002/0470011815. b2a16019, DOI 10.1002/0470011815.B2A16019, 10.1002/0470011815.b2a16019]; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Cody M.L., 1985, P3; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Dial RJ, 2016, GLOBAL CHANGE BIOL, V22, P1841, DOI 10.1111/gcb.13207; Fieberg J, 2015, J WILDLIFE MANAGE, V79, P708, DOI 10.1002/jwmg.894; Fiske I, J STAT SOFTW, V43; Grant TA, 2004, WILDLIFE SOC B, V32, P807, DOI 10.2193/0091-7648(2004)032[0807:TASIIN]2.0.CO;2; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hocking DJ, 2013, FOREST ECOL MANAG, V287, P32, DOI 10.1016/j.foreco.2012.09.013; Hudson JMG, 2009, ECOLOGY, V90, P2657, DOI 10.1890/09-0102.1; Hussell DJT, 2002, BIRDS N AM ONLINE; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2015, APPL HIERARCHICAL MO, V1; Kessel B., 1989, BIRDS SEWARD PENNINS; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Marcot BG, 2015, CLIMATIC CHANGE, V130, P145, DOI 10.1007/s10584-015-1354-x; McNew LB, 2015, ECOL APPL, V25, P1669, DOI 10.1890/14-1248.1; Mizel JD, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1264; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Myers-Smith IH, 2011, AMBIO, V40, P610, DOI 10.1007/s13280-011-0168-y; R Core Team, 2021, R LANGUAGE ENV STAT; Raynolds MK, 2005, PHYTOCOENOLOGIA, V35, P821, DOI 10.1127/0340-269X/2005/0035-0821; Rich ME, 2013, ECOGRAPHY, V36, P994, DOI 10.1111/j.1600-0587.2012.00078.x; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Rupp TS, 2000, GLOBAL CHANGE BIOL, V6, P541, DOI 10.1046/j.1365-2486.2000.00337.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Swanson JD, 1985, RANGE SURVEY SEWARD; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Thompson SJ, 2014, CONDOR, V116, P303, DOI 10.1650/CONDOR-13-072.1; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Wahrhaftig C, 1965, PHYSIOGRAPHIC DIVISI; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; Zellweger F, 2016, J BIOGEOGR, V43, P1080, DOI 10.1111/jbi.12696; Zuur AF, 2007, STAT BIOL HEALTH, P163	55	23	24	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0164755	10.1371/journal.pone.0164755	http://dx.doi.org/10.1371/journal.pone.0164755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851768	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300006
J	Soldano, S; Pizzorni, C; Paolino, S; Trombetta, AC; Montagna, P; Brizzolara, R; Ruaro, B; Sulli, A; Cutolo, M				Soldano, Stefano; Pizzorni, Carmen; Paolino, Sabrina; Trombetta, Amelia Chiara; Montagna, Paola; Brizzolara, Renata; Ruaro, Barbara; Sulli, Alberto; Cutolo, Maurizio			Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; EPITHELIAL-MESENCHYMAL TRANSITION; SYSTEMIC-SCLEROSIS; TISSUE-REPAIR; CANCER-CELLS; FIBROSIS; DISEASE; SKIN; POLARIZATION; PLASTICITY	Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing profibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its profibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET(A/B)RA, bosentan 10(-5) M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.	[Soldano, Stefano] Univ Genoa, Dept Internal Med, Res Lab, Genoa, Italy; Univ Genoa, Dept Internal Med, Acad Div Clin Rheumatol, Genoa, Italy	University of Genoa; University of Genoa	Soldano, S (corresponding author), Univ Genoa, Dept Internal Med, Res Lab, Genoa, Italy.	stefano.soldano@unige.it	Soldano, Stefano/AAE-6043-2022; Trombetta, Amelia Chiara/AAL-1841-2021; Ruaro, Barbara/AAA-4408-2019; Sulli, Alberto/AAD-1257-2022	Ruaro, Barbara/0000-0001-8990-859X; Montagna, Paola/0000-0002-0595-1484; Soldano, Stefano/0000-0001-8796-6032				Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Barisione C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149276; Beamer CA, 2005, AM J PHYSIOL-LUNG C, V289, pL186, DOI 10.1152/ajplung.00474.2004; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Christmann RB, 2011, ARTHRITIS RHEUM-US, V63, P1718, DOI 10.1002/art.30318; Cipriani P, 2015, J RHEUMATOL, V42, P1808, DOI 10.3899/jrheum.150088; Cutolo M, 2013, CLIN EXP RHEUMATOL; Cutolo M, 2015, NAT REV RHEUMATOL, V11, P570, DOI 10.1038/nrrheum.2015.111; Cutolo M, 2015, J RHEUMATOL, V42, P456, DOI 10.3899/jrheum.141070; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Elisa T, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/147616; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Fujimura T, 2016, J DERMATOL SCI, V83, P167, DOI 10.1016/j.jdermsci.2016.05.015; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Hashimoto O, 2016, J PATHOL, V240, P211, DOI 10.1002/path.4769; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Higashi-Kuwata N, 2009, EXP DERMATOL, V18, P727, DOI 10.1111/j.1600-0625.2008.00828.x; Kurzepa J, 2014, HEPATOB PANCREAT DIS, V13, P570, DOI 10.1016/S1499-3872(14)60261-7; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manetti M, 2015, EXP DERMATOL, V24, P576, DOI 10.1111/exd.12727; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Park JY, 2016, CLIN RES HEPATOL GAS, V40, P357, DOI 10.1016/j.clinre.2015.09.005; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Stifano G, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-015-0554-8; Sulli A, 2009, J RHEUMATOL, V36, P1235, DOI 10.3899/jrheum.081030; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tulapurkar ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118010; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang Y, 2015, AGING CELL, V14, P678, DOI 10.1111/acel.12350; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yu AP, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0108-2; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84	50	42	42	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166433	10.1371/journal.pone.0166433	http://dx.doi.org/10.1371/journal.pone.0166433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846260	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600063
J	Venkatraman, L; Regan, ER; Bentley, K				Venkatraman, Lakshmi; Regan, Erzsebet Ravasz; Bentley, Katie			Time to Decide? Dynamical Analysis Predicts Partial Tip/Stalk Patterning States Arise during Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BCL-2 APOPTOTIC SWITCH; TUMOR ANGIOGENESIS; NOTCH; CELLS; FEEDBACK; EXPRESSION; SIRT1; DLL4; SOMITOGENESIS	Angiogenesis is a highly dynamic morphogenesis process; however, surprisingly little is known about the timing of the different molecular processes involved. Although the role of the VEGF-notch-DLL4 signaling pathway has been established as essential for tip/stalk cell competition during sprouting, the speed and dynamic properties of the underlying process at the individual cell level has not been fully elucidated. In this study, using mathematical modeling we investigate how specific, biologically meaningful, local conditions around and within an individual cell can influence their unique tip/stalk phenotype switching kinetics. To this end we constructed an ordinary differential equation model of VEGF-notch-DLL4 signaling in a system of two, coupled endothelial cells (EC). Our studies reveal that at any given point in an angiogenic vessel the time it takes a cell to decide to take on a tip or stalk phenotype may be drastically different, and this asynchrony of tip/stalk cell decisions along vessels itself acts to speed up later competitions. We unexpectedly uncover intermediate "partial" yet stable states lying between the tip and stalk cell fates, and identify that internal cellular factors, such as NAD-dependent deacetylase sirtuin-1 (Sirt1) and Lunatic fringe 1 (Lfng1), can specifically determine the length of time a cell spends in these newly identified partial tip/stalk states. Importantly, the model predicts that these partial EC states can arise during normal angiogenesis, in particular during cell rearrangement in sprouts, providing a novel two-stage mechanism for rapid adaptive behavior to the cells highly dynamic environment. Overall, this study demonstrates that different factors (both internal and external to EC) can be used to modulate the speed of tip/stalk decisions, opening up new opportunities and challenges for future biological experiments and therapeutic targeting to manipulate vascular network topology, and our basic understanding of developmental/pathological angiogenesis.	[Venkatraman, Lakshmi; Regan, Erzsebet Ravasz; Bentley, Katie] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02115 USA; [Regan, Erzsebet Ravasz] Coll Wooster, Dept Biochem & Mol Biol, Wooster, OH 44691 USA; [Bentley, Katie] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; College of Wooster; Uppsala University	Venkatraman, L; Bentley, K (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02115 USA.; Bentley, K (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Venkatraman.lakshmi@gmail.com; kbentley@bidmc.harvard.edu	Regan, Erzsébet Ravasz/AAG-8989-2019	Regan, Erzsébet Ravasz/0000-0002-8663-3153; Bentley, Katie/0000-0002-9391-659X	Marfan Foundation; Beth Israel Medical Deaconess Center; NSF [1517390]; Knut and Alice Wallenberg Foundation	Marfan Foundation; Beth Israel Medical Deaconess Center; NSF(National Science Foundation (NSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	LV is funded by Victor A. McKusick Fellowship from the Marfan Foundation. ER and KB are funded by Beth Israel Medical Deaconess Center. KB is also funded by NSF (Ref. 1517390) and the Knut and Alice Wallenberg Foundation.; LV is funded by Victor A. McKusick Fellowship from the Marfan Foundation. ER and KB are funded by Beth Israel Medical Deaconess Center. KB is also funded by NSF (Ref. 1517390) and the Knut and Alice Wallenberg Foundation. LV performed the simulations. LV and KB designed the study; LV, ER and KB analyzed and interpreted the simulation results, prepared and edited the manuscript.	AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentley K, 2014, HETEROGENEOUS COLLEC, P1; Bentley K, CAN ACTIVE PERCEPTIO; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2014, DEV CELL, V29, P146, DOI 10.1016/j.devcel.2014.03.019; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bernard S, 2006, PHILOS T R SOC A, V364, P1155, DOI 10.1098/rsta.2006.1761; Blanco R, 2013, PLOS ONE, V3; Boareto M, 2015, P NATL ACAD SCI USA, V112, pE3836, DOI 10.1073/pnas.1511814112; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Cui J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001469; Dardik R, 2003, J CELL PHYSL, V194, P237, DOI [10.1002/jcp.10208, DOI 10.1002/JCP.10208]; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kageyama R, 2012, WIRES DEV BIOL, V1, P629, DOI 10.1002/wdev.46; Kato TM, 2010, MOL CELL NEUROSCI, V45, P12, DOI 10.1016/j.mcn.2010.05.004; Kim JJ, 2012, J ENDODONT, V38, P899, DOI 10.1016/j.joen.2012.04.006; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Kur E, 2016, ELIFE, V5, DOI 10.7554/eLife.13212; Larrivee B, 2012, DEV CELL NIH PUBLIC, V22, P500; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Meinhardt H, 2004, BIOESSAYS, V26, P1260, DOI 10.1002/bies.20135; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; PHILLIPS GD, 1991, AM J ANAT, V192, P257, DOI 10.1002/aja.1001920305; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Ubezio B, 2016, ELIFE, V5, DOI 10.7554/eLife.12167; Uexkull Jakob von, 1920, THEORETISCHE BIOLOGI; Vaggi F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002088; Venkatraman L, 2012, BIOPHYS J, V102, p730A, DOI 10.1016/j.bpj.2011.11.3964; Xie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045331; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009	52	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166489	10.1371/journal.pone.0166489	http://dx.doi.org/10.1371/journal.pone.0166489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846305	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600070
J	Zeman, D; Kusnierova, P; Svagera, Z; Vsiansky, F; Byrtusova, M; Hradilek, P; Kurkova, B; Zapletalova, O; Bartos, V				Zeman, David; Kusnierova, Pavlina; Svagera, Zdenek; Vsiansky, Frantisek; Byrtusova, Monika; Hradilek, Pavel; Kurkova, Barbora; Zapletalova, Olga; Bartos, Vladimir			Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting	PLOS ONE			English	Article							FREE KAPPA-LIGHT; CEREBROSPINAL-FLUID CSF; MULTIPLE-SCLEROSIS; HIGH-SENSITIVITY; LAMBDA-BANDS; SERUM; SPECIFICITY; ELISAS; QUANTIFICATION; ANTIBODIES	Objectives We aimed to compare various methods for free light chain (fLC) quantitation in cerebrospinal fluid (CSF) and serum and to determine whether quantitative CSF measurements could reliably predict intrathecal fLC synthesis. In addition, we wished to determine the relationship between free kappa and free lambda light chain concentrations in CSF and serum in various disease groups. Methods We analysed 166 paired CSF and serum samples by at least one of the following methods: turbidimetry (Freelite (TM), SPA(PLUS)), nephelometry (N Latex FLC (TM), BN ProSpec), and two different (commercially available and in-house developed) sandwich ELISAs. The results were compared with oligoclonal fLC detected by affinity-mediated immunoblotting after isoelectric focusing. Results Although the correlations between quantitative methods were good, both proportional and systematic differences were discerned. However, no major differences were observed in the prediction of positive oligoclonal fLC test. Surprisingly, CSF free kappa/free lambda light chain ratios were lower than those in serum in about 75% of samples with negative oligoclonal fLC test. In about a half of patients with multiple sclerosis and clinically isolated syndrome, profoundly increased free kappa/free lambda light chain ratios were found in the CSF. Conclusions Our results show that using appropriate method-specific cut-offs, different methods of CSF fLC quantitation can be used for the prediction of intrathecal fLC synthesis. The reason for unexpectedly low free kappa/free lambda light chain ratios in normal CSFs remains to be elucidated. Whereas CSF free kappa light chain concentration is increased in most patients with multiple sclerosis and clinically isolated syndrome, CSF free lambda light chain values show large interindividual variability in these patients and should be investigated further for possible immunopathological and prognostic significance.	[Zeman, David; Kusnierova, Pavlina; Svagera, Zdenek; Vsiansky, Frantisek; Bartos, Vladimir] Univ Hosp Ostrava, Inst Lab Diagnost, 17 Listopadu 1790, Ostrava 70852, Czech Republic; [Zeman, David; Hradilek, Pavel; Kurkova, Barbora; Zapletalova, Olga] Univ Hosp Ostrava, Neurol Clin, 17 Listopadu 1790, Ostrava 70852, Czech Republic; [Byrtusova, Monika] St Elisabeth Univ Hlth & Social Work Bratislava, Inst Healthcare Disciplines, Palackeho 1,POB 104, Bratislava 81000, Slovakia	University Hospital Ostrava; University Hospital Ostrava	Zeman, D (corresponding author), Univ Hosp Ostrava, Inst Lab Diagnost, 17 Listopadu 1790, Ostrava 70852, Czech Republic.; Zeman, D (corresponding author), Univ Hosp Ostrava, Neurol Clin, 17 Listopadu 1790, Ostrava 70852, Czech Republic.	david.zeman@fno.cz	Švagera, Zdeněk/D-8025-2018; Hradílek, Pavel/ABF-4148-2021; Zeman, David/D-7064-2014; Kušnierová, Pavlína/D-8376-2014; Zeman, David/GLR-3225-2022; Vsiansky, Frantisek/M-7103-2019	Švagera, Zdeněk/0000-0002-7937-3197; Hradílek, Pavel/0000-0001-7896-2523; Zeman, David/0000-0001-6822-2572; Kušnierová, Pavlína/0000-0001-8835-2155; Zeman, David/0000-0001-6822-2572; 	Ministry of Health of the Czech Republic (MH CZ - DRO-FNOs)	Ministry of Health of the Czech Republic (MH CZ - DRO-FNOs)	The study was supported by the grant of the Ministry of Health of the Czech Republic (MH CZ - DRO-FNOs/2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneth B, 2009, ACTA NEUROL SCAND, V119, P39, DOI 10.1111/j.1600-0404.2008.01058.x; BRACCO F, 1987, J NEUROL, V234, P303, DOI 10.1007/BF00314285; Bradwell AR, 2001, CLIN CHEM, V47, P673; Byrtusova M, 2015, THESIS, P1; DECARLI C, 1987, NEUROLOGY, V37, P1334, DOI 10.1212/WNL.37.8.1334; Desplat-Jego S, 2005, J CLIN IMMUNOL, V25, P338, DOI 10.1007/s10875-005-5371-9; Dimopoulos M, 2011, INT MYELOMA WORKSHOP, V3, P4701, DOI DOI 10.1182/BL00D-2010-10-299529; Duranti F, 2013, J NEUROIMMUNOL, V263, P116, DOI 10.1016/j.jneuroim.2013.07.006; FAGNART OC, 1988, J NEUROIMMUNOL, V19, P119, DOI 10.1016/0165-5728(88)90041-0; Fischer C, 2004, CLIN CHEM, V50, P1809, DOI 10.1373/clinchem.2004.033977; GALLO P, 1989, J NEUROL SCI, V94, P241, DOI 10.1016/0022-510X(89)90234-7; Hassan-Smith G, 2014, J NEUROIMMUNOL, V276, P175, DOI 10.1016/j.jneuroim.2014.08.003; IWASHITA H, 1974, J NEUROL, V207, P45, DOI 10.1007/BF00312591; Kaplan B, 2013, J IMMUNOL METHODS, V390, P74, DOI 10.1016/j.jim.2013.01.010; Kaplan B, 2011, THESCIENTIFICWORLDJO, V11, P726, DOI 10.1100/tsw.2011.65; Kaplan B, 2010, J NEUROIMMUNOL, V229, P263, DOI 10.1016/j.jneuroim.2010.09.002; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Krakauer M, 1998, ACTA NEUROL SCAND, V98, P161, DOI 10.1111/j.1600-0404.1998.tb07287.x; LAMERS KJB, 1995, J NEUROIMMUNOL, V62, P19, DOI 10.1016/0165-5728(95)00086-H; LOLLI F, 1989, CLIN CHIM ACTA, V182, P229, DOI 10.1016/0009-8981(89)90081-8; Makshakov G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143375; Monson NL, 2005, J NEUROIMMUNOL, V158, P170, DOI 10.1016/j.jneuroim.2004.04.022; Nakano T, 2006, J IMMUNOASS IMMUNOCH, V27, P129, DOI 10.1080/15321810600573069; Nakano T, 2004, J IMMUNOL METHODS, V293, P183, DOI 10.1016/j.jim.2004.08.002; Nakano T, 2003, J IMMUNOL METHODS, V275, P9, DOI 10.1016/S0022-1759(02)00512-4; Nakano T, 2006, CLIN CHEM LAB MED, V44, P522, DOI 10.1515/CCLM.2006.118; Pieri M, 2014, RIV ITAL MED LAB, V10, P167; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Prak ETL, 2011, ANN NY ACAD SCI, V1217, P96, DOI 10.1111/j.1749-6632.2010.05877.x; Presslauer S, 2016, MULT SCLER J, V22, P502, DOI 10.1177/1352458515594044; Presslauer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089945; Presslauer S, 2008, J NEUROL, V255, P1508, DOI 10.1007/s00415-008-0954-z; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; REIBER H, 1995, CLIN CHEM, V41, P256; Reiber H, 2009, ACTA NEUROL SCAND, V120, P445, DOI 10.1111/j.1600-0404.2009.01244.x; RUDICK RA, 1985, NEUROLOGY, V35, P1443, DOI 10.1212/WNL.35.10.1443; RUDICK RA, 1986, ANN NEUROL, V20, P63, DOI 10.1002/ana.410200111; Senel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088680; SINDIC CJM, 1991, J NEUROIMMUNOL, V33, P63, DOI 10.1016/0165-5728(91)90035-6; STANESCU GL, 1991, J CLIN LAB ANAL, V5, P206, DOI 10.1002/jcla.1860050310; Sukumar S, 2011, J IMMUNOL, V186, P1301, DOI 10.4049/jimmunol.1090129; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; VAKAET A, 1985, J NEUROL NEUROSUR PS, V48, P995, DOI 10.1136/jnnp.48.10.995; Velthuis HT, 2011, CLIN CHEM LAB MED, V49, P1323, DOI 10.1515/CCLM.2011.624; Villar LM, 2012, CLIN CHIM ACTA, V413, P1813, DOI 10.1016/j.cca.2012.07.007; Zeman D, 2008, THESIS, P1; Zeman D, 2016, ANN CLIN BIOCHEM, V53, P174, DOI 10.1177/0004563215579110; Zeman D, 2015, BIOMED PAP, V159, P104, DOI 10.5507/bp.2014.058; Zeman D, 2012, FLUIDS BARRIERS CNS, V9, DOI [10.1186/PREACCEPT-1492155671621564, 10.1186/2045-8118-9-5]	49	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166556	10.1371/journal.pone.0166556	http://dx.doi.org/10.1371/journal.pone.0166556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846293	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600081
J	Kinoshita, M; Higashihara, E; Kawano, H; Higashiyama, R; Koga, D; Fukui, T; Gondo, N; Oka, T; Kawahara, K; Rigo, K; Hague, T; Katsuragi, K; Sudo, K; Takeshi, M; Horie, S; Nutahara, K				Kinoshita, Moritoshi; Higashihara, Eiji; Kawano, Haruna; Higashiyama, Ryo; Koga, Daisuke; Fukui, Takafumi; Gondo, Nobuhisa; Oka, Takehiko; Kawahara, Kozo; Rigo, Krisztina; Hague, Tim; Katsuragi, Kiyonori; Sudo, Kimiyoshi; Takeshi, Masahiko; Horie, Shigeo; Nutahara, Kikuo			Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System	PLOS ONE			English	Article							ION TORRENT; GENE; TOLVAPTAN; PROGNOSIS; DIAGNOSIS; RISK; PCR	Genetic testing of PKD1 and PKD2 is expected to play an increasingly important role in determining allelic influences in autosomal dominant polycystic kidney disease (ADPKD) in the near future. However, to date, genetic testing is not commonly employed because it is expensive, complicated because of genetic heterogeneity, and does not easily identify pathogenic variants. In this study, we developed a genetic testing system based on next-generation sequencing (NGS), long-range polymerase chain reaction, and a new software package. The new software package integrated seven databases and provided access to five cloud-based computing systems. The database integrated 241 polymorphic nonpathogenic variants detected in 140 healthy Japanese volunteers aged > 35 years, who were confirmed by ultrasonography as having no cysts in either kidney. Using this system, we identified 60 novel and 30 known pathogenic mutations in 101 Japanese patients with ADPKD, with an overall detection rate of 89.1% (90/101) [95% confidence interval (CI), 83.0%-95.2%]. The sensitivity of the system increased to 93.1% (94/101) (95% CI, 88.1% - 98.0%) when combined with multiplex ligation-dependent probe amplification analysis, making it sufficient for use in a clinical setting. In 82 (87.2%) of the patients, pathogenic mutations were detected in PKD1 (95% CI, 79.0%-92.5%), whereas in 12 (12.8%) patients pathogenic mutations were detected in PKD2 (95% CI, 7.5%-21.0%); this is consistent with previously reported findings. In addition, we were able to reconfirm our pathogenic mutation identification results using Sanger sequencing. In conclusion, we developed a high-sensitivity NGS-based system and successfully employed it to identify pathogenic mutations in PKD1 and PKD2 in Japanese patients with ADPKD.	[Kinoshita, Moritoshi; Higashiyama, Ryo; Koga, Daisuke; Katsuragi, Kiyonori; Sudo, Kimiyoshi] Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima, Japan; [Higashihara, Eiji] Kyorin Univ, Sch Med, Dept ADPKD Res, Tokyo, Japan; [Higashihara, Eiji; Nutahara, Kikuo] Kyorin Univ, Sch Med, Dept Urol, Tokyo, Japan; [Kawano, Haruna; Horie, Shigeo] Juntendo Univ, Grad Sch Med, Dept Urol, Tokyo, Japan; [Fukui, Takafumi; Gondo, Nobuhisa] FALCO Biosyst Ltd, Kyoto, Japan; [Oka, Takehiko; Kawahara, Kozo] World Fus Co Ltd, Tokyo, Japan; [Rigo, Krisztina; Hague, Tim] Omixon Ltd, Budapest, Hungary; [Takeshi, Masahiko] Med Corp Shinanokai, Samon Cho Clin, Tokyo, Japan; [Takeshi, Masahiko] Med Corp Shinanokai, Shinanozaka Clin, Tokyo, Japan	Otsuka Pharmaceutical; Kyorin University; Kyorin University; Juntendo University	Kinoshita, M (corresponding author), Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima, Japan.	kinoshaamo@otsuka.jp			Otsuka Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical	Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Otsuka Pharmaceutical(Otsuka Pharmaceutical)	This study was funded by Otsuka Pharmaceutical Co., Ltd. The funder only provided financial support in the form of salaries for MK, RH, DK, KK, and KS and did not have any additional role in the study design, data collection and analysis, decision to publish, or manuscript preparation. Similarly, FALCO Biosystems, World Fusion, Omixon, and Samon-cho clinic provided support in the form of salaries for TF, NG, TO, KK, KR, TH, and MT but did not have any additional role in the study design, data collection and analysis, decision to publish, or manuscript preparation. EH, SH, and KN have received research funding from Otsuka Pharmaceutical. HK and MT have no conflict of interest directly relevant to the content of this article.	Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; Bogdanova N, 2001, GENOMICS, V74, P333, DOI 10.1006/geno.2001.6568; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Consugar MB, 2008, KIDNEY INT, V74, P1468, DOI 10.1038/ki.2008.485; Dicks E, 2006, CLIN J AM SOC NEPHRO, V1, P710, DOI 10.2215/CJN.01581105; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Eisenberger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116680; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GRANTHAM JJ, 1990, AM J KIDNEY DIS, V15, P110, DOI 10.1016/S0272-6386(12)80507-5; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; Higashihara E, 2011, CLIN J AM SOC NEPHRO, V6, P2499, DOI 10.2215/CJN.03530411; Huang E, 2009, TRANSPLANTATION, V87, P133, DOI 10.1097/TP.0b013e318191e729; Kurashige M, 2015, CLIN GENET, V87, P266, DOI 10.1111/cge.12372; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oliver Gavin R, 2012, F1000Res, V1, P2, DOI 10.12688/f1000research.1-2.v1; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Rossetti S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tan AY, 2014, J MOL DIAGN, V16, P216, DOI 10.1016/j.jmoldx.2013.10.005; Tan YC, 2012, J MOL DIAGN, V14, P305, DOI 10.1016/j.jmoldx.2012.02.007; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Thomsen HS, 1997, EUR RADIOL, V7, P1267, DOI 10.1007/s003300050288; Torra R, 1996, J AM SOC NEPHROL, V7, P2142; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Trujillano D, 2014, MOL GENET GENOM MED, V2, P412, DOI 10.1002/mgg3.82; Vogel U, 2012, J CLIN MICROBIOL, V50, P1889, DOI 10.1128/JCM.00038-12; WARD CJ, 1994, CELL, V77, P881; Yang T, 2014, SPRINGER EURASIP J W, V1, P1, DOI DOI 10.1016/J.CCA.2014.02.011	39	22	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166288	10.1371/journal.pone.0166288	http://dx.doi.org/10.1371/journal.pone.0166288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835667	Green Submitted, Green Published, gold			2022-12-27	WOS:000387779200034
J	Buckley, RF; Laming, G; Chen, LPE; Crole, A; Hester, R				Buckley, Rachel F.; Laming, Gemma; Chen, Li Peng Evelyn; Crole, Alice; Hester, Robert			Assessing Error Awareness as a Mediator of the Relationship between Subjective Concerns and Cognitive Performance in Older Adults	PLOS ONE			English	Article							MEMORY COMPLAINTS; AGE; IMPAIRMENT; DEPRESSION; TASK; METAANALYSIS; BIOMARKERS; DOPAMINE; DEMENTIA; SPEED	Objectives Subjective concerns of cognitive decline (SCD) often manifest in older adults who exhibit objectively normal cognitive functioning. This subjective-objective discrepancy is counterintuitive when mounting evidence suggests that subjective concerns relate to future clinical progression to Alzheimer's disease, and so possess the potential to be a sensitive early behavioural marker of disease. In the current study, we aimed to determine whether individual variability in conscious awareness of errors in daily life might mediate this subjective objective relationship. Methods 67 cognitively-normal older adults underwent cognitive, SCD and mood tests, and an error awareness task. Results Poorer error awareness was not found to mediate a relationship between SCD and objective performance. Furthermore, non-clinical levels of depressive symptomatology were a primary driving factor of SCD and error awareness, and significantly mediated a relationship between the two. Discussion We were unable to show that poorer error awareness mediates SCD and cognitive performance in older adults. Our study does suggest, however, that underlying depressive symptoms influence both poorer error awareness and greater SCD severity. Error awareness is thus not recommended as a proxy for SCD, as reduced levels of error awareness do not seem to be reflected by greater SCD.	[Buckley, Rachel F.] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Buckley, Rachel F.; Laming, Gemma; Chen, Li Peng Evelyn; Crole, Alice; Hester, Robert] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Buckley, Rachel F.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Buckley, Rachel F.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Buckley, RF (corresponding author), Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.; Buckley, RF (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.; Buckley, RF (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.; Buckley, RF (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	rbuckley@mgh.harvard.edu	; Hester, Robert/F-2097-2011	Buckley, Rachel/0000-0002-5356-5537; Hester, Robert/0000-0003-0982-8026	National Health and Medical Research Council of Australia [1008044]; NHMRC/ARC Dementia Research Fellowship [APP1105576]; Australian Research Council [FT110100088.]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/ARC Dementia Research Fellowship; Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia (grant number 1008044). Dr Buckley is funded by the NHMRC/ARC Dementia Research Fellowship (APP1105576), and A/Prof Hester is funded by Australian Research Council FT110100088.	Backman L, 2000, AM J PSYCHIAT, V157, P635; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Buckley R, 2013, INT PSYCHOGERIATR, V25, P1307, DOI 10.1017/S1041610213000665; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Darby D, 2014, J CLIN NEURO, V21, P4; Edmonds EC, 2014, J INT NEUROPSYCH SOC, V20, P836, DOI 10.1017/S135561771400068X; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Falkenstein M, 2001, EXP BRAIN RES, V138, P258, DOI 10.1007/s002210100712; Farias ST, 2008, NEUROPSYCHOLOGY, V22, P531, DOI 10.1037/0894-4105.22.4.531; Fiske A, 2009, ANNU REV CLIN PSYCHO, V5, P363, DOI 10.1146/annurev.clinpsy.032408.153621; Harty S, 2013, PSYCHOL AGING, V28, P1032, DOI 10.1037/a0033567; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hester R, 2005, NEUROIMAGE, V27, P602, DOI 10.1016/j.neuroimage.2005.04.035; Hohman TJ, 2011, NEUROPSYCHOLOGY, V25, P125, DOI 10.1037/a0020859; Hulur G, 2015, GERONTOLOGY, V61, P232, DOI 10.1159/000369010; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Mathewson KJ, 2005, BIOL PSYCHOL, V70, P88, DOI 10.1016/j.biopsycho.2004.12.005; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Orr C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00177; Perri RL, 2015, NEUROIMAGE; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; Rabin LA, 2015, J ALZHEIMERS DIS, P1; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Silva D, 2014, J GERIATR PSYCH NEUR, V27, P259, DOI 10.1177/0891988714532018; Stogmann E, 2016, J ALZHEIMERS DIS, V49, P1043, DOI 10.3233/JAD-150785; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628	31	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166315	10.1371/journal.pone.0166315	http://dx.doi.org/10.1371/journal.pone.0166315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832173	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000094
J	Chen, HL; Lee, WT; Lee, PL; Liu, PL; Yang, RC				Chen, Hsiu-Lin; Lee, Wei-Te; Lee, Pei-Lun; Liu, Po-Len; Yang, Rei-Cheng			Postnatal Changes in Tibial Bone Speed of Sound of Preterm and Term Infants during Infancy	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; QUANTITATIVE ULTRASOUND; GESTATIONAL-AGE; ADOLESCENTS; CHILDREN; OSTEOPOROSIS; OSTEOPENIA; CHILDHOOD; FRACTURES; RICKETS	This study aimed to evaluate changes in tibial bone speed of sound (SOS) over time, in preterm and term infants during infancy, in addition to identifying factors influencing the development of tibial SOS during infancy. Preterm (n = 155) and term (n = 65) infants were enrolled in this study. Tibial bone SOS was measured using quantitative ultrasonography (QUS) on the left tibia of newborn infants after birth (within 7 days), at 1 month old, and then every 2 months until subjects were approximately 12-15 months old. Follow-up checks included anthropometric measurements and tibial bone SOS. Mean tibial bone SOS at birth was significantly higher in term infants (mean-SD, 2968.5-99.7 m/s) than in preterm infants (2912.2-122.6 m/s). Values of follow-up tibial bone SOS declined for the first 4 months, and then increased gradually until 12-15 months old. This increasing trend was greater in preterm infants after 2 months of corrected age than in term infants. There were no significant differences by 12-15 months of age between preterm and term infants. A longitudinal mixed-effect model controlling for internal correlations and other covariates in the two groups showed that age and the SOS value at birth were important factors affecting the tibial bone SOS in both preterm and term newborn infants during infancy. There are significant differences in the pattern of change in tibial bone SOS values between preterm and term infants during the first 12-15 months of life. Age and SOS value at birth were important factors affecting the pattern of tibial bone SOS change in both preterm and term newborn infants during infancy.	[Chen, Hsiu-Lin; Lee, Wei-Te; Lee, Pei-Lun; Yang, Rei-Cheng] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Hsiu-Lin; Liu, Po-Len] Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan; [Yang, Rei-Cheng] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chen, HL (corresponding author), Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Chen, HL (corresponding author), Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan.	ch840062@kmi.edu.tw	Chen, Hsiu-Lin/B-9238-2012; Chen, Hsiu-Lin/S-8325-2019; Chen, Hsiu-Lin/GRY-7492-2022	Chen, Hsiu-Lin/0000-0002-0565-4631; Chen, Hsiu-Lin/0000-0002-0565-4631; Lee, Wei-Te/0000-0002-9366-6180	Kaohsiung Medical University Research Foundation [KMU-Q098014]	Kaohsiung Medical University Research Foundation	This study was supported by a grant from Kaohsiung Medical University Research Foundation (KMU-Q098014)(HLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Chen HL, 2012, EARLY HUM DEV, V88, P617, DOI 10.1016/j.earlhumdev.2012.01.008; Chen HL, 2010, J PAEDIATR CHILD H, V46, P653, DOI 10.1111/j.1440-1754.2010.01822.x; De Cunto A, 2014, ARCH DIS CHILD-FETAL, V99, pF238, DOI 10.1136/archdischild-2013-305386; Guglielmi G, 2009, EUR RADIOL, V19, P1837, DOI 10.1007/s00330-009-1354-1; Gursoy T, 2008, J PEDIATR ENDOCR MET, V21, P1065; Hsieh Wu-Shiun, 2006, Acta Paediatrica Taiwanica, V47, P25; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Kaga M, 2002, J BONE MINER METAB, V20, P111, DOI 10.1007/s007740200015; Koo WWK, 2008, PEDIATR RADIOL, V38, P1323, DOI 10.1007/s00247-008-1040-5; Koo WWK, 1998, J AM COLL NUTR, V17, P65, DOI 10.1080/07315724.1998.10720457; KOO WWK, 1985, AM J DIS CHILD, V139, P1045, DOI 10.1001/archpedi.1985.02140120091034; KOO WWK, 1989, J PEDIATR ORTHOPED, V9, P326, DOI 10.1097/01202412-198909030-00012; Land C, 2008, BEST PRACT RES CL EN, V22, P107, DOI 10.1016/j.beem.2007.09.005; Lequin MH, 2000, CALCIFIED TISSUE INT, V67, P101, DOI 10.1007/s00223001119; Liao XP, 2005, PEDIATR RADIOL, V35, P847, DOI 10.1007/s00247-005-1481-z; Littner Y, 2003, J PEDIATR ENDOCR MET, V16, P43; McDevitt H, 2005, ARCH DIS CHILD-FETAL, V90, pF341, DOI 10.1136/adc.2004.065276; Moshang TJ., 2005, PEDIAT ENDOCRINOLOGY, P241; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Pereda Lourdes, 2003, J Perinatol, V23, P655, DOI 10.1038/sj.jp.7211006; Prevrhal S, 2001, OSTEOPOROSIS INT, V12, P28, DOI 10.1007/s001980170154; Rauch F, 2001, J BONE MINER RES, V16, P597, DOI 10.1359/jbmr.2001.16.4.597; Ritschl E, 2005, PEDIATR RES, V58, P341, DOI 10.1203/01.PDR.0000169996.25179.EC; Rubinacci A, 2003, EUR J ENDOCRINOL, V149, P307, DOI 10.1530/eje.0.1490307; Teitelbaum JE, 2006, J CLIN DENSITOM, V9, P358, DOI 10.1016/j.jocd.2006.03.013; Vignolo M, 2003, CALCIFIED TISSUE INT, V72, P681, DOI 10.1007/s00223-002-2028-z; Williford AL, 2008, NEONATAL NETW, V27, P57, DOI 10.1891/0730-0832.27.1.57	29	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166434	10.1371/journal.pone.0166434	http://dx.doi.org/10.1371/journal.pone.0166434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832193	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000123
J	Jesky, MD; Dutton, M; Dasgupta, I; Yadav, P; Ng, KP; Fenton, A; Kyte, D; Ferro, CJ; Calvert, M; Cockwell, P; Stringer, SJ				Jesky, Mark D.; Dutton, Mary; Dasgupta, Indranil; Yadav, Punit; Ng, Khai Ping; Fenton, Anthony; Kyte, Derek; Ferro, Charles J.; Calvert, Melanie; Cockwell, Paul; Stringer, Stephanie J.			Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SECONDARY CARE RIISC; CKD; RISKS; FRAILTY; POPULATION; IMPAIRMENT; DEPRESSION; RATIONALE; OUTCOMES	Background Chronic kidney disease (CKD) is associated with reduced health-related quality of life (HRQL). However, the relationship between pre-dialysis CKD, HRQL and clinical outcomes, including mortality and progression to end-stage renal disease (ESRD) is unclear. Methods All 745 participants recruited into the Renal Impairment In Secondary Care study to end March 2014 were included. Demographic, clinical and laboratory data were collected at baseline including an assessment of HRQL using the Euroqol EQ-5D-3L. Health states were converted into an EQ-5D(index) score using a set of weighted preferences specific to the UK population. Multivariable Cox proportional hazards regression and competing risk analyses were undertaken to evaluate the association of HRQL with progression to ESRD or all cause mortality. Regression analyses were then performed to identify variables associated with the significant HRQL components. Results Median eGFR was 25.8 ml/min/1.73 m(2) (IQR 19.6-33.7ml/min) and median ACR was 33 mg/mmol (IQR 6.6-130.3 mg/mmol). Five hundred and fifty five participants (75.7%) reported problems with one or more EQ-5D domains. When adjusted for age, gender, comorbidity, eGFR and ACR, both reported problems with self-care [hazard ratio 2.542, 95% confidence interval 1.222-5.286, p = 0.013] and reduced EQ-5D(index) score [hazard ratio 0.283, 95% confidence interval 0.099-0.810, p = 0.019] were significantly associated with an increase in all-cause mortality. Similar findings were observed for competing risk analyses. Reduced HRQL was not a risk factor for progression to ESRD in multivariable analyses. Conclusions Impaired HRQL is common in the pre-dialysis CKD population. Reduced HRQL, as demonstrated by problems with self-care or a lower EQ-5D(index) score, is associated with a higher risk for death but not ESRD. Multiple factors influence these aspects of HRQL but renal function, as measured by eGFR and ACR, are not among them.	[Jesky, Mark D.; Dutton, Mary; Yadav, Punit; Ng, Khai Ping; Fenton, Anthony; Ferro, Charles J.; Cockwell, Paul; Stringer, Stephanie J.] Univ Hosp Birmingham NHS Fdn Trust, Dept Renal Med, Birmingham, W Midlands, England; [Jesky, Mark D.; Yadav, Punit; Fenton, Anthony; Cockwell, Paul; Stringer, Stephanie J.] Univ Birmingham, Inst Translat Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Dasgupta, Indranil] Heart England NHS Fdn Trust, Renal Unit, Birmingham, W Midlands, England; [Ng, Khai Ping; Ferro, Charles J.] Univ Birmingham, Inst Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kyte, Derek; Calvert, Melanie] Univ Birmingham, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham	Jesky, MD (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Renal Med, Birmingham, W Midlands, England.; Jesky, MD (corresponding author), Univ Birmingham, Inst Translat Med, Coll Med & Dent Sci, Birmingham, W Midlands, England.	mark.jesky@uhb.nhs.uk	ferro, charles/L-7250-2019; Ferro, Charles J./O-8912-2016; Dasgupta, Indranil/ABC-3409-2020; Calvert, Melanie/F-7055-2011	ferro, charles/0000-0003-0577-7081; Ferro, Charles J./0000-0003-0577-7081; Calvert, Melanie/0000-0002-1856-837X; Fenton, Anthony/0000-0003-2665-6924; Cockwell, Paul/0000-0003-1975-266X; kyte, Derek/0000-0002-7679-6741	JABBS Foundation (Birmingham, United Kingdom); Queen Elizabeth Hospital Birmingham Charity	JABBS Foundation (Birmingham, United Kingdom); Queen Elizabeth Hospital Birmingham Charity	The study is supported by JABBS Foundation (Birmingham, United Kingdom) (URL: http://opencharities.org/charities/1128402) and The Queen Elizabeth Hospital Birmingham Charity (URL: https://qehb.org/).	Abdel-Kader K, 2009, CLIN J AM SOC NEPHRO, V4, P1057, DOI 10.2215/CJN.00430109; Aitken Grant R, 2014, BMJ Open, V4, pe005480, DOI 10.1136/bmjopen-2014-005480; [Anonymous], 2007, EQ 5D VALUE SETS INV; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Barbour SJ, 2010, NEPHROL DIAL TRANSPL, V25, P3663, DOI 10.1093/ndt/gfq189; Brothwell S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-218; Bruck K, 2015, J AM SOC NEPHROL; Campbell KL, 2008, CLIN NUTR, V27, P537, DOI 10.1016/j.clnu.2008.05.002; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Cohen SD, 2007, CLIN J AM SOC NEPHRO, V2, P919, DOI 10.2215/CJN.00820207; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finkelstein FO, 2009, KIDNEY INT, V76, P946, DOI 10.1038/ki.2009.307; Finkelstein FO, 2009, CLIN J AM SOC NEPHRO, V4, P33, DOI 10.2215/CJN.00630208; Gibbons E, 2010, STRUCTURED REV PATIE; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gorodetskaya I, 2005, KIDNEY INT, V68, P2801, DOI 10.1111/j.1523-1755.2005.00752.x; Gyamlani G, 2011, AM J MED SCI, V342, P186, DOI 10.1097/MAJ.0b013e3182113d9e; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Jain P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100831; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; Lee SJ, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0270-0; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mujais SK, 2009, CLIN J AM SOC NEPHRO, V4, P1293, DOI 10.2215/CJN.05541008; National Institute for Health and Clinical Excellence, 2008, CG73 CHRON KIDN DIS; Pagels AA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-71; Porter A, 2014, J AM SOC NEPHROL, V25, P1849, DOI 10.1681/ASN.2013080835; Porter AC, 2016, CLIN J AM SOC NEPHRO, V11, P1154, DOI 10.2215/CJN.09990915; Roshanravan B, 2012, AM J KIDNEY DIS, V60, P912, DOI 10.1053/j.ajkd.2012.05.017; Rossi AP, 2014, CLIN J AM SOC NEPHRO, V9, P2052, DOI 10.2215/CJN.11791113; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Seidel UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091176; Sharma P, 2014, J CLIN PERIODONTOL, V41, P653, DOI 10.1111/jcpe.12263; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Sud M, 2014, AM J KIDNEY DIS, V63, P928, DOI 10.1053/j.ajkd.2013.12.008; Tsai YC, 2010, NEPHROL DIAL TRANSPL, V25, P1621, DOI 10.1093/ndt/gfp671; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	41	23	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165675	10.1371/journal.pone.0165675	http://dx.doi.org/10.1371/journal.pone.0165675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832126	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000024
J	Kovanis, M; Porcher, R; Ravaud, P; Trinquart, L				Kovanis, Michail; Porcher, Raphael; Ravaud, Philippe; Trinquart, Ludovic			The Global Burden of Journal Peer Review in the Biomedical Literature: Strong Imbalance in the Collective Enterprise	PLOS ONE			English	Article							SYSTEM	The growth in scientific production may threaten the capacity for the scientific community to handle the ever-increasing demand for peer review of scientific publications. There is little evidence regarding the sustainability of the peer-review system and how the scientific community copes with the burden it poses. We used mathematical modeling to estimate the overall quantitative annual demand for peer review and the supply in biomedical research. The modeling was informed by empirical data from various sources in the biomedical domain, including all articles indexed at MEDLINE. We found that for 2015, across a range of scenarios, the supply exceeded by 15% to 249% the demand for reviewers and reviews. However, 20% of the researchers performed 69% to 94% of the reviews. Among researchers actually contributing to peer review, 70% dedicated 1% or less of their research work time to peer review while 5% dedicated 13% or more of it. An estimated 63.4 million hours were devoted to peer review in 2015, among which 18.9 million hours were provided by the top 5% contributing reviewers. Our results support that the system is sustainable in terms of volume but emphasizes a considerable imbalance in the distribution of the peer-review effort across the scientific community. Finally, various individual interactions between authors, editors and reviewers may reduce to some extent the number of reviewers who are available to editors at any point.	[Kovanis, Michail; Porcher, Raphael; Ravaud, Philippe; Trinquart, Ludovic] INSERM, U1153, Paris, France; [Kovanis, Michail; Porcher, Raphael; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Porcher, Raphael; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Paris, France; [Ravaud, Philippe; Trinquart, Ludovic] Cochrane France, Paris, France; [Ravaud, Philippe] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Columbia University	Kovanis, M (corresponding author), INSERM, U1153, Paris, France.; Kovanis, M (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	michail.kovanis@aphp.fr	ravaud, philippe/C-1694-2009; Trinquart, Ludovic/H-4961-2019; Kovanis, Michail/C-6230-2016	Trinquart, Ludovic/0000-0002-3028-4900; Kovanis, Michail/0000-0001-7783-9769; Porcher, Raphael/0000-0002-5277-4679; Ravaud, Philippe/0000-0001-8264-9206	Sorbonne Paris Cite	Sorbonne Paris Cite	Michail Kovanis is the recipient of a PhD grant from Sorbonne Paris Cite.	Alberts B, 2008, SCIENCE, V321, P15, DOI 10.1126/science.1162115; [Anonymous], 2011, PEER REV SCI PUBL, V1, P46; [Anonymous], 2014, NATURE, V514, P274, DOI DOI 10.1038/514274A; [Anonymous], 2012, NAT MAT, V11, P743; Arns M, 2014, NATURE, V515, P467, DOI 10.1038/515467a; Bollen J, 2014, EMBO REP, V15, P131, DOI 10.1002/embr.201338068; Breuning M, 2015, PS-POLIT SCI POLIT, V48, P595, DOI 10.1017/S1049096515000827; Calcagno V, 2012, SCIENCE, V338, P1065, DOI 10.1126/science.1227833; Callaham M.L., 2003, PEER REV HLTH SCI, V2nd ed., P164; Chetty R, 2014, J ECON PERSPECT, V28, P169, DOI 10.1257/jep.28.3.169; Gasparyan AY, 2015, J KOREAN MED SCI, V30, P360, DOI 10.3346/jkms.2015.30.4.360; Golden M, 2012, B AM METEOROL SOC, V93, P337, DOI 10.1175/BAMS-D-11-00129.1; Hauser M, 2007, PLOS BIOL, V5, P703, DOI 10.1371/journal.pbio.0050107; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V312, P483, DOI 10.1001/jama.2014.6932; Ismail S., 2009, EVALUATING GRANT PEE; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2786, DOI 10.1001/jama.287.21.2786; Jennings CG, 2006, NATURE PEER REV DEBA, DOI [10.1038/nature05032, DOI 10.1038/NATURE05032]; Johan Bollen, 2013, ARXIV13041067PHYSICS; Kovanis M, 2016, SCIENTOMETRICS, V106, P695, DOI 10.1007/s11192-015-1800-6; Kraus RHS, 2016, NATURE, V531, P448, DOI 10.1038/531448e; Laakso M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020961; Lerchenmueller MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158731; Lock S., 1985, DIFFICULT BALANCE ED; Look H., 2010, VALUE UK HEIS CONTRI; Moher D, 2016, EUR J CLIN INVEST, V46, P383, DOI 10.1111/eci.12612; Mulligan A, 2011, STM FRANKF C OCT 11; Mulligan A, 2013, J AM SOC INF SCI TEC, V64, P132, DOI 10.1002/asi.22798; Ott S, 2014, NATURE, V506, P295, DOI 10.1038/506295b; Park IU, 2014, NATURE, V506, P93, DOI 10.1038/nature12786; Petchey OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092896; Powell K, 2016, NATURE, V530, P148, DOI 10.1038/530148a; Rachel B, IMPACT INTERVE UNPUB; Ray R, 2007, EEE POLICY BRIEF, V3, DOI [10.1038/4681041a, DOI 10.1038/4681041A]; Rennie D, 2016, NATURE, V535, P31, DOI 10.1038/535031a; Robertson M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-18; Rockey S, 2015, UNDERSTANDING CAPACI; Rubriq, 2013, WE FOUND 15 MILL HOU; Schulz C, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0011-3; Siler K, 2015, P NATL ACAD SCI USA, V112, P360, DOI 10.1073/pnas.1418218112; Stahel PF, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0179-1; Summerskill W, 2016, LANCET, V387, P211, DOI 10.1016/S0140-6736(16)00083-0; Vines T, 2010, NATURE, V468, P1041, DOI 10.1038/4681041a; Walker R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00169; Ware Mark, 2008, Information Services & Use, V28, P109, DOI 10.3233/ISU-2008-0568; Ware Mark, 2015, COPYRIGHT FAIR USE S; Warne V, 2016, LEARN PUBL, V29, P41, DOI 10.1002/leap.1002	46	86	87	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166387	10.1371/journal.pone.0166387	http://dx.doi.org/10.1371/journal.pone.0166387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832157	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000119
J	Morzelle, MC; Salgado, JM; Telles, M; Mourelle, D; Bachiega, P; Buck, HS; Viel, TA				Morzelle, Maressa Caldeira; Salgado, Jocelem Mastrodi; Telles, Milena; Mourelle, Danilo; Bachiega, Patricia; Buck, Hudson Sousa; Viel, Tania Araujo			Neuroprotective Effects of Pomegranate Peel Extract after Chronic Infusion with Amyloid-beta Peptide in Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VITRO; COGNITIVE IMPAIRMENT; RAT-BRAIN; ANTIBACTERIAL ACTIVITY; SUPEROXIDE-DISMUTASE; NEUROTROPHIC FACTOR; TRANSGENIC MOUSE; OXIDATIVE DAMAGE; FREE-RADICALS	Alzheimer's disease is a chronic and degenerative condition that had no treatment until recently. The current therapeutic strategies reduce progression of the disease but are expensive and commonly cause side effects that are uncomfortable for treated patients. Functional foods to prevent and/or treat many conditions, including neurodegenerative diseases, represent a promising field of study currently gaining attention. To this end, here we demonstrate the effects of pomegranate (Punica granatum) peel extract (PPE) regarding spatial memory, biomarkers of neuroplasticity, oxidative stress and inflammation in a mouse model of neurodegeneration. Male C57Bl/6 mice were chronically infused for 35 days with amyloid-beta peptide 1-42 (A beta) or vehicle (control) using mini-osmotic pumps. Another group, also infused with A beta, was treated with PPE (p.o. -beta A+PPE, 800 mg/kg/day). Spatial memory was evaluated in the Barnes maze. Animals treated with PPE and in the control group exhibited a reduction in failure to find the escape box, a finding that was not observed in the A beta group. The consumption of PPE reduced amyloid plaque density, increased the expression of neurotrophin BDNF and reduced the activity of acetylcholinesterase enzyme. A reduction in lipid peroxidation and in the concentration of the pro-inflammatory cytokine TNF-alpha was also observed in the PPE group. No hepatic lesions were observed in animals treated with PPE. In conclusion, administration of pomegranate peel extract has neuroprotective effects involving multiple mechanisms to prevent establishment and progression of the neurodegenerative process induced by infusion with amyloid-beta peptide in mice.	[Morzelle, Maressa Caldeira; Salgado, Jocelem Mastrodi; Bachiega, Patricia] Univ Sao Paulo, Dept Agrifood Ind Food & Nutr, Luiz de Queiroz Coll Agr, Padua Dias Ave,POB 9, BR-13418900 Piracicaba, SP, Brazil; [Telles, Milena; Mourelle, Danilo; Viel, Tania Araujo] Univ Sao Paulo, Inst Biomed Sci, Grad Course Pharmacol, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil; [Buck, Hudson Sousa] Santa Casa Sao Paulo Sch Med Sci, Dept Physiol Sci, R Dr Cesario Motta Jr 61,111 Andar, BR-01221020 Sao Paulo, SP, Brazil; [Viel, Tania Araujo] Univ Sao Paulo, Sch Arts Sci & Humanities, Av Arlindo Bettio 1000, BR-03828080 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Viel, TA (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Grad Course Pharmacol, Ave Prof Lineu Prestes 1524, BR-05508900 Sao Paulo, Brazil.; Viel, TA (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Av Arlindo Bettio 1000, BR-03828080 Sao Paulo, SP, Brazil.	taniaviel@usp.br	Morzelle, Maressa C/N-4461-2015; Viel, Tania/K-2909-2016; Buck, Hudson/E-7664-2013	Viel, Tania/0000-0002-4015-785X; Buck, Hudson/0000-0002-1867-2441; Bachiega, Patricia/0000-0002-6517-5464	Sao Paulo Research Foundation [2013/0898-1, 2013/13656-1, 2012/12917-3]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation 2013/0898-1, 2013/13656-1 and 2012/12917-3 (www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademosun AO, 2012, J MED FOOD, V15, P428, DOI 10.1089/jmf.2011.0226; Ahmed S, 2005, J NUTR, V135, P2096, DOI 10.1093/jn/135.9.2096; Ahmed T, 2014, PHYTOTHER RES, V28, P517, DOI 10.1002/ptr.5030; Akhtar S, 2015, FOOD CHEM, V174, P417, DOI 10.1016/j.foodchem.2014.11.035; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Allen SJ, 2011, CURR NEUROPHARMACOL, V9, P559, DOI 10.2174/157015911798376190; Amaral FA, 2010, NEUROPEPTIDES, V44, P93, DOI 10.1016/j.npep.2009.10.006; BALAZS L, 1994, NEUROCHEM RES, V19, P1131, DOI 10.1007/BF00965146; Baraldi T, 2013, EXP GERONTOL, V48, P831, DOI 10.1016/j.exger.2013.05.055; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Benamar H, 2010, J BIOL SCI, V10, P100; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10256; Choi SJ, 2011, J MED FOOD, V14, P695, DOI 10.1089/jmf.2010.1452; Essa MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120964; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Franklin K., 2007, MOUSE BRAIN STEREOTA; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Gao YL, 2012, ENVIRON TOXICOL PHAR, V33, P304, DOI 10.1016/j.etap.2011.12.022; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gomez-Pinilla F, 2012, NUTR NEUROSCI, V15, P127, DOI 10.1179/1476830511Y.0000000035; Gullon B, 2016, FOOD CONTROL, V59, P94, DOI 10.1016/j.foodcont.2015.05.025; Hartman RE, 2006, NEUROBIOL DIS, V24, P506, DOI 10.1016/j.nbd.2006.08.006; Hu SQ, 2015, J MOL NEUROSCI, V55, P1014, DOI 10.1007/s12031-014-0458-5; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Iores-Marcal LM, 2006, PEPTIDES, V27, P3363, DOI 10.1016/j.peptides.2006.08.012; Johanningsmeier SD, 2011, ANNU REV FOOD SCI T, V2, P181, DOI 10.1146/annurev-food-030810-153709; Kreutz F, 2013, NEUROCHEM RES, V38, P2342, DOI 10.1007/s11064-013-1145-6; Kwak HM, 2005, ARCH PHARM RES, V28, P1328, DOI 10.1007/BF02977896; LEVIMONTALCINI R, 1987, BIOSCIENCE REP, V7, P681, DOI 10.1007/BF01116861; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Luque-Rodriguez JM, 2007, BIORESOURCE TECHNOL, V98, P2705, DOI 10.1016/j.biortech.2006.09.019; Lyras L, 1997, J NEUROCHEM, V68, P2061; Mahboubi A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0887-x; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Morris MC, 2005, AM J CLIN NUTR, V81, P508; Nunes MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142267; Oh MH, 2004, PHYTOMEDICINE, V11, P544, DOI 10.1016/j.phymed.2004.03.001; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ozcankaya R, 2002, CROAT MED J, V43, P28; Pervin M, 2014, MOLECULES, V19, P9403, DOI 10.3390/molecules19079403; Qu W, 2009, T ASABE, V52, P1997, DOI 10.13031/2013.29196; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; RICHARDSON JS, 1993, ANN NY ACAD SCI, V695, P73, DOI 10.1111/j.1749-6632.1993.tb23031.x; Rojanathammanee L, 2013, J NUTR, V143, P597, DOI 10.3945/jn.112.169516; Ryu HW, 2012, FOOD CHEM, V132, P1244, DOI 10.1016/j.foodchem.2011.11.093; Salgado JM, 2012, PLANT FOOD HUM NUTR, V67, P39, DOI 10.1007/s11130-011-0264-y; Schrag M, 2013, NEUROBIOL DIS, V59, P100, DOI 10.1016/j.nbd.2013.07.005; Schubert SY, 1999, J ETHNOPHARMACOL, V66, P11, DOI 10.1016/S0378-8741(98)00222-0; Schulz V, 2003, PHYTOMEDICINE, V10, P74, DOI 10.1078/1433-187X-00302; Seeram N, 2005, SEP PURIF TECHNOL, V41, P49, DOI 10.1016/j.seppur.2004.04.003; Small SA, 2000, MICROSC RES TECHNIQ, V51, P101, DOI 10.1002/1097-0029(20001001)51:1<101::AID-JEMT11>3.0.CO;2-H; Sorensen G, 1996, Z LEBENSM UNTERS FOR, V202, P205, DOI 10.1007/BF01263541; Spencer JPE, 2009, ARCH BIOCHEM BIOPHYS, V492, P1, DOI 10.1016/j.abb.2009.10.003; Subash S, 2015, NUTRITION, V31, P223, DOI 10.1016/j.nut.2014.06.004; Szwajgier D, 2014, POL J FOOD NUTR SCI, V64, P59, DOI 10.2478/v10222-012-0089-x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vardin H, 2012, INT J FOOD SCI TECH, V47, P167, DOI 10.1111/j.1365-2621.2011.02823.x; Venkatesan R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814068; Viel TA, 2012, CURR ALZHEIMER RES, V2011; Viel TA, 2008, NEUROBIOL AGING, V29, P1805, DOI 10.1016/j.neurobiolaging.2007.04.019; Wang DL, 2012, BIOL PHARM BULL, V35, P2128, DOI 10.1248/bpb.b12-00238; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; Yang JP, 2016, FOOD CHEM, V194, P1300, DOI 10.1016/j.foodchem.2015.08.099; Yu TX, 2015, INT J CLIN EXP PATHO, V8, P6740; ZEMLAN FP, 1989, BRAIN RES, V476, P160, DOI 10.1016/0006-8993(89)91550-3; Zhang JS, 2016, NEUROSCIENCE, V325, P1, DOI 10.1016/j.neuroscience.2016.03.024	72	45	46	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166123	10.1371/journal.pone.0166123	http://dx.doi.org/10.1371/journal.pone.0166123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829013	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300084
J	Silva, KR; Rezende, RA; Pereira, FDAS; Gruber, P; Stuart, MP; Ovsianikov, A; Brakke, K; Kasyanov, V; da Silva, JVL; Granjeiro, JM; Baptista, LS; Mironov, V				Silva, Karina R.; Rezende, Rodrigo A.; Pereira, Frederico D. A. S.; Gruber, Peter; Stuart, Mellannie P.; Ovsianikov, Aleksandr; Brakke, Ken; Kasyanov, Vladimir; da Silva, Jorge V. L.; Granjeiro, Jose M.; Baptista, Leandra S.; Mironov, Vladimir			Delivery of Human Adipose Stem Cells Spheroids into Lockyballs	PLOS ONE			English	Article							2-PHOTON POLYMERIZATION; CULTURE; SHRINKAGE; CARTILAGE; MATRICES	Adipose stem cells (ASCs) spheroids show enhanced regenerative effects compared to single cells. Also, spheroids have been recently introduced as building blocks in directed self assembly strategy. Recent efforts aim to improve long-term cell retention and integration by the use of microencapsulation delivery systems that can rapidly integrate in the implantation site. Interlockable solid synthetic microscaffolds, so called lockyballs, were recently designed with hooks and loops to enhance cell retention and integration at the implantation site as well as to support spheroids aggregation after transplantation. Here we present an efficient methodology for human ASCs spheroids biofabrication and lockyballs cellularization using micro-molded non-adhesive agarose hydrogel. Lockyballs were produced using two-photon polymerization with an estimated mechanical strength. The Young's modulus was calculated at level 0.1362 +/-0.009 MPa. Interlocking in vitro test demonstrates high level of loading induced interlockability of fabricated lockyballs. Diameter measurements and elongation coefficient calculation revealed that human ASCs spheroids biofabricated in resections of micro-molded non-adhesive hydrogel had a more regular size distribution and shape than spheroids biofabricated in hanging drops. Cellularization of lockyballs using human ASCs spheroids did not alter the level of cells viability (p > 0,999) and gene fold expression for SOX-9 and RUNX2 (p> 0,195). The biofabrication of ASCs spheroids into lockyballs represents an innovative strategy in regenerative medicine, which combines solid scaffold-based and directed self-assembly approaches, fostering opportunities for rapid in situ biofabrication of 3D building-blocks.	[Silva, Karina R.; Stuart, Mellannie P.; Granjeiro, Jose M.; Baptista, Leandra S.; Mironov, Vladimir] Natl Inst Metrol Qual & Technol Inmetro, Lab Tissue Bioengn, Rio De Janeiro, Brazil; [Silva, Karina R.; Baptista, Leandra S.] Fed Univ Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Biol Numpex Bio, Rio De Janeiro, Brazil; [Rezende, Rodrigo A.; Pereira, Frederico D. A. S.; da Silva, Jorge V. L.; Mironov, Vladimir] Renato Archer Ctr Informat Technol CTI, Div Technol 3D, Campinas, SP, Brazil; [Gruber, Peter; Ovsianikov, Aleksandr] TU Wien, Inst Mat Sci & Technol, Vienna, Austria; [Brakke, Ken] Susquehanna Univ, Dept Math, Selinsgrove, PA USA; [Kasyanov, Vladimir] Riga Stradins Univ, Riga, Latvia; [Kasyanov, Vladimir] Riga Tech Univ, Riga, Latvia; [Granjeiro, Jose M.] Univ Fed Fluminense, Bioengn Lab, Rio De Janeiro, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Technische Universitat Wien; Susquehanna University; Riga Stradins University; Riga Technical University; Universidade Federal Fluminense	Baptista, LS; Mironov, V (corresponding author), Natl Inst Metrol Qual & Technol Inmetro, Lab Tissue Bioengn, Rio De Janeiro, Brazil.; Baptista, LS (corresponding author), Fed Univ Rio de Janeiro Xerem, Nucleus Multidisciplinary Res Biol Numpex Bio, Rio De Janeiro, Brazil.; Mironov, V (corresponding author), Renato Archer Ctr Informat Technol CTI, Div Technol 3D, Campinas, SP, Brazil.	leandra.baptista@gmail.com; vladmir.mironov54@gmail.com	Mironov, Vladimir/AAC-5926-2022; da Silva, Jorge Vicente Lopes/C-8502-2012; Baptista, Leandra/D-4259-2013; Granjeiro, Jose/D-8289-2012; Ovsianikov, Aleksandr/K-8128-2015	da Silva, Jorge Vicente Lopes/0000-0002-2347-5215; Baptista, Leandra/0000-0001-9998-8044; Granjeiro, Jose/0000-0002-8027-8293; Kasyanovs, Vladimirs/0000-0003-4411-1020; Ribeiro Silva, Karina/0000-0001-7394-2494; Ovsianikov, Aleksandr/0000-0001-5846-0198	MCTI/CNPq/CT-Saude/CT-Biotecnologia/MS/SCTIE/DECIT-Novas Terapias Portadoras de Futuro [CNPq-457541/2013-0-47/2013]; European Research Council [307701]; CNPq Regenerative Medicine [467643/2014-8]; Brazilian Institute of Biofabrication (INCT-BIOFABRIS) [08/57860-3]	MCTI/CNPq/CT-Saude/CT-Biotecnologia/MS/SCTIE/DECIT-Novas Terapias Portadoras de Futuro; European Research Council(European Research Council (ERC)European Commission); CNPq Regenerative Medicine; Brazilian Institute of Biofabrication (INCT-BIOFABRIS)	This work was funded by CNPq-457541/2013-0-Chamada No 47/2013 MCTI/CNPq/CT-Saude/CT-Biotecnologia/MS/SCTIE/DECIT-Novas Terapias Portadoras de Futuro to JMG; European Research Council (Starting Grant 307701) to AO; CNPq Regenerative Medicine project 467643/2014-8 to JVLS; and Brazilian Institute of Biofabrication (INCT-BIOFABRIS) 08/57860-3 to JVLS.	Achilli TM, 2014, MOL PHARMACEUT, V11, P2071, DOI 10.1021/mp500002y; Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066; Baptista LS, 2009, CYTOTHERAPY, V11, P706, DOI 10.3109/14653240902981144; Baraniak PR, 2012, J MECH BEHAV BIOMED, V11, P63, DOI 10.1016/j.jmbbm.2012.02.018; Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035; Caplan AI, 2015, STEM CELL TRANSL MED, V4, P695, DOI 10.5966/sctm.2014-0291; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; Danilevicius P, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4922646; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Guven S, 2015, TRENDS BIOTECHNOL, V33, P269, DOI 10.1016/j.tibtech.2015.02.003; Kelm JM, 2010, ADV DRUG DELIVER REV, V62, P753, DOI 10.1016/j.addr.2010.02.003; Kelm JM, 2010, J BIOTECHNOL, V148, P46, DOI 10.1016/j.jbiotec.2010.03.002; Kinney MA, 2014, ANN BIOMED ENG, V42, P352, DOI 10.1007/s10439-013-0953-9; Kirn TG, 2010, ADV FUNCT MATER, V20, P2303, DOI 10.1002/adfm.201000458; Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]; Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Oliveira MB, 2011, BIOTECHNOL PROGR, V27, P897, DOI 10.1002/btpr.618; Oubaha M, 2011, J MATER SCI, V46, P400, DOI 10.1007/s10853-010-4853-1; Ovsianikov A, 2012, EXPERT REV MED DEVIC, V9, P613, DOI [10.1586/ERD.12.48, 10.1586/erd.12.48]; Ovsianikov A, 2008, ACS NANO, V2, P2257, DOI 10.1021/nn800451w; Ovsianikov A, 2009, OPT EXPRESS, V17, P2143, DOI 10.1364/OE.17.002143; Paul A, 2009, REGEN MED, V4, P733, DOI 10.2217/RME.09.43; Przybyt E, 2013, CURR STEM CELL RES T, V8, P270, DOI 10.2174/1574888X11308040002; Rago AP, 2009, BIOTECHNOL BIOENG, V102, P1231, DOI 10.1002/bit.22162; Raimondi MT, 2013, ACTA BIOMATER, V9, P4579, DOI 10.1016/j.actbio.2012.08.022; Raimondi MT, 2012, J APPL BIOMATER FUNC, V10, P56, DOI 10.5301/JABFM.2012.9278; Rezende RA, 2012, VIRTUAL PHYS PROTOTY, V7, P287, DOI 10.1080/17452759.2012.740877; Schon BS, 2012, CELL TISSUE RES, V347, P629, DOI 10.1007/s00441-011-1311-6; Svoronos AA, 2014, TISSUE ENG PT A, V20, P1134, DOI [10.1089/ten.TEA.2013.0297, 10.1089/ten.tea.2013.0297]; Wang HA, 2012, TISSUE ENG PART B-RE, V18, P24, DOI [10.1089/ten.teb.2011.0184, 10.1089/ten.TEB.2011.0184]	36	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166073	10.1371/journal.pone.0166073	http://dx.doi.org/10.1371/journal.pone.0166073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829016	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300079
J	Yoon, S; Kim, SY; Nam, D				Yoon, Sora; Kim, Seon-Young; Nam, Dougu			Improving Gene-Set Enrichment Analysis of RNA-Seq Data with Small Replicates	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; BIOCONDUCTOR PACKAGE; NORMALIZATION; TOOLS	Deregulated pathways identified from transcriptome data of two sample groups have played a key role in many genomic studies. Gene-set enrichment analysis (GSEA) has been commonly used for pathway or functional analysis of microarray data, and it is also being applied to RNA-seq data. However, most RNA-seq data so far have only small replicates. This enforces to apply the gene-permuting GSEA method (or preranked GSEA) which results in a great number of false positives due to the inter-gene correlation in each gene-set. We demonstrate that incorporating the absolute gene statistic in one-tailed GSEA considerably improves the false-positive control and the overall discriminatory ability of the gene-permuting GSEA methods for RNA-seq data. To test the performance, a simulation method to generate correlated read counts within a gene-set was newly developed, and a dozen of currently available RNA-seq enrichment analysis methods were compared, where the proposed methods outperformed others that do not account for the inter-gene correlation. Analysis of real RNA-seq data also supported the proposed methods in terms of false positive control, ranks of true positives and biological relevance. An efficient R package (AbsFilterG-SEA) coded with C++ (Rcpp) is available from CRAN.	[Yoon, Sora; Nam, Dougu] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Kim, Seon-Young] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Daejeon, South Korea; [Kim, Seon-Young] Univ Sci & Technol, Dept Bioinformat, Daejeon, South Korea; [Nam, Dougu] Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Ulsan National Institute of Science & Technology (UNIST)	Nam, D (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea.; Nam, D (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Math Sci, Ulsan, South Korea.	dougnam@unist.ac.kr	Nam, Dougu/F-5057-2010; Nam, Dougu/AAC-7173-2019; Nam, Dougu/AAA-4046-2019	Nam, Dougu/0000-0003-0239-2899; Nam, Dougu/0000-0003-0239-2899; Yoon, Sora/0000-0002-0107-0057	National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning, KRIBB Research Initiative [NRF-2014M3C9A3068554, 2014M3C9A3068555]; Basic Science Research Program through a National Research Foundation (NRF) - Korean government (MOE) [2014R1A1A2056353]	National Research Foundation (NRF) - Ministry of Science, ICT, and Future Planning, KRIBB Research Initiative; Basic Science Research Program through a National Research Foundation (NRF) - Korean government (MOE)	The genomics programs (NRF-2014M3C9A3068554 and 2014M3C9A3068555) of the National Research Foundation (NRF, http://www.nrf.re.kr/) of Korea, funded by the Ministry of Science, ICT, and Future Planning, the KRIBB Research Initiative. Basic Science Research Program through a National Research Foundation (NRF) grants funded by the Korean government (MOE) (2014R1A1A2056353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barry WT, 2008, ANN APPL STAT, V2, P286, DOI 10.1214/07-AOAS146; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang H, 2001, BIOTECHNIQUES, V31, P38, DOI 10.2144/01311bm05; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kovalchik S., 2015, RISmed: Download Content from NCBI Databases. R package version 2.1.5; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee C, 2016, BIOINFORMATICS, V32, P1100, DOI 10.1093/bioinformatics/btv694; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nam D, 2017, STAT METHODS MED RES, V26, P1248, DOI 10.1177/0962280215574014; Nam D, 2010, BIOINFORMATICS, V26, pi511, DOI 10.1093/bioinformatics/btq380; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; R Core Team, 2013, R LANG ENV STAT COMP; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; Schwarz JK, 2012, CLIN CANCER RES, V18, P1464, DOI 10.1158/1078-0432.CCR-11-2485; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang X, 2014, BIOINFORMATICS, V30, P1777, DOI 10.1093/bioinformatics/btu090; Wang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S16; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Xiong Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep06347; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	48	9	9	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165919	10.1371/journal.pone.0165919	http://dx.doi.org/10.1371/journal.pone.0165919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829002	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300067
J	Alam, M; Ihsan, A; Khan, MA; Javaid, Q; Khan, A; Manzoor, J; Akhundzada, A; Khan, MK; Farooq, S				Alam, Masoom; Ihsan, Asif; Khan, Muazzam A.; Javaid, Qaisar; Khan, Abid; Manzoor, Jawad; Akhundzada, Adnan; Khan, M. Khurram; Farooq, Sajid			Optimizing SIEM Throughput on the Cloud Using Parallelization	PLOS ONE			English	Article							EVENT	Processing large amounts of data in real time for identifying security issues pose several performance challenges, especially when hardware infrastructure is limited. Managed Security Service Providers (MSSP), mostly hosting their applications on the Cloud, receive events at a very high rate that varies from a few hundred to a couple of thousand events per second (EPS). It is critical to process this data efficiently, so that attacks could be identified quickly and necessary response could be initiated. This paper evaluates the performance of a security framework OSTROM built on the Esper complex event processing (CEP) engine under a parallel and non-parallel computational framework. We explain three architectures under which Esper can be used to process events. We investigated the effect on throughput, memory and CPU usage in each configuration setting. The results indicate that the performance of the engine is limited by the number of events coming in rather than the queries being processed. The architecture where 1/4th of the total events are submitted to each instance and all the queries are processed by all the units shows best results in terms of throughput, memory and CPU usage.	[Alam, Masoom; Khan, Abid; Manzoor, Jawad; Akhundzada, Adnan; Farooq, Sajid] COMSATS Inst Informat Technol, Dept Comp Sci, Islamabad, Pakistan; [Ihsan, Asif] Trillium Informat Secur Syst, Rawalpindi, Pakistan; [Khan, Muazzam A.] Natl Univ Sci & Technol, NUST Coll EME, Islamabad, Pakistan; [Javaid, Qaisar] Int Islamic Univ, Dept Comp Sci, Islamabad, Pakistan; [Khan, M. Khurram] King Saud Univ, Riyadh, Saudi Arabia	COMSATS University Islamabad (CUI); National University of Sciences & Technology - Pakistan; International Islamic University, Pakistan; King Saud University	Alam, M (corresponding author), COMSATS Inst Informat Technol, Dept Comp Sci, Islamabad, Pakistan.	masoom.alam@comsats.edu.pk	KHAN, MUHAMMAD KHURRAM/E-4836-2014; Khattak, Muazzam A. Khan/AAF-1494-2020; Akhunzada, Adnan/O-2186-2016	KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533; Khattak, Muazzam A. Khan/0000-0001-6140-1201; Akhunzada, Adnan/0000-0001-8370-9290; Khan, Abid/0000-0003-2712-1956	Deanship of Scientific Research at King Saud University [PRG-1436-16]; Trillium Information Security Systems, Rawalpindi, Pakistan	Deanship of Scientific Research at King Saud University(King Saud University); Trillium Information Security Systems, Rawalpindi, Pakistan	The authors extend their sincere appreciations to the Deanship of Scientific Research at King Saud University for its funding this Prolific Research Group (PRG-1436-16). Al received funding in the form of salary from commercial company Trillium Information Security Systems, Rawalpindi, Pakistan, during this study. The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of co-author Al are articulated in the 'author contributions' section.	Akoglu L., 2013, P 6 ACM INT C WEB SE, P773, DOI DOI 10.1145/2433396.2433496; Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Amoroso EG, 2011, CYBER ATTACKS: PROTECTING NATIONAL INFRASTRUCTURE, P1; Barros A, 2007, LECT NOTES COMPUT SC, V4422, P245; Bulow S., 2013, LNBIP, P277, DOI DOI 10.1007/978-3-319-06257-0_22; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Cammert M, 2016, U. S. Patent No, Patent No. [9,286,354, 9286354]; Cerullo G, 2016, STUD COMPUT INTELL, V616, P427, DOI 10.1007/978-3-319-25017-5_40; Cezar A, 2014, MANAGE SCI, V60, P638, DOI 10.1287/mnsc.2013.1763; Choras M, 2010, WEBIST 2010: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS AND TECHNOLOGY, VOL 1, P171; Cordeschi N, 2013, COMPUT NETW, V57, P3479, DOI 10.1016/j.comnet.2013.08.002; Dayarathna Miyuru, 2013, Quantitative Evaluation of Systems. 10th International Conference, QEST 2013. Proceedings: LNCS 8054, P225, DOI 10.1007/978-3-642-40196-1_19; Dunren Che, 2013, Database Systems for Advanced Applications. 18th International Conference, DASFAA 2013. International Workshops: BDMA, SNSM, SeCop. Proceedings: LNCS 7827, P1, DOI 10.1007/978-3-642-40270-8_1; Fulop Lajos Jeno, 2010, P BCI CIT, P26; Grabs T, 2011, LNCS, P83; Guofei G, 2008, P 15 ANN NETW DISTR; Hayes Michael A, 2015, J BIG DATA, V2, P2, DOI [DOI 10.1186/S40537-014-0011-Y, 10.1186/s40537-014-0011-y]; Jose A G, 2016, J COMPUTER SCI TECHN, V16; Ku M, 2014, INT J COMMUN SYST, V27, P898, DOI 10.1002/dac.2734; Kuboi S, 2014, 2014 IIAI 3RD INTERNATIONAL CONFERENCE ON ADVANCED APPLIED INFORMATICS (IIAI-AAI 2014), P190, DOI 10.1109/IIAI-AAI.2014.48; Kumar H, 2013, J NONLINEAR OPT PHYS, V22, DOI 10.1142/S021886351350001X; Li CH, 2014, LECT NOTES COMPUT SC, V8391, P125, DOI 10.1007/978-3-319-04936-6_9; Luigi C, 2013, ENH SIEM TECHN PROT, P10; Mendes MRN, 2009, LECT NOTES COMPUT SC, V5895, P221, DOI 10.1007/978-3-642-10424-4_16; Miller D. R., 2010, SECURITY INFORM EVEN; Najafabadi M.M., 2015, J BIG DATA-GER, V2, DOI [10.1186/s40537-014-0007-7, DOI 10.1186/S40537-014-0007-7]; Nepal S, 2011, CLOUD COMP CLOUD 201; Roland R., 2015, J WIREL MOB NETW UBI, V6, P21; Roland R, 2014, 2014 22 EUR INT C PA; Rudige G., 2015, THESIS; Seiger R, 2018, SOFTW SYST MODEL, V17, P551, DOI 10.1007/s10270-016-0551-z; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Singh Dilpreet, 2015, J Big Data, V2, P8; Solaimani M, 2014, 2014 IEEE 15TH INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION (IRI), P458, DOI 10.1109/IRI.2014.7051925; Suad S, P 10 ACM INT C DISTR, P281; Wei H., 2013, LECT NOTES ELECT ENG, V206, P269; Wei W, IMPERFECT INFORM DYN; Wen H., 2010, JISUANJI YINGYONG YU, V27, P60; White S., 2008, P 2 INT C DISTR EV B, P193; Wrench C, 2016, ADV BUS INFORM SYST, P24, DOI 10.4018/978-1-5225-0293-7.ch003; Zuech R., 2015, J BIG DATA, V2, P3, DOI DOI 10.1186/S40537-015-0013-4	41	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0162746	10.1371/journal.pone.0162746	http://dx.doi.org/10.1371/journal.pone.0162746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851762	gold, Green Published			2022-12-27	WOS:000387909300002
J	Chen, B; Dai, DN; Tang, HL; Ai, XH; Chen, X; Zhang, XY; Li, ZY; Xie, XM				Chen, Bo; Dai, Danian; Tang, Hailin; Ai, Xiaohong; Chen, Xi; Zhang, Xiaoyan; Li, Zhiyan; Xie, Xiaoming			Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; ANEMIA; IMPACT; ERYTHROPOIETIN; HYPOXIA; CARCINOMA; SURVIVAL; LEVEL	Background Anemia usually refers to low hemoglobin (Hb) levels. Previous studies indicated that anemia negatively influence the survival in various cancers. Hematocrit (HCT) is the volume percentage of red blood cells in blood, which could indicate anemia in both individuals and populations. This study compared the value of HCT with that of Hb for predicting outcomes of patients who underwent treatment for triple negative breast cancer (TNBC). Methods A retrospective study of 293 triple negative breast cancer patients, accepting treatment from January 2004 to December 2009 at Sun Yat-sen University Cancer Center, was conducted. Kaplan-Meier curves and multivariate Cox proportional models were used to calculate disease free survival (DFS) and overall survival (OS). Results The cut-off value of HCT was 35.9% determined by X-tile software analysis. The cut-off value of Hb was 12.0 g/dl based on the World Health Organization (WHO) criteria. In univariate analysis, low HCT and low Hb were both significantly associated with decreased DFS and OS. In multivariate analysis, HCT (HR: 0.570; 95% CI: 0.331-0.981, P = 0.042 for DFS; HR: 0.456; 95% CI: 0.256-0.813, P = 0.008 for OS) was still identified as independent predictor of outcome, but not Hb. Conclusion Pretreatment low HCT is independently associated with poor prognosis in TNBC patients. However, HCT was found to be superior to Hb in terms of predicting breast cancer mortality.In the future, large-scale prospective studies or validation studies are needed to verify our findings.	[Chen, Bo; Dai, Danian; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Ai, Xiaohong] Univ South China, Affiliated Hosp 1, Dept Radiotherapy, Hengyang, Hunan, Peoples R China; [Chen, Xi] Univ South China, Coll Med, Dept Anat, Hengyang, Hunan, Peoples R China; [Zhang, Xiaoyan; Li, Zhiyan] Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang, Hunan, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; University of South China; University of South China; University of South China	Xie, XM (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China.	xiexm@sysucc.org.cn			National Natural Science Foundation of China [81472575, 81272514, 81372133, 81472469]; Science and Technology Planning Projects of Guangdong and Guangzhou [2014J4100169, 20136060300009, 20156020211002, 20156090901050, 2014A020212079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Projects of Guangdong and Guangzhou	This work was supported by funds from the National Natural Science Foundation of China (81472575, 81272514 and 81372133 to X. Xie; 81472469 to H. Tang), the Science and Technology Planning Projects of Guangdong and Guangzhou (2014J4100169 to H. Tang; 20136060300009, 20156020211002, 20156090901050 and 2014A020212079 to X. Xie).	Barkati M, 2013, INT J GYNECOL CANCER, V23, P724, DOI 10.1097/IGC.0b013e31828a0623; Bissinger R, 2016, ONCOTARGET; Boehm DU, 2007, ANTICANCER RES, V27, P1223; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; DUNPHY EP, 1989, INT J RADIAT ONCOL, V16, P1173, DOI 10.1016/0360-3016(89)90277-0; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Erkut N, 2015, CANCER BIOMARK, V15, P559, DOI 10.3233/CBM-150495; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Grogan M, 1999, CANCER, V86, P1528, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E; Habler OP, 2000, ADV DRUG DELIVER REV, V40, P171, DOI 10.1016/S0169-409X(99)00048-4; Hartz A, 2012, CANCER CAUSE CONTROL, V23, P1599, DOI 10.1007/s10552-012-0037-4; Hu Kenneth, 2005, Curr Treat Options Oncol, V6, P31, DOI 10.1007/s11864-005-0011-4; Kadri Z, 2015, GENE DEV, V29, P2603, DOI 10.1101/gad.267633.115; Keen M L, 1998, ANNA J, V25, P83; Kemal Y, 2015, CLIN CHEM LAB MED, V53, P823, DOI 10.1515/cclm-2014-0699; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Koma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080240; Kozak MM, 2017, AM J CLIN ONCOL-CANC, V40, P405, DOI 10.1097/COC.0000000000000183; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lim Soyi, 2014, Obstet Gynecol Sci, V57, P471, DOI 10.5468/ogs.2014.57.6.471; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Metzger ML, 2008, J CLIN ONCOL, V26, P1282, DOI 10.1200/JCO.2007.14.0699; Ortega Seda Carlos Javier, 2011, Archivos Espanoles de Urologia, V64, P883; Rodriguez-Morales AJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-166; Schwartz RN, 2007, AM J HEALTH-SYST PH, V64, pS5, DOI 10.2146/ajhp060601; Shamseddine A, 1998, EUR J GYNAECOL ONCOL, V19, P591; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun JF, 2012, EXP MOL MED, V44, P674, DOI 10.3858/emm.2012.44.11.076; Szkandera J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107297; van de Nieuwenhof HP, 2010, VIRCHOWS ARCH, V457, P693, DOI 10.1007/s00428-010-0981-x; van de Pol SMG, 2006, ORAL ONCOL, V42, P131, DOI 10.1016/j.oraloncology.2005.06.021; van Rensburg S J, 1983, Nutr Cancer, V4, P206, DOI 10.1080/01635588209513759; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Wan GX, 2016, CLIN CHIM ACTA, V452, P199, DOI 10.1016/j.cca.2015.11.025; Wang C, 2015, CANCER CAUSE CONTROL, V26, P45, DOI 10.1007/s10552-014-0481-4; Zhang YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-844; Zheng R, 2015, CANC LETT; Zhu WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136268	40	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165133	10.1371/journal.pone.0165133	http://dx.doi.org/10.1371/journal.pone.0165133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851755	Green Submitted, gold, Green Published			2022-12-27	WOS:000387909300011
J	Korvel-Hanquist, A; Koch, A; Niclasen, J; Dammeye, J; Lous, J; Olsen, SF; Homoe, P				Korvel-Hanquist, Asbjorn; Koch, Anders; Niclasen, Janni; Dammeye, Jesper; Lous, Jorgen; Olsen, Sjurdur Frodi; Homoe, Preben			Risk Factors of Early Otitis Media in the Danish National Birth Cohort	PLOS ONE			English	Article							SYNCYTIAL VIRUS-INFECTION; PARENT-REPORTED SYMPTOMS; YOUNG-CHILDREN; ONSET; INFANTS; EXPOSURE; EFFUSION; EPIDEMIOLOGY; ANTIBIOTICS; EFFICACY	Objective To assess risk factors of otitis media (OM) in six-months-old children. Method The sample consisted of 69,105 mothers and their children from the Danish National Birth Cohort. The women were interviewed twice during pregnancy and again 6 months after birth. The outcome "one or more" maternal reported episodes of OM at age six months. In total 37 factors were assessed, covering prenatal, maternal, perinatal and postnatal factors. Results At age six months 5.3% (95% CI 5.1-5.5) of the children had experienced one or more episodes of OM. From the regression analysis, 11 variables were associated with a risk of OM. When a Bonferroni correction was introduced, gender, prematurity, parity, maternal age, maternal self-estimated health, taking penicillin during pregnancy, and terminating breast-feeding before age six months, was associated with a risk of early OM. The adjusted ORs of OM for boys versus girls was 1.30 (95% CI 1.18-1.44). The OR having one sibling versus no siblings was 3.0 (95% CI 2.64-3.41). If the woman had been taking penicillin during pregnancy, the OR was 1.35 (95% CI 1.15-1.58). Children born before 38 th gestational week had an increased OR for early OM of 1.49 (95% CI 1.21-1.82). Children of young women had an increased OR of early OM compared to children of older women. Additionally, children of women who rated their own health low compared to those rating their health as high, had an increased OR of 1.38 (95% CI 1.10-1.74). Finally, children being breastfeed less than 6 months, had an increased OR of 1.42 (95% CI 1.28-1.58) compared to children being breastfeed beyond 6 months. Conclusion These findings indicate that prenatal factors are of less importance regarding early OM before the age of six months. Postnatal risk factors seem to pose the main risk of early OM.	[Korvel-Hanquist, Asbjorn; Homoe, Preben] Zealand Univ Hosp, Dept Otorhinolaryngol & Maxillofacial Surg, Koge, Denmark; [Koch, Anders] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Koch, Anders] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark; [Niclasen, Janni; Dammeye, Jesper] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Niclasen, Janni] Aarhus Univ, Ctr Collaborat Hlth, Aarhus, Denmark; [Lous, Jorgen] Univ Southern Denmark, Res Unit Gen Practice, Inst Publ Hlth, Odense, Denmark; [Olsen, Sjurdur Frodi] Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol Res, Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut; University of Copenhagen; Aarhus University; University of Southern Denmark; Statens Serum Institut	Korvel-Hanquist, A (corresponding author), Zealand Univ Hosp, Dept Otorhinolaryngol & Maxillofacial Surg, Koge, Denmark.	Asbp@regionsjaelland.dk		Koch, Anders/0000-0001-9205-1048; Homoe, Preben/0000-0003-2877-3518; Dammeyer, Jesper/0000-0001-6753-8516; Korvel-Hanquist, Asbjorn/0000-0002-6645-1926; Olsen, Sjurdur/0000-0003-3017-7096	Region Zealand Research Foundation [12-000095, 13-00835]; Oticon Foundation [14-3586]; Danish National Research Foundation; Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation	Region Zealand Research Foundation; Oticon Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation	The study was funded by the Region Zealand Research Foundation (Grant ref 12-000095 and 13-00835) and the Oticon Foundation (14-3586). The Danish National Birth Cohort was funded by The Danish National Research Foundation, the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation.; The Danish National Research Foundation has established the Danish Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this Foundation. Additional support for the Danish National Birth Cohort is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation.	Aarhus L, 2014, EAR HEAR; ALHO OP, 1990, AM J EPIDEMIOL, V132, P1164, DOI 10.1093/oxfordjournals.aje.a115759; ALHO OP, 1990, INT J PEDIATR OTORHI, V19, P151, DOI 10.1016/0165-5876(90)90221-C; Rodriguez DA, 2014, PEDIATR PULM, V49, P269, DOI 10.1002/ppul.22781; [Anonymous], 2005, INTERNET J EPIDEMIOL; Azab SN, 2014, INT J PEDIATR OTORHI, V78, P670, DOI 10.1016/j.ijporl.2014.01.033; Bentdal YE, 2010, INT J PEDIATR OTORHI, V74, P168, DOI 10.1016/j.ijporl.2009.11.001; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brennan-Jones CG, 2015, J PAEDIATR CHILD H, V51, P403, DOI 10.1111/jpc.12741; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Daly KA, 1999, PEDIATRICS, V103, P1158, DOI 10.1542/peds.103.6.1158; Daly KA, 2007, AM J PUBLIC HEALTH, V97, P317, DOI 10.2105/AJPH.2004.052837; Daly KA, 2010, INT J PEDIATR OTORHI, V74, P231, DOI 10.1016/j.ijporl.2009.09.006; Engel J, 2000, SCAND J PRIM HEALTH, V18, P25; Engel JAM, 1999, CLIN OTOLARYNGOL, V24, P417, DOI 10.1046/j.1365-2273.1999.00281.x; Engel JAM, 2005, INT J PEDIATR OTORHI, V69, P533, DOI 10.1016/j.ijporl.2004.11.026; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Flynn T, 2009, INT J PEDIATR OTORHI, V73, P1441, DOI 10.1016/j.ijporl.2009.07.015; Fortanier AC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub4; Greene N, 2011, EPIDEMIOLOGY, V22, P815, DOI 10.1097/EDE.0b013e31822939fd; Gunville CF, 2010, J PEDIATR-US, V157, P209, DOI 10.1016/j.jpeds.2010.02.006; Haberg SE, 2010, ACTA PAEDIATR, V99, P99, DOI 10.1111/j.1651-2227.2009.01506.x; Hogan A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-65; Jackson C, 1995, HOUSEHOLDS UNPAID WO; Jacobsen TN, 2010, EUR J EPIDEMIOL, V25, P349, DOI 10.1007/s10654-010-9448-2; Jensen RG, 2013, ENVIRON INT, V54, P112, DOI 10.1016/j.envint.2013.01.015; Jones LL, 2012, ARCH PEDIAT ADOL MED, V166, P18, DOI 10.1001/archpediatrics.2011.158; Kayhty H, 2005, PEDIATR INFECT DIS J, V24, P108, DOI 10.1097/01.inf.0000151022.92222.be; Kvestad E, 2006, INT J PEDIATR OTORHI, V70, P597, DOI 10.1016/j.ijporl.2005.08.005; Lasisi AO, 2008, EUR ARCH OTO-RHINO-L, V265, P765, DOI 10.1007/s00405-007-0544-1; Lieu JEC, 2002, ARCH PEDIAT ADOL MED, V156, P147, DOI 10.1001/archpedi.156.2.147; MacIntyre EA, 2010, PAED CHILD HEALT-CAN, V15, P437, DOI 10.1093/pch/15.7.437; Maruthy S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-17; Miyashita C, 2011, ENVIRON RES, V111, P551, DOI 10.1016/j.envres.2011.01.021; Niclasen J, 2016, INT J PEDIATR OTORHI, V84, P12, DOI 10.1016/j.ijporl.2016.02.017; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen J, 2014, NOR EPIDEMIOL, V24; Otters HBM, 2004, J ANTIMICROB CHEMOTH, V53, P361, DOI 10.1093/jac/dkh062; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Pettigrew MM, 2004, PAEDIATR PERINAT EP, V18, P441, DOI 10.1111/j.1365-3016.2004.00596.x; Pottegard A, 2015, PEDIATR INFECT DIS J, V34, pE16, DOI 10.1097/INF.0000000000000519; Rvachew S, 1999, J ACOUST SOC AM, V105, P467, DOI 10.1121/1.424575; Sarpong EM, 2015, HEALTH SERV RES, V50, P830, DOI 10.1111/1475-6773.12260; Simon A, 2007, EUR J PEDIATR, V166, P1273, DOI 10.1007/s00431-007-0426-y; Speets AM, 2011, SCAND J PUBLIC HEALT, V39, P137, DOI 10.1177/1403494810393553; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Todberg T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111732; Uhari M, 1996, CLIN INFECT DIS, V22, P1079, DOI 10.1093/clinids/22.6.1079; Ventola C Lee, 2015, P T, V40, P277; Vernacchio L, 2007, J AM BOARD FAM MED, V20, P160, DOI 10.3122/jabfm.2007.02.060125; Winskel H, 2006, BRIT J EDUC PSYCHOL, V76, P727, DOI 10.1348/000709905X68312; Yiengprugsawan V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-28	55	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166465	10.1371/journal.pone.0166465	http://dx.doi.org/10.1371/journal.pone.0166465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851778	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300053
J	Nadimpalli, M; Stewart, JR; Pierce, E; Pisanic, N; Love, DC; Hall, D; Larsen, J; Carroll, KC; Tekle, T; Perl, TM; Heaney, CD				Nadimpalli, Maya; Stewart, Jill R.; Pierce, Elizabeth; Pisanic, Nora; Love, David C.; Hall, Devon; Larsen, Jesper; Carroll, Karen C.; Tekle, Tsigereda; Perl, Trish M.; Heaney, Christopher D.			Livestock-Associated, Antibiotic-Resistant Staphylococcus aureus Nasal Carriage and Recent Skin and Soft Tissue Infection among Industrial Hog Operation Workers	PLOS ONE			English	Article							LACERATION INJURIES; PUBLIC-HEALTH; CC398; MRSA; IDENTIFICATION; COLONIZATION; TETRACYCLINE; TRANSMISSION; CONFIRMATION; PERSISTENCE	Swine production work is a risk factor for nasal carriage of livestock-associated (LA-) Staphylococcus aureus and also for skin and soft tissue infection (SSTI). However, whether LA-S. aureus nasal carriage is associated with increased risk of SSTI remains unclear. We aimed to examine S. aureus nasal carriage and recent (<= 3 months prior to enrollment) SSTI symptoms among industrial hog operation (IHO) workers and their household contacts. IHO workers and their household contacts provided a nasal swab and responded to a questionnaire assessing self-reported personal and occupational exposures and recent SSTI symptoms. Nasal swabs were analyzed for S. aureus, including methicillin-resistant S. aureus (MRSA), multidrug-resistant-S. aureus (MDRSA), absence of scn (livestock association), and spa type. S. aureus with at least one indicator of LA was observed among 19% of 103 IHO workers and 6% of 80 household members. Prevalence of recent SSTI was 6% among IHO workers and 11% among 54 minor household members (0/26 adult household members reported SSTI). Among IHO workers, nasal carriers of MDRSA and scn-negative S. aureus were 8.8 (95% CI: 1.8, 43.9) and 5.1 (95% CI: 1.2, 22.2) times as likely to report recent SSTI as non-carriers, respectively. In one household, both an IHO worker and child reported recent SSTI and carried the same S. aureus spa type (t4976) intranasally. Prevalence of scn-negative S. aureus (PR: 5.0, 95% CI: 1.2, 21.4) was elevated among IHO workers who reported never versus always wearing a face mask at work. Although few SSTI were reported, this study of IHO workers and their household contacts is the first to characterize a relation between nasal carriage of antibiotic-resistant LA-S. aureus and SSTI. The direction and temporality of this relation and IHO workers' use of face masks to prevent nasal carriage of these bacteria warrant further investigation.	[Nadimpalli, Maya; Stewart, Jill R.; Pierce, Elizabeth] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Pisanic, Nora; Love, David C.; Heaney, Christopher D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA; [Love, David C.] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD USA; [Hall, Devon] Rural Empowerment Assoc Community Help, Warsaw, NC USA; [Larsen, Jesper] Statens Serum Inst, Microbiol & Infect Control, Copenhagen, Denmark; [Carroll, Karen C.] Johns Hopkins Univ, Sch Med, Div Med Microbiol, Baltimore, MD USA; [Carroll, Karen C.; Tekle, Tsigereda] Johns Hopkins Univ Hosp, Microbiol Lab, Baltimore, MD 21287 USA; [Perl, Trish M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Perl, Trish M.; Heaney, Christopher D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Statens Serum Institut; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Heaney, CD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA.; Heaney, CD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cheaney1@jhu.edu	Larsen, Jesper/AAJ-3161-2021; Stewart, Jill/T-6862-2018	Larsen, Jesper/0000-0003-0582-0457; Stewart, Jill/0000-0002-3474-5233; Pisanic, Nora/0000-0002-0042-9232	National Institute for Occupational Health and Safety (NIOSH) [1K010H010193-01A1]; Johns Hopkins NIOSH Education and Research Center; Johns Hopkins Center fora Livable Future from the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program at the Johns Hopkins University [018HEA2013]; School of Medicine; Department of Medicine; Division of Infectious Diseases; NSF, NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program [1316318]; National Institute of Environmental Health Sciences [5T32ES007141-30]; Royster Society fellowship; EPA Science to Achieve Results fellowship; GRACE Communications Foundation; National Institute of Allergy and Infectious Diseases [1R01A1101371-01A1]; NIOSH [1K010H010193-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER; Division Of Environmental Biology [1316318] Funding Source: National Science Foundation	National Institute for Occupational Health and Safety (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Johns Hopkins NIOSH Education and Research Center; Johns Hopkins Center fora Livable Future from the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program at the Johns Hopkins University; School of Medicine; Department of Medicine; Division of Infectious Diseases; NSF, NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Royster Society fellowship; EPA Science to Achieve Results fellowship; GRACE Communications Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this study was provided by National Institute for Occupational Health and Safety (NIOSH) grant 1K010H010193-01A1, the Johns Hopkins NIOSH Education and Research Center, a directed research award from the Johns Hopkins Center fora Livable Future, Award 018HEA2013 from the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program at the Johns Hopkins University, School of Medicine, Department of Medicine, Division of Infectious Diseases, and NSF grant 1316318 as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. NP was supported by National Institute of Environmental Health Sciences award no. 5T32ES007141-30. MN was supported by a Royster Society fellowship and an EPA Science to Achieve Results fellowship. DL was supported by a gift from the GRACE Communications Foundation. JL was supported by the National Institute of Allergy and Infectious Diseases grant 1R01A1101371-01A1. CDH was supported by NIOSH grant 1K010H010193-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmatov MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048508; Argudin MA, 2011, APPL ENV MICROBIOL; Ballhausen B, 2014, INT J MED MICROBIOL, V304, P777, DOI 10.1016/j.ijmm.2014.06.006; Becker K, 2015, VET MICROBIOL; Benito D, 2014, INT J MED MICROBIOL, V304, P1226, DOI 10.1016/j.ijmm.2014.09.004; Bootsma MCJ, 2010, J R SOC INTERFACE; Bosch T, 2015, APPL ENVIRON MICROB, V81, P124, DOI 10.1128/AEM.02803-14; Cai CB, 2005, AM J IND MED, V47, P403, DOI 10.1002/ajim.20157; Census of Agriculture, 2007, 2007 CENS AGR; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT SUC S; Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721; Culp Kennith, 2008, J Agromedicine, V13, P7, DOI 10.1080/10599240801985373; DONHAM KJ, 1977, J OCCUP ENVIRON MED, V19, P383, DOI 10.1097/00043764-197706000-00004; European Union Reference Laboratory for Antimicrobial Resistance, 2009, PROT SPA TYP; Fritz SA, 2011, INFECT CONT HOSP EP, V32, P872, DOI 10.1086/661285; Goerge T, 2017, VET MICROBIOL, V200, P6, DOI 10.1016/j.vetmic.2015.10.027; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Ip DKM, 2012, J INFECT DIS, V205, P631, DOI 10.1093/infdis/jir803; Kyeremateng-Amoah E, 2014, AM J IND MED, V57, P669, DOI 10.1002/ajim.22325; Larsen J, 2015, EURO SURVEILL B EUR, V20; Larson KRL, 2010, ANN AGR ENV MED, V17, P331; LeJeune J, 2010, J AGRIC SAF HEALTH, V16, P161, DOI 10.13031/2013.32041; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lozano C, 2012, J ANTIMICROB CHEMOTH, V67, P330, DOI 10.1093/jac/dkr497; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Nadimpalli M, 2013, J MED MICROBIOL, V62, P1365, DOI 10.1099/jmm.0.058248-0; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Patchanee P, 2014, J VET SCI, V15, P529, DOI 10.4142/jvs.2014.15.4.529; Paterson GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7560; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Reischl U, 2000, J CLIN MICROBIOL, V38, P2429; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; Salim B, 2005, J INFECT DIS, V191, P444; Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2014, CURR ENV HEAL REPORT, V2, P41; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; United States Department of Agriculture, 2010, 2010 NAT AGR STAT SE; United States Department of Commerce, 2010, 2010 CURR POP SURV; Van Cleef BA, 2016, EPIDEMIOL INFECT, DOI [10.1016/j.ijmm.21014.09.004, DOI 10.1016/J.IJMM.2014.09.004]; van Rijen MML, 2014, LIVESTOCK ASS MRSA C; Wardyn SE, 2015, CLIN INFECT DIS; Wertheim H, 2001, J CLIN MICROBIOL, V39, P2660, DOI 10.1128/JCM.39.7.2660-2662.2001; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yang ES, 2010, CLIN MICROBIOL INFEC, V16, P425, DOI 10.1111/j.1469-0691.2009.02836.x; Ye XH, 2016, APPL ENVIRON MICROB, V82, P3892, DOI 10.1128/AEM.00091-16; Ye XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19184	52	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165713	10.1371/journal.pone.0165713	http://dx.doi.org/10.1371/journal.pone.0165713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851746	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300024
J	Eminaga, O; Wei, W; Hawley, SJ; Auman, H; Newcomb, LF; Simko, J; Hurtado-Coll, A; Troyer, DA; Carroll, PR; Gleave, ME; Lin, DW; Nelson, PS; Thompson, IM; True, LD; McKenney, JK; Feng, ZD; Fazli, L; Brooks, JD				Eminaga, Okyaz; Wei, Wei; Hawley, Sarah J.; Auman, Heidi; Newcomb, Lisa F.; Simko, Jeff; Hurtado-Coll, Antonio; Troyer, Dean A.; Carroll, Peter R.; Gleave, Martin E.; Lin, Daniel W.; Nelson, Peter S.; Thompson, Ian M.; True, Lawrence D.; McKenney, Jesse K.; Feng, Ziding; Fazli, Ladan; Brooks, James D.			MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study	PLOS ONE			English	Article							GENE-EXPRESSION; O-GLYCOSYLATION; CELL-LINES; GRADE; CARCINOMA; MUCINS; DEATH	Background The uncertainties inherent in clinical measures of prostate cancer (CaP) aggressiveness endorse the investigation of clinically validated tissue biomarkers. MUC1 expression has been previously reported to independently predict aggressive localized prostate cancer. We used a large cohort to validate whether MUC1 protein levels measured by immunohistochemistry (IHC) predict aggressive cancer, recurrence and survival outcomes after radical prostatectomy independent of clinical and pathological parameters. Material and Methods MUC1 IHC was performed on a multi-institutional tissue microarray (TMA) resource including 1,326 men with a median follow-up of 5 years. Associations with clinical and pathological parameters were tested by the Chi-square test and the Wilcoxon rank sum test. Relationships with outcome were assessed with univariable and multivariable Cox proportional hazard models and the Log-rank test. Results The presence of MUC1 expression was significantly associated with extracapsular extension and higher Gleason score, but not with seminal vesicle invasion, age, positive surgical margins or pre-operative serum PSA levels. In univariable analyses, positive MUC1 staining was significantly associated with a worse recurrence free survival (RFS) (HR: 1.24, CI 1.03-1.49, P = 0.02), although not with disease specific survival (DSS, P>0.5). On multivariable analyses, the presence of positive surgical margins, extracapsular extension, seminal vesicle invasion, as well as higher pre-operative PSA and increasing Gleason score were independently associated with RFS, while MUC1 expression was not. Positive MUC1 expression was not independently associated with disease specific survival (DSS), but was weakly associated with overall survival (OS). Conclusion In our large, rigorously designed validation cohort, MUC1 protein expression was associated with adverse pathological features, although it was not an independent predictor of outcome after radical prostatectomy.	[Eminaga, Okyaz; Brooks, James D.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Eminaga, Okyaz] Univ Hosp Cologne, Dept Urol, Cologne, Nrw, Germany; [Wei, Wei; Feng, Ziding] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hawley, Sarah J.; Auman, Heidi] Canary Fdn, Canary Ctr Stanford, 3155 Porter Dr, Palo Alto, CA USA; [Newcomb, Lisa F.; Lin, Daniel W.] Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; [Simko, Jeff] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Hurtado-Coll, Antonio; Gleave, Martin E.; Fazli, Ladan] Dept Urol Sci, Vancouver, BC, Canada; [Hurtado-Coll, Antonio; Gleave, Martin E.; Fazli, Ladan] Vancouver Prostate Ctr, Vancouver, BC, Canada; [Troyer, Dean A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Troyer, Dean A.] Eastern Virginia Med Sch, Pathol & Microbiol & Mol Biol, Norfolk, VA 23501 USA; [Carroll, Peter R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Thompson, Ian M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [True, Lawrence D.] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [McKenney, Jesse K.] Cleveland Clin, Dept Pathol, Cleveland, OH 44106 USA	Stanford University; University of Cologne; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Eastern Virginia Medical School; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health San Antonio; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation	Brooks, JD (corresponding author), Stanford Univ, Dept Urol, Stanford, CA 94305 USA.	jdbrooks@stanford.edu	Eminaga, Okyaz/ABH-7208-2020	Gleave, Martin/0000-0003-4235-0167	Canary Foundation; Department of Defense [W81XWH-11-1-0380]; NCI [CM 96387]; NCI Early Detection Research Network [CM 52737-01, CA08636815]; Dr. Werner Jackstaedt Scholarship; NATIONAL CANCER INSTITUTE [P30CA016672, U01CA196387] Funding Source: NIH RePORTER	Canary Foundation; Department of Defense(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dr. Werner Jackstaedt Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canary Foundation, the Department of Defense (W81XWH-11-1-0380 to JDB and ZF), the NCI (CM 96387 to JDB), and the NCI Early Detection Research Network (CM 52737-01 to JDB and CA08636815 to ZF). OE received Dr. Werner Jackstaedt Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren O, 2007, BRIT J CANCER, V97, P730, DOI 10.1038/sj.bjc.6603944; Arai T, 2005, INT J UROL, V12, P654, DOI 10.1111/j.1442-2042.2005.01112.x; Brooks JD, 2016, PROSTATE, V76, P1409, DOI 10.1002/pros.23225; Brooks JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132343; Burke PA, 2006, INT J ONCOL, V29, P49; Chachadi VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057416; Chen ZX, 2014, PROSTATE, V74, P1059, DOI 10.1002/pros.22826; Cozzi PJ, 2005, CLIN EXP METASTAS, V22, P565, DOI 10.1007/s10585-005-5376-z; Garbar C, 2008, ANAL QUANT CYTOL, V30, P71; Genitsch V, 2016, PROSTATE CANCER P D, DOI [10.1038/pcan.2016.11, DOI 10.1038/PCAN.2016.11PMID:27165976.]; Gnemmi V, 2014, CANCER LETT, V346, P225, DOI 10.1016/j.canlet.2013.12.029; Gunia S, 2010, PATHOL ONCOL RES, V16, P371, DOI 10.1007/s12253-009-9231-4; Hawley S, 2013, ADV ANAT PATHOL, V20, P39, DOI 10.1097/PAP.0b013e31827b665b; Heidenreich A, 2013, EUR UROL, V64, P347, DOI 10.1016/j.eururo.2013.06.051; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; King CR, 2006, UROLOGY, V67, P1229, DOI 10.1016/j.urology.2005.12.031; Kirschenbaum A, 1999, MOL UROL, V3, P163; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lotan TL, 2016, EUR UROL FOCUS, V2, P180, DOI 10.1016/j.euf.2015.07.005; Lotan TL, 2016, MODERN PATHOL, V29, P904, DOI 10.1038/modpathol.2016.88; Mitchell S, 2002, NEOPLASIA, V4, P9, DOI 10.1038/sj.neo.7900194; Newcomb LF, 2016, J UROLOGY, V195, P313, DOI 10.1016/j.juro.2015.08.087; O'Connor JC, 2005, PROSTATE CANCER P D, V8, P36, DOI 10.1038/sj.pcan.4500762; Okamoto T, 2013, MOL MED REP, V7, P359, DOI 10.3892/mmr.2012.1189; Pandey JP, 2013, HUM IMMUNOL, V74, P1030, DOI 10.1016/j.humimm.2013.04.008; Premaratne P, 2011, TUMOR BIOL, V32, P203, DOI 10.1007/s13277-010-0114-9; Rabiau N, 2009, IN VIVO, V23, P203; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Russo CL, 2006, HUM REPROD, V21, P2783, DOI 10.1093/humrep/del164; Sanchez C, 2013, PROSTATE CANCER P D, V16, P123, DOI 10.1038/pcan.2012.49; Satoh S, 2000, INT J CANCER, V88, P507, DOI 10.1002/1097-0215(20001115)88:4<507::AID-IJC1>3.0.CO;2-0; Scholfield DP, 2003, BJU INT, V91, P560, DOI 10.1046/j.1464-410X.2003.04132.x; Schut IC, 2003, BJU INT, V91, P278, DOI 10.1046/j.1464-410X.2003.03062.x; Severi G, 2014, CANCER MED-US, V3, P1266, DOI 10.1002/cam4.281; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Tretiakova MS, 2016, PROSTATE CANCER P D, V19, P264, DOI 10.1038/pcan.2016.12; Troyer DA, 2015, PROSTATE, V75, P1206, DOI 10.1002/pros.23003; Williams SJ, 1999, CANCER RES, V59, P4083	39	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165236	10.1371/journal.pone.0165236	http://dx.doi.org/10.1371/journal.pone.0165236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846218	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600010
J	Werner, SJ; Hobson, KA; Van Wilgenburg, SL; Fischer, JW				Werner, Scott J.; Hobson, Keith A.; Van Wilgenburg, Steven L.; Fischer, Justin W.			Multi-Isotopic (delta H-2, delta C-13, delta N-15) Tracing of Molt Origin for Red-Winged Blackbirds Associated with Agro-Ecosystems	PLOS ONE			English	Article							MIGRATORY CONNECTIVITY; WINTERING GROUNDS; NITROGEN ISOTOPES; ANIMAL MIGRATION; FEATHER ISOSCAPE; STABLE HYDROGEN; BIRDS; REPELLENT; FIDELITY; DAMAGE	We analyzed stable-hydrogen (delta H-2), carbon (delta C-13) and nitrogen (delta N-15) isotope ratios in feathers to better understand the molt origin and food habits of Red-winged Blackbirds (Agelaius phoeniceus) near sunflower production in the Upper Midwest and rice production in the Mid-South of the United States. Outer primary feathers were used from 661 after-second-year (ASY) male blackbirds collected in Minnesota, Montana, North Dakota and South Dakota (spring collection), and Arkansas, Louisiana, Mississippi, Missouri and Texas (winter collection). The best-fit model indicated that the combination of feather delta H-2, delta C-13 and delta N-15 best predicted the state of sample collections and thus supported the use of this approach for tracing molt origins in Red-winged Blackbirds. When considering only birds collected in spring, 56% of birds were classified to their collection state on the basis of delta H-2 and delta C-13 alone. We then developed feather isoscapes for delta C-13 based upon these data and for delta H-2 based upon continental patterns of delta H-2 in precipitation. We used 81 birds collected at the ten independent sites for model validation. The spatially-explicit assignment of these 81 birds to the delta H-2 isoscape resulted in relatively high rates (similar to 77%) of accurate assignment to collection states. We also modeled the spatial extent of C3 (e.g. rice, sunflower) and C4 (corn, millet, sorghum) agricultural crops grown throughout the Upper Midwest and Mid-South United States to predict the relative use of C3-versus C4-based foodwebs among sampled blackbirds. Estimates of C3 inputs to diet ranged from 50% in Arkansas to 27% in Minnesota. As a novel contribution to blackbird conservation and management, we demonstrate how such feather isoscapes can be used to predict the molt origin and interstate movements of migratory blackbirds for subsequent investigations of breeding biology (e.g. sex-specific philopatry), agricultural depredation, feeding ecology, physiology of migration and sensitivity to environmental change.	[Werner, Scott J.; Fischer, Justin W.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA; [Hobson, Keith A.] Environm Canada, 11 Innovat Blvd, Saskatoon, SK S7N 3H5, Canada; [Hobson, Keith A.] Univ Western Ontario, Dept Biol, 1151 Richmond St N, London, ON N6A 5B7, Canada; [Van Wilgenburg, Steven L.] Environm Canada, Prairie & Northern Wildlife Res Ctr, Canadian Wildlife Serv, 115 Perimeter Rd, Saskatoon, SK S7N 0X4, Canada	United States Department of Agriculture (USDA); Environment & Climate Change Canada; Western University (University of Western Ontario); Environment & Climate Change Canada; Canadian Wildlife Service	Werner, SJ (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA.	Scott.J.Werner@aphis.usda.gov	Hobson, Keith/Q-9306-2019	Fischer, Justin/0000-0002-9472-8945; Van Wilgenburg, Steven/0000-0002-6742-4567	USDA's National Wildlife Research Center	USDA's National Wildlife Research Center	SW and KH received Blue Sky Grant from USDA's National Wildlife Research Center for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BELETSKY LD, 1991, ECOLOGY, V72, P787, DOI 10.2307/1940581; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Cade BS, 2015, ECOLOGY, V96, P2370, DOI 10.1890/14-1639.1; Carlson JC, 2013, APPL ANIM BEHAV SCI, V145, P26, DOI 10.1016/j.applanim.2013.01.011; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cummings JL, 2011, J WILDLIFE MANAGE, V75, P353, DOI 10.1002/jwmg.65; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Grocke DR, 1997, EARTH PLANET SC LETT, V153, P279, DOI 10.1016/S0012-821X(97)00189-1; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2008, HDB TERRESTRIAL ECOL; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2016, AUK, V133, P86, DOI 10.1642/AUK-15-149.1; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2014, ACTA ORNITHOL, V49, P57, DOI 10.3161/000164514X682896; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Linz GM, 2011, BIOSCIENCE, V61, P960, DOI 10.1525/bio.2011.61.12.6; Mayer B, 2012, J GREAT LAKES RES, V38, P135, DOI 10.1016/j.jglr.2012.02.004; Meanley B., 1965, Wilson Bulletin, V77, P217; Meanley B, 1970, Bird Banding, V41, P22; Nadelhoffer KJ, 1994, STABLE ISOTOPES ECOL; Nagy, 1988, STABLE ISOTOPES ECOL, P1; NERO RW, 1984, REDWINGS; Oksanen J, 2022, R PACKAGE VERSION; Pardieck KL, 2007, BIRD POPULATIONS, V8, P28; Pardo LH, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P221, DOI 10.1007/978-90-481-3354-3_11; Partners in Flight Scientific Committee, POP EST DAT VERS 201; PICMAN J, 1981, CAN J ZOOL, V59, P2284, DOI 10.1139/z81-307; R Core Team, 2013, R LANG ENV STAT COMP; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Terzer S, 2013, HYDROL EARTH SYST SC, V17, P4713, DOI 10.5194/hess-17-4713-2013; Tupper SK, 2009, WILDLIFE RES, V36, P319, DOI 10.1071/WR09015; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Vander Zanden HB, 2014, METHODS ECOL EVOL, V5, P891, DOI 10.1111/2041-210X.12229; Veen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098075; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Werner SJ, 2014, APPL ANIM BEHAV SCI, V159, P107, DOI 10.1016/j.applanim.2014.06.012; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; Yasukawa K., 1995, BIRDS N AM, DOI [10.2173/bna.184, DOI 10.2173/BNA.184]	48	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165996	10.1371/journal.pone.0165996	http://dx.doi.org/10.1371/journal.pone.0165996			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846302	Green Published, gold			2022-12-27	WOS:000387794600026
J	Aibana, O; Acharya, X; Huang, CC; Becerra, MC; Galea, JT; Chiang, SS; Contreras, C; Calderon, R; Yataco, R; Velasquez, GE; Tintaya, K; Jimenez, J; Lecca, L; Murray, MB				Aibana, Omowunmi; Acharya, Xeno; Huang, Chuan-Chin; Becerra, Mercedes C.; Galea, Jerome T.; Chiang, Silvia S.; Contreras, Carmen; Calderon, Roger; Yataco, Rosa; Velasquez, Gustavo E.; Tintaya, Karen; Jimenez, Judith; Lecca, Leonid; Murray, Megan B.			Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts	PLOS ONE			English	Article							BODY-MASS INDEX; MYCOBACTERIUM-TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; INFECTION; LEPTIN; PERSISTENCE; MACROPHAGES; MECHANISMS; CHILDHOOD; CHILDREN	Background Studies show obesity decreases risk of tuberculosis (TB) disease. There is limited evidence on whether high body mass index also protects against TB infection; how very high body mass indices influence TB risk; or whether nutritional status predicts this risk in children. We assessed the impact of body mass index on incident TB infection and disease among adults and children. Methods and Findings We conducted a prospective cohort study among household contacts of pulmonary TB cases in Lima, Peru. We determined body mass index at baseline and followed participants for one year for TB infection and disease. We used Cox proportional regression analyses to estimate hazard ratios for incident TB infection and disease. We enrolled 14,044 household contacts, and among 6853 negative for TB infection and disease at baseline, 1787 (26.1%) became infected. A total of 406 contacts developed secondary TB disease during follow-up. Body mass index did not predict risk of TB infection but overweight household contacts had significantly decreased risk of TB disease (HR 0.48; 95% CI 0.37-0.64; p < 0.001) compared to those with normal weight. Among adults, body mass index >= 35 kg/m(2) continued to predict a lower risk of TB disease (HR 0.30; 95% CI 0.12-0.74; p 0.009). We found no association between high body mass index and TB infection or disease among children under 12 years of age. Conclusions High body mass index protects adults against TB disease even at levels >= 35 kg/m(2). This protective effect does not extend to TB infection and is not seen in children.	[Aibana, Omowunmi] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gen Internal Med, McGovern Med Sch, Houston, TX 77030 USA; [Acharya, Xeno] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England; [Huang, Chuan-Chin] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Becerra, Mercedes C.; Galea, Jerome T.; Velasquez, Gustavo E.; Murray, Megan B.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Becerra, Mercedes C.; Galea, Jerome T.; Contreras, Carmen; Calderon, Roger; Yataco, Rosa; Tintaya, Karen; Jimenez, Judith; Lecca, Leonid] Partners Hlth Socios Salud Sucursal Peru, Lima, Peru; [Chiang, Silvia S.] Brown Univ, Dept Pediat, Alpert Sch Med, Providence, RI 02912 USA; [Chiang, Silvia S.] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI USA; [Velasquez, Gustavo E.] Brigham & Womens Hosp, Dept Internal Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Brigham & Women's Hospital	Murray, MB (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.	megan.murray.epi@gmail.com	Galea, Jerome T./AAF-2172-2019; Galea, Jerome T/HGV-0203-2022	Galea, Jerome T./0000-0001-8732-6959; Galea, Jerome T/0000-0001-8732-6959; Velasquez, Gustavo/0000-0003-1438-0692; Lecca, Leonid/0000-0003-1363-3985; Chiang, Silvia/0000-0002-2318-3802; Aibana, Omowunmi/0000-0003-0665-5393; Calderon, Roger I./0000-0001-8932-0489	National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse [T32 DA013911];  [U19 AI076217];  [U01 AI057786];  [T32 AI007433];  [L30 AI120170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433, U01AI057786, U19AI076217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Allergy and Infectious Diseases [U19 AI076217 to MBM; U01 AI057786 to MCB; T32 AI007433 and L30 AI120170 to GEV] and the National Institute on Drug Abuse [T32 DA013911 to OA and SC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2014, MICROBES INFECT, V16, P571, DOI 10.1016/j.micinf.2014.04.006; Andersen CJ, 2016, ADV NUTR, V7, P66, DOI 10.3945/an.115.010207; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BOUTTON TW, 1987, AM J CLIN NUTR, V45, P513, DOI 10.1093/ajcn/45.3.513; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; EDWARDS LB, 1971, ARCH ENVIRON HEALTH, V22, P106, DOI 10.1080/00039896.1971.10665820; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Heitzinger K, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-19; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Koethe JR, 2011, CLIN INFECT DIS, V53, P952, DOI 10.1093/cid/cir606; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lumeng CN, 2013, MOL ASPECTS MED, V34, P12, DOI 10.1016/j.mam.2012.10.002; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; PALMER CE, 1957, AM REV TUBERC PULM, V76, P517; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Perez-Guzman C, 2014, SALUD PUBLICA MEXICO, V56, P189; Peru Ministerio de Salud. Norma Tecnica de Salud para el Control de la Tuberculosis. Direccion General de Salud de las Personas, 2006, NORM TECN SAL CONTR; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Seclen SN, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000110; Tobin DM, 2013, CURR OPIN PHARMACOL, V13, P641, DOI 10.1016/j.coph.2013.06.007; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; TVERDAL A, 1986, EUR J RESPIR DIS, V69, P355; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; World Health Organization (WHO), 2011, CHILD GROWTH STAND; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031	45	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166333	10.1371/journal.pone.0166333	http://dx.doi.org/10.1371/journal.pone.0166333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835678	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000387779200039
J	Lee, J; Han, JH; Jang, A; Kim, JW; Hong, SA; Myung, SC				Lee, Jaehyouk; Han, Jun Hyun; Jang, Ara; Kim, Jin Wook; Hong, Soon Auck; Myung, Soon Chul			DNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GENE; HYPERMETHYLATION; DISEASE; MICRODISSECTION; BETA-DEFENSIN-1; CARCINOGENESIS; ASSOCIATION; EPIGENETICS; CARCINOMA	Epigenetic aberrations play crucial roles in prostate cancer (PCa) development and progression. The DEFB1 gene, which encodes human beta-defensin-1 (HBD-1), contributes to innate immune responses and functions as a potential tumor suppressor in urological cancers. We investigated whether differential DNA methylation at the low CpG-content promoter (LCP) of DEFB1 was associated with transcriptional regulation of DEFB1 in PCa cells. To identify distinct CpG loci within the DEFB1 LCP related to the epigenetic regulation of DEFB1, we performed an in vitro methylated reporter assay followed by bisulfite sequencing of the DEFB1 promoter fragment. The methylation status of two adjacent CpG loci in the DEFB1 LCP was found to be important for DEFB1 expression in PCa cells. Paired epithelial specimens of PCa patients (n = 60), which were distinguished as non-tumor and tumor tissues by microdissection, were analyzed by bisulfite pyrosequencing of site-specific CpG dinucleotide units in the DEFB1 LCP. CpG methylation frequencies in the DEFB1 LCP were significantly higher in malignant tissues than in adjacent benign tissues across almost all PCa patients. These results suggested that methylation status of each CpG site in the DEFB1 promoter could mediate downregulation of DEFB1 in PCa cells.	[Lee, Jaehyouk; Jang, Ara; Myung, Soon Chul] Chung Ang Univ, Dept Urol, Coll Med, Seoul 06974, South Korea; [Lee, Jaehyouk; Jang, Ara; Myung, Soon Chul] Chung Ang Univ, Adv Urogenital Dis Res Ctr, Coll Med, Seoul 06974, South Korea; [Lee, Jaehyouk; Jang, Ara; Kim, Jin Wook; Myung, Soon Chul] Chung Ang Univ, Biointegrat Res Ctr Nutra Pharmaceut Epigenet, Seoul 06974, South Korea; [Han, Jun Hyun] Hallym Univ, Dept Urol, Dongtan Sacred Heart Hosp, Hwaseong Si 18450, South Korea; [Hong, Soon Auck] Soonchunhyang Univ, Dept Pathol, Coll Med, Cheonan 31151, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Hallym University; Soonchunhyang University	Myung, SC (corresponding author), Chung Ang Univ, Dept Urol, Coll Med, Seoul 06974, South Korea.; Myung, SC (corresponding author), Chung Ang Univ, Adv Urogenital Dis Res Ctr, Coll Med, Seoul 06974, South Korea.; Myung, SC (corresponding author), Chung Ang Univ, Biointegrat Res Ctr Nutra Pharmaceut Epigenet, Seoul 06974, South Korea.	uromyung@cau.ac.kr	Kim, Jin Wook/AAW-3716-2021	Kim, Jin Wook/0000-0003-4157-9365	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2011824]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Chung-Ang University Hospital Biomedical Research Institute for kindly offering research equipment. This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011824).	Andresen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021898; Blute ML, 2015, CURR OPIN UROL, V25, P83, DOI 10.1097/MOU.0000000000000132; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; Enokida H, 2005, CLIN CANCER RES, V11, P6582, DOI 10.1158/1078-0432.CCR-05-0658; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Graca I, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0264-8; Henrique R, 2006, MOL CANCER RES, V4, P1, DOI 10.1158/1541-7786.MCR-05-0113; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Keil KP, 2015, EPIGENOMICS-UK, V7, P413, DOI 10.2217/epi.15.8; Kim HJ, 2011, BJU INT, V107, P144, DOI 10.1111/j.1464-410X.2010.09469.x; Kuzmin I, 2002, CANCER RES, V62, P3498; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lee JY, 1998, VIRCHOWS ARCH, V433, P305, DOI 10.1007/s004280050253; Liu LM, 2002, ONCOGENE, V21, P6835, DOI 10.1038/sj.onc.1205814; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Patel AR, 2009, NAT CLIN PRACT UROL, V6, P87, DOI 10.1038/ncpuro1290; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Strand SH, 2014, INT J MOL SCI, V15, P16544, DOI 10.3390/ijms150916544; Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294; Valdes-Mora F, 2015, ONCOGENE, V34, P1609, DOI 10.1038/onc.2014.111; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Woodson K, 2006, EPIGENETICS-US, V1, P183, DOI 10.4161/epi.1.4.3530	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166664	10.1371/journal.pone.0166664	http://dx.doi.org/10.1371/journal.pone.0166664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835705	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200064
J	Zhou, ZW; Song, K; Qiu, J; Wang, YY; Liu, CX; Zhou, H; Xu, YF; Guo, ZR; Zhang, B; Dong, C				Zhou, Zhiwei; Song, Kai; Qiu, Jing; Wang, Yiying; Liu, Chunxing; Zhou, Hui; Xu, Yunfang; Guo, Zhirong; Zhang, Biao; Dong, Chen			Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males	PLOS ONE			English	Article							METABOLIC SYNDROME; METAANALYSIS; POPULATION; ULTRASONOGRAPHY; DYSFUNCTION; CHILDREN; RISK	Epidemiological studies suggest that higher serum uric acid (sUA) level is significantly associated with nonalcoholic fatty liver disease (NAFLD) development. However, little information is available on the relationships between sUA and NAFLD remission. In the present study, 841 NAFLD males (30-75 years) were recruited from a Chinese prospective cohort study (PMMJS) and followed up for five years. The baseline sUA levels of participants were categorized into four quartiles: 191 mu mol/L <= sUA <= 347 mu mol/L, 347 mu mol/L < sUA <= 392 mu mol/L, 392 mu mol/L < sUA <= 441 mu mol/L and 441 mu mol/L < SUA <= 676 mu mol/L. As the results show, participants with elevated sUA levels at baseline were significantly associated with the decreased rate of NAFLD remission at the end of study (p<0.0001). After adjustment, RR (95% CI) for remitted NAFLD comparing Q1 to Q3 vs Q4 of sUA were 2.95 (1.49-5.83), 2.40 (1.22-4.73) and 1.39 (0.67-2.86), respectively. Furthermore, the sensitivity analysis showed these significant associations were not affected even after exclusion of participants who had hypertension, diabetes mellitus, MetS and hyperlipidemia. Additionally, the presence of the lowest quartile of sUA levels was still significantly associated with remitted NAFLD when the study population was stratified according to the smoking, and the median values of age, ALT, AST, serum creatinine, HDL-C and LDL-C. Therefore, our present study extended the previous findings and suggested that modulation of sUA levels may attenuate the progression of NAFLD.	[Zhou, Zhiwei; Song, Kai; Qiu, Jing; Wang, Yiying; Liu, Chunxing; Guo, Zhirong; Dong, Chen] Soochow Univ, Dept Epidemiol & Stat, Jiangsu Key Lab & Translat Med Geriatr Dis, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China; [Zhou, Hui] Suzhou Ind Pk Ctr Dis Control & Prevent, Suzhou, Peoples R China; [Xu, Yunfang; Zhang, Biao] Huaian Forth Hosp, Huaian, Peoples R China	Soochow University - China	Dong, C (corresponding author), Soochow Univ, Dept Epidemiol & Stat, Jiangsu Key Lab & Translat Med Geriatr Dis, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China.; Zhang, B (corresponding author), Huaian Forth Hosp, Huaian, Peoples R China.	hasykjk@163.com; cdong1974@163.com						Babio N, 2015, NUTR METAB CARDIOVAS, V25, P173, DOI 10.1016/j.numecd.2014.10.006; Chacko KR, 2016, CLIN LIVER DIS, V20, P387, DOI 10.1016/j.cld.2015.10.004; Choi H, 2016, ARCH GERONTOL GERIAT, V64, P51, DOI 10.1016/j.archger.2016.01.005; El-Koofy N, 2012, EUR J RADIOL, V81, P3120, DOI 10.1016/j.ejrad.2012.06.020; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; Fan Jian-gao, 2007, Zhonghua Gan Zang Bing Za Zhi, V15, P552; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goh GBB, 2016, DIGEST DIS SCI, V61, P1226, DOI 10.1007/s10620-016-4095-4; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Huh JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143560; Kuriyama S, 2015, CLIN EXP NEPHROL, V19, P1127, DOI 10.1007/s10157-015-1120-4; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Liu ZT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14325; Lonardo A, 2002, DIGEST LIVER DIS, V34, P204, DOI 10.1016/S1590-8658(02)80194-3; Luo WS, 2016, ANN HUM BIOL, V43, P67, DOI 10.3109/03014460.2015.1023847; Pascale A, 2010, J GASTROINTEST LIVER, V19, P415; Patterson RA, 2003, J LIPID RES, V44, P512, DOI 10.1194/jlr.M200407-JLR200; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Shih MH, 2015, J FORMOS MED ASSOC, V114, P314, DOI 10.1016/j.jfma.2012.11.014; Tarantino G, 2014, J GASTROINTEST LIVER, V23, P291, DOI [10.1543/jgld.2014.1121.233.gvt, 10.15403/jgld.2014.1121.233.gvt]; Valle M, 2015, PEDIATR DIABETES, V16, P441, DOI 10.1111/pedi.12199; Wang B, 2016, CLIN EXP HYPERTENS, V38, P312, DOI 10.3109/10641963.2015.1107088; Wu AH, 2016, INT J CARDIOL, V213, P4, DOI 10.1016/j.ijcard.2015.08.110; Wu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000802; Xia X, 2016, NUTR METAB CARDIOVAS, V26, P20, DOI 10.1016/j.numecd.2015.10.011; Xie YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067152; Ye X, 2014, J DIABETES, V6, P42, DOI 10.1111/1753-0407.12079; Zhou YJ, 2016, CLIN BIOCHEM, V49, P636, DOI 10.1016/j.clinbiochem.2015.12.010; Zhu JZ, 2015, DIGEST DIS SCI, V60, P3194, DOI 10.1007/s10620-015-3728-3	30	11	11	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166072	10.1371/journal.pone.0166072	http://dx.doi.org/10.1371/journal.pone.0166072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835657	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200023
J	Izugami, S; Takase, K				Izugami, Satoko; Takase, Kozo			Consumer Perception of Inpatient Medical Services	PLOS ONE			English	Article							CAHPS(R) HOSPITAL SURVEY; PATIENT-CENTERED CARE; HEALTH-CARE; EXPERIENCE QUESTIONNAIRE; QUALITY; SATISFACTION; PERSPECTIVE; MODEL	Although it is currently popular to reflect consumers' perspectives to medical service management, insufficient attempts have been made to understand detailed perception of the consumer side of medical services to promote medical services' evaluation from the consumer viewpoint. The aim of this study was to descriptively reveal how consumers perceive medical services that they receive, focusing on inpatient medical services. We conducted semi-structured interviews with 10 adults who experienced hospitalization of five or more days. Constant comparative analysis was performed on the obtained descriptive data. We identified 1) medical procedures, 2) explanations from medical professionals, 3) behavior of medical service providers, 4) somatic sensations, and 5) self-perceived physical conditions as target factors that medical service consumers perceived during hospitalization. The response to the perceived target factors, "compared with the expectation that the consumer had before the hospitalization," suggests that it is an important medical service consumer reaction to check if the service met their expectations for perceived factors. The response to the medical services perception targets suggested that medical service consumers are involved in medical services and interested in various perception targets. The expectations that medical service consumers have prior to hospitalization can largely influence inpatient medical services evaluation.	[Izugami, Satoko; Takase, Kozo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Publ Hlth, Res Dev Dept, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Izugami, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Div Publ Hlth, Res Dev Dept, Tokyo, Japan.	tizugami.rdev@tmd.ac.jp						Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; BITNER MJ, 1990, J MARKETING, V54, P69, DOI 10.2307/1251871; Castle NG, 2005, HEALTH SERV RES, V40, P1996, DOI 10.1111/j.1475-6773.2005.00475.x; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Darby C, 2005, HEALTH SERV RES, V40, P1973, DOI 10.1111/j.1475-6773.2005.00490.x; Davis RE, 2013, J EVAL CLIN PRACT, V19, P132, DOI 10.1111/j.1365-2753.2011.01783.x; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Elliott MN, 2010, HEALTH AFFAIR, V29, P2061, DOI 10.1377/hlthaff.2009.0876; Ferguson LM, 2013, NURSE EDUC PRACT, V13, P283, DOI 10.1016/j.nepr.2013.03.016; Goldstein E, 2005, HEALTH SERV RES, V40, P1977, DOI 10.1111/j.1475-6773.2005.00477.x; Gr/nroos C., 1990, SERVICE MANAGEMENT M; Gremler DD., 2009, SERVICES MARKETING; Institute of Medicine, 2001, CROSSING QUALITY CHA; Isaac T, 2010, HEALTH SERV RES, V45, P1024, DOI 10.1111/j.1475-6773.2010.01122.x; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Kobayashi H, 2011, SCAND J CARING SCI, V25, P419, DOI 10.1111/j.1471-6712.2010.00836.x; Lazar EJ, 2013, ANNU REV MED, V64, P485, DOI 10.1146/annurev-med-061511-135544; Lees Carolyn, 2011, Nurse Res, V19, P25; Lovelock CH., 1992, MANAGING SERVICES; Mazurenko O, 2015, J HEALTHC MANAG, V60, P332, DOI 10.1097/00115514-201509000-00007; MariaMurante A, 2014, INT J HEALTH PLAN M, V29, pE247, DOI 10.1002/hpm.2201; OLIVER RL, 1980, J MARKETING RES, V17, P460, DOI 10.2307/3150499; PARASURAMAN A, 1988, J RETAILING, V64, P12; Pomey MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122499; Price RA, 2014, MED CARE RES REV, V71, P522, DOI 10.1177/1077558714541480; Rathert C, 2015, HEALTH EXPECT, V18, P199, DOI 10.1111/hex.12020; Sherlock ZV, 2009, J CRIT CARE, V24, P501, DOI 10.1016/j.jcrc.2008.10.007; Sofaer S, 2005, HEALTH SERV RES, V40, P2018, DOI 10.1111/j.1475-6773.2005.00473.x; Sofaer S, 2005, ANNU REV PUBL HEALTH, V26, P513, DOI 10.1146/annurev.publhealth.25.050503.153958; Steele JR, 2015, J AM COLL RADIOL, V12, P587, DOI 10.1016/j.jacr.2014.10.008; Strauss A., 1998, BASICS QUALITATIVE R; Tsianakas V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-271; Vargo SL, 2004, J MARKETING, V68, P1, DOI 10.1509/jmkg.68.1.1.24036; Vargo SL, 2008, J ACAD MARKET SCI, V36, P1, DOI 10.1007/s11747-007-0069-6; Veenstra M, 2003, MED CARE, V41, P490, DOI 10.1097/00005650-200304000-00005; Wong ELY, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-265	38	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166117	10.1371/journal.pone.0166117	http://dx.doi.org/10.1371/journal.pone.0166117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832165	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000065
J	Wang, L; Branson, OE; Shilo, K; Hitchcock, CL; Freitas, MA				Wang, Linan; Branson, Owen E.; Shilo, Konstantin; Hitchcock, Charles L.; Freitas, Michael A.			Proteomic Signatures of Thymomas	PLOS ONE			English	Article							T-CELL DEVELOPMENT; LARGE GENE LISTS; DAVID BIOINFORMATICS RESOURCES; THYMIC EPITHELIAL TUMORS; ALPHA-B-CRYSTALLIN; HISTOLOGIC CLASSIFICATION; STATHMIN 1; LINEAGE COMMITMENT; PROTHYMOSIN-ALPHA; THYMOSIN ALPHA-1	Based on the histological features and outcome, the current WHO classification separates thymomas into A, AB, B1, B2 and B3 subtypes. It is hypothesized that the type A thymomas are derived from the thymic medulla while the type B thymomas are derived from the cortex. Due to occasional histological overlap between the tumor subtypes creating difficulties in their separation, the aim of this study was to provide their proteomic characterization and identify potential immunohistochemical markers aiding in tissue diagnosis. Pair-wise comparison of neoplastic and normal thymus by liquid chromatography tandem mass spectrometry (LC-MS/MS) of formalin fixed paraffin embedded tissue revealed 61 proteins differentially expressed in thymomas compared to normal tissue. Hierarchical clustering showed distinct segregation of subtypes AB, B1 and B2 from that of A and B3. Most notably, desmoyokin, a protein that is encoded by the AHNAK gene, was associated with type A thymomas and medulla of normal thymus, by LC-MS/MS and immunohistochemistry. In this global proteomic characterization of the thymoma, several proteins unique to different thymic compartments and thymoma subtypes were identified. Among differentially expressed proteins, desmoyokin is a marker specific for thymic medulla and is potentially promising immunohistochemical marker in separation of type A and B3 thymomas.	[Wang, Linan; Branson, Owen E.; Freitas, Michael A.] Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Wang, Linan; Branson, Owen E.; Freitas, Michael A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Shilo, Konstantin; Hitchcock, Charles L.] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Freitas, MA (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA.; Freitas, MA (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.	freitas.5@osu.edu	Freitas, Michael/C-8953-2009; Shilo, K/AAV-2360-2020	Freitas, Michael/0000-0002-3103-8410; Shilo, K/0000-0002-6702-3130				ALLEN TC, 1992, LAB METHODS HISTOTEC, P53; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Brodeur JF, 2009, J IMMUNOL, V182, P4844, DOI 10.4049/jimmunol.0803679; Carney BK, 2010, CANCER BIOL THER, V9, P699, DOI 10.4161/cbt.9.9.11430; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Chen G, 2002, CANCER, V95, P420, DOI 10.1002/cncr.10665; Chen J, 2013, ONCOGENE, V32, P1330, DOI 10.1038/onc.2012.141; Chiang YJ, 2016, EUR J IMMUNOL, V46, P2401, DOI 10.1002/eji.201646440; Chin D, 2005, LARYNGOSCOPE, V115, P1239, DOI 10.1097/01.MLG.0000164715.86240.55; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danzl NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086129; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Dooley J, 2007, DEV DYNAM, V236, P3459, DOI 10.1002/dvdy.21364; Engels EA, 2010, J THORAC ONCOL, V5, pS260, DOI 10.1097/JTO.0b013e3181f1f62d; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Filbert EL, 2012, J IMMUNOL, V188, P5421, DOI 10.4049/jimmunol.1200242; Fischer A, 2010, SEMIN IMMUNOPATHOL, V32, P107, DOI 10.1007/s00281-010-0196-x; Gelkop S, 2005, J IMMUNOL, V175, P8123, DOI 10.4049/jimmunol.175.12.8123; Hager-Theodorides AL, 2007, EUR J IMMUNOL, V37, P487, DOI 10.1002/eji.200636503; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Hassan Mohamed Kamel, 2015, Oncoscience, V2, P294; Hayashi M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-108; He XY, 2016, TUMOR BIOL, V37, P9951, DOI 10.1007/s13277-016-4869-5; Hemdan T, 2014, BRIT J CANCER, V111, P1180, DOI 10.1038/bjc.2014.427; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Ho PY, 2013, UROL ONCOL-SEMIN ORI, V31, P1367, DOI 10.1016/j.urolonc.2012.01.015; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khor GH, 2013, INT J MED SCI, V10, P1727, DOI 10.7150/ijms.6884; Kim YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-576; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Kondo K, 2004, ANN THORAC SURG, V77, P1183, DOI 10.1016/j.athoracsur.2003.07.042; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Liu PT, 2010, IMMUNOL REV, V238, P138, DOI 10.1111/j.1600-065X.2010.00953.x; Liu XL, 2015, INT J CLIN EXP MED, V8, P6502; LOPEZ F, 1991, CYTOMETRY, V12, P42, DOI 10.1002/cyto.990120107; Machado-Neto JA, 2014, BMB REP, V47, P660, DOI 10.5483/BMBRep.2014.47.12.020; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Murre C, 2007, IMMUNITY, V26, P751, DOI 10.1016/j.immuni.2007.06.001; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nemunaitis J, 2012, EXPERT OPIN THER TAR, V16, P631, DOI 10.1517/14728222.2012.696101; Nipp M, 2012, J MOL MED, V90, P163, DOI 10.1007/s00109-011-0815-6; Novak M, 2015, GYNECOL ONCOL, V139, P104, DOI 10.1016/j.ygyno.2015.07.100; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Okamoto T, 2007, CURR PHARM DESIGN, V13, P447, DOI 10.2174/138161207780162944; Okumura M, 2002, CANCER-AM CANCER SOC, V94, P624, DOI 10.1002/cncr.10226; Paweletz CP, 2000, CANCER RES, V60, P6293; Pierluigi B, 2010, ANN NY ACAD SCI, V1194, P1, DOI 10.1111/j.1749-6632.2010.05465.x; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Ried M, 2016, EUR J CARDIO-THORAC, V49, P1545, DOI 10.1093/ejcts/ezv426; Rodriguez-Vicente AE, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1212-2; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Scorsetti M, 2016, CRIT REV ONCOL HEMAT, V99, P332, DOI 10.1016/j.critrevonc.2016.01.012; Serafino A, 2012, ANN NY ACAD SCI, V1270, P13, DOI 10.1111/j.1749-6632.2012.06707.x; Shapiro JP, 2012, J PROTEOMICS, V77, P433, DOI 10.1016/j.jprot.2012.09.019; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Strobel P, 2014, HISTOPATHOLOGY, V64, P557, DOI 10.1111/his.12279; Sun QL, 2012, CHINESE MED J-PEKING, V125, P2811, DOI 10.3760/cma.j.issn.0366-6999.2012.16.003; TSITSILONI OE, 1994, J IMMUNOL METHODS, V169, P163, DOI 10.1016/0022-1759(94)90260-7; TSITSILONI OE, 1993, P NATL ACAD SCI USA, V90, P9504, DOI 10.1073/pnas.90.20.9504; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Wang F, 2014, ASIAN PAC J CANCER P, V15, P3613, DOI 10.7314/APJCP.2014.15.8.3613; Wang NH, 1998, INT IMMUNOL, V10, P1777, DOI 10.1093/intimm/10.12.1777; Wei B, 2015, CLIN CHIM ACTA, V447, P72, DOI 10.1016/j.cca.2015.05.016; WHITELAND JL, 1995, J HISTOCHEM CYTOCHEM, V43, P313, DOI 10.1177/43.3.7868861; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yamada Y, 2011, AM J SURG PATHOL, V35, P1296, DOI 10.1097/PAS.0b013e3182237f5d	81	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166494	10.1371/journal.pone.0166494	http://dx.doi.org/10.1371/journal.pone.0166494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832160	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000130
J	Zhou, P; Tijssen, R; Leydesdorff, L				Zhou, Ping; Tijssen, Robert; Leydesdorff, Loet			University-Industry Collaboration in China and the USA: A Bibliometric Comparison	PLOS ONE			English	Article								In this study, university-industry collaborations in China and the USA are analyzed in terms of co-authored publications indexed in the Web of Science (WoS). Results show a wide gap between China and the USA: Chinese universities are much less active in collaborations with industry in terms of either publication productivity or collaboration intensity. In selecting local and foreign industrial partners, however, more variation exists among Chinese universities than among US universities. The US system is domestically oriented more than that of China. In the USA, the intensity of university-industry collaboration is determined by research quality, whereas in China this is not the case. In both China and the USA, distance is not critical for the establishment of domestic university-industry collaboration. A high correlation is found between productivity indicators including total publications and university-industry co-authored publications. However, the productivity indicators are less correlated with the intensity of university-industry collaboration. Large research universities with strong ties to domestic industry play critical roles in both national publication systems.	[Zhou, Ping] Zhejiang Univ, Sch Publ Affairs, Dept Informat Resources Management, Hangzhou, Zhejiang, Peoples R China; [Tijssen, Robert] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; [Leydesdorff, Loet] Univ Amsterdam, Amsterdam Sch Commun Res ASCoR, Amsterdam, Netherlands	Zhejiang University; Leiden University; Leiden University - Excl LUMC; University of Amsterdam	Zhou, P (corresponding author), Zhejiang Univ, Sch Publ Affairs, Dept Informat Resources Management, Hangzhou, Zhejiang, Peoples R China.	pingzhou@zju.edu.cn	Leydesdorff, Loet/E-2903-2010; ZHOU, PING/D-7848-2011	Leydesdorff, Loet/0000-0002-7835-3098; ZHOU, PING/0000-0001-5471-5261; Tijssen, Robert/0000-0001-5237-9583	National Natural Science Foundation of China (NSFC) [71473219]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The study is supported by National Natural Science Foundation of China (NSFC) with webstie at www.nsfc.gov.cn. The Grant Number is 71473219. PZ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author is supported by the National Natural Science Foundation of China (NSFC) with Grant Number 71473219. We thank Dennis Gray and Lena Leonchuk from North Carolina State University for providing AUTM data.	Agrawal A, 2002, MANAGE SCI, V48, P44, DOI 10.1287/mnsc.48.1.44.14279; Ankrah SN, 2013, TECHNOVATION, V33, P50, DOI 10.1016/j.technovation.2012.11.001; Audretsch DB, 2014, J TECHNOL TRANSFER, V39, P313, DOI 10.1007/s10961-012-9288-1; Azoulay P, 2007, J ECON BEHAV ORGAN, V63, P599, DOI 10.1016/j.jebo.2006.05.015; Banal-Estanol A, 2015, RES POLICY, V44, P1160, DOI 10.1016/j.respol.2015.02.006; Breschi S, 2007, ECON INNOV NEW TECH, V16, P101, DOI 10.1080/10438590600982830; Callaert J, 2015, RES POLICY, V44, P990, DOI 10.1016/j.respol.2015.02.003; Etzkowitz H, 2000, RES POLICY, V29, P313, DOI 10.1016/S0048-7333(99)00069-4; Etzkowitz H, 1995, EASST REV, V1, P11; Etzkowitz H., 1994, EVOLUTIONARY EC CHAO, P139; Fabrizio KR, 2008, RES POLICY, V37, P914, DOI 10.1016/j.respol.2008.01.010; Moutinho PSF, 2007, SCIENTOMETRICS, V70, P355, DOI 10.1007/s11192-007-0207-4; Florida R, 1999, INDUSTRIALIZING KNOWLEDGE, P589; GIBBONS M., 1994, NEW PRODUCTION KNOWL; Gulbrandsen M., 2007, U STRATEGIC KNOWLEDG, P112; ISTIC, 2014, STAT DAT CHIN S T PA; Leydesdorff L., 1996, SCI PUBL POL, V23, P279, DOI [10.1093/spp/23.5.279, DOI 10.1093/SPP/23.5.279]; Leydesdorff L, 2012, SCIENTOMETRICS, V92, P781, DOI 10.1007/s11192-012-0636-6; Nelson R.R, 1994, EVOLUTIONARY EC CHAO, P21; Nelson RR, 1993, NATL RES SYSTEMS COM; OLIVER C, 1990, ACAD MANAGE REV, V15, P241, DOI 10.2307/258156; Owen-Smith J, 2001, J TECHNOLOGY TRANSFE, V1, P99, DOI [10.1023/A:1007892413701, DOI 10.1023/A:1007892413701]; Ponomariov B, 2013, J TECHNOL TRANSFER, V38, P749, DOI 10.1007/s10961-013-9301-3; Tijssen R., 2011, ASSESS EVAL HIGH EDU, V5, P19; Tijssen RJW, 2012, RES EVALUAT, V21, P204, DOI 10.1093/reseval/rvs013; Tijssen RJW, 2009, RES EVALUAT, V18, P13, DOI 10.3152/095820209X393145; Urbano D, 2013, ECON DEV Q, V27, P40, DOI 10.1177/0891242412471973; van Rijnsoever FJ, 2008, RES POLICY, V37, P1255, DOI 10.1016/j.respol.2008.04.020; Wong PK, 2013, SCIENTOMETRICS, V97, P245, DOI 10.1007/s11192-013-1029-1; Zhou P., 2008, ISSI NEWLETTER, V4, P7	30	21	22	7	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165277	10.1371/journal.pone.0165277	http://dx.doi.org/10.1371/journal.pone.0165277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832084	gold, Green Submitted, Green Published			2022-12-27	WOS:000387725000012
J	Liu, H; Dong, SY; Sun, DY; Liu, W; Gu, FW; Liu, YZ; Guo, T; Wang, H; Wang, JF; Chen, ZQ				Liu, Hao; Dong, Shuangyu; Sun, Dayuan; Liu, Wei; Gu, Fengwei; Liu, Yongzhu; Guo, Tao; Wang, Hui; Wang, Jiafeng; Chen, Zhiqiang			CONSTANS-Like 9 (OsCOL9) Interacts with Receptor for Activated C-Kinase 1(OsRACK1) to Regulate Blast Resistance through Salicylic Acid and Ethylene Signaling Pathways	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTORS; DISEASE RESISTANCE; MOLECULAR CHARACTERIZATION; STRESS TOLERANCE; RICE; GENE; EXPRESSION; ARABIDOPSIS; FAMILY; TRANSFORMATION	In a previous transcriptome analysis of early response genes in rice during Magnaporthe oryzae infection, we identified a CONSTANS-like (COL) gene OsCOL9. In the present study, we investigated the functional roles of OsCOL9 in blast resistance. OsCOL9 belonged to group II of the COL protein family, and it contained a BB-box and a C-terminal CCT (CONSTANS, COL and TOC1) domain. OsCOL9 was found in the nucleus of rice cells, and it exerted transcriptional activation activities through its middle region (MR). Magnaporthe oryzae infection induced OsCOL9 expression, and transgenic OsCOL9 knock-out rice plants showed increased pathogen susceptibility. OsCOL9 was a critical regulator of pathogen-related genes, especially PR1b, which were also activated by exogenous salicylic acid (SA) and 1-aminocyclopropane-1-carboxylicacid (ACC), the precursor of ethylene (ET). Further analysis indicated that OsCOL9 over-expression increased the expressions of phytohormone biosynthetic genes, NPR1, WRKY45, OsACO1 and OsACS1, which were related to SA and ET biosynthesis. Interestingly, we found that OsCOL9 physically interacted with the scaffold protein OsRACK1 through its CCT domain, and the OsRACK1 expression was induced in response to exogenous SA and ACC as well as M. oryzae infection. Taken together, these results indicated that the COL protein OsCOL9 interacted with OsRACK1, and it enhanced the rice blast resistance through SA and ET signaling pathways.	[Liu, Hao; Dong, Shuangyu; Liu, Wei; Gu, Fengwei; Liu, Yongzhu; Guo, Tao; Wang, Hui; Wang, Jiafeng; Chen, Zhiqiang] South China Agr Univ, Natl Engn Res Ctr Plant Space Breeding, Guangzhou 510642, Guangdong, Peoples R China; [Sun, Dayuan] Guangdong Acad Agr Sci, Plant Protect Res Inst, Guangdong Prov Key Lab High Technol Plant Protect, Guangzhou 510640, Guangdong, Peoples R China	South China Agricultural University; Guangdong Academy of Agricultural Sciences	Wang, JF; Chen, ZQ (corresponding author), South China Agr Univ, Natl Engn Res Ctr Plant Space Breeding, Guangzhou 510642, Guangdong, Peoples R China.	bcjfwang@gmail.com; chenlin.@scau.edu.cn	guo, tao/AAI-2936-2020		"863" High Technology Research and Development Program of China (863 Program) [2011AA10A101]; Specialized Research Fund for the Doctoral Program of Higher Education [20124404120007]	"863" High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by two fundings: "863" High Technology Research and Development Program of China (863 Program) (2011AA10A101),Zhicliang Chen received the funding; and Specialized Research Fund for the Doctoral Program of Higher Education (20124404120007), Jiafeng Wang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2000, BIOCHEM BIOPH RES CO, V278, P290, DOI 10.1006/bbrc.2000.3781; Agrawal GK, 2000, BIOCHEM BIOPH RES CO, V274, P157, DOI 10.1006/bbrc.2000.3114; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Buscaill P, 2014, CURR OPIN PLANT BIOL, V20, P35, DOI 10.1016/j.pbi.2014.04.004; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Chae HS, 2000, PLANT CELL PHYSIOL, V41, P354, DOI 10.1093/pcp/41.3.354; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Chen J, 2012, GENE, V496, P110, DOI 10.1016/j.gene.2012.01.008; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Crocco CD, 2013, GENE, V531, P44, DOI 10.1016/j.gene.2013.08.037; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Inoue H, 2013, P NATL ACAD SCI USA, V110, P9577, DOI 10.1073/pnas.1222155110; Iwai T, 2006, PLANT PHYSIOL, V142, P1202, DOI 10.1104/pp.106.085258; Iwamoto M, 2010, PLANT CELL ENVIRON, V33, P805, DOI 10.1111/j.1365-3040.2009.02106.x; Jiang CH, 2016, J EXP BOT, V67, P157, DOI 10.1093/jxb/erv445; Johansson M, 2015, J EXP BOT, V66, P719, DOI 10.1093/jxb/eru441; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Lin J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005867; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Min JH, 2015, J INTEGR PLANT BIOL, V57, P313, DOI 10.1111/jipb.12246; Mitsuhara I, 2008, MOL GENET GENOMICS, V279, P415, DOI 10.1007/s00438-008-0322-9; Nakano T, 2006, PLANT CELL PHYSIOL, V47, P554, DOI 10.1093/pcp/pcj017; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shrestha R, 2014, ANN BOT-LONDON, V114, P1445, DOI 10.1093/aob/mcu032; Singh RP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00937; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Sun YD, 2015, PLANT CELL REP, V34, P1295, DOI 10.1007/s00299-015-1787-8; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Xiao WM, 2011, MOL BREEDING, V28, P303, DOI 10.1007/s11032-010-9481-6; Yang JW, 2014, PLANT MOL BIOL REP, V32, P153, DOI 10.1007/s11105-013-0633-9; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zhai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098067; Zhang DP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103747, 10.1371/journal.pone.0097120]; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07663; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhu XY, 2015, PLANT J, V84, P597, DOI 10.1111/tpj.13030	55	22	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166249	10.1371/journal.pone.0166249	http://dx.doi.org/10.1371/journal.pone.0166249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829023	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300099
J	Ericsson, AC; Johnson, PJ; Lopes, MA; Perry, SC; Lanter, HR				Ericsson, Aaron C.; Johnson, Philip J.; Lopes, Marco A.; Perry, Sonja C.; Lanter, Hannah R.			A Microbiological Map of the Healthy Equine Gastrointestinal Tract	PLOS ONE			English	Article							RISK-FACTORS; HORSES; MICROBIOTA; DIETARY; CONCENTRATE; MICROFLORA; DIVERSITY; PATTERNS	Horses are exquisitely sensitive to non-specific gastrointestinal disturbances as well as systemic and extraintestinal conditions related to gut health, yet minimal data are available regarding the composition of the microbiota present in the equine stomach, small intestine, and cecum and their relation to fecal microbiota. Moreover, there is minimal information regarding the concordance of the luminal and mucosal microbial communities throughout the equine gut. Illumina-based 16S rRNA gene amplicon sequencing of the luminal and mucosal microbiota present in seven regions of the gastrointestinal tract of nine healthy adult horses revealed a distinct compositional divide between the small and large intestines. This disparity in composition was more pronounced within the luminal contents, but was also detected within mucosal populations. Moreover, the uniformity of the gut microbiota was much higher in the cecum and colon relative to that in the stomach, jejunum and ileum, despite a significantly higher number of unique sequences detected in the colon. Collectively, the current data suggest that while colonic samples (a proxy for feces) may provide a reasonable profile of the luminal contents of the healthy equine large intestine, they are not informative with regard to the contents of the stomach or small intestine. In contrast to the distinct difference between the highly variable upper gastrointestinal tract microbiota and relatively uniform large bowel microbiota present within the lumen, these data also demonstrate a regional continuity present in mucosal microbial communities throughout the length of the equine gut.	[Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Dept Vet Pathobiol, 4011 Discovery Dr, Columbia, MO 65201 USA; [Ericsson, Aaron C.; Johnson, Philip J.; Lopes, Marco A.; Perry, Sonja C.; Lanter, Hannah R.] Univ Missouri, Coll Vet Med, 1600 Rollins Rd, Columbia, MO 65211 USA; [Johnson, Philip J.; Lopes, Marco A.] Univ Missouri, Dept Vet Med & Surg, 1600 Rollins Rd, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC (corresponding author), Univ Missouri, Metagen Ctr, Dept Vet Pathobiol, 4011 Discovery Dr, Columbia, MO 65201 USA.; Ericsson, AC (corresponding author), Univ Missouri, Coll Vet Med, 1600 Rollins Rd, Columbia, MO 65211 USA.	ericssona@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021; Lopes, Marco/AEN-2677-2022	Ericsson, Aaron C./0000-0002-3053-7269; Lopes, Marco/0000-0003-4901-9733	USDA National Institute of Food and Agriculture, Animal Health project [1005882]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019924] Funding Source: NIH RePORTER	USDA National Institute of Food and Agriculture, Animal Health project; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by the USDA National Institute of Food and Agriculture, Animal Health project 1005882 (ACE) and internal funding for Clinician Scientists at the University of Missouri College of Veterinary Medicine (PJJ).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cohen ND, 1999, J AM VET MED ASSOC, V215, P53; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Costa MC, 2015, VET J, V205, P74, DOI 10.1016/j.tvjl.2015.03.018; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; de Fombelle A, 2003, ANIM SCI, V77, P293; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Hammer O., PAST 3 X 2016; Hart ML, 2015, PLOS ONE INPRESS; Hillyer MH, 2001, EQUINE VET J, V33, P380, DOI 10.2746/042516401776249499; Kaneene JB, 1997, PREV VET MED, V30, P23, DOI 10.1016/S0167-5877(96)01102-6; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; MACKIE RI, 1988, APPL ENVIRON MICROB, V54, P2155, DOI 10.1128/AEM.54.9.2155-2160.1988; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Milinovich GJ, 2007, ENVIRON MICROBIOL, V9, P2090, DOI 10.1111/j.1462-2920.2007.01327.x; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Respondek F, 2011, J ANIM SCI, V89, P77, DOI 10.2527/jas.2010-3108; Schoster A., 2015, EQUINE VET J; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; Traub-Dargatz JL, 2001, J AM VET MED ASSOC, V219, P67, DOI 10.2460/javma.2001.219.67; Tsugawa H., 2016, PLATFORM RIKEN METAB; Van Weyenberg S, 2006, LIVEST SCI, V99, P3, DOI 10.1016/j.livprodsci.2005.04.008; Varloud M, 2007, J ANIM SCI, V85, P2508, DOI 10.2527/jas.2006-182; Weese JS, 2015, EQUINE VET J, V47, P641, DOI 10.1111/evj.12361; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yuki N, 2000, APPL ENVIRON MICROB, V66, P5030, DOI 10.1128/AEM.66.11.5030-5034.2000; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	39	62	65	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166523	10.1371/journal.pone.0166523	http://dx.doi.org/10.1371/journal.pone.0166523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846295	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600075
J	Wang, JQ; Fei, XC; Wu, WZ; Chen, XH; Su, LP; Zhu, ZG; Zhou, YY				Wang, Junqing; Fei, Xiaochun; Wu, Weize; Chen, Xuehua; Su, Liping; Zhu, Zhenggang; Zhou, Yunyun			SLC7A5 Functions as a Downstream Target Modulated by CRKL in Metastasis Process of Gastric Cancer SGC-7901 Cells	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; EXPRESSION; LAT1; CARCINOMA; PROLIFERATION; MIR-126; GROWTH	SLC7A5, who is also named LAT-1, has been validated as a promoter regulated by miRNA-126 in our previous research for gastric cancer cells. However, the mechanisms driving SLC7A5 to affect the bio-function of gastric cancer cells are unclear, remaining us lots of to elucidate. The aim of this study is to investigate the regulating effect of CRKL, one of the critical genes involving with gastric cancer progression, on SLC7A5 expression. By studying the gastric cancer cell lines and clinical pathological specimens, we found that the expression of SLC7A5 was significantly correlated to CRKL. By depleting CRKL in gastric cancer SGC-7901 cells, the SLC7A5 expression was impaired, and the invasion and migration of SGC-7901 cells were suppressed. Ectopic expression of SLC7A5 could drastically rescue the phenotypes induced by CRKL depletion in this study. Accordingly, we conclude that SLC7A5 functions as a promoter in gastric cancer metastasis, and CRKL could be one of its regulators modulating the expression of SLC7A5 and consequentially affect the metastatic feature of SGC-7901 cells. The findings in this study indicate a regulation relationship between CRKL and SLC7A5, and provide useful evidence for gastric cancer therapeutic strategies.	[Wang, Junqing; Wu, Weize; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Surg, Sch Med, Shanghai, Peoples R China; [Wang, Junqing; Wu, Weize; Chen, Xuehua; Su, Liping; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms, Sch Med, Shanghai, Peoples R China; [Wang, Junqing; Wu, Weize; Chen, Xuehua; Su, Liping; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Sch Med, Shanghai, Peoples R China; [Fei, Xiaochun] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China; [Zhou, Yunyun] Univ Mississippi, Med Ctr, Dept Data Sci, Jackson, MS 39216 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Mississippi; University of Mississippi Medical Center	Wang, JQ (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Surg, Sch Med, Shanghai, Peoples R China.; Wang, JQ (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms, Sch Med, Shanghai, Peoples R China.; Wang, JQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Sch Med, Shanghai, Peoples R China.; Zhou, YY (corresponding author), Univ Mississippi, Med Ctr, Dept Data Sci, Jackson, MS 39216 USA.	wangjunqingmd@hotmail.com; zhouyy666041@126.com		/0000-0001-6874-9614	National Natural Science Foundation of China [81602544, 81372187]; Techpool Fund commercial in China [UF201401]; Liu Haoqing Foundation for Medicine, Ruijin Hospital Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Techpool Fund commercial in China; Liu Haoqing Foundation for Medicine, Ruijin Hospital Shanghai	This study was kindly supported by grants from the following: National Natural Science Foundation of China (No. 81602544, No. 81372187), Techpool Fund commercial in China (No. UF201401), and Liu Haoqing Foundation for Medicine, Ruijin Hospital Shanghai.	[Anonymous], 2011, ANN SURG ONCOL, V18, P1060, DOI [10.1245/s10434-010-1424-2, DOI 10.1245/S10434-010-1424-2]; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dolgodilina E, 2016, J CEREBR BLOOD F MET, V36, P1929, DOI 10.1177/0271678X15609331; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Furuya M, 2012, NIHON RINSHO S7, V70, P443; Galluccio M, 2013, PROTEIN J, V32, P442, DOI 10.1007/s10930-013-9503-4; Ghosh A, 2016, INT J CANCER, V138, P2732, DOI 10.1002/ijc.29999; Habermeier A, 2015, AMINO ACIDS, V47, P335, DOI 10.1007/s00726-014-1863-3; Huang YP, 2015, J CLIN INVEST, V125, P1019, DOI 10.1172/JCI77278; Kalmar A, 2013, METHODS, V59, pS16, DOI 10.1016/j.ymeth.2012.09.011; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Li Nan, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P809, DOI 10.3969/j.issn.1672-7347.2013.08.009; Lindskog C, 2015, EXPERT REV MOL DIAGN, V15, P471, DOI 10.1586/14737159.2015.1002772; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Napolitano L, 2015, INT J BIOCHEM CELL B, V67, P25, DOI 10.1016/j.biocel.2015.08.004; Panigrahi S, 2012, PLOS ONE, V7, P6, DOI 10.1371/journal.pone.0028395; Patel M, 2013, INT J PHARMACEUT, V443, P245, DOI 10.1016/j.ijpharm.2012.12.029; Rosilio C, 2015, LEUKEMIA, V29, P1253, DOI 10.1038/leu.2014.338; Russo F, 2014, WORLD J GASTROENTERO, V20, P13258, DOI 10.3748/wjg.v20.i37.13258; Singer CF, 2006, ONCOL REP, V15, P353; Ungewiss C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18652; Wang JQ, 2013, CHEM-BIOL INTERACT, V206, P230, DOI 10.1016/j.cbi.2013.09.003; Wang JQ, 2013, BIOMED PHARMACOTHER, V67, P693, DOI 10.1016/j.biopha.2013.05.003; Wang W, COMP UICC TNM STAGIN; Xie XL, 2013, FOOD CHEM TOXICOL, V59, P137, DOI 10.1016/j.fct.2013.05.044; Xu MH, 2016, J UROLOGY, V195, P1588, DOI 10.1016/j.juro.2015.11.071; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	29	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166147	10.1371/journal.pone.0166147	http://dx.doi.org/10.1371/journal.pone.0166147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846244	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600034
J	Fallah, Z; Jamali, Y; Rafii-Tabar, H				Fallah, Zohreh; Jamali, Yousef; Rafii-Tabar, Hashem			Structural and Functional Effect of an Oscillating Electric Field on the Dopamine-D3 Receptor: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; D-3 RECEPTORS; HEPTAHELICAL RECEPTORS; THERAPEUTIC AGENTS; MEMBRANE-PROTEINS; D3 RECEPTOR; IONIC LOCK	Dopamine as a neurotransmitter plays a critical role in the functioning of the central nervous system. The structure of D3 receptor as a member of class A G-protein coupled receptors (GPCRs) has been reported. We used MD simulation to investigate the effect of an oscillating electric field, with frequencies in the range 0.6-800 GHz applied along the z-direction, on the dopamine-D3R complex. The simulations showed that at some frequencies, the application of an external oscillating electric field along the z-direction has a considerable effect on the dopamine-D3R. However, there is no enough evidence for prediction of changes in specific frequency, implying that there is no order in changes. Computing the correlation coefficient parameter showed that increasing the field frequency can weaken the interaction between dopamine and D3R and may decrease the Arg128{3.50}-Glu324{6.30} distance. Because of high stability of a helices along the z-direction, applying an oscillating electric field in this direction with an amplitude 10-time higher did not have a considerable effect. However, applying the oscillating field at the frequency of 0.6 GHz along other directions, such as X-Y and Y-Z planes, could change the energy between the dopamine and the D3R, and the number of internal hydrogen bonds of the protein. This can be due to the effect of the direction of the electric field vis-a-vis the ligands orientation and the interaction of the oscillating electric field with the dipole moment of the protein.	[Fallah, Zohreh; Jamali, Yousef] Inst Res Fundamental Sci IPM, Sch Nanosci, Tehran, Iran; [Jamali, Yousef] Tarbiat Modares Univ, Dept Math, Tehran, Iran; [Rafii-Tabar, Hashem] Shahid Beheshti Univ Med Sci, Dept Med Phys & Biomed Engn, Fac Med, Tehran, Iran	Tarbiat Modares University; Shahid Beheshti University Medical Sciences	Rafii-Tabar, H (corresponding author), Shahid Beheshti Univ Med Sci, Dept Med Phys & Biomed Engn, Fac Med, Tehran, Iran.	rafii-tabar@nano.ipm.ac.ir	Jamali, Yousef/V-5156-2019	Jamali, Yousef/0000-0002-5709-3821				Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boeckler F, 2005, J MED CHEM, V48, P694, DOI 10.1021/jm049612a; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; CIVELLI O, 1991, EUR J PHARM-MOLEC PH, V207, P277, DOI 10.1016/0922-4106(91)90001-X; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Feng ZW, 2012, J MOL MODEL, V18, P5051, DOI 10.1007/s00894-012-1509-x; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Garate JA, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3529428; Grossfield A, 2007, PROTEINS, V67, P31, DOI 10.1002/prot.21308; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hall DA, 1999, BIOCHEM PHARMACOL, V58, P285, DOI 10.1016/S0006-2952(99)00101-X; Heidbreder CA, 2005, BRAIN RES REV, V49, P77, DOI 10.1016/j.brainresrev.2004.12.033; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isberg V, 2011, J CHEM INF MODEL, V51, P315, DOI 10.1021/ci100402f; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Jurkiewicz P, 2012, BBA-BIOMEMBRANES, V1818, P609, DOI 10.1016/j.bbamem.2011.11.033; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Levant B, 1997, PHARMACOL REV, V49, P231; Lindahl E, 2008, CURR OPIN STRUC BIOL, V18, P425, DOI 10.1016/j.sbi.2008.02.003; Lohrasebi A, 2012, PHYS MEDICA, V28, P221, DOI 10.1016/j.ejmp.2011.07.004; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Newman AH, 2005, J MED CHEM, V48, P3663, DOI 10.1021/jm040190e; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ortega R, 2009, BIOORG MED CHEM LETT, V19, P1773, DOI 10.1016/j.bmcl.2009.01.067; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Plesnar E, 2012, BBA-BIOMEMBRANES, V1818, P520, DOI 10.1016/j.bbamem.2011.10.023; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sajadi M, 2014, MOL SIMULAT, V40, P399, DOI 10.1080/08927022.2013.812789; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	59	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166412	10.1371/journal.pone.0166412	http://dx.doi.org/10.1371/journal.pone.0166412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832207	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000122
J	Ge, BB; Liu, BH; Nwet, TT; Zhao, WJ; Shi, LM; Zhang, KC				Ge, Beibei; Liu, Binghua; Thinn Thinn Nwet; Zhao, Wenjun; Shi, Liming; Zhang, Kecheng			Bacillus methylotrophicus Strain NKG-1, Isolated from Changbai Mountain, China, Has Potential Applications as a Biofertilizer or Biocontrol Agent	PLOS ONE			English	Article							PLANT-GROWTH PROMOTION; BIOLOGICAL-CONTROL; SUBTILIS; BIOSURFACTANT; LIPOPEPTIDES; BACTERIUM; DISEASE; ACID	Chemical pesticides are widely used in agriculture, which endangers both environmental health and food safety. Biocontrol is an environmentally-friendly and cost-effective green technique in environmental protection and agricultural production; it generally uses selected bioresources, including beneficial microorganisms. We isolated a novel bacterial strain (NKG-1) from the rare dormant volcanic soils of Changbai Mountain in China's Jilin Province. The strain was identified as Bacillus methylotrophicus using morphological, biochemical, physiological, and phylogenetic 16S rDNA sequencing data. This strain was able to suppress mycelial growth and conidial germination of numerous plant pathogenic fungi on solid media. A greenhouse experiment showed that application of NKG-1 fermentation broth prior to inoculation of Botrytis cinerea, the cause of gray tomato mold, inhibited growth of the mold by 60%. Furthermore, application of a 100x dilution of NKG-1 fermentation broth to tomato seedlings yielded a significant increase in seedling fresh weight (27.4%), seedling length (12.5%), and root length (57.7%) compared to the control. When the same dosage was applied in the field, we observed increases in tomato plant height (14.7%), stem diameter (12.7%), crown width (16.3%), and maximum fruit diameter (11.5%). These results suggest that NKG-1 has potential commercial application as a biofertilizer or biocontrol agent.	[Ge, Beibei; Liu, Binghua; Zhao, Wenjun; Shi, Liming; Zhang, Kecheng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Thinn Thinn Nwet] Kyaukse Technol Univ, Dept Biotechnol, Kyaukse, Mandalay, Myanmar	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, KC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	zhangkecheng@sina.com			National Natural Science Foundation [31401796, 31371985]; Special Fund for Agro-Scientific Research in the Public Interest in China [201303025]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest in China	This work was supported by grants from the National Natural Science Foundation (31401796, 31371985) and the Special Fund for Agro-Scientific Research in the Public Interest in China (201303025).	Abdallah RAB, 2006, BIOL CONTROL, V97, P80; Almoneafy A. A., 2012, African Journal of Biotechnology, V11, P7193; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Cavaglieri L, 2005, RES MICROBIOL, V156, P748, DOI 10.1016/j.resmic.2005.03.001; Chandankere R, 2013, BIOCHEM ENG J, V74, P46, DOI 10.1016/j.bej.2013.02.018; Chaves JQ, 2011, INT J FOOD MICROBIOL, V147, P12, DOI 10.1016/j.ijfoodmicro.2011.02.029; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; De Cal A, 2009, BIOL CONTROL, V46, P267; FERREIRA JHS, 1991, PHYTOPATHOLOGY, V81, P283, DOI 10.1094/Phyto-81-283; Garrity G.M., 2004, BERGEYS MANUAL SYSTE; GEISSBUHLER H, 1982, SCIENCE, V217, P505, DOI 10.1126/science.217.4559.505; Goudjal Y, 2014, MICROBIOL RES, V169, P59, DOI 10.1016/j.micres.2013.06.014; Huang XQ, 2012, MICROBIOL RES, V167, P135, DOI 10.1016/j.micres.2011.06.002; Joshi S, 2008, BIORESOURCE TECHNOL, V99, P4603, DOI 10.1016/j.biortech.2007.07.030; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Lee JP, 2006, BIOL CONTROL, V37, P329, DOI 10.1016/j.biocontrol.2006.01.001; Leelasuphakul W, 2008, POSTHARVEST BIOL TEC, V48, P113, DOI 10.1016/j.postharvbio.2007.09.024; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Liu B, 2010, PESTIC BIOCHEM PHYS, V98, P305, DOI 10.1016/j.pestbp.2010.07.001; Lucy M, 2004, ANTON LEEUW INT J G, V86, P25; Ma Y, 2008, BIOL CONTROL, V44, P24, DOI 10.1016/j.biocontrol.2007.10.005; Mehta P, 2014, ACTA PHYSIOL PLANT, V36, P2033, DOI 10.1007/s11738-014-1581-1; Meschke H, 2010, MICROB BIOTECHNOL, V3, P428, DOI 10.1111/j.1751-7915.2010.00165.x; Montealegre JR, 2003, ELECTRON J BIOTECHN, V6, P115, DOI 10.2225/vol6-issue2-fulltext-8; Muslim A., 2003, Mycoscience, V44, P77, DOI 10.1007/s10267-002-0084-x; Naureen Z, 2009, CROP PROT, V28, P1052, DOI 10.1016/j.cropro.2009.08.007; Nielsen MN, 1998, APPL ENVIRON MICROB, V64, P3563; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Sadeghi A., 2006, Pakistan Journal of Biological Sciences, V9, P904, DOI 10.3923/pjbs.2006.904.910; Shan HY, 2013, CROP PROT, V44, P29, DOI 10.1016/j.cropro.2012.10.012; Smibert Robert M., 1994, P607; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tindall BJ., 2007, METHODS GEN MOL MICR, V3, P330, DOI DOI 10.1128/9781555817497.CH15; Toure Y, 2004, J APPL MICROBIOL, V96, P1151, DOI 10.1111/j.1365-2672.2004.02252.x; Xue QY, 2009, BIOL CONTROL, V48, P252, DOI 10.1016/j.biocontrol.2008.11.004; Zhang QL, 2012, BIORESOURCE TECHNOL, V108, P35, DOI 10.1016/j.biortech.2011.12.139; Zhang Y, 2015, PLANT SOIL, V392, P309, DOI 10.1007/s11104-015-2464-y; Zhao QY, 2013, BIOCONTROL, V58, P283, DOI 10.1007/s10526-012-9496-5; Zou CS, 2010, J MICROBIOL, V48, P460, DOI 10.1007/s12275-010-0068-z	40	21	32	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166079	10.1371/journal.pone.0166079	http://dx.doi.org/10.1371/journal.pone.0166079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832162	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000062
J	Gupta, S; Chaudhary, K; Dhanda, SK; Kumar, R; Kumar, S; Sehgal, M; Nagpal, G; Raghava, GPS				Gupta, Sudheer; Chaudhary, Kumardeep; Dhanda, Sandeep Kumar; Kumar, Rahul; Kumar, Shailesh; Sehgal, Manika; Nagpal, Gandharva; Raghava, Gajendra P. S.			A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer	PLOS ONE			English	Article							T-CELL EPITOPES; IN-SILICO PREDICTION; HLA-DR; C-KIT; IDENTIFICATION; PEPTIDES; ANTIGENS; MELANOMA; LIGANDS; MOUSE	Due to advancement in sequencing technology, genomes of thousands of cancer tissues or cell-lines have been sequenced. Identification of cancer-specific epitopes or neoepitopes from cancer genomes is one of the major challenges in the field of immunotherapy or vaccine development. This paper describes a platform Cancertope, developed for designing genome-based immunotherapy or vaccine against a cancer cell. Broadly, the integrated resources on this platform are apportioned into three precise sections. First section explains a cancer-specific database of neoepitopes generated from genome of 905 cancer cell lines. This database harbors wide range of epitopes (e.g., B-cell, CD8(+) T-cell, HLA class I, HLA class II) against 60 cancer-specific vaccine antigens. Second section describes a partially personalized module developed for predicting potential neoepitopes against a user-specific cancer genome. Finally, we describe a fully personalized module developed for identification of neoepitopes from genomes of cancerous and healthy cells of a cancer-patient. In order to assist the scientific community, wide range of tools are incorporated in this platform that includes screening of epitopes against human reference proteome (http://vvvvw.imtech. res.inkaghavaibancertope/).	[Gupta, Sudheer; Chaudhary, Kumardeep; Dhanda, Sandeep Kumar; Kumar, Rahul; Kumar, Shailesh; Sehgal, Manika; Nagpal, Gandharva; Raghava, Gajendra P. S.] CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India.	raghava@imtech.res.in	Dhanda, Sandeep Kumar/J-8471-2016; Kumar, Rahul/ABB-3530-2020; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; kumar, rahul/GZG-2171-2022; Chaudhary, Kumardeep/Q-9740-2018	Dhanda, Sandeep Kumar/0000-0003-1381-7434; Raghava, Gajendra P.S./0000-0002-8902-2876; Chaudhary, Kumardeep/0000-0002-4117-6403; Kumar, Rahul/0000-0002-6927-5390; Gupta, Sudheer/0000-0002-6836-6696; Kumar, Shailesh/0000-0002-1872-9903	project Open Source Drug Discovery (OSDD); GENESIS [BSC0121]	project Open Source Drug Discovery (OSDD); GENESIS	Authors are thankful to project Open Source Drug Discovery (OSDD) and GENESIS BSC0121.	Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Ashman LK, 2013, EXPERT OPIN INV DRUG, V22, P103, DOI 10.1517/13543784.2013.740010; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bergot Anne-Sophie, 2011, Cancers (Basel), V3, P3461, DOI 10.3390/cancers3033461; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bodey B, 2000, ANTICANCER RES, V20, P2665; Brossart P, 1999, BLOOD, V93, P4309, DOI 10.1182/blood.V93.12.4309.412k19_4309_4317; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Cai A, 2012, CLIN CANCER RES, V18, P5761, DOI 10.1158/1078-0432.CCR-12-1182; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Dhanda SK, 2016, BRIEF BIOINFORM; Emens LA, 2008, EXPERT OPIN EMERG DR, V13, P295, DOI [10.1517/14728214.13.2.295, 10.1517/14728214.13.2.295 ]; Fidler IJ, 2012, HUM VACC IMMUNOTHER, V8, P1141, DOI 10.4161/hv.19643; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Fisk B, 1997, INT J ONCOL, V10, P159; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kato M, 2004, CANCER RES, V64, P801, DOI 10.1158/0008-5472.CAN-03-2532; Khalili JS, 2012, ONCOIMMUNOLOGY, V1, P1281, DOI 10.4161/onci.21511; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Kwak LW, 2011, CANCER PREV RES, V4, P954, DOI 10.1158/1940-6207.CAPR-11-0236; Lata Sneh, 2009, BMC Res Notes, V2, P61, DOI 10.1186/1756-0500-2-61; Li J, 2010, HUM MUTAT, V31, P219, DOI 10.1002/humu.21176; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morrow MP, 2013, EXPERT REV VACCINES, V12, P271, DOI [10.1586/ERV.13.23, 10.1586/erv.13.23]; Mustafa AS, 2011, CLIN VACCINE IMMUNOL, V18, P1752, DOI 10.1128/CVI.05260-11; Mustafa AS, 2006, TUBERCULOSIS, V86, P115, DOI 10.1016/j.tube.2005.05.001; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Roider J, 2014, IMMUNOLOGY, V143, P193, DOI 10.1111/imm.12301; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha Sudipto, 2007, V409, P387, DOI 10.1007/978-1-60327-118-9_29; Schirle M, 2000, EUR J IMMUNOL, V30, P2216, DOI 10.1002/1521-4141(2000)30:18<2216::AID-IMMU2216>3.3.CO;2-F; Schuler Mathias M., 2007, V409, P75; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Somasundaram R, 2006, CANCER RES, V66, P3287, DOI 10.1158/0008-5472.CAN-05-1932; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Warren RL, 2010, HUM IMMUNOL, V71, P245, DOI 10.1016/j.humimm.2009.12.007; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078389; Zhang LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030483; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166372	10.1371/journal.pone.0166372	http://dx.doi.org/10.1371/journal.pone.0166372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832200	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000113
J	Janssens, W; Goedecke, J; de Bree, GJ; Aderibigbe, SA; Akande, TM; Mesnard, A				Janssens, Wendy; Goedecke, Jann; de Bree, Godelieve J.; Aderibigbe, Sunday A.; Akande, Tanimola M.; Mesnard, Alice			The Financial Burden of Non-Communicable Chronic Diseases in Rural Nigeria: Wealth and Gender Heterogeneity in Health Care Utilization and Health Expenditures	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CHOICE; PROVIDER; INDIA; DISTANCE; SEEKING; AFRICA; ACCESS	Objectives Better insights into health care utilization and out-of-pocket expenditures for non-communicable chronic diseases (NCCD) are needed to develop accessible health care and limit the increasing financial burden of NCCDs in Sub-Saharan Africa. Methods A household survey was conducted in rural Kwara State, Nigeria, among 5,761 individuals. Data were obtained using biomedical and socio-economic questionnaires. Health care utilization, NCCD-related health expenditures and distances to health care providers were compared by sex and by wealth quintile, and a Heckman regression model was used to estimate health expenditures taking selection bias in health care utilization into account. Results The prevalence of NCCDs in our sample was 6.2%. NCCD-affected individuals from the wealthiest quintile utilized formal health care nearly twice as often as those from the lowest quintile (87.8% vs 46.2%, p = 0.002). Women reported foregone formal care more often than men (43.5% vs. 27.0%, p = 0.058). Health expenditures relative to annual consumption of the poorest quintile exceeded those of the highest quintile 2.2-fold, and the poorest quintile exhibited a higher rate of catastrophic health spending (10.8% among NCCD-affected households) than the three upper quintiles (4.2% to 6.7%). Long travel distances to the nearest provider, highest for the poorest quintile, were a significant deterrent to seeking care. Using distance to the nearest facility as instrument to account for selection into health care utilization, we estimated out-of-pocket health care expenditures for NCCDs to be significantly higher in the lowest wealth quintile compared to the three upper quintiles. Conclusions Facing potentially high health care costs and poor accessibility of health care facilities, many individuals suffering from NCCDs particularly women and the poor forego formal care, thereby increasing the risk of more severe illness in the future. When seeking care, the poor spend less on treatment than the rich, suggestive of lower quality care, while their expenditures represent a higher share of their annual household consumption. This calls for targeted interventions that enhance health care accessibility and provide financial protection from the consequences of NCCDs, especially for vulnerable populations.	[Janssens, Wendy] Vrije Univ Amsterdam, Fac Econ, Amsterdam, Netherlands; [Janssens, Wendy] Tinbergen Inst, Amsterdam, Netherlands; [Janssens, Wendy] Amsterdam Inst Int Dev, Amsterdam, Netherlands; [Goedecke, Jann] Katholieke Univ Leuven, Fac Econ & Business, Campus Brussel, Brussels, Belgium; [Goedecke, Jann] Univ Agder, Sch Business & Law, Kristiansand, Norway; [de Bree, Godelieve J.] PharmAccess Fdn, Amsterdam, Netherlands; [de Bree, Godelieve J.] Univ Amsterdam, Acad Med Ctr, Ctr Trop & Travel Med, Amsterdam, Netherlands; [Aderibigbe, Sunday A.; Akande, Tanimola M.] Univ Ilorin, Dept Epidemiol & Community Hlth, Teaching Hosp, Ilorin, Nigeria; [Mesnard, Alice] City Univ London, London, England; [Mesnard, Alice] Inst Fiscal Studies, London, England; [Mesnard, Alice] CEPR, London, England; [Mesnard, Alice] Ctr Global Dev, London, England	Vrije Universiteit Amsterdam; Tinbergen Institute; KU Leuven; University of Agder; University of Amsterdam; Academic Medical Center Amsterdam; University of Ilorin; City University London; University of London; London School Economics & Political Science; Centre for Economic Policy Research - UK; Center for Global Development - Europe	Goedecke, J (corresponding author), Katholieke Univ Leuven, Fac Econ & Business, Campus Brussel, Brussels, Belgium.; Goedecke, J (corresponding author), Univ Agder, Sch Business & Law, Kristiansand, Norway.	janng@uia.no	Akande, Tanimola Makanjuola/U-1362-2019	Goedecke, Jann/0000-0002-2288-8464; Janssens, Wendy/0000-0002-2085-8608	Health Insurance Fund; Netherlands Organisation for Scientific Research [451-10-002]; Agence Frangaise de Developpement (AFD); Institut de recherche pour le developpement (IRD); Agence inter-etablissements de recherche pour le developpement (AIRD); William and Flora Hewlett foundation	Health Insurance Fund; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Agence Frangaise de Developpement (AFD); Institut de recherche pour le developpement (IRD); Agence inter-etablissements de recherche pour le developpement (AIRD); William and Flora Hewlett foundation	The authors thank the Health Insurance Fund (www.hifund.org) for funding the data collection. The Netherlands Organisation for Scientific Research (www.nwo.nl/en) has provided funding for research time of WJ under grant nr. 451-10-002. The financial support through the grant "Health risks and Migration" by Agence Frangaise de Developpement (AFD), Institut de recherche pour le developpement (IRD), Agence inter-etablissements de recherche pour le developpement (AIRD) and the William and Flora Hewlett foundation is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Adisa O, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0188-5; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akin JS, 1999, HEALTH POLICY PLANN, V14, P135, DOI 10.1093/heapol/14.2.135; Amaghionyeodiwe LA, 2008, HEALTH CARE MANAG SC, V11, P215, DOI 10.1007/s10729-007-9038-3; Arsanjani JJ, 2015, LECT NOTES GEOINF CA, P1, DOI 10.1007/978-3-319-14280-7; Binnendijk E, 2012, TROP MED INT HEALTH, V17, P1376, DOI 10.1111/j.1365-3156.2012.03070.x; Borah BJ, 2006, HEALTH ECON, V15, P915, DOI 10.1002/hec.1166; BURBIDGE JB, 1988, J AM STAT ASSOC, V83, P123, DOI 10.2307/2288929; Central Bank of Nigeria, ANN REP STAT ACC; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Dean N, 2015, J SURV STAT METHODOL, V3, P484, DOI [10.1093/jssam/smv024, DOI 10.1093/JSSAM/SMV024]; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; DOR A, 1987, J HEALTH ECON, V6, P291, DOI 10.1016/0167-6296(87)90017-8; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; ESCOBAR ML, 2011, IMPACT HLTH INSURANC; Fagbamigbe AF, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0043-9; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Habtom GK, 2007, HEALTH POLICY, V80, P202, DOI 10.1016/j.healthpol.2006.02.012; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hjortsberg C, 2003, HEALTH ECON, V12, P755, DOI 10.1002/hec.839; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huber S, 2016, STATA J, V16, P416, DOI 10.1177/1536867X1601600209; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Klemick H, 2009, AM J AGR ECON, V91, P347, DOI 10.1111/j.1467-8276.2009.01252.x; Louw QA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-105; Marquez PV, 2013, CHALLENGE NONCOMMUNI; Matul M., 2013, 17 MICR INN FAC; Ministry of Health Nigeria (TWG-NSHDP/HEALTH SECTOR DEVELOPMENT TEAM), 2009, NAT STRAT HLTH DEV P; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Mohanty Sanjay K., 2009, Genus, V65, P113; Murray C.J.L., 2003, HLTH SYSTEMS PERFORM; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Onwujekwe O, 2005, SOC SCI MED, V61, P455, DOI 10.1016/j.socscimed.2004.11.066; Onwujekwe Obinna, 2005, Health Policy, V71, P383, DOI 10.1016/j.healthpol.2004.06.006; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Puhani PA, 2000, J ECON SURV, V14, P53, DOI 10.1111/1467-6419.00104; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Sarma S, 2009, APPL HEALTH ECON HEA, V7, P265, DOI 10.2165/10899650-000000000-00000; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; Steyn K, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P247; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organization, 2013, PROJ MORT BURD DIS 2; World Health Organization (WHO), 2016, GLOBAL STATUS REPORT; WYSZEWIANSKI L, 1986, INQUIRY-J HEALTH CAR, V23, P382; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	51	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166121	10.1371/journal.pone.0166121	http://dx.doi.org/10.1371/journal.pone.0166121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832107	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000066
J	Kalra, S; Pradeep, MA; Mohanty, AK; Kaushik, JK				Kalra, Shalini; Pradeep, Mangottil Ayyappan; Mohanty, Ashok K.; Kaushik, Jai K.			Structural, Functional and Phylogenetic Analysis of Sperm Lysozyme-Like Proteins	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; X-RAY-STRUCTURE; PROTEOMIC ANALYSIS; SUBSITE-F; CARBOHYDRATE INTERACTIONS; STOMACH LYSOZYMES; MOLECULAR-DYNAMICS; CATALYTIC ACTION; BINDING ABILITY; RAINBOW-TROUT	Sperm lysozyme-like proteins belonging to c-type lysozyme family evolved in multiple forms. Lysozyme-like proteins, viz., LYZL2, LYZL3 or SLLP1, LYZL4, LYZL5 and LYZL6 are expressed in the testis of mammals. Not all members of LYZL family have been uniformly and unambiguously identified in the genome and proteome of mammals. Some studies suggested a role of SLLP1 and LYZL4 in fertilization; however, the function of other LYZL proteins is unknown. We identified all known forms of LYZL proteins in buffalo sperm by LC-MS/MS. Cloning and sequence analysis of the Lyz/cDNA showed 38-50% identity at amino acid level among the buffalo LYZL paralogs, complete conservation of eight cysteines and other signature sequences of c-type lysozyme family. Catalytic residues in SLLP1, LYZL4 and LYZL5 have undergone replacement. The substrate binding residues showed significant variation in LYZL proteins. Residues at sites 62, 101, 114 in LYZL4; 101 in SLLP1; 37, 62, and 101 in LYZL6 were more variable among diverse species. Sites 63 and 108 occupied by tryptophan were least tolerant to variation. Site 37 also showed lower tolerance to substitution in SLLP1, LYZL4 and LYZL5, but more variable in non-testicular lysozymes. Models of LYZL proteins were created by homology modeling and the substrate binding pockets were analyzed in term of binding energies and contacting residues of LYZL proteins with tri-N-acetylglucosamine (NAG)3 in the A-B-C and B-C-D binding mode. Except LYZL6, LYZL proteins did not show significant difference in binding energies in comparison to hen egg white lysozyme in the A-B-C mode. (NAG)3 binding energy in the B-C-D mode was higher by 1.3-2.2 kcal/mol than in A-B-C mode. Structural analysis indicated that (NAG)3 was involved in making more extensive interactions including hydrogen bonding with LYZL proteins in B-C-D mode than in A-B-C mode. Despite large sequence divergence among themselves and with respect to c-type lysozymes, substrate binding residues as well as hydrogen bonding network between (NAG)3 and proteins were mostly conserved. LYZL5 in buffalo and other mammalian species contained additional 10-12 amino acid sequence at c-terminal that matched with ankyrin repeat domain-containing protein 27. Phylogenetic analysis indicated LYZL2 to be most ancient among all the LYZL proteins and that the evolution of LYZL proteins occurred through several gene duplications preceding the speciation of mammals from other vertebrates as distant as reptiles and amphibians.	[Kalra, Shalini; Pradeep, Mangottil Ayyappan; Mohanty, Ashok K.; Kaushik, Jai K.] Natl Dairy Res Inst, BTIS SubDIC Anim Biotechnol Ctr, Karnal 132001, Haryana, India; [Pradeep, Mangottil Ayyappan] Cent Marine Fisheries Res Inst, Marine Biotechnol Div, Kochi 682018, Kerala, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Marine Fisheries Research Institute	Kaushik, JK (corresponding author), Natl Dairy Res Inst, BTIS SubDIC Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	jaikr1@gmail.com			Council for Scientific and Industrial Research, New Delhi	Council for Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	SK was supported by the Junior and Senior Research Fellowships of Council for Scientific and Industrial Research, New Delhi, for doctoral program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SK was supported by the Junior and Senior Research Fellowships of Council for Scientific and Industrial Research, New Delhi, for doctoral program. The authors thank the Department of Biotechnology, Ministry of Science and Technology for providing computational facility under the framework of BTISnet.	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0007-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral A, 2014, J PROTEOME RES, V13, P5670, DOI 10.1021/pr500652y; Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; Baker MA, 2007, PROTEOM CLIN APPL, V1, P524, DOI 10.1002/prca.200601013; Baker MA, 2013, PROTEOMICS, V13, P61, DOI 10.1002/pmic.201200350; Baldwin E, 1996, J MOL BIOL, V259, P542, DOI 10.1006/jmbi.1996.0338; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; Byrne K, 2012, PROTEOMICS, V12, P3559, DOI 10.1002/pmic.201200133; CHEETHAM JC, 1992, J MOL BIOL, V224, P613, DOI 10.1016/0022-2836(92)90548-X; Chiu WWC, 2004, HUM REPROD, V19, P243, DOI 10.1093/humrep/deh050; de Mateo S, 2007, PROTEOMICS, V7, P4264, DOI 10.1002/pmic.200700521; de Mateo S, 2011, PROTEOMICS, V11, P2714, DOI 10.1002/pmic.201000799; DOBSON DE, 1984, J BIOL CHEM, V259, P1607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gadave KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087618; Garcia-Hernandez E, 2003, PROTEIN SCI, V12, P135, DOI 10.1110/ps.0222503; Gu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019386; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; HADFIELD AT, 1994, J MOL BIOL, V243, P856, DOI 10.1006/jmbi.1994.1688; Harata K, 1997, ACTA CRYSTALLOGR D, V53, P650, DOI 10.1107/S0907444997005362; HARATA K, 1993, J MOL BIOL, V233, P524, DOI 10.1006/jmbi.1993.1529; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Imoto T, 1972, ENZYMES, V7, P665; INOUE M, 1992, BIOCHEMISTRY-US, V31, P5545, DOI 10.1021/bi00139a017; Irwin D.M., 1996, Experientia Supplementum (Basel), V75, P347; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; IRWIN DM, 1989, J BIOL CHEM, V264, P11387; IRWIN DM, 1990, J BIOL CHEM, V265, P4944; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; KARLSEN S, 1995, ACTA CRYSTALLOGR D, V51, P962, DOI 10.1107/S0907444995005105; Kaushik JK, 2006, BIOCHEMISTRY-US, V45, P7100, DOI 10.1021/bi052610n; Kawaguchi Y, 2015, BIOSCI BIOTECH BIOCH, V79, P196, DOI 10.1080/09168451.2014.963502; Kawamura S, 2004, BIOSCI BIOTECH BIOCH, V68, P593, DOI 10.1271/bbb.68.593; Kawamura S, 2008, BIOSCI BIOTECH BIOCH, V72, P823, DOI 10.1271/bbb.70694; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Kovac JR, 2013, FERTIL STERIL, V99, P998, DOI 10.1016/j.fertnstert.2013.01.111; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KUMAGAI I, 1989, J BIOCHEM-TOKYO, V105, P946, DOI 10.1093/oxfordjournals.jbchem.a122784; KUMAGAI I, 1987, J BIOCHEM-TOKYO, V102, P733, DOI 10.1093/oxfordjournals.jbchem.a122111; KUMAGAI I, 1992, J BIOL CHEM, V267, P4608; KUMAGAI I, 1993, EUR J BIOCHEM, V212, P151, DOI 10.1111/j.1432-1033.1993.tb17645.x; Kwon WS, 2015, MOL CELL PROTEOMICS, V14, P1230, DOI 10.1074/mcp.M114.045369; Le SQ, 1993, MOL BIOL EVOL, V18, P691; LUMB KJ, 1994, J MOL BIOL, V235, P1072, DOI 10.1006/jmbi.1994.1058; MAENAKA K, 1995, J MOL BIOL, V247, P281, DOI 10.1006/jmbi.1994.0139; Maenaka K, 1998, BBA-PROTEIN STRUCT M, V1384, P23, DOI 10.1016/S0167-4838(97)00199-4; Maenaka K, 1998, BIOCHEM J, V333, P71, DOI 10.1042/bj3330071; MAENAKA K, 1994, J BIOL CHEM, V269, P7070; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; MARDH PA, 1974, SCAND J UROL NEPHROL, V8, P179, DOI 10.3109/00365597409132126; Martinez-Heredia J, 2006, PROTEOMICS, V6, P4356, DOI 10.1002/pmic.200600094; McKenzie H.A., 1996, Experientia Supplementum (Basel), V75, P365; MCKENZIE HA, 1991, ADV PROTEIN CHEM, V41, P173; McReynolds S, 2014, FERTIL STERIL, V102, P692, DOI 10.1016/j.fertnstert.2014.05.021; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; MULVEY RS, 1973, BIOCHEMISTRY-US, V12, P2683, DOI 10.1021/bi00738a021; MULVEY RS, 1974, BIOCHEMISTRY-US, V13, P782, DOI 10.1021/bi00701a021; Muraki M, 2000, BIOCHEMISTRY-US, V39, P292, DOI 10.1021/bi991402q; MURAKI M, 1991, BIOCHIM BIOPHYS ACTA, V1079, P229, DOI 10.1016/0167-4838(91)90130-R; MURAKI M, 1989, EUR J BIOCHEM, V179, P573, DOI 10.1111/j.1432-1033.1989.tb14585.x; Narmadha G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027659; Naz RK, 2010, J REPROD IMMUNOL, V84, P24, DOI 10.1016/j.jri.2009.10.006; NITTA K, 1988, BIOL CHEM H-S, V369, P671, DOI 10.1515/bchm3.1988.369.2.671; Ose T, 2009, J BIOCHEM, V146, P651, DOI 10.1093/jb/mvp110; Paasch U, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007187; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Puri P, 2008, BIOL REPROD, V79, P1183, DOI 10.1095/biolreprod.108.068734; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; RUPLEY JA, 1967, PROC R SOC SER B-BIO, V167, P416, DOI 10.1098/rspb.1967.0038; Saadi HAS, 2013, J PROTEOMICS, V82, P64, DOI 10.1016/j.jprot.2013.02.027; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; Schafer IB, 2012, NAT STRUCT MOL BIOL, V19, P1300, DOI 10.1038/nsmb.2414; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; SONG HW, 1994, J MOL BIOL, V244, P522, DOI 10.1006/jmbi.1994.1750; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Sun RL, 2011, ACTA BIOCH BIOPH SIN, V43, P346, DOI 10.1093/abbs/gmr017; Swegen A, 2015, REPRODUCTION, V149, P235, DOI 10.1530/REP-14-0500; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toshima G, 2003, BIOSCI BIOTECH BIOCH, V67, P540, DOI 10.1271/bbb.67.540; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vollan VB, 1999, ACTA CRYSTALLOGR D, V55, P60, DOI 10.1107/S0907444998006623; Von Dreele RB, 2005, ACTA CRYSTALLOGR D, V61, P22, DOI 10.1107/S0907444904025715; Wagner A, 2014, REPROD SCI, V10, P1; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wei J, 2013, ASIAN J ANDROL, V15, P824, DOI 10.1038/aja.2013.93; Yu M, 1996, MOL PHYLOGENET EVOL, V5, P298, DOI 10.1006/mpev.1996.0025; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zheng H, 2015, ANDROLOGY-US, V3, P756, DOI 10.1111/andr.12057; Zhong Y, 2013, J COMPUT CHEM, V34, P163, DOI 10.1002/jcc.23109	98	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166321	10.1371/journal.pone.0166321	http://dx.doi.org/10.1371/journal.pone.0166321			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832206	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000097
J	Kohajda, Z; Farkas-Morvay, N; Jost, N; Nagy, N; Geramipour, A; Horvath, A; Varga, RS; Hornyik, T; Corici, C; Acsai, K; Horvath, B; Prorok, J; Ordog, B; Deri, S; Toth, D; Levijoki, J; Pollesello, P; Koskelainen, T; Otsomaa, L; Toth, A; Baczko, I; Lepran, I; Nanasi, PP; Papp, JG; Varro, A; Virag, L				Kohajda, Zsofia; Farkas-Morvay, Nikolett; Jost, Norbert; Nagy, Norbert; Geramipour, Amir; Horvath, Andras; Varga, Richard S.; Hornyik, Tibor; Corici, Claudia; Acsai, Karoly; Horvath, Balazs; Prorok, Janos; Ordog, Balks; Deri, Szilvia; Toth, Daniel; Levijoki, Jouko; Pollesello, Piero; Koskelainen, Tuula; Otsomaa, Leena; Toth, Andras; Baczko, Istvan; Lepran, Istvan; Nanasi, Peter P.; Papp, Julius Gy; Varro, Andras; Virag, Laszlo			The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGE; REPERFUSION-INDUCED ARRHYTHMIAS; OUABAIN-INDUCED ARRHYTHMIAS; RAT VENTRICULAR MYOCYTES; NA+/CA2+ EXCHANGE; NA/CA EXCHANGE; REPOLARIZATION RESERVE; POTASSIUM CHANNELS; IONIC CURRENTS; CA2+ OVERLOAD	Background In this study the effects of a new, highly selective sodium-calcium exchanger (NCX) inhibitor, ORM-10962 were investigated on cardiac NCX current, Ca2+ transients, cell shortening and in experimental arrhythmias. The level of selectivity of the novel inhibitor on several major transmembrane ion currents (L-type Ca2+ current, major repolarizing K+ currents, late Na+ current, Na+/K+ pump current) was also determined. Methods Ion currents in single dog ventricular cells (cardiac myocytes; CM), and action potentials in dog cardiac multicellular preparations were recorded utilizing the whole-cell patch clamp and standard microelectrode techniques, respectively. Ca2+ transients and cell shortening were measured in fluorescent dye loaded isolated dog myocytes. Antiarrhythmic effects of ORM-10962 were studied in anesthetized ouabain (10 mu g/kg/min i.v.) pretreated guinea pigs and in ischemia-reperfusion models (I/R) of anesthetized coronary artery occluded rats and Langendorff perfused guinea pigs hearts. Results ORM-10962 significantly reduced the inward/outward NCX currents with estimated EC50 values of 55/67 nM, respectively. The compound, even at a high concentration of 1 mu M, did not modify significantly the magnitude of I-CaL in CMs, neither had any apparent influence on the inward rectifier, transient outward, the rapid and slow components of the delayed rectifier potassium currents, the late and peak sodium and Na+/K+ pump currents. NCX inhibition exerted moderate positive inotropic effect under normal condition, negative inotropy when reverse, and further positive inotropic effect when forward mode was facilitated. In dog Purkinje fibres 1 mu M ORM-10962 decreased the amplitude of digoxin induced delayed afterdepolarizations (DADs). Pre-treatment with 0.3 mg/kg ORM-10962 (i.v.) 10 min before starting ouabain infusion significantly delayed the development and recurrence of ventricular extra-systoles (by about 50%) or ventricular tachycardia (by about 30%) in anesthetized guinea pigs. On the contrary, ORM-10962 pre-treatment had no apparent influence on the time of onset or the severity of I/R induced arrhythmias in anesthetized rats and in Langendorff perfused guinea-pig hearts. Conclusions The present study provides strong evidence for a high efficacy and selectivity of the NCX-inhibitory effect of ORM-10962. Selective NCX inhibition can exert positive as well as negative inotropic effect depending on the actual operation mode of NCX. Selective NCX blockade may contribute to the prevention of DAD based arrhythmogenesis, in vivo, however, its effect on I/R induced arrhythmias is still uncertain.	[Farkas-Morvay, Nikolett; Geramipour, Amir; Horvath, Andras; Varga, Richard S.; Hornyik, Tibor; Corici, Claudia; Prorok, Janos; Ordog, Balks; Deri, Szilvia; Toth, Andras; Baczko, Istvan; Lepran, Istvan; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary; [Kohajda, Zsofia; Jost, Norbert; Nagy, Norbert; Horvath, Andras; Acsai, Karoly; Toth, Daniel; Toth, Andras; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary; [Jost, Norbert; Lepran, Istvan] Victor Babes Univ Med & Pharm, Dept Pathophysiol, Timisoara, Romania; [Horvath, Balazs; Nanasi, Peter P.] Univ Debrecen, Dept Physiol, Fac Med, Debrecen, Hungary; [Nanasi, Peter P.] Univ Debrecen, Dept Dent Physiol & Pharmacol, Fac Dent, Debrecen, Hungary; [Levijoki, Jouko; Pollesello, Piero; Koskelainen, Tuula; Otsomaa, Leena] Orion Pharma, Espoo, Finland	Szeged University; Hungarian Academy of Sciences; Victor Babes University of Medicine & Pharmacy, Timisoara; University of Debrecen; University of Debrecen; Orion Corporation	Virag, L (corresponding author), Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary.; Virag, L (corresponding author), Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary.	varrot.andras@med.u_szeged.hu	Baczko, István/I-7752-2019; Horvath, Balazs/T-6637-2019; Pollesello, Piero/I-6884-2019	Baczko, István/0000-0002-9588-0797; Pollesello, Piero/0000-0001-6994-768X; Ordog, Balazs/0000-0002-8971-3079; Nagy, Norbert/0000-0002-4557-8442	Hungarian Scientific Research Fund [OTKA NK-104331, K100151, NN-109904, ANN-113273]; National Office for Research and Technology-Baross and Anyos Jedlik Programmes [REG-DA-09-2-2009-0115-NCXINHIB, NKFP_07_01-RYT07_AF]; Hungarian Academy of Sciences; Ministry of National Education; national excellence program of the ministry of human capacities [UNKP-16-3 - IKT/147-1787/8/2016-OSZT-95]; CNCS UEFISCDI [PN-II-ID-PCE-2012-4-0512]; Orion Pharma	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Office for Research and Technology-Baross and Anyos Jedlik Programmes; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Ministry of National Education; national excellence program of the ministry of human capacities; CNCS UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Orion Pharma	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA NK-104331 for AV, K100151 for IB, NN-109904 for NJ and ANN-113273 for AT), National Office for Research and Technology-Baross and Anyos Jedlik Programmes (REG-DA-09-2-2009-0115-NCXINHIB for NJ and AT and NKFP_07_01-RYT07_AF for AV and NJ), the Hungarian Academy of Sciences (for AV, NJ and AT), the Ministry of National Education, the UNKP-16-3 - IKT/147-1787/8/2016-OSZT-95 (new national excellence program of the ministry of human capacities, FOR ZK), CNCS UEFISCDI, project number PN-II-ID-PCE-2012-4-0512 (for NJ and IB) and by the Orion Pharma. The funders provided support in the form of salaries for some authors (JL, PP, TK, LO by Orion Pharma), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders read the manuscript and agreed to publish the paper in PLOS ONE.	Acsai K, 2007, EUR J PHARMACOL, V576, P1, DOI 10.1016/j.ejphar.2007.07.047; Antoons G, 2012, PHARMACOL THERAPEUT, V134, P26, DOI 10.1016/j.pharmthera.2011.12.001; Baczko I, 1997, J CARDIOVASC PHARM, V29, P196, DOI 10.1097/00005344-199702000-00007; Baczko I, 2003, J PHYSIOL-LONDON, V550, P889, DOI 10.1113/jphysiol.2003.043372; Banyasz T, 2012, HEART RHYTHM, V9, P134, DOI 10.1016/j.hrthm.2011.08.029; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Birinyi P, 2005, N-S ARCH PHARMACOL, V372, P63, DOI 10.1007/s00210-005-1079-x; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BRIDGE JHB, 1991, ANN NY ACAD SCI, V639, P34, DOI 10.1111/j.1749-6632.1991.tb17287.x; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; EISNER DA, 1985, AM J PHYSIOL, V248, pC189, DOI 10.1152/ajpcell.1985.248.3.C189; Elias CL, 2001, AM J PHYSIOL-HEART C, V281, pH1334, DOI 10.1152/ajpheart.2001.281.3.H1334; Gandhi A, 2013, CARDIOVASC THER, V31, pE115, DOI 10.1111/1755-5922.12045; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HILGEMANN DW, 1988, PROG BIOPHYS MOL BIO, V51, P1, DOI 10.1016/0079-6107(88)90009-0; HILGEMANN DW, 1989, PFLUG ARCH EUR J PHY, V415, P247, DOI 10.1007/BF00370601; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Hobai IA, 1997, PFLUG ARCH EUR J PHY, V433, P455, DOI 10.1007/s004240050300; Hryshko, 2001, HDB PHYSL; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Jost N, 2013, J PHYSIOL-LONDON, V591, P4189, DOI 10.1113/jphysiol.2013.261198; LEPRAN I, 1992, J CARDIOVASC PHARM, V19, P40, DOI 10.1097/00005344-199201000-00006; Livshitz L, 2012, J PHYSIOL-LONDON, V590, P4423, DOI 10.1113/jphysiol.2012.228791; Lu HR, 1999, EUR J PHARMACOL, V365, P233, DOI 10.1016/S0014-2999(98)00878-4; Miyamoto S, 2002, JPN J PHARMACOL, V90, P229, DOI 10.1254/jjp.90.229; Morita N, 2011, AM J PHYSIOL-HEART C, V301, pH180, DOI 10.1152/ajpheart.00128.2011; Nagasawa Y, 2005, EUR J PHARMACOL, V506, P249, DOI 10.1016/j.ejphar.2004.11.011; Nagy N, 2014, BRIT J PHARMACOL, V171, P5665, DOI 10.1111/bph.12867; Nagy ZA, 2004, BRIT J PHARMACOL, V143, P827, DOI 10.1038/sj.bjp.0706026; NOBLE D, 1991, ANN NY ACAD SCI, V639, P334, DOI 10.1111/j.1749-6632.1991.tb17323.x; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Schafer C, 2001, CARDIOVASC RES, V51, P241, DOI 10.1016/S0008-6363(01)00282-6; Sipido KR, 2000, CIRCULATION, V102, P2137, DOI 10.1161/01.CIR.102.17.2137; Szepesi J, 2015, J PHYSIOL PHARMACOL, V66, P215; Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2; Tanaka H, 2002, BRIT J PHARMACOL, V135, P1096, DOI 10.1038/sj.bjp.0704574; THOMAS GP, 1986, BRIT J PHARMACOL, V89, P385, DOI 10.1111/j.1476-5381.1986.tb10271.x; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Watano T, 1999, BRIT J PHARMACOL, V127, P1846, DOI 10.1038/sj.bjp.0702740; Yamamura K, 2001, CARDIOVASC RES, V52, P397, DOI 10.1016/S0008-6363(01)00409-6	47	36	36	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166041	10.1371/journal.pone.0166041	http://dx.doi.org/10.1371/journal.pone.0166041			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832106	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000387725000057
J	Marchioro, CA				Marchioro, Cesar A.			Global Potential Distribution of Bactrocera carambolae and the Risks for Fruit Production in Brazil	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOLOGICAL NICHE MODELS; BIOLOGICAL INVASIONS; CLIMATE-CHANGE; LEPIDOPTERA-NOCTUIDAE; DIPTERA TEPHRITIDAE; SAMPLING BIAS; COMPLEXITY; PERFORMANCE; MOVEMENT	The carambola fruit fly, Bactrocera carambolae, is a tephritid native to Asia that has invaded South America through small-scale trade of fruits from Indonesia. The economic losses associated with biological invasions of other fruit flies around the world and the polyphagous behaviour of B. carambolae have prompted much concern among government agencies and farmers with the potential spread of this pest. Here, ecological niche models were employed to identify suitable environments available to B. carambolae in a global scale and assess the extent of the fruit acreage that may be at risk of attack in Brazil. Overall, 30 MaxEnt models built with different combinations of environmental predictors and settings were evaluated for predicting the potential distribution of the carambola fruit fly. The best model was selected based on threshold-independent and threshold-dependent metrics. Climatically suitable areas were identified in tropical and subtropical regions of Central and South America, Sub-Saharan Africa, west and east coast of India and northern Australia. The suitability map of B. carambola was intersected against maps of fruit acreage in Brazil. The acreage under potential risk of attack varied widely among fruit species, which is expected because the production areas are concentrated in different regions of the country. The production of cashew is the one that is at higher risk, with almost 90% of its acreage within the suitable range of B. carambolae, followed by papaya (78%), tangerine (51%), guava (38%), lemon (30%), orange (29%), mango (24%) and avocado (20%). This study provides an important contribution to the knowledge of the ecology of B. carambolae, and the information generated here can be used by government agencies as a decision-making tool to prevent the carambola fruit fly spread across the world.	[Marchioro, Cesar A.] Univ Fed Santa Catarina, Dept Agr Biodivers & Forest, Ctr Rural Sci, Campus Curitibanos, Curitibanos, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Marchioro, CA (corresponding author), Univ Fed Santa Catarina, Dept Agr Biodivers & Forest, Ctr Rural Sci, Campus Curitibanos, Curitibanos, SC, Brazil.	cesmarc@gmail.com	Marchioro, Cesar Augusto/AAU-7562-2021	Marchioro, Cesar Augusto/0000-0002-7257-8114				[Anonymous], FRUIT FLIES EC IMPOR; Bacon SJ, 2014, DIVERS DISTRIB, V20, P84, DOI 10.1111/ddi.12149; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Estay SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102592; FAO, 2013, OR PROD COUNTR; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Froerer K. M., 2010, American Entomologist, V56, P88; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090121; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Jimenez-Valverde A, 2013, GLOBAL ECOL BIOGEOGR, V22, P508, DOI 10.1111/geb.12007; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Lemos LD, 2014, FLA ENTOMOL, V97, P841, DOI 10.1653/024.097.0274; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Martinez-Meyer Enrique, 2005, Biodiversity Informatics, V2, P42; Measey GJ, 2012, BIOL INVASIONS, V14, P2255, DOI 10.1007/s10530-012-0227-8; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Meyer ALS, 2014, AM J PRIMATOL, V76, P551, DOI 10.1002/ajp.22247; Moreno-Amat E, 2015, ECOL MODEL, V312, P308, DOI 10.1016/j.ecolmodel.2015.05.035; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peck SL, 2005, J ECON ENTOMOL, V98, P1539, DOI 10.1603/0022-0493-98.5.1539; Peterson A.T., 2011, ECOLOGICAL NICHES GE, P314; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pomari-Fernandes A., 2015, Current Agricultural Science and Technology, V21, P1; Qin YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116424; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rutherford M. C., 1997, P91; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Sheppard CS, 2013, WEED RES, V53, P259, DOI 10.1111/wre.12021; Silva OLR, 1997, MOSCA CARAMBOLA BACT, P10; Slater H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032202; Slva RA, 2005, REV CIENTIFICA ELETR, P4; SPECHT A, 2013, PESQUI AGROPECU BRAS, V48, P689; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Van Sauers-Muller A, 2005, NEOTROP ENTOMOL, V34, P203, DOI 10.1590/S1519-566X2005000200008; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; West AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117893; Wittenberg R., 2001, Invasive alien species: a toolkit of best prevention and management practices, DOI 10.1079/9780851995694.0000; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	65	16	18	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166142	10.1371/journal.pone.0166142	http://dx.doi.org/10.1371/journal.pone.0166142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832144	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000068
J	Moon, JH; Kim, KM; Kim, JH; Moon, JH; Choi, SH; Lim, S; Lim, JY; Kim, KW; Park, KS; Jang, HC				Moon, Joon Ho; Kim, Kyoung Min; Kim, Jung Hee; Moon, Jae Hoon; Choi, Sung Hee; Lim, Soo; Lim, Jae-Young; Kim, Ki Woong; Park, Kyong Soo; Jang, Hak Chul			Predictive Values of the New Sarcopenia Index by the Foundation for the National Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults	PLOS ONE			English	Article							MUSCLE MASS; SKELETAL-MUSCLE; CONSENSUS; RISK; MEN; ASSOCIATION; IMPAIRMENT; STRENGTH; CRITERIA	Objective We evaluated the Foundation for the National Institutes of Health (FNIH) Sarcopenia Project's recommended criteria for sarcopenia's association with mortality among older Korean adults. Methods We conducted a community-based prospective cohort study which included 560 (285 men and 275 women) older Korean adults aged >= 65 years. Muscle mass (appendicular skeletal muscle mass-to-body mass index ratio (ASM/BMI)), handgrip strength, and walking velocity were evaluated in association with all-cause mortality during 6-year follow-up. Both the lowest quintile for each parameter (ethnic-specific cutoff) and FNIH-recommended values were used as cutoffs. Results Forty men (14.0%) and 21 women (7.6%) died during 6-year follow-up. The deceased subjects were older and had lower ASM, handgrip strength, and walking velocity. Sarcopenia defined by both low lean mass and weakness had a 4.13 (95% CI, 1.69-10.11) times higher risk of death, and sarcopenia defined by a combination of low lean mass, weakness, and slowness had a 9.56 (3.16-28.90) times higher risk of death after adjusting for covariates in men. However, these significant associations were not observed in women. In terms of cutoffs of each parameter, using the lowest quintile showed better predictive values in mortality than using the FNIH-recommended values. Moreover, new muscle mass index, ASM/BMI, provided better prognostic values than ASM/height 2 in all associations. Conclusions New sarcopenia definition by FNIH was better able to predict 6-year mortality among Korean men. Moreover, ethnic-specific cutoffs, the lowest quintile for each parameter, predicted the higher risk of mortality than the FNIH-recommended values.	[Moon, Joon Ho; Kim, Kyoung Min; Kim, Jung Hee; Moon, Jae Hoon; Choi, Sung Hee; Lim, Soo; Park, Kyong Soo; Jang, Hak Chul] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Moon, Joon Ho; Kim, Jung Hee; Park, Kyong Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Kyoung Min; Moon, Jae Hoon; Choi, Sung Hee; Lim, Soo; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lim, Jae-Young] Seoul Natl Univ, Bundang Hosp, Dept Rehabil Med, Seongnam, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jang, HC (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Jang, HC (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	janghak@snu.ac.kr	Park, Kyong Soo/C-2265-2008; Lim, Soo/AAU-8107-2020; Lim, Jae-Young/J-5622-2012	Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; Lim, Jae-Young/0000-0002-9454-0344; CHOI, SUNG HEE/0000-0003-0740-8116; Moon, Joon Ho/0000-0003-1897-0905; Kim, Kyoung Min/0000-0001-8150-0266	National Research Foundation Grant - Ministry of Education, Science, and Technology, Republic of Korea [2006-2005410]; Seoul National University Bundang Hospital [02-2011-015]	National Research Foundation Grant - Ministry of Education, Science, and Technology, Republic of Korea; Seoul National University Bundang Hospital	This work was supported by National Research Foundation Grant by Ministry of Education, Science, and Technology, Republic of Korea (2006-2005410, URL: http://www.nrf.re.kr/) and the grant from Seoul National University Bundang Hospital (02-2011-015, URL: https.//www.snubh.org/).	Arango-Lopera VE, 2013, J NUTR HEALTH AGING, V17, P259, DOI 10.1007/s12603-012-0434-0; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Cawthon PM, 2013, GERONTOLOGIST, V53, P594, DOI 10.1093/gerona/glu023; Cawthon PM, 2015, J AM GERIATR SOC, V63, P2247, DOI 10.1111/jgs.13788; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim JH, 2014, J GERONTOL A-BIOL, V69, P1244, DOI 10.1093/gerona/glu050; Kim KM, 2014, IJC METAB ENDOCR, V4, P63, DOI 10.1016/j.ijcme.2014.06.001; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Landi F, 2012, J AM MED DIR ASSOC, V13, P121, DOI 10.1016/j.jamda.2011.07.004; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; MATHIOWETZ V, 1985, J HAND SURG-AM, V10A, P694, DOI 10.1016/S0363-5023(85)80210-0; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Moon JH, 2016, J NUTR HEALTH AGING, V20, P496, DOI 10.1007/s12603-015-0613-x; Morley JE, 2008, J NUTR HEALTH AGING, V12, P452, DOI 10.1007/BF02982705; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; ROSENBERG IH, 1995, ANN INTERN MED, V123, P727, DOI 10.7326/0003-4819-123-9-199511010-00014; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; The Population Reference Bureau, 2014, 2014 WORLD POP DAT S; Won C.W., 2002, J KOREAN GERIATRICS, V6, P273; Woo J, 2014, EUR GERIATR MED, V5, P155, DOI 10.1016/j.eurger.2014.04.003; Woo J, 2015, J GERONTOL A; Woo J, 2009, J AM GERIATR SOC, V57, P2224, DOI 10.1111/j.1532-5415.2009.02566.x	32	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166344	10.1371/journal.pone.0166344	http://dx.doi.org/10.1371/journal.pone.0166344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832145	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000104
J	Nilsonne, G; Lekander, M; Akerstedt, T; Axelsson, J; Ingre, M				Nilsonne, Gustav; Lekander, Mats; Akerstedt, Torbjorn; Axelsson, John; Ingre, Michael			Diurnal Variation of Circulating Interleukin-6 in Humans: A Meta-Analysis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PINEAL HORMONE MELATONIN; ADRENAL AXIS HORMONES; HEALTHY-MEN; RHEUMATOID-ARTHRITIS; SERUM INTERLEUKIN-6; SLEEP-DEPRIVATION; PLASMA INTERLEUKIN-6; CIRCADIAN-RHYTHMS; INFLAMMATORY MARKERS	The pleiotropic cytokine interleukin-6 (IL-6) has been proposed to contribute to circadian regulation of sleepiness by increasing in the blood at night. Earlier studies have reported diurnal variation of IL-6, but phase estimates are conflicting. We have therefore performed a meta-analysis on the diurnal variation of circulating IL-6. Studies were included if they reported IL-6 in plasma or serum recorded at least twice within 24 hours in the same individual. A systematic search resulted in the inclusion of 43 studies with 56 datasets, for a total of 1100 participants. Individual participant data were available from 4 datasets with a total of 56 participants. Mixed-effects meta-regression modelling confirmed that IL-6 varied across the day, the most conspicuous effect being a trough in the morning. These results stand in contrast to earlier findings of a peak in the evening or night, and suggest that diurnal variation should be taken into account in order to avoid confounding by time of day in studies of IL-6 in plasma or serum.	[Nilsonne, Gustav; Lekander, Mats; Akerstedt, Torbjorn; Axelsson, John; Ingre, Michael] Stockholm Univ, Stress Res Inst, Stockholm, Sweden; [Nilsonne, Gustav; Lekander, Mats; Akerstedt, Torbjorn; Axelsson, John] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Nilsonne, G (corresponding author), Stockholm Univ, Stress Res Inst, Stockholm, Sweden.; Nilsonne, G (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	gustav.nilsonne@ki.se	Axelsson, John/AAH-5998-2019	Axelsson, John/0000-0003-3932-7310; Akerstedt, Torbjorn/0000-0001-8049-8504; Nilsonne, Gustav/0000-0001-5273-0150; Ingre, Michael/0000-0003-0678-4494				Abedelmalek S, 2013, EUR J APPL PHYSIOL, V113, P241, DOI 10.1007/s00421-012-2432-7; Ackermann K, DIURNAL RHYTHMS BLOO, DOI [10.5665/sleep.1954, DOI 10.5665/SLEEP.1954]; Agorastos A, 2014, PSYCHONEUROENDOCRINO, V44, P71, DOI 10.1016/j.psyneuen.2014.02.020; Alberti A, 2003, J SLEEP RES, V12, P305, DOI 10.1111/j.1365-2869.2003.00361.x; Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; ARVIDSON NG, 1994, ANN RHEUM DIS, V53, P521, DOI 10.1136/ard.53.8.521; Baker DG, 2001, NEUROIMMUNOMODULAT, V9, P209, DOI 10.1159/000049028; BAUER J, 1994, CLIN INVESTIGATOR, V72, P315; Benedict C, 2009, FASEB J, V23, P3629, DOI 10.1096/fj.08-122853; Borbely AA, 1998, HORM RES, V49, P114, DOI 10.1159/000023156; Born J, 1997, J IMMUNOL, V158, P4454; Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Burgos I, 2006, BRAIN BEHAV IMMUN, V20, P246, DOI 10.1016/j.bbi.2005.06.007; Chennaoui M, 2011, CYTOKINE, V56, P318, DOI 10.1016/j.cyto.2011.06.002; Crispim CA, 2012, CHRONOBIOL INT, V29, P587, DOI 10.3109/07420528.2012.675847; Crofford LJ, 1997, J CLIN ENDOCR METAB, V82, P1279, DOI 10.1210/jc.82.4.1279; Cutolo M, 2008, ANN RHEUM DIS, V67, P905, DOI 10.1136/ard.2008.088955; Cutolo M, 2008, AUTOIMMUN REV, V7, P223, DOI 10.1016/j.autrev.2007.11.019; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Dominguez-Rodriguez A, 2004, CYTOKINE, V26, P89, DOI 10.1016/j.cyto.2004.01.003; Dugue B, 1998, CLIN CHEM LAB MED, V36, P323, DOI 10.1515/CCLM.1998.054; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; Eisenberger NI, 2009, NEUROIMAGE, V47, P881, DOI 10.1016/j.neuroimage.2009.04.040; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Gamaldo CE, 2012, NEUROL CLIN, V30, P1313, DOI 10.1016/j.ncl.2012.08.007; Genesca J, 2000, AM J GASTROENTEROL, V95, P1539; Gill J, 2010, BIOL PSYCHIAT, V68, P999, DOI 10.1016/j.biopsych.2010.07.033; Grigoleit JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028330; Grigoleit JS, 2012, BRAIN BEHAV IMMUN, V26, P234, DOI 10.1016/j.bbi.2011.09.001; GUDEWILL S, 1992, EUR ARCH PSY CLIN N, V242, P53, DOI 10.1007/BF02190343; Gudmundsson A, 1997, CLIN CHEM, V43, P2199; Haack M, 2000, CYTOKINE, V12, P694, DOI 10.1006/cyto.1999.0665; Haack M, 2002, PSYCHONEUROENDOCRINO, V27, P921, DOI 10.1016/S0306-4530(02)00006-9; Haack M, 2001, PSYCHOSOM MED, V63, P568, DOI 10.1097/00006842-200107000-00008; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Hermann DM, 1998, PSYCHONEUROENDOCRINO, V23, P427; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Irwin M, 2004, BRAIN BEHAV IMMUN, V18, P349, DOI 10.1016/j.bbi.2004.02.001; Irwin M, 2002, BRAIN BEHAV IMMUN, V16, P503, DOI 10.1016/S0889-1591(02)00003-X; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Johansson A, 2000, J CLIN ENDOCR METAB, V85, P3169, DOI 10.1210/jc.85.9.3169; Kanabrocki EL, 1999, CLIN APPL THROMB-HEM, V5, P37, DOI 10.1177/107602969900500108; Karshikoff B, 2015, BRAIN BEHAV IMMUN, V46, P35, DOI 10.1016/j.bbi.2014.11.014; Korth C, 1996, INFECT IMMUN, V64, P1110, DOI 10.1128/IAI.64.4.1110-1115.1996; Kritikou I, 2014, EUR RESPIR J, V43, P145, DOI 10.1183/09031936.00126712; Lange T, 2002, BRAIN BEHAV IMMUN, V16, P663, DOI 10.1016/S0889-1591(02)00018-1; Lasselin J, 2015, BRAIN BEHAV IMMUN, V47, P93, DOI 10.1016/j.bbi.2014.10.004; Lekander M, 2013, BRAIN BEHAV IMMUN, V34, P43, DOI 10.1016/j.bbi.2013.06.005; Lemmer B, 1992, Eur Cytokine Netw, V3, P335; Lindahl MS, 2007, FERTIL STERIL, V87, P136, DOI 10.1016/j.fertnstert.2006.06.029; Lissoni P, 1998, NAT IMMUN, V16, P1, DOI 10.1159/000069464; Mastorakos G, 2000, Z RHEUMATOL, V59, P75; Mehra R, 2006, ARCH INTERN MED, V166, P1725, DOI 10.1001/archinte.166.16.1725; Miles MP, 2008, J APPL PHYSIOL, V104, P451, DOI 10.1152/japplphysiol.00572.2007; Miles MP, 2012, MED SCI SPORT EXER, V44, P2290, DOI 10.1249/MSS.0b013e318267b209; Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947, DOI 10.1152/ajpregu.2000.278.4.R947; Nilsonne G, IL6 DIURNAL RELESE P; Nilsonne G., 2015, ENDOTOXIN RESTINGSTA; Peeling P, 2009, INT J SPORT NUTR EXE, V19, P583, DOI 10.1123/ijsnem.19.6.583; Pejovic S, 2013, AM J PHYSIOL-ENDOC M, V305, pE890, DOI 10.1152/ajpendo.00301.2013; Phillips MD, 2010, MED SCI SPORT EXER, V42, P314, DOI 10.1249/MSS.0b013e3181b11ab7; Pinheiro J, 2015, NLME LINEAR NONLINEA; Pledge D, 2011, CYTOKINE, V55, P318, DOI 10.1016/j.cyto.2011.05.005; Pollmacher T, 1996, J INFECT DIS, V174, P1040, DOI 10.1093/infdis/174.5.1040; Pollmacher T, 1993, AM J PHYSL 2, V264; R Core Team, 2013, R LANG ENV STAT COMP; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; Rief W, 2010, PSYCHOSOM MED, V72, P755, DOI 10.1097/PSY.0b013e3181f367e2; RODRIGUEZ AD, 2003, REV ESP CARDIOL, V56, P555; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Schrepf A, PAIN; Scott HA, 2015, ANN ALLERG ASTHMA IM, V114, P470, DOI 10.1016/j.anai.2015.04.002; SEILER W, 1994, CLIN CHEM, V40, P1778; Seiler W, 1995, ANN NY ACAD SCI, V762, P468; Sennels HP, 2011, SCAND J CLIN LAB INV, V71, P532, DOI 10.3109/00365513.2011.602422; Shaw JA, 2001, CIRCULATION, V103, P806, DOI 10.1161/01.CIR.103.6.806; Sothern R B, 1995, In Vivo, V9, P331; SOTHERN RB, 1995, J ALLERGY CLIN IMMUN, V95, P1029, DOI 10.1016/S0091-6749(95)70104-4; Spath-Schwalbe E, 2000, CYTOKINE, V12, P518, DOI 10.1006/cyto.1999.0587; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; Szczudlik A, 2004, J ENDOCRINOL INVEST, V27, P37, DOI 10.1007/BF03350908; Undar L, 1999, THROMB HAEMOSTASIS, V81, P571; Vgontzas AN, 2008, EUR J CLIN INVEST, V38, P585, DOI 10.1111/j.1365-2362.2008.01984.x; Vgontzas AN, 2007, AM J PHYSIOL-ENDOC M, V292, pE253, DOI 10.1152/ajpendo.00651.2005; Vgontzas AN, 2003, J CLIN ENDOCR METAB, V88, P2087, DOI 10.1210/jc.2002-021176; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Vgontzas AN, 2002, METABOLISM, V51, P887, DOI 10.1053/meta.2002.33357; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; Voderholzer U, 2012, J NEUROPSYCH CLIN N, V24, P354, DOI 10.1176/appi.neuropsych.11060142; Wegner A, BRAIN BEHAV IMMUNITY	96	69	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165799	10.1371/journal.pone.0165799	http://dx.doi.org/10.1371/journal.pone.0165799			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832117	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000035
J	Pettengill, JB; Pightling, AW; Baugher, JD; Rand, H; Strain, E				Pettengill, James B.; Pightling, Arthur W.; Baugher, Joseph D.; Rand, Hugh; Strain, Errol			Real-Time Pathogen Detection in the Era of Whole-Genome Sequencing and Big Data: Comparison of k-mer and Site-Based Methods for Inferring the Genetic Distances among Tens of Thousands of Salmonella Samples	PLOS ONE			English	Article							SURVEILLANCE; PIPELINE	The adoption of whole-genome sequencing within the public health realm for molecular characterization of bacterial pathogens has been followed by an increased emphasis on real-time detection of emerging outbreaks (e.g., food-borne Salmonellosis). In turn, large databases of whole-genome sequence data are being populated. These databases currently contain tens of thousands of samples and are expected to grow to hundreds of thousands within a few years. For these databases to be of optimal use one must be able to quickly interrogate them to accurately determine the genetic distances among a set of samples. Being able to do so is challenging due to both biological (evolutionary diverse samples) and computational (petabytes of sequence data) issues. We evaluated seven measures of genetic distance, which were estimated from either k-mer profiles (Jaccard, Euclidean, Manhattan, Mash Jaccard, and Mash distances) or nucleotide sites (NUCmer and an extended multi-locus sequence typing (MLST) scheme). When analyzing empirical data (whole-genome sequence data from 18,997 Salmonella isolates) there are features (e.g., genomic, assembly, and contamination) that cause distances inferred from k-mer profiles, which treat absent data as informative, to fail to accurately capture the distance between samples when compared to distances inferred from differences in nucleotide sites. Thus, site-based distances, like NUCmer and extended MLST, are superior in performance, but accessing the computing resources necessary to perform them may be challenging when analyzing large databases.	[Pettengill, James B.; Pightling, Arthur W.; Baugher, Joseph D.; Rand, Hugh; Strain, Errol] US FDA, Biostat & Bioinformat Staff, Ctr Food Safety & Appl Nutr, 5001 Campus Dr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Strain, E (corresponding author), US FDA, Biostat & Bioinformat Staff, Ctr Food Safety & Appl Nutr, 5001 Campus Dr, College Pk, MD 20740 USA.	errol.strain@fda.hhs.gov	PIGHTLING, ARTHUR/AAD-6621-2020	Baugher, Joseph/0000-0003-2466-3047	U.S. Department of Energy; FDA Center for Food Safety and Applied Nutrition; FDA	U.S. Department of Energy(United States Department of Energy (DOE)); FDA Center for Food Safety and Applied Nutrition; FDA(United States Department of Health & Human Services)	This project was supported in part by an appointment to the Research Participation Program at the Center for Food Safety and Applied Nutrition, Office of Foods and Veterinary Medicine, U.S. Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and FDA.; We thank A. Schpuntoff for assistance with conducting the analyses on the high performance computing cluster and FDA Center for Food Safety and Applied Nutrition for supporting this research.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Broder AZ, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P21, DOI 10.1109/SEQUEN.1997.666900; Carrillo CD, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00057; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; Deng XY, 2016, ANNU REV FOOD SCI T, V7, P353, DOI 10.1146/annurev-food-041715-033259; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Ondov BD, 2015, FAST GENOME METAGENO, DOI [10.1101/029827, DOI 10.1101/029827]; Pightling AW, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0526-1; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	23	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166162	10.1371/journal.pone.0166162	http://dx.doi.org/10.1371/journal.pone.0166162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832109	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000070
J	Lino, VTS; Rodrigues, NCP; O'Dwyer, G; de Noronha Andrade, MK; Mattos, IE; Portela, MC				Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; O'Dwyer, Gisele; de Noronha Andrade, Monica Kramer; Mattos, Ines Echenique; Portela, Margareth Crisostomo			Handgrip Strength and Factors Associated in Poor Elderly Assisted at a Primary Care Unit in Rio de Janeiro, Brazil	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; SELF-RATED HEALTH; GRIP STRENGTH; MUSCLE STRENGTH; GAIT SPEED; OLDER; SARCOPENIA; POPULATION; DEPRESSION; FRAILTY	Introduction Sarcopenia is a condition diagnosed when the patient presents low muscle mass, plus low muscle strength or low physical performance. Muscle weakness in the oldest (dynapenia) is a major public health concern because it predicts future all-cause mortality and is associated with falls, disability, cardiovascular mortality and morbidity. Grip strength is a simple method for assessment of muscle function in clinical practice. Objective To estimate the grip strength and identify factors associated with handgrip strength variation in elderly people with low socioeconomic status. Methods Cross-sectional study based on a multidimensional assessment of primary care users that were 60 years or older. The sample size was calculated using an estimated prevalence of depression in older adults of 20%. A kappa coefficient of 0.6 with a 95% confidence interval was used to generate a conservative sample size of 180 individuals. Procedures: tests and scales to assess humor, cognition (MMSE), basic (ADL) and instrumental activities (IADL) of daily living, mobility (Timed Up and Go), strength, height, Body Mass Index (BMI) and social support were applied. Questions about falls, chronic diseases and self-rated health (SRH) were also included. Statistical Analysis: Mean, standard deviation and statistical tests were used to compare grip strength means by demographic and health factors. A multivariate linear model was used to explain the relationship of the predictors with grip strength. Results The group was composed predominantly by women (73%) with a very low level of education (mean 3 years of schooling), mean age of 73.09 (+/- 7.05) years old, good mobility and without IADL impairment. Mean grip strength of male and female were 31.86Kg (SD 5.55) and 21.69Kg (SD 4.48) [p-0.0001], respectively. Low grip strength was present in 27.7% of women and 39.6% of men. As expected, men and younger participants had higher grip strength than women and older individuals. In the adjusted model, age (p-0.03), female sex (p-0.0001), mobility (p-0.05), height (p-0.03) and depression (p-0.03) were independently associated with low grip strength. For every second more in the mobility test, there was a mean decrease of 0.08 Kg in the grip strength. Elders with depression had a mean reduction of 1.74Kg in the grip strength in relation to those in the comparison groups. There was an average reduction of 8.36Kg in the grip strength of elderly females relative to males. For each year of age after 60 years, it was expected an average reduction of 0.11 Kg in the grip strength. Conclusion our results suggest that low grip strength is associated with age, female sex, height, depression and mobility problems in poor elderly. Grip strength can be a simple, quick and inexpensive means of stratifying elders' risk of sarcopenia in the primary care setting. Efforts should be made to recognize weaker persons and the conditions associated to low grip strength in order to target early interventions to prevent frailty and disability.	[Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; O'Dwyer, Gisele; de Noronha Andrade, Monica Kramer] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Primary Care, Rio De Janeiro, RJ, Brazil; [Mattos, Ines Echenique] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Portela, Margareth Crisostomo] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Hlth Adm & Planning, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Lino, VTS (corresponding author), Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Primary Care, Rio De Janeiro, RJ, Brazil.	valerialino@ensp.fiocruz.br	Portela, Margareth C/G-6699-2012; Lino, Valeria/ADI-4254-2022	Portela, Margareth C/0000-0002-9858-9276; 				Alexandre TD, 2014, J NUTR HEALTH AGING, V18, P547, DOI [10.1007/s12603-014-0465-9, 10.1007/s12603-013-0424-x]; Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; [Anonymous], 2009, WINPEPI PEPI FOR WIN; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Busch TD, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0031-2; Carvalho M, 2012, INTEGRATED TERRITORY; Confortin SC, 2015, J GERIATR PHYS THER, V38, P162, DOI 10.1519/JPT.0000000000000027; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Alexandre TD, 2014, J NUTR HEALTH AGING, V18, P751, DOI [10.1007/s12603-014-0450-3, 10.1007/s12603-014-0540-2]; Bez JPD, 2014, CIENC SAUDE COLETIVA, V19, P3343, DOI 10.1590/1413-81232014198.09592013; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Griep Rosane Harter, 2005, Cad. Saúde Pública, V21, P703, DOI 10.1590/S0102-311X2005000300004; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hansen AW, 2013, PREV MED, V57, P792, DOI 10.1016/j.ypmed.2013.08.029; Health Mo, 2009, VIGITEL BRAZ 2009 PR, P150; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kim NH, 2011, J AM GERIATR SOC, V59, P2062, DOI 10.1111/j.1532-5415.2011.03664.x; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Mhaolain AMN, 2012, INT PSYCHOGERIATR, V24, P1265, DOI 10.1017/S1041610211002110; Moreira VG, 2013, CLINICS, V68, P979, DOI 10.6061/clinics/2013(07)15; Pasco JA, 2015, CURR OSTEOPOROS REP, V13, P351, DOI 10.1007/s11914-015-0279-7; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ramlagan Shandir, 2014, BMC Res Notes, V7, P8, DOI 10.1186/1756-0500-7-8; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Lino VTS, 2008, CAD SAUDE PUBLICA, V24, P103, DOI 10.1590/S0102-311X2008000100010; Lino VTS, 2014, CAD SAUDE PUBLICA, V30, P2691, DOI 10.1590/0102-311X00023114; Sayer AA, 2006, AM J EPIDEMIOL, V164, P665, DOI 10.1093/aje/kwj255; Sayer AA, 2015, LANCET, V386, P226, DOI 10.1016/S0140-6736(14)62349-7; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Souza Edinilsa Ramos de, 2008, Ciênc. saúde coletiva, V13, P1153, DOI 10.1590/S1413-81232008000400011; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x; Syddall HE, 2009, J NUTR HEALTH AGING, V13, P57, DOI 10.1007/s12603-009-0010-4	41	38	44	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166373	10.1371/journal.pone.0166373	http://dx.doi.org/10.1371/journal.pone.0166373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832209	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000114
J	Sharma, RK; Sonkar, K; Sinha, N; Rebala, P; Albani, AE; Behari, A; Reddy, DN; Farooqui, A; Kapoor, VK				Sharma, Raj Kumar; Sonkar, Kanchan; Sinha, Neeraj; Rebala, Pradeep; Albani, Ahmad Ebrah; Behari, Anu; Reddy, Duvvuri Nageshwar; Farooqui, Alvina; Kapoor, Vinay Kumar			Gallstones: A Worldwide Multifaceted Disease and Its Correlations with Gallbladder Carcinoma	PLOS ONE			English	Article							CANCER; DIET; RISK	Background Gallstones (GS) associated diseases are among the most recurrent and frequent diseases delineated in India and United Arab Emirates. Several reports suggest that the association of GS with gallbladder cancer (GBC) is very high in Northern part of India; however, its occurrence in UAE and Southern part of India is notably low. Therefore, in the present study, we aimed to perform compositional analysis of GS in three different geographical areas by Solid State Nuclear Magnetic Resonance and Fourier Transformed Infrared spectroscopy. Methods Natural abundance C-13 cross polarization magic angle spinning Nuclear Magnetic Resonance and Fourier Transform Infrared spectroscopy is employed for the analysis of human gallstone. Results Cholesterol, bilirubin and calcium carbonate were present in variant concentrations in GS obtained from three different geographical regions. Cholesterol was present predominantly in gallstones from North India. Bilirubin was found to be a main constituent in gallstones pertaining to South India. Whereas GS from UAE showed both cholesterol and bilirubin as their major constituents. Calcium carbonate was found in varying concentrations in gallstones acquired from different regions. Conclusion Variation in environmental condition and dietary habits may contribute and affect the GS formation. Alterations in bile composition influence the GB and augment the crystallization of cholesterol. Analysis of different geographical regions GS could be an important stride to understand the etiology of GS diseases.	[Sharma, Raj Kumar; Sonkar, Kanchan; Sinha, Neeraj] Sanjay Gandhi Post Grad Inst Med Sci SGPGIMS Camp, Ctr Biomed Res, Lucknow, Uttar Pradesh, India; [Sharma, Raj Kumar; Farooqui, Alvina] Integral Univ, Dept Biosci, Kursi Rd, Lucknow, Uttar Pradesh, India; [Sonkar, Kanchan] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rebala, Pradeep; Reddy, Duvvuri Nageshwar] Asian Inst Gastroenterol, Dept Surg Gastroenterol, Hyderabad, Andhra Pradesh, India; [Albani, Ahmad Ebrah] Zayad Mil Hosp, Dept Surg, Abu Dhabi, U Arab Emirates; [Behari, Anu; Kapoor, Vinay Kumar] SGPGIMS, Dept Surg Gastroenterol, Raibarelly Rd, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Integral University; University of Pennsylvania; Pennsylvania Medicine; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Sinha, N (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci SGPGIMS Camp, Ctr Biomed Res, Lucknow, Uttar Pradesh, India.	neerajcbmr@gmail.com	Sharma, Raj Kumar/AAQ-5288-2021; Sonkar, Kanchan/AAF-9054-2019	Sharma, Raj Kumar/0000-0003-0623-3238; Sinha, Neeraj/0000-0003-3235-6127				AHO AJ, 1985, SCAND J GASTROENTERO, V20, P901, DOI 10.3109/00365528509088843; Akoka S, 1999, ANAL CHEM, V71, P2554, DOI 10.1021/ac981422i; Athanasiadou D, 2013, J TRACE ELEM MED BIO, V27, P79, DOI 10.1016/j.jtemb.2012.08.004; Attili AF, 1998, HEPATOLOGY, V27, P1492, DOI 10.1002/hep.510270605; CAREY MC, 1996, BILE ACIDS CHOLESTAS, P147; Chhabra D, 2012, ASIAN PAC J CANCER P, V13, P187, DOI 10.7314/APJCP.2012.13.1.187; CHOUDHURI G, 1995, J GASTROEN HEPATOL, V10, P241, DOI 10.1111/j.1440-1746.1995.tb01087.x; Jayalakshmi K, 2009, SOLID STATE NUCL MAG, V36, P60, DOI 10.1016/j.ssnmr.2009.06.001; Jayanthi V, 2005, Indian J Gastroenterol, V24, P97; Kapoor VK, 2007, J HEPATO-BILIARY-PAN, V14, P366, DOI 10.1007/s00534-006-1189-y; Kapoor VK, 2006, J SURG ONCOL, V93, P607, DOI 10.1002/jso.20525; Kapoor VK, 2003, NATL MED J INDIA, V16, P209; Kleiner O, 2002, BMC GASTROENTEROL, V2, P11; LOWENFELS AB, 1985, JNCI-J NATL CANCER I, V75, P77; Misciagna G, 1999, AM J CLIN NUTR, V69, P120; Rai RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083478; Raman RG., 2008, ROMANIAN J BIOPHYS, V18, P309; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Sikkandar S., 2011, INT J CHEM TECH RES, V3, P149; Srivastava M, 2008, HEPATOL RES, V38, P997, DOI 10.1111/j.1872-034X.2008.00356.x; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Sum PL, 1999, TXB GASTROENTEROLOGY, V2, P2258; SUTOR DJ, 1969, GUT, V10, P681, DOI 10.1136/gut.10.8.681; SUTOR DJ, 1971, GUT, V12, P55, DOI 10.1136/gut.12.1.55; van Erpecum KJ, 2005, BIOL CELL, V97, P815, DOI 10.1042/BC20040088; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429	26	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166351	10.1371/journal.pone.0166351	http://dx.doi.org/10.1371/journal.pone.0166351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832205	Green Submitted, gold, Green Published			2022-12-27	WOS:000387725000106
J	Canelon, SP; Wallace, JM				Canelon, Silvia P.; Wallace, Joseph M.			beta-Aminopropionitrile-Induced Reduction in Enzymatic Crosslinking Causes In Vitro Changes in Collagen Morphology and Molecular Composition	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURES; BRTL MOUSE MODEL; NANOSCALE MORPHOLOGY; BONE; EXPRESSION; MECHANICS; MUTATION; FIBRILS; ALTERS	Type I collagen morphology can be characterized using fibril D-spacing, a metric which describes the periodicity of repeating bands of gap and overlap regions of collagen molecules arranged into collagen fibrils. This fibrillar structure is stabilized by enzymatic crosslinks initiated by lysyl oxidase (LOX), a step which can be disrupted using P-aminopropionitrile (BAPN). Murine in vivo studies have confirmed effects of BAPN on collagen nano structure and the objective of this study was to evaluate the mechanism of these effects in vitro by measuring D-spacing, evaluating the ratio of mature to immature crosslinks, and quantifying gene expression of type I collagen and LOX. Osteoblasts were cultured in complete media, and differentiated using ascorbic acid, in the presence or absence of 0.25mM BAPN-fumarate. The matrix produced was imaged using atomic force microscopy (AFM) and 2D Fast Fourier transforms were performed to extract D-spacing from individual fibrils. The experiment was repeated for quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Fourier Transform infrared spectroscopy (FTIR) analyses. The D-spacing distribution of collagen produced in the presence of BAPN was shifted toward higher D spacing values, indicating BAPN affects the morphology of collagen produced in vitro, supporting aforementioned in vivo experiments. In contrast, no difference in gene expression was found for any target gene, suggesting LOX inhibition does not upregulate the LOX gene to compensate for the reduction in aldehyde formation, or regulate expression of genes encoding type I collagen. Finally, the mature to immature crosslink ratio decreased with BAPN treatment and was linked to a reduction in peak percent area of mature crosslink hydroxylysylpyridinoline (HP). In conclusion, in vitro treatment of osteoblasts with low levels of BAPN did not induce changes in genes encoding LOX or type I collagen, but led to an increase in collagen D-spacing as well as a decrease in mature crosslinks.	[Canelon, Silvia P.; Wallace, Joseph M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Wallace, Joseph M.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Wallace, Joseph M.] Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Wallace, JM (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Wallace, JM (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.; Wallace, JM (corresponding author), Indiana Univ Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA.	jmwalla@iupui.edu	Wallace, Joseph Michael/G-7906-2012	Wallace, Joseph Michael/0000-0001-6077-8058	NIH [1K25AR067221-01A1]; IUPUI departmental start-up funds; IUPUI Office of the Vice Chancellor for Research; IUPUI Biomechanics and Biomaterials Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K25AR067221] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IUPUI departmental start-up funds; IUPUI Office of the Vice Chancellor for Research; IUPUI Biomechanics and Biomaterials Research Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding from the NIH (1K25AR067221-01A1), IUPUI departmental start-up funds, Research Support Funds Grant from the IUPUI Office of the Vice Chancellor for Research and funding from the IUPUI Biomechanics and Biomaterials Research Center.	Avery Nicholas C., 2009, V522, P103, DOI 10.1007/978-1-59745-413-1_6; Becker S, 2008, BALLOON KYPHOPLASTY, V16, P1, DOI DOI 10.1007/978-3-211-74221-1_1; Boskey AL, 1999, J BONE MINER RES, V14, P330, DOI 10.1359/jbmr.1999.14.3.330; Burr D.B., 2013, BASIC APPL BONE BIOL; Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; Byler DM, EXAMINATION SECONDAR, DOI [10.1002/bip.360250307, DOI 10.1002/BIP.360250307]; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; DASLER W, 1954, SCIENCE, V120, P307, DOI 10.1126/science.120.3112.307; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Erickson B, 2013, BIOTECHNOL J, V8, P117, DOI 10.1002/biot.201200174; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Fernandes H, 2008, BONE, V42, pS21, DOI 10.1016/j.bone.2007.12.020; Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011; GERSTENFELD LC, 1988, J CELL BIOL, V106, P979, DOI 10.1083/jcb.106.3.979; Gonzalez AD, 2014, J BIOMECH, V47, P681, DOI 10.1016/j.jbiomech.2013.11.045; Hammond MA, 2016, BONE, V88, P85, DOI 10.1016/j.bone.2016.04.021; Hammond MA, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.12; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1; Jepsen KJ, 1997, J BIOMECH, V30, P1141, DOI 10.1016/S0021-9290(97)00088-2; Kadler KE, 1996, BIOCHEM J, V316, P1; Kemp AD, 2012, J STRUCT BIOL, V180, P428, DOI 10.1016/j.jsb.2012.09.012; Lazarev YA, INFRARED SPECTRA STR; LEES S, 1994, J BONE MINER RES, V9, P1377; McNerny EMB, 2015, J BONE MINER RES, V30, P446, DOI 10.1002/jbmr.2356; Nagan Narasimhan, 1998, Frontiers in Bioscience, V3, pA23; NIMNI ME, 1977, P ROY SOC MED, V70, P65, DOI 10.1177/00359157770700S322; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; Paschalis EP, 2015, CALCIFIED TISSUE INT, V96, P18, DOI 10.1007/s00223-014-9933-9; Paschalis EP, 2011, BONE, V49, P1232, DOI 10.1016/j.bone.2011.08.027; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; SIEGEL RC, 1977, J BIOL CHEM, V252, P254; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Turecek C, 2008, CALCIFIED TISSUE INT, V82, P392, DOI 10.1007/s00223-008-9136-3; Varga F, 2010, BIOCHEM BIOPH RES CO, V402, P180, DOI 10.1016/j.bbrc.2010.08.022; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wallace JM, 2015, CONNECT TISSUE RES, V56, P68, DOI 10.3109/03008207.2015.1005209; Wallace JM, 2011, J STRUCT BIOL, V173, P146, DOI 10.1016/j.jsb.2010.08.003; Wallace JM, 2010, LANGMUIR, V26, P7349, DOI 10.1021/la100006a; Wallace JM, 2010, BONE, V46, P1349, DOI 10.1016/j.bone.2009.11.020; Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/jbmr.081259, 10.1359/JBMR.081259]; WHO, 1994, WHO TECH REP SER, V843, DOI [10.1007/BF01622200, DOI 10.1007/BF01622200]; Yang HY, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.024	53	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166392	10.1371/journal.pone.0166392	http://dx.doi.org/10.1371/journal.pone.0166392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829073	gold, Green Published, Green Submitted			2022-12-27	WOS:000387724300107
J	Kirschner, S; Murle, B; Felix, M; Arns, A; Groden, C; Wenz, F; Hug, A; Glatting, G; Kramer, M; Giordano, FA; Brockmann, MA				Kirschner, Stefanie; Muerle, Bettina; Felix, Manuela; Arns, Anna; Groden, Christoph; Wenz, Frederik; Hug, Andreas; Glatting, Gerhard; Kramer, Martin; Giordano, Frank A.; Brockmann, Marc A.			Imaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and Histology	PLOS ONE			English	Article							RAY COMPUTED-TOMOGRAPHY; LOW-DOSE IRRADIATION; IN-VIVO; MAGNETIC-RESONANCE; MOUSE MODEL; TUMOR-GROWTH; LUNG-CANCER; RADIATION; BRAIN; GLIOMA	Purpose There is an increasing need for small animal in vivo imaging in murine orthotopic glioma models. Because dedicated small animal scanners are not available ubiquitously, the applicability of a clinical CT scanner for visualization and measurement of intracerebrally growing glioma xenografts in living mice was validated. Materials and Methods 2.5x10(6) U87MG cells were orthotopically implanted in NOD/SCID/yc(-/-) mice (n = 9). Mice underwent contrast-enhanced (300 mu l lomeprol i.v.) imaging using a micro-CT (80 kV, 75 mu As, 360 degrees rotation, 1,000 projections, scan time 33 s, resolution 40 x 40 x 53 mu m) and a clinical CT scanner (4-row multislice detector; 120 kV, 150 mAs, slice thickness 0.5 mm, feed rotation 0.5 mm, resolution 98 x 98 x 500 mu m). Mice were sacrificed and the brain was worked up histologically. In all modalities tumor volume was measured by two independent readers. Contrast-to-noise ratio (CNR) and Signal-to-noise ratio (SNR) were measured from reconstructed CT-scans (0.5 mm slice thickness; n = 18). Results Tumor volumes (mean +/- SD mm(3)) were similar between both CT-modalities (micro-CT: 19.8 +/- 19.0, clinical CT: 19.8 +/- 18.8; Wilcoxon signed-rank test p = 0.813). Moreover, between reader analyses for each modality showed excellent agreement as demonstrated by correlation analysis (Spearman-Rho >0.9; p<0.01 for all correlations). Histologically measured tumor volumes (11.0 +/- 11.2) were significantly smaller due to shrinkage artifacts (p<0.05). CNR and SNR were 2.1 +/- 1.0 and 1.1 +/- 0.04 for micro-CT and 23.1 +/- 24.0 and 1.9 +/- 0.7 for the clinical CTscanner, respectively. Conclusion Clinical CT scanners may reliably be used for in vivo imaging and volumetric analysis of brain tumor growth in mice.	[Kirschner, Stefanie; Muerle, Bettina; Groden, Christoph] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Neuroradiol, D-68167 Mannheim, Germany; [Felix, Manuela; Glatting, Gerhard] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Med Radiat Phys Protect,Dept Radiat Oncol, D-68167 Mannheim, Germany; [Arns, Anna; Wenz, Frederik; Giordano, Frank A.] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Radiat Oncol, D-68167 Mannheim, Germany; [Hug, Andreas] Univ Heidelberg Hosp, Spinal Cord Injury Ctr, Schlierbacher Landstr 200a, D-69118 Heidelberg, Germany; [Kramer, Martin] Justus Liebig Univ, Small Anim Clin, Dept Vet Clin Sci, D-35392 Giessen, Germany; [Brockmann, Marc A.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuroradiol, D-55131 Mainz, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen; Johannes Gutenberg University of Mainz	Brockmann, MA (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuroradiol, D-55131 Mainz, Germany.	brockmann@gmx.de	Hug, Andreas/O-5508-2014; Glatting, Gerhard/ABF-2506-2020; Giordano, Frank Anton/AAA-5456-2021	Hug, Andreas/0000-0002-7764-1813; Glatting, Gerhard/0000-0001-7916-1576; Giordano, Frank Anton/0000-0001-5243-4781	Federal Ministry of Education and Research; Land Baden-Wurttemberg (HBFG) [125-648]; Deutsche Forschungsgemeinschaft [FL 880/1-1, GI 771/1-1, GL 236/9-1, WE 2063/9-1]; Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research) [BMBF 01EZ1130]; Klaus Tschira Stiftung [00.211.2012]; Bundesamt fur Strahlenschutz (Federal Office for Radiation Protection) [Bfs 3608S04001]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Land Baden-Wurttemberg (HBFG); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research); Klaus Tschira Stiftung; Bundesamt fur Strahlenschutz (Federal Office for Radiation Protection)	None of the authors of the above manuscript have declared any conflict of interest. The acquisition of the micro-CT (Yxlon Y. Fox) was funded by the Federal Ministry of Education and Research and the Land Baden-Wurttemberg (HBFG grant #125-648). This work was funded by the Deutsche Forschungsgemeinschaft (grants FL 880/1-1, GI 771/1-1, GL 236/9-1 and WE 2063/9-1), the Bundesministerium fur Bildung and Forschung (Federal Ministry of Education and Research, grant BMBF 01EZ1130), the Klaus Tschira Stiftung (grant 00.211.2012) and the Bundesamt fur Strahlenschutz (Federal Office for Radiation Protection, grant BfS 3608S04001) for establishment of the endowed professorship Medizinische Strahlenphysik/Strahlenschutz (Medical Radiation Physics/Radiation Protection).	Alieva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035148; Boll H, 2013, ACAD RADIOL, V20, P1137, DOI 10.1016/j.acra.2013.06.002; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; Boll H, 2011, INT J COLORECTAL DIS, V26, P721, DOI 10.1007/s00384-011-1181-0; Boll H, 2010, J COMPUT ASSIST TOMO, V34, P783, DOI 10.1097/RCT.0b013e3181e1050a; Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; Brockmann MA, 2006, BRAIN RES, V1068, P138, DOI 10.1016/j.brainres.2005.10.098; Brockmann MA, 2007, METHODS, V43, P1, DOI 10.1016/j.ymeth.2007.08.002; Carlson SK, 2007, MOL IMAGING BIOL, V9, P78, DOI 10.1007/s11307-007-0080-9; Cavanaugh Dawn, 2004, Mol Imaging, V3, P55, DOI 10.1162/153535004773861723; Chatterjee Shailja, 2014, J Oral Maxillofac Pathol, V18, pS111, DOI 10.4103/0973-029X.141346; Detombe SA, 2013, ACTA RADIOL, V54, P435, DOI 10.1177/0284185113475608; Dilworth JT, 2013, RADIOTHER ONCOL, V108, P149, DOI 10.1016/j.radonc.2013.05.022; Doblas S, 2010, J MAGN RESON IMAGING, V32, P267, DOI 10.1002/jmri.22263; Engelhorn T, 2009, NEUROSCI LETT, V458, P28, DOI 10.1016/j.neulet.2009.04.033; Fei XF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-84; Felix MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126246; Fiebig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031179; Figueiredo G, 2012, AM J NEURORADIOL, V33, P1702, DOI 10.3174/ajnr.A3071; Figueiredo G, 2012, CLIN NEURORADIOL, V22, P21, DOI 10.1007/s00062-011-0113-2; Figueiredo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130661; Ford NL, 2003, MED PHYS, V30, P2869, DOI 10.1118/1.1617353; Gaedicke S, 2014, P NATL ACAD SCI USA, V111, pE692, DOI 10.1073/pnas.1314189111; Goertzen AL, 2002, PHYS MED BIOL, V47, P4315, DOI 10.1088/0031-9155/47/24/301; Herrmann KH, 2012, MAGN RESON MATER PHY, V25, P233, DOI 10.1007/s10334-011-0284-5; Hoff BA, 2012, TRANSL ONCOL, V5, P415, DOI 10.1593/tlo.12298; Janbazian L, 2014, J NEURO-ONCOL, V118, P1, DOI 10.1007/s11060-014-1401-x; Jost SC, 2009, MOL IMAGING, V8, P245, DOI 10.2310/7290.2009.00023; Kirschner S, 2015, J NEURO-ONCOL, V122, P245, DOI 10.1007/s11060-014-1708-7; Koo V, 2006, CELL ONCOL, V28, P127; Kunkel P, 2001, CANCER RES, V61, P6624; Lee DY, 2013, INT J RADIAT ONCOL, V86, P978, DOI 10.1016/j.ijrobp.2013.04.034; Lobo MR, 2013, NEURO-ONCOLOGY, V15, P1673, DOI 10.1093/neuonc/not119; Ma CM, 2001, MED PHYS, V28, P868, DOI 10.1118/1.1374247; Mayo-Smith WW, 2014, RADIOLOGY, V273, P657, DOI 10.1148/radiol.14132328; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Menichetti L, 2011, APPL RADIAT ISOTOPES, V69, P1717, DOI 10.1016/j.apradiso.2011.02.037; Minami Y, 2015, LIVER CANCER, V4, P106, DOI 10.1159/000367733; Mitchel REJ, 2003, RADIAT RES, V159, P320, DOI 10.1667/0033-7587(2003)159[0320:LDORIT]2.0.CO;2; Mokhtar M, 2014, ONCOL REP, V31, P2007, DOI 10.3892/or.2014.3056; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Murakami Y, 2010, AM J NEURORADIOL, V31, P620, DOI 10.3174/ajnr.A1871; Newcomb EW, 2006, CLIN CANCER RES, V12, P4730, DOI 10.1158/1078-0432.CCR-06-0593; Palmowski K, 2013, EUR J RADIOL, V82, P1318, DOI 10.1016/j.ejrad.2013.01.028; Park SS, 2011, INT J RADIAT ONCOL, V80, P885, DOI 10.1016/j.ijrobp.2011.01.045; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Psarros TG, 2005, NEUROL RES, V27, P57, DOI 10.1179/016164105X18250; Ritman EL, 2004, ANNU REV BIOMED ENG, V6, P185, DOI 10.1146/annurev.bioeng.6.040803.140130; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003; Schwarz M, 2010, ROFO-FORTSCHR RONTG, V182, P322, DOI 10.1055/s-0028-1109817; SHOPE TB, 1981, MED PHYS, V8, P488, DOI 10.1118/1.594995; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun A, 2010, NEUROSURGERY, V66, P751, DOI 10.1227/01.NEU.0000367452.37534.B1; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Tatsumi M, 2003, CANCER RES, V63, P6252; Wehrl HF, 2015, HISTOL HISTOPATHOL, V30, P601, DOI 10.14670/HH-30.601; Winkelmann CT, 2006, MOL IMAGING, V5, P105, DOI 10.2310/7290.2006.00011; Wolf G, 2009, INT J RADIAT BIOL, V85, P752, DOI 10.1080/09553000902954520; Yahyanejad S, 2015, MOL IMAGING, V14, DOI 10.2310/7290.2014.00038; Yang ZY, 2012, J NEUROSCI METH, V211, P210, DOI 10.1016/j.jneumeth.2012.08.021; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7	63	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165994	10.1371/journal.pone.0165994	http://dx.doi.org/10.1371/journal.pone.0165994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829015	Green Published, gold, Green Submitted			2022-12-27	WOS:000387724300072
J	Li, YH; Wang, PP; Li, XX; Yu, CY; Yang, H; Zhou, J; Xue, WW; Tan, J; Zhu, F				Li, Ying Hong; Wang, Pan Pan; Li, Xiao Xu; Yu, Chun Yan; Yang, Hong; Zhou, Jin; Xue, Wei Wei; Tan, Jun; Zhu, Feng			The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective	PLOS ONE			English	Article							POLYPHARMACOLOGY; DATABASE; DISCOVERY; UPDATE; PROLIFERATION; PHARMACOLOGY; INHIBITORS; LAPATINIB; RESOURCE; LEUKEMIA	The human kinome is one of the most productive classes of drug target, and there is emerging necessity for treating complex diseases by means of polypharmacology (multi-target drugs and combination products). However, the advantages of the multi-target drugs and the combination products are still under debate. A comparative analysis between FDA approved multi-target drugs and combination products, targeting the human kinome, was conducted by mapping targets onto the phylogenetic tree of the human kinome. The approach of network medicine illustrating the drug-target interactions was applied to identify popular targets of multi-target drugs and combination products. As identified, the multi-target drugs tended to inhibit target pairs in the human kinome, especially the receptor tyrosine kinase family, while the combination products were able to against targets of distant homology relationship. This finding asked for choosing the combination products as a better solution for designing drugs aiming at targets of distant homology relationship. Moreover, sub-networks of drug-target interactions in specific disease were generated, and mechanisms shared by multi-target drugs and combination products were identified. In conclusion, this study performed an analysis between approved multi-target drugs and combination products against the human kinome, which could assist the discovery of next generation polypharmacology.	[Li, Ying Hong; Wang, Pan Pan; Li, Xiao Xu; Yu, Chun Yan; Yang, Hong; Zhou, Jin; Xue, Wei Wei; Zhu, Feng] Chongqing Univ, Innovat Drug Res Ctr, Innovat Drug Res & Bioinformat Grp, Chongqing, Peoples R China; [Li, Ying Hong; Wang, Pan Pan; Li, Xiao Xu; Yu, Chun Yan; Yang, Hong; Zhou, Jin; Xue, Wei Wei; Zhu, Feng] Chongqing Univ, Sch Pharmaceut Sci, Chongqing, Peoples R China; [Tan, Jun] Chongqing Univ Posts & Telecommun, Inst Bioinformat, Chongqing, Peoples R China	Chongqing University; Chongqing University; Chongqing University of Posts & Telecommunications	Zhu, F (corresponding author), Chongqing Univ, Innovat Drug Res Ctr, Innovat Drug Res & Bioinformat Grp, Chongqing, Peoples R China.; Zhu, F (corresponding author), Chongqing Univ, Sch Pharmaceut Sci, Chongqing, Peoples R China.	zhufeng@cqu.edu.cn	Li, Ying Hong/U-4004-2017; ZHU, Feng/ABF-5843-2021; ZHU, Feng/X-2659-2018; Xue, Weiwei/C-7461-2016	Li, Ying Hong/0000-0003-3629-519X; ZHU, Feng/0000-0001-8069-0053; ZHU, Feng/0000-0001-8069-0053; Xue, Weiwei/0000-0002-3285-0574; Wang, Panpan/0000-0003-2829-3063	National Natural Science Foundation of China [81202459, 21505009]; Chongqing Graduate Student Research Innovation Project [CYB14027]; Fundamental Research Funds for the Central Universities [CDJZR14468801, CDJKX1314011, 2015CDJXY]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Graduate Student Research Innovation Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the research support of National Natural Science Foundation of China (81202459, 21505009); by the Chongqing Graduate Student Research Innovation Project (CYB14027); and by Fundamental Research Funds for the Central Universities (CDJZR14468801, CDJKX1314011, 2015CDJXY).	Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bolognesi ML, 2013, CURR MED CHEM, V20, P1639; Boran ADW, 2010, CURR OPIN DRUG DISC, V13, P297; Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2; Byrd John C, 2012, Am Soc Clin Oncol Educ Book, P691, DOI 10.14694/EdBook_AM.2012.32.691; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; Dar AC, 2012, NATURE, V486, P80, DOI 10.1038/nature11127; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flemming A, 2010, NAT REV DRUG DISCOV, V9, P681, DOI 10.1038/nrd3262; Higa GM, 2007, EXPERT REV ANTICANC, V7, P1183, DOI 10.1586/14737140.7.9.1183; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kantarjian H, 2006, NAT REV DRUG DISCOV, V5, P717, DOI 10.1038/nrd2135; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li SG, 2008, LEUKEMIA LYMPHOMA, V49, P19, DOI 10.1080/10428190701713689; Li X, 2014, CANCER LETT, V342, P159, DOI 10.1016/j.canlet.2013.08.046; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Lindsay MA, 2003, NAT REV DRUG DISCOV, V2, P831, DOI 10.1038/nrd1202; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marech I, 2014, INT J MOL SCI, V15, P13060, DOI 10.3390/ijms150713060; Meng WX, 2014, CANCER RES, V74, P2306, DOI 10.1158/0008-5472.CAN-13-2275; Nelson MH, 2006, ANN PHARMACOTHER, V40, P261, DOI 10.1345/aph.1G387; O'Brien SM, 2015, BLOOD, V126, P2686, DOI 10.1182/blood-2015-03-630947; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puls LN, 2011, ONCOLOGIST, V16, P566, DOI 10.1634/theoncologist.2010-0408; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Rask-Andersen M, 2014, TRENDS PHARMACOL SCI, V35, P60, DOI 10.1016/j.tips.2014.09.007; Reddy AS, 2013, EXPERT REV CLIN PHAR, V6, P41, DOI [10.1586/ECP.12.74, 10.1586/ecp.12.74]; Rini BI, 2009, CANCER-AM CANCER SOC, V115, P2306, DOI 10.1002/cncr.24227; Rosini M, 2014, FUTURE MED CHEM, V6, P485, DOI 10.4155/fmc.14.25; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song CC, 2016, NAT REV DRUG DISCOV, V15, P97, DOI 10.1038/nrd.2015.15; Srinivas NR, 2009, CURR CLIN PHARMACOL, V4, P220, DOI 10.2174/157488409789375285; Stone EL, 2015, BIOORGAN MED CHEM, V23, P6891, DOI 10.1016/j.bmc.2015.09.052; Storey S, 2009, NAT REV DRUG DISCOV, V8, P447, DOI [10.1038/nrd2908, 10.1038/nrd2873]; Tao L, 2015, PHARMACOL RES, V102, P123, DOI 10.1016/j.phrs.2015.09.019; Terme M, 2013, CANCER RES, V73, P539, DOI 10.1158/0008-5472.CAN-12-2325; Vidalin O, 2009, CURR OPIN PHARMACOL, V9, P669, DOI 10.1016/j.coph.2009.06.017; Wakita S, 2011, LEUKEMIA, V25, P1423, DOI 10.1038/leu.2011.104; Wang P, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/767136; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Xue WW, 2016, PHYS CHEM CHEM PHYS, V18, P3260, DOI 10.1039/c5cp05771j; Yamamoto-Ibusuki M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0369-5; Yanase T, 2003, J STEROID BIOCHEM, V86, P393, DOI 10.1016/S0960-0760(03)00349-2; Yang H, 2016, NUCLEIC ACIDS RES, V44, pD1069, DOI 10.1093/nar/gkv1230; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang W, 2016, CURR PHARM DES; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; Zou Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810514	56	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165737	10.1371/journal.pone.0165737	http://dx.doi.org/10.1371/journal.pone.0165737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27828998	Green Published, gold			2022-12-27	WOS:000387724300056
J	Perez, LM; Inzitari, M; Quinn, TJ; Montaner, J; Gavalda, R; Duarte, E; Coll-Planas, L; Cerda, M; Santaeugenia, S; Closa, C; Gallofre, M				Perez, Laura M.; Inzitari, Marco; Quinn, Terence J.; Montaner, Joan; Gavalda, Ricard; Duarte, Esther; Coll-Planas, Laura; Cerda, Merce; Santaeugenia, Sebastia; Closa, Conxita; Gallofre, Miguel			Rehabilitation Profiles of Older Adult Stroke Survivors Admitted to Intermediate Care Units: A Multi-Centre Study	PLOS ONE			English	Article							FUNCTIONAL OUTCOMES; DISCHARGE; PREDICTOR; RECOVERY; SCALE; DESTINATION; POPULATION; VALIDATION; DISABILITY; ADMISSION	Background Stroke is a major cause of disability in older adults, but the evidence around post-acute treatment is limited and heterogeneous. We aimed to identify profiles of older adult stroke survivors admitted to intermediate care geriatric rehabilitation units. Methods We performed a cohort study, enrolling stroke survivors aged 65 years or older, admitted to 9 intermediate care units in Catalonia-Spain. To identify potential profiles, we included age, caregiver presence, comorbidity, pre-stroke and post-stroke disability, cognitive impairment and stroke severity in a cluster analysis. We also proposed a practical decision tree for patient's classification in clinical practice. We analyzed differences between profiles in functional improvement (Barthel index), relative functional gain (Montebello index), length of hospital stay (LOS), rehabilitation efficiency (functional improvement by LOS), and new institutionalization using multivariable regression models (for continuous and dichotomous outcomes). Results Among 384 patients (79.1 +/- 7.9 years, 50.8% women), we identified 3 complexity profiles: a) Lower Complexity with Caregiver (LCC), b) Moderate Complexity without Caregiver (MCN), and c) Higher Complexity with Caregiver (HCC). The decision tree showed high agreement with cluster analysis (96.6%). Using either linear (continuous outcomes) or logistic regression, both LCC and MCN, compared to HCC, showed statistically significant higher chances of functional improvement (OR = 4.68, 95% Cl= 2.54-8.63 and OR = 3.0, 95%Cl = 1.52-5.87, respectively, for Barthel index improvement >= 20), relative functional gain (OR = 4.41, 95%Cl = 1.81-10.75 and OR = 3.45, 95%Cl= 1.31-9.04, respectively, for top Vs lower tertiles), and rehabilitation efficiency (OR = 7.88, 95%Cl= 3.65-17.03 and OR = 3.87, 95%Cl= 1.69-8.89, respectively, for top Vs lower tertiles). In relation to LOS, MCN cluster had lower chance of shorter LOS than LCC (OR = 0.41, 95%Cl= 0.23-0.75) and HCC (OR = 0.37, 95)%Cl= 0.19-0.73), for LOS lower Vs higher tertiles. Conclusion Our data suggest that post-stroke rehabilitation profiles could be identified using routine assessment tools and showed differential recovery. If confirmed, these findings might help to develop tailored interventions to optimize recovery of older stroke patients.	[Perez, Laura M.; Inzitari, Marco] Hosp Parc Sanitari Pere Virgili, Convalescence & Rehabil Unit, Barcelona, Spain; [Perez, Laura M.; Inzitari, Marco; Santaeugenia, Sebastia] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Quinn, Terence J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Montaner, Joan] Vall DHebron Hosp, Dept Neurol, Neurovasc Res Lab VHIR, Barcelona, Spain; [Gavalda, Ricard] Univ Politecn Cataluna, Dept Comp Sci, Barcelona, Spain; [Duarte, Esther] Parc Salut Mar, Phys Med & Rehabil Dept, Barcelona, Spain; [Coll-Planas, Laura] Univ Autonoma Barcelona, Fundacio Salut & Envillement, Barcelona, Spain; [Cerda, Merce] Govt Catalonia, Catalan Healthcare Serv, Barcelona, Spain; [Santaeugenia, Sebastia] Badalona Serv Assistencials, Dept Geriatr Med & Palliat Care, Badalona, Spain; [Closa, Conxita] Corp Fisiogest, Rehabil Dept, Barcelona, Spain; [Gallofre, Miguel] Govt Catalonia, Dept Hlth, Malaltia Vasc Cerebral, Barcelona, Spain	Autonomous University of Barcelona; University of Glasgow; Hospital Universitari Vall d'Hebron; Universitat Politecnica de Catalunya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona	Perez, LM (corresponding author), Hosp Parc Sanitari Pere Virgili, Convalescence & Rehabil Unit, Barcelona, Spain.; Perez, LM (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.	lperez@perevirgili.catsalut.net	Duarte, Esther/L-9771-2017; Montaner, Joan/D-3063-2015; Inzitari, Marco/ABC-1529-2021; Quinn, Terence Joseph/H-7000-2019; coll planas, laura/ABC-4362-2021	Duarte, Esther/0000-0002-4058-1802; Montaner, Joan/0000-0003-4845-2279; Quinn, Terence Joseph/0000-0003-1401-0181; Inzitari, Marco/0000-0002-3796-0625; Santaeugenia Gonzalez, Sebastia J/0000-0002-2725-4065; Perez, Laura Monica/0000-0003-3152-9882; Coll-Planas, Laura/0000-0001-5204-8717; Gavalda, Ricard/0000-0003-4736-7179	Generalitat de Catalunya; Stroke Association/Chief Scientist Office Senior Clinical Lecturer Fellowship; AGAUR (Agenda de Gestio d'Ajuts Universitaris i de Recerca) [SGR2014-890]; MINECO (Ministry of Economy and Competitiveness) project APCOM	Generalitat de Catalunya(Generalitat de Catalunya); Stroke Association/Chief Scientist Office Senior Clinical Lecturer Fellowship; AGAUR (Agenda de Gestio d'Ajuts Universitaris i de Recerca); MINECO (Ministry of Economy and Competitiveness) project APCOM	This study was partially funded by the Generalitat de Catalunya.-Dr. Quinn is supported by a joint Stroke Association/Chief Scientist Office Senior Clinical Lecturer Fellowship. The mathematical analysis was supported by the projects SGR2014-890 (MACDA) of AGAUR (Agenda de Gestio d'Ajuts Universitaris i de Recerca) and by MINECO (Ministry of Economy and Competitiveness) project APCOM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahim AH, 2015, STROKE, V46, P395, DOI 10.1161/STROKEAHA.114.006837; Armstrong JJ, 2012, ARCH PHYS MED REHAB, V93, P2198, DOI 10.1016/j.apmr.2012.05.026; Baztan JJ, 2009, GERONTOLOGY, V55, P269, DOI 10.1159/000193068; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brown AW, 2015, STROKE, V46, P1038, DOI 10.1161/STROKEAHA.114.007392; Buijck BI, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-443; Catalan Department of Health, 2006, PLA DIR SOC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Denti L, 2015, J STROKE CEREBROVASC, V24, P330, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.034; Dominguez R, 2006, MAYO CLIN PROC, V81, P476, DOI 10.4065/81.4.476; Drubach DA, 1994, J NEUROL REHABIL, V8, P92; Duarte E, 2010, REHAB, V44, P60, DOI [10.1016/j.rh.2009.10.001, DOI 10.1016/J.RH.2009.10.001]; Gagnon P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123626; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; Koh GCH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003483; Kwakkel G, 2011, STROKE, V42, P342, DOI 10.1161/STROKEAHA.110.599035; Langhorne P, 2001, STROKE, V32, P268, DOI 10.1161/01.STR.32.1.268; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Louie SWS, 2009, NEUROREHABILITATION, V25, P129, DOI 10.3233/NRE-2009-0508; Luengo-Fernandez R, 2013, STROKE, V44, P2854, DOI 10.1161/STROKEAHA.113.001584; Mahoney FI, 1965, MD STATE MED J, V14, P61; McLachlan G J, 1992, Stat Methods Med Res, V1, P27, DOI 10.1177/096228029200100103; Meyer MJ, 2015, DISABIL REHABIL, V37, P1316, DOI 10.3109/09638288.2014.963706; Perez LM, 2015, NEUROL SCI, V36, P1875, DOI 10.1007/s10072-015-2273-3; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Pinedo S, 2014, EUR J PHYS REHAB MED, V50, P323; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Sucharew H, 2013, STROKE, V44, P2182, DOI 10.1161/STROKEAHA.113.001255; Tanwir S, 2014, EUR J PHYS REHAB MED, V50, P355; Tinetti ME, 2014, MED CARE, V52, pS3, DOI 10.1097/MLR.0000000000000093; van Almenkerk S, 2013, DISABIL REHABIL, V35, P1774, DOI 10.3109/09638288.2012.756941; Young J, 2007, BMJ-BRIT MED J, V334, P86, DOI 10.1136/bmj.39059.456794.68	34	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0166304	10.1371/journal.pone.0166304	http://dx.doi.org/10.1371/journal.pone.0166304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9OG	27829011	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000387724300105
J	Hubert-Dibon, G; Bru, M; Le Guen, CG; Launay, E; Roy, A				Hubert-Dibon, Gaelle; Bru, Marie; Le Guen, Christele Gras; Launay, Elise; Roy, Arnaud			Health-Related Quality of Life for Children and Adolescents with Specific Language Impairment: A Cohort Study by a Learning Disabilities Reference Center	PLOS ONE			English	Article							CROSS-CULTURAL SURVEY; SOCIAL-BEHAVIOR; YOUNG-PEOPLE; DIFFICULTIES; VICTIMIZATION; DETERMINANTS; CHILDHOOD; DISORDER; HISTORY; SAMPLE	Objectives To assess the health-related quality of life (HRQOL) of children with specific language impairment (SLI). Study Design In a prospective sample at a Learning Disabilities Reference Center, proxy-rated HRQOL (KIDSCREEN-27) was assessed for children with SLI and unaffected children from January 1, 2014 to March 31, 2015. Quality of life predictors for children with SLI were evaluated by recording the length and number of speech therapy and psychotherapy sessions and the specific school organization that the children had participated in. The KIDSCREEN scores of the two groups were compared using nonparametric statistics. Results The questionnaires were completed by the parents of 67 children with SLI and 67 unaffected children. For children with SLI, the mean HRQOL scores were significantly lower for physical and psychological well-being, autonomy and parent relation, social support, and school environment compared to the reference group, controlling for age and parental education (beta = -6.7 (- 12.7;-.7) P = 0.03, beta = -4.9 (-9.5;-.3) P = 0.04, beta = -8.4 (-14.2;-2.6) P = 0.005, beta = -11.6 (-19.5;-3.7) P = 0.004, beta = -7.1(-12.4;-1.7) P = 0.010, respectively). Multivariate analyses in the group of children with SLI found that children who had undergone psychotherapy sessions or who had been enrolled in specific schooling programs had reduced HRQOL scores in social support and school environment and that children who were in a special class had higher scores in physical well-being.Conclusion Children with SLI had significantly lower HRQOL scores as compared to unaffected children. Measurement of HRQOL could serve as one of the strategies employed throughout the follow-up of these individuals to provide them with the most appropriate and comprehensive care possible. Conclusion Children with SLI had significantly lower HRQOL scores as compared to unaffected children. Measurement of HRQOL could serve as one of the strategies employed throughout the follow-up of these individuals to provide them with the most appropriate and comprehensive care possible.	[Hubert-Dibon, Gaelle; Bru, Marie; Le Guen, Christele Gras; Launay, Elise] Univ Hosp Nantes, Dept Pediat, Nantes, France; [Bru, Marie; Roy, Arnaud] Univ Hosp Nantes, Learning Disabil Reference Ctr, Nantes, France; [Roy, Arnaud] Univ Angers, Psychol Lab Pays Loire, Angers, France	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Universite d'Angers	Hubert-Dibon, G (corresponding author), Univ Hosp Nantes, Dept Pediat, Nantes, France.	gaelle.hubert@chu-nantes.fr		Launay, Elise/0000-0002-4081-4653; GRAS-LE GUEN, Christele/0000-0001-9060-2344				Aaronson N, 2002, QUAL LIFE RES, V11, P193; Arkkila E, 2011, FOLIA PHONIATR LOGO, V63, P27, DOI 10.1159/000319735; Arkkila E, 2009, INT J PEDIATR OTORHI, V73, P1288, DOI 10.1016/j.ijporl.2009.05.023; Beitchman JH, 2008, J CHILD PSYCHOL PSYC, V49, P626, DOI 10.1111/j.1469-7610.2008.01878.x; Conti-Ramsden G, 2004, J SPEECH LANG HEAR R, V47, P145, DOI 10.1044/1092-4388(2004/013); Conti-Ramsden G, 2013, RES DEV DISABIL, V34, P4161, DOI 10.1016/j.ridd.2013.08.043; Conti-Ramsden G, 2012, LANG SPEECH HEAR SER, V43, P507, DOI 10.1044/0161-1461(2012/11-0067); Croteau C, 2015, J COMMUN DISORD, V58, P21, DOI 10.1016/j.jcomdis.2015.07.005; Delahaie M, 2004, EVOLUTION LANGAGE CH; Dey M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-73; Durkin K, 2007, CHILD DEV, V78, P1441, DOI 10.1111/j.1467-8624.2007.01076.x; Finlay JCS, 2013, RES DEV DISABIL, V34, P2533, DOI 10.1016/j.ridd.2013.05.015; Flapper BCT, 2013, RES DEV DISABIL, V34, P756, DOI 10.1016/j.ridd.2012.10.014; GoorhuisBrouwer SM, 1996, FOLIA PHONIATR LOGO, V48, P269, DOI 10.1159/000266421; Hart KI, 2004, J SPEECH LANG HEAR R, V47, P647, DOI 10.1044/1092-4388(2004/050); Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Law J, 2009, J SPEECH LANG HEAR R, V52, P1401, DOI 10.1044/1092-4388(2009/08-0142); Lee CW, 2000, J CLIN EPIDEMIOL, V53, P451, DOI 10.1016/S0895-4356(99)00221-8; Mansour ME, 2003, PEDIATRICS, V111, P1372, DOI 10.1542/peds.111.6.1372; Nicola K, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0326-1; Plante E, 1998, J SPEECH LANG HEAR R, V41, P951, DOI 10.1044/jslhr.4104.951; Ravens-Sieberer U, 2001, SOZ PRAVENTIV MED, V46, P294, DOI 10.1007/BF01321080; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Ravens-Sieberer U, 2007, QUAL LIFE RES, V16, P1347, DOI 10.1007/s11136-007-9240-2; Records N., 1992, AM J SPEECH-LANG PAT, V1, P44, DOI DOI 10.1044/1058-0360.0102.44; Redmond SM, 2011, LANG SPEECH HEAR SER, V42, P520, DOI 10.1044/0161-1461(2011/10-0078); Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Robitail S, 2007, QUAL LIFE RES, V16, P1335, DOI 10.1007/s11136-007-9241-1; Schoon I, 2010, PEDIATRICS, V126, pE73, DOI 10.1542/peds.2009-3282; Schoon I, 2010, PEDIATRICS, V125, pE459, DOI 10.1542/peds.2008-2111; Soares-Boucaud I, 2009, DYSPHASIES DEV TROUB; Spurrier NJ, 2003, AUST NZ J PUBL HEAL, V27, P27, DOI 10.1111/j.1467-842X.2003.tb00376.x; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; Sylvestre A, 2016, DISABIL REHABIL, V38, P1146, DOI 10.3109/09638288.2015.1074730; The KIDSCREEN Group Europe, 2006, KIDSCREEN QUEST QUAL; US Department of Health and Human Services Center for Disease Control and Prevention, 2000, MEAS HLTH DAYS; van Agt H, 2011, DEV MED CHILD NEUROL, V53, P81, DOI 10.1111/j.1469-8749.2010.03794.x; van Agt HME, 2005, QUAL LIFE RES, V14, P1345, DOI 10.1007/s11136-004-6013-z; von Rueden U, 2006, J EPIDEMIOL COMMUN H, V60, P130, DOI 10.1136/jech.2005.039792; Wadman R, 2011, INT J LANG COMM DIS, V46, P641, DOI 10.1111/j.1460-6984.2011.00033.x; Wadman R, 2011, J ADOLESCENCE, V34, P421, DOI 10.1016/j.adolescence.2010.06.010; Young AR, 2002, J CHILD PSYCHOL PSYC, V43, P635, DOI 10.1111/1469-7610.00052	42	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166541	10.1371/journal.pone.0166541	http://dx.doi.org/10.1371/journal.pone.0166541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851795	gold, Green Published, Green Submitted			2022-12-27	WOS:000387909300063
J	Dirihan, S; Helander, M; Vare, H; Gundel, PE; Garibaldi, LA; Irisarri, JGN; Saloniemi, I; Saikkonen, K				Dirihan, Serdar; Helander, Marjo; Vare, Henry; Gundel, Pedro E.; Garibaldi, Lucas A.; Irisarri, J. Gonzalo N.; Saloniemi, Irma; Saikkonen, Kari			Geographic Variation in Festuca rubra L. Ploidy Levels and Systemic Fungal Endophyte Frequencies	PLOS ONE			English	Article							VERTICAL TRANSMISSION; PLANT; POLYPLOIDY; GRASSES; EVOLUTION; SYMBIOSIS; TOLERANCE; MUTUALISM; WILD	Polyploidy and symbiotic Epichloe fungal endophytes are common and heritable characteristics that can facilitate environmental range expansion in grasses. Here we examined geographic patterns of polyploidy and the frequency of fungal endophyte colonized plants in 29 Festuca rubra L. populations from eight geographic sites across latitudes from Spain to northernmost Finland and Greenland. Ploidy seemed to be positively and negatively correlated with latitude and productivity, respectively. However, the correlations were nonlinear; 84% of the plants were hexaploids (2n = 6x = 42), and the positive correlation between ploidy level and latitude is the result of only four populations skewing the data. In the southern-most end of the gradient 86% of the plants were tetraploids (2n = 4x = 28), whereas in the northernmost end of the gradient one population had only octoploid plants (2n = 8x = 56). Endophytes were detected in 22 out of the 29 populations. Endophyte frequencies varied among geographic sites, and populations and habitats within geographic sites irrespective of ploidy, latitude or productivity. The highest overall endophyte frequencies were found in the southernmost end of the gradient, Spain, where 69% of plants harbored endophytes. In northern Finland, endophytes were detected in 30% of grasses but endophyte frequencies varied among populations from 0% to 75%, being higher in meadows compared to riverbanks. The endophytes were detected in 36%, 30% and 27% of the plants in Faroe Islands, Iceland and Switzerland, respectively. Practically all examined plants collected from southern Finland and Greenland were endophyte-free, whereas in other geographic sites endophyte frequencies were highly variable among populations. Common to all populations with high endophyte frequencies is heavy vertebrate grazing. We propose that the detected endophyte frequencies and ploidy levels mirror past distribution history of F. rubra after the last glaciation period, and local adaptations to past or prevailing selection forces such as vertebrate grazing.	[Dirihan, Serdar; Helander, Marjo; Saloniemi, Irma] Univ Turku, Dept Biol, Turku, Finland; [Helander, Marjo; Saikkonen, Kari] Nat Resources Inst Finland Luke, Turku, Finland; [Vare, Henry] Univ Helsinki, Bot Museum, Finnish Museum Nat Hist, Helsinki, Finland; [Gundel, Pedro E.; Irisarri, J. Gonzalo N.] Univ Buenos Aires, CONICET, Fac Agron, IFEVA, Buenos Aires, DF, Argentina; [Garibaldi, Lucas A.] UNRN, Grp Invest Agroecol AGRECO, San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina	University of Turku; Natural Resources Institute Finland (Luke); University of Helsinki; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Dirihan, S (corresponding author), Univ Turku, Dept Biol, Turku, Finland.	serdir@utu.fi	Saloniemi, Irma/C-8893-2011; Gundel, Pedro/A-5314-2013; Garibaldi, Lucas A/D-7302-2013	Gundel, Pedro/0000-0003-3246-0282; Helander, Marjo/0000-0002-9759-4321; Irisarri, Gonzalo/0000-0001-8610-3040; Garibaldi, Lucas Alejandro/0000-0003-0725-4049; Vare, Henry/0000-0002-6170-885X	Academy of Finland [137909, 281354, 292732]; INTERACT under the European Community's Seventh Framework Programme [262693]	Academy of Finland(Academy of Finland); INTERACT under the European Community's Seventh Framework Programme	This work was supported by the Academy of Finland grants 137909, 281354 and 292732 Fund receiver author: KS, as well as INTERACT (Grant Agreement No. 262693) under the European Community's Seventh Framework Programme.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Afkhami ME, 2014, ECOL LETT, V17, P1265, DOI 10.1111/ele.12332; Aiken S.G., 1990, FESCUE GRASSES CANAD; Bao GS, 2015, FUNGAL ECOL, V17, P114, DOI 10.1016/j.funeco.2015.05.006; Bazely DR, 1997, J APPL ECOL, V34, P847, DOI 10.2307/2405276; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Chao DY, 2013, SCIENCE, V341, P658, DOI 10.1126/science.1240561; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Cheplick Gregory P., 1998, P84, DOI 10.1017/CBO9780511525445.005; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1990, ANNU REV ECOL SYST, V21, P275, DOI 10.1146/annurev.es.21.110190.001423; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Colpaert A, 2003, ARCTIC, V56, P147; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; DARLINGTON C. D., 1969, The handling of chromosomes.; Dirihan S, 2013, CARYOLOGIA, V66, P251, DOI 10.1080/00087114.2013.849414; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Faeth SH, 2004, ECOL LETT, V7, P304, DOI 10.1111/j.1461-0248.2004.00578.x; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; FINE PEM, 1975, ANN NY ACAD SCI, V266, P173, DOI 10.1111/j.1749-6632.1975.tb35099.x; Granath G, 2007, ECOGRAPHY, V30, P422, DOI [10.1111/j.2007.0906-7590.05027.x, 10.1111/j.0906-7590.2007.05027.x]; Gundel PE, 2014, PLANT SYST EVOL, V300, P1683, DOI 10.1007/s00606-014-0994-z; HARBERD D. J., 1961, NEW PHYTOL, V60, P184, DOI 10.1111/j.1469-8137.1961.tb06251.x; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Kim S, 2012, PLANT SYST EVOL, V298, P1073, DOI 10.1007/s00606-012-0617-5; Kover PX, 1998, AM NAT, V152, P165, DOI 10.1086/286159; LIPSITCH M, 1995, P ROY SOC B-BIOL SCI, V260, P321, DOI 10.1098/rspb.1995.0099; LOVE ASKELL, 1957, PROC GENET SOC CANADA, V2, P23; Maechler M., 2011, LME4 LINEAR MIXED EF; MuMIn K., 2012, MULTIMODEL INFERENCE; Neiman M, 2013, HEREDITY, V110, P152, DOI 10.1038/hdy.2012.78; Nemani R, 1997, ECOL APPL, V7, P79, DOI 10.1890/1051-0761(1997)007[0079:LCCUMR]2.0.CO;2; Pandit MK, 2014, NEW PHYTOL, V203, P687; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Pineiro G, 2006, ECOSYSTEMS, V9, P357, DOI 10.1007/s10021-005-0013-x; PRINCE SD, 1991, INT J REMOTE SENS, V12, P1301, DOI 10.1080/01431169108929727; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Saikkonen K, 2002, P ROY SOC B-BIOL SCI, V269, P1397, DOI 10.1098/rspb.2002.2006; Saikkonen K, 2000, ECOGRAPHY, V23, P360, DOI 10.1034/j.1600-0587.2000.d01-1645.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2013, AGR ECOSYST ENVIRON, V165, P1, DOI 10.1016/j.agee.2012.12.002; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Sampoux JP, 2009, J BIOGEOGR, V36, P1978, DOI 10.1111/j.1365-2699.2009.02133.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; SELLERS PJ, 1992, REMOTE SENS ENVIRON, V42, P187, DOI 10.1016/0034-4257(92)90102-P; Semmartin M, 2015, J ECOL, V103, P184, DOI 10.1111/1365-2745.12343; sitelova T, 2013, NEW PHYTOL, V199, P1022, DOI [10.1111/nph.12348, DOI 10.1111/NPH.12348]; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Song ML, 2015, FUNGAL ECOL, V13, P44, DOI 10.1016/j.funeco.2014.07.004; Stebbins G. L., 1971, CHROMOSOMAL EVOLUTIO; STEBBINS GL, 1984, BOT HELV, V94, P1; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Thompson J. N., 2005, INTERSPEC INTERACT; TUCKER CJ, 1985, REMOTE SENS ENVIRON, V17, P233, DOI 10.1016/0034-4257(85)90097-5; Wali PR, 2007, MICROB ECOL, V53, P20, DOI 10.1007/s00248-006-9076-2; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, VI; Yang XH, 2011, PLANT CELL TISS ORG, V104, P387, DOI 10.1007/s11240-010-9826-1; Zabalgogeazcoa I, 2013, FUNGAL DIVERS, V60, P25, DOI 10.1007/s13225-013-0233-x; Zuur A, 2009, MIXED EFFECTS MODELS	66	10	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166264	10.1371/journal.pone.0166264	http://dx.doi.org/10.1371/journal.pone.0166264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846291	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000387794600044
J	Kong, J; Wang, O; Nie, M; Shi, J; Hui, YY; Jiang, Y; Li, M; Xia, WB; Meng, XW; Xing, XP				Kong, Jing; Wang, Ou; Nie, Min; Shi, Jie; Hui, Yingying; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping			Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese	PLOS ONE			English	Article							MEN1 GENE; MUTATION; BONE; EXPRESSION; GUIDELINES; SEVERITY; FAMILY	Objective Multiple endocrine neoplasia type 1-related primary hyperparathyroidism (MHPT) differs in many aspects from sporadic PHPT (SHPT). The aims of this study were to summarize the clinical features and genetic background of Chinese MHPT patients and compare the severity of the disease with those of SHPT. Design and Methods A total of 40 MHPT (27 sporadic, 7 families) and 169 SHPT cases of Chinese descent were retrospectively analyzed. X-rays and ultrasound were used to assess the bone and urinary system. Dual energy x-ray absorptiometry (DXA) were performed to measure bone mineral density (BMD). Besides direct sequencing of the MEN1 and CDKN1B genes, multiplex ligation- dependent probe amplification (MLPA) was used to screen gross deletion for the MEN1 gene. Results Compared with SHPT patients, MHPT patients showed lower prevalence of typical X-ray changes related to PHPT (26.3% vs. 55.7%, P = 0.001) but higher prevalence of urolithiasis/renal calcification (40.2% vs. 60.0%, P = 0.024). MHPT patients showed higher phosphate level (0.84 vs. 0.73mmol/L, P< 0.05) but lower ALP (103.0 vs. 174.0U/L, P< 0.001) and PTH (4.0 vs. 9.8xupper limit, P< 0.001) levels than SHPT patients. There were no significant differences in BMD Z-scores at the lumbar spine and femoral neck between the two groups. Mutations in the MEN1 gene were detected in 27 MHPT cases. Among the nine novel mutations were novel, one of them involved the deletion of exon 5 and 6. Conclusions MHPT patients experienced more common kidney complications but less skeletal issues, and a milder biochemical manifestation compared with SHPT patients. MEN1 mutation detection rate was 79.4% and 9 of the identified mutations were novel.	[Kong, Jing; Wang, Ou; Nie, Min; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China; [Kong, Jing; Wang, Ou; Nie, Min; Shi, Jie; Hui, Yingying; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping] Peking Union Med Coll, Beijing, Peoples R China; [Shi, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China; [Hui, Yingying] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, O (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China.; Wang, O (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	wang_ou2010@126.com; xiaopingxing@126.com			National Natural Science Foundation of China [81100559]; National Key Program of Clinical Science [WBYZ 2011-873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program of Clinical Science	This work was supported by the National Natural Science Foundation of China (grant number 81100559) and National Key Program of Clinical Science (grant number WBYZ 2011-873).	Agarwal SK, 2013, FRONT HORM RES, V41, P1, DOI 10.1159/000345666; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Burgess JR, 1999, ARCH SURG-CHICAGO, V134, P1119, DOI 10.1001/archsurg.134.10.1119; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Christopoulos C, 2005, BJU INT, V96, P884, DOI 10.1111/j.1464-410X.2005.05731.x; Cosme Angel, 2008, Gastroenterol Hepatol, V31, P637, DOI 10.1016/S0210-5705(08)75811-4; Eller-Vainicher C, 2009, J BONE MINER RES, V24, P1404, DOI [10.1359/JBMR.090304, 10.1359/jbmr.090304]; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Jap TS, 2005, CLIN ENDOCRINOL, V62, P336, DOI 10.1111/j.1365-2265.2005.02219.x; [贾慧英 JIA Hui-ying], 2009, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V25, P478; Jiang XH, 2007, ENDOCR-RELAT CANCER, V14, P1073, DOI 10.1677/ERC-07-0015; [姜晓华 JIANG Xiaohua], 2006, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V22, P37; LAMERS CBHW, 1979, AM J MED, V66, P422, DOI 10.1016/0002-9343(79)91062-3; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Li JL, 2013, PANCREAS, V42, P353, DOI 10.1097/MPA.0b013e318258f233; Liu W, 2013, EUR REV MED PHARMACO, V17, P3111; Lourenco DM, 2008, EUR J ENDOCRINOL, V159, P259, DOI 10.1530/EJE-08-0153; Lourenco DM, 2012, CLINICS, V67, P99, DOI 10.6061/clinics/2012(Sup01)17; Lourenco DM, 2010, J BONE MINER RES, V25, P2382, DOI 10.1002/jbmr.125; Marcocci C, 2012, THER ADV MUSCULOSKEL, V4, P357, DOI 10.1177/1759720X12441869; Ning ZW, 2015, MOL MED REP, V12, P6152, DOI 10.3892/mmr.2015.4138; Owens M, 2008, CLIN ENDOCRINOL, V68, P350, DOI 10.1111/j.1365-2265.2007.03045.x; Pontikides N, 2014, J BONE MINER METAB, V32, P351, DOI 10.1007/s00774-013-0551-9; Raef H, 2011, CLIN ENDOCRINOL, V75, P791, DOI 10.1111/j.1365-2265.2011.04134.x; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Sakurai A, 2012, CLIN ENDOCRINOL, V76, P533, DOI 10.1111/j.1365-2265.2011.04227.x; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Tham E, 2007, J CLIN ENDOCR METAB, V92, P3389, DOI 10.1210/jc.2007-0476; Tso AWK, 2003, CLIN ENDOCRINOL, V59, P129, DOI 10.1046/j.1365-2265.2003.01812.x; Turner JJO, 2010, HUM MUTAT, V31, pE1089, DOI 10.1002/humu.21170; Xu D, 2013, J NANCHANG U MED SCI, V53, P99; Xu HY, 2013, ZHEJIANG YI XUE, V35, P1002; Yu W, 1996, CHIN J RAD, V30, P625; Zatelli MC, 2014, FAM CANCER, V13, P273, DOI 10.1007/s10689-014-9702-y; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]	35	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166634	10.1371/journal.pone.0166634	http://dx.doi.org/10.1371/journal.pone.0166634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846313	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600094
J	Kuo, YM; Yu, HL; Kuan, WH; Kuo, MH; Lin, HJ				Kuo, Yi-Ming; Yu, Hwa-Lung; Kuan, Wen-Hui; Kuo, Mei-Hwa; Lin, Hsing-Juh			Factors Controlling Changes in Epilithic Algal Biomass in the Mountain Streams of Subtropical Taiwan	PLOS ONE			English	Article							AGRICULTURAL STREAMS; PERIPHYTON GROWTH; DIATOM COMMUNITY; DISSOLVED-OXYGEN; NUTRIENT; HABITAT; RIVER; DYNAMICS; LIMITATION; ABUNDANCE	In upstream reaches, epilithic algae are one of the major primary producers and their biomass may alter the energy flow of food webs in stream ecosystems. However, the overgrowth of epilithic algae may deteriorate water quality. In this study, the effects of environmental variables on epilithic algal biomass were examined at 5 monitoring sites in mountain streams of the Wuling basin of subtropical Taiwan over a 5-year period (20062011) by using a generalized additive model (GAM). Epilithic algal biomass and some variables observed at pristine sites obviously differed from those at the channelized stream with intensive agricultural activity. The results of the optimal GAM showed that water temperature, turbidity, current velocity, dissolved oxygen (DO), pH, and ammonium N (NH4-N) were the main factors explaining seasonal variations of epilithic algal biomass in the streams. The change points of smoothing curves for velocity, DO, NH4-N, pH, turbidity, and water temperature were approximately 0.40 m s(-1), 8.0 mg L-1, 0.01 mg L-1, 8.5, 0.60 NTU, and 15 degrees C, respectively. When aforementioned variables were greater than relevant change points, epilithic algal biomass was increased with pH and water temperature, and decreased with water velocity, DO, turbidity, and NH4-N. These change points may serve as a framework for managing the growth of epilithic algae. Understanding the relationship between environmental variables and epilithic algal biomass can provide a useful approach for maintaining the functioning in stream ecosystems.	[Kuo, Yi-Ming] China Univ Geosci, Sch Environm Studies, Lab Basin Hydrol & Wetland Ecorestorat, Wuhan 430074, Peoples R China; [Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10617, Taiwan; [Kuan, Wen-Hui] Ming Chi Univ Technol, Dept Safety Hlth & Environm Engn, New Taipei 24301, Taiwan; [Kuo, Mei-Hwa] Natl Chung Hsing Univ, Dept Entomol, Taichung 402, Taiwan; [Lin, Hsing-Juh] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Lin, Hsing-Juh] Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan; [Lin, Hsing-Juh] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	China University of Geosciences; National Taiwan University; Ming Chi University of Technology; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan	Lin, HJ (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan.; Lin, HJ (corresponding author), Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan.; Lin, HJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	hjlin@dragon.nchu.edu.tw		Lin, Hsing-Juh/0000-0001-8322-7195; , Yi-Ming/0000-0003-1049-8116	National Science Council in Taiwan [NSC 101-2313-B-451-003]; Natural Science Foundation of Hubei Province of China [2015CFA050]; Taiwan's Shei-Pa National Park Headquarters; Ministry of Science and Technology [MOST103-2621-M-002-002]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Taiwan's Shei-Pa National Park Headquarters; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was financially supported by the National Science Council in Taiwan (NSC 101-2313-B-451-003) to YMK; the Natural Science Foundation of Hubei Province of China (2015CFA050) to YMK; Taiwan's Shei-Pa National Park Headquarters and by Ministry of Science and Technology under Grant MOST103-2621-M-002-002 to HJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allan JD, 2006, STREAM ECOLOGY STRUC; [Anonymous], 1986, PLANT PHYSIOL; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Baulch HM, 2009, CAN J FISH AQUAT SCI, V66, P1989, DOI 10.1139/F09-122; Biggs BJF, 2000, J N AM BENTHOL SOC, V19, P17, DOI 10.2307/1468279; Biggs BJF, 1998, J PHYCOL, V34, P598, DOI 10.1046/j.1529-8817.1998.340598.x; Bowman MF, 2005, CAN J FISH AQUAT SCI, V62, P174, DOI 10.1139/F04-244; Breneman A, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012058; Brenning A, 2009, REMOTE SENS ENVIRON, V113, P239, DOI 10.1016/j.rse.2008.09.005; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Carslaw DC, 2007, ATMOS ENVIRON, V41, P5289, DOI 10.1016/j.atmosenv.2007.02.032; Chang HY, 2012, FRESHWATER BIOL, V57, P1839, DOI 10.1111/j.1365-2427.2012.02843.x; Chapra SC, 1997, SURFACE WATER QUALIT; Chung LC, 2008, ZOOL STUD, V47, P25; Clesceri L.S., 1998, STANDARD METHODS EXA; DeNicola DM, 2003, ARCH HYDROBIOL, V157, P67, DOI 10.1127/0003-9136/2003/0157-0067; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; Dodds WK, 2002, CAN J FISH AQUAT SCI, V59, P865, DOI 10.1139/F02-063; DUNCAN SW, 1989, J PHYCOL, V25, P455, DOI 10.1111/j.1529-8817.1989.tb00250.x; Figueroa-Nieves D, 2006, HYDROBIOLOGIA, V568, P287, DOI 10.1007/s10750-006-0114-3; GEORGE DG, 1978, J ECOL, V66, P133, DOI 10.2307/2259185; Hastie T., 1986, STAT SCI, V1, P297; Heath MW, 2015, RIVER RES APPL, V31, P98, DOI 10.1002/rra.2722; Heinanen S, 2008, ECOGRAPHY, V31, P601, DOI 10.1111/j.0906-7590.2008.05410.x; Hill BH, 2000, J N AM BENTHOL SOC, V19, P50, DOI 10.2307/1468281; HILL WR, 1988, J PHYCOL, V24, P125; Hill WR, 2002, FRESHWATER BIOL, V47, P1245, DOI 10.1046/j.1365-2427.2002.00837.x; Holomuzki JR, 2010, J N AM BENTHOL SOC, V29, P220, DOI 10.1899/08-044.1; HORNER RR, 1990, FRESHWATER BIOL, V24, P215, DOI 10.1111/j.1365-2427.1990.tb00704.x; Hsu CB, 2010, AQUAT BIOL, V10, P227, DOI 10.3354/ab00280; Jorgensen SE, 2000, ECOL MODEL, V126, P249, DOI 10.1016/S0304-3800(00)00268-4; Kivrak E, 2012, J FRESHWATER ECOL, V27, P443, DOI 10.1080/02705060.2012.671147; Kottelat M., 1996, IUCN RED LIST THREAT; Lin HJ, 2012, AQUAT BIOL, V17, P269, DOI 10.3354/ab00481; Lindstrom EA, 2004, HYDROBIOLOGIA, V521, P63, DOI 10.1023/B:HYDR.0000026351.68927.ee; Lobban CS, 1988, EXPT PHYCOLOGY LAB M; LOHMAN K, 1992, CAN J FISH AQUAT SCI, V49, P1198, DOI 10.1139/f92-135; Merritt R.W., 1996, INTRO AQUATIC INSECT; Miltner RJ, 2010, ENVIRON MANAGE, V45, P842, DOI 10.1007/s00267-010-9439-9; Mosisch TD, 1999, AQUAT BOT, V64, P167, DOI 10.1016/S0304-3770(99)00014-5; MUNN MD, 1989, HYDROBIOLOGIA, V174, P89, DOI 10.1007/BF00014057; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Pan YD, 1999, J PHYCOL, V35, P460, DOI 10.1046/j.1529-8817.1999.3530460.x; Park NW, 2008, INT J REMOTE SENS, V29, P247, DOI 10.1080/01431160701227661; Quinn JM, 1997, NEW ZEAL J MAR FRESH, V31, P665, DOI 10.1080/00288330.1997.9516797; Ritter A, 2009, VADOSE ZONE J, V8, P437, DOI 10.2136/vzj2008.0054; Robinson CT, 2008, ECOL APPL, V18, P511, DOI 10.1890/07-0886.1; Robinson KL, 2009, CAN J CIVIL ENG, V36, P492, DOI 10.1139/L08-126; ROUT J, 1994, HYDROBIOLOGIA, V291, P61, DOI 10.1007/BF00024239; Sanchez E, 2007, ECOL INDIC, V7, P315, DOI 10.1016/j.ecolind.2006.02.005; Schlink U, 2006, ENVIRON MODELL SOFTW, V21, P547, DOI 10.1016/j.envsoft.2004.12.002; Scrimgeour GJ, 2000, CAN J FISH AQUAT SCI, V57, P1342, DOI 10.1139/cjfas-57-7-1342; Soininen J, 2004, AQUAT ECOL, V38, P63, DOI 10.1023/B:AECO.0000021004.06965.bd; Soininen J, 2002, ARCH HYDROBIOL, V154, P1; Tao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032020; Tien CJ, 2009, CHEMOSPHERE, V76, P1288, DOI 10.1016/j.chemosphere.2009.06.013; Townsend SA, 2012, FRESHW SCI, V31, P1233, DOI 10.1899/11-163.1; Tsai JW, 2014, MAR FRESHWATER RES, V65, P25, DOI 10.1071/MF13058; Uehlinger U, 1996, FRESHWATER BIOL, V36, P249, DOI 10.1046/j.1365-2427.1996.00082.x; VanDam H, 1995, FRESHWATER BIOL, V34, P579, DOI 10.1111/j.1365-2427.1995.tb00915.x; VanNieuwenhuyse EE, 1996, CAN J FISH AQUAT SCI, V53, P99, DOI 10.1139/cjfas-53-1-99; Vermaat JE, 1994, LAKE VELUWE MACROPHY, V21, P193, DOI DOI 10.1007/978-94-011-2032-6; Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x; Yeh CH, 2006, TECHNICAL REPORT; Yu SF, 2009, BOT STUD, V50, P73; Zuur Alain F., 2009, P1	67	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166604	10.1371/journal.pone.0166604	http://dx.doi.org/10.1371/journal.pone.0166604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846322	Green Published, Green Submitted, gold			2022-12-27	WOS:000387794600090
J	Lennard, KS; Goosen, RW; Blackburn, JM				Lennard, Katie S.; Goosen, Ryan W.; Blackburn, Jonathan M.			Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; EXTRACELLULAR-SUPEROXIDE; OXIDATIVE STRESS; EPITHELIAL-CELLS; MESSENGER-RNA; EXPRESSION; FUSOBACTERIUM; INSTABILITY; COAGGREGATION; PROTEIN	The relevance of specific microbial colonisation to colorectal cancer (CRC) disease pathogenesis is increasingly recognised, but our understanding of possible underlying molecular mechanisms that may link colonisation to disease in vivo remains limited. Here, we investigate the relationships between the most commonly studied CRC-associated bacteria (Enterotoxigenic Bacteroides fragilis, pks+ Escherichia coli, Fusobacterium spp., afaC+ E. coli, Enterococcus faecalis & Enteropathogenic E. coli) and altered transcriptomic and methylation profiles of CRC patients, in order to gain insight into the potential contribution of these bacteria in the aetiopathogenesis of CRC. We show that colonisation by E. faecalis and high levels of Fusobacterium is associated with a specific transcriptomic subtype of CRC that is characterised by CpG island methylation, microsatellite instability and a significant increase in inflammatory and DNA damage pathways. Analysis of the significant, bacterially- associated changes in host gene expression, both at the level of individual genes as well as pathways, revealed a transcriptional remodeling that provides a plausible mechanistic link between specific bacterial colonisation and colorectal cancer disease development and progression in this subtype; these included upregulation of REG3A, REG1A and REG1P in the case of high-level colonization by Fusobacterium, and CXCL10 and BMI1 in the case of colonisation by E. faecalis. The enrichment of both E. faecalis and Fusobacterium in this CRC subtype suggests that polymicrobial colonisation of the colonic epithelium may well be an important aspect of colonic tumourigenesis.	[Blackburn, Jonathan M.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; Univ Cape Town, Dept Integrat Biomed Sci, Cape Town, South Africa	University of Cape Town; University of Cape Town	Blackburn, JM (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.	jonathan.blackburn@uct.ac.za		Blackburn, Jonathan/0000-0001-8988-9595	Cancer Association of South Africa (CANSA); National Research Foundation (NRF); Harry Crossley Foundation; German Academic Exchange Service (DAAD); UCT; NRF; University of Cape Town	Cancer Association of South Africa (CANSA); National Research Foundation (NRF); Harry Crossley Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); UCT; NRF; University of Cape Town	This work was supported by Cancer Association of South Africa (CANSA: www.cansa.org.za) to JMB and the National Research Foundation (NRF: www.nrf.ac.za) to JMB. The Harry Crossley Foundation, the German Academic Exchange Service (DAAD), UCT, and the NRF provided financial support through bursaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the Cancer Association of South Africa (CANSA) for their financial support of this project. KSL thanks the University of Cape Town, the Harry Crossley Foundation, the National Research Foundation (NRF) and the German Academic Exchange Service (DAAD) for their financial support through bursaries. RWG thanks UCT and the NRF for their financial support through bursaries. JMB thanks the NRF for a South African Research Chair grant. We thank Ms Alvera Vorster and Henry Adeola for their technical assistance.	Ak S, 2013, J SURG RES, V185, P626, DOI 10.1016/j.jss.2013.07.014; Allen-Vercoe E, 2014, IMMUNOL LETT, V162, P54, DOI 10.1016/j.imlet.2014.05.014; Astrosini C, 2008, INT J CANCER, V123, P409, DOI 10.1002/ijc.23466; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; Barnett MPG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-39; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Cavard C, 2006, ONCOGENE, V25, P599, DOI 10.1038/sj.onc.1208860; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Diaz PI, 2000, FEMS MICROBIOL LETT, V187, P31, DOI 10.1016/S0378-1097(00)00174-9; Du JJ, 2010, MED ONCOL, V27, P1273, DOI 10.1007/s12032-009-9373-y; Granlund AV, 2013, CELL TISSUE RES, V352, P639, DOI 10.1007/s00441-013-1592-z; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hoffmann M, 2009, J PROTEOME RES, V8, P1183, DOI 10.1021/pr800785m; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Johnson EM, 2006, J ENDODONT, V32, P946, DOI 10.1016/j.joen.2006.03.023; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; Kayaoglu G, 2004, CRIT REV ORAL BIOL M, V15, P308, DOI 10.1177/154411130401500506; Kloor M, 2010, INT J CANCER, V127, P1001, DOI 10.1002/ijc.25283; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Pun JCS, 2014, MOL CLIN ONCOL, V2, P817, DOI 10.3892/mco.2014.321; Rechreche H, 1999, INT J CANCER, V81, P688, DOI 10.1002/(SICI)1097-0215(19990531)81:5<688::AID-IJC3>3.0.CO;2-R; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Siegmund KD, 2004, BIOINFORMATICS, V20, P1896, DOI 10.1093/bioinformatics/bth176; Silva VL, 2005, MICROB PATHOGENESIS, V39, P131, DOI 10.1016/j.micpath.2005.07.002; Steeves CH, 2011, PROTEOMICS, V11, P2027, DOI 10.1002/pmic.201000631; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462; Viljoen KS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-14; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Yoshino N, 2005, AM J GASTROENTEROL, V100, P2157, DOI 10.1111/j.1572-0241.2005.41915.x	48	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166282	10.1371/journal.pone.0166282	http://dx.doi.org/10.1371/journal.pone.0166282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846243	gold, Green Published, Green Submitted			2022-12-27	WOS:000387794600046
J	Samsa, LA; Ito, CE; Brown, DR; Qian, L; Liu, JD				Samsa, Leigh Ann; Ito, Cade Ellis; Brown, Daniel Ross; Qian, Li; Liu, Jiandong			IgG-Containing Isoforms of Neuregulin-1 Are Dispensable for Cardiac Trabeculation in Zebrafish	PLOS ONE			English	Article							RECOMBINANT HUMAN NEUREGULIN-1; SCHWANN-CELL MIGRATION; CHRONIC HEART-FAILURE; CARDIOVASCULAR-SYSTEM; CHAMBER MATURATION; MYOCARDIUM; GENOME; ERBB2; SPECIFICATION; CONSEQUENCES	The Neuregulin-1 (Nrg1) signaling pathway has been widely implicated in many aspects of heart development including cardiac trabeculation. Cardiac trabeculation is an important morphogenetic process where clusters of ventricular cardiomyocytes extrude and expand into the lumen of the ventricular chambers. In mouse, Nrg1 isoforms containing an immunoglobulin- like (IgG) domain are essential for cardiac trabeculation through interaction with heterodimers of the epidermal growth factor-like (EGF-like) receptors ErbB2/ErbB4. Recent reports have underscored the importance of Nrg1 signaling in cardiac homeostasis and disease, however, placental development has precluded refined evaluation of the role of this pathway in mammals. ErbB2 has been shown to have a developmentally conserved role in cardiac trabeculation in zebrafish, a vertebrate model organism with completely external development, but the requirement for Nrg1 has not been examined. We found that among the multiple Nrg1 isoforms, the IgG domain-containing, type I Nrg1 (nrg1-I) is the only isoform detectable in the heart. Then, using CRISPR/Cas9 gene editing, we targeted the IgG domain of Nrg1 to produce novel alleles, nrg1(nc28) and nrg1(nc29), encoding nrg1-I and nrg1-II truncations. Our results indicated that zebrafish deficient for nrg1-I developed trabeculae in an ErbB2-dependent manner. Further, these mutants survive to reproductive adulthood with no overt cardiovascular defects. We also found that additional EGF-like ligands were expressed in the zebrafish heart during development of trabeculae. Together, these results suggest that Nrg1 is not the primary effector of trabeculation and/or that other EGF-like ligand(s) activates the ErbB2/ErbB4 pathway, either through functioning as the primary ligand or acting in a redundant manner. Overall, our work provides an example of cross-species differences in EGF family member requirements for an evolutionary conserved process.	[Samsa, Leigh Ann] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Samsa, Leigh Ann; Ito, Cade Ellis; Brown, Daniel Ross; Qian, Li; Liu, Jiandong] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Ito, Cade Ellis; Brown, Daniel Ross; Qian, Li; Liu, Jiandong] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Liu, JD (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA.; Liu, JD (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	jiandong_liu@med.unc.edu	, Zebrafish Aquaculture Facility/AAE-2716-2022; , Histology Research Core Facility/ABF-6317-2021	Samsa, Leigh/0000-0002-7629-0660	National Institutes of Health T32 grant [HL069768-14]; National Institutes of Health/National Institute of General Medical Science grant [5K12GM678-17]; American Heart Association Scientist Development Grant [13SDG17060010]; Ellison Medical Foundation New Scholar Grant [AG-NS-1064-13]; National Institutes of Health/National Heart, Lung, and Blood Institute [R00 HL109079]; American Heart Association [15GRNT25530005]; National Institutes of Health T32 grant [HL069768-14]; National Institutes of Health/National Institute of General Medical Science grant [5K12GM678-17]; American Heart Association Scientist Development Grant [13SDG17060010]; Ellison Medical Foundation New Scholar Grant [AG-NS-1064-13]; National Institutes of Health/National Heart, Lung, and Blood Institute [R00 HL109079]; American Heart Association [15GRNT25530005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768, R00HL109079, R01HL128331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	National Institutes of Health T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of General Medical Science grant; American Heart Association Scientist Development Grant(American Heart Association); Ellison Medical Foundation New Scholar Grant; National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Institutes of Health T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of General Medical Science grant; American Heart Association Scientist Development Grant(American Heart Association); Ellison Medical Foundation New Scholar Grant; National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LAS is supported by National Institutes of Health T32 grant (HL069768-14; PI, Christopher Mack). DRB is supported by National Institutes of Health/National Institute of General Medical Science grant 5K12GM678-17 (PI, Linda Dyksta). This study was supported by the American Heart Association Scientist Development Grant (13SDG17060010 to LQ) and the Ellison Medical Foundation New Scholar Grant (AG-NS-1064-13 to LQ). National Institutes of Health/National Heart, Lung, and Blood Institute (R00 HL109079 grant to JL) and American Heart Association (grant 15GRNT25530005 to JL).r We thank the University of North Carolina Olympus Imaging Research Center for confocal microscope use, and the University of North Carolina Zebrafish Aquaculture Core Facility for fish care and microscope use. Histology services provided by the Histology Research Core Facility in the Department of Cell Biology and Physiology at the University of North Carolina, Chapel Hill NC. L.A.S. is supported by National Institutes of Health T32 grant (HL069768-14; PI, Christopher Mack). D.R.B. is supported by National Institutes of Health/National Institute of General Medical Science grant 5K12GM678-17 (PI, Linda Dyksta). This study was supported by the American Heart Association Scientist Development Grant (13SDG17060010 to L.Q.) and the Ellison Medical Foundation New Scholar Grant (AG-NS-1064-13 to L.Q.). National Institutes of Health/National Heart, Lung, and Blood Institute (R00 HL109079 grant to J.L.) and American Heart Association (grant 15GRNT25530005 to J.L.).	Abdallah SJ, 2015, J EXP BIOL, V218, P1777, DOI 10.1242/jeb.116343; Bang A, 2004, J FISH BIOL, V64, P1285, DOI 10.1111/j.0022-1112.2004.00391.x; Brown DR, 2016, J CARDIOVASC DEV DIS, P3; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen JN, 1996, DEVELOPMENT, V123, P293; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Fang SJ, 2010, CHINESE MED J-PEKING, V123, P3597, DOI 10.3760/cma.j.issn.0366-6999.2010.24.018; Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Guo YF, 2012, CHINESE MED J-PEKING, V125, P807, DOI 10.3760/cma.j.issn.0366-6999.2012.05.015; Hill MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055741; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Jenni R, 1999, NEW ENGL J MED, V340, P966, DOI 10.1056/NEJM199903253401215; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Minot C. S., 1901, Journal of the Boston Society of Medical Sciences, Vv, P325; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Moran AE, 2014, GLOB HEART, V9, P3, DOI 10.1016/j.gheart.2014.03.1220; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Perlin JR, 2011, DEVELOPMENT, V138, P4639, DOI 10.1242/dev.068072; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Rees BB, 2001, J EXP ZOOL, V289, P266, DOI 10.1002/1097-010X(20010401/30)289:4&lt;266::AID-JEZ7&gt;3.0.CO;2-5; Rothschild SC, 2009, DEV BIOL, V330, P175, DOI 10.1016/j.ydbio.2009.03.024; Rupert CE, 2015, BIOMARK INSIGHTS, V10, P1, DOI [10.4137/BMI.S20061, 10.4137/BMIMI.S20061]; RYCHTER Z, 1971, Folia Morphologica (Prague), V19, P31; Samsa LA, 2016, ISOLATION CHARACTERI; Samsa LA, 2015, DEVELOPMENT, V142, P4080, DOI 10.1242/dev.125724; Samsa LA, 2013, AM J MED GENET C, V163, P157, DOI 10.1002/ajmg.c.31366; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Strecker R, 2011, COMP BIOCHEM PHYS C, V153, P318, DOI 10.1016/j.cbpc.2010.12.002; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x	61	8	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166734	10.1371/journal.pone.0166734	http://dx.doi.org/10.1371/journal.pone.0166734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846271	gold, Green Submitted, Green Published			2022-12-27	WOS:000387794600104
J	Hrydziuszko, O; Perera, MTPR; Laing, R; Kirwan, J; Silva, MA; Richards, DA; Murphy, N; Mirza, DF; Viant, MR				Hrydziuszko, Olga; Perera, M. Thamara P. R.; Laing, Richard; Kirwan, Jennifer; Silva, Michael A.; Richards, Douglas A.; Murphy, Nick; Mirza, Darius F.; Viant, Mark R.			Mass Spectrometry Based Metabolomics Comparison of Liver Grafts from Donors after Circulatory Death (DCD) and Donors after Brain Death (DBD) Used in Human Orthotopic Liver Transplantation	PLOS ONE			English	Article							EARLY ALLOGRAFT DYSFUNCTION; CARDIAC DEATH; CONTROLLED DONATION; SINGLE-CENTER; EXPERIENCE; ACCURACY; ISCHEMIA; FAILURE; GENOMES; INJURY	Use of marginal liver grafts, especially those from donors after circulatory death (DCD), has been considered as a solution to organ shortage. Inferior outcomes have been attributed to donor warm ischaemic damage in these DCD organs. Here we sought to profile the metabolic mechanisms underpinning donor warm ischaemia. Non-targeted Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry metabolomics was applied to biopsies of liver grafts from donors after brain death (DBD; n = 27) and DCD (n = 10), both during static cold storage (T-1) as well as post-reperfusion (T-2). Furthermore 6 biopsies from DBD donors prior to the organ donation (T-0) were also profiled. Considering DBD and DCD together, significant metabolic differences were discovered between T-1 and T-2 (688 peaks) that were primarily related to amino acid metabolism, meanwhile T-0 biopsies grouped together with T-2, denoting the distinctively different metabolic activity of the perfused state. Major metabolic differences were discovered between DCD and DBD during cold-phase (T-1) primarily related to glucose, tryptophan and kynurenine metabolism, and in the post-reperfusion phase (T-2) related to amino acid and glutathione metabolism. We propose tryptophan/kynurenine and S-adenosylmethionine as possible biomarkers for the previously established higher graft failure of DCD livers, and conclude that the associated pathways should be targeted in more exhaustive and quantitative investigations.	[Hrydziuszko, Olga; Kirwan, Jennifer; Mirza, Darius F.; Viant, Mark R.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Perera, M. Thamara P. R.; Laing, Richard; Silva, Michael A.] Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England; [Richards, Douglas A.] Univ Birmingham, Dept Pharmacol, Sch Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Murphy, Nick] Queen Elizabeth Hosp, Dept Crit Care & Anaesthesia, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Viant, MR (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	m.viant@bham.ac.uk	Dethlefsen, Olga/AAE-1395-2022; Viant, Mark R/B-6339-2009; Dethlefsen, Olga/I-5163-2012	Dethlefsen, Olga/0000-0003-0502-1401; Viant, Mark R/0000-0001-5898-4119; Dethlefsen, Olga/0000-0003-0502-1401; Perera, Thamara/0000-0002-5417-3850; Murphy, Nick/0000-0001-8074-1447; Kirwan, Jennifer/0000-0002-5423-1651	Astellas Pharmaceuticals (UK)	Astellas Pharmaceuticals (UK)	This study was supported by a limited study grant by Astellas Pharmaceuticals (UK) not exceeding 60000.00GBP to MTPRP, MAS and DFM for phase II study investigating biomarkers of poor allograft function following human liver transplantation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amathieu R, 2011, J PROTEOME RES, V10, P3239, DOI 10.1021/pr200265z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohra R, 2013, TRANSPL INT, V26, P225, DOI 10.1111/tri.12003; Callaghan CJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003287; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Cortes M, 2014, J HEPATOL, V61, P564, DOI 10.1016/j.jhep.2014.04.023; de Vera ME, 2009, AM J TRANSPLANT, V9, P773, DOI 10.1111/j.1600-6143.2009.02560.x; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Feng L, 2007, LIVER TRANSPLANT, V13, P1125, DOI 10.1002/lt.21208; Foley DP, 2005, ANN SURG, V242, P724, DOI 10.1097/01.sla.0000186178.07110.92; Grewal HP, 2009, LIVER TRANSPLANT, V15, P1028, DOI 10.1002/lt.21811; Hrydziuszko O, 2012, METABOLOMICS, V8, pS161, DOI 10.1007/s11306-011-0366-4; Hrydziuszko O, 2010, OMICS, V14, P143, DOI 10.1089/omi.2009.0139; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134; Mateo R, 2006, AM J TRANSPLANT, V6, P791, DOI 10.1111/j.1600-6143.2006.01243.x; Mathur AK, 2010, AM J TRANSPLANT, V10, P2512, DOI 10.1111/j.1600-6143.2010.03293.x; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; Monbaliu D, 2012, J HEPATOL, V56, P474, DOI 10.1016/j.jhep.2011.07.004; Naesens M, 2010, NAT REV NEPHROL, V6, P614, DOI 10.1038/nrneph.2010.113; Papaspyridonos K, 2008, J SEP SCI, V31, P3058, DOI 10.1002/jssc.200800194; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Payne TG, 2009, J AM SOC MASS SPECTR, V20, P1087, DOI 10.1016/j.jasms.2009.02.001; Reich DJ, 2009, AM J TRANSPLANT, V9, P2004, DOI 10.1111/j.1600-6143.2009.02739.x; Rossouw JE, 1977, INT J VITAM NUTR RES, V48, P281; Serkova NJ, 2007, TRANSPLANTATION, V83, P517, DOI 10.1097/01.tp.0000251649.01148.f8; Serkova NJ, 2006, EXPERT REV MOL DIAGN, V6, P717, DOI 10.1586/14737159.6.5.717; Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p; Totsuka E, 2004, TRANSPL P, V36, P1955, DOI 10.1016/j.transproceed.2004.08.068; Wishart DS, 2005, AM J TRANSPLANT, V5, P2814, DOI 10.1111/j.1600-6143.2005.01119.x; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Xu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17737	33	12	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165884	10.1371/journal.pone.0165884	http://dx.doi.org/10.1371/journal.pone.0165884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835640	Green Accepted, gold, Green Published			2022-12-27	WOS:000387779200015
J	Lopez-Liria, R; Vega-Ramirez, FA; Rocamora-Perez, P; Aguilar-Parra, JM; Padilla-Gongora, D				Lopez-Liria, Remedios; Antonio Vega-Ramirez, Francisco; Rocamora-Perez, Patricia; Manuel Aguilar-Parra, Jose; Padilla-Gongora, David			Comparison of Two Post-Stroke Rehabilitation Programs: A Follow-Up Study among Primary versus Specialized Health Care	PLOS ONE			English	Article							QUALITY-OF-LIFE; STROKE PATIENTS; HOME; VALIDATION; DISABILITY; DISCHARGE; SURVIVORS; PEOPLE; COSTS; INDEX	Objective To compare home-based rehabilitation (RITH) and standard outpatient rehabilitation in a hospital setting, in terms of improving the functional recovery and quality of life of stroke patients. Study Design and Setting This was a prospective cohort study in Andalusia (Spain). Participants One hundred and forty-five patients completed the outcome data. Measures Daily activities were measured by the Barthel index, Canadian Neurological Scale (to assess mental state), Tinetti scale (balance and gait), and Short Form Health Survey-36 (SF-36 to compare the quality of life). Results No statistically significant differences were found between the two groups regarding the clinical characteristics of patients in the initial measurement, except for age and mental state (younger and with greater neurological impairment in the hospital group). After physical therapy, both groups showed statistically significant improvements from baseline in each of the measures. These improvements were better in RITH patients than in the hospital patients on all functionality scales with a smaller number of sessions. Conclusions Home rehabilitation is at least as effective as the outpatient rehabilitation programs in a hospital setting, in terms of recovery of functionality in post-stroke patients. Overall quality of life is severely impaired in both groups, as stroke is a very disabling disease that radically affects patients' lives.	[Lopez-Liria, Remedios; Rocamora-Perez, Patricia] Univ Almeria, Dept Nursing Physiotherapy & Med, Almeria, Spain; [Antonio Vega-Ramirez, Francisco] Complejo Hosp Torrecardenas, Serv Andaluz Salud, Almeria, Spain; [Manuel Aguilar-Parra, Jose; Padilla-Gongora, David] Univ Almeria, Dept Psychol, Almeria, Spain; [Lopez-Liria, Remedios; Rocamora-Perez, Patricia; Manuel Aguilar-Parra, Jose; Padilla-Gongora, David] Univ Almeria, Carretera Sacramento S-N, La Canada De San Urbano 04120, Almeria, Spain	Universidad de Almeria; Hospital Torrecardenas; Universidad de Almeria; Universidad de Almeria	Lopez-Liria, R (corresponding author), Univ Almeria, Dept Nursing Physiotherapy & Med, Almeria, Spain.; Lopez-Liria, R (corresponding author), Univ Almeria, Carretera Sacramento S-N, La Canada De San Urbano 04120, Almeria, Spain.	rll040@ual.es	López-Liria, Remedios/V-3851-2019; Rocamora-Perez, Patricia/AAW-3775-2021; PARRA, JOSE MANUEL AGUILAR/AAD-6978-2019	López-Liria, Remedios/0000-0002-3416-2791; PARRA, JOSE MANUEL AGUILAR/0000-0002-6703-0680	Ministry of Health of the Government of Andalusia [PI 0449/2008]	Ministry of Health of the Government of Andalusia	The authors would like to acknowledge the Andalusian Regional Government for funding this investigation. Research Project PI 0449/2008 issued by the Ministry of Health of the Government of Andalusia, through the General Secretariat of Quality and Modernization, within the Biomedical and Health Sciences Research frame in Andalusia (resolution of 26th December, 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agencia de Evaluacion de Tecnologia e Investigacion Medicas, 2005, PLAN DIR ENF VASC CE; Aprile I, 2006, NEUROL SCI, V27, P40, DOI 10.1007/s10072-006-0563-5; Arias-Cuadrado A., 2009, GALICIA CLIN, V70, P25; Aziz NA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005952.pub2; Bobath B., 1982, HEMIPLEJIA ADULTO EV; Chaiyawat P, 2012, CLIN NEUROL NEUROSUR, V114, P866, DOI 10.1016/j.clineuro.2012.01.018; Chaiyawat Pakaratee, 2009, Neurol Int, V1, pe10, DOI 10.4081/ni.2009.e10; COTE R, 1989, NEUROLOGY, V39, P638, DOI 10.1212/WNL.39.5.638; Direccion General de Asistencia Sanitaria, 2002, EQUIPOS MOVILES; Doig E, 2010, DISABIL REHABIL, V32, P2061, DOI 10.3109/09638281003797356; Eng XW, 2014, STROKE RES TREAT, V2014, DOI 10.1155/2014/626538; Jimenez-Caballero PE, 2012, REV NEUROLOGIA, V55, P337, DOI 10.33588/rn.5506.2012307; Graessel E, 2014, INT J REHABIL RES, V37, P212, DOI 10.1097/MRR.0000000000000060; Gustafsson L, 2013, DISABIL REHABIL, V35, P1380, DOI 10.3109/09638288.2012.740134; Hamza AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/350281; Hervas-Angulo A, 2006, REV NEUROLOGIA, V43, P518, DOI 10.33588/rn.4309.2005830; Hillier S, 2010, INT J STROKE, V5, P178, DOI 10.1111/j.1747-4949.2010.00427.x; Hole E, 2014, SCI WORLD J, DOI 10.1155/2014/349151; Janssen H, 2014, DISABIL REHABIL, V36, P255, DOI 10.3109/09638288.2013.788218; Lopez-Liria R, 2013, REV NEUROLOGIA, V56, P601, DOI 10.33588/rn.5612.2013098; Lopez-Liria R, 2012, GAC SANIT, V26, P284, DOI 10.1016/j.gaceta.2011.09.017; Lopez-Liria R, 2010, ATEN PRIM, V42, P278, DOI 10.1016/j.aprim.2009.10.005; Mar J, 2013, NEUROLOGIA, V28, P332, DOI 10.1016/j.nrl.2012.07.004; Markle-Reid M, 2011, CAN J NEUROL SCI, V38, P317, DOI 10.1017/S0317167100011537; Montagut F, 2014, REHABILITACION DOMIC; Morone G, 2014, BIOMED RES INT; Musicco M, 2003, ARCH PHYS MED REHAB, V84, P551, DOI 10.1053/apmr.2003.50084; Paolucci S, 2015, EUR J PHYS REHAB MED, V51, P233; Rasmussen RS, 2016, CLIN REHABIL, V30, P225, DOI 10.1177/0269215515575165; Rodrigo-Gil J, 2012, REV NEUROLOGIA, V54, P151, DOI 10.33588/rn.5403.2011189; Rodriguez-Yanez M, 2013, NEUROLOGIA, V28, P236, DOI 10.1016/j.nrl.2011.03.010; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Stineman MG, 2014, AM J PHYS MED REHAB, V93, P217, DOI 10.1097/PHM.0b013e3182a92bfb; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Ware J., 1993, SF 36 HLTH SURVEY MA; Ytterberg C, 2010, J NEUROL SCI, V294, P86, DOI 10.1016/j.jns.2010.03.027	36	9	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166242	10.1371/journal.pone.0166242	http://dx.doi.org/10.1371/journal.pone.0166242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835673	Green Published, Green Submitted, gold			2022-12-27	WOS:000387779200033
J	Nadeau, MB; Khasa, DP				Nadeau, Martin B.; Khasa, Damase P.			Edaphic Selection Pressures as Drivers of Contrasting White Spruce Ectomycorrhizal Fungal Community Structure and Diversity in the Canadian Boreal Forest of Abitibi-Temiscamingue Region	PLOS ONE			English	Article							NUTRIENT-UPTAKE; PICEA-GLAUCA; INOCULATION; MYCORRHIZAE; GRADIENT; NURSERY; GROWTH; PLANTS; SUCCESSION; SEEDLINGS	Little is known about edaphic selection pressures as drivers of contrasting white spruce ectomycorrhizal fungal community structure and diversity in the Canadian boreal forest. We hypothesized that community composition differs among the four sites sampled-nursery, mining site, forest edge, and natural forest. Ectomycorrhizal (ECM) fungal community structure and diversity was studied at the four locations with soil fertility gradient through morphomolecular and phylogenetic analyses in relationships with rhizospheric soil chemical properties. 41 different species were identified. Mining site had a significantly different species composition than the surrounding environments. Soil pH and percentage of roots colonized by ECM fungi increased while soil P, N, Fe, C, K, Mg, Al, Ca, and Na contents declined across the soil fertility gradient: nursery -> natural forest -> forest edge -> mining site. Contrary to the preference of acid soils by ECM fungi, a few ecologically adapted to high pH, poor soil chemical fertility, and low organic matter content colonize white spruce roots on the non-acidogenic mining site, allowing natural regeneration of white spruce seedlings. Other ECM fungi are adapted to high fertigation level of commercial nursery. This study clearly shows the contrasting difference in white spruce ectomycorrhizal fungal community structure and diversity driven by edaphic selection pressures.	[Nadeau, Martin B.] Univ Laval, Ctr Forest Res, Inst Integrat & Syst Biol, Quebec City, PQ G1V 0A6, Canada; Univ Laval, Canadian Res Chair Forest & Environm Genom, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University	Nadeau, MB (corresponding author), Univ Laval, Ctr Forest Res, Inst Integrat & Syst Biol, Quebec City, PQ G1V 0A6, Canada.	martin.beaudoin-nadeau.1@ulaval.ca		Khasa, Damase/0000-0002-9336-7770	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Natural Sciences and Engineering Research Council of Canada (NSERC) provided financial support for this study. Furthermore, we are grateful to Andre Gagne and Marie-Eve Beaulieu for their invaluable help and advice over the course of this research. The authors also thank Mathieu Boudreau for his assistance in the laboratory, Alain Brousseau for performing the soil chemical analyses, and Mark Mazerolle for his statistical guidance. Lastly, we are grateful to Drs. Suzanne Simard (University of British Columbia) and Line Lapointe (Universite Laval) for their careful review that helped improve the quality of the manuscript. We are also immensely grateful to Dr W.F.J. Parsons from the Centre d'etude de la foret (CEF) for his constructive comments on an earlier version of the manuscript.	Adriaensen K, 2005, APPL ENVIRON MICROB, V71, P7279, DOI 10.1128/AEM.71.11.7279-7284.2005; Allen EB, 2003, ECOL APPL, V13, P1701, DOI 10.1890/02-5309; Allen MF, 2003, ANNU REV PHYTOPATHOL, V41, P271, DOI 10.1146/annurev.phyto.41.052002.095518; AMACHER MC, 1990, SOIL SCI SOC AM J, V54, P1036, DOI 10.2136/sssaj1990.03615995005400040018x; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Balogh-Brunstad Z, 2008, GEOCHIM COSMOCHIM AC, V72, P2601, DOI 10.1016/j.gca.2008.04.003; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Beaudoin-Nadeau M, 2016, CAN J MICROBIOL, V62, P543, DOI 10.1139/cjm-2015-0703; Berner C, 2012, MYCORRHIZA, V22, P615, DOI 10.1007/s00572-012-0438-y; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; BRUNS TD, 1995, PLANT SOIL, V170, P63, DOI 10.1007/BF02183055; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burns RM, 1990, AGR HDB, V654; Cairney JWG, 1999, MYCORRHIZA, V9, P125, DOI 10.1007/s005720050297; Colpaert JV, 2011, ANN FOREST SCI, V68, P17, DOI 10.1007/s13595-010-0003-9; Colpaert JV, 2000, NEW PHYTOL, V147, P367, DOI 10.1046/j.1469-8137.2000.00694.x; Colpaert JV., 2008, STRESS YEASTS FILAME, P157, DOI [10.1016/S0275-0287(08)80053-7, DOI 10.1016/S0275-0287(08)80053-7]; Dahlberg A, 2001, NEW PHYTOL, V150, P555, DOI 10.1046/j.1469-8137.2001.00142.x; DeBellis T, 2006, MICROB ECOL, V52, P114, DOI 10.1007/s00248-006-9038-8; DIXON RK, 1988, PLANT SOIL, V105, P265, DOI 10.1007/BF02376791; Erlandson SR, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv148; Gagne A, 2006, CAN J FOREST RES, V36, P1684, DOI 10.1139/X06-063; Gehring CA, 1998, ECOLOGY, V79, P1562, DOI 10.1890/0012-9658(1998)079[1562:EFCSOP]2.0.CO;2; Hoffland E, 2004, FRONT ECOL ENVIRON, V2, P258; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hunt GA, 1991, FRDA HDB; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Jumpponen A., 2005, MYCOL SER, V23, P139, DOI DOI 10.1201/CRCMYCOLOGY; KEIZER PJ, 1994, MYCORRHIZA, V4, P147, DOI 10.1007/BF00203533; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kernaghan G, 2003, MICROB ECOL, V45, P128, DOI 10.1007/s00248-002-1024-1; Korkama T, 2006, NEW PHYTOL, V171, P815, DOI 10.1111/j.1469-8137.2006.01786.x; Kranabetter JM, 2009, MYCORRHIZA, V19, P99, DOI 10.1007/s00572-008-0208-z; Krpata D, 2008, MYCOL RES, V112, P1069, DOI 10.1016/j.mycres.2008.02.004; LAMHAMEDI MS, 1991, CAN J BOT, V69, P1927, DOI 10.1139/b91-242; Landeweert R, 2001, TRENDS ECOL EVOL, V16, P248, DOI 10.1016/S0169-5347(01)02122-X; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Lilleskov EA, 2001, ECOL APPL, V11, P397, DOI 10.1890/1051-0761(2001)011[0397:EFACCO]2.0.CO;2; McCune B., 1999, MULTIVARIATE ANAL EC; MRNF, 2012, VEG ZON BIOCL DOM QU; Nadeau MB, 2016, MICROBES PLANT STRES; Nienstaedt H, 1990, AGR HDB, V654; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; Nilsson LO, 2003, NEW PHYTOL, V158, P409, DOI 10.1046/j.1469-8137.2003.00728.x; Peck JE, 2010, MUTIVARIATE ANAL COM; QuikChem Systems, 1992, 13107062D QUIKCHEM S; Quoreshi AM, 2008, BIOMASS BIOENERG, V32, P381, DOI 10.1016/j.biombioe.2007.10.010; Quoreshi A. M., 2007, Native Plants Journal, V8, P271, DOI 10.2979/NPJ.2007.8.3.271; Quoreshi AM, 2008, NEW FOREST, V35, P235, DOI 10.1007/s11056-007-9074-3; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Roy S, 2007, CAN J BOT, V85, P237, DOI 10.1139/B07-017; SAS Institute Inc, 2014, SAS 9 4 SOFTW; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smits MM, 2012, GEOBIOLOGY, V10, P445, DOI 10.1111/j.1472-4669.2012.00331.x; Sutton RF, USITC PUBL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Toljander JF, 2006, NEW PHYTOL, V170, P873, DOI 10.1111/j.1469-8137.2006.01718.x; Twieg BD, 2007, NEW PHYTOL, V176, P437, DOI 10.1111/j.1469-8137.2007.02173.x; Twieg BD, 2009, MYCORRHIZA, V19, P305, DOI 10.1007/s00572-009-0232-7; Villeneuve N, 1989, CAN J BOT, V67, P2616; Wallander H, 2004, SYMBIOSIS, V37, P249; Wright SHA, 2009, MYCORRHIZA, V19, P267, DOI 10.1007/s00572-008-0218-x; Wurzburger N, 2001, CAN J BOT, V79, P1211, DOI 10.1139/cjb-79-10-1211; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027	65	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166420	10.1371/journal.pone.0166420	http://dx.doi.org/10.1371/journal.pone.0166420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835688	Green Published, gold, Green Submitted			2022-12-27	WOS:000387779200048
J	Kunisawa, S; Fushimi, K; Imanaka, Y				Kunisawa, Susumu; Fushimi, Kiyohide; Imanaka, Yuichi			Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals	PLOS ONE			English	Article							COLORECTAL RESECTION; EARLY DISCHARGE	Background The Japanese government has worked to reduce the length of hospital stay by introducing a per-diem hospital payment system that financially incentivizes the timely discharge of patients. However, there are concerns that excessively reducing length of stay may reduce healthcare quality, such as increasing readmission rates. The objective of this study was to investigate the temporal changes in length of stay and readmission rates as quality indicators in Japanese acute care hospitals. Methods We used an administrative claims database under the Diagnosis Procedure Combination Per-Diem Payment System for Japanese hospitals. Using this database, we selected hospitals that provided data continuously from July 2010 to March 2014 to enable analyses of temporal changes in length of stay and readmission rates. We selected stage I (T1N0M0) gastric, colon, and lung cancer surgical patients who had been discharged alive from the index hospitalization. The outcome measures were length of stay during the index hospitalization and unplanned emergency readmissions within 30 days after discharge. Results From among 804 hospitals, we analyzed 42,585, 15,467, and 40,156 surgical patients for gastric, colon, and lung cancer, respectively. Length of stay was reduced by approximately 0.5 days per year. In contrast, readmission rates were generally stable at approximately 2% or had decreased slightly over the 4-year period. Conclusions In early-stage gastric, colon, and lung cancer surgical patients in Japan, reductions in length of stay did not result in increased readmission rates.	[Kunisawa, Susumu; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Kyoto, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Tokyo, Japan	Kyoto University; Tokyo Medical & Dental University (TMDU)	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Kyoto, Japan.	imanaka-y@umin.net	KUNISAWA, Susumu/HCH-1094-2022		Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan [H28-seisaku-shitei-009]; Japan Society for the Promotion of Science [16H02634]	Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan (H28-seisaku-shitei-009), http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/, and a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (16H02634), https://www.jsps.go.jp/i-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooke BS, 2013, J VASC SURG, V57, P734, DOI 10.1016/j.jvs.2012.07.055; Gash KJ, 2012, COLORECTAL DIS, V14, P1287, DOI 10.1111/j.1463-1318.2012.02969.x; Hamada H, 2012, HEALTH POLICY, V107, P194, DOI 10.1016/j.healthpol.2012.01.002; Hoffman RL, 2014, J SURG RES, V190, P579, DOI 10.1016/j.jss.2014.02.006; Mackenzie SJ, 2016, J HEALTHC QUAL, V38, P187, DOI 10.1111/jhq.12080; Ministry of Health Labour and Welfare, HEIS 26 NEND BYOSH K, V26; Ministry of Health Labour and Welfare, 2014, HEIS 25 NEN IN PRESS; Ministry of Health Labour and Welfare, 2015, YOK SAIN KEIN; OECD Indicators, 2015, HLTH GLANC 2015; Otsubo T, 2012, READMISSION RATE HLT, V67, P62	10	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166269	10.1371/journal.pone.0166269	http://dx.doi.org/10.1371/journal.pone.0166269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832182	gold, Green Published, Green Submitted			2022-12-27	WOS:000387725000086
J	Li, W; Lu, JX; Lu, K; Yuan, JL; Huang, JH; Du, H; Li, JN				Li, Wei; Lu, Junxing; Lu, Kun; Yuan, Jianglian; Huang, Jieheng; Du, Hai; Li, Jiana			Cloning and Phylogenetic Analysis of Brassica napus L. Caffeic Acid O-Methyltransferase 1 Gene Family and Its Expression Pattern under Drought Stress	PLOS ONE			English	Article							WALL RELATED GENES; ARABIDOPSIS-THALIANA; DOWN-REGULATION; GENOME SIZE; N-ACETYLSEROTONIN; INTRON EVOLUTION; LEAF SENESCENCE; MELATONIN; LIGNIN; MAIZE	For many plants, regulating lignin content and composition to improve lodging resistance is a crucial issue. Caffeic acid O-methyltransferase (COMT) is a lignin monomer-specific enzyme that controls S subunit synthesis in plant vascular cell walls. Here, we identified 12 BnCOMT1 gene homologues, namely BnCOMT1-1 to BnCOMT1-12. Ten of 12 genes were composed of four highly conserved exons and three weakly conserved introns. The length of intron I, in particular, showed enormous diversification. Intron I of homologous BnCOMT1 genes showed high identity with counterpart genes in Brassica rapa and Brassica oleracea, and intron I from positional close genes in the same chromosome were relatively highly conserved. A phylogenetic analysis suggested that COMT genes experience considerable diversification and conservation in Brassicaceae species, and some COMT1 genes are unique in the Brassica genus. Our expression studies indicated that BnCOMT1 genes were differentially expressed in different tissues, with BnCOMT1-4, BnCOMT1-5, BnCOMT1-8, and BnCOMT1-10 exhibiting stem specificity. These four BnCOMT1 genes were expressed at all developmental periods (the bud, early flowering, late flowering and mature stages) and their expression level peaked in the early flowering stage in the stem. Drought stress augmented and accelerated lignin accumulation in high-lignin plants but delayed it in low-lignin plants. The expression levels of BnCOMT1s were generally reduced in water deficit condition. The desynchrony of the accumulation processes of total lignin and BnCOMT1s transcripts in most growth stages indicated that BnCOMT1s could be responsible for the synthesis of a specific subunit of lignin or that they participate in other pathways such as the melatonin biosynthesis pathway.	[Li, Wei; Lu, Kun; Yuan, Jianglian; Huang, Jieheng; Du, Hai; Li, Jiana] Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China; [Lu, Junxing] Chongqing Normal Univ, Coll Life Sci, Chongqing Key Lab Mol Biol Plants Environm Adapt, Chongqing 401331, Peoples R China	Southwest University - China; Chongqing Normal University	Li, JN (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China.	lin1950@swu.edu.cn	Lu, Kun/C-2597-2008; Du, Hai/AHD-1445-2022; Lu, Junxing/GZH-2188-2022	Lu, Kun/0000-0003-1370-8633; Lu, Junxing/0000-0002-1447-2768; Du, Hai/0000-0003-4274-5724	973 Project [2015CB150201]; National Science Foundation of China [U1302266, 31271756, 31571701]; National Key Research and Development Plan [2016YFD0101007]; National Key Technology Support Program [2013BAD01B03-12]; 111 Project [B12006]	973 Project(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan; National Key Technology Support Program(National Key Technology R&D Program); 111 Project(Ministry of Education, China - 111 Project)	The 973 Project (2015CB150201), the National Science Foundation of China (U1302266, 31271756, and 31571701), the National Key Research and Development Plan (2016YFD0101007), the National Key Technology Support Program (2013BAD01B03-12) and the 111 Project (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Arnao MB, 2014, TRENDS PLANT SCI, V19, P789, DOI 10.1016/j.tplants.2014.07.006; ATANASSOVA R, 1995, PLANT J, V8, P465, DOI 10.1046/j.1365-313X.1995.8040465.x; Bajrovic K, 1999, J FOREST RES, V4, P161, DOI [10.1007/BF02762242, DOI 10.1007/BF02762242]; Bajwa VS, 2014, J PINEAL RES, V56, P238, DOI 10.1111/jpi.12115; Bongoni R, 2014, PLANT FOOD HUM NUTR, V69, P228, DOI 10.1007/s11130-014-0420-2; Bout S, 2003, MOL GENET GENOMICS, V269, P205, DOI 10.1007/s00438-003-0824-4; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; BUGOS RC, 1991, PLANT MOL BIOL, V17, P1203, DOI 10.1007/BF00028736; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byeon Y, 2015, J EXP BOT, V66, P6917, DOI 10.1093/jxb/erv396; Byeon Y, 2014, J PINEAL RES, V57, P219, DOI 10.1111/jpi.12160; Byeon Y, 2014, J PINEAL RES, V56, P107, DOI 10.1111/jpi.12103; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chai YR, 2009, MOL GENET GENOMICS, V281, P109, DOI 10.1007/s00438-008-0399-1; Chen GQ, 2013, PLANT J, V74, P663, DOI 10.1111/tpj.12151; Comeron JM, 2000, GENETICS, V156, P1175; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; Guillaumie S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-71; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang Y-R, 2009, WATER RESOURCE PROTE, V25, P25, DOI DOI 10.1007/S11103-008-9408-3; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Kang K, 2013, J PINEAL RES, V55, P7, DOI 10.1111/jpi.12011; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; KUBITZKI K, 1987, J PLANT PHYSIOL, V131, P17, DOI 10.1016/S0176-1617(87)80263-8; Lagercrantz U, 1998, GENETICS, V150, P1217; Lee HY, 2014, J PINEAL RES, V57, P418, DOI 10.1111/jpi.12181; Lee HY, 2014, J PINEAL RES, V57, P262, DOI 10.1111/jpi.12165; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI [10.1186/1754-6834-5-71, 10.1186/1754-6834-5-2]; Liang WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-392; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Matsunaga W, 2012, PLANT CELL PHYSIOL, V53, P824, DOI 10.1093/pcp/pcr179; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moinuddin SGA, 2010, ORG BIOMOL CHEM, V8, P3928, DOI 10.1039/c004817h; Moura-Sobczak J., 2011, EUCALYPTUS BMC PROC, V5, P103, DOI [10. 1186/1753-6561-5-S7-P103, DOI 10.1186/1753-6561-5-S7-P103]; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Park S, 2012, J PINEAL RES, V52, P211, DOI [10.1111/j.1600-079X.2011.00930.x, 10.1111/j.1600-079X.2012.01029.x]; Parkin IAP, 2003, GENOME, V46, P291, DOI [10.1139/g03-006, 10.1139/G03-006]; Parsch J, 2003, GENETICS, V165, P1843; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Piquemal J, 2002, PLANT PHYSIOL, V130, P1675, DOI 10.1104/pp.012237; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Sena JS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-95; Srivastava S, 2015, PHYSIOL MOL BIOL PLA, V21, P197, DOI 10.1007/s12298-015-0289-z; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tiryaki I, 2012, J PINEAL RES, V52, P332, DOI 10.1111/j.1600-079X.2011.00947.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; U. N., 1935, Japanese Journal of Botany, V7, P389; VanDoorsselaere J, 1995, PLANT J, V8, P855, DOI 10.1046/j.1365-313X.1995.8060855.x; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; VIGNOLS F, 1995, PLANT CELL, V7, P407, DOI 10.1105/tpc.7.4.407; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561; Wang P, 2013, J PINEAL RES, V55, P424, DOI 10.1111/jpi.12091; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Wendel JF, 2002, MOL BIOL EVOL, V19, P2346, DOI 10.1093/oxfordjournals.molbev.a004062; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Yang L, 2006, RUSS J PLANT PHYSL+, V53, P390, DOI 10.1134/S1021443706030150; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	71	12	13	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165975	10.1371/journal.pone.0165975	http://dx.doi.org/10.1371/journal.pone.0165975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832102	Green Submitted, Green Published, gold			2022-12-27	WOS:000387725000051
J	Mimoun, C; Fauconnier, A; Varas, C; Huchon, C				Mimoun, Camille; Fauconnier, Arnaud; Varas, Catalina; Huchon, Cyrille			Is a Self-Assessed Questionnaire Useful for the Diagnosis of Ectopic Pregnancy in Hospitalized Patients?	PLOS ONE			English	Article							UNITED-STATES; LAPAROSCOPY; PREDICTION; MODEL	Background Delayed diagnosis of ectopic pregnancy (EP) is responsible for maternal morbidity and mortality. Our objective was to develop and validate decision rules for the diagnosis of EP, in patients in their first trimester of pregnancy with symptoms, based solely on a self-assessment questionnaire. Methods From September 2006 to March 2008, 574 patients, who have consulted for acute pelvic pain at the gynecologic emergency department (ED) of five hospitals, completed a Self Assessment Questionnaire for Gynecological Emergencies (SAO-GE). We included for our study only women in their first trimester of pregnancy experiencing acute pelvic pain and/or vaginal bleeding who were hospitalized (262 patients). Two-thirds of patients were selected to derive the SAO-GE EP score which was built on multiple logistic regression. One third of patients were used for internal validation. Results Five variables were independently and significantly (p<0.05) associated with EP: no frequent need to change sanitary towels (aDOR = 6.1; 95% CI [2.1-17.8]), duration of bleeding > 24 hours (aDOR = 4,3; 95% CI [1,7-11,0]), pain during coughing (aDOR = 3.1; CI 95% [1,4-6,7]), brown discharge (aDOR = 3.0; 95% CI [1.3-7.1]) and unilateral pelvic pain (aDOR = 2.7; 95% CI [1.3-5.9]). The SAO-GE ectopic pregnancy score was based on these five criteria with values ranging from 0 to 100. The low-risk group of EP (score<25) had a sensitivity of 95.9% 95% CI [89.8-98,9] and an LR-of 0.2 95% CI [0.1-0.5]. The high-risk group (score>70) had a specificity of 97.4 95% CI [90.9-99.7] and a LR+ of 12.3 95% CI [3.0-49.8]. The percentages of EP observed in the validation sample were: 0% in the low-risk group and 88.9% in the high-risk group. Discussion These prediction rules that classify patients in a low-risk or high-risk group may prove useful for triaging pregnant women in their first trimester with symptoms before complementary exams.	[Mimoun, Camille; Fauconnier, Arnaud; Huchon, Cyrille] Univ Versailles St Quentin, Ctr Hosp Intercommunal Poissy St Germai, Dept Gynecol & Obstet, Poissy, France; [Mimoun, Camille; Fauconnier, Arnaud; Varas, Catalina; Huchon, Cyrille] Univ Versailles St Quentin, Res Unit EA Risk & Safety Clin Med Women & Perina, Poissy, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Mimoun, C (corresponding author), Univ Versailles St Quentin, Ctr Hosp Intercommunal Poissy St Germai, Dept Gynecol & Obstet, Poissy, France.; Mimoun, C (corresponding author), Univ Versailles St Quentin, Res Unit EA Risk & Safety Clin Med Women & Perina, Poissy, France.	camillemimoun@hotmail.com			l'Association maternites et medecine de la reproduction Poissy-Saint Germain	l'Association maternites et medecine de la reproduction Poissy-Saint Germain	Camille Mimoun has received funding from l'Association maternites et medecine de la reproduction Poissy-Saint Germain.	ABBOTT J, 1990, AM J EMERG MED, V8, P515, DOI 10.1016/0735-6757(90)90154-R; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; ANKUM WM, 1993, HUM REPROD, V8, P1301, DOI 10.1093/oxfordjournals.humrep.a138246; Ardaens Y, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, pS28; Berg CJ, 2011, OBSTET GYNECOL, V117, P1230, DOI 10.1097/AOG.0b013e31821769ed; Bouquier J, 2014, SEX TRANSM DIS, V41, P525, DOI 10.1097/OLQ.0000000000000169; Bouyer J, 2002, HUM REPROD, V17, P3224, DOI 10.1093/humrep/17.12.3224; Buckley RG, 1998, ACAD EMERG MED, V5, P951, DOI 10.1111/j.1553-2712.1998.tb02770.x; Colaizzi P., 1978, PSYCHOL RES PHENOMEN; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Coste J, 1997, AM J EPIDEMIOL, V145, P278; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Demco L, 1998, J AM ASSOC GYN LAP, V5, P241, DOI 10.1016/S1074-3804(98)80026-1; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Fauconnier A, 2013, HUM REPROD, V28, P2686, DOI 10.1093/humrep/det310; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hoover KW, 2010, OBSTET GYNECOL, V115, P495, DOI 10.1097/AOG.0b013e3181d0c328; Huchon C, 2012, HUM REPROD, V27, P2359, DOI 10.1093/humrep/des186; Huchon C, 2012, ACAD EMERG MED, V19, P24, DOI 10.1111/j.1553-2712.2011.01238.x; Mol BWJ, 1998, FERTIL STERIL, V70, P972, DOI 10.1016/S0015-0282(98)00278-7	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0155054	10.1371/journal.pone.0155054	http://dx.doi.org/10.1371/journal.pone.0155054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832075	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000001
J	Schumacher, FR; Schubert, S; Hannus, M; Sonnichsen, B; Ittrich, C; Kreideweiss, S; Kurz, T; Rippmann, JF				Schumacher, Frances-Rose; Schubert, Steffen; Hannus, Michael; Soennichsen, Birte; Ittrich, Carina; Kreideweiss, Stefan; Kurz, Thimo; Rippmann, Joerg F.			RNAi Screen for NRF2 Inducers Identifies Targets That Rescue Primary Lung Epithelial Cells from Cigarette Smoke Induced Radical Stress	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; INDUCED EMPHYSEMA; ERR-ALPHA; KEAP1; DYSFUNCTION; ACTIVATION; STRATEGIES; PATHWAYS	Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent condition characterized by inflammation and progressive obstruction of the airways. At present, there is no treatment that suppresses the chronic inflammation of the disease, and COPD patients often succumb to the condition. Excessive oxidative stress caused by smoke inhalation is a major driving force of the disease. The transcription factor NRF2 is a critical player in the battle against oxidative stress and its function is impaired in COPD. Increasing NRF2 activity may therefore be a viable therapeutic option for COPD treatment. We show that down regulation of KEAP1, a NRF2 inhibitor, protects primary human lung epithelial cells from cigarette-smoke-extract (CSE) induced cell death in an established in vitro model of radical stress. To identify new potential drug targets with a similar effect, we performed a siRNA screen of the 'druggable' genome using a NRF2 transcriptional reporter cell line. This screen identified multiple genes that when down regulated increased NRF2 transcriptional activity and provided a survival benefit in the in vitro model. Our results suggest that inhibiting components of the ubiquitin-proteasome system will have the strongest effects on NRF2 transcriptional activity by increasing NRF2 levels. We also find that down regulation of the small GTPase Rab28 or the Estrogen Receptor ESRRA provide a survival benefit. Rab28 knockdown increased NRF2 protein levels, indicating that Rab28 may regulate NRF2 proteolysis. Conversely ESRRA down regulation increased NRF2 transcriptional activity without affecting NRF2 levels, suggesting a proteasome-independent mechanism.	[Ittrich, Carina; Kreideweiss, Stefan; Rippmann, Joerg F.] Boehringer Ingelheim Pharma GmbH & Co KG, Res Germany, D-8400 Biberach, Germany; [Schubert, Steffen; Hannus, Michael; Soennichsen, Birte] Cenix BioSci GmbH, D-01307 Dresden, Germany; [Schumacher, Frances-Rose; Kurz, Thimo] Univ Dundee, Sir James Black Ctr, Prot Phosphorylat & Ubiquitylat Unit, MRC, Dow St, Dundee DD1 5EH, Scotland; [Schumacher, Frances-Rose] Genentech Inc, Dept Prot Chem, Prote & Biol Resource Management, 1 DNA Way, San Francisco, CA 94080 USA; [Schubert, Steffen] Silence Therapeut, D-13125 Berlin, Germany; [Hannus, Michael] Life Sci Inkubator Sachsen, D-01307 Dresden, Germany; [Soennichsen, Birte] SiTools Biotech GmbH, D-82152 Planegg, Germany; [Kurz, Thimo] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	Boehringer Ingelheim; University of Dundee; Roche Holding; Genentech; University of Glasgow	Kurz, T (corresponding author), Univ Dundee, Sir James Black Ctr, Prot Phosphorylat & Ubiquitylat Unit, MRC, Dow St, Dundee DD1 5EH, Scotland.; Kurz, T (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	thimo.kurz@glasgow.ac.uk		Kurz, Thimo/0000-0003-0700-6993	Medical Research Council Grant [MRC_MC_UU_12016/7]; University of Glasgow; Boehringer-Ingelheim Funds; MRC [MC_UU_12016/7] Funding Source: UKRI	Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Glasgow; Boehringer-Ingelheim Funds(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Grant MRC_MC_UU_12016/7 (mre.ac.uk) to the MRC Protein Phosphorylation and Ubiquitylation Unit, by start-up funds from the University of Glasgow to TK and by Boehringer-Ingelheim Funds to SK and JR. Boehringer-Ingelheim Pharma GmbH & Co. and Cenix BioScience GmbH provided support in the form of salaries for authors CI, SK, JR and MH, SS, BS, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC; Blanco-Ayala T, 2014, FREE RADICAL RES, V48, P623, DOI 10.3109/10715762.2014.899694; Bodas M, 2012, CURR MOL MED, V12, P807, DOI 10.2174/156652412801318809; Chisamore MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005624; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Dimopoulos MA, 2015, NAT REV CLIN ONCOL, V12, P42, DOI 10.1038/nrclinonc.2014.200; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Huss JM, 2015, BBA-MOL BASIS DIS, V1852, P1912, DOI 10.1016/j.bbadis.2015.06.016; Tran I, 2015, AM J RESP CELL MOL, V53, P159, DOI 10.1165/rcmb.2014-0107OC; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kageyama S, 2014, J BIOL CHEM, V289, P24944, DOI 10.1074/jbc.M114.580357; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Lin JL, 2010, COPD, V7, P291, DOI 10.3109/15412555.2010.496818; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rahman I, 2012, CURR OPIN PHARMACOL, V12, P256, DOI 10.1016/j.coph.2012.01.015; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Smith KR, 2000, P NATL ACAD SCI USA, V97, P13286, DOI 10.1073/pnas.97.24.13286; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spira A, 2004, AM J RESP CELL MOL, V31, P601, DOI 10.1165/rcmb.2004-0273OC; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166352	10.1371/journal.pone.0166352	http://dx.doi.org/10.1371/journal.pone.0166352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832175	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000387725000107
J	Bondo, KJ; Pearl, DL; Janecko, N; Boerlin, P; Reid-Smith, RJ; Parmley, J; Jardine, CM				Bondo, Kristin J.; Pearl, David L.; Janecko, Nicol; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.			Epidemiology of Antimicrobial Resistance in Escherichia coli Isolates from Raccoons (Procyon lotor) and the Environment on Swine Farms and Conservation Areas in Southern Ontario	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; EXTENDED-SPECTRUM; CLOACAL SWABS; WILD BIRDS; SALMONELLA; PREVALENCE; BACTERIA; SUSCEPTIBILITY; SEROTYPES; PATTERNS	Antimicrobial resistance is a global threat to livestock, human and environmental health. Although resistant bacteria have been detected in wildlife, their role in the epidemiology of antimicrobial resistance is not clear. Our objective was to investigate demographic, temporal and climatic factors associated with carriage of antimicrobial resistant Escherichia coli in raccoons and the environment. We collected samples from raccoon paws and feces and from soil, manure pit and dumpsters on five swine farms and five conservation areas in Ontario, Canada once every five weeks from May to November, 2011-2013 and tested them for E. coli and susceptibility to 15 antimicrobials. Of samples testing positive for E. coli, resistance to >= 1 antimicrobials was detected in 7.4% (77/1044; 95% CI, 5.9-9.1) of raccoon fecal samples, 6.3% (23/365; 95% CI, 4.0-9.3) of paw samples, 9.6% (121/1260; 8.0-11.4) of soil samples, 57.4% (31/54; 95% CI, 43.2-70.8) of manure pit samples, and 13.8% (4/29; 95% CI, 3.9-31.7) of dumpster samples. Using univariable logistic regression, there was no significant difference in the occurrence of resistant E. coli in raccoon feces on conservation areas versus farms; however, E. coli isolates resistant to >= 1 antimicrobials were significantly less likely to be detected from raccoon paw samples on swine farms than conservation areas and significantly more likely to be detected in soil samples from swine farms than conservation areas. Resistant phenotypes and genotypes that were absent from the swine farm environment were detected in raccoons from conservation areas, suggesting that conservation areas and swine farms may have different exposures to resistant bacteria. However, the similar resistance patterns and genes in E. coli from raccoon fecal and environmental samples from the same location types suggest that resistant bacteria may be exchanged between raccoons and their environment.	[Bondo, Kristin J.; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Pearl, David L.; Janecko, Nicol; Reid-Smith, Richard J.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Janecko, Nicol; Reid-Smith, Richard J.; Parmley, Jane] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Janecko, Nicol] Univ Vet & Pharmaceut Sci Brno, Dept Biol & Wildlife Dis, Brno, Czech Republic; [Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada	University of Guelph; University of Guelph; Public Health Agency of Canada; University of Veterinary Sciences Brno; University of Guelph	Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON, Canada.; Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada.	cjardi01@uoguelph.ca			National Science and Engineering Research Council (NSERC); United States Department of Agriculture (USDA); Ontario Graduate Scholarship (OGS)	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship)	Funding was provided by the National Science and Engineering Research Council (NSERC) and the United States Department of Agriculture (USDA). KJB also received support through an Ontario Graduate Scholarship (OGS). In-kind support was provided by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agga GE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132586; Ahmed Lubna N, 2015, BMC Res Notes, V8, P137, DOI 10.1186/s13104-015-1103-2; Allen SE, 2011, APPL ENVIRON MICROB, V77, P882, DOI 10.1128/AEM.01111-10; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bondo KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P303, DOI 10.1111/zph.12232; Bondo KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161497; Bonnedahl J, 2008, POLAR BIOL, V31, P759, DOI 10.1007/s00300-008-0430-3; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Carlson JC, 2015, VET MICROBIOL, V179, P60, DOI 10.1016/j.vetmic.2015.04.009; Cole D, 2005, EMERG INFECT DIS, V11, P935; Cristobal-Azkarate J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107719; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dohoo IR, 2009, VET EPIDEMIOLOGIC RE, P151; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; GOODLIFFE L, 2014, AMMI ANN C VICT CAN; GOVERNMENT OF CANADA, 2014, CAN INT PROGR ANT RE; Government of Canada, 2013, OV FOODNET CAN FORM; Government of Canada, 2012, CAN INT PROGR ANT RE; GOVERNMENT OF CANADA, 2015, CAN INT PROGR ANT RE; Grand River Conservation Authority, 2008, GRAND RIV WAT CHAR R; Guenther S, 2010, ENV MICROBIOL REP, V2, P641, DOI 10.1111/j.1758-2229.2010.00148.x; Guenther S, 2010, SCI TOTAL ENVIRON, V408, P3519, DOI 10.1016/j.scitotenv.2010.05.005; Human K., 2005, CLIN INFECT DIS, V41, P1613, DOI [10.1086/497599, DOI 10.1086/497599]; Jardine CM, 2012, APPL ENVIRON MICROB, V78, P3873, DOI 10.1128/AEM.00705-12; Jobbins SE, 2015, J WILDLIFE DIS, V51, P811, DOI 10.7589/2014-11-257; Kobayashi H, 2007, J VET MED SCI, V69, P309, DOI 10.1292/jvms.69.309; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106; Madsen M, 1998, J ZOO WILDLIFE MED, V29, P31; Miranda CD, 2001, MAR POLLUT BULL, V42, P1096, DOI 10.1016/S0025-326X(01)00093-5; Nhung NT, 2015, APPL ENVIRON MICROB, V81, P812, DOI 10.1128/AEM.03366-14; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Palmgren H, 2000, EPIDEMIOL INFECT, V125, P257, DOI 10.1017/S0950268899004586; Procter TD, 2014, ZOONOSES PUBLIC HLTH, V61, P250, DOI 10.1111/zph.12064; ROLLAND RM, 1985, APPL ENVIRON MICROB, V49, P791, DOI 10.1128/AEM.49.4.791-794.1985; Rosatte R, 2010, J MAMMAL, V91, P122, DOI 10.1644/08-MAMM-A-201R2.1; Sayah RS, 2005, APPL ENVIRON MICROB, V71, P1394, DOI 10.1128/AEM.71.3.1394-1404.2005; Schaufler K, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv155; Schaufler Katharina, 2015, Infection Ecology & Epidemiology, V5, P25334, DOI 10.3402/iee.v5.25334; Schroeder CM, 2003, INT J FOOD MICROBIOL, V85, P197, DOI 10.1016/S0168-1605(02)00508-1; Skurnik D, 2006, J ANTIMICROB CHEMOTH, V57, P1215, DOI 10.1093/jac/dkl122; SONENSHINE DE, 1972, J WILDLIFE MANAGE, V36, P838, DOI 10.2307/3799438; Sulzner K, 2014, J ZOO WILDLIFE MED, V45, P931, DOI 10.1638/2012-0217.1; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Travis RM, 2006, J ANTIMICROB CHEMOTH, V58, P173, DOI 10.1093/jac/dkl207; Veterinary Drugs Directorate, 2009, CAT ANT DRUGS BAS IM; Vigo GB, 2011, POLAR BIOL, V34, P675, DOI 10.1007/s00300-010-0923-8; Watkinson AJ, 2007, APPL ENVIRON MICROB, V73, P5667, DOI 10.1128/AEM.00763-07; Williams NJ, 2011, J APPL MICROBIOL, V110, P962, DOI 10.1111/j.1365-2672.2011.04952.x; Witte W, 1998, SCIENCE, V279, P996, DOI 10.1126/science.279.5353.996	54	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165303	10.1371/journal.pone.0165303	http://dx.doi.org/10.1371/journal.pone.0165303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829035	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300037
J	Chen, S; Chen, X; Sun, KX; Xiu, YL; Liu, BL; Feng, MX; Sang, XB; Zhao, Y				Chen, Shuo; Chen, Xi; Sun, Kai-Xuan; Xiu, Yin-Ling; Liu, Bo-Liang; Feng, Miao-Xiao; Sang, Xiu-Bo; Zhao, Yang			MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; LUNG ADENOCARCINOMA; METASTASIS; SUPPRESSES; INVASION; GROWTH; FOXA1; OVEREXPRESSION; RECEPTOR; PATHWAY	MicroRNA-93, derived from a paralog (miR-106b-25) of the miR-17-92 cluster, is involved in the tumorigenesis and progression of many cancers such as breast, colorectal, hepatocellular, lung, ovarian, and pancreatic cancer. However, the role of miR-93 in endometrial carcinoma and the potential molecular mechanisms involved remain unknown. Our results showed that miR-93 was overexpressed in endometrial carcinoma tissues than normal endometrial tissues. The endometrial carcinoma cell lines HEC-1B and Ishikawa were transfected with miR-93-5P, after which cell migration and invasion ability and the expression of relevant molecules were detected. MiR-93 overexpression promoted cell migration and invasion, and downregulated E-cadherin expression while increasing N-cadherin expression. Dual-luciferase reporter assay showed that miR-93 may directly bind to the 30 untranslated region of forkhead box A1 (FOXA1); furthermore, miR-93 overexpression downregulated FOXA1 expression while miR-93 inhibitor transfection upregulated FOXA1 expression at both mRNA and protein level. In addition, transfection with the most effective FOXA1 small interfering RNA promoted both endometrial cancer cell migration and invasion, and downregulated E-cadherin expression while upregulating N-cadherin expression. Therefore, we suggest that miR-93 may promote the process of epithelial-mesenchymal transition in endometrial carcinoma cells by targeting FOXA1.	[Chen, Shuo; Chen, Xi; Sun, Kai-Xuan; Xiu, Yin-Ling; Liu, Bo-Liang; Feng, Miao-Xiao; Sang, Xiu-Bo; Zhao, Yang] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Liaoning, Peoples R China	China Medical University	Zhao, Y (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Liaoning, Peoples R China.	yida.zhaoyang@163.com		Shuo, Chen/0000-0002-5122-3656; Zhao, Yang/0000-0003-3226-8127	National Natural Science Foundation of China [81202049, 81472440, 81602266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Yang Zhao, Nos. 81202049, 81472440; and Shuo Chen, No. 81602266).	Azmi AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16077; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Chen SP, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1738-3; Chen X, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0304-6; Cheng CW, 2015, ONCOTARGET, V6, P44222, DOI 10.18632/oncotarget.5826; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; De Mattos-Arruda L, 2015, ONCOTARGET, V6, P37269, DOI 10.18632/oncotarget.5495; Dong PX, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0231-0; Dong PX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/130362; Ghahhari NM, 2015, EUR J CANCER, V51, P1638, DOI 10.1016/j.ejca.2015.04.021; Gou WF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-477; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Huang JZ, 2016, J PATHOL, V239, P186, DOI 10.1002/path.4716; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jin HJ, 2013, CANCER RES, V73, P3725, DOI 10.1158/0008-5472.CAN-12-3468; Lin YC, 2014, J CELL SCI, V127, P85, DOI 10.1242/jcs.132779; Liu TM, 2015, MOL MED REP, V12, P7403, DOI 10.3892/mmr.2015.4374; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Long HX, 2015, ONCOTARGET, V6, P38705, DOI 10.18632/oncotarget.5478; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Meng X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.32; Mitra A, 2015, ONCOTARGET, V6, P10697, DOI 10.18632/oncotarget.4037; Qiu MT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-78; Qu JJ, 2015, INT J ONCOL, V47, P2141, DOI 10.3892/ijo.2015.3187; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Wang JY, 2014, ONCOL REP, V31, P1225, DOI 10.3892/or.2014.2982; Wang L, 2015, ONCOTARGET, V6, P35978, DOI 10.18632/oncotarget.5427; Wang SS, 2015, ONCOTARGETS THER, V8, P2973, DOI 10.2147/OTT.S91863; Wu S, 2016, BIOL CHEM, V397, P75, DOI 10.1515/hsz-2015-0215; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang WN, 2014, J GYNECOL ONCOL, V25, P36, DOI 10.3802/jgo.2014.25.1.36; Ye ZX, 2015, INT J GYNECOL CANCER, V25, P1574, DOI 10.1097/IGC.0000000000000546; Yeramian A, 2013, ONCOGENE, V32, P403, DOI 10.1038/onc.2012.76; Zhang XL, 2015, ARCH BIOCHEM BIOPHYS, V585, P10, DOI 10.1016/j.abb.2015.09.006; Zhao MY, 2015, ONCOTARGET, V6, P15610, DOI 10.18632/oncotarget.3639	37	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165776	10.1371/journal.pone.0165776	http://dx.doi.org/10.1371/journal.pone.0165776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829043	Green Published, Green Submitted, gold			2022-12-27	WOS:000387724300059
J	Xu, J; Spitale, RC; Guan, LN; Flynn, RA; Torre, EA; Li, R; Reber, I; Qu, K; Kern, D; Knaggs, HE; Chang, HY; Chang, ALS				Xu, Jin; Spitale, Robert C.; Guan, Linna; Flynn, Ryan A.; Torre, Eduardo A.; Li, Rui; Reber, Inbar; Qu, Kun; Kern, Dale; Knaggs, Helen E.; Chang, Howard Y.; Chang, Anne Lynn S.			Novel Gene Expression Profile of Women with Intrinsic Skin Youthfulness by Whole Transcriptome Sequencing	PLOS ONE			English	Article							AGED HUMAN SKIN; IMMUNE-RESPONSES; T-CELLS; RNA; GENOME; LONGEVITY; REVEALS; INSIGHTS; HAS2	While much is known about genes that promote aging, little is known about genes that protect against or prevent aging, particularly in human skin. The main objective of this study was to perform an unbiased, whole transcriptome search for genes that associate with intrinsic skin youthfulness. To accomplish this, healthy women (n = 122) of European descent, ages 18-89 years with Fitzpatrick skin type I/II were examined for facial skin aging parameters and clinical covariates, including smoking and ultraviolet exposure. Skin youthfulness was defined as the top 10% of individuals whose assessed skin aging features were most discrepant with their chronological ages. Skin biopsies from sun-protected inner arm were subjected to 3'-end sequencing for expression quantification, with results verified by quantitative reverse transcriptase-polymerase chain reaction. Unbiased clustering revealed gene expression signatures characteristic of older women with skin youthfulness (n = 12) compared to older women without skin youthfulness (n = 33), after accounting for gene expression changes associated with chronological age alone. Gene set analysis was performed using Genomica open-access software. This study identified a novel set of candidate skin youthfulness genes demonstrating differences between SY and non-SY group, including pleckstrin homology like domain family A member 1 (PHLDA1) (p = 2.4x10(-5)), a follicle stem cell marker, and hyaluronan synthase 2-anti-sense 1 (HAS2-AS1) (p = 0.00105), a non-coding RNA that is part of the hyaluronan synthesis pathway. We show that immunologic gene sets are the most significantly altered in skin youthfulness (with the most significant gene set p = 2.4x10(-5)), suggesting the immune system plays an important role in skin youthfulness, a finding that has not previously been recognized. These results are a valuable resource from which multiple future studies may be undertaken to better understand the mechanisms that promote skin youthfulness in humans.	[Xu, Jin; Guan, Linna; Flynn, Ryan A.; Torre, Eduardo A.; Li, Rui; Reber, Inbar; Qu, Kun; Chang, Howard Y.; Chang, Anne Lynn S.] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA; [Spitale, Robert C.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA USA; [Kern, Dale; Knaggs, Helen E.] Nu Skin Int, Provo, UT USA	Stanford University; University of California System; University of California Irvine	Chang, ALS (corresponding author), Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA.	alschang@stanford.edu	Qu, Kun/G-3359-2012; Xu, Jin/M-9532-2016	Xu, Jin/0000-0003-0944-9835	Nuskin International; Nu Skin; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER	Nuskin International; Nu Skin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by a research award from Nuskin International to Anne Lynn S. Chang, the clinical investigator. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank John Coller, PhD, at the Stanford Functional Genomics Facility for whole transcriptome sequencing, and Gefei Alex Zhu, Rashmi Tarhalkar and Hoa Nguyen for assistance with clinical data acquisition and curation. This study was funded by a research award from Nu Skin to the principal investigator Anne Lynn S. Chang, MD.	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896; Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P4768, DOI 10.1210/jc.2009-0808; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Borlon C, 2008, BIOGERONTOLOGY, V9, P197, DOI 10.1007/s10522-008-9127-9; Chang ALS, 2014, J INVEST DERMATOL, V134, P651, DOI 10.1038/jid.2013.381; Chang ALS, 2013, J INVEST DERMATOL, V133, P394, DOI 10.1038/jid.2012.287; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; Guinot C, 2002, ARCH DERMATOL, V138, P1454, DOI 10.1001/archderm.138.11.1454; Haq K, 2014, CURR OPIN IMMUNOL, V29, P38, DOI 10.1016/j.coi.2014.03.008; Kim C, 2017, CLIN EXP IMMUNOL, V187, P71, DOI 10.1111/cei.12829; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lener T, 2006, EXP GERONTOL, V41, P387, DOI 10.1016/j.exger.2006.01.012; Lennox KA, 2016, NUCLEIC ACIDS RES, V44, P863, DOI 10.1093/nar/gkv1206; Li Y, 2012, INT J CLIN EXP PATHO, V5, P624; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; Mayer D, 2012, J AM ACAD DERMATOL, V66, pE9, DOI 10.1016/j.jaad.2010.10.002; Oh JH, 2011, EXP DERMATOL, V20, P455, DOI 10.1111/j.1600-0625.2011.01258.x; Papakonstantinou E, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.21923; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rilla K, 2002, J CELL SCI, V115, P3633, DOI 10.1242/jcs.00042; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Schulz AR, 2015, J IMMUNOL, V195, P4699, DOI 10.4049/jimmunol.1500598; Sellheyer K, 2011, BRIT J DERMATOL, V164, P141, DOI 10.1111/j.1365-2133.2010.10045.x; Singh P, 2012, FRONT GENET, P3; Swindell WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033204; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Vachiramon V, 2011, DERMATOLOGIST; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vukmanovic-Stejic M, 2011, CURR OPIN IMMUNOL, V23, P525, DOI 10.1016/j.coi.2011.05.008; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Yu SG, 1997, MECH AGEING DEV, V94, P103, DOI 10.1016/S0047-6374(97)01868-X; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhu GFA, 2016, BMC DERMATOL, V16, DOI 10.1186/s12895-016-0038-1	50	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165913	10.1371/journal.pone.0165913	http://dx.doi.org/10.1371/journal.pone.0165913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829007	Green Published, gold			2022-12-27	WOS:000387724300066
J	Fenton, IS; Pearson, PN; Jones, TD; Purvis, A				Fenton, Isabel S.; Pearson, Paul N.; Jones, Tom Dunkley; Purvis, Andy			Environmental Predictors of Diversity in Recent Planktonic Foraminifera as Recorded in Marine Sediments	PLOS ONE			English	Article							GLOBAL PATTERNS; SPECIES RICHNESS; METABOLIC THEORY; TEMPERATURE; EVOLUTION; GRADIENT; TROPICS; BIODIVERSITY; EXTINCTION; SPECIATION	Global diversity patterns are thought to result from a combination of environmental and historical factors. This study tests the set of ecological and evolutionary hypotheses proposed to explain the global variation in present-day coretop diversity in the macroperforate planktonic foraminifera, a clade with an exceptional fossil record. Within this group, marine surface sediment assemblages are thought to represent an accurate, although centennial to millennial time-averaged, representation of recent diversity patterns. Environmental variables chosen to capture ocean temperature, structure, productivity and seasonality were used to model a range of diversity measures across the world's oceans. Spatial autoregressive models showed that the same broad suite of environmental variables were important in shaping each of the four largely independent diversity measures (rarefied species richness, Simpson's evenness, functional richness and mean evolutionary age). Sea-surface temperature explains the largest portion of diversity in all four diversity measures, but not in the way predicted by the metabolic theory of ecology. Vertical structure could be linked to increased diversity through the strength of stratification, but not through the depth of the mixed layer. There is limited evidence that seasonal turnover explains diversity patterns. There is evidence for functional redundancy in the low-latitude sites. The evolutionary mechanism of deep-time stability finds mixed support whilst there is relatively little evidence for an out-of-the-tropics model. These results suggest the diversity patterns of planktonic foraminifera cannot be explained by any one environmental variable or proposed mechanism, but instead reflect multiple processes acting in concert.	[Fenton, Isabel S.; Purvis, Andy] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [Fenton, Isabel S.; Purvis, Andy] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England; [Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Jones, Tom Dunkley] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England	Natural History Museum London; Imperial College London; Cardiff University; University of Birmingham	Fenton, IS (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.; Fenton, IS (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	isabel.fenton@cantab.net	Purvis, Andy/A-7529-2008; Fenton, Isabel S/V-3240-2019; Jones, Tom Dunkley/A-8441-2008	Purvis, Andy/0000-0002-8609-6204; Fenton, Isabel S/0000-0001-7174-0725; Jones, Tom Dunkley/0000-0002-9518-8143	Natural Environment Research Council UK (NERC grant) [NE/I005595/1]; NERC; NERC [NE/I00551X/1, NE/I005870/1, NE/I005595/1, NE/M003736/1] Funding Source: UKRI; Natural Environment Research Council [NE/I005595/1, NE/I00551X/1, 1233267, NE/M003736/1, NE/I005870/1] Funding Source: researchfish	Natural Environment Research Council UK (NERC grant)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council UK ("Descent into the Icehouse" project), http://www.nerc.ac.uk/, (NERC grant NE/I005595/1), as part of ISF's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Michal Kaera, Brian Huber and an anonymous reviewer for their thoughtful comments; these have significantly improved the manuscript. We are very grateful to researchers in the Purvis lab and in the NERC funded "Descent into the Icehouse" project for the support they have provided during the writing of this paper.	Al-Saboui N, 2007, MAR MICROPALEONTOL, V63, P75, DOI 10.1016/j.marmicro.2006.11.002; Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; [Anonymous], 2004, STAT ANAL DATA DISPL; [Anonymous], 2014, R LANG ENV STAT COMP; Antonov J. I., 2010, WORLD OCEAN ATLAS 20, V2; Archer DE, 1996, GLOBAL BIOGEOCHEM CY, V10, P159, DOI 10.1029/95GB03016; Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Be A. W. H, 1977, Micropaleontology, V23, P369, DOI 10.2307/1485406; BE AWH, 1985, MAR MICROPALEONTOL, V9, P307, DOI 10.1016/0377-8398(85)90002-7; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Beaugrand G, 2013, GLOBAL ECOL BIOGEOGR, V22, P440, DOI 10.1111/geb.12009; BERGER WH, 1970, MAR GEOL, V8, P111, DOI 10.1016/0025-3227(70)90001-0; BIJMA J, 1990, J FORAMIN RES, V20, P95, DOI 10.2113/gsjfr.20.2.95; Birch H, 2013, MAR MICROPALEONTOL, V101, P127, DOI 10.1016/j.marmicro.2013.02.002; Bivand R, 2014, R SPDEP SPATIAL DEPE; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Brayard A, 2005, J ZOOL SYST EVOL RES, V43, P178, DOI 10.1111/j.1439-0469.2005.00311.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Clarke Andrew, 2003, P130; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Coxall HK, 2007, PALEOBIOLOGY, V33, P495, DOI 10.1666/06034.1; Crame JA, 2000, GEOL SOC SPEC PUBL, V177, P347, DOI 10.1144/GSL.SP.2000.177.01.23; Crawley M.J., 2007, R BOOK; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; ECONOMOS AC, 1979, GERONTOLOGY, V26, P82, DOI 10.1159/000212399; Ezard THG, 2015, PALEOCEANOGRAPHY, V30, P151, DOI 10.1002/2014PA002735; Ezard THG, 2012, BIOL LETTERS, V8, P139, DOI 10.1098/rsbl.2011.0699; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Feldman AH, 2003, EVOLUTIONARY ORIGIN; Fritz SA, 2013, TRENDS ECOL EVOL, V28, P509, DOI 10.1016/j.tree.2013.05.004; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Garcia H. E., 2010, WORLD OCEAN ATLAS 20, V3; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JABLONSKI D, 1993, NATURE, V364, P142, DOI 10.1038/364142a0; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski David, 2003, P368; Jablonski D, 2013, P NATL ACAD SCI USA, V110, P10487, DOI 10.1073/pnas.1308997110; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; Kasemann SA, 2008, EARTH PLANET SC LETT, V271, P292, DOI 10.1016/j.epsl.2008.04.007; Kidwell SM, 2013, PALAEONTOLOGY, V56, P487, DOI 10.1111/pala.12042; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kucera M, 2005, QUATERNARY SCI REV, V24, P813, DOI 10.1016/j.quascirev.2004.07.017; Kucera M, 2013, WELLINGTON KAOHSIUNG; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Locarnini R. A., 2010, NOAA ATLAS NESDIS, V68, P1; Longhurst AR, 2007, ECOLOGICAL GEOGRAPHY; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McKinney ML, 1998, BIODIVERSITY DYNAMICS, P1; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Montegut CD, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003953; MOORE TC, 1981, PALAEOGEOGR PALAEOCL, V35, P357, DOI 10.1016/0031-0182(81)90102-4; Morey AE, 2005, QUATERNARY SCI REV, V24, P925, DOI 10.1016/j.quascirev.2003.09.011; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peters SE, 2013, NATURE, V493, P398, DOI 10.1038/nature11815; Pigot AL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001260; Powell MG, 2012, J BIOGEOGR, V39, P1687, DOI 10.1111/j.1365-2699.2012.02719.x; Powell MG, 2002, GEOLOGY, V30, P331, DOI 10.1130/0091-7613(2002)030<0331:IIEASA>2.0.CO;2; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Purvis A, 2011, PHILOS T R SOC B, V366, P2462, DOI 10.1098/rstb.2011.0025; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schabenberger O., 2004, STAT METHODS SPATIAL; Schiebel Ralf, 2005, Palaeontologische Zeitschrift, V79, P135; Schlitzer R., 2021, OCEAN DATA VIEW VS 5; SEN GUPTA B. K., 2002, MODERN FORAMINIFERA; Siccha M, 2009, MAR MICROPALEONTOL, V72, P146, DOI 10.1016/j.marmicro.2009.04.002; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Veal A, 2010, COPES RULE CENOZOIC; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiner AKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092148; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zaric S, 2005, MAR MICROPALEONTOL, V55, P75, DOI 10.1016/j.marmicro.2005.01.002; [No title captured]	99	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165522	10.1371/journal.pone.0165522	http://dx.doi.org/10.1371/journal.pone.0165522			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851751	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000387909300019
J	Wang, Z; Ramsey, BJ; Wang, DL; Wong, K; Li, HS; Wang, E; Bao, ZR				Wang, Zi; Ramsey, Benjamin J.; Wang, Dali; Wong, Kwai; Li, Husheng; Wang, Eric; Bao, Zhirong			An Observation-Driven Agent-Based Modeling and Analysis Framework for C-elegans Embryogenesis	PLOS ONE			English	Article							SINGLE-CELL RESOLUTION; CAENORHABDITIS-ELEGANS; MORPHOGENESIS; SIMULATION; EMBRYO	With cutting-edge live microscopy and image analysis, biologists can now systematically track individual cells in complex tissues and quantify cellular behavior over extended time windows. Computational approaches that utilize the systematic and quantitative data are needed to understand how cells interact in vivo to give rise to the different cell types and 3D morphology of tissues. An agent-based, minimum descriptive modeling and analysis framework is presented in this paper to study C. elegans embryogenesis. The framework is designed to incorporate the large amounts of experimental observations on cellular behavior and reserve data structures/interfaces that allow regulatory mechanisms to be added as more insights are gained. Observed cellular behaviors are organized into lineage identity, timing and direction of cell division, and path of cell movement. The framework also includes global parameters such as the eggshell and a clock. Division and movement behaviors are driven by statistical models of the observations. Data structures/interfaces are reserved for gene list, cell-cell interaction, cell fate and landscape, and other global parameters until the descriptive model is replaced by a regulatory mechanism. This approach provides a framework to handle the ongoing experiments of single-cell analysis of complex tissues where mechanistic insights lag data collection and need to be validated on complex observations.	[Wang, Zi; Li, Husheng] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN USA; [Ramsey, Benjamin J.; Wong, Kwai] Univ Tennessee, Joint Inst Computat Sci, Knoxville, TN USA; [Wang, Dali] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37830 USA; [Wang, Eric] Farragut High Sch, Knoxville, TN USA; [Bao, Zhirong] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; Memorial Sloan Kettering Cancer Center	Wang, DL (corresponding author), Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37830 USA.	wangd@ornl.gov	Wang, Dali/AAU-3519-2021	Wang, Dali/0000-0001-6806-5108; Wang, Zi/0000-0002-5081-661X	NIH [R01GM097576, P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by an NIH research project grant to Z. Bao at MSKCC (R01GM097576, with a subcontract to D. Wang at UTK). Research in the Bao lab is also supported by an NIH center grant to MSKCC (P30CA008748).; This study is supported by an NIH research project grant to Z. Bao at MSKCC (R01GM097576, with a subcontract to D. Wang at UTK). Research in the Bao lab is also supported by an NIH center grant to MSKCC (P30CA008748).	Atwell K, 2015, DEVELOPMENT, V142, P3902, DOI 10.1242/dev.126359; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Du Z, 2015, DEV CELL, V34, P592, DOI 10.1016/j.devcel.2015.07.014; Du Z, 2014, CELL, V156, P359, DOI 10.1016/j.cell.2013.11.046; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Gontis V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102201; Gorochowski TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042790; Hench J, 2009, DEV BIOL, V333, P1, DOI 10.1016/j.ydbio.2009.06.014; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093661; Kyoda K, 2013, NUCLEIC ACIDS RES, V41, pD732, DOI 10.1093/nar/gks1107; Macal CM, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P2, DOI 10.1109/WSC.2005.1574234; Moore JL, 2013, DEVELOPMENT, V140, P3266, DOI 10.1242/dev.096040; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Polhill JG, 2008, JASSS-J ARTIF SOC S, V11; Railsback S., 2012, AGENT BASED INDIVIDU; Reece J. B., 2011, CAMPBELL BIOL, V10th, P321; Rizzi B, 2014, J CHEM BIOL, V7, P17, DOI [10.1007/912154-013-0101-x, DOI 10.1007/912154-013-0101-X]; Rizzi Barbara, 2014, Journal of Chemical Biology, V7, P17, DOI 10.1007/s12154-013-0101-x; Sakamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151157; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Setty Y, 2012, BIOINFORMATICS, V28, P2022, DOI 10.1093/bioinformatics/bts307; Setty Y, 2012, DEVELOPMENT, V139, P47, DOI 10.1242/dev.067512; Setty Y, 2008, P NATL ACAD SCI USA, V105, P20374, DOI 10.1073/pnas.0808725105; Voss-Bohme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042852	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166551	10.1371/journal.pone.0166551	http://dx.doi.org/10.1371/journal.pone.0166551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851808	Green Published, Green Submitted, gold			2022-12-27	WOS:000387909300065
J	Wu, Y; Li, YH; Yu, SB; Li, WG; Liu, XS; Zhao, L; Lu, JX				Wu, Yuan; Li, Yin-hu; Yu, Shuan-bao; Li, Wen-ge; Liu, Xiao-shu; Zhao, Lei; Lu, Jin-xing			A Genome-Wide Transcriptional Analysis of Yeast-Hyphal Transition in Candida tropicalis by RNA-Seq	PLOS ONE			English	Article							ALBICANS; EPIDEMIOLOGY; LANDSCAPE; PATHOGENICITY; MORPHOLOGY; EVOLUTION; VIRULENCE	Candida tropicalis is considered as the leading pathogen in nosocomial fungemia and hepatosplenic fungal infections in patients with cancer, particularly in leukemia. The yeast-filament transition is required for virulent infection by Candida. Several studies have explored the genome-wide transcription profile of Candida, however, no report on the transcriptional profile of C. tropicalis under yeast-filament transition has been published. In this study, the transcriptomes of three C. tropicalis isolates with different adhesion and biofilm formation abilities, identified in our previous studies, were analyzed in both the yeast and filament states using RNA-Seq. Differentially expressed genes were found for each isolate during the transition. A total of 115 genes were up-or down-regulated in the two hyphal-producing isolates (ZRCT 4 and ZRCT 45). Among these differentially expressed genes, only two were down-regulated during the yeast-filament transition. Furthermore, six filament associated genes were up-regulated in the hyphae-producing isolates. According to Candida Hypha Growth Database established in this study, 331 hyphae-related genes were discovered in C. tropicalis. ALS1 and ALS3 were down-regulated and up-regulated, respectively, during filamentous growth of C. tropicalis. These findings proved a better understanding of gene expression dynamics during the yeast-filament transition in C. tropicalis.	[Wu, Yuan; Yu, Shuan-bao; Li, Wen-ge; Liu, Xiao-shu; Lu, Jin-xing] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Chang Bai Rd 155, Beijing, Peoples R China; [Li, Yin-hu] BGI Shenzhen, Microbial Res Dept, Main Bldg, Shenzhen, Peoples R China; [Zhao, Lei] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Beijing Genomics Institute (BGI); University of Iowa	Lu, JX (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Chang Bai Rd 155, Beijing, Peoples R China.	lujinxing@icdc.cn	Li, Yinhu/U-9020-2019		National Natural Science Foundation of China [81301409]; National Key Technology Support Program [2012BAI11B05]; National Sci-Tech Key Project [2013ZX10004203-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); National Sci-Tech Key Project	This research was supported by the National Natural Science Foundation of China (Youth Project no. 81301409), the National Key Technology Support Program (grant no. 2012BAI11B05), and the National Sci-Tech Key Project (grant no. 2013ZX10004203-002).	Bedini A, 2006, CLIN MICROBIOL INFEC, V12, P75, DOI 10.1111/j.1469-0691.2005.01310.x; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Carlisle PL, 2013, MOL BIOL CELL, V24, P246, DOI 10.1091/mbc.E12-01-0065; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Chalmers C, 2011, MYCOSES, V54, pE795, DOI 10.1111/j.1439-0507.2011.02027.x; Chen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072483; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Desnos-Ollivier M, 2008, EMERG INFECT DIS, V14, P557, DOI 10.3201/eid1404.071083; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Falagas ME, 2010, INT J INFECT DIS, V14, pE954, DOI 10.1016/j.ijid.2010.04.006; Galan-Ladero MA, 2010, MED MYCOL, V48, P207, DOI 10.3109/13693780902801242; Goldani LZ, 2010, BRAZ J INFECT DIS, V14, P631, DOI 10.1590/S1413-86702010000600014; Grumaz C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-212; Guida A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-628; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lackey E, 2013, EUKARYOT CELL, V12, P1356, DOI 10.1128/EC.00164-13; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Linde J, 2015, NUCLEIC ACIDS RES, V43, P1392, DOI 10.1093/nar/gku1357; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Negri M, 2012, EUR J CLIN MICROBIOL, V31, P1399, DOI 10.1007/s10096-011-1455-z; Novodvorska M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-246; Sherry L, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-182; Silva S, 2011, CLIN MICROBIOL INFEC, V17, P264, DOI 10.1111/j.1469-0691.2010.03248.x; Silva S, 2011, TRENDS MICROBIOL, V19, P241, DOI 10.1016/j.tim.2011.02.003; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Thompson DS, 2011, EUKARYOT CELL, V10, P1173, DOI 10.1128/EC.05085-11; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Yu SB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01175; Yu Shuanbao, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1162; Zhang QY, 2016, MOL MICROBIOL, V99, P528, DOI 10.1111/mmi.13247	34	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166645	10.1371/journal.pone.0166645	http://dx.doi.org/10.1371/journal.pone.0166645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851809	gold, Green Submitted, Green Published			2022-12-27	WOS:000387909300076
J	Burkhardt, D; Bartosova, M; Schaefer, B; Grabe, N; Lahrmann, B; Nasser, H; Freise, C; Schneider, A; Lingnau, A; Degenhardt, P; Ranchin, B; Sallay, P; Cerkauskiene, R; Malina, M; Ariceta, G; Schmitt, CP; Querfeld, U				Burkhardt, Dorothea; Bartosova, Maria; Schaefer, Betti; Grabe, Niels; Lahrmann, Bernd; Nasser, Hamoud; Freise, Christian; Schneider, Axel; Lingnau, Anja; Degenhardt, Petra; Ranchin, Bruno; Sallay, Peter; Cerkauskiene, Rimante; Malina, Michal; Ariceta, Gema; Schmitt, Claus Peter; Querfeld, Uwe			Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; CAPILLARY RAREFACTION; RENAL-FUNCTION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RATS; VEGF; ANGIOGENESIS; DYSFUNCTION; HEART	Background Endothelial dysfunction is an early manifestation of cardiovascular disease (CVD) and consistently observed in patients with chronic kidney disease (CKD). We hypothesized that CKD is associated with systemic damage to the microcirculation, preceding macrovascular pathology. To assess the degree of "uremic microangiopathy", we have measured microvascular density in biopsies of the omentum of children with CKD. Patients and Methods Omental tissue was collected from 32 healthy children (0-18 years) undergoing elective abdominal surgery and from 23 age-matched cases with stage 5 CKD at the time of catheter insertion for initiation of peritoneal dialysis. Biopsies were analyzed by independent observers using either a manual or an automated imaging system for the assessment of microvascular density. Quantitative immunohistochemistry was performed for markers of autophagy and apoptosis, and for the abundance of the angiogenesis-regulating proteins VEGF-A, VEGF-R2, Angpt1 and Angpt2. Results Microvascular density was significantly reduced in uremic children compared to healthy controls, both by manual imaging with a digital microscope (median surface area 0.61% vs. 0.95%, p<0.0021 and by automated quantification (total microvascular surface area 0.89% vs. 1.17% p = 0.01). Density measured by manual imaging was significantly associated with age, height, weight and body surface area in CKD patients and healthy controls. In multivariate analysis, age and serum creatinine level were the only independent, significant predictors of microvascular density (r(2) = 0.73). There was no immunohistochemical evidence for apoptosis or autophagy. Quantitative staining showed similar expression levels of the angiogenesis regulators VEGF-A, VEGF-receptor 2 and Angpt1 (p = 0.11), but Angpt2 was significantly lower in CKD children (p = 0.01). Conclusions Microvascular density is profoundly reduced in omental biopsies of children with stage 5 CKD and associated with diminished Angpt2 signaling. Microvascular rarefaction could be an early systemic manifestation of CKD-induced cardiovascular disease.	[Burkhardt, Dorothea; Querfeld, Uwe] Charite, Dept Pediat Nephrol, Berlin, Germany; [Bartosova, Maria; Schaefer, Betti; Schmitt, Claus Peter] Heidelberg Univ, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Grabe, Niels; Lahrmann, Bernd] Heidelberg Univ, Hamamatsu Imaging & Anal TIGA Ctr, Bioquant, Heidelberg, Germany; [Nasser, Hamoud; Freise, Christian; Querfeld, Uwe] Charite, Ctr Cardiovasc Res, Berlin, Germany; [Schneider, Axel; Degenhardt, Petra] Charite, Dept Pediat Surg, Berlin, Germany; [Lingnau, Anja] Charite, Dept Pediat Urol, Berlin, Germany; [Degenhardt, Petra] Klinikum Ernst Von Bergmann, Dept Pediat Surg, Potsdam, Germany; [Ranchin, Bruno] Hop Femme Mere Enfant, Hosp Civils Lyon, Serv Nephrol Pediat & Epicime, Ctr Invest Clin 1407, Lyon, France; [Sallay, Peter] Semmelweis Univ, Dept Pediat 1, Budapest, Hungary; [Cerkauskiene, Rimante] Vilnius Univ Hosp Santariskiu Klin, Childrens Hosp, Coordinating Ctr Childrens Rare Dis, Vilnius, Lithuania; [Malina, Michal] Charles Univ Prague, Fac Med 2, Dept Pediat, Prague 5, Czech Republic; [Ariceta, Gema] Hosp Univ Vall dHebron, Serv Nefrol Pediat, Barcelona, Spain	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Klinikum Ernst von Bergmann; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Semmelweis University; Vilnius University Hospital Santariskiu Klinikos; Charles University Prague; Hospital Universitari Vall d'Hebron	Querfeld, U (corresponding author), Charite, Dept Pediat Nephrol, Berlin, Germany.; Querfeld, U (corresponding author), Charite, Ctr Cardiovasc Res, Berlin, Germany.	uwaquerfeld@charite.de	Malina, Michal/A-5037-2012; Freise, Christian/P-4285-2019; Freise, Christian/H-9892-2012; Querfeld, Uwe/AAF-6330-2020; Grabe, Niels/I-6214-2016; Grabe, Niels/AAP-6493-2020	Malina, Michal/0000-0002-9434-1521; Freise, Christian/0000-0003-2602-226X; Degenhardt, Petra/0000-0001-7506-9457; Grabe, Niels/0000-0003-1732-3706; Querfeld, Uwe/0000-0001-6783-3822	Medical Faculty of Heidelberg; European Training and Research in PD consortium, EuTriPD [287813]; Else-Kroner-Fresenius Stiftung [2011-A19]; ERA-EDTA; KfH Foundation for Preventive Medicine	Medical Faculty of Heidelberg; European Training and Research in PD consortium, EuTriPD; Else-Kroner-Fresenius Stiftung; ERA-EDTA; KfH Foundation for Preventive Medicine	BS was funded by the Medical Faculty of Heidelberg, and MB by the European Training and Research in PD consortium, EuTriPD (FP7, 287813). Christian Freise was supported by the Else-Kroner-Fresenius Stiftung (2011-A19). Further support was received from ERA-EDTA, and the KfH Foundation for Preventive Medicine.	Adair A, 2007, TRANSPLANTATION, V83, P1542, DOI 10.1097/01.tp.0000266689.93615.cd; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Amann K, 1997, AM J KIDNEY DIS, V30, P382, DOI 10.1016/S0272-6386(97)90283-3; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Baumann M, 2009, KIDNEY BLOOD PRESS R, V32, P428, DOI 10.1159/000264650; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Collins D, 2009, J GASTROINTEST SURG, V13, P1138, DOI 10.1007/s11605-009-0855-1; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; Deva R, 2011, CLIN J AM SOC NEPHRO, V6, P1866, DOI 10.2215/CJN.10321110; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Drueke TB, 2010, NAT REV NEPHROL, V6, P723, DOI 10.1038/nrneph.2010.143; Edwards-Richards A, 2014, CLIN KIDNEY J, V7, P569, DOI 10.1093/ckj/sfu106; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Feihl F, 2009, CURR HYPERTENS REP, V11, P182, DOI 10.1007/s11906-009-0033-6; Fliser D, 2011, KIDNEY INT SUPPL, V1, P6, DOI 10.1038/kisup.2011.6; Flisinski M, 2008, RENAL FAILURE, V30, P443, DOI 10.1080/08860220801985694; Franke D, 2010, NEPHROL DIAL TRANSPL, V25, P3918, DOI 10.1093/ndt/gfq300; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Hsu YJ, 2015, J VASC SURG, V62, P210, DOI 10.1016/j.jvs.2014.02.040; Jacobi J, 2006, KIDNEY INT, V69, P2013, DOI 10.1038/sj.ki.5000448; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kobayashi N, 2005, ARTERIOSCL THROM VAS, V25, P2114, DOI 10.1161/01.ATV.0000178993.13222.f2; Kom C, 2015, DEV CELL, V34, P5, DOI 10.1016/j.devcel.2015.06.004; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lockhart CJ, 2009, CLIN SCI, V116, P175, DOI 10.1042/CS20080069; Maric-Bilkan C, 2012, AM J PHYSIOL-RENAL, V302, pF308, DOI 10.1152/ajprenal.00421.2011; Mayer G, 2011, NEPHROL DIAL TRANSPL, V26, P1132, DOI 10.1093/ndt/gfq832; Norman M, 2008, ACTA PAEDIATR, V97, P1165, DOI 10.1111/j.1651-2227.2008.00904.x; Nussenzweig SC, 2015, CIRC RES, V116, P480, DOI 10.1161/CIRCRESAHA.116.303805; Ooi QL, 2011, CLIN J AM SOC NEPHRO, V6, P1872, DOI 10.2215/CJN.10291110; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Pries AR, 2014, PHYSIOLOGY, V29, P446, DOI 10.1152/physiol.00012.2014; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Sabanayagam C, 2009, AM J EPIDEMIOL, V169, P625, DOI 10.1093/aje/kwn367; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schaefer B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21344; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Shimizu A, 1997, AM J PATHOL, V151, P1231; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Shroff RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056273; Singh AK, 2008, CELL TISSUE RES, V332, P81, DOI 10.1007/s00441-007-0560-x; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Thang OHD, 2011, NEPHROL DIAL TRANSPL, V26, P3529, DOI 10.1093/ndt/gfr089; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Tran ED, 2011, MICROCIRCULATION, V18, P228, DOI 10.1111/j.1549-8719.2011.00082.x; Tsai YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135181; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377	53	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166050	10.1371/journal.pone.0166050	http://dx.doi.org/10.1371/journal.pone.0166050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846250	Green Submitted, Green Published, gold			2022-12-27	WOS:000387794600029
J	Chen, XD; Tzekov, R; Su, MY; Hong, HY; Min, W; Han, AD; Li, WS				Chen, Xiaodong; Tzekov, Radouil; Su, Mingyang; Hong, Haiyan; Min, Wang; Han, Aidong; Li, Wensheng			Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase Signaling Pathway	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; INDUCED APOPTOSIS; RHEUMATOID-ARTHRITIS; THIOREDOXIN; STRESS; PHOSPHORYLATION; DIFFERENTIATION; MECHANISMS; MIGRATION; CANCER	Abnormal survival of retinal pigment epithelium (RPE) cells contributes to the pathogenesis of proliferative vitreoretinopathy (PVR), a sight-threatening disease. In this study, we explored the effect of the anti-rheumatic agent auranofin (AF) on RPE cell survival and studied the underlying signaling mechanisms in vitro. Our results showed that AF inhibited ARPE-19 cell survival in a dose and time-dependent manner. Application of AF induced several effects: a significant decrease in total epidermal growth factor receptor (EGFR) and an increase in phosphorylated EGFR and mitogen-activated protein kinase (MAPK), including extracellular signal-regulated kinase (ERK), P38 mitogen-activated protein kinase (P38MAPK), c-Jun N-terminal kinase (JNK), c-Jun, mitogen activated protein kinase activated protein kinase 2(MAPKAPK2), and heat shock protein 27 (HSP27). AF also inhibited epidermal growth factor (EGF)-dependent cell proliferation and migration through affecting EGFR/MAPK signaling. The antioxidant N-acetylcysteine (NAC) blocked the AF-induced increase of reactive oxygen species (ROS) production, the reduction of total EGFR, and the phosphorylation of multiple nodes in EGFR/MAPK signaling pathway. P38MAPK inhibitor SB203580, but not inhibitors of EGFR (erlotinib), ERK (FR180204) and JNK (SP600125), suppressed AF-induced phosphorylation of EGFR/p38MAPK/MAPKAPK2/Hsp27. In conclusion, the ROS-dependent phosphorylation of EGFR/MAPK is an important signaling pathway for AF-induced inhibition of RPE cell survival, and AF may have the potential for treatment of abnormal survival of RPE cells in PVR.	[Chen, Xiaodong; Li, Wensheng] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Chen, Xiaodong] First Hosp Xian, Shanxi Inst Ophthalmol, Shanxi Prov Key Lab Ophthalmol, Dept Ophthalmol, Xian, Shanxi, Peoples R China; [Chen, Xiaodong; Su, Mingyang; Hong, Haiyan; Han, Aidong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Tzekov, Radouil] Univ S Florida, Dept Ophthalmol, Tampa, FL USA; [Tzekov, Radouil] Roskamp Inst, Sarasota, FL USA; [Min, Wang] Yale Univ, Sch Med, Dept Pathol, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06510 USA	Xiamen University; Xiamen University; State University System of Florida; University of South Florida; Yale University	Li, WS (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China.; Han, AD (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.	ahan@xmu.edu.cn; drlws@qq.com	chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022	Tzekov, Radouil/0000-0002-3662-9818	China Postdoctoral Science Foundation Funded Project [2015M582044]; National Natural Science Foundation of China [81570875, 31170685, 90919036]; Health Systems Young Personnel Training Projects Foundation in Fujian Province of China [2013-ZQN-JC-37]; Science and Technology Program Foundation of Xiamen City in China [3502720144044]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115148] Funding Source: NIH RePORTER	China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Systems Young Personnel Training Projects Foundation in Fujian Province of China; Science and Technology Program Foundation of Xiamen City in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study design, data collection and analysis, decision to publish, or preparation of the manuscript were supported by grants from the China Postdoctoral Science Foundation Funded Project (No.2015M582044 to XC [http://jj.chinapostdoctor.org.cn], the National Natural Science Foundation of China (No. 81570875 to WL; 31170685 and 90919036 to AH [http://www.nsfc.gov.cn] the Health Systems Young Personnel Training Projects Foundation in Fujian Province of China (No. 2013-ZQN-JC-37 to WL [http://www.fjhfpc.gov.cn] Science and Technology Program Foundation of Xiamen City in China (No. 3502720144044 to WL [http://www.xminfo.net.cn].	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Chen XD, 2014, ANTI-CANCER AGENT ME, V14, P946, DOI 10.2174/1871520614666140610102651; Chen Z, 2010, PATHOBIOLOGY, V77, P88, DOI 10.1159/000278290; Cohen-Kutner M, 2013, BIOCHEM PHARMACOL, V85, P977, DOI 10.1016/j.bcp.2013.01.003; Defoe DM, 2004, EXP EYE RES, V79, P51, DOI 10.1016/j.exer.2004.02.017; Ducournau Y, 2012, GRAEF ARCH CLIN EXP, V250, P409, DOI 10.1007/s00417-011-1797-3; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Filosto S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023240; FINKELSTEIN AE, 1976, ANN RHEUM DIS, V35, P251, DOI 10.1136/ard.35.3.251; FROSCIO M, 1988, SCAND J RHEUMATOL, V17, P281, DOI 10.3109/03009748809098797; FROSCIO M, 1987, BIOCHEM PHARMACOL, V36, P769, DOI 10.1016/0006-2952(87)90733-7; Gurgis FMS, 2014, MOL PHARMACOL, V85, P345, DOI 10.1124/mol.113.090365; He SK, 2010, INVEST OPHTH VIS SCI, V51, P543, DOI 10.1167/iovs.09-3475; Kalariya NM, 2009, EXP EYE RES, V89, P494, DOI 10.1016/j.exer.2009.05.011; Lee JS, 2006, ARCH TOXICOL, V80, P337, DOI 10.1007/s00204-005-0052-2; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li H, 2016, ONCOTARGET, V7, P3548, DOI 10.18632/oncotarget.6516; Liu J, 2000, INFLAMM RES, V49, P445, DOI 10.1007/s000110050615; Madeira JM, 2013, LIFE SCI, V92, P1072, DOI 10.1016/j.lfs.2013.04.005; Madeira J. M., 2012, Inflammopharmacology, V20, P297, DOI 10.1007/s10787-012-0149-1; MATSUBARA T, 1987, J CLIN INVEST, V79, P1440, DOI 10.1172/JCI112972; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Morescalchi F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/269787; Palma-Nicolas JP, 2008, BIOSCIENCE REP, V28, P307, DOI 10.1042/BSR20080083; Park SJ, 2005, BRIT J PHARMACOL, V146, P506, DOI 10.1038/sj.bjp.0706360; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Roder C, 2015, DRUGS R&D, V15, P13, DOI 10.1007/s40268-015-0083-y; Roduit R, 2008, APOPTOSIS, V13, P343, DOI 10.1007/s10495-008-0179-8; Samuel W, 2008, J NEUROCHEM, V106, P591, DOI 10.1111/j.1471-4159.2008.05409.x; Steindl-Kuscher K, 2011, GRAEF ARCH CLIN EXP, V249, P1195, DOI 10.1007/s00417-011-1673-1; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tamagno E, 2003, EXP NEUROL, V180, P144, DOI 10.1016/S0014-4886(02)00059-6; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Tian XY, 2012, J MOL CELL CARDIOL, V52, P237, DOI 10.1016/j.yjmcc.2011.10.013; WARD JR, 1983, ARTHRITIS RHEUM, V26, P1303, DOI 10.1002/art.1780261102; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yan F, 2007, OPHTHALMOLOGICA, V221, P244, DOI 10.1159/000101926; Zou P, 2015, ONCOTARGET, V6, P36505, DOI 10.18632/oncotarget.5364	40	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166386	10.1371/journal.pone.0166386	http://dx.doi.org/10.1371/journal.pone.0166386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846303	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600055
J	Manguso, F; Bennato, R; Lombardi, G; Riccio, E; Costantino, G; Fries, W				Manguso, Francesco; Bennato, Raffaele; Lombardi, Giovanni; Riccio, Elisabetta; Costantino, Giuseppe; Fries, Walter			Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SODIUM-PHOSPHATE ENEMAS; 5-AMINOSALICYLIC ACID; DOUBLE-BLIND; BECLOMETASONE DIPROPIONATE; CROHNS-DISEASE; 3 MG; CORTICOSTEROIDS; MESALAZINE; MANAGEMENT; REMISSION	Background and Aim We performed a systematic review and meta-analysis of all the available evidence comparing efficacy and safety of oral prolonged released beclomethasone dipropionate (BDP) to active oral controls in patients with mild-to-moderate ulcerative colitis (UC). A subgroupanalysis compared the effectiveness of BDP and 5-ASA. Methods Literature research was performed in different databases, as well as manual search to identify abstracts from international meetings with data not included in extensive publications. Experts in the field and companies involved in BDP development and manufacture were contacted to identify unpublished studies used for registration purposes. Dichotomous data were pooled to obtain odds ratio meta-analysis. Results Five randomized controlled trials that compared oral BDP 5mg/day vs. all oral active controls in treating UC were identified as eligible. Efficacy and safety have been addressed after 4-week treatment period. One study evaluated efficacy and safety of BDP vs. prednisone and 4 of BDP vs. 5-ASA. Treatment with oral BDP 5 mg/day induces a significant better clinical response compared to oral 5-ASA (OR 1.86, 95% CI = 1.23-2.82, P = 0.003). The effect is detectable even when the comparison to prednisone is added (OR 1.41, 95% CI = 1.03-1.93, P = 0.03). Data on remission indicate that the potential clinical efficacy of BDP may be better than 5-ASA (OR 1.55, 95% CI = 1.00-2.40, P = 0.05). This difference is lost when the comparison with prednisone is added (OR 1.30, 95% CI = 0.76-2.23, P = 0.34). The safety analysis showed no differences between BDP and 5-ASA (OR 0.55, 95% CI = 0.24-1.27, P = 0.16). The lack of difference is maintained even when the study with prednisone is added (OR 0.67, 95% CI = 0.44-1.01, P = 0.06). However, the trend of difference is clear and indicates a more favourable safety profile of BDP compared to 5-ASA and PD. Conclusions Oral prolonged release BDP showed a superior efficacy vs. oral 5-ASA in inducing clinical improvement of mild-to-moderate UC with a similar safety profile.	[Manguso, Francesco; Bennato, Raffaele; Lombardi, Giovanni; Riccio, Elisabetta] AORNA Cardarelli, UOSC Gastroenterol & Endoscopy, Dept Transplantat, Naples, Italy; [Costantino, Giuseppe; Fries, Walter] Univ Messina, Dept Clin & Expt Med, Clin Unit Chron Bowel Disorders, Messina, Italy	University of Messina	Manguso, F (corresponding author), AORNA Cardarelli, UOSC Gastroenterol & Endoscopy, Dept Transplantat, Naples, Italy.	manguso@alice.it	Fries, Walter/AAB-8703-2022	COSTANTINO, GIUSEPPE/0000-0003-4369-4252; FRIES, Walter/0000-0001-6159-7478; Manguso, Francesco/0000-0002-9617-7892				Abdalla MI, 2016, EXPERT OPIN PHARMACO, V17, P1549, DOI 10.1080/14656566.2016.1183648; [Anonymous], 2003, RAPR140500100; Astegiano M, 2007, BIOMED PHARMACOTHER, V61, P370, DOI 10.1016/j.biopha.2007.02.013; BANSKY G, 1987, DIS COLON RECTUM, V30, P288, DOI 10.1007/BF02556177; BARON JH, 1964, BRIT MED J, V1, P89, DOI 10.1136/bmj.1.5375.89; Bechi P, 1980, Minerva Dietol Gastroenterol, V26, P143; Borzio M, 1999, Minerva Gastroenterol Dietol, V45, P59; BOTH H, 1983, SCAND J GASTROENTERO, V18, P987, DOI 10.3109/00365528309182127; Bressler B, 2015, GASTROENTEROLOGY, V148, P1035, DOI 10.1053/j.gastro.2015.03.001; BROWN HM, 1972, BRIT MED J, V1, P585, DOI 10.1136/bmj.1.5800.585; Campieri M, 2003, ALIMENT PHARM THER, V17, P1471, DOI 10.1046/j.1365-2036.2003.01609.x; Campieri M, 1998, ALIMENT PHARM THER, V12, P361; D'Arienzo A, 1998, ITAL J GASTROENTEROL, V30, P254; D'Haens G, 2016, ALIMENT PHARM THER, V44, P1018, DOI 10.1111/apt.13803; Di Caro S, 2012, GASTROENTEROL INSIGH, V4, P28, DOI 10.4081/gi.2012.e9; Dignass A, 2012, J CROHNS COLITIS, V6, P991, DOI 10.1016/j.crohns.2012.09.002; Franze A, 1999, Minerva Gastroenterol Dietol, V45, P287; Gabbani T, 2015, EXPERT OPIN ORPHAN D, V3, P87, DOI 10.1517/21678707.2014.968125; Gionchetti P, 2014, J CROHNS COLITIS, V8, P649, DOI 10.1016/j.crohns.2013.12.001; Guslandi M, 2008, SCAND J GASTROENTERO, V43, P639, DOI 10.1080/00365520801908688; HALPERN Z, 1991, J CLIN GASTROENTEROL, V13, P38, DOI 10.1097/00004836-199102000-00009; HARRIS DM, 1975, J STEROID BIOCHEM, V6, P711, DOI 10.1016/0022-4731(75)90057-6; HARRIS DM, 1975, POSTGRAD MED J, V51, P20; HARTING JW, 1992, PHARM WEEKBLAD, V14, P275, DOI 10.1007/BF01962550; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; KUMANA CR, 1982, LANCET, V1, P579; LEVINE DS, 1987, GASTROENTEROLOGY, V92, P1037, DOI 10.1016/0016-5085(87)90980-2; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LIBRETTO SE, 1995, ARCH TOXICOL, V69, P509, DOI 10.1007/s002040050206; Manguso F, 2007, ALIMENT PHARM THER, V26, P21, DOI 10.1111/j.1365-2036.2007.03349.x; Manguso F, 2014, WORLD J GASTROENTERO, V20, P10895, DOI 10.3748/wjg.v20.i31.10895; Marshall JK, 1997, GUT, V40, P775, DOI 10.1136/gut.40.6.775; Maxwell RA, 1990, DRUG DISCOVERY CASEB, P349; MULDER CJJ, 1989, NETH J MED, V35, pS27; MULDER CJJ, 1989, NETH J MED, V35, P18; Nunes T, 2010, J CROHNS COLITIS, V4, P629, DOI 10.1016/j.crohns.2010.07.003; Papi C, 2010, DIGEST DIS SCI, V55, P2002, DOI 10.1007/s10620-009-0962-6; Pica R, 2013, J GASTROEN HEPATOL, V28, P577; RACHMILEWITZ D, 1989, BMJ-BRIT MED J, V298, P82, DOI 10.1136/bmj.298.6666.82; Rizzello F, 2001, ADV THER, V18, P261, DOI 10.1007/BF02850196; Rizzello F, 2002, ALIMENT PHARM THERAP, V16, P1109, DOI 10.1046/j.1365-2036.2002.01298.x; Romano C, 2010, J PEDIATR GASTR NUTR, V50, P385, DOI 10.1097/MPG.0b013e3181bb3457; Simondi D, 2010, REV ESP ENFERM DIG, V102, P381, DOI 10.4321/s1130-01082010000600007; Spurio FF, 2013, J GASTROINTEST LIVER, V22, P65; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Takashima S, 2014, INTERNAL MED, V53, P1315, DOI 10.2169/internalmedicine.53.1858; TRUELOVE SC, 1956, BRIT MED J, V1, P1315, DOI 10.1136/bmj.1.4979.1315; TRUELOVE SC, 1958, BRIT MED J, V2, P1072, DOI 10.1136/bmj.2.5104.1072; Tursi A, 2012, INT J COLORECTAL DIS, V27, P179, DOI 10.1007/s00384-011-1296-3; Van Assche G, 2015, AM J GASTROENTEROL, V110, P708, DOI 10.1038/ajg.2015.114; VANDERHEIDE H, 1988, J CLIN GASTROENTEROL, V10, P169, DOI 10.1097/00004836-198804000-00013; Zhao X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160500	53	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166455	10.1371/journal.pone.0166455	http://dx.doi.org/10.1371/journal.pone.0166455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846307	Green Published, gold			2022-12-27	WOS:000387794600065
J	Mendo, T; Simon, C; Green, B; Gardner, C				Mendo, Tania; Simon, Cedric; Green, Bridget; Gardner, Caleb			Spatial Variability in Condition of Southern Rock Lobsters (Jasus edwardsii) at the Start of the Tasmanian Fishing Season	PLOS ONE			English	Article							NUTRITIONAL CONDITION; RESPIRATORY RESPONSES; LIVE TRANSPORT; SURVIVAL; RESERVES	The southern rock lobster (Jasus edwardsii) industry in Australia favours red lobsters, which are usually caught in shallow waters, over paler (brindle) lobsters. This preference is driven partly by the Chinese market, where red is associated with luck and prosperity, and additionally, by the widely held perception within the industry that brindles have greater mortality rates during out of water transport than reds. Limited scientific evidence supports these industry observations; however, these studies did not evaluate the initial condition of lobsters. This study aimed first, to determine which variables better describe condition in J. edwardsii and second, to compare condition among lobsters in several sites around Tasmania at the typical time of high transport mortality. Male lobsters were collected from the South West, South East, East and North coast of Tasmania in late November/December 2014, which correspond to the start of the Tasmanian fishing season. A comprehensive condition assessment was applied by measuring tissue proximal composition, Brix index, Total Haemocyte Count, pH, haemocyanin and another 16 haemolymph parameters of interest. A useful framework to compare condition in J. edwardsii was established by first, using Brix index as a measure of nutritional condition, second, using pH, magnesium, and bicarbonate to evaluate differences in physiological condition and finally, using THC counts as a proxy for lobster health condition. Lobsters from different sites had different nutritional, physiological and health condition, consistent with industry observations, however our results indicate that some red shallow water lobsters exhibited poorer nutritional and health condition, while some deep water brindle lobsters were in good condition. Differences in condition could not be directly associated to catch depth of lobsters and was related to other spatially discrete factors which sometimes vary over distances < 3 km.	[Mendo, Tania; Simon, Cedric; Green, Bridget; Gardner, Caleb] Univ Tasmania, Fisheries & Aquaculture Ctr, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia; [Mendo, Tania] Univ St Andrews, Scottish Oceans Inst, St Andrews KY1 6LB, Fife, Scotland; [Simon, Cedric] CSIRO, Bribie Isl Res Ctr, 144 North St, Woorim 4507, Australia	University of Tasmania; University of St Andrews; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Department of Agriculture & Fisheries	Mendo, T (corresponding author), Univ Tasmania, Fisheries & Aquaculture Ctr, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia.; Mendo, T (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews KY1 6LB, Fife, Scotland.	tm96@st-andrews.ac.uk	Simon, Cedric/ABC-3830-2020; Simon, Cedric/AAX-5264-2020; Mendo, Tania/AAH-7734-2020; Gardner, Caleb/I-7086-2013	Simon, Cedric/0000-0002-7535-3332; Simon, Cedric/0000-0002-7535-3332; Mendo, Tania/0000-0003-4397-2064; Gardner, Caleb/0000-0003-0324-4337	Australian Seafood Cooperative Research Centre; Fisheries Research and Development Corporation [2014/726]; Australian Research Council's Industrial Transformation Research Program [IH120100032]; Tasmanian Department of Primary Industry, Parks, Water and the Environment	Australian Seafood Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Fisheries Research and Development Corporation; Australian Research Council's Industrial Transformation Research Program(Australian Research Council); Tasmanian Department of Primary Industry, Parks, Water and the Environment	This research was funded by the Australian Seafood Cooperative Research Centre and the Fisheries Research and Development Corporation (project number 2014/726) (http://www.seafoodcrc.com/) (http://frdc.com.au/Pages/home.aspx). The Australian Research Council's Industrial Transformation Research Program (project number IH120100032) is gratefully acknowledged for providing further financial support for two authors to present this work at the Crustacean Society and International Association of Astacology Mid-year Meeting, 19-23 July 2015 (http://www.arc.gov.au/industrial-transformation-research-programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Field and laboratory technical support was provided by Neville Barrett, Justin Hulls, Colin Fry, Keerthi Elizabeth Chinappa and Michael Porteus. Ben Lawler helped with collection of lobsters and Michael Blake of SALCO provided access to lobsters and valuable project support. The project was also supported by the Tasmanian Department of Primary Industry, Parks, Water and the Environment, especially James Parkinson. Many volunteers assisted with laboratory work and fieldwork throughout the project. We thank Dr Andrea Battison (CrustiPath) for her assistance with the analysis of haemolymph biochemistry.	Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Battison A, 2014, MOULT RECOVERY LOBST; Chandrapavan A, 2011, MAR FRESHW BEHAV PHY, V44, P21, DOI 10.1080/10236244.2010.533518; Chandrapavan A, 2009, J EXP MAR BIOL ECOL, V375, P9, DOI 10.1016/j.jembe.2009.04.021; Chandrapavan A, 2009, NEW ZEAL J MAR FRESH, V43, P537, DOI 10.1080/00288330909510020; Ciaramella MA, 2014, J CRUSTACEAN BIOL, V34, P629, DOI 10.1163/1937240X-00002262; DEFUR PL, 1990, BIOL BULL, V178, P46, DOI 10.2307/1541536; Fotedar S, 2011, J INVERTEBR PATHOL, V106, P143, DOI 10.1016/j.jip.2010.09.011; HAGERMAN L, 1983, MAR BIOL, V77, P11, DOI 10.1007/BF00393205; HAGERMAN L, 1973, Ophelia, V12, P141; Hawthorne P, 2009, EFFECTS DEEP WATER H; Huberty CJ, 2000, HDB APPL MULTIVARIAT; Jussila J, 1997, MAR FRESHWATER RES, V48, P863, DOI 10.1071/MF97216; Konosu S, 2000, SPINY LOBSTERS, P625; Linnane A, 2014, TACTICAL RES FUND AS; McLeod LE, 2004, J SHELLFISH RES, V23, P257; Morris S, 1999, COMP BIOCHEM PHYS A, V122, P299, DOI 10.1016/S1095-6433(99)00003-3; MORRITT D, 1993, COMP BIOCHEM PHYS A, V106, P19, DOI 10.1016/0300-9629(93)90032-Y; Musgrove RJB, 2000, J CRUSTACEAN BIOL, V20, P44, DOI 10.1651/0278-0372(2000)020[0044:MSITSR]2.0.CO;2; Oliver MD, 2001, MAR FRESHWATER RES, V52, P1395, DOI 10.1071/MF01030; Paterson BD, 2005, NEW ZEAL J MAR FRESH, V39, P1129, DOI 10.1080/00288330.2005.9517380; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, R FDN R LANG ENV STA; Simon CJ, 2015, PHYSIOL BIOCHEM ZOOL, V88, P266, DOI 10.1086/681000; Simon CJ, 2016, COMP BIOCHEM PHYS A, V201, P101, DOI 10.1016/j.cbpa.2016.07.001; Simon CJ, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0159671, DOI 10.1371/J0URNAL.P0NE.0159671]; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Taylor HH, 1997, MAR FRESHWATER RES, V48, P817, DOI 10.1071/MF97197; Taylor HH, 1997, MAR FRESHWATER RES, V48, P889, DOI 10.1071/MF97071; Wagner T, 2004, CAN J FISH AQUAT SCI, V61, P1066, DOI [10.1139/f04-050, 10.1139/F04-050]; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Zuur Alain F., 2009, P1	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166343	10.1371/journal.pone.0166343	http://dx.doi.org/10.1371/journal.pone.0166343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846289	Green Published, gold			2022-12-27	WOS:000387794600047
J	Smitz, MF; Witter, S; Lemiere, C; Eozenou, PHV; Lievens, T; Zaman, RU; Engelhardt, K; Hou, XH				Smitz, Marc-Francois; Witter, Sophie; Lemiere, Christophe; Eozenou, Patrick Hoang-Vu; Lievens, Tomas; Zaman, Rashid U.; Engelhardt, Kay; Hou, Xiaohui			Understanding Health Workers' Job Preferences to Improve Rural Retention in Timor-Leste: Findings from a Discrete Choice Experiment	PLOS ONE			English	Article							CHALLENGES	Background Timor-Leste built its health workforce up from extremely low levels after its war of independence, with the assistance of Cuban training, but faces challenges as the first cohorts of doctors will shortly be freed from their contracts with government. Retaining doctors, nurses and midwives in remote areas requires a good understanding of health worker preferences. Methods The article reports on a discrete choice experiment (DCE) carried out amongst 441 health workers, including 173 doctors, 150 nurses and 118 midwives. Qualitative methods were conducted during the design phase. The attributes which emerged were wages, skills upgrading/specialisation, location, working conditions, transportation and housing. Findings One of the main findings of the study is the relative lack of importance of wages for doctors, which could be linked to high intrinsic motivation, perceptions of having an already highly paid job (relative to local conditions), and/or being in a relatively early stage of their career for most respondents. Professional development provides the highest satisfaction with jobs, followed by the working conditions. Doctors with less experience, males and the unmarried are more flexible about location. For nurses and midwives, skill upgrading emerged as the most cost effective method. Conclusions The study is the first of its kind conducted in Timor-Leste. It provides policy-relevant information to balance financial and non-financial incentives for different cadres and profiles of staff. It also augments a thin literature on the preferences of working doctors (as opposed to medical students) in low and middle income countries and provides insights into the ability to instil motivation to work in rural areas, which may be influenced by rural recruitment and Cuban-style training, with its emphasis on community service.	[Smitz, Marc-Francois; Witter, Sophie; Lievens, Tomas; Zaman, Rashid U.; Engelhardt, Kay] Oxford Policy Management, Oxford, England; [Witter, Sophie] Queen Margaret Univ, Edinburgh, Midlothian, Scotland; [Lemiere, Christophe; Eozenou, Patrick Hoang-Vu; Hou, Xiaohui] World Bank, Washington, DC 20433 USA	Queen Margaret University; The World Bank	Witter, S (corresponding author), Oxford Policy Management, Oxford, England.; Witter, S (corresponding author), Queen Margaret Univ, Edinburgh, Midlothian, Scotland.	switter@qmu.ac.uk	Zaman, Rashid/AAM-5209-2020	Engelhardt, Kay/0000-0001-8141-3904; Zaman, Rashid/0000-0002-8556-4993	Australian Department of Foreign Affairs and Trade; European Commission; Multi-Donor Trust Fund	Australian Department of Foreign Affairs and Trade(Australian Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Multi-Donor Trust Fund	The authors thank the Australian Department of Foreign Affairs and Trade and the European Commission for their financial support.; Financial support for this work came from the Multi-Donor Trust Fund, which received funding from the Australian Department of Foreign Affairs and Trade and the European Commission. The authors would like to thank Eileen Sullivan, Juan Munoz, Estanislau Saldanha, Afonso Almeida, Fernanda Julia, Katie McIntosh, Sourovi De, Mahmud Hassan, Wirya Wardaya, enumerators and data management staff for contributing in various aspect of this survey. The authors are also thankful to the officials at Ministry of Health, World Bank Timor-Leste and development partners who provided invaluable support in the design and implementation of this survey.	Anderson T., 2010, SOCIAL MED, V5, P182; Anderson Tim, 2008, INT J CUBAN STUDIES, P53; Asante AD, 2014, B WORLD HEALTH ORGAN, V92, P277, DOI 10.2471/BLT.13.123141; Asante AD, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-10; Blaauw D, 2010, B WORLD HEALTH ORGAN, V88, P350, DOI 10.2471/BLT.09.072918; Cabral J, 2010, PROJECT APPRAISAL DO; Cabral J, 2013, SOC SCI MED, V96, P285, DOI 10.1016/j.socscimed.2013.07.008; Government of Timor-Leste, 2011, TIM LEST STRAT DEV P; Grobler L, 2009, COCHRANE DB SYST REV, V1, P1; Hou X, HUMAN RESOU IN PRESS; Huber J, 1996, J MARKETING RES, V33, P307, DOI 10.2307/3152127; KRAUT AI, 1975, J APPL PSYCHOL, V60, P774; Kruk ME, 2010, SOC SCI MED, V70, P89, DOI 10.1016/j.socscimed.2009.09.042; Kuhfeld W. F., 2010, MARKETING RES METHOD; KUHFELD WF, 1994, J MARKETING RES, V31, P545, DOI 10.2307/3151882; Lagarde M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-62; Lancaster K. J, 1996, J POLITICAL EC, V4, P132; Lehmann U, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-19; Mandeville KL, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-367; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Martins N, 2006, PLOS MED, V3, P1765, DOI 10.1371/journal.pmed.0030383; MCFADDEN D, 1976, ANN ECON SOC MEAS, V5, P363; Ryan M, 2012, CONDUCT DISCRETE CHO; Vujicic M, 2010, WORLD BANK HLTH NUTR, P58020; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2006, WORLD HLTH REP; World Bank, 2014, HLTH EQ FIN PROT REP; World Health Organization, 2012, STRENGTH MAN HUM RES; Ziller E., 2009, RURAL URBAN DIFFEREN	29	24	25	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165940	10.1371/journal.pone.0165940	http://dx.doi.org/10.1371/journal.pone.0165940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846242	Green Published, gold, Green Submitted			2022-12-27	WOS:000387794600024
J	Navarro-Quiroz, E; Pacheco-Lugo, L; Lorenzi, H; Diaz-Olmos, Y; Almendrales, L; Rico, E; Navarro, R; Espana-Puccini, P; Iglesias, A; Egea, E; Aroca, G				Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Lorenzi, Hernan; Diaz-Olmos, Yirys; Almendrales, Lisneth; Rico, Edwin; Navarro, Roberto; Espana-Puccini, Pierine; Iglesias, Antonio; Egea, Eduardo; Aroca, Gustavo			High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							MICRORNA EXPRESSION; NEPHRITIS; CELLS; GLOMERULONEPHRITIS; MECHANISMS; DISEASE; RNA	Renal involvement is one of the most severe manifestations of systemic lupus erythematosus (SLE). Renal biopsy is the gold standard when it comes to knowing whether a patient has lupus nephritis, and the degree of renal disease present. However, the biopsy has various complications, bleeding being the most common. Therefore, the development of alternative, non-invasive diagnostic tests for kidney disease in patients with SLE is a priority. Micro RNAs (miRNAs) are differentially expressed in various tissues, and changes in their expression have been associated with several pathological processes. The aim of this study was to identify changes in the abundance of miRNAs in plasma samples from patients with lupus nephritis that could potentially allow the diagnosis of renal damage in SLE patients. This is an observational case-control cross-sectional study, in which we characterized the differential abundance profiles of miRNAs among patients with different degrees of lupus compared with SLE patients without renal involvement and healthy control individuals. We found 89 miRNAs with changes in their abundance between lupus nephritis patients and healthy controls, and 17 miRNAs that showed significant variations between SLE patients with or without renal involvement. Validation for qPCR of a group of miRNAs on additional samples from lupus patients with or without nephritis, and from healthy individuals, showed that five miRNAs presented an average detection sensitivity of 97%, a specificity of 70.3%, a positive predictive value of 82.5%, a negative predictive value of 96% and a diagnosis efficiency of 87.9%. These results strongly suggest that miR-221- 5p, miR-380-3p, miR-556-5p, miR-758-3p and miR-3074-3p are potential diagnostic biomarkers of lupus nephritis in patients with SLE. The observed differential pattern of miRNA abundance may have functional implications in the pathophysiology of SLE renal damage.	[Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Diaz-Olmos, Yirys; Almendrales, Lisneth; Rico, Edwin; Aroca, Gustavo] Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia; [Lorenzi, Hernan] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA; [Navarro, Roberto] Univ Cooperat Colombia, Grp Genet, Santa Marta, Colombia; [Espana-Puccini, Pierine] Monomeros, Barranquilla, Colombia; [Iglesias, Antonio] Univ Nacl Colombia, Unidad Reumatol, Bogota, Colombia; [Egea, Eduardo] Univ Norte, Grp Invest Inmunol & Biol Mol, Barranquilla, Colombia; [Aroca, Gustavo] Clin Costa, Barranquilla, Colombia	J. Craig Venter Institute; Universidad Cooperativa de Colombia; Universidad Nacional de Colombia; Universidad del Norte	Navarro-Quiroz, E (corresponding author), Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia.	enavarro26@unisimonbolivar.edu.co	Aroca Martinez, Gustavo/N-9133-2013; QUIROZ, ROBERTO CARLOS NAVARRO/P-9517-2017; Quiroz, Elkin Navarro/AAB-6381-2019; Aroca, Gustavo/P-9173-2016; Navarro-Quiroz, Elkin/P-5715-2016	Aroca Martinez, Gustavo/0000-0002-9222-3257; QUIROZ, ROBERTO CARLOS NAVARRO/0000-0002-3604-3702; Quiroz, Elkin Navarro/0000-0001-7567-6409; Aroca, Gustavo/0000-0002-9222-3257; Navarro-Quiroz, Elkin/0000-0001-7567-6409; Pacheco-Lugo, Lisandro/0000-0002-9248-4596; egea, eduardo/0000-0001-7548-1257; Lorenzi, Hernan/0000-0003-0910-7894	Colciencias Codigo [125356934453]; Numero de la convocatoria [569, 0032-2013]; Programa Nacional de Ciencias Basicas	Colciencias Codigo; Numero de la convocatoria; Programa Nacional de Ciencias Basicas	This work was supported by Colciencias Codigo 125356934453, Numero de la convocatoria 569, Numero de contrato 0032-2013, Programa Nacional de Ciencias Basicas.; Research supported by Colciencias grants 125356934453.	Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Azkargorta M, 2006, PROTEOMICS, V6, pS42, DOI 10.1002/pmic.200500438; Balakrishnan I, 2014, STEM CELLS, V32, P662, DOI 10.1002/stem.1531; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Dooley MA, 1997, KIDNEY INT, V51, P1188, DOI 10.1038/ki.1997.162; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hosmer D. W., APPL LOGISTIC REGRES; Jones B, 2014, LUPUS NEPHRITIS NUCL, V10, P4, DOI [10.1038/nrneph.2013.246, DOI 10.1038/NRNEPH.2013.246]; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Korbet SM, 2000, AM J KIDNEY DIS, V35, P904, DOI 10.1016/S0272-6386(00)70262-9; Li Yajuan, 2013, Genomics Proteomics & Bioinformatics, V11, P158, DOI 10.1016/j.gpb.2013.05.003; Lu J, 2012, NEPHROLOGY, V17, P346, DOI 10.1111/j.1440-1797.2012.01573.x; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mok CC, 2005, ARTHRITIS RHEUM-US, V52, P2774, DOI 10.1002/art.21224; Mok CC, 2004, AM J MED, V117, P791, DOI 10.1016/j.amjmed.2004.04.029; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Olin AI, 2014, ARTHRITIS RHEUMATOL, V66, P397, DOI 10.1002/art.38250; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SABATINI M, 1988, P NATL ACAD SCI USA, V85, P5235, DOI 10.1073/pnas.85.14.5235; Sato N, 2011, LUPUS, V20, P1378, DOI 10.1177/0961203311415561; Soto H, 1997, NEPHROL DIAL TRANSPL, V12, P273, DOI 10.1093/ndt/12.2.273; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D	28	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166202	10.1371/journal.pone.0166202	http://dx.doi.org/10.1371/journal.pone.0166202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835701	gold, Green Published, Green Submitted			2022-12-27	WOS:000387779200032
J	Arauz, A; Morelos, E; Colin, J; Roldan, J; Barboza, MA				Arauz, Antonio; Morelos, Eugenia; Colin, Jonathan; Roldan, Javier; Barboza, Miguel A.			Comparison of Functional Outcome and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source (ESUS) vs. Cardioembolic Stroke Patients	PLOS ONE			English	Article							ISCHEMIC-STROKE; ATRIAL-FIBRILLATION; CRYPTOGENIC STROKE; DOUBLE-BLIND; MULTICENTER; PREVENTION; PROGNOSIS; REGISTRY	Background Embolic stroke of undetermined source (ESUS) recurrence and functional outcome from long-term follow-up is not well delineated. The purpose of this study is to compare these functional variables between ESUS vs. cardioembolic stroke (CS) patients. Methods We analyzed data of consecutive ESUS and CS patients from our institutional database, from January 2003 until April 2015. The endpoints were stroke recurrence, mortality and poor clinical outcome (Modified Rankin Score 3-6), at discharge, 6 months and final follow-up. Adjusted multivariate Cox analysis and Kaplan-Meier curves were used to estimate the probability of recurrence and death. Results 149 ESUS (median age 44 years) and 235 CS (median age 66 years) consecutive patients were included in the study. Median follow-up period for the entire sample was 19 months (interquartile range 6.0-45.0 months). Stroke recurrence was similar between ESUS and CS patients (5.4% vs. 9.8% respectively, p = 0.12). Death occurred in 30 CS cases (12.8%), with a cumulative probability of survival of 77%. Poor functional outcome was present in 58.3%, 54.0% and 54.9% at discharge, 6 months and final follow-up respectively in CS patients, significantly worst compared to ESUS cases (HR 3.1; CI 95% 1.96-4.68). Oral anticoagulation presents with a HR 8.01 for recurrence, and antiplatelet therapy had the highest risk for recurrence for both groups (HR 24.3). Conclusion ESUS patients are substantially younger than CS patients but have a stroke recurrence rate similar to CS patients, with a lower mortality rate, and better functional outcome on long-term follow-up.	[Arauz, Antonio; Morelos, Eugenia; Colin, Jonathan; Barboza, Miguel A.] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Stroke Clin, Mexico City, DF, Mexico; [Roldan, Javier] Inst Nacl Cardiol Ignacio Chavez, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico	Barboza, MA (corresponding author), Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Stroke Clin, Mexico City, DF, Mexico.	miguel.barboza_e@ucr.ac.cr	Barboza, Miguel/AAU-2368-2020	Barboza, Miguel/0000-0002-1037-962X	Boheringer-Ingelheim; BMS/Pfizer; Bayer	Boheringer-Ingelheim; BMS/Pfizer(Pfizer); Bayer(Bayer AG)	The authors received no specific funding for this work. However, Antonio Arauz, MD, PhD is a member of the steering committee of NAVIGATE-ESUS trial, and received speaker fees from Boheringer-Ingelheim, BMS/Pfizer and Bayer; these companies played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amarenco P, 2013, CEREBROVASC DIS, V36, P1, DOI 10.1159/000352050; Arai K, 2011, J CHILD NEUROL, V26, P1193, DOI 10.1177/0883073811408610; Arauz A, 2012, INT J STROKE, V7, P631, DOI 10.1111/j.1747-4949.2011.00641.x; Arboix A, 1998, CEREBROVASC DIS, V8, P8, DOI 10.1159/000015809; Coutts SB, 2015, INT J STROKE, V10, P282, DOI 10.1111/ijs.12439; Diener HC, 2015, INT J STROKE, V10, P1309, DOI 10.1111/ijs.12630; Favilla CG, 2015, STROKE, V46, P1210, DOI 10.1161/STROKEAHA.114.007763; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Gladstone DJ, 2014, NEW ENGL J MED, V370, P2467, DOI 10.1056/NEJMoa1311376; Grau-Olivares M, 2009, EXPERT REV NEUROTHER, V9, P1201, DOI [10.1586/ern.09.73, 10.1586/ERN.09.73]; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Ladeira F, 2015, INT J STROKE, V10, P165, DOI 10.1111/ijs.12596; Ntaios G, 2015, STROKE, V46, P2087, DOI 10.1161/STROKEAHA.115.009334; Ntaios G, 2015, STROKE, V46, P176, DOI 10.1161/STROKEAHA.114.007240; Perera KS, 2016, INT J STROKE, V11, P526, DOI 10.1177/1747493016641967; Putaala J, 2015, ANN MED, V47, P406, DOI 10.3109/07853890.2015.1057612; Putaala J, 2010, ANN NEUROL, V68, P661, DOI 10.1002/ana.22091; Sanna T, 2014, NEW ENGL J MED, V370, P2478, DOI 10.1056/NEJMoa1313600; Sharma M, 2015, INT J STROKE, V10, P36; Vallejos J, 2012, J STROKE CEREBROVASC, V21, P621, DOI 10.1016/j.jstrokecerebrovasdis.2011.02.005; Weber R, 2009, CEREBROVASC DIS, V28, P611, DOI 10.1159/000251172	24	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166091	10.1371/journal.pone.0166091	http://dx.doi.org/10.1371/journal.pone.0166091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832136	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000064
J	Minchole, E; Figueredo, AL; Omenaca, M; Panadero, C; Royo, L; Vengoechea, JJ; Fandos, S; de Pablo, F; Bello, S				Minchole, Elisa; Figueredo, Ana L.; Omenaca, Manuel; Panadero, Carolina; Royo, Laura; Vengoechea, Jose J.; Fandos, Sergio; de Pablo, Francisco; Bello, Salvador			Seasonal Influenza A H1N1 pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; PANDEMIC INFLUENZA; CLINICAL CHARACTERISTICS; INFECTION; MORTALITY; ADULTS; HOSPITALIZATION; PNEUMONIA; CHILDREN; BURDEN	Background Recent pandemics of influenza A H1N1pdm09 virus have caused severe illness, especially in young people. Very few studies on influenza A H1 N1 pdm09 in post-pandemic periods exist, and there is no information on the severity of both seasonal influenza A(H1 N1) and A (H3N2) from the same season, adjusting for potential confounders, including vaccine. Methods and Results We performed a retrospective observational study of adults hospitalized during the 2014 season with influenza A(H1N1) or A(H3N2). All patients underwent the same diagnostic and therapeutic protocol in a single hospital, including early Oseltamivir therapy. We included 234 patients: 146 (62.4%) influenza A(H1N1) and 88 (37.6%) A(H3N2). A(H1N1) patients were younger (p<0.01), developed more pneumonia (p<0.01), respiratory complications (p = 0.015), ARDS (p = 0.047), and septic shock (p = 0.049), were more frequently admitted to the ICU (p = 0.022), required IMV (p = 0.049), and were less frequently vaccinated (p = 0.008). After adjusting for age, comorbidities, time from onset of illness, and vaccine status, influenza A(H1N1) (OR, 2.525), coinfection (OR, 2.821), and no vaccination (OR, 3.086) were independent risk factors for severe disease. Conclusions Hospitalized patients with influenza A(H1 N1) were more than twice as likely to have severe influenza. They were younger and most had not received the vaccine. Our findings suggest that seasonal influenza A(H1 N1) maintains some features of pandemic viruses, and recommend wider use of vaccination in younger adult high-risk patients.	[Minchole, Elisa; Figueredo, Ana L.; Panadero, Carolina; Royo, Laura; Vengoechea, Jose J.; Fandos, Sergio; de Pablo, Francisco; Bello, Salvador] Hosp Univ Miguel Servet, Serv Neumol, Zaragoza, Spain; [Omenaca, Manuel] Hosp Univ Miguel Servet, Serv Microbiol, Zaragoza, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital	Bello, S (corresponding author), Hosp Univ Miguel Servet, Serv Neumol, Zaragoza, Spain.	sbello@salud.aragon.es		Panadero, Carolina/0000-0001-6810-0436				Adalja AA, 2011, JAMA-J AM MED ASSOC, V305, P39, DOI 10.1001/jama.2010.1888; Belongia EA, 2010, JAMA-J AM MED ASSOC, V304, P1091, DOI 10.1001/jama.2010.1277; Castilla J, 2013, CLIN INFECT DIS, V57, P167, DOI 10.1093/cid/cit194; Catania J, 2014, AM J RESP CRIT CARE, V189, P485, DOI 10.1164/rccm.201401-0066LE; Centers for Disease Control and Prevention (CDC), 2013, MMWR-MORBID MORTAL W, V62, P997; Chaves SS, 2013, J INFECT DIS, V208, P1305, DOI 10.1093/infdis/jit316; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cilloniz C, 2012, J INFECTION, V65, P223, DOI 10.1016/j.jinf.2012.04.009; Cox CM, 2012, J INFECT DIS, V206, P1350, DOI 10.1093/infdis/jis517; Dalton CB, 2010, MED J AUSTRALIA, V192, P357, DOI 10.5694/j.1326-5377.2010.tb03547.x; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Grijalva CG, 2015, JAMA-J AM MED ASSOC, V314, P1488, DOI 10.1001/jama.2015.12160; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Guihot A, 2014, AM J RESP CRIT CARE, V189, P1240, DOI 10.1164/rccm.201311-2071OC; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jimenez-Jorge S, 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20727; Kidd M, 2014, CURR OPIN PULM MED, V20, P242, DOI 10.1097/MCP.0000000000000049; Kok J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055631; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Lehners N, 2013, EMERG INFECT DIS, V19, P748, DOI [10.3201/eid1905.120034, 10.3201/eid1905.130034]; Liang W, 2012, CHINA PUBLIC HLTH, V126, P427, DOI DOI 10.1016/J; Mandelboim M, 2014, BMC INFECT DIS, V14, DOI [10.1186/1471-2334-14-346, 10.1186/s12879-014-0710-1]; Martin-Loeches I, 2011, CHEST, V139, P555, DOI 10.1378/chest.10-1396; Meningher T, 2014, INFLUENZA OTHER RESP, V8, P422, DOI 10.1111/irv.12249; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Radigan KA, 2014, AM J RESP CRIT CARE, V189, P1159, DOI 10.1164/rccm.201403-0587ED; Rahamat-Langendoen JC, 2012, J CLIN VIROL, V54, P135, DOI 10.1016/j.jcv.2012.02.010; Reed C, 2014, CLIN INFECT DIS, V59, P166, DOI 10.1093/cid/ciu285; Santa-Olalla Peralta P, 2010, EURO SURVEILL, V15, P19667; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Viasus D, 2012, CLIN MICROBIOL INFEC, V18, pE55, DOI 10.1111/j.1469-0691.2011.03753.x; Weil M, 2013, INFLUENZA OTHER RESP, V7, P838, DOI 10.1111/irv.12071; Widdowson MA, 2014, LANCET INFECT DIS, V14, P670, DOI 10.1016/S1473-3099(14)70835-7; Yap J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-12	44	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165711	10.1371/journal.pone.0165711	http://dx.doi.org/10.1371/journal.pone.0165711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832114	Green Published, Green Submitted, gold			2022-12-27	WOS:000387725000029
J	Pompeiano, A; Damiani, CR; Stefanini, S; Vernieri, P; Reyes, TH; Volterrani, M; Guglielminetti, L				Pompeiano, Antonio; Damiani, Claudia Roberta; Stefanini, Sara; Vernieri, Paolo; Reyes, Thais Huarancca; Volterrani, Marco; Guglielminetti, Lorenzo			Seedling Establishment of Tall Fescue Exposed to Long-Term Starvation Stress	PLOS ONE			English	Article							FESTUCA-ARUNDINACEA SCHREB; ABSCISIC-ACID; ALPHA-AMYLASE; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODY; GENOME PLASTICITY; SUGAR STARVATION; CEREAL SEEDS; TEMPERATURE; GERMINATION	In germinating seeds under unfavorable environmental conditions, the mobilization of stores in the cotyledons is delayed, which may result in a different modulation of carbohydrates balance and a decrease in seedling vigor. Tall fescue (Festuca arundinacea Schreb.) caryopses grown at 4 degrees C in the dark for an extended period in complete absence of nutrients, showed an unexpected ability to survive. Seedlings grown at 4 degrees C for 210 days were morphologically identical to seedlings grown at 23 degrees C for 21 days. After 400 days, seedlings grown at 4 degrees C were able to differentiate plastids to chloroplast in just few days once transferred to the light and 23 degrees C. Tall fescue exposed to prolonged period at 4 degrees C showed marked anatomical changes: cell wall thickening, undifferentiated plastids, more root hairs and less xylem lignification. Physiological modifications were also observed, in particular related to sugar content, GA and ABA levels and amylolytic enzymes pattern. The phytohormones profiles exhibited at 4 and 23 degrees C were comparable when normalized to the respective physiological states. Both the onset and the completion of germination were linked to GA and ABA levels, as well as to the ratio between these two hormones. All plants showed a sharp decline in carbohydrate content, with a consequent onset of gradual sugar starvation. This explained the slowed then full arrest in growth under both treatment regimes. The analysis of amylolytic activity showed that Ca2+ played a central role in the stabilization of several isoforms. Overall, convergence of starvation and hormone signals meet in crosstalk to regulate germination, growth and development in tall fescue.	[Pompeiano, Antonio] Global Change Res Inst CAS, Lab Ecol Plant Physiol, Brno, Czech Republic; [Damiani, Claudia Roberta] Fed Univ Grande Dourados, Dourados, Brazil; [Stefanini, Sara; Vernieri, Paolo; Reyes, Thais Huarancca; Volterrani, Marco; Guglielminetti, Lorenzo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Universidade Federal da Grande Dourados; University of Pisa	Guglielminetti, L (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	lorenzo.guglielminetti@unipi.it	Huarancca Reyes, Thais/ABI-2552-2020; Pompeiano, Antonio/A-1330-2017	Huarancca Reyes, Thais/0000-0003-2988-0980; Pompeiano, Antonio/0000-0001-7375-1014; Damiani, Claudia Roberta/0000-0003-1418-4851; GUGLIELMINETTI, LORENZO/0000-0002-0250-454X				ANCHORDOGUY TJ, 1987, CRYOBIOLOGY, V24, P324, DOI 10.1016/0011-2240(87)90036-8; Bartholomew PW, 2005, CROP SCI, V45, P529, DOI 10.2135/cropsci2005.0529; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Burns JC, 1979, ADAPTATION TALL FESC, P9; BUSH DS, 1989, J BIOL CHEM, V264, P19392; BUSH DS, 1986, PLANT PHYSIOL, V82, P566, DOI 10.1104/pp.82.2.566; Ceccarelli M, 1997, THEOR APPL GENET, V94, P309, DOI 10.1007/s001220050416; Ceccarelli M, 2002, THEOR APPL GENET, V104, P901, DOI 10.1007/s00122-001-0862-4; DANIELSON HR, 1976, CROP SCI, V16, P317, DOI 10.2135/cropsci1976.0011183X001600030001x; de Mendiburu F., 2019, AGRICOLAE STAT PROCE; Dierking RM, 2012, CROP SCI, V52, P460, DOI 10.2135/cropsci2011.03.0160; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Gianinetti A, 2007, J EXP BOT, V58, P3449, DOI 10.1093/jxb/erm198; GUGLIELMINETTI L, 1995, PLANT PHYSIOL, V109, P1069, DOI 10.1104/pp.109.3.1069; Guglielminetti L, 2000, J PLANT RES, V113, P185, DOI 10.1007/PL00013929; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Hopkins AA, 2009, AGRONOMY MONOGRAPHS, P339; HURRY VM, 1995, PLANT PHYSIOL, V109, P697, DOI 10.1104/pp.109.2.697; Ikeda A, 2002, PLANT CELL PHYSIOL, V43, P974, DOI 10.1093/pcp/pcf115; JONES RL, 1967, PLANTA, V72, P155, DOI 10.1007/BF00387479; Karssen C. M., 1986, Plant growth substances 1985. Proceedings of the 12th international conference on plant growth substances., P315; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Lu HF, 2008, AGR FOREST METEOROL, V148, P931, DOI 10.1016/j.agrformet.2008.01.004; Paparelli E, 2013, PLANT CELL, V25, P3760, DOI 10.1105/tpc.113.115519; Penfield S, 2009, P ROY SOC B-BIOL SCI, V276, P3561, DOI 10.1098/rspb.2009.0592; PERATA P, 1993, PLANTA, V191, P402, DOI 10.1007/BF00195699; PERATA P, 1992, PLANTA, V188, P611, DOI 10.1007/BF00197056; Pompeiano A, 2013, J PLANT RES, V126, P787, DOI 10.1007/s10265-013-0567-1; Qian Y. L., 2001, International Turfgrass Society Research Journal, V9, P334; R Core Team, 2013, R LANG ENV STAT COMP; Saxena P, 2014, CROP SCI, V54, P1205, DOI 10.2135/cropsci2013.08.0565; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; THOMAS H, 1995, NEW PHYTOL, V130, P125, DOI 10.1111/j.1469-8137.1995.tb01822.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; TOBIAS RB, 1992, PLANT PHYSIOL, V99, P146, DOI 10.1104/pp.99.1.146; Ufele R, 1999, ANN BOT-LONDON, V83, P577, DOI [10.1006/anbo.1999.0864, DOI 10.1006/ANBO.1999.0864]; VERNIERI P, 1989, J PLANT PHYSIOL, V134, P441, DOI 10.1016/S0176-1617(89)80007-0; WALKERSIMMONS MK, 1991, PLANT PHYSIOL, V95, P46, DOI 10.1104/pp.95.1.46; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yoshida R, 1996, PLANT PHYSIOL, V110, P997, DOI 10.1104/pp.110.3.997; Yu SM, 1999, PLANT PHYSIOL, V121, P687, DOI 10.1104/pp.121.3.687; Zhang HX, 2013, CROP SCI, V53, P240, DOI 10.2135/cropsci2012.02.0085	42	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166131	10.1371/journal.pone.0166131	http://dx.doi.org/10.1371/journal.pone.0166131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832166	Green Published, gold, Green Submitted			2022-12-27	WOS:000387725000067
J	He, YQ; Jin, M; Chen, KN; Zhang, HL; Yang, H; Zhuo, F; Zhao, DJ; Zeng, HT; Yao, XJ; Zhang, Z; Chen, L; Zhou, YP; Duan, ZJ				He, Yaqing; Jin, Miao; Chen, Kena; Zhang, Hailong; Yang, Hong; Zhuo, Fei; Zhao, Dejian; Zeng, Huatang; Yao, Xiangjie; Zhang, Zhen; Chen, Long; Zhou, Yuanping; Duan, Zhao-jun			Gastroenteritis Outbreaks Associated with the Emergence of the New GII.4 Sydney Norovirus Variant during the Epidemic of 2012/13 in Shenzhen City, China	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; UNITED-STATES; MULTIPLE OUTBREAKS; STRAIN; IDENTIFICATION; RECOMBINATION; CALICIVIRUSES; DYNAMICS	Noroviruses (NoVs) are the leading cause of gastroenteritis outbreaks in humans worldwide. Since late 2012, a new GII. 4 variant Sydney 2012 has caused a significant increase in NoV epidemics in several countries. From November of 2012 to January of 2013, three gastroenteritis outbreaks occurred in two social welfare homes (Outbreaks A and B) and a factory (Outbreak C) in Shenzhen city of China. Feces and swabs were collected for laboratory tests for causative agents. While no bacterial pathogen was identified, all three outbreaks were caused by NoVs with detection rates of 26.2% (16/61) at Outbreak A, 35.2% (38/108) at Outbreak B), and 59.3% (16/27) at Outbreaks C. For Outbreak B, 25 of the 29 symptomatic individuals (86.2%) and 13 of the 79 asymptomatic individuals (16.5%) were found NoV-positive. For Outbreak C, an asymptomatic food handler was NoV-positive. All thirteen NoV sequences from the three outbreaks were classified into genogroup II and genotype 4 (GII.4), which we identified to be the GII.4 Sydney 2012 variant. The genome of two isolates from Outbreaks A and B were recombinant with the opening reading frame (ORF) 1 of GII.4 Osaka 2007 and ORF2 and 3 of the GII.4 New Orleans. Our study indicated that the GII.4 Sydney 2012 variant emerged and caused the outbreaks in China.	[He, Yaqing; Zhou, Yuanping] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [He, Yaqing; Zhang, Hailong; Yang, Hong; Zhao, Dejian; Zeng, Huatang; Yao, Xiangjie; Zhang, Zhen; Chen, Long] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Jin, Miao; Chen, Kena; Duan, Zhao-jun] China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol & Viral Dis, Beijing, Peoples R China; [Zhuo, Fei] Shenzhen Luohu Ctr Dis Control & Prevent, Shenzhen, Peoples R China	Southern Medical University - China; Shenzhen Center for Disease Control & Prevention (SZCDC); Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhou, YP (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.; Duan, ZJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Key Lab Med Virol & Viral Dis, Beijing, Peoples R China.	yuanpingzhou@163.com; zhaojund@126.com	Chen, Long/N-4705-2019	Chen, Long/0000-0003-1110-6495	Key Project of Science and Technology - Ministry of Science and Technology of China [2012ZX10004215]; Health Industry Research - National Health and Family Planning Commission of China [201302004]; National Natural Science foundation of China [81470856]	Key Project of Science and Technology - Ministry of Science and Technology of China; Health Industry Research - National Health and Family Planning Commission of China; National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by The Key Project of Science and Technology (Grant No. 2012ZX10004215) funded by the Ministry of Science and Technology of China and the Health Industry Research (Grant No. 201302004) funded by National Health and Family Planning Commission of China to Miao Jin. The study was also supported by the National Natural Science foundation of China (Grant No. 81470856) to Yuanping Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088978; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Belliot G, 2010, J CLIN MICROBIOL, V48, P994, DOI 10.1128/JCM.01888-09; Bennett S, 2013, EURO SURVEILL, V18; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P55; Chan MCW, 2014, EMERG INFECT DIS, V20, P658, DOI [10.3201/eid2004.131457, 10.3201/eid2004.13457]; Drinka PJ, 2005, J AM GERIATR SOC, V53, P1839, DOI 10.1111/j.1532-5415.2005.53528_6.x; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Fonager J, 2013, EURO SURVEILL, V18; Fonager J, 2013, EUROSURVEILLANCE, V18, DOI DOI 10.2807/1560-7917.ES2013.18.25.20506; Green KY., 2001, FIELDS VIROLOGY, V4, P841; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Johnston CP, 2007, CLIN INFECT DIS, V45, P534, DOI 10.1086/520666; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; KAPLAN JE, 1982, ANN INTERN MED, V96, P756, DOI 10.7326/0003-4819-96-6-756; Khanna N, 2003, J HOSP INFECT, V55, P131, DOI 10.1016/S0195-6701(03)00257-3; KOBAYASHI S, 1991, EPIDEMIOL INFECT, V107, P81, DOI 10.1017/S0950268800048706; Koopmans M, 2000, J INFECT DIS, V181, pS262, DOI 10.1086/315573; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Leshem E, 2013, EMERG INFECT DIS, V19, P1231, DOI 10.3201/eid1908.130458; Lopman BA, 2004, CLIN INFECT DIS, V39, P318, DOI 10.1086/421948; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163; Mans J, 2010, J CLIN VIROL, V49, P258, DOI 10.1016/j.jcv.2010.08.011; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; Marshall JA, 2001, J MED MICROBIOL, V50, P143, DOI 10.1099/0022-1317-50-2-143; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; Mattison K, 2010, J MED VIROL, V82, P321, DOI 10.1002/jmv.21682; Meijer A, 2012, EUROSURVEILLANCE, V17, P2; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Motomura K, 2010, J VIROL, V84, P8085, DOI 10.1128/JVI.02125-09; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Ozawa K, 2007, J CLIN MICROBIOL, V45, P3996, DOI 10.1128/JCM.01516-07; Pang XLL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011599; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; My PVT, 2013, INFECT GENET EVOL, V18, P335, DOI 10.1016/j.meegid.2013.04.014; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Thongprachum A, 2014, INFECT GENET EVOL, V23, P65, DOI 10.1016/j.meegid.2014.01.030; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wang QH, 2005, EMERG INFECT DIS, V11, P1874, DOI 10.3201/eid1112.050485; Webby RJ, 2007, CLIN INFECT DIS, V44, P1026, DOI 10.1086/512807; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	55	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2016	11	11							e0165880	10.1371/journal.pone.0165880	http://dx.doi.org/10.1371/journal.pone.0165880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9OG	27829005	Green Submitted, Green Published, gold			2022-12-27	WOS:000387724300065
